data_2ml3_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ml3 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo . . . . . 0 CA--C 1.54 0.811 0 N-CA-C 114.262 0.832 . . . . 25.0 114.262 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.27 58.33 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.208 0 N-CA-C 108.362 -1.895 . . . . 25.0 108.362 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.1 p -60.29 132.77 25.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 123.219 1.485 . . . . 25.0 112.064 -170.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -101.26 -11.56 19.39 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.789 -1.096 . . . . 25.0 110.065 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.75 -151.63 14.46 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 114.735 -1.12 . . . . 25.0 112.61 177.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.2 p 73.08 158.17 0.16 Allowed Pre-proline 0 N--CA 1.496 1.854 0 C-N-CA 126.242 1.817 . . . . 25.0 110.187 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -65.68 -0.81 4.11 Favored 'Trans proline' 0 C--N 1.349 0.602 0 N-CA-C 116.465 1.679 . . . . 25.0 116.465 -175.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.58 -19.23 20.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 114.311 1.226 . . . . 25.0 114.311 -173.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.5 p -140.45 136.05 36.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 114.096 1.147 . . . . 25.0 114.096 -174.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.44 25.57 56.57 Favored Glycine 0 C--O 1.242 0.652 0 N-CA-C 117.343 1.697 . . . . 25.0 117.343 172.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.9 t -50.09 -54.58 19.51 Favored 'General case' 0 C--O 1.22 -0.468 0 O-C-N 121.15 -1.206 . . . . 25.0 113.459 -175.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -80.17 4.64 16.79 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 116.447 2.018 . . . . 25.0 116.447 -171.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 pp -142.04 168.4 19.83 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 112.915 0.709 . . . . 25.0 112.915 -174.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -61.67 130.45 45.91 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.695 0.798 . . . . 25.0 112.03 -175.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -125.23 168.67 13.15 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 116.442 2.016 . . . . 50.0 116.442 -175.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -129.72 96.9 4.36 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 105.654 -1.98 . . . . 25.0 105.654 164.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 81.2 mt -108.92 113.03 25.59 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 112.462 0.541 . . . . 25.0 112.462 -176.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -104.38 113.69 27.42 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 108.409 -0.96 . . . . 25.0 108.409 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.47 177.85 48.79 Favored Glycine 0 CA--C 1.51 -0.23 0 N-CA-C 117.331 1.692 . . . . 25.0 117.331 -174.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.2 p -77.06 168.82 19.43 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-O 122.0 0.905 . . . . 25.0 112.501 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 77.6 mt -85.63 24.61 1.19 Allowed 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 114.624 -1.171 . . . . 25.0 111.531 176.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -128.77 179.36 16.68 Favored Glycine 0 N--CA 1.467 0.703 0 N-CA-C 110.48 -1.048 . . . . 25.0 110.48 175.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.1 t -66.53 137.41 56.77 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 117.86 0.83 . . . . 25.0 111.736 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -146.46 165.68 28.67 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 122.027 -0.421 . . . . 50.0 110.88 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -116.16 121.21 41.45 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 102.67 -3.085 . . . . 25.0 102.67 170.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 46.6 mm -117.12 129.29 73.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 107.523 -1.288 . . . . 25.0 107.523 -176.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.1 mp -128.77 125.18 37.31 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 105.399 -2.075 . . . . 25.0 105.399 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.14 -35.1 24.86 Favored Glycine 0 C--O 1.255 1.453 0 N-CA-C 115.698 1.039 . . . . 25.0 115.698 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.03 -148.43 44.48 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.38 -0.914 . . . . 25.0 111.434 -178.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.96 165.23 54.8 Favored Glycine 0 C--O 1.248 1.015 0 CA-C-O 122.471 1.039 . . . . 25.0 111.705 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.31 162.69 33.3 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 114.731 -0.734 . . . . 25.0 113.488 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.9 101.0 12.48 Favored 'General case' 0 C--O 1.203 -1.343 0 N-CA-C 105.022 -2.214 . . . . 25.0 105.022 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -96.82 151.62 19.49 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 115.88 -0.6 . . . . 50.0 110.536 -170.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -110.81 103.22 11.72 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 106.552 -1.647 . . . . 25.0 106.552 171.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 43.3 mt -106.3 132.12 52.72 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 124.032 0.833 . . . . 25.0 111.064 -174.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -130.15 104.26 7.21 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 121.465 0.65 . . . . 25.0 110.959 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.98 -30.23 63.65 Favored Glycine 0 N--CA 1.466 0.635 0 N-CA-C 116.165 1.226 . . . . 25.0 116.165 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 50.3 -151.35 0.2 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 118.29 1.045 . . . . 25.0 112.857 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.06 160.51 15.02 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.413 0.894 . . . . 25.0 113.413 -175.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.83 157.02 31.73 Favored Glycine 0 C--O 1.238 0.345 0 CA-C-N 114.778 -1.101 . . . . 25.0 111.192 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -80.4 102.91 9.91 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.236 -1.024 . . . . 25.0 108.236 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -106.05 157.75 17.3 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.344 0.592 . . . . 50.0 111.249 -169.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 mp -114.96 131.9 56.75 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 106.17 -1.789 . . . . 25.0 106.17 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.5 mp -132.71 127.09 34.02 Favored 'General case' 0 C--O 1.25 1.107 0 N-CA-C 115.217 1.562 . . . . 25.0 115.217 -174.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -120.04 145.16 47.1 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 107.333 -1.358 . . . . 25.0 107.333 172.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -98.3 -39.78 3.64 Favored Glycine 0 N--CA 1.465 0.618 0 C-N-CA 120.963 -0.637 . . . . 25.0 113.715 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.97 -167.74 54.71 Favored Glycine 0 N--CA 1.465 0.632 0 N-CA-C 110.107 -1.197 . . . . 25.0 110.107 -177.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.67 143.67 29.61 Favored 'General case' 0 CA--C 1.557 1.241 0 CA-C-O 121.85 0.833 . . . . 25.0 111.959 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.35 167.43 32.68 Favored Glycine 0 C--O 1.245 0.781 0 CA-C-N 115.169 -0.923 . . . . 25.0 113.365 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.94 114.05 23.24 Favored 'General case' 0 C--O 1.208 -1.124 0 N-CA-C 104.731 -2.322 . . . . 25.0 104.731 175.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -103.48 151.76 22.46 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.915 -0.584 . . . . 50.0 109.814 -173.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -116.09 122.83 46.31 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 104.869 -2.271 . . . . 25.0 104.869 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -145.42 138.52 26.28 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 117.651 2.463 . . . . 25.0 117.651 -169.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.2 m -111.13 141.12 45.05 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-N 115.332 -0.849 . . . . 25.0 108.998 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.13 -37.74 6.62 Favored Glycine 0 N--CA 1.44 -1.069 0 N-CA-C 110.296 -1.122 . . . . 25.0 110.296 172.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.51 -169.78 54.86 Favored Glycine 0 CA--C 1.507 -0.423 0 C-N-CA 119.941 -1.124 . . . . 25.0 113.439 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -63.51 154.95 30.82 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.604 -0.939 . . . . 25.0 111.369 176.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.75 162.66 30.06 Favored Glycine 0 C--O 1.244 0.729 0 N-CA-C 109.914 -1.274 . . . . 25.0 109.914 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.04 110.99 19.33 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.056 -1.09 . . . . 25.0 108.056 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -103.97 154.53 19.56 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.569 -0.453 . . . . 50.0 112.113 -170.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.5 m -120.22 105.71 11.22 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.438 -0.578 . . . . 25.0 109.438 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -89.1 93.65 9.66 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 105.159 -2.163 . . . . 25.0 105.159 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -92.55 -30.28 15.75 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 112.888 0.699 . . . . 25.0 112.888 -166.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 63.56 156.41 0.06 Allowed 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 124.337 1.055 . . . . 25.0 112.838 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.88 -67.51 0.7 Allowed 'General case' 0 C--O 1.252 1.203 0 N-CA-C 115.896 1.813 . . . . 25.0 115.896 -170.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.8 mt -137.92 -177.69 4.93 Favored 'General case' 0 C--O 1.216 -0.663 0 O-C-N 121.523 -0.736 . . . . 25.0 109.239 -173.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -53.24 -30.14 36.41 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.709 -0.848 . . . . 25.0 108.709 170.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -76.66 4.2 9.96 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 115.391 1.626 . . . . 25.0 115.391 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -118.09 142.15 47.72 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 118.173 0.442 . . . . 25.0 111.639 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.2 t 49.28 53.27 12.93 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 122.469 1.128 . . . . 25.0 112.272 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 31.9 p-80 -137.1 174.05 11.03 Favored 'General case' 0 C--O 1.212 -0.905 0 CA-C-N 114.754 -1.112 . . . . 25.0 109.229 -174.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -126.01 143.26 51.17 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 105.754 -1.943 . . . . 25.0 105.754 173.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.6 p -133.25 170.8 10.43 Favored Pre-proline 0 C--N 1.318 -0.778 0 N-CA-C 108.122 -1.066 . . . . 25.0 108.122 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.42 -16.79 43.9 Favored 'Trans proline' 0 C--O 1.206 -1.121 0 C-N-CA 117.09 -1.473 . . . . 25.0 114.043 177.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 88.8 mt -77.83 -29.81 50.8 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 120.101 -0.64 . . . . 25.0 110.966 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.55 -178.35 34.8 Favored Glycine 0 C--O 1.219 -0.829 0 N-CA-C 110.607 -0.997 . . . . 25.0 110.607 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t -96.43 148.06 23.19 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-O 122.755 1.264 . . . . 25.0 111.1 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -134.74 28.05 3.6 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 113.639 -1.619 . . . . 25.0 107.844 176.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.34 137.72 29.74 Favored Glycine 0 C--N 1.34 0.799 0 N-CA-C 108.861 -1.696 . . . . 25.0 108.861 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -87.58 165.09 15.72 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 121.321 -1.105 . . . . 50.0 110.393 -172.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -119.18 100.23 7.2 Favored 'General case' 0 C--O 1.257 1.454 0 CA-C-O 121.352 0.596 . . . . 25.0 111.687 -171.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.8 mt -89.26 132.88 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-O 123.011 1.386 . . . . 25.0 107.951 -175.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.7 mt -83.93 -43.09 15.61 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 114.81 1.411 . . . . 25.0 114.81 -174.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -138.64 40.21 2.2 Favored 'General case' 0 C--O 1.26 1.608 0 N-CA-C 115.28 1.585 . . . . 25.0 115.28 -172.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.405 ' CE2' ' HA ' ' A' ' 89' ' ' PRO . 80.1 t80 -56.75 128.39 36.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.525 0.678 . . . . 25.0 111.914 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -97.96 108.1 44.47 Favored Pre-proline 0 N--CA 1.469 0.492 0 N-CA-C 106.911 -1.515 . . . . 25.0 106.911 175.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.405 ' HA ' ' CE2' ' A' ' 87' ' ' PHE . 93.4 Cg_endo -72.4 -4.55 15.47 Favored 'Trans proline' 0 CA--C 1.552 1.394 0 N-CA-C 115.63 1.358 . . . . 25.0 115.63 -174.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 29.7 t -95.0 -46.75 6.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.085 0.469 . . . . 25.0 109.859 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -92.15 -40.52 10.97 Favored 'General case' 0 C--O 1.245 0.867 0 N-CA-C 114.382 1.253 . . . . 25.0 114.382 -172.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -84.87 171.52 12.15 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.695 0.76 . . . . 75.0 110.079 -173.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.63 155.62 45.71 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.606 0.763 . . . . 25.0 111.32 174.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 77.9 mt -125.44 124.34 66.77 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 106.796 -1.557 . . . . 25.0 106.796 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -86.25 150.75 24.15 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 119.728 -0.789 . . . . 25.0 109.179 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.9 p -154.64 -1.6 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 115.418 -0.81 . . . . 25.0 111.674 -176.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.2 t -66.28 -51.28 59.0 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.635 0.605 . . . . 25.0 112.635 -174.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.9 -24.35 60.83 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.886 0.699 . . . . 25.0 112.886 -176.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.56 -29.35 9.23 Favored 'General case' 0 C--O 1.212 -0.872 0 N-CA-C 118.075 2.621 . . . . 25.0 118.075 -174.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -121.69 -65.21 0.24 Allowed Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.456 -0.878 . . . . 25.0 115.03 -172.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -162.26 163.55 28.08 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 117.21 0.505 . . . . 25.0 109.759 -175.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 77.8 p -114.7 -28.79 6.99 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.557 0.536 . . . . 25.0 110.647 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -103.29 120.35 6.72 Favored Glycine 0 C--O 1.239 0.431 0 N-CA-C 110.642 -0.983 . . . . 25.0 110.642 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -67.24 151.18 47.99 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 118.865 1.333 . . . . 25.0 111.597 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -97.55 -157.33 30.48 Favored Glycine 0 CA--C 1.507 -0.435 0 CA-C-N 115.141 -0.936 . . . . 25.0 112.965 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -54.91 136.74 46.87 Favored 'General case' 0 C--O 1.245 0.868 0 N-CA-C 113.954 1.094 . . . . 25.0 113.954 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 165.94 172.43 33.29 Favored Glycine 0 C--O 1.22 -0.746 0 N-CA-C 109.457 -1.457 . . . . 25.0 109.457 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -141.18 166.68 24.11 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.022 0.911 . . . . 25.0 109.194 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 56.2 34.21 23.53 Favored 'General case' 0 CA--C 1.551 1.009 0 O-C-N 124.305 1.003 . . . . 25.0 113.127 -176.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.07 38.68 59.49 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 111.132 -0.787 . . . . 25.0 111.132 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.1 t -139.99 -174.23 3.86 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.803 0.802 . . . . 25.0 113.152 -176.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 52.2 mt -114.9 150.71 35.21 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 101.127 -3.657 . . . . 25.0 101.127 174.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.93 132.45 47.98 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-O 121.357 0.598 . . . . 25.0 110.058 -175.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 32.9 m -97.02 164.85 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 115.435 -0.802 . . . . 25.0 111.533 -176.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.8 m -139.95 164.54 29.74 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 110.313 -0.255 . . . . 25.0 110.313 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.3 m -126.78 166.31 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 107.584 -1.265 . . . . 25.0 107.584 176.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 30.3 t -81.55 -56.63 3.9 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 106.961 -1.496 . . . . 25.0 106.961 173.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -161.98 -147.59 0.13 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 105.263 -2.125 . . . . 25.0 105.263 -177.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -66.64 -21.68 66.11 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.371 0.268 . . . . 25.0 110.409 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -138.68 -150.38 5.59 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 110.385 -1.086 . . . . 25.0 110.385 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.19 -155.59 0.35 Allowed 'General case' 0 C--O 1.259 1.594 0 C-N-CA 123.053 0.541 . . . . 25.0 111.049 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 54.0 mtt85 -85.19 160.75 19.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 122.017 0.913 . . . . 25.0 113.018 -172.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 12.3 p -107.8 163.83 12.77 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 106.187 -1.783 . . . . 25.0 106.187 173.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -135.01 158.05 45.36 Favored 'General case' 0 CA--C 1.51 -0.587 0 O-C-N 123.529 0.518 . . . . 25.0 112.325 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 45.2 tp -128.7 136.17 50.23 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 103.759 -2.682 . . . . 25.0 103.759 172.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -127.44 148.81 50.29 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 122.468 1.128 . . . . 25.0 110.955 -176.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 32.4 t -101.96 146.5 27.78 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 103.874 -2.639 . . . . 25.0 103.874 168.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -108.82 10.45 26.59 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.406 0.622 . . . . 25.0 109.667 -174.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -94.45 143.51 26.35 Favored 'General case' 0 C--O 1.259 1.57 0 CA-C-N 113.608 -1.633 . . . . 25.0 108.938 167.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -149.12 156.7 42.58 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.809 -0.811 . . . . 25.0 108.809 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -70.24 160.58 31.92 Favored 'General case' 0 C--O 1.217 -0.635 0 N-CA-C 107.823 -1.177 . . . . 25.0 107.823 173.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.91 -21.53 66.51 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.401 -0.592 . . . . 25.0 109.401 175.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -79.68 -3.56 47.87 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.04 0.755 . . . . 25.0 113.04 177.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.96 24.01 46.86 Favored Glycine 0 N--CA 1.466 0.66 0 C-N-CA 121.113 -0.565 . . . . 25.0 113.42 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 35.9 mt -94.8 111.71 23.47 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.628 -1.249 . . . . 25.0 107.628 176.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 42.9 p -122.42 174.17 7.2 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 118.645 -0.693 . . . . 25.0 109.474 -174.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -116.39 126.3 53.27 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.344 0.52 . . . . 25.0 111.247 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -145.77 153.82 41.36 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 107.207 -1.405 . . . . 25.0 107.207 171.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 11.7 p -145.89 145.66 20.0 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 N-CA-C 106.77 -1.567 . . . . 25.0 106.77 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -106.16 143.82 33.74 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.884 -0.784 . . . . 25.0 108.884 -175.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mp -134.46 134.35 41.44 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.514 -1.291 . . . . 25.0 107.514 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -110.8 8.88 22.55 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 119.706 1.139 . . . . 25.0 112.668 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -78.91 -10.68 85.96 Favored Glycine 0 C--O 1.243 0.695 0 C-N-CA 119.596 -1.287 . . . . 25.0 112.57 174.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 48.4 t0 49.45 64.43 1.75 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 122.946 1.355 . . . . 25.0 112.051 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -130.52 36.54 3.93 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 106.274 -1.751 . . . . 25.0 106.274 176.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.55 -33.58 71.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.718 -1.128 . . . . 25.0 108.162 174.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.92 -11.73 49.39 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 113.302 0.852 . . . . 25.0 113.302 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -119.85 1.71 11.01 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 121.671 -0.643 . . . . 25.0 112.069 -178.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 14.9 mt -72.19 148.45 45.58 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.303 -0.559 . . . . 25.0 111.433 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 83.7 p -147.45 159.37 43.79 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 106.635 -1.617 . . . . 25.0 106.635 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.59 -1.9 52.16 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 108.698 -0.852 . . . . 25.0 108.698 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -68.84 -35.68 77.25 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.536 -0.913 . . . . 25.0 108.536 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -89.15 0.08 57.02 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.786 -0.571 . . . . 25.0 110.374 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 46.3 mm -94.85 113.74 29.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 104.251 -2.499 . . . . 25.0 104.251 174.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.7 p -98.78 101.91 12.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 124.081 1.896 . . . . 25.0 111.905 -170.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -116.78 -14.17 10.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 112.983 -1.917 . . . . 25.0 109.962 173.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -81.91 28.48 0.42 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.02 1.118 . . . . 25.0 114.02 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 55.66 33.32 21.04 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.232 0.827 . . . . 25.0 113.232 177.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.78 25.07 11.47 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.179 0.991 . . . . 25.0 112.698 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -90.01 133.76 34.63 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.594 -1.262 . . . . 25.0 107.594 174.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -112.82 23.04 13.86 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.203 0.601 . . . . 25.0 111.623 -176.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.79 -32.81 71.49 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 122.098 -0.376 . . . . 25.0 111.314 176.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -104.5 -156.13 0.56 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 123.29 0.636 . . . . 25.0 110.562 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 67.09 175.08 0.25 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.046 1.338 . . . . 25.0 113.824 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 87.04 9.1 74.39 Favored Glycine 0 C--O 1.224 -0.49 0 CA-C-N 115.757 -0.656 . . . . 25.0 112.478 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -82.84 100.06 10.1 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-O 121.197 0.522 . . . . 25.0 110.722 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -126.33 149.07 49.41 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.43 0.633 . . . . 25.0 109.849 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.91 33.89 2.4 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 110.746 -0.941 . . . . 25.0 110.746 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 45.1 t -73.6 -29.55 27.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.751 -0.724 . . . . 25.0 109.418 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 19.2 tt -57.18 134.67 21.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 N-CA-C 112.84 0.681 . . . . 25.0 112.84 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 158.02 157.59 8.53 Favored Glycine 0 C--O 1.222 -0.596 0 N-CA-C 114.681 0.632 . . . . 25.0 114.681 175.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -146.08 136.35 23.82 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 123.456 0.151 . . . . 25.0 110.639 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 53.6 p -152.73 163.96 38.68 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 106.97 -1.493 . . . . 25.0 106.97 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -167.44 162.46 36.25 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 114.738 0.655 . . . . 25.0 114.738 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -133.45 80.18 58.28 Favored Pre-proline 0 N--CA 1.468 0.432 0 N-CA-C 108.832 -0.803 . . . . 25.0 108.832 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -72.82 152.79 52.94 Favored 'Trans proline' 0 C--N 1.352 0.763 0 N-CA-C 114.889 1.073 . . . . 25.0 114.889 -171.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -111.01 157.13 20.29 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.42 -0.955 . . . . 25.0 108.42 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -132.12 75.01 75.71 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 112.722 0.638 . . . . 25.0 112.722 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.49 158.72 47.5 Favored 'Trans proline' 0 C--O 1.219 -0.46 0 CA-C-O 121.11 0.379 . . . . 25.0 112.845 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.7 t -132.32 -0.5 3.65 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.611 0.72 . . . . 25.0 111.837 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 C--O 1.247 0.922 0 N-CA-C 108.808 -0.812 . . . . 25.0 108.808 178.288 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo . . . . . 0 C--O 1.241 0.628 0 N-CA-C 115.002 1.116 . . . . 25.0 115.002 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.53 75.2 0.06 OUTLIER Glycine 0 C--O 1.22 -0.779 0 N-CA-C 108.797 -1.721 . . . . 25.0 108.797 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.3 p -57.48 131.71 21.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-O 122.312 1.053 . . . . 25.0 111.59 -172.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -88.99 -15.04 35.15 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 114.616 -1.174 . . . . 25.0 110.987 -176.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -88.08 -141.03 7.23 Favored Glycine 0 CA--C 1.506 -0.499 0 C-N-CA 121.263 -0.494 . . . . 25.0 114.17 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.0 p 71.85 157.31 0.16 Allowed Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 126.854 2.061 . . . . 25.0 111.179 -176.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.464 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 37.6 Cg_exo -65.49 1.39 2.15 Favored 'Trans proline' 0 C--N 1.362 1.249 0 N-CA-C 117.358 2.022 . . . . 25.0 117.358 -178.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.9 p -62.86 -19.0 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 115.486 1.661 . . . . 25.0 115.486 -172.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.6 p -146.61 136.12 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 113.917 1.08 . . . . 25.0 113.917 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.08 29.68 14.53 Favored Glycine 0 N--CA 1.462 0.422 0 N-CA-C 116.856 1.502 . . . . 25.0 116.856 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.9 t -57.25 -65.29 0.65 Allowed 'General case' 0 C--O 1.239 0.538 0 N-CA-C 114.132 1.16 . . . . 25.0 114.132 -177.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -80.35 10.2 4.88 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 114.347 1.24 . . . . 25.0 114.347 -170.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.91 174.56 10.39 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 118.912 -0.566 . . . . 25.0 110.461 -172.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -60.52 150.27 31.96 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 118.861 0.755 . . . . 25.0 111.72 -177.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -128.12 156.22 43.18 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.588 1.329 . . . . 50.0 114.588 -175.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -137.15 94.27 2.93 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 102.851 -3.018 . . . . 25.0 102.851 163.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.0 mt -120.25 111.72 18.16 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 114.483 1.29 . . . . 25.0 114.483 -173.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -98.19 104.94 17.01 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 115.744 -0.662 . . . . 25.0 111.484 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.95 179.55 52.68 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 117.584 1.794 . . . . 25.0 117.584 -173.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.0 p -74.63 169.54 17.59 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 112.246 0.461 . . . . 25.0 112.246 -177.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 51.2 mt -89.05 14.12 11.4 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.912 0.863 . . . . 25.0 110.332 175.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.67 178.77 17.79 Favored Glycine 0 C--O 1.223 -0.56 0 N-CA-C 108.638 -1.785 . . . . 25.0 108.638 175.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.7 t -70.29 140.91 52.41 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 117.356 0.578 . . . . 25.0 111.351 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -146.15 164.35 32.5 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.784 -0.821 . . . . 50.0 108.784 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -106.35 121.76 44.88 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 102.777 -3.045 . . . . 25.0 102.777 162.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.0 mm -109.18 111.31 35.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 107.487 -1.301 . . . . 25.0 107.487 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.464 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 4.4 mp -112.34 117.51 32.67 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.609 -1.256 . . . . 25.0 107.609 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.4 -27.69 38.78 Favored Glycine 0 C--O 1.206 -1.608 0 CA-C-O 119.133 -0.815 . . . . 25.0 114.425 -176.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.6 -147.08 44.76 Favored Glycine 0 C--O 1.243 0.658 0 C-N-CA 120.152 -1.023 . . . . 25.0 111.636 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.85 177.13 53.4 Favored Glycine 0 C--O 1.242 0.623 0 N-CA-C 112.054 -0.418 . . . . 25.0 112.054 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.04 166.87 29.31 Favored Glycine 0 C--N 1.316 -0.564 0 CA-C-N 115.854 -0.173 . . . . 25.0 112.906 176.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.01 105.19 13.8 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 106.875 -1.528 . . . . 25.0 106.875 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -104.81 138.84 40.47 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.772 -0.771 . . . . 50.0 111.596 -168.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -106.33 96.11 6.24 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.094 -1.817 . . . . 25.0 106.094 173.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 45.5 mt -105.65 143.51 33.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.247 -0.433 . . . . 25.0 110.454 -172.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -136.77 107.46 6.57 Favored 'General case' 0 C--O 1.248 0.983 0 CA-C-O 121.319 0.581 . . . . 25.0 110.698 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.05 -23.47 71.6 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 117.94 -1.478 . . . . 25.0 116.649 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.4 ' HB3' ' H ' ' A' ' 41' ' ' ALA . 69.2 m-85 52.71 -159.13 0.13 Allowed 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 119.217 1.508 . . . . 25.0 111.814 -176.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.4 ' H ' ' HB3' ' A' ' 40' ' ' TYR . . . -66.73 167.63 10.9 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 121.475 -0.765 . . . . 25.0 112.728 -175.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.75 155.77 32.24 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.963 -0.855 . . . . 25.0 110.963 -177.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -83.65 97.06 8.88 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.687 -0.856 . . . . 25.0 108.687 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -98.02 161.37 13.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.273 -0.421 . . . . 50.0 111.867 -169.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mp -119.55 131.93 55.64 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 105.549 -2.019 . . . . 25.0 105.549 175.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.4 mp -130.8 125.3 33.36 Favored 'General case' 0 C--O 1.248 0.996 0 N-CA-C 115.021 1.489 . . . . 25.0 115.021 -171.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -125.86 93.2 3.77 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.005 -1.452 . . . . 25.0 109.503 177.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.33 -27.02 70.05 Favored Glycine 0 C--N 1.342 0.874 0 C-N-CA 120.898 -0.668 . . . . 25.0 114.121 -177.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.99 -172.71 46.28 Favored Glycine 0 CA--C 1.522 0.514 0 CA-C-N 118.022 0.911 . . . . 25.0 113.106 177.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.94 148.72 16.61 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.94 0.876 . . . . 25.0 113.124 -175.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.59 159.04 35.23 Favored Glycine 0 C--O 1.219 -0.814 0 N-CA-C 110.274 -1.13 . . . . 25.0 110.274 -177.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -82.01 121.94 27.17 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 107.451 -1.314 . . . . 25.0 107.451 -177.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -112.02 161.42 16.49 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 119.537 -0.268 . . . . 50.0 111.686 -172.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.72 101.1 5.75 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 105.128 -2.175 . . . . 25.0 105.128 175.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -122.7 138.12 54.71 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 114.755 1.391 . . . . 25.0 114.755 -170.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 61.0 m -103.66 145.33 30.21 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.911 -1.144 . . . . 25.0 107.911 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.78 -33.18 6.5 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.781 -0.927 . . . . 25.0 110.781 173.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.59 -173.86 52.93 Favored Glycine 0 C--O 1.239 0.414 0 O-C-N 121.54 -0.976 . . . . 25.0 112.058 -177.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -58.1 149.49 23.5 Favored 'General case' 0 C--O 1.251 1.157 0 N-CA-C 112.108 0.41 . . . . 25.0 112.108 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.26 160.56 29.26 Favored Glycine 0 C--O 1.245 0.803 0 CA-C-O 119.588 -0.562 . . . . 25.0 111.752 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.04 106.56 12.15 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.966 0.412 . . . . 25.0 110.308 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -101.05 155.29 18.07 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.603 0.716 . . . . 50.0 110.524 -171.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.4 m -121.11 125.45 47.27 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.243 -0.889 . . . . 25.0 108.701 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -112.1 130.63 55.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.802 -1.555 . . . . 25.0 106.802 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 -122.28 -27.54 4.47 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 120.051 -0.66 . . . . 25.0 112.601 -177.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 63.92 161.77 0.11 Allowed 'General case' 0 N--CA 1.476 0.856 0 O-C-N 124.725 1.265 . . . . 25.0 112.241 -173.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.22 -50.66 10.6 Favored 'General case' 0 C--O 1.247 0.972 0 N-CA-C 114.595 1.332 . . . . 25.0 114.595 -171.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.7 mt -152.31 179.56 8.43 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.08 -0.711 . . . . 25.0 109.08 -172.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -54.26 -29.21 46.18 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.749 0.785 . . . . 25.0 110.451 167.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -69.55 -1.93 10.04 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 114.715 -1.129 . . . . 25.0 113.584 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.81 147.18 37.48 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-O 121.259 0.552 . . . . 25.0 112.385 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.1 t 43.95 60.36 2.76 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 114.471 -1.24 . . . . 25.0 113.934 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 53.5 p-80 -135.12 169.07 18.01 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 115.74 -0.664 . . . . 25.0 110.18 -175.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -116.95 142.62 46.72 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 104.034 -2.58 . . . . 25.0 104.034 171.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 94.7 p -128.0 168.92 13.8 Favored Pre-proline 0 N--CA 1.471 0.602 0 N-CA-C 105.643 -1.984 . . . . 25.0 105.643 -177.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.88 -22.34 62.11 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 117.223 -1.384 . . . . 25.0 113.272 176.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.6 mt -76.71 -18.06 58.73 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.02 0.748 . . . . 25.0 113.02 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 134.99 -176.92 19.7 Favored Glycine 0 C--N 1.31 -0.905 0 N-CA-C 110.853 -0.899 . . . . 25.0 110.853 -177.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.0 t -82.31 147.47 28.86 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 115.601 1.704 . . . . 25.0 115.601 -177.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -135.66 29.89 3.19 Favored 'General case' 0 C--O 1.249 1.031 0 CA-C-N 113.619 -1.628 . . . . 25.0 107.866 173.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.57 147.23 50.64 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 114.27 -1.332 . . . . 25.0 111.957 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -86.69 165.46 16.08 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 107.518 -1.289 . . . . 50.0 107.518 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -121.42 120.12 34.06 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 110.209 -0.293 . . . . 25.0 110.209 -176.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.5 mt -99.1 128.99 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 107.76 -1.2 . . . . 25.0 107.76 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.6 mt -85.2 -46.96 10.57 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 114.929 1.455 . . . . 25.0 114.929 -169.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 42.2 p-10 -131.56 35.59 3.82 Favored 'General case' 0 C--O 1.247 0.948 0 O-C-N 121.27 -0.894 . . . . 25.0 112.751 -175.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -51.37 140.14 17.97 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.821 -1.082 . . . . 25.0 112.323 -176.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -106.84 108.04 61.32 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 108.146 -1.057 . . . . 25.0 108.146 175.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -73.73 -2.3 12.01 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 N-CA-C 115.098 1.153 . . . . 25.0 115.098 -173.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.6 t -101.82 -36.34 8.71 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-O 121.851 0.834 . . . . 25.0 110.093 178.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -98.47 -39.33 8.81 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 113.734 1.013 . . . . 25.0 113.734 -171.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -84.66 169.98 13.78 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.783 -0.573 . . . . 75.0 110.818 -172.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.55 147.81 30.5 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 120.934 -0.307 . . . . 25.0 111.341 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.0 mt -129.33 130.05 67.47 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 N-CA-C 108.284 -1.006 . . . . 25.0 108.284 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.63 139.89 30.1 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 108.507 -0.923 . . . . 25.0 108.507 173.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.7 p -133.69 -5.48 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.237 -0.892 . . . . 25.0 111.446 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.1 t -74.22 -33.08 63.25 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.422 -0.799 . . . . 25.0 111.958 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.97 -43.15 93.59 Favored 'General case' 0 C--O 1.247 0.934 0 O-C-N 121.748 -0.595 . . . . 25.0 111.656 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.16 -13.07 15.83 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 114.853 1.427 . . . . 25.0 114.853 -172.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.68 -80.55 0.25 Allowed Glycine 0 C--O 1.22 -0.753 0 N-CA-C 116.513 1.365 . . . . 25.0 116.513 -172.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -158.14 157.52 32.91 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 117.436 0.618 . . . . 25.0 112.02 -170.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.7 t -108.37 -28.01 9.64 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 123.839 0.712 . . . . 25.0 111.23 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -92.27 106.15 3.37 Favored Glycine 0 CA--C 1.5 -0.906 0 O-C-N 121.369 -0.832 . . . . 25.0 112.288 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.75 143.39 57.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.856 0.828 . . . . 25.0 110.541 -176.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.61 -154.32 30.6 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 116.012 -0.54 . . . . 25.0 114.126 -175.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -59.24 138.19 57.69 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 113.39 0.885 . . . . 25.0 113.39 -176.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 172.73 -168.55 41.62 Favored Glycine 0 C--O 1.252 1.251 0 N-CA-C 110.079 -1.208 . . . . 25.0 110.079 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -155.98 165.49 36.29 Favored 'General case' 0 C--O 1.247 0.957 0 N-CA-C 108.018 -1.105 . . . . 25.0 108.018 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 54.44 36.65 26.06 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 114.984 1.476 . . . . 25.0 114.984 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.32 40.81 32.55 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 109.72 -1.352 . . . . 25.0 109.72 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.7 t -153.74 178.47 9.84 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 117.885 0.843 . . . . 25.0 110.848 -176.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 71.5 mt -95.89 159.78 14.8 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 104.232 -2.507 . . . . 25.0 104.232 168.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.34 130.9 44.78 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 119.711 -0.796 . . . . 25.0 109.186 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.8 m -98.72 155.72 3.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 CA-C-N 115.607 -0.724 . . . . 25.0 109.505 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 97.5 p -144.03 167.01 23.38 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.405 -0.591 . . . . 25.0 109.405 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.3 m -120.52 161.98 19.64 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 N-CA-C 108.807 -0.812 . . . . 25.0 108.807 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.6 t -66.04 -51.77 55.18 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.952 -1.129 . . . . 25.0 107.952 174.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -172.04 -156.28 0.1 Allowed 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 103.261 -2.866 . . . . 25.0 103.261 -178.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -73.48 5.28 3.89 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 113.761 1.022 . . . . 25.0 113.761 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -148.86 -156.88 7.33 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 106.397 -2.681 . . . . 25.0 106.397 175.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 56.64 -164.06 0.16 Allowed 'General case' 0 CA--C 1.562 1.422 0 O-C-N 124.287 0.639 . . . . 25.0 112.527 176.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.6 mtt85 -75.09 159.22 31.94 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.788 1.033 . . . . 25.0 113.788 -170.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.76 159.69 15.11 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 104.499 -2.408 . . . . 25.0 104.499 174.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -130.95 152.05 50.69 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-O 122.564 1.173 . . . . 25.0 110.681 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 39.0 tp -126.78 117.48 22.74 Favored 'General case' 0 C--O 1.245 0.853 0 N-CA-C 103.69 -2.707 . . . . 25.0 103.69 172.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -119.74 152.25 37.49 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 111.952 0.353 . . . . 25.0 111.952 -174.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.9 t -94.45 152.65 18.42 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 104.726 -2.324 . . . . 25.0 104.726 168.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -117.32 17.55 14.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.978 0.894 . . . . 25.0 109.032 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -112.56 146.81 37.89 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 105.607 -1.997 . . . . 25.0 105.607 174.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -139.45 151.87 46.57 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.236 0.541 . . . . 25.0 110.036 -175.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -72.28 160.23 32.74 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 106.305 -1.739 . . . . 25.0 106.305 175.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.36 -18.92 65.11 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.151 0.501 . . . . 25.0 110.106 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -69.36 -8.78 49.51 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.205 0.817 . . . . 25.0 113.205 173.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.17 20.45 57.25 Favored Glycine 0 C--O 1.22 -0.726 0 C-N-CA 120.169 -1.015 . . . . 25.0 110.765 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.2 mt -106.37 119.61 39.71 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.881 -0.785 . . . . 25.0 108.881 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.8 p -116.68 174.97 5.79 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 106.132 -1.803 . . . . 25.0 106.132 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -114.95 131.68 56.82 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 118.681 0.673 . . . . 25.0 110.436 -177.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -145.98 156.86 43.79 Favored 'General case' 0 C--O 1.256 1.413 0 N-CA-C 109.323 -0.621 . . . . 25.0 109.323 166.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.8 p -146.24 141.1 21.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 106.045 -1.835 . . . . 25.0 106.045 177.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -99.13 147.78 24.74 Favored 'General case' 0 C--O 1.249 1.047 0 N-CA-C 107.699 -1.223 . . . . 25.0 107.699 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.6 mp -134.42 133.38 40.45 Favored 'General case' 0 C--O 1.206 -1.186 0 N-CA-C 103.341 -2.837 . . . . 25.0 103.341 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -110.01 13.41 23.35 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 120.051 -0.66 . . . . 25.0 110.966 -177.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -79.11 -5.9 88.95 Favored Glycine 0 C--O 1.217 -0.931 0 CA-C-N 114.809 -1.087 . . . . 25.0 112.04 172.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 14.2 t0 51.5 55.11 9.9 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 114.594 1.331 . . . . 25.0 114.594 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -128.81 46.22 2.65 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.988 -0.551 . . . . 25.0 109.536 -174.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.62 -31.91 66.71 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 113.625 0.972 . . . . 25.0 113.625 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.86 -28.74 65.91 Favored 'General case' 0 CA--C 1.554 1.106 0 O-C-N 121.482 -0.761 . . . . 25.0 111.943 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -93.64 -18.28 22.34 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 112.322 0.49 . . . . 25.0 112.322 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.5 mt -66.48 123.66 20.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 122.195 0.998 . . . . 25.0 111.486 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.45 ' C ' ' H ' ' A' ' 152' ' ' ASP . 70.9 m -137.51 164.06 29.64 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 105.522 -2.029 . . . . 25.0 105.522 177.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -71.51 10.63 0.6 Allowed 'General case' 0 C--O 1.219 -0.511 0 CA-C-O 121.225 0.536 . . . . 25.0 110.866 175.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.45 ' H ' ' C ' ' A' ' 150' ' ' SER . 46.8 t0 -72.61 -30.04 64.0 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 122.631 1.205 . . . . 25.0 110.129 177.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -94.12 8.76 40.43 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.889 -1.051 . . . . 25.0 111.65 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 39.6 mm -116.49 144.67 23.64 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 105.675 -1.972 . . . . 25.0 105.675 175.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.3 p -123.66 127.34 73.92 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 CA-C-O 122.172 0.986 . . . . 25.0 110.827 174.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.85 -30.59 5.36 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 114.379 -1.282 . . . . 25.0 109.873 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -85.42 84.25 7.69 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 115.637 1.717 . . . . 25.0 115.637 -172.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 54.75 25.24 6.33 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.759 1.763 . . . . 25.0 115.759 172.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.41 17.19 4.62 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.872 1.269 . . . . 25.0 113.514 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -98.42 125.49 43.6 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-O 121.234 0.54 . . . . 25.0 110.404 -176.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -67.24 3.09 1.31 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.469 0.914 . . . . 25.0 113.469 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.73 -15.23 63.53 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.33 0.652 . . . . 25.0 111.23 176.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.79 171.06 11.21 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 113.212 0.819 . . . . 25.0 113.212 -177.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 62.93 -170.92 0.17 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.328 1.451 . . . . 25.0 113.981 177.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 77.09 20.23 75.98 Favored Glycine 0 C--O 1.247 0.953 0 CA-C-N 115.304 -0.862 . . . . 25.0 111.15 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -124.9 109.0 12.48 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.806 -0.813 . . . . 25.0 108.806 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -127.54 150.71 49.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.313 -0.995 . . . . 25.0 108.313 -177.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -123.34 40.94 1.87 Allowed Glycine 0 CA--C 1.519 0.337 0 N-CA-C 108.961 -1.656 . . . . 25.0 108.961 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 59.5 t -94.63 -31.95 4.48 Favored 'Isoleucine or valine' 0 C--O 1.251 1.171 0 C-N-CA 122.628 0.371 . . . . 25.0 110.676 -175.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.43 130.05 16.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 CA-C-O 122.705 1.24 . . . . 25.0 113.125 -174.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 151.72 155.64 7.09 Favored Glycine 0 CA--C 1.532 1.145 0 N-CA-C 108.561 -1.815 . . . . 25.0 108.561 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -153.34 147.38 25.53 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 117.849 0.825 . . . . 25.0 110.535 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 98.2 p -149.64 164.98 33.68 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.964 -1.124 . . . . 25.0 107.964 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -175.6 -170.12 38.09 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.995 -0.621 . . . . 25.0 112.369 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -152.59 99.56 2.8 Favored Pre-proline 0 C--N 1.314 -0.963 0 N-CA-C 107.819 -1.178 . . . . 25.0 107.819 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -71.02 153.58 63.07 Favored 'Trans proline' 0 C--O 1.247 0.936 0 C-N-CA 117.05 -1.5 . . . . 25.0 113.396 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -118.79 154.0 33.56 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 106.861 -1.533 . . . . 25.0 106.861 177.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -141.98 77.44 18.44 Favored Pre-proline 0 N--CA 1.47 0.529 0 CA-C-O 121.065 0.459 . . . . 25.0 111.813 -178.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -69.76 145.97 58.77 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 117.462 -1.226 . . . . 25.0 111.666 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 13.4 t -132.36 8.89 4.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.881 0.848 . . . . 25.0 109.526 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 C--N 1.324 -0.512 0 CA-C-N 115.035 -0.984 . . . . 25.0 109.708 177.656 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo . . . . . 0 CA--C 1.53 0.295 0 CA-C-O 122.414 0.922 . . . . 25.0 114.197 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.15 62.7 0.05 OUTLIER Glycine 0 C--O 1.241 0.578 0 N-CA-C 108.47 -1.852 . . . . 25.0 108.47 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.488 HG23 ' H ' ' A' ' 7' ' ' GLY . 12.2 p -48.5 131.47 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 113.512 0.93 . . . . 25.0 113.512 -172.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -100.68 12.34 37.65 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 114.95 -1.023 . . . . 25.0 110.619 -175.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.488 ' H ' HG23 ' A' ' 5' ' ' VAL . . . -116.9 -151.39 9.45 Favored Glycine 0 N--CA 1.439 -1.117 0 CA-C-N 115.797 -0.638 . . . . 25.0 112.832 -178.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 p 71.53 157.81 0.16 Allowed Pre-proline 0 CA--C 1.555 1.166 0 C-N-CA 126.292 1.837 . . . . 25.0 110.807 -177.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -67.71 6.99 0.62 Allowed 'Trans proline' 0 C--N 1.356 0.932 0 N-CA-C 117.279 1.992 . . . . 25.0 117.279 -176.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.1 p -67.99 -14.43 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 N-CA-C 114.779 1.4 . . . . 25.0 114.779 -173.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.1 p -150.24 144.41 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.269 0 N-CA-C 115.116 1.525 . . . . 25.0 115.116 -175.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.32 17.39 79.69 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 117.726 1.85 . . . . 25.0 117.726 169.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.2 t -50.45 -53.38 30.09 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 114.037 1.125 . . . . 25.0 114.037 -171.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -83.07 8.16 13.74 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 116.541 2.052 . . . . 25.0 116.541 -173.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -141.27 171.9 13.43 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 120.754 -1.216 . . . . 25.0 113.541 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -58.76 127.37 31.87 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.719 0.771 . . . . 25.0 112.478 -174.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -123.75 166.68 15.15 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 113.351 0.871 . . . . 50.0 113.351 -175.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -131.29 95.53 3.8 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 103.349 -2.834 . . . . 25.0 103.349 163.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 64.1 mt -102.99 128.7 49.72 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.15 0.5 . . . . 25.0 110.375 -177.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -124.67 116.04 21.74 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.818 0.818 . . . . 25.0 109.911 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.49 -177.69 49.55 Favored Glycine 0 N--CA 1.462 0.397 0 N-CA-C 116.867 1.507 . . . . 25.0 116.867 -174.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.8 p -84.52 172.9 11.26 Favored 'General case' 0 C--O 1.248 0.982 0 C-N-CA 124.838 1.255 . . . . 25.0 113.467 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.1 mt -87.94 36.56 0.77 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.262 0.553 . . . . 25.0 110.25 171.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -144.19 176.18 23.58 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 107.91 -2.076 . . . . 25.0 107.91 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.5 t -65.57 138.01 57.76 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 112.76 0.652 . . . . 25.0 112.76 -177.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -146.77 164.34 33.1 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.717 -0.674 . . . . 50.0 110.527 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -109.43 114.38 27.98 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 105.202 -2.148 . . . . 25.0 105.202 163.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 40.3 mm -104.1 115.64 46.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 106.764 -1.569 . . . . 25.0 106.764 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 9.8 mp -107.5 127.77 53.91 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 106.484 -1.673 . . . . 25.0 106.484 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.66 -33.08 8.69 Favored Glycine 0 C--N 1.313 -0.724 0 CA-C-O 119.297 -0.724 . . . . 25.0 112.474 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.58 -146.06 49.82 Favored Glycine 0 C--O 1.256 1.47 0 CA-C-N 118.745 1.273 . . . . 25.0 111.996 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.75 168.13 54.1 Favored Glycine 0 C--O 1.248 1.007 0 O-C-N 122.601 -0.353 . . . . 25.0 113.286 -176.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.59 169.13 35.17 Favored Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 111.581 -0.608 . . . . 25.0 111.581 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.95 118.93 25.73 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.51 -1.292 . . . . 25.0 107.51 176.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -116.57 148.47 40.86 Favored 'General case' 0 CA--C 1.511 -0.532 0 O-C-N 121.335 -0.853 . . . . 50.0 111.602 -171.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -104.8 107.38 18.32 Favored 'General case' 0 C--O 1.249 1.054 0 N-CA-C 106.42 -1.696 . . . . 25.0 106.42 171.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 64.3 mt -112.56 133.77 54.44 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 121.99 -0.444 . . . . 25.0 111.008 -175.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -131.93 107.06 8.45 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 121.449 0.642 . . . . 25.0 110.778 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.37 -26.79 50.63 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-O 119.023 -0.876 . . . . 25.0 115.095 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 51.48 -152.15 0.22 Allowed 'General case' 0 C--O 1.244 0.815 0 CA-C-N 117.716 0.758 . . . . 25.0 111.782 -175.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.37 164.29 16.47 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.768 1.025 . . . . 25.0 113.768 -175.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.22 155.43 31.69 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 114.853 -1.067 . . . . 25.0 110.859 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -79.62 102.49 8.94 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 106.665 -1.605 . . . . 25.0 106.665 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -104.85 155.24 19.09 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 121.097 0.475 . . . . 50.0 111.779 -173.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 mp -111.66 134.27 53.34 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 105.87 -1.9 . . . . 25.0 105.87 174.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.5 mp -131.73 117.63 18.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.577 0.703 . . . . 25.0 110.724 -174.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -118.14 89.94 3.23 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.978 -1.01 . . . . 25.0 109.663 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.31 -31.59 74.27 Favored Glycine 0 N--CA 1.468 0.809 0 N-CA-C 116.92 1.528 . . . . 25.0 116.92 -172.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.9 -163.94 51.33 Favored Glycine 0 C--O 1.243 0.705 0 O-C-N 121.864 -0.786 . . . . 25.0 111.269 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.21 161.53 19.09 Favored 'General case' 0 C--O 1.248 1.009 0 C-N-CA 123.051 0.541 . . . . 25.0 109.798 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.93 161.4 32.23 Favored Glycine 0 C--O 1.248 0.991 0 CA-C-O 118.941 -0.921 . . . . 25.0 111.209 177.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -80.85 121.19 25.65 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 105.785 -1.932 . . . . 25.0 105.785 177.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -111.51 152.35 27.6 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.343 -0.844 . . . . 50.0 109.855 -177.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -118.86 119.1 33.37 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 105.742 -1.948 . . . . 25.0 105.742 177.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -141.65 134.74 29.12 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 115.159 1.54 . . . . 25.0 115.159 -168.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.5 m -103.38 141.51 35.82 Favored 'General case' 0 C--O 1.249 1.032 0 N-CA-C 107.229 -1.397 . . . . 25.0 107.229 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.21 -37.36 5.97 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 108.442 -1.863 . . . . 25.0 108.442 175.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.84 -171.11 55.14 Favored Glycine 0 C--O 1.248 1.003 0 C-N-CA 120.626 -0.797 . . . . 25.0 111.859 -178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -65.73 157.09 31.12 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 117.498 0.649 . . . . 25.0 110.061 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.46 164.86 32.0 Favored Glycine 0 C--O 1.245 0.808 0 CA-C-N 115.606 -0.725 . . . . 25.0 112.656 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.15 96.25 9.84 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 123.593 0.757 . . . . 25.0 110.319 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -90.71 159.89 16.12 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 123.462 0.705 . . . . 50.0 112.066 -170.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.1 m -125.51 125.43 43.24 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.797 -0.638 . . . . 25.0 109.385 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -114.68 89.15 3.03 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.398 -0.964 . . . . 25.0 108.398 177.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -88.84 -34.48 17.0 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 119.321 -0.371 . . . . 25.0 111.735 -175.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 66.74 160.82 0.15 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.542 1.137 . . . . 25.0 111.632 -173.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -90.83 -42.88 10.39 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 116.196 1.925 . . . . 25.0 116.196 -166.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.3 mt -140.65 170.49 15.68 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.139 0.792 . . . . 25.0 113.139 -172.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.99 -25.19 43.07 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 123.751 0.82 . . . . 25.0 110.914 175.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -79.12 -12.13 59.99 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 115.112 -0.949 . . . . 25.0 112.906 -178.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -81.73 139.55 34.81 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.412 -0.805 . . . . 25.0 112.911 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.4 t 45.91 40.06 6.27 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 116.52 2.045 . . . . 25.0 116.52 171.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -107.37 170.09 8.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.239 -1.346 . . . . 25.0 110.964 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -124.23 146.66 48.59 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 106.13 -1.804 . . . . 25.0 106.13 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 87.9 p -142.37 168.64 12.89 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 108.613 -0.884 . . . . 25.0 108.613 -177.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -61.04 -27.03 83.98 Favored 'Trans proline' 0 CA--C 1.553 1.44 0 C-N-CA 117.631 -1.112 . . . . 25.0 111.566 175.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.4 mt -65.6 -32.29 73.79 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.861 0.689 . . . . 25.0 112.861 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.53 -174.48 35.65 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 109.974 -1.25 . . . . 25.0 109.974 -176.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.8 t -105.55 144.67 31.98 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.407 1.099 . . . . 25.0 112.74 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -123.82 16.68 9.42 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.027 -1.442 . . . . 25.0 108.964 177.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -62.0 140.94 47.06 Favored Glycine 0 C--N 1.335 0.524 0 CA-C-N 115.645 -0.707 . . . . 25.0 112.649 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -87.03 170.68 11.33 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 117.858 0.829 . . . . 50.0 113.057 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.04 98.36 5.95 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.518 -0.765 . . . . 25.0 110.799 -172.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.2 mt -89.65 133.02 32.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 107.837 -1.171 . . . . 25.0 107.837 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 76.8 mt -85.5 -49.06 8.37 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 115.323 1.601 . . . . 25.0 115.323 -171.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -131.13 36.04 3.87 Favored 'General case' 0 C--O 1.247 0.953 0 CA-C-O 121.458 0.647 . . . . 25.0 112.695 -173.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -53.78 131.59 39.82 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.261 -0.882 . . . . 25.0 112.263 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -103.59 105.66 48.4 Favored Pre-proline 0 C--O 1.238 0.474 0 N-CA-C 108.185 -1.042 . . . . 25.0 108.185 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.78 -9.68 26.92 Favored 'Trans proline' 0 C--N 1.35 0.611 0 N-CA-C 116.119 1.546 . . . . 25.0 116.119 -173.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.1 t -95.9 -36.87 10.94 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.27 -0.572 . . . . 25.0 109.774 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -95.62 -38.02 10.58 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 114.001 1.111 . . . . 25.0 114.001 -173.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -87.77 172.41 9.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.403 0.62 . . . . 75.0 110.478 -173.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -145.08 148.81 34.08 Favored 'General case' 0 C--O 1.252 1.199 0 CA-C-N 116.084 -0.507 . . . . 25.0 111.739 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 85.7 mt -129.09 133.07 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 108.486 -0.931 . . . . 25.0 108.486 -176.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -85.83 149.03 25.53 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 121.694 0.759 . . . . 25.0 109.122 173.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.0 p -146.25 -13.03 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 O-C-N 121.641 -0.662 . . . . 25.0 112.75 176.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.1 t -63.48 -39.95 95.81 Favored 'General case' 0 C--O 1.219 -0.524 0 O-C-N 121.565 -0.709 . . . . 25.0 111.432 -174.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.78 -8.61 59.57 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-N 115.398 -0.819 . . . . 25.0 112.661 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.7 mt -106.18 -29.64 9.72 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.815 0.672 . . . . 25.0 112.815 -174.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.39 -71.6 0.01 OUTLIER Glycine 0 N--CA 1.465 0.574 0 N-CA-C 117.598 1.799 . . . . 25.0 117.598 -176.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -144.96 158.23 43.88 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.794 -0.817 . . . . 25.0 108.794 -170.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 41.0 t -113.55 -28.74 7.4 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 123.651 0.594 . . . . 25.0 112.286 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -100.39 119.6 6.57 Favored Glycine 0 N--CA 1.472 1.054 0 C-N-CA 121.495 -0.383 . . . . 25.0 112.323 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.29 146.4 34.36 Favored 'General case' 0 C--O 1.245 0.853 0 N-CA-C 114.065 1.135 . . . . 25.0 114.065 -174.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -95.86 -151.95 28.65 Favored Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.824 -0.703 . . . . 25.0 114.26 -177.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -59.51 131.73 51.85 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 122.446 1.117 . . . . 25.0 111.639 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 160.38 170.44 24.97 Favored Glycine 0 C--O 1.24 0.476 0 N-CA-C 107.573 -2.211 . . . . 25.0 107.573 -179.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -148.22 167.73 24.35 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 118.299 1.05 . . . . 25.0 109.4 -177.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 62.98 38.6 10.94 Favored 'General case' 0 C--O 1.248 1.011 0 C-N-CA 124.518 1.127 . . . . 25.0 111.801 -174.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 65.82 44.18 92.56 Favored Glycine 0 C--O 1.242 0.629 0 N-CA-C 109.938 -1.265 . . . . 25.0 109.938 177.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.7 t -151.58 179.76 8.1 Favored 'General case' 0 C--O 1.212 -0.873 0 O-C-N 122.391 -0.476 . . . . 25.0 111.18 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 85.1 mt -106.8 167.02 10.16 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 103.855 -2.646 . . . . 25.0 103.855 173.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.54 131.17 42.88 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 119.597 1.09 . . . . 25.0 110.21 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 18.6 m -95.44 163.47 2.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.426 -0.806 . . . . 25.0 109.838 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 80.0 p -149.03 160.09 43.63 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.538 -0.726 . . . . 25.0 110.6 -177.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 28.0 m -122.44 165.16 18.71 Favored 'Isoleucine or valine' 0 C--O 1.252 1.221 0 N-CA-C 109.727 -0.471 . . . . 25.0 109.727 -177.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.3 t -76.28 -50.75 13.55 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 122.22 1.01 . . . . 25.0 109.682 176.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -162.18 -152.77 0.25 Allowed 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 103.753 -2.684 . . . . 25.0 103.753 -176.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -73.31 -6.19 44.47 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 119.211 0.914 . . . . 25.0 110.63 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -148.21 -146.68 4.38 Favored Glycine 0 C--O 1.247 0.958 0 N-CA-C 109.922 -1.271 . . . . 25.0 109.922 174.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.25 -152.55 0.39 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.051 0.541 . . . . 25.0 112.416 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -75.71 162.37 28.28 Favored 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 113.919 1.081 . . . . 25.0 113.919 -171.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.61 158.0 21.38 Favored 'General case' 0 C--O 1.213 -0.851 0 N-CA-C 105.978 -1.86 . . . . 25.0 105.978 175.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -129.66 144.57 51.34 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 124.12 0.887 . . . . 25.0 111.419 175.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 49.4 tp -115.41 122.77 46.83 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 102.778 -3.045 . . . . 25.0 102.778 173.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -121.59 155.29 35.38 Favored 'General case' 0 C--O 1.211 -0.957 0 CA-C-O 121.39 0.614 . . . . 25.0 110.411 -173.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 41.0 t -92.04 152.57 19.91 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.49 -1.3 . . . . 25.0 107.49 171.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -123.01 19.17 10.05 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 108.539 -0.912 . . . . 25.0 108.539 175.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -118.96 139.84 51.0 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 105.223 -2.14 . . . . 25.0 105.223 170.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -139.25 165.08 28.13 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.528 0.68 . . . . 25.0 110.231 -177.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -85.68 163.96 17.95 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.021 -1.474 . . . . 25.0 107.021 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.31 -24.41 67.27 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 108.116 -1.068 . . . . 25.0 108.116 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -74.86 -5.55 44.21 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.432 -0.804 . . . . 25.0 112.472 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.75 1.23 83.06 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 120.33 -0.938 . . . . 25.0 111.811 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.8 mt -75.74 133.99 40.59 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.417 -0.586 . . . . 25.0 109.417 175.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 88.1 p -144.44 -172.71 3.85 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 106.199 -1.778 . . . . 25.0 106.199 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -131.4 141.35 49.84 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 121.293 -0.163 . . . . 25.0 110.614 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -154.45 158.81 40.52 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 106.99 -1.485 . . . . 25.0 106.99 166.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.2 p -145.23 144.37 21.53 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 N-CA-C 108.247 -1.02 . . . . 25.0 108.247 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -105.36 136.67 44.48 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 108.453 -0.943 . . . . 25.0 108.453 -177.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.1 mp -134.03 129.8 36.62 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 106.957 -1.497 . . . . 25.0 106.957 -177.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -90.96 -1.75 57.79 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 119.224 -0.99 . . . . 25.0 112.482 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -66.35 -21.24 70.23 Favored Glycine 0 C--O 1.242 0.607 0 N-CA-C 115.139 0.816 . . . . 25.0 115.139 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 29.4 t0 53.14 59.11 4.65 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 123.626 1.679 . . . . 25.0 111.324 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -120.98 41.0 3.42 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 112.217 -2.265 . . . . 25.0 107.711 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.36 -35.39 75.57 Favored 'General case' 0 C--O 1.214 -0.796 0 CA-C-N 114.961 -1.018 . . . . 25.0 113.511 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.17 -29.42 62.83 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 118.232 0.469 . . . . 25.0 110.794 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -85.21 -13.22 50.61 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 112.8 0.667 . . . . 25.0 112.8 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 14.5 mt -69.87 128.2 35.55 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.94 0.719 . . . . 25.0 112.94 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 34.4 m -138.59 161.65 36.57 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.34 -0.985 . . . . 25.0 108.34 171.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.92 4.93 5.69 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 109.5 -0.556 . . . . 25.0 109.5 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -66.75 -30.74 71.04 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.684 0.615 . . . . 25.0 110.451 177.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -91.63 -4.0 55.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.129 0.49 . . . . 25.0 111.338 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 48.2 mm -94.02 126.26 46.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 106.542 -1.651 . . . . 25.0 106.542 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.2 p -103.43 114.57 43.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 122.113 0.958 . . . . 25.0 110.827 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -156.18 -9.17 0.11 Allowed 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.729 1.751 . . . . 25.0 115.729 -177.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -88.18 71.93 9.16 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 118.855 0.752 . . . . 25.0 111.264 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 56.49 21.15 5.36 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.27 1.028 . . . . 25.0 113.347 -178.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 53.84 38.33 28.41 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.756 -0.656 . . . . 25.0 111.415 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -123.26 124.8 43.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.36 0.6 . . . . 25.0 111.332 -178.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.09 -4.28 28.02 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.726 -0.67 . . . . 25.0 112.303 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.34 -13.01 61.03 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.644 -0.502 . . . . 25.0 109.644 174.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.24 -176.31 6.26 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 122.727 0.411 . . . . 25.0 110.497 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 58.85 -162.45 0.24 Allowed 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.201 -1.363 . . . . 25.0 113.045 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.15 22.04 77.05 Favored Glycine 0 C--N 1.336 0.578 0 N-CA-C 110.945 -0.862 . . . . 25.0 110.945 -175.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -112.99 93.85 4.62 Favored 'General case' 0 C--O 1.246 0.875 0 C-N-CA 123.673 0.789 . . . . 25.0 110.535 -176.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -128.84 145.57 51.17 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 109.148 -0.686 . . . . 25.0 109.148 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -119.35 24.08 8.28 Favored Glycine 0 N--CA 1.462 0.424 0 N-CA-C 111.368 -0.693 . . . . 25.0 111.368 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 44.6 t -71.59 -30.15 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 122.083 0.944 . . . . 25.0 109.44 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.49 134.58 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 122.196 0.998 . . . . 25.0 109.211 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 154.81 152.14 6.05 Favored Glycine 0 C--O 1.242 0.611 0 CA-C-N 115.393 -0.821 . . . . 25.0 112.992 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -148.38 123.62 10.21 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.355 -0.609 . . . . 25.0 109.355 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 56.2 p -151.97 160.14 43.57 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.316 -0.994 . . . . 25.0 108.316 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 166.06 -172.8 41.52 Favored Glycine 0 C--N 1.319 -0.374 0 C-N-CA 121.252 -0.499 . . . . 25.0 112.161 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -138.99 109.3 7.67 Favored Pre-proline 0 C--O 1.244 0.766 0 N-CA-C 107.943 -1.132 . . . . 25.0 107.943 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.92 164.48 31.54 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 117.655 -1.097 . . . . 25.0 113.266 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -128.52 156.03 43.93 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.531 -0.759 . . . . 25.0 109.124 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -132.01 87.74 43.37 Favored Pre-proline 0 C--O 1.243 0.733 0 N-CA-C 108.912 -0.773 . . . . 25.0 108.912 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -71.29 156.18 59.35 Favored 'Trans proline' 0 C--N 1.353 0.8 0 N-CA-C 113.893 0.689 . . . . 25.0 113.893 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 11.8 t -123.3 -11.49 7.93 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.286 0.565 . . . . 25.0 110.927 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 10.1 p . . . . . 0 C--O 1.235 0.342 0 N-CA-C 107.654 -1.239 . . . . 25.0 107.654 177.341 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo . . . . . 0 N--CA 1.472 0.233 0 N-CA-C 113.503 0.54 . . . . 25.0 113.503 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.41 56.82 0.01 OUTLIER Glycine 0 C--O 1.225 -0.416 0 O-C-N 121.921 -0.487 . . . . 25.0 112.023 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.416 HG23 ' H ' ' A' ' 7' ' ' GLY . 7.2 p -64.42 137.71 24.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 122.027 0.917 . . . . 25.0 111.287 -176.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -105.66 -4.53 20.94 Favored 'General case' 0 C--O 1.242 0.661 0 O-C-N 121.742 -0.599 . . . . 25.0 110.849 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.416 ' H ' HG23 ' A' ' 5' ' ' VAL . . . -84.99 -141.54 5.51 Favored Glycine 0 C--O 1.221 -0.692 0 C-N-CA 121.492 -0.385 . . . . 25.0 113.384 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.0 p 69.78 157.8 0.15 Allowed Pre-proline 0 N--CA 1.485 1.31 0 C-N-CA 125.413 1.485 . . . . 25.0 111.61 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -72.84 3.07 4.7 Favored 'Trans proline' 0 C--N 1.353 0.774 0 N-CA-C 116.46 1.677 . . . . 25.0 116.46 -177.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.4 p -67.17 -18.15 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 116.196 1.925 . . . . 25.0 116.196 -170.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.4 p -148.27 144.28 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 CA-C-N 119.222 0.919 . . . . 25.0 113.39 -176.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.29 15.59 80.77 Favored Glycine 0 C--N 1.333 0.379 0 N-CA-C 117.18 1.632 . . . . 25.0 117.18 174.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.3 t -52.64 -48.68 66.25 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.887 1.069 . . . . 25.0 113.887 -171.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -77.72 3.82 13.11 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 115.198 1.555 . . . . 25.0 115.198 -173.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.93 168.82 18.99 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.903 1.075 . . . . 25.0 113.903 -177.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.62 129.39 41.69 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.573 0.583 . . . . 25.0 112.573 -175.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -128.52 159.88 34.07 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 115.451 1.649 . . . . 50.0 115.451 -174.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -112.86 118.1 33.97 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 104.529 -2.397 . . . . 25.0 104.529 162.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.2 mt -121.14 85.82 2.47 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.956 0.884 . . . . 25.0 111.627 -173.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -90.01 110.64 21.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.296 -0.865 . . . . 25.0 109.984 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.02 170.45 43.42 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 116.181 1.232 . . . . 25.0 116.181 -176.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.2 p -71.81 174.89 6.27 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.753 0.787 . . . . 25.0 112.989 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 73.6 mt -86.13 18.6 3.01 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.099 -0.955 . . . . 25.0 111.193 176.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.66 176.35 16.06 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.402 -1.079 . . . . 25.0 110.402 176.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.4 t -70.73 136.63 49.06 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 117.649 0.725 . . . . 25.0 110.517 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -143.51 159.32 42.64 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 120.903 0.382 . . . . 50.0 110.044 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -95.96 131.12 42.66 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 102.959 -2.978 . . . . 25.0 102.959 161.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.8 mm -121.36 121.9 65.92 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 N-CA-C 105.497 -2.038 . . . . 25.0 105.497 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.5 tt -123.45 124.0 41.92 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.066 -1.087 . . . . 25.0 108.066 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.3 -38.27 11.24 Favored Glycine 0 CA--C 1.502 -0.722 0 C-N-CA 119.947 -1.12 . . . . 25.0 113.102 -177.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 72.19 -147.25 40.73 Favored Glycine 0 C--O 1.254 1.364 0 CA-C-N 118.983 1.391 . . . . 25.0 112.018 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.95 164.78 54.63 Favored Glycine 0 C--O 1.243 0.691 0 N-CA-C 111.751 -0.54 . . . . 25.0 111.751 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.22 163.67 34.82 Favored Glycine 0 C--O 1.244 0.719 0 CA-C-O 119.462 -0.632 . . . . 25.0 113.741 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.5 103.34 11.97 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.165 -1.42 . . . . 25.0 107.165 176.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -103.32 157.63 16.89 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.471 -0.491 . . . . 50.0 110.258 -172.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -120.56 90.66 3.37 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 108.82 -0.807 . . . . 25.0 108.82 177.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.0 mp -86.06 136.5 33.21 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.035 -0.529 . . . . 25.0 110.694 -175.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -138.55 106.62 5.72 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.331 -0.618 . . . . 25.0 109.331 174.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.98 -28.17 54.85 Favored Glycine 0 N--CA 1.467 0.766 0 CA-C-O 118.011 -1.438 . . . . 25.0 116.184 -175.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 54.8 -147.99 0.49 Allowed 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 118.187 0.994 . . . . 25.0 111.428 -177.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.94 163.47 19.64 Favored 'General case' 0 C--O 1.256 1.409 0 CA-C-O 122.153 0.978 . . . . 25.0 112.495 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.05 157.63 33.66 Favored Glycine 0 CA--C 1.521 0.452 0 CA-C-N 114.358 -1.292 . . . . 25.0 110.173 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -81.77 110.96 17.57 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 105.635 -1.987 . . . . 25.0 105.635 177.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -110.6 150.81 28.44 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.934 -0.706 . . . . 50.0 110.02 -171.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 mp -112.9 95.07 5.21 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.957 0.786 . . . . 25.0 109.457 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.8 mp -100.74 116.34 32.4 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 114.963 1.468 . . . . 25.0 114.963 -170.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -118.03 111.92 19.56 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 115.3 -0.864 . . . . 25.0 109.207 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.37 -32.61 79.86 Favored Glycine 0 C--O 1.254 1.389 0 N-CA-C 117.262 1.665 . . . . 25.0 117.262 -174.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.47 -163.78 42.97 Favored Glycine 0 N--CA 1.458 0.143 0 C-N-CA 120.91 -0.662 . . . . 25.0 111.909 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.2 159.46 17.63 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.307 0.575 . . . . 25.0 112.317 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.38 173.1 47.55 Favored Glycine 0 C--O 1.227 -0.291 0 CA-C-N 115.447 -0.797 . . . . 25.0 114.113 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.54 125.26 33.65 Favored 'General case' 0 C--O 1.208 -1.112 0 N-CA-C 104.069 -2.567 . . . . 25.0 104.069 176.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -117.96 157.56 26.51 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.907 0.384 . . . . 50.0 110.967 -174.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -113.26 131.04 56.07 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 102.869 -3.011 . . . . 25.0 102.869 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -148.98 149.05 30.52 Favored 'General case' 0 C--O 1.248 0.997 0 C-N-CA 119.374 -0.93 . . . . 25.0 111.691 -175.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.19 146.76 35.61 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 109.6 -0.519 . . . . 25.0 109.6 -176.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -98.85 -42.75 2.79 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-O 118.649 -1.084 . . . . 25.0 113.445 -174.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.34 -169.6 52.79 Favored Glycine 0 C--O 1.248 0.991 0 CA-C-N 118.843 1.322 . . . . 25.0 111.534 -177.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -60.58 155.08 19.51 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.846 -0.797 . . . . 25.0 110.21 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.0 163.23 32.24 Favored Glycine 0 C--O 1.249 1.063 0 CA-C-N 115.312 -0.858 . . . . 25.0 111.036 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.75 96.09 9.15 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 123.395 0.678 . . . . 25.0 110.028 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -88.94 158.25 18.12 Favored 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 123.258 0.623 . . . . 50.0 111.622 -170.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.1 m -123.15 134.04 54.22 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.965 -0.754 . . . . 25.0 108.965 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -126.45 100.81 6.42 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.467 -1.309 . . . . 25.0 107.467 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 54.2 mtt85 -100.13 -27.67 13.42 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.552 0.945 . . . . 25.0 113.552 -178.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 67.77 162.22 0.19 Allowed 'General case' 0 CA--C 1.534 0.356 0 O-C-N 125.276 1.61 . . . . 25.0 110.386 -174.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.8 -49.56 17.73 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 116.166 1.913 . . . . 25.0 116.166 -170.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 81.8 mt -153.98 -179.65 8.06 Favored 'General case' 0 C--O 1.205 -1.251 0 O-C-N 121.45 -0.781 . . . . 25.0 109.535 -171.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -55.86 -27.1 50.07 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.635 -0.876 . . . . 25.0 108.635 167.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -71.29 -10.28 59.49 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 112.965 0.728 . . . . 25.0 112.965 -178.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -99.34 155.32 17.58 Favored 'General case' 0 C--O 1.215 -0.719 0 O-C-N 121.76 -0.588 . . . . 25.0 110.463 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.4 m 42.83 56.49 3.95 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.093 -0.958 . . . . 25.0 113.464 169.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 42.8 p-80 -134.38 168.79 18.27 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 122.02 0.914 . . . . 25.0 111.482 -174.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -125.75 138.93 53.88 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 102.992 -2.966 . . . . 25.0 102.992 173.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.5 p -134.99 172.51 7.13 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 108.316 -0.994 . . . . 25.0 108.316 -173.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -60.13 -15.73 35.74 Favored 'Trans proline' 0 CA--C 1.555 1.559 0 N-CA-C 114.782 1.032 . . . . 25.0 114.782 175.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.6 mt -85.23 -24.67 27.73 Favored 'General case' 0 C--O 1.215 -0.723 0 N-CA-C 111.8 0.296 . . . . 25.0 111.8 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.06 -165.21 30.68 Favored Glycine 0 C--O 1.21 -1.393 0 C-N-CA 120.39 -0.909 . . . . 25.0 111.618 -175.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.9 t -106.55 141.41 37.88 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 122.762 1.268 . . . . 25.0 112.089 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -132.96 32.95 3.72 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-N 114.989 -1.005 . . . . 25.0 109.73 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -73.16 160.99 54.21 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 110.481 -1.047 . . . . 25.0 110.481 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -104.46 169.79 8.27 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 117.994 0.897 . . . . 50.0 110.539 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -121.07 104.58 9.89 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.432 1.093 . . . . 25.0 110.545 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.4 mt -94.02 135.13 29.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 106.747 -1.575 . . . . 25.0 106.747 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 21.6 mt -84.48 -45.63 12.45 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.729 1.751 . . . . 25.0 115.729 -174.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -135.27 38.1 2.95 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 115.134 -0.939 . . . . 25.0 113.429 -169.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -59.26 125.07 22.13 Favored 'General case' 0 C--O 1.218 -0.605 0 N-CA-C 108.791 -0.818 . . . . 25.0 108.791 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -92.1 103.82 9.2 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.897 -0.592 . . . . 25.0 109.697 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -69.04 -4.25 13.17 Favored 'Trans proline' 0 CA--C 1.548 1.209 0 N-CA-C 115.841 1.439 . . . . 25.0 115.841 -175.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.6 t -95.78 -43.3 7.93 Favored 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 122.193 -0.317 . . . . 25.0 110.829 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -97.43 -38.08 9.75 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 113.812 1.041 . . . . 25.0 113.812 -174.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -86.81 170.57 11.58 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.729 -0.388 . . . . 75.0 110.687 -172.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -145.62 149.34 34.35 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 116.208 -0.451 . . . . 25.0 111.006 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 67.7 mt -124.92 125.83 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 107.6 -1.259 . . . . 25.0 107.6 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -89.34 136.23 33.14 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-O 122.02 0.914 . . . . 25.0 108.913 173.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 p -134.46 2.97 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 114.452 -1.249 . . . . 25.0 108.539 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.466 ' HB2' ' HA ' ' A' ' 156' ' ' PHE . 23.7 t -67.32 -47.84 69.34 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 120.722 -0.391 . . . . 25.0 111.146 -175.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.19 -36.0 82.18 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.894 0.702 . . . . 25.0 112.894 -175.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.3 -49.64 4.19 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.585 0.958 . . . . 25.0 113.585 -175.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.31 -78.8 1.32 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 116.375 1.31 . . . . 25.0 116.375 -169.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -157.06 171.37 20.58 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 117.518 0.659 . . . . 25.0 110.114 -168.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 30.6 t -105.51 -36.25 7.19 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.587 0.755 . . . . 25.0 111.451 -177.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -105.91 145.68 15.97 Favored Glycine 0 N--CA 1.468 0.819 0 CA-C-O 118.355 -1.247 . . . . 25.0 111.354 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -61.61 148.31 42.84 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-N 118.814 1.307 . . . . 25.0 110.245 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.0 -167.1 41.15 Favored Glycine 0 C--O 1.243 0.708 0 CA-C-N 114.764 -1.107 . . . . 25.0 113.309 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -65.23 142.11 58.41 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.385 -0.968 . . . . 25.0 108.385 177.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 169.9 178.2 40.77 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 108.723 -1.751 . . . . 25.0 108.723 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -138.18 168.93 18.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 118.102 0.951 . . . . 25.0 109.485 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 61.05 35.28 18.88 Favored 'General case' 0 C--O 1.253 1.241 0 O-C-N 123.958 0.786 . . . . 25.0 112.489 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 65.03 39.32 96.32 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 120.785 -0.722 . . . . 25.0 111.74 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.7 t -146.24 177.43 9.0 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.752 -0.462 . . . . 25.0 109.752 -176.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 92.5 mt -90.08 170.27 10.47 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 105.507 -2.034 . . . . 25.0 105.507 175.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.21 111.72 1.84 Allowed 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 118.575 0.625 . . . . 25.0 110.679 -177.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 17.0 m -102.57 155.19 5.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 107.078 -1.453 . . . . 25.0 107.078 174.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 83.5 p -156.46 173.52 16.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 118.316 0.507 . . . . 25.0 110.715 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.1 m -118.97 160.39 18.87 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 N-CA-C 109.245 -0.65 . . . . 25.0 109.245 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.6 t -69.71 -52.48 25.14 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.837 -1.542 . . . . 25.0 106.837 173.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -164.28 -160.74 0.55 Allowed 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 102.947 -2.983 . . . . 25.0 102.947 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -55.16 -38.87 68.85 Favored 'General case' 0 C--O 1.252 1.225 0 CA-C-N 118.078 0.399 . . . . 25.0 111.104 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.72 -156.42 13.57 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 112.073 -0.411 . . . . 25.0 112.073 176.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.87 -168.67 0.18 Allowed 'General case' 0 C--O 1.251 1.132 0 C-N-CA 124.128 0.971 . . . . 25.0 111.475 177.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 64.9 mtt85 -72.83 160.35 32.3 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.46 0.911 . . . . 25.0 113.46 -171.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -102.6 168.16 9.45 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 105.575 -2.009 . . . . 25.0 105.575 175.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -131.57 156.03 46.46 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.778 0.799 . . . . 25.0 111.961 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 52.5 tp -127.32 116.21 20.17 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 102.976 -2.972 . . . . 25.0 102.976 174.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -122.69 162.99 20.92 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 108.601 -0.889 . . . . 25.0 108.601 -173.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.0 t -140.09 144.41 36.77 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 103.123 -2.918 . . . . 25.0 103.123 172.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -102.4 12.45 36.53 Favored 'General case' 0 C--O 1.245 0.859 0 N-CA-C 109.163 -0.68 . . . . 25.0 109.163 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -81.25 135.11 35.7 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 105.192 -2.151 . . . . 25.0 105.192 172.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -141.91 147.35 36.93 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 122.367 1.08 . . . . 25.0 110.96 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.26 159.51 31.13 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.232 -1.396 . . . . 25.0 107.232 174.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.07 -20.32 66.13 Favored 'General case' 0 CA--C 1.548 0.886 0 O-C-N 121.688 -0.632 . . . . 25.0 109.665 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -77.29 -4.45 45.03 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.49 -0.777 . . . . 25.0 113.072 175.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.18 6.14 63.29 Favored Glycine 0 CA--C 1.51 -0.247 0 N-CA-C 116.571 1.388 . . . . 25.0 116.571 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 69.2 mt -86.52 120.02 27.4 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 110.313 -0.255 . . . . 25.0 110.313 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 25.6 p -119.51 176.57 5.3 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.442 0.697 . . . . 25.0 109.248 -178.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -118.1 132.06 56.38 Favored 'General case' 0 C--O 1.257 1.456 0 N-CA-C 114.126 1.158 . . . . 25.0 114.126 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -152.57 151.69 30.96 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.169 -1.048 . . . . 25.0 108.169 167.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.5 p -149.09 147.83 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 106.113 -1.81 . . . . 25.0 106.113 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -109.73 145.22 36.95 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 111.685 0.254 . . . . 25.0 111.685 -177.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mp -134.0 128.34 34.16 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.451 -1.314 . . . . 25.0 107.451 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -86.9 -12.77 46.75 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 114.905 1.446 . . . . 25.0 114.905 -173.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -75.75 -6.22 81.11 Favored Glycine 0 C--O 1.212 -1.267 0 N-CA-C 116.347 1.299 . . . . 25.0 116.347 -171.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 47.7 t0 50.87 54.11 11.82 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 122.216 1.008 . . . . 25.0 113.068 -175.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 14.5 p80 -114.35 41.44 2.3 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 107.227 -1.397 . . . . 25.0 107.227 174.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.53 -36.61 84.33 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.004 -0.998 . . . . 25.0 111.624 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -77.49 -24.04 50.18 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.105 -0.997 . . . . 25.0 111.219 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.13 -24.71 37.46 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.541 -0.754 . . . . 25.0 110.699 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 8.1 mt -63.22 139.12 58.74 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 119.8 -0.76 . . . . 25.0 111.756 177.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 92.8 p -138.27 165.74 25.95 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.543 -0.91 . . . . 25.0 108.543 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.68 -3.18 29.82 Favored 'General case' 0 C--N 1.312 -1.03 0 O-C-N 120.997 -1.064 . . . . 25.0 109.879 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -77.43 -37.0 52.59 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 120.944 -1.098 . . . . 25.0 111.398 -177.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -89.72 -5.44 57.01 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 121.138 -0.225 . . . . 25.0 111.421 -177.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 44.4 mm -99.63 122.01 50.96 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.793 0 N-CA-C 103.833 -2.654 . . . . 25.0 103.833 173.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.7 p -112.82 125.08 70.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 122.779 1.276 . . . . 25.0 111.377 -174.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.466 ' HA ' ' HB2' ' A' ' 97' ' ' SER . 1.3 p90 -141.68 -32.22 0.54 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 112.774 -2.012 . . . . 25.0 109.717 -176.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -75.47 55.41 0.81 Allowed 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.674 1.361 . . . . 25.0 114.674 -176.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 60.1 15.88 5.51 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 115.616 1.71 . . . . 25.0 115.616 175.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.4 m 65.29 -23.99 0.09 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.965 1.706 . . . . 25.0 115.599 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -58.86 125.35 23.18 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.248 0.619 . . . . 25.0 111.24 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -96.89 15.04 23.32 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.174 0.805 . . . . 25.0 113.174 -175.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.9 2.26 12.94 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.92 1.081 . . . . 25.0 113.92 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -145.87 -174.96 4.56 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.323 -1.362 . . . . 25.0 107.323 177.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 67.74 -178.24 0.21 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.442 1.097 . . . . 25.0 111.58 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 86.59 21.44 51.09 Favored Glycine 0 C--O 1.24 0.498 0 N-CA-C 109.159 -1.576 . . . . 25.0 109.159 -172.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -77.56 89.44 3.89 Favored 'General case' 0 C--O 1.247 0.96 0 C-N-CA 123.198 0.599 . . . . 25.0 111.659 -177.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -123.28 143.36 50.11 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.598 -0.889 . . . . 25.0 108.598 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -140.79 32.92 2.09 Favored Glycine 0 N--CA 1.461 0.358 0 N-CA-C 109.781 -1.328 . . . . 25.0 109.781 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 47.9 t -71.48 -35.08 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 112.03 0.382 . . . . 25.0 112.03 -175.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.27 130.19 25.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-O 121.195 0.521 . . . . 25.0 111.374 -177.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 152.58 158.67 8.6 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 109.298 -1.521 . . . . 25.0 109.298 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -151.95 144.49 24.18 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 118.625 1.213 . . . . 25.0 110.593 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 68.9 p -142.7 162.77 34.61 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 105.637 -1.986 . . . . 25.0 105.637 175.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -174.02 161.83 32.21 Favored Glycine 0 C--N 1.318 -0.427 0 C-N-CA 120.249 -0.977 . . . . 25.0 113.283 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -136.7 83.29 30.27 Favored Pre-proline 0 C--O 1.241 0.645 0 N-CA-C 108.364 -0.976 . . . . 25.0 108.364 177.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.24 161.54 45.62 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 118.15 -0.767 . . . . 25.0 112.376 -174.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -113.24 150.49 32.31 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 123.51 0.724 . . . . 25.0 110.212 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -138.17 70.73 48.03 Favored Pre-proline 0 N--CA 1.479 0.998 0 CA-C-O 120.903 0.382 . . . . 25.0 110.967 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -73.06 153.85 52.28 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 116.918 -1.588 . . . . 25.0 112.875 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.6 t -84.63 7.05 21.58 Favored 'General case' 0 C--O 1.25 1.085 0 CA-C-O 120.902 0.382 . . . . 25.0 111.658 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 C--O 1.254 1.33 0 CA-C-O 116.833 -1.556 . . . . 25.0 110.335 -177.664 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 N--CA 1.476 0.468 0 N-CA-C 114.409 0.888 . . . . 25.0 114.409 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.09 65.95 0.05 OUTLIER Glycine 0 C--O 1.222 -0.655 0 C-N-CA 121.106 -0.569 . . . . 25.0 112.489 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.7 p -61.49 132.0 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 122.742 1.258 . . . . 25.0 111.417 -176.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -91.94 -19.88 21.98 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 114.986 -1.007 . . . . 25.0 111.203 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.76 -146.13 7.78 Favored Glycine 0 C--O 1.223 -0.568 0 N-CA-C 116.899 1.52 . . . . 25.0 116.899 -175.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.7 p 73.36 155.59 0.16 Allowed Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 126.928 2.091 . . . . 25.0 110.427 -175.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -67.4 13.12 0.17 Allowed 'Trans proline' 0 CA--C 1.545 1.07 0 N-CA-C 117.386 2.033 . . . . 25.0 117.386 -175.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.55 -20.78 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 115.38 1.622 . . . . 25.0 115.38 -174.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.7 p -146.47 141.5 20.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.999 0.74 . . . . 25.0 112.999 -175.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.56 17.15 69.14 Favored Glycine 0 C--O 1.241 0.585 0 N-CA-C 118.324 2.09 . . . . 25.0 118.324 173.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.2 t -51.51 -54.6 25.56 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.517 0.932 . . . . 25.0 113.517 -174.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -82.48 12.6 4.36 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 117.535 2.42 . . . . 25.0 117.535 -174.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -147.95 170.48 17.62 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 122.038 -0.414 . . . . 25.0 111.837 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -58.3 136.24 57.32 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 112.795 0.665 . . . . 25.0 112.795 -175.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -123.0 160.79 25.54 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 116.221 1.934 . . . . 50.0 116.221 -173.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -137.23 105.36 5.69 Favored 'General case' 0 C--O 1.249 1.042 0 N-CA-C 103.795 -2.668 . . . . 25.0 103.795 160.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.6 mt -125.29 131.21 53.11 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.312 0.486 . . . . 25.0 112.312 -175.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -118.59 111.86 19.12 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 122.489 0.316 . . . . 25.0 111.839 -176.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.32 -177.9 51.38 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 117.916 1.926 . . . . 25.0 117.916 -174.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.1 p -81.55 173.32 12.5 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.051 0.94 . . . . 25.0 112.054 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.4 mt -84.56 5.89 25.95 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.748 -0.595 . . . . 25.0 111.494 174.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -100.23 -179.24 30.06 Favored Glycine 0 N--CA 1.464 0.544 0 N-CA-C 111.83 -0.508 . . . . 25.0 111.83 177.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.3 t -78.54 124.92 28.67 Favored 'General case' 0 C--O 1.24 0.585 0 O-C-N 122.121 -0.635 . . . . 25.0 110.053 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -131.36 156.24 45.86 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.899 0.38 . . . . 50.0 111.018 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -98.42 129.14 45.05 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 102.825 -3.028 . . . . 25.0 102.825 163.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.8 mm -126.59 124.48 65.3 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.56 0 N-CA-C 105.969 -1.863 . . . . 25.0 105.969 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.8 mp -125.85 121.72 34.04 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.35 -1.352 . . . . 25.0 107.35 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.23 -34.31 37.35 Favored Glycine 0 C--N 1.318 -0.424 0 C-N-CA 120.68 -0.771 . . . . 25.0 114.933 -178.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 72.31 -145.59 37.82 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 110.415 -1.074 . . . . 25.0 110.415 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -78.63 169.79 54.46 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-O 121.897 0.721 . . . . 25.0 111.352 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.77 159.92 27.52 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.574 -0.822 . . . . 25.0 113.553 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.72 104.49 13.01 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 105.629 -1.989 . . . . 25.0 105.629 176.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -103.31 148.9 25.27 Favored 'General case' 0 C--N 1.314 -0.941 0 O-C-N 121.365 -0.834 . . . . 50.0 111.073 -169.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -112.34 98.57 7.38 Favored 'General case' 0 C--O 1.246 0.92 0 N-CA-C 105.135 -2.172 . . . . 25.0 105.135 176.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 62.8 mt -106.86 133.55 51.35 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.118 -0.492 . . . . 25.0 111.532 -172.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -130.3 106.87 8.86 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 122.659 0.384 . . . . 25.0 110.166 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.12 -19.69 49.38 Favored Glycine 0 CA--C 1.534 1.279 0 N-CA-C 117.682 1.833 . . . . 25.0 117.682 -178.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 53.35 -148.18 0.46 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 118.711 1.255 . . . . 25.0 113.188 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.63 165.87 20.27 Favored 'General case' 0 C--O 1.254 1.292 0 CA-C-O 121.247 0.546 . . . . 25.0 112.087 -176.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.37 153.53 30.16 Favored Glycine 0 N--CA 1.452 -0.269 0 N-CA-C 109.629 -1.388 . . . . 25.0 109.629 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -80.07 101.03 8.48 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.644 -1.613 . . . . 25.0 106.644 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -101.8 151.65 21.81 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.801 -0.636 . . . . 50.0 111.568 -170.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.7 mp -114.0 95.8 5.49 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.591 -0.522 . . . . 25.0 109.591 177.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.7 mp -101.46 128.03 47.86 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.336 0.589 . . . . 25.0 112.103 -173.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -125.73 135.94 52.62 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 106.485 -1.672 . . . . 25.0 106.485 174.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -89.54 -41.07 5.83 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 119.778 -1.201 . . . . 25.0 114.826 -174.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.46 -166.21 50.83 Favored Glycine 0 C--O 1.238 0.353 0 CA-C-N 117.662 0.731 . . . . 25.0 112.829 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.68 149.65 21.34 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.099 0.407 . . . . 25.0 112.099 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.4 153.64 29.03 Favored Glycine 0 C--O 1.238 0.365 0 CA-C-N 115.38 -0.827 . . . . 25.0 112.837 -177.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.34 120.26 21.36 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 105.193 -2.151 . . . . 25.0 105.193 176.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -109.05 156.2 20.05 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.983 -0.377 . . . . 50.0 109.983 -172.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -123.9 117.99 26.07 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 103.928 -2.619 . . . . 25.0 103.928 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -144.23 132.28 21.63 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 116.753 2.131 . . . . 25.0 116.753 -168.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 64.3 m -100.63 135.49 41.99 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.454 -0.573 . . . . 25.0 109.454 176.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.49 -32.91 7.85 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.038 -1.225 . . . . 25.0 110.038 173.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.07 -163.01 54.5 Favored Glycine 0 C--O 1.247 0.954 0 CA-C-O 122.836 1.242 . . . . 25.0 111.805 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -67.23 161.01 25.81 Favored 'General case' 0 C--N 1.322 -0.629 0 O-C-N 121.922 -0.752 . . . . 25.0 110.108 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.44 164.42 37.15 Favored Glycine 0 CA--C 1.521 0.418 0 CA-C-N 115.757 -0.656 . . . . 25.0 111.807 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.66 92.08 8.08 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-O 122.352 1.072 . . . . 25.0 109.957 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -86.01 152.35 22.98 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.105 -0.952 . . . . 50.0 112.338 -172.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.5 m -121.93 127.99 51.02 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.899 -1.046 . . . . 25.0 109.735 -178.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -122.8 84.56 2.28 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.605 -1.257 . . . . 25.0 107.605 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 54.8 mtt85 -85.64 -21.72 28.28 Favored 'General case' 0 CA--C 1.497 -1.068 0 O-C-N 121.54 -0.725 . . . . 25.0 111.358 -178.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 68.22 159.07 0.16 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.017 1.327 . . . . 25.0 112.173 -175.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -93.62 -28.13 16.19 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 115.795 1.776 . . . . 25.0 115.795 -167.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 70.7 mt -145.91 166.02 27.22 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.39 0.515 . . . . 25.0 112.39 -171.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.33 -28.15 69.01 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.642 -0.873 . . . . 25.0 108.642 170.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -82.87 -0.19 47.09 Favored 'General case' 0 C--O 1.252 1.187 0 CA-C-N 114.363 -1.289 . . . . 25.0 113.814 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -91.0 134.65 34.32 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 121.719 -0.613 . . . . 25.0 110.145 -173.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.3 t 47.32 42.75 14.31 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 115.291 1.589 . . . . 25.0 115.291 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 15.5 p-80 -110.79 165.44 11.84 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.419 -0.81 . . . . 25.0 112.375 -174.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -116.06 142.24 47.06 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 106.805 -1.554 . . . . 25.0 106.805 176.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 82.5 p -136.27 166.56 27.03 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 108.278 -1.008 . . . . 25.0 108.278 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -61.14 -22.49 74.84 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 117.885 -0.944 . . . . 25.0 113.528 174.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 86.9 mt -76.79 -21.82 54.59 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.733 0.778 . . . . 25.0 111.174 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 150.52 175.18 22.31 Favored Glycine 0 CA--C 1.506 -0.479 0 CA-C-N 116.17 -0.468 . . . . 25.0 112.11 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.0 t -95.09 148.4 22.4 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 122.01 0.909 . . . . 25.0 111.137 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -131.55 30.82 4.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.833 -1.076 . . . . 25.0 108.448 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.0 142.03 44.34 Favored Glycine 0 C--O 1.243 0.675 0 N-CA-C 111.157 -0.777 . . . . 25.0 111.157 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -85.52 169.22 13.8 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 120.575 0.226 . . . . 50.0 110.393 -177.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -124.08 98.38 5.76 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.001 0.52 . . . . 25.0 111.468 -173.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.9 mt -85.34 132.73 31.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 107.56 -1.274 . . . . 25.0 107.56 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 98.0 mt -84.66 -44.55 13.33 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 114.894 1.442 . . . . 25.0 114.894 -169.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 57.5 p30 -134.45 38.62 3.09 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 114.799 1.407 . . . . 25.0 114.799 -174.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -57.35 129.64 42.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.703 0.763 . . . . 25.0 112.384 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -99.66 105.07 31.8 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 108.212 -1.033 . . . . 25.0 108.212 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -67.61 -16.83 47.68 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 116.228 -2.048 . . . . 25.0 115.802 -176.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.7 t -82.86 -26.66 31.41 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 120.607 0.241 . . . . 25.0 110.988 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -115.78 -33.1 5.26 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 115.432 1.641 . . . . 25.0 115.432 -173.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -91.8 167.63 12.02 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 123.432 0.457 . . . . 50.0 110.367 -170.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -144.65 145.91 31.99 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.212 0.449 . . . . 25.0 112.212 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 88.3 mt -127.41 127.83 69.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.281 -1.007 . . . . 25.0 108.281 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -91.25 148.0 22.65 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.509 -0.923 . . . . 25.0 108.509 173.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.4 p -147.79 -6.72 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 113.175 0.806 . . . . 25.0 113.175 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 26.4 t -61.44 -43.77 98.28 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.532 0.568 . . . . 25.0 112.532 -175.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.05 -28.86 54.91 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.9 1.074 . . . . 25.0 113.9 -178.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.62 -0.33 13.04 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 116.655 2.094 . . . . 25.0 116.655 -169.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -145.0 -72.45 0.02 OUTLIER Glycine 0 C--O 1.241 0.576 0 N-CA-C 116.555 1.382 . . . . 25.0 116.555 -178.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -157.98 169.25 25.01 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.597 -0.89 . . . . 25.0 108.597 -175.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 38.5 t -124.11 -39.8 2.33 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.111 0.482 . . . . 25.0 110.344 177.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -88.48 121.72 6.08 Favored Glycine 0 N--CA 1.465 0.585 0 N-CA-C 111.053 -0.819 . . . . 25.0 111.053 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -73.53 154.16 39.98 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 117.633 0.716 . . . . 25.0 111.87 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.15 -171.84 45.75 Favored Glycine 0 N--CA 1.463 0.467 0 CA-C-N 116.281 -0.418 . . . . 25.0 112.108 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -75.6 81.71 2.6 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.611 0.967 . . . . 25.0 113.611 -177.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -105.86 176.62 22.21 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 108.973 -1.651 . . . . 25.0 108.973 173.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -125.96 166.19 17.38 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 118.106 0.953 . . . . 25.0 110.683 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 54.09 36.43 24.67 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 114.083 1.142 . . . . 25.0 114.083 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 77.35 31.26 52.13 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 120.214 -0.993 . . . . 25.0 112.11 177.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.3 t -138.78 -174.37 3.82 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 117.382 0.591 . . . . 25.0 110.468 -177.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.56 161.01 15.23 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 102.294 -3.225 . . . . 25.0 102.294 173.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.78 115.01 10.48 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 118.744 0.702 . . . . 25.0 110.325 -173.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.1 m -85.3 165.1 2.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 108.112 -1.07 . . . . 25.0 108.112 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 92.0 p -150.39 162.59 40.26 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.673 -0.492 . . . . 25.0 109.673 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.5 m -115.95 164.2 12.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.698 -0.853 . . . . 25.0 108.698 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.5 t -76.55 -56.4 4.65 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.186 -1.413 . . . . 25.0 107.186 170.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -161.31 -159.94 0.68 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 103.436 -2.801 . . . . 25.0 103.436 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -66.52 -24.22 66.35 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 121.062 0.458 . . . . 25.0 110.311 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -118.86 -159.02 10.94 Favored Glycine 0 C--O 1.244 0.758 0 N-CA-C 109.661 -1.376 . . . . 25.0 109.661 176.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 59.44 -161.85 0.26 Allowed 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 112.913 0.708 . . . . 25.0 112.913 176.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 39.4 mtt85 -76.33 163.81 26.64 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.292 1.219 . . . . 25.0 114.292 -169.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.14 159.91 18.76 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 106.233 -1.766 . . . . 25.0 106.233 171.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -132.01 159.21 39.44 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.245 0.545 . . . . 25.0 110.452 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 55.7 tp -133.05 119.37 19.94 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 104.356 -2.461 . . . . 25.0 104.356 170.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -116.51 155.62 28.31 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.435 -0.58 . . . . 25.0 109.435 -175.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.4 t -100.02 149.92 22.98 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 104.272 -2.492 . . . . 25.0 104.272 166.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -116.13 9.56 14.74 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 122.089 0.947 . . . . 25.0 109.783 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -102.18 143.17 32.31 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 104.185 -2.524 . . . . 25.0 104.185 171.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -138.7 155.12 48.52 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.604 0.716 . . . . 25.0 109.802 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -75.29 160.01 30.84 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 105.543 -2.021 . . . . 25.0 105.543 175.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.7 -16.65 63.96 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.496 0.589 . . . . 25.0 111.485 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -76.13 -9.44 58.63 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.157 0.503 . . . . 25.0 112.141 174.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.69 3.29 68.81 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.483 -0.647 . . . . 25.0 111.483 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.3 mt -73.76 138.47 44.59 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.372 -0.973 . . . . 25.0 108.372 177.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.87 -178.43 6.35 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 106.848 -1.538 . . . . 25.0 106.848 -175.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -132.35 140.99 48.74 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-N 118.91 0.777 . . . . 25.0 112.995 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -153.58 156.02 37.22 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 108.06 -1.089 . . . . 25.0 108.06 170.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.5 p -146.06 143.93 21.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 N-CA-C 105.818 -1.919 . . . . 25.0 105.818 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -107.36 142.64 36.86 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.032 -1.47 . . . . 25.0 107.032 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.9 mp -131.49 127.92 38.31 Favored 'General case' 0 C--O 1.207 -1.141 0 N-CA-C 103.552 -2.759 . . . . 25.0 103.552 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -100.19 3.53 43.78 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 119.278 0.945 . . . . 25.0 113.304 -174.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -79.07 -2.28 86.8 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 120.668 -0.777 . . . . 25.0 113.775 177.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 44.8 t0 49.16 48.93 20.39 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 122.075 0.94 . . . . 25.0 112.14 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -108.18 32.67 4.61 Favored 'General case' 0 C--O 1.249 1.03 0 CA-C-O 122.53 1.157 . . . . 25.0 108.615 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -55.1 -34.3 63.56 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.044 -0.98 . . . . 25.0 112.492 176.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.97 -12.78 61.98 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 113.275 0.842 . . . . 25.0 113.275 -178.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -116.86 -5.0 11.53 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.635 0.605 . . . . 25.0 112.635 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 16.1 mt -70.7 127.37 32.41 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.495 -0.928 . . . . 25.0 108.495 178.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 71.2 m -127.64 164.37 22.19 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.616 -1.624 . . . . 25.0 106.616 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -73.64 -1.87 20.68 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.197 -0.668 . . . . 25.0 109.197 176.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -71.33 -29.77 65.4 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 115.673 -0.694 . . . . 25.0 112.385 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -98.15 1.14 47.17 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 122.065 -0.397 . . . . 25.0 111.324 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 38.9 mm -105.5 111.36 34.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 105.535 -2.024 . . . . 25.0 105.535 175.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.8 p -98.15 115.95 39.62 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-O 123.064 1.412 . . . . 25.0 112.558 -173.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -137.36 0.51 2.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 112.98 -1.918 . . . . 25.0 110.362 174.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -81.61 43.95 0.78 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 122.752 0.421 . . . . 25.0 111.441 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 55.94 24.39 7.57 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.202 1.186 . . . . 25.0 114.202 -177.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.56 9.09 0.73 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.657 1.725 . . . . 25.0 115.657 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -79.01 134.94 36.77 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 121.353 -0.842 . . . . 25.0 110.787 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.34 -19.69 63.04 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.354 -0.61 . . . . 25.0 109.354 178.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.3 47.39 0.68 Allowed 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 121.264 0.554 . . . . 25.0 111.513 176.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -150.3 173.18 14.27 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.164 -1.421 . . . . 25.0 107.164 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 62.77 -172.1 0.16 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.64 1.176 . . . . 25.0 111.905 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 81.55 23.41 58.35 Favored Glycine 0 C--N 1.32 -0.311 0 N-CA-C 110.081 -1.207 . . . . 25.0 110.081 -176.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -121.34 101.74 7.83 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 109.38 -0.6 . . . . 25.0 109.38 -176.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -127.8 157.49 40.28 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.179 -0.674 . . . . 25.0 109.179 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -136.74 26.01 3.05 Favored Glycine 0 N--CA 1.464 0.532 0 CA-C-N 116.426 -0.352 . . . . 25.0 113.636 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 47.1 t -80.96 -31.99 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 116.915 0.357 . . . . 25.0 110.8 -177.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.15 133.67 27.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 CA-C-O 121.571 0.7 . . . . 25.0 111.135 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.38 168.0 26.85 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 108.614 -1.794 . . . . 25.0 108.614 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -146.29 143.58 29.25 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.436 1.618 . . . . 25.0 110.601 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 80.5 p -155.51 167.82 29.12 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.556 -0.905 . . . . 25.0 108.556 178.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 179.3 -179.74 48.84 Favored Glycine 0 CA--C 1.507 -0.418 0 C-N-CA 120.628 -0.796 . . . . 25.0 114.299 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -145.82 106.19 4.26 Favored Pre-proline 0 N--CA 1.468 0.456 0 N-CA-C 107.895 -1.15 . . . . 25.0 107.895 177.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -72.94 152.23 51.6 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 116.194 -2.07 . . . . 25.0 113.67 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -113.24 144.5 42.6 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.835 -1.913 . . . . 25.0 105.835 175.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -136.2 67.2 61.44 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 112.644 0.609 . . . . 25.0 112.644 -174.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -73.45 150.83 46.94 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 117.874 -0.951 . . . . 25.0 112.575 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.7 t -139.95 20.96 2.47 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 122.02 0.914 . . . . 25.0 109.803 -177.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.4 p . . . . . 0 C--O 1.248 0.975 0 CA-C-O 117.618 -1.182 . . . . 25.0 110.759 -178.19 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 C--O 1.247 0.967 0 N-CA-C 114.293 0.844 . . . . 25.0 114.293 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.9 51.52 0.06 OUTLIER Glycine 0 C--O 1.237 0.3 0 N-CA-C 109.625 -1.39 . . . . 25.0 109.625 -177.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.9 p -57.86 133.58 22.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.758 0.79 . . . . 25.0 111.03 -174.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -102.37 -8.81 20.86 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.197 -0.91 . . . . 25.0 110.204 -173.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -82.52 -141.79 4.04 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.882 -0.599 . . . . 25.0 112.413 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.5 p 69.12 159.4 0.15 Allowed Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 126.064 1.746 . . . . 25.0 110.835 -175.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -65.97 -5.06 11.28 Favored 'Trans proline' 0 N--CA 1.483 0.9 0 N-CA-C 116.64 1.746 . . . . 25.0 116.64 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.97 -4.2 4.22 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 N-CA-C 114.192 1.182 . . . . 25.0 114.192 -170.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.3 p -141.34 141.35 30.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 121.56 0.695 . . . . 25.0 111.713 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.48 18.5 73.67 Favored Glycine 0 C--N 1.336 0.577 0 N-CA-C 119.681 2.633 . . . . 25.0 119.681 171.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.2 t -51.4 -51.63 53.06 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 120.641 -1.505 . . . . 25.0 113.826 -172.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -85.85 13.94 6.67 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 115.187 1.551 . . . . 25.0 115.187 -171.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.24 168.58 19.44 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.32 0.489 . . . . 25.0 112.32 -176.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -63.93 130.86 45.79 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 118.208 0.458 . . . . 25.0 110.809 -177.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -127.0 170.09 12.66 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 116.6 2.074 . . . . 50.0 116.6 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -136.01 92.56 2.81 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 104.449 -2.426 . . . . 25.0 104.449 168.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 52.4 mt -106.95 123.28 47.95 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.385 0.884 . . . . 25.0 113.385 -173.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -111.43 114.77 28.12 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.815 -0.629 . . . . 25.0 109.401 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.07 174.71 51.21 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 116.948 1.539 . . . . 25.0 116.948 -175.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.3 p -69.47 169.69 12.01 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.504 0.669 . . . . 25.0 111.574 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 89.3 mt -87.33 16.09 5.71 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.521 -0.763 . . . . 25.0 110.905 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -120.6 -178.96 16.19 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.368 -0.693 . . . . 25.0 111.368 175.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.7 t -68.17 135.07 51.51 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 117.365 0.582 . . . . 25.0 110.924 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -144.92 166.44 25.29 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.083 0.553 . . . . 50.0 109.791 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -109.78 129.8 55.59 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 103.284 -2.858 . . . . 25.0 103.284 162.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.4 mm -119.23 121.71 67.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 108.138 -1.06 . . . . 25.0 108.138 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 9.0 mp -124.36 125.96 45.19 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 105.801 -1.926 . . . . 25.0 105.801 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.21 -26.62 27.9 Favored Glycine 0 C--O 1.246 0.904 0 N-CA-C 115.355 0.902 . . . . 25.0 115.355 -176.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.24 -147.33 47.33 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.122 -1.037 . . . . 25.0 112.003 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.31 174.3 52.21 Favored Glycine 0 C--O 1.248 0.983 0 O-C-N 122.73 -0.277 . . . . 25.0 112.889 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.49 160.92 20.99 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.597 -0.811 . . . . 25.0 113.82 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.57 92.0 8.75 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 122.526 1.155 . . . . 25.0 108.008 175.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -89.31 157.29 18.25 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.762 -1.108 . . . . 50.0 112.635 -169.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -117.35 94.99 4.77 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 107.469 -1.308 . . . . 25.0 107.469 172.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 49.6 mt -101.83 134.73 44.55 Favored 'General case' 0 C--O 1.213 -0.847 0 N-CA-C 112.614 0.598 . . . . 25.0 112.614 -172.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -131.51 106.79 8.44 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.174 0.512 . . . . 25.0 111.015 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.96 -25.61 57.51 Favored Glycine 0 C--O 1.246 0.845 0 N-CA-C 116.066 1.186 . . . . 25.0 116.066 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 49.99 -152.19 0.17 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.928 1.084 . . . . 25.0 113.928 -178.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.97 160.39 20.85 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 113.164 0.801 . . . . 25.0 113.164 -173.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.06 156.5 31.35 Favored Glycine 0 C--O 1.247 0.955 0 N-CA-C 109.591 -1.404 . . . . 25.0 109.591 -177.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 22.0 m-20 -81.42 106.08 13.1 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 107.149 -1.426 . . . . 25.0 107.149 177.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -106.84 161.8 14.37 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 120.946 0.403 . . . . 50.0 111.098 -170.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 mp -119.87 136.88 54.32 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 104.832 -2.284 . . . . 25.0 104.832 174.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 mp -136.1 125.42 24.83 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 114.49 1.293 . . . . 25.0 114.49 -172.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -125.19 137.84 54.13 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 113.968 -1.469 . . . . 25.0 107.542 174.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.48 -31.79 8.64 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.32 -0.943 . . . . 25.0 114.704 -178.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.98 -171.0 55.12 Favored Glycine 0 C--O 1.253 1.285 0 N-CA-C 110.784 -0.926 . . . . 25.0 110.784 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.6 157.11 9.61 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.956 0.884 . . . . 25.0 112.422 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.38 164.73 40.48 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-N 115.212 -0.903 . . . . 25.0 111.888 -176.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.97 123.72 33.57 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 104.7 -2.333 . . . . 25.0 104.7 176.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -113.44 157.08 22.4 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.663 0.986 . . . . 50.0 113.663 -169.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -113.2 127.08 56.07 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 103.493 -2.78 . . . . 25.0 103.493 174.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -147.83 137.3 22.43 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.901 1.074 . . . . 25.0 113.901 -176.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 62.1 m -116.04 142.59 46.6 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.02 -1.104 . . . . 25.0 108.02 176.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -93.49 -34.21 6.76 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 111.079 -0.808 . . . . 25.0 111.079 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.81 -173.25 55.33 Favored Glycine 0 C--O 1.244 0.732 0 CA-C-N 117.987 0.893 . . . . 25.0 113.462 -178.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -66.1 159.21 26.62 Favored 'General case' 0 C--O 1.241 0.612 0 O-C-N 121.455 -1.027 . . . . 25.0 109.65 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.1 156.45 32.21 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.57 -1.012 . . . . 25.0 110.57 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.97 124.09 26.33 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 109.184 -0.672 . . . . 25.0 109.184 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -116.3 151.6 35.53 Favored 'General case' 0 C--N 1.313 -0.987 0 O-C-N 121.614 -0.679 . . . . 50.0 112.08 -173.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 98.5 m -114.27 122.57 47.15 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 109.046 -0.724 . . . . 25.0 109.046 177.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -108.96 124.37 50.58 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 106.424 -1.695 . . . . 25.0 106.424 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 49.2 mtt85 -122.49 -36.68 2.89 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.121 0.785 . . . . 25.0 113.121 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 71.69 155.1 0.15 Allowed 'General case' 0 N--CA 1.475 0.817 0 O-C-N 125.07 1.481 . . . . 25.0 108.101 -169.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.52 -43.19 19.12 Favored 'General case' 0 C--N 1.318 -0.765 0 O-C-N 121.852 -0.53 . . . . 25.0 112.158 -165.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 58.6 mt -130.9 163.46 27.42 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 122.054 0.93 . . . . 25.0 111.423 -173.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -56.14 -27.56 54.56 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 114.497 -1.228 . . . . 25.0 108.868 169.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -72.71 -4.68 32.74 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 115.01 1.485 . . . . 25.0 115.01 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -99.09 153.55 18.8 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.41 -0.806 . . . . 25.0 112.894 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.9 t 43.35 48.7 5.93 Favored 'General case' 0 C--O 1.217 -0.649 0 N-CA-C 114.806 1.41 . . . . 25.0 114.806 170.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 28.0 p-80 -131.91 170.23 15.18 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.143 -0.935 . . . . 25.0 110.195 -175.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.5 ttt180 -122.55 142.65 50.39 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 105.707 -1.96 . . . . 25.0 105.707 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 77.9 p -137.55 168.95 14.4 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.207 -0.664 . . . . 25.0 109.207 -176.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -61.45 -24.23 78.02 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 CA-C-N 118.841 0.622 . . . . 25.0 113.266 175.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.2 mt -75.59 -26.49 57.92 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.542 0.687 . . . . 25.0 111.303 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.17 -174.13 32.65 Favored Glycine 0 N--CA 1.463 0.455 0 N-CA-C 110.595 -1.002 . . . . 25.0 110.595 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.8 t -103.18 149.21 24.88 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-O 122.742 1.258 . . . . 25.0 112.956 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -129.03 21.61 5.79 Favored 'General case' 0 C--O 1.252 1.2 0 CA-C-N 114.247 -1.342 . . . . 25.0 109.004 175.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.04 140.5 46.32 Favored Glycine 0 N--CA 1.473 1.105 0 O-C-N 124.549 1.156 . . . . 25.0 111.414 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -96.99 167.37 11.12 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 108.35 -0.981 . . . . 50.0 108.35 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.89 109.32 13.45 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.135 0.791 . . . . 25.0 113.135 -175.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 41.5 mt -87.98 139.46 17.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 105.865 -1.902 . . . . 25.0 105.865 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.2 mt -90.9 -44.44 9.37 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 114.868 1.432 . . . . 25.0 114.868 -176.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.6 p-10 -130.13 39.51 3.66 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 116.165 1.913 . . . . 25.0 116.165 -173.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -55.99 126.84 27.64 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 122.3 -0.25 . . . . 25.0 111.114 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -97.57 104.14 19.46 Favored Pre-proline 0 N--CA 1.474 0.771 0 N-CA-C 108.878 -0.786 . . . . 25.0 108.878 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -70.67 -4.97 15.71 Favored 'Trans proline' 0 C--O 1.213 -0.757 0 N-CA-C 114.973 1.105 . . . . 25.0 114.973 -176.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.8 t -89.42 -28.71 19.56 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.087 0.47 . . . . 25.0 111.08 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -118.72 -38.28 3.13 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 115.217 1.562 . . . . 25.0 115.217 -172.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -85.76 175.01 8.94 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.714 0.635 . . . . 75.0 112.714 -172.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.72 152.26 36.31 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.182 0.808 . . . . 25.0 113.182 170.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 55.9 mt -119.03 132.03 70.1 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 N-CA-C 108.854 -0.795 . . . . 25.0 108.854 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -85.6 145.05 27.53 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 122.32 1.057 . . . . 25.0 111.458 173.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.0 p -143.19 -0.85 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 CA-C-N 114.724 -1.125 . . . . 25.0 110.085 178.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.41 ' HB2' ' HA ' ' A' ' 156' ' ' PHE . 22.8 t -64.76 -42.51 95.07 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.283 0.563 . . . . 25.0 111.11 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.92 -27.85 63.1 Favored 'General case' 0 C--O 1.249 1.066 0 CA-C-N 115.656 -0.702 . . . . 25.0 111.693 -177.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.0 mt -99.12 -58.07 2.02 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 114.255 1.206 . . . . 25.0 114.255 -169.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -104.33 -65.26 0.69 Allowed Glycine 0 C--O 1.242 0.643 0 N-CA-C 116.609 1.404 . . . . 25.0 116.609 -168.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -156.47 164.8 37.82 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.012 0.478 . . . . 25.0 110.451 -168.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.9 p -117.57 -19.74 9.28 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.99 0.516 . . . . 25.0 110.47 173.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -108.32 117.12 4.97 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 109.199 -1.56 . . . . 25.0 109.199 175.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -60.08 151.44 26.66 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 116.216 1.932 . . . . 25.0 116.216 -175.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.89 -169.25 36.63 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 114.856 -1.066 . . . . 25.0 114.798 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -55.8 135.46 51.76 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 113.435 0.902 . . . . 25.0 113.435 -177.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 168.4 177.68 39.62 Favored Glycine 0 C--O 1.236 0.257 0 N-CA-C 107.961 -2.056 . . . . 25.0 107.961 178.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -142.99 168.96 18.48 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.119 1.46 . . . . 25.0 109.21 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 57.8 35.74 25.77 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.737 0.815 . . . . 25.0 111.527 -177.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 69.37 36.66 78.63 Favored Glycine 0 C--N 1.32 -0.333 0 N-CA-C 111.114 -0.795 . . . . 25.0 111.114 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.3 t -140.09 177.85 7.69 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.193 -0.669 . . . . 25.0 109.193 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 84.3 mt -104.5 155.29 18.94 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 102.347 -3.205 . . . . 25.0 102.347 172.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.39 136.37 55.66 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 119.367 -0.933 . . . . 25.0 109.257 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.0 m -110.74 161.62 9.01 Favored 'Isoleucine or valine' 0 C--O 1.248 1.008 0 N-CA-C 108.89 -0.781 . . . . 25.0 108.89 -177.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 80.4 p -142.56 163.32 33.13 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 116.569 -0.287 . . . . 25.0 111.557 -177.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.2 m -116.41 160.99 15.49 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 N-CA-C 107.555 -1.276 . . . . 25.0 107.555 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.5 t -74.07 -48.78 27.49 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.739 -1.208 . . . . 25.0 107.739 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.4 ' C ' ' H ' ' A' ' 120' ' ' GLY . 5.9 p-10 -168.09 -162.47 0.42 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 102.175 -3.268 . . . . 25.0 102.175 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -77.55 12.55 1.56 Allowed 'General case' 0 CA--C 1.546 0.803 0 CA-C-O 121.754 0.788 . . . . 25.0 111.746 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 118' ' ' ASP . . . -150.91 -164.13 11.8 Favored Glycine 0 C--O 1.243 0.716 0 N-CA-C 107.438 -2.265 . . . . 25.0 107.438 176.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.42 -154.85 0.36 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.028 0.381 . . . . 25.0 112.028 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.8 mtt180 -84.08 166.52 17.62 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.925 0.713 . . . . 25.0 112.925 -173.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.68 165.98 12.22 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 105.584 -2.006 . . . . 25.0 105.584 174.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -134.55 158.4 44.08 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.762 0.791 . . . . 25.0 111.8 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 41.8 tp -127.08 129.27 47.66 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 103.834 -2.654 . . . . 25.0 103.834 174.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -123.6 154.21 39.62 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.327 0.584 . . . . 25.0 111.346 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.1 t -99.44 151.21 21.37 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 104.533 -2.395 . . . . 25.0 104.533 167.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -118.67 14.66 13.55 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 107.943 -1.132 . . . . 25.0 107.943 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -105.23 140.41 38.42 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 104.578 -2.378 . . . . 25.0 104.578 172.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -138.43 155.44 48.48 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 123.937 0.773 . . . . 25.0 109.64 -177.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -85.73 163.87 17.96 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.57 -0.741 . . . . 25.0 109.633 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.75 -24.0 67.48 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-O 121.444 0.64 . . . . 25.0 111.819 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -74.33 -4.13 34.44 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.754 0.65 . . . . 25.0 112.754 175.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.18 17.73 64.25 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.568 -0.825 . . . . 25.0 112.247 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.2 mt -93.69 141.95 27.91 Favored 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 107.311 -1.366 . . . . 25.0 107.311 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 63.9 p -141.49 178.41 7.46 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 106.854 -1.535 . . . . 25.0 106.854 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -123.31 133.17 54.18 Favored 'General case' 0 C--O 1.252 1.198 0 CA-C-N 118.544 0.611 . . . . 25.0 111.818 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -148.89 151.43 34.66 Favored 'General case' 0 C--O 1.25 1.103 0 N-CA-C 108.56 -0.904 . . . . 25.0 108.56 171.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.1 p -149.19 146.7 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 107.313 -1.366 . . . . 25.0 107.313 -178.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -104.98 145.57 30.24 Favored 'General case' 0 C--O 1.247 0.972 0 N-CA-C 109.025 -0.732 . . . . 25.0 109.025 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.9 mp -135.45 120.31 18.52 Favored 'General case' 0 C--O 1.211 -0.921 0 N-CA-C 105.1 -2.185 . . . . 25.0 105.1 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -88.06 -13.1 42.36 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 118.302 2.704 . . . . 25.0 118.302 -169.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -78.36 9.0 36.6 Favored Glycine 0 CA--C 1.535 1.332 0 N-CA-C 117.009 1.563 . . . . 25.0 117.009 -175.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 39.9 t0 48.46 51.14 15.78 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 122.716 1.246 . . . . 25.0 112.957 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -110.97 31.97 5.63 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.753 -1.203 . . . . 25.0 107.753 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.29 -38.43 83.59 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 115.232 -0.895 . . . . 25.0 110.968 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.42 -22.41 66.95 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.101 0.56 . . . . 25.0 112.111 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -98.23 -10.71 23.6 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.037 0.754 . . . . 25.0 113.037 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 13.9 mt -66.1 145.85 55.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.776 0.798 . . . . 25.0 112.214 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 72.1 m -142.97 157.34 44.65 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.853 -1.165 . . . . 25.0 107.853 177.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -81.4 9.04 7.88 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.451 0.3 . . . . 25.0 110.424 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -92.72 -22.87 19.14 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.857 0.36 . . . . 25.0 110.071 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -99.17 20.63 13.14 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 122.79 1.281 . . . . 25.0 109.048 173.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 39.8 mm -122.04 130.01 74.92 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 N-CA-C 101.753 -3.425 . . . . 25.0 101.753 170.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.2 p -108.64 128.34 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 119.35 0.977 . . . . 25.0 110.948 -172.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.41 ' HA ' ' HB2' ' A' ' 97' ' ' SER . 25.0 p90 -167.17 -24.64 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.885 -1.052 . . . . 25.0 113.376 -176.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -82.16 80.63 8.33 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.719 -0.613 . . . . 25.0 110.802 -172.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 59.22 8.61 1.13 Allowed 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 115.326 1.602 . . . . 25.0 115.326 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 m 66.37 -37.87 0.29 Allowed 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 116.59 2.07 . . . . 25.0 116.59 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -65.3 138.07 57.95 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 122.009 -0.432 . . . . 25.0 111.414 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.0 -6.22 31.88 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 121.009 0.433 . . . . 25.0 110.83 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.85 -13.7 61.75 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 116.175 -0.466 . . . . 25.0 111.083 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -102.88 160.33 14.7 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 109.764 -0.458 . . . . 25.0 109.764 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 56.56 -163.52 0.16 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.945 1.461 . . . . 25.0 114.945 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 90.43 15.97 56.11 Favored Glycine 0 N--CA 1.459 0.207 0 N-CA-C 114.662 0.625 . . . . 25.0 114.662 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -83.41 115.9 22.25 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 117.271 0.535 . . . . 25.0 111.696 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -110.68 134.12 52.73 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.133 -0.691 . . . . 25.0 109.133 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.8 45.78 0.7 Allowed Glycine 0 C--O 1.224 -0.505 0 N-CA-C 111.513 -0.635 . . . . 25.0 111.513 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 43.1 t -84.46 -32.01 7.8 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 CA-C-O 121.678 0.752 . . . . 25.0 109.619 -177.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.68 135.4 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 CA-C-O 121.713 0.768 . . . . 25.0 112.082 -176.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 161.84 133.88 1.55 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.622 -1.391 . . . . 25.0 109.622 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -148.49 152.12 36.35 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 117.393 0.597 . . . . 25.0 110.941 -177.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 51.2 p -155.41 166.54 33.22 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.365 -0.976 . . . . 25.0 108.365 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 161.67 146.99 4.83 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 121.179 -0.534 . . . . 25.0 113.707 176.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -98.56 110.15 55.73 Favored Pre-proline 0 C--O 1.247 0.957 0 C-N-CA 123.599 0.76 . . . . 25.0 109.512 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.59 150.13 79.76 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 116.936 -1.576 . . . . 25.0 111.853 176.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -110.3 141.46 43.27 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 109.662 -0.496 . . . . 25.0 109.662 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -130.41 79.29 72.7 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-O 120.955 0.407 . . . . 25.0 111.81 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.3 157.81 52.82 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 N-CA-C 114.066 0.756 . . . . 25.0 114.066 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.8 t -99.04 -17.4 18.28 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.248 -0.649 . . . . 25.0 109.248 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 12.0 p . . . . . 0 C--O 1.246 0.894 0 CA-C-O 117.338 -1.315 . . . . 25.0 108.473 173.411 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo . . . . . 0 C--O 1.234 0.302 0 N-CA-C 115.691 1.381 . . . . 25.0 115.691 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.27 51.76 0.29 Allowed Glycine 0 C--O 1.211 -1.3 0 N-CA-C 106.807 -2.517 . . . . 25.0 106.807 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.6 p -55.35 125.83 11.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 N-CA-C 114.564 1.32 . . . . 25.0 114.564 -172.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -105.64 11.2 32.52 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-O 122.189 0.995 . . . . 25.0 109.555 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -94.31 -155.73 31.85 Favored Glycine 0 N--CA 1.447 -0.625 0 O-C-N 121.38 -0.825 . . . . 25.0 113.704 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.0 p 70.18 158.2 0.16 Allowed Pre-proline 0 N--CA 1.486 1.343 0 C-N-CA 126.08 1.752 . . . . 25.0 112.518 -176.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.42 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 35.2 Cg_exo -66.2 -0.78 4.5 Favored 'Trans proline' 0 C--N 1.358 1.073 0 N-CA-C 116.957 1.868 . . . . 25.0 116.957 -174.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.1 p -65.56 -11.28 11.9 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 N-CA-C 115.91 1.818 . . . . 25.0 115.91 -171.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.8 p -146.42 127.2 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 N-CA-C 114.713 1.375 . . . . 25.0 114.713 -176.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.26 18.66 71.53 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 118.148 2.019 . . . . 25.0 118.148 173.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.7 t -50.86 -37.33 42.67 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 115.331 1.604 . . . . 25.0 115.331 -174.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -75.12 2.43 10.77 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 114.88 1.437 . . . . 25.0 114.88 -175.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.25 173.22 11.72 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 118.971 0.805 . . . . 25.0 110.598 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -51.11 128.41 21.7 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 112.886 0.698 . . . . 25.0 112.886 -177.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -129.91 159.4 36.75 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.39 0.885 . . . . 50.0 113.39 -173.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -125.9 95.98 4.6 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 105.353 -2.092 . . . . 25.0 105.353 165.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 80.9 mt -103.57 108.49 19.78 Favored 'General case' 0 C--O 1.212 -0.895 0 N-CA-C 112.976 0.732 . . . . 25.0 112.976 -176.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -98.82 109.75 22.46 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.962 -0.563 . . . . 25.0 109.596 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.0 172.53 51.63 Favored Glycine 0 C--O 1.219 -0.813 0 N-CA-C 115.893 1.117 . . . . 25.0 115.893 -175.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.8 p -72.31 175.76 5.86 Favored 'General case' 0 C--O 1.246 0.889 0 C-N-CA 123.656 0.782 . . . . 25.0 111.404 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 66.6 mt -87.91 16.73 5.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.52 0.676 . . . . 25.0 110.712 174.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.91 179.5 17.94 Favored Glycine 0 N--CA 1.461 0.331 0 N-CA-C 110.029 -1.228 . . . . 25.0 110.029 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.8 t -74.39 133.24 42.47 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.818 0.447 . . . . 25.0 110.454 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -144.54 166.56 24.81 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.453 0.701 . . . . 50.0 109.495 -177.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -110.37 121.89 46.39 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 104.839 -2.282 . . . . 25.0 104.839 164.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.0 mm -111.03 122.41 65.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 107.1 -1.445 . . . . 25.0 107.1 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.42 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 10.9 mp -119.58 122.72 42.22 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.467 -0.938 . . . . 25.0 108.467 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.17 -37.48 32.18 Favored Glycine 0 CA--C 1.496 -1.115 0 CA-C-O 117.888 -1.506 . . . . 25.0 116.074 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.64 -150.21 51.79 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 119.498 1.649 . . . . 25.0 112.357 -177.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.04 168.79 47.02 Favored Glycine 0 CA--C 1.526 0.776 0 O-C-N 121.855 -0.791 . . . . 25.0 114.12 -178.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.05 167.03 29.65 Favored Glycine 0 C--O 1.246 0.871 0 C-N-CA 121.378 -0.439 . . . . 25.0 113.391 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.44 101.25 12.46 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 106.601 -1.629 . . . . 25.0 106.601 177.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -96.32 152.16 18.84 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 113.255 0.835 . . . . 50.0 113.255 -169.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -119.06 88.42 2.93 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 107.531 -1.285 . . . . 25.0 107.531 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 52.4 mt -97.41 143.77 27.81 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.581 -0.736 . . . . 25.0 110.437 -169.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -137.21 106.65 6.11 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 121.905 -0.497 . . . . 25.0 111.497 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.62 -30.1 53.78 Favored Glycine 0 N--CA 1.466 0.659 0 CA-C-O 118.721 -1.044 . . . . 25.0 113.667 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 50.46 -149.71 0.27 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 117.865 0.832 . . . . 25.0 111.51 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.49 163.09 27.54 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.933 0.873 . . . . 25.0 112.736 -174.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.72 156.65 31.64 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 110.514 -1.034 . . . . 25.0 110.514 -174.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -86.82 100.57 12.63 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.213 -1.403 . . . . 25.0 107.213 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -102.84 152.0 21.78 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.23 -0.896 . . . . 50.0 112.955 -169.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mp -110.72 122.79 48.69 Favored 'General case' 0 C--O 1.217 -0.605 0 N-CA-C 107.005 -1.479 . . . . 25.0 107.005 176.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.9 mp -123.21 130.85 53.32 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 114.598 1.332 . . . . 25.0 114.598 -172.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -121.65 143.44 49.33 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.563 1.545 . . . . 25.0 109.011 175.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.76 -37.6 3.16 Favored Glycine 0 C--O 1.242 0.621 0 N-CA-C 115.296 0.878 . . . . 25.0 115.296 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.03 -168.38 54.71 Favored Glycine 0 C--O 1.246 0.885 0 CA-C-N 117.868 0.834 . . . . 25.0 111.974 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.61 151.72 23.98 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.196 -1.179 . . . . 25.0 112.427 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.99 162.13 38.19 Favored Glycine 0 N--CA 1.466 0.698 0 CA-C-N 115.353 -0.84 . . . . 25.0 111.693 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.74 122.71 29.01 Favored 'General case' 0 C--O 1.212 -0.892 0 N-CA-C 105.255 -2.128 . . . . 25.0 105.255 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -114.42 156.71 24.0 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 122.017 0.913 . . . . 50.0 110.526 -172.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -114.88 122.29 45.86 Favored 'General case' 0 C--O 1.218 -0.595 0 N-CA-C 102.305 -3.22 . . . . 25.0 102.305 177.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -142.19 131.01 22.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 119.165 0.893 . . . . 25.0 113.194 -175.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.99 142.03 34.78 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 115.722 -0.672 . . . . 25.0 109.26 177.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.91 -40.57 5.53 Favored Glycine 0 C--O 1.246 0.868 0 N-CA-C 109.294 -1.522 . . . . 25.0 109.294 175.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.0 -172.97 55.05 Favored Glycine 0 C--O 1.244 0.77 0 C-N-CA 120.278 -0.963 . . . . 25.0 112.786 -176.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -64.07 159.02 21.18 Favored 'General case' 0 C--O 1.251 1.142 0 O-C-N 122.178 -0.601 . . . . 25.0 110.864 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.75 161.87 37.24 Favored Glycine 0 C--O 1.247 0.91 0 CA-C-N 115.141 -0.936 . . . . 25.0 111.413 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.95 105.74 14.19 Favored 'General case' 0 C--O 1.217 -0.649 0 N-CA-C 107.807 -1.183 . . . . 25.0 107.807 -178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -99.54 156.74 16.89 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 122.666 0.387 . . . . 50.0 111.826 -172.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 47.8 m -123.71 111.52 16.27 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.82 0.819 . . . . 25.0 110.09 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -88.39 96.46 10.6 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 104.917 -2.253 . . . . 25.0 104.917 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.4 mmt85 -81.22 -37.69 28.21 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.595 0.591 . . . . 25.0 112.595 -174.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 64.36 149.3 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 O-C-N 125.882 1.989 . . . . 25.0 111.998 -172.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.32 -59.99 2.56 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 114.995 1.48 . . . . 25.0 114.995 -168.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 48.7 mt -135.52 175.65 9.39 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 108.286 -1.005 . . . . 25.0 108.286 -170.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.62 -27.81 42.23 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.019 0.928 . . . . 25.0 110.838 171.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -76.06 -7.38 54.56 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 115.114 1.524 . . . . 25.0 115.114 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -90.16 136.49 33.01 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.325 -0.859 . . . . 25.0 112.84 -174.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.0 t 43.97 44.16 5.83 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 116.312 1.967 . . . . 25.0 116.312 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -113.66 173.91 6.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.886 -1.052 . . . . 25.0 112.18 -177.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -125.69 139.93 53.13 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 104.076 -2.565 . . . . 25.0 104.076 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 57.7 p -134.27 169.47 13.8 Favored Pre-proline 0 C--O 1.214 -0.786 0 N-CA-C 108.501 -0.925 . . . . 25.0 108.501 -176.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -61.91 -15.82 45.51 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 120.399 0.733 . . . . 25.0 112.764 176.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 89.7 mt -84.76 -31.48 23.95 Favored 'General case' 0 C--O 1.245 0.819 0 O-C-N 121.622 -0.674 . . . . 25.0 111.077 177.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.34 177.47 32.46 Favored Glycine 0 CA--C 1.503 -0.716 0 C-N-CA 121.108 -0.567 . . . . 25.0 112.761 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.2 t -88.49 146.8 24.98 Favored 'General case' 0 C--O 1.253 1.255 0 CA-C-O 121.983 0.896 . . . . 25.0 112.127 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -135.1 32.58 3.16 Favored 'General case' 0 C--O 1.254 1.331 0 CA-C-N 113.8 -1.545 . . . . 25.0 108.371 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -64.91 137.38 38.68 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 109.541 -1.424 . . . . 25.0 109.541 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -87.49 168.59 12.96 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 117.699 0.75 . . . . 50.0 110.659 -177.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -118.25 107.46 13.93 Favored 'General case' 0 C--O 1.245 0.847 0 O-C-N 123.789 0.681 . . . . 25.0 111.44 -175.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 52.7 mt -86.93 131.39 35.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 107.05 -1.463 . . . . 25.0 107.05 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.0 mt -75.88 -49.57 17.51 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 116.175 1.917 . . . . 25.0 116.175 -173.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -137.78 41.59 2.33 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.537 0.684 . . . . 25.0 112.282 -169.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -56.51 138.61 51.5 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.902 0.858 . . . . 25.0 110.72 -176.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -105.84 99.19 20.91 Favored Pre-proline 0 C--O 1.215 -0.74 0 N-CA-C 109.224 -0.658 . . . . 25.0 109.224 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -67.53 1.6 3.01 Favored 'Trans proline' 0 C--N 1.358 1.034 0 N-CA-C 115.39 1.265 . . . . 25.0 115.39 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.5 t -103.89 -42.27 5.64 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 117.515 0.143 . . . . 25.0 110.795 175.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -99.39 -36.99 9.41 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 115.15 1.537 . . . . 25.0 115.15 -175.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -85.08 170.74 12.64 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.028 -0.73 . . . . 75.0 109.028 -171.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -146.42 158.04 43.84 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.953 0.901 . . . . 25.0 110.363 177.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 64.9 mt -130.34 134.84 61.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.91 -0.774 . . . . 25.0 108.91 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -90.12 148.48 22.98 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 122.197 0.999 . . . . 25.0 109.367 175.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.5 p -153.55 -9.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 114.803 -1.09 . . . . 25.0 110.841 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.8 t -60.82 -39.71 90.04 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.036 0.446 . . . . 25.0 111.358 -178.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -86.48 -7.87 58.05 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 115.084 1.513 . . . . 25.0 115.084 -176.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.78 0.28 1.78 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 116.074 1.879 . . . . 25.0 116.074 -172.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -143.26 -69.38 0.02 OUTLIER Glycine 0 N--CA 1.467 0.76 0 N-CA-C 116.094 1.198 . . . . 25.0 116.094 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -156.03 163.81 39.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 117.467 0.634 . . . . 25.0 110.174 -174.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 30.8 t -112.71 -34.15 5.89 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 122.034 0.921 . . . . 25.0 110.552 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -107.12 137.38 13.93 Favored Glycine 0 C--O 1.223 -0.587 0 N-CA-C 107.824 -2.111 . . . . 25.0 107.824 176.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.88 151.39 45.74 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 118.936 -1.106 . . . . 25.0 109.269 -177.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -92.37 -164.11 38.11 Favored Glycine 0 C--O 1.222 -0.645 0 CA-C-N 115.839 -0.619 . . . . 25.0 112.04 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -53.59 129.04 31.45 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.798 0.809 . . . . 25.0 111.801 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 174.99 -176.47 47.14 Favored Glycine 0 C--O 1.215 -1.051 0 N-CA-C 109.928 -1.269 . . . . 25.0 109.928 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -155.94 167.62 29.81 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 118.451 1.126 . . . . 25.0 111.09 -178.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 53.92 43.7 30.5 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 124.319 1.048 . . . . 25.0 112.65 -178.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 68.94 30.24 72.34 Favored Glycine 0 C--O 1.219 -0.796 0 CA-C-N 115.291 -0.868 . . . . 25.0 112.864 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.2 t -142.51 171.69 13.72 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 118.316 1.058 . . . . 25.0 111.722 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 83.6 mt -90.42 164.1 14.42 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 103.329 -2.841 . . . . 25.0 103.329 171.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.68 110.36 7.91 Favored 'General case' 0 C--O 1.252 1.226 0 N-CA-C 107.753 -1.203 . . . . 25.0 107.753 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 18.7 m -71.89 162.7 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-N 115.349 -0.841 . . . . 25.0 109.587 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 29.5 m -145.8 169.78 17.85 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 120.292 -0.563 . . . . 25.0 109.883 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 34.9 m -121.77 164.38 18.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 108.738 -0.838 . . . . 25.0 108.738 177.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.8 t -76.14 -48.64 19.84 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.319 -1.363 . . . . 25.0 107.319 170.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -165.73 -170.42 1.79 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 101.502 -3.518 . . . . 25.0 101.502 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -69.85 -2.84 13.38 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 119.164 0.893 . . . . 25.0 112.856 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -137.35 -160.94 8.75 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 106.204 -2.759 . . . . 25.0 106.204 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.45 HG23 ' H ' ' A' ' 122' ' ' ARG . 0.2 OUTLIER 59.16 -160.34 0.28 Allowed 'General case' 0 C--O 1.249 1.062 0 CA-C-N 117.865 0.832 . . . . 25.0 111.093 177.79 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.45 ' H ' HG23 ' A' ' 121' ' ' THR . 47.0 mtt85 -71.08 166.86 20.51 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 122.279 1.038 . . . . 25.0 112.975 -171.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.1 p -114.15 165.92 12.16 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 105.74 -1.948 . . . . 25.0 105.74 173.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -133.55 153.56 51.55 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 121.14 0.495 . . . . 25.0 111.772 -177.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 28.2 tp -128.01 118.92 24.4 Favored 'General case' 0 C--O 1.25 1.099 0 N-CA-C 103.684 -2.709 . . . . 25.0 103.684 171.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -115.23 145.17 42.69 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 115.829 -0.623 . . . . 25.0 112.298 -174.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.9 t -99.71 147.83 25.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 105.221 -2.14 . . . . 25.0 105.221 168.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -114.79 11.48 16.76 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.889 1.328 . . . . 25.0 108.456 -177.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -93.62 141.17 28.78 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 105.53 -2.026 . . . . 25.0 105.53 174.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -140.83 150.34 43.16 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 122.055 0.931 . . . . 25.0 109.81 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -76.6 167.01 22.59 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.331 -1.304 . . . . 25.0 108.791 177.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.96 -32.39 73.7 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.591 -0.892 . . . . 25.0 108.591 176.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -65.42 -9.28 23.95 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 114.423 1.268 . . . . 25.0 114.423 174.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.57 21.85 61.23 Favored Glycine 0 C--O 1.241 0.581 0 N-CA-C 109.453 -1.459 . . . . 25.0 109.453 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.5 mt -92.05 136.8 32.88 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 106.092 -1.818 . . . . 25.0 106.092 175.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.6 p -141.55 -179.7 6.31 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.867 -1.16 . . . . 25.0 107.867 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -127.94 131.77 49.3 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 119.085 -1.046 . . . . 25.0 113.222 -178.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -147.61 153.95 40.04 Favored 'General case' 0 C--O 1.26 1.619 0 N-CA-C 106.818 -1.549 . . . . 25.0 106.818 168.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.1 p -142.12 146.6 22.42 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 106.93 -1.508 . . . . 25.0 106.93 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -103.2 140.93 36.72 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 107.094 -1.447 . . . . 25.0 107.094 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.2 mp -129.42 131.2 46.72 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 105.177 -2.157 . . . . 25.0 105.177 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -108.9 15.83 23.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.142 0.973 . . . . 25.0 110.541 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -72.91 -8.42 73.2 Favored Glycine 0 C--O 1.238 0.386 0 CA-C-N 114.761 -1.109 . . . . 25.0 110.719 171.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 40.0 t0 51.08 55.92 8.79 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.585 0.707 . . . . 25.0 112.445 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -133.14 43.55 2.93 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-O 122.178 0.989 . . . . 25.0 109.913 -174.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.66 -31.03 64.0 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 121.633 -0.667 . . . . 25.0 111.061 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.74 -14.83 61.63 Favored 'General case' 0 C--O 1.256 1.399 0 N-CA-C 112.406 0.521 . . . . 25.0 112.406 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -109.48 -10.72 14.87 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.108 0.48 . . . . 25.0 111.743 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 29.7 mt -73.69 126.21 29.8 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 123.193 1.473 . . . . 25.0 112.562 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 68.0 m -127.96 158.72 37.08 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 105.553 -2.017 . . . . 25.0 105.553 175.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.13 -3.57 49.38 Favored 'General case' 0 C--O 1.211 -0.95 0 CA-C-N 115.854 -0.612 . . . . 25.0 110.418 -178.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -67.1 -35.98 80.97 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 117.69 0.223 . . . . 25.0 111.297 -173.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -75.89 -11.44 59.97 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 120.307 -0.557 . . . . 25.0 110.597 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 22.5 mm -83.91 119.9 33.89 Favored 'Isoleucine or valine' 0 C--O 1.247 0.957 0 N-CA-C 106.449 -1.685 . . . . 25.0 106.449 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.6 p -95.94 109.37 22.59 Favored 'Isoleucine or valine' 0 C--O 1.253 1.247 0 CA-C-O 123.044 1.402 . . . . 25.0 113.797 -174.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -145.21 -12.92 0.53 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.649 -1.614 . . . . 25.0 112.185 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -76.75 54.19 0.96 Allowed 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 113.302 0.853 . . . . 25.0 113.302 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 57.87 27.65 14.92 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 113.784 1.031 . . . . 25.0 113.784 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 55.98 0.65 0.06 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 119.361 3.097 . . . . 25.0 119.361 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -88.12 134.23 33.81 Favored 'General case' 0 C--N 1.314 -0.962 0 O-C-N 121.255 -0.903 . . . . 25.0 110.758 -176.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -68.84 -14.28 62.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.918 -0.583 . . . . 25.0 109.578 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.11 -28.1 69.39 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.121 0.486 . . . . 25.0 111.626 177.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.1 162.06 28.86 Favored 'General case' 0 C--O 1.251 1.138 0 CA-C-O 121.264 0.555 . . . . 25.0 111.822 -177.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 61.38 -157.38 0.34 Allowed 'General case' 0 C--O 1.242 0.663 0 CA-C-N 114.629 -1.169 . . . . 25.0 112.619 177.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 90.95 -1.25 77.57 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.597 -0.335 . . . . 25.0 112.429 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -104.32 115.28 30.1 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.779 -0.823 . . . . 25.0 108.779 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -123.53 139.94 53.51 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.274 -0.639 . . . . 25.0 109.274 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -113.93 26.0 10.33 Favored Glycine 0 C--O 1.241 0.59 0 N-CA-C 112.314 -0.314 . . . . 25.0 112.314 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 52.3 t -79.18 -37.27 19.08 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 N-CA-C 109.463 -0.569 . . . . 25.0 109.463 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.43 135.64 24.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.629 0.728 . . . . 25.0 111.238 -175.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 133.58 141.78 4.62 Favored Glycine 0 C--O 1.247 0.969 0 N-CA-C 110.935 -0.866 . . . . 25.0 110.935 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -151.72 161.12 43.2 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.272 -0.64 . . . . 25.0 109.272 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 84.7 p -152.91 165.67 34.74 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 107.732 -1.21 . . . . 25.0 107.732 176.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -177.31 -171.13 40.52 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 119.887 -1.149 . . . . 25.0 112.114 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -138.78 92.54 11.22 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 117.587 0.693 . . . . 25.0 110.96 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.12 161.67 40.38 Favored 'Trans proline' 0 C--O 1.232 0.209 0 O-C-N 122.801 0.895 . . . . 25.0 112.115 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -134.64 151.43 51.04 Favored 'General case' 0 CA--C 1.508 -0.638 0 C-N-CA 123.535 0.734 . . . . 25.0 109.772 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -122.86 75.1 47.7 Favored Pre-proline 0 N--CA 1.481 1.084 0 CA-C-O 121.399 0.619 . . . . 25.0 110.842 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -77.44 160.33 32.16 Favored 'Trans proline' 0 CA--C 1.513 -0.526 0 C-N-CA 116.787 -1.675 . . . . 25.0 112.533 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 12.2 t -125.64 -4.9 7.06 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.211 -0.904 . . . . 25.0 110.741 174.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 6.3 p . . . . . 0 C--O 1.246 0.871 0 N-CA-C 109.61 -0.515 . . . . 25.0 109.61 176.72 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo . . . . . 0 C--O 1.234 0.283 0 N-CA-C 113.097 0.384 . . . . 25.0 113.097 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -150.25 44.49 0.7 Allowed Glycine 0 CA--C 1.536 1.352 0 N-CA-C 114.533 0.573 . . . . 25.0 114.533 -177.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.9 p -52.51 129.94 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 114.776 1.398 . . . . 25.0 114.776 -176.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -93.49 -7.71 43.58 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.838 -1.073 . . . . 25.0 111.536 -178.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.93 -149.5 7.47 Favored Glycine 0 CA--C 1.507 -0.464 0 CA-C-N 115.597 -0.729 . . . . 25.0 114.344 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.2 p 71.94 156.43 0.16 Allowed Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 126.266 1.826 . . . . 25.0 110.581 -173.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.582 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 24.6 Cg_exo -69.27 -0.21 6.19 Favored 'Trans proline' 0 C--N 1.354 0.849 0 N-CA-C 114.846 1.056 . . . . 25.0 114.846 -175.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.8 p -66.9 -14.43 18.03 Favored 'Isoleucine or valine' 0 C--O 1.248 0.983 0 N-CA-C 113.954 1.094 . . . . 25.0 113.954 -171.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.4 p -133.57 132.12 57.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 N-CA-C 113.758 1.022 . . . . 25.0 113.758 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.7 13.62 74.97 Favored Glycine 0 C--O 1.246 0.888 0 N-CA-C 118.642 2.217 . . . . 25.0 118.642 171.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.3 t -51.2 -41.78 60.46 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.153 1.168 . . . . 25.0 114.153 -171.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -78.61 4.96 12.09 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 116.243 1.942 . . . . 25.0 116.243 -174.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.93 176.94 9.11 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 118.832 -0.604 . . . . 25.0 111.438 -177.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -57.64 133.28 55.17 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.339 0.59 . . . . 25.0 111.585 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -130.18 157.27 42.93 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.539 0.941 . . . . 50.0 113.539 -173.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -132.25 73.08 1.51 Allowed 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 106.738 -1.578 . . . . 25.0 106.738 169.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.6 mt -91.48 125.8 36.35 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 114.366 1.247 . . . . 25.0 114.366 -174.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -110.1 109.93 20.64 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 116.327 -0.397 . . . . 25.0 110.901 176.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -80.62 176.61 54.62 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 115.855 1.102 . . . . 25.0 115.855 -175.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.7 p -69.08 170.76 9.36 Favored 'General case' 0 C--O 1.256 1.444 0 C-N-CA 123.885 0.874 . . . . 25.0 110.361 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 48.6 mt -87.06 20.82 2.53 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.657 -0.702 . . . . 25.0 110.769 170.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -128.62 -174.01 13.61 Favored Glycine 0 C--O 1.223 -0.56 0 CA-C-O 118.615 -1.103 . . . . 25.0 112.505 176.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.9 t -71.08 133.1 46.01 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 113.857 1.058 . . . . 25.0 113.857 -176.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -145.18 158.52 43.8 Favored 'General case' 0 C--O 1.219 -0.541 0 O-C-N 123.211 0.32 . . . . 50.0 111.682 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -99.61 134.15 42.91 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 103.352 -2.833 . . . . 25.0 103.352 162.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.9 mm -128.41 117.92 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 105.676 -1.972 . . . . 25.0 105.676 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.582 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 8.3 mp -115.55 116.19 27.74 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 106.888 -1.523 . . . . 25.0 106.888 178.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.76 -36.11 90.72 Favored Glycine 0 CA--C 1.502 -0.779 0 C-N-CA 120.567 -0.825 . . . . 25.0 115.062 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.34 -147.21 45.37 Favored Glycine 0 C--O 1.254 1.39 0 C-N-CA 120.813 -0.708 . . . . 25.0 112.027 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.99 165.66 54.74 Favored Glycine 0 C--O 1.249 1.039 0 N-CA-C 111.847 -0.501 . . . . 25.0 111.847 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.84 162.96 28.94 Favored Glycine 0 C--N 1.316 -0.546 0 N-CA-C 114.967 0.747 . . . . 25.0 114.967 174.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.78 106.65 16.47 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 106.524 -1.658 . . . . 25.0 106.524 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -103.58 155.3 18.65 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 112.892 0.701 . . . . 50.0 112.892 -169.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -122.77 93.7 4.05 Favored 'General case' 0 C--O 1.246 0.906 0 N-CA-C 106.277 -1.749 . . . . 25.0 106.277 176.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.8 mt -101.21 140.09 35.98 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 114.881 -1.054 . . . . 25.0 111.356 -170.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -135.64 102.73 5.19 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.563 -0.532 . . . . 25.0 109.563 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.56 -20.7 59.57 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 116.463 1.345 . . . . 25.0 116.463 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 50.29 -150.51 0.23 Allowed 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 119.548 1.674 . . . . 25.0 115.126 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.68 162.2 13.62 Favored 'General case' 0 CA--C 1.552 1.041 0 O-C-N 120.908 -1.12 . . . . 25.0 112.752 -177.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.86 156.12 28.25 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 114.828 -1.078 . . . . 25.0 111.574 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -77.91 106.6 9.86 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 106.943 -1.503 . . . . 25.0 106.943 173.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -111.93 151.83 28.74 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 121.577 -0.702 . . . . 50.0 110.649 -170.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mp -116.13 94.82 4.81 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.966 -1.124 . . . . 25.0 107.966 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 mp -99.25 127.01 45.19 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.701 0.8 . . . . 25.0 112.912 -175.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -124.4 148.81 47.32 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 104.35 -2.463 . . . . 25.0 104.35 175.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.47 -39.37 3.46 Favored Glycine 0 N--CA 1.462 0.432 0 N-CA-C 116.193 1.237 . . . . 25.0 116.193 -175.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.38 -175.55 48.77 Favored Glycine 0 C--O 1.243 0.718 0 N-CA-C 110.266 -1.134 . . . . 25.0 110.266 -177.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.01 149.14 12.31 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 112.752 0.649 . . . . 25.0 112.752 -178.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.41 153.47 29.6 Favored Glycine 0 N--CA 1.46 0.251 0 N-CA-C 111.017 -0.833 . . . . 25.0 111.017 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.5 125.38 29.28 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 104.222 -2.511 . . . . 25.0 104.222 177.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -109.65 153.12 24.68 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.328 -0.619 . . . . 50.0 109.328 -173.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -116.02 122.62 45.74 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 102.409 -3.182 . . . . 25.0 102.409 177.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -145.41 130.86 18.72 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 114.707 1.373 . . . . 25.0 114.707 -171.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.0 m -107.44 132.25 53.4 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 105.99 -1.855 . . . . 25.0 105.99 176.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -91.57 -27.53 17.15 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 111.581 -0.607 . . . . 25.0 111.581 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.21 -169.41 54.91 Favored Glycine 0 N--CA 1.466 0.648 0 CA-C-N 118.022 0.911 . . . . 25.0 113.704 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -66.2 163.41 17.84 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.903 -0.763 . . . . 25.0 110.956 177.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.44 160.29 36.39 Favored Glycine 0 C--O 1.25 1.124 0 CA-C-O 119.897 -0.391 . . . . 25.0 112.678 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.33 102.3 6.7 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.631 0.729 . . . . 25.0 109.853 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -94.85 154.1 17.4 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.773 -0.649 . . . . 50.0 111.545 -174.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.5 m -121.96 127.91 50.9 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.054 -1.461 . . . . 25.0 107.054 -177.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -116.8 82.09 1.74 Allowed 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 106.992 -1.484 . . . . 25.0 106.992 176.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.71 -27.27 40.66 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-N 115.634 -0.712 . . . . 25.0 110.946 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 66.98 153.84 0.09 Allowed 'General case' 0 N--CA 1.479 1.018 0 O-C-N 125.678 1.861 . . . . 25.0 112.112 -172.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.06 -50.8 8.67 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.917 1.08 . . . . 25.0 113.917 -166.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 46.6 mt -130.4 168.86 16.29 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-O 121.372 0.605 . . . . 25.0 109.564 -172.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.17 -28.47 53.09 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.977 0.911 . . . . 25.0 110.585 173.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -75.4 -12.88 60.34 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 115.576 1.695 . . . . 25.0 115.576 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -73.26 134.74 44.35 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.026 1.121 . . . . 25.0 114.026 -174.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.3 t 50.22 42.56 25.62 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 114.759 -1.109 . . . . 25.0 113.655 176.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -107.75 162.45 13.97 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.135 -0.484 . . . . 25.0 111.623 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -122.9 144.6 49.11 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 103.799 -2.667 . . . . 25.0 103.799 177.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 99.3 p -140.12 172.08 6.86 Favored Pre-proline 0 C--N 1.325 -0.478 0 C-N-CA 123.71 0.804 . . . . 25.0 108.963 -173.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -61.1 -19.26 62.56 Favored 'Trans proline' 0 C--N 1.354 0.829 0 O-C-N 122.653 0.817 . . . . 25.0 113.592 174.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.0 mt -79.36 -23.62 43.23 Favored 'General case' 0 C--O 1.245 0.857 0 N-CA-C 113.037 0.754 . . . . 25.0 113.037 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 148.51 -172.35 28.73 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 116.216 -0.447 . . . . 25.0 112.09 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.7 t -101.23 137.71 39.22 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.734 0.778 . . . . 25.0 111.859 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -122.63 29.93 6.68 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.22 -1.355 . . . . 25.0 107.694 173.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.91 146.56 50.43 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 109.765 -1.334 . . . . 25.0 109.765 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -95.84 163.66 13.07 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.41 -1.053 . . . . 50.0 110.316 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -126.04 104.06 8.07 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 111.992 0.367 . . . . 25.0 111.992 -170.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 21.6 mt -86.47 135.1 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 107.206 -1.405 . . . . 25.0 107.206 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.3 mt -89.02 -42.49 11.73 Favored 'General case' 0 C--O 1.21 -0.991 0 N-CA-C 114.77 1.396 . . . . 25.0 114.77 -175.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 46.8 p-10 -127.62 41.17 3.56 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.989 1.477 . . . . 25.0 114.989 -172.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -60.23 142.76 54.02 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 113.399 0.889 . . . . 25.0 113.399 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -117.1 100.13 53.11 Favored Pre-proline 0 N--CA 1.476 0.835 0 N-CA-C 108.948 -0.76 . . . . 25.0 108.948 177.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.9 1.66 4.32 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 N-CA-C 117.129 1.934 . . . . 25.0 117.129 -172.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.6 t -100.7 -35.84 9.33 Favored 'General case' 0 CA--C 1.554 1.099 0 O-C-N 121.763 -0.585 . . . . 25.0 110.753 175.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -98.86 -39.14 8.74 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 114.281 1.215 . . . . 25.0 114.281 -177.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -83.48 163.69 20.34 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.973 -0.558 . . . . 75.0 110.525 -172.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -142.26 146.14 34.82 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.003 0.814 . . . . 25.0 112.486 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 80.1 mt -125.96 131.92 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 107.753 -1.203 . . . . 25.0 107.753 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -88.29 144.5 26.38 Favored 'General case' 0 C--O 1.214 -0.814 0 O-C-N 120.958 -1.089 . . . . 25.0 110.185 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.4 p -146.69 4.42 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.359 0 CA-C-N 115.232 -0.894 . . . . 25.0 110.242 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.2 t -55.67 -57.72 10.8 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 112.9 0.704 . . . . 25.0 112.9 -173.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.44 -14.1 57.46 Favored 'General case' 0 C--O 1.256 1.404 0 N-CA-C 112.445 0.535 . . . . 25.0 112.445 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.9 mt -89.44 -52.91 4.79 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.285 0.564 . . . . 25.0 112.299 -175.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -109.03 -65.2 0.56 Allowed Glycine 0 CA--C 1.506 -0.523 0 N-CA-C 116.637 1.415 . . . . 25.0 116.637 -171.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -157.84 169.31 24.89 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 117.003 0.401 . . . . 25.0 111.353 -171.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.0 t -109.52 -23.6 11.41 Favored 'General case' 0 CA--C 1.557 1.233 0 O-C-N 123.869 0.731 . . . . 25.0 111.977 177.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -120.4 145.03 17.42 Favored Glycine 0 C--O 1.235 0.173 0 N-CA-C 105.593 -3.003 . . . . 25.0 105.593 172.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -58.28 154.0 14.23 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.095 1.146 . . . . 25.0 114.095 -173.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -90.17 -166.2 41.16 Favored Glycine 0 C--O 1.223 -0.59 0 CA-C-N 115.272 -0.876 . . . . 25.0 112.989 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -57.04 131.38 49.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.356 0.598 . . . . 25.0 112.202 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 160.41 178.1 34.1 Favored Glycine 0 N--CA 1.466 0.698 0 N-CA-C 107.054 -2.418 . . . . 25.0 107.054 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -141.76 166.72 23.95 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.932 1.366 . . . . 25.0 110.321 -175.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 55.04 34.23 22.04 Favored 'General case' 0 C--O 1.26 1.627 0 C-N-CA 123.392 0.677 . . . . 25.0 112.038 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.09 41.3 54.56 Favored Glycine 0 C--O 1.216 -1.018 0 N-CA-C 111.269 -0.732 . . . . 25.0 111.269 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.5 t -142.95 175.87 9.51 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.887 -0.782 . . . . 25.0 108.887 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 82.6 mt -106.48 164.65 11.88 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 105.655 -1.98 . . . . 25.0 105.655 173.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.412 ' HB3' ' CE1' ' A' ' 128' ' ' TYR . . . -72.89 120.5 18.6 Favored 'General case' 0 C--O 1.245 0.85 0 N-CA-C 108.302 -0.999 . . . . 25.0 108.302 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.9 m -89.71 158.36 2.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.874 -0.788 . . . . 25.0 108.874 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.4 m -132.98 154.09 50.82 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.038 -0.727 . . . . 25.0 109.038 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.3 m -120.33 160.38 20.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 108.633 -0.877 . . . . 25.0 108.633 177.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 17.2 t -75.84 -47.4 25.72 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 105.828 -1.915 . . . . 25.0 105.828 170.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -173.86 -162.52 0.15 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 101.229 -3.619 . . . . 25.0 101.229 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -61.02 -35.93 78.17 Favored 'General case' 0 C--O 1.246 0.88 0 CA-C-N 118.157 0.435 . . . . 25.0 111.088 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -103.01 -154.05 24.48 Favored Glycine 0 C--O 1.225 -0.463 0 CA-C-O 121.574 0.541 . . . . 25.0 112.293 176.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.91 -138.75 0.4 Allowed 'General case' 0 C--O 1.237 0.435 0 C-N-CA 122.75 0.42 . . . . 25.0 111.747 174.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 33.7 mtt85 -105.48 167.05 10.01 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 121.679 -0.638 . . . . 25.0 112.188 -174.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.28 165.58 13.28 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 105.402 -2.073 . . . . 25.0 105.402 177.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -138.45 152.65 48.52 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.767 -0.827 . . . . 25.0 108.767 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 27.0 tp -128.75 114.8 17.04 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 105.1 -2.185 . . . . 25.0 105.1 175.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -116.97 151.18 37.26 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 122.588 1.185 . . . . 25.0 112.101 -171.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.1 t -93.77 142.55 27.24 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 104.543 -2.392 . . . . 25.0 104.543 171.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.412 ' CE1' ' HB3' ' A' ' 113' ' ' ALA . 62.7 m-85 -115.6 11.08 15.74 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 122.539 1.161 . . . . 25.0 108.207 176.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -91.1 136.1 33.32 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 105.258 -2.127 . . . . 25.0 105.258 168.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -131.5 152.43 50.73 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-O 121.892 0.853 . . . . 25.0 110.433 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -86.54 166.72 15.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.392 -1.276 . . . . 25.0 109.382 -176.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -61.38 -32.14 72.05 Favored 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 122.676 0.39 . . . . 25.0 111.192 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -76.6 -4.54 43.46 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.325 0.861 . . . . 25.0 113.325 175.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.01 13.64 63.98 Favored Glycine 0 CA--C 1.501 -0.838 0 C-N-CA 120.919 -0.657 . . . . 25.0 112.176 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 65.7 mt -83.47 158.3 22.1 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 106.472 -1.677 . . . . 25.0 106.472 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.6 p -154.56 177.77 10.83 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 104.851 -2.278 . . . . 25.0 104.851 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -127.77 137.55 52.46 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-O 119.044 -0.503 . . . . 25.0 110.199 -176.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -152.56 153.49 33.52 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 118.996 0.816 . . . . 25.0 109.071 171.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.2 p -143.7 142.05 25.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 106.792 -1.559 . . . . 25.0 106.792 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -100.31 146.76 26.55 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.361 -0.977 . . . . 25.0 108.361 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.0 mp -137.48 132.76 33.78 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 104.669 -2.345 . . . . 25.0 104.669 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -101.82 12.16 37.49 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 121.26 1.845 . . . . 25.0 115.803 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -73.81 -14.91 79.7 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.398 -0.906 . . . . 25.0 113.081 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 42.2 t0 53.26 43.0 32.07 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 123.826 1.774 . . . . 25.0 110.902 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -109.55 41.1 1.73 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 113.547 -1.661 . . . . 25.0 107.606 -176.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.94 -29.95 63.59 Favored 'General case' 0 C--O 1.209 -1.047 0 CA-C-N 113.923 -1.49 . . . . 25.0 113.293 177.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.58 -31.66 57.66 Favored 'General case' 0 C--N 1.319 -0.756 0 O-C-N 120.285 -1.51 . . . . 25.0 112.135 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -77.27 -29.83 54.03 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.975 0.731 . . . . 25.0 112.975 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 15.9 mt -60.91 129.9 43.78 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 122.65 1.214 . . . . 25.0 110.413 -176.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.9 m -138.73 163.8 31.21 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 104.999 -2.222 . . . . 25.0 104.999 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.04 4.47 17.0 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 118.562 0.619 . . . . 25.0 109.734 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -75.01 -29.86 60.98 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.39 -0.823 . . . . 25.0 111.662 -177.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -87.32 -8.74 56.35 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 122.092 -0.38 . . . . 25.0 110.8 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 40.6 mm -91.95 132.78 35.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 104.609 -2.367 . . . . 25.0 104.609 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.4 p -115.11 132.76 63.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 122.053 0.93 . . . . 25.0 111.496 -175.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -155.33 -34.13 0.09 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 114.701 1.371 . . . . 25.0 114.701 -174.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.33 60.43 5.58 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 113.234 0.827 . . . . 25.0 113.234 -173.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 58.75 21.17 8.63 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.843 1.053 . . . . 25.0 113.843 176.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.65 11.52 2.44 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 114.675 1.361 . . . . 25.0 114.675 175.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -89.87 129.59 36.21 Favored 'General case' 0 C--O 1.238 0.448 0 O-C-N 121.999 -0.438 . . . . 25.0 110.304 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -66.69 -15.29 63.4 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.376 0.608 . . . . 25.0 111.07 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.7 -19.08 64.35 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 121.699 -0.626 . . . . 25.0 112.269 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.48 157.4 22.42 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 111.982 0.364 . . . . 25.0 111.982 -178.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 56.59 -163.79 0.16 Allowed 'General case' 0 CA--C 1.549 0.933 0 O-C-N 124.434 1.084 . . . . 25.0 113.417 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 97.67 0.98 58.96 Favored Glycine 0 N--CA 1.465 0.628 0 N-CA-C 114.94 0.736 . . . . 25.0 114.94 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -75.85 110.87 10.64 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 117.239 0.519 . . . . 25.0 111.193 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -129.85 155.44 46.0 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.553 0.341 . . . . 25.0 111.01 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -136.44 39.86 1.59 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.096 -1.202 . . . . 25.0 110.096 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 60.8 t -73.99 -36.21 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 109.76 -0.459 . . . . 25.0 109.76 -176.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.4 130.93 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-O 121.684 0.754 . . . . 25.0 111.639 -177.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 139.0 155.25 6.61 Favored Glycine 0 C--O 1.247 0.929 0 CA-C-N 115.336 -0.847 . . . . 25.0 111.741 -178.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -163.2 170.72 17.32 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 108.731 -0.84 . . . . 25.0 108.731 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 77.4 p -150.58 168.73 23.4 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 105.826 -1.916 . . . . 25.0 105.826 173.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -159.04 140.68 7.03 Favored Glycine 0 CA--C 1.501 -0.808 0 C-N-CA 119.728 -1.225 . . . . 25.0 115.062 177.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -131.64 80.16 67.08 Favored Pre-proline 0 C--O 1.24 0.561 0 N-CA-C 106.998 -1.482 . . . . 25.0 106.998 177.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -68.75 155.33 69.09 Favored 'Trans proline' 0 C--O 1.236 0.406 0 N-CA-C 113.582 0.57 . . . . 25.0 113.582 -174.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -120.66 151.96 38.81 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 106.871 -1.529 . . . . 25.0 106.871 -177.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -143.47 64.85 14.19 Favored Pre-proline 0 C--O 1.248 0.997 0 N-CA-C 115.559 1.689 . . . . 25.0 115.559 -178.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -71.53 151.28 58.71 Favored 'Trans proline' 0 C--O 1.244 0.814 0 C-N-CA 116.969 -1.554 . . . . 25.0 111.345 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 11.5 t -137.63 22.68 2.91 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.397 0.618 . . . . 25.0 110.919 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 C--O 1.247 0.944 0 CA-C-O 116.874 -1.536 . . . . 25.0 110.825 -179.665 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo . . . . . 0 CA--C 1.536 0.607 0 CA-C-O 121.516 0.548 . . . . 25.0 113.268 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.88 46.39 0.04 OUTLIER Glycine 0 CA--C 1.522 0.511 0 CA-C-N 115.427 -0.806 . . . . 25.0 111.11 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.1 p -57.54 133.85 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 CA-C-O 121.497 0.665 . . . . 25.0 109.997 -175.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -99.76 -11.57 20.71 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.703 -0.68 . . . . 25.0 109.742 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.33 -147.55 8.43 Favored Glycine 0 CA--C 1.501 -0.836 0 CA-C-N 115.621 -0.718 . . . . 25.0 113.028 177.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.2 p 71.3 159.09 0.16 Allowed Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 125.632 1.573 . . . . 25.0 111.135 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.521 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 31.2 Cg_exo -66.19 1.76 2.25 Favored 'Trans proline' 0 C--N 1.351 0.67 0 N-CA-C 117.406 2.041 . . . . 25.0 117.406 -175.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.3 p -63.98 -24.06 34.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 115.735 1.754 . . . . 25.0 115.735 -168.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.6 p -145.93 140.43 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 114.233 1.197 . . . . 25.0 114.233 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.85 10.0 86.53 Favored Glycine 0 N--CA 1.466 0.678 0 CA-C-N 114.753 -1.112 . . . . 25.0 115.434 171.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.6 t -50.95 -39.3 54.71 Favored 'General case' 0 C--O 1.21 -1.025 0 N-CA-C 114.075 1.139 . . . . 25.0 114.075 -170.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -81.71 8.07 10.9 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 115.044 1.498 . . . . 25.0 115.044 -175.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -142.99 173.96 11.09 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 118.852 -0.594 . . . . 25.0 111.459 176.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -58.79 124.12 18.72 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 115.314 1.598 . . . . 25.0 115.314 -173.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -124.32 164.47 19.54 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.611 1.708 . . . . 50.0 115.611 -175.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -130.85 77.03 1.76 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 107.469 -1.308 . . . . 25.0 107.469 169.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.1 mt -90.74 120.24 31.62 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.861 1.06 . . . . 25.0 113.861 -175.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -110.9 124.54 52.29 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 122.799 0.44 . . . . 25.0 110.69 178.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.45 172.72 41.52 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-O 122.626 1.126 . . . . 25.0 114.973 -176.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.8 p -84.97 175.44 9.06 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.037 -1.081 . . . . 25.0 110.484 175.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 66.2 mt -79.42 4.22 16.11 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.507 0.723 . . . . 25.0 112.733 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.61 177.78 24.82 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 119.438 -0.646 . . . . 25.0 113.879 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.1 t -70.14 129.98 40.85 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 117.303 0.552 . . . . 25.0 111.995 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -145.51 159.36 43.22 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.129 -0.357 . . . . 50.0 110.774 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -94.33 138.97 31.68 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 106.119 -1.808 . . . . 25.0 106.119 164.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.3 mm -129.69 105.99 12.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 105.49 -2.041 . . . . 25.0 105.49 178.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.521 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 8.9 mp -105.57 117.45 34.06 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.735 -0.839 . . . . 25.0 108.735 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.64 -42.54 62.44 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.196 -1.002 . . . . 25.0 114.303 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.8 -149.55 48.12 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 120.277 -0.963 . . . . 25.0 112.53 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.46 168.16 52.91 Favored Glycine 0 C--O 1.247 0.929 0 CA-C-O 122.001 0.778 . . . . 25.0 114.25 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.85 167.22 26.47 Favored Glycine 0 C--O 1.24 0.47 0 N-CA-C 111.954 -0.458 . . . . 25.0 111.954 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.06 120.15 28.03 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 105.773 -1.936 . . . . 25.0 105.773 176.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -115.09 154.74 28.35 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 120.41 -0.516 . . . . 50.0 111.984 -172.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -118.86 90.63 3.37 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 107.068 -1.456 . . . . 25.0 107.068 177.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.4 mt -98.4 138.22 35.95 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 123.078 0.551 . . . . 25.0 111.876 -171.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -135.31 105.78 6.42 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 118.554 0.616 . . . . 25.0 111.537 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.27 -30.65 45.02 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 115.316 0.887 . . . . 25.0 115.316 -175.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 53.93 -150.1 0.4 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.058 0.943 . . . . 25.0 112.289 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.36 162.9 24.3 Favored 'General case' 0 C--O 1.254 1.305 0 O-C-N 121.072 -1.018 . . . . 25.0 112.353 -175.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.75 159.04 32.54 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 114.922 -1.036 . . . . 25.0 111.71 -177.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -81.02 102.78 10.41 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.058 -1.089 . . . . 25.0 108.058 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -106.04 150.07 26.09 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.521 0.677 . . . . 50.0 112.72 -170.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 mp -113.05 89.37 3.06 Favored 'General case' 0 C--O 1.217 -0.626 0 N-CA-C 108.436 -0.95 . . . . 25.0 108.436 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.9 mp -92.75 129.67 38.61 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.303 0.482 . . . . 25.0 112.303 -176.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -127.1 146.61 50.32 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 104.516 -2.402 . . . . 25.0 104.516 175.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -98.19 -33.74 5.61 Favored Glycine 0 N--CA 1.466 0.689 0 N-CA-C 117.253 1.661 . . . . 25.0 117.253 -176.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.94 -162.19 52.66 Favored Glycine 0 C--O 1.257 1.587 0 N-CA-C 110.608 -0.997 . . . . 25.0 110.608 -174.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.68 161.79 7.39 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.674 0.75 . . . . 25.0 112.758 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.4 170.95 37.94 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 115.07 -0.968 . . . . 25.0 113.683 174.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.72 124.03 30.46 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 106.28 -1.748 . . . . 25.0 106.28 177.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -115.56 152.36 33.19 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 120.979 0.418 . . . . 50.0 111.593 -175.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -115.09 129.53 56.71 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 103.879 -2.637 . . . . 25.0 103.879 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -148.41 127.45 12.8 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 115.884 1.809 . . . . 25.0 115.884 -174.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.9 m -99.37 134.2 42.57 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.481 -0.781 . . . . 25.0 108.899 172.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.03 -33.95 9.25 Favored Glycine 0 C--O 1.244 0.777 0 C-N-CA 120.07 -1.062 . . . . 25.0 112.681 175.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.6 -169.39 54.73 Favored Glycine 0 C--O 1.255 1.442 0 CA-C-O 122.54 1.078 . . . . 25.0 115.111 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -67.75 162.45 23.83 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.375 -1.073 . . . . 25.0 110.605 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.77 164.48 39.63 Favored Glycine 0 C--O 1.244 0.761 0 N-CA-C 111.218 -0.753 . . . . 25.0 111.218 -177.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.74 105.13 16.05 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 109.619 -0.511 . . . . 25.0 109.619 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -99.15 151.71 20.68 Favored 'General case' 0 C--O 1.215 -0.73 0 CA-C-N 115.691 -0.686 . . . . 50.0 110.531 -170.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 58.9 m -121.64 126.67 49.58 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.925 -0.769 . . . . 25.0 108.925 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -114.36 87.59 2.67 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.615 -1.254 . . . . 25.0 107.615 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 30.8 mtt85 -85.87 -23.22 27.17 Favored 'General case' 0 CA--C 1.505 -0.763 0 O-C-N 121.602 -0.686 . . . . 25.0 112.661 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 67.75 142.6 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 O-C-N 125.161 1.538 . . . . 25.0 112.876 -174.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.28 -52.91 10.89 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 114.791 1.404 . . . . 25.0 114.791 -163.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 98.0 mt -135.82 176.53 8.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.308 1.051 . . . . 25.0 110.04 -176.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.58 -28.41 32.03 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.104 -0.953 . . . . 25.0 112.362 173.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -77.91 -10.83 59.77 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 114.707 1.373 . . . . 25.0 114.707 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.15 138.4 41.99 Favored 'General case' 0 C--O 1.213 -0.844 0 O-C-N 120.845 -1.159 . . . . 25.0 111.709 -175.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.8 t 45.61 39.42 4.9 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-N 113.682 -1.599 . . . . 25.0 114.005 173.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -104.31 167.31 9.83 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.097 -0.956 . . . . 25.0 109.434 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -127.47 143.84 51.14 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 104.791 -2.3 . . . . 25.0 104.791 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.6 p -135.9 166.76 25.86 Favored Pre-proline 0 C--N 1.315 -0.904 0 N-CA-C 108.021 -1.103 . . . . 25.0 108.021 -176.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -63.04 -23.48 73.81 Favored 'Trans proline' 0 C--N 1.353 0.774 0 CA-C-N 118.917 0.649 . . . . 25.0 112.68 175.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 73.7 mt -72.85 -23.85 60.81 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.418 0.628 . . . . 25.0 111.036 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 149.23 177.49 23.41 Favored Glycine 0 CA--C 1.5 -0.847 0 N-CA-C 111.028 -0.829 . . . . 25.0 111.028 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.3 t -97.59 155.12 17.12 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 118.072 0.936 . . . . 25.0 112.765 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -136.36 24.78 3.21 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 106.622 -1.621 . . . . 25.0 106.622 175.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.53 146.33 48.49 Favored Glycine 0 C--O 1.218 -0.865 0 CA-C-O 118.885 -0.953 . . . . 25.0 111.733 178.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -98.37 166.27 11.46 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 118.11 0.955 . . . . 50.0 112.311 -177.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -124.11 99.82 6.42 Favored 'General case' 0 C--O 1.253 1.26 0 O-C-N 123.593 0.558 . . . . 25.0 111.844 -172.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.8 mt -84.19 135.49 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 106.082 -1.821 . . . . 25.0 106.082 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.44 ' HA ' ' HG2' ' A' ' 142' ' ' GLU . 12.9 mt -89.99 -45.13 9.39 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 115.607 1.706 . . . . 25.0 115.607 -171.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -131.23 32.11 4.3 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.816 1.043 . . . . 25.0 113.816 -170.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -51.25 138.97 19.74 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.795 1.035 . . . . 25.0 113.795 -175.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -107.93 106.93 59.62 Favored Pre-proline 0 C--O 1.235 0.329 0 N-CA-C 108.293 -1.003 . . . . 25.0 108.293 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -69.8 -8.17 22.93 Favored 'Trans proline' 0 CA--C 1.547 1.161 0 N-CA-C 117.743 2.17 . . . . 25.0 117.743 -174.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.8 t -96.84 -35.81 10.81 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-O 120.481 0.181 . . . . 25.0 111.41 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -98.83 -37.66 9.35 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 113.349 0.87 . . . . 25.0 113.349 -173.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -86.59 167.0 14.96 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.922 0.391 . . . . 75.0 110.551 -173.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -145.59 149.09 33.91 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 109.356 -0.609 . . . . 25.0 109.356 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 68.5 mt -125.51 133.21 69.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 108.05 -1.093 . . . . 25.0 108.05 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -95.59 144.33 26.13 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.754 -1.202 . . . . 25.0 107.754 174.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.1 p -143.41 -10.16 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.722 -0.672 . . . . 25.0 111.612 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 39.0 t -58.85 -42.6 89.74 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.416 0.895 . . . . 25.0 113.416 -175.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.54 -20.82 61.98 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 113.977 1.102 . . . . 25.0 113.977 -176.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.79 -45.38 1.9 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 116.436 2.013 . . . . 25.0 116.436 -170.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -94.74 -75.57 1.29 Allowed Glycine 0 N--CA 1.463 0.47 0 C-N-CA 119.999 -1.096 . . . . 25.0 113.099 -175.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -148.75 167.09 26.51 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.068 -0.716 . . . . 25.0 109.068 -175.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.8 t -124.38 -27.96 3.7 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.453 0.644 . . . . 25.0 110.362 176.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -101.0 120.14 6.78 Favored Glycine 0 N--CA 1.466 0.691 0 N-CA-C 108.294 -1.922 . . . . 25.0 108.294 172.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -66.24 150.4 48.87 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 119.776 1.788 . . . . 25.0 109.55 -176.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -102.57 -146.33 17.4 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-O 122.755 1.197 . . . . 25.0 115.723 -173.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -60.01 134.35 56.96 Favored 'General case' 0 C--O 1.251 1.16 0 CA-C-N 113.605 -1.298 . . . . 25.0 112.238 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 159.28 -176.98 36.01 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 123.28 0.363 . . . . 25.0 112.504 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -144.57 179.07 7.52 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 109.609 -0.515 . . . . 25.0 109.609 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 56.74 32.85 21.93 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 113.967 1.099 . . . . 25.0 113.967 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 69.06 29.7 72.24 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 109.964 -1.254 . . . . 25.0 109.964 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.414 ' HB2' ' HA ' ' A' ' 150' ' ' SER . 3.8 t -143.32 174.3 10.85 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.373 0.606 . . . . 25.0 109.69 -178.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 5.5 mp -92.7 161.82 14.39 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 103.337 -2.838 . . . . 25.0 103.337 173.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.84 118.01 10.49 Favored 'General case' 0 C--O 1.269 2.087 0 CA-C-N 118.953 0.797 . . . . 25.0 112.196 -172.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 26.4 m -79.75 162.05 3.9 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 CA-C-O 121.56 0.695 . . . . 25.0 109.363 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 56.1 m -145.88 171.3 15.01 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.714 -0.847 . . . . 25.0 108.714 -177.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 34.0 m -125.17 162.68 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 109.156 -0.683 . . . . 25.0 109.156 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 40.2 t -80.92 -40.17 25.01 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.464 -1.68 . . . . 25.0 106.464 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -174.27 -163.49 0.16 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 102.628 -3.101 . . . . 25.0 102.628 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -63.63 -23.76 67.51 Favored 'General case' 0 C--O 1.248 1.013 0 N-CA-C 112.39 0.515 . . . . 25.0 112.39 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -121.6 -153.61 9.0 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 109.499 -1.441 . . . . 25.0 109.499 175.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.83 -154.01 0.37 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 122.859 0.464 . . . . 25.0 110.295 175.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.0 mtt85 -81.46 160.29 24.03 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 114.43 1.27 . . . . 25.0 114.43 -173.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.1 p -105.21 162.62 13.25 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 105.642 -1.985 . . . . 25.0 105.642 172.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -130.27 150.68 51.4 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.394 0.616 . . . . 25.0 112.175 -177.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 64.8 tp -127.53 120.05 27.39 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 104.022 -2.584 . . . . 25.0 104.022 171.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -118.41 146.19 44.63 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.686 0.624 . . . . 25.0 112.686 -171.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.2 t -89.15 147.94 23.93 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 106.201 -1.778 . . . . 25.0 106.201 167.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -116.5 -0.04 12.59 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.624 -1.251 . . . . 25.0 107.624 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -86.0 137.43 32.72 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 104.085 -2.561 . . . . 25.0 104.085 169.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -146.2 158.42 43.88 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 124.697 1.248 . . . . 25.0 109.38 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -80.6 160.61 25.06 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.733 -1.122 . . . . 25.0 107.976 175.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.47 -22.37 66.94 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 122.002 -0.436 . . . . 25.0 110.625 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -69.41 -11.82 61.14 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 113.455 0.909 . . . . 25.0 113.455 174.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.63 16.14 57.18 Favored Glycine 0 C--O 1.22 -0.781 0 N-CA-C 111.64 -0.584 . . . . 25.0 111.64 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.3 mt -88.66 130.21 35.35 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.985 -1.117 . . . . 25.0 107.985 178.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 72.7 p -138.95 -179.69 5.98 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.477 -0.564 . . . . 25.0 109.477 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -122.13 133.11 54.76 Favored 'General case' 0 C--O 1.257 1.453 0 CA-C-O 119.177 -0.44 . . . . 25.0 110.452 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.4 pt-20 -145.91 152.17 39.02 Favored 'General case' 0 C--O 1.247 0.956 0 N-CA-C 108.293 -1.002 . . . . 25.0 108.293 171.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.8 p -145.85 139.82 21.31 Favored 'Isoleucine or valine' 0 C--O 1.248 0.985 0 N-CA-C 106.712 -1.588 . . . . 25.0 106.712 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -103.41 147.6 26.93 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 107.704 -1.221 . . . . 25.0 107.704 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.7 mp -136.61 129.96 31.55 Favored 'General case' 0 C--O 1.208 -1.132 0 N-CA-C 105.186 -2.153 . . . . 25.0 105.186 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.44 ' HG2' ' HA ' ' A' ' 85' ' ' LEU . 17.4 pt-20 -99.66 6.54 45.62 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 119.889 1.222 . . . . 25.0 112.158 -175.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -71.1 -12.35 71.71 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.718 -0.753 . . . . 25.0 112.275 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 38.7 t0 53.53 54.86 9.4 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.915 0.864 . . . . 25.0 111.371 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -126.94 39.63 3.88 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.56 -1.2 . . . . 25.0 109.129 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.74 -37.01 82.66 Favored 'General case' 0 C--O 1.214 -0.791 0 O-C-N 121.792 -0.567 . . . . 25.0 111.673 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.16 -10.29 59.46 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 121.53 -0.731 . . . . 25.0 112.085 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -98.12 -26.13 14.68 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 111.789 0.292 . . . . 25.0 111.789 175.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.0 mt -62.69 136.06 57.69 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 122.581 1.181 . . . . 25.0 111.357 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.414 ' HA ' ' HB2' ' A' ' 111' ' ' SER . 47.5 m -135.81 164.26 28.32 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 105.558 -2.016 . . . . 25.0 105.558 171.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -77.05 8.38 3.94 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.71 0.29 . . . . 25.0 110.716 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -65.66 -39.34 91.26 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.301 0.482 . . . . 25.0 112.301 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -81.54 -10.41 59.46 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.075 -0.966 . . . . 25.0 111.079 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 13.4 mm -91.27 126.1 43.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 106.312 -1.736 . . . . 25.0 106.312 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.0 p -103.05 122.77 55.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 O-C-N 120.996 -1.065 . . . . 25.0 111.555 -177.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -157.22 -16.05 0.09 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 114.684 -1.144 . . . . 25.0 113.563 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.96 61.48 6.45 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 121.878 -0.514 . . . . 25.0 111.261 -172.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 55.44 15.39 1.42 Allowed 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 115.94 1.83 . . . . 25.0 115.94 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 64.76 -21.82 0.08 Allowed 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 116.557 2.058 . . . . 25.0 116.557 176.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -70.64 116.48 11.01 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.917 -1.114 . . . . 25.0 110.201 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.42 -5.7 44.0 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 113.238 0.829 . . . . 25.0 113.238 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.24 -20.11 65.62 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.316 0.579 . . . . 25.0 110.811 177.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -90.99 -162.26 0.89 Allowed 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.588 -0.733 . . . . 25.0 111.198 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 60.79 -160.45 0.3 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.138 0.975 . . . . 25.0 113.106 176.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 79.98 24.05 60.51 Favored Glycine 0 C--O 1.228 -0.263 0 C-N-CA 121.367 -0.444 . . . . 25.0 112.272 -178.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -97.37 93.49 6.52 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.791 -0.829 . . . . 25.0 109.788 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -121.86 152.67 39.33 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.249 0.547 . . . . 25.0 109.834 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -140.5 33.77 2.03 Favored Glycine 0 CA--C 1.51 -0.251 0 CA-C-O 122.281 0.934 . . . . 25.0 111.173 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 61.3 t -82.69 -35.79 12.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 O-C-N 122.221 -0.576 . . . . 25.0 110.675 -176.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -53.27 137.84 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 115.843 -0.617 . . . . 25.0 111.246 -178.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 140.35 155.3 6.5 Favored Glycine 0 C--O 1.245 0.784 0 CA-C-N 115.843 -0.617 . . . . 25.0 112.759 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -155.94 143.67 19.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.565 0.683 . . . . 25.0 110.077 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 87.1 p -154.13 163.67 39.74 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 122.477 0.311 . . . . 25.0 110.916 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 172.41 -179.25 44.09 Favored Glycine 0 N--CA 1.47 0.956 0 N-CA-C 110.982 -0.847 . . . . 25.0 110.982 176.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -138.99 113.06 8.25 Favored Pre-proline 0 C--O 1.248 0.98 0 CA-C-N 118.152 0.976 . . . . 25.0 110.917 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.82 169.06 23.01 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 N-CA-C 115.365 1.256 . . . . 25.0 115.365 -177.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -122.49 149.02 44.46 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.078 -0.712 . . . . 25.0 109.078 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -138.49 73.78 41.62 Favored Pre-proline 0 N--CA 1.472 0.641 0 C-N-CA 123.349 0.66 . . . . 25.0 110.372 175.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -76.4 155.2 36.51 Favored 'Trans proline' 0 N--CA 1.478 0.577 0 C-N-CA 118.448 -0.568 . . . . 25.0 113.29 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.7 t -96.08 -2.16 47.21 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 121.951 -0.468 . . . . 25.0 111.965 -177.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 C--O 1.257 1.496 0 CA-C-O 118.554 -0.736 . . . . 25.0 110.017 -177.827 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo . . . . . 0 CA--C 1.538 0.677 0 CA-C-O 120.677 0.199 . . . . 25.0 112.194 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.64 60.67 0.03 OUTLIER Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.993 -0.623 . . . . 25.0 111.899 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -55.84 134.68 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 122.504 1.145 . . . . 25.0 111.217 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -101.99 0.31 34.97 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 121.556 0.693 . . . . 25.0 111.045 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -92.08 -147.96 21.6 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.499 -0.773 . . . . 25.0 113.694 176.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.8 p 69.98 155.59 0.15 Allowed Pre-proline 0 N--CA 1.489 1.521 0 C-N-CA 126.011 1.724 . . . . 25.0 111.226 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -73.89 4.68 3.96 Favored 'Trans proline' 0 C--O 1.24 0.625 0 C-N-CA 121.631 1.554 . . . . 25.0 115.318 -177.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.0 p -54.18 -31.5 21.98 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 N-CA-C 116.02 1.859 . . . . 25.0 116.02 -170.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.0 p -148.26 152.83 12.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 O-C-N 120.943 -1.098 . . . . 25.0 111.01 -177.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.91 7.32 88.44 Favored Glycine 0 N--CA 1.468 0.788 0 N-CA-C 115.425 0.93 . . . . 25.0 115.425 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.2 t -56.65 -40.4 75.39 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 113.914 1.079 . . . . 25.0 113.914 -172.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -78.87 10.17 3.6 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 116.41 2.004 . . . . 25.0 116.41 -175.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.59 169.74 18.97 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 119.205 -0.426 . . . . 25.0 110.545 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -51.0 139.01 18.34 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 118.664 0.666 . . . . 25.0 111.892 -177.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -131.0 161.93 30.88 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.436 1.273 . . . . 50.0 114.436 -175.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -133.87 96.15 3.6 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 104.682 -2.34 . . . . 25.0 104.682 163.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 97.5 mt -112.01 126.26 54.95 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 121.341 0.591 . . . . 25.0 111.213 -176.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -119.72 117.19 27.6 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.226 -0.897 . . . . 25.0 109.753 -176.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.58 177.29 51.38 Favored Glycine 0 CA--C 1.502 -0.763 0 N-CA-C 116.063 1.185 . . . . 25.0 116.063 -175.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.7 p -79.81 174.26 11.76 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 114.302 -0.949 . . . . 25.0 111.407 178.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 77.3 mt -87.3 18.3 3.85 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 121.551 -0.718 . . . . 25.0 111.336 175.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -123.92 179.4 16.15 Favored Glycine 0 CA--C 1.502 -0.76 0 N-CA-C 111.475 -0.65 . . . . 25.0 111.475 177.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.2 t -67.29 134.09 50.92 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.146 0.424 . . . . 25.0 112.146 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -147.02 171.96 14.47 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 123.402 0.681 . . . . 50.0 111.843 -176.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -119.34 126.77 52.21 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.802 -1.555 . . . . 25.0 106.802 166.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.9 mm -123.75 130.41 74.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 106.652 -1.61 . . . . 25.0 106.652 -178.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.6 tt -134.78 123.93 24.36 Favored 'General case' 0 C--O 1.21 -1.012 0 N-CA-C 106.761 -1.57 . . . . 25.0 106.761 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.2 -34.33 37.41 Favored Glycine 0 CA--C 1.497 -1.051 0 N-CA-C 116.22 1.248 . . . . 25.0 116.22 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.38 -143.91 38.13 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.465 -0.874 . . . . 25.0 110.99 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.44 165.9 54.72 Favored Glycine 0 CA--C 1.498 -1.014 0 CA-C-O 122.672 1.151 . . . . 25.0 113.201 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.14 167.28 30.38 Favored Glycine 0 N--CA 1.459 0.212 0 CA-C-N 114.837 -0.682 . . . . 25.0 113.495 178.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.11 111.61 19.48 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 106.498 -1.667 . . . . 25.0 106.498 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -109.36 152.55 25.16 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 113.67 0.989 . . . . 50.0 113.67 -171.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -114.7 105.14 12.7 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 106.816 -1.549 . . . . 25.0 106.816 171.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 58.1 mt -110.8 133.6 53.22 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.221 0.452 . . . . 25.0 112.221 -174.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -131.71 110.59 11.0 Favored 'General case' 0 C--N 1.316 -0.875 0 O-C-N 121.224 -0.922 . . . . 25.0 112.99 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.25 -29.72 29.93 Favored Glycine 0 C--O 1.242 0.601 0 N-CA-C 117.713 1.845 . . . . 25.0 117.713 -174.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 53.01 -154.42 0.22 Allowed 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.683 0.994 . . . . 25.0 113.683 -177.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.93 160.3 15.1 Favored 'General case' 0 C--O 1.258 1.515 0 N-CA-C 112.306 0.484 . . . . 25.0 112.306 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.63 152.11 27.94 Favored Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 110.316 -1.113 . . . . 25.0 110.316 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -78.95 119.04 21.54 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 106.385 -1.709 . . . . 25.0 106.385 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -119.18 151.77 37.76 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 111.797 0.295 . . . . 50.0 111.797 -172.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.82 127.77 48.48 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 107.089 -1.449 . . . . 25.0 107.089 170.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.7 mp -127.37 121.34 30.71 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 122.015 0.912 . . . . 25.0 112.747 -176.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -118.93 135.14 54.74 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 108.553 -0.906 . . . . 25.0 108.553 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.61 -38.5 5.54 Favored Glycine 0 CA--C 1.498 -0.987 0 O-C-N 120.137 -1.602 . . . . 25.0 113.519 -174.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.83 -166.67 50.68 Favored Glycine 0 C--O 1.246 0.884 0 CA-C-O 121.947 0.748 . . . . 25.0 111.396 -177.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.91 157.94 14.22 Favored 'General case' 0 C--O 1.248 1.003 0 C-N-CA 123.241 0.617 . . . . 25.0 111.631 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.41 165.38 32.47 Favored Glycine 0 N--CA 1.466 0.695 0 CA-C-N 116.063 -0.517 . . . . 25.0 114.009 178.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.58 122.86 28.64 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 105.286 -2.116 . . . . 25.0 105.286 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -114.24 156.99 23.32 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.625 -0.509 . . . . 50.0 109.625 -175.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -124.19 122.95 39.17 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 106.382 -1.71 . . . . 25.0 106.382 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -146.38 139.89 25.95 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 116.728 2.121 . . . . 25.0 116.728 -170.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 70.3 m -108.31 143.33 37.33 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 114.958 -1.019 . . . . 25.0 108.473 175.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.9 -32.24 6.93 Favored Glycine 0 C--N 1.323 -0.173 0 N-CA-C 109.005 -1.638 . . . . 25.0 109.005 175.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.45 -174.88 54.52 Favored Glycine 0 CA--C 1.502 -0.741 0 C-N-CA 119.599 -1.286 . . . . 25.0 112.834 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -62.62 159.04 16.81 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.794 -0.827 . . . . 25.0 110.84 177.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.34 156.52 32.72 Favored Glycine 0 C--O 1.224 -0.487 0 CA-C-N 114.875 -1.057 . . . . 25.0 111.089 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.62 108.36 14.19 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.934 -1.136 . . . . 25.0 107.934 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -101.08 159.93 14.81 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.31 -0.859 . . . . 50.0 110.969 -172.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 57.4 m -124.67 119.09 28.01 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 109.102 -0.703 . . . . 25.0 109.102 177.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -99.65 83.94 2.86 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 106.589 -1.634 . . . . 25.0 106.589 175.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -83.16 -20.86 33.92 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.277 -0.874 . . . . 25.0 111.229 -173.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 61.91 160.6 0.07 Allowed 'General case' 0 CA--C 1.547 0.845 0 O-C-N 124.858 1.349 . . . . 25.0 112.181 -176.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -93.45 -70.39 0.7 Allowed 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.81 1.041 . . . . 25.0 113.81 -168.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.1 mt -116.48 175.17 5.68 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.68 0.753 . . . . 25.0 111.482 -171.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.94 -32.34 32.7 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.484 0.714 . . . . 25.0 111.435 176.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -80.02 -6.94 58.5 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.52 0.933 . . . . 25.0 113.52 -174.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.68 127.89 34.51 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 122.087 0.946 . . . . 25.0 111.594 -177.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.1 t 49.94 39.56 18.91 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 115.63 1.715 . . . . 25.0 115.63 173.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -103.59 160.94 14.31 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.722 -1.126 . . . . 25.0 110.12 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -115.09 139.91 49.5 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 104.056 -2.572 . . . . 25.0 104.056 176.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 62.8 p -124.29 166.0 21.7 Favored Pre-proline 0 C--N 1.317 -0.824 0 N-CA-C 108.623 -0.881 . . . . 25.0 108.623 -175.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -65.07 -19.5 63.41 Favored 'Trans proline' 0 C--O 1.245 0.861 0 C-N-CA 117.769 -1.02 . . . . 25.0 112.702 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 81.2 mt -76.17 -29.65 57.79 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.283 0.563 . . . . 25.0 112.181 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 160.76 179.15 35.33 Favored Glycine 0 N--CA 1.472 1.044 0 CA-C-O 118.412 -1.216 . . . . 25.0 110.182 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.4 t -98.02 148.78 23.15 Favored 'General case' 0 C--O 1.251 1.146 0 CA-C-N 118.884 1.342 . . . . 25.0 113.034 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -130.29 28.95 4.93 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-N 114.643 -1.162 . . . . 25.0 108.156 174.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.51 146.92 50.27 Favored Glycine 0 N--CA 1.463 0.455 0 N-CA-C 109.073 -1.611 . . . . 25.0 109.073 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -93.69 166.29 12.29 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 117.343 0.571 . . . . 50.0 111.405 -176.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.92 104.6 9.95 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 122.656 0.383 . . . . 25.0 111.65 -173.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.0 mt -91.16 135.7 26.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 107.889 -1.152 . . . . 25.0 107.889 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.5 mt -88.32 -56.57 3.26 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.539 0.94 . . . . 25.0 113.539 -174.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -124.61 39.37 3.99 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.672 0.99 . . . . 25.0 113.672 -171.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -55.53 138.77 45.9 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.76 0.79 . . . . 25.0 111.665 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -105.85 102.75 40.62 Favored Pre-proline 0 N--CA 1.469 0.497 0 N-CA-C 108.804 -0.813 . . . . 25.0 108.804 177.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -67.74 -6.7 17.46 Favored 'Trans proline' 0 C--N 1.359 1.087 0 N-CA-C 116.31 1.619 . . . . 25.0 116.31 -174.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.9 t -97.48 -42.87 7.51 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.005 0.522 . . . . 25.0 109.97 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -96.31 -43.11 7.83 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 113.283 0.845 . . . . 25.0 113.283 -171.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -82.44 164.81 20.73 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 121.472 -0.767 . . . . 75.0 110.336 -173.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -142.05 152.07 43.01 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.9 -0.591 . . . . 25.0 111.347 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 77.5 mt -126.49 131.92 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 107.63 -1.248 . . . . 25.0 107.63 -177.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -93.2 151.03 20.07 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 108.526 -0.916 . . . . 25.0 108.526 174.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 p -150.41 -3.91 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 N-CA-C 112.834 0.679 . . . . 25.0 112.834 -175.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.6 t -60.68 -48.49 81.54 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.831 1.048 . . . . 25.0 113.831 -173.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.54 -31.63 60.14 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.158 0.799 . . . . 25.0 113.158 -177.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.55 -22.95 16.24 Favored 'General case' 0 C--O 1.246 0.881 0 N-CA-C 115.919 1.822 . . . . 25.0 115.919 -173.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -134.11 -72.76 0.08 OUTLIER Glycine 0 CA--C 1.53 1.024 0 N-CA-C 116.102 1.201 . . . . 25.0 116.102 -174.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -154.57 167.06 31.38 Favored 'General case' 0 C--O 1.211 -0.926 0 CA-C-N 117.471 0.636 . . . . 25.0 109.438 -173.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 30.9 t -120.45 -47.77 2.33 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.191 -1.04 . . . . 25.0 108.191 176.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.15 120.9 5.37 Favored Glycine 0 CA--C 1.501 -0.814 0 N-CA-C 108.588 -1.805 . . . . 25.0 108.588 175.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -68.41 158.13 34.3 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 117.302 0.551 . . . . 25.0 111.744 -175.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -100.51 -160.31 27.99 Favored Glycine 0 N--CA 1.457 0.073 0 N-CA-C 115.109 0.804 . . . . 25.0 115.109 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -48.35 134.7 14.64 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.681 -0.76 . . . . 25.0 112.794 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 158.98 -175.07 35.99 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 108.676 -1.769 . . . . 25.0 108.676 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -152.9 168.21 26.54 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 118.694 1.247 . . . . 25.0 108.343 -177.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 52.59 39.04 27.41 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.85 1.056 . . . . 25.0 113.85 -177.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 69.47 35.1 74.83 Favored Glycine 0 C--O 1.245 0.801 0 N-CA-C 110.751 -0.939 . . . . 25.0 110.751 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.523 ' HA ' ' H ' ' A' ' 151' ' ' ALA . 7.6 t -136.97 176.57 8.59 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 121.623 -0.928 . . . . 25.0 109.905 -178.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.1 mt -110.34 164.58 12.54 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 102.47 -3.159 . . . . 25.0 102.47 176.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.63 120.98 23.33 Favored 'General case' 0 C--O 1.258 1.509 0 N-CA-C 108.063 -1.088 . . . . 25.0 108.063 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.7 m -80.23 159.32 4.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 C-N-CA 122.86 0.464 . . . . 25.0 111.374 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 73.3 m -134.83 163.0 30.81 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.438 -0.949 . . . . 25.0 108.438 177.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.0 m -124.37 165.51 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.362 0 N-CA-C 107.544 -1.28 . . . . 25.0 107.544 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.6 t -80.13 -49.07 12.23 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 106.574 -1.639 . . . . 25.0 106.574 173.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -161.57 -161.99 0.84 Allowed 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 101.941 -3.355 . . . . 25.0 101.941 174.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -67.09 -0.22 3.11 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.498 0.666 . . . . 25.0 112.536 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -142.64 -155.72 6.53 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 108.786 -1.726 . . . . 25.0 108.786 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 53.32 -145.86 0.57 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.116 0.784 . . . . 25.0 113.116 176.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.4 mtt85 -75.89 174.04 10.42 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.934 0.873 . . . . 25.0 113.336 -173.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.26 163.19 29.86 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 105.342 -2.095 . . . . 25.0 105.342 176.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -136.92 155.1 50.17 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.703 -0.48 . . . . 25.0 109.703 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 29.7 tp -125.43 127.17 46.1 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.161 -1.792 . . . . 25.0 106.161 171.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -126.37 151.51 47.53 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.386 0.513 . . . . 25.0 112.386 -171.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 84.0 p -88.63 150.01 23.25 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 105.115 -2.18 . . . . 25.0 105.115 169.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -117.33 27.78 8.88 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 105.621 -1.992 . . . . 25.0 105.621 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -122.88 141.67 51.63 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 112.578 -2.101 . . . . 25.0 106.468 174.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -138.41 153.83 48.9 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 124.221 0.95 . . . . 25.0 111.465 -178.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -77.96 160.29 28.29 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.498 -1.297 . . . . 25.0 107.498 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.73 -20.07 65.45 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-O 122.505 1.145 . . . . 25.0 109.142 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -74.12 -12.3 60.56 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 114.682 -1.145 . . . . 25.0 113.549 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.25 9.02 67.8 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 115.888 -0.596 . . . . 25.0 113.776 -178.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 63.0 mt -83.33 147.53 27.88 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 108.128 -1.064 . . . . 25.0 108.128 174.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 69.6 p -149.76 179.57 7.91 Favored 'General case' 0 C--O 1.248 0.976 0 N-CA-C 107.642 -1.244 . . . . 25.0 107.642 177.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -123.8 135.61 53.9 Favored 'General case' 0 C--O 1.253 1.268 0 CA-C-N 118.871 0.76 . . . . 25.0 111.76 -176.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -151.41 154.97 37.67 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.756 -1.572 . . . . 25.0 106.756 171.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.69 139.39 19.66 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 105.771 -1.937 . . . . 25.0 105.771 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -101.53 143.92 30.93 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 107.685 -1.228 . . . . 25.0 107.685 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mp -136.5 139.13 42.06 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 106.29 -1.744 . . . . 25.0 106.29 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -110.15 11.65 23.66 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.992 1.269 . . . . 25.0 110.603 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -68.41 -19.82 72.95 Favored Glycine 0 CA--C 1.499 -0.944 0 CA-C-N 115.218 -0.901 . . . . 25.0 111.006 173.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.1 t0 54.74 51.69 13.39 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 122.999 1.381 . . . . 25.0 110.733 175.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -121.63 42.75 3.02 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 113.513 -1.676 . . . . 25.0 108.151 -175.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -55.84 -31.59 62.85 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 114.596 -1.184 . . . . 25.0 112.462 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -77.18 -29.43 54.42 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 118.678 0.672 . . . . 25.0 111.878 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.55 -20.33 26.6 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 120.574 -0.45 . . . . 25.0 111.799 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 22.2 mt -62.12 136.54 57.99 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 121.082 0.468 . . . . 25.0 111.088 177.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 70.3 m -144.7 161.5 39.05 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 107.541 -1.281 . . . . 25.0 107.541 175.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.523 ' H ' ' HA ' ' A' ' 111' ' ' SER . . . -79.74 -0.09 32.83 Favored 'General case' 0 C--O 1.206 -1.206 0 N-CA-C 107.367 -1.346 . . . . 25.0 107.367 177.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -74.09 -26.77 60.55 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.372 -0.831 . . . . 25.0 110.788 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -89.66 -6.72 55.89 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.591 -0.693 . . . . 25.0 109.524 176.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 49.1 mm -90.22 136.6 23.46 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.621 0 N-CA-C 103.708 -2.701 . . . . 25.0 103.708 173.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.9 p -116.39 128.93 73.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 122.656 1.217 . . . . 25.0 110.861 -176.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -158.05 -17.13 0.08 Allowed 'General case' 0 C--O 1.211 -0.937 0 CA-C-N 113.95 -1.477 . . . . 25.0 113.121 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.75 43.34 0.91 Allowed 'General case' 0 C--O 1.246 0.897 0 O-C-N 121.454 -0.779 . . . . 25.0 112.183 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 58.17 29.09 17.42 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.891 0.877 . . . . 25.0 112.964 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.4 m 51.53 37.26 19.09 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 122.334 1.064 . . . . 25.0 111.342 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -76.36 123.81 26.53 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.71 1.004 . . . . 25.0 113.71 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.82 -18.32 60.47 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.29 -0.868 . . . . 25.0 112.719 177.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -81.07 -21.5 39.97 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 122.305 -0.247 . . . . 25.0 110.596 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.45 177.56 8.89 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.835 0.454 . . . . 25.0 111.108 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 63.47 178.66 0.16 Allowed 'General case' 0 CA--C 1.547 0.861 0 O-C-N 124.682 1.239 . . . . 25.0 113.939 176.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 82.04 22.63 58.97 Favored Glycine 0 C--O 1.237 0.294 0 CA-C-N 115.296 -0.865 . . . . 25.0 111.141 -177.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -106.99 104.79 14.55 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 112.338 0.496 . . . . 25.0 112.338 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -130.29 151.59 50.63 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 107.62 -1.252 . . . . 25.0 107.62 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -135.57 33.72 2.38 Favored Glycine 0 CA--C 1.502 -0.761 0 N-CA-C 110.802 -0.919 . . . . 25.0 110.802 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 54.6 t -79.53 -27.27 12.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 CA-C-O 121.939 0.876 . . . . 25.0 108.774 -176.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -53.86 134.39 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 CA-C-N 114.485 -1.234 . . . . 25.0 113.025 -174.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 141.12 150.66 5.43 Favored Glycine 0 C--O 1.246 0.895 0 N-CA-C 109.5 -1.44 . . . . 25.0 109.5 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -142.86 145.36 33.07 Favored 'General case' 0 C--O 1.252 1.232 0 O-C-N 122.197 -0.59 . . . . 25.0 111.249 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 13.3 p -150.72 154.77 38.0 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.725 0.774 . . . . 25.0 111.306 175.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 176.71 166.74 34.27 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 115.138 -0.937 . . . . 25.0 113.85 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -133.55 111.07 12.53 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 107.312 -1.366 . . . . 25.0 107.312 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.88 160.91 39.92 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 116.879 -1.614 . . . . 25.0 113.137 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -119.15 147.02 44.65 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.032 -1.099 . . . . 25.0 108.032 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -143.74 73.11 17.08 Favored Pre-proline 0 C--O 1.251 1.171 0 O-C-N 123.536 0.523 . . . . 25.0 111.198 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -69.9 164.07 36.06 Favored 'Trans proline' 0 C--O 1.249 1.031 0 N-CA-C 113.857 0.676 . . . . 25.0 113.857 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 12.6 t -125.66 8.68 7.62 Favored 'General case' 0 C--O 1.256 1.414 0 N-CA-C 109.652 -0.499 . . . . 25.0 109.652 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 C--O 1.245 0.853 0 N-CA-C 108.565 -0.902 . . . . 25.0 108.565 178.043 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo . . . . . 0 CA--C 1.531 0.356 0 N-CA-C 113.856 0.675 . . . . 25.0 113.856 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -163.66 31.64 0.27 Allowed Glycine 0 CA--C 1.521 0.417 0 CA-C-O 119.429 -0.651 . . . . 25.0 112.26 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.5 p -60.35 133.11 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 122.027 0.918 . . . . 25.0 111.194 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -99.07 -18.57 17.67 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.647 -0.706 . . . . 25.0 112.197 -177.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.79 -134.11 3.84 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-O 121.715 0.62 . . . . 25.0 114.56 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.9 p 69.08 156.64 0.15 Allowed Pre-proline 0 N--CA 1.483 1.208 0 C-N-CA 125.858 1.663 . . . . 25.0 110.392 -173.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.408 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 32.4 Cg_exo -65.9 0.11 3.43 Favored 'Trans proline' 0 N--CA 1.485 1.008 0 N-CA-C 117.707 2.156 . . . . 25.0 117.707 -173.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.6 p -68.01 -22.14 27.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 114.787 1.403 . . . . 25.0 114.787 -172.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.2 p -128.1 121.57 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 117.329 2.344 . . . . 25.0 117.329 -171.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.05 20.6 79.06 Favored Glycine 0 C--O 1.224 -0.47 0 N-CA-C 117.423 1.729 . . . . 25.0 117.423 173.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.2 t -50.07 -37.87 35.56 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 114.726 1.38 . . . . 25.0 114.726 -174.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -80.74 13.61 2.52 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 114.649 1.352 . . . . 25.0 114.649 -176.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -149.63 171.22 17.02 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.531 -0.73 . . . . 25.0 110.542 176.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.76 121.57 14.32 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.293 0.637 . . . . 25.0 111.538 -173.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -120.72 169.69 10.16 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 115.296 1.591 . . . . 50.0 115.296 -173.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -123.35 114.55 20.32 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 103.775 -2.676 . . . . 25.0 103.775 160.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 82.3 mt -120.04 102.57 8.63 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.536 0.684 . . . . 25.0 111.761 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -93.4 121.8 35.16 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.709 -0.678 . . . . 25.0 109.837 177.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.15 -174.29 47.67 Favored Glycine 0 N--CA 1.464 0.565 0 N-CA-C 115.245 0.858 . . . . 25.0 115.245 -178.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.7 p -91.67 173.71 7.73 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.778 0.831 . . . . 25.0 112.404 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 75.4 mt -83.67 12.41 5.88 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.356 0.873 . . . . 25.0 113.356 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.85 179.31 20.04 Favored Glycine 0 N--CA 1.462 0.378 0 CA-C-N 116.284 -0.416 . . . . 25.0 112.175 178.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.5 t -71.48 130.93 42.51 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 122.701 0.4 . . . . 25.0 110.635 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -143.41 165.89 26.29 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 123.265 0.353 . . . . 50.0 111.527 -174.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -111.11 125.49 53.83 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 106.108 -1.812 . . . . 25.0 106.108 166.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.0 mm -115.49 129.22 72.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 107.043 -1.465 . . . . 25.0 107.043 -177.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.408 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 1.0 OUTLIER -129.27 123.33 31.63 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 105.418 -2.067 . . . . 25.0 105.418 179.677 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.54 -36.32 23.53 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 114.969 0.747 . . . . 25.0 114.969 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.52 -149.03 50.42 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.268 -0.733 . . . . 25.0 111.268 -176.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -78.41 170.47 54.84 Favored Glycine 0 C--O 1.257 1.585 0 O-C-N 121.728 -0.866 . . . . 25.0 112.061 -176.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.34 165.06 33.83 Favored Glycine 0 C--N 1.316 -0.557 0 CA-C-O 119.639 -0.534 . . . . 25.0 112.91 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.14 101.07 13.14 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.053 -1.091 . . . . 25.0 108.053 178.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -98.48 153.57 18.51 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.915 0.709 . . . . 50.0 112.915 -168.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -115.15 99.85 7.73 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 105.745 -1.946 . . . . 25.0 105.745 175.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 33.2 mt -104.26 137.82 41.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.798 -1.092 . . . . 25.0 111.571 -171.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.414 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 60.0 m-85 -133.77 99.42 4.46 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.925 0.713 . . . . 25.0 112.925 -178.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.38 -35.2 63.47 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-O 118.342 -1.255 . . . . 25.0 115.8 -177.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 55.17 -154.47 0.29 Allowed 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 118.814 1.307 . . . . 25.0 113.672 -178.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.97 160.13 15.56 Favored 'General case' 0 C--O 1.249 1.034 0 N-CA-C 113.486 0.921 . . . . 25.0 113.486 -176.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.12 159.93 33.51 Favored Glycine 0 C--O 1.223 -0.546 0 CA-C-N 115.187 -0.915 . . . . 25.0 111.451 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -82.15 115.5 21.29 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 104.688 -2.338 . . . . 25.0 104.688 177.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -116.67 154.33 30.76 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.758 -0.377 . . . . 50.0 110.514 -171.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 mp -114.05 133.08 55.76 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 105.792 -1.929 . . . . 25.0 105.792 174.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.6 mp -133.28 128.92 36.84 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 113.967 1.099 . . . . 25.0 113.967 -173.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -129.92 135.13 47.99 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.181 -1.414 . . . . 25.0 107.181 177.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -93.36 -40.65 4.73 Favored Glycine 0 N--CA 1.475 1.26 0 N-CA-C 115.409 0.924 . . . . 25.0 115.409 -175.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.34 -174.92 55.22 Favored Glycine 0 C--O 1.24 0.491 0 N-CA-C 110.88 -0.888 . . . . 25.0 110.88 -176.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.83 154.06 9.88 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.328 0.585 . . . . 25.0 109.911 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.1 150.66 24.12 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.493 -0.776 . . . . 25.0 112.028 -176.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -74.92 127.87 34.23 Favored 'General case' 0 C--O 1.212 -0.92 0 N-CA-C 104.737 -2.32 . . . . 25.0 104.737 176.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -117.68 150.94 38.22 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 121.707 -0.62 . . . . 50.0 111.046 -174.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -112.76 121.56 45.09 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 103.764 -2.68 . . . . 25.0 103.764 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -144.7 131.5 20.16 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 117.743 2.497 . . . . 25.0 117.743 -171.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.414 ' HB2' ' HA ' ' A' ' 38' ' ' TYR . 69.3 m -99.45 141.19 32.55 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-N 115.8 -0.637 . . . . 25.0 109.534 174.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -94.72 -35.71 5.8 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 110.443 -1.063 . . . . 25.0 110.443 172.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.17 -176.33 51.74 Favored Glycine 0 N--CA 1.465 0.62 0 CA-C-N 118.198 0.999 . . . . 25.0 113.373 -178.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -59.51 156.1 13.92 Favored 'General case' 0 C--O 1.246 0.884 0 O-C-N 121.595 -0.944 . . . . 25.0 110.724 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.01 162.54 34.63 Favored Glycine 0 C--O 1.246 0.903 0 N-CA-C 108.943 -1.663 . . . . 25.0 108.943 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.95 121.32 26.36 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 106.842 -1.54 . . . . 25.0 106.842 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -112.0 152.19 28.41 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.184 0.516 . . . . 50.0 110.17 -175.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.5 m -117.47 110.31 17.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.851 0.834 . . . . 25.0 110.329 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -94.21 119.94 33.75 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 106.032 -1.84 . . . . 25.0 106.032 176.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.9 mmt85 -114.5 -32.25 5.96 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.967 -0.561 . . . . 25.0 112.339 -177.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 68.09 148.53 0.06 Allowed 'General case' 0 CA--C 1.55 0.948 0 O-C-N 124.741 1.275 . . . . 25.0 110.667 -174.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.16 -34.98 21.99 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 114.822 1.416 . . . . 25.0 114.822 -165.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 70.5 mt -132.25 161.66 32.9 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.1 0.476 . . . . 25.0 110.602 -172.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.83 -31.35 66.55 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 107.095 -1.446 . . . . 25.0 107.095 169.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -87.69 9.34 21.82 Favored 'General case' 0 C--O 1.254 1.31 0 N-CA-C 115.571 1.693 . . . . 25.0 115.571 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -94.7 141.54 28.5 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.034 -1.042 . . . . 25.0 110.101 -177.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.8 t 47.32 50.48 14.48 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 114.556 1.317 . . . . 25.0 114.556 -178.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 31.0 p-80 -114.35 169.54 8.96 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.47 -0.786 . . . . 25.0 111.403 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -121.45 148.79 43.97 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 104.621 -2.362 . . . . 25.0 104.621 173.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 92.4 p -139.59 170.96 8.74 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 107.299 -1.371 . . . . 25.0 107.299 -177.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -62.79 -20.45 71.21 Favored 'Trans proline' 0 C--N 1.361 1.185 0 CA-C-N 119.044 0.694 . . . . 25.0 113.087 174.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 80.9 mt -73.64 -27.5 61.3 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 121.748 -0.595 . . . . 25.0 110.91 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.91 -177.95 30.29 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.683 -0.967 . . . . 25.0 110.683 -174.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.3 t -101.7 141.73 34.12 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 122.811 1.291 . . . . 25.0 111.54 -178.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -127.71 27.36 5.77 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 114.678 -1.146 . . . . 25.0 109.167 176.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.2 145.17 45.77 Favored Glycine 0 N--CA 1.462 0.39 0 O-C-N 124.07 0.856 . . . . 25.0 112.124 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -85.33 170.1 13.09 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 122.694 -0.297 . . . . 50.0 111.321 -177.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -128.11 105.95 8.72 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.694 0.798 . . . . 25.0 111.394 -174.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.0 mt -87.82 133.91 29.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 121.853 0.835 . . . . 25.0 108.789 -178.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.0 mt -85.1 -43.93 13.45 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 116.401 2.001 . . . . 25.0 116.401 -172.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -137.67 40.16 2.39 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.09 1.144 . . . . 25.0 114.09 -173.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.418 ' CE2' ' HA ' ' A' ' 89' ' ' PRO . 60.9 t80 -55.97 132.21 49.29 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.579 -0.737 . . . . 25.0 112.287 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -102.37 105.43 43.36 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 106.011 -1.848 . . . . 25.0 106.011 174.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.418 ' HA ' ' CE2' ' A' ' 87' ' ' PHE . 95.9 Cg_endo -70.48 -4.39 14.42 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 N-CA-C 116.622 1.739 . . . . 25.0 116.622 -172.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.3 t -97.29 -45.62 6.42 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.201 0.524 . . . . 25.0 111.079 174.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -82.53 -41.26 19.88 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.357 0.873 . . . . 25.0 113.357 -174.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -84.95 165.44 17.61 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.694 -0.484 . . . . 75.0 109.694 -169.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -140.73 146.24 37.5 Favored 'General case' 0 C--O 1.246 0.874 0 N-CA-C 108.523 -0.917 . . . . 25.0 108.523 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 76.5 mt -128.66 126.52 65.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 107.926 -1.138 . . . . 25.0 107.926 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -80.91 148.14 30.0 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.809 0.814 . . . . 25.0 110.361 172.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.0 p -143.32 -7.91 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.317 -0.856 . . . . 25.0 110.628 176.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.8 t -63.92 -41.16 97.73 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.282 0.563 . . . . 25.0 111.943 -173.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.62 -4.61 57.97 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.028 0.751 . . . . 25.0 113.028 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 11.9 mt -115.04 -38.25 3.93 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.989 1.477 . . . . 25.0 114.989 -169.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -136.42 -54.68 0.06 OUTLIER Glycine 0 C--O 1.24 0.477 0 N-CA-C 117.644 1.818 . . . . 25.0 117.644 -174.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -155.04 164.02 39.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 117.569 0.684 . . . . 25.0 109.826 -174.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 45.8 t -121.26 -25.53 5.23 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 124.12 0.887 . . . . 25.0 109.018 173.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -100.65 121.59 7.29 Favored Glycine 0 N--CA 1.464 0.565 0 N-CA-C 107.615 -2.194 . . . . 25.0 107.615 172.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.68 146.49 53.72 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 118.565 1.183 . . . . 25.0 113.246 -174.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -80.85 -175.19 49.45 Favored Glycine 0 C--N 1.32 -0.316 0 CA-C-N 115.349 -0.841 . . . . 25.0 114.415 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -60.84 142.62 56.01 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 121.196 0.522 . . . . 25.0 111.701 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 166.83 -171.94 41.84 Favored Glycine 0 C--O 1.245 0.787 0 N-CA-C 109.363 -1.495 . . . . 25.0 109.363 -177.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -141.52 165.25 28.0 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.833 1.317 . . . . 25.0 111.465 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 57.52 33.9 23.88 Favored 'General case' 0 C--O 1.246 0.878 0 O-C-N 124.454 1.096 . . . . 25.0 113.541 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 74.56 39.32 41.81 Favored Glycine 0 C--O 1.222 -0.653 0 N-CA-C 109.969 -1.252 . . . . 25.0 109.969 177.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 11.1 t -148.6 167.64 24.92 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 108.998 -0.741 . . . . 25.0 108.998 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.4 mt -84.78 159.91 20.36 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 103.069 -2.937 . . . . 25.0 103.069 169.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.66 128.9 38.03 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 119.291 -0.964 . . . . 25.0 109.158 178.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.9 m -91.48 159.23 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 109.65 -0.5 . . . . 25.0 109.65 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.19 164.71 26.77 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 110.169 -0.308 . . . . 25.0 110.169 -177.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.4 m -118.58 162.64 16.5 Favored 'Isoleucine or valine' 0 C--O 1.25 1.08 0 N-CA-C 106.726 -1.583 . . . . 25.0 106.726 175.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.8 t -83.06 -51.23 7.72 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 106.295 -1.743 . . . . 25.0 106.295 170.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -166.69 -164.58 0.66 Allowed 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 100.825 -3.768 . . . . 25.0 100.825 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -68.12 -25.07 65.11 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 119.173 0.897 . . . . 25.0 110.658 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -106.9 -164.64 22.3 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 108.17 -1.972 . . . . 25.0 108.17 174.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 56.18 -162.79 0.17 Allowed 'General case' 0 C--O 1.248 0.976 0 N-CA-C 113.538 0.94 . . . . 25.0 113.538 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 64.3 mtt85 -79.24 169.29 18.35 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.755 1.02 . . . . 25.0 113.755 -168.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.7 p -115.3 165.56 12.82 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 105.111 -2.181 . . . . 25.0 105.111 174.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -134.73 157.97 45.33 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 121.404 0.621 . . . . 25.0 111.357 -177.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 51.1 tp -130.13 113.97 15.15 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 103.781 -2.674 . . . . 25.0 103.781 171.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -116.13 148.67 40.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.979 0.419 . . . . 25.0 110.19 -174.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 43.0 t -97.27 147.18 24.4 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 106.061 -1.829 . . . . 25.0 106.061 171.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -116.9 17.28 15.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.562 0.696 . . . . 25.0 110.532 -177.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -107.8 140.06 41.45 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 104.674 -2.343 . . . . 25.0 104.674 172.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -140.04 154.65 47.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.698 0.761 . . . . 25.0 112.404 -176.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -75.03 166.22 24.01 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.924 -1.035 . . . . 25.0 109.318 177.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.83 -25.27 66.35 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 108.443 -0.947 . . . . 25.0 108.443 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -74.02 -5.37 41.0 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.372 -0.831 . . . . 25.0 112.995 175.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.32 10.48 77.47 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 121.299 -0.477 . . . . 25.0 112.619 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.5 mt -83.8 134.03 34.74 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 122.288 -0.536 . . . . 25.0 109.663 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 59.8 p -138.69 176.89 8.3 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 106.605 -1.628 . . . . 25.0 106.605 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -125.64 134.46 51.87 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 120.328 -0.549 . . . . 25.0 110.349 -175.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -152.76 152.93 32.22 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 108.979 -0.749 . . . . 25.0 108.979 171.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 13.0 p -145.23 143.78 21.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 106.244 -1.762 . . . . 25.0 106.244 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -102.45 146.14 28.53 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 107.081 -1.452 . . . . 25.0 107.081 -177.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.5 mp -132.19 134.98 46.0 Favored 'General case' 0 C--O 1.201 -1.479 0 N-CA-C 104.908 -2.256 . . . . 25.0 104.908 177.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -103.18 10.55 37.73 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 119.923 1.238 . . . . 25.0 111.059 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.7 -10.2 66.92 Favored Glycine 0 N--CA 1.458 0.164 0 C-N-CA 120.952 -0.642 . . . . 25.0 113.57 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 37.9 t0 53.09 40.9 31.98 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 123.327 1.536 . . . . 25.0 110.557 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -115.92 38.29 3.38 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.053 -1.43 . . . . 25.0 109.811 -179.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.28 -32.57 68.54 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.067 0.766 . . . . 25.0 113.067 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.14 -28.49 62.27 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.017 0.377 . . . . 25.0 112.017 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -85.49 -29.56 24.17 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-N 116.744 -0.207 . . . . 25.0 111.041 -177.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 29.4 mt -59.35 139.5 56.97 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-O 122.431 1.11 . . . . 25.0 112.581 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.4 m -143.06 160.43 40.39 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.3 -1.741 . . . . 25.0 106.3 176.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.64 3.76 15.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.17 0.509 . . . . 25.0 109.987 176.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -68.38 -29.59 68.33 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.174 -0.466 . . . . 25.0 110.307 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -92.07 1.63 57.08 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.39 0.614 . . . . 25.0 110.867 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 31.4 mm -101.02 125.42 54.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.821 0 N-CA-C 104.821 -2.289 . . . . 25.0 104.821 178.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.74 119.4 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 122.934 1.35 . . . . 25.0 112.14 -174.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -156.0 -20.76 0.1 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 113.248 -1.797 . . . . 25.0 110.908 177.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -76.11 52.18 0.71 Allowed 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.211 1.189 . . . . 25.0 114.211 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 63.68 11.37 5.74 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 115.229 1.566 . . . . 25.0 115.229 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.5 m 64.96 -59.2 0.25 Allowed 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 116.686 2.106 . . . . 25.0 116.686 176.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -64.27 137.91 58.17 Favored 'General case' 0 C--O 1.244 0.772 0 O-C-N 121.946 -0.471 . . . . 25.0 111.381 -175.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -81.69 61.09 4.92 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 113.349 0.87 . . . . 25.0 113.349 -176.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.04 -37.02 78.35 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.77 -0.826 . . . . 25.0 108.77 177.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -135.87 -104.73 0.21 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.534 -0.757 . . . . 25.0 109.702 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 55.71 -159.7 0.2 Allowed 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.247 1.019 . . . . 25.0 111.17 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 63.44 25.83 68.99 Favored Glycine 0 C--O 1.218 -0.863 0 C-N-CA 121.227 -0.511 . . . . 25.0 112.648 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -82.54 94.94 7.59 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.596 0.712 . . . . 25.0 110.647 -174.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -125.32 150.73 46.87 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 108.493 -0.929 . . . . 25.0 108.493 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -146.0 32.0 1.57 Allowed Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 109.125 -1.59 . . . . 25.0 109.125 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 39.9 t -65.34 -37.66 80.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 109.99 -0.374 . . . . 25.0 109.99 -175.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.8 128.65 21.09 Favored 'Isoleucine or valine' 0 C--O 1.244 0.8 0 CA-C-O 122.197 0.999 . . . . 25.0 110.913 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 158.58 146.27 4.48 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 109.082 -1.607 . . . . 25.0 109.082 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -141.09 154.57 46.0 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-N 117.503 0.652 . . . . 25.0 111.159 -176.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 93.7 p -149.86 158.24 43.98 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.339 -1.356 . . . . 25.0 107.339 176.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 178.79 174.27 44.86 Favored Glycine 0 C--O 1.241 0.541 0 C-N-CA 120.06 -1.067 . . . . 25.0 113.578 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -152.9 85.49 4.33 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 107.728 -1.212 . . . . 25.0 107.728 178.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.42 150.28 75.58 Favored 'Trans proline' 0 C--N 1.354 0.818 0 O-C-N 122.015 0.481 . . . . 25.0 112.054 -177.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -114.81 154.51 28.46 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.201 -0.454 . . . . 25.0 110.575 -174.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -136.32 61.16 37.19 Favored Pre-proline 0 C--O 1.25 1.087 0 N-CA-C 113.225 0.824 . . . . 25.0 113.225 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -71.97 160.27 48.08 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 115.623 -2.451 . . . . 25.0 112.498 177.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.9 t -120.22 -15.75 8.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.017 -0.538 . . . . 25.0 111.181 -177.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.746 -0.645 . . . . 25.0 110.763 177.266 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo . . . . . 0 N--CA 1.48 0.7 0 N-CA-C 113.692 0.612 . . . . 25.0 113.692 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -178.02 54.04 0.1 OUTLIER Glycine 0 C--O 1.224 -0.528 0 N-CA-C 110.557 -1.017 . . . . 25.0 110.557 -178.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.4 p -60.52 132.41 25.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 122.261 1.029 . . . . 25.0 112.346 -174.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -103.11 -6.14 22.54 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.397 -1.274 . . . . 25.0 110.482 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.97 -148.12 4.91 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 116.36 -0.382 . . . . 25.0 112.717 178.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.4 p 68.39 159.85 0.15 Allowed Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 125.974 1.71 . . . . 25.0 112.204 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -66.52 1.3 2.7 Favored 'Trans proline' 0 C--N 1.359 1.122 0 N-CA-C 116.634 1.744 . . . . 25.0 116.634 -176.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.3 p -68.53 -18.98 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 N-CA-C 115.24 1.57 . . . . 25.0 115.24 -170.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.3 p -146.92 143.64 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 113.288 0.848 . . . . 25.0 113.288 -177.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.32 13.68 81.44 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 115.607 1.003 . . . . 25.0 115.607 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.2 t -54.21 -50.95 65.94 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 122.337 -0.508 . . . . 25.0 111.459 -173.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -86.8 19.26 3.03 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 114.758 1.392 . . . . 25.0 114.758 -172.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -152.39 170.83 19.13 Favored 'General case' 0 CA--C 1.561 1.397 0 O-C-N 121.653 -0.654 . . . . 25.0 111.391 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -59.38 134.18 56.77 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 112.47 0.544 . . . . 25.0 112.47 -175.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -121.54 163.22 19.22 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 115.575 1.694 . . . . 50.0 115.575 -173.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -138.08 87.04 2.21 Favored 'General case' 0 C--O 1.249 1.043 0 N-CA-C 102.857 -3.016 . . . . 25.0 102.857 164.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 89.2 mt -102.65 122.6 44.75 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 117.764 0.256 . . . . 25.0 111.551 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -110.75 122.88 48.91 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 123.61 0.568 . . . . 25.0 110.257 -179.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.99 176.65 40.95 Favored Glycine 0 CA--C 1.54 1.646 0 C-N-CA 120.59 -0.814 . . . . 25.0 114.349 -178.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.1 p -87.43 179.33 6.59 Favored 'General case' 0 C--O 1.256 1.429 0 C-N-CA 123.581 0.752 . . . . 25.0 110.981 177.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 51.7 mt -82.48 13.96 3.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.232 -0.895 . . . . 25.0 112.736 175.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.4 176.04 20.7 Favored Glycine 0 C--O 1.242 0.597 0 CA-C-N 115.479 -0.782 . . . . 25.0 111.834 177.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.3 t -78.07 131.35 37.27 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 121.85 -0.794 . . . . 25.0 108.884 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -142.65 153.58 43.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.308 0.575 . . . . 50.0 110.545 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -87.52 133.97 33.69 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 102.809 -3.034 . . . . 25.0 102.809 164.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 34.6 mm -127.04 116.69 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 105.292 -2.114 . . . . 25.0 105.292 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.1 tt -122.36 122.22 38.53 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.462 -1.31 . . . . 25.0 107.462 -177.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.21 -38.71 28.84 Favored Glycine 0 N--CA 1.445 -0.733 0 O-C-N 123.986 0.804 . . . . 25.0 114.71 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.66 -147.48 38.66 Favored Glycine 0 C--O 1.241 0.552 0 O-C-N 121.485 -1.009 . . . . 25.0 110.991 -176.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.37 165.02 54.77 Favored Glycine 0 CA--C 1.505 -0.588 0 CA-C-O 121.181 0.323 . . . . 25.0 112.762 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.57 167.27 36.46 Favored Glycine 0 C--O 1.236 0.274 0 C-N-CA 121.024 -0.608 . . . . 25.0 113.875 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.7 107.68 15.51 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.282 -1.007 . . . . 25.0 108.282 177.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -106.4 147.56 29.12 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.086 0.773 . . . . 50.0 113.086 -170.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -113.34 107.03 15.31 Favored 'General case' 0 C--O 1.249 1.073 0 N-CA-C 107.343 -1.354 . . . . 25.0 107.343 172.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 53.6 mt -111.39 133.51 53.64 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 116.161 -0.472 . . . . 25.0 110.613 -171.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -128.83 107.3 9.53 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.483 0.659 . . . . 25.0 111.715 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.71 -34.12 28.78 Favored Glycine 0 N--CA 1.463 0.489 0 N-CA-C 116.732 1.453 . . . . 25.0 116.732 -175.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 55.48 -153.5 0.33 Allowed 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 118.374 1.087 . . . . 25.0 111.959 -173.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.83 164.53 9.97 Favored 'General case' 0 C--O 1.252 1.193 0 N-CA-C 112.798 0.666 . . . . 25.0 112.798 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.67 155.19 31.66 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 115.279 -0.873 . . . . 25.0 111.351 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -78.59 98.54 6.19 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 106.99 -1.485 . . . . 25.0 106.99 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -100.24 151.42 21.47 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 122.032 -0.417 . . . . 50.0 110.183 -171.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.9 mp -113.16 90.6 3.39 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.767 -0.827 . . . . 25.0 108.767 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.4 mp -92.92 125.24 37.42 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 112.14 0.422 . . . . 25.0 112.14 -172.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -122.79 132.76 54.36 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 106.937 -1.505 . . . . 25.0 106.937 173.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.1 -38.76 8.32 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 119.715 -1.231 . . . . 25.0 115.028 -177.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.71 -171.83 51.44 Favored Glycine 0 C--O 1.223 -0.546 0 O-C-N 121.824 -0.81 . . . . 25.0 111.612 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.34 149.48 12.96 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.533 0.683 . . . . 25.0 110.935 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.35 166.93 42.35 Favored Glycine 0 C--N 1.332 0.327 0 CA-C-N 115.482 -0.781 . . . . 25.0 111.939 -178.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.71 129.23 34.86 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 105.16 -2.163 . . . . 25.0 105.16 176.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -120.85 154.16 36.18 Favored 'General case' 0 C--O 1.251 1.153 0 O-C-N 121.733 -0.605 . . . . 50.0 111.656 -175.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -116.57 128.3 55.29 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 103.607 -2.738 . . . . 25.0 103.607 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -147.76 141.58 25.74 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 115.831 1.789 . . . . 25.0 115.831 -174.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.6 m -109.3 138.02 46.29 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.194 -1.409 . . . . 25.0 107.194 176.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.03 -38.57 5.69 Favored Glycine 0 C--N 1.317 -0.512 0 N-CA-C 111.06 -0.816 . . . . 25.0 111.06 174.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.52 -170.37 54.54 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 118.749 1.274 . . . . 25.0 111.992 -177.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -64.15 161.63 15.95 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.088 0.471 . . . . 25.0 111.419 176.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.99 164.06 40.01 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-N 115.503 -0.771 . . . . 25.0 111.724 -176.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.13 106.5 16.63 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.129 -1.063 . . . . 25.0 108.129 -177.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -97.04 156.65 16.27 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 112.548 0.573 . . . . 50.0 112.548 -170.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 57.1 m -122.63 125.66 46.09 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.524 -0.917 . . . . 25.0 108.524 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -120.51 85.57 2.41 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.942 -0.762 . . . . 25.0 108.942 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -89.12 -23.95 22.36 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 112.313 0.486 . . . . 25.0 112.313 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 66.41 162.02 0.16 Allowed 'General case' 0 CA--C 1.548 0.898 0 O-C-N 125.212 1.57 . . . . 25.0 108.595 -171.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.13 -46.1 21.54 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 115.663 1.727 . . . . 25.0 115.663 -165.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.9 mt -144.12 169.28 18.15 Favored 'General case' 0 C--O 1.197 -1.691 0 C-N-CA 123.008 0.523 . . . . 25.0 111.246 -169.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.68 -32.69 30.8 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.574 -0.739 . . . . 25.0 110.571 169.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -80.99 1.44 31.2 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.732 1.382 . . . . 25.0 114.732 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -104.16 142.58 34.25 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.95 0.722 . . . . 25.0 112.95 -175.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.9 t 51.87 54.38 10.99 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 115.142 1.534 . . . . 25.0 115.142 177.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 36.9 p-80 -132.13 170.64 14.71 Favored 'General case' 0 C--O 1.208 -1.111 0 CA-C-N 116.441 -0.345 . . . . 25.0 111.884 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -118.07 144.92 45.21 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 106.696 -1.594 . . . . 25.0 106.696 178.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.9 p -133.31 164.83 41.17 Favored Pre-proline 0 C--O 1.244 0.797 0 N-CA-C 108.443 -0.947 . . . . 25.0 108.443 178.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -64.66 -15.84 52.16 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 117.504 -1.198 . . . . 25.0 113.436 174.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 87.9 mt -82.34 -21.51 35.96 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.075 -0.511 . . . . 25.0 111.817 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.77 171.77 24.13 Favored Glycine 0 C--O 1.219 -0.839 0 N-CA-C 109.875 -1.29 . . . . 25.0 109.875 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.1 t -101.13 147.88 25.72 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 122.659 1.218 . . . . 25.0 112.91 178.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -131.21 21.45 4.84 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.235 -0.893 . . . . 25.0 110.647 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.2 152.04 51.7 Favored Glycine 0 N--CA 1.473 1.164 0 N-CA-C 109.572 -1.411 . . . . 25.0 109.572 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -96.94 171.34 8.56 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 118.529 1.165 . . . . 50.0 110.536 -174.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.85 108.5 11.06 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 121.931 -0.481 . . . . 25.0 112.231 -175.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.3 mt -89.39 138.68 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 109.212 -0.662 . . . . 25.0 109.212 -176.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.404 ' HA ' ' HG2' ' A' ' 142' ' ' GLU . 76.9 mt -86.33 -52.62 5.51 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 115.77 1.767 . . . . 25.0 115.77 -175.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -127.82 32.46 4.95 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 113.982 1.105 . . . . 25.0 113.982 -168.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -52.94 143.33 17.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.423 -1.262 . . . . 25.0 114.029 -175.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -118.17 103.35 49.78 Favored Pre-proline 0 C--O 1.237 0.398 0 C-N-CA 123.032 0.533 . . . . 25.0 111.333 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.23 -13.21 35.6 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 N-CA-C 114.549 0.942 . . . . 25.0 114.549 -175.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.0 t -81.26 -39.33 25.45 Favored 'General case' 0 C--O 1.245 0.836 0 N-CA-C 108.737 -0.838 . . . . 25.0 108.737 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -95.33 -43.53 7.99 Favored 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 117.196 2.295 . . . . 25.0 117.196 -175.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -90.19 172.75 8.58 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.572 -1.195 . . . . 75.0 112.03 -162.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -142.81 147.32 35.28 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 112.36 0.504 . . . . 25.0 112.36 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 90.7 mt -127.35 128.78 70.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 108.604 -0.887 . . . . 25.0 108.604 -178.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -86.62 148.6 25.41 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 122.124 0.964 . . . . 25.0 111.617 174.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.4 p -146.75 -2.8 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 115.566 -0.743 . . . . 25.0 111.043 175.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 44.9 t -60.97 -44.57 97.15 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.662 0.744 . . . . 25.0 111.464 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.82 -28.53 58.33 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.372 -0.831 . . . . 25.0 112.074 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.6 mt -92.09 -41.61 10.4 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 116.288 1.958 . . . . 25.0 116.288 -171.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -138.54 -48.12 0.06 OUTLIER Glycine 0 N--CA 1.463 0.491 0 N-CA-C 118.156 2.022 . . . . 25.0 118.156 -172.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -160.14 153.03 21.45 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 118.579 1.19 . . . . 25.0 112.714 -172.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 25.2 t -109.15 -16.94 13.98 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.511 -0.552 . . . . 25.0 109.511 178.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -121.46 132.61 9.12 Favored Glycine 0 N--CA 1.47 0.912 0 N-CA-C 108.363 -1.895 . . . . 25.0 108.363 176.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -68.15 156.0 38.43 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.963 1.468 . . . . 25.0 114.963 -172.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -101.77 -161.25 26.79 Favored Glycine 0 N--CA 1.464 0.53 0 O-C-N 121.583 -0.698 . . . . 25.0 112.828 -177.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -54.57 138.99 39.62 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 113.482 0.919 . . . . 25.0 113.482 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 168.72 -176.42 42.98 Favored Glycine 0 C--O 1.227 -0.292 0 CA-C-N 115.242 -0.89 . . . . 25.0 110.995 177.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -146.56 165.93 28.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.573 0.687 . . . . 25.0 109.283 -177.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 54.99 34.02 21.5 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 114.449 1.277 . . . . 25.0 114.449 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.62 25.39 65.35 Favored Glycine 0 N--CA 1.465 0.617 0 N-CA-C 111.159 -0.776 . . . . 25.0 111.159 177.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.8 t -136.64 176.4 8.74 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 109.01 -0.737 . . . . 25.0 109.01 -178.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 69.7 mt -89.48 164.89 14.63 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 104.056 -2.572 . . . . 25.0 104.056 169.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.66 108.12 4.24 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 122.199 1.0 . . . . 25.0 109.894 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 18.0 m -73.16 160.34 5.36 Favored 'Isoleucine or valine' 0 C--O 1.247 0.968 0 N-CA-C 108.893 -0.78 . . . . 25.0 108.893 -177.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.47 168.87 20.8 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 110.382 -0.229 . . . . 25.0 110.382 -176.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.6 m -124.97 160.09 30.76 Favored 'Isoleucine or valine' 0 C--O 1.251 1.138 0 O-C-N 121.876 -0.515 . . . . 25.0 110.222 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.6 t -73.5 -49.12 28.3 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.692 -1.225 . . . . 25.0 107.692 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -168.94 -160.59 0.28 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 103.854 -2.647 . . . . 25.0 103.854 -177.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -72.82 -0.08 12.41 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 121.291 -0.88 . . . . 25.0 111.987 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -143.63 -157.79 7.31 Favored Glycine 0 C--O 1.241 0.575 0 N-CA-C 108.007 -2.037 . . . . 25.0 108.007 177.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.65 -153.59 0.37 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.184 0.809 . . . . 25.0 113.184 178.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.4 mtt85 -80.72 161.58 24.52 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 113.496 0.924 . . . . 25.0 113.496 -172.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.64 164.58 11.68 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 105.827 -1.916 . . . . 25.0 105.827 171.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -128.77 155.92 44.38 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 121.603 0.716 . . . . 25.0 110.357 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 29.8 tp -132.5 115.92 16.11 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 102.705 -3.072 . . . . 25.0 102.705 169.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -116.7 153.49 32.26 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 112.638 0.607 . . . . 25.0 112.638 -174.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 33.4 t -97.25 149.66 21.8 Favored 'General case' 0 C--O 1.215 -0.721 0 N-CA-C 103.889 -2.634 . . . . 25.0 103.889 168.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -119.35 10.17 11.85 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 124.828 1.33 . . . . 25.0 109.581 -178.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -97.95 152.78 18.89 Favored 'General case' 0 C--O 1.251 1.154 0 CA-C-N 114.291 -1.322 . . . . 25.0 107.504 171.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -142.88 160.4 40.41 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 122.234 1.016 . . . . 25.0 112.537 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -75.18 165.07 25.77 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 106.277 -1.749 . . . . 25.0 106.277 172.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.62 -22.83 67.11 Favored 'General case' 0 C--O 1.248 0.999 0 CA-C-O 122.287 1.042 . . . . 25.0 109.374 176.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -80.27 -6.78 58.47 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.859 -1.064 . . . . 25.0 112.788 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.59 2.53 72.72 Favored Glycine 0 C--O 1.223 -0.58 0 N-CA-C 114.419 0.528 . . . . 25.0 114.419 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.9 mt -72.68 137.17 45.83 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.83 -1.174 . . . . 25.0 107.83 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 88.7 p -140.25 -179.88 6.24 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 109.461 -0.57 . . . . 25.0 109.461 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -122.84 140.2 53.2 Favored 'General case' 0 C--O 1.247 0.951 0 O-C-N 121.926 -0.484 . . . . 25.0 111.717 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -156.97 155.49 31.38 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 107.476 -1.305 . . . . 25.0 107.476 170.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.8 p -148.78 147.07 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 N-CA-C 105.12 -2.178 . . . . 25.0 105.12 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -115.38 149.64 37.63 Favored 'General case' 0 C--O 1.254 1.305 0 N-CA-C 109.306 -0.627 . . . . 25.0 109.306 -175.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mp -139.15 129.22 25.18 Favored 'General case' 0 C--O 1.205 -1.254 0 N-CA-C 107.522 -1.288 . . . . 25.0 107.522 -175.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.404 ' HG2' ' HA ' ' A' ' 85' ' ' LEU . 6.9 pt-20 -86.33 0.77 53.21 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.347 -0.941 . . . . 25.0 113.058 -177.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -65.17 -17.84 64.17 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 116.033 1.173 . . . . 25.0 116.033 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 38.5 t0 54.4 45.77 26.43 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 122.423 1.106 . . . . 25.0 112.199 -178.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -122.05 43.37 2.88 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 113.993 -1.458 . . . . 25.0 109.418 -174.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -52.63 -37.51 58.58 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 113.995 1.109 . . . . 25.0 113.995 178.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.59 -28.18 63.64 Favored 'General case' 0 C--O 1.248 0.996 0 CA-C-N 118.923 0.783 . . . . 25.0 111.473 -178.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.56 -27.47 34.33 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 121.413 0.625 . . . . 25.0 112.377 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 46.1 mt -66.6 128.58 36.79 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 119.87 -0.732 . . . . 25.0 110.337 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.9 m -131.15 160.93 33.31 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.176 -1.416 . . . . 25.0 107.176 177.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -79.51 1.37 26.02 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 107.619 -1.252 . . . . 25.0 107.619 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -68.47 -30.8 69.73 Favored 'General case' 0 N--CA 1.437 -1.106 0 O-C-N 123.465 0.478 . . . . 25.0 111.803 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -91.31 -10.41 41.43 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.733 -0.469 . . . . 25.0 109.733 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 26.9 mm -83.75 136.01 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 104.435 -2.432 . . . . 25.0 104.435 175.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.9 p -113.51 126.35 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 O-C-N 120.47 -1.394 . . . . 25.0 110.965 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -153.77 -30.43 0.12 Allowed 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 114.38 -1.282 . . . . 25.0 112.743 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -82.77 69.84 9.64 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 112.849 0.685 . . . . 25.0 112.849 -175.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 54.37 20.77 2.87 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.871 1.063 . . . . 25.0 113.871 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.12 17.95 4.89 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.705 0.802 . . . . 25.0 111.721 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -98.57 131.55 44.69 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.553 0.341 . . . . 25.0 110.976 -174.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.4 -10.33 58.78 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.957 0.725 . . . . 25.0 112.957 -176.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.07 -32.3 72.83 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.221 0.452 . . . . 25.0 112.221 -178.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.71 162.97 26.58 Favored 'General case' 0 C--O 1.247 0.961 0 N-CA-C 111.978 0.362 . . . . 25.0 111.978 -175.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 57.59 -169.81 0.11 Allowed 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 114.034 1.124 . . . . 25.0 114.034 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 90.83 2.18 72.41 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.787 -0.721 . . . . 25.0 113.789 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -102.48 115.29 30.28 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.841 -1.17 . . . . 25.0 107.841 176.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -134.47 161.78 34.09 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.287 -1.005 . . . . 25.0 108.287 -177.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -135.11 27.34 3.16 Favored Glycine 0 C--O 1.242 0.606 0 N-CA-C 110.419 -1.072 . . . . 25.0 110.419 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 47.7 t -70.2 -34.83 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.32 0.648 . . . . 25.0 110.355 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -58.36 133.69 23.32 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 CA-C-O 121.727 0.775 . . . . 25.0 111.735 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 156.81 160.18 9.93 Favored Glycine 0 C--N 1.336 0.564 0 N-CA-C 110.757 -0.937 . . . . 25.0 110.757 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -136.37 152.42 50.62 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 122.382 -0.481 . . . . 25.0 110.031 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 54.5 p -148.71 159.16 44.38 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.239 0.542 . . . . 25.0 110.0 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -179.93 168.77 39.25 Favored Glycine 0 N--CA 1.461 0.318 0 O-C-N 121.677 -0.639 . . . . 25.0 113.717 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -154.23 114.19 2.5 Favored Pre-proline 0 C--O 1.246 0.908 0 N-CA-C 107.767 -1.197 . . . . 25.0 107.767 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -68.84 157.05 63.4 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 117.304 -1.331 . . . . 25.0 112.559 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -117.75 146.67 43.62 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 108.208 -1.034 . . . . 25.0 108.208 177.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -140.15 64.27 25.9 Favored Pre-proline 0 N--CA 1.478 0.969 0 N-CA-C 112.405 0.52 . . . . 25.0 112.405 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.21 161.39 32.26 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 117.579 -1.147 . . . . 25.0 112.616 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 15.2 t -119.17 2.91 11.43 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 116.328 -0.396 . . . . 25.0 110.894 177.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 C--O 1.254 1.307 0 CA-C-O 117.494 -1.241 . . . . 25.0 111.283 178.829 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo . . . . . 0 CA--C 1.527 0.174 0 N-CA-C 112.653 0.213 . . . . 25.0 112.653 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.79 36.34 0.22 Allowed Glycine 0 N--CA 1.473 1.107 0 C-N-CA 121.173 -0.537 . . . . 25.0 113.838 -177.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -50.03 119.6 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 114.119 1.155 . . . . 25.0 114.119 -175.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -93.43 8.5 40.29 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 122.176 0.989 . . . . 25.0 108.341 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.92 -152.67 17.71 Favored Glycine 0 C--O 1.22 -0.742 0 CA-C-N 115.865 -0.607 . . . . 25.0 113.993 176.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.6 p 69.13 158.19 0.15 Allowed Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 125.988 1.715 . . . . 25.0 112.048 -174.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -69.7 22.77 0.17 Allowed 'Trans proline' 0 C--N 1.359 1.098 0 N-CA-C 118.803 2.578 . . . . 25.0 118.803 -176.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.07 -25.76 17.07 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.504 0 N-CA-C 114.516 1.302 . . . . 25.0 114.516 -171.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.6 p -146.69 145.76 19.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 CA-C-N 119.644 1.111 . . . . 25.0 112.223 -175.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.2 24.15 41.69 Favored Glycine 0 N--CA 1.466 0.681 0 N-CA-C 118.719 2.247 . . . . 25.0 118.719 172.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.7 t -49.49 -66.11 0.45 Allowed 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 118.641 1.22 . . . . 25.0 112.719 -175.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -86.49 17.83 3.62 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 115.588 1.699 . . . . 25.0 115.588 -167.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.16 168.75 19.07 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 120.821 -1.175 . . . . 25.0 110.927 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -68.9 132.22 46.37 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.233 0.54 . . . . 25.0 110.848 -175.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -123.67 160.46 27.14 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.896 1.443 . . . . 50.0 114.896 -174.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -124.38 99.03 6.01 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 104.492 -2.41 . . . . 25.0 104.492 161.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 87.1 mt -108.44 109.72 21.07 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 111.664 0.246 . . . . 25.0 111.664 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -103.18 117.12 33.81 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.498 -0.556 . . . . 25.0 109.498 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.78 -171.59 46.04 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 117.644 1.818 . . . . 25.0 117.644 -168.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.426 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 81.8 p -87.1 169.02 12.76 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.561 0.744 . . . . 25.0 109.102 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 68.7 mt -86.54 11.28 13.03 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.23 -0.441 . . . . 25.0 111.464 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -112.26 175.78 17.35 Favored Glycine 0 N--CA 1.461 0.357 0 N-CA-C 109.115 -1.594 . . . . 25.0 109.115 177.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.3 t -66.33 140.74 58.12 Favored 'General case' 0 C--O 1.207 -1.143 0 CA-C-N 117.978 0.889 . . . . 25.0 110.745 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.426 ' CD ' ' H ' ' A' ' 22' ' ' THR . 26.2 mt-10 -149.11 156.99 43.03 Favored 'General case' 0 C--O 1.246 0.895 0 C-N-CA 122.917 0.487 . . . . 50.0 110.106 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -89.93 138.23 31.67 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 104.544 -2.391 . . . . 25.0 104.544 161.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.5 mm -126.62 92.98 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 106.042 -1.836 . . . . 25.0 106.042 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 11.0 mp -104.5 120.96 42.46 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 104.652 -2.351 . . . . 25.0 104.652 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.27 -26.39 36.69 Favored Glycine 0 CA--C 1.505 -0.586 0 CA-C-O 119.729 -0.484 . . . . 25.0 112.051 -174.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.6 -149.24 46.49 Favored Glycine 0 C--O 1.249 1.077 0 N-CA-C 110.165 -1.174 . . . . 25.0 110.165 -173.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.49 179.12 40.82 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-O 123.059 1.366 . . . . 25.0 112.475 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.97 164.19 19.97 Favored Glycine 0 C--O 1.248 0.976 0 CA-C-N 114.207 -0.996 . . . . 25.0 114.266 179.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.56 100.02 12.11 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 106.722 -1.584 . . . . 25.0 106.722 176.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -96.83 156.36 16.38 Favored 'General case' 0 C--O 1.214 -0.783 0 C-N-CA 120.207 -0.597 . . . . 50.0 112.148 -170.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -115.61 91.26 3.55 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 106.233 -1.766 . . . . 25.0 106.233 174.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 70.0 mt -97.77 136.19 38.46 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-N 114.024 -1.444 . . . . 25.0 112.613 -172.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -131.64 95.14 3.66 Favored 'General case' 0 C--O 1.252 1.189 0 CA-C-O 121.53 0.681 . . . . 25.0 111.743 -176.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.88 -27.13 69.49 Favored Glycine 0 CA--C 1.521 0.426 0 CA-C-O 119.118 -0.823 . . . . 25.0 113.926 -176.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 48.79 -148.25 0.24 Allowed 'General case' 0 C--O 1.243 0.721 0 C-N-CA 124.405 1.082 . . . . 25.0 111.852 -176.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.91 159.58 34.41 Favored 'General case' 0 C--O 1.25 1.11 0 CA-C-O 121.69 0.757 . . . . 25.0 111.633 -177.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.33 156.64 21.49 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.51 -1.036 . . . . 25.0 110.51 -175.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -86.45 90.15 8.12 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.516 -0.92 . . . . 25.0 108.516 176.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -90.57 160.28 16.02 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.028 -0.987 . . . . 50.0 112.43 -170.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 tp -124.27 99.69 6.34 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.378 -0.971 . . . . 25.0 108.378 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.3 mp -101.83 117.83 35.66 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 116.016 1.858 . . . . 25.0 116.016 -166.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -122.23 101.62 7.63 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.117 -0.947 . . . . 25.0 109.137 174.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.42 -29.17 70.88 Favored Glycine 0 CA--C 1.523 0.585 0 O-C-N 120.141 -1.599 . . . . 25.0 112.769 -177.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.57 -168.08 54.1 Favored Glycine 0 N--CA 1.471 1.029 0 N-CA-C 108.938 -1.665 . . . . 25.0 108.938 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.86 151.89 33.27 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.86 0.689 . . . . 25.0 112.86 -175.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.79 165.98 33.12 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 115.847 1.099 . . . . 25.0 115.847 -175.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.402 ' HD2' ' HA ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -91.03 105.84 18.1 Favored 'General case' 0 C--O 1.212 -0.893 0 N-CA-C 105.667 -1.975 . . . . 25.0 105.667 176.293 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -99.98 151.45 21.33 Favored 'General case' 0 CA--C 1.483 -1.63 0 O-C-N 123.879 0.737 . . . . 50.0 112.093 -168.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -112.03 125.36 53.99 Favored 'General case' 0 C--O 1.211 -0.955 0 N-CA-C 103.374 -2.825 . . . . 25.0 103.374 177.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -149.31 132.68 16.56 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 122.348 1.07 . . . . 25.0 113.27 -174.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 71.5 m -96.77 136.11 37.78 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 106.979 -1.489 . . . . 25.0 106.979 173.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -88.06 -40.94 6.42 Favored Glycine 0 CA--C 1.499 -0.909 0 N-CA-C 110.357 -1.097 . . . . 25.0 110.357 174.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.62 -171.64 54.09 Favored Glycine 0 C--O 1.252 1.228 0 CA-C-O 122.633 1.129 . . . . 25.0 113.402 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -63.01 163.09 10.33 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 121.661 -0.905 . . . . 25.0 110.225 176.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.91 164.52 40.3 Favored Glycine 0 C--O 1.243 0.684 0 CA-C-O 118.554 -1.137 . . . . 25.0 112.514 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.51 113.24 20.11 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.967 -0.753 . . . . 25.0 108.967 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -104.9 154.41 20.11 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 121.541 -0.724 . . . . 50.0 110.576 -177.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.3 m -120.58 129.08 53.61 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 106.271 -1.751 . . . . 25.0 106.271 177.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -115.38 128.7 56.24 Favored 'General case' 0 C--O 1.207 -1.153 0 N-CA-C 104.827 -2.286 . . . . 25.0 104.827 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 61.9 mtt85 -133.41 -29.88 1.35 Allowed 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 113.393 0.886 . . . . 25.0 113.393 174.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 68.23 163.03 0.21 Allowed 'General case' 0 CA--C 1.537 0.459 0 O-C-N 124.794 1.309 . . . . 25.0 110.201 -172.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.22 -41.34 49.58 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.473 1.657 . . . . 25.0 115.473 -165.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 66.5 mt -136.53 170.39 16.14 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 115.217 1.562 . . . . 25.0 115.217 -171.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.09 -28.33 64.5 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.13 -1.396 . . . . 25.0 109.198 168.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -81.29 6.98 12.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.161 -1.381 . . . . 25.0 114.423 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -111.32 152.96 26.64 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.119 -1.613 . . . . 25.0 113.237 -174.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.6 t 41.27 50.77 3.48 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 117.897 2.554 . . . . 25.0 117.897 -178.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 24.5 p-80 -125.43 161.28 27.43 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 114.411 -1.268 . . . . 25.0 112.237 -176.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -109.37 138.72 45.29 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 104.859 -2.275 . . . . 25.0 104.859 174.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.4 p -122.6 172.14 5.66 Favored Pre-proline 0 C--N 1.322 -0.629 0 O-C-N 124.129 0.893 . . . . 25.0 109.975 -178.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -61.94 -23.97 76.45 Favored 'Trans proline' 0 C--O 1.254 1.315 0 C-N-CA 117.707 -1.062 . . . . 25.0 112.639 174.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 75.1 mt -78.22 -29.03 48.07 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.339 0.496 . . . . 25.0 112.339 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.23 -179.6 32.88 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.08 -1.208 . . . . 25.0 110.08 -172.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.5 t -98.12 151.42 20.41 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.106 1.15 . . . . 25.0 114.106 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.402 ' HA ' ' HD2' ' A' ' 52' ' ' ARG . 72.7 m-85 -135.47 29.73 3.26 Favored 'General case' 0 C--O 1.251 1.166 0 CA-C-N 114.419 -1.264 . . . . 25.0 108.889 175.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.53 146.8 42.77 Favored Glycine 0 C--N 1.335 0.476 0 O-C-N 124.102 0.876 . . . . 25.0 112.138 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -84.2 169.46 14.76 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 122.543 -0.387 . . . . 50.0 111.647 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -128.78 108.22 10.28 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 110.166 -0.309 . . . . 25.0 110.166 -176.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.5 mt -98.13 135.67 31.91 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 N-CA-C 107.618 -1.253 . . . . 25.0 107.618 -177.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.6 mt -84.83 -41.19 16.3 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 115.723 1.749 . . . . 25.0 115.723 -171.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.9 p-10 -137.22 39.07 2.51 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.991 1.108 . . . . 25.0 113.991 -172.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -58.24 132.89 54.94 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.126 -0.943 . . . . 25.0 110.655 -177.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -113.7 106.25 54.03 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 108.375 -0.972 . . . . 25.0 108.375 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.1 -16.64 56.08 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 N-CA-C 116.338 1.63 . . . . 25.0 116.338 -173.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.7 t -88.33 -29.11 20.57 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.895 0.378 . . . . 25.0 111.374 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -93.44 -48.93 6.17 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.609 0.719 . . . . 25.0 111.575 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -96.56 165.5 12.13 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 114.169 -1.378 . . . . 50.0 110.92 -159.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -142.18 151.54 42.3 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 113.921 1.082 . . . . 25.0 113.921 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 75.3 mt -126.51 123.54 63.43 Favored 'Isoleucine or valine' 0 C--O 1.247 0.969 0 N-CA-C 107.55 -1.278 . . . . 25.0 107.55 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -81.58 147.35 29.65 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 122.257 1.027 . . . . 25.0 108.363 173.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -155.63 -12.02 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 115.232 -0.895 . . . . 25.0 112.45 -179.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.6 t -62.67 -38.34 89.95 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 120.738 -1.226 . . . . 25.0 110.237 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.65 -21.0 56.05 Favored 'General case' 0 CA--C 1.555 1.149 0 N-CA-C 114.812 1.412 . . . . 25.0 114.812 -176.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.39 0.63 2.81 Favored 'General case' 0 CA--C 1.556 1.176 0 N-CA-C 117.61 2.448 . . . . 25.0 117.61 -170.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -143.32 -67.05 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 119.021 0.828 . . . . 25.0 115.012 177.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -160.11 164.92 32.64 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.99 0.9 . . . . 25.0 110.992 -174.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.8 t -119.48 -26.76 5.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.773 -1.103 . . . . 25.0 110.521 174.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -93.95 120.68 6.39 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 118.718 -1.046 . . . . 25.0 112.699 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -65.93 157.17 31.37 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.442 1.621 . . . . 25.0 112.356 178.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -90.7 -172.03 43.88 Favored Glycine 0 C--N 1.32 -0.332 0 CA-C-O 118.88 -0.956 . . . . 25.0 112.263 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -79.54 83.1 5.57 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 118.646 1.223 . . . . 25.0 112.111 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.06 -175.43 17.96 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 108.348 -1.901 . . . . 25.0 108.348 168.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -127.05 160.7 30.34 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.971 1.385 . . . . 25.0 111.879 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 51.83 47.24 25.18 Favored 'General case' 0 C--O 1.266 1.951 0 N-CA-C 114.946 1.462 . . . . 25.0 114.946 -176.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.26 48.69 36.96 Favored Glycine 0 N--CA 1.48 1.591 0 N-CA-C 109.253 -1.539 . . . . 25.0 109.253 176.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.5 t -148.33 173.84 12.64 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 117.838 0.819 . . . . 25.0 111.905 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.7 mp -105.36 168.57 8.99 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 101.816 -3.402 . . . . 25.0 101.816 173.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.55 135.48 39.27 Favored 'General case' 0 C--O 1.254 1.31 0 C-N-CA 117.915 -1.514 . . . . 25.0 108.009 -176.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.7 m -102.35 163.58 3.42 Favored 'Isoleucine or valine' 0 C--O 1.248 0.997 0 CA-C-O 118.524 -0.75 . . . . 25.0 109.165 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.0 p -149.78 163.41 38.05 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-N 118.514 0.597 . . . . 25.0 112.247 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 28.0 m -115.89 160.82 15.05 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 N-CA-C 105.787 -1.931 . . . . 25.0 105.787 176.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.9 t -78.76 -42.67 27.42 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 107.055 -1.461 . . . . 25.0 107.055 176.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -168.31 -169.13 1.03 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 103.78 -2.674 . . . . 25.0 103.78 -175.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -59.76 -24.78 64.35 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.662 0.601 . . . . 25.0 112.534 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -126.9 -147.38 6.72 Favored Glycine 0 C--O 1.252 1.231 0 N-CA-C 111.114 -0.795 . . . . 25.0 111.114 174.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 53.72 -142.69 0.78 Allowed 'General case' 0 C--O 1.246 0.872 0 N-CA-C 113.891 1.071 . . . . 25.0 113.891 -179.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.7 mtt85 -91.39 162.83 14.42 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 114.716 1.376 . . . . 25.0 114.716 -170.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.5 p -113.08 162.48 15.88 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 104.73 -2.322 . . . . 25.0 104.73 176.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -132.7 156.14 47.55 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 109.245 -0.65 . . . . 25.0 109.245 -175.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 33.6 tp -135.16 127.66 30.6 Favored 'General case' 0 C--O 1.251 1.17 0 N-CA-C 102.695 -3.076 . . . . 25.0 102.695 171.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -128.65 159.6 35.07 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 115.787 -0.642 . . . . 25.0 112.673 -170.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.2 t -94.64 149.77 20.91 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.295 -1.372 . . . . 25.0 107.295 171.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -119.82 24.15 10.7 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 106.93 -1.507 . . . . 25.0 106.93 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -125.91 135.88 52.41 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 106.364 -1.717 . . . . 25.0 106.364 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -139.39 156.31 47.07 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 122.558 1.17 . . . . 25.0 109.672 -172.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -74.08 159.35 32.75 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-N 114.782 -1.099 . . . . 25.0 109.225 173.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.29 -20.64 66.5 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.733 -0.604 . . . . 25.0 109.789 173.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -69.89 -12.27 61.49 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 118.675 -0.678 . . . . 25.0 112.502 175.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.13 22.93 46.75 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 111.51 -0.636 . . . . 25.0 111.51 -177.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.7 mt -100.18 141.01 33.6 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 107.636 -1.246 . . . . 25.0 107.636 177.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 59.7 p -147.61 171.43 15.61 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 106.789 -1.56 . . . . 25.0 106.789 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -115.76 138.38 51.18 Favored 'General case' 0 C--O 1.257 1.453 0 CA-C-N 118.667 0.667 . . . . 25.0 112.624 -173.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -152.63 153.21 32.87 Favored 'General case' 0 C--O 1.248 1.02 0 CA-C-O 121.717 0.77 . . . . 25.0 110.088 172.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.9 p -145.03 143.79 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.784 0 N-CA-C 105.858 -1.904 . . . . 25.0 105.858 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -107.86 142.69 37.55 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.41 -1.329 . . . . 25.0 107.41 -176.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.6 mp -131.13 137.13 48.9 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.489 -1.3 . . . . 25.0 107.489 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -109.71 7.29 24.27 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 121.251 1.841 . . . . 25.0 115.858 -176.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -76.9 4.94 51.45 Favored Glycine 0 N--CA 1.469 0.894 0 N-CA-C 116.322 1.289 . . . . 25.0 116.322 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 46.6 t0 51.34 51.94 15.83 Favored 'General case' 0 C--O 1.256 1.43 0 C-N-CA 124.046 0.939 . . . . 25.0 111.875 176.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -129.84 29.83 4.94 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 124.849 1.26 . . . . 25.0 110.714 -174.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.85 -31.98 70.26 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 119.275 -0.97 . . . . 25.0 111.52 176.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.6 -20.95 66.12 Favored 'General case' 0 C--O 1.251 1.171 0 CA-C-N 118.777 0.717 . . . . 25.0 111.349 177.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -95.67 -27.77 15.13 Favored 'General case' 0 C--O 1.259 1.603 0 N-CA-C 114.048 1.129 . . . . 25.0 114.048 176.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 74.6 mt -58.39 137.36 57.31 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 114.126 1.158 . . . . 25.0 114.126 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 62.7 m -137.15 167.15 22.1 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 105.642 -1.985 . . . . 25.0 105.642 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -77.45 -2.88 37.52 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 120.458 -1.401 . . . . 25.0 111.324 174.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -68.42 -29.09 67.68 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.777 -0.577 . . . . 25.0 112.353 -176.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -87.02 -2.48 58.66 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.882 -0.599 . . . . 25.0 111.209 174.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 36.7 mm -96.64 127.32 48.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 104.679 -2.341 . . . . 25.0 104.679 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.1 p -105.42 104.4 16.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 124.063 1.887 . . . . 25.0 114.78 -174.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -141.81 -1.1 1.29 Allowed 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 112.625 -2.079 . . . . 25.0 111.091 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -80.91 53.5 1.97 Allowed 'General case' 0 CA--C 1.549 0.905 0 O-C-N 121.151 -0.968 . . . . 25.0 112.603 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 58.85 18.07 5.8 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 114.434 1.272 . . . . 25.0 114.434 -175.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.58 -39.88 0.39 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 118.264 2.69 . . . . 25.0 118.264 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -70.81 150.01 46.27 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-O 121.388 0.613 . . . . 25.0 110.622 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -80.3 19.93 0.72 Allowed 'General case' 0 C--O 1.218 -0.564 0 C-N-CA 124.09 0.956 . . . . 25.0 112.32 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.74 -21.78 66.84 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 115.487 1.662 . . . . 25.0 115.487 -177.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -140.28 -160.59 1.09 Allowed 'General case' 0 CA--C 1.547 0.862 0 CA-C-O 121.567 0.699 . . . . 25.0 111.37 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 64.21 -171.11 0.18 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 115.359 1.614 . . . . 25.0 115.359 177.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 81.38 24.38 56.87 Favored Glycine 0 C--O 1.225 -0.456 0 CA-C-O 122.985 1.325 . . . . 25.0 110.515 -175.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -98.7 114.59 27.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.444 -0.878 . . . . 25.0 109.165 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -123.68 143.22 50.39 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 108.532 -0.914 . . . . 25.0 108.532 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -111.07 16.83 27.45 Favored Glycine 0 C--O 1.225 -0.432 0 N-CA-C 112.155 -0.378 . . . . 25.0 112.155 -177.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 49.0 t -68.59 -37.33 77.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.697 -0.252 . . . . 25.0 111.297 -174.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.0 133.31 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-O 121.599 0.714 . . . . 25.0 111.57 -176.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 149.04 159.01 8.33 Favored Glycine 0 N--CA 1.463 0.435 0 N-CA-C 110.058 -1.217 . . . . 25.0 110.058 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -151.69 153.04 33.6 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-O 122.285 1.04 . . . . 25.0 111.338 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 92.6 p -165.34 163.11 19.95 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 105.074 -2.195 . . . . 25.0 105.074 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 174.7 159.84 21.7 Favored Glycine 0 C--O 1.245 0.803 0 C-N-CA 119.963 -1.113 . . . . 25.0 114.241 174.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -116.86 110.75 41.58 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 109.047 -0.724 . . . . 25.0 109.047 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.37 169.5 21.83 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 116.328 -1.981 . . . . 25.0 114.335 -175.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -124.57 140.95 52.47 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.368 -0.975 . . . . 25.0 108.368 175.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -143.66 73.47 17.1 Favored Pre-proline 0 N--CA 1.487 1.383 0 CA-C-O 121.11 0.481 . . . . 25.0 111.75 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -67.99 152.89 76.36 Favored 'Trans proline' 0 C--O 1.242 0.682 0 N-CA-C 114.062 0.755 . . . . 25.0 114.062 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.6 t -124.05 11.05 8.86 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.712 -0.676 . . . . 25.0 109.363 -176.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.257 1.457 0 N-CA-C 109.157 -0.683 . . . . 25.0 109.157 178.717 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo . . . . . 0 C--O 1.243 0.749 0 N-CA-C 114.297 0.845 . . . . 25.0 114.297 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -163.83 49.76 0.3 Allowed Glycine 0 N--CA 1.467 0.759 0 N-CA-C 108.467 -1.853 . . . . 25.0 108.467 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.2 p -54.58 128.87 15.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-O 122.918 1.342 . . . . 25.0 110.495 -175.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -101.19 -1.63 33.36 Favored 'General case' 0 C--O 1.252 1.226 0 O-C-N 121.289 -0.882 . . . . 25.0 110.389 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.48 -142.55 6.99 Favored Glycine 0 C--O 1.241 0.539 0 CA-C-N 116.421 -0.354 . . . . 25.0 112.79 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.0 p 68.43 157.75 0.15 Allowed Pre-proline 0 N--CA 1.486 1.353 0 C-N-CA 125.811 1.644 . . . . 25.0 111.739 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.563 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 25.5 Cg_exo -71.1 -2.35 10.97 Favored 'Trans proline' 0 C--N 1.354 0.86 0 N-CA-C 116.046 1.518 . . . . 25.0 116.046 -172.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.6 p -65.04 -13.59 15.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 115.974 1.842 . . . . 25.0 115.974 -171.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.3 p -139.69 134.94 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 114.693 1.368 . . . . 25.0 114.693 -177.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.6 13.18 83.21 Favored Glycine 0 N--CA 1.466 0.665 0 N-CA-C 117.026 1.57 . . . . 25.0 117.026 174.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.7 t -47.12 -49.74 21.5 Favored 'General case' 0 C--O 1.209 -1.028 0 CA-C-N 118.98 1.39 . . . . 25.0 113.279 -168.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -78.61 6.91 7.68 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 116.85 2.167 . . . . 25.0 116.85 -174.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 pp -142.57 169.52 17.42 Favored 'General case' 0 C--O 1.203 -1.352 0 O-C-N 121.277 -0.889 . . . . 25.0 111.428 -177.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -61.5 128.47 36.44 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 113.139 0.792 . . . . 25.0 113.139 -174.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -130.08 167.15 18.78 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 114.081 1.141 . . . . 50.0 114.081 -175.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -125.34 107.73 10.98 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 104.008 -2.59 . . . . 25.0 104.008 169.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.3 mt -122.66 114.43 20.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 119.069 0.85 . . . . 25.0 110.143 -175.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -108.22 121.94 45.91 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.618 -0.882 . . . . 25.0 108.618 173.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.2 -177.89 47.33 Favored Glycine 0 N--CA 1.471 1.026 0 N-CA-C 115.063 0.785 . . . . 25.0 115.063 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.4 p -81.02 178.11 8.63 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.021 0.928 . . . . 25.0 111.229 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 79.7 mt -90.31 13.55 15.08 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.193 0.52 . . . . 25.0 110.103 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.77 -177.09 20.64 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.455 -0.658 . . . . 25.0 111.455 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.8 t -75.38 129.4 37.29 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.128 1.159 . . . . 25.0 114.128 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -145.01 159.82 42.34 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.045 -1.034 . . . . 50.0 112.998 -174.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -98.66 120.97 39.99 Favored 'General case' 0 C--O 1.26 1.608 0 N-CA-C 105.498 -2.038 . . . . 25.0 105.498 164.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.1 mm -115.98 107.88 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 N-CA-C 105.291 -2.115 . . . . 25.0 105.291 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.563 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 9.2 mp -115.89 132.11 56.74 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 105.084 -2.191 . . . . 25.0 105.084 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.89 -33.94 9.4 Favored Glycine 0 CA--C 1.483 -1.962 0 N-CA-C 114.72 0.648 . . . . 25.0 114.72 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 72.94 -145.59 36.81 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 111.793 -0.523 . . . . 25.0 111.793 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.39 163.13 52.76 Favored Glycine 0 N--CA 1.438 -1.185 0 CA-C-O 121.783 0.657 . . . . 25.0 113.569 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.24 166.76 41.44 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.216 -0.754 . . . . 25.0 111.216 177.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.38 112.08 20.02 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.045 -1.094 . . . . 25.0 108.045 176.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -107.09 157.7 17.63 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 113.662 0.986 . . . . 50.0 113.662 -172.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -117.93 87.17 2.66 Favored 'General case' 0 C--O 1.255 1.386 0 N-CA-C 106.668 -1.604 . . . . 25.0 106.668 178.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 53.6 mt -96.34 137.99 34.61 Favored 'General case' 0 C--O 1.207 -1.141 0 CA-C-N 115.572 -0.74 . . . . 25.0 112.07 -174.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -131.34 112.77 13.04 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 107.117 -1.438 . . . . 25.0 107.117 177.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -92.14 -22.68 29.3 Favored Glycine 0 CA--C 1.507 -0.453 0 CA-C-O 118.877 -0.957 . . . . 25.0 115.455 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 51.12 -147.47 0.41 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.127 0.971 . . . . 25.0 113.303 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.34 165.03 19.51 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 123.313 1.53 . . . . 25.0 112.326 -177.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.11 157.12 32.79 Favored Glycine 0 C--O 1.246 0.869 0 CA-C-N 113.876 -1.511 . . . . 25.0 111.253 -176.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.2 m-20 -78.29 114.81 17.53 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 103.853 -2.647 . . . . 25.0 103.853 177.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -119.78 160.13 23.2 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.986 -0.746 . . . . 50.0 108.986 -172.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.0 mp -111.12 124.56 52.42 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 104.31 -2.478 . . . . 25.0 104.31 171.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.59 100.89 7.26 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 121.875 -0.516 . . . . 25.0 111.991 -175.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -117.74 103.73 10.28 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.971 -1.122 . . . . 25.0 107.971 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.86 -24.53 68.42 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 116.88 1.512 . . . . 25.0 116.88 -177.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.39 -168.09 51.28 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 118.371 -1.238 . . . . 25.0 111.036 -178.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.41 153.86 3.78 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.55 1.315 . . . . 25.0 114.55 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.03 171.78 47.82 Favored Glycine 0 CA--C 1.502 -0.74 0 O-C-N 124.6 1.187 . . . . 25.0 110.406 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.08 156.18 27.18 Favored 'General case' 0 C--O 1.203 -1.35 1 N-CA-C 99.922 -4.103 . . . . 25.0 99.922 173.258 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -144.77 156.61 44.14 Favored 'General case' 0 C--O 1.247 0.948 0 C-N-CA 120.437 -0.505 . . . . 50.0 110.821 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -119.91 121.38 38.88 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 103.33 -2.841 . . . . 25.0 103.33 174.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.7 130.72 26.33 Favored 'General case' 0 C--O 1.211 -0.921 0 N-CA-C 113.916 1.08 . . . . 25.0 113.916 -171.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.29 126.84 52.55 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.157 -0.965 . . . . 25.0 108.816 -178.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -80.85 -48.43 6.14 Favored Glycine 0 C--O 1.247 0.916 0 C-N-CA 119.94 -1.124 . . . . 25.0 112.624 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.63 -167.8 53.22 Favored Glycine 0 CA--C 1.535 1.339 0 O-C-N 122.414 -0.462 . . . . 25.0 114.244 -177.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -67.12 159.77 28.17 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 121.274 -1.133 . . . . 25.0 111.086 177.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.21 156.99 33.12 Favored Glycine 0 C--O 1.242 0.599 0 N-CA-C 110.538 -1.025 . . . . 25.0 110.538 -177.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.81 98.64 5.64 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 122.121 0.962 . . . . 25.0 110.853 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -89.21 155.94 19.09 Favored 'General case' 0 C--O 1.252 1.21 0 CA-C-N 114.391 -1.277 . . . . 50.0 112.587 -174.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 46.8 m -128.12 125.23 38.76 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.156 0.503 . . . . 25.0 110.025 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -113.32 103.16 11.04 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.914 -0.772 . . . . 25.0 108.914 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 24.6 mmt85 -105.0 -30.32 9.86 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-N 115.916 -0.584 . . . . 25.0 110.052 -178.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 64.75 165.79 0.16 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.88 1.272 . . . . 25.0 110.437 -171.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -87.13 -38.77 16.15 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.862 0.69 . . . . 25.0 112.862 -168.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.1 mt -136.03 161.6 35.23 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 122.089 0.947 . . . . 25.0 111.538 -173.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.93 -25.68 63.67 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 114.894 -1.048 . . . . 25.0 109.051 172.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -78.06 3.09 15.81 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.389 -1.278 . . . . 25.0 114.171 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -95.57 148.52 22.42 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 115.386 1.625 . . . . 25.0 115.386 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.6 t 53.23 39.41 29.67 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.871 1.434 . . . . 25.0 114.871 173.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 27.2 p-80 -114.7 163.67 15.12 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.326 -0.852 . . . . 25.0 112.737 -175.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -110.49 142.89 41.63 Favored 'General case' 0 C--O 1.208 -1.097 0 N-CA-C 103.564 -2.754 . . . . 25.0 103.564 173.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 97.5 p -135.32 170.07 12.09 Favored Pre-proline 0 CA--C 1.512 -0.506 0 N-CA-C 107.039 -1.467 . . . . 25.0 107.039 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -62.48 -18.78 65.07 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 CA-C-N 119.385 0.816 . . . . 25.0 113.32 173.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.4 mt -77.82 -24.29 48.77 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.304 0.573 . . . . 25.0 111.822 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 144.68 -176.95 23.52 Favored Glycine 0 C--O 1.25 1.117 0 N-CA-C 110.155 -1.178 . . . . 25.0 110.155 -178.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.4 t -84.13 147.29 27.42 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 122.788 1.28 . . . . 25.0 112.193 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -133.94 27.32 3.91 Favored 'General case' 0 C--O 1.256 1.409 0 N-CA-C 105.731 -1.952 . . . . 25.0 105.731 169.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.16 143.95 42.08 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 114.323 -1.308 . . . . 25.0 110.545 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -87.65 166.69 14.5 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.493 -0.928 . . . . 50.0 108.493 -174.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -130.06 117.43 19.99 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 107.466 -1.309 . . . . 25.0 107.466 -175.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.0 mt -100.42 135.83 34.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 106.906 -1.516 . . . . 25.0 106.906 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.6 mt -79.49 -55.64 4.9 Favored 'General case' 0 C--O 1.217 -0.608 0 C-N-CA 124.037 0.935 . . . . 25.0 112.938 -173.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 -132.12 51.07 2.18 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-O 122.749 1.262 . . . . 25.0 113.309 -175.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -61.76 143.52 56.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.773 -1.103 . . . . 25.0 108.933 175.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -125.11 107.06 28.09 Favored Pre-proline 0 CA--C 1.505 -0.756 0 N-CA-C 107.392 -1.336 . . . . 25.0 107.392 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.37 -9.68 26.42 Favored 'Trans proline' 0 CA--C 1.555 1.552 0 N-CA-C 117.538 2.092 . . . . 25.0 117.538 -172.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.6 t -76.76 -37.24 56.25 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.603 -0.888 . . . . 25.0 108.603 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -111.37 -33.71 6.33 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 115.522 1.675 . . . . 25.0 115.522 -171.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -90.36 152.0 21.2 Favored 'General case' 0 C--O 1.212 -0.869 0 CA-C-N 117.908 0.322 . . . . 50.0 110.429 -170.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -129.34 141.97 50.94 Favored 'General case' 0 C--O 1.26 1.623 0 CA-C-O 119.141 -0.456 . . . . 25.0 110.126 -174.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 77.0 mt -125.52 133.12 69.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.277 -0.638 . . . . 25.0 109.277 178.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.55 141.59 28.42 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.884 -0.784 . . . . 25.0 108.884 172.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.6 p -139.65 -4.66 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.096 -0.956 . . . . 25.0 112.193 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.3 t -73.17 -31.46 64.25 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.962 -0.755 . . . . 25.0 108.962 -177.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.85 -36.73 80.84 Favored 'General case' 0 C--O 1.254 1.298 0 CA-C-N 115.641 -0.709 . . . . 25.0 112.713 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.79 -29.63 8.98 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 117.354 2.353 . . . . 25.0 117.354 -170.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -124.26 -72.44 0.23 Allowed Glycine 0 CA--C 1.5 -0.87 0 N-CA-C 117.931 1.932 . . . . 25.0 117.931 -168.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -154.61 172.76 17.33 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 109.705 -0.48 . . . . 25.0 109.705 -167.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.9 t -128.0 -20.26 3.85 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 112.065 0.394 . . . . 25.0 112.065 174.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -97.59 126.95 9.05 Favored Glycine 0 N--CA 1.488 2.136 0 O-C-N 121.421 -0.799 . . . . 25.0 112.703 176.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.63 151.14 47.94 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.618 0.599 . . . . 25.0 112.618 178.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -88.46 -173.26 47.1 Favored Glycine 0 C--O 1.223 -0.563 0 N-CA-C 114.771 0.668 . . . . 25.0 114.771 -175.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -76.11 82.36 2.94 Favored 'General case' 0 C--O 1.258 1.505 0 CA-C-N 118.919 1.36 . . . . 25.0 110.874 -178.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -115.62 -172.85 17.18 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 109.214 -1.554 . . . . 25.0 109.214 174.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -143.03 168.35 19.92 Favored 'General case' 0 C--O 1.241 0.632 0 O-C-N 121.815 -0.815 . . . . 25.0 110.301 175.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 58.38 32.11 21.71 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.776 1.23 . . . . 25.0 113.76 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 80.54 23.41 60.44 Favored Glycine 0 C--N 1.316 -0.581 0 CA-C-O 118.863 -0.965 . . . . 25.0 111.55 176.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.2 t -132.79 169.65 16.41 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 119.04 1.42 . . . . 25.0 109.671 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.4 mp -88.6 163.46 15.83 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 103.302 -2.851 . . . . 25.0 103.302 171.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.42 122.55 19.19 Favored 'General case' 0 C--O 1.257 1.468 0 C-N-CA 119.081 -1.047 . . . . 25.0 111.141 -176.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.9 m -90.75 160.73 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 107.032 -1.47 . . . . 25.0 107.032 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 60.0 p -147.81 166.28 28.04 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 123.918 0.761 . . . . 25.0 109.45 -177.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 22.0 m -117.64 166.81 11.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 107.629 -1.248 . . . . 25.0 107.629 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.8 t -74.66 -55.08 6.27 Favored 'General case' 0 C--O 1.216 -0.69 0 N-CA-C 106.828 -1.545 . . . . 25.0 106.828 169.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -159.6 -158.34 0.65 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 105.216 -2.142 . . . . 25.0 105.216 -176.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -61.15 -33.36 73.29 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 120.153 -0.619 . . . . 25.0 109.793 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -119.34 -148.51 8.3 Favored Glycine 0 C--O 1.244 0.77 0 N-CA-C 109.647 -1.381 . . . . 25.0 109.647 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.89 -144.18 0.53 Allowed 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 113.893 1.072 . . . . 25.0 113.893 177.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.9 mtt85 -82.33 167.29 18.71 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.994 0.902 . . . . 25.0 112.704 -171.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.86 161.43 18.25 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 105.524 -2.028 . . . . 25.0 105.524 171.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -137.01 145.9 44.66 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 108.704 -0.85 . . . . 25.0 108.704 -177.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 43.0 tp -125.15 125.95 44.49 Favored 'General case' 0 C--O 1.257 1.499 0 N-CA-C 103.427 -2.805 . . . . 25.0 103.427 177.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -121.77 154.75 36.54 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.262 -0.881 . . . . 25.0 109.379 -173.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 37.6 t -99.47 155.42 17.57 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 106.023 -1.843 . . . . 25.0 106.023 169.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -122.38 13.71 10.29 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.834 0.35 . . . . 25.0 111.116 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -106.63 132.49 52.56 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 106.646 -1.612 . . . . 25.0 106.646 171.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -128.13 153.21 47.1 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-O 122.699 1.238 . . . . 25.0 109.08 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -79.51 165.5 22.94 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.692 -1.14 . . . . 25.0 111.198 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.94 -34.31 67.87 Favored 'General case' 0 C--O 1.21 -0.978 0 CA-C-O 122.218 1.009 . . . . 25.0 109.024 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -72.46 -2.34 19.17 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 115.25 1.574 . . . . 25.0 115.25 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.87 7.82 85.14 Favored Glycine 0 N--CA 1.471 1.012 0 CA-C-O 122.353 0.974 . . . . 25.0 113.15 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 41.3 mt -84.32 139.28 32.4 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.436 -1.038 . . . . 25.0 109.798 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 95.2 p -147.81 -179.55 6.98 Favored 'General case' 0 C--O 1.249 1.066 0 N-CA-C 107.351 -1.352 . . . . 25.0 107.351 -177.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -119.47 136.52 54.28 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.608 -0.837 . . . . 25.0 112.955 -178.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -147.74 148.7 31.26 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.876 -1.157 . . . . 25.0 107.876 167.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.3 p -145.33 148.28 17.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 105.381 -2.081 . . . . 25.0 105.381 175.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -108.44 148.13 30.62 Favored 'General case' 0 C--O 1.264 1.861 0 N-CA-C 108.593 -0.892 . . . . 25.0 108.593 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.8 mp -139.0 124.07 18.95 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 105.067 -2.197 . . . . 25.0 105.067 -177.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -103.99 9.22 36.66 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 120.832 1.651 . . . . 25.0 113.625 -171.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -69.38 -16.34 71.31 Favored Glycine 0 N--CA 1.459 0.176 0 C-N-CA 120.515 -0.85 . . . . 25.0 112.805 175.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 31.2 t0 58.01 58.33 3.63 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 122.039 0.924 . . . . 25.0 111.982 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -124.26 42.02 3.35 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.394 -1.276 . . . . 25.0 109.229 -177.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.51 -34.48 72.66 Favored 'General case' 0 C--O 1.206 -1.234 0 N-CA-C 113.466 0.913 . . . . 25.0 113.466 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.49 -23.75 62.73 Favored 'General case' 0 C--O 1.254 1.293 0 CA-C-N 119.358 0.981 . . . . 25.0 112.067 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -89.84 -25.41 21.05 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 113.75 1.019 . . . . 25.0 113.75 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 11.8 mt -63.33 126.41 27.36 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.196 -0.911 . . . . 25.0 111.108 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 39.8 m -135.06 157.62 46.46 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 107.633 -1.247 . . . . 25.0 107.633 174.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.08 -2.56 24.92 Favored 'General case' 0 C--N 1.349 0.551 0 N-CA-C 112.656 0.613 . . . . 25.0 112.656 -176.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.27 -30.73 71.63 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.462 0.649 . . . . 25.0 110.115 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -90.22 0.67 57.09 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 112.619 0.6 . . . . 25.0 112.619 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 34.7 mm -105.33 122.87 59.17 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 N-CA-C 103.985 -2.598 . . . . 25.0 103.985 175.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 14.8 p -105.64 119.98 55.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 O-C-N 120.885 -1.134 . . . . 25.0 113.611 -176.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -148.84 18.51 1.0 Allowed 'General case' 0 C--O 1.243 0.759 0 CA-C-N 112.757 -2.02 . . . . 25.0 108.465 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -102.47 41.89 1.19 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.729 0.776 . . . . 25.0 111.187 -175.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 55.22 25.79 7.71 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 114.431 1.271 . . . . 25.0 114.431 -173.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.8 m 64.75 -10.63 0.15 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.581 1.696 . . . . 25.0 115.581 176.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -72.35 139.98 48.21 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.761 -1.212 . . . . 25.0 109.389 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -91.4 4.78 51.62 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.748 -0.66 . . . . 25.0 110.465 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.03 16.66 0.12 Allowed 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.639 0.776 . . . . 25.0 112.994 177.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -144.02 -158.32 0.87 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 107.913 -1.143 . . . . 25.0 107.913 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 60.58 178.69 0.1 Allowed 'General case' 0 CA--C 1.555 1.144 0 N-CA-C 114.333 1.234 . . . . 25.0 114.333 176.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.74 24.17 75.02 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 115.876 -0.602 . . . . 25.0 112.898 -176.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -91.26 114.72 27.32 Favored 'General case' 0 C--N 1.316 -0.858 0 O-C-N 122.399 -0.471 . . . . 25.0 112.168 -175.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.48 144.08 48.9 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.309 0.576 . . . . 25.0 109.624 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -145.92 33.55 1.5 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.894 -0.882 . . . . 25.0 110.894 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.3 t -93.85 -29.79 4.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 113.288 0.847 . . . . 25.0 113.288 -172.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.01 132.82 27.86 Favored 'Isoleucine or valine' 0 C--O 1.248 0.98 0 CA-C-N 115.337 -0.847 . . . . 25.0 112.229 -174.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 168.58 159.61 14.61 Favored Glycine 0 N--CA 1.48 1.597 0 N-CA-C 110.227 -1.149 . . . . 25.0 110.227 175.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -147.68 146.71 29.39 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 119.264 1.532 . . . . 25.0 112.161 -176.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 93.1 p -155.22 174.71 14.82 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 106.217 -1.771 . . . . 25.0 106.217 177.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -177.52 167.21 38.11 Favored Glycine 0 C--N 1.309 -0.936 0 C-N-CA 120.104 -1.046 . . . . 25.0 114.854 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 11.9 tp-100 -146.12 81.03 9.93 Favored Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 108.229 -1.026 . . . . 25.0 108.229 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -70.6 151.66 64.41 Favored 'Trans proline' 0 CA--C 1.509 -0.736 0 C-N-CA 121.054 1.17 . . . . 25.0 113.071 -173.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -107.38 147.32 30.51 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.413 -0.812 . . . . 25.0 111.004 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -144.76 75.57 14.45 Favored Pre-proline 0 C--N 1.312 -1.045 0 O-C-N 124.191 0.932 . . . . 25.0 110.414 177.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -72.97 169.62 21.74 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 121.587 1.525 . . . . 25.0 113.255 -175.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.5 t -120.02 2.46 10.97 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 116.417 -0.356 . . . . 25.0 110.358 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 C--O 1.249 1.059 0 CA-C-O 116.707 -1.616 . . . . 25.0 110.817 -178.605 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 CA--C 1.542 0.904 0 N-CA-C 113.877 0.683 . . . . 25.0 113.877 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.79 59.69 0.03 OUTLIER Glycine 0 CA--C 1.524 0.612 0 C-N-CA 121.052 -0.594 . . . . 25.0 111.816 -176.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.8 p -63.9 132.82 29.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 121.734 0.778 . . . . 25.0 110.05 -173.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -91.02 -15.4 29.68 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 119.622 -0.831 . . . . 25.0 110.789 -178.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.28 -147.13 3.87 Favored Glycine 0 C--O 1.207 -1.55 0 N-CA-C 115.952 1.141 . . . . 25.0 115.952 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.7 p 77.96 156.9 0.15 Allowed Pre-proline 0 CA--C 1.558 1.274 0 C-N-CA 126.832 2.053 . . . . 25.0 110.408 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.624 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 50.1 Cg_exo -62.55 -3.36 4.25 Favored 'Trans proline' 0 C--N 1.362 1.249 0 N-CA-C 117.761 2.177 . . . . 25.0 117.761 -175.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.6 p -63.65 -17.67 20.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 114.757 1.391 . . . . 25.0 114.757 -173.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.5 p -142.44 140.95 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-O 122.554 1.168 . . . . 25.0 113.373 -178.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.32 16.03 80.9 Favored Glycine 0 C--O 1.226 -0.344 0 N-CA-C 118.248 2.059 . . . . 25.0 118.248 175.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.2 t -46.21 -58.96 3.2 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 114.15 1.167 . . . . 25.0 114.15 -175.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -78.24 3.14 16.14 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 116.076 1.88 . . . . 25.0 116.076 -169.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.28 171.82 13.62 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.456 -0.778 . . . . 25.0 111.82 -172.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -58.9 135.32 57.52 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.149 0.58 . . . . 25.0 112.534 -177.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -128.52 163.35 25.15 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 113.537 0.94 . . . . 50.0 113.537 -174.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -136.53 108.66 7.22 Favored 'General case' 0 C--O 1.255 1.348 0 N-CA-C 101.683 -3.451 . . . . 25.0 101.683 161.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 89.7 mt -126.0 126.13 43.8 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.909 0.861 . . . . 25.0 110.46 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -114.69 134.6 54.95 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 107.507 -1.294 . . . . 25.0 107.507 178.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -106.14 178.39 22.75 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 115.294 0.878 . . . . 25.0 115.294 -173.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.5 p -79.86 175.41 10.65 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-O 121.856 0.836 . . . . 25.0 112.558 178.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 39.0 mt -83.6 10.54 8.91 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 113.25 0.833 . . . . 25.0 113.25 176.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.07 178.35 25.63 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 123.073 0.368 . . . . 25.0 112.208 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.2 t -74.68 128.66 36.11 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.888 0.475 . . . . 25.0 110.92 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -143.96 151.18 39.41 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.006 0.431 . . . . 50.0 110.542 -174.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -94.36 125.59 39.09 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 102.546 -3.131 . . . . 25.0 102.546 168.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.3 mm -119.02 103.86 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.018 0 N-CA-C 107.257 -1.386 . . . . 25.0 107.257 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.624 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 9.8 mp -100.69 131.55 46.53 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 104.06 -2.57 . . . . 25.0 104.06 177.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.86 -29.83 14.63 Favored Glycine 0 C--N 1.313 -0.745 0 CA-C-N 114.907 -1.042 . . . . 25.0 113.086 176.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.04 -148.7 50.63 Favored Glycine 0 N--CA 1.466 0.685 0 C-N-CA 120.293 -0.956 . . . . 25.0 112.278 -178.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.7 170.68 52.57 Favored Glycine 0 C--O 1.247 0.929 0 CA-C-N 118.219 1.01 . . . . 25.0 113.096 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.25 162.51 23.84 Favored Glycine 0 C--O 1.256 1.525 0 O-C-N 124.035 0.491 . . . . 25.0 114.225 176.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.08 108.58 11.47 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 106.678 -1.601 . . . . 25.0 106.678 177.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -107.57 149.33 28.15 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.992 -0.744 . . . . 50.0 108.992 -173.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -116.61 105.14 12.11 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 106.856 -1.535 . . . . 25.0 106.856 171.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 80.8 mt -111.37 129.11 56.11 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.58 -0.736 . . . . 25.0 112.568 -170.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -125.11 102.48 7.51 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-O 121.802 0.81 . . . . 25.0 110.449 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.45 -29.43 61.87 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-O 118.742 -1.032 . . . . 25.0 115.204 -176.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 53.54 -156.11 0.2 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.09 0.956 . . . . 25.0 112.461 -177.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.19 166.77 9.19 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.098 -1.001 . . . . 25.0 112.767 -175.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.29 160.0 34.26 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 108.239 -1.944 . . . . 25.0 108.239 -176.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -85.73 106.36 16.93 Favored 'General case' 0 C--O 1.251 1.151 0 O-C-N 122.125 -0.633 . . . . 25.0 109.387 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -109.43 144.4 37.71 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.84 -0.744 . . . . 50.0 111.677 -168.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 mp -105.65 92.89 4.37 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.274 -0.876 . . . . 25.0 108.873 177.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 mp -97.3 113.98 25.68 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-O 121.894 0.854 . . . . 25.0 111.783 -174.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -117.41 94.76 4.68 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 106.709 -1.589 . . . . 25.0 106.709 178.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -57.2 -20.53 36.03 Favored Glycine 0 N--CA 1.473 1.133 0 CA-C-O 118.478 -1.179 . . . . 25.0 115.198 -175.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.98 -168.86 49.73 Favored Glycine 0 C--O 1.249 1.06 0 CA-C-N 119.163 1.482 . . . . 25.0 110.531 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.74 153.07 11.22 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 114.805 -0.697 . . . . 25.0 112.49 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.82 177.1 45.31 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.588 -0.733 . . . . 25.0 111.876 178.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -97.34 132.24 43.26 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 105.779 -1.934 . . . . 25.0 105.779 176.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -125.62 159.78 31.29 Favored 'General case' 0 CA--C 1.485 -1.542 0 CA-C-O 118.851 -0.595 . . . . 50.0 110.743 -172.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -121.67 121.97 38.55 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 103.399 -2.815 . . . . 25.0 103.399 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -146.73 131.4 17.87 Favored 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 116.402 2.001 . . . . 25.0 116.402 -167.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 27.5 m -100.54 141.45 33.37 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.33 0.586 . . . . 25.0 112.26 176.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.96 -35.09 5.2 Favored Glycine 0 C--O 1.206 -1.597 0 O-C-N 121.499 -0.751 . . . . 25.0 111.887 177.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.92 -167.91 50.66 Favored Glycine 0 C--O 1.245 0.83 0 O-C-N 121.644 -0.915 . . . . 25.0 113.776 -177.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -59.83 161.51 6.33 Favored 'General case' 0 C--O 1.251 1.156 0 O-C-N 121.204 -1.174 . . . . 25.0 110.672 176.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.76 167.3 36.31 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 115.215 -0.902 . . . . 25.0 113.195 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.82 93.9 9.62 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 122.102 0.953 . . . . 25.0 110.931 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.14 153.44 22.06 Favored 'General case' 0 C--O 1.247 0.927 0 CA-C-N 115.302 -0.863 . . . . 50.0 111.651 -170.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.3 m -125.27 116.52 22.08 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 122.314 1.055 . . . . 25.0 109.685 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -104.38 102.55 12.21 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.714 -1.217 . . . . 25.0 107.714 177.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -106.75 -23.14 12.5 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 113.541 0.941 . . . . 25.0 113.541 -177.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 67.79 160.46 0.17 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.508 1.523 . . . . 25.0 112.13 -176.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.72 -45.49 14.36 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 115.345 1.609 . . . . 25.0 115.345 -168.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 65.4 mt -139.23 169.56 17.54 Favored 'General case' 0 C--O 1.207 -1.137 0 CA-C-O 121.43 0.633 . . . . 25.0 111.925 -174.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.78 -23.95 32.84 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.273 0.629 . . . . 25.0 110.76 171.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -80.35 -6.63 58.3 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.307 1.043 . . . . 25.0 113.745 -177.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -90.13 152.77 20.97 Favored 'General case' 0 C--O 1.213 -0.831 0 N-CA-C 113.658 0.984 . . . . 25.0 113.658 176.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.8 t 45.14 48.77 9.86 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.702 1.601 . . . . 25.0 113.807 165.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -135.83 165.8 24.77 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 115.178 -0.919 . . . . 25.0 111.162 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 59.2 ttt180 -112.89 136.42 52.56 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 105.375 -2.083 . . . . 25.0 105.375 176.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 81.2 p -126.28 171.17 8.29 Favored Pre-proline 0 C--N 1.325 -0.467 0 C-N-CA 125.023 1.329 . . . . 25.0 108.167 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.22 -24.6 68.04 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 117.828 -0.981 . . . . 25.0 113.618 177.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 38.1 mt -71.89 -27.31 62.75 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 112.997 0.739 . . . . 25.0 112.997 177.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 145.56 -176.41 24.57 Favored Glycine 0 C--O 1.213 -1.195 0 N-CA-C 111.019 -0.832 . . . . 25.0 111.019 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 15.2 t -86.07 146.32 26.68 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 122.817 1.294 . . . . 25.0 112.6 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -127.28 28.7 5.68 Favored 'General case' 0 C--O 1.246 0.896 0 C-N-CA 125.432 1.493 . . . . 25.0 107.316 169.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -62.22 143.9 48.88 Favored Glycine 0 C--N 1.34 0.802 0 N-CA-C 110.57 -1.012 . . . . 25.0 110.57 178.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -92.05 163.11 14.09 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 120.277 -0.569 . . . . 50.0 110.944 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.75 110.06 15.01 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.178 0.299 . . . . 25.0 110.485 -175.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 30.3 mt -91.7 136.59 24.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.094 -1.076 . . . . 25.0 108.094 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.6 mt -83.64 -42.8 16.28 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 114.457 1.281 . . . . 25.0 114.457 -172.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 47.3 p-10 -137.86 38.82 2.38 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.46 1.282 . . . . 25.0 114.46 -169.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -56.24 139.06 49.16 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.041 0.386 . . . . 25.0 112.041 -177.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -116.16 101.52 53.87 Favored Pre-proline 0 C--O 1.248 0.98 0 N-CA-C 108.012 -1.107 . . . . 25.0 108.012 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.03 -9.16 25.59 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 N-CA-C 114.643 0.978 . . . . 25.0 114.643 -172.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.6 t -80.41 -45.02 18.35 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-O 121.228 0.537 . . . . 25.0 109.724 177.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -95.91 -39.23 9.9 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 115.006 1.484 . . . . 25.0 115.006 -173.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -89.3 173.06 8.6 Favored 'General case' 0 C--O 1.218 -0.585 0 CA-C-N 115.837 -0.619 . . . . 75.0 110.542 -167.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -151.77 152.85 33.23 Favored 'General case' 0 C--O 1.26 1.652 0 CA-C-N 116.214 -0.448 . . . . 25.0 110.509 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 45.6 mt -129.03 132.04 67.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 109.346 -0.613 . . . . 25.0 109.346 -178.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -84.85 150.61 24.88 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 123.039 1.399 . . . . 25.0 108.831 174.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.2 p -150.17 -9.5 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.333 0 O-C-N 121.18 -0.95 . . . . 25.0 112.155 176.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.425 ' HB2' ' HA ' ' A' ' 156' ' ' PHE . 31.5 t -61.15 -47.16 87.48 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.657 0.741 . . . . 25.0 109.731 -175.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.29 -43.15 67.7 Favored 'General case' 0 C--O 1.251 1.158 0 N-CA-C 114.451 1.278 . . . . 25.0 114.451 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.47 -3.87 20.45 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 116.094 1.887 . . . . 25.0 116.094 -169.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -139.77 -72.53 0.04 OUTLIER Glycine 0 CA--C 1.533 1.185 0 N-CA-C 118.312 2.085 . . . . 25.0 118.312 -176.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -158.05 170.61 21.91 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 119.058 1.429 . . . . 25.0 109.543 -175.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.9 t -121.45 -33.54 3.62 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 112.453 0.538 . . . . 25.0 112.453 172.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -91.89 129.1 9.67 Favored Glycine 0 N--CA 1.466 0.694 0 O-C-N 120.754 -1.217 . . . . 25.0 110.309 177.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -69.61 148.25 49.61 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 118.374 1.087 . . . . 25.0 111.645 -177.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -81.67 -167.9 39.83 Favored Glycine 0 C--O 1.223 -0.572 0 CA-C-N 115.894 -0.594 . . . . 25.0 112.375 -176.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -79.53 70.5 6.0 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.305 0.854 . . . . 25.0 113.305 -176.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -105.69 -168.29 23.51 Favored Glycine 0 C--O 1.211 -1.282 0 N-CA-C 107.873 -2.091 . . . . 25.0 107.873 172.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -138.26 164.54 28.97 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 120.023 1.912 . . . . 25.0 109.425 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 54.78 35.63 24.54 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 122.944 0.498 . . . . 25.0 111.563 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.09 39.57 73.04 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 120.64 -1.288 . . . . 25.0 112.312 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 8.4 t -135.6 -178.75 5.26 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 117.778 0.789 . . . . 25.0 109.82 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 85.2 mt -101.07 164.88 11.59 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 102.149 -3.278 . . . . 25.0 102.149 173.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.04 111.95 10.79 Favored 'General case' 0 C--O 1.267 1.996 0 CA-C-O 123.119 1.438 . . . . 25.0 107.32 -178.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.8 m -70.25 153.11 8.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 N-CA-C 108.348 -0.982 . . . . 25.0 108.348 -176.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.39 162.29 33.46 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.852 -1.155 . . . . 25.0 110.526 -175.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.7 m -127.65 161.92 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 108.631 -0.878 . . . . 25.0 108.631 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.6 t -82.03 -50.75 8.74 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 105.67 -1.974 . . . . 25.0 105.67 172.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -166.21 -162.84 0.56 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 100.666 -3.827 . . . . 25.0 100.666 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -67.28 -19.21 65.46 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 109.258 -0.645 . . . . 25.0 109.258 -178.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -119.81 -153.01 9.15 Favored Glycine 0 C--O 1.238 0.393 0 N-CA-C 111.115 -0.794 . . . . 25.0 111.115 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 56.91 -132.23 1.48 Allowed 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 112.806 0.669 . . . . 25.0 112.806 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.4 mtt85 -103.5 157.42 17.05 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.425 0.898 . . . . 25.0 113.425 -173.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.31 158.66 16.47 Favored 'General case' 0 C--O 1.253 1.249 0 N-CA-C 105.952 -1.87 . . . . 25.0 105.952 171.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -130.1 160.05 34.91 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.39 -0.967 . . . . 25.0 108.39 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 30.5 tp -132.87 102.81 5.78 Favored 'General case' 0 C--O 1.216 -0.684 0 N-CA-C 103.132 -2.914 . . . . 25.0 103.132 171.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -103.77 151.93 22.47 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.353 0.597 . . . . 25.0 109.947 -172.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 41.5 t -92.03 154.74 18.57 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 104.225 -2.509 . . . . 25.0 104.225 171.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -126.76 26.33 6.23 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 122.874 1.321 . . . . 25.0 108.415 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -117.14 147.07 42.76 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 103.592 -2.744 . . . . 25.0 103.592 171.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -149.16 151.52 34.49 Favored 'General case' 0 C--O 1.217 -0.654 0 O-C-N 124.158 0.911 . . . . 25.0 110.662 -175.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -77.09 164.58 25.57 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 124.091 0.957 . . . . 25.0 110.033 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.11 -19.72 64.86 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.742 -0.599 . . . . 25.0 112.181 -175.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -75.99 -9.02 58.27 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 122.526 0.331 . . . . 25.0 111.543 176.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 92.2 14.07 56.53 Favored Glycine 0 C--O 1.219 -0.805 0 CA-C-O 121.963 0.757 . . . . 25.0 112.573 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.0 mt -83.92 137.48 33.63 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 121.323 -1.104 . . . . 25.0 109.663 178.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 84.4 p -145.73 174.48 11.17 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.482 -0.562 . . . . 25.0 109.482 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -115.95 141.6 47.89 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 118.273 0.488 . . . . 25.0 111.649 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -150.93 156.42 41.15 Favored 'General case' 0 C--O 1.251 1.145 0 N-CA-C 106.343 -1.725 . . . . 25.0 106.343 169.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 13.4 p -146.96 147.69 17.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 104.933 -2.247 . . . . 25.0 104.933 173.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -107.59 141.95 38.27 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.018 -1.475 . . . . 25.0 107.018 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.2 mp -131.39 125.24 32.12 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 103.363 -2.828 . . . . 25.0 103.363 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -104.87 15.22 28.2 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 120.395 -1.441 . . . . 25.0 111.698 -173.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -83.95 4.41 82.93 Favored Glycine 0 C--O 1.241 0.57 0 CA-C-N 114.994 -1.003 . . . . 25.0 114.732 177.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 28.2 t0 49.34 47.04 22.78 Favored 'General case' 0 C--O 1.252 1.202 0 N-CA-C 114.586 1.328 . . . . 25.0 114.586 175.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -122.88 41.08 3.54 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.24 -0.891 . . . . 25.0 111.272 -175.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.67 -29.62 64.78 Favored 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 113.685 0.994 . . . . 25.0 113.685 173.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.99 -17.77 62.63 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 119.506 1.048 . . . . 25.0 110.371 -177.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -102.1 -8.48 21.37 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 113.341 0.867 . . . . 25.0 113.341 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.9 mt -79.37 133.66 36.58 Favored 'General case' 0 C--O 1.207 -1.161 0 C-N-CA 120.33 -0.548 . . . . 25.0 109.806 -176.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.0 m -141.32 165.81 26.5 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 106.932 -1.507 . . . . 25.0 106.932 172.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -81.79 4.02 23.68 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 121.733 0.778 . . . . 25.0 109.865 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -66.37 -31.31 72.0 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.119 -1.4 . . . . 25.0 110.656 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -94.16 0.35 55.73 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 112.14 0.422 . . . . 25.0 112.14 177.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 26.3 mm -99.33 123.45 52.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 N-CA-C 104.329 -2.471 . . . . 25.0 104.329 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.1 p -100.71 119.36 48.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 122.592 1.187 . . . . 25.0 113.281 -172.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.425 ' HA ' ' HB2' ' A' ' 97' ' ' SER . 9.3 p90 -149.63 -12.25 0.29 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 112.835 -1.984 . . . . 25.0 111.567 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.43 53.01 2.37 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 121.086 -1.009 . . . . 25.0 113.231 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 60.42 25.98 15.55 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 115.857 1.799 . . . . 25.0 115.857 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 m 65.63 -45.13 0.38 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 117.887 2.551 . . . . 25.0 117.887 177.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.19 120.13 13.25 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 121.439 -0.788 . . . . 25.0 110.44 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -79.14 31.09 0.21 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.439 0.903 . . . . 25.0 113.439 -174.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.62 -2.8 15.48 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 112.756 0.65 . . . . 25.0 112.756 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -151.52 -176.42 5.59 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 123.793 0.683 . . . . 25.0 110.596 -176.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 63.72 -166.65 0.22 Allowed 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 114.026 1.121 . . . . 25.0 114.026 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.36 25.89 67.2 Favored Glycine 0 CA--C 1.535 1.322 0 N-CA-C 111.372 -0.691 . . . . 25.0 111.372 -177.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -92.54 134.49 34.93 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.668 -0.864 . . . . 25.0 108.668 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -129.39 141.04 51.15 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 107.704 -1.221 . . . . 25.0 107.704 176.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -126.85 38.38 2.19 Favored Glycine 0 N--CA 1.464 0.501 0 CA-C-O 122.371 0.984 . . . . 25.0 111.26 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 26.3 t -84.25 -28.5 7.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 O-C-N 121.945 -0.738 . . . . 25.0 110.546 -174.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.39 133.18 24.78 Favored 'Isoleucine or valine' 0 C--O 1.26 1.607 0 CA-C-O 122.872 1.32 . . . . 25.0 111.071 -178.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 164.99 156.72 9.21 Favored Glycine 0 C--O 1.239 0.441 0 CA-C-N 115.076 -0.966 . . . . 25.0 112.277 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -151.02 142.81 23.78 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 121.621 -0.929 . . . . 25.0 110.482 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 59.0 p -149.96 163.53 37.85 Favored 'General case' 0 C--O 1.248 1.003 0 N-CA-C 106.484 -1.673 . . . . 25.0 106.484 176.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.53 -174.33 40.44 Favored Glycine 0 C--O 1.246 0.859 0 C-N-CA 120.415 -0.898 . . . . 25.0 114.322 176.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -154.4 86.39 3.65 Favored Pre-proline 0 C--O 1.252 1.198 0 C-N-CA 123.449 0.699 . . . . 25.0 109.533 -178.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -69.28 160.55 49.39 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 117.703 -1.065 . . . . 25.0 112.568 -176.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -131.16 155.27 47.3 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 124.446 1.091 . . . . 25.0 108.066 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -141.43 80.49 16.33 Favored Pre-proline 0 C--O 1.245 0.819 0 CA-C-N 118.387 0.539 . . . . 25.0 112.088 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.74 135.53 28.35 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 118.169 -0.754 . . . . 25.0 112.146 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.9 t -88.81 -4.41 58.5 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 112.822 0.675 . . . . 25.0 112.822 -177.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 3.7 p . . . . . 0 C--O 1.254 1.297 0 CA-C-O 118.213 -0.898 . . . . 25.0 109.671 179.959 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo . . . . . 0 CA--C 1.541 0.832 0 CA-C-O 121.358 0.482 . . . . 25.0 113.215 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.14 49.32 0.08 OUTLIER Glycine 0 N--CA 1.473 1.157 0 N-CA-C 110.961 -0.855 . . . . 25.0 110.961 178.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.9 p -55.41 132.06 18.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 123.657 0.783 . . . . 25.0 112.048 -176.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -98.06 -2.05 41.11 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.366 -0.834 . . . . 25.0 110.302 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -85.03 -145.11 7.32 Favored Glycine 0 C--O 1.206 -1.624 0 CA-C-N 116.032 -0.531 . . . . 25.0 113.336 177.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.0 p 67.76 153.97 0.13 Allowed Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 126.006 1.723 . . . . 25.0 112.672 -173.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.591 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 47.0 Cg_exo -61.91 -3.91 4.25 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.74 2.293 . . . . 25.0 116.148 -178.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.3 p -63.66 -16.63 18.68 Favored 'Isoleucine or valine' 0 C--O 1.248 0.986 0 N-CA-C 116.85 2.167 . . . . 25.0 116.85 -167.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.8 p -143.82 131.76 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 113.341 0.867 . . . . 25.0 113.341 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.87 19.88 56.9 Favored Glycine 0 N--CA 1.469 0.855 0 N-CA-C 117.592 1.797 . . . . 25.0 117.592 176.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.9 t -47.68 -56.76 6.58 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 117.985 0.893 . . . . 25.0 112.346 -176.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -75.19 -1.99 25.84 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 115.496 1.665 . . . . 25.0 115.496 -170.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -137.57 174.64 10.38 Favored 'General case' 0 C--O 1.207 -1.158 0 CA-C-N 116.234 -0.439 . . . . 25.0 111.784 -171.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.27 144.1 47.28 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-O 122.276 1.036 . . . . 25.0 109.135 -175.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -131.06 150.25 52.23 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 114.632 -1.167 . . . . 50.0 113.018 -176.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -131.22 105.03 7.4 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 100.541 -3.874 . . . . 25.0 100.541 165.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 89.0 mt -127.95 132.72 49.22 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 109.734 -0.469 . . . . 25.0 109.734 -175.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -120.0 115.9 24.67 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.272 -1.381 . . . . 25.0 107.272 -178.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -80.5 176.38 54.67 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 116.554 1.382 . . . . 25.0 116.554 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.5 p -82.33 175.8 9.96 Favored 'General case' 0 C--O 1.251 1.132 0 C-N-CA 124.349 1.06 . . . . 25.0 110.582 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 82.3 mt -80.65 4.46 18.63 Favored 'General case' 0 N--CA 1.463 0.198 0 O-C-N 121.99 -0.443 . . . . 25.0 111.334 174.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -95.85 -176.0 36.66 Favored Glycine 0 C--O 1.226 -0.39 0 CA-C-O 121.374 0.43 . . . . 25.0 112.063 -178.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.6 t -82.12 131.1 35.24 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 109.18 -0.674 . . . . 25.0 109.18 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -145.57 159.89 42.45 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.756 0.788 . . . . 50.0 109.203 -177.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -100.82 131.94 46.46 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 104.773 -2.306 . . . . 25.0 104.773 165.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.4 mm -120.29 103.75 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 N-CA-C 106.736 -1.579 . . . . 25.0 106.736 178.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.591 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 5.3 mp -105.78 128.39 53.68 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 104.427 -2.435 . . . . 25.0 104.427 -178.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.95 -32.19 11.2 Favored Glycine 0 C--N 1.307 -1.049 0 N-CA-C 117.447 1.739 . . . . 25.0 117.447 -177.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.91 -147.14 49.18 Favored Glycine 0 C--O 1.243 0.659 0 CA-C-N 118.934 1.367 . . . . 25.0 111.944 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.95 175.61 50.25 Favored Glycine 0 C--O 1.244 0.768 0 O-C-N 121.734 -0.862 . . . . 25.0 112.837 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.26 160.73 12.51 Favored Glycine 0 C--O 1.256 1.529 0 C-N-CA 120.329 -0.939 . . . . 25.0 111.523 175.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.7 113.02 20.99 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 105.565 -2.013 . . . . 25.0 105.565 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -105.0 154.08 20.59 Favored 'General case' 0 C--O 1.251 1.156 0 N-CA-C 113.211 0.819 . . . . 50.0 113.211 -172.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -121.36 92.61 3.79 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 107.093 -1.447 . . . . 25.0 107.093 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 34.5 mt -108.3 137.3 46.49 Favored 'General case' 0 C--O 1.203 -1.364 0 N-CA-C 114.455 1.28 . . . . 25.0 114.455 -169.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -131.71 117.6 18.84 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.299 0.571 . . . . 25.0 111.719 -179.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -87.92 -24.7 34.27 Favored Glycine 0 C--O 1.245 0.831 0 CA-C-O 117.247 -1.863 . . . . 25.0 116.78 -178.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 53.14 -153.36 0.25 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.978 1.389 . . . . 25.0 112.068 -177.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.71 167.22 15.74 Favored 'General case' 0 C--O 1.249 1.055 0 O-C-N 120.615 -1.303 . . . . 25.0 111.376 -178.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.5 158.52 31.67 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 114.993 -1.003 . . . . 25.0 111.606 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -85.71 94.29 9.07 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 107.385 -1.339 . . . . 25.0 107.385 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -99.38 159.83 14.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.175 -0.921 . . . . 50.0 110.588 -170.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 mp -120.38 106.37 11.79 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 108.529 -0.915 . . . . 25.0 108.529 174.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 mp -111.7 106.15 14.86 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 113.05 0.759 . . . . 25.0 113.05 -172.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -118.99 92.41 3.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.736 -1.12 . . . . 25.0 108.986 -177.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.38 -12.42 32.17 Favored Glycine 0 N--CA 1.467 0.719 0 N-CA-C 118.366 2.106 . . . . 25.0 118.366 -177.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 61.48 -162.45 24.76 Favored Glycine 0 N--CA 1.462 0.399 0 CA-C-N 119.546 1.673 . . . . 25.0 113.853 177.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.69 158.86 1.21 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 114.227 1.195 . . . . 25.0 114.227 -177.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.93 179.46 51.78 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 115.138 -0.937 . . . . 25.0 112.809 -177.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.79 141.62 29.03 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 101.498 -3.519 . . . . 25.0 101.498 176.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -133.53 158.12 43.93 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.57 -0.9 . . . . 50.0 108.57 -175.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -124.01 120.09 31.42 Favored 'General case' 0 C--O 1.212 -0.906 0 N-CA-C 107.766 -1.198 . . . . 25.0 107.766 173.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -141.64 132.48 25.84 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 115.644 1.72 . . . . 25.0 115.644 -169.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 63.9 m -95.22 140.98 29.36 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 123.278 0.631 . . . . 25.0 109.752 175.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.39 -39.18 4.54 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 107.9 -2.08 . . . . 25.0 107.9 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.03 -164.38 52.87 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 117.997 0.898 . . . . 25.0 113.387 -177.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.0 158.73 15.72 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.03 0.532 . . . . 25.0 110.202 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.97 157.85 26.24 Favored Glycine 0 N--CA 1.476 1.324 0 N-CA-C 111.502 -0.639 . . . . 25.0 111.502 175.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.0 110.91 8.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.627 1.203 . . . . 25.0 111.915 -176.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -104.86 155.22 19.12 Favored 'General case' 0 C--O 1.25 1.123 0 CA-C-N 114.625 -1.17 . . . . 50.0 109.505 -173.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 88.0 m -125.33 131.01 53.1 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.418 0.687 . . . . 25.0 110.444 -177.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -124.31 104.05 8.57 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 108.015 -1.105 . . . . 25.0 108.015 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 54.5 mtt85 -115.09 -16.59 11.59 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 121.669 -0.645 . . . . 25.0 111.531 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 62.44 164.22 0.1 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.692 1.597 . . . . 25.0 111.571 -175.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.15 -39.49 48.99 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 114.317 1.228 . . . . 25.0 114.317 -172.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.7 mt -135.37 164.81 26.91 Favored 'General case' 0 C--O 1.207 -1.149 0 C-N-CA 123.114 0.566 . . . . 25.0 112.341 -170.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -17.97 64.2 Favored 'General case' 0 C--O 1.209 -1.067 0 N-CA-C 108.386 -0.968 . . . . 25.0 108.386 170.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -82.53 6.06 18.74 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.811 1.041 . . . . 25.0 113.811 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -111.22 151.81 27.83 Favored 'General case' 0 C--O 1.213 -0.849 0 N-CA-C 115.798 1.777 . . . . 25.0 115.798 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.0 t 54.91 36.32 26.45 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 113.712 -1.586 . . . . 25.0 112.975 175.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 24.0 p-80 -121.05 167.65 12.39 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.869 -1.06 . . . . 25.0 112.507 -173.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 -123.44 140.99 52.44 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 106.748 -1.575 . . . . 25.0 106.748 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.6 p -133.94 173.29 6.01 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 107.949 -1.13 . . . . 25.0 107.949 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -61.39 -25.68 80.36 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 115.831 -2.313 . . . . 25.0 112.999 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 68.6 mt -68.77 -27.09 65.59 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.533 0.682 . . . . 25.0 111.916 -178.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.53 -173.83 32.94 Favored Glycine 0 CA--C 1.498 -0.995 0 N-CA-C 110.414 -1.074 . . . . 25.0 110.414 -177.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.1 t -100.41 148.02 25.19 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.487 1.137 . . . . 25.0 111.345 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -134.09 31.0 3.59 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 114.622 -1.172 . . . . 25.0 108.496 172.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.56 148.94 50.28 Favored Glycine 0 C--O 1.249 1.057 0 CA-C-N 114.085 -1.416 . . . . 25.0 109.578 176.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -91.8 167.18 12.34 Favored 'General case' 0 C--N 1.314 -0.961 0 O-C-N 121.888 -0.772 . . . . 50.0 110.133 -176.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -120.75 111.34 17.47 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.575 0.75 . . . . 25.0 109.989 -177.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.8 mt -97.32 129.36 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-O 121.676 0.75 . . . . 25.0 109.021 -177.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 81.4 mt -83.78 -41.71 17.29 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 115.717 1.747 . . . . 25.0 115.717 -170.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.4 p-10 -140.45 45.63 1.83 Allowed 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.755 1.391 . . . . 25.0 114.755 -176.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -55.83 129.92 41.42 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 122.241 1.02 . . . . 25.0 112.943 -178.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -91.97 105.11 12.39 Favored Pre-proline 0 C--O 1.246 0.872 0 CA-C-N 114.231 -1.35 . . . . 25.0 108.081 174.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.38 3.93 3.79 Favored 'Trans proline' 0 C--O 1.205 -1.143 0 N-CA-C 115.779 1.415 . . . . 25.0 115.779 -173.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.2 t -110.83 -43.8 3.74 Favored 'General case' 0 C--O 1.253 1.281 0 O-C-N 121.809 -0.557 . . . . 25.0 111.259 176.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -87.26 -38.66 16.11 Favored 'General case' 0 C--O 1.241 0.624 0 O-C-N 123.51 0.506 . . . . 25.0 110.58 -172.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -88.43 158.44 18.36 Favored 'General case' 0 CA--C 1.552 1.048 0 N-CA-C 112.271 0.471 . . . . 50.0 112.271 -170.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -137.81 147.89 45.0 Favored 'General case' 0 C--O 1.252 1.201 0 N-CA-C 113.859 1.059 . . . . 25.0 113.859 -175.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 68.2 mt -131.81 130.39 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 108.773 -0.825 . . . . 25.0 108.773 -175.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -90.05 147.44 23.65 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.047 -1.033 . . . . 25.0 108.927 171.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.0 p -141.35 -5.02 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 115.484 -0.78 . . . . 25.0 109.417 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.0 t -65.65 -41.96 91.94 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 121.294 0.569 . . . . 25.0 111.313 -170.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.91 -34.3 57.72 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 119.937 -0.705 . . . . 25.0 112.855 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.97 -3.25 18.98 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 116.502 2.038 . . . . 25.0 116.502 -169.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -142.58 -74.08 0.03 OUTLIER Glycine 0 C--O 1.214 -1.124 0 CA-C-O 119.256 -0.747 . . . . 25.0 114.561 -178.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -160.23 165.16 32.0 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 117.814 0.807 . . . . 25.0 112.007 -173.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.9 t -121.27 -10.9 8.88 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 121.0 0.429 . . . . 25.0 112.1 176.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.43 133.41 11.07 Favored Glycine 0 N--CA 1.467 0.722 0 N-CA-C 108.613 -1.795 . . . . 25.0 108.613 170.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.15 150.11 42.45 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-N 117.314 0.557 . . . . 25.0 112.172 -175.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -86.06 -177.7 49.96 Favored Glycine 0 C--O 1.223 -0.545 0 O-C-N 122.125 -0.36 . . . . 25.0 113.1 -174.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -63.81 101.15 0.34 Allowed 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.624 0.602 . . . . 25.0 112.624 -175.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -150.85 -165.62 12.94 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.006 -1.237 . . . . 25.0 110.006 175.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -148.43 165.88 29.8 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 119.645 1.722 . . . . 25.0 113.164 -177.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 58.94 33.97 23.35 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.464 1.283 . . . . 25.0 114.464 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 77.36 30.54 53.89 Favored Glycine 0 N--CA 1.465 0.617 0 C-N-CA 119.857 -1.163 . . . . 25.0 110.27 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.6 t -143.61 168.63 19.42 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 121.32 -1.106 . . . . 25.0 108.965 -178.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.8 mt -93.02 172.24 8.44 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 106.144 -1.799 . . . . 25.0 106.144 175.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.58 118.95 19.75 Favored 'General case' 0 C--O 1.254 1.323 0 CA-C-N 119.446 1.021 . . . . 25.0 110.099 177.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.8 m -87.85 159.15 3.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 109.45 -0.574 . . . . 25.0 109.45 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 99.4 p -147.0 163.69 35.42 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 108.77 -0.826 . . . . 25.0 108.77 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.5 m -126.02 165.89 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 N-CA-C 107.532 -1.284 . . . . 25.0 107.532 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.1 t -74.49 -49.32 22.65 Favored 'General case' 0 C--O 1.255 1.346 0 N-CA-C 104.251 -2.5 . . . . 25.0 104.251 173.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -168.8 -170.89 1.25 Allowed 'General case' 0 C--O 1.207 -1.133 1 N-CA-C 99.201 -4.37 . . . . 25.0 99.201 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -60.23 -20.46 58.95 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 119.175 0.898 . . . . 25.0 111.912 -178.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.22 -151.45 9.68 Favored Glycine 0 C--O 1.216 -1.02 0 N-CA-C 110.602 -0.999 . . . . 25.0 110.602 176.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 54.66 -133.75 1.66 Allowed 'General case' 0 N--CA 1.465 0.325 0 O-C-N 124.066 0.51 . . . . 25.0 112.094 -179.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 22.8 mtt85 -105.37 155.53 19.03 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 112.473 0.546 . . . . 25.0 112.473 -174.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.3 p -103.3 163.01 12.52 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.173 -2.528 . . . . 25.0 104.173 175.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -141.33 149.86 41.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 118.63 0.65 . . . . 25.0 111.328 -176.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 55.8 tp -124.57 128.21 48.56 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 105.298 -2.112 . . . . 25.0 105.298 177.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -126.15 155.75 41.21 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 122.597 1.189 . . . . 25.0 112.218 -172.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 32.3 t -90.96 158.28 16.81 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 103.481 -2.785 . . . . 25.0 103.481 168.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -129.69 17.08 5.82 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 106.773 -1.566 . . . . 25.0 106.773 176.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -115.44 144.78 43.31 Favored 'General case' 0 C--O 1.25 1.125 0 CA-C-N 112.525 -2.125 . . . . 25.0 106.667 173.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -144.52 168.18 20.74 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.334 0.587 . . . . 25.0 110.18 -178.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -97.13 161.35 13.86 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.946 -1.131 . . . . 25.0 107.946 176.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.22 -26.72 68.64 Favored 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 109.647 -0.501 . . . . 25.0 109.647 -176.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -67.26 -7.16 22.06 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 112.929 0.715 . . . . 25.0 112.929 174.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.89 22.18 53.63 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 121.84 0.689 . . . . 25.0 113.404 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 78.1 mt -90.99 133.48 35.25 Favored 'General case' 0 CA--C 1.506 -0.728 0 O-C-N 121.899 -0.766 . . . . 25.0 109.951 177.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 66.3 p -141.43 -179.46 6.15 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.414 -1.328 . . . . 25.0 107.414 178.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -124.77 136.26 53.7 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 119.614 -0.232 . . . . 25.0 111.221 -178.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -149.15 152.53 36.24 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 106.622 -1.622 . . . . 25.0 106.622 166.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.5 p -144.63 144.65 21.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 105.004 -2.221 . . . . 25.0 105.004 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -105.54 142.98 34.35 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.963 -1.495 . . . . 25.0 106.963 -176.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.8 mp -130.77 132.66 45.42 Favored 'General case' 0 C--O 1.195 -1.81 0 N-CA-C 105.404 -2.073 . . . . 25.0 105.404 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -105.35 6.19 32.46 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 119.646 -1.909 . . . . 25.0 114.195 -174.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -87.34 8.66 76.12 Favored Glycine 0 CA--C 1.542 1.765 0 C-N-CA 120.753 -0.737 . . . . 25.0 113.415 -179.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 35.7 t0 43.98 57.36 4.2 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 114.7 1.371 . . . . 25.0 114.7 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -123.82 36.16 4.69 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-N 114.95 -1.023 . . . . 25.0 109.284 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.97 -33.32 68.74 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.348 -0.387 . . . . 25.0 112.027 174.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.36 -22.91 62.73 Favored 'General case' 0 C--O 1.255 1.374 0 O-C-N 121.297 -0.877 . . . . 25.0 112.442 178.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.5 -15.92 20.35 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 112.333 0.494 . . . . 25.0 112.333 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 12.9 mt -64.59 139.02 58.72 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 123.009 1.385 . . . . 25.0 112.265 176.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 57.8 m -143.52 154.7 43.89 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 106.66 -1.607 . . . . 25.0 106.66 177.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.05 -2.93 29.61 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.657 0.614 . . . . 25.0 112.657 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -67.0 -31.55 72.19 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 108.366 -0.975 . . . . 25.0 108.366 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -85.6 -5.03 59.32 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 120.377 -0.529 . . . . 25.0 112.309 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 48.3 mm -97.27 122.79 49.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 104.481 -2.414 . . . . 25.0 104.481 176.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.1 p -103.2 112.93 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-O 123.12 1.438 . . . . 25.0 113.568 -174.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -142.0 -7.21 0.94 Allowed 'General case' 0 C--O 1.251 1.158 0 CA-C-N 112.656 -2.066 . . . . 25.0 111.782 176.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -85.86 50.61 2.01 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.56 0.948 . . . . 25.0 113.56 -176.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 60.09 20.06 9.28 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.456 2.021 . . . . 25.0 116.456 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.0 -21.28 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 119.886 3.291 . . . . 25.0 119.886 174.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -70.0 139.8 52.82 Favored 'General case' 0 N--CA 1.444 -0.746 0 O-C-N 121.606 -0.684 . . . . 25.0 110.196 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.434 ' C ' ' H ' ' A' ' 163' ' ' ALA . . . -75.25 -1.83 25.27 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.462 0.912 . . . . 25.0 113.462 178.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.29 34.97 0.21 Allowed 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.883 0.849 . . . . 25.0 111.164 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.434 ' H ' ' C ' ' A' ' 161' ' ' ALA . . . -145.66 -171.59 3.72 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.267 -0.879 . . . . 25.0 108.921 -175.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 59.65 -168.98 0.15 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.632 1.573 . . . . 25.0 113.083 175.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 80.18 6.2 89.31 Favored Glycine 0 C--O 1.25 1.145 0 CA-C-O 121.682 0.601 . . . . 25.0 114.418 -173.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -81.86 69.73 8.61 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.868 0.867 . . . . 25.0 111.364 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -125.01 141.15 52.31 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 122.853 0.461 . . . . 25.0 111.297 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -142.67 44.76 0.95 Allowed Glycine 0 CA--C 1.527 0.784 0 O-C-N 124.222 0.951 . . . . 25.0 112.097 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 45.6 t -70.87 -37.26 67.67 Favored 'Isoleucine or valine' 0 C--O 1.251 1.143 0 O-C-N 121.758 -0.848 . . . . 25.0 111.684 -178.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.11 136.47 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-O 122.245 1.022 . . . . 25.0 111.645 -177.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 166.84 170.38 31.66 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 109.22 -1.552 . . . . 25.0 109.22 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -146.55 148.8 32.54 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.855 0.836 . . . . 25.0 110.721 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 95.2 p -158.42 169.93 23.35 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-N 114.782 -1.099 . . . . 25.0 110.169 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 150.58 167.12 14.19 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 116.289 1.276 . . . . 25.0 116.289 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -136.66 95.0 12.82 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 124.948 1.299 . . . . 25.0 107.618 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.86 158.29 57.97 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 119.809 0.339 . . . . 25.0 112.094 -178.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -114.03 154.75 27.15 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 107.951 -1.129 . . . . 25.0 107.951 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -127.2 67.88 71.55 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 115.574 -0.739 . . . . 25.0 110.818 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -72.15 158.19 52.55 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 CA-C-O 122.945 1.144 . . . . 25.0 112.25 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.2 t -132.48 27.52 4.39 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 105.828 -1.915 . . . . 25.0 105.828 172.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 C--O 1.25 1.115 0 CA-C-N 113.876 -1.511 . . . . 25.0 111.821 179.056 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo . . . . . 0 CA--C 1.515 -0.464 0 N-CA-C 113.531 0.55 . . . . 25.0 113.531 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.64 46.1 0.04 OUTLIER Glycine 0 N--CA 1.472 1.087 0 CA-C-O 117.539 -1.701 . . . . 25.0 110.474 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -51.67 120.89 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 O-C-N 125.592 1.407 . . . . 25.0 113.0 -176.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -92.29 -8.59 44.75 Favored 'General case' 0 C--O 1.259 1.557 0 CA-C-N 113.516 -1.675 . . . . 25.0 110.899 -173.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.01 -137.17 3.34 Favored Glycine 0 C--N 1.298 -1.567 0 O-C-N 124.01 0.819 . . . . 25.0 113.403 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.7 p 65.69 156.34 0.13 Allowed Pre-proline 0 N--CA 1.498 1.966 0 C-N-CA 126.225 1.81 . . . . 25.0 111.665 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.591 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 47.3 Cg_exo -64.23 -3.31 5.98 Favored 'Trans proline' 0 C--N 1.364 1.344 0 N-CA-C 118.17 2.335 . . . . 25.0 118.17 -177.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 p -68.74 -9.92 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 116.822 2.156 . . . . 25.0 116.822 -173.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.7 p -138.87 133.02 40.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 113.547 0.943 . . . . 25.0 113.547 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.11 15.8 74.66 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 118.093 1.997 . . . . 25.0 118.093 172.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 89.4 p -54.75 -35.21 63.51 Favored 'General case' 0 CA--C 1.565 1.549 0 O-C-N 120.776 -1.426 . . . . 25.0 113.815 -170.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -78.22 3.81 14.33 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 117.576 2.435 . . . . 25.0 117.576 -175.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.4 pp -149.98 177.64 9.67 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 123.181 0.592 . . . . 25.0 110.478 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -59.32 128.7 38.39 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 112.548 0.573 . . . . 25.0 112.548 -174.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -125.9 160.61 29.48 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 114.298 1.222 . . . . 50.0 114.298 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -124.24 97.39 5.3 Favored 'General case' 0 C--O 1.279 2.639 0 N-CA-C 106.237 -1.764 . . . . 25.0 106.237 159.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.4 mt -104.44 128.68 52.39 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.932 0.872 . . . . 25.0 112.691 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -115.67 120.47 39.48 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 109.114 -0.699 . . . . 25.0 109.114 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.83 173.88 40.35 Favored Glycine 0 N--CA 1.472 1.083 0 N-CA-C 120.238 2.855 . . . . 25.0 120.238 -178.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.5 p -71.72 174.42 6.84 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.521 1.153 . . . . 25.0 113.06 175.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.5 mt -93.5 16.85 12.61 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.483 -0.78 . . . . 25.0 109.904 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -119.24 -177.62 16.48 Favored Glycine 0 C--O 1.24 0.494 0 N-CA-C 109.479 -1.448 . . . . 25.0 109.479 174.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.7 t -68.45 133.92 49.36 Favored 'General case' 0 C--O 1.253 1.278 0 C-N-CA 123.347 0.659 . . . . 25.0 111.483 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -144.98 160.5 41.25 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.974 -1.121 . . . . 50.0 107.974 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -104.27 124.55 49.35 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 104.916 -2.253 . . . . 25.0 104.916 163.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.0 mm -114.84 128.65 71.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 N-CA-C 106.378 -1.712 . . . . 25.0 106.378 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.591 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 4.4 mp -126.9 124.46 39.6 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 102.942 -2.985 . . . . 25.0 102.942 178.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.32 -30.87 56.24 Favored Glycine 0 N--CA 1.483 1.777 0 N-CA-C 114.625 0.61 . . . . 25.0 114.625 176.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.5 -149.56 48.59 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 118.781 1.29 . . . . 25.0 111.352 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -79.14 170.43 54.57 Favored Glycine 0 C--N 1.298 -1.561 0 N-CA-C 109.362 -1.495 . . . . 25.0 109.362 -177.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.82 167.98 41.92 Favored Glycine 0 C--N 1.307 -1.032 0 N-CA-C 110.861 -0.896 . . . . 25.0 110.861 177.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.91 102.97 15.58 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.53 1.132 . . . . 25.0 108.319 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -102.78 147.25 27.09 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 122.589 1.185 . . . . 50.0 111.381 -167.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -118.16 92.29 3.79 Favored 'General case' 0 C--O 1.285 2.934 0 N-CA-C 107.477 -1.305 . . . . 25.0 107.477 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 23.3 mt -102.69 140.37 37.05 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.558 0.947 . . . . 25.0 113.558 -169.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -134.31 106.18 6.98 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.633 -0.877 . . . . 25.0 108.633 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.38 -17.75 63.79 Favored Glycine 0 N--CA 1.476 1.354 0 N-CA-C 115.86 1.104 . . . . 25.0 115.86 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 47.93 -149.64 0.16 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 119.335 1.568 . . . . 25.0 113.939 -177.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.98 163.1 25.36 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-N 115.633 -0.712 . . . . 25.0 112.918 -173.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.5 160.62 35.97 Favored Glycine 0 C--O 1.252 1.258 0 O-C-N 124.979 1.424 . . . . 25.0 113.672 -175.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -81.59 102.53 10.7 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.901 -1.148 . . . . 25.0 107.901 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -109.69 152.95 24.96 Favored 'General case' 0 CA--C 1.505 -0.754 0 C-N-CA 119.48 -0.888 . . . . 50.0 110.92 -169.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.44 120.79 43.15 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 105.15 -2.167 . . . . 25.0 105.15 177.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.8 mp -124.14 121.3 34.75 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.275 1.213 . . . . 25.0 114.275 -176.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -116.08 148.02 40.68 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 113.801 -1.545 . . . . 25.0 106.888 174.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.15 -34.32 4.87 Favored Glycine 0 N--CA 1.476 1.333 0 N-CA-C 116.173 1.229 . . . . 25.0 116.173 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.72 -171.38 53.5 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-O 123.593 1.663 . . . . 25.0 110.335 -177.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.28 149.64 16.01 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 114.253 -0.973 . . . . 25.0 112.422 -176.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.56 168.32 44.47 Favored Glycine 0 CA--C 1.496 -1.155 0 CA-C-O 118.31 -1.272 . . . . 25.0 111.723 -176.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.49 134.32 33.62 Favored 'General case' 0 C--O 1.209 -1.07 0 N-CA-C 101.637 -3.468 . . . . 25.0 101.637 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -123.1 157.71 32.25 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 109.655 -0.498 . . . . 50.0 109.655 -174.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -120.73 127.59 52.15 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 101.994 -3.336 . . . . 25.0 101.994 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -149.48 135.04 18.51 Favored 'General case' 0 C--O 1.2 -1.507 0 N-CA-C 116.493 2.034 . . . . 25.0 116.493 -174.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.2 m -99.55 145.6 27.33 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.995 -1.002 . . . . 25.0 110.228 171.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.92 -34.54 5.4 Favored Glycine 0 C--O 1.215 -1.076 0 N-CA-C 108.779 -1.728 . . . . 25.0 108.779 173.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.69 -165.1 53.56 Favored Glycine 0 C--O 1.217 -0.946 0 CA-C-O 122.009 0.783 . . . . 25.0 111.659 -177.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -71.16 156.06 40.02 Favored 'General case' 0 C--O 1.258 1.53 0 CA-C-O 121.938 0.875 . . . . 25.0 109.344 178.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.54 161.45 33.61 Favored Glycine 0 C--O 1.258 1.605 0 CA-C-O 117.982 -1.454 . . . . 25.0 110.121 -175.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.75 112.29 17.99 Favored 'General case' 0 C--O 1.2 -1.532 0 O-C-N 124.697 0.881 . . . . 25.0 109.428 177.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -104.15 153.4 20.98 Favored 'General case' 0 CA--C 1.487 -1.462 0 CA-C-N 116.58 -0.282 . . . . 50.0 110.901 -174.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 79.5 m -116.36 122.54 45.17 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 107.843 -1.169 . . . . 25.0 107.843 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -108.13 89.26 2.94 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 104.137 -2.542 . . . . 25.0 104.137 177.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -92.12 -25.84 18.55 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 114.822 -1.081 . . . . 25.0 111.626 -174.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 66.86 150.03 0.06 Allowed 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.477 1.511 . . . . 25.0 112.198 -175.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.65 -43.36 31.61 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 117.061 2.245 . . . . 25.0 117.061 -165.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.4 mt -142.9 173.57 11.43 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.572 -0.899 . . . . 25.0 108.572 -165.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.55 -30.23 69.64 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-N 115.179 -0.919 . . . . 25.0 110.125 167.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -78.17 -6.59 55.27 Favored 'General case' 0 C--O 1.263 1.796 0 N-CA-C 114.539 1.311 . . . . 25.0 114.539 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -90.59 151.17 21.43 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 121.209 -0.932 . . . . 25.0 109.499 -172.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.8 t 29.1 47.05 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 117.569 2.433 . . . . 25.0 117.569 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 -119.15 178.63 4.44 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.56 -0.746 . . . . 25.0 109.532 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -126.84 140.17 52.55 Favored 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 107.963 -1.125 . . . . 25.0 107.963 176.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 84.1 p -129.81 166.1 28.52 Favored Pre-proline 0 C--O 1.189 -2.108 0 N-CA-C 108.216 -1.031 . . . . 25.0 108.216 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -64.68 -24.58 62.25 Favored 'Trans proline' 0 C--O 1.243 0.735 0 C-N-CA 115.667 -2.422 . . . . 25.0 112.677 178.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 31.7 mt -65.64 -38.99 90.94 Favored 'General case' 0 C--O 1.201 -1.498 0 CA-C-O 121.826 0.822 . . . . 25.0 112.459 178.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 171.46 167.29 31.48 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 115.001 -1.0 . . . . 25.0 111.383 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.8 t -86.42 149.64 24.86 Favored 'General case' 0 C--N 1.353 0.751 0 CA-C-O 124.425 2.059 . . . . 25.0 110.855 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -132.83 28.09 4.24 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 112.337 -2.21 . . . . 25.0 111.355 175.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.74 140.41 36.59 Favored Glycine 0 N--CA 1.474 1.231 0 CA-C-O 122.31 0.95 . . . . 25.0 111.917 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -91.18 169.39 10.88 Favored 'General case' 0 C--O 1.249 1.067 0 O-C-N 119.884 -1.95 . . . . 50.0 111.998 -176.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -122.18 97.4 5.46 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.662 0.785 . . . . 25.0 110.936 -170.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 22.1 mt -84.41 132.7 30.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 N-CA-C 106.92 -1.511 . . . . 25.0 106.92 -178.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.42 ' HA ' ' HG2' ' A' ' 142' ' ' GLU . 90.4 mt -87.47 -43.81 11.78 Favored 'General case' 0 C--O 1.253 1.289 0 N-CA-C 115.774 1.768 . . . . 25.0 115.774 -172.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 54.0 p-10 -137.78 44.55 2.2 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.539 0.57 . . . . 25.0 112.539 -174.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.433 ' CE2' ' HA ' ' A' ' 89' ' ' PRO . 87.8 t80 -57.28 138.55 54.64 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.823 1.249 . . . . 25.0 111.971 178.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -106.16 105.5 54.02 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 106.807 -1.553 . . . . 25.0 106.807 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.433 ' HA ' ' CE2' ' A' ' 87' ' ' PHE . 96.3 Cg_endo -68.05 -5.4 14.59 Favored 'Trans proline' 0 C--O 1.199 -1.427 0 N-CA-C 117.703 2.155 . . . . 25.0 117.703 -177.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 37.7 t -99.87 -38.78 8.5 Favored 'General case' 0 CA--C 1.557 1.213 0 CA-C-O 120.815 0.341 . . . . 25.0 110.921 177.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -93.45 -42.3 9.33 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-N 116.668 -0.242 . . . . 25.0 111.578 -174.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -87.56 167.66 13.74 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 115.134 -0.939 . . . . 50.0 109.516 -170.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -139.99 151.11 45.23 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 122.977 0.511 . . . . 25.0 110.733 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 86.0 mt -124.93 133.71 68.78 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.596 0 N-CA-C 107.945 -1.131 . . . . 25.0 107.945 177.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -100.15 154.53 18.37 Favored 'General case' 0 C--O 1.212 -0.914 0 N-CA-C 107.896 -1.15 . . . . 25.0 107.896 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.8 p -154.33 2.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 121.467 -0.771 . . . . 25.0 111.448 -176.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 11.0 t -62.74 -45.97 90.26 Favored 'General case' 0 C--O 1.258 1.546 0 N-CA-C 115.464 1.653 . . . . 25.0 115.464 -173.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.63 -42.01 22.88 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.9 -0.591 . . . . 25.0 111.07 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.37 -8.32 48.33 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 117.136 2.273 . . . . 25.0 117.136 -172.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -140.44 -72.07 0.04 OUTLIER Glycine 0 C--N 1.337 0.613 0 N-CA-C 116.72 1.448 . . . . 25.0 116.72 -176.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -160.63 168.61 24.57 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 108.283 -1.006 . . . . 25.0 108.283 -176.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.0 t -127.73 -30.99 2.48 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.8 0.81 . . . . 25.0 111.925 175.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -94.06 121.36 6.65 Favored Glycine 0 CA--C 1.483 -1.968 0 N-CA-C 107.467 -2.253 . . . . 25.0 107.467 175.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.82 146.07 47.61 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.038 -0.581 . . . . 25.0 111.813 -178.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -102.68 -160.3 25.81 Favored Glycine 0 C--O 1.244 0.727 0 CA-C-O 122.415 1.008 . . . . 25.0 114.539 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -56.48 139.36 49.51 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 122.262 1.03 . . . . 25.0 113.673 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 164.28 -175.67 40.32 Favored Glycine 0 C--O 1.25 1.141 0 N-CA-C 110.15 -1.18 . . . . 25.0 110.15 -177.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -146.61 165.26 30.07 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.834 1.317 . . . . 25.0 110.995 -177.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 56.4 37.38 28.78 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 113.243 0.831 . . . . 25.0 113.243 177.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 79.02 32.6 39.23 Favored Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.204 -1.474 . . . . 25.0 110.945 176.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.7 t -148.59 179.72 7.6 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 120.02 1.91 . . . . 25.0 110.682 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 65.4 mt -90.52 168.58 11.72 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 104.519 -2.401 . . . . 25.0 104.519 168.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.77 121.94 20.72 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 108.07 -1.085 . . . . 25.0 108.07 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 28.9 m -93.86 162.37 2.42 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 O-C-N 125.081 1.488 . . . . 25.0 108.945 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.4 p -148.93 163.84 36.28 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.414 0.894 . . . . 25.0 113.414 -177.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.8 m -120.91 167.69 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 106.729 -1.582 . . . . 25.0 106.729 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 37.4 t -75.51 -55.07 6.03 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 106.615 -1.624 . . . . 25.0 106.615 173.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -165.6 -150.95 0.13 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 103.854 -2.647 . . . . 25.0 103.854 -176.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -69.39 -15.08 63.23 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 122.44 1.114 . . . . 25.0 111.114 -176.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -140.09 -155.24 6.51 Favored Glycine 0 C--O 1.258 1.606 0 CA-C-O 117.391 -1.783 . . . . 25.0 110.895 178.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 68.01 -150.25 0.16 Allowed 'General case' 0 C--O 1.247 0.973 0 C-N-CA 125.113 1.365 . . . . 25.0 111.061 177.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 46.6 mtt85 -93.16 168.8 10.87 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-O 122.062 0.934 . . . . 25.0 111.419 -174.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 8.4 p -109.97 165.38 11.77 Favored 'General case' 0 C--O 1.251 1.146 0 N-CA-C 104.023 -2.584 . . . . 25.0 104.023 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -133.01 156.71 46.86 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-O 123.817 1.77 . . . . 25.0 110.056 175.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 59.9 tp -128.41 127.93 43.51 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 104.212 -2.514 . . . . 25.0 104.212 170.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -125.37 152.79 44.32 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.067 -0.716 . . . . 25.0 109.067 -172.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 41.1 t -96.07 149.88 21.11 Favored 'General case' 0 C--O 1.248 0.987 0 N-CA-C 106.039 -1.837 . . . . 25.0 106.039 171.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -115.31 19.74 15.34 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 122.551 1.167 . . . . 25.0 107.957 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -115.12 149.78 37.04 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 106.635 -1.617 . . . . 25.0 106.635 176.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -149.55 153.01 36.48 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 124.062 0.851 . . . . 25.0 111.516 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -83.18 162.35 21.27 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.509 -1.293 . . . . 25.0 107.509 177.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.99 -20.49 66.52 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 118.418 0.554 . . . . 25.0 111.381 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -82.39 -1.25 49.4 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 112.736 0.643 . . . . 25.0 112.736 176.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.26 14.4 68.95 Favored Glycine 0 CA--C 1.497 -1.035 0 O-C-N 124.112 0.882 . . . . 25.0 111.728 177.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 80.9 mt -83.87 139.16 32.81 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.634 -1.617 . . . . 25.0 106.634 177.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 61.4 p -149.85 -177.1 5.71 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 116.331 -1.795 . . . . 25.0 106.349 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -133.04 133.97 43.76 Favored 'General case' 0 C--O 1.274 2.39 0 N-CA-C 115.055 1.502 . . . . 25.0 115.055 -176.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -144.09 156.4 44.34 Favored 'General case' 0 C--O 1.269 2.114 0 N-CA-C 109.316 -0.624 . . . . 25.0 109.316 169.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.9 p -144.76 144.6 21.85 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 N-CA-C 107.252 -1.388 . . . . 25.0 107.252 -178.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -112.04 138.56 48.52 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 118.992 0.814 . . . . 25.0 110.445 -177.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.6 mp -130.4 135.37 47.95 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.741 -0.837 . . . . 25.0 108.741 -175.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.42 ' HG2' ' HA ' ' A' ' 85' ' ' LEU . 17.4 pt-20 -102.3 7.83 40.53 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 117.918 -1.513 . . . . 25.0 111.622 -176.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -73.44 -6.4 70.3 Favored Glycine 0 C--O 1.216 -1.021 0 O-C-N 124.3 1.0 . . . . 25.0 113.121 178.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 49.1 t0 49.98 47.22 23.6 Favored 'General case' 0 C--O 1.262 1.743 0 CA-C-O 122.051 0.929 . . . . 25.0 111.689 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -125.17 35.49 4.76 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 107.279 -1.378 . . . . 25.0 107.279 -178.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.4 -32.21 69.96 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 121.007 0.432 . . . . 25.0 110.093 172.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.27 -11.45 60.72 Favored 'General case' 0 C--O 1.26 1.647 0 C-N-CA 119.834 -0.746 . . . . 25.0 111.675 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -110.21 -1.08 17.55 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 113.852 1.056 . . . . 25.0 113.852 174.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 20.6 mt -79.25 120.94 24.44 Favored 'General case' 0 C--O 1.248 0.997 0 O-C-N 123.831 0.707 . . . . 25.0 111.636 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 71.8 m -135.56 160.45 38.46 Favored 'General case' 0 N--CA 1.4 -2.972 0 CA-C-N 114.405 -1.27 . . . . 25.0 108.292 176.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -68.1 -7.53 30.39 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 122.47 1.129 . . . . 25.0 110.474 -177.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -61.14 -27.22 68.24 Favored 'General case' 0 C--O 1.208 -1.106 0 CA-C-N 114.426 -1.261 . . . . 25.0 109.131 177.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -103.1 -1.89 28.36 Favored 'General case' 0 C--O 1.26 1.613 0 N-CA-C 114.509 1.3 . . . . 25.0 114.509 176.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 23.1 mm -101.08 114.88 41.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 104.931 -2.248 . . . . 25.0 104.931 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 13.7 p -97.78 110.72 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 119.735 -1.853 . . . . 25.0 113.86 -168.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -151.07 -4.04 0.31 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 113.083 -1.871 . . . . 25.0 113.824 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -84.96 58.65 5.14 Favored 'General case' 0 C--N 1.346 0.443 0 N-CA-C 113.574 0.953 . . . . 25.0 113.574 -175.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 52.35 26.62 4.21 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 116.854 2.168 . . . . 25.0 116.854 178.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.11 -6.23 0.11 Allowed 'General case' 0 CA--C 1.564 1.502 0 N-CA-C 117.244 2.313 . . . . 25.0 117.244 178.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -65.75 133.72 51.63 Favored 'General case' 0 CA--C 1.551 0.991 0 O-C-N 121.442 -0.786 . . . . 25.0 111.174 -176.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.3 -18.74 61.17 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.02 0.528 . . . . 25.0 109.674 175.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -77.87 -8.44 58.08 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.83 -0.433 . . . . 25.0 109.83 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.37 168.84 18.88 Favored 'General case' 0 C--O 1.252 1.227 0 CA-C-O 121.159 0.504 . . . . 25.0 110.73 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 51.58 -155.56 0.15 Allowed 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 115.175 1.546 . . . . 25.0 115.175 177.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.95 16.37 74.7 Favored Glycine 0 C--O 1.247 0.93 0 N-CA-C 114.936 0.734 . . . . 25.0 114.936 -178.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -101.55 97.66 8.07 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 124.388 0.699 . . . . 25.0 109.834 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.25 136.96 54.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 122.273 1.035 . . . . 25.0 111.768 -176.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -140.11 28.18 2.5 Favored Glycine 0 C--N 1.336 0.583 0 N-CA-C 109.251 -1.54 . . . . 25.0 109.251 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 60.4 t -74.85 -37.76 42.6 Favored 'Isoleucine or valine' 0 C--O 1.251 1.147 0 N-CA-C 108.451 -0.944 . . . . 25.0 108.451 -177.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.63 128.02 16.44 Favored 'Isoleucine or valine' 0 C--O 1.246 0.872 0 O-C-N 124.57 1.169 . . . . 25.0 111.009 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 166.16 167.29 26.58 Favored Glycine 0 N--CA 1.43 -1.731 0 CA-C-N 114.046 -1.434 . . . . 25.0 110.836 -177.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -149.91 139.64 21.74 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.196 -1.038 . . . . 25.0 108.196 -176.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 85.0 p -154.74 158.07 38.99 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.128 -1.064 . . . . 25.0 108.128 177.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 159.58 161.08 10.93 Favored Glycine 0 C--O 1.24 0.472 0 N-CA-C 116.097 1.199 . . . . 25.0 116.097 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 -105.16 107.37 58.77 Favored Pre-proline 0 C--O 1.251 1.162 0 CA-C-O 121.022 0.439 . . . . 25.0 109.871 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -71.04 163.17 40.16 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 116.636 -1.776 . . . . 25.0 111.892 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -129.85 154.82 46.89 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 106.82 -1.548 . . . . 25.0 106.82 -178.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -140.3 69.12 33.54 Favored Pre-proline 0 C--N 1.306 -1.297 0 O-C-N 121.694 -0.629 . . . . 25.0 109.579 -178.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.19 139.45 42.24 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 116.382 -1.946 . . . . 25.0 112.921 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 15.3 t -93.52 -14.95 26.01 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.217 -0.901 . . . . 25.0 111.501 -176.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 10.7 p . . . . . 0 C--O 1.258 1.55 0 N-CA-C 107.592 -1.262 . . . . 25.0 107.592 179.373 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 CA--C 1.511 -0.643 0 CA-C-O 121.494 0.539 . . . . 25.0 112.968 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -155.2 61.64 0.36 Allowed Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 107.764 -2.134 . . . . 25.0 107.764 177.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.4 p -54.76 126.49 11.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 124.158 0.983 . . . . 25.0 110.236 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -100.54 8.96 43.15 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.506 -0.77 . . . . 25.0 110.841 -178.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -90.25 -146.95 16.68 Favored Glycine 0 C--O 1.215 -1.088 0 CA-C-N 115.527 -0.76 . . . . 25.0 112.503 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.7 p 68.92 154.74 0.14 Allowed Pre-proline 0 CA--C 1.563 1.458 0 C-N-CA 126.084 1.753 . . . . 25.0 112.628 -175.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.62 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 50.1 Cg_exo -62.68 1.25 1.11 Allowed 'Trans proline' 0 N--CA 1.498 1.746 0 N-CA-C 117.254 1.982 . . . . 25.0 117.254 -177.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.8 p -63.98 -18.17 22.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 118.831 2.9 . . . . 25.0 118.831 -168.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.5 p -134.8 119.1 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 117.308 2.336 . . . . 25.0 117.308 -175.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.56 36.28 91.18 Favored Glycine 0 C--O 1.211 -1.283 0 CA-C-N 115.481 -0.781 . . . . 25.0 113.945 174.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.3 t -51.98 -38.55 57.03 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 119.219 -0.42 . . . . 25.0 111.678 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -80.73 5.61 15.26 Favored 'General case' 0 C--O 1.249 1.037 0 N-CA-C 115.266 1.58 . . . . 25.0 115.266 -173.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 pp -143.15 178.4 7.73 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-O 118.029 -0.986 . . . . 25.0 109.773 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -56.71 132.75 52.94 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 114.023 1.12 . . . . 25.0 114.023 -173.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -134.33 155.66 49.85 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 114.266 1.21 . . . . 50.0 114.266 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -122.93 113.35 18.99 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 104.128 -2.545 . . . . 25.0 104.128 164.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 88.7 mt -120.74 118.35 29.83 Favored 'General case' 0 C--O 1.207 -1.139 0 CA-C-O 121.394 0.616 . . . . 25.0 110.122 -177.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -110.06 106.99 16.69 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.593 -1.262 . . . . 25.0 107.593 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.51 -171.3 47.06 Favored Glycine 0 C--O 1.244 0.73 0 N-CA-C 118.753 2.261 . . . . 25.0 118.753 -172.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.1 p -82.49 175.72 9.98 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.761 -0.72 . . . . 25.0 111.315 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 69.2 mt -90.97 -2.86 57.65 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 123.546 0.529 . . . . 25.0 110.711 173.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -95.39 -174.27 37.17 Favored Glycine 0 C--O 1.244 0.74 0 N-CA-C 110.02 -1.232 . . . . 25.0 110.02 176.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.4 t -74.91 138.89 42.71 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.676 0.621 . . . . 25.0 112.676 -177.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -145.8 152.9 40.27 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 117.806 0.276 . . . . 50.0 111.538 -178.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -98.09 128.51 44.64 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 103.0 -2.963 . . . . 25.0 103.0 166.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 34.2 mm -124.59 108.65 20.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 107.513 -1.291 . . . . 25.0 107.513 -178.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.62 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 9.6 mp -108.85 118.0 35.65 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 104.408 -2.441 . . . . 25.0 104.408 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.43 -36.5 59.19 Favored Glycine 0 CA--C 1.497 -1.078 0 CA-C-O 119.517 -0.602 . . . . 25.0 113.353 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.87 -151.81 41.44 Favored Glycine 0 CA--C 1.497 -1.091 0 C-N-CA 119.834 -1.174 . . . . 25.0 112.303 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -78.35 169.21 54.31 Favored Glycine 0 C--O 1.247 0.948 0 N-CA-C 110.262 -1.135 . . . . 25.0 110.262 -177.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.3 164.95 23.14 Favored Glycine 0 N--CA 1.432 -1.608 0 C-N-CA 120.819 -0.705 . . . . 25.0 113.507 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.63 109.85 17.18 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.104 -1.073 . . . . 25.0 108.104 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -106.8 156.64 18.45 Favored 'General case' 0 C--N 1.316 -0.873 0 O-C-N 124.252 0.97 . . . . 50.0 112.403 -170.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -127.91 95.28 4.16 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 105.368 -2.086 . . . . 25.0 105.368 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.1 mt -102.21 138.0 39.72 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 113.739 -1.573 . . . . 25.0 112.034 -170.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -134.88 103.13 5.48 Favored 'General case' 0 C--O 1.267 1.986 0 CA-C-O 121.969 0.89 . . . . 25.0 111.502 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.74 -26.91 52.67 Favored Glycine 0 C--N 1.314 -0.68 0 CA-C-N 115.257 -0.883 . . . . 25.0 114.393 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 52.39 -145.75 0.54 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.384 1.074 . . . . 25.0 111.363 -176.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.56 169.19 13.12 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 121.503 -0.748 . . . . 25.0 112.724 -175.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.67 157.29 30.14 Favored Glycine 0 C--O 1.225 -0.417 0 CA-C-N 115.14 -0.936 . . . . 25.0 111.579 -173.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -79.36 112.49 16.64 Favored 'General case' 0 C--O 1.261 1.671 0 N-CA-C 105.812 -1.921 . . . . 25.0 105.812 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -113.68 149.16 35.1 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.023 -0.671 . . . . 50.0 109.598 -171.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mp -111.31 92.86 4.2 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.922 0.889 . . . . 25.0 109.34 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.1 mp -107.09 120.99 43.6 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.479 1.289 . . . . 25.0 114.479 -170.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -123.51 139.41 54.04 Favored 'General case' 0 C--O 1.246 0.876 0 N-CA-C 107.728 -1.212 . . . . 25.0 107.728 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -90.71 -36.59 6.78 Favored Glycine 0 C--O 1.257 1.539 0 CA-C-O 118.105 -1.386 . . . . 25.0 115.588 -173.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.91 -166.42 52.98 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 118.552 1.176 . . . . 25.0 112.388 -176.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.14 148.19 22.7 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.319 -0.94 . . . . 25.0 111.412 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.53 162.57 38.01 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-O 122.518 1.066 . . . . 25.0 114.534 -176.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -88.54 127.94 35.55 Favored 'General case' 0 CA--C 1.479 -1.776 0 N-CA-C 101.692 -3.447 . . . . 25.0 101.692 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -121.87 156.93 32.25 Favored 'General case' 0 C--O 1.255 1.357 0 C-N-CA 122.74 0.416 . . . . 50.0 111.211 -170.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -119.3 125.54 49.32 Favored 'General case' 0 C--O 1.212 -0.91 0 N-CA-C 101.821 -3.4 . . . . 25.0 101.821 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -145.41 132.77 20.64 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 115.689 1.737 . . . . 25.0 115.689 -174.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 63.9 m -102.0 140.45 36.27 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.526 -0.916 . . . . 25.0 108.526 175.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.92 -44.52 4.78 Favored Glycine 0 N--CA 1.467 0.721 0 N-CA-C 109.183 -1.567 . . . . 25.0 109.183 174.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.32 -175.09 54.89 Favored Glycine 0 N--CA 1.465 0.593 0 CA-C-N 116.988 0.394 . . . . 25.0 112.648 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -60.83 155.24 19.97 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 122.701 1.238 . . . . 25.0 110.371 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.37 159.62 32.12 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 115.18 -0.918 . . . . 25.0 111.717 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.58 107.55 13.48 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 122.206 1.003 . . . . 25.0 108.445 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -95.6 162.93 13.42 Favored 'General case' 0 C--O 1.27 2.132 0 CA-C-N 115.075 -0.966 . . . . 50.0 111.137 -172.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.8 m -128.35 132.02 48.59 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 122.536 1.16 . . . . 25.0 109.002 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -122.32 129.06 51.79 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 105.3 -2.111 . . . . 25.0 105.3 175.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 26.4 mmt85 -127.13 -15.42 5.27 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 121.277 0.561 . . . . 25.0 109.953 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 60.59 174.8 0.1 Allowed 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 115.216 -0.902 . . . . 25.0 112.426 -171.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -89.92 -51.87 5.26 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 115.108 1.522 . . . . 25.0 115.108 -172.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.1 mt -141.87 174.07 10.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.906 -1.043 . . . . 25.0 109.519 -173.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.12 -27.58 63.87 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 107.725 -1.213 . . . . 25.0 107.725 171.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -72.02 -9.2 58.06 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-O 122.758 1.266 . . . . 25.0 113.447 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -94.1 141.41 28.57 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.843 1.306 . . . . 25.0 111.732 -173.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.3 t 46.85 42.58 12.23 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 113.389 -1.732 . . . . 25.0 115.347 175.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -118.7 162.03 19.12 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.423 -1.262 . . . . 25.0 111.427 -178.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -104.68 146.49 28.87 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 105.403 -2.073 . . . . 25.0 105.403 175.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.7 p -138.71 167.44 19.46 Favored Pre-proline 0 C--O 1.211 -0.932 0 N-CA-C 108.165 -1.05 . . . . 25.0 108.165 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -61.03 -20.06 65.93 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 CA-C-O 122.377 0.907 . . . . 25.0 113.234 174.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 73.1 mt -79.26 -23.58 43.55 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 119.924 -1.735 . . . . 25.0 111.13 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 147.99 -175.73 27.16 Favored Glycine 0 C--O 1.212 -1.232 0 CA-C-N 115.384 -0.825 . . . . 25.0 111.916 177.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.0 t -89.15 137.99 31.82 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 123.375 1.559 . . . . 25.0 112.485 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -117.64 17.9 14.31 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-N 114.768 -1.105 . . . . 25.0 110.532 171.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.35 138.41 49.38 Favored Glycine 0 C--N 1.338 0.661 0 CA-C-N 115.184 -0.916 . . . . 25.0 111.519 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -85.22 173.53 10.33 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 117.353 0.576 . . . . 50.0 111.745 -176.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.74 103.89 7.77 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 123.217 0.607 . . . . 25.0 112.105 -179.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.8 mt -87.02 133.75 29.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 106.579 -1.638 . . . . 25.0 106.579 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.84 -38.9 22.38 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.608 0.966 . . . . 25.0 113.608 -172.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.6 p-10 -144.79 44.32 1.37 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.787 1.032 . . . . 25.0 113.787 -167.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -61.1 131.14 49.59 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.95 1.093 . . . . 25.0 113.95 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -96.39 106.32 28.45 Favored Pre-proline 0 N--CA 1.48 1.065 0 N-CA-C 106.749 -1.575 . . . . 25.0 106.749 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -77.56 -4.29 14.47 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 N-CA-C 114.17 0.796 . . . . 25.0 114.17 -171.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 45.6 t -93.28 -41.93 9.6 Favored 'General case' 0 C--N 1.315 -0.918 0 O-C-N 124.26 0.975 . . . . 25.0 111.091 177.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -98.19 -37.15 9.81 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.979 1.474 . . . . 25.0 114.979 -172.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -87.16 168.63 13.07 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.259 0.466 . . . . 50.0 112.259 -172.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -146.04 145.84 30.74 Favored 'General case' 0 C--O 1.263 1.785 0 O-C-N 121.805 -0.559 . . . . 25.0 112.288 -178.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 75.1 mt -130.74 129.1 63.79 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 N-CA-C 109.266 -0.642 . . . . 25.0 109.266 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -91.69 141.24 28.9 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 119.771 -1.83 . . . . 25.0 107.393 174.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.7 p -134.09 -5.9 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 121.463 0.649 . . . . 25.0 111.423 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.87 -36.27 78.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.851 -0.613 . . . . 25.0 111.929 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.46 -24.69 53.9 Favored 'General case' 0 C--O 1.248 0.989 0 N-CA-C 113.91 1.078 . . . . 25.0 113.91 -178.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.88 9.4 5.37 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 115.946 1.832 . . . . 25.0 115.946 -168.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -151.08 -75.05 0.01 OUTLIER Glycine 0 C--O 1.219 -0.81 0 C-N-CA 119.868 -1.158 . . . . 25.0 115.067 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -155.39 167.74 29.4 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 109.592 -0.521 . . . . 25.0 109.592 -171.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.2 t -120.22 -39.81 2.76 Favored 'General case' 0 C--O 1.248 0.997 0 N-CA-C 108.963 -0.755 . . . . 25.0 108.963 176.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -92.04 123.15 7.11 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 109.31 -1.516 . . . . 25.0 109.31 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.16 148.81 46.99 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.254 0.55 . . . . 25.0 111.222 -177.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -83.16 -176.48 51.51 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 115.945 -0.571 . . . . 25.0 112.008 -177.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -61.94 100.2 0.15 Allowed 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 115.05 1.5 . . . . 25.0 115.05 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -141.03 -157.4 7.16 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-O 117.222 -1.876 . . . . 25.0 108.659 176.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -152.99 162.97 40.68 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 121.114 2.457 . . . . 25.0 112.566 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 51.16 44.33 28.76 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.214 1.006 . . . . 25.0 113.118 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.24 31.82 63.36 Favored Glycine 0 C--O 1.257 1.579 0 N-CA-C 111.031 -0.828 . . . . 25.0 111.031 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.6 t -139.76 174.23 10.72 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 117.719 0.759 . . . . 25.0 110.364 -177.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.7 mt -95.18 172.64 7.99 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 101.424 -3.547 . . . . 25.0 101.424 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.33 119.8 22.88 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.652 -1.24 . . . . 25.0 107.652 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.4 m -80.06 157.6 4.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.148 -0.686 . . . . 25.0 109.148 -176.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.46 160.25 40.92 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.754 -0.832 . . . . 25.0 108.754 -176.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.3 m -123.31 163.9 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 116.33 -0.395 . . . . 25.0 110.268 177.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 35.1 t -70.84 -52.44 20.33 Favored 'General case' 0 C--O 1.204 -1.325 0 N-CA-C 107.52 -1.289 . . . . 25.0 107.52 174.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -159.61 -143.79 0.1 Allowed 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 104.997 -2.223 . . . . 25.0 104.997 -178.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -69.92 -21.14 63.32 Favored 'General case' 0 C--O 1.253 1.285 0 N-CA-C 109.564 -0.532 . . . . 25.0 109.564 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -141.54 -145.44 4.55 Favored Glycine 0 C--O 1.24 0.509 0 N-CA-C 110.532 -1.027 . . . . 25.0 110.532 178.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.55 -145.13 0.33 Allowed 'General case' 0 C--O 1.245 0.843 0 C-N-CA 124.082 0.953 . . . . 25.0 109.784 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.6 mtt85 -82.09 159.06 23.5 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 113.127 0.788 . . . . 25.0 113.127 -176.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -111.3 166.28 11.23 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 104.822 -2.288 . . . . 25.0 104.822 177.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -135.65 151.4 50.18 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.997 -0.547 . . . . 25.0 111.378 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 34.4 tp -124.61 104.34 8.64 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 103.595 -2.743 . . . . 25.0 103.595 168.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -104.46 153.03 21.63 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.634 -0.712 . . . . 25.0 110.793 -172.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 43.5 t -99.5 150.87 21.77 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.397 -2.075 . . . . 25.0 105.397 170.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -119.81 25.02 10.24 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 106.534 -1.654 . . . . 25.0 106.534 -178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -116.1 134.84 54.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.367 -1.288 . . . . 25.0 109.461 174.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -134.12 150.02 51.11 Favored 'General case' 0 C--O 1.216 -0.673 0 O-C-N 125.176 1.547 . . . . 25.0 110.549 -175.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -74.52 165.13 25.72 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 124.11 0.964 . . . . 25.0 109.127 174.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.97 -15.33 62.9 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.683 0.754 . . . . 25.0 111.463 178.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -79.03 -11.34 60.0 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.614 -0.721 . . . . 25.0 112.348 174.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.58 26.26 39.54 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 120.505 -0.855 . . . . 25.0 112.162 -176.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 69.5 mt -101.07 141.97 33.19 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.386 -1.338 . . . . 25.0 107.386 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 80.1 p -149.24 -175.44 4.98 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.338 -1.356 . . . . 25.0 107.338 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -123.2 139.21 54.29 Favored 'General case' 0 C--O 1.247 0.926 0 N-CA-C 113.223 0.823 . . . . 25.0 113.223 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -152.07 153.99 35.04 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.789 -1.189 . . . . 25.0 107.789 166.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 10.5 p -148.51 143.8 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 N-CA-C 104.603 -2.369 . . . . 25.0 104.603 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -105.86 148.93 27.01 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 107.186 -1.413 . . . . 25.0 107.186 -175.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.5 mp -137.98 131.03 30.17 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 104.301 -2.481 . . . . 25.0 104.301 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -104.37 4.91 33.98 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 121.198 1.817 . . . . 25.0 114.758 -174.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -77.16 1.58 63.83 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 120.283 -0.961 . . . . 25.0 114.817 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 47.7 t0 52.84 61.68 3.07 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-O 122.08 0.943 . . . . 25.0 110.728 175.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -130.98 41.92 3.3 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.707 -1.133 . . . . 25.0 111.762 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.95 -25.18 66.63 Favored 'General case' 0 C--O 1.209 -1.051 0 C-N-CA 119.345 -0.942 . . . . 25.0 110.809 176.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.12 -32.15 70.03 Favored 'General case' 0 C--O 1.275 2.418 0 C-N-CA 124.094 0.957 . . . . 25.0 112.282 177.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -93.62 -27.31 16.66 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.734 1.013 . . . . 25.0 113.734 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 11.4 mt -62.84 139.79 58.74 Favored 'General case' 0 C--O 1.247 0.923 0 CA-C-O 121.947 0.88 . . . . 25.0 109.492 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 72.5 m -141.77 159.78 41.52 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 102.012 -3.329 . . . . 25.0 102.012 169.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -86.24 10.36 14.93 Favored 'General case' 0 C--O 1.214 -0.813 0 N-CA-C 108.107 -1.072 . . . . 25.0 108.107 -176.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -72.11 -26.23 62.05 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.692 0.758 . . . . 25.0 110.386 178.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 24.3 p30 -86.06 -1.25 57.2 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 109.694 -0.484 . . . . 25.0 109.694 176.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 37.3 mm -98.39 128.88 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 102.415 -3.18 . . . . 25.0 102.415 173.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.3 p -105.82 113.77 43.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 122.936 1.35 . . . . 25.0 111.665 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -142.42 9.12 1.82 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 112.524 -2.125 . . . . 25.0 107.379 178.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.9 51.75 1.57 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.421 1.088 . . . . 25.0 111.301 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 56.43 33.7 22.92 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.384 1.073 . . . . 25.0 113.665 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 18.2 m 65.29 -43.99 0.35 Allowed 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 117.468 2.396 . . . . 25.0 117.468 176.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -76.65 154.11 34.59 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 114.27 1.211 . . . . 25.0 114.27 -173.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -80.77 20.14 0.78 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.26 -0.882 . . . . 25.0 111.752 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.85 -25.52 56.29 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.986 -0.552 . . . . 25.0 111.833 -177.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -112.0 -161.32 0.75 Allowed 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 108.839 -0.8 . . . . 25.0 108.839 -174.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 67.49 -174.2 0.19 Allowed 'General case' 0 C--O 1.25 1.13 0 N-CA-C 115.796 1.776 . . . . 25.0 115.796 175.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 81.46 17.44 71.15 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 114.195 0.438 . . . . 25.0 114.195 175.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -98.94 109.86 22.55 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 122.466 -0.432 . . . . 25.0 110.888 -174.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -127.35 157.71 39.22 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 107.425 -1.324 . . . . 25.0 107.425 178.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -140.78 30.45 2.28 Favored Glycine 0 C--O 1.209 -1.451 0 N-CA-C 110.761 -0.935 . . . . 25.0 110.761 178.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.11 -28.38 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 CA-C-O 122.157 0.98 . . . . 25.0 110.939 -175.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.12 136.38 26.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 CA-C-O 122.167 0.984 . . . . 25.0 109.823 -177.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 161.89 157.52 8.95 Favored Glycine 0 N--CA 1.466 0.654 0 CA-C-N 114.605 -1.18 . . . . 25.0 111.951 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -149.67 141.97 24.18 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 108.584 -0.895 . . . . 25.0 108.584 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 88.6 p -159.46 171.54 19.53 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.865 0.866 . . . . 25.0 110.097 177.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 171.17 174.9 39.28 Favored Glycine 0 C--O 1.25 1.102 0 CA-C-N 118.814 0.734 . . . . 25.0 111.773 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -136.75 101.9 9.54 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 108.702 -0.851 . . . . 25.0 108.702 177.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.35 152.64 49.89 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 N-CA-C 115.471 1.296 . . . . 25.0 115.471 -174.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -121.84 151.38 40.71 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 107.805 -1.183 . . . . 25.0 107.805 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -141.51 76.84 20.27 Favored Pre-proline 0 C--O 1.24 0.599 0 CA-C-N 118.366 0.53 . . . . 25.0 110.49 176.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.11 155.48 61.29 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 118.35 -0.634 . . . . 25.0 113.404 -176.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.9 t -122.68 -3.46 8.76 Favored 'General case' 0 C--O 1.245 0.827 0 O-C-N 121.49 -0.756 . . . . 25.0 111.977 -177.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--O 1.271 2.214 0 N-CA-C 107.943 -1.132 . . . . 25.0 107.943 176.918 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo . . . . . 0 C--O 1.245 0.842 0 CA-C-O 120.713 0.214 . . . . 25.0 112.3 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.83 57.43 0.03 OUTLIER Glycine 0 C--O 1.244 0.727 0 N-CA-C 109.836 -1.306 . . . . 25.0 109.836 -177.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.7 p -63.87 131.82 29.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 122.08 0.943 . . . . 25.0 111.568 -172.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -96.61 -6.42 36.79 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 115.3 -0.864 . . . . 25.0 110.978 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.58 -152.57 13.47 Favored Glycine 0 C--O 1.244 0.762 0 CA-C-N 115.758 -0.655 . . . . 25.0 112.704 177.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 p 73.38 159.69 0.16 Allowed Pre-proline 0 CA--C 1.563 1.459 0 C-N-CA 126.343 1.857 . . . . 25.0 109.474 -177.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.441 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 30.3 Cg_exo -68.52 6.89 0.8 Allowed 'Trans proline' 0 CA--C 1.553 1.427 0 N-CA-C 116.069 1.526 . . . . 25.0 116.069 -174.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.8 p -69.01 -16.74 21.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 115.926 1.824 . . . . 25.0 115.926 -169.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.85 139.04 22.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 O-C-N 121.218 -0.927 . . . . 25.0 113.199 -174.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.87 9.09 70.02 Favored Glycine 0 N--CA 1.469 0.852 0 N-CA-C 117.586 1.794 . . . . 25.0 117.586 171.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.5 t -50.72 -43.02 57.85 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 114.272 1.212 . . . . 25.0 114.272 -169.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -77.47 7.4 5.49 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 114.167 1.173 . . . . 25.0 114.167 -176.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.33 175.28 10.21 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 120.27 -1.519 . . . . 25.0 111.221 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -56.65 125.33 21.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 123.702 0.626 . . . . 25.0 111.308 -175.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -121.94 162.83 20.36 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.981 0.734 . . . . 50.0 112.981 -173.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -130.73 114.96 16.02 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 102.518 -3.142 . . . . 25.0 102.518 163.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.0 mt -128.05 128.87 45.74 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 122.077 0.942 . . . . 25.0 109.66 -177.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 66.9 m80 -117.45 121.3 40.65 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.218 -0.901 . . . . 25.0 110.35 177.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.15 175.26 46.24 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 122.644 1.136 . . . . 25.0 115.094 -174.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.2 p -82.24 172.42 13.16 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.109 -1.046 . . . . 25.0 109.81 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.6 mt -86.79 12.09 11.7 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.176 0.512 . . . . 25.0 111.938 177.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -111.69 -172.91 19.37 Favored Glycine 0 N--CA 1.471 0.975 0 CA-C-N 114.826 -1.079 . . . . 25.0 111.581 177.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.2 t -77.16 134.02 38.79 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.013 0.745 . . . . 25.0 113.013 -178.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -148.02 163.99 35.18 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.457 -0.777 . . . . 50.0 110.853 -173.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -112.32 125.3 54.03 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 101.078 -3.675 . . . . 25.0 101.078 169.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 40.6 mm -119.13 99.95 8.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 104.92 -2.252 . . . . 25.0 104.92 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.441 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 9.4 mp -107.9 120.23 41.7 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 103.646 -2.724 . . . . 25.0 103.646 -176.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.22 -27.54 36.46 Favored Glycine 0 CA--C 1.488 -1.628 0 N-CA-C 115.264 0.866 . . . . 25.0 115.264 -171.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.74 -149.86 50.2 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 109.982 -1.247 . . . . 25.0 109.982 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.4 172.41 47.91 Favored Glycine 0 C--O 1.247 0.952 0 CA-C-N 114.901 -0.65 . . . . 25.0 114.473 -175.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.42 172.57 24.53 Favored Glycine 0 N--CA 1.439 -1.101 0 CA-C-O 119.132 -0.815 . . . . 25.0 114.281 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.8 112.78 24.72 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 104.722 -2.325 . . . . 25.0 104.722 177.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -108.96 156.35 19.81 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.052 -0.522 . . . . 50.0 110.578 -169.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -119.55 90.89 3.42 Favored 'General case' 0 C--O 1.248 1.019 0 N-CA-C 107.099 -1.445 . . . . 25.0 107.099 175.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 31.9 mt -100.81 128.63 46.77 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 113.862 -1.517 . . . . 25.0 110.869 -171.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -125.43 105.2 8.89 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.137 0.494 . . . . 25.0 112.008 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.73 -26.09 47.36 Favored Glycine 0 C--O 1.246 0.853 0 CA-C-O 116.797 -2.113 . . . . 25.0 115.929 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 52.77 -150.38 0.35 Allowed 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 119.551 1.676 . . . . 25.0 111.952 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.38 165.76 9.24 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.588 0.958 . . . . 25.0 113.588 -178.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.11 157.55 33.58 Favored Glycine 0 N--CA 1.438 -1.193 0 N-CA-C 110.097 -1.201 . . . . 25.0 110.097 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -80.87 115.29 20.28 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.52 -1.659 . . . . 25.0 106.52 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -123.56 147.55 47.18 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 119.887 -0.725 . . . . 50.0 111.166 -169.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 mp -108.65 104.57 13.9 Favored 'General case' 0 C--O 1.204 -1.308 0 N-CA-C 108.121 -1.066 . . . . 25.0 108.121 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 mp -109.21 109.83 20.88 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.784 0.802 . . . . 25.0 112.848 -174.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -118.78 96.44 5.26 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-N 113.977 -1.465 . . . . 25.0 108.101 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -59.74 -22.26 56.74 Favored Glycine 0 C--O 1.216 -0.989 0 N-CA-C 118.474 2.15 . . . . 25.0 118.474 -177.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.84 -159.07 53.79 Favored Glycine 0 C--O 1.245 0.839 0 CA-C-N 118.427 1.113 . . . . 25.0 112.444 -178.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.14 159.36 14.82 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-O 122.046 0.927 . . . . 25.0 112.524 -176.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.67 -178.32 53.3 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 114.826 -1.079 . . . . 25.0 114.229 -177.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -96.91 145.39 25.93 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 101.779 -3.415 . . . . 25.0 101.779 172.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -135.36 155.14 51.08 Favored 'General case' 0 CA--C 1.5 -0.943 0 C-N-CA 120.745 -0.382 . . . . 50.0 111.682 -170.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -109.17 122.36 47.14 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 104.994 -2.224 . . . . 25.0 104.994 174.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -142.05 136.19 29.94 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 122.466 1.126 . . . . 25.0 113.244 -176.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.7 m -113.63 133.89 55.04 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 115.169 -0.923 . . . . 25.0 110.181 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.04 -44.0 4.25 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.2 -1.16 . . . . 25.0 110.2 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.86 -161.24 52.19 Favored Glycine 0 C--O 1.252 1.234 0 C-N-CA 123.13 0.395 . . . . 25.0 113.019 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -67.25 161.82 24.03 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 122.176 -0.602 . . . . 25.0 112.296 174.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.44 167.24 41.7 Favored Glycine 0 CA--C 1.533 1.215 0 N-CA-C 111.129 -0.788 . . . . 25.0 111.129 -177.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.9 107.09 18.53 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.755 0.788 . . . . 25.0 109.711 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -102.38 153.2 20.24 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.853 -0.612 . . . . 50.0 110.479 -172.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.9 m -128.54 123.41 33.4 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-N 115.172 -0.922 . . . . 25.0 110.302 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -115.34 117.9 31.74 Favored 'General case' 0 C--O 1.21 -1.003 0 N-CA-C 108.432 -0.951 . . . . 25.0 108.432 -177.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 51.2 mtt85 -114.94 -33.41 5.44 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 113.007 0.743 . . . . 25.0 113.007 177.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 71.78 151.46 0.11 Allowed 'General case' 0 CA--C 1.551 1.017 0 O-C-N 125.195 1.559 . . . . 25.0 109.723 -173.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.74 -51.03 45.78 Favored 'General case' 0 C--O 1.24 0.576 0 O-C-N 121.015 -1.053 . . . . 25.0 113.562 -167.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.7 mt -131.8 166.6 21.21 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 121.918 0.866 . . . . 25.0 109.224 -174.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.89 -21.06 56.72 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.695 0.798 . . . . 25.0 109.341 175.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -73.8 3.27 6.8 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 115.049 1.5 . . . . 25.0 115.049 176.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -114.53 149.88 35.77 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.998 0.904 . . . . 25.0 112.202 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.2 t 55.03 46.1 24.94 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 122.903 1.335 . . . . 25.0 113.697 169.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 47.6 p-80 -134.97 -178.98 5.34 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.198 -0.91 . . . . 25.0 109.225 -175.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -122.63 145.41 48.38 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 103.823 -2.658 . . . . 25.0 103.823 175.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.8 p -133.98 167.56 22.28 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 107.129 -1.434 . . . . 25.0 107.129 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.32 -22.79 67.06 Favored 'Trans proline' 0 C--N 1.367 1.538 0 C-N-CA 116.393 -1.938 . . . . 25.0 113.693 177.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.9 -27.05 67.91 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 122.051 0.929 . . . . 25.0 111.173 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 139.5 179.05 17.2 Favored Glycine 0 C--O 1.246 0.852 0 N-CA-C 109.687 -1.365 . . . . 25.0 109.687 -171.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.6 t -81.87 150.07 27.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 123.461 1.6 . . . . 25.0 113.258 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -131.42 29.93 4.51 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 113.521 -1.672 . . . . 25.0 107.503 170.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.93 140.3 32.68 Favored Glycine 0 CA--C 1.501 -0.808 0 N-CA-C 109.144 -1.582 . . . . 25.0 109.144 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -82.03 167.91 18.36 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 118.72 -0.657 . . . . 50.0 109.517 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -124.41 114.08 19.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 118.438 0.563 . . . . 25.0 109.897 -176.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mt -100.16 127.13 53.43 Favored 'Isoleucine or valine' 0 C--O 1.25 1.122 0 N-CA-C 108.207 -1.035 . . . . 25.0 108.207 -178.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.3 mt -81.05 -44.24 18.32 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 115.292 1.59 . . . . 25.0 115.292 -173.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 57.0 p30 -133.54 44.78 2.75 Favored 'General case' 0 C--O 1.252 1.188 0 N-CA-C 113.585 0.957 . . . . 25.0 113.585 -172.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -59.24 145.23 43.64 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.351 0.66 . . . . 25.0 111.962 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -121.6 103.17 41.21 Favored Pre-proline 0 N--CA 1.473 0.695 0 CA-C-N 115.763 -0.653 . . . . 25.0 109.784 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -65.08 -12.4 34.49 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 N-CA-C 117.985 2.264 . . . . 25.0 117.985 -174.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.3 t -91.69 -32.32 15.48 Favored 'General case' 0 C--O 1.209 -1.069 0 N-CA-C 109.521 -0.548 . . . . 25.0 109.521 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -89.73 -48.23 7.4 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 113.954 1.094 . . . . 25.0 113.954 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -93.08 172.26 8.42 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.281 -1.327 . . . . 50.0 113.373 -161.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -146.64 149.95 34.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 119.343 -0.361 . . . . 25.0 110.843 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 86.2 mt -129.34 126.64 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 123.265 0.626 . . . . 25.0 109.732 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -86.44 139.63 30.73 Favored 'General case' 0 CA--C 1.502 -0.903 0 O-C-N 121.579 -0.701 . . . . 25.0 109.624 178.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.0 p -141.5 -8.3 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.173 0 CA-C-O 120.844 0.354 . . . . 25.0 110.85 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.6 t -67.42 -40.14 85.53 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 122.54 1.162 . . . . 25.0 109.495 -175.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.28 -23.61 63.85 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.407 -0.815 . . . . 25.0 111.942 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.5 mt -96.62 -65.95 0.93 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.745 1.017 . . . . 25.0 113.745 -172.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -116.24 -49.12 0.46 Allowed Glycine 0 CA--C 1.502 -0.773 0 N-CA-C 118.532 2.173 . . . . 25.0 118.532 -167.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -155.27 165.85 35.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 118.396 1.098 . . . . 25.0 111.93 -173.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.69 -24.76 3.22 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.194 0.521 . . . . 25.0 111.201 178.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -95.02 126.75 8.86 Favored Glycine 0 C--O 1.245 0.792 0 N-CA-C 110.594 -1.002 . . . . 25.0 110.594 173.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.11 140.74 57.81 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.981 0.896 . . . . 25.0 111.096 -176.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.29 -158.38 34.61 Favored Glycine 0 C--N 1.335 0.479 0 N-CA-C 110.833 -0.907 . . . . 25.0 110.833 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -67.75 140.46 56.71 Favored 'General case' 0 C--O 1.254 1.307 0 CA-C-O 122.175 0.988 . . . . 25.0 113.057 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 165.58 -172.95 41.23 Favored Glycine 0 C--O 1.253 1.292 0 N-CA-C 108.955 -1.658 . . . . 25.0 108.955 175.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -149.17 168.84 22.15 Favored 'General case' 0 C--O 1.245 0.857 0 C-N-CA 122.496 0.318 . . . . 25.0 110.294 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 56.58 36.49 27.69 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.26 1.207 . . . . 25.0 114.26 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 69.92 28.34 71.97 Favored Glycine 0 CA--C 1.538 1.513 0 N-CA-C 111.393 -0.683 . . . . 25.0 111.393 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 8.6 t -138.14 -178.32 5.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 117.383 0.591 . . . . 25.0 110.343 -175.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 87.2 mt -113.85 167.51 10.57 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 103.432 -2.803 . . . . 25.0 103.432 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.66 119.7 17.26 Favored 'General case' 0 C--O 1.257 1.465 0 C-N-CA 118.091 -1.444 . . . . 25.0 112.474 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.7 m -98.31 161.74 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 124.107 0.963 . . . . 25.0 109.151 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 54.0 p -148.73 171.11 16.75 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 118.901 -0.571 . . . . 25.0 111.621 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.5 m -120.95 162.6 19.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.473 0 N-CA-C 108.289 -1.004 . . . . 25.0 108.289 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.6 t -74.45 -53.72 9.0 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 106.121 -1.807 . . . . 25.0 106.121 170.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -159.83 -160.9 0.85 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 104.26 -2.496 . . . . 25.0 104.26 -177.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -65.56 -16.3 63.56 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 122.121 0.962 . . . . 25.0 111.877 176.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -133.52 -156.6 8.07 Favored Glycine 0 N--CA 1.469 0.851 0 N-CA-C 107.428 -2.269 . . . . 25.0 107.428 175.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.67 -142.25 0.32 Allowed 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.056 0.542 . . . . 25.0 109.7 178.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -96.21 170.21 9.42 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.296 1.221 . . . . 25.0 114.296 -168.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.36 160.72 28.68 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 105.952 -1.87 . . . . 25.0 105.952 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -134.89 153.78 51.92 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 117.536 0.153 . . . . 25.0 110.663 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 31.9 tp -127.65 120.85 28.97 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 104.848 -2.279 . . . . 25.0 104.848 172.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -121.95 153.43 38.51 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 118.405 0.548 . . . . 25.0 111.914 -172.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.6 t -102.55 147.25 27.0 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 103.654 -2.721 . . . . 25.0 103.654 171.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -115.5 19.04 15.67 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.931 -0.766 . . . . 25.0 108.931 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -110.89 143.37 41.61 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 105.521 -2.029 . . . . 25.0 105.521 171.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -141.12 157.69 44.94 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.879 0.737 . . . . 25.0 111.097 -176.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -80.16 164.6 23.18 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.332 -0.988 . . . . 25.0 108.332 175.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.72 -30.18 71.19 Favored 'General case' 0 C--O 1.221 -0.44 0 O-C-N 121.515 -0.74 . . . . 25.0 110.78 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -70.58 -5.06 26.4 Favored 'General case' 0 CA--C 1.554 1.096 0 C-N-CA 123.401 0.68 . . . . 25.0 112.342 177.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.59 7.53 84.31 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 115.66 -0.7 . . . . 25.0 111.915 -178.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 88.8 mt -73.16 136.83 44.82 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 106.595 -1.632 . . . . 25.0 106.595 174.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 94.4 p -148.92 -177.43 5.8 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 107.654 -1.239 . . . . 25.0 107.654 -175.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -128.38 132.54 48.53 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 119.426 1.012 . . . . 25.0 113.381 -175.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -152.51 156.71 39.93 Favored 'General case' 0 C--O 1.256 1.421 0 N-CA-C 107.205 -1.405 . . . . 25.0 107.205 168.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.9 p -146.66 147.38 17.94 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.804 0 N-CA-C 105.919 -1.882 . . . . 25.0 105.919 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -112.31 143.01 44.12 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.747 -0.66 . . . . 25.0 109.967 -170.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.8 mp -132.17 154.28 49.7 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.932 -1.136 . . . . 25.0 107.932 -177.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.51 0.97 10.06 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 116.992 2.219 . . . . 25.0 116.992 -177.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.3 -3.65 88.58 Favored Glycine 0 C--O 1.224 -0.493 0 C-N-CA 120.04 -1.076 . . . . 25.0 112.997 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 50.5 t0 48.74 61.41 3.1 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 122.323 1.058 . . . . 25.0 111.488 -177.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -123.3 41.48 3.46 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.282 -1.326 . . . . 25.0 107.624 175.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.53 -25.95 68.48 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 115.192 -0.913 . . . . 25.0 112.949 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.56 -23.82 64.54 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.424 0.63 . . . . 25.0 111.01 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -101.8 -0.04 34.92 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.769 -0.65 . . . . 25.0 112.031 -175.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 11.4 mt -78.0 134.39 37.83 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.111 -0.635 . . . . 25.0 109.328 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.2 m -135.54 162.27 33.14 Favored 'General case' 0 CA--C 1.492 -1.252 0 CA-C-N 114.605 -1.18 . . . . 25.0 109.036 173.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.44 -1.6 57.22 Favored 'General case' 0 C--O 1.204 -1.296 0 CA-C-O 122.624 1.202 . . . . 25.0 109.473 -177.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.36 -31.69 72.99 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.178 -1.374 . . . . 25.0 109.383 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -89.21 -7.05 56.34 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.877 1.323 . . . . 25.0 112.849 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 47.0 mm -95.93 108.13 20.68 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.012 0 N-CA-C 104.944 -2.243 . . . . 25.0 104.944 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 14.5 p -94.83 121.48 45.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 122.545 1.164 . . . . 25.0 111.695 -169.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -152.98 -3.57 0.22 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 112.968 -1.924 . . . . 25.0 112.298 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -74.55 51.36 0.46 Allowed 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.73 1.011 . . . . 25.0 113.73 -177.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 54.32 22.65 3.85 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.207 0.817 . . . . 25.0 113.207 -175.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.07 3.1 0.9 Allowed 'General case' 0 C--O 1.246 0.916 0 N-CA-C 115.247 1.573 . . . . 25.0 115.247 175.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -82.09 137.39 35.03 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.394 -0.522 . . . . 25.0 110.572 178.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -76.88 -12.37 59.95 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 109.198 -0.667 . . . . 25.0 109.198 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -82.72 42.64 0.79 Allowed 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 112.292 0.479 . . . . 25.0 112.292 176.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -154.25 175.16 13.84 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.065 0.946 . . . . 25.0 109.012 -178.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 62.3 -156.98 0.34 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.831 1.252 . . . . 25.0 111.638 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 58.33 28.72 62.21 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 121.926 -0.178 . . . . 25.0 113.269 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -106.63 98.64 8.28 Favored 'General case' 0 C--O 1.249 1.056 0 C-N-CA 123.083 0.553 . . . . 25.0 109.582 -176.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.87 145.11 47.97 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 121.636 0.731 . . . . 25.0 112.712 -178.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -121.94 29.7 5.5 Favored Glycine 0 C--O 1.222 -0.595 0 CA-C-N 115.154 -0.93 . . . . 25.0 112.342 174.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 58.1 t -70.64 -38.93 75.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 O-C-N 121.757 -0.849 . . . . 25.0 112.425 -174.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.9 133.05 30.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.832 0.825 . . . . 25.0 110.581 -175.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 170.07 153.43 8.64 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-N 114.607 -1.178 . . . . 25.0 110.892 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -150.88 143.66 24.51 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 117.854 0.827 . . . . 25.0 109.878 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.6 p -150.77 169.23 22.15 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 106.193 -1.78 . . . . 25.0 106.193 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -175.39 163.99 34.17 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 115.625 1.01 . . . . 25.0 115.625 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -137.38 83.56 25.87 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 107.815 -1.18 . . . . 25.0 107.815 175.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.17 161.23 46.76 Favored 'Trans proline' 0 C--N 1.349 0.589 0 O-C-N 121.99 0.469 . . . . 25.0 112.67 -176.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -130.67 159.79 36.2 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.937 -0.764 . . . . 25.0 108.937 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -135.73 84.48 32.77 Favored Pre-proline 0 C--O 1.246 0.87 0 C-N-CA 122.74 0.416 . . . . 25.0 112.034 -177.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.23 161.14 43.71 Favored 'Trans proline' 0 C--O 1.246 0.897 0 C-N-CA 116.995 -1.537 . . . . 25.0 113.323 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.5 t -127.78 17.27 6.85 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 122.061 0.934 . . . . 25.0 110.44 176.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 C--O 1.258 1.537 0 CA-C-O 117.349 -1.31 . . . . 25.0 109.566 178.639 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 C--O 1.24 0.587 0 CA-C-O 121.85 0.688 . . . . 25.0 111.929 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.33 56.84 0.26 Allowed Glycine 0 C--O 1.244 0.76 0 CA-C-O 119.043 -0.865 . . . . 25.0 112.803 -176.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 p -70.4 125.29 28.33 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.965 0 CA-C-O 122.08 0.943 . . . . 25.0 111.525 -176.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -100.27 4.22 44.03 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.156 -0.929 . . . . 25.0 110.732 -176.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -97.96 -145.2 18.47 Favored Glycine 0 C--O 1.24 0.513 0 N-CA-C 111.211 -0.756 . . . . 25.0 111.211 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.4 p 73.86 156.67 0.16 Allowed Pre-proline 0 N--CA 1.483 1.177 0 C-N-CA 126.508 1.923 . . . . 25.0 109.024 -176.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.521 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 32.8 Cg_exo -63.63 1.0 1.56 Allowed 'Trans proline' 0 N--CA 1.478 0.603 0 N-CA-C 116.25 1.596 . . . . 25.0 116.25 -176.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.5 p -63.8 -25.09 37.38 Favored 'Isoleucine or valine' 0 C--O 1.258 1.538 0 N-CA-C 114.786 1.402 . . . . 25.0 114.786 -171.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.8 p -130.7 135.84 59.47 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 CA-C-O 122.857 1.313 . . . . 25.0 114.477 -172.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.47 14.54 79.42 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 114.582 -1.19 . . . . 25.0 115.405 171.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.5 t -45.82 -48.67 15.67 Favored 'General case' 0 C--O 1.209 -1.043 0 N-CA-C 114.349 1.241 . . . . 25.0 114.349 -171.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -78.14 0.39 25.05 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 115.694 1.739 . . . . 25.0 115.694 -175.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.77 169.73 17.18 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.118 -0.989 . . . . 25.0 111.637 -175.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -60.07 125.87 25.32 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 124.431 1.082 . . . . 25.0 110.991 -171.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -120.46 165.7 14.59 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.725 1.38 . . . . 50.0 114.725 -176.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -128.47 101.13 6.05 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 101.967 -3.346 . . . . 25.0 101.967 163.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.3 mt -109.62 120.31 42.11 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 119.239 -0.41 . . . . 25.0 111.899 -177.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -112.9 113.45 25.52 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 123.537 0.523 . . . . 25.0 110.71 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.63 -177.72 49.42 Favored Glycine 0 N--CA 1.469 0.871 0 N-CA-C 116.534 1.374 . . . . 25.0 116.534 -172.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.9 p -76.66 172.82 12.42 Favored 'General case' 0 C--O 1.252 1.236 0 C-N-CA 123.326 0.65 . . . . 25.0 110.541 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 44.6 mt -86.15 9.89 16.11 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.314 0.578 . . . . 25.0 109.918 174.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.37 -179.4 26.01 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.926 -0.579 . . . . 25.0 111.679 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.6 t -72.09 130.4 40.82 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 122.672 0.389 . . . . 25.0 110.879 175.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -142.37 157.32 44.92 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.491 -0.559 . . . . 50.0 109.491 -177.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -94.85 123.52 38.36 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 102.942 -2.985 . . . . 25.0 102.942 160.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.1 mm -114.0 100.96 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 108.374 -0.973 . . . . 25.0 108.374 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.521 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 10.4 mp -104.93 127.47 52.78 Favored 'General case' 0 C--O 1.212 -0.88 0 N-CA-C 103.766 -2.679 . . . . 25.0 103.766 -177.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.43 -32.1 14.55 Favored Glycine 0 CA--C 1.493 -1.309 0 C-N-CA 120.167 -1.016 . . . . 25.0 113.262 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.23 -143.34 39.12 Favored Glycine 0 C--O 1.242 0.608 0 N-CA-C 110.648 -0.981 . . . . 25.0 110.648 178.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.7 164.96 53.98 Favored Glycine 0 C--O 1.248 0.988 0 N-CA-C 114.443 0.537 . . . . 25.0 114.443 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.44 164.94 33.8 Favored Glycine 0 C--O 1.248 1.025 0 N-CA-C 114.743 0.657 . . . . 25.0 114.743 175.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.19 99.5 7.83 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.34 -1.356 . . . . 25.0 107.34 173.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -94.1 152.14 18.98 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 113.665 0.987 . . . . 50.0 113.665 -175.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -117.35 96.69 5.53 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.616 -1.253 . . . . 25.0 107.616 174.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 32.7 mt -104.53 137.56 42.2 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.573 -0.739 . . . . 25.0 110.329 -168.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -128.43 97.7 4.81 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.722 -0.611 . . . . 25.0 109.509 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.57 -33.47 60.85 Favored Glycine 0 C--N 1.318 -0.425 0 N-CA-C 116.352 1.301 . . . . 25.0 116.352 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 53.3 -149.6 0.4 Allowed 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.602 1.161 . . . . 25.0 113.948 -178.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.96 161.48 30.87 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-O 121.451 0.643 . . . . 25.0 110.368 -173.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.6 158.74 31.64 Favored Glycine 0 C--O 1.246 0.879 0 N-CA-C 109.549 -1.42 . . . . 25.0 109.549 -176.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -84.67 101.49 12.22 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.222 -1.029 . . . . 25.0 108.222 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -103.38 148.0 26.41 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 113.731 1.011 . . . . 50.0 113.731 -172.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mp -108.27 107.93 18.73 Favored 'General case' 0 C--O 1.217 -0.631 0 N-CA-C 107.052 -1.462 . . . . 25.0 107.052 177.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 mp -109.21 113.43 26.26 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 122.62 1.2 . . . . 25.0 112.976 -171.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -118.15 96.55 5.38 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 105.221 -2.14 . . . . 25.0 105.221 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.56 -28.57 71.56 Favored Glycine 0 C--O 1.253 1.282 0 O-C-N 121.734 -0.604 . . . . 25.0 114.373 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.1 -157.18 52.82 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 120.748 -0.739 . . . . 25.0 112.617 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.22 154.54 12.99 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 122.407 1.099 . . . . 25.0 113.504 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.97 178.59 52.52 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 114.32 -1.309 . . . . 25.0 109.964 -177.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -96.88 143.51 27.7 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 101.345 -3.576 . . . . 25.0 101.345 176.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -130.65 153.08 49.32 Favored 'General case' 0 CA--C 1.5 -0.948 0 C-N-CA 120.065 -0.654 . . . . 50.0 110.258 -171.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -110.71 126.75 54.88 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 101.445 -3.539 . . . . 25.0 101.445 174.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -149.6 129.86 13.71 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-O 123.136 1.446 . . . . 25.0 113.956 -175.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.3 m -96.55 140.33 31.34 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.335 -1.302 . . . . 25.0 109.489 177.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.1 -40.19 4.35 Favored Glycine 0 C--O 1.242 0.632 0 N-CA-C 111.608 -0.597 . . . . 25.0 111.608 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.91 -167.39 54.05 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-O 123.298 1.499 . . . . 25.0 113.771 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -63.95 162.96 12.91 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 113.646 -1.277 . . . . 25.0 108.789 175.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.05 163.0 38.56 Favored Glycine 0 C--N 1.344 1.005 0 N-CA-C 111.644 -0.583 . . . . 25.0 111.644 -177.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.89 109.46 20.24 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 122.038 0.923 . . . . 25.0 109.214 178.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -105.49 150.8 25.0 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.462 -0.79 . . . . 50.0 111.17 -169.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.4 m -121.27 128.23 52.15 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 124.195 0.935 . . . . 25.0 111.119 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -115.38 103.23 10.59 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.39 -0.823 . . . . 25.0 110.953 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 60.9 mtt85 -109.68 -28.98 8.56 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 118.516 0.598 . . . . 25.0 110.859 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 68.22 161.65 0.19 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.391 -0.966 . . . . 25.0 108.391 -175.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.91 -37.88 23.61 Favored 'General case' 0 C--O 1.246 0.875 0 O-C-N 120.939 -1.1 . . . . 25.0 113.964 -165.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.4 mt -137.5 166.34 24.11 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.925 0.869 . . . . 25.0 111.252 -176.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.13 -28.2 57.02 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.977 1.311 . . . . 25.0 108.474 169.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -75.17 -2.98 30.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.43 -0.805 . . . . 25.0 112.123 -177.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -105.96 154.16 20.98 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 115.721 1.749 . . . . 25.0 115.721 -177.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.7 t 50.58 48.39 22.67 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.542 1.682 . . . . 25.0 115.542 174.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 35.1 p-80 -133.44 175.58 9.29 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 114.356 -1.293 . . . . 25.0 108.966 -178.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -122.97 140.37 53.09 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 105.357 -2.09 . . . . 25.0 105.357 174.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 55.3 p -128.52 171.29 8.83 Favored Pre-proline 0 N--CA 1.471 0.624 0 O-C-N 125.165 1.54 . . . . 25.0 109.564 -178.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -58.16 -22.47 56.68 Favored 'Trans proline' 0 C--N 1.364 1.347 0 CA-C-N 119.616 0.899 . . . . 25.0 113.565 174.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.1 mt -82.9 -10.78 58.65 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.605 0.594 . . . . 25.0 112.605 -176.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 143.54 -171.3 25.3 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-O 117.681 -1.621 . . . . 25.0 113.376 -177.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.2 t -102.84 147.24 27.13 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.393 1.596 . . . . 25.0 113.153 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -126.08 20.57 7.56 Favored 'General case' 0 C--O 1.263 1.771 0 CA-C-N 113.719 -1.582 . . . . 25.0 109.48 174.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.86 143.48 41.83 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 111.249 -0.74 . . . . 25.0 111.249 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -92.62 167.98 11.55 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.945 -0.738 . . . . 50.0 111.006 -172.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.57 103.44 8.43 Favored 'General case' 0 C--O 1.259 1.56 0 O-C-N 121.915 -0.491 . . . . 25.0 111.882 -171.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 mt -92.07 130.43 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-O 122.085 0.945 . . . . 25.0 108.535 -174.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.3 mt -82.58 -41.67 19.26 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 116.248 1.944 . . . . 25.0 116.248 -173.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 44.5 p-10 -139.51 53.44 1.71 Allowed 'General case' 0 C--O 1.252 1.193 0 CA-C-O 122.137 0.97 . . . . 25.0 113.594 -176.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -64.66 131.57 47.29 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 114.887 -1.051 . . . . 25.0 110.218 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -111.66 104.66 56.3 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 106.919 -1.512 . . . . 25.0 106.919 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -69.23 -12.26 33.47 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 N-CA-C 116.287 1.61 . . . . 25.0 116.287 -175.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.2 p -85.02 -16.7 39.89 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.627 -0.879 . . . . 25.0 108.627 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -108.78 -48.04 3.37 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 115.028 1.492 . . . . 25.0 115.028 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -92.08 169.13 10.88 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.218 -0.901 . . . . 50.0 112.348 -160.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -146.11 146.08 30.76 Favored 'General case' 0 C--O 1.249 1.052 0 C-N-CA 123.275 0.63 . . . . 25.0 111.812 -176.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 67.2 mt -127.73 134.87 64.52 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.051 0 N-CA-C 107.524 -1.288 . . . . 25.0 107.524 -177.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.77 139.49 30.52 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 107.446 -1.316 . . . . 25.0 107.446 174.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.3 p -137.76 -12.38 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 115.714 1.746 . . . . 25.0 115.714 -178.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.7 t -72.17 -27.57 62.67 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.709 1.14 . . . . 25.0 109.816 -177.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.31 -24.82 61.38 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.626 -1.17 . . . . 25.0 112.141 174.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 16.5 mt -107.19 -45.08 4.2 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.781 1.4 . . . . 25.0 114.781 -172.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -123.03 -66.58 0.22 Allowed Glycine 0 N--CA 1.472 1.035 0 N-CA-C 117.974 1.95 . . . . 25.0 117.974 -171.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -150.63 166.85 29.06 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 109.675 -0.491 . . . . 25.0 109.675 -170.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.7 t -118.51 -31.12 5.0 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.708 -1.133 . . . . 25.0 110.841 176.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -100.98 122.32 7.56 Favored Glycine 0 N--CA 1.462 0.373 0 N-CA-C 106.967 -2.453 . . . . 25.0 106.967 175.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.25 145.4 55.81 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-O 121.383 0.611 . . . . 25.0 111.744 -177.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -81.0 -170.97 44.11 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 115.328 -0.851 . . . . 25.0 113.773 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -64.33 132.94 51.63 Favored 'General case' 0 C--O 1.253 1.278 0 CA-C-O 121.769 0.795 . . . . 25.0 111.532 -177.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -177.95 -172.36 42.32 Favored Glycine 0 CA--C 1.539 1.59 0 N-CA-C 109.045 -1.622 . . . . 25.0 109.045 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -143.43 167.14 22.89 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 118.847 1.323 . . . . 25.0 112.017 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 55.11 42.24 30.94 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.143 1.377 . . . . 25.0 112.901 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 69.36 32.98 72.24 Favored Glycine 0 C--O 1.245 0.83 0 N-CA-C 110.097 -1.201 . . . . 25.0 110.097 176.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.5 t -146.78 166.43 26.68 Favored 'General case' 0 C--O 1.214 -0.788 0 CA-C-N 118.349 1.074 . . . . 25.0 110.573 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.5 mt -88.37 166.57 14.17 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 104.421 -2.437 . . . . 25.0 104.421 176.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.49 119.27 15.4 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-N 119.245 0.929 . . . . 25.0 110.241 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 35.4 m -85.79 162.1 2.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.047 -0.979 . . . . 25.0 110.481 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.7 m -140.86 168.41 19.87 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 110.32 -0.252 . . . . 25.0 110.32 -177.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 30.4 m -128.54 161.75 36.69 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 N-CA-C 107.223 -1.399 . . . . 25.0 107.223 175.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.2 t -72.09 -47.37 51.88 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 106.518 -1.66 . . . . 25.0 106.518 173.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -167.03 -161.51 0.43 Allowed 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 102.13 -3.285 . . . . 25.0 102.13 -176.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -68.32 -17.73 64.34 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 120.259 1.391 . . . . 25.0 112.039 -177.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -129.33 -155.04 8.37 Favored Glycine 0 N--CA 1.44 -1.048 0 N-CA-C 108.497 -1.841 . . . . 25.0 108.497 176.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 56.06 -150.68 0.42 Allowed 'General case' 0 N--CA 1.473 0.708 0 O-C-N 122.82 -0.223 . . . . 25.0 111.137 -178.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 27.8 mtt85 -77.45 158.78 29.83 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 116.851 2.167 . . . . 25.0 116.851 -169.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.0 163.36 16.03 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 113.47 -1.695 . . . . 25.0 106.591 177.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -137.51 154.32 49.88 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 118.451 0.569 . . . . 25.0 111.519 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 33.8 tp -123.56 119.63 30.48 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 105.754 -1.943 . . . . 25.0 105.754 169.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -119.24 154.9 32.69 Favored 'General case' 0 C--O 1.246 0.91 0 CA-C-O 121.712 0.768 . . . . 25.0 112.811 -173.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.1 t -103.0 153.69 19.98 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 104.666 -2.346 . . . . 25.0 104.666 169.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -120.67 9.52 10.81 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 122.346 1.069 . . . . 25.0 109.054 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -93.92 136.58 34.05 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 105.423 -2.065 . . . . 25.0 105.423 171.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -139.11 147.56 42.12 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.895 0.855 . . . . 25.0 110.057 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -73.99 159.25 32.98 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.012 -1.107 . . . . 25.0 108.012 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -61.98 -23.8 66.62 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 120.867 0.365 . . . . 25.0 110.587 177.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -75.83 -2.45 30.05 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.702 0.801 . . . . 25.0 111.934 177.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.39 15.8 70.55 Favored Glycine 0 C--O 1.238 0.351 0 C-N-CA 121.365 -0.445 . . . . 25.0 112.895 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 75.4 mt -88.87 139.48 30.42 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.529 -1.286 . . . . 25.0 107.529 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 86.8 p -148.56 176.19 10.53 Favored 'General case' 0 C--O 1.249 1.05 0 N-CA-C 108.771 -0.826 . . . . 25.0 108.771 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -122.28 131.8 54.1 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 113.439 0.903 . . . . 25.0 113.439 -176.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -150.28 154.21 37.5 Favored 'General case' 0 C--O 1.266 1.924 0 N-CA-C 107.317 -1.364 . . . . 25.0 107.317 168.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.4 p -145.73 146.79 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 106.813 -1.551 . . . . 25.0 106.813 175.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -112.1 142.45 44.53 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.533 -0.914 . . . . 25.0 108.533 -171.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.2 mp -133.78 143.96 48.74 Favored 'General case' 0 C--O 1.197 -1.685 0 N-CA-C 103.617 -2.734 . . . . 25.0 103.617 -173.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -115.88 5.56 14.07 Favored 'General case' 0 C--O 1.206 -1.225 0 N-CA-C 117.885 2.55 . . . . 25.0 117.885 -175.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.94 0.59 86.78 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 116.244 1.258 . . . . 25.0 116.244 177.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 41.8 t0 55.45 53.07 10.28 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 122.832 1.301 . . . . 25.0 110.359 178.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -118.65 38.64 3.7 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 113.455 -1.702 . . . . 25.0 108.428 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.9 -39.49 78.04 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.773 -0.648 . . . . 25.0 112.084 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.78 -19.47 62.0 Favored 'General case' 0 CA--C 1.577 2.005 0 O-C-N 121.156 -0.965 . . . . 25.0 112.545 -177.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.22 -26.42 20.1 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 116.132 -0.486 . . . . 25.0 111.805 177.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 22.0 mt -60.25 132.39 53.76 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 121.203 0.525 . . . . 25.0 109.646 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.9 m -135.22 160.96 36.73 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 107.529 -1.286 . . . . 25.0 107.529 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.83 -1.29 57.1 Favored 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 108.232 -1.025 . . . . 25.0 108.232 178.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -69.2 -30.04 68.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.884 -0.598 . . . . 25.0 110.838 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -90.44 -5.93 55.5 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.268 0.556 . . . . 25.0 111.018 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 17.0 mm -89.91 123.99 42.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 105.785 -1.932 . . . . 25.0 105.785 176.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.7 p -98.45 117.1 42.88 Favored 'Isoleucine or valine' 0 C--O 1.251 1.145 0 CA-C-O 122.831 1.301 . . . . 25.0 113.318 -175.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -143.97 0.56 1.08 Allowed 'General case' 0 C--O 1.251 1.146 0 CA-C-N 112.358 -2.201 . . . . 25.0 108.547 178.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.15 45.0 0.98 Allowed 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.009 0.374 . . . . 25.0 112.009 -178.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 53.49 37.57 26.02 Favored 'General case' 0 CA--C 1.561 1.4 0 CA-C-O 121.172 0.51 . . . . 25.0 112.363 -178.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.99 -4.32 0.2 Allowed 'General case' 0 CA--C 1.56 1.363 0 N-CA-C 115.636 1.717 . . . . 25.0 115.636 177.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -89.96 125.32 35.33 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 120.713 -1.242 . . . . 25.0 113.612 -177.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -77.22 -4.18 43.45 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 113.405 0.891 . . . . 25.0 113.405 -177.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -77.04 40.5 0.26 Allowed 'General case' 0 C--O 1.217 -0.649 0 N-CA-C 114.577 1.325 . . . . 25.0 114.577 178.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -152.93 -165.43 2.18 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.128 -0.694 . . . . 25.0 109.128 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 60.97 -167.11 0.19 Allowed 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 113.6 0.963 . . . . 25.0 113.6 174.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 82.2 15.89 73.28 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.374 -0.69 . . . . 25.0 111.374 -177.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -99.66 108.61 21.02 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.95 0.722 . . . . 25.0 112.95 -176.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -128.57 155.68 44.53 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 106.71 -1.589 . . . . 25.0 106.71 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -125.95 31.19 4.17 Favored Glycine 0 C--O 1.217 -0.945 0 CA-C-O 121.746 0.636 . . . . 25.0 111.895 175.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 92.3 t -73.45 -38.11 52.21 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 O-C-N 122.286 -0.538 . . . . 25.0 110.33 -175.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.56 137.73 23.83 Favored 'Isoleucine or valine' 0 C--O 1.258 1.532 0 CA-C-O 121.459 0.647 . . . . 25.0 110.442 -175.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 153.9 165.95 14.29 Favored Glycine 0 C--O 1.245 0.836 0 CA-C-N 115.482 -0.781 . . . . 25.0 111.991 -178.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -143.85 139.53 29.32 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 112.957 0.725 . . . . 25.0 112.957 176.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 84.4 p -142.69 179.9 6.71 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.857 -1.164 . . . . 25.0 107.857 175.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 135.5 172.96 12.86 Favored Glycine 0 C--O 1.24 0.517 0 N-CA-C 115.034 0.774 . . . . 25.0 115.034 175.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -137.04 113.54 9.75 Favored Pre-proline 0 C--O 1.26 1.608 0 CA-C-N 114.929 -0.635 . . . . 25.0 110.382 178.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -68.06 153.95 73.77 Favored 'Trans proline' 0 C--N 1.356 0.964 0 O-C-N 122.509 0.741 . . . . 25.0 110.663 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -128.36 139.52 52.34 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.772 -1.196 . . . . 25.0 107.772 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -131.52 69.11 81.64 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 112.689 0.626 . . . . 25.0 112.689 -177.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -70.26 150.25 64.88 Favored 'Trans proline' 0 C--N 1.346 0.419 0 CA-C-O 122.107 0.795 . . . . 25.0 113.016 -178.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.4 t -97.71 1.33 48.42 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.357 -0.838 . . . . 25.0 111.734 -175.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 C--O 1.253 1.281 0 CA-C-O 118.089 -0.957 . . . . 25.0 110.86 -177.429 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 110.193 -0.299 . . . . 25.0 110.193 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -141.05 113.0 6.84 Favored Pre-proline 0 C--O 1.245 0.867 0 N-CA-C 112.965 0.728 . . . . 25.0 112.965 -178.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.39 157.09 45.62 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 116.537 -1.842 . . . . 25.0 114.262 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.27 58.33 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.208 0 N-CA-C 108.362 -1.895 . . . . 25.0 108.362 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.1 p -60.29 132.77 25.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 123.219 1.485 . . . . 25.0 112.064 -170.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -101.26 -11.56 19.39 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.789 -1.096 . . . . 25.0 110.065 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.75 -151.63 14.46 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 114.735 -1.12 . . . . 25.0 112.61 177.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.2 p 73.08 158.17 0.16 Allowed Pre-proline 0 N--CA 1.496 1.854 0 C-N-CA 126.242 1.817 . . . . 25.0 110.187 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -65.68 -0.81 4.11 Favored 'Trans proline' 0 C--N 1.349 0.602 0 N-CA-C 116.465 1.679 . . . . 25.0 116.465 -175.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.58 -19.23 20.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 114.311 1.226 . . . . 25.0 114.311 -173.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.5 p -140.45 136.05 36.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 114.096 1.147 . . . . 25.0 114.096 -174.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.44 25.57 56.57 Favored Glycine 0 C--O 1.242 0.652 0 N-CA-C 117.343 1.697 . . . . 25.0 117.343 172.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.9 t -50.09 -54.58 19.51 Favored 'General case' 0 C--O 1.22 -0.468 0 O-C-N 121.15 -1.206 . . . . 25.0 113.459 -175.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -80.17 4.64 16.79 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 116.447 2.018 . . . . 25.0 116.447 -171.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 pp -142.04 168.4 19.83 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 112.915 0.709 . . . . 25.0 112.915 -174.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -61.67 130.45 45.91 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.695 0.798 . . . . 25.0 112.03 -175.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -125.23 168.67 13.15 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 116.442 2.016 . . . . 50.0 116.442 -175.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -129.72 96.9 4.36 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 105.654 -1.98 . . . . 25.0 105.654 164.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 81.2 mt -108.92 113.03 25.59 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 112.462 0.541 . . . . 25.0 112.462 -176.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -104.38 113.69 27.42 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 108.409 -0.96 . . . . 25.0 108.409 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.47 177.85 48.79 Favored Glycine 0 CA--C 1.51 -0.23 0 N-CA-C 117.331 1.692 . . . . 25.0 117.331 -174.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.2 p -77.06 168.82 19.43 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-O 122.0 0.905 . . . . 25.0 112.501 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 77.6 mt -85.63 24.61 1.19 Allowed 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 114.624 -1.171 . . . . 25.0 111.531 176.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -128.77 179.36 16.68 Favored Glycine 0 N--CA 1.467 0.703 0 N-CA-C 110.48 -1.048 . . . . 25.0 110.48 175.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.1 t -66.53 137.41 56.77 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 117.86 0.83 . . . . 25.0 111.736 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -146.46 165.68 28.67 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 122.027 -0.421 . . . . 50.0 110.88 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -116.16 121.21 41.45 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 102.67 -3.085 . . . . 25.0 102.67 170.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 46.6 mm -117.12 129.29 73.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 107.523 -1.288 . . . . 25.0 107.523 -176.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.1 mp -128.77 125.18 37.31 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 105.399 -2.075 . . . . 25.0 105.399 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.14 -35.1 24.86 Favored Glycine 0 C--O 1.255 1.453 0 N-CA-C 115.698 1.039 . . . . 25.0 115.698 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.03 -148.43 44.48 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.38 -0.914 . . . . 25.0 111.434 -178.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.96 165.23 54.8 Favored Glycine 0 C--O 1.248 1.015 0 CA-C-O 122.471 1.039 . . . . 25.0 111.705 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.31 162.69 33.3 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 114.731 -0.734 . . . . 25.0 113.488 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.9 101.0 12.48 Favored 'General case' 0 C--O 1.203 -1.343 0 N-CA-C 105.022 -2.214 . . . . 25.0 105.022 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -96.82 151.62 19.49 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 115.88 -0.6 . . . . 50.0 110.536 -170.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -110.81 103.22 11.72 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 106.552 -1.647 . . . . 25.0 106.552 171.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 43.3 mt -106.3 132.12 52.72 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 124.032 0.833 . . . . 25.0 111.064 -174.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -130.15 104.26 7.21 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 121.465 0.65 . . . . 25.0 110.959 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.98 -30.23 63.65 Favored Glycine 0 N--CA 1.466 0.635 0 N-CA-C 116.165 1.226 . . . . 25.0 116.165 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 50.3 -151.35 0.2 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 118.29 1.045 . . . . 25.0 112.857 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.06 160.51 15.02 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.413 0.894 . . . . 25.0 113.413 -175.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.83 157.02 31.73 Favored Glycine 0 C--O 1.238 0.345 0 CA-C-N 114.778 -1.101 . . . . 25.0 111.192 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -80.4 102.91 9.91 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.236 -1.024 . . . . 25.0 108.236 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -106.05 157.75 17.3 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.344 0.592 . . . . 50.0 111.249 -169.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 mp -114.96 131.9 56.75 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 106.17 -1.789 . . . . 25.0 106.17 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.5 mp -132.71 127.09 34.02 Favored 'General case' 0 C--O 1.25 1.107 0 N-CA-C 115.217 1.562 . . . . 25.0 115.217 -174.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -120.04 145.16 47.1 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 107.333 -1.358 . . . . 25.0 107.333 172.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -98.3 -39.78 3.64 Favored Glycine 0 N--CA 1.465 0.618 0 C-N-CA 120.963 -0.637 . . . . 25.0 113.715 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.97 -167.74 54.71 Favored Glycine 0 N--CA 1.465 0.632 0 N-CA-C 110.107 -1.197 . . . . 25.0 110.107 -177.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.67 143.67 29.61 Favored 'General case' 0 CA--C 1.557 1.241 0 CA-C-O 121.85 0.833 . . . . 25.0 111.959 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.35 167.43 32.68 Favored Glycine 0 C--O 1.245 0.781 0 CA-C-N 115.169 -0.923 . . . . 25.0 113.365 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.94 114.05 23.24 Favored 'General case' 0 C--O 1.208 -1.124 0 N-CA-C 104.731 -2.322 . . . . 25.0 104.731 175.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -103.48 151.76 22.46 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.915 -0.584 . . . . 50.0 109.814 -173.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -116.09 122.83 46.31 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 104.869 -2.271 . . . . 25.0 104.869 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -145.42 138.52 26.28 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 117.651 2.463 . . . . 25.0 117.651 -169.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.2 m -111.13 141.12 45.05 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-N 115.332 -0.849 . . . . 25.0 108.998 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.13 -37.74 6.62 Favored Glycine 0 N--CA 1.44 -1.069 0 N-CA-C 110.296 -1.122 . . . . 25.0 110.296 172.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.51 -169.78 54.86 Favored Glycine 0 CA--C 1.507 -0.423 0 C-N-CA 119.941 -1.124 . . . . 25.0 113.439 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -63.51 154.95 30.82 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.604 -0.939 . . . . 25.0 111.369 176.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.75 162.66 30.06 Favored Glycine 0 C--O 1.244 0.729 0 N-CA-C 109.914 -1.274 . . . . 25.0 109.914 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.04 110.99 19.33 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.056 -1.09 . . . . 25.0 108.056 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -103.97 154.53 19.56 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.569 -0.453 . . . . 50.0 112.113 -170.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.5 m -120.22 105.71 11.22 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.438 -0.578 . . . . 25.0 109.438 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -89.1 93.65 9.66 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 105.159 -2.163 . . . . 25.0 105.159 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -92.55 -30.28 15.75 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 112.888 0.699 . . . . 25.0 112.888 -166.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 63.56 156.41 0.06 Allowed 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 124.337 1.055 . . . . 25.0 112.838 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.88 -67.51 0.7 Allowed 'General case' 0 C--O 1.252 1.203 0 N-CA-C 115.896 1.813 . . . . 25.0 115.896 -170.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.8 mt -137.92 -177.69 4.93 Favored 'General case' 0 C--O 1.216 -0.663 0 O-C-N 121.523 -0.736 . . . . 25.0 109.239 -173.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -53.24 -30.14 36.41 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.709 -0.848 . . . . 25.0 108.709 170.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -76.66 4.2 9.96 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 115.391 1.626 . . . . 25.0 115.391 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -118.09 142.15 47.72 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 118.173 0.442 . . . . 25.0 111.639 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.2 t 49.28 53.27 12.93 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 122.469 1.128 . . . . 25.0 112.272 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 31.9 p-80 -137.1 174.05 11.03 Favored 'General case' 0 C--O 1.212 -0.905 0 CA-C-N 114.754 -1.112 . . . . 25.0 109.229 -174.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -126.01 143.26 51.17 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 105.754 -1.943 . . . . 25.0 105.754 173.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.6 p -133.25 170.8 10.43 Favored Pre-proline 0 C--N 1.318 -0.778 0 N-CA-C 108.122 -1.066 . . . . 25.0 108.122 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.42 -16.79 43.9 Favored 'Trans proline' 0 C--O 1.206 -1.121 0 C-N-CA 117.09 -1.473 . . . . 25.0 114.043 177.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 88.8 mt -77.83 -29.81 50.8 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 120.101 -0.64 . . . . 25.0 110.966 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.55 -178.35 34.8 Favored Glycine 0 C--O 1.219 -0.829 0 N-CA-C 110.607 -0.997 . . . . 25.0 110.607 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t -96.43 148.06 23.19 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-O 122.755 1.264 . . . . 25.0 111.1 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -134.74 28.05 3.6 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 113.639 -1.619 . . . . 25.0 107.844 176.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.34 137.72 29.74 Favored Glycine 0 C--N 1.34 0.799 0 N-CA-C 108.861 -1.696 . . . . 25.0 108.861 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -87.58 165.09 15.72 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 121.321 -1.105 . . . . 50.0 110.393 -172.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -119.18 100.23 7.2 Favored 'General case' 0 C--O 1.257 1.454 0 CA-C-O 121.352 0.596 . . . . 25.0 111.687 -171.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.8 mt -89.26 132.88 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-O 123.011 1.386 . . . . 25.0 107.951 -175.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.7 mt -83.93 -43.09 15.61 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 114.81 1.411 . . . . 25.0 114.81 -174.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -138.64 40.21 2.2 Favored 'General case' 0 C--O 1.26 1.608 0 N-CA-C 115.28 1.585 . . . . 25.0 115.28 -172.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.405 ' CE2' ' HA ' ' A' ' 89' ' ' PRO . 80.1 t80 -56.75 128.39 36.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.525 0.678 . . . . 25.0 111.914 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -97.96 108.1 44.47 Favored Pre-proline 0 N--CA 1.469 0.492 0 N-CA-C 106.911 -1.515 . . . . 25.0 106.911 175.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.405 ' HA ' ' CE2' ' A' ' 87' ' ' PHE . 93.4 Cg_endo -72.4 -4.55 15.47 Favored 'Trans proline' 0 CA--C 1.552 1.394 0 N-CA-C 115.63 1.358 . . . . 25.0 115.63 -174.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 29.7 t -95.0 -46.75 6.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.085 0.469 . . . . 25.0 109.859 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -92.15 -40.52 10.97 Favored 'General case' 0 C--O 1.245 0.867 0 N-CA-C 114.382 1.253 . . . . 25.0 114.382 -172.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -84.87 171.52 12.15 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.695 0.76 . . . . 75.0 110.079 -173.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.63 155.62 45.71 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.606 0.763 . . . . 25.0 111.32 174.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 77.9 mt -125.44 124.34 66.77 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 106.796 -1.557 . . . . 25.0 106.796 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -86.25 150.75 24.15 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 119.728 -0.789 . . . . 25.0 109.179 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.9 p -154.64 -1.6 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 115.418 -0.81 . . . . 25.0 111.674 -176.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.2 t -66.28 -51.28 59.0 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.635 0.605 . . . . 25.0 112.635 -174.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.9 -24.35 60.83 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.886 0.699 . . . . 25.0 112.886 -176.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.56 -29.35 9.23 Favored 'General case' 0 C--O 1.212 -0.872 0 N-CA-C 118.075 2.621 . . . . 25.0 118.075 -174.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -121.69 -65.21 0.24 Allowed Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.456 -0.878 . . . . 25.0 115.03 -172.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -162.26 163.55 28.08 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 117.21 0.505 . . . . 25.0 109.759 -175.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 77.8 p -114.7 -28.79 6.99 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.557 0.536 . . . . 25.0 110.647 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -103.29 120.35 6.72 Favored Glycine 0 C--O 1.239 0.431 0 N-CA-C 110.642 -0.983 . . . . 25.0 110.642 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -67.24 151.18 47.99 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 118.865 1.333 . . . . 25.0 111.597 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -97.55 -157.33 30.48 Favored Glycine 0 CA--C 1.507 -0.435 0 CA-C-N 115.141 -0.936 . . . . 25.0 112.965 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -54.91 136.74 46.87 Favored 'General case' 0 C--O 1.245 0.868 0 N-CA-C 113.954 1.094 . . . . 25.0 113.954 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 165.94 172.43 33.29 Favored Glycine 0 C--O 1.22 -0.746 0 N-CA-C 109.457 -1.457 . . . . 25.0 109.457 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -141.18 166.68 24.11 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.022 0.911 . . . . 25.0 109.194 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 56.2 34.21 23.53 Favored 'General case' 0 CA--C 1.551 1.009 0 O-C-N 124.305 1.003 . . . . 25.0 113.127 -176.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.07 38.68 59.49 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 111.132 -0.787 . . . . 25.0 111.132 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.1 t -139.99 -174.23 3.86 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.803 0.802 . . . . 25.0 113.152 -176.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 52.2 mt -114.9 150.71 35.21 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 101.127 -3.657 . . . . 25.0 101.127 174.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.93 132.45 47.98 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-O 121.357 0.598 . . . . 25.0 110.058 -175.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 32.9 m -97.02 164.85 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 115.435 -0.802 . . . . 25.0 111.533 -176.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.8 m -139.95 164.54 29.74 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 110.313 -0.255 . . . . 25.0 110.313 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.3 m -126.78 166.31 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 107.584 -1.265 . . . . 25.0 107.584 176.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 30.3 t -81.55 -56.63 3.9 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 106.961 -1.496 . . . . 25.0 106.961 173.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -161.98 -147.59 0.13 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 105.263 -2.125 . . . . 25.0 105.263 -177.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -66.64 -21.68 66.11 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.371 0.268 . . . . 25.0 110.409 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -138.68 -150.38 5.59 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 110.385 -1.086 . . . . 25.0 110.385 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.19 -155.59 0.35 Allowed 'General case' 0 C--O 1.259 1.594 0 C-N-CA 123.053 0.541 . . . . 25.0 111.049 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 54.0 mtt85 -85.19 160.75 19.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 122.017 0.913 . . . . 25.0 113.018 -172.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 12.3 p -107.8 163.83 12.77 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 106.187 -1.783 . . . . 25.0 106.187 173.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -135.01 158.05 45.36 Favored 'General case' 0 CA--C 1.51 -0.587 0 O-C-N 123.529 0.518 . . . . 25.0 112.325 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 45.2 tp -128.7 136.17 50.23 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 103.759 -2.682 . . . . 25.0 103.759 172.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -127.44 148.81 50.29 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 122.468 1.128 . . . . 25.0 110.955 -176.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 32.4 t -101.96 146.5 27.78 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 103.874 -2.639 . . . . 25.0 103.874 168.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -108.82 10.45 26.59 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.406 0.622 . . . . 25.0 109.667 -174.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -94.45 143.51 26.35 Favored 'General case' 0 C--O 1.259 1.57 0 CA-C-N 113.608 -1.633 . . . . 25.0 108.938 167.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -149.12 156.7 42.58 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.809 -0.811 . . . . 25.0 108.809 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -70.24 160.58 31.92 Favored 'General case' 0 C--O 1.217 -0.635 0 N-CA-C 107.823 -1.177 . . . . 25.0 107.823 173.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.91 -21.53 66.51 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.401 -0.592 . . . . 25.0 109.401 175.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -79.68 -3.56 47.87 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.04 0.755 . . . . 25.0 113.04 177.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.96 24.01 46.86 Favored Glycine 0 N--CA 1.466 0.66 0 C-N-CA 121.113 -0.565 . . . . 25.0 113.42 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 35.9 mt -94.8 111.71 23.47 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.628 -1.249 . . . . 25.0 107.628 176.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 42.9 p -122.42 174.17 7.2 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 118.645 -0.693 . . . . 25.0 109.474 -174.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -116.39 126.3 53.27 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.344 0.52 . . . . 25.0 111.247 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -145.77 153.82 41.36 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 107.207 -1.405 . . . . 25.0 107.207 171.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 11.7 p -145.89 145.66 20.0 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 N-CA-C 106.77 -1.567 . . . . 25.0 106.77 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -106.16 143.82 33.74 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.884 -0.784 . . . . 25.0 108.884 -175.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mp -134.46 134.35 41.44 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.514 -1.291 . . . . 25.0 107.514 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -110.8 8.88 22.55 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 119.706 1.139 . . . . 25.0 112.668 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -78.91 -10.68 85.96 Favored Glycine 0 C--O 1.243 0.695 0 C-N-CA 119.596 -1.287 . . . . 25.0 112.57 174.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 48.4 t0 49.45 64.43 1.75 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 122.946 1.355 . . . . 25.0 112.051 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -130.52 36.54 3.93 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 106.274 -1.751 . . . . 25.0 106.274 176.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.55 -33.58 71.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.718 -1.128 . . . . 25.0 108.162 174.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.92 -11.73 49.39 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 113.302 0.852 . . . . 25.0 113.302 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -119.85 1.71 11.01 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 121.671 -0.643 . . . . 25.0 112.069 -178.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 14.9 mt -72.19 148.45 45.58 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.303 -0.559 . . . . 25.0 111.433 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 83.7 p -147.45 159.37 43.79 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 106.635 -1.617 . . . . 25.0 106.635 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.59 -1.9 52.16 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 108.698 -0.852 . . . . 25.0 108.698 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -68.84 -35.68 77.25 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.536 -0.913 . . . . 25.0 108.536 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -89.15 0.08 57.02 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.786 -0.571 . . . . 25.0 110.374 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 46.3 mm -94.85 113.74 29.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 104.251 -2.499 . . . . 25.0 104.251 174.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.7 p -98.78 101.91 12.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 124.081 1.896 . . . . 25.0 111.905 -170.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -116.78 -14.17 10.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 112.983 -1.917 . . . . 25.0 109.962 173.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -81.91 28.48 0.42 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.02 1.118 . . . . 25.0 114.02 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 55.66 33.32 21.04 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.232 0.827 . . . . 25.0 113.232 177.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.78 25.07 11.47 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.179 0.991 . . . . 25.0 112.698 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -90.01 133.76 34.63 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.594 -1.262 . . . . 25.0 107.594 174.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -112.82 23.04 13.86 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.203 0.601 . . . . 25.0 111.623 -176.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.79 -32.81 71.49 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 122.098 -0.376 . . . . 25.0 111.314 176.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -104.5 -156.13 0.56 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 123.29 0.636 . . . . 25.0 110.562 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 67.09 175.08 0.25 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.046 1.338 . . . . 25.0 113.824 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 87.04 9.1 74.39 Favored Glycine 0 C--O 1.224 -0.49 0 CA-C-N 115.757 -0.656 . . . . 25.0 112.478 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -82.84 100.06 10.1 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-O 121.197 0.522 . . . . 25.0 110.722 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -126.33 149.07 49.41 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.43 0.633 . . . . 25.0 109.849 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.91 33.89 2.4 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 110.746 -0.941 . . . . 25.0 110.746 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 45.1 t -73.6 -29.55 27.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.751 -0.724 . . . . 25.0 109.418 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 19.2 tt -57.18 134.67 21.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 N-CA-C 112.84 0.681 . . . . 25.0 112.84 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 158.02 157.59 8.53 Favored Glycine 0 C--O 1.222 -0.596 0 N-CA-C 114.681 0.632 . . . . 25.0 114.681 175.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -146.08 136.35 23.82 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 123.456 0.151 . . . . 25.0 110.639 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 53.6 p -152.73 163.96 38.68 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 106.97 -1.493 . . . . 25.0 106.97 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -167.44 162.46 36.25 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 114.738 0.655 . . . . 25.0 114.738 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -133.45 80.18 58.28 Favored Pre-proline 0 N--CA 1.468 0.432 0 N-CA-C 108.832 -0.803 . . . . 25.0 108.832 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -72.82 152.79 52.94 Favored 'Trans proline' 0 C--N 1.352 0.763 0 N-CA-C 114.889 1.073 . . . . 25.0 114.889 -171.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -111.01 157.13 20.29 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.42 -0.955 . . . . 25.0 108.42 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -132.12 75.01 75.71 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 112.722 0.638 . . . . 25.0 112.722 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.49 158.72 47.5 Favored 'Trans proline' 0 C--O 1.219 -0.46 0 CA-C-O 121.11 0.379 . . . . 25.0 112.845 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.7 t -132.32 -0.5 3.65 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.611 0.72 . . . . 25.0 111.837 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 C--O 1.247 0.922 0 N-CA-C 108.808 -0.812 . . . . 25.0 108.808 178.288 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.695 0.76 . . . . 25.0 110.481 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -127.46 91.82 44.94 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 108.643 -0.873 . . . . 25.0 108.643 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -70.51 153.98 65.09 Favored 'Trans proline' 0 C--O 1.241 0.628 0 N-CA-C 115.002 1.116 . . . . 25.0 115.002 -175.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.53 75.2 0.06 OUTLIER Glycine 0 C--O 1.22 -0.779 0 N-CA-C 108.797 -1.721 . . . . 25.0 108.797 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.3 p -57.48 131.71 21.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-O 122.312 1.053 . . . . 25.0 111.59 -172.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -88.99 -15.04 35.15 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 114.616 -1.174 . . . . 25.0 110.987 -176.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -88.08 -141.03 7.23 Favored Glycine 0 CA--C 1.506 -0.499 0 C-N-CA 121.263 -0.494 . . . . 25.0 114.17 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.0 p 71.85 157.31 0.16 Allowed Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 126.854 2.061 . . . . 25.0 111.179 -176.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.464 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 37.6 Cg_exo -65.49 1.39 2.15 Favored 'Trans proline' 0 C--N 1.362 1.249 0 N-CA-C 117.358 2.022 . . . . 25.0 117.358 -178.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.9 p -62.86 -19.0 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 115.486 1.661 . . . . 25.0 115.486 -172.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.6 p -146.61 136.12 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 113.917 1.08 . . . . 25.0 113.917 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.08 29.68 14.53 Favored Glycine 0 N--CA 1.462 0.422 0 N-CA-C 116.856 1.502 . . . . 25.0 116.856 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.9 t -57.25 -65.29 0.65 Allowed 'General case' 0 C--O 1.239 0.538 0 N-CA-C 114.132 1.16 . . . . 25.0 114.132 -177.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -80.35 10.2 4.88 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 114.347 1.24 . . . . 25.0 114.347 -170.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.91 174.56 10.39 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 118.912 -0.566 . . . . 25.0 110.461 -172.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -60.52 150.27 31.96 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 118.861 0.755 . . . . 25.0 111.72 -177.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -128.12 156.22 43.18 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.588 1.329 . . . . 50.0 114.588 -175.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -137.15 94.27 2.93 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 102.851 -3.018 . . . . 25.0 102.851 163.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.0 mt -120.25 111.72 18.16 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 114.483 1.29 . . . . 25.0 114.483 -173.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -98.19 104.94 17.01 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 115.744 -0.662 . . . . 25.0 111.484 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.95 179.55 52.68 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 117.584 1.794 . . . . 25.0 117.584 -173.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.0 p -74.63 169.54 17.59 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 112.246 0.461 . . . . 25.0 112.246 -177.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 51.2 mt -89.05 14.12 11.4 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.912 0.863 . . . . 25.0 110.332 175.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.67 178.77 17.79 Favored Glycine 0 C--O 1.223 -0.56 0 N-CA-C 108.638 -1.785 . . . . 25.0 108.638 175.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.7 t -70.29 140.91 52.41 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 117.356 0.578 . . . . 25.0 111.351 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -146.15 164.35 32.5 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.784 -0.821 . . . . 50.0 108.784 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -106.35 121.76 44.88 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 102.777 -3.045 . . . . 25.0 102.777 162.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.0 mm -109.18 111.31 35.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 107.487 -1.301 . . . . 25.0 107.487 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.464 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 4.4 mp -112.34 117.51 32.67 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.609 -1.256 . . . . 25.0 107.609 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.4 -27.69 38.78 Favored Glycine 0 C--O 1.206 -1.608 0 CA-C-O 119.133 -0.815 . . . . 25.0 114.425 -176.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.6 -147.08 44.76 Favored Glycine 0 C--O 1.243 0.658 0 C-N-CA 120.152 -1.023 . . . . 25.0 111.636 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.85 177.13 53.4 Favored Glycine 0 C--O 1.242 0.623 0 N-CA-C 112.054 -0.418 . . . . 25.0 112.054 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.04 166.87 29.31 Favored Glycine 0 C--N 1.316 -0.564 0 CA-C-N 115.854 -0.173 . . . . 25.0 112.906 176.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.01 105.19 13.8 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 106.875 -1.528 . . . . 25.0 106.875 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -104.81 138.84 40.47 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.772 -0.771 . . . . 50.0 111.596 -168.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -106.33 96.11 6.24 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.094 -1.817 . . . . 25.0 106.094 173.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 45.5 mt -105.65 143.51 33.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.247 -0.433 . . . . 25.0 110.454 -172.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -136.77 107.46 6.57 Favored 'General case' 0 C--O 1.248 0.983 0 CA-C-O 121.319 0.581 . . . . 25.0 110.698 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.05 -23.47 71.6 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 117.94 -1.478 . . . . 25.0 116.649 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.4 ' HB3' ' H ' ' A' ' 41' ' ' ALA . 69.2 m-85 52.71 -159.13 0.13 Allowed 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 119.217 1.508 . . . . 25.0 111.814 -176.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.4 ' H ' ' HB3' ' A' ' 40' ' ' TYR . . . -66.73 167.63 10.9 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 121.475 -0.765 . . . . 25.0 112.728 -175.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.75 155.77 32.24 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.963 -0.855 . . . . 25.0 110.963 -177.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -83.65 97.06 8.88 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.687 -0.856 . . . . 25.0 108.687 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -98.02 161.37 13.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.273 -0.421 . . . . 50.0 111.867 -169.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mp -119.55 131.93 55.64 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 105.549 -2.019 . . . . 25.0 105.549 175.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.4 mp -130.8 125.3 33.36 Favored 'General case' 0 C--O 1.248 0.996 0 N-CA-C 115.021 1.489 . . . . 25.0 115.021 -171.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -125.86 93.2 3.77 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.005 -1.452 . . . . 25.0 109.503 177.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.33 -27.02 70.05 Favored Glycine 0 C--N 1.342 0.874 0 C-N-CA 120.898 -0.668 . . . . 25.0 114.121 -177.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.99 -172.71 46.28 Favored Glycine 0 CA--C 1.522 0.514 0 CA-C-N 118.022 0.911 . . . . 25.0 113.106 177.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.94 148.72 16.61 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.94 0.876 . . . . 25.0 113.124 -175.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.59 159.04 35.23 Favored Glycine 0 C--O 1.219 -0.814 0 N-CA-C 110.274 -1.13 . . . . 25.0 110.274 -177.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -82.01 121.94 27.17 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 107.451 -1.314 . . . . 25.0 107.451 -177.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -112.02 161.42 16.49 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 119.537 -0.268 . . . . 50.0 111.686 -172.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.72 101.1 5.75 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 105.128 -2.175 . . . . 25.0 105.128 175.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -122.7 138.12 54.71 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 114.755 1.391 . . . . 25.0 114.755 -170.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 61.0 m -103.66 145.33 30.21 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.911 -1.144 . . . . 25.0 107.911 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.78 -33.18 6.5 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.781 -0.927 . . . . 25.0 110.781 173.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.59 -173.86 52.93 Favored Glycine 0 C--O 1.239 0.414 0 O-C-N 121.54 -0.976 . . . . 25.0 112.058 -177.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -58.1 149.49 23.5 Favored 'General case' 0 C--O 1.251 1.157 0 N-CA-C 112.108 0.41 . . . . 25.0 112.108 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.26 160.56 29.26 Favored Glycine 0 C--O 1.245 0.803 0 CA-C-O 119.588 -0.562 . . . . 25.0 111.752 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.04 106.56 12.15 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.966 0.412 . . . . 25.0 110.308 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -101.05 155.29 18.07 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.603 0.716 . . . . 50.0 110.524 -171.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.4 m -121.11 125.45 47.27 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.243 -0.889 . . . . 25.0 108.701 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -112.1 130.63 55.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.802 -1.555 . . . . 25.0 106.802 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 -122.28 -27.54 4.47 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 120.051 -0.66 . . . . 25.0 112.601 -177.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 63.92 161.77 0.11 Allowed 'General case' 0 N--CA 1.476 0.856 0 O-C-N 124.725 1.265 . . . . 25.0 112.241 -173.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.22 -50.66 10.6 Favored 'General case' 0 C--O 1.247 0.972 0 N-CA-C 114.595 1.332 . . . . 25.0 114.595 -171.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.7 mt -152.31 179.56 8.43 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.08 -0.711 . . . . 25.0 109.08 -172.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -54.26 -29.21 46.18 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.749 0.785 . . . . 25.0 110.451 167.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -69.55 -1.93 10.04 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 114.715 -1.129 . . . . 25.0 113.584 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.81 147.18 37.48 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-O 121.259 0.552 . . . . 25.0 112.385 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.1 t 43.95 60.36 2.76 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 114.471 -1.24 . . . . 25.0 113.934 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 53.5 p-80 -135.12 169.07 18.01 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 115.74 -0.664 . . . . 25.0 110.18 -175.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -116.95 142.62 46.72 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 104.034 -2.58 . . . . 25.0 104.034 171.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 94.7 p -128.0 168.92 13.8 Favored Pre-proline 0 N--CA 1.471 0.602 0 N-CA-C 105.643 -1.984 . . . . 25.0 105.643 -177.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.88 -22.34 62.11 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 117.223 -1.384 . . . . 25.0 113.272 176.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.6 mt -76.71 -18.06 58.73 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.02 0.748 . . . . 25.0 113.02 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 134.99 -176.92 19.7 Favored Glycine 0 C--N 1.31 -0.905 0 N-CA-C 110.853 -0.899 . . . . 25.0 110.853 -177.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.0 t -82.31 147.47 28.86 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 115.601 1.704 . . . . 25.0 115.601 -177.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -135.66 29.89 3.19 Favored 'General case' 0 C--O 1.249 1.031 0 CA-C-N 113.619 -1.628 . . . . 25.0 107.866 173.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.57 147.23 50.64 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 114.27 -1.332 . . . . 25.0 111.957 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -86.69 165.46 16.08 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 107.518 -1.289 . . . . 50.0 107.518 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -121.42 120.12 34.06 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 110.209 -0.293 . . . . 25.0 110.209 -176.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.5 mt -99.1 128.99 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 107.76 -1.2 . . . . 25.0 107.76 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.6 mt -85.2 -46.96 10.57 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 114.929 1.455 . . . . 25.0 114.929 -169.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 42.2 p-10 -131.56 35.59 3.82 Favored 'General case' 0 C--O 1.247 0.948 0 O-C-N 121.27 -0.894 . . . . 25.0 112.751 -175.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -51.37 140.14 17.97 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.821 -1.082 . . . . 25.0 112.323 -176.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -106.84 108.04 61.32 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 108.146 -1.057 . . . . 25.0 108.146 175.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -73.73 -2.3 12.01 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 N-CA-C 115.098 1.153 . . . . 25.0 115.098 -173.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.6 t -101.82 -36.34 8.71 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-O 121.851 0.834 . . . . 25.0 110.093 178.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -98.47 -39.33 8.81 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 113.734 1.013 . . . . 25.0 113.734 -171.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -84.66 169.98 13.78 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.783 -0.573 . . . . 75.0 110.818 -172.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.55 147.81 30.5 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 120.934 -0.307 . . . . 25.0 111.341 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.0 mt -129.33 130.05 67.47 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 N-CA-C 108.284 -1.006 . . . . 25.0 108.284 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.63 139.89 30.1 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 108.507 -0.923 . . . . 25.0 108.507 173.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.7 p -133.69 -5.48 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.237 -0.892 . . . . 25.0 111.446 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.1 t -74.22 -33.08 63.25 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.422 -0.799 . . . . 25.0 111.958 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.97 -43.15 93.59 Favored 'General case' 0 C--O 1.247 0.934 0 O-C-N 121.748 -0.595 . . . . 25.0 111.656 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.16 -13.07 15.83 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 114.853 1.427 . . . . 25.0 114.853 -172.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.68 -80.55 0.25 Allowed Glycine 0 C--O 1.22 -0.753 0 N-CA-C 116.513 1.365 . . . . 25.0 116.513 -172.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -158.14 157.52 32.91 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 117.436 0.618 . . . . 25.0 112.02 -170.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.7 t -108.37 -28.01 9.64 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 123.839 0.712 . . . . 25.0 111.23 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -92.27 106.15 3.37 Favored Glycine 0 CA--C 1.5 -0.906 0 O-C-N 121.369 -0.832 . . . . 25.0 112.288 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.75 143.39 57.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.856 0.828 . . . . 25.0 110.541 -176.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.61 -154.32 30.6 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 116.012 -0.54 . . . . 25.0 114.126 -175.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -59.24 138.19 57.69 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 113.39 0.885 . . . . 25.0 113.39 -176.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 172.73 -168.55 41.62 Favored Glycine 0 C--O 1.252 1.251 0 N-CA-C 110.079 -1.208 . . . . 25.0 110.079 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -155.98 165.49 36.29 Favored 'General case' 0 C--O 1.247 0.957 0 N-CA-C 108.018 -1.105 . . . . 25.0 108.018 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 54.44 36.65 26.06 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 114.984 1.476 . . . . 25.0 114.984 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.32 40.81 32.55 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 109.72 -1.352 . . . . 25.0 109.72 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.7 t -153.74 178.47 9.84 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 117.885 0.843 . . . . 25.0 110.848 -176.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 71.5 mt -95.89 159.78 14.8 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 104.232 -2.507 . . . . 25.0 104.232 168.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.34 130.9 44.78 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 119.711 -0.796 . . . . 25.0 109.186 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.8 m -98.72 155.72 3.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 CA-C-N 115.607 -0.724 . . . . 25.0 109.505 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 97.5 p -144.03 167.01 23.38 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.405 -0.591 . . . . 25.0 109.405 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.3 m -120.52 161.98 19.64 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 N-CA-C 108.807 -0.812 . . . . 25.0 108.807 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.6 t -66.04 -51.77 55.18 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.952 -1.129 . . . . 25.0 107.952 174.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -172.04 -156.28 0.1 Allowed 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 103.261 -2.866 . . . . 25.0 103.261 -178.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -73.48 5.28 3.89 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 113.761 1.022 . . . . 25.0 113.761 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -148.86 -156.88 7.33 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 106.397 -2.681 . . . . 25.0 106.397 175.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 56.64 -164.06 0.16 Allowed 'General case' 0 CA--C 1.562 1.422 0 O-C-N 124.287 0.639 . . . . 25.0 112.527 176.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.6 mtt85 -75.09 159.22 31.94 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.788 1.033 . . . . 25.0 113.788 -170.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.76 159.69 15.11 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 104.499 -2.408 . . . . 25.0 104.499 174.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -130.95 152.05 50.69 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-O 122.564 1.173 . . . . 25.0 110.681 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 39.0 tp -126.78 117.48 22.74 Favored 'General case' 0 C--O 1.245 0.853 0 N-CA-C 103.69 -2.707 . . . . 25.0 103.69 172.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -119.74 152.25 37.49 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 111.952 0.353 . . . . 25.0 111.952 -174.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.9 t -94.45 152.65 18.42 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 104.726 -2.324 . . . . 25.0 104.726 168.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -117.32 17.55 14.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.978 0.894 . . . . 25.0 109.032 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -112.56 146.81 37.89 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 105.607 -1.997 . . . . 25.0 105.607 174.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -139.45 151.87 46.57 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.236 0.541 . . . . 25.0 110.036 -175.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -72.28 160.23 32.74 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 106.305 -1.739 . . . . 25.0 106.305 175.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.36 -18.92 65.11 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.151 0.501 . . . . 25.0 110.106 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -69.36 -8.78 49.51 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.205 0.817 . . . . 25.0 113.205 173.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.17 20.45 57.25 Favored Glycine 0 C--O 1.22 -0.726 0 C-N-CA 120.169 -1.015 . . . . 25.0 110.765 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.2 mt -106.37 119.61 39.71 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.881 -0.785 . . . . 25.0 108.881 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.8 p -116.68 174.97 5.79 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 106.132 -1.803 . . . . 25.0 106.132 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -114.95 131.68 56.82 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 118.681 0.673 . . . . 25.0 110.436 -177.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -145.98 156.86 43.79 Favored 'General case' 0 C--O 1.256 1.413 0 N-CA-C 109.323 -0.621 . . . . 25.0 109.323 166.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.8 p -146.24 141.1 21.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 106.045 -1.835 . . . . 25.0 106.045 177.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -99.13 147.78 24.74 Favored 'General case' 0 C--O 1.249 1.047 0 N-CA-C 107.699 -1.223 . . . . 25.0 107.699 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.6 mp -134.42 133.38 40.45 Favored 'General case' 0 C--O 1.206 -1.186 0 N-CA-C 103.341 -2.837 . . . . 25.0 103.341 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -110.01 13.41 23.35 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 120.051 -0.66 . . . . 25.0 110.966 -177.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -79.11 -5.9 88.95 Favored Glycine 0 C--O 1.217 -0.931 0 CA-C-N 114.809 -1.087 . . . . 25.0 112.04 172.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 14.2 t0 51.5 55.11 9.9 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 114.594 1.331 . . . . 25.0 114.594 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -128.81 46.22 2.65 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.988 -0.551 . . . . 25.0 109.536 -174.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.62 -31.91 66.71 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 113.625 0.972 . . . . 25.0 113.625 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.86 -28.74 65.91 Favored 'General case' 0 CA--C 1.554 1.106 0 O-C-N 121.482 -0.761 . . . . 25.0 111.943 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -93.64 -18.28 22.34 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 112.322 0.49 . . . . 25.0 112.322 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.5 mt -66.48 123.66 20.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 122.195 0.998 . . . . 25.0 111.486 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.45 ' C ' ' H ' ' A' ' 152' ' ' ASP . 70.9 m -137.51 164.06 29.64 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 105.522 -2.029 . . . . 25.0 105.522 177.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -71.51 10.63 0.6 Allowed 'General case' 0 C--O 1.219 -0.511 0 CA-C-O 121.225 0.536 . . . . 25.0 110.866 175.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.45 ' H ' ' C ' ' A' ' 150' ' ' SER . 46.8 t0 -72.61 -30.04 64.0 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 122.631 1.205 . . . . 25.0 110.129 177.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -94.12 8.76 40.43 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.889 -1.051 . . . . 25.0 111.65 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 39.6 mm -116.49 144.67 23.64 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 105.675 -1.972 . . . . 25.0 105.675 175.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.3 p -123.66 127.34 73.92 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 CA-C-O 122.172 0.986 . . . . 25.0 110.827 174.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.85 -30.59 5.36 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 114.379 -1.282 . . . . 25.0 109.873 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -85.42 84.25 7.69 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 115.637 1.717 . . . . 25.0 115.637 -172.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 54.75 25.24 6.33 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.759 1.763 . . . . 25.0 115.759 172.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.41 17.19 4.62 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.872 1.269 . . . . 25.0 113.514 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -98.42 125.49 43.6 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-O 121.234 0.54 . . . . 25.0 110.404 -176.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -67.24 3.09 1.31 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.469 0.914 . . . . 25.0 113.469 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.73 -15.23 63.53 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.33 0.652 . . . . 25.0 111.23 176.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.79 171.06 11.21 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 113.212 0.819 . . . . 25.0 113.212 -177.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 62.93 -170.92 0.17 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.328 1.451 . . . . 25.0 113.981 177.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 77.09 20.23 75.98 Favored Glycine 0 C--O 1.247 0.953 0 CA-C-N 115.304 -0.862 . . . . 25.0 111.15 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -124.9 109.0 12.48 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.806 -0.813 . . . . 25.0 108.806 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -127.54 150.71 49.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.313 -0.995 . . . . 25.0 108.313 -177.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -123.34 40.94 1.87 Allowed Glycine 0 CA--C 1.519 0.337 0 N-CA-C 108.961 -1.656 . . . . 25.0 108.961 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 59.5 t -94.63 -31.95 4.48 Favored 'Isoleucine or valine' 0 C--O 1.251 1.171 0 C-N-CA 122.628 0.371 . . . . 25.0 110.676 -175.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.43 130.05 16.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 CA-C-O 122.705 1.24 . . . . 25.0 113.125 -174.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 151.72 155.64 7.09 Favored Glycine 0 CA--C 1.532 1.145 0 N-CA-C 108.561 -1.815 . . . . 25.0 108.561 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -153.34 147.38 25.53 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 117.849 0.825 . . . . 25.0 110.535 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 98.2 p -149.64 164.98 33.68 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.964 -1.124 . . . . 25.0 107.964 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -175.6 -170.12 38.09 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.995 -0.621 . . . . 25.0 112.369 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -152.59 99.56 2.8 Favored Pre-proline 0 C--N 1.314 -0.963 0 N-CA-C 107.819 -1.178 . . . . 25.0 107.819 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -71.02 153.58 63.07 Favored 'Trans proline' 0 C--O 1.247 0.936 0 C-N-CA 117.05 -1.5 . . . . 25.0 113.396 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -118.79 154.0 33.56 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 106.861 -1.533 . . . . 25.0 106.861 177.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -141.98 77.44 18.44 Favored Pre-proline 0 N--CA 1.47 0.529 0 CA-C-O 121.065 0.459 . . . . 25.0 111.813 -178.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -69.76 145.97 58.77 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 117.462 -1.226 . . . . 25.0 111.666 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 13.4 t -132.36 8.89 4.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.881 0.848 . . . . 25.0 109.526 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 C--N 1.324 -0.512 0 CA-C-N 115.035 -0.984 . . . . 25.0 109.708 177.656 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.727 0.298 . . . . 25.0 110.357 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -116.66 91.57 34.97 Favored Pre-proline 0 N--CA 1.479 1.002 0 N-CA-C 108.446 -0.946 . . . . 25.0 108.446 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -71.86 150.46 55.51 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 117.088 -1.475 . . . . 25.0 114.197 -175.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.15 62.7 0.05 OUTLIER Glycine 0 C--O 1.241 0.578 0 N-CA-C 108.47 -1.852 . . . . 25.0 108.47 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.488 HG23 ' H ' ' A' ' 7' ' ' GLY . 12.2 p -48.5 131.47 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 113.512 0.93 . . . . 25.0 113.512 -172.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -100.68 12.34 37.65 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 114.95 -1.023 . . . . 25.0 110.619 -175.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.488 ' H ' HG23 ' A' ' 5' ' ' VAL . . . -116.9 -151.39 9.45 Favored Glycine 0 N--CA 1.439 -1.117 0 CA-C-N 115.797 -0.638 . . . . 25.0 112.832 -178.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 p 71.53 157.81 0.16 Allowed Pre-proline 0 CA--C 1.555 1.166 0 C-N-CA 126.292 1.837 . . . . 25.0 110.807 -177.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -67.71 6.99 0.62 Allowed 'Trans proline' 0 C--N 1.356 0.932 0 N-CA-C 117.279 1.992 . . . . 25.0 117.279 -176.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.1 p -67.99 -14.43 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 N-CA-C 114.779 1.4 . . . . 25.0 114.779 -173.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.1 p -150.24 144.41 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.269 0 N-CA-C 115.116 1.525 . . . . 25.0 115.116 -175.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.32 17.39 79.69 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 117.726 1.85 . . . . 25.0 117.726 169.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.2 t -50.45 -53.38 30.09 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 114.037 1.125 . . . . 25.0 114.037 -171.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -83.07 8.16 13.74 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 116.541 2.052 . . . . 25.0 116.541 -173.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -141.27 171.9 13.43 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 120.754 -1.216 . . . . 25.0 113.541 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -58.76 127.37 31.87 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.719 0.771 . . . . 25.0 112.478 -174.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -123.75 166.68 15.15 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 113.351 0.871 . . . . 50.0 113.351 -175.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -131.29 95.53 3.8 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 103.349 -2.834 . . . . 25.0 103.349 163.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 64.1 mt -102.99 128.7 49.72 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.15 0.5 . . . . 25.0 110.375 -177.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -124.67 116.04 21.74 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.818 0.818 . . . . 25.0 109.911 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.49 -177.69 49.55 Favored Glycine 0 N--CA 1.462 0.397 0 N-CA-C 116.867 1.507 . . . . 25.0 116.867 -174.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.8 p -84.52 172.9 11.26 Favored 'General case' 0 C--O 1.248 0.982 0 C-N-CA 124.838 1.255 . . . . 25.0 113.467 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.1 mt -87.94 36.56 0.77 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.262 0.553 . . . . 25.0 110.25 171.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -144.19 176.18 23.58 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 107.91 -2.076 . . . . 25.0 107.91 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.5 t -65.57 138.01 57.76 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 112.76 0.652 . . . . 25.0 112.76 -177.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -146.77 164.34 33.1 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.717 -0.674 . . . . 50.0 110.527 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -109.43 114.38 27.98 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 105.202 -2.148 . . . . 25.0 105.202 163.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 40.3 mm -104.1 115.64 46.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 106.764 -1.569 . . . . 25.0 106.764 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 9.8 mp -107.5 127.77 53.91 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 106.484 -1.673 . . . . 25.0 106.484 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.66 -33.08 8.69 Favored Glycine 0 C--N 1.313 -0.724 0 CA-C-O 119.297 -0.724 . . . . 25.0 112.474 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.58 -146.06 49.82 Favored Glycine 0 C--O 1.256 1.47 0 CA-C-N 118.745 1.273 . . . . 25.0 111.996 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.75 168.13 54.1 Favored Glycine 0 C--O 1.248 1.007 0 O-C-N 122.601 -0.353 . . . . 25.0 113.286 -176.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.59 169.13 35.17 Favored Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 111.581 -0.608 . . . . 25.0 111.581 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.95 118.93 25.73 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.51 -1.292 . . . . 25.0 107.51 176.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -116.57 148.47 40.86 Favored 'General case' 0 CA--C 1.511 -0.532 0 O-C-N 121.335 -0.853 . . . . 50.0 111.602 -171.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -104.8 107.38 18.32 Favored 'General case' 0 C--O 1.249 1.054 0 N-CA-C 106.42 -1.696 . . . . 25.0 106.42 171.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 64.3 mt -112.56 133.77 54.44 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 121.99 -0.444 . . . . 25.0 111.008 -175.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -131.93 107.06 8.45 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 121.449 0.642 . . . . 25.0 110.778 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.37 -26.79 50.63 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-O 119.023 -0.876 . . . . 25.0 115.095 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 51.48 -152.15 0.22 Allowed 'General case' 0 C--O 1.244 0.815 0 CA-C-N 117.716 0.758 . . . . 25.0 111.782 -175.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.37 164.29 16.47 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.768 1.025 . . . . 25.0 113.768 -175.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.22 155.43 31.69 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 114.853 -1.067 . . . . 25.0 110.859 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -79.62 102.49 8.94 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 106.665 -1.605 . . . . 25.0 106.665 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -104.85 155.24 19.09 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 121.097 0.475 . . . . 50.0 111.779 -173.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 mp -111.66 134.27 53.34 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 105.87 -1.9 . . . . 25.0 105.87 174.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.5 mp -131.73 117.63 18.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.577 0.703 . . . . 25.0 110.724 -174.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -118.14 89.94 3.23 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.978 -1.01 . . . . 25.0 109.663 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.31 -31.59 74.27 Favored Glycine 0 N--CA 1.468 0.809 0 N-CA-C 116.92 1.528 . . . . 25.0 116.92 -172.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.9 -163.94 51.33 Favored Glycine 0 C--O 1.243 0.705 0 O-C-N 121.864 -0.786 . . . . 25.0 111.269 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.21 161.53 19.09 Favored 'General case' 0 C--O 1.248 1.009 0 C-N-CA 123.051 0.541 . . . . 25.0 109.798 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.93 161.4 32.23 Favored Glycine 0 C--O 1.248 0.991 0 CA-C-O 118.941 -0.921 . . . . 25.0 111.209 177.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -80.85 121.19 25.65 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 105.785 -1.932 . . . . 25.0 105.785 177.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -111.51 152.35 27.6 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.343 -0.844 . . . . 50.0 109.855 -177.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -118.86 119.1 33.37 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 105.742 -1.948 . . . . 25.0 105.742 177.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -141.65 134.74 29.12 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 115.159 1.54 . . . . 25.0 115.159 -168.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.5 m -103.38 141.51 35.82 Favored 'General case' 0 C--O 1.249 1.032 0 N-CA-C 107.229 -1.397 . . . . 25.0 107.229 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.21 -37.36 5.97 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 108.442 -1.863 . . . . 25.0 108.442 175.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.84 -171.11 55.14 Favored Glycine 0 C--O 1.248 1.003 0 C-N-CA 120.626 -0.797 . . . . 25.0 111.859 -178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -65.73 157.09 31.12 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 117.498 0.649 . . . . 25.0 110.061 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.46 164.86 32.0 Favored Glycine 0 C--O 1.245 0.808 0 CA-C-N 115.606 -0.725 . . . . 25.0 112.656 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.15 96.25 9.84 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 123.593 0.757 . . . . 25.0 110.319 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -90.71 159.89 16.12 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 123.462 0.705 . . . . 50.0 112.066 -170.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.1 m -125.51 125.43 43.24 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.797 -0.638 . . . . 25.0 109.385 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -114.68 89.15 3.03 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.398 -0.964 . . . . 25.0 108.398 177.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -88.84 -34.48 17.0 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 119.321 -0.371 . . . . 25.0 111.735 -175.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 66.74 160.82 0.15 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.542 1.137 . . . . 25.0 111.632 -173.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -90.83 -42.88 10.39 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 116.196 1.925 . . . . 25.0 116.196 -166.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.3 mt -140.65 170.49 15.68 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.139 0.792 . . . . 25.0 113.139 -172.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.99 -25.19 43.07 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 123.751 0.82 . . . . 25.0 110.914 175.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -79.12 -12.13 59.99 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 115.112 -0.949 . . . . 25.0 112.906 -178.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -81.73 139.55 34.81 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.412 -0.805 . . . . 25.0 112.911 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.4 t 45.91 40.06 6.27 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 116.52 2.045 . . . . 25.0 116.52 171.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -107.37 170.09 8.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.239 -1.346 . . . . 25.0 110.964 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -124.23 146.66 48.59 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 106.13 -1.804 . . . . 25.0 106.13 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 87.9 p -142.37 168.64 12.89 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 108.613 -0.884 . . . . 25.0 108.613 -177.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -61.04 -27.03 83.98 Favored 'Trans proline' 0 CA--C 1.553 1.44 0 C-N-CA 117.631 -1.112 . . . . 25.0 111.566 175.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.4 mt -65.6 -32.29 73.79 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.861 0.689 . . . . 25.0 112.861 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.53 -174.48 35.65 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 109.974 -1.25 . . . . 25.0 109.974 -176.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.8 t -105.55 144.67 31.98 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.407 1.099 . . . . 25.0 112.74 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -123.82 16.68 9.42 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.027 -1.442 . . . . 25.0 108.964 177.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -62.0 140.94 47.06 Favored Glycine 0 C--N 1.335 0.524 0 CA-C-N 115.645 -0.707 . . . . 25.0 112.649 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -87.03 170.68 11.33 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 117.858 0.829 . . . . 50.0 113.057 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.04 98.36 5.95 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.518 -0.765 . . . . 25.0 110.799 -172.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.2 mt -89.65 133.02 32.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 107.837 -1.171 . . . . 25.0 107.837 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 76.8 mt -85.5 -49.06 8.37 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 115.323 1.601 . . . . 25.0 115.323 -171.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -131.13 36.04 3.87 Favored 'General case' 0 C--O 1.247 0.953 0 CA-C-O 121.458 0.647 . . . . 25.0 112.695 -173.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -53.78 131.59 39.82 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.261 -0.882 . . . . 25.0 112.263 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -103.59 105.66 48.4 Favored Pre-proline 0 C--O 1.238 0.474 0 N-CA-C 108.185 -1.042 . . . . 25.0 108.185 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.78 -9.68 26.92 Favored 'Trans proline' 0 C--N 1.35 0.611 0 N-CA-C 116.119 1.546 . . . . 25.0 116.119 -173.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.1 t -95.9 -36.87 10.94 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.27 -0.572 . . . . 25.0 109.774 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -95.62 -38.02 10.58 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 114.001 1.111 . . . . 25.0 114.001 -173.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -87.77 172.41 9.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.403 0.62 . . . . 75.0 110.478 -173.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -145.08 148.81 34.08 Favored 'General case' 0 C--O 1.252 1.199 0 CA-C-N 116.084 -0.507 . . . . 25.0 111.739 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 85.7 mt -129.09 133.07 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 108.486 -0.931 . . . . 25.0 108.486 -176.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -85.83 149.03 25.53 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 121.694 0.759 . . . . 25.0 109.122 173.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.0 p -146.25 -13.03 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 O-C-N 121.641 -0.662 . . . . 25.0 112.75 176.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.1 t -63.48 -39.95 95.81 Favored 'General case' 0 C--O 1.219 -0.524 0 O-C-N 121.565 -0.709 . . . . 25.0 111.432 -174.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.78 -8.61 59.57 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-N 115.398 -0.819 . . . . 25.0 112.661 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.7 mt -106.18 -29.64 9.72 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.815 0.672 . . . . 25.0 112.815 -174.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.39 -71.6 0.01 OUTLIER Glycine 0 N--CA 1.465 0.574 0 N-CA-C 117.598 1.799 . . . . 25.0 117.598 -176.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -144.96 158.23 43.88 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.794 -0.817 . . . . 25.0 108.794 -170.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 41.0 t -113.55 -28.74 7.4 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 123.651 0.594 . . . . 25.0 112.286 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -100.39 119.6 6.57 Favored Glycine 0 N--CA 1.472 1.054 0 C-N-CA 121.495 -0.383 . . . . 25.0 112.323 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.29 146.4 34.36 Favored 'General case' 0 C--O 1.245 0.853 0 N-CA-C 114.065 1.135 . . . . 25.0 114.065 -174.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -95.86 -151.95 28.65 Favored Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.824 -0.703 . . . . 25.0 114.26 -177.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -59.51 131.73 51.85 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 122.446 1.117 . . . . 25.0 111.639 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 160.38 170.44 24.97 Favored Glycine 0 C--O 1.24 0.476 0 N-CA-C 107.573 -2.211 . . . . 25.0 107.573 -179.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -148.22 167.73 24.35 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 118.299 1.05 . . . . 25.0 109.4 -177.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 62.98 38.6 10.94 Favored 'General case' 0 C--O 1.248 1.011 0 C-N-CA 124.518 1.127 . . . . 25.0 111.801 -174.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 65.82 44.18 92.56 Favored Glycine 0 C--O 1.242 0.629 0 N-CA-C 109.938 -1.265 . . . . 25.0 109.938 177.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.7 t -151.58 179.76 8.1 Favored 'General case' 0 C--O 1.212 -0.873 0 O-C-N 122.391 -0.476 . . . . 25.0 111.18 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 85.1 mt -106.8 167.02 10.16 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 103.855 -2.646 . . . . 25.0 103.855 173.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.54 131.17 42.88 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 119.597 1.09 . . . . 25.0 110.21 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 18.6 m -95.44 163.47 2.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.426 -0.806 . . . . 25.0 109.838 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 80.0 p -149.03 160.09 43.63 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.538 -0.726 . . . . 25.0 110.6 -177.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 28.0 m -122.44 165.16 18.71 Favored 'Isoleucine or valine' 0 C--O 1.252 1.221 0 N-CA-C 109.727 -0.471 . . . . 25.0 109.727 -177.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.3 t -76.28 -50.75 13.55 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 122.22 1.01 . . . . 25.0 109.682 176.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -162.18 -152.77 0.25 Allowed 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 103.753 -2.684 . . . . 25.0 103.753 -176.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -73.31 -6.19 44.47 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 119.211 0.914 . . . . 25.0 110.63 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -148.21 -146.68 4.38 Favored Glycine 0 C--O 1.247 0.958 0 N-CA-C 109.922 -1.271 . . . . 25.0 109.922 174.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.25 -152.55 0.39 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.051 0.541 . . . . 25.0 112.416 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -75.71 162.37 28.28 Favored 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 113.919 1.081 . . . . 25.0 113.919 -171.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.61 158.0 21.38 Favored 'General case' 0 C--O 1.213 -0.851 0 N-CA-C 105.978 -1.86 . . . . 25.0 105.978 175.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -129.66 144.57 51.34 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 124.12 0.887 . . . . 25.0 111.419 175.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 49.4 tp -115.41 122.77 46.83 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 102.778 -3.045 . . . . 25.0 102.778 173.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -121.59 155.29 35.38 Favored 'General case' 0 C--O 1.211 -0.957 0 CA-C-O 121.39 0.614 . . . . 25.0 110.411 -173.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 41.0 t -92.04 152.57 19.91 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.49 -1.3 . . . . 25.0 107.49 171.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -123.01 19.17 10.05 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 108.539 -0.912 . . . . 25.0 108.539 175.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -118.96 139.84 51.0 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 105.223 -2.14 . . . . 25.0 105.223 170.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -139.25 165.08 28.13 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.528 0.68 . . . . 25.0 110.231 -177.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -85.68 163.96 17.95 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.021 -1.474 . . . . 25.0 107.021 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.31 -24.41 67.27 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 108.116 -1.068 . . . . 25.0 108.116 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -74.86 -5.55 44.21 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.432 -0.804 . . . . 25.0 112.472 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.75 1.23 83.06 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 120.33 -0.938 . . . . 25.0 111.811 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.8 mt -75.74 133.99 40.59 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.417 -0.586 . . . . 25.0 109.417 175.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 88.1 p -144.44 -172.71 3.85 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 106.199 -1.778 . . . . 25.0 106.199 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -131.4 141.35 49.84 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 121.293 -0.163 . . . . 25.0 110.614 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -154.45 158.81 40.52 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 106.99 -1.485 . . . . 25.0 106.99 166.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.2 p -145.23 144.37 21.53 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 N-CA-C 108.247 -1.02 . . . . 25.0 108.247 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -105.36 136.67 44.48 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 108.453 -0.943 . . . . 25.0 108.453 -177.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.1 mp -134.03 129.8 36.62 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 106.957 -1.497 . . . . 25.0 106.957 -177.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -90.96 -1.75 57.79 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 119.224 -0.99 . . . . 25.0 112.482 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -66.35 -21.24 70.23 Favored Glycine 0 C--O 1.242 0.607 0 N-CA-C 115.139 0.816 . . . . 25.0 115.139 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 29.4 t0 53.14 59.11 4.65 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 123.626 1.679 . . . . 25.0 111.324 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -120.98 41.0 3.42 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 112.217 -2.265 . . . . 25.0 107.711 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.36 -35.39 75.57 Favored 'General case' 0 C--O 1.214 -0.796 0 CA-C-N 114.961 -1.018 . . . . 25.0 113.511 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.17 -29.42 62.83 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 118.232 0.469 . . . . 25.0 110.794 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -85.21 -13.22 50.61 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 112.8 0.667 . . . . 25.0 112.8 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 14.5 mt -69.87 128.2 35.55 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.94 0.719 . . . . 25.0 112.94 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 34.4 m -138.59 161.65 36.57 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.34 -0.985 . . . . 25.0 108.34 171.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.92 4.93 5.69 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 109.5 -0.556 . . . . 25.0 109.5 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -66.75 -30.74 71.04 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.684 0.615 . . . . 25.0 110.451 177.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -91.63 -4.0 55.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.129 0.49 . . . . 25.0 111.338 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 48.2 mm -94.02 126.26 46.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 106.542 -1.651 . . . . 25.0 106.542 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.2 p -103.43 114.57 43.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 122.113 0.958 . . . . 25.0 110.827 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -156.18 -9.17 0.11 Allowed 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.729 1.751 . . . . 25.0 115.729 -177.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -88.18 71.93 9.16 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 118.855 0.752 . . . . 25.0 111.264 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 56.49 21.15 5.36 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.27 1.028 . . . . 25.0 113.347 -178.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 53.84 38.33 28.41 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.756 -0.656 . . . . 25.0 111.415 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -123.26 124.8 43.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.36 0.6 . . . . 25.0 111.332 -178.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.09 -4.28 28.02 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.726 -0.67 . . . . 25.0 112.303 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.34 -13.01 61.03 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.644 -0.502 . . . . 25.0 109.644 174.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.24 -176.31 6.26 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 122.727 0.411 . . . . 25.0 110.497 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 58.85 -162.45 0.24 Allowed 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.201 -1.363 . . . . 25.0 113.045 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.15 22.04 77.05 Favored Glycine 0 C--N 1.336 0.578 0 N-CA-C 110.945 -0.862 . . . . 25.0 110.945 -175.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -112.99 93.85 4.62 Favored 'General case' 0 C--O 1.246 0.875 0 C-N-CA 123.673 0.789 . . . . 25.0 110.535 -176.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -128.84 145.57 51.17 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 109.148 -0.686 . . . . 25.0 109.148 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -119.35 24.08 8.28 Favored Glycine 0 N--CA 1.462 0.424 0 N-CA-C 111.368 -0.693 . . . . 25.0 111.368 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 44.6 t -71.59 -30.15 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 122.083 0.944 . . . . 25.0 109.44 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.49 134.58 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 122.196 0.998 . . . . 25.0 109.211 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 154.81 152.14 6.05 Favored Glycine 0 C--O 1.242 0.611 0 CA-C-N 115.393 -0.821 . . . . 25.0 112.992 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -148.38 123.62 10.21 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.355 -0.609 . . . . 25.0 109.355 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 56.2 p -151.97 160.14 43.57 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.316 -0.994 . . . . 25.0 108.316 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 166.06 -172.8 41.52 Favored Glycine 0 C--N 1.319 -0.374 0 C-N-CA 121.252 -0.499 . . . . 25.0 112.161 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -138.99 109.3 7.67 Favored Pre-proline 0 C--O 1.244 0.766 0 N-CA-C 107.943 -1.132 . . . . 25.0 107.943 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.92 164.48 31.54 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 117.655 -1.097 . . . . 25.0 113.266 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -128.52 156.03 43.93 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.531 -0.759 . . . . 25.0 109.124 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -132.01 87.74 43.37 Favored Pre-proline 0 C--O 1.243 0.733 0 N-CA-C 108.912 -0.773 . . . . 25.0 108.912 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -71.29 156.18 59.35 Favored 'Trans proline' 0 C--N 1.353 0.8 0 N-CA-C 113.893 0.689 . . . . 25.0 113.893 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 11.8 t -123.3 -11.49 7.93 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.286 0.565 . . . . 25.0 110.927 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 10.1 p . . . . . 0 C--O 1.235 0.342 0 N-CA-C 107.654 -1.239 . . . . 25.0 107.654 177.341 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.456 0.17 . . . . 25.0 110.67 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -140.21 114.2 7.57 Favored Pre-proline 0 C--O 1.248 0.998 0 N-CA-C 108.184 -1.043 . . . . 25.0 108.184 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.02 167.04 28.41 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 118.119 -0.787 . . . . 25.0 113.503 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.41 56.82 0.01 OUTLIER Glycine 0 C--O 1.225 -0.416 0 O-C-N 121.921 -0.487 . . . . 25.0 112.023 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.416 HG23 ' H ' ' A' ' 7' ' ' GLY . 7.2 p -64.42 137.71 24.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 122.027 0.917 . . . . 25.0 111.287 -176.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -105.66 -4.53 20.94 Favored 'General case' 0 C--O 1.242 0.661 0 O-C-N 121.742 -0.599 . . . . 25.0 110.849 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.416 ' H ' HG23 ' A' ' 5' ' ' VAL . . . -84.99 -141.54 5.51 Favored Glycine 0 C--O 1.221 -0.692 0 C-N-CA 121.492 -0.385 . . . . 25.0 113.384 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.0 p 69.78 157.8 0.15 Allowed Pre-proline 0 N--CA 1.485 1.31 0 C-N-CA 125.413 1.485 . . . . 25.0 111.61 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -72.84 3.07 4.7 Favored 'Trans proline' 0 C--N 1.353 0.774 0 N-CA-C 116.46 1.677 . . . . 25.0 116.46 -177.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.4 p -67.17 -18.15 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 116.196 1.925 . . . . 25.0 116.196 -170.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.4 p -148.27 144.28 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 CA-C-N 119.222 0.919 . . . . 25.0 113.39 -176.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.29 15.59 80.77 Favored Glycine 0 C--N 1.333 0.379 0 N-CA-C 117.18 1.632 . . . . 25.0 117.18 174.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.3 t -52.64 -48.68 66.25 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.887 1.069 . . . . 25.0 113.887 -171.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -77.72 3.82 13.11 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 115.198 1.555 . . . . 25.0 115.198 -173.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.93 168.82 18.99 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.903 1.075 . . . . 25.0 113.903 -177.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.62 129.39 41.69 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.573 0.583 . . . . 25.0 112.573 -175.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -128.52 159.88 34.07 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 115.451 1.649 . . . . 50.0 115.451 -174.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -112.86 118.1 33.97 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 104.529 -2.397 . . . . 25.0 104.529 162.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.2 mt -121.14 85.82 2.47 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.956 0.884 . . . . 25.0 111.627 -173.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -90.01 110.64 21.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.296 -0.865 . . . . 25.0 109.984 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.02 170.45 43.42 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 116.181 1.232 . . . . 25.0 116.181 -176.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.2 p -71.81 174.89 6.27 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.753 0.787 . . . . 25.0 112.989 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 73.6 mt -86.13 18.6 3.01 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.099 -0.955 . . . . 25.0 111.193 176.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.66 176.35 16.06 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.402 -1.079 . . . . 25.0 110.402 176.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.4 t -70.73 136.63 49.06 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 117.649 0.725 . . . . 25.0 110.517 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -143.51 159.32 42.64 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 120.903 0.382 . . . . 50.0 110.044 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -95.96 131.12 42.66 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 102.959 -2.978 . . . . 25.0 102.959 161.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.8 mm -121.36 121.9 65.92 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 N-CA-C 105.497 -2.038 . . . . 25.0 105.497 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.5 tt -123.45 124.0 41.92 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.066 -1.087 . . . . 25.0 108.066 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.3 -38.27 11.24 Favored Glycine 0 CA--C 1.502 -0.722 0 C-N-CA 119.947 -1.12 . . . . 25.0 113.102 -177.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 72.19 -147.25 40.73 Favored Glycine 0 C--O 1.254 1.364 0 CA-C-N 118.983 1.391 . . . . 25.0 112.018 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.95 164.78 54.63 Favored Glycine 0 C--O 1.243 0.691 0 N-CA-C 111.751 -0.54 . . . . 25.0 111.751 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.22 163.67 34.82 Favored Glycine 0 C--O 1.244 0.719 0 CA-C-O 119.462 -0.632 . . . . 25.0 113.741 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.5 103.34 11.97 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.165 -1.42 . . . . 25.0 107.165 176.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -103.32 157.63 16.89 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.471 -0.491 . . . . 50.0 110.258 -172.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -120.56 90.66 3.37 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 108.82 -0.807 . . . . 25.0 108.82 177.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.0 mp -86.06 136.5 33.21 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.035 -0.529 . . . . 25.0 110.694 -175.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -138.55 106.62 5.72 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.331 -0.618 . . . . 25.0 109.331 174.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.98 -28.17 54.85 Favored Glycine 0 N--CA 1.467 0.766 0 CA-C-O 118.011 -1.438 . . . . 25.0 116.184 -175.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 54.8 -147.99 0.49 Allowed 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 118.187 0.994 . . . . 25.0 111.428 -177.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.94 163.47 19.64 Favored 'General case' 0 C--O 1.256 1.409 0 CA-C-O 122.153 0.978 . . . . 25.0 112.495 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.05 157.63 33.66 Favored Glycine 0 CA--C 1.521 0.452 0 CA-C-N 114.358 -1.292 . . . . 25.0 110.173 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -81.77 110.96 17.57 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 105.635 -1.987 . . . . 25.0 105.635 177.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -110.6 150.81 28.44 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.934 -0.706 . . . . 50.0 110.02 -171.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 mp -112.9 95.07 5.21 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.957 0.786 . . . . 25.0 109.457 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.8 mp -100.74 116.34 32.4 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 114.963 1.468 . . . . 25.0 114.963 -170.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -118.03 111.92 19.56 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 115.3 -0.864 . . . . 25.0 109.207 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.37 -32.61 79.86 Favored Glycine 0 C--O 1.254 1.389 0 N-CA-C 117.262 1.665 . . . . 25.0 117.262 -174.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.47 -163.78 42.97 Favored Glycine 0 N--CA 1.458 0.143 0 C-N-CA 120.91 -0.662 . . . . 25.0 111.909 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.2 159.46 17.63 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.307 0.575 . . . . 25.0 112.317 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.38 173.1 47.55 Favored Glycine 0 C--O 1.227 -0.291 0 CA-C-N 115.447 -0.797 . . . . 25.0 114.113 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.54 125.26 33.65 Favored 'General case' 0 C--O 1.208 -1.112 0 N-CA-C 104.069 -2.567 . . . . 25.0 104.069 176.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -117.96 157.56 26.51 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.907 0.384 . . . . 50.0 110.967 -174.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -113.26 131.04 56.07 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 102.869 -3.011 . . . . 25.0 102.869 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -148.98 149.05 30.52 Favored 'General case' 0 C--O 1.248 0.997 0 C-N-CA 119.374 -0.93 . . . . 25.0 111.691 -175.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.19 146.76 35.61 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 109.6 -0.519 . . . . 25.0 109.6 -176.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -98.85 -42.75 2.79 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-O 118.649 -1.084 . . . . 25.0 113.445 -174.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.34 -169.6 52.79 Favored Glycine 0 C--O 1.248 0.991 0 CA-C-N 118.843 1.322 . . . . 25.0 111.534 -177.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -60.58 155.08 19.51 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.846 -0.797 . . . . 25.0 110.21 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.0 163.23 32.24 Favored Glycine 0 C--O 1.249 1.063 0 CA-C-N 115.312 -0.858 . . . . 25.0 111.036 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.75 96.09 9.15 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 123.395 0.678 . . . . 25.0 110.028 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -88.94 158.25 18.12 Favored 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 123.258 0.623 . . . . 50.0 111.622 -170.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.1 m -123.15 134.04 54.22 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.965 -0.754 . . . . 25.0 108.965 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -126.45 100.81 6.42 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.467 -1.309 . . . . 25.0 107.467 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 54.2 mtt85 -100.13 -27.67 13.42 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.552 0.945 . . . . 25.0 113.552 -178.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 67.77 162.22 0.19 Allowed 'General case' 0 CA--C 1.534 0.356 0 O-C-N 125.276 1.61 . . . . 25.0 110.386 -174.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.8 -49.56 17.73 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 116.166 1.913 . . . . 25.0 116.166 -170.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 81.8 mt -153.98 -179.65 8.06 Favored 'General case' 0 C--O 1.205 -1.251 0 O-C-N 121.45 -0.781 . . . . 25.0 109.535 -171.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -55.86 -27.1 50.07 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.635 -0.876 . . . . 25.0 108.635 167.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -71.29 -10.28 59.49 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 112.965 0.728 . . . . 25.0 112.965 -178.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -99.34 155.32 17.58 Favored 'General case' 0 C--O 1.215 -0.719 0 O-C-N 121.76 -0.588 . . . . 25.0 110.463 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.4 m 42.83 56.49 3.95 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.093 -0.958 . . . . 25.0 113.464 169.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 42.8 p-80 -134.38 168.79 18.27 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 122.02 0.914 . . . . 25.0 111.482 -174.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -125.75 138.93 53.88 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 102.992 -2.966 . . . . 25.0 102.992 173.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.5 p -134.99 172.51 7.13 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 108.316 -0.994 . . . . 25.0 108.316 -173.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -60.13 -15.73 35.74 Favored 'Trans proline' 0 CA--C 1.555 1.559 0 N-CA-C 114.782 1.032 . . . . 25.0 114.782 175.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.6 mt -85.23 -24.67 27.73 Favored 'General case' 0 C--O 1.215 -0.723 0 N-CA-C 111.8 0.296 . . . . 25.0 111.8 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.06 -165.21 30.68 Favored Glycine 0 C--O 1.21 -1.393 0 C-N-CA 120.39 -0.909 . . . . 25.0 111.618 -175.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.9 t -106.55 141.41 37.88 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 122.762 1.268 . . . . 25.0 112.089 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -132.96 32.95 3.72 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-N 114.989 -1.005 . . . . 25.0 109.73 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -73.16 160.99 54.21 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 110.481 -1.047 . . . . 25.0 110.481 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -104.46 169.79 8.27 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 117.994 0.897 . . . . 50.0 110.539 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -121.07 104.58 9.89 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.432 1.093 . . . . 25.0 110.545 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.4 mt -94.02 135.13 29.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 106.747 -1.575 . . . . 25.0 106.747 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 21.6 mt -84.48 -45.63 12.45 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.729 1.751 . . . . 25.0 115.729 -174.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -135.27 38.1 2.95 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 115.134 -0.939 . . . . 25.0 113.429 -169.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -59.26 125.07 22.13 Favored 'General case' 0 C--O 1.218 -0.605 0 N-CA-C 108.791 -0.818 . . . . 25.0 108.791 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -92.1 103.82 9.2 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.897 -0.592 . . . . 25.0 109.697 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -69.04 -4.25 13.17 Favored 'Trans proline' 0 CA--C 1.548 1.209 0 N-CA-C 115.841 1.439 . . . . 25.0 115.841 -175.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.6 t -95.78 -43.3 7.93 Favored 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 122.193 -0.317 . . . . 25.0 110.829 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -97.43 -38.08 9.75 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 113.812 1.041 . . . . 25.0 113.812 -174.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -86.81 170.57 11.58 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.729 -0.388 . . . . 75.0 110.687 -172.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -145.62 149.34 34.35 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 116.208 -0.451 . . . . 25.0 111.006 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 67.7 mt -124.92 125.83 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 107.6 -1.259 . . . . 25.0 107.6 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -89.34 136.23 33.14 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-O 122.02 0.914 . . . . 25.0 108.913 173.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 p -134.46 2.97 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 114.452 -1.249 . . . . 25.0 108.539 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.466 ' HB2' ' HA ' ' A' ' 156' ' ' PHE . 23.7 t -67.32 -47.84 69.34 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 120.722 -0.391 . . . . 25.0 111.146 -175.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.19 -36.0 82.18 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.894 0.702 . . . . 25.0 112.894 -175.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.3 -49.64 4.19 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.585 0.958 . . . . 25.0 113.585 -175.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.31 -78.8 1.32 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 116.375 1.31 . . . . 25.0 116.375 -169.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -157.06 171.37 20.58 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 117.518 0.659 . . . . 25.0 110.114 -168.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 30.6 t -105.51 -36.25 7.19 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.587 0.755 . . . . 25.0 111.451 -177.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -105.91 145.68 15.97 Favored Glycine 0 N--CA 1.468 0.819 0 CA-C-O 118.355 -1.247 . . . . 25.0 111.354 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -61.61 148.31 42.84 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-N 118.814 1.307 . . . . 25.0 110.245 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.0 -167.1 41.15 Favored Glycine 0 C--O 1.243 0.708 0 CA-C-N 114.764 -1.107 . . . . 25.0 113.309 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -65.23 142.11 58.41 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.385 -0.968 . . . . 25.0 108.385 177.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 169.9 178.2 40.77 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 108.723 -1.751 . . . . 25.0 108.723 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -138.18 168.93 18.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 118.102 0.951 . . . . 25.0 109.485 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 61.05 35.28 18.88 Favored 'General case' 0 C--O 1.253 1.241 0 O-C-N 123.958 0.786 . . . . 25.0 112.489 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 65.03 39.32 96.32 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 120.785 -0.722 . . . . 25.0 111.74 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.7 t -146.24 177.43 9.0 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.752 -0.462 . . . . 25.0 109.752 -176.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 92.5 mt -90.08 170.27 10.47 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 105.507 -2.034 . . . . 25.0 105.507 175.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.21 111.72 1.84 Allowed 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 118.575 0.625 . . . . 25.0 110.679 -177.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 17.0 m -102.57 155.19 5.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 107.078 -1.453 . . . . 25.0 107.078 174.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 83.5 p -156.46 173.52 16.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 118.316 0.507 . . . . 25.0 110.715 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.1 m -118.97 160.39 18.87 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 N-CA-C 109.245 -0.65 . . . . 25.0 109.245 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.6 t -69.71 -52.48 25.14 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.837 -1.542 . . . . 25.0 106.837 173.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -164.28 -160.74 0.55 Allowed 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 102.947 -2.983 . . . . 25.0 102.947 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -55.16 -38.87 68.85 Favored 'General case' 0 C--O 1.252 1.225 0 CA-C-N 118.078 0.399 . . . . 25.0 111.104 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.72 -156.42 13.57 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 112.073 -0.411 . . . . 25.0 112.073 176.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.87 -168.67 0.18 Allowed 'General case' 0 C--O 1.251 1.132 0 C-N-CA 124.128 0.971 . . . . 25.0 111.475 177.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 64.9 mtt85 -72.83 160.35 32.3 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.46 0.911 . . . . 25.0 113.46 -171.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -102.6 168.16 9.45 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 105.575 -2.009 . . . . 25.0 105.575 175.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -131.57 156.03 46.46 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.778 0.799 . . . . 25.0 111.961 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 52.5 tp -127.32 116.21 20.17 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 102.976 -2.972 . . . . 25.0 102.976 174.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -122.69 162.99 20.92 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 108.601 -0.889 . . . . 25.0 108.601 -173.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.0 t -140.09 144.41 36.77 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 103.123 -2.918 . . . . 25.0 103.123 172.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -102.4 12.45 36.53 Favored 'General case' 0 C--O 1.245 0.859 0 N-CA-C 109.163 -0.68 . . . . 25.0 109.163 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -81.25 135.11 35.7 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 105.192 -2.151 . . . . 25.0 105.192 172.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -141.91 147.35 36.93 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 122.367 1.08 . . . . 25.0 110.96 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.26 159.51 31.13 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.232 -1.396 . . . . 25.0 107.232 174.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.07 -20.32 66.13 Favored 'General case' 0 CA--C 1.548 0.886 0 O-C-N 121.688 -0.632 . . . . 25.0 109.665 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -77.29 -4.45 45.03 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.49 -0.777 . . . . 25.0 113.072 175.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.18 6.14 63.29 Favored Glycine 0 CA--C 1.51 -0.247 0 N-CA-C 116.571 1.388 . . . . 25.0 116.571 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 69.2 mt -86.52 120.02 27.4 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 110.313 -0.255 . . . . 25.0 110.313 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 25.6 p -119.51 176.57 5.3 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.442 0.697 . . . . 25.0 109.248 -178.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -118.1 132.06 56.38 Favored 'General case' 0 C--O 1.257 1.456 0 N-CA-C 114.126 1.158 . . . . 25.0 114.126 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -152.57 151.69 30.96 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.169 -1.048 . . . . 25.0 108.169 167.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.5 p -149.09 147.83 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 106.113 -1.81 . . . . 25.0 106.113 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -109.73 145.22 36.95 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 111.685 0.254 . . . . 25.0 111.685 -177.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mp -134.0 128.34 34.16 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.451 -1.314 . . . . 25.0 107.451 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -86.9 -12.77 46.75 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 114.905 1.446 . . . . 25.0 114.905 -173.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -75.75 -6.22 81.11 Favored Glycine 0 C--O 1.212 -1.267 0 N-CA-C 116.347 1.299 . . . . 25.0 116.347 -171.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 47.7 t0 50.87 54.11 11.82 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 122.216 1.008 . . . . 25.0 113.068 -175.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 14.5 p80 -114.35 41.44 2.3 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 107.227 -1.397 . . . . 25.0 107.227 174.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.53 -36.61 84.33 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.004 -0.998 . . . . 25.0 111.624 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -77.49 -24.04 50.18 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.105 -0.997 . . . . 25.0 111.219 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.13 -24.71 37.46 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.541 -0.754 . . . . 25.0 110.699 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 8.1 mt -63.22 139.12 58.74 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 119.8 -0.76 . . . . 25.0 111.756 177.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 92.8 p -138.27 165.74 25.95 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.543 -0.91 . . . . 25.0 108.543 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.68 -3.18 29.82 Favored 'General case' 0 C--N 1.312 -1.03 0 O-C-N 120.997 -1.064 . . . . 25.0 109.879 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -77.43 -37.0 52.59 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 120.944 -1.098 . . . . 25.0 111.398 -177.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -89.72 -5.44 57.01 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 121.138 -0.225 . . . . 25.0 111.421 -177.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 44.4 mm -99.63 122.01 50.96 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.793 0 N-CA-C 103.833 -2.654 . . . . 25.0 103.833 173.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.7 p -112.82 125.08 70.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 122.779 1.276 . . . . 25.0 111.377 -174.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.466 ' HA ' ' HB2' ' A' ' 97' ' ' SER . 1.3 p90 -141.68 -32.22 0.54 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 112.774 -2.012 . . . . 25.0 109.717 -176.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -75.47 55.41 0.81 Allowed 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.674 1.361 . . . . 25.0 114.674 -176.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 60.1 15.88 5.51 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 115.616 1.71 . . . . 25.0 115.616 175.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.4 m 65.29 -23.99 0.09 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.965 1.706 . . . . 25.0 115.599 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -58.86 125.35 23.18 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.248 0.619 . . . . 25.0 111.24 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -96.89 15.04 23.32 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.174 0.805 . . . . 25.0 113.174 -175.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.9 2.26 12.94 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.92 1.081 . . . . 25.0 113.92 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -145.87 -174.96 4.56 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.323 -1.362 . . . . 25.0 107.323 177.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 67.74 -178.24 0.21 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.442 1.097 . . . . 25.0 111.58 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 86.59 21.44 51.09 Favored Glycine 0 C--O 1.24 0.498 0 N-CA-C 109.159 -1.576 . . . . 25.0 109.159 -172.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -77.56 89.44 3.89 Favored 'General case' 0 C--O 1.247 0.96 0 C-N-CA 123.198 0.599 . . . . 25.0 111.659 -177.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -123.28 143.36 50.11 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.598 -0.889 . . . . 25.0 108.598 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -140.79 32.92 2.09 Favored Glycine 0 N--CA 1.461 0.358 0 N-CA-C 109.781 -1.328 . . . . 25.0 109.781 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 47.9 t -71.48 -35.08 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 112.03 0.382 . . . . 25.0 112.03 -175.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.27 130.19 25.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-O 121.195 0.521 . . . . 25.0 111.374 -177.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 152.58 158.67 8.6 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 109.298 -1.521 . . . . 25.0 109.298 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -151.95 144.49 24.18 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 118.625 1.213 . . . . 25.0 110.593 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 68.9 p -142.7 162.77 34.61 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 105.637 -1.986 . . . . 25.0 105.637 175.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -174.02 161.83 32.21 Favored Glycine 0 C--N 1.318 -0.427 0 C-N-CA 120.249 -0.977 . . . . 25.0 113.283 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -136.7 83.29 30.27 Favored Pre-proline 0 C--O 1.241 0.645 0 N-CA-C 108.364 -0.976 . . . . 25.0 108.364 177.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.24 161.54 45.62 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 118.15 -0.767 . . . . 25.0 112.376 -174.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -113.24 150.49 32.31 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 123.51 0.724 . . . . 25.0 110.212 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -138.17 70.73 48.03 Favored Pre-proline 0 N--CA 1.479 0.998 0 CA-C-O 120.903 0.382 . . . . 25.0 110.967 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -73.06 153.85 52.28 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 116.918 -1.588 . . . . 25.0 112.875 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.6 t -84.63 7.05 21.58 Favored 'General case' 0 C--O 1.25 1.085 0 CA-C-O 120.902 0.382 . . . . 25.0 111.658 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 C--O 1.254 1.33 0 CA-C-O 116.833 -1.556 . . . . 25.0 110.335 -177.664 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.452 0 N-CA-C 110.158 -0.312 . . . . 25.0 110.158 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -129.35 112.51 18.12 Favored Pre-proline 0 C--O 1.254 1.311 0 N-CA-C 108.062 -1.088 . . . . 25.0 108.062 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.71 149.67 67.51 Favored 'Trans proline' 0 N--CA 1.476 0.468 0 C-N-CA 116.882 -1.612 . . . . 25.0 114.409 -177.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.09 65.95 0.05 OUTLIER Glycine 0 C--O 1.222 -0.655 0 C-N-CA 121.106 -0.569 . . . . 25.0 112.489 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.7 p -61.49 132.0 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 122.742 1.258 . . . . 25.0 111.417 -176.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -91.94 -19.88 21.98 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 114.986 -1.007 . . . . 25.0 111.203 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.76 -146.13 7.78 Favored Glycine 0 C--O 1.223 -0.568 0 N-CA-C 116.899 1.52 . . . . 25.0 116.899 -175.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.7 p 73.36 155.59 0.16 Allowed Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 126.928 2.091 . . . . 25.0 110.427 -175.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -67.4 13.12 0.17 Allowed 'Trans proline' 0 CA--C 1.545 1.07 0 N-CA-C 117.386 2.033 . . . . 25.0 117.386 -175.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.55 -20.78 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 115.38 1.622 . . . . 25.0 115.38 -174.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.7 p -146.47 141.5 20.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.999 0.74 . . . . 25.0 112.999 -175.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.56 17.15 69.14 Favored Glycine 0 C--O 1.241 0.585 0 N-CA-C 118.324 2.09 . . . . 25.0 118.324 173.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.2 t -51.51 -54.6 25.56 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.517 0.932 . . . . 25.0 113.517 -174.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -82.48 12.6 4.36 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 117.535 2.42 . . . . 25.0 117.535 -174.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -147.95 170.48 17.62 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 122.038 -0.414 . . . . 25.0 111.837 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -58.3 136.24 57.32 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 112.795 0.665 . . . . 25.0 112.795 -175.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -123.0 160.79 25.54 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 116.221 1.934 . . . . 50.0 116.221 -173.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -137.23 105.36 5.69 Favored 'General case' 0 C--O 1.249 1.042 0 N-CA-C 103.795 -2.668 . . . . 25.0 103.795 160.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.6 mt -125.29 131.21 53.11 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.312 0.486 . . . . 25.0 112.312 -175.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -118.59 111.86 19.12 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 122.489 0.316 . . . . 25.0 111.839 -176.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.32 -177.9 51.38 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 117.916 1.926 . . . . 25.0 117.916 -174.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.1 p -81.55 173.32 12.5 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.051 0.94 . . . . 25.0 112.054 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.4 mt -84.56 5.89 25.95 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.748 -0.595 . . . . 25.0 111.494 174.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -100.23 -179.24 30.06 Favored Glycine 0 N--CA 1.464 0.544 0 N-CA-C 111.83 -0.508 . . . . 25.0 111.83 177.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.3 t -78.54 124.92 28.67 Favored 'General case' 0 C--O 1.24 0.585 0 O-C-N 122.121 -0.635 . . . . 25.0 110.053 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -131.36 156.24 45.86 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.899 0.38 . . . . 50.0 111.018 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -98.42 129.14 45.05 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 102.825 -3.028 . . . . 25.0 102.825 163.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.8 mm -126.59 124.48 65.3 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.56 0 N-CA-C 105.969 -1.863 . . . . 25.0 105.969 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.8 mp -125.85 121.72 34.04 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.35 -1.352 . . . . 25.0 107.35 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.23 -34.31 37.35 Favored Glycine 0 C--N 1.318 -0.424 0 C-N-CA 120.68 -0.771 . . . . 25.0 114.933 -178.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 72.31 -145.59 37.82 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 110.415 -1.074 . . . . 25.0 110.415 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -78.63 169.79 54.46 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-O 121.897 0.721 . . . . 25.0 111.352 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.77 159.92 27.52 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.574 -0.822 . . . . 25.0 113.553 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.72 104.49 13.01 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 105.629 -1.989 . . . . 25.0 105.629 176.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -103.31 148.9 25.27 Favored 'General case' 0 C--N 1.314 -0.941 0 O-C-N 121.365 -0.834 . . . . 50.0 111.073 -169.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -112.34 98.57 7.38 Favored 'General case' 0 C--O 1.246 0.92 0 N-CA-C 105.135 -2.172 . . . . 25.0 105.135 176.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 62.8 mt -106.86 133.55 51.35 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.118 -0.492 . . . . 25.0 111.532 -172.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -130.3 106.87 8.86 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 122.659 0.384 . . . . 25.0 110.166 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.12 -19.69 49.38 Favored Glycine 0 CA--C 1.534 1.279 0 N-CA-C 117.682 1.833 . . . . 25.0 117.682 -178.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 53.35 -148.18 0.46 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 118.711 1.255 . . . . 25.0 113.188 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.63 165.87 20.27 Favored 'General case' 0 C--O 1.254 1.292 0 CA-C-O 121.247 0.546 . . . . 25.0 112.087 -176.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.37 153.53 30.16 Favored Glycine 0 N--CA 1.452 -0.269 0 N-CA-C 109.629 -1.388 . . . . 25.0 109.629 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -80.07 101.03 8.48 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.644 -1.613 . . . . 25.0 106.644 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -101.8 151.65 21.81 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.801 -0.636 . . . . 50.0 111.568 -170.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.7 mp -114.0 95.8 5.49 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.591 -0.522 . . . . 25.0 109.591 177.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.7 mp -101.46 128.03 47.86 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.336 0.589 . . . . 25.0 112.103 -173.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -125.73 135.94 52.62 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 106.485 -1.672 . . . . 25.0 106.485 174.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -89.54 -41.07 5.83 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 119.778 -1.201 . . . . 25.0 114.826 -174.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.46 -166.21 50.83 Favored Glycine 0 C--O 1.238 0.353 0 CA-C-N 117.662 0.731 . . . . 25.0 112.829 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.68 149.65 21.34 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.099 0.407 . . . . 25.0 112.099 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.4 153.64 29.03 Favored Glycine 0 C--O 1.238 0.365 0 CA-C-N 115.38 -0.827 . . . . 25.0 112.837 -177.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.34 120.26 21.36 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 105.193 -2.151 . . . . 25.0 105.193 176.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -109.05 156.2 20.05 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.983 -0.377 . . . . 50.0 109.983 -172.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -123.9 117.99 26.07 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 103.928 -2.619 . . . . 25.0 103.928 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -144.23 132.28 21.63 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 116.753 2.131 . . . . 25.0 116.753 -168.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 64.3 m -100.63 135.49 41.99 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.454 -0.573 . . . . 25.0 109.454 176.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.49 -32.91 7.85 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.038 -1.225 . . . . 25.0 110.038 173.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.07 -163.01 54.5 Favored Glycine 0 C--O 1.247 0.954 0 CA-C-O 122.836 1.242 . . . . 25.0 111.805 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -67.23 161.01 25.81 Favored 'General case' 0 C--N 1.322 -0.629 0 O-C-N 121.922 -0.752 . . . . 25.0 110.108 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.44 164.42 37.15 Favored Glycine 0 CA--C 1.521 0.418 0 CA-C-N 115.757 -0.656 . . . . 25.0 111.807 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.66 92.08 8.08 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-O 122.352 1.072 . . . . 25.0 109.957 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -86.01 152.35 22.98 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.105 -0.952 . . . . 50.0 112.338 -172.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.5 m -121.93 127.99 51.02 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.899 -1.046 . . . . 25.0 109.735 -178.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -122.8 84.56 2.28 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.605 -1.257 . . . . 25.0 107.605 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 54.8 mtt85 -85.64 -21.72 28.28 Favored 'General case' 0 CA--C 1.497 -1.068 0 O-C-N 121.54 -0.725 . . . . 25.0 111.358 -178.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 68.22 159.07 0.16 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.017 1.327 . . . . 25.0 112.173 -175.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -93.62 -28.13 16.19 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 115.795 1.776 . . . . 25.0 115.795 -167.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 70.7 mt -145.91 166.02 27.22 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.39 0.515 . . . . 25.0 112.39 -171.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.33 -28.15 69.01 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.642 -0.873 . . . . 25.0 108.642 170.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -82.87 -0.19 47.09 Favored 'General case' 0 C--O 1.252 1.187 0 CA-C-N 114.363 -1.289 . . . . 25.0 113.814 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -91.0 134.65 34.32 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 121.719 -0.613 . . . . 25.0 110.145 -173.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.3 t 47.32 42.75 14.31 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 115.291 1.589 . . . . 25.0 115.291 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 15.5 p-80 -110.79 165.44 11.84 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.419 -0.81 . . . . 25.0 112.375 -174.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -116.06 142.24 47.06 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 106.805 -1.554 . . . . 25.0 106.805 176.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 82.5 p -136.27 166.56 27.03 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 108.278 -1.008 . . . . 25.0 108.278 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -61.14 -22.49 74.84 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 117.885 -0.944 . . . . 25.0 113.528 174.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 86.9 mt -76.79 -21.82 54.59 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.733 0.778 . . . . 25.0 111.174 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 150.52 175.18 22.31 Favored Glycine 0 CA--C 1.506 -0.479 0 CA-C-N 116.17 -0.468 . . . . 25.0 112.11 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.0 t -95.09 148.4 22.4 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 122.01 0.909 . . . . 25.0 111.137 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -131.55 30.82 4.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.833 -1.076 . . . . 25.0 108.448 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.0 142.03 44.34 Favored Glycine 0 C--O 1.243 0.675 0 N-CA-C 111.157 -0.777 . . . . 25.0 111.157 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -85.52 169.22 13.8 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 120.575 0.226 . . . . 50.0 110.393 -177.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -124.08 98.38 5.76 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.001 0.52 . . . . 25.0 111.468 -173.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.9 mt -85.34 132.73 31.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 107.56 -1.274 . . . . 25.0 107.56 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 98.0 mt -84.66 -44.55 13.33 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 114.894 1.442 . . . . 25.0 114.894 -169.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 57.5 p30 -134.45 38.62 3.09 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 114.799 1.407 . . . . 25.0 114.799 -174.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -57.35 129.64 42.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.703 0.763 . . . . 25.0 112.384 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -99.66 105.07 31.8 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 108.212 -1.033 . . . . 25.0 108.212 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -67.61 -16.83 47.68 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 116.228 -2.048 . . . . 25.0 115.802 -176.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.7 t -82.86 -26.66 31.41 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 120.607 0.241 . . . . 25.0 110.988 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -115.78 -33.1 5.26 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 115.432 1.641 . . . . 25.0 115.432 -173.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -91.8 167.63 12.02 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 123.432 0.457 . . . . 50.0 110.367 -170.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -144.65 145.91 31.99 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.212 0.449 . . . . 25.0 112.212 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 88.3 mt -127.41 127.83 69.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.281 -1.007 . . . . 25.0 108.281 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -91.25 148.0 22.65 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.509 -0.923 . . . . 25.0 108.509 173.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.4 p -147.79 -6.72 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 113.175 0.806 . . . . 25.0 113.175 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 26.4 t -61.44 -43.77 98.28 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.532 0.568 . . . . 25.0 112.532 -175.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.05 -28.86 54.91 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.9 1.074 . . . . 25.0 113.9 -178.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.62 -0.33 13.04 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 116.655 2.094 . . . . 25.0 116.655 -169.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -145.0 -72.45 0.02 OUTLIER Glycine 0 C--O 1.241 0.576 0 N-CA-C 116.555 1.382 . . . . 25.0 116.555 -178.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -157.98 169.25 25.01 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.597 -0.89 . . . . 25.0 108.597 -175.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 38.5 t -124.11 -39.8 2.33 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.111 0.482 . . . . 25.0 110.344 177.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -88.48 121.72 6.08 Favored Glycine 0 N--CA 1.465 0.585 0 N-CA-C 111.053 -0.819 . . . . 25.0 111.053 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -73.53 154.16 39.98 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 117.633 0.716 . . . . 25.0 111.87 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.15 -171.84 45.75 Favored Glycine 0 N--CA 1.463 0.467 0 CA-C-N 116.281 -0.418 . . . . 25.0 112.108 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -75.6 81.71 2.6 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.611 0.967 . . . . 25.0 113.611 -177.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -105.86 176.62 22.21 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 108.973 -1.651 . . . . 25.0 108.973 173.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -125.96 166.19 17.38 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 118.106 0.953 . . . . 25.0 110.683 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 54.09 36.43 24.67 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 114.083 1.142 . . . . 25.0 114.083 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 77.35 31.26 52.13 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 120.214 -0.993 . . . . 25.0 112.11 177.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.3 t -138.78 -174.37 3.82 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 117.382 0.591 . . . . 25.0 110.468 -177.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.56 161.01 15.23 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 102.294 -3.225 . . . . 25.0 102.294 173.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.78 115.01 10.48 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 118.744 0.702 . . . . 25.0 110.325 -173.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.1 m -85.3 165.1 2.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 108.112 -1.07 . . . . 25.0 108.112 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 92.0 p -150.39 162.59 40.26 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.673 -0.492 . . . . 25.0 109.673 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.5 m -115.95 164.2 12.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.698 -0.853 . . . . 25.0 108.698 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.5 t -76.55 -56.4 4.65 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.186 -1.413 . . . . 25.0 107.186 170.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -161.31 -159.94 0.68 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 103.436 -2.801 . . . . 25.0 103.436 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -66.52 -24.22 66.35 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 121.062 0.458 . . . . 25.0 110.311 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -118.86 -159.02 10.94 Favored Glycine 0 C--O 1.244 0.758 0 N-CA-C 109.661 -1.376 . . . . 25.0 109.661 176.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 59.44 -161.85 0.26 Allowed 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 112.913 0.708 . . . . 25.0 112.913 176.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 39.4 mtt85 -76.33 163.81 26.64 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.292 1.219 . . . . 25.0 114.292 -169.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.14 159.91 18.76 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 106.233 -1.766 . . . . 25.0 106.233 171.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -132.01 159.21 39.44 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.245 0.545 . . . . 25.0 110.452 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 55.7 tp -133.05 119.37 19.94 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 104.356 -2.461 . . . . 25.0 104.356 170.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -116.51 155.62 28.31 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.435 -0.58 . . . . 25.0 109.435 -175.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.4 t -100.02 149.92 22.98 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 104.272 -2.492 . . . . 25.0 104.272 166.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -116.13 9.56 14.74 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 122.089 0.947 . . . . 25.0 109.783 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -102.18 143.17 32.31 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 104.185 -2.524 . . . . 25.0 104.185 171.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -138.7 155.12 48.52 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.604 0.716 . . . . 25.0 109.802 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -75.29 160.01 30.84 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 105.543 -2.021 . . . . 25.0 105.543 175.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.7 -16.65 63.96 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.496 0.589 . . . . 25.0 111.485 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -76.13 -9.44 58.63 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.157 0.503 . . . . 25.0 112.141 174.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.69 3.29 68.81 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.483 -0.647 . . . . 25.0 111.483 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.3 mt -73.76 138.47 44.59 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.372 -0.973 . . . . 25.0 108.372 177.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.87 -178.43 6.35 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 106.848 -1.538 . . . . 25.0 106.848 -175.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -132.35 140.99 48.74 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-N 118.91 0.777 . . . . 25.0 112.995 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -153.58 156.02 37.22 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 108.06 -1.089 . . . . 25.0 108.06 170.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.5 p -146.06 143.93 21.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 N-CA-C 105.818 -1.919 . . . . 25.0 105.818 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -107.36 142.64 36.86 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.032 -1.47 . . . . 25.0 107.032 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.9 mp -131.49 127.92 38.31 Favored 'General case' 0 C--O 1.207 -1.141 0 N-CA-C 103.552 -2.759 . . . . 25.0 103.552 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -100.19 3.53 43.78 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 119.278 0.945 . . . . 25.0 113.304 -174.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -79.07 -2.28 86.8 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 120.668 -0.777 . . . . 25.0 113.775 177.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 44.8 t0 49.16 48.93 20.39 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 122.075 0.94 . . . . 25.0 112.14 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -108.18 32.67 4.61 Favored 'General case' 0 C--O 1.249 1.03 0 CA-C-O 122.53 1.157 . . . . 25.0 108.615 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -55.1 -34.3 63.56 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.044 -0.98 . . . . 25.0 112.492 176.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.97 -12.78 61.98 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 113.275 0.842 . . . . 25.0 113.275 -178.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -116.86 -5.0 11.53 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.635 0.605 . . . . 25.0 112.635 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 16.1 mt -70.7 127.37 32.41 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.495 -0.928 . . . . 25.0 108.495 178.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 71.2 m -127.64 164.37 22.19 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.616 -1.624 . . . . 25.0 106.616 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -73.64 -1.87 20.68 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.197 -0.668 . . . . 25.0 109.197 176.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -71.33 -29.77 65.4 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 115.673 -0.694 . . . . 25.0 112.385 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -98.15 1.14 47.17 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 122.065 -0.397 . . . . 25.0 111.324 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 38.9 mm -105.5 111.36 34.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 105.535 -2.024 . . . . 25.0 105.535 175.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.8 p -98.15 115.95 39.62 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-O 123.064 1.412 . . . . 25.0 112.558 -173.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -137.36 0.51 2.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 112.98 -1.918 . . . . 25.0 110.362 174.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -81.61 43.95 0.78 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 122.752 0.421 . . . . 25.0 111.441 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 55.94 24.39 7.57 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.202 1.186 . . . . 25.0 114.202 -177.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.56 9.09 0.73 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.657 1.725 . . . . 25.0 115.657 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -79.01 134.94 36.77 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 121.353 -0.842 . . . . 25.0 110.787 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.34 -19.69 63.04 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.354 -0.61 . . . . 25.0 109.354 178.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.3 47.39 0.68 Allowed 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 121.264 0.554 . . . . 25.0 111.513 176.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -150.3 173.18 14.27 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.164 -1.421 . . . . 25.0 107.164 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 62.77 -172.1 0.16 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.64 1.176 . . . . 25.0 111.905 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 81.55 23.41 58.35 Favored Glycine 0 C--N 1.32 -0.311 0 N-CA-C 110.081 -1.207 . . . . 25.0 110.081 -176.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -121.34 101.74 7.83 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 109.38 -0.6 . . . . 25.0 109.38 -176.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -127.8 157.49 40.28 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.179 -0.674 . . . . 25.0 109.179 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -136.74 26.01 3.05 Favored Glycine 0 N--CA 1.464 0.532 0 CA-C-N 116.426 -0.352 . . . . 25.0 113.636 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 47.1 t -80.96 -31.99 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 116.915 0.357 . . . . 25.0 110.8 -177.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.15 133.67 27.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 CA-C-O 121.571 0.7 . . . . 25.0 111.135 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.38 168.0 26.85 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 108.614 -1.794 . . . . 25.0 108.614 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -146.29 143.58 29.25 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.436 1.618 . . . . 25.0 110.601 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 80.5 p -155.51 167.82 29.12 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.556 -0.905 . . . . 25.0 108.556 178.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 179.3 -179.74 48.84 Favored Glycine 0 CA--C 1.507 -0.418 0 C-N-CA 120.628 -0.796 . . . . 25.0 114.299 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -145.82 106.19 4.26 Favored Pre-proline 0 N--CA 1.468 0.456 0 N-CA-C 107.895 -1.15 . . . . 25.0 107.895 177.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -72.94 152.23 51.6 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 116.194 -2.07 . . . . 25.0 113.67 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -113.24 144.5 42.6 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.835 -1.913 . . . . 25.0 105.835 175.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -136.2 67.2 61.44 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 112.644 0.609 . . . . 25.0 112.644 -174.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -73.45 150.83 46.94 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 117.874 -0.951 . . . . 25.0 112.575 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.7 t -139.95 20.96 2.47 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 122.02 0.914 . . . . 25.0 109.803 -177.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.4 p . . . . . 0 C--O 1.248 0.975 0 CA-C-O 117.618 -1.182 . . . . 25.0 110.759 -178.19 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.784 0 N-CA-C 110.025 -0.361 . . . . 25.0 110.025 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -123.54 118.23 27.51 Favored Pre-proline 0 C--O 1.241 0.65 0 O-C-N 123.296 0.372 . . . . 25.0 110.652 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.37 142.75 46.01 Favored 'Trans proline' 0 C--O 1.247 0.967 0 C-N-CA 116.726 -1.716 . . . . 25.0 114.293 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.9 51.52 0.06 OUTLIER Glycine 0 C--O 1.237 0.3 0 N-CA-C 109.625 -1.39 . . . . 25.0 109.625 -177.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.9 p -57.86 133.58 22.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.758 0.79 . . . . 25.0 111.03 -174.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -102.37 -8.81 20.86 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.197 -0.91 . . . . 25.0 110.204 -173.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -82.52 -141.79 4.04 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.882 -0.599 . . . . 25.0 112.413 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.5 p 69.12 159.4 0.15 Allowed Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 126.064 1.746 . . . . 25.0 110.835 -175.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -65.97 -5.06 11.28 Favored 'Trans proline' 0 N--CA 1.483 0.9 0 N-CA-C 116.64 1.746 . . . . 25.0 116.64 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.97 -4.2 4.22 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 N-CA-C 114.192 1.182 . . . . 25.0 114.192 -170.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.3 p -141.34 141.35 30.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 121.56 0.695 . . . . 25.0 111.713 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.48 18.5 73.67 Favored Glycine 0 C--N 1.336 0.577 0 N-CA-C 119.681 2.633 . . . . 25.0 119.681 171.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.2 t -51.4 -51.63 53.06 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 120.641 -1.505 . . . . 25.0 113.826 -172.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -85.85 13.94 6.67 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 115.187 1.551 . . . . 25.0 115.187 -171.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.24 168.58 19.44 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.32 0.489 . . . . 25.0 112.32 -176.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -63.93 130.86 45.79 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 118.208 0.458 . . . . 25.0 110.809 -177.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -127.0 170.09 12.66 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 116.6 2.074 . . . . 50.0 116.6 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -136.01 92.56 2.81 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 104.449 -2.426 . . . . 25.0 104.449 168.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 52.4 mt -106.95 123.28 47.95 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.385 0.884 . . . . 25.0 113.385 -173.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -111.43 114.77 28.12 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.815 -0.629 . . . . 25.0 109.401 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.07 174.71 51.21 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 116.948 1.539 . . . . 25.0 116.948 -175.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.3 p -69.47 169.69 12.01 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.504 0.669 . . . . 25.0 111.574 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 89.3 mt -87.33 16.09 5.71 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.521 -0.763 . . . . 25.0 110.905 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -120.6 -178.96 16.19 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.368 -0.693 . . . . 25.0 111.368 175.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.7 t -68.17 135.07 51.51 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 117.365 0.582 . . . . 25.0 110.924 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -144.92 166.44 25.29 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.083 0.553 . . . . 50.0 109.791 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -109.78 129.8 55.59 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 103.284 -2.858 . . . . 25.0 103.284 162.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.4 mm -119.23 121.71 67.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 108.138 -1.06 . . . . 25.0 108.138 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 9.0 mp -124.36 125.96 45.19 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 105.801 -1.926 . . . . 25.0 105.801 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.21 -26.62 27.9 Favored Glycine 0 C--O 1.246 0.904 0 N-CA-C 115.355 0.902 . . . . 25.0 115.355 -176.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.24 -147.33 47.33 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.122 -1.037 . . . . 25.0 112.003 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.31 174.3 52.21 Favored Glycine 0 C--O 1.248 0.983 0 O-C-N 122.73 -0.277 . . . . 25.0 112.889 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.49 160.92 20.99 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.597 -0.811 . . . . 25.0 113.82 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.57 92.0 8.75 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 122.526 1.155 . . . . 25.0 108.008 175.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -89.31 157.29 18.25 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.762 -1.108 . . . . 50.0 112.635 -169.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -117.35 94.99 4.77 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 107.469 -1.308 . . . . 25.0 107.469 172.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 49.6 mt -101.83 134.73 44.55 Favored 'General case' 0 C--O 1.213 -0.847 0 N-CA-C 112.614 0.598 . . . . 25.0 112.614 -172.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -131.51 106.79 8.44 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.174 0.512 . . . . 25.0 111.015 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.96 -25.61 57.51 Favored Glycine 0 C--O 1.246 0.845 0 N-CA-C 116.066 1.186 . . . . 25.0 116.066 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 49.99 -152.19 0.17 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.928 1.084 . . . . 25.0 113.928 -178.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.97 160.39 20.85 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 113.164 0.801 . . . . 25.0 113.164 -173.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.06 156.5 31.35 Favored Glycine 0 C--O 1.247 0.955 0 N-CA-C 109.591 -1.404 . . . . 25.0 109.591 -177.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 22.0 m-20 -81.42 106.08 13.1 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 107.149 -1.426 . . . . 25.0 107.149 177.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -106.84 161.8 14.37 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 120.946 0.403 . . . . 50.0 111.098 -170.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 mp -119.87 136.88 54.32 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 104.832 -2.284 . . . . 25.0 104.832 174.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 mp -136.1 125.42 24.83 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 114.49 1.293 . . . . 25.0 114.49 -172.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -125.19 137.84 54.13 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 113.968 -1.469 . . . . 25.0 107.542 174.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.48 -31.79 8.64 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.32 -0.943 . . . . 25.0 114.704 -178.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.98 -171.0 55.12 Favored Glycine 0 C--O 1.253 1.285 0 N-CA-C 110.784 -0.926 . . . . 25.0 110.784 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.6 157.11 9.61 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.956 0.884 . . . . 25.0 112.422 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.38 164.73 40.48 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-N 115.212 -0.903 . . . . 25.0 111.888 -176.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.97 123.72 33.57 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 104.7 -2.333 . . . . 25.0 104.7 176.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -113.44 157.08 22.4 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.663 0.986 . . . . 50.0 113.663 -169.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -113.2 127.08 56.07 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 103.493 -2.78 . . . . 25.0 103.493 174.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -147.83 137.3 22.43 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.901 1.074 . . . . 25.0 113.901 -176.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 62.1 m -116.04 142.59 46.6 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.02 -1.104 . . . . 25.0 108.02 176.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -93.49 -34.21 6.76 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 111.079 -0.808 . . . . 25.0 111.079 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.81 -173.25 55.33 Favored Glycine 0 C--O 1.244 0.732 0 CA-C-N 117.987 0.893 . . . . 25.0 113.462 -178.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -66.1 159.21 26.62 Favored 'General case' 0 C--O 1.241 0.612 0 O-C-N 121.455 -1.027 . . . . 25.0 109.65 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.1 156.45 32.21 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.57 -1.012 . . . . 25.0 110.57 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.97 124.09 26.33 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 109.184 -0.672 . . . . 25.0 109.184 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -116.3 151.6 35.53 Favored 'General case' 0 C--N 1.313 -0.987 0 O-C-N 121.614 -0.679 . . . . 50.0 112.08 -173.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 98.5 m -114.27 122.57 47.15 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 109.046 -0.724 . . . . 25.0 109.046 177.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -108.96 124.37 50.58 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 106.424 -1.695 . . . . 25.0 106.424 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 49.2 mtt85 -122.49 -36.68 2.89 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.121 0.785 . . . . 25.0 113.121 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 71.69 155.1 0.15 Allowed 'General case' 0 N--CA 1.475 0.817 0 O-C-N 125.07 1.481 . . . . 25.0 108.101 -169.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.52 -43.19 19.12 Favored 'General case' 0 C--N 1.318 -0.765 0 O-C-N 121.852 -0.53 . . . . 25.0 112.158 -165.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 58.6 mt -130.9 163.46 27.42 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 122.054 0.93 . . . . 25.0 111.423 -173.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -56.14 -27.56 54.56 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 114.497 -1.228 . . . . 25.0 108.868 169.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -72.71 -4.68 32.74 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 115.01 1.485 . . . . 25.0 115.01 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -99.09 153.55 18.8 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.41 -0.806 . . . . 25.0 112.894 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.9 t 43.35 48.7 5.93 Favored 'General case' 0 C--O 1.217 -0.649 0 N-CA-C 114.806 1.41 . . . . 25.0 114.806 170.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 28.0 p-80 -131.91 170.23 15.18 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.143 -0.935 . . . . 25.0 110.195 -175.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.5 ttt180 -122.55 142.65 50.39 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 105.707 -1.96 . . . . 25.0 105.707 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 77.9 p -137.55 168.95 14.4 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.207 -0.664 . . . . 25.0 109.207 -176.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -61.45 -24.23 78.02 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 CA-C-N 118.841 0.622 . . . . 25.0 113.266 175.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.2 mt -75.59 -26.49 57.92 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.542 0.687 . . . . 25.0 111.303 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.17 -174.13 32.65 Favored Glycine 0 N--CA 1.463 0.455 0 N-CA-C 110.595 -1.002 . . . . 25.0 110.595 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.8 t -103.18 149.21 24.88 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-O 122.742 1.258 . . . . 25.0 112.956 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -129.03 21.61 5.79 Favored 'General case' 0 C--O 1.252 1.2 0 CA-C-N 114.247 -1.342 . . . . 25.0 109.004 175.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.04 140.5 46.32 Favored Glycine 0 N--CA 1.473 1.105 0 O-C-N 124.549 1.156 . . . . 25.0 111.414 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -96.99 167.37 11.12 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 108.35 -0.981 . . . . 50.0 108.35 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.89 109.32 13.45 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.135 0.791 . . . . 25.0 113.135 -175.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 41.5 mt -87.98 139.46 17.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 105.865 -1.902 . . . . 25.0 105.865 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.2 mt -90.9 -44.44 9.37 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 114.868 1.432 . . . . 25.0 114.868 -176.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.6 p-10 -130.13 39.51 3.66 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 116.165 1.913 . . . . 25.0 116.165 -173.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -55.99 126.84 27.64 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 122.3 -0.25 . . . . 25.0 111.114 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -97.57 104.14 19.46 Favored Pre-proline 0 N--CA 1.474 0.771 0 N-CA-C 108.878 -0.786 . . . . 25.0 108.878 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -70.67 -4.97 15.71 Favored 'Trans proline' 0 C--O 1.213 -0.757 0 N-CA-C 114.973 1.105 . . . . 25.0 114.973 -176.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.8 t -89.42 -28.71 19.56 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.087 0.47 . . . . 25.0 111.08 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -118.72 -38.28 3.13 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 115.217 1.562 . . . . 25.0 115.217 -172.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -85.76 175.01 8.94 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.714 0.635 . . . . 75.0 112.714 -172.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.72 152.26 36.31 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.182 0.808 . . . . 25.0 113.182 170.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 55.9 mt -119.03 132.03 70.1 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 N-CA-C 108.854 -0.795 . . . . 25.0 108.854 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -85.6 145.05 27.53 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 122.32 1.057 . . . . 25.0 111.458 173.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.0 p -143.19 -0.85 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 CA-C-N 114.724 -1.125 . . . . 25.0 110.085 178.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.41 ' HB2' ' HA ' ' A' ' 156' ' ' PHE . 22.8 t -64.76 -42.51 95.07 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.283 0.563 . . . . 25.0 111.11 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.92 -27.85 63.1 Favored 'General case' 0 C--O 1.249 1.066 0 CA-C-N 115.656 -0.702 . . . . 25.0 111.693 -177.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.0 mt -99.12 -58.07 2.02 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 114.255 1.206 . . . . 25.0 114.255 -169.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -104.33 -65.26 0.69 Allowed Glycine 0 C--O 1.242 0.643 0 N-CA-C 116.609 1.404 . . . . 25.0 116.609 -168.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -156.47 164.8 37.82 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.012 0.478 . . . . 25.0 110.451 -168.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.9 p -117.57 -19.74 9.28 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.99 0.516 . . . . 25.0 110.47 173.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -108.32 117.12 4.97 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 109.199 -1.56 . . . . 25.0 109.199 175.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -60.08 151.44 26.66 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 116.216 1.932 . . . . 25.0 116.216 -175.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.89 -169.25 36.63 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 114.856 -1.066 . . . . 25.0 114.798 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -55.8 135.46 51.76 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 113.435 0.902 . . . . 25.0 113.435 -177.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 168.4 177.68 39.62 Favored Glycine 0 C--O 1.236 0.257 0 N-CA-C 107.961 -2.056 . . . . 25.0 107.961 178.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -142.99 168.96 18.48 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.119 1.46 . . . . 25.0 109.21 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 57.8 35.74 25.77 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.737 0.815 . . . . 25.0 111.527 -177.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 69.37 36.66 78.63 Favored Glycine 0 C--N 1.32 -0.333 0 N-CA-C 111.114 -0.795 . . . . 25.0 111.114 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.3 t -140.09 177.85 7.69 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.193 -0.669 . . . . 25.0 109.193 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 84.3 mt -104.5 155.29 18.94 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 102.347 -3.205 . . . . 25.0 102.347 172.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.39 136.37 55.66 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 119.367 -0.933 . . . . 25.0 109.257 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.0 m -110.74 161.62 9.01 Favored 'Isoleucine or valine' 0 C--O 1.248 1.008 0 N-CA-C 108.89 -0.781 . . . . 25.0 108.89 -177.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 80.4 p -142.56 163.32 33.13 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 116.569 -0.287 . . . . 25.0 111.557 -177.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.2 m -116.41 160.99 15.49 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 N-CA-C 107.555 -1.276 . . . . 25.0 107.555 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.5 t -74.07 -48.78 27.49 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.739 -1.208 . . . . 25.0 107.739 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.4 ' C ' ' H ' ' A' ' 120' ' ' GLY . 5.9 p-10 -168.09 -162.47 0.42 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 102.175 -3.268 . . . . 25.0 102.175 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -77.55 12.55 1.56 Allowed 'General case' 0 CA--C 1.546 0.803 0 CA-C-O 121.754 0.788 . . . . 25.0 111.746 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 118' ' ' ASP . . . -150.91 -164.13 11.8 Favored Glycine 0 C--O 1.243 0.716 0 N-CA-C 107.438 -2.265 . . . . 25.0 107.438 176.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.42 -154.85 0.36 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.028 0.381 . . . . 25.0 112.028 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.8 mtt180 -84.08 166.52 17.62 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.925 0.713 . . . . 25.0 112.925 -173.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.68 165.98 12.22 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 105.584 -2.006 . . . . 25.0 105.584 174.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -134.55 158.4 44.08 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.762 0.791 . . . . 25.0 111.8 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 41.8 tp -127.08 129.27 47.66 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 103.834 -2.654 . . . . 25.0 103.834 174.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -123.6 154.21 39.62 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.327 0.584 . . . . 25.0 111.346 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.1 t -99.44 151.21 21.37 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 104.533 -2.395 . . . . 25.0 104.533 167.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -118.67 14.66 13.55 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 107.943 -1.132 . . . . 25.0 107.943 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -105.23 140.41 38.42 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 104.578 -2.378 . . . . 25.0 104.578 172.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -138.43 155.44 48.48 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 123.937 0.773 . . . . 25.0 109.64 -177.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -85.73 163.87 17.96 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.57 -0.741 . . . . 25.0 109.633 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.75 -24.0 67.48 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-O 121.444 0.64 . . . . 25.0 111.819 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -74.33 -4.13 34.44 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.754 0.65 . . . . 25.0 112.754 175.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.18 17.73 64.25 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.568 -0.825 . . . . 25.0 112.247 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.2 mt -93.69 141.95 27.91 Favored 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 107.311 -1.366 . . . . 25.0 107.311 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 63.9 p -141.49 178.41 7.46 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 106.854 -1.535 . . . . 25.0 106.854 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -123.31 133.17 54.18 Favored 'General case' 0 C--O 1.252 1.198 0 CA-C-N 118.544 0.611 . . . . 25.0 111.818 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -148.89 151.43 34.66 Favored 'General case' 0 C--O 1.25 1.103 0 N-CA-C 108.56 -0.904 . . . . 25.0 108.56 171.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.1 p -149.19 146.7 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 107.313 -1.366 . . . . 25.0 107.313 -178.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -104.98 145.57 30.24 Favored 'General case' 0 C--O 1.247 0.972 0 N-CA-C 109.025 -0.732 . . . . 25.0 109.025 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.9 mp -135.45 120.31 18.52 Favored 'General case' 0 C--O 1.211 -0.921 0 N-CA-C 105.1 -2.185 . . . . 25.0 105.1 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -88.06 -13.1 42.36 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 118.302 2.704 . . . . 25.0 118.302 -169.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -78.36 9.0 36.6 Favored Glycine 0 CA--C 1.535 1.332 0 N-CA-C 117.009 1.563 . . . . 25.0 117.009 -175.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 39.9 t0 48.46 51.14 15.78 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 122.716 1.246 . . . . 25.0 112.957 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -110.97 31.97 5.63 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.753 -1.203 . . . . 25.0 107.753 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.29 -38.43 83.59 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 115.232 -0.895 . . . . 25.0 110.968 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.42 -22.41 66.95 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.101 0.56 . . . . 25.0 112.111 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -98.23 -10.71 23.6 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.037 0.754 . . . . 25.0 113.037 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 13.9 mt -66.1 145.85 55.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.776 0.798 . . . . 25.0 112.214 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 72.1 m -142.97 157.34 44.65 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.853 -1.165 . . . . 25.0 107.853 177.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -81.4 9.04 7.88 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.451 0.3 . . . . 25.0 110.424 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -92.72 -22.87 19.14 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.857 0.36 . . . . 25.0 110.071 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -99.17 20.63 13.14 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 122.79 1.281 . . . . 25.0 109.048 173.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 39.8 mm -122.04 130.01 74.92 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 N-CA-C 101.753 -3.425 . . . . 25.0 101.753 170.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.2 p -108.64 128.34 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 119.35 0.977 . . . . 25.0 110.948 -172.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.41 ' HA ' ' HB2' ' A' ' 97' ' ' SER . 25.0 p90 -167.17 -24.64 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.885 -1.052 . . . . 25.0 113.376 -176.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -82.16 80.63 8.33 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.719 -0.613 . . . . 25.0 110.802 -172.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 59.22 8.61 1.13 Allowed 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 115.326 1.602 . . . . 25.0 115.326 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 m 66.37 -37.87 0.29 Allowed 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 116.59 2.07 . . . . 25.0 116.59 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -65.3 138.07 57.95 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 122.009 -0.432 . . . . 25.0 111.414 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.0 -6.22 31.88 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 121.009 0.433 . . . . 25.0 110.83 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.85 -13.7 61.75 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 116.175 -0.466 . . . . 25.0 111.083 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -102.88 160.33 14.7 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 109.764 -0.458 . . . . 25.0 109.764 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 56.56 -163.52 0.16 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.945 1.461 . . . . 25.0 114.945 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 90.43 15.97 56.11 Favored Glycine 0 N--CA 1.459 0.207 0 N-CA-C 114.662 0.625 . . . . 25.0 114.662 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -83.41 115.9 22.25 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 117.271 0.535 . . . . 25.0 111.696 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -110.68 134.12 52.73 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.133 -0.691 . . . . 25.0 109.133 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.8 45.78 0.7 Allowed Glycine 0 C--O 1.224 -0.505 0 N-CA-C 111.513 -0.635 . . . . 25.0 111.513 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 43.1 t -84.46 -32.01 7.8 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 CA-C-O 121.678 0.752 . . . . 25.0 109.619 -177.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.68 135.4 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 CA-C-O 121.713 0.768 . . . . 25.0 112.082 -176.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 161.84 133.88 1.55 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.622 -1.391 . . . . 25.0 109.622 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -148.49 152.12 36.35 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 117.393 0.597 . . . . 25.0 110.941 -177.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 51.2 p -155.41 166.54 33.22 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.365 -0.976 . . . . 25.0 108.365 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 161.67 146.99 4.83 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 121.179 -0.534 . . . . 25.0 113.707 176.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -98.56 110.15 55.73 Favored Pre-proline 0 C--O 1.247 0.957 0 C-N-CA 123.599 0.76 . . . . 25.0 109.512 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.59 150.13 79.76 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 116.936 -1.576 . . . . 25.0 111.853 176.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -110.3 141.46 43.27 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 109.662 -0.496 . . . . 25.0 109.662 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -130.41 79.29 72.7 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-O 120.955 0.407 . . . . 25.0 111.81 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.3 157.81 52.82 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 N-CA-C 114.066 0.756 . . . . 25.0 114.066 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.8 t -99.04 -17.4 18.28 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.248 -0.649 . . . . 25.0 109.248 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 12.0 p . . . . . 0 C--O 1.246 0.894 0 CA-C-O 117.338 -1.315 . . . . 25.0 108.473 173.411 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 119.791 -0.147 . . . . 25.0 110.67 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -104.9 91.45 4.34 Favored Pre-proline 0 C--O 1.244 0.791 0 C-N-CA 123.679 0.792 . . . . 25.0 110.24 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -68.75 135.28 32.49 Favored 'Trans proline' 0 C--N 1.349 0.586 0 N-CA-C 115.691 1.381 . . . . 25.0 115.691 -174.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.27 51.76 0.29 Allowed Glycine 0 C--O 1.211 -1.3 0 N-CA-C 106.807 -2.517 . . . . 25.0 106.807 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.6 p -55.35 125.83 11.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 N-CA-C 114.564 1.32 . . . . 25.0 114.564 -172.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -105.64 11.2 32.52 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-O 122.189 0.995 . . . . 25.0 109.555 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -94.31 -155.73 31.85 Favored Glycine 0 N--CA 1.447 -0.625 0 O-C-N 121.38 -0.825 . . . . 25.0 113.704 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.0 p 70.18 158.2 0.16 Allowed Pre-proline 0 N--CA 1.486 1.343 0 C-N-CA 126.08 1.752 . . . . 25.0 112.518 -176.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.42 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 35.2 Cg_exo -66.2 -0.78 4.5 Favored 'Trans proline' 0 C--N 1.358 1.073 0 N-CA-C 116.957 1.868 . . . . 25.0 116.957 -174.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.1 p -65.56 -11.28 11.9 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 N-CA-C 115.91 1.818 . . . . 25.0 115.91 -171.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.8 p -146.42 127.2 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 N-CA-C 114.713 1.375 . . . . 25.0 114.713 -176.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.26 18.66 71.53 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 118.148 2.019 . . . . 25.0 118.148 173.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.7 t -50.86 -37.33 42.67 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 115.331 1.604 . . . . 25.0 115.331 -174.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -75.12 2.43 10.77 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 114.88 1.437 . . . . 25.0 114.88 -175.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.25 173.22 11.72 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 118.971 0.805 . . . . 25.0 110.598 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -51.11 128.41 21.7 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 112.886 0.698 . . . . 25.0 112.886 -177.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -129.91 159.4 36.75 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.39 0.885 . . . . 50.0 113.39 -173.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -125.9 95.98 4.6 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 105.353 -2.092 . . . . 25.0 105.353 165.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 80.9 mt -103.57 108.49 19.78 Favored 'General case' 0 C--O 1.212 -0.895 0 N-CA-C 112.976 0.732 . . . . 25.0 112.976 -176.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -98.82 109.75 22.46 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.962 -0.563 . . . . 25.0 109.596 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.0 172.53 51.63 Favored Glycine 0 C--O 1.219 -0.813 0 N-CA-C 115.893 1.117 . . . . 25.0 115.893 -175.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.8 p -72.31 175.76 5.86 Favored 'General case' 0 C--O 1.246 0.889 0 C-N-CA 123.656 0.782 . . . . 25.0 111.404 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 66.6 mt -87.91 16.73 5.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.52 0.676 . . . . 25.0 110.712 174.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.91 179.5 17.94 Favored Glycine 0 N--CA 1.461 0.331 0 N-CA-C 110.029 -1.228 . . . . 25.0 110.029 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.8 t -74.39 133.24 42.47 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.818 0.447 . . . . 25.0 110.454 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -144.54 166.56 24.81 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.453 0.701 . . . . 50.0 109.495 -177.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -110.37 121.89 46.39 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 104.839 -2.282 . . . . 25.0 104.839 164.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.0 mm -111.03 122.41 65.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 107.1 -1.445 . . . . 25.0 107.1 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.42 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 10.9 mp -119.58 122.72 42.22 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.467 -0.938 . . . . 25.0 108.467 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.17 -37.48 32.18 Favored Glycine 0 CA--C 1.496 -1.115 0 CA-C-O 117.888 -1.506 . . . . 25.0 116.074 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.64 -150.21 51.79 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 119.498 1.649 . . . . 25.0 112.357 -177.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.04 168.79 47.02 Favored Glycine 0 CA--C 1.526 0.776 0 O-C-N 121.855 -0.791 . . . . 25.0 114.12 -178.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.05 167.03 29.65 Favored Glycine 0 C--O 1.246 0.871 0 C-N-CA 121.378 -0.439 . . . . 25.0 113.391 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.44 101.25 12.46 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 106.601 -1.629 . . . . 25.0 106.601 177.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -96.32 152.16 18.84 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 113.255 0.835 . . . . 50.0 113.255 -169.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -119.06 88.42 2.93 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 107.531 -1.285 . . . . 25.0 107.531 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 52.4 mt -97.41 143.77 27.81 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.581 -0.736 . . . . 25.0 110.437 -169.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -137.21 106.65 6.11 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 121.905 -0.497 . . . . 25.0 111.497 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.62 -30.1 53.78 Favored Glycine 0 N--CA 1.466 0.659 0 CA-C-O 118.721 -1.044 . . . . 25.0 113.667 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 50.46 -149.71 0.27 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 117.865 0.832 . . . . 25.0 111.51 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.49 163.09 27.54 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.933 0.873 . . . . 25.0 112.736 -174.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.72 156.65 31.64 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 110.514 -1.034 . . . . 25.0 110.514 -174.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -86.82 100.57 12.63 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.213 -1.403 . . . . 25.0 107.213 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -102.84 152.0 21.78 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.23 -0.896 . . . . 50.0 112.955 -169.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mp -110.72 122.79 48.69 Favored 'General case' 0 C--O 1.217 -0.605 0 N-CA-C 107.005 -1.479 . . . . 25.0 107.005 176.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.9 mp -123.21 130.85 53.32 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 114.598 1.332 . . . . 25.0 114.598 -172.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -121.65 143.44 49.33 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.563 1.545 . . . . 25.0 109.011 175.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.76 -37.6 3.16 Favored Glycine 0 C--O 1.242 0.621 0 N-CA-C 115.296 0.878 . . . . 25.0 115.296 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.03 -168.38 54.71 Favored Glycine 0 C--O 1.246 0.885 0 CA-C-N 117.868 0.834 . . . . 25.0 111.974 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.61 151.72 23.98 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.196 -1.179 . . . . 25.0 112.427 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.99 162.13 38.19 Favored Glycine 0 N--CA 1.466 0.698 0 CA-C-N 115.353 -0.84 . . . . 25.0 111.693 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.74 122.71 29.01 Favored 'General case' 0 C--O 1.212 -0.892 0 N-CA-C 105.255 -2.128 . . . . 25.0 105.255 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -114.42 156.71 24.0 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 122.017 0.913 . . . . 50.0 110.526 -172.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -114.88 122.29 45.86 Favored 'General case' 0 C--O 1.218 -0.595 0 N-CA-C 102.305 -3.22 . . . . 25.0 102.305 177.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -142.19 131.01 22.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 119.165 0.893 . . . . 25.0 113.194 -175.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.99 142.03 34.78 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 115.722 -0.672 . . . . 25.0 109.26 177.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.91 -40.57 5.53 Favored Glycine 0 C--O 1.246 0.868 0 N-CA-C 109.294 -1.522 . . . . 25.0 109.294 175.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.0 -172.97 55.05 Favored Glycine 0 C--O 1.244 0.77 0 C-N-CA 120.278 -0.963 . . . . 25.0 112.786 -176.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -64.07 159.02 21.18 Favored 'General case' 0 C--O 1.251 1.142 0 O-C-N 122.178 -0.601 . . . . 25.0 110.864 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.75 161.87 37.24 Favored Glycine 0 C--O 1.247 0.91 0 CA-C-N 115.141 -0.936 . . . . 25.0 111.413 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.95 105.74 14.19 Favored 'General case' 0 C--O 1.217 -0.649 0 N-CA-C 107.807 -1.183 . . . . 25.0 107.807 -178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -99.54 156.74 16.89 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 122.666 0.387 . . . . 50.0 111.826 -172.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 47.8 m -123.71 111.52 16.27 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.82 0.819 . . . . 25.0 110.09 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -88.39 96.46 10.6 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 104.917 -2.253 . . . . 25.0 104.917 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.4 mmt85 -81.22 -37.69 28.21 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.595 0.591 . . . . 25.0 112.595 -174.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 64.36 149.3 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 O-C-N 125.882 1.989 . . . . 25.0 111.998 -172.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.32 -59.99 2.56 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 114.995 1.48 . . . . 25.0 114.995 -168.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 48.7 mt -135.52 175.65 9.39 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 108.286 -1.005 . . . . 25.0 108.286 -170.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.62 -27.81 42.23 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.019 0.928 . . . . 25.0 110.838 171.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -76.06 -7.38 54.56 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 115.114 1.524 . . . . 25.0 115.114 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -90.16 136.49 33.01 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.325 -0.859 . . . . 25.0 112.84 -174.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.0 t 43.97 44.16 5.83 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 116.312 1.967 . . . . 25.0 116.312 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -113.66 173.91 6.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.886 -1.052 . . . . 25.0 112.18 -177.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -125.69 139.93 53.13 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 104.076 -2.565 . . . . 25.0 104.076 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 57.7 p -134.27 169.47 13.8 Favored Pre-proline 0 C--O 1.214 -0.786 0 N-CA-C 108.501 -0.925 . . . . 25.0 108.501 -176.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -61.91 -15.82 45.51 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 120.399 0.733 . . . . 25.0 112.764 176.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 89.7 mt -84.76 -31.48 23.95 Favored 'General case' 0 C--O 1.245 0.819 0 O-C-N 121.622 -0.674 . . . . 25.0 111.077 177.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.34 177.47 32.46 Favored Glycine 0 CA--C 1.503 -0.716 0 C-N-CA 121.108 -0.567 . . . . 25.0 112.761 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.2 t -88.49 146.8 24.98 Favored 'General case' 0 C--O 1.253 1.255 0 CA-C-O 121.983 0.896 . . . . 25.0 112.127 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -135.1 32.58 3.16 Favored 'General case' 0 C--O 1.254 1.331 0 CA-C-N 113.8 -1.545 . . . . 25.0 108.371 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -64.91 137.38 38.68 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 109.541 -1.424 . . . . 25.0 109.541 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -87.49 168.59 12.96 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 117.699 0.75 . . . . 50.0 110.659 -177.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -118.25 107.46 13.93 Favored 'General case' 0 C--O 1.245 0.847 0 O-C-N 123.789 0.681 . . . . 25.0 111.44 -175.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 52.7 mt -86.93 131.39 35.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 107.05 -1.463 . . . . 25.0 107.05 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.0 mt -75.88 -49.57 17.51 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 116.175 1.917 . . . . 25.0 116.175 -173.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -137.78 41.59 2.33 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.537 0.684 . . . . 25.0 112.282 -169.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -56.51 138.61 51.5 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.902 0.858 . . . . 25.0 110.72 -176.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -105.84 99.19 20.91 Favored Pre-proline 0 C--O 1.215 -0.74 0 N-CA-C 109.224 -0.658 . . . . 25.0 109.224 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -67.53 1.6 3.01 Favored 'Trans proline' 0 C--N 1.358 1.034 0 N-CA-C 115.39 1.265 . . . . 25.0 115.39 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.5 t -103.89 -42.27 5.64 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 117.515 0.143 . . . . 25.0 110.795 175.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -99.39 -36.99 9.41 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 115.15 1.537 . . . . 25.0 115.15 -175.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -85.08 170.74 12.64 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.028 -0.73 . . . . 75.0 109.028 -171.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -146.42 158.04 43.84 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.953 0.901 . . . . 25.0 110.363 177.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 64.9 mt -130.34 134.84 61.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.91 -0.774 . . . . 25.0 108.91 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -90.12 148.48 22.98 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 122.197 0.999 . . . . 25.0 109.367 175.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.5 p -153.55 -9.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 114.803 -1.09 . . . . 25.0 110.841 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.8 t -60.82 -39.71 90.04 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.036 0.446 . . . . 25.0 111.358 -178.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -86.48 -7.87 58.05 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 115.084 1.513 . . . . 25.0 115.084 -176.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.78 0.28 1.78 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 116.074 1.879 . . . . 25.0 116.074 -172.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -143.26 -69.38 0.02 OUTLIER Glycine 0 N--CA 1.467 0.76 0 N-CA-C 116.094 1.198 . . . . 25.0 116.094 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -156.03 163.81 39.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 117.467 0.634 . . . . 25.0 110.174 -174.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 30.8 t -112.71 -34.15 5.89 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 122.034 0.921 . . . . 25.0 110.552 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -107.12 137.38 13.93 Favored Glycine 0 C--O 1.223 -0.587 0 N-CA-C 107.824 -2.111 . . . . 25.0 107.824 176.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.88 151.39 45.74 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 118.936 -1.106 . . . . 25.0 109.269 -177.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -92.37 -164.11 38.11 Favored Glycine 0 C--O 1.222 -0.645 0 CA-C-N 115.839 -0.619 . . . . 25.0 112.04 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -53.59 129.04 31.45 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.798 0.809 . . . . 25.0 111.801 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 174.99 -176.47 47.14 Favored Glycine 0 C--O 1.215 -1.051 0 N-CA-C 109.928 -1.269 . . . . 25.0 109.928 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -155.94 167.62 29.81 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 118.451 1.126 . . . . 25.0 111.09 -178.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 53.92 43.7 30.5 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 124.319 1.048 . . . . 25.0 112.65 -178.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 68.94 30.24 72.34 Favored Glycine 0 C--O 1.219 -0.796 0 CA-C-N 115.291 -0.868 . . . . 25.0 112.864 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.2 t -142.51 171.69 13.72 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 118.316 1.058 . . . . 25.0 111.722 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 83.6 mt -90.42 164.1 14.42 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 103.329 -2.841 . . . . 25.0 103.329 171.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.68 110.36 7.91 Favored 'General case' 0 C--O 1.252 1.226 0 N-CA-C 107.753 -1.203 . . . . 25.0 107.753 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 18.7 m -71.89 162.7 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-N 115.349 -0.841 . . . . 25.0 109.587 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 29.5 m -145.8 169.78 17.85 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 120.292 -0.563 . . . . 25.0 109.883 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 34.9 m -121.77 164.38 18.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 108.738 -0.838 . . . . 25.0 108.738 177.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.8 t -76.14 -48.64 19.84 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.319 -1.363 . . . . 25.0 107.319 170.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -165.73 -170.42 1.79 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 101.502 -3.518 . . . . 25.0 101.502 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -69.85 -2.84 13.38 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 119.164 0.893 . . . . 25.0 112.856 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -137.35 -160.94 8.75 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 106.204 -2.759 . . . . 25.0 106.204 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.45 HG23 ' H ' ' A' ' 122' ' ' ARG . 0.2 OUTLIER 59.16 -160.34 0.28 Allowed 'General case' 0 C--O 1.249 1.062 0 CA-C-N 117.865 0.832 . . . . 25.0 111.093 177.79 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.45 ' H ' HG23 ' A' ' 121' ' ' THR . 47.0 mtt85 -71.08 166.86 20.51 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 122.279 1.038 . . . . 25.0 112.975 -171.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.1 p -114.15 165.92 12.16 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 105.74 -1.948 . . . . 25.0 105.74 173.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -133.55 153.56 51.55 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 121.14 0.495 . . . . 25.0 111.772 -177.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 28.2 tp -128.01 118.92 24.4 Favored 'General case' 0 C--O 1.25 1.099 0 N-CA-C 103.684 -2.709 . . . . 25.0 103.684 171.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -115.23 145.17 42.69 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 115.829 -0.623 . . . . 25.0 112.298 -174.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.9 t -99.71 147.83 25.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 105.221 -2.14 . . . . 25.0 105.221 168.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -114.79 11.48 16.76 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.889 1.328 . . . . 25.0 108.456 -177.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -93.62 141.17 28.78 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 105.53 -2.026 . . . . 25.0 105.53 174.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -140.83 150.34 43.16 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 122.055 0.931 . . . . 25.0 109.81 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -76.6 167.01 22.59 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.331 -1.304 . . . . 25.0 108.791 177.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.96 -32.39 73.7 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.591 -0.892 . . . . 25.0 108.591 176.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -65.42 -9.28 23.95 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 114.423 1.268 . . . . 25.0 114.423 174.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.57 21.85 61.23 Favored Glycine 0 C--O 1.241 0.581 0 N-CA-C 109.453 -1.459 . . . . 25.0 109.453 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.5 mt -92.05 136.8 32.88 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 106.092 -1.818 . . . . 25.0 106.092 175.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.6 p -141.55 -179.7 6.31 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.867 -1.16 . . . . 25.0 107.867 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -127.94 131.77 49.3 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 119.085 -1.046 . . . . 25.0 113.222 -178.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -147.61 153.95 40.04 Favored 'General case' 0 C--O 1.26 1.619 0 N-CA-C 106.818 -1.549 . . . . 25.0 106.818 168.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.1 p -142.12 146.6 22.42 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 106.93 -1.508 . . . . 25.0 106.93 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -103.2 140.93 36.72 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 107.094 -1.447 . . . . 25.0 107.094 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.2 mp -129.42 131.2 46.72 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 105.177 -2.157 . . . . 25.0 105.177 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -108.9 15.83 23.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.142 0.973 . . . . 25.0 110.541 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -72.91 -8.42 73.2 Favored Glycine 0 C--O 1.238 0.386 0 CA-C-N 114.761 -1.109 . . . . 25.0 110.719 171.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 40.0 t0 51.08 55.92 8.79 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.585 0.707 . . . . 25.0 112.445 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -133.14 43.55 2.93 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-O 122.178 0.989 . . . . 25.0 109.913 -174.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.66 -31.03 64.0 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 121.633 -0.667 . . . . 25.0 111.061 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.74 -14.83 61.63 Favored 'General case' 0 C--O 1.256 1.399 0 N-CA-C 112.406 0.521 . . . . 25.0 112.406 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -109.48 -10.72 14.87 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.108 0.48 . . . . 25.0 111.743 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 29.7 mt -73.69 126.21 29.8 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 123.193 1.473 . . . . 25.0 112.562 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 68.0 m -127.96 158.72 37.08 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 105.553 -2.017 . . . . 25.0 105.553 175.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.13 -3.57 49.38 Favored 'General case' 0 C--O 1.211 -0.95 0 CA-C-N 115.854 -0.612 . . . . 25.0 110.418 -178.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -67.1 -35.98 80.97 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 117.69 0.223 . . . . 25.0 111.297 -173.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -75.89 -11.44 59.97 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 120.307 -0.557 . . . . 25.0 110.597 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 22.5 mm -83.91 119.9 33.89 Favored 'Isoleucine or valine' 0 C--O 1.247 0.957 0 N-CA-C 106.449 -1.685 . . . . 25.0 106.449 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.6 p -95.94 109.37 22.59 Favored 'Isoleucine or valine' 0 C--O 1.253 1.247 0 CA-C-O 123.044 1.402 . . . . 25.0 113.797 -174.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -145.21 -12.92 0.53 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.649 -1.614 . . . . 25.0 112.185 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -76.75 54.19 0.96 Allowed 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 113.302 0.853 . . . . 25.0 113.302 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 57.87 27.65 14.92 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 113.784 1.031 . . . . 25.0 113.784 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 55.98 0.65 0.06 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 119.361 3.097 . . . . 25.0 119.361 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -88.12 134.23 33.81 Favored 'General case' 0 C--N 1.314 -0.962 0 O-C-N 121.255 -0.903 . . . . 25.0 110.758 -176.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -68.84 -14.28 62.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.918 -0.583 . . . . 25.0 109.578 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.11 -28.1 69.39 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.121 0.486 . . . . 25.0 111.626 177.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.1 162.06 28.86 Favored 'General case' 0 C--O 1.251 1.138 0 CA-C-O 121.264 0.555 . . . . 25.0 111.822 -177.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 61.38 -157.38 0.34 Allowed 'General case' 0 C--O 1.242 0.663 0 CA-C-N 114.629 -1.169 . . . . 25.0 112.619 177.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 90.95 -1.25 77.57 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.597 -0.335 . . . . 25.0 112.429 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -104.32 115.28 30.1 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.779 -0.823 . . . . 25.0 108.779 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -123.53 139.94 53.51 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.274 -0.639 . . . . 25.0 109.274 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -113.93 26.0 10.33 Favored Glycine 0 C--O 1.241 0.59 0 N-CA-C 112.314 -0.314 . . . . 25.0 112.314 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 52.3 t -79.18 -37.27 19.08 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 N-CA-C 109.463 -0.569 . . . . 25.0 109.463 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.43 135.64 24.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.629 0.728 . . . . 25.0 111.238 -175.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 133.58 141.78 4.62 Favored Glycine 0 C--O 1.247 0.969 0 N-CA-C 110.935 -0.866 . . . . 25.0 110.935 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -151.72 161.12 43.2 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.272 -0.64 . . . . 25.0 109.272 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 84.7 p -152.91 165.67 34.74 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 107.732 -1.21 . . . . 25.0 107.732 176.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -177.31 -171.13 40.52 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 119.887 -1.149 . . . . 25.0 112.114 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -138.78 92.54 11.22 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 117.587 0.693 . . . . 25.0 110.96 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.12 161.67 40.38 Favored 'Trans proline' 0 C--O 1.232 0.209 0 O-C-N 122.801 0.895 . . . . 25.0 112.115 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -134.64 151.43 51.04 Favored 'General case' 0 CA--C 1.508 -0.638 0 C-N-CA 123.535 0.734 . . . . 25.0 109.772 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -122.86 75.1 47.7 Favored Pre-proline 0 N--CA 1.481 1.084 0 CA-C-O 121.399 0.619 . . . . 25.0 110.842 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -77.44 160.33 32.16 Favored 'Trans proline' 0 CA--C 1.513 -0.526 0 C-N-CA 116.787 -1.675 . . . . 25.0 112.533 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 12.2 t -125.64 -4.9 7.06 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.211 -0.904 . . . . 25.0 110.741 174.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 6.3 p . . . . . 0 C--O 1.246 0.871 0 N-CA-C 109.61 -0.515 . . . . 25.0 109.61 176.72 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.866 0 CA-C-O 120.442 0.163 . . . . 25.0 110.573 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -150.28 101.72 3.15 Favored Pre-proline 0 C--N 1.33 -0.246 0 C-N-CA 122.236 0.214 . . . . 25.0 110.637 177.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.74 147.07 74.82 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 118.594 0.533 . . . . 25.0 113.097 -175.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -150.25 44.49 0.7 Allowed Glycine 0 CA--C 1.536 1.352 0 N-CA-C 114.533 0.573 . . . . 25.0 114.533 -177.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.9 p -52.51 129.94 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 114.776 1.398 . . . . 25.0 114.776 -176.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -93.49 -7.71 43.58 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.838 -1.073 . . . . 25.0 111.536 -178.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.93 -149.5 7.47 Favored Glycine 0 CA--C 1.507 -0.464 0 CA-C-N 115.597 -0.729 . . . . 25.0 114.344 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.2 p 71.94 156.43 0.16 Allowed Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 126.266 1.826 . . . . 25.0 110.581 -173.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.582 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 24.6 Cg_exo -69.27 -0.21 6.19 Favored 'Trans proline' 0 C--N 1.354 0.849 0 N-CA-C 114.846 1.056 . . . . 25.0 114.846 -175.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.8 p -66.9 -14.43 18.03 Favored 'Isoleucine or valine' 0 C--O 1.248 0.983 0 N-CA-C 113.954 1.094 . . . . 25.0 113.954 -171.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.4 p -133.57 132.12 57.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 N-CA-C 113.758 1.022 . . . . 25.0 113.758 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.7 13.62 74.97 Favored Glycine 0 C--O 1.246 0.888 0 N-CA-C 118.642 2.217 . . . . 25.0 118.642 171.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.3 t -51.2 -41.78 60.46 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.153 1.168 . . . . 25.0 114.153 -171.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -78.61 4.96 12.09 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 116.243 1.942 . . . . 25.0 116.243 -174.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.93 176.94 9.11 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 118.832 -0.604 . . . . 25.0 111.438 -177.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -57.64 133.28 55.17 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.339 0.59 . . . . 25.0 111.585 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -130.18 157.27 42.93 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.539 0.941 . . . . 50.0 113.539 -173.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -132.25 73.08 1.51 Allowed 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 106.738 -1.578 . . . . 25.0 106.738 169.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.6 mt -91.48 125.8 36.35 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 114.366 1.247 . . . . 25.0 114.366 -174.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -110.1 109.93 20.64 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 116.327 -0.397 . . . . 25.0 110.901 176.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -80.62 176.61 54.62 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 115.855 1.102 . . . . 25.0 115.855 -175.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.7 p -69.08 170.76 9.36 Favored 'General case' 0 C--O 1.256 1.444 0 C-N-CA 123.885 0.874 . . . . 25.0 110.361 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 48.6 mt -87.06 20.82 2.53 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.657 -0.702 . . . . 25.0 110.769 170.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -128.62 -174.01 13.61 Favored Glycine 0 C--O 1.223 -0.56 0 CA-C-O 118.615 -1.103 . . . . 25.0 112.505 176.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.9 t -71.08 133.1 46.01 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 113.857 1.058 . . . . 25.0 113.857 -176.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -145.18 158.52 43.8 Favored 'General case' 0 C--O 1.219 -0.541 0 O-C-N 123.211 0.32 . . . . 50.0 111.682 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -99.61 134.15 42.91 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 103.352 -2.833 . . . . 25.0 103.352 162.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.9 mm -128.41 117.92 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 105.676 -1.972 . . . . 25.0 105.676 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.582 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 8.3 mp -115.55 116.19 27.74 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 106.888 -1.523 . . . . 25.0 106.888 178.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.76 -36.11 90.72 Favored Glycine 0 CA--C 1.502 -0.779 0 C-N-CA 120.567 -0.825 . . . . 25.0 115.062 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.34 -147.21 45.37 Favored Glycine 0 C--O 1.254 1.39 0 C-N-CA 120.813 -0.708 . . . . 25.0 112.027 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.99 165.66 54.74 Favored Glycine 0 C--O 1.249 1.039 0 N-CA-C 111.847 -0.501 . . . . 25.0 111.847 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.84 162.96 28.94 Favored Glycine 0 C--N 1.316 -0.546 0 N-CA-C 114.967 0.747 . . . . 25.0 114.967 174.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.78 106.65 16.47 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 106.524 -1.658 . . . . 25.0 106.524 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -103.58 155.3 18.65 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 112.892 0.701 . . . . 50.0 112.892 -169.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -122.77 93.7 4.05 Favored 'General case' 0 C--O 1.246 0.906 0 N-CA-C 106.277 -1.749 . . . . 25.0 106.277 176.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.8 mt -101.21 140.09 35.98 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 114.881 -1.054 . . . . 25.0 111.356 -170.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -135.64 102.73 5.19 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.563 -0.532 . . . . 25.0 109.563 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.56 -20.7 59.57 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 116.463 1.345 . . . . 25.0 116.463 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 50.29 -150.51 0.23 Allowed 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 119.548 1.674 . . . . 25.0 115.126 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.68 162.2 13.62 Favored 'General case' 0 CA--C 1.552 1.041 0 O-C-N 120.908 -1.12 . . . . 25.0 112.752 -177.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.86 156.12 28.25 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 114.828 -1.078 . . . . 25.0 111.574 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -77.91 106.6 9.86 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 106.943 -1.503 . . . . 25.0 106.943 173.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -111.93 151.83 28.74 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 121.577 -0.702 . . . . 50.0 110.649 -170.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mp -116.13 94.82 4.81 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.966 -1.124 . . . . 25.0 107.966 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 mp -99.25 127.01 45.19 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.701 0.8 . . . . 25.0 112.912 -175.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -124.4 148.81 47.32 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 104.35 -2.463 . . . . 25.0 104.35 175.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.47 -39.37 3.46 Favored Glycine 0 N--CA 1.462 0.432 0 N-CA-C 116.193 1.237 . . . . 25.0 116.193 -175.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.38 -175.55 48.77 Favored Glycine 0 C--O 1.243 0.718 0 N-CA-C 110.266 -1.134 . . . . 25.0 110.266 -177.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.01 149.14 12.31 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 112.752 0.649 . . . . 25.0 112.752 -178.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.41 153.47 29.6 Favored Glycine 0 N--CA 1.46 0.251 0 N-CA-C 111.017 -0.833 . . . . 25.0 111.017 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.5 125.38 29.28 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 104.222 -2.511 . . . . 25.0 104.222 177.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -109.65 153.12 24.68 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.328 -0.619 . . . . 50.0 109.328 -173.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -116.02 122.62 45.74 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 102.409 -3.182 . . . . 25.0 102.409 177.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -145.41 130.86 18.72 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 114.707 1.373 . . . . 25.0 114.707 -171.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.0 m -107.44 132.25 53.4 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 105.99 -1.855 . . . . 25.0 105.99 176.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -91.57 -27.53 17.15 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 111.581 -0.607 . . . . 25.0 111.581 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.21 -169.41 54.91 Favored Glycine 0 N--CA 1.466 0.648 0 CA-C-N 118.022 0.911 . . . . 25.0 113.704 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -66.2 163.41 17.84 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.903 -0.763 . . . . 25.0 110.956 177.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.44 160.29 36.39 Favored Glycine 0 C--O 1.25 1.124 0 CA-C-O 119.897 -0.391 . . . . 25.0 112.678 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.33 102.3 6.7 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.631 0.729 . . . . 25.0 109.853 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -94.85 154.1 17.4 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.773 -0.649 . . . . 50.0 111.545 -174.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.5 m -121.96 127.91 50.9 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.054 -1.461 . . . . 25.0 107.054 -177.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -116.8 82.09 1.74 Allowed 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 106.992 -1.484 . . . . 25.0 106.992 176.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.71 -27.27 40.66 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-N 115.634 -0.712 . . . . 25.0 110.946 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 66.98 153.84 0.09 Allowed 'General case' 0 N--CA 1.479 1.018 0 O-C-N 125.678 1.861 . . . . 25.0 112.112 -172.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.06 -50.8 8.67 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.917 1.08 . . . . 25.0 113.917 -166.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 46.6 mt -130.4 168.86 16.29 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-O 121.372 0.605 . . . . 25.0 109.564 -172.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.17 -28.47 53.09 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.977 0.911 . . . . 25.0 110.585 173.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -75.4 -12.88 60.34 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 115.576 1.695 . . . . 25.0 115.576 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -73.26 134.74 44.35 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.026 1.121 . . . . 25.0 114.026 -174.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.3 t 50.22 42.56 25.62 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 114.759 -1.109 . . . . 25.0 113.655 176.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -107.75 162.45 13.97 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.135 -0.484 . . . . 25.0 111.623 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -122.9 144.6 49.11 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 103.799 -2.667 . . . . 25.0 103.799 177.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 99.3 p -140.12 172.08 6.86 Favored Pre-proline 0 C--N 1.325 -0.478 0 C-N-CA 123.71 0.804 . . . . 25.0 108.963 -173.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -61.1 -19.26 62.56 Favored 'Trans proline' 0 C--N 1.354 0.829 0 O-C-N 122.653 0.817 . . . . 25.0 113.592 174.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.0 mt -79.36 -23.62 43.23 Favored 'General case' 0 C--O 1.245 0.857 0 N-CA-C 113.037 0.754 . . . . 25.0 113.037 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 148.51 -172.35 28.73 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 116.216 -0.447 . . . . 25.0 112.09 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.7 t -101.23 137.71 39.22 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.734 0.778 . . . . 25.0 111.859 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -122.63 29.93 6.68 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.22 -1.355 . . . . 25.0 107.694 173.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.91 146.56 50.43 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 109.765 -1.334 . . . . 25.0 109.765 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -95.84 163.66 13.07 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.41 -1.053 . . . . 50.0 110.316 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -126.04 104.06 8.07 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 111.992 0.367 . . . . 25.0 111.992 -170.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 21.6 mt -86.47 135.1 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 107.206 -1.405 . . . . 25.0 107.206 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.3 mt -89.02 -42.49 11.73 Favored 'General case' 0 C--O 1.21 -0.991 0 N-CA-C 114.77 1.396 . . . . 25.0 114.77 -175.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 46.8 p-10 -127.62 41.17 3.56 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.989 1.477 . . . . 25.0 114.989 -172.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -60.23 142.76 54.02 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 113.399 0.889 . . . . 25.0 113.399 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -117.1 100.13 53.11 Favored Pre-proline 0 N--CA 1.476 0.835 0 N-CA-C 108.948 -0.76 . . . . 25.0 108.948 177.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.9 1.66 4.32 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 N-CA-C 117.129 1.934 . . . . 25.0 117.129 -172.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.6 t -100.7 -35.84 9.33 Favored 'General case' 0 CA--C 1.554 1.099 0 O-C-N 121.763 -0.585 . . . . 25.0 110.753 175.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -98.86 -39.14 8.74 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 114.281 1.215 . . . . 25.0 114.281 -177.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -83.48 163.69 20.34 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.973 -0.558 . . . . 75.0 110.525 -172.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -142.26 146.14 34.82 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.003 0.814 . . . . 25.0 112.486 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 80.1 mt -125.96 131.92 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 107.753 -1.203 . . . . 25.0 107.753 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -88.29 144.5 26.38 Favored 'General case' 0 C--O 1.214 -0.814 0 O-C-N 120.958 -1.089 . . . . 25.0 110.185 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.4 p -146.69 4.42 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.359 0 CA-C-N 115.232 -0.894 . . . . 25.0 110.242 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.2 t -55.67 -57.72 10.8 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 112.9 0.704 . . . . 25.0 112.9 -173.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.44 -14.1 57.46 Favored 'General case' 0 C--O 1.256 1.404 0 N-CA-C 112.445 0.535 . . . . 25.0 112.445 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.9 mt -89.44 -52.91 4.79 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.285 0.564 . . . . 25.0 112.299 -175.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -109.03 -65.2 0.56 Allowed Glycine 0 CA--C 1.506 -0.523 0 N-CA-C 116.637 1.415 . . . . 25.0 116.637 -171.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -157.84 169.31 24.89 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 117.003 0.401 . . . . 25.0 111.353 -171.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.0 t -109.52 -23.6 11.41 Favored 'General case' 0 CA--C 1.557 1.233 0 O-C-N 123.869 0.731 . . . . 25.0 111.977 177.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -120.4 145.03 17.42 Favored Glycine 0 C--O 1.235 0.173 0 N-CA-C 105.593 -3.003 . . . . 25.0 105.593 172.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -58.28 154.0 14.23 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.095 1.146 . . . . 25.0 114.095 -173.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -90.17 -166.2 41.16 Favored Glycine 0 C--O 1.223 -0.59 0 CA-C-N 115.272 -0.876 . . . . 25.0 112.989 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -57.04 131.38 49.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.356 0.598 . . . . 25.0 112.202 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 160.41 178.1 34.1 Favored Glycine 0 N--CA 1.466 0.698 0 N-CA-C 107.054 -2.418 . . . . 25.0 107.054 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -141.76 166.72 23.95 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.932 1.366 . . . . 25.0 110.321 -175.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 55.04 34.23 22.04 Favored 'General case' 0 C--O 1.26 1.627 0 C-N-CA 123.392 0.677 . . . . 25.0 112.038 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.09 41.3 54.56 Favored Glycine 0 C--O 1.216 -1.018 0 N-CA-C 111.269 -0.732 . . . . 25.0 111.269 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.5 t -142.95 175.87 9.51 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.887 -0.782 . . . . 25.0 108.887 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 82.6 mt -106.48 164.65 11.88 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 105.655 -1.98 . . . . 25.0 105.655 173.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.412 ' HB3' ' CE1' ' A' ' 128' ' ' TYR . . . -72.89 120.5 18.6 Favored 'General case' 0 C--O 1.245 0.85 0 N-CA-C 108.302 -0.999 . . . . 25.0 108.302 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.9 m -89.71 158.36 2.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.874 -0.788 . . . . 25.0 108.874 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.4 m -132.98 154.09 50.82 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.038 -0.727 . . . . 25.0 109.038 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.3 m -120.33 160.38 20.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 108.633 -0.877 . . . . 25.0 108.633 177.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 17.2 t -75.84 -47.4 25.72 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 105.828 -1.915 . . . . 25.0 105.828 170.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -173.86 -162.52 0.15 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 101.229 -3.619 . . . . 25.0 101.229 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -61.02 -35.93 78.17 Favored 'General case' 0 C--O 1.246 0.88 0 CA-C-N 118.157 0.435 . . . . 25.0 111.088 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -103.01 -154.05 24.48 Favored Glycine 0 C--O 1.225 -0.463 0 CA-C-O 121.574 0.541 . . . . 25.0 112.293 176.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.91 -138.75 0.4 Allowed 'General case' 0 C--O 1.237 0.435 0 C-N-CA 122.75 0.42 . . . . 25.0 111.747 174.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 33.7 mtt85 -105.48 167.05 10.01 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 121.679 -0.638 . . . . 25.0 112.188 -174.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.28 165.58 13.28 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 105.402 -2.073 . . . . 25.0 105.402 177.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -138.45 152.65 48.52 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.767 -0.827 . . . . 25.0 108.767 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 27.0 tp -128.75 114.8 17.04 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 105.1 -2.185 . . . . 25.0 105.1 175.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -116.97 151.18 37.26 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 122.588 1.185 . . . . 25.0 112.101 -171.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.1 t -93.77 142.55 27.24 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 104.543 -2.392 . . . . 25.0 104.543 171.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.412 ' CE1' ' HB3' ' A' ' 113' ' ' ALA . 62.7 m-85 -115.6 11.08 15.74 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 122.539 1.161 . . . . 25.0 108.207 176.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -91.1 136.1 33.32 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 105.258 -2.127 . . . . 25.0 105.258 168.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -131.5 152.43 50.73 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-O 121.892 0.853 . . . . 25.0 110.433 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -86.54 166.72 15.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.392 -1.276 . . . . 25.0 109.382 -176.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -61.38 -32.14 72.05 Favored 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 122.676 0.39 . . . . 25.0 111.192 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -76.6 -4.54 43.46 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.325 0.861 . . . . 25.0 113.325 175.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.01 13.64 63.98 Favored Glycine 0 CA--C 1.501 -0.838 0 C-N-CA 120.919 -0.657 . . . . 25.0 112.176 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 65.7 mt -83.47 158.3 22.1 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 106.472 -1.677 . . . . 25.0 106.472 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.6 p -154.56 177.77 10.83 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 104.851 -2.278 . . . . 25.0 104.851 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -127.77 137.55 52.46 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-O 119.044 -0.503 . . . . 25.0 110.199 -176.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -152.56 153.49 33.52 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 118.996 0.816 . . . . 25.0 109.071 171.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.2 p -143.7 142.05 25.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 106.792 -1.559 . . . . 25.0 106.792 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -100.31 146.76 26.55 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.361 -0.977 . . . . 25.0 108.361 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.0 mp -137.48 132.76 33.78 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 104.669 -2.345 . . . . 25.0 104.669 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -101.82 12.16 37.49 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 121.26 1.845 . . . . 25.0 115.803 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -73.81 -14.91 79.7 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.398 -0.906 . . . . 25.0 113.081 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 42.2 t0 53.26 43.0 32.07 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 123.826 1.774 . . . . 25.0 110.902 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -109.55 41.1 1.73 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 113.547 -1.661 . . . . 25.0 107.606 -176.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.94 -29.95 63.59 Favored 'General case' 0 C--O 1.209 -1.047 0 CA-C-N 113.923 -1.49 . . . . 25.0 113.293 177.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.58 -31.66 57.66 Favored 'General case' 0 C--N 1.319 -0.756 0 O-C-N 120.285 -1.51 . . . . 25.0 112.135 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -77.27 -29.83 54.03 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.975 0.731 . . . . 25.0 112.975 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 15.9 mt -60.91 129.9 43.78 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 122.65 1.214 . . . . 25.0 110.413 -176.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.9 m -138.73 163.8 31.21 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 104.999 -2.222 . . . . 25.0 104.999 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.04 4.47 17.0 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 118.562 0.619 . . . . 25.0 109.734 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -75.01 -29.86 60.98 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.39 -0.823 . . . . 25.0 111.662 -177.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -87.32 -8.74 56.35 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 122.092 -0.38 . . . . 25.0 110.8 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 40.6 mm -91.95 132.78 35.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 104.609 -2.367 . . . . 25.0 104.609 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.4 p -115.11 132.76 63.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 122.053 0.93 . . . . 25.0 111.496 -175.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -155.33 -34.13 0.09 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 114.701 1.371 . . . . 25.0 114.701 -174.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.33 60.43 5.58 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 113.234 0.827 . . . . 25.0 113.234 -173.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 58.75 21.17 8.63 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.843 1.053 . . . . 25.0 113.843 176.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.65 11.52 2.44 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 114.675 1.361 . . . . 25.0 114.675 175.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -89.87 129.59 36.21 Favored 'General case' 0 C--O 1.238 0.448 0 O-C-N 121.999 -0.438 . . . . 25.0 110.304 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -66.69 -15.29 63.4 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.376 0.608 . . . . 25.0 111.07 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.7 -19.08 64.35 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 121.699 -0.626 . . . . 25.0 112.269 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.48 157.4 22.42 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 111.982 0.364 . . . . 25.0 111.982 -178.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 56.59 -163.79 0.16 Allowed 'General case' 0 CA--C 1.549 0.933 0 O-C-N 124.434 1.084 . . . . 25.0 113.417 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 97.67 0.98 58.96 Favored Glycine 0 N--CA 1.465 0.628 0 N-CA-C 114.94 0.736 . . . . 25.0 114.94 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -75.85 110.87 10.64 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 117.239 0.519 . . . . 25.0 111.193 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -129.85 155.44 46.0 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.553 0.341 . . . . 25.0 111.01 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -136.44 39.86 1.59 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.096 -1.202 . . . . 25.0 110.096 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 60.8 t -73.99 -36.21 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 109.76 -0.459 . . . . 25.0 109.76 -176.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.4 130.93 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-O 121.684 0.754 . . . . 25.0 111.639 -177.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 139.0 155.25 6.61 Favored Glycine 0 C--O 1.247 0.929 0 CA-C-N 115.336 -0.847 . . . . 25.0 111.741 -178.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -163.2 170.72 17.32 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 108.731 -0.84 . . . . 25.0 108.731 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 77.4 p -150.58 168.73 23.4 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 105.826 -1.916 . . . . 25.0 105.826 173.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -159.04 140.68 7.03 Favored Glycine 0 CA--C 1.501 -0.808 0 C-N-CA 119.728 -1.225 . . . . 25.0 115.062 177.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -131.64 80.16 67.08 Favored Pre-proline 0 C--O 1.24 0.561 0 N-CA-C 106.998 -1.482 . . . . 25.0 106.998 177.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -68.75 155.33 69.09 Favored 'Trans proline' 0 C--O 1.236 0.406 0 N-CA-C 113.582 0.57 . . . . 25.0 113.582 -174.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -120.66 151.96 38.81 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 106.871 -1.529 . . . . 25.0 106.871 -177.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -143.47 64.85 14.19 Favored Pre-proline 0 C--O 1.248 0.997 0 N-CA-C 115.559 1.689 . . . . 25.0 115.559 -178.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -71.53 151.28 58.71 Favored 'Trans proline' 0 C--O 1.244 0.814 0 C-N-CA 116.969 -1.554 . . . . 25.0 111.345 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 11.5 t -137.63 22.68 2.91 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.397 0.618 . . . . 25.0 110.919 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 C--O 1.247 0.944 0 CA-C-O 116.874 -1.536 . . . . 25.0 110.825 -179.665 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.971 0 N-CA-C 109.914 -0.402 . . . . 25.0 109.914 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -128.04 121.05 21.61 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 107.357 -1.349 . . . . 25.0 107.357 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.51 146.65 68.69 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 115.069 -2.82 . . . . 25.0 113.268 -175.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.88 46.39 0.04 OUTLIER Glycine 0 CA--C 1.522 0.511 0 CA-C-N 115.427 -0.806 . . . . 25.0 111.11 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.1 p -57.54 133.85 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 CA-C-O 121.497 0.665 . . . . 25.0 109.997 -175.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -99.76 -11.57 20.71 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.703 -0.68 . . . . 25.0 109.742 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.33 -147.55 8.43 Favored Glycine 0 CA--C 1.501 -0.836 0 CA-C-N 115.621 -0.718 . . . . 25.0 113.028 177.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.2 p 71.3 159.09 0.16 Allowed Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 125.632 1.573 . . . . 25.0 111.135 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.521 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 31.2 Cg_exo -66.19 1.76 2.25 Favored 'Trans proline' 0 C--N 1.351 0.67 0 N-CA-C 117.406 2.041 . . . . 25.0 117.406 -175.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.3 p -63.98 -24.06 34.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 115.735 1.754 . . . . 25.0 115.735 -168.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.6 p -145.93 140.43 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 114.233 1.197 . . . . 25.0 114.233 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.85 10.0 86.53 Favored Glycine 0 N--CA 1.466 0.678 0 CA-C-N 114.753 -1.112 . . . . 25.0 115.434 171.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.6 t -50.95 -39.3 54.71 Favored 'General case' 0 C--O 1.21 -1.025 0 N-CA-C 114.075 1.139 . . . . 25.0 114.075 -170.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -81.71 8.07 10.9 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 115.044 1.498 . . . . 25.0 115.044 -175.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -142.99 173.96 11.09 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 118.852 -0.594 . . . . 25.0 111.459 176.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -58.79 124.12 18.72 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 115.314 1.598 . . . . 25.0 115.314 -173.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -124.32 164.47 19.54 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.611 1.708 . . . . 50.0 115.611 -175.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -130.85 77.03 1.76 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 107.469 -1.308 . . . . 25.0 107.469 169.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.1 mt -90.74 120.24 31.62 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.861 1.06 . . . . 25.0 113.861 -175.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -110.9 124.54 52.29 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 122.799 0.44 . . . . 25.0 110.69 178.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.45 172.72 41.52 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-O 122.626 1.126 . . . . 25.0 114.973 -176.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.8 p -84.97 175.44 9.06 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.037 -1.081 . . . . 25.0 110.484 175.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 66.2 mt -79.42 4.22 16.11 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.507 0.723 . . . . 25.0 112.733 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.61 177.78 24.82 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 119.438 -0.646 . . . . 25.0 113.879 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.1 t -70.14 129.98 40.85 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 117.303 0.552 . . . . 25.0 111.995 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -145.51 159.36 43.22 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.129 -0.357 . . . . 50.0 110.774 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -94.33 138.97 31.68 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 106.119 -1.808 . . . . 25.0 106.119 164.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.3 mm -129.69 105.99 12.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 105.49 -2.041 . . . . 25.0 105.49 178.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.521 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 8.9 mp -105.57 117.45 34.06 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.735 -0.839 . . . . 25.0 108.735 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.64 -42.54 62.44 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.196 -1.002 . . . . 25.0 114.303 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.8 -149.55 48.12 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 120.277 -0.963 . . . . 25.0 112.53 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.46 168.16 52.91 Favored Glycine 0 C--O 1.247 0.929 0 CA-C-O 122.001 0.778 . . . . 25.0 114.25 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.85 167.22 26.47 Favored Glycine 0 C--O 1.24 0.47 0 N-CA-C 111.954 -0.458 . . . . 25.0 111.954 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.06 120.15 28.03 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 105.773 -1.936 . . . . 25.0 105.773 176.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -115.09 154.74 28.35 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 120.41 -0.516 . . . . 50.0 111.984 -172.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -118.86 90.63 3.37 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 107.068 -1.456 . . . . 25.0 107.068 177.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.4 mt -98.4 138.22 35.95 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 123.078 0.551 . . . . 25.0 111.876 -171.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -135.31 105.78 6.42 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 118.554 0.616 . . . . 25.0 111.537 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.27 -30.65 45.02 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 115.316 0.887 . . . . 25.0 115.316 -175.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 53.93 -150.1 0.4 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.058 0.943 . . . . 25.0 112.289 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.36 162.9 24.3 Favored 'General case' 0 C--O 1.254 1.305 0 O-C-N 121.072 -1.018 . . . . 25.0 112.353 -175.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.75 159.04 32.54 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 114.922 -1.036 . . . . 25.0 111.71 -177.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -81.02 102.78 10.41 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.058 -1.089 . . . . 25.0 108.058 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -106.04 150.07 26.09 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.521 0.677 . . . . 50.0 112.72 -170.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 mp -113.05 89.37 3.06 Favored 'General case' 0 C--O 1.217 -0.626 0 N-CA-C 108.436 -0.95 . . . . 25.0 108.436 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.9 mp -92.75 129.67 38.61 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.303 0.482 . . . . 25.0 112.303 -176.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -127.1 146.61 50.32 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 104.516 -2.402 . . . . 25.0 104.516 175.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -98.19 -33.74 5.61 Favored Glycine 0 N--CA 1.466 0.689 0 N-CA-C 117.253 1.661 . . . . 25.0 117.253 -176.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.94 -162.19 52.66 Favored Glycine 0 C--O 1.257 1.587 0 N-CA-C 110.608 -0.997 . . . . 25.0 110.608 -174.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.68 161.79 7.39 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.674 0.75 . . . . 25.0 112.758 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.4 170.95 37.94 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 115.07 -0.968 . . . . 25.0 113.683 174.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.72 124.03 30.46 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 106.28 -1.748 . . . . 25.0 106.28 177.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -115.56 152.36 33.19 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 120.979 0.418 . . . . 50.0 111.593 -175.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -115.09 129.53 56.71 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 103.879 -2.637 . . . . 25.0 103.879 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -148.41 127.45 12.8 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 115.884 1.809 . . . . 25.0 115.884 -174.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.9 m -99.37 134.2 42.57 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.481 -0.781 . . . . 25.0 108.899 172.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.03 -33.95 9.25 Favored Glycine 0 C--O 1.244 0.777 0 C-N-CA 120.07 -1.062 . . . . 25.0 112.681 175.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.6 -169.39 54.73 Favored Glycine 0 C--O 1.255 1.442 0 CA-C-O 122.54 1.078 . . . . 25.0 115.111 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -67.75 162.45 23.83 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.375 -1.073 . . . . 25.0 110.605 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.77 164.48 39.63 Favored Glycine 0 C--O 1.244 0.761 0 N-CA-C 111.218 -0.753 . . . . 25.0 111.218 -177.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.74 105.13 16.05 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 109.619 -0.511 . . . . 25.0 109.619 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -99.15 151.71 20.68 Favored 'General case' 0 C--O 1.215 -0.73 0 CA-C-N 115.691 -0.686 . . . . 50.0 110.531 -170.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 58.9 m -121.64 126.67 49.58 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.925 -0.769 . . . . 25.0 108.925 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -114.36 87.59 2.67 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.615 -1.254 . . . . 25.0 107.615 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 30.8 mtt85 -85.87 -23.22 27.17 Favored 'General case' 0 CA--C 1.505 -0.763 0 O-C-N 121.602 -0.686 . . . . 25.0 112.661 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 67.75 142.6 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 O-C-N 125.161 1.538 . . . . 25.0 112.876 -174.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.28 -52.91 10.89 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 114.791 1.404 . . . . 25.0 114.791 -163.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 98.0 mt -135.82 176.53 8.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.308 1.051 . . . . 25.0 110.04 -176.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.58 -28.41 32.03 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.104 -0.953 . . . . 25.0 112.362 173.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -77.91 -10.83 59.77 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 114.707 1.373 . . . . 25.0 114.707 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.15 138.4 41.99 Favored 'General case' 0 C--O 1.213 -0.844 0 O-C-N 120.845 -1.159 . . . . 25.0 111.709 -175.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.8 t 45.61 39.42 4.9 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-N 113.682 -1.599 . . . . 25.0 114.005 173.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -104.31 167.31 9.83 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.097 -0.956 . . . . 25.0 109.434 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -127.47 143.84 51.14 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 104.791 -2.3 . . . . 25.0 104.791 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.6 p -135.9 166.76 25.86 Favored Pre-proline 0 C--N 1.315 -0.904 0 N-CA-C 108.021 -1.103 . . . . 25.0 108.021 -176.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -63.04 -23.48 73.81 Favored 'Trans proline' 0 C--N 1.353 0.774 0 CA-C-N 118.917 0.649 . . . . 25.0 112.68 175.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 73.7 mt -72.85 -23.85 60.81 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.418 0.628 . . . . 25.0 111.036 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 149.23 177.49 23.41 Favored Glycine 0 CA--C 1.5 -0.847 0 N-CA-C 111.028 -0.829 . . . . 25.0 111.028 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.3 t -97.59 155.12 17.12 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 118.072 0.936 . . . . 25.0 112.765 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -136.36 24.78 3.21 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 106.622 -1.621 . . . . 25.0 106.622 175.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.53 146.33 48.49 Favored Glycine 0 C--O 1.218 -0.865 0 CA-C-O 118.885 -0.953 . . . . 25.0 111.733 178.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -98.37 166.27 11.46 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 118.11 0.955 . . . . 50.0 112.311 -177.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -124.11 99.82 6.42 Favored 'General case' 0 C--O 1.253 1.26 0 O-C-N 123.593 0.558 . . . . 25.0 111.844 -172.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.8 mt -84.19 135.49 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 106.082 -1.821 . . . . 25.0 106.082 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.44 ' HA ' ' HG2' ' A' ' 142' ' ' GLU . 12.9 mt -89.99 -45.13 9.39 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 115.607 1.706 . . . . 25.0 115.607 -171.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -131.23 32.11 4.3 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.816 1.043 . . . . 25.0 113.816 -170.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -51.25 138.97 19.74 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.795 1.035 . . . . 25.0 113.795 -175.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -107.93 106.93 59.62 Favored Pre-proline 0 C--O 1.235 0.329 0 N-CA-C 108.293 -1.003 . . . . 25.0 108.293 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -69.8 -8.17 22.93 Favored 'Trans proline' 0 CA--C 1.547 1.161 0 N-CA-C 117.743 2.17 . . . . 25.0 117.743 -174.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.8 t -96.84 -35.81 10.81 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-O 120.481 0.181 . . . . 25.0 111.41 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -98.83 -37.66 9.35 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 113.349 0.87 . . . . 25.0 113.349 -173.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -86.59 167.0 14.96 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.922 0.391 . . . . 75.0 110.551 -173.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -145.59 149.09 33.91 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 109.356 -0.609 . . . . 25.0 109.356 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 68.5 mt -125.51 133.21 69.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 108.05 -1.093 . . . . 25.0 108.05 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -95.59 144.33 26.13 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.754 -1.202 . . . . 25.0 107.754 174.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.1 p -143.41 -10.16 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.722 -0.672 . . . . 25.0 111.612 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 39.0 t -58.85 -42.6 89.74 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.416 0.895 . . . . 25.0 113.416 -175.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.54 -20.82 61.98 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 113.977 1.102 . . . . 25.0 113.977 -176.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.79 -45.38 1.9 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 116.436 2.013 . . . . 25.0 116.436 -170.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -94.74 -75.57 1.29 Allowed Glycine 0 N--CA 1.463 0.47 0 C-N-CA 119.999 -1.096 . . . . 25.0 113.099 -175.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -148.75 167.09 26.51 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.068 -0.716 . . . . 25.0 109.068 -175.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.8 t -124.38 -27.96 3.7 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.453 0.644 . . . . 25.0 110.362 176.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -101.0 120.14 6.78 Favored Glycine 0 N--CA 1.466 0.691 0 N-CA-C 108.294 -1.922 . . . . 25.0 108.294 172.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -66.24 150.4 48.87 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 119.776 1.788 . . . . 25.0 109.55 -176.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -102.57 -146.33 17.4 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-O 122.755 1.197 . . . . 25.0 115.723 -173.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -60.01 134.35 56.96 Favored 'General case' 0 C--O 1.251 1.16 0 CA-C-N 113.605 -1.298 . . . . 25.0 112.238 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 159.28 -176.98 36.01 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 123.28 0.363 . . . . 25.0 112.504 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -144.57 179.07 7.52 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 109.609 -0.515 . . . . 25.0 109.609 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 56.74 32.85 21.93 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 113.967 1.099 . . . . 25.0 113.967 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 69.06 29.7 72.24 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 109.964 -1.254 . . . . 25.0 109.964 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.414 ' HB2' ' HA ' ' A' ' 150' ' ' SER . 3.8 t -143.32 174.3 10.85 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.373 0.606 . . . . 25.0 109.69 -178.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 5.5 mp -92.7 161.82 14.39 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 103.337 -2.838 . . . . 25.0 103.337 173.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.84 118.01 10.49 Favored 'General case' 0 C--O 1.269 2.087 0 CA-C-N 118.953 0.797 . . . . 25.0 112.196 -172.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 26.4 m -79.75 162.05 3.9 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 CA-C-O 121.56 0.695 . . . . 25.0 109.363 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 56.1 m -145.88 171.3 15.01 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.714 -0.847 . . . . 25.0 108.714 -177.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 34.0 m -125.17 162.68 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 109.156 -0.683 . . . . 25.0 109.156 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 40.2 t -80.92 -40.17 25.01 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.464 -1.68 . . . . 25.0 106.464 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -174.27 -163.49 0.16 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 102.628 -3.101 . . . . 25.0 102.628 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -63.63 -23.76 67.51 Favored 'General case' 0 C--O 1.248 1.013 0 N-CA-C 112.39 0.515 . . . . 25.0 112.39 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -121.6 -153.61 9.0 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 109.499 -1.441 . . . . 25.0 109.499 175.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.83 -154.01 0.37 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 122.859 0.464 . . . . 25.0 110.295 175.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.0 mtt85 -81.46 160.29 24.03 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 114.43 1.27 . . . . 25.0 114.43 -173.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.1 p -105.21 162.62 13.25 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 105.642 -1.985 . . . . 25.0 105.642 172.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -130.27 150.68 51.4 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.394 0.616 . . . . 25.0 112.175 -177.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 64.8 tp -127.53 120.05 27.39 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 104.022 -2.584 . . . . 25.0 104.022 171.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -118.41 146.19 44.63 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.686 0.624 . . . . 25.0 112.686 -171.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.2 t -89.15 147.94 23.93 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 106.201 -1.778 . . . . 25.0 106.201 167.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -116.5 -0.04 12.59 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.624 -1.251 . . . . 25.0 107.624 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -86.0 137.43 32.72 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 104.085 -2.561 . . . . 25.0 104.085 169.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -146.2 158.42 43.88 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 124.697 1.248 . . . . 25.0 109.38 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -80.6 160.61 25.06 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.733 -1.122 . . . . 25.0 107.976 175.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.47 -22.37 66.94 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 122.002 -0.436 . . . . 25.0 110.625 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -69.41 -11.82 61.14 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 113.455 0.909 . . . . 25.0 113.455 174.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.63 16.14 57.18 Favored Glycine 0 C--O 1.22 -0.781 0 N-CA-C 111.64 -0.584 . . . . 25.0 111.64 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.3 mt -88.66 130.21 35.35 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.985 -1.117 . . . . 25.0 107.985 178.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 72.7 p -138.95 -179.69 5.98 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.477 -0.564 . . . . 25.0 109.477 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -122.13 133.11 54.76 Favored 'General case' 0 C--O 1.257 1.453 0 CA-C-O 119.177 -0.44 . . . . 25.0 110.452 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.4 pt-20 -145.91 152.17 39.02 Favored 'General case' 0 C--O 1.247 0.956 0 N-CA-C 108.293 -1.002 . . . . 25.0 108.293 171.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.8 p -145.85 139.82 21.31 Favored 'Isoleucine or valine' 0 C--O 1.248 0.985 0 N-CA-C 106.712 -1.588 . . . . 25.0 106.712 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -103.41 147.6 26.93 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 107.704 -1.221 . . . . 25.0 107.704 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.7 mp -136.61 129.96 31.55 Favored 'General case' 0 C--O 1.208 -1.132 0 N-CA-C 105.186 -2.153 . . . . 25.0 105.186 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.44 ' HG2' ' HA ' ' A' ' 85' ' ' LEU . 17.4 pt-20 -99.66 6.54 45.62 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 119.889 1.222 . . . . 25.0 112.158 -175.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -71.1 -12.35 71.71 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.718 -0.753 . . . . 25.0 112.275 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 38.7 t0 53.53 54.86 9.4 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.915 0.864 . . . . 25.0 111.371 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -126.94 39.63 3.88 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.56 -1.2 . . . . 25.0 109.129 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.74 -37.01 82.66 Favored 'General case' 0 C--O 1.214 -0.791 0 O-C-N 121.792 -0.567 . . . . 25.0 111.673 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.16 -10.29 59.46 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 121.53 -0.731 . . . . 25.0 112.085 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -98.12 -26.13 14.68 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 111.789 0.292 . . . . 25.0 111.789 175.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.0 mt -62.69 136.06 57.69 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 122.581 1.181 . . . . 25.0 111.357 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.414 ' HA ' ' HB2' ' A' ' 111' ' ' SER . 47.5 m -135.81 164.26 28.32 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 105.558 -2.016 . . . . 25.0 105.558 171.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -77.05 8.38 3.94 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.71 0.29 . . . . 25.0 110.716 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -65.66 -39.34 91.26 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.301 0.482 . . . . 25.0 112.301 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -81.54 -10.41 59.46 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.075 -0.966 . . . . 25.0 111.079 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 13.4 mm -91.27 126.1 43.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 106.312 -1.736 . . . . 25.0 106.312 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.0 p -103.05 122.77 55.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 O-C-N 120.996 -1.065 . . . . 25.0 111.555 -177.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -157.22 -16.05 0.09 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 114.684 -1.144 . . . . 25.0 113.563 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.96 61.48 6.45 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 121.878 -0.514 . . . . 25.0 111.261 -172.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 55.44 15.39 1.42 Allowed 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 115.94 1.83 . . . . 25.0 115.94 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 64.76 -21.82 0.08 Allowed 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 116.557 2.058 . . . . 25.0 116.557 176.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -70.64 116.48 11.01 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.917 -1.114 . . . . 25.0 110.201 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.42 -5.7 44.0 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 113.238 0.829 . . . . 25.0 113.238 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.24 -20.11 65.62 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.316 0.579 . . . . 25.0 110.811 177.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -90.99 -162.26 0.89 Allowed 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.588 -0.733 . . . . 25.0 111.198 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 60.79 -160.45 0.3 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.138 0.975 . . . . 25.0 113.106 176.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 79.98 24.05 60.51 Favored Glycine 0 C--O 1.228 -0.263 0 C-N-CA 121.367 -0.444 . . . . 25.0 112.272 -178.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -97.37 93.49 6.52 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.791 -0.829 . . . . 25.0 109.788 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -121.86 152.67 39.33 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.249 0.547 . . . . 25.0 109.834 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -140.5 33.77 2.03 Favored Glycine 0 CA--C 1.51 -0.251 0 CA-C-O 122.281 0.934 . . . . 25.0 111.173 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 61.3 t -82.69 -35.79 12.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 O-C-N 122.221 -0.576 . . . . 25.0 110.675 -176.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -53.27 137.84 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 115.843 -0.617 . . . . 25.0 111.246 -178.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 140.35 155.3 6.5 Favored Glycine 0 C--O 1.245 0.784 0 CA-C-N 115.843 -0.617 . . . . 25.0 112.759 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -155.94 143.67 19.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.565 0.683 . . . . 25.0 110.077 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 87.1 p -154.13 163.67 39.74 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 122.477 0.311 . . . . 25.0 110.916 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 172.41 -179.25 44.09 Favored Glycine 0 N--CA 1.47 0.956 0 N-CA-C 110.982 -0.847 . . . . 25.0 110.982 176.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -138.99 113.06 8.25 Favored Pre-proline 0 C--O 1.248 0.98 0 CA-C-N 118.152 0.976 . . . . 25.0 110.917 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.82 169.06 23.01 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 N-CA-C 115.365 1.256 . . . . 25.0 115.365 -177.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -122.49 149.02 44.46 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.078 -0.712 . . . . 25.0 109.078 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -138.49 73.78 41.62 Favored Pre-proline 0 N--CA 1.472 0.641 0 C-N-CA 123.349 0.66 . . . . 25.0 110.372 175.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -76.4 155.2 36.51 Favored 'Trans proline' 0 N--CA 1.478 0.577 0 C-N-CA 118.448 -0.568 . . . . 25.0 113.29 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.7 t -96.08 -2.16 47.21 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 121.951 -0.468 . . . . 25.0 111.965 -177.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 C--O 1.257 1.496 0 CA-C-O 118.554 -0.736 . . . . 25.0 110.017 -177.827 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 109.557 -0.535 . . . . 25.0 109.557 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -102.95 115.22 64.51 Favored Pre-proline 0 C--O 1.25 1.081 0 N-CA-C 110.029 -0.36 . . . . 25.0 110.029 178.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -67.98 146.39 71.09 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 117.223 -1.385 . . . . 25.0 112.194 -177.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.64 60.67 0.03 OUTLIER Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.993 -0.623 . . . . 25.0 111.899 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -55.84 134.68 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 122.504 1.145 . . . . 25.0 111.217 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -101.99 0.31 34.97 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 121.556 0.693 . . . . 25.0 111.045 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -92.08 -147.96 21.6 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.499 -0.773 . . . . 25.0 113.694 176.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.8 p 69.98 155.59 0.15 Allowed Pre-proline 0 N--CA 1.489 1.521 0 C-N-CA 126.011 1.724 . . . . 25.0 111.226 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -73.89 4.68 3.96 Favored 'Trans proline' 0 C--O 1.24 0.625 0 C-N-CA 121.631 1.554 . . . . 25.0 115.318 -177.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.0 p -54.18 -31.5 21.98 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 N-CA-C 116.02 1.859 . . . . 25.0 116.02 -170.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.0 p -148.26 152.83 12.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 O-C-N 120.943 -1.098 . . . . 25.0 111.01 -177.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.91 7.32 88.44 Favored Glycine 0 N--CA 1.468 0.788 0 N-CA-C 115.425 0.93 . . . . 25.0 115.425 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.2 t -56.65 -40.4 75.39 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 113.914 1.079 . . . . 25.0 113.914 -172.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -78.87 10.17 3.6 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 116.41 2.004 . . . . 25.0 116.41 -175.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.59 169.74 18.97 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 119.205 -0.426 . . . . 25.0 110.545 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -51.0 139.01 18.34 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 118.664 0.666 . . . . 25.0 111.892 -177.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -131.0 161.93 30.88 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.436 1.273 . . . . 50.0 114.436 -175.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -133.87 96.15 3.6 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 104.682 -2.34 . . . . 25.0 104.682 163.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 97.5 mt -112.01 126.26 54.95 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 121.341 0.591 . . . . 25.0 111.213 -176.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -119.72 117.19 27.6 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.226 -0.897 . . . . 25.0 109.753 -176.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.58 177.29 51.38 Favored Glycine 0 CA--C 1.502 -0.763 0 N-CA-C 116.063 1.185 . . . . 25.0 116.063 -175.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.7 p -79.81 174.26 11.76 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 114.302 -0.949 . . . . 25.0 111.407 178.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 77.3 mt -87.3 18.3 3.85 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 121.551 -0.718 . . . . 25.0 111.336 175.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -123.92 179.4 16.15 Favored Glycine 0 CA--C 1.502 -0.76 0 N-CA-C 111.475 -0.65 . . . . 25.0 111.475 177.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.2 t -67.29 134.09 50.92 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.146 0.424 . . . . 25.0 112.146 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -147.02 171.96 14.47 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 123.402 0.681 . . . . 50.0 111.843 -176.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -119.34 126.77 52.21 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.802 -1.555 . . . . 25.0 106.802 166.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.9 mm -123.75 130.41 74.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 106.652 -1.61 . . . . 25.0 106.652 -178.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.6 tt -134.78 123.93 24.36 Favored 'General case' 0 C--O 1.21 -1.012 0 N-CA-C 106.761 -1.57 . . . . 25.0 106.761 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.2 -34.33 37.41 Favored Glycine 0 CA--C 1.497 -1.051 0 N-CA-C 116.22 1.248 . . . . 25.0 116.22 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.38 -143.91 38.13 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.465 -0.874 . . . . 25.0 110.99 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.44 165.9 54.72 Favored Glycine 0 CA--C 1.498 -1.014 0 CA-C-O 122.672 1.151 . . . . 25.0 113.201 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.14 167.28 30.38 Favored Glycine 0 N--CA 1.459 0.212 0 CA-C-N 114.837 -0.682 . . . . 25.0 113.495 178.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.11 111.61 19.48 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 106.498 -1.667 . . . . 25.0 106.498 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -109.36 152.55 25.16 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 113.67 0.989 . . . . 50.0 113.67 -171.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -114.7 105.14 12.7 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 106.816 -1.549 . . . . 25.0 106.816 171.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 58.1 mt -110.8 133.6 53.22 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.221 0.452 . . . . 25.0 112.221 -174.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -131.71 110.59 11.0 Favored 'General case' 0 C--N 1.316 -0.875 0 O-C-N 121.224 -0.922 . . . . 25.0 112.99 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.25 -29.72 29.93 Favored Glycine 0 C--O 1.242 0.601 0 N-CA-C 117.713 1.845 . . . . 25.0 117.713 -174.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 53.01 -154.42 0.22 Allowed 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.683 0.994 . . . . 25.0 113.683 -177.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.93 160.3 15.1 Favored 'General case' 0 C--O 1.258 1.515 0 N-CA-C 112.306 0.484 . . . . 25.0 112.306 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.63 152.11 27.94 Favored Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 110.316 -1.113 . . . . 25.0 110.316 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -78.95 119.04 21.54 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 106.385 -1.709 . . . . 25.0 106.385 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -119.18 151.77 37.76 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 111.797 0.295 . . . . 50.0 111.797 -172.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.82 127.77 48.48 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 107.089 -1.449 . . . . 25.0 107.089 170.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.7 mp -127.37 121.34 30.71 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 122.015 0.912 . . . . 25.0 112.747 -176.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -118.93 135.14 54.74 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 108.553 -0.906 . . . . 25.0 108.553 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.61 -38.5 5.54 Favored Glycine 0 CA--C 1.498 -0.987 0 O-C-N 120.137 -1.602 . . . . 25.0 113.519 -174.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.83 -166.67 50.68 Favored Glycine 0 C--O 1.246 0.884 0 CA-C-O 121.947 0.748 . . . . 25.0 111.396 -177.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.91 157.94 14.22 Favored 'General case' 0 C--O 1.248 1.003 0 C-N-CA 123.241 0.617 . . . . 25.0 111.631 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.41 165.38 32.47 Favored Glycine 0 N--CA 1.466 0.695 0 CA-C-N 116.063 -0.517 . . . . 25.0 114.009 178.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.58 122.86 28.64 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 105.286 -2.116 . . . . 25.0 105.286 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -114.24 156.99 23.32 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.625 -0.509 . . . . 50.0 109.625 -175.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -124.19 122.95 39.17 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 106.382 -1.71 . . . . 25.0 106.382 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -146.38 139.89 25.95 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 116.728 2.121 . . . . 25.0 116.728 -170.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 70.3 m -108.31 143.33 37.33 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 114.958 -1.019 . . . . 25.0 108.473 175.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.9 -32.24 6.93 Favored Glycine 0 C--N 1.323 -0.173 0 N-CA-C 109.005 -1.638 . . . . 25.0 109.005 175.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.45 -174.88 54.52 Favored Glycine 0 CA--C 1.502 -0.741 0 C-N-CA 119.599 -1.286 . . . . 25.0 112.834 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -62.62 159.04 16.81 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.794 -0.827 . . . . 25.0 110.84 177.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.34 156.52 32.72 Favored Glycine 0 C--O 1.224 -0.487 0 CA-C-N 114.875 -1.057 . . . . 25.0 111.089 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.62 108.36 14.19 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.934 -1.136 . . . . 25.0 107.934 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -101.08 159.93 14.81 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.31 -0.859 . . . . 50.0 110.969 -172.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 57.4 m -124.67 119.09 28.01 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 109.102 -0.703 . . . . 25.0 109.102 177.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -99.65 83.94 2.86 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 106.589 -1.634 . . . . 25.0 106.589 175.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -83.16 -20.86 33.92 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.277 -0.874 . . . . 25.0 111.229 -173.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 61.91 160.6 0.07 Allowed 'General case' 0 CA--C 1.547 0.845 0 O-C-N 124.858 1.349 . . . . 25.0 112.181 -176.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -93.45 -70.39 0.7 Allowed 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.81 1.041 . . . . 25.0 113.81 -168.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.1 mt -116.48 175.17 5.68 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.68 0.753 . . . . 25.0 111.482 -171.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.94 -32.34 32.7 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.484 0.714 . . . . 25.0 111.435 176.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -80.02 -6.94 58.5 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.52 0.933 . . . . 25.0 113.52 -174.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.68 127.89 34.51 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 122.087 0.946 . . . . 25.0 111.594 -177.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.1 t 49.94 39.56 18.91 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 115.63 1.715 . . . . 25.0 115.63 173.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -103.59 160.94 14.31 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.722 -1.126 . . . . 25.0 110.12 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -115.09 139.91 49.5 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 104.056 -2.572 . . . . 25.0 104.056 176.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 62.8 p -124.29 166.0 21.7 Favored Pre-proline 0 C--N 1.317 -0.824 0 N-CA-C 108.623 -0.881 . . . . 25.0 108.623 -175.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -65.07 -19.5 63.41 Favored 'Trans proline' 0 C--O 1.245 0.861 0 C-N-CA 117.769 -1.02 . . . . 25.0 112.702 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 81.2 mt -76.17 -29.65 57.79 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.283 0.563 . . . . 25.0 112.181 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 160.76 179.15 35.33 Favored Glycine 0 N--CA 1.472 1.044 0 CA-C-O 118.412 -1.216 . . . . 25.0 110.182 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.4 t -98.02 148.78 23.15 Favored 'General case' 0 C--O 1.251 1.146 0 CA-C-N 118.884 1.342 . . . . 25.0 113.034 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -130.29 28.95 4.93 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-N 114.643 -1.162 . . . . 25.0 108.156 174.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.51 146.92 50.27 Favored Glycine 0 N--CA 1.463 0.455 0 N-CA-C 109.073 -1.611 . . . . 25.0 109.073 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -93.69 166.29 12.29 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 117.343 0.571 . . . . 50.0 111.405 -176.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.92 104.6 9.95 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 122.656 0.383 . . . . 25.0 111.65 -173.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.0 mt -91.16 135.7 26.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 107.889 -1.152 . . . . 25.0 107.889 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.5 mt -88.32 -56.57 3.26 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.539 0.94 . . . . 25.0 113.539 -174.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -124.61 39.37 3.99 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.672 0.99 . . . . 25.0 113.672 -171.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -55.53 138.77 45.9 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.76 0.79 . . . . 25.0 111.665 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -105.85 102.75 40.62 Favored Pre-proline 0 N--CA 1.469 0.497 0 N-CA-C 108.804 -0.813 . . . . 25.0 108.804 177.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -67.74 -6.7 17.46 Favored 'Trans proline' 0 C--N 1.359 1.087 0 N-CA-C 116.31 1.619 . . . . 25.0 116.31 -174.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.9 t -97.48 -42.87 7.51 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.005 0.522 . . . . 25.0 109.97 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -96.31 -43.11 7.83 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 113.283 0.845 . . . . 25.0 113.283 -171.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -82.44 164.81 20.73 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 121.472 -0.767 . . . . 75.0 110.336 -173.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -142.05 152.07 43.01 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.9 -0.591 . . . . 25.0 111.347 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 77.5 mt -126.49 131.92 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 107.63 -1.248 . . . . 25.0 107.63 -177.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -93.2 151.03 20.07 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 108.526 -0.916 . . . . 25.0 108.526 174.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 p -150.41 -3.91 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 N-CA-C 112.834 0.679 . . . . 25.0 112.834 -175.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.6 t -60.68 -48.49 81.54 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.831 1.048 . . . . 25.0 113.831 -173.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.54 -31.63 60.14 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.158 0.799 . . . . 25.0 113.158 -177.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.55 -22.95 16.24 Favored 'General case' 0 C--O 1.246 0.881 0 N-CA-C 115.919 1.822 . . . . 25.0 115.919 -173.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -134.11 -72.76 0.08 OUTLIER Glycine 0 CA--C 1.53 1.024 0 N-CA-C 116.102 1.201 . . . . 25.0 116.102 -174.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -154.57 167.06 31.38 Favored 'General case' 0 C--O 1.211 -0.926 0 CA-C-N 117.471 0.636 . . . . 25.0 109.438 -173.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 30.9 t -120.45 -47.77 2.33 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.191 -1.04 . . . . 25.0 108.191 176.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.15 120.9 5.37 Favored Glycine 0 CA--C 1.501 -0.814 0 N-CA-C 108.588 -1.805 . . . . 25.0 108.588 175.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -68.41 158.13 34.3 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 117.302 0.551 . . . . 25.0 111.744 -175.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -100.51 -160.31 27.99 Favored Glycine 0 N--CA 1.457 0.073 0 N-CA-C 115.109 0.804 . . . . 25.0 115.109 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -48.35 134.7 14.64 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.681 -0.76 . . . . 25.0 112.794 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 158.98 -175.07 35.99 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 108.676 -1.769 . . . . 25.0 108.676 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -152.9 168.21 26.54 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 118.694 1.247 . . . . 25.0 108.343 -177.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 52.59 39.04 27.41 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.85 1.056 . . . . 25.0 113.85 -177.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 69.47 35.1 74.83 Favored Glycine 0 C--O 1.245 0.801 0 N-CA-C 110.751 -0.939 . . . . 25.0 110.751 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.523 ' HA ' ' H ' ' A' ' 151' ' ' ALA . 7.6 t -136.97 176.57 8.59 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 121.623 -0.928 . . . . 25.0 109.905 -178.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.1 mt -110.34 164.58 12.54 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 102.47 -3.159 . . . . 25.0 102.47 176.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.63 120.98 23.33 Favored 'General case' 0 C--O 1.258 1.509 0 N-CA-C 108.063 -1.088 . . . . 25.0 108.063 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.7 m -80.23 159.32 4.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 C-N-CA 122.86 0.464 . . . . 25.0 111.374 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 73.3 m -134.83 163.0 30.81 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.438 -0.949 . . . . 25.0 108.438 177.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.0 m -124.37 165.51 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.362 0 N-CA-C 107.544 -1.28 . . . . 25.0 107.544 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.6 t -80.13 -49.07 12.23 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 106.574 -1.639 . . . . 25.0 106.574 173.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -161.57 -161.99 0.84 Allowed 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 101.941 -3.355 . . . . 25.0 101.941 174.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -67.09 -0.22 3.11 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.498 0.666 . . . . 25.0 112.536 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -142.64 -155.72 6.53 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 108.786 -1.726 . . . . 25.0 108.786 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 53.32 -145.86 0.57 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.116 0.784 . . . . 25.0 113.116 176.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.4 mtt85 -75.89 174.04 10.42 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.934 0.873 . . . . 25.0 113.336 -173.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.26 163.19 29.86 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 105.342 -2.095 . . . . 25.0 105.342 176.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -136.92 155.1 50.17 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.703 -0.48 . . . . 25.0 109.703 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 29.7 tp -125.43 127.17 46.1 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.161 -1.792 . . . . 25.0 106.161 171.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -126.37 151.51 47.53 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.386 0.513 . . . . 25.0 112.386 -171.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 84.0 p -88.63 150.01 23.25 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 105.115 -2.18 . . . . 25.0 105.115 169.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -117.33 27.78 8.88 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 105.621 -1.992 . . . . 25.0 105.621 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -122.88 141.67 51.63 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 112.578 -2.101 . . . . 25.0 106.468 174.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -138.41 153.83 48.9 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 124.221 0.95 . . . . 25.0 111.465 -178.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -77.96 160.29 28.29 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.498 -1.297 . . . . 25.0 107.498 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.73 -20.07 65.45 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-O 122.505 1.145 . . . . 25.0 109.142 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -74.12 -12.3 60.56 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 114.682 -1.145 . . . . 25.0 113.549 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.25 9.02 67.8 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 115.888 -0.596 . . . . 25.0 113.776 -178.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 63.0 mt -83.33 147.53 27.88 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 108.128 -1.064 . . . . 25.0 108.128 174.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 69.6 p -149.76 179.57 7.91 Favored 'General case' 0 C--O 1.248 0.976 0 N-CA-C 107.642 -1.244 . . . . 25.0 107.642 177.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -123.8 135.61 53.9 Favored 'General case' 0 C--O 1.253 1.268 0 CA-C-N 118.871 0.76 . . . . 25.0 111.76 -176.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -151.41 154.97 37.67 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.756 -1.572 . . . . 25.0 106.756 171.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.69 139.39 19.66 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 105.771 -1.937 . . . . 25.0 105.771 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -101.53 143.92 30.93 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 107.685 -1.228 . . . . 25.0 107.685 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mp -136.5 139.13 42.06 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 106.29 -1.744 . . . . 25.0 106.29 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -110.15 11.65 23.66 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.992 1.269 . . . . 25.0 110.603 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -68.41 -19.82 72.95 Favored Glycine 0 CA--C 1.499 -0.944 0 CA-C-N 115.218 -0.901 . . . . 25.0 111.006 173.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.1 t0 54.74 51.69 13.39 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 122.999 1.381 . . . . 25.0 110.733 175.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -121.63 42.75 3.02 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 113.513 -1.676 . . . . 25.0 108.151 -175.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -55.84 -31.59 62.85 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 114.596 -1.184 . . . . 25.0 112.462 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -77.18 -29.43 54.42 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 118.678 0.672 . . . . 25.0 111.878 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.55 -20.33 26.6 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 120.574 -0.45 . . . . 25.0 111.799 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 22.2 mt -62.12 136.54 57.99 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 121.082 0.468 . . . . 25.0 111.088 177.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 70.3 m -144.7 161.5 39.05 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 107.541 -1.281 . . . . 25.0 107.541 175.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.523 ' H ' ' HA ' ' A' ' 111' ' ' SER . . . -79.74 -0.09 32.83 Favored 'General case' 0 C--O 1.206 -1.206 0 N-CA-C 107.367 -1.346 . . . . 25.0 107.367 177.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -74.09 -26.77 60.55 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.372 -0.831 . . . . 25.0 110.788 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -89.66 -6.72 55.89 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.591 -0.693 . . . . 25.0 109.524 176.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 49.1 mm -90.22 136.6 23.46 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.621 0 N-CA-C 103.708 -2.701 . . . . 25.0 103.708 173.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.9 p -116.39 128.93 73.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 122.656 1.217 . . . . 25.0 110.861 -176.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -158.05 -17.13 0.08 Allowed 'General case' 0 C--O 1.211 -0.937 0 CA-C-N 113.95 -1.477 . . . . 25.0 113.121 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.75 43.34 0.91 Allowed 'General case' 0 C--O 1.246 0.897 0 O-C-N 121.454 -0.779 . . . . 25.0 112.183 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 58.17 29.09 17.42 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.891 0.877 . . . . 25.0 112.964 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.4 m 51.53 37.26 19.09 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 122.334 1.064 . . . . 25.0 111.342 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -76.36 123.81 26.53 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.71 1.004 . . . . 25.0 113.71 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.82 -18.32 60.47 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.29 -0.868 . . . . 25.0 112.719 177.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -81.07 -21.5 39.97 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 122.305 -0.247 . . . . 25.0 110.596 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.45 177.56 8.89 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.835 0.454 . . . . 25.0 111.108 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 63.47 178.66 0.16 Allowed 'General case' 0 CA--C 1.547 0.861 0 O-C-N 124.682 1.239 . . . . 25.0 113.939 176.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 82.04 22.63 58.97 Favored Glycine 0 C--O 1.237 0.294 0 CA-C-N 115.296 -0.865 . . . . 25.0 111.141 -177.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -106.99 104.79 14.55 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 112.338 0.496 . . . . 25.0 112.338 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -130.29 151.59 50.63 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 107.62 -1.252 . . . . 25.0 107.62 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -135.57 33.72 2.38 Favored Glycine 0 CA--C 1.502 -0.761 0 N-CA-C 110.802 -0.919 . . . . 25.0 110.802 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 54.6 t -79.53 -27.27 12.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 CA-C-O 121.939 0.876 . . . . 25.0 108.774 -176.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -53.86 134.39 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 CA-C-N 114.485 -1.234 . . . . 25.0 113.025 -174.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 141.12 150.66 5.43 Favored Glycine 0 C--O 1.246 0.895 0 N-CA-C 109.5 -1.44 . . . . 25.0 109.5 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -142.86 145.36 33.07 Favored 'General case' 0 C--O 1.252 1.232 0 O-C-N 122.197 -0.59 . . . . 25.0 111.249 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 13.3 p -150.72 154.77 38.0 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.725 0.774 . . . . 25.0 111.306 175.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 176.71 166.74 34.27 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 115.138 -0.937 . . . . 25.0 113.85 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -133.55 111.07 12.53 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 107.312 -1.366 . . . . 25.0 107.312 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.88 160.91 39.92 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 116.879 -1.614 . . . . 25.0 113.137 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -119.15 147.02 44.65 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.032 -1.099 . . . . 25.0 108.032 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -143.74 73.11 17.08 Favored Pre-proline 0 C--O 1.251 1.171 0 O-C-N 123.536 0.523 . . . . 25.0 111.198 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -69.9 164.07 36.06 Favored 'Trans proline' 0 C--O 1.249 1.031 0 N-CA-C 113.857 0.676 . . . . 25.0 113.857 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 12.6 t -125.66 8.68 7.62 Favored 'General case' 0 C--O 1.256 1.414 0 N-CA-C 109.652 -0.499 . . . . 25.0 109.652 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 C--O 1.245 0.853 0 N-CA-C 108.565 -0.902 . . . . 25.0 108.565 178.043 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 120.776 0.322 . . . . 25.0 110.36 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -135.73 115.51 11.41 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 107.463 -1.31 . . . . 25.0 107.463 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -69.33 144.24 55.63 Favored 'Trans proline' 0 CA--C 1.531 0.356 0 C-N-CA 116.407 -1.929 . . . . 25.0 113.856 -176.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -163.66 31.64 0.27 Allowed Glycine 0 CA--C 1.521 0.417 0 CA-C-O 119.429 -0.651 . . . . 25.0 112.26 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.5 p -60.35 133.11 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 122.027 0.918 . . . . 25.0 111.194 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -99.07 -18.57 17.67 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.647 -0.706 . . . . 25.0 112.197 -177.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.79 -134.11 3.84 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-O 121.715 0.62 . . . . 25.0 114.56 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.9 p 69.08 156.64 0.15 Allowed Pre-proline 0 N--CA 1.483 1.208 0 C-N-CA 125.858 1.663 . . . . 25.0 110.392 -173.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.408 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 32.4 Cg_exo -65.9 0.11 3.43 Favored 'Trans proline' 0 N--CA 1.485 1.008 0 N-CA-C 117.707 2.156 . . . . 25.0 117.707 -173.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.6 p -68.01 -22.14 27.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 114.787 1.403 . . . . 25.0 114.787 -172.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.2 p -128.1 121.57 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 117.329 2.344 . . . . 25.0 117.329 -171.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.05 20.6 79.06 Favored Glycine 0 C--O 1.224 -0.47 0 N-CA-C 117.423 1.729 . . . . 25.0 117.423 173.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.2 t -50.07 -37.87 35.56 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 114.726 1.38 . . . . 25.0 114.726 -174.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -80.74 13.61 2.52 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 114.649 1.352 . . . . 25.0 114.649 -176.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -149.63 171.22 17.02 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.531 -0.73 . . . . 25.0 110.542 176.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.76 121.57 14.32 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.293 0.637 . . . . 25.0 111.538 -173.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -120.72 169.69 10.16 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 115.296 1.591 . . . . 50.0 115.296 -173.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -123.35 114.55 20.32 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 103.775 -2.676 . . . . 25.0 103.775 160.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 82.3 mt -120.04 102.57 8.63 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.536 0.684 . . . . 25.0 111.761 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -93.4 121.8 35.16 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.709 -0.678 . . . . 25.0 109.837 177.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.15 -174.29 47.67 Favored Glycine 0 N--CA 1.464 0.565 0 N-CA-C 115.245 0.858 . . . . 25.0 115.245 -178.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.7 p -91.67 173.71 7.73 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.778 0.831 . . . . 25.0 112.404 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 75.4 mt -83.67 12.41 5.88 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.356 0.873 . . . . 25.0 113.356 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.85 179.31 20.04 Favored Glycine 0 N--CA 1.462 0.378 0 CA-C-N 116.284 -0.416 . . . . 25.0 112.175 178.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.5 t -71.48 130.93 42.51 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 122.701 0.4 . . . . 25.0 110.635 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -143.41 165.89 26.29 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 123.265 0.353 . . . . 50.0 111.527 -174.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -111.11 125.49 53.83 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 106.108 -1.812 . . . . 25.0 106.108 166.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.0 mm -115.49 129.22 72.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 107.043 -1.465 . . . . 25.0 107.043 -177.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.408 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 1.0 OUTLIER -129.27 123.33 31.63 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 105.418 -2.067 . . . . 25.0 105.418 179.677 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.54 -36.32 23.53 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 114.969 0.747 . . . . 25.0 114.969 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.52 -149.03 50.42 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.268 -0.733 . . . . 25.0 111.268 -176.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -78.41 170.47 54.84 Favored Glycine 0 C--O 1.257 1.585 0 O-C-N 121.728 -0.866 . . . . 25.0 112.061 -176.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.34 165.06 33.83 Favored Glycine 0 C--N 1.316 -0.557 0 CA-C-O 119.639 -0.534 . . . . 25.0 112.91 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.14 101.07 13.14 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.053 -1.091 . . . . 25.0 108.053 178.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -98.48 153.57 18.51 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.915 0.709 . . . . 50.0 112.915 -168.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -115.15 99.85 7.73 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 105.745 -1.946 . . . . 25.0 105.745 175.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 33.2 mt -104.26 137.82 41.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.798 -1.092 . . . . 25.0 111.571 -171.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.414 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 60.0 m-85 -133.77 99.42 4.46 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.925 0.713 . . . . 25.0 112.925 -178.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.38 -35.2 63.47 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-O 118.342 -1.255 . . . . 25.0 115.8 -177.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 55.17 -154.47 0.29 Allowed 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 118.814 1.307 . . . . 25.0 113.672 -178.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.97 160.13 15.56 Favored 'General case' 0 C--O 1.249 1.034 0 N-CA-C 113.486 0.921 . . . . 25.0 113.486 -176.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.12 159.93 33.51 Favored Glycine 0 C--O 1.223 -0.546 0 CA-C-N 115.187 -0.915 . . . . 25.0 111.451 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -82.15 115.5 21.29 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 104.688 -2.338 . . . . 25.0 104.688 177.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -116.67 154.33 30.76 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.758 -0.377 . . . . 50.0 110.514 -171.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 mp -114.05 133.08 55.76 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 105.792 -1.929 . . . . 25.0 105.792 174.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.6 mp -133.28 128.92 36.84 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 113.967 1.099 . . . . 25.0 113.967 -173.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -129.92 135.13 47.99 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.181 -1.414 . . . . 25.0 107.181 177.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -93.36 -40.65 4.73 Favored Glycine 0 N--CA 1.475 1.26 0 N-CA-C 115.409 0.924 . . . . 25.0 115.409 -175.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.34 -174.92 55.22 Favored Glycine 0 C--O 1.24 0.491 0 N-CA-C 110.88 -0.888 . . . . 25.0 110.88 -176.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.83 154.06 9.88 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.328 0.585 . . . . 25.0 109.911 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.1 150.66 24.12 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.493 -0.776 . . . . 25.0 112.028 -176.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -74.92 127.87 34.23 Favored 'General case' 0 C--O 1.212 -0.92 0 N-CA-C 104.737 -2.32 . . . . 25.0 104.737 176.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -117.68 150.94 38.22 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 121.707 -0.62 . . . . 50.0 111.046 -174.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -112.76 121.56 45.09 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 103.764 -2.68 . . . . 25.0 103.764 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -144.7 131.5 20.16 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 117.743 2.497 . . . . 25.0 117.743 -171.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.414 ' HB2' ' HA ' ' A' ' 38' ' ' TYR . 69.3 m -99.45 141.19 32.55 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-N 115.8 -0.637 . . . . 25.0 109.534 174.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -94.72 -35.71 5.8 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 110.443 -1.063 . . . . 25.0 110.443 172.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.17 -176.33 51.74 Favored Glycine 0 N--CA 1.465 0.62 0 CA-C-N 118.198 0.999 . . . . 25.0 113.373 -178.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -59.51 156.1 13.92 Favored 'General case' 0 C--O 1.246 0.884 0 O-C-N 121.595 -0.944 . . . . 25.0 110.724 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.01 162.54 34.63 Favored Glycine 0 C--O 1.246 0.903 0 N-CA-C 108.943 -1.663 . . . . 25.0 108.943 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.95 121.32 26.36 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 106.842 -1.54 . . . . 25.0 106.842 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -112.0 152.19 28.41 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.184 0.516 . . . . 50.0 110.17 -175.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.5 m -117.47 110.31 17.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.851 0.834 . . . . 25.0 110.329 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -94.21 119.94 33.75 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 106.032 -1.84 . . . . 25.0 106.032 176.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.9 mmt85 -114.5 -32.25 5.96 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.967 -0.561 . . . . 25.0 112.339 -177.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 68.09 148.53 0.06 Allowed 'General case' 0 CA--C 1.55 0.948 0 O-C-N 124.741 1.275 . . . . 25.0 110.667 -174.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.16 -34.98 21.99 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 114.822 1.416 . . . . 25.0 114.822 -165.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 70.5 mt -132.25 161.66 32.9 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.1 0.476 . . . . 25.0 110.602 -172.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.83 -31.35 66.55 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 107.095 -1.446 . . . . 25.0 107.095 169.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -87.69 9.34 21.82 Favored 'General case' 0 C--O 1.254 1.31 0 N-CA-C 115.571 1.693 . . . . 25.0 115.571 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -94.7 141.54 28.5 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.034 -1.042 . . . . 25.0 110.101 -177.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.8 t 47.32 50.48 14.48 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 114.556 1.317 . . . . 25.0 114.556 -178.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 31.0 p-80 -114.35 169.54 8.96 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.47 -0.786 . . . . 25.0 111.403 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -121.45 148.79 43.97 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 104.621 -2.362 . . . . 25.0 104.621 173.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 92.4 p -139.59 170.96 8.74 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 107.299 -1.371 . . . . 25.0 107.299 -177.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -62.79 -20.45 71.21 Favored 'Trans proline' 0 C--N 1.361 1.185 0 CA-C-N 119.044 0.694 . . . . 25.0 113.087 174.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 80.9 mt -73.64 -27.5 61.3 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 121.748 -0.595 . . . . 25.0 110.91 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.91 -177.95 30.29 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.683 -0.967 . . . . 25.0 110.683 -174.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.3 t -101.7 141.73 34.12 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 122.811 1.291 . . . . 25.0 111.54 -178.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -127.71 27.36 5.77 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 114.678 -1.146 . . . . 25.0 109.167 176.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.2 145.17 45.77 Favored Glycine 0 N--CA 1.462 0.39 0 O-C-N 124.07 0.856 . . . . 25.0 112.124 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -85.33 170.1 13.09 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 122.694 -0.297 . . . . 50.0 111.321 -177.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -128.11 105.95 8.72 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.694 0.798 . . . . 25.0 111.394 -174.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.0 mt -87.82 133.91 29.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 121.853 0.835 . . . . 25.0 108.789 -178.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.0 mt -85.1 -43.93 13.45 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 116.401 2.001 . . . . 25.0 116.401 -172.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -137.67 40.16 2.39 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.09 1.144 . . . . 25.0 114.09 -173.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.418 ' CE2' ' HA ' ' A' ' 89' ' ' PRO . 60.9 t80 -55.97 132.21 49.29 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.579 -0.737 . . . . 25.0 112.287 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -102.37 105.43 43.36 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 106.011 -1.848 . . . . 25.0 106.011 174.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.418 ' HA ' ' CE2' ' A' ' 87' ' ' PHE . 95.9 Cg_endo -70.48 -4.39 14.42 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 N-CA-C 116.622 1.739 . . . . 25.0 116.622 -172.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.3 t -97.29 -45.62 6.42 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.201 0.524 . . . . 25.0 111.079 174.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -82.53 -41.26 19.88 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.357 0.873 . . . . 25.0 113.357 -174.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -84.95 165.44 17.61 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.694 -0.484 . . . . 75.0 109.694 -169.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -140.73 146.24 37.5 Favored 'General case' 0 C--O 1.246 0.874 0 N-CA-C 108.523 -0.917 . . . . 25.0 108.523 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 76.5 mt -128.66 126.52 65.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 107.926 -1.138 . . . . 25.0 107.926 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -80.91 148.14 30.0 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.809 0.814 . . . . 25.0 110.361 172.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.0 p -143.32 -7.91 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.317 -0.856 . . . . 25.0 110.628 176.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.8 t -63.92 -41.16 97.73 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.282 0.563 . . . . 25.0 111.943 -173.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.62 -4.61 57.97 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.028 0.751 . . . . 25.0 113.028 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 11.9 mt -115.04 -38.25 3.93 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.989 1.477 . . . . 25.0 114.989 -169.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -136.42 -54.68 0.06 OUTLIER Glycine 0 C--O 1.24 0.477 0 N-CA-C 117.644 1.818 . . . . 25.0 117.644 -174.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -155.04 164.02 39.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 117.569 0.684 . . . . 25.0 109.826 -174.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 45.8 t -121.26 -25.53 5.23 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 124.12 0.887 . . . . 25.0 109.018 173.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -100.65 121.59 7.29 Favored Glycine 0 N--CA 1.464 0.565 0 N-CA-C 107.615 -2.194 . . . . 25.0 107.615 172.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.68 146.49 53.72 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 118.565 1.183 . . . . 25.0 113.246 -174.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -80.85 -175.19 49.45 Favored Glycine 0 C--N 1.32 -0.316 0 CA-C-N 115.349 -0.841 . . . . 25.0 114.415 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -60.84 142.62 56.01 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 121.196 0.522 . . . . 25.0 111.701 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 166.83 -171.94 41.84 Favored Glycine 0 C--O 1.245 0.787 0 N-CA-C 109.363 -1.495 . . . . 25.0 109.363 -177.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -141.52 165.25 28.0 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.833 1.317 . . . . 25.0 111.465 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 57.52 33.9 23.88 Favored 'General case' 0 C--O 1.246 0.878 0 O-C-N 124.454 1.096 . . . . 25.0 113.541 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 74.56 39.32 41.81 Favored Glycine 0 C--O 1.222 -0.653 0 N-CA-C 109.969 -1.252 . . . . 25.0 109.969 177.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 11.1 t -148.6 167.64 24.92 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 108.998 -0.741 . . . . 25.0 108.998 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.4 mt -84.78 159.91 20.36 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 103.069 -2.937 . . . . 25.0 103.069 169.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.66 128.9 38.03 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 119.291 -0.964 . . . . 25.0 109.158 178.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.9 m -91.48 159.23 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 109.65 -0.5 . . . . 25.0 109.65 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.19 164.71 26.77 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 110.169 -0.308 . . . . 25.0 110.169 -177.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.4 m -118.58 162.64 16.5 Favored 'Isoleucine or valine' 0 C--O 1.25 1.08 0 N-CA-C 106.726 -1.583 . . . . 25.0 106.726 175.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.8 t -83.06 -51.23 7.72 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 106.295 -1.743 . . . . 25.0 106.295 170.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -166.69 -164.58 0.66 Allowed 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 100.825 -3.768 . . . . 25.0 100.825 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -68.12 -25.07 65.11 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 119.173 0.897 . . . . 25.0 110.658 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -106.9 -164.64 22.3 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 108.17 -1.972 . . . . 25.0 108.17 174.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 56.18 -162.79 0.17 Allowed 'General case' 0 C--O 1.248 0.976 0 N-CA-C 113.538 0.94 . . . . 25.0 113.538 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 64.3 mtt85 -79.24 169.29 18.35 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.755 1.02 . . . . 25.0 113.755 -168.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.7 p -115.3 165.56 12.82 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 105.111 -2.181 . . . . 25.0 105.111 174.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -134.73 157.97 45.33 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 121.404 0.621 . . . . 25.0 111.357 -177.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 51.1 tp -130.13 113.97 15.15 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 103.781 -2.674 . . . . 25.0 103.781 171.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -116.13 148.67 40.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.979 0.419 . . . . 25.0 110.19 -174.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 43.0 t -97.27 147.18 24.4 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 106.061 -1.829 . . . . 25.0 106.061 171.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -116.9 17.28 15.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.562 0.696 . . . . 25.0 110.532 -177.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -107.8 140.06 41.45 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 104.674 -2.343 . . . . 25.0 104.674 172.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -140.04 154.65 47.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.698 0.761 . . . . 25.0 112.404 -176.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -75.03 166.22 24.01 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.924 -1.035 . . . . 25.0 109.318 177.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.83 -25.27 66.35 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 108.443 -0.947 . . . . 25.0 108.443 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -74.02 -5.37 41.0 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.372 -0.831 . . . . 25.0 112.995 175.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.32 10.48 77.47 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 121.299 -0.477 . . . . 25.0 112.619 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.5 mt -83.8 134.03 34.74 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 122.288 -0.536 . . . . 25.0 109.663 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 59.8 p -138.69 176.89 8.3 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 106.605 -1.628 . . . . 25.0 106.605 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -125.64 134.46 51.87 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 120.328 -0.549 . . . . 25.0 110.349 -175.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -152.76 152.93 32.22 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 108.979 -0.749 . . . . 25.0 108.979 171.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 13.0 p -145.23 143.78 21.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 106.244 -1.762 . . . . 25.0 106.244 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -102.45 146.14 28.53 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 107.081 -1.452 . . . . 25.0 107.081 -177.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.5 mp -132.19 134.98 46.0 Favored 'General case' 0 C--O 1.201 -1.479 0 N-CA-C 104.908 -2.256 . . . . 25.0 104.908 177.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -103.18 10.55 37.73 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 119.923 1.238 . . . . 25.0 111.059 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.7 -10.2 66.92 Favored Glycine 0 N--CA 1.458 0.164 0 C-N-CA 120.952 -0.642 . . . . 25.0 113.57 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 37.9 t0 53.09 40.9 31.98 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 123.327 1.536 . . . . 25.0 110.557 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -115.92 38.29 3.38 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.053 -1.43 . . . . 25.0 109.811 -179.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.28 -32.57 68.54 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.067 0.766 . . . . 25.0 113.067 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.14 -28.49 62.27 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.017 0.377 . . . . 25.0 112.017 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -85.49 -29.56 24.17 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-N 116.744 -0.207 . . . . 25.0 111.041 -177.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 29.4 mt -59.35 139.5 56.97 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-O 122.431 1.11 . . . . 25.0 112.581 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.4 m -143.06 160.43 40.39 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.3 -1.741 . . . . 25.0 106.3 176.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.64 3.76 15.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.17 0.509 . . . . 25.0 109.987 176.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -68.38 -29.59 68.33 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.174 -0.466 . . . . 25.0 110.307 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -92.07 1.63 57.08 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.39 0.614 . . . . 25.0 110.867 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 31.4 mm -101.02 125.42 54.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.821 0 N-CA-C 104.821 -2.289 . . . . 25.0 104.821 178.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.74 119.4 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 122.934 1.35 . . . . 25.0 112.14 -174.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -156.0 -20.76 0.1 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 113.248 -1.797 . . . . 25.0 110.908 177.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -76.11 52.18 0.71 Allowed 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.211 1.189 . . . . 25.0 114.211 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 63.68 11.37 5.74 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 115.229 1.566 . . . . 25.0 115.229 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.5 m 64.96 -59.2 0.25 Allowed 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 116.686 2.106 . . . . 25.0 116.686 176.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -64.27 137.91 58.17 Favored 'General case' 0 C--O 1.244 0.772 0 O-C-N 121.946 -0.471 . . . . 25.0 111.381 -175.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -81.69 61.09 4.92 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 113.349 0.87 . . . . 25.0 113.349 -176.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.04 -37.02 78.35 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.77 -0.826 . . . . 25.0 108.77 177.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -135.87 -104.73 0.21 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.534 -0.757 . . . . 25.0 109.702 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 55.71 -159.7 0.2 Allowed 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.247 1.019 . . . . 25.0 111.17 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 63.44 25.83 68.99 Favored Glycine 0 C--O 1.218 -0.863 0 C-N-CA 121.227 -0.511 . . . . 25.0 112.648 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -82.54 94.94 7.59 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.596 0.712 . . . . 25.0 110.647 -174.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -125.32 150.73 46.87 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 108.493 -0.929 . . . . 25.0 108.493 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -146.0 32.0 1.57 Allowed Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 109.125 -1.59 . . . . 25.0 109.125 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 39.9 t -65.34 -37.66 80.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 109.99 -0.374 . . . . 25.0 109.99 -175.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.8 128.65 21.09 Favored 'Isoleucine or valine' 0 C--O 1.244 0.8 0 CA-C-O 122.197 0.999 . . . . 25.0 110.913 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 158.58 146.27 4.48 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 109.082 -1.607 . . . . 25.0 109.082 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -141.09 154.57 46.0 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-N 117.503 0.652 . . . . 25.0 111.159 -176.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 93.7 p -149.86 158.24 43.98 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.339 -1.356 . . . . 25.0 107.339 176.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 178.79 174.27 44.86 Favored Glycine 0 C--O 1.241 0.541 0 C-N-CA 120.06 -1.067 . . . . 25.0 113.578 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -152.9 85.49 4.33 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 107.728 -1.212 . . . . 25.0 107.728 178.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.42 150.28 75.58 Favored 'Trans proline' 0 C--N 1.354 0.818 0 O-C-N 122.015 0.481 . . . . 25.0 112.054 -177.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -114.81 154.51 28.46 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.201 -0.454 . . . . 25.0 110.575 -174.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -136.32 61.16 37.19 Favored Pre-proline 0 C--O 1.25 1.087 0 N-CA-C 113.225 0.824 . . . . 25.0 113.225 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -71.97 160.27 48.08 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 115.623 -2.451 . . . . 25.0 112.498 177.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.9 t -120.22 -15.75 8.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.017 -0.538 . . . . 25.0 111.181 -177.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.746 -0.645 . . . . 25.0 110.763 177.266 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 110.428 -0.212 . . . . 25.0 110.428 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -138.89 107.73 7.56 Favored Pre-proline 0 C--O 1.243 0.716 0 C-N-CA 122.533 0.333 . . . . 25.0 110.659 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.9 154.19 71.37 Favored 'Trans proline' 0 N--CA 1.48 0.7 0 N-CA-C 113.692 0.612 . . . . 25.0 113.692 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -178.02 54.04 0.1 OUTLIER Glycine 0 C--O 1.224 -0.528 0 N-CA-C 110.557 -1.017 . . . . 25.0 110.557 -178.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.4 p -60.52 132.41 25.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 122.261 1.029 . . . . 25.0 112.346 -174.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -103.11 -6.14 22.54 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.397 -1.274 . . . . 25.0 110.482 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.97 -148.12 4.91 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 116.36 -0.382 . . . . 25.0 112.717 178.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.4 p 68.39 159.85 0.15 Allowed Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 125.974 1.71 . . . . 25.0 112.204 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -66.52 1.3 2.7 Favored 'Trans proline' 0 C--N 1.359 1.122 0 N-CA-C 116.634 1.744 . . . . 25.0 116.634 -176.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.3 p -68.53 -18.98 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 N-CA-C 115.24 1.57 . . . . 25.0 115.24 -170.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.3 p -146.92 143.64 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 113.288 0.848 . . . . 25.0 113.288 -177.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.32 13.68 81.44 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 115.607 1.003 . . . . 25.0 115.607 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.2 t -54.21 -50.95 65.94 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 122.337 -0.508 . . . . 25.0 111.459 -173.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -86.8 19.26 3.03 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 114.758 1.392 . . . . 25.0 114.758 -172.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -152.39 170.83 19.13 Favored 'General case' 0 CA--C 1.561 1.397 0 O-C-N 121.653 -0.654 . . . . 25.0 111.391 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -59.38 134.18 56.77 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 112.47 0.544 . . . . 25.0 112.47 -175.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -121.54 163.22 19.22 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 115.575 1.694 . . . . 50.0 115.575 -173.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -138.08 87.04 2.21 Favored 'General case' 0 C--O 1.249 1.043 0 N-CA-C 102.857 -3.016 . . . . 25.0 102.857 164.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 89.2 mt -102.65 122.6 44.75 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 117.764 0.256 . . . . 25.0 111.551 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -110.75 122.88 48.91 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 123.61 0.568 . . . . 25.0 110.257 -179.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.99 176.65 40.95 Favored Glycine 0 CA--C 1.54 1.646 0 C-N-CA 120.59 -0.814 . . . . 25.0 114.349 -178.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.1 p -87.43 179.33 6.59 Favored 'General case' 0 C--O 1.256 1.429 0 C-N-CA 123.581 0.752 . . . . 25.0 110.981 177.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 51.7 mt -82.48 13.96 3.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.232 -0.895 . . . . 25.0 112.736 175.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.4 176.04 20.7 Favored Glycine 0 C--O 1.242 0.597 0 CA-C-N 115.479 -0.782 . . . . 25.0 111.834 177.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.3 t -78.07 131.35 37.27 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 121.85 -0.794 . . . . 25.0 108.884 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -142.65 153.58 43.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.308 0.575 . . . . 50.0 110.545 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -87.52 133.97 33.69 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 102.809 -3.034 . . . . 25.0 102.809 164.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 34.6 mm -127.04 116.69 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 105.292 -2.114 . . . . 25.0 105.292 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.1 tt -122.36 122.22 38.53 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.462 -1.31 . . . . 25.0 107.462 -177.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.21 -38.71 28.84 Favored Glycine 0 N--CA 1.445 -0.733 0 O-C-N 123.986 0.804 . . . . 25.0 114.71 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.66 -147.48 38.66 Favored Glycine 0 C--O 1.241 0.552 0 O-C-N 121.485 -1.009 . . . . 25.0 110.991 -176.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.37 165.02 54.77 Favored Glycine 0 CA--C 1.505 -0.588 0 CA-C-O 121.181 0.323 . . . . 25.0 112.762 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.57 167.27 36.46 Favored Glycine 0 C--O 1.236 0.274 0 C-N-CA 121.024 -0.608 . . . . 25.0 113.875 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.7 107.68 15.51 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.282 -1.007 . . . . 25.0 108.282 177.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -106.4 147.56 29.12 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.086 0.773 . . . . 50.0 113.086 -170.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -113.34 107.03 15.31 Favored 'General case' 0 C--O 1.249 1.073 0 N-CA-C 107.343 -1.354 . . . . 25.0 107.343 172.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 53.6 mt -111.39 133.51 53.64 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 116.161 -0.472 . . . . 25.0 110.613 -171.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -128.83 107.3 9.53 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.483 0.659 . . . . 25.0 111.715 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.71 -34.12 28.78 Favored Glycine 0 N--CA 1.463 0.489 0 N-CA-C 116.732 1.453 . . . . 25.0 116.732 -175.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 55.48 -153.5 0.33 Allowed 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 118.374 1.087 . . . . 25.0 111.959 -173.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.83 164.53 9.97 Favored 'General case' 0 C--O 1.252 1.193 0 N-CA-C 112.798 0.666 . . . . 25.0 112.798 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.67 155.19 31.66 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 115.279 -0.873 . . . . 25.0 111.351 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -78.59 98.54 6.19 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 106.99 -1.485 . . . . 25.0 106.99 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -100.24 151.42 21.47 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 122.032 -0.417 . . . . 50.0 110.183 -171.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.9 mp -113.16 90.6 3.39 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.767 -0.827 . . . . 25.0 108.767 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.4 mp -92.92 125.24 37.42 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 112.14 0.422 . . . . 25.0 112.14 -172.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -122.79 132.76 54.36 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 106.937 -1.505 . . . . 25.0 106.937 173.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.1 -38.76 8.32 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 119.715 -1.231 . . . . 25.0 115.028 -177.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.71 -171.83 51.44 Favored Glycine 0 C--O 1.223 -0.546 0 O-C-N 121.824 -0.81 . . . . 25.0 111.612 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.34 149.48 12.96 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.533 0.683 . . . . 25.0 110.935 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.35 166.93 42.35 Favored Glycine 0 C--N 1.332 0.327 0 CA-C-N 115.482 -0.781 . . . . 25.0 111.939 -178.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.71 129.23 34.86 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 105.16 -2.163 . . . . 25.0 105.16 176.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -120.85 154.16 36.18 Favored 'General case' 0 C--O 1.251 1.153 0 O-C-N 121.733 -0.605 . . . . 50.0 111.656 -175.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -116.57 128.3 55.29 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 103.607 -2.738 . . . . 25.0 103.607 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -147.76 141.58 25.74 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 115.831 1.789 . . . . 25.0 115.831 -174.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.6 m -109.3 138.02 46.29 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.194 -1.409 . . . . 25.0 107.194 176.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.03 -38.57 5.69 Favored Glycine 0 C--N 1.317 -0.512 0 N-CA-C 111.06 -0.816 . . . . 25.0 111.06 174.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.52 -170.37 54.54 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 118.749 1.274 . . . . 25.0 111.992 -177.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -64.15 161.63 15.95 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.088 0.471 . . . . 25.0 111.419 176.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.99 164.06 40.01 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-N 115.503 -0.771 . . . . 25.0 111.724 -176.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.13 106.5 16.63 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.129 -1.063 . . . . 25.0 108.129 -177.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -97.04 156.65 16.27 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 112.548 0.573 . . . . 50.0 112.548 -170.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 57.1 m -122.63 125.66 46.09 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.524 -0.917 . . . . 25.0 108.524 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -120.51 85.57 2.41 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.942 -0.762 . . . . 25.0 108.942 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -89.12 -23.95 22.36 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 112.313 0.486 . . . . 25.0 112.313 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 66.41 162.02 0.16 Allowed 'General case' 0 CA--C 1.548 0.898 0 O-C-N 125.212 1.57 . . . . 25.0 108.595 -171.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.13 -46.1 21.54 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 115.663 1.727 . . . . 25.0 115.663 -165.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.9 mt -144.12 169.28 18.15 Favored 'General case' 0 C--O 1.197 -1.691 0 C-N-CA 123.008 0.523 . . . . 25.0 111.246 -169.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.68 -32.69 30.8 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.574 -0.739 . . . . 25.0 110.571 169.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -80.99 1.44 31.2 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.732 1.382 . . . . 25.0 114.732 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -104.16 142.58 34.25 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.95 0.722 . . . . 25.0 112.95 -175.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.9 t 51.87 54.38 10.99 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 115.142 1.534 . . . . 25.0 115.142 177.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 36.9 p-80 -132.13 170.64 14.71 Favored 'General case' 0 C--O 1.208 -1.111 0 CA-C-N 116.441 -0.345 . . . . 25.0 111.884 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -118.07 144.92 45.21 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 106.696 -1.594 . . . . 25.0 106.696 178.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.9 p -133.31 164.83 41.17 Favored Pre-proline 0 C--O 1.244 0.797 0 N-CA-C 108.443 -0.947 . . . . 25.0 108.443 178.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -64.66 -15.84 52.16 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 117.504 -1.198 . . . . 25.0 113.436 174.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 87.9 mt -82.34 -21.51 35.96 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.075 -0.511 . . . . 25.0 111.817 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.77 171.77 24.13 Favored Glycine 0 C--O 1.219 -0.839 0 N-CA-C 109.875 -1.29 . . . . 25.0 109.875 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.1 t -101.13 147.88 25.72 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 122.659 1.218 . . . . 25.0 112.91 178.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -131.21 21.45 4.84 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.235 -0.893 . . . . 25.0 110.647 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.2 152.04 51.7 Favored Glycine 0 N--CA 1.473 1.164 0 N-CA-C 109.572 -1.411 . . . . 25.0 109.572 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -96.94 171.34 8.56 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 118.529 1.165 . . . . 50.0 110.536 -174.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.85 108.5 11.06 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 121.931 -0.481 . . . . 25.0 112.231 -175.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.3 mt -89.39 138.68 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 109.212 -0.662 . . . . 25.0 109.212 -176.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.404 ' HA ' ' HG2' ' A' ' 142' ' ' GLU . 76.9 mt -86.33 -52.62 5.51 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 115.77 1.767 . . . . 25.0 115.77 -175.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -127.82 32.46 4.95 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 113.982 1.105 . . . . 25.0 113.982 -168.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -52.94 143.33 17.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.423 -1.262 . . . . 25.0 114.029 -175.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -118.17 103.35 49.78 Favored Pre-proline 0 C--O 1.237 0.398 0 C-N-CA 123.032 0.533 . . . . 25.0 111.333 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.23 -13.21 35.6 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 N-CA-C 114.549 0.942 . . . . 25.0 114.549 -175.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.0 t -81.26 -39.33 25.45 Favored 'General case' 0 C--O 1.245 0.836 0 N-CA-C 108.737 -0.838 . . . . 25.0 108.737 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -95.33 -43.53 7.99 Favored 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 117.196 2.295 . . . . 25.0 117.196 -175.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -90.19 172.75 8.58 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.572 -1.195 . . . . 75.0 112.03 -162.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -142.81 147.32 35.28 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 112.36 0.504 . . . . 25.0 112.36 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 90.7 mt -127.35 128.78 70.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 108.604 -0.887 . . . . 25.0 108.604 -178.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -86.62 148.6 25.41 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 122.124 0.964 . . . . 25.0 111.617 174.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.4 p -146.75 -2.8 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 115.566 -0.743 . . . . 25.0 111.043 175.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 44.9 t -60.97 -44.57 97.15 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.662 0.744 . . . . 25.0 111.464 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.82 -28.53 58.33 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.372 -0.831 . . . . 25.0 112.074 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.6 mt -92.09 -41.61 10.4 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 116.288 1.958 . . . . 25.0 116.288 -171.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -138.54 -48.12 0.06 OUTLIER Glycine 0 N--CA 1.463 0.491 0 N-CA-C 118.156 2.022 . . . . 25.0 118.156 -172.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -160.14 153.03 21.45 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 118.579 1.19 . . . . 25.0 112.714 -172.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 25.2 t -109.15 -16.94 13.98 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.511 -0.552 . . . . 25.0 109.511 178.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -121.46 132.61 9.12 Favored Glycine 0 N--CA 1.47 0.912 0 N-CA-C 108.363 -1.895 . . . . 25.0 108.363 176.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -68.15 156.0 38.43 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.963 1.468 . . . . 25.0 114.963 -172.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -101.77 -161.25 26.79 Favored Glycine 0 N--CA 1.464 0.53 0 O-C-N 121.583 -0.698 . . . . 25.0 112.828 -177.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -54.57 138.99 39.62 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 113.482 0.919 . . . . 25.0 113.482 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 168.72 -176.42 42.98 Favored Glycine 0 C--O 1.227 -0.292 0 CA-C-N 115.242 -0.89 . . . . 25.0 110.995 177.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -146.56 165.93 28.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.573 0.687 . . . . 25.0 109.283 -177.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 54.99 34.02 21.5 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 114.449 1.277 . . . . 25.0 114.449 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.62 25.39 65.35 Favored Glycine 0 N--CA 1.465 0.617 0 N-CA-C 111.159 -0.776 . . . . 25.0 111.159 177.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.8 t -136.64 176.4 8.74 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 109.01 -0.737 . . . . 25.0 109.01 -178.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 69.7 mt -89.48 164.89 14.63 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 104.056 -2.572 . . . . 25.0 104.056 169.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.66 108.12 4.24 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 122.199 1.0 . . . . 25.0 109.894 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 18.0 m -73.16 160.34 5.36 Favored 'Isoleucine or valine' 0 C--O 1.247 0.968 0 N-CA-C 108.893 -0.78 . . . . 25.0 108.893 -177.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.47 168.87 20.8 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 110.382 -0.229 . . . . 25.0 110.382 -176.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.6 m -124.97 160.09 30.76 Favored 'Isoleucine or valine' 0 C--O 1.251 1.138 0 O-C-N 121.876 -0.515 . . . . 25.0 110.222 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.6 t -73.5 -49.12 28.3 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.692 -1.225 . . . . 25.0 107.692 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -168.94 -160.59 0.28 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 103.854 -2.647 . . . . 25.0 103.854 -177.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -72.82 -0.08 12.41 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 121.291 -0.88 . . . . 25.0 111.987 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -143.63 -157.79 7.31 Favored Glycine 0 C--O 1.241 0.575 0 N-CA-C 108.007 -2.037 . . . . 25.0 108.007 177.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.65 -153.59 0.37 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.184 0.809 . . . . 25.0 113.184 178.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.4 mtt85 -80.72 161.58 24.52 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 113.496 0.924 . . . . 25.0 113.496 -172.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.64 164.58 11.68 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 105.827 -1.916 . . . . 25.0 105.827 171.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -128.77 155.92 44.38 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 121.603 0.716 . . . . 25.0 110.357 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 29.8 tp -132.5 115.92 16.11 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 102.705 -3.072 . . . . 25.0 102.705 169.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -116.7 153.49 32.26 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 112.638 0.607 . . . . 25.0 112.638 -174.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 33.4 t -97.25 149.66 21.8 Favored 'General case' 0 C--O 1.215 -0.721 0 N-CA-C 103.889 -2.634 . . . . 25.0 103.889 168.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -119.35 10.17 11.85 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 124.828 1.33 . . . . 25.0 109.581 -178.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -97.95 152.78 18.89 Favored 'General case' 0 C--O 1.251 1.154 0 CA-C-N 114.291 -1.322 . . . . 25.0 107.504 171.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -142.88 160.4 40.41 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 122.234 1.016 . . . . 25.0 112.537 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -75.18 165.07 25.77 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 106.277 -1.749 . . . . 25.0 106.277 172.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.62 -22.83 67.11 Favored 'General case' 0 C--O 1.248 0.999 0 CA-C-O 122.287 1.042 . . . . 25.0 109.374 176.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -80.27 -6.78 58.47 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.859 -1.064 . . . . 25.0 112.788 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.59 2.53 72.72 Favored Glycine 0 C--O 1.223 -0.58 0 N-CA-C 114.419 0.528 . . . . 25.0 114.419 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.9 mt -72.68 137.17 45.83 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.83 -1.174 . . . . 25.0 107.83 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 88.7 p -140.25 -179.88 6.24 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 109.461 -0.57 . . . . 25.0 109.461 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -122.84 140.2 53.2 Favored 'General case' 0 C--O 1.247 0.951 0 O-C-N 121.926 -0.484 . . . . 25.0 111.717 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -156.97 155.49 31.38 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 107.476 -1.305 . . . . 25.0 107.476 170.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.8 p -148.78 147.07 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 N-CA-C 105.12 -2.178 . . . . 25.0 105.12 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -115.38 149.64 37.63 Favored 'General case' 0 C--O 1.254 1.305 0 N-CA-C 109.306 -0.627 . . . . 25.0 109.306 -175.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mp -139.15 129.22 25.18 Favored 'General case' 0 C--O 1.205 -1.254 0 N-CA-C 107.522 -1.288 . . . . 25.0 107.522 -175.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.404 ' HG2' ' HA ' ' A' ' 85' ' ' LEU . 6.9 pt-20 -86.33 0.77 53.21 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.347 -0.941 . . . . 25.0 113.058 -177.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -65.17 -17.84 64.17 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 116.033 1.173 . . . . 25.0 116.033 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 38.5 t0 54.4 45.77 26.43 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 122.423 1.106 . . . . 25.0 112.199 -178.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -122.05 43.37 2.88 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 113.993 -1.458 . . . . 25.0 109.418 -174.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -52.63 -37.51 58.58 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 113.995 1.109 . . . . 25.0 113.995 178.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.59 -28.18 63.64 Favored 'General case' 0 C--O 1.248 0.996 0 CA-C-N 118.923 0.783 . . . . 25.0 111.473 -178.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.56 -27.47 34.33 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 121.413 0.625 . . . . 25.0 112.377 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 46.1 mt -66.6 128.58 36.79 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 119.87 -0.732 . . . . 25.0 110.337 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.9 m -131.15 160.93 33.31 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.176 -1.416 . . . . 25.0 107.176 177.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -79.51 1.37 26.02 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 107.619 -1.252 . . . . 25.0 107.619 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -68.47 -30.8 69.73 Favored 'General case' 0 N--CA 1.437 -1.106 0 O-C-N 123.465 0.478 . . . . 25.0 111.803 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -91.31 -10.41 41.43 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.733 -0.469 . . . . 25.0 109.733 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 26.9 mm -83.75 136.01 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 104.435 -2.432 . . . . 25.0 104.435 175.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.9 p -113.51 126.35 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 O-C-N 120.47 -1.394 . . . . 25.0 110.965 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -153.77 -30.43 0.12 Allowed 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 114.38 -1.282 . . . . 25.0 112.743 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -82.77 69.84 9.64 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 112.849 0.685 . . . . 25.0 112.849 -175.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 54.37 20.77 2.87 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.871 1.063 . . . . 25.0 113.871 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.12 17.95 4.89 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.705 0.802 . . . . 25.0 111.721 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -98.57 131.55 44.69 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.553 0.341 . . . . 25.0 110.976 -174.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.4 -10.33 58.78 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.957 0.725 . . . . 25.0 112.957 -176.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.07 -32.3 72.83 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.221 0.452 . . . . 25.0 112.221 -178.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.71 162.97 26.58 Favored 'General case' 0 C--O 1.247 0.961 0 N-CA-C 111.978 0.362 . . . . 25.0 111.978 -175.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 57.59 -169.81 0.11 Allowed 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 114.034 1.124 . . . . 25.0 114.034 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 90.83 2.18 72.41 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.787 -0.721 . . . . 25.0 113.789 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -102.48 115.29 30.28 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.841 -1.17 . . . . 25.0 107.841 176.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -134.47 161.78 34.09 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.287 -1.005 . . . . 25.0 108.287 -177.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -135.11 27.34 3.16 Favored Glycine 0 C--O 1.242 0.606 0 N-CA-C 110.419 -1.072 . . . . 25.0 110.419 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 47.7 t -70.2 -34.83 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.32 0.648 . . . . 25.0 110.355 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -58.36 133.69 23.32 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 CA-C-O 121.727 0.775 . . . . 25.0 111.735 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 156.81 160.18 9.93 Favored Glycine 0 C--N 1.336 0.564 0 N-CA-C 110.757 -0.937 . . . . 25.0 110.757 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -136.37 152.42 50.62 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 122.382 -0.481 . . . . 25.0 110.031 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 54.5 p -148.71 159.16 44.38 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.239 0.542 . . . . 25.0 110.0 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -179.93 168.77 39.25 Favored Glycine 0 N--CA 1.461 0.318 0 O-C-N 121.677 -0.639 . . . . 25.0 113.717 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -154.23 114.19 2.5 Favored Pre-proline 0 C--O 1.246 0.908 0 N-CA-C 107.767 -1.197 . . . . 25.0 107.767 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -68.84 157.05 63.4 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 117.304 -1.331 . . . . 25.0 112.559 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -117.75 146.67 43.62 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 108.208 -1.034 . . . . 25.0 108.208 177.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -140.15 64.27 25.9 Favored Pre-proline 0 N--CA 1.478 0.969 0 N-CA-C 112.405 0.52 . . . . 25.0 112.405 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.21 161.39 32.26 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 117.579 -1.147 . . . . 25.0 112.616 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 15.2 t -119.17 2.91 11.43 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 116.328 -0.396 . . . . 25.0 110.894 177.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 C--O 1.254 1.307 0 CA-C-O 117.494 -1.241 . . . . 25.0 111.283 178.829 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 121.429 0.633 . . . . 25.0 109.906 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -148.76 113.82 3.7 Favored Pre-proline 0 N--CA 1.477 0.893 0 O-C-N 121.626 -0.671 . . . . 25.0 109.901 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -70.18 147.22 59.7 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 117.65 -1.1 . . . . 25.0 112.653 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.79 36.34 0.22 Allowed Glycine 0 N--CA 1.473 1.107 0 C-N-CA 121.173 -0.537 . . . . 25.0 113.838 -177.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -50.03 119.6 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 114.119 1.155 . . . . 25.0 114.119 -175.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -93.43 8.5 40.29 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 122.176 0.989 . . . . 25.0 108.341 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.92 -152.67 17.71 Favored Glycine 0 C--O 1.22 -0.742 0 CA-C-N 115.865 -0.607 . . . . 25.0 113.993 176.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.6 p 69.13 158.19 0.15 Allowed Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 125.988 1.715 . . . . 25.0 112.048 -174.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -69.7 22.77 0.17 Allowed 'Trans proline' 0 C--N 1.359 1.098 0 N-CA-C 118.803 2.578 . . . . 25.0 118.803 -176.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.07 -25.76 17.07 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.504 0 N-CA-C 114.516 1.302 . . . . 25.0 114.516 -171.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.6 p -146.69 145.76 19.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 CA-C-N 119.644 1.111 . . . . 25.0 112.223 -175.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.2 24.15 41.69 Favored Glycine 0 N--CA 1.466 0.681 0 N-CA-C 118.719 2.247 . . . . 25.0 118.719 172.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.7 t -49.49 -66.11 0.45 Allowed 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 118.641 1.22 . . . . 25.0 112.719 -175.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -86.49 17.83 3.62 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 115.588 1.699 . . . . 25.0 115.588 -167.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.16 168.75 19.07 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 120.821 -1.175 . . . . 25.0 110.927 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -68.9 132.22 46.37 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.233 0.54 . . . . 25.0 110.848 -175.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -123.67 160.46 27.14 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.896 1.443 . . . . 50.0 114.896 -174.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -124.38 99.03 6.01 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 104.492 -2.41 . . . . 25.0 104.492 161.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 87.1 mt -108.44 109.72 21.07 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 111.664 0.246 . . . . 25.0 111.664 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -103.18 117.12 33.81 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.498 -0.556 . . . . 25.0 109.498 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.78 -171.59 46.04 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 117.644 1.818 . . . . 25.0 117.644 -168.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.426 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 81.8 p -87.1 169.02 12.76 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.561 0.744 . . . . 25.0 109.102 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 68.7 mt -86.54 11.28 13.03 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.23 -0.441 . . . . 25.0 111.464 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -112.26 175.78 17.35 Favored Glycine 0 N--CA 1.461 0.357 0 N-CA-C 109.115 -1.594 . . . . 25.0 109.115 177.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.3 t -66.33 140.74 58.12 Favored 'General case' 0 C--O 1.207 -1.143 0 CA-C-N 117.978 0.889 . . . . 25.0 110.745 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.426 ' CD ' ' H ' ' A' ' 22' ' ' THR . 26.2 mt-10 -149.11 156.99 43.03 Favored 'General case' 0 C--O 1.246 0.895 0 C-N-CA 122.917 0.487 . . . . 50.0 110.106 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -89.93 138.23 31.67 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 104.544 -2.391 . . . . 25.0 104.544 161.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.5 mm -126.62 92.98 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 106.042 -1.836 . . . . 25.0 106.042 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 11.0 mp -104.5 120.96 42.46 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 104.652 -2.351 . . . . 25.0 104.652 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.27 -26.39 36.69 Favored Glycine 0 CA--C 1.505 -0.586 0 CA-C-O 119.729 -0.484 . . . . 25.0 112.051 -174.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.6 -149.24 46.49 Favored Glycine 0 C--O 1.249 1.077 0 N-CA-C 110.165 -1.174 . . . . 25.0 110.165 -173.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.49 179.12 40.82 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-O 123.059 1.366 . . . . 25.0 112.475 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.97 164.19 19.97 Favored Glycine 0 C--O 1.248 0.976 0 CA-C-N 114.207 -0.996 . . . . 25.0 114.266 179.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.56 100.02 12.11 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 106.722 -1.584 . . . . 25.0 106.722 176.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -96.83 156.36 16.38 Favored 'General case' 0 C--O 1.214 -0.783 0 C-N-CA 120.207 -0.597 . . . . 50.0 112.148 -170.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -115.61 91.26 3.55 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 106.233 -1.766 . . . . 25.0 106.233 174.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 70.0 mt -97.77 136.19 38.46 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-N 114.024 -1.444 . . . . 25.0 112.613 -172.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -131.64 95.14 3.66 Favored 'General case' 0 C--O 1.252 1.189 0 CA-C-O 121.53 0.681 . . . . 25.0 111.743 -176.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.88 -27.13 69.49 Favored Glycine 0 CA--C 1.521 0.426 0 CA-C-O 119.118 -0.823 . . . . 25.0 113.926 -176.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 48.79 -148.25 0.24 Allowed 'General case' 0 C--O 1.243 0.721 0 C-N-CA 124.405 1.082 . . . . 25.0 111.852 -176.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.91 159.58 34.41 Favored 'General case' 0 C--O 1.25 1.11 0 CA-C-O 121.69 0.757 . . . . 25.0 111.633 -177.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.33 156.64 21.49 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.51 -1.036 . . . . 25.0 110.51 -175.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -86.45 90.15 8.12 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.516 -0.92 . . . . 25.0 108.516 176.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -90.57 160.28 16.02 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.028 -0.987 . . . . 50.0 112.43 -170.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 tp -124.27 99.69 6.34 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.378 -0.971 . . . . 25.0 108.378 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.3 mp -101.83 117.83 35.66 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 116.016 1.858 . . . . 25.0 116.016 -166.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -122.23 101.62 7.63 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.117 -0.947 . . . . 25.0 109.137 174.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.42 -29.17 70.88 Favored Glycine 0 CA--C 1.523 0.585 0 O-C-N 120.141 -1.599 . . . . 25.0 112.769 -177.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.57 -168.08 54.1 Favored Glycine 0 N--CA 1.471 1.029 0 N-CA-C 108.938 -1.665 . . . . 25.0 108.938 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.86 151.89 33.27 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.86 0.689 . . . . 25.0 112.86 -175.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.79 165.98 33.12 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 115.847 1.099 . . . . 25.0 115.847 -175.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.402 ' HD2' ' HA ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -91.03 105.84 18.1 Favored 'General case' 0 C--O 1.212 -0.893 0 N-CA-C 105.667 -1.975 . . . . 25.0 105.667 176.293 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -99.98 151.45 21.33 Favored 'General case' 0 CA--C 1.483 -1.63 0 O-C-N 123.879 0.737 . . . . 50.0 112.093 -168.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -112.03 125.36 53.99 Favored 'General case' 0 C--O 1.211 -0.955 0 N-CA-C 103.374 -2.825 . . . . 25.0 103.374 177.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -149.31 132.68 16.56 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 122.348 1.07 . . . . 25.0 113.27 -174.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 71.5 m -96.77 136.11 37.78 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 106.979 -1.489 . . . . 25.0 106.979 173.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -88.06 -40.94 6.42 Favored Glycine 0 CA--C 1.499 -0.909 0 N-CA-C 110.357 -1.097 . . . . 25.0 110.357 174.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.62 -171.64 54.09 Favored Glycine 0 C--O 1.252 1.228 0 CA-C-O 122.633 1.129 . . . . 25.0 113.402 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -63.01 163.09 10.33 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 121.661 -0.905 . . . . 25.0 110.225 176.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.91 164.52 40.3 Favored Glycine 0 C--O 1.243 0.684 0 CA-C-O 118.554 -1.137 . . . . 25.0 112.514 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.51 113.24 20.11 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.967 -0.753 . . . . 25.0 108.967 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -104.9 154.41 20.11 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 121.541 -0.724 . . . . 50.0 110.576 -177.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.3 m -120.58 129.08 53.61 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 106.271 -1.751 . . . . 25.0 106.271 177.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -115.38 128.7 56.24 Favored 'General case' 0 C--O 1.207 -1.153 0 N-CA-C 104.827 -2.286 . . . . 25.0 104.827 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 61.9 mtt85 -133.41 -29.88 1.35 Allowed 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 113.393 0.886 . . . . 25.0 113.393 174.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 68.23 163.03 0.21 Allowed 'General case' 0 CA--C 1.537 0.459 0 O-C-N 124.794 1.309 . . . . 25.0 110.201 -172.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.22 -41.34 49.58 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.473 1.657 . . . . 25.0 115.473 -165.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 66.5 mt -136.53 170.39 16.14 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 115.217 1.562 . . . . 25.0 115.217 -171.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.09 -28.33 64.5 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.13 -1.396 . . . . 25.0 109.198 168.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -81.29 6.98 12.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.161 -1.381 . . . . 25.0 114.423 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -111.32 152.96 26.64 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.119 -1.613 . . . . 25.0 113.237 -174.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.6 t 41.27 50.77 3.48 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 117.897 2.554 . . . . 25.0 117.897 -178.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 24.5 p-80 -125.43 161.28 27.43 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 114.411 -1.268 . . . . 25.0 112.237 -176.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -109.37 138.72 45.29 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 104.859 -2.275 . . . . 25.0 104.859 174.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.4 p -122.6 172.14 5.66 Favored Pre-proline 0 C--N 1.322 -0.629 0 O-C-N 124.129 0.893 . . . . 25.0 109.975 -178.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -61.94 -23.97 76.45 Favored 'Trans proline' 0 C--O 1.254 1.315 0 C-N-CA 117.707 -1.062 . . . . 25.0 112.639 174.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 75.1 mt -78.22 -29.03 48.07 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.339 0.496 . . . . 25.0 112.339 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.23 -179.6 32.88 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.08 -1.208 . . . . 25.0 110.08 -172.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.5 t -98.12 151.42 20.41 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.106 1.15 . . . . 25.0 114.106 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.402 ' HA ' ' HD2' ' A' ' 52' ' ' ARG . 72.7 m-85 -135.47 29.73 3.26 Favored 'General case' 0 C--O 1.251 1.166 0 CA-C-N 114.419 -1.264 . . . . 25.0 108.889 175.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.53 146.8 42.77 Favored Glycine 0 C--N 1.335 0.476 0 O-C-N 124.102 0.876 . . . . 25.0 112.138 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -84.2 169.46 14.76 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 122.543 -0.387 . . . . 50.0 111.647 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -128.78 108.22 10.28 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 110.166 -0.309 . . . . 25.0 110.166 -176.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.5 mt -98.13 135.67 31.91 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 N-CA-C 107.618 -1.253 . . . . 25.0 107.618 -177.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.6 mt -84.83 -41.19 16.3 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 115.723 1.749 . . . . 25.0 115.723 -171.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.9 p-10 -137.22 39.07 2.51 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.991 1.108 . . . . 25.0 113.991 -172.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -58.24 132.89 54.94 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.126 -0.943 . . . . 25.0 110.655 -177.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -113.7 106.25 54.03 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 108.375 -0.972 . . . . 25.0 108.375 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.1 -16.64 56.08 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 N-CA-C 116.338 1.63 . . . . 25.0 116.338 -173.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.7 t -88.33 -29.11 20.57 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.895 0.378 . . . . 25.0 111.374 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -93.44 -48.93 6.17 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.609 0.719 . . . . 25.0 111.575 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -96.56 165.5 12.13 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 114.169 -1.378 . . . . 50.0 110.92 -159.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -142.18 151.54 42.3 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 113.921 1.082 . . . . 25.0 113.921 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 75.3 mt -126.51 123.54 63.43 Favored 'Isoleucine or valine' 0 C--O 1.247 0.969 0 N-CA-C 107.55 -1.278 . . . . 25.0 107.55 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -81.58 147.35 29.65 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 122.257 1.027 . . . . 25.0 108.363 173.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -155.63 -12.02 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 115.232 -0.895 . . . . 25.0 112.45 -179.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.6 t -62.67 -38.34 89.95 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 120.738 -1.226 . . . . 25.0 110.237 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.65 -21.0 56.05 Favored 'General case' 0 CA--C 1.555 1.149 0 N-CA-C 114.812 1.412 . . . . 25.0 114.812 -176.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.39 0.63 2.81 Favored 'General case' 0 CA--C 1.556 1.176 0 N-CA-C 117.61 2.448 . . . . 25.0 117.61 -170.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -143.32 -67.05 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 119.021 0.828 . . . . 25.0 115.012 177.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -160.11 164.92 32.64 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.99 0.9 . . . . 25.0 110.992 -174.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.8 t -119.48 -26.76 5.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.773 -1.103 . . . . 25.0 110.521 174.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -93.95 120.68 6.39 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 118.718 -1.046 . . . . 25.0 112.699 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -65.93 157.17 31.37 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.442 1.621 . . . . 25.0 112.356 178.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -90.7 -172.03 43.88 Favored Glycine 0 C--N 1.32 -0.332 0 CA-C-O 118.88 -0.956 . . . . 25.0 112.263 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -79.54 83.1 5.57 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 118.646 1.223 . . . . 25.0 112.111 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.06 -175.43 17.96 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 108.348 -1.901 . . . . 25.0 108.348 168.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -127.05 160.7 30.34 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.971 1.385 . . . . 25.0 111.879 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 51.83 47.24 25.18 Favored 'General case' 0 C--O 1.266 1.951 0 N-CA-C 114.946 1.462 . . . . 25.0 114.946 -176.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.26 48.69 36.96 Favored Glycine 0 N--CA 1.48 1.591 0 N-CA-C 109.253 -1.539 . . . . 25.0 109.253 176.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.5 t -148.33 173.84 12.64 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 117.838 0.819 . . . . 25.0 111.905 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.7 mp -105.36 168.57 8.99 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 101.816 -3.402 . . . . 25.0 101.816 173.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.55 135.48 39.27 Favored 'General case' 0 C--O 1.254 1.31 0 C-N-CA 117.915 -1.514 . . . . 25.0 108.009 -176.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.7 m -102.35 163.58 3.42 Favored 'Isoleucine or valine' 0 C--O 1.248 0.997 0 CA-C-O 118.524 -0.75 . . . . 25.0 109.165 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.0 p -149.78 163.41 38.05 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-N 118.514 0.597 . . . . 25.0 112.247 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 28.0 m -115.89 160.82 15.05 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 N-CA-C 105.787 -1.931 . . . . 25.0 105.787 176.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.9 t -78.76 -42.67 27.42 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 107.055 -1.461 . . . . 25.0 107.055 176.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -168.31 -169.13 1.03 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 103.78 -2.674 . . . . 25.0 103.78 -175.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -59.76 -24.78 64.35 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.662 0.601 . . . . 25.0 112.534 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -126.9 -147.38 6.72 Favored Glycine 0 C--O 1.252 1.231 0 N-CA-C 111.114 -0.795 . . . . 25.0 111.114 174.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 53.72 -142.69 0.78 Allowed 'General case' 0 C--O 1.246 0.872 0 N-CA-C 113.891 1.071 . . . . 25.0 113.891 -179.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.7 mtt85 -91.39 162.83 14.42 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 114.716 1.376 . . . . 25.0 114.716 -170.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.5 p -113.08 162.48 15.88 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 104.73 -2.322 . . . . 25.0 104.73 176.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -132.7 156.14 47.55 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 109.245 -0.65 . . . . 25.0 109.245 -175.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 33.6 tp -135.16 127.66 30.6 Favored 'General case' 0 C--O 1.251 1.17 0 N-CA-C 102.695 -3.076 . . . . 25.0 102.695 171.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -128.65 159.6 35.07 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 115.787 -0.642 . . . . 25.0 112.673 -170.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.2 t -94.64 149.77 20.91 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.295 -1.372 . . . . 25.0 107.295 171.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -119.82 24.15 10.7 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 106.93 -1.507 . . . . 25.0 106.93 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -125.91 135.88 52.41 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 106.364 -1.717 . . . . 25.0 106.364 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -139.39 156.31 47.07 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 122.558 1.17 . . . . 25.0 109.672 -172.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -74.08 159.35 32.75 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-N 114.782 -1.099 . . . . 25.0 109.225 173.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.29 -20.64 66.5 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.733 -0.604 . . . . 25.0 109.789 173.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -69.89 -12.27 61.49 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 118.675 -0.678 . . . . 25.0 112.502 175.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.13 22.93 46.75 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 111.51 -0.636 . . . . 25.0 111.51 -177.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.7 mt -100.18 141.01 33.6 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 107.636 -1.246 . . . . 25.0 107.636 177.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 59.7 p -147.61 171.43 15.61 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 106.789 -1.56 . . . . 25.0 106.789 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -115.76 138.38 51.18 Favored 'General case' 0 C--O 1.257 1.453 0 CA-C-N 118.667 0.667 . . . . 25.0 112.624 -173.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -152.63 153.21 32.87 Favored 'General case' 0 C--O 1.248 1.02 0 CA-C-O 121.717 0.77 . . . . 25.0 110.088 172.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.9 p -145.03 143.79 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.784 0 N-CA-C 105.858 -1.904 . . . . 25.0 105.858 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -107.86 142.69 37.55 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.41 -1.329 . . . . 25.0 107.41 -176.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.6 mp -131.13 137.13 48.9 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.489 -1.3 . . . . 25.0 107.489 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -109.71 7.29 24.27 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 121.251 1.841 . . . . 25.0 115.858 -176.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -76.9 4.94 51.45 Favored Glycine 0 N--CA 1.469 0.894 0 N-CA-C 116.322 1.289 . . . . 25.0 116.322 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 46.6 t0 51.34 51.94 15.83 Favored 'General case' 0 C--O 1.256 1.43 0 C-N-CA 124.046 0.939 . . . . 25.0 111.875 176.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -129.84 29.83 4.94 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 124.849 1.26 . . . . 25.0 110.714 -174.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.85 -31.98 70.26 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 119.275 -0.97 . . . . 25.0 111.52 176.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.6 -20.95 66.12 Favored 'General case' 0 C--O 1.251 1.171 0 CA-C-N 118.777 0.717 . . . . 25.0 111.349 177.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -95.67 -27.77 15.13 Favored 'General case' 0 C--O 1.259 1.603 0 N-CA-C 114.048 1.129 . . . . 25.0 114.048 176.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 74.6 mt -58.39 137.36 57.31 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 114.126 1.158 . . . . 25.0 114.126 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 62.7 m -137.15 167.15 22.1 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 105.642 -1.985 . . . . 25.0 105.642 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -77.45 -2.88 37.52 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 120.458 -1.401 . . . . 25.0 111.324 174.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -68.42 -29.09 67.68 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.777 -0.577 . . . . 25.0 112.353 -176.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -87.02 -2.48 58.66 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.882 -0.599 . . . . 25.0 111.209 174.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 36.7 mm -96.64 127.32 48.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 104.679 -2.341 . . . . 25.0 104.679 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.1 p -105.42 104.4 16.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 124.063 1.887 . . . . 25.0 114.78 -174.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -141.81 -1.1 1.29 Allowed 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 112.625 -2.079 . . . . 25.0 111.091 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -80.91 53.5 1.97 Allowed 'General case' 0 CA--C 1.549 0.905 0 O-C-N 121.151 -0.968 . . . . 25.0 112.603 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 58.85 18.07 5.8 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 114.434 1.272 . . . . 25.0 114.434 -175.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.58 -39.88 0.39 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 118.264 2.69 . . . . 25.0 118.264 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -70.81 150.01 46.27 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-O 121.388 0.613 . . . . 25.0 110.622 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -80.3 19.93 0.72 Allowed 'General case' 0 C--O 1.218 -0.564 0 C-N-CA 124.09 0.956 . . . . 25.0 112.32 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.74 -21.78 66.84 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 115.487 1.662 . . . . 25.0 115.487 -177.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -140.28 -160.59 1.09 Allowed 'General case' 0 CA--C 1.547 0.862 0 CA-C-O 121.567 0.699 . . . . 25.0 111.37 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 64.21 -171.11 0.18 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 115.359 1.614 . . . . 25.0 115.359 177.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 81.38 24.38 56.87 Favored Glycine 0 C--O 1.225 -0.456 0 CA-C-O 122.985 1.325 . . . . 25.0 110.515 -175.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -98.7 114.59 27.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.444 -0.878 . . . . 25.0 109.165 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -123.68 143.22 50.39 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 108.532 -0.914 . . . . 25.0 108.532 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -111.07 16.83 27.45 Favored Glycine 0 C--O 1.225 -0.432 0 N-CA-C 112.155 -0.378 . . . . 25.0 112.155 -177.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 49.0 t -68.59 -37.33 77.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.697 -0.252 . . . . 25.0 111.297 -174.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.0 133.31 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-O 121.599 0.714 . . . . 25.0 111.57 -176.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 149.04 159.01 8.33 Favored Glycine 0 N--CA 1.463 0.435 0 N-CA-C 110.058 -1.217 . . . . 25.0 110.058 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -151.69 153.04 33.6 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-O 122.285 1.04 . . . . 25.0 111.338 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 92.6 p -165.34 163.11 19.95 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 105.074 -2.195 . . . . 25.0 105.074 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 174.7 159.84 21.7 Favored Glycine 0 C--O 1.245 0.803 0 C-N-CA 119.963 -1.113 . . . . 25.0 114.241 174.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -116.86 110.75 41.58 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 109.047 -0.724 . . . . 25.0 109.047 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.37 169.5 21.83 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 116.328 -1.981 . . . . 25.0 114.335 -175.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -124.57 140.95 52.47 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.368 -0.975 . . . . 25.0 108.368 175.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -143.66 73.47 17.1 Favored Pre-proline 0 N--CA 1.487 1.383 0 CA-C-O 121.11 0.481 . . . . 25.0 111.75 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -67.99 152.89 76.36 Favored 'Trans proline' 0 C--O 1.242 0.682 0 N-CA-C 114.062 0.755 . . . . 25.0 114.062 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.6 t -124.05 11.05 8.86 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.712 -0.676 . . . . 25.0 109.363 -176.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.257 1.457 0 N-CA-C 109.157 -0.683 . . . . 25.0 109.157 178.717 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.526 3.327 0 N-CA-C 110.156 -0.313 . . . . 25.0 110.156 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -140.86 100.12 6.63 Favored Pre-proline 0 N--CA 1.486 1.358 0 O-C-N 121.788 -0.57 . . . . 25.0 109.512 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -71.16 142.9 42.88 Favored 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 117.02 -1.52 . . . . 25.0 114.297 -177.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -163.83 49.76 0.3 Allowed Glycine 0 N--CA 1.467 0.759 0 N-CA-C 108.467 -1.853 . . . . 25.0 108.467 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.2 p -54.58 128.87 15.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-O 122.918 1.342 . . . . 25.0 110.495 -175.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -101.19 -1.63 33.36 Favored 'General case' 0 C--O 1.252 1.226 0 O-C-N 121.289 -0.882 . . . . 25.0 110.389 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.48 -142.55 6.99 Favored Glycine 0 C--O 1.241 0.539 0 CA-C-N 116.421 -0.354 . . . . 25.0 112.79 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.0 p 68.43 157.75 0.15 Allowed Pre-proline 0 N--CA 1.486 1.353 0 C-N-CA 125.811 1.644 . . . . 25.0 111.739 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.563 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 25.5 Cg_exo -71.1 -2.35 10.97 Favored 'Trans proline' 0 C--N 1.354 0.86 0 N-CA-C 116.046 1.518 . . . . 25.0 116.046 -172.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.6 p -65.04 -13.59 15.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 115.974 1.842 . . . . 25.0 115.974 -171.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.3 p -139.69 134.94 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 114.693 1.368 . . . . 25.0 114.693 -177.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.6 13.18 83.21 Favored Glycine 0 N--CA 1.466 0.665 0 N-CA-C 117.026 1.57 . . . . 25.0 117.026 174.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.7 t -47.12 -49.74 21.5 Favored 'General case' 0 C--O 1.209 -1.028 0 CA-C-N 118.98 1.39 . . . . 25.0 113.279 -168.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -78.61 6.91 7.68 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 116.85 2.167 . . . . 25.0 116.85 -174.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 pp -142.57 169.52 17.42 Favored 'General case' 0 C--O 1.203 -1.352 0 O-C-N 121.277 -0.889 . . . . 25.0 111.428 -177.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -61.5 128.47 36.44 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 113.139 0.792 . . . . 25.0 113.139 -174.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -130.08 167.15 18.78 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 114.081 1.141 . . . . 50.0 114.081 -175.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -125.34 107.73 10.98 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 104.008 -2.59 . . . . 25.0 104.008 169.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.3 mt -122.66 114.43 20.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 119.069 0.85 . . . . 25.0 110.143 -175.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -108.22 121.94 45.91 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.618 -0.882 . . . . 25.0 108.618 173.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.2 -177.89 47.33 Favored Glycine 0 N--CA 1.471 1.026 0 N-CA-C 115.063 0.785 . . . . 25.0 115.063 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.4 p -81.02 178.11 8.63 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.021 0.928 . . . . 25.0 111.229 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 79.7 mt -90.31 13.55 15.08 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.193 0.52 . . . . 25.0 110.103 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.77 -177.09 20.64 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.455 -0.658 . . . . 25.0 111.455 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.8 t -75.38 129.4 37.29 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.128 1.159 . . . . 25.0 114.128 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -145.01 159.82 42.34 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.045 -1.034 . . . . 50.0 112.998 -174.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -98.66 120.97 39.99 Favored 'General case' 0 C--O 1.26 1.608 0 N-CA-C 105.498 -2.038 . . . . 25.0 105.498 164.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.1 mm -115.98 107.88 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 N-CA-C 105.291 -2.115 . . . . 25.0 105.291 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.563 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 9.2 mp -115.89 132.11 56.74 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 105.084 -2.191 . . . . 25.0 105.084 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.89 -33.94 9.4 Favored Glycine 0 CA--C 1.483 -1.962 0 N-CA-C 114.72 0.648 . . . . 25.0 114.72 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 72.94 -145.59 36.81 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 111.793 -0.523 . . . . 25.0 111.793 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.39 163.13 52.76 Favored Glycine 0 N--CA 1.438 -1.185 0 CA-C-O 121.783 0.657 . . . . 25.0 113.569 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.24 166.76 41.44 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.216 -0.754 . . . . 25.0 111.216 177.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.38 112.08 20.02 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.045 -1.094 . . . . 25.0 108.045 176.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -107.09 157.7 17.63 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 113.662 0.986 . . . . 50.0 113.662 -172.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -117.93 87.17 2.66 Favored 'General case' 0 C--O 1.255 1.386 0 N-CA-C 106.668 -1.604 . . . . 25.0 106.668 178.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 53.6 mt -96.34 137.99 34.61 Favored 'General case' 0 C--O 1.207 -1.141 0 CA-C-N 115.572 -0.74 . . . . 25.0 112.07 -174.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -131.34 112.77 13.04 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 107.117 -1.438 . . . . 25.0 107.117 177.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -92.14 -22.68 29.3 Favored Glycine 0 CA--C 1.507 -0.453 0 CA-C-O 118.877 -0.957 . . . . 25.0 115.455 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 51.12 -147.47 0.41 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.127 0.971 . . . . 25.0 113.303 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.34 165.03 19.51 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 123.313 1.53 . . . . 25.0 112.326 -177.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.11 157.12 32.79 Favored Glycine 0 C--O 1.246 0.869 0 CA-C-N 113.876 -1.511 . . . . 25.0 111.253 -176.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.2 m-20 -78.29 114.81 17.53 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 103.853 -2.647 . . . . 25.0 103.853 177.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -119.78 160.13 23.2 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.986 -0.746 . . . . 50.0 108.986 -172.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.0 mp -111.12 124.56 52.42 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 104.31 -2.478 . . . . 25.0 104.31 171.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.59 100.89 7.26 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 121.875 -0.516 . . . . 25.0 111.991 -175.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -117.74 103.73 10.28 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.971 -1.122 . . . . 25.0 107.971 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.86 -24.53 68.42 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 116.88 1.512 . . . . 25.0 116.88 -177.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.39 -168.09 51.28 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 118.371 -1.238 . . . . 25.0 111.036 -178.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.41 153.86 3.78 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.55 1.315 . . . . 25.0 114.55 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.03 171.78 47.82 Favored Glycine 0 CA--C 1.502 -0.74 0 O-C-N 124.6 1.187 . . . . 25.0 110.406 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.08 156.18 27.18 Favored 'General case' 0 C--O 1.203 -1.35 1 N-CA-C 99.922 -4.103 . . . . 25.0 99.922 173.258 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -144.77 156.61 44.14 Favored 'General case' 0 C--O 1.247 0.948 0 C-N-CA 120.437 -0.505 . . . . 50.0 110.821 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -119.91 121.38 38.88 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 103.33 -2.841 . . . . 25.0 103.33 174.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.7 130.72 26.33 Favored 'General case' 0 C--O 1.211 -0.921 0 N-CA-C 113.916 1.08 . . . . 25.0 113.916 -171.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.29 126.84 52.55 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.157 -0.965 . . . . 25.0 108.816 -178.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -80.85 -48.43 6.14 Favored Glycine 0 C--O 1.247 0.916 0 C-N-CA 119.94 -1.124 . . . . 25.0 112.624 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.63 -167.8 53.22 Favored Glycine 0 CA--C 1.535 1.339 0 O-C-N 122.414 -0.462 . . . . 25.0 114.244 -177.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -67.12 159.77 28.17 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 121.274 -1.133 . . . . 25.0 111.086 177.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.21 156.99 33.12 Favored Glycine 0 C--O 1.242 0.599 0 N-CA-C 110.538 -1.025 . . . . 25.0 110.538 -177.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.81 98.64 5.64 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 122.121 0.962 . . . . 25.0 110.853 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -89.21 155.94 19.09 Favored 'General case' 0 C--O 1.252 1.21 0 CA-C-N 114.391 -1.277 . . . . 50.0 112.587 -174.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 46.8 m -128.12 125.23 38.76 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.156 0.503 . . . . 25.0 110.025 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -113.32 103.16 11.04 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.914 -0.772 . . . . 25.0 108.914 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 24.6 mmt85 -105.0 -30.32 9.86 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-N 115.916 -0.584 . . . . 25.0 110.052 -178.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 64.75 165.79 0.16 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.88 1.272 . . . . 25.0 110.437 -171.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -87.13 -38.77 16.15 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.862 0.69 . . . . 25.0 112.862 -168.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.1 mt -136.03 161.6 35.23 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 122.089 0.947 . . . . 25.0 111.538 -173.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.93 -25.68 63.67 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 114.894 -1.048 . . . . 25.0 109.051 172.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -78.06 3.09 15.81 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.389 -1.278 . . . . 25.0 114.171 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -95.57 148.52 22.42 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 115.386 1.625 . . . . 25.0 115.386 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.6 t 53.23 39.41 29.67 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.871 1.434 . . . . 25.0 114.871 173.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 27.2 p-80 -114.7 163.67 15.12 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.326 -0.852 . . . . 25.0 112.737 -175.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -110.49 142.89 41.63 Favored 'General case' 0 C--O 1.208 -1.097 0 N-CA-C 103.564 -2.754 . . . . 25.0 103.564 173.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 97.5 p -135.32 170.07 12.09 Favored Pre-proline 0 CA--C 1.512 -0.506 0 N-CA-C 107.039 -1.467 . . . . 25.0 107.039 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -62.48 -18.78 65.07 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 CA-C-N 119.385 0.816 . . . . 25.0 113.32 173.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.4 mt -77.82 -24.29 48.77 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.304 0.573 . . . . 25.0 111.822 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 144.68 -176.95 23.52 Favored Glycine 0 C--O 1.25 1.117 0 N-CA-C 110.155 -1.178 . . . . 25.0 110.155 -178.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.4 t -84.13 147.29 27.42 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 122.788 1.28 . . . . 25.0 112.193 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -133.94 27.32 3.91 Favored 'General case' 0 C--O 1.256 1.409 0 N-CA-C 105.731 -1.952 . . . . 25.0 105.731 169.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.16 143.95 42.08 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 114.323 -1.308 . . . . 25.0 110.545 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -87.65 166.69 14.5 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.493 -0.928 . . . . 50.0 108.493 -174.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -130.06 117.43 19.99 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 107.466 -1.309 . . . . 25.0 107.466 -175.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.0 mt -100.42 135.83 34.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 106.906 -1.516 . . . . 25.0 106.906 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.6 mt -79.49 -55.64 4.9 Favored 'General case' 0 C--O 1.217 -0.608 0 C-N-CA 124.037 0.935 . . . . 25.0 112.938 -173.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 -132.12 51.07 2.18 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-O 122.749 1.262 . . . . 25.0 113.309 -175.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -61.76 143.52 56.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.773 -1.103 . . . . 25.0 108.933 175.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -125.11 107.06 28.09 Favored Pre-proline 0 CA--C 1.505 -0.756 0 N-CA-C 107.392 -1.336 . . . . 25.0 107.392 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.37 -9.68 26.42 Favored 'Trans proline' 0 CA--C 1.555 1.552 0 N-CA-C 117.538 2.092 . . . . 25.0 117.538 -172.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.6 t -76.76 -37.24 56.25 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.603 -0.888 . . . . 25.0 108.603 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -111.37 -33.71 6.33 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 115.522 1.675 . . . . 25.0 115.522 -171.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -90.36 152.0 21.2 Favored 'General case' 0 C--O 1.212 -0.869 0 CA-C-N 117.908 0.322 . . . . 50.0 110.429 -170.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -129.34 141.97 50.94 Favored 'General case' 0 C--O 1.26 1.623 0 CA-C-O 119.141 -0.456 . . . . 25.0 110.126 -174.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 77.0 mt -125.52 133.12 69.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.277 -0.638 . . . . 25.0 109.277 178.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.55 141.59 28.42 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.884 -0.784 . . . . 25.0 108.884 172.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.6 p -139.65 -4.66 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.096 -0.956 . . . . 25.0 112.193 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.3 t -73.17 -31.46 64.25 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.962 -0.755 . . . . 25.0 108.962 -177.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.85 -36.73 80.84 Favored 'General case' 0 C--O 1.254 1.298 0 CA-C-N 115.641 -0.709 . . . . 25.0 112.713 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.79 -29.63 8.98 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 117.354 2.353 . . . . 25.0 117.354 -170.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -124.26 -72.44 0.23 Allowed Glycine 0 CA--C 1.5 -0.87 0 N-CA-C 117.931 1.932 . . . . 25.0 117.931 -168.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -154.61 172.76 17.33 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 109.705 -0.48 . . . . 25.0 109.705 -167.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.9 t -128.0 -20.26 3.85 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 112.065 0.394 . . . . 25.0 112.065 174.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -97.59 126.95 9.05 Favored Glycine 0 N--CA 1.488 2.136 0 O-C-N 121.421 -0.799 . . . . 25.0 112.703 176.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.63 151.14 47.94 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.618 0.599 . . . . 25.0 112.618 178.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -88.46 -173.26 47.1 Favored Glycine 0 C--O 1.223 -0.563 0 N-CA-C 114.771 0.668 . . . . 25.0 114.771 -175.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -76.11 82.36 2.94 Favored 'General case' 0 C--O 1.258 1.505 0 CA-C-N 118.919 1.36 . . . . 25.0 110.874 -178.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -115.62 -172.85 17.18 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 109.214 -1.554 . . . . 25.0 109.214 174.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -143.03 168.35 19.92 Favored 'General case' 0 C--O 1.241 0.632 0 O-C-N 121.815 -0.815 . . . . 25.0 110.301 175.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 58.38 32.11 21.71 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.776 1.23 . . . . 25.0 113.76 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 80.54 23.41 60.44 Favored Glycine 0 C--N 1.316 -0.581 0 CA-C-O 118.863 -0.965 . . . . 25.0 111.55 176.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.2 t -132.79 169.65 16.41 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 119.04 1.42 . . . . 25.0 109.671 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.4 mp -88.6 163.46 15.83 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 103.302 -2.851 . . . . 25.0 103.302 171.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.42 122.55 19.19 Favored 'General case' 0 C--O 1.257 1.468 0 C-N-CA 119.081 -1.047 . . . . 25.0 111.141 -176.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.9 m -90.75 160.73 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 107.032 -1.47 . . . . 25.0 107.032 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 60.0 p -147.81 166.28 28.04 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 123.918 0.761 . . . . 25.0 109.45 -177.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 22.0 m -117.64 166.81 11.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 107.629 -1.248 . . . . 25.0 107.629 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.8 t -74.66 -55.08 6.27 Favored 'General case' 0 C--O 1.216 -0.69 0 N-CA-C 106.828 -1.545 . . . . 25.0 106.828 169.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -159.6 -158.34 0.65 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 105.216 -2.142 . . . . 25.0 105.216 -176.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -61.15 -33.36 73.29 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 120.153 -0.619 . . . . 25.0 109.793 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -119.34 -148.51 8.3 Favored Glycine 0 C--O 1.244 0.77 0 N-CA-C 109.647 -1.381 . . . . 25.0 109.647 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.89 -144.18 0.53 Allowed 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 113.893 1.072 . . . . 25.0 113.893 177.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.9 mtt85 -82.33 167.29 18.71 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.994 0.902 . . . . 25.0 112.704 -171.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.86 161.43 18.25 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 105.524 -2.028 . . . . 25.0 105.524 171.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -137.01 145.9 44.66 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 108.704 -0.85 . . . . 25.0 108.704 -177.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 43.0 tp -125.15 125.95 44.49 Favored 'General case' 0 C--O 1.257 1.499 0 N-CA-C 103.427 -2.805 . . . . 25.0 103.427 177.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -121.77 154.75 36.54 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.262 -0.881 . . . . 25.0 109.379 -173.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 37.6 t -99.47 155.42 17.57 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 106.023 -1.843 . . . . 25.0 106.023 169.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -122.38 13.71 10.29 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.834 0.35 . . . . 25.0 111.116 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -106.63 132.49 52.56 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 106.646 -1.612 . . . . 25.0 106.646 171.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -128.13 153.21 47.1 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-O 122.699 1.238 . . . . 25.0 109.08 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -79.51 165.5 22.94 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.692 -1.14 . . . . 25.0 111.198 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.94 -34.31 67.87 Favored 'General case' 0 C--O 1.21 -0.978 0 CA-C-O 122.218 1.009 . . . . 25.0 109.024 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -72.46 -2.34 19.17 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 115.25 1.574 . . . . 25.0 115.25 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.87 7.82 85.14 Favored Glycine 0 N--CA 1.471 1.012 0 CA-C-O 122.353 0.974 . . . . 25.0 113.15 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 41.3 mt -84.32 139.28 32.4 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.436 -1.038 . . . . 25.0 109.798 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 95.2 p -147.81 -179.55 6.98 Favored 'General case' 0 C--O 1.249 1.066 0 N-CA-C 107.351 -1.352 . . . . 25.0 107.351 -177.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -119.47 136.52 54.28 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.608 -0.837 . . . . 25.0 112.955 -178.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -147.74 148.7 31.26 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.876 -1.157 . . . . 25.0 107.876 167.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.3 p -145.33 148.28 17.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 105.381 -2.081 . . . . 25.0 105.381 175.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -108.44 148.13 30.62 Favored 'General case' 0 C--O 1.264 1.861 0 N-CA-C 108.593 -0.892 . . . . 25.0 108.593 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.8 mp -139.0 124.07 18.95 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 105.067 -2.197 . . . . 25.0 105.067 -177.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -103.99 9.22 36.66 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 120.832 1.651 . . . . 25.0 113.625 -171.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -69.38 -16.34 71.31 Favored Glycine 0 N--CA 1.459 0.176 0 C-N-CA 120.515 -0.85 . . . . 25.0 112.805 175.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 31.2 t0 58.01 58.33 3.63 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 122.039 0.924 . . . . 25.0 111.982 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -124.26 42.02 3.35 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.394 -1.276 . . . . 25.0 109.229 -177.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.51 -34.48 72.66 Favored 'General case' 0 C--O 1.206 -1.234 0 N-CA-C 113.466 0.913 . . . . 25.0 113.466 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.49 -23.75 62.73 Favored 'General case' 0 C--O 1.254 1.293 0 CA-C-N 119.358 0.981 . . . . 25.0 112.067 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -89.84 -25.41 21.05 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 113.75 1.019 . . . . 25.0 113.75 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 11.8 mt -63.33 126.41 27.36 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.196 -0.911 . . . . 25.0 111.108 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 39.8 m -135.06 157.62 46.46 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 107.633 -1.247 . . . . 25.0 107.633 174.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.08 -2.56 24.92 Favored 'General case' 0 C--N 1.349 0.551 0 N-CA-C 112.656 0.613 . . . . 25.0 112.656 -176.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.27 -30.73 71.63 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.462 0.649 . . . . 25.0 110.115 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -90.22 0.67 57.09 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 112.619 0.6 . . . . 25.0 112.619 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 34.7 mm -105.33 122.87 59.17 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 N-CA-C 103.985 -2.598 . . . . 25.0 103.985 175.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 14.8 p -105.64 119.98 55.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 O-C-N 120.885 -1.134 . . . . 25.0 113.611 -176.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -148.84 18.51 1.0 Allowed 'General case' 0 C--O 1.243 0.759 0 CA-C-N 112.757 -2.02 . . . . 25.0 108.465 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -102.47 41.89 1.19 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.729 0.776 . . . . 25.0 111.187 -175.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 55.22 25.79 7.71 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 114.431 1.271 . . . . 25.0 114.431 -173.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.8 m 64.75 -10.63 0.15 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.581 1.696 . . . . 25.0 115.581 176.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -72.35 139.98 48.21 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.761 -1.212 . . . . 25.0 109.389 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -91.4 4.78 51.62 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.748 -0.66 . . . . 25.0 110.465 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.03 16.66 0.12 Allowed 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.639 0.776 . . . . 25.0 112.994 177.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -144.02 -158.32 0.87 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 107.913 -1.143 . . . . 25.0 107.913 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 60.58 178.69 0.1 Allowed 'General case' 0 CA--C 1.555 1.144 0 N-CA-C 114.333 1.234 . . . . 25.0 114.333 176.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.74 24.17 75.02 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 115.876 -0.602 . . . . 25.0 112.898 -176.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -91.26 114.72 27.32 Favored 'General case' 0 C--N 1.316 -0.858 0 O-C-N 122.399 -0.471 . . . . 25.0 112.168 -175.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.48 144.08 48.9 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.309 0.576 . . . . 25.0 109.624 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -145.92 33.55 1.5 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.894 -0.882 . . . . 25.0 110.894 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.3 t -93.85 -29.79 4.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 113.288 0.847 . . . . 25.0 113.288 -172.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.01 132.82 27.86 Favored 'Isoleucine or valine' 0 C--O 1.248 0.98 0 CA-C-N 115.337 -0.847 . . . . 25.0 112.229 -174.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 168.58 159.61 14.61 Favored Glycine 0 N--CA 1.48 1.597 0 N-CA-C 110.227 -1.149 . . . . 25.0 110.227 175.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -147.68 146.71 29.39 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 119.264 1.532 . . . . 25.0 112.161 -176.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 93.1 p -155.22 174.71 14.82 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 106.217 -1.771 . . . . 25.0 106.217 177.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -177.52 167.21 38.11 Favored Glycine 0 C--N 1.309 -0.936 0 C-N-CA 120.104 -1.046 . . . . 25.0 114.854 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 11.9 tp-100 -146.12 81.03 9.93 Favored Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 108.229 -1.026 . . . . 25.0 108.229 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -70.6 151.66 64.41 Favored 'Trans proline' 0 CA--C 1.509 -0.736 0 C-N-CA 121.054 1.17 . . . . 25.0 113.071 -173.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -107.38 147.32 30.51 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.413 -0.812 . . . . 25.0 111.004 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -144.76 75.57 14.45 Favored Pre-proline 0 C--N 1.312 -1.045 0 O-C-N 124.191 0.932 . . . . 25.0 110.414 177.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -72.97 169.62 21.74 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 121.587 1.525 . . . . 25.0 113.255 -175.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.5 t -120.02 2.46 10.97 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 116.417 -0.356 . . . . 25.0 110.358 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 C--O 1.249 1.059 0 CA-C-O 116.707 -1.616 . . . . 25.0 110.817 -178.605 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 110.038 -0.356 . . . . 25.0 110.038 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -139.99 118.94 8.72 Favored Pre-proline 0 C--N 1.317 -0.834 0 O-C-N 123.703 0.627 . . . . 25.0 111.061 -178.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.03 151.96 56.48 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 117.256 -1.363 . . . . 25.0 113.877 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.79 59.69 0.03 OUTLIER Glycine 0 CA--C 1.524 0.612 0 C-N-CA 121.052 -0.594 . . . . 25.0 111.816 -176.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.8 p -63.9 132.82 29.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 121.734 0.778 . . . . 25.0 110.05 -173.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -91.02 -15.4 29.68 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 119.622 -0.831 . . . . 25.0 110.789 -178.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.28 -147.13 3.87 Favored Glycine 0 C--O 1.207 -1.55 0 N-CA-C 115.952 1.141 . . . . 25.0 115.952 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.7 p 77.96 156.9 0.15 Allowed Pre-proline 0 CA--C 1.558 1.274 0 C-N-CA 126.832 2.053 . . . . 25.0 110.408 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.624 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 50.1 Cg_exo -62.55 -3.36 4.25 Favored 'Trans proline' 0 C--N 1.362 1.249 0 N-CA-C 117.761 2.177 . . . . 25.0 117.761 -175.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.6 p -63.65 -17.67 20.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 114.757 1.391 . . . . 25.0 114.757 -173.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.5 p -142.44 140.95 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-O 122.554 1.168 . . . . 25.0 113.373 -178.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.32 16.03 80.9 Favored Glycine 0 C--O 1.226 -0.344 0 N-CA-C 118.248 2.059 . . . . 25.0 118.248 175.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.2 t -46.21 -58.96 3.2 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 114.15 1.167 . . . . 25.0 114.15 -175.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -78.24 3.14 16.14 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 116.076 1.88 . . . . 25.0 116.076 -169.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.28 171.82 13.62 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.456 -0.778 . . . . 25.0 111.82 -172.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -58.9 135.32 57.52 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.149 0.58 . . . . 25.0 112.534 -177.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -128.52 163.35 25.15 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 113.537 0.94 . . . . 50.0 113.537 -174.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -136.53 108.66 7.22 Favored 'General case' 0 C--O 1.255 1.348 0 N-CA-C 101.683 -3.451 . . . . 25.0 101.683 161.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 89.7 mt -126.0 126.13 43.8 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.909 0.861 . . . . 25.0 110.46 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -114.69 134.6 54.95 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 107.507 -1.294 . . . . 25.0 107.507 178.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -106.14 178.39 22.75 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 115.294 0.878 . . . . 25.0 115.294 -173.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.5 p -79.86 175.41 10.65 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-O 121.856 0.836 . . . . 25.0 112.558 178.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 39.0 mt -83.6 10.54 8.91 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 113.25 0.833 . . . . 25.0 113.25 176.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.07 178.35 25.63 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 123.073 0.368 . . . . 25.0 112.208 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.2 t -74.68 128.66 36.11 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.888 0.475 . . . . 25.0 110.92 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -143.96 151.18 39.41 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.006 0.431 . . . . 50.0 110.542 -174.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -94.36 125.59 39.09 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 102.546 -3.131 . . . . 25.0 102.546 168.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.3 mm -119.02 103.86 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.018 0 N-CA-C 107.257 -1.386 . . . . 25.0 107.257 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.624 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 9.8 mp -100.69 131.55 46.53 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 104.06 -2.57 . . . . 25.0 104.06 177.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.86 -29.83 14.63 Favored Glycine 0 C--N 1.313 -0.745 0 CA-C-N 114.907 -1.042 . . . . 25.0 113.086 176.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.04 -148.7 50.63 Favored Glycine 0 N--CA 1.466 0.685 0 C-N-CA 120.293 -0.956 . . . . 25.0 112.278 -178.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.7 170.68 52.57 Favored Glycine 0 C--O 1.247 0.929 0 CA-C-N 118.219 1.01 . . . . 25.0 113.096 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.25 162.51 23.84 Favored Glycine 0 C--O 1.256 1.525 0 O-C-N 124.035 0.491 . . . . 25.0 114.225 176.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.08 108.58 11.47 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 106.678 -1.601 . . . . 25.0 106.678 177.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -107.57 149.33 28.15 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.992 -0.744 . . . . 50.0 108.992 -173.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -116.61 105.14 12.11 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 106.856 -1.535 . . . . 25.0 106.856 171.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 80.8 mt -111.37 129.11 56.11 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.58 -0.736 . . . . 25.0 112.568 -170.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -125.11 102.48 7.51 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-O 121.802 0.81 . . . . 25.0 110.449 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.45 -29.43 61.87 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-O 118.742 -1.032 . . . . 25.0 115.204 -176.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 53.54 -156.11 0.2 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.09 0.956 . . . . 25.0 112.461 -177.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.19 166.77 9.19 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.098 -1.001 . . . . 25.0 112.767 -175.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.29 160.0 34.26 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 108.239 -1.944 . . . . 25.0 108.239 -176.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -85.73 106.36 16.93 Favored 'General case' 0 C--O 1.251 1.151 0 O-C-N 122.125 -0.633 . . . . 25.0 109.387 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -109.43 144.4 37.71 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.84 -0.744 . . . . 50.0 111.677 -168.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 mp -105.65 92.89 4.37 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.274 -0.876 . . . . 25.0 108.873 177.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 mp -97.3 113.98 25.68 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-O 121.894 0.854 . . . . 25.0 111.783 -174.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -117.41 94.76 4.68 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 106.709 -1.589 . . . . 25.0 106.709 178.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -57.2 -20.53 36.03 Favored Glycine 0 N--CA 1.473 1.133 0 CA-C-O 118.478 -1.179 . . . . 25.0 115.198 -175.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.98 -168.86 49.73 Favored Glycine 0 C--O 1.249 1.06 0 CA-C-N 119.163 1.482 . . . . 25.0 110.531 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.74 153.07 11.22 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 114.805 -0.697 . . . . 25.0 112.49 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.82 177.1 45.31 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.588 -0.733 . . . . 25.0 111.876 178.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -97.34 132.24 43.26 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 105.779 -1.934 . . . . 25.0 105.779 176.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -125.62 159.78 31.29 Favored 'General case' 0 CA--C 1.485 -1.542 0 CA-C-O 118.851 -0.595 . . . . 50.0 110.743 -172.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -121.67 121.97 38.55 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 103.399 -2.815 . . . . 25.0 103.399 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -146.73 131.4 17.87 Favored 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 116.402 2.001 . . . . 25.0 116.402 -167.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 27.5 m -100.54 141.45 33.37 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.33 0.586 . . . . 25.0 112.26 176.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.96 -35.09 5.2 Favored Glycine 0 C--O 1.206 -1.597 0 O-C-N 121.499 -0.751 . . . . 25.0 111.887 177.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.92 -167.91 50.66 Favored Glycine 0 C--O 1.245 0.83 0 O-C-N 121.644 -0.915 . . . . 25.0 113.776 -177.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -59.83 161.51 6.33 Favored 'General case' 0 C--O 1.251 1.156 0 O-C-N 121.204 -1.174 . . . . 25.0 110.672 176.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.76 167.3 36.31 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 115.215 -0.902 . . . . 25.0 113.195 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.82 93.9 9.62 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 122.102 0.953 . . . . 25.0 110.931 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.14 153.44 22.06 Favored 'General case' 0 C--O 1.247 0.927 0 CA-C-N 115.302 -0.863 . . . . 50.0 111.651 -170.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.3 m -125.27 116.52 22.08 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 122.314 1.055 . . . . 25.0 109.685 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -104.38 102.55 12.21 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.714 -1.217 . . . . 25.0 107.714 177.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -106.75 -23.14 12.5 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 113.541 0.941 . . . . 25.0 113.541 -177.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 67.79 160.46 0.17 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.508 1.523 . . . . 25.0 112.13 -176.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.72 -45.49 14.36 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 115.345 1.609 . . . . 25.0 115.345 -168.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 65.4 mt -139.23 169.56 17.54 Favored 'General case' 0 C--O 1.207 -1.137 0 CA-C-O 121.43 0.633 . . . . 25.0 111.925 -174.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.78 -23.95 32.84 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.273 0.629 . . . . 25.0 110.76 171.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -80.35 -6.63 58.3 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.307 1.043 . . . . 25.0 113.745 -177.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -90.13 152.77 20.97 Favored 'General case' 0 C--O 1.213 -0.831 0 N-CA-C 113.658 0.984 . . . . 25.0 113.658 176.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.8 t 45.14 48.77 9.86 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.702 1.601 . . . . 25.0 113.807 165.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -135.83 165.8 24.77 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 115.178 -0.919 . . . . 25.0 111.162 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 59.2 ttt180 -112.89 136.42 52.56 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 105.375 -2.083 . . . . 25.0 105.375 176.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 81.2 p -126.28 171.17 8.29 Favored Pre-proline 0 C--N 1.325 -0.467 0 C-N-CA 125.023 1.329 . . . . 25.0 108.167 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.22 -24.6 68.04 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 117.828 -0.981 . . . . 25.0 113.618 177.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 38.1 mt -71.89 -27.31 62.75 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 112.997 0.739 . . . . 25.0 112.997 177.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 145.56 -176.41 24.57 Favored Glycine 0 C--O 1.213 -1.195 0 N-CA-C 111.019 -0.832 . . . . 25.0 111.019 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 15.2 t -86.07 146.32 26.68 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 122.817 1.294 . . . . 25.0 112.6 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -127.28 28.7 5.68 Favored 'General case' 0 C--O 1.246 0.896 0 C-N-CA 125.432 1.493 . . . . 25.0 107.316 169.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -62.22 143.9 48.88 Favored Glycine 0 C--N 1.34 0.802 0 N-CA-C 110.57 -1.012 . . . . 25.0 110.57 178.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -92.05 163.11 14.09 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 120.277 -0.569 . . . . 50.0 110.944 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.75 110.06 15.01 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.178 0.299 . . . . 25.0 110.485 -175.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 30.3 mt -91.7 136.59 24.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.094 -1.076 . . . . 25.0 108.094 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.6 mt -83.64 -42.8 16.28 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 114.457 1.281 . . . . 25.0 114.457 -172.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 47.3 p-10 -137.86 38.82 2.38 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.46 1.282 . . . . 25.0 114.46 -169.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -56.24 139.06 49.16 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.041 0.386 . . . . 25.0 112.041 -177.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -116.16 101.52 53.87 Favored Pre-proline 0 C--O 1.248 0.98 0 N-CA-C 108.012 -1.107 . . . . 25.0 108.012 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.03 -9.16 25.59 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 N-CA-C 114.643 0.978 . . . . 25.0 114.643 -172.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.6 t -80.41 -45.02 18.35 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-O 121.228 0.537 . . . . 25.0 109.724 177.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -95.91 -39.23 9.9 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 115.006 1.484 . . . . 25.0 115.006 -173.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -89.3 173.06 8.6 Favored 'General case' 0 C--O 1.218 -0.585 0 CA-C-N 115.837 -0.619 . . . . 75.0 110.542 -167.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -151.77 152.85 33.23 Favored 'General case' 0 C--O 1.26 1.652 0 CA-C-N 116.214 -0.448 . . . . 25.0 110.509 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 45.6 mt -129.03 132.04 67.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 109.346 -0.613 . . . . 25.0 109.346 -178.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -84.85 150.61 24.88 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 123.039 1.399 . . . . 25.0 108.831 174.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.2 p -150.17 -9.5 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.333 0 O-C-N 121.18 -0.95 . . . . 25.0 112.155 176.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.425 ' HB2' ' HA ' ' A' ' 156' ' ' PHE . 31.5 t -61.15 -47.16 87.48 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.657 0.741 . . . . 25.0 109.731 -175.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.29 -43.15 67.7 Favored 'General case' 0 C--O 1.251 1.158 0 N-CA-C 114.451 1.278 . . . . 25.0 114.451 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.47 -3.87 20.45 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 116.094 1.887 . . . . 25.0 116.094 -169.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -139.77 -72.53 0.04 OUTLIER Glycine 0 CA--C 1.533 1.185 0 N-CA-C 118.312 2.085 . . . . 25.0 118.312 -176.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -158.05 170.61 21.91 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 119.058 1.429 . . . . 25.0 109.543 -175.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.9 t -121.45 -33.54 3.62 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 112.453 0.538 . . . . 25.0 112.453 172.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -91.89 129.1 9.67 Favored Glycine 0 N--CA 1.466 0.694 0 O-C-N 120.754 -1.217 . . . . 25.0 110.309 177.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -69.61 148.25 49.61 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 118.374 1.087 . . . . 25.0 111.645 -177.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -81.67 -167.9 39.83 Favored Glycine 0 C--O 1.223 -0.572 0 CA-C-N 115.894 -0.594 . . . . 25.0 112.375 -176.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -79.53 70.5 6.0 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.305 0.854 . . . . 25.0 113.305 -176.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -105.69 -168.29 23.51 Favored Glycine 0 C--O 1.211 -1.282 0 N-CA-C 107.873 -2.091 . . . . 25.0 107.873 172.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -138.26 164.54 28.97 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 120.023 1.912 . . . . 25.0 109.425 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 54.78 35.63 24.54 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 122.944 0.498 . . . . 25.0 111.563 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.09 39.57 73.04 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 120.64 -1.288 . . . . 25.0 112.312 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 8.4 t -135.6 -178.75 5.26 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 117.778 0.789 . . . . 25.0 109.82 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 85.2 mt -101.07 164.88 11.59 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 102.149 -3.278 . . . . 25.0 102.149 173.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.04 111.95 10.79 Favored 'General case' 0 C--O 1.267 1.996 0 CA-C-O 123.119 1.438 . . . . 25.0 107.32 -178.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.8 m -70.25 153.11 8.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 N-CA-C 108.348 -0.982 . . . . 25.0 108.348 -176.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.39 162.29 33.46 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.852 -1.155 . . . . 25.0 110.526 -175.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.7 m -127.65 161.92 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 108.631 -0.878 . . . . 25.0 108.631 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.6 t -82.03 -50.75 8.74 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 105.67 -1.974 . . . . 25.0 105.67 172.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -166.21 -162.84 0.56 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 100.666 -3.827 . . . . 25.0 100.666 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -67.28 -19.21 65.46 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 109.258 -0.645 . . . . 25.0 109.258 -178.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -119.81 -153.01 9.15 Favored Glycine 0 C--O 1.238 0.393 0 N-CA-C 111.115 -0.794 . . . . 25.0 111.115 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 56.91 -132.23 1.48 Allowed 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 112.806 0.669 . . . . 25.0 112.806 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.4 mtt85 -103.5 157.42 17.05 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.425 0.898 . . . . 25.0 113.425 -173.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.31 158.66 16.47 Favored 'General case' 0 C--O 1.253 1.249 0 N-CA-C 105.952 -1.87 . . . . 25.0 105.952 171.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -130.1 160.05 34.91 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.39 -0.967 . . . . 25.0 108.39 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 30.5 tp -132.87 102.81 5.78 Favored 'General case' 0 C--O 1.216 -0.684 0 N-CA-C 103.132 -2.914 . . . . 25.0 103.132 171.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -103.77 151.93 22.47 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.353 0.597 . . . . 25.0 109.947 -172.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 41.5 t -92.03 154.74 18.57 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 104.225 -2.509 . . . . 25.0 104.225 171.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -126.76 26.33 6.23 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 122.874 1.321 . . . . 25.0 108.415 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -117.14 147.07 42.76 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 103.592 -2.744 . . . . 25.0 103.592 171.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -149.16 151.52 34.49 Favored 'General case' 0 C--O 1.217 -0.654 0 O-C-N 124.158 0.911 . . . . 25.0 110.662 -175.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -77.09 164.58 25.57 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 124.091 0.957 . . . . 25.0 110.033 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.11 -19.72 64.86 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.742 -0.599 . . . . 25.0 112.181 -175.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -75.99 -9.02 58.27 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 122.526 0.331 . . . . 25.0 111.543 176.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 92.2 14.07 56.53 Favored Glycine 0 C--O 1.219 -0.805 0 CA-C-O 121.963 0.757 . . . . 25.0 112.573 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.0 mt -83.92 137.48 33.63 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 121.323 -1.104 . . . . 25.0 109.663 178.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 84.4 p -145.73 174.48 11.17 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.482 -0.562 . . . . 25.0 109.482 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -115.95 141.6 47.89 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 118.273 0.488 . . . . 25.0 111.649 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -150.93 156.42 41.15 Favored 'General case' 0 C--O 1.251 1.145 0 N-CA-C 106.343 -1.725 . . . . 25.0 106.343 169.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 13.4 p -146.96 147.69 17.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 104.933 -2.247 . . . . 25.0 104.933 173.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -107.59 141.95 38.27 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.018 -1.475 . . . . 25.0 107.018 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.2 mp -131.39 125.24 32.12 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 103.363 -2.828 . . . . 25.0 103.363 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -104.87 15.22 28.2 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 120.395 -1.441 . . . . 25.0 111.698 -173.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -83.95 4.41 82.93 Favored Glycine 0 C--O 1.241 0.57 0 CA-C-N 114.994 -1.003 . . . . 25.0 114.732 177.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 28.2 t0 49.34 47.04 22.78 Favored 'General case' 0 C--O 1.252 1.202 0 N-CA-C 114.586 1.328 . . . . 25.0 114.586 175.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -122.88 41.08 3.54 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.24 -0.891 . . . . 25.0 111.272 -175.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.67 -29.62 64.78 Favored 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 113.685 0.994 . . . . 25.0 113.685 173.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.99 -17.77 62.63 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 119.506 1.048 . . . . 25.0 110.371 -177.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -102.1 -8.48 21.37 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 113.341 0.867 . . . . 25.0 113.341 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.9 mt -79.37 133.66 36.58 Favored 'General case' 0 C--O 1.207 -1.161 0 C-N-CA 120.33 -0.548 . . . . 25.0 109.806 -176.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.0 m -141.32 165.81 26.5 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 106.932 -1.507 . . . . 25.0 106.932 172.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -81.79 4.02 23.68 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 121.733 0.778 . . . . 25.0 109.865 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -66.37 -31.31 72.0 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.119 -1.4 . . . . 25.0 110.656 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -94.16 0.35 55.73 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 112.14 0.422 . . . . 25.0 112.14 177.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 26.3 mm -99.33 123.45 52.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 N-CA-C 104.329 -2.471 . . . . 25.0 104.329 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.1 p -100.71 119.36 48.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 122.592 1.187 . . . . 25.0 113.281 -172.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.425 ' HA ' ' HB2' ' A' ' 97' ' ' SER . 9.3 p90 -149.63 -12.25 0.29 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 112.835 -1.984 . . . . 25.0 111.567 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.43 53.01 2.37 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 121.086 -1.009 . . . . 25.0 113.231 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 60.42 25.98 15.55 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 115.857 1.799 . . . . 25.0 115.857 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 m 65.63 -45.13 0.38 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 117.887 2.551 . . . . 25.0 117.887 177.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.19 120.13 13.25 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 121.439 -0.788 . . . . 25.0 110.44 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -79.14 31.09 0.21 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.439 0.903 . . . . 25.0 113.439 -174.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.62 -2.8 15.48 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 112.756 0.65 . . . . 25.0 112.756 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -151.52 -176.42 5.59 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 123.793 0.683 . . . . 25.0 110.596 -176.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 63.72 -166.65 0.22 Allowed 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 114.026 1.121 . . . . 25.0 114.026 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.36 25.89 67.2 Favored Glycine 0 CA--C 1.535 1.322 0 N-CA-C 111.372 -0.691 . . . . 25.0 111.372 -177.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -92.54 134.49 34.93 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.668 -0.864 . . . . 25.0 108.668 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -129.39 141.04 51.15 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 107.704 -1.221 . . . . 25.0 107.704 176.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -126.85 38.38 2.19 Favored Glycine 0 N--CA 1.464 0.501 0 CA-C-O 122.371 0.984 . . . . 25.0 111.26 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 26.3 t -84.25 -28.5 7.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 O-C-N 121.945 -0.738 . . . . 25.0 110.546 -174.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.39 133.18 24.78 Favored 'Isoleucine or valine' 0 C--O 1.26 1.607 0 CA-C-O 122.872 1.32 . . . . 25.0 111.071 -178.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 164.99 156.72 9.21 Favored Glycine 0 C--O 1.239 0.441 0 CA-C-N 115.076 -0.966 . . . . 25.0 112.277 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -151.02 142.81 23.78 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 121.621 -0.929 . . . . 25.0 110.482 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 59.0 p -149.96 163.53 37.85 Favored 'General case' 0 C--O 1.248 1.003 0 N-CA-C 106.484 -1.673 . . . . 25.0 106.484 176.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.53 -174.33 40.44 Favored Glycine 0 C--O 1.246 0.859 0 C-N-CA 120.415 -0.898 . . . . 25.0 114.322 176.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -154.4 86.39 3.65 Favored Pre-proline 0 C--O 1.252 1.198 0 C-N-CA 123.449 0.699 . . . . 25.0 109.533 -178.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -69.28 160.55 49.39 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 117.703 -1.065 . . . . 25.0 112.568 -176.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -131.16 155.27 47.3 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 124.446 1.091 . . . . 25.0 108.066 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -141.43 80.49 16.33 Favored Pre-proline 0 C--O 1.245 0.819 0 CA-C-N 118.387 0.539 . . . . 25.0 112.088 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.74 135.53 28.35 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 118.169 -0.754 . . . . 25.0 112.146 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.9 t -88.81 -4.41 58.5 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 112.822 0.675 . . . . 25.0 112.822 -177.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 3.7 p . . . . . 0 C--O 1.254 1.297 0 CA-C-O 118.213 -0.898 . . . . 25.0 109.671 179.959 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 110.425 -0.213 . . . . 25.0 110.425 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -147.63 129.6 7.51 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-O 121.238 0.542 . . . . 25.0 109.727 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.89 147.24 43.67 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 117.444 -1.238 . . . . 25.0 113.215 -174.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.14 49.32 0.08 OUTLIER Glycine 0 N--CA 1.473 1.157 0 N-CA-C 110.961 -0.855 . . . . 25.0 110.961 178.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.9 p -55.41 132.06 18.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 123.657 0.783 . . . . 25.0 112.048 -176.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -98.06 -2.05 41.11 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.366 -0.834 . . . . 25.0 110.302 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -85.03 -145.11 7.32 Favored Glycine 0 C--O 1.206 -1.624 0 CA-C-N 116.032 -0.531 . . . . 25.0 113.336 177.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.0 p 67.76 153.97 0.13 Allowed Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 126.006 1.723 . . . . 25.0 112.672 -173.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.591 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 47.0 Cg_exo -61.91 -3.91 4.25 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.74 2.293 . . . . 25.0 116.148 -178.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.3 p -63.66 -16.63 18.68 Favored 'Isoleucine or valine' 0 C--O 1.248 0.986 0 N-CA-C 116.85 2.167 . . . . 25.0 116.85 -167.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.8 p -143.82 131.76 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 113.341 0.867 . . . . 25.0 113.341 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.87 19.88 56.9 Favored Glycine 0 N--CA 1.469 0.855 0 N-CA-C 117.592 1.797 . . . . 25.0 117.592 176.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.9 t -47.68 -56.76 6.58 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 117.985 0.893 . . . . 25.0 112.346 -176.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -75.19 -1.99 25.84 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 115.496 1.665 . . . . 25.0 115.496 -170.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -137.57 174.64 10.38 Favored 'General case' 0 C--O 1.207 -1.158 0 CA-C-N 116.234 -0.439 . . . . 25.0 111.784 -171.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.27 144.1 47.28 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-O 122.276 1.036 . . . . 25.0 109.135 -175.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -131.06 150.25 52.23 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 114.632 -1.167 . . . . 50.0 113.018 -176.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -131.22 105.03 7.4 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 100.541 -3.874 . . . . 25.0 100.541 165.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 89.0 mt -127.95 132.72 49.22 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 109.734 -0.469 . . . . 25.0 109.734 -175.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -120.0 115.9 24.67 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.272 -1.381 . . . . 25.0 107.272 -178.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -80.5 176.38 54.67 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 116.554 1.382 . . . . 25.0 116.554 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.5 p -82.33 175.8 9.96 Favored 'General case' 0 C--O 1.251 1.132 0 C-N-CA 124.349 1.06 . . . . 25.0 110.582 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 82.3 mt -80.65 4.46 18.63 Favored 'General case' 0 N--CA 1.463 0.198 0 O-C-N 121.99 -0.443 . . . . 25.0 111.334 174.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -95.85 -176.0 36.66 Favored Glycine 0 C--O 1.226 -0.39 0 CA-C-O 121.374 0.43 . . . . 25.0 112.063 -178.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.6 t -82.12 131.1 35.24 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 109.18 -0.674 . . . . 25.0 109.18 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -145.57 159.89 42.45 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.756 0.788 . . . . 50.0 109.203 -177.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -100.82 131.94 46.46 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 104.773 -2.306 . . . . 25.0 104.773 165.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.4 mm -120.29 103.75 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 N-CA-C 106.736 -1.579 . . . . 25.0 106.736 178.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.591 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 5.3 mp -105.78 128.39 53.68 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 104.427 -2.435 . . . . 25.0 104.427 -178.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.95 -32.19 11.2 Favored Glycine 0 C--N 1.307 -1.049 0 N-CA-C 117.447 1.739 . . . . 25.0 117.447 -177.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.91 -147.14 49.18 Favored Glycine 0 C--O 1.243 0.659 0 CA-C-N 118.934 1.367 . . . . 25.0 111.944 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.95 175.61 50.25 Favored Glycine 0 C--O 1.244 0.768 0 O-C-N 121.734 -0.862 . . . . 25.0 112.837 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.26 160.73 12.51 Favored Glycine 0 C--O 1.256 1.529 0 C-N-CA 120.329 -0.939 . . . . 25.0 111.523 175.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.7 113.02 20.99 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 105.565 -2.013 . . . . 25.0 105.565 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -105.0 154.08 20.59 Favored 'General case' 0 C--O 1.251 1.156 0 N-CA-C 113.211 0.819 . . . . 50.0 113.211 -172.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -121.36 92.61 3.79 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 107.093 -1.447 . . . . 25.0 107.093 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 34.5 mt -108.3 137.3 46.49 Favored 'General case' 0 C--O 1.203 -1.364 0 N-CA-C 114.455 1.28 . . . . 25.0 114.455 -169.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -131.71 117.6 18.84 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.299 0.571 . . . . 25.0 111.719 -179.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -87.92 -24.7 34.27 Favored Glycine 0 C--O 1.245 0.831 0 CA-C-O 117.247 -1.863 . . . . 25.0 116.78 -178.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 53.14 -153.36 0.25 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.978 1.389 . . . . 25.0 112.068 -177.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.71 167.22 15.74 Favored 'General case' 0 C--O 1.249 1.055 0 O-C-N 120.615 -1.303 . . . . 25.0 111.376 -178.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.5 158.52 31.67 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 114.993 -1.003 . . . . 25.0 111.606 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -85.71 94.29 9.07 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 107.385 -1.339 . . . . 25.0 107.385 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -99.38 159.83 14.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.175 -0.921 . . . . 50.0 110.588 -170.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 mp -120.38 106.37 11.79 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 108.529 -0.915 . . . . 25.0 108.529 174.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 mp -111.7 106.15 14.86 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 113.05 0.759 . . . . 25.0 113.05 -172.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -118.99 92.41 3.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.736 -1.12 . . . . 25.0 108.986 -177.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.38 -12.42 32.17 Favored Glycine 0 N--CA 1.467 0.719 0 N-CA-C 118.366 2.106 . . . . 25.0 118.366 -177.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 61.48 -162.45 24.76 Favored Glycine 0 N--CA 1.462 0.399 0 CA-C-N 119.546 1.673 . . . . 25.0 113.853 177.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.69 158.86 1.21 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 114.227 1.195 . . . . 25.0 114.227 -177.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.93 179.46 51.78 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 115.138 -0.937 . . . . 25.0 112.809 -177.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.79 141.62 29.03 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 101.498 -3.519 . . . . 25.0 101.498 176.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -133.53 158.12 43.93 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.57 -0.9 . . . . 50.0 108.57 -175.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -124.01 120.09 31.42 Favored 'General case' 0 C--O 1.212 -0.906 0 N-CA-C 107.766 -1.198 . . . . 25.0 107.766 173.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -141.64 132.48 25.84 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 115.644 1.72 . . . . 25.0 115.644 -169.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 63.9 m -95.22 140.98 29.36 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 123.278 0.631 . . . . 25.0 109.752 175.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.39 -39.18 4.54 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 107.9 -2.08 . . . . 25.0 107.9 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.03 -164.38 52.87 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 117.997 0.898 . . . . 25.0 113.387 -177.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.0 158.73 15.72 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.03 0.532 . . . . 25.0 110.202 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.97 157.85 26.24 Favored Glycine 0 N--CA 1.476 1.324 0 N-CA-C 111.502 -0.639 . . . . 25.0 111.502 175.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.0 110.91 8.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.627 1.203 . . . . 25.0 111.915 -176.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -104.86 155.22 19.12 Favored 'General case' 0 C--O 1.25 1.123 0 CA-C-N 114.625 -1.17 . . . . 50.0 109.505 -173.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 88.0 m -125.33 131.01 53.1 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.418 0.687 . . . . 25.0 110.444 -177.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -124.31 104.05 8.57 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 108.015 -1.105 . . . . 25.0 108.015 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 54.5 mtt85 -115.09 -16.59 11.59 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 121.669 -0.645 . . . . 25.0 111.531 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 62.44 164.22 0.1 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.692 1.597 . . . . 25.0 111.571 -175.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.15 -39.49 48.99 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 114.317 1.228 . . . . 25.0 114.317 -172.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.7 mt -135.37 164.81 26.91 Favored 'General case' 0 C--O 1.207 -1.149 0 C-N-CA 123.114 0.566 . . . . 25.0 112.341 -170.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -17.97 64.2 Favored 'General case' 0 C--O 1.209 -1.067 0 N-CA-C 108.386 -0.968 . . . . 25.0 108.386 170.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -82.53 6.06 18.74 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.811 1.041 . . . . 25.0 113.811 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -111.22 151.81 27.83 Favored 'General case' 0 C--O 1.213 -0.849 0 N-CA-C 115.798 1.777 . . . . 25.0 115.798 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.0 t 54.91 36.32 26.45 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 113.712 -1.586 . . . . 25.0 112.975 175.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 24.0 p-80 -121.05 167.65 12.39 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.869 -1.06 . . . . 25.0 112.507 -173.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 -123.44 140.99 52.44 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 106.748 -1.575 . . . . 25.0 106.748 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.6 p -133.94 173.29 6.01 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 107.949 -1.13 . . . . 25.0 107.949 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -61.39 -25.68 80.36 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 115.831 -2.313 . . . . 25.0 112.999 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 68.6 mt -68.77 -27.09 65.59 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.533 0.682 . . . . 25.0 111.916 -178.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.53 -173.83 32.94 Favored Glycine 0 CA--C 1.498 -0.995 0 N-CA-C 110.414 -1.074 . . . . 25.0 110.414 -177.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.1 t -100.41 148.02 25.19 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.487 1.137 . . . . 25.0 111.345 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -134.09 31.0 3.59 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 114.622 -1.172 . . . . 25.0 108.496 172.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.56 148.94 50.28 Favored Glycine 0 C--O 1.249 1.057 0 CA-C-N 114.085 -1.416 . . . . 25.0 109.578 176.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -91.8 167.18 12.34 Favored 'General case' 0 C--N 1.314 -0.961 0 O-C-N 121.888 -0.772 . . . . 50.0 110.133 -176.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -120.75 111.34 17.47 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.575 0.75 . . . . 25.0 109.989 -177.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.8 mt -97.32 129.36 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-O 121.676 0.75 . . . . 25.0 109.021 -177.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 81.4 mt -83.78 -41.71 17.29 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 115.717 1.747 . . . . 25.0 115.717 -170.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.4 p-10 -140.45 45.63 1.83 Allowed 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.755 1.391 . . . . 25.0 114.755 -176.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -55.83 129.92 41.42 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 122.241 1.02 . . . . 25.0 112.943 -178.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -91.97 105.11 12.39 Favored Pre-proline 0 C--O 1.246 0.872 0 CA-C-N 114.231 -1.35 . . . . 25.0 108.081 174.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.38 3.93 3.79 Favored 'Trans proline' 0 C--O 1.205 -1.143 0 N-CA-C 115.779 1.415 . . . . 25.0 115.779 -173.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.2 t -110.83 -43.8 3.74 Favored 'General case' 0 C--O 1.253 1.281 0 O-C-N 121.809 -0.557 . . . . 25.0 111.259 176.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -87.26 -38.66 16.11 Favored 'General case' 0 C--O 1.241 0.624 0 O-C-N 123.51 0.506 . . . . 25.0 110.58 -172.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -88.43 158.44 18.36 Favored 'General case' 0 CA--C 1.552 1.048 0 N-CA-C 112.271 0.471 . . . . 50.0 112.271 -170.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -137.81 147.89 45.0 Favored 'General case' 0 C--O 1.252 1.201 0 N-CA-C 113.859 1.059 . . . . 25.0 113.859 -175.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 68.2 mt -131.81 130.39 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 108.773 -0.825 . . . . 25.0 108.773 -175.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -90.05 147.44 23.65 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.047 -1.033 . . . . 25.0 108.927 171.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.0 p -141.35 -5.02 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 115.484 -0.78 . . . . 25.0 109.417 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.0 t -65.65 -41.96 91.94 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 121.294 0.569 . . . . 25.0 111.313 -170.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.91 -34.3 57.72 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 119.937 -0.705 . . . . 25.0 112.855 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.97 -3.25 18.98 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 116.502 2.038 . . . . 25.0 116.502 -169.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -142.58 -74.08 0.03 OUTLIER Glycine 0 C--O 1.214 -1.124 0 CA-C-O 119.256 -0.747 . . . . 25.0 114.561 -178.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -160.23 165.16 32.0 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 117.814 0.807 . . . . 25.0 112.007 -173.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.9 t -121.27 -10.9 8.88 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 121.0 0.429 . . . . 25.0 112.1 176.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.43 133.41 11.07 Favored Glycine 0 N--CA 1.467 0.722 0 N-CA-C 108.613 -1.795 . . . . 25.0 108.613 170.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.15 150.11 42.45 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-N 117.314 0.557 . . . . 25.0 112.172 -175.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -86.06 -177.7 49.96 Favored Glycine 0 C--O 1.223 -0.545 0 O-C-N 122.125 -0.36 . . . . 25.0 113.1 -174.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -63.81 101.15 0.34 Allowed 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.624 0.602 . . . . 25.0 112.624 -175.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -150.85 -165.62 12.94 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.006 -1.237 . . . . 25.0 110.006 175.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -148.43 165.88 29.8 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 119.645 1.722 . . . . 25.0 113.164 -177.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 58.94 33.97 23.35 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.464 1.283 . . . . 25.0 114.464 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 77.36 30.54 53.89 Favored Glycine 0 N--CA 1.465 0.617 0 C-N-CA 119.857 -1.163 . . . . 25.0 110.27 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.6 t -143.61 168.63 19.42 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 121.32 -1.106 . . . . 25.0 108.965 -178.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.8 mt -93.02 172.24 8.44 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 106.144 -1.799 . . . . 25.0 106.144 175.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.58 118.95 19.75 Favored 'General case' 0 C--O 1.254 1.323 0 CA-C-N 119.446 1.021 . . . . 25.0 110.099 177.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.8 m -87.85 159.15 3.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 109.45 -0.574 . . . . 25.0 109.45 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 99.4 p -147.0 163.69 35.42 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 108.77 -0.826 . . . . 25.0 108.77 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.5 m -126.02 165.89 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 N-CA-C 107.532 -1.284 . . . . 25.0 107.532 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.1 t -74.49 -49.32 22.65 Favored 'General case' 0 C--O 1.255 1.346 0 N-CA-C 104.251 -2.5 . . . . 25.0 104.251 173.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -168.8 -170.89 1.25 Allowed 'General case' 0 C--O 1.207 -1.133 1 N-CA-C 99.201 -4.37 . . . . 25.0 99.201 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -60.23 -20.46 58.95 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 119.175 0.898 . . . . 25.0 111.912 -178.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.22 -151.45 9.68 Favored Glycine 0 C--O 1.216 -1.02 0 N-CA-C 110.602 -0.999 . . . . 25.0 110.602 176.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 54.66 -133.75 1.66 Allowed 'General case' 0 N--CA 1.465 0.325 0 O-C-N 124.066 0.51 . . . . 25.0 112.094 -179.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 22.8 mtt85 -105.37 155.53 19.03 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 112.473 0.546 . . . . 25.0 112.473 -174.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.3 p -103.3 163.01 12.52 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.173 -2.528 . . . . 25.0 104.173 175.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -141.33 149.86 41.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 118.63 0.65 . . . . 25.0 111.328 -176.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 55.8 tp -124.57 128.21 48.56 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 105.298 -2.112 . . . . 25.0 105.298 177.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -126.15 155.75 41.21 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 122.597 1.189 . . . . 25.0 112.218 -172.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 32.3 t -90.96 158.28 16.81 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 103.481 -2.785 . . . . 25.0 103.481 168.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -129.69 17.08 5.82 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 106.773 -1.566 . . . . 25.0 106.773 176.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -115.44 144.78 43.31 Favored 'General case' 0 C--O 1.25 1.125 0 CA-C-N 112.525 -2.125 . . . . 25.0 106.667 173.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -144.52 168.18 20.74 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.334 0.587 . . . . 25.0 110.18 -178.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -97.13 161.35 13.86 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.946 -1.131 . . . . 25.0 107.946 176.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.22 -26.72 68.64 Favored 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 109.647 -0.501 . . . . 25.0 109.647 -176.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -67.26 -7.16 22.06 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 112.929 0.715 . . . . 25.0 112.929 174.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.89 22.18 53.63 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 121.84 0.689 . . . . 25.0 113.404 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 78.1 mt -90.99 133.48 35.25 Favored 'General case' 0 CA--C 1.506 -0.728 0 O-C-N 121.899 -0.766 . . . . 25.0 109.951 177.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 66.3 p -141.43 -179.46 6.15 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.414 -1.328 . . . . 25.0 107.414 178.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -124.77 136.26 53.7 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 119.614 -0.232 . . . . 25.0 111.221 -178.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -149.15 152.53 36.24 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 106.622 -1.622 . . . . 25.0 106.622 166.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.5 p -144.63 144.65 21.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 105.004 -2.221 . . . . 25.0 105.004 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -105.54 142.98 34.35 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.963 -1.495 . . . . 25.0 106.963 -176.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.8 mp -130.77 132.66 45.42 Favored 'General case' 0 C--O 1.195 -1.81 0 N-CA-C 105.404 -2.073 . . . . 25.0 105.404 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -105.35 6.19 32.46 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 119.646 -1.909 . . . . 25.0 114.195 -174.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -87.34 8.66 76.12 Favored Glycine 0 CA--C 1.542 1.765 0 C-N-CA 120.753 -0.737 . . . . 25.0 113.415 -179.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 35.7 t0 43.98 57.36 4.2 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 114.7 1.371 . . . . 25.0 114.7 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -123.82 36.16 4.69 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-N 114.95 -1.023 . . . . 25.0 109.284 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.97 -33.32 68.74 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.348 -0.387 . . . . 25.0 112.027 174.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.36 -22.91 62.73 Favored 'General case' 0 C--O 1.255 1.374 0 O-C-N 121.297 -0.877 . . . . 25.0 112.442 178.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.5 -15.92 20.35 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 112.333 0.494 . . . . 25.0 112.333 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 12.9 mt -64.59 139.02 58.72 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 123.009 1.385 . . . . 25.0 112.265 176.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 57.8 m -143.52 154.7 43.89 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 106.66 -1.607 . . . . 25.0 106.66 177.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.05 -2.93 29.61 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.657 0.614 . . . . 25.0 112.657 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -67.0 -31.55 72.19 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 108.366 -0.975 . . . . 25.0 108.366 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -85.6 -5.03 59.32 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 120.377 -0.529 . . . . 25.0 112.309 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 48.3 mm -97.27 122.79 49.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 104.481 -2.414 . . . . 25.0 104.481 176.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.1 p -103.2 112.93 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-O 123.12 1.438 . . . . 25.0 113.568 -174.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -142.0 -7.21 0.94 Allowed 'General case' 0 C--O 1.251 1.158 0 CA-C-N 112.656 -2.066 . . . . 25.0 111.782 176.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -85.86 50.61 2.01 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.56 0.948 . . . . 25.0 113.56 -176.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 60.09 20.06 9.28 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.456 2.021 . . . . 25.0 116.456 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.0 -21.28 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 119.886 3.291 . . . . 25.0 119.886 174.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -70.0 139.8 52.82 Favored 'General case' 0 N--CA 1.444 -0.746 0 O-C-N 121.606 -0.684 . . . . 25.0 110.196 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.434 ' C ' ' H ' ' A' ' 163' ' ' ALA . . . -75.25 -1.83 25.27 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.462 0.912 . . . . 25.0 113.462 178.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.29 34.97 0.21 Allowed 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.883 0.849 . . . . 25.0 111.164 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.434 ' H ' ' C ' ' A' ' 161' ' ' ALA . . . -145.66 -171.59 3.72 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.267 -0.879 . . . . 25.0 108.921 -175.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 59.65 -168.98 0.15 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.632 1.573 . . . . 25.0 113.083 175.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 80.18 6.2 89.31 Favored Glycine 0 C--O 1.25 1.145 0 CA-C-O 121.682 0.601 . . . . 25.0 114.418 -173.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -81.86 69.73 8.61 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.868 0.867 . . . . 25.0 111.364 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -125.01 141.15 52.31 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 122.853 0.461 . . . . 25.0 111.297 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -142.67 44.76 0.95 Allowed Glycine 0 CA--C 1.527 0.784 0 O-C-N 124.222 0.951 . . . . 25.0 112.097 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 45.6 t -70.87 -37.26 67.67 Favored 'Isoleucine or valine' 0 C--O 1.251 1.143 0 O-C-N 121.758 -0.848 . . . . 25.0 111.684 -178.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.11 136.47 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-O 122.245 1.022 . . . . 25.0 111.645 -177.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 166.84 170.38 31.66 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 109.22 -1.552 . . . . 25.0 109.22 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -146.55 148.8 32.54 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.855 0.836 . . . . 25.0 110.721 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 95.2 p -158.42 169.93 23.35 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-N 114.782 -1.099 . . . . 25.0 110.169 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 150.58 167.12 14.19 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 116.289 1.276 . . . . 25.0 116.289 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -136.66 95.0 12.82 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 124.948 1.299 . . . . 25.0 107.618 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.86 158.29 57.97 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 119.809 0.339 . . . . 25.0 112.094 -178.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -114.03 154.75 27.15 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 107.951 -1.129 . . . . 25.0 107.951 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -127.2 67.88 71.55 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 115.574 -0.739 . . . . 25.0 110.818 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -72.15 158.19 52.55 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 CA-C-O 122.945 1.144 . . . . 25.0 112.25 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.2 t -132.48 27.52 4.39 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 105.828 -1.915 . . . . 25.0 105.828 172.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 C--O 1.25 1.115 0 CA-C-N 113.876 -1.511 . . . . 25.0 111.821 179.056 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.34 0 N-CA-C 110.506 -0.183 . . . . 25.0 110.506 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -103.39 112.37 65.64 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 119.404 -0.331 . . . . 25.0 111.451 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -69.66 140.08 42.17 Favored 'Trans proline' 0 C--N 1.324 -0.724 0 N-CA-C 113.531 0.55 . . . . 25.0 113.531 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.64 46.1 0.04 OUTLIER Glycine 0 N--CA 1.472 1.087 0 CA-C-O 117.539 -1.701 . . . . 25.0 110.474 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -51.67 120.89 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 O-C-N 125.592 1.407 . . . . 25.0 113.0 -176.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -92.29 -8.59 44.75 Favored 'General case' 0 C--O 1.259 1.557 0 CA-C-N 113.516 -1.675 . . . . 25.0 110.899 -173.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.01 -137.17 3.34 Favored Glycine 0 C--N 1.298 -1.567 0 O-C-N 124.01 0.819 . . . . 25.0 113.403 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.7 p 65.69 156.34 0.13 Allowed Pre-proline 0 N--CA 1.498 1.966 0 C-N-CA 126.225 1.81 . . . . 25.0 111.665 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.591 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 47.3 Cg_exo -64.23 -3.31 5.98 Favored 'Trans proline' 0 C--N 1.364 1.344 0 N-CA-C 118.17 2.335 . . . . 25.0 118.17 -177.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 p -68.74 -9.92 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 116.822 2.156 . . . . 25.0 116.822 -173.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.7 p -138.87 133.02 40.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 113.547 0.943 . . . . 25.0 113.547 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.11 15.8 74.66 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 118.093 1.997 . . . . 25.0 118.093 172.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 89.4 p -54.75 -35.21 63.51 Favored 'General case' 0 CA--C 1.565 1.549 0 O-C-N 120.776 -1.426 . . . . 25.0 113.815 -170.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -78.22 3.81 14.33 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 117.576 2.435 . . . . 25.0 117.576 -175.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.4 pp -149.98 177.64 9.67 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 123.181 0.592 . . . . 25.0 110.478 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -59.32 128.7 38.39 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 112.548 0.573 . . . . 25.0 112.548 -174.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -125.9 160.61 29.48 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 114.298 1.222 . . . . 50.0 114.298 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -124.24 97.39 5.3 Favored 'General case' 0 C--O 1.279 2.639 0 N-CA-C 106.237 -1.764 . . . . 25.0 106.237 159.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.4 mt -104.44 128.68 52.39 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.932 0.872 . . . . 25.0 112.691 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -115.67 120.47 39.48 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 109.114 -0.699 . . . . 25.0 109.114 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.83 173.88 40.35 Favored Glycine 0 N--CA 1.472 1.083 0 N-CA-C 120.238 2.855 . . . . 25.0 120.238 -178.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.5 p -71.72 174.42 6.84 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.521 1.153 . . . . 25.0 113.06 175.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.5 mt -93.5 16.85 12.61 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.483 -0.78 . . . . 25.0 109.904 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -119.24 -177.62 16.48 Favored Glycine 0 C--O 1.24 0.494 0 N-CA-C 109.479 -1.448 . . . . 25.0 109.479 174.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.7 t -68.45 133.92 49.36 Favored 'General case' 0 C--O 1.253 1.278 0 C-N-CA 123.347 0.659 . . . . 25.0 111.483 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -144.98 160.5 41.25 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.974 -1.121 . . . . 50.0 107.974 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -104.27 124.55 49.35 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 104.916 -2.253 . . . . 25.0 104.916 163.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.0 mm -114.84 128.65 71.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 N-CA-C 106.378 -1.712 . . . . 25.0 106.378 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.591 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 4.4 mp -126.9 124.46 39.6 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 102.942 -2.985 . . . . 25.0 102.942 178.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.32 -30.87 56.24 Favored Glycine 0 N--CA 1.483 1.777 0 N-CA-C 114.625 0.61 . . . . 25.0 114.625 176.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.5 -149.56 48.59 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 118.781 1.29 . . . . 25.0 111.352 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -79.14 170.43 54.57 Favored Glycine 0 C--N 1.298 -1.561 0 N-CA-C 109.362 -1.495 . . . . 25.0 109.362 -177.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.82 167.98 41.92 Favored Glycine 0 C--N 1.307 -1.032 0 N-CA-C 110.861 -0.896 . . . . 25.0 110.861 177.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.91 102.97 15.58 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.53 1.132 . . . . 25.0 108.319 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -102.78 147.25 27.09 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 122.589 1.185 . . . . 50.0 111.381 -167.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -118.16 92.29 3.79 Favored 'General case' 0 C--O 1.285 2.934 0 N-CA-C 107.477 -1.305 . . . . 25.0 107.477 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 23.3 mt -102.69 140.37 37.05 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.558 0.947 . . . . 25.0 113.558 -169.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -134.31 106.18 6.98 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.633 -0.877 . . . . 25.0 108.633 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.38 -17.75 63.79 Favored Glycine 0 N--CA 1.476 1.354 0 N-CA-C 115.86 1.104 . . . . 25.0 115.86 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 47.93 -149.64 0.16 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 119.335 1.568 . . . . 25.0 113.939 -177.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.98 163.1 25.36 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-N 115.633 -0.712 . . . . 25.0 112.918 -173.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.5 160.62 35.97 Favored Glycine 0 C--O 1.252 1.258 0 O-C-N 124.979 1.424 . . . . 25.0 113.672 -175.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -81.59 102.53 10.7 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.901 -1.148 . . . . 25.0 107.901 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -109.69 152.95 24.96 Favored 'General case' 0 CA--C 1.505 -0.754 0 C-N-CA 119.48 -0.888 . . . . 50.0 110.92 -169.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.44 120.79 43.15 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 105.15 -2.167 . . . . 25.0 105.15 177.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.8 mp -124.14 121.3 34.75 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.275 1.213 . . . . 25.0 114.275 -176.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -116.08 148.02 40.68 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 113.801 -1.545 . . . . 25.0 106.888 174.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.15 -34.32 4.87 Favored Glycine 0 N--CA 1.476 1.333 0 N-CA-C 116.173 1.229 . . . . 25.0 116.173 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.72 -171.38 53.5 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-O 123.593 1.663 . . . . 25.0 110.335 -177.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.28 149.64 16.01 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 114.253 -0.973 . . . . 25.0 112.422 -176.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.56 168.32 44.47 Favored Glycine 0 CA--C 1.496 -1.155 0 CA-C-O 118.31 -1.272 . . . . 25.0 111.723 -176.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.49 134.32 33.62 Favored 'General case' 0 C--O 1.209 -1.07 0 N-CA-C 101.637 -3.468 . . . . 25.0 101.637 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -123.1 157.71 32.25 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 109.655 -0.498 . . . . 50.0 109.655 -174.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -120.73 127.59 52.15 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 101.994 -3.336 . . . . 25.0 101.994 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -149.48 135.04 18.51 Favored 'General case' 0 C--O 1.2 -1.507 0 N-CA-C 116.493 2.034 . . . . 25.0 116.493 -174.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.2 m -99.55 145.6 27.33 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.995 -1.002 . . . . 25.0 110.228 171.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.92 -34.54 5.4 Favored Glycine 0 C--O 1.215 -1.076 0 N-CA-C 108.779 -1.728 . . . . 25.0 108.779 173.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.69 -165.1 53.56 Favored Glycine 0 C--O 1.217 -0.946 0 CA-C-O 122.009 0.783 . . . . 25.0 111.659 -177.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -71.16 156.06 40.02 Favored 'General case' 0 C--O 1.258 1.53 0 CA-C-O 121.938 0.875 . . . . 25.0 109.344 178.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.54 161.45 33.61 Favored Glycine 0 C--O 1.258 1.605 0 CA-C-O 117.982 -1.454 . . . . 25.0 110.121 -175.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.75 112.29 17.99 Favored 'General case' 0 C--O 1.2 -1.532 0 O-C-N 124.697 0.881 . . . . 25.0 109.428 177.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -104.15 153.4 20.98 Favored 'General case' 0 CA--C 1.487 -1.462 0 CA-C-N 116.58 -0.282 . . . . 50.0 110.901 -174.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 79.5 m -116.36 122.54 45.17 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 107.843 -1.169 . . . . 25.0 107.843 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -108.13 89.26 2.94 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 104.137 -2.542 . . . . 25.0 104.137 177.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -92.12 -25.84 18.55 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 114.822 -1.081 . . . . 25.0 111.626 -174.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 66.86 150.03 0.06 Allowed 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.477 1.511 . . . . 25.0 112.198 -175.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.65 -43.36 31.61 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 117.061 2.245 . . . . 25.0 117.061 -165.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.4 mt -142.9 173.57 11.43 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.572 -0.899 . . . . 25.0 108.572 -165.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.55 -30.23 69.64 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-N 115.179 -0.919 . . . . 25.0 110.125 167.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -78.17 -6.59 55.27 Favored 'General case' 0 C--O 1.263 1.796 0 N-CA-C 114.539 1.311 . . . . 25.0 114.539 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -90.59 151.17 21.43 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 121.209 -0.932 . . . . 25.0 109.499 -172.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.8 t 29.1 47.05 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 117.569 2.433 . . . . 25.0 117.569 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 -119.15 178.63 4.44 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.56 -0.746 . . . . 25.0 109.532 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -126.84 140.17 52.55 Favored 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 107.963 -1.125 . . . . 25.0 107.963 176.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 84.1 p -129.81 166.1 28.52 Favored Pre-proline 0 C--O 1.189 -2.108 0 N-CA-C 108.216 -1.031 . . . . 25.0 108.216 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -64.68 -24.58 62.25 Favored 'Trans proline' 0 C--O 1.243 0.735 0 C-N-CA 115.667 -2.422 . . . . 25.0 112.677 178.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 31.7 mt -65.64 -38.99 90.94 Favored 'General case' 0 C--O 1.201 -1.498 0 CA-C-O 121.826 0.822 . . . . 25.0 112.459 178.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 171.46 167.29 31.48 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 115.001 -1.0 . . . . 25.0 111.383 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.8 t -86.42 149.64 24.86 Favored 'General case' 0 C--N 1.353 0.751 0 CA-C-O 124.425 2.059 . . . . 25.0 110.855 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -132.83 28.09 4.24 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 112.337 -2.21 . . . . 25.0 111.355 175.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.74 140.41 36.59 Favored Glycine 0 N--CA 1.474 1.231 0 CA-C-O 122.31 0.95 . . . . 25.0 111.917 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -91.18 169.39 10.88 Favored 'General case' 0 C--O 1.249 1.067 0 O-C-N 119.884 -1.95 . . . . 50.0 111.998 -176.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -122.18 97.4 5.46 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.662 0.785 . . . . 25.0 110.936 -170.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 22.1 mt -84.41 132.7 30.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 N-CA-C 106.92 -1.511 . . . . 25.0 106.92 -178.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.42 ' HA ' ' HG2' ' A' ' 142' ' ' GLU . 90.4 mt -87.47 -43.81 11.78 Favored 'General case' 0 C--O 1.253 1.289 0 N-CA-C 115.774 1.768 . . . . 25.0 115.774 -172.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 54.0 p-10 -137.78 44.55 2.2 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.539 0.57 . . . . 25.0 112.539 -174.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.433 ' CE2' ' HA ' ' A' ' 89' ' ' PRO . 87.8 t80 -57.28 138.55 54.64 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.823 1.249 . . . . 25.0 111.971 178.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -106.16 105.5 54.02 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 106.807 -1.553 . . . . 25.0 106.807 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.433 ' HA ' ' CE2' ' A' ' 87' ' ' PHE . 96.3 Cg_endo -68.05 -5.4 14.59 Favored 'Trans proline' 0 C--O 1.199 -1.427 0 N-CA-C 117.703 2.155 . . . . 25.0 117.703 -177.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 37.7 t -99.87 -38.78 8.5 Favored 'General case' 0 CA--C 1.557 1.213 0 CA-C-O 120.815 0.341 . . . . 25.0 110.921 177.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -93.45 -42.3 9.33 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-N 116.668 -0.242 . . . . 25.0 111.578 -174.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -87.56 167.66 13.74 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 115.134 -0.939 . . . . 50.0 109.516 -170.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -139.99 151.11 45.23 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 122.977 0.511 . . . . 25.0 110.733 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 86.0 mt -124.93 133.71 68.78 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.596 0 N-CA-C 107.945 -1.131 . . . . 25.0 107.945 177.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -100.15 154.53 18.37 Favored 'General case' 0 C--O 1.212 -0.914 0 N-CA-C 107.896 -1.15 . . . . 25.0 107.896 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.8 p -154.33 2.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 121.467 -0.771 . . . . 25.0 111.448 -176.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 11.0 t -62.74 -45.97 90.26 Favored 'General case' 0 C--O 1.258 1.546 0 N-CA-C 115.464 1.653 . . . . 25.0 115.464 -173.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.63 -42.01 22.88 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.9 -0.591 . . . . 25.0 111.07 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.37 -8.32 48.33 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 117.136 2.273 . . . . 25.0 117.136 -172.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -140.44 -72.07 0.04 OUTLIER Glycine 0 C--N 1.337 0.613 0 N-CA-C 116.72 1.448 . . . . 25.0 116.72 -176.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -160.63 168.61 24.57 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 108.283 -1.006 . . . . 25.0 108.283 -176.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.0 t -127.73 -30.99 2.48 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.8 0.81 . . . . 25.0 111.925 175.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -94.06 121.36 6.65 Favored Glycine 0 CA--C 1.483 -1.968 0 N-CA-C 107.467 -2.253 . . . . 25.0 107.467 175.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.82 146.07 47.61 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.038 -0.581 . . . . 25.0 111.813 -178.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -102.68 -160.3 25.81 Favored Glycine 0 C--O 1.244 0.727 0 CA-C-O 122.415 1.008 . . . . 25.0 114.539 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -56.48 139.36 49.51 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 122.262 1.03 . . . . 25.0 113.673 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 164.28 -175.67 40.32 Favored Glycine 0 C--O 1.25 1.141 0 N-CA-C 110.15 -1.18 . . . . 25.0 110.15 -177.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -146.61 165.26 30.07 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.834 1.317 . . . . 25.0 110.995 -177.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 56.4 37.38 28.78 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 113.243 0.831 . . . . 25.0 113.243 177.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 79.02 32.6 39.23 Favored Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.204 -1.474 . . . . 25.0 110.945 176.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.7 t -148.59 179.72 7.6 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 120.02 1.91 . . . . 25.0 110.682 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 65.4 mt -90.52 168.58 11.72 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 104.519 -2.401 . . . . 25.0 104.519 168.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.77 121.94 20.72 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 108.07 -1.085 . . . . 25.0 108.07 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 28.9 m -93.86 162.37 2.42 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 O-C-N 125.081 1.488 . . . . 25.0 108.945 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.4 p -148.93 163.84 36.28 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.414 0.894 . . . . 25.0 113.414 -177.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.8 m -120.91 167.69 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 106.729 -1.582 . . . . 25.0 106.729 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 37.4 t -75.51 -55.07 6.03 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 106.615 -1.624 . . . . 25.0 106.615 173.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -165.6 -150.95 0.13 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 103.854 -2.647 . . . . 25.0 103.854 -176.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -69.39 -15.08 63.23 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 122.44 1.114 . . . . 25.0 111.114 -176.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -140.09 -155.24 6.51 Favored Glycine 0 C--O 1.258 1.606 0 CA-C-O 117.391 -1.783 . . . . 25.0 110.895 178.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 68.01 -150.25 0.16 Allowed 'General case' 0 C--O 1.247 0.973 0 C-N-CA 125.113 1.365 . . . . 25.0 111.061 177.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 46.6 mtt85 -93.16 168.8 10.87 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-O 122.062 0.934 . . . . 25.0 111.419 -174.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 8.4 p -109.97 165.38 11.77 Favored 'General case' 0 C--O 1.251 1.146 0 N-CA-C 104.023 -2.584 . . . . 25.0 104.023 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -133.01 156.71 46.86 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-O 123.817 1.77 . . . . 25.0 110.056 175.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 59.9 tp -128.41 127.93 43.51 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 104.212 -2.514 . . . . 25.0 104.212 170.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -125.37 152.79 44.32 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.067 -0.716 . . . . 25.0 109.067 -172.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 41.1 t -96.07 149.88 21.11 Favored 'General case' 0 C--O 1.248 0.987 0 N-CA-C 106.039 -1.837 . . . . 25.0 106.039 171.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -115.31 19.74 15.34 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 122.551 1.167 . . . . 25.0 107.957 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -115.12 149.78 37.04 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 106.635 -1.617 . . . . 25.0 106.635 176.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -149.55 153.01 36.48 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 124.062 0.851 . . . . 25.0 111.516 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -83.18 162.35 21.27 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.509 -1.293 . . . . 25.0 107.509 177.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.99 -20.49 66.52 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 118.418 0.554 . . . . 25.0 111.381 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -82.39 -1.25 49.4 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 112.736 0.643 . . . . 25.0 112.736 176.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.26 14.4 68.95 Favored Glycine 0 CA--C 1.497 -1.035 0 O-C-N 124.112 0.882 . . . . 25.0 111.728 177.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 80.9 mt -83.87 139.16 32.81 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.634 -1.617 . . . . 25.0 106.634 177.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 61.4 p -149.85 -177.1 5.71 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 116.331 -1.795 . . . . 25.0 106.349 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -133.04 133.97 43.76 Favored 'General case' 0 C--O 1.274 2.39 0 N-CA-C 115.055 1.502 . . . . 25.0 115.055 -176.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -144.09 156.4 44.34 Favored 'General case' 0 C--O 1.269 2.114 0 N-CA-C 109.316 -0.624 . . . . 25.0 109.316 169.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.9 p -144.76 144.6 21.85 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 N-CA-C 107.252 -1.388 . . . . 25.0 107.252 -178.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -112.04 138.56 48.52 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 118.992 0.814 . . . . 25.0 110.445 -177.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.6 mp -130.4 135.37 47.95 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.741 -0.837 . . . . 25.0 108.741 -175.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.42 ' HG2' ' HA ' ' A' ' 85' ' ' LEU . 17.4 pt-20 -102.3 7.83 40.53 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 117.918 -1.513 . . . . 25.0 111.622 -176.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -73.44 -6.4 70.3 Favored Glycine 0 C--O 1.216 -1.021 0 O-C-N 124.3 1.0 . . . . 25.0 113.121 178.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 49.1 t0 49.98 47.22 23.6 Favored 'General case' 0 C--O 1.262 1.743 0 CA-C-O 122.051 0.929 . . . . 25.0 111.689 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -125.17 35.49 4.76 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 107.279 -1.378 . . . . 25.0 107.279 -178.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.4 -32.21 69.96 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 121.007 0.432 . . . . 25.0 110.093 172.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.27 -11.45 60.72 Favored 'General case' 0 C--O 1.26 1.647 0 C-N-CA 119.834 -0.746 . . . . 25.0 111.675 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -110.21 -1.08 17.55 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 113.852 1.056 . . . . 25.0 113.852 174.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 20.6 mt -79.25 120.94 24.44 Favored 'General case' 0 C--O 1.248 0.997 0 O-C-N 123.831 0.707 . . . . 25.0 111.636 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 71.8 m -135.56 160.45 38.46 Favored 'General case' 0 N--CA 1.4 -2.972 0 CA-C-N 114.405 -1.27 . . . . 25.0 108.292 176.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -68.1 -7.53 30.39 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 122.47 1.129 . . . . 25.0 110.474 -177.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -61.14 -27.22 68.24 Favored 'General case' 0 C--O 1.208 -1.106 0 CA-C-N 114.426 -1.261 . . . . 25.0 109.131 177.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -103.1 -1.89 28.36 Favored 'General case' 0 C--O 1.26 1.613 0 N-CA-C 114.509 1.3 . . . . 25.0 114.509 176.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 23.1 mm -101.08 114.88 41.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 104.931 -2.248 . . . . 25.0 104.931 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 13.7 p -97.78 110.72 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 119.735 -1.853 . . . . 25.0 113.86 -168.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -151.07 -4.04 0.31 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 113.083 -1.871 . . . . 25.0 113.824 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -84.96 58.65 5.14 Favored 'General case' 0 C--N 1.346 0.443 0 N-CA-C 113.574 0.953 . . . . 25.0 113.574 -175.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 52.35 26.62 4.21 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 116.854 2.168 . . . . 25.0 116.854 178.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.11 -6.23 0.11 Allowed 'General case' 0 CA--C 1.564 1.502 0 N-CA-C 117.244 2.313 . . . . 25.0 117.244 178.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -65.75 133.72 51.63 Favored 'General case' 0 CA--C 1.551 0.991 0 O-C-N 121.442 -0.786 . . . . 25.0 111.174 -176.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.3 -18.74 61.17 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.02 0.528 . . . . 25.0 109.674 175.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -77.87 -8.44 58.08 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.83 -0.433 . . . . 25.0 109.83 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.37 168.84 18.88 Favored 'General case' 0 C--O 1.252 1.227 0 CA-C-O 121.159 0.504 . . . . 25.0 110.73 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 51.58 -155.56 0.15 Allowed 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 115.175 1.546 . . . . 25.0 115.175 177.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.95 16.37 74.7 Favored Glycine 0 C--O 1.247 0.93 0 N-CA-C 114.936 0.734 . . . . 25.0 114.936 -178.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -101.55 97.66 8.07 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 124.388 0.699 . . . . 25.0 109.834 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.25 136.96 54.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 122.273 1.035 . . . . 25.0 111.768 -176.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -140.11 28.18 2.5 Favored Glycine 0 C--N 1.336 0.583 0 N-CA-C 109.251 -1.54 . . . . 25.0 109.251 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 60.4 t -74.85 -37.76 42.6 Favored 'Isoleucine or valine' 0 C--O 1.251 1.147 0 N-CA-C 108.451 -0.944 . . . . 25.0 108.451 -177.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.63 128.02 16.44 Favored 'Isoleucine or valine' 0 C--O 1.246 0.872 0 O-C-N 124.57 1.169 . . . . 25.0 111.009 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 166.16 167.29 26.58 Favored Glycine 0 N--CA 1.43 -1.731 0 CA-C-N 114.046 -1.434 . . . . 25.0 110.836 -177.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -149.91 139.64 21.74 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.196 -1.038 . . . . 25.0 108.196 -176.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 85.0 p -154.74 158.07 38.99 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.128 -1.064 . . . . 25.0 108.128 177.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 159.58 161.08 10.93 Favored Glycine 0 C--O 1.24 0.472 0 N-CA-C 116.097 1.199 . . . . 25.0 116.097 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 -105.16 107.37 58.77 Favored Pre-proline 0 C--O 1.251 1.162 0 CA-C-O 121.022 0.439 . . . . 25.0 109.871 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -71.04 163.17 40.16 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 116.636 -1.776 . . . . 25.0 111.892 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -129.85 154.82 46.89 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 106.82 -1.548 . . . . 25.0 106.82 -178.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -140.3 69.12 33.54 Favored Pre-proline 0 C--N 1.306 -1.297 0 O-C-N 121.694 -0.629 . . . . 25.0 109.579 -178.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.19 139.45 42.24 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 116.382 -1.946 . . . . 25.0 112.921 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 15.3 t -93.52 -14.95 26.01 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.217 -0.901 . . . . 25.0 111.501 -176.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 10.7 p . . . . . 0 C--O 1.258 1.55 0 N-CA-C 107.592 -1.262 . . . . 25.0 107.592 179.373 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.933 0 CA-C-O 121.978 0.894 . . . . 25.0 110.781 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -143.61 101.79 5.04 Favored Pre-proline 0 C--O 1.241 0.638 0 N-CA-C 106.869 -1.53 . . . . 25.0 106.869 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.85 139.84 28.08 Favored 'Trans proline' 0 CA--C 1.511 -0.643 0 C-N-CA 116.258 -2.028 . . . . 25.0 112.968 -171.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -155.2 61.64 0.36 Allowed Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 107.764 -2.134 . . . . 25.0 107.764 177.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.4 p -54.76 126.49 11.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 124.158 0.983 . . . . 25.0 110.236 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -100.54 8.96 43.15 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.506 -0.77 . . . . 25.0 110.841 -178.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -90.25 -146.95 16.68 Favored Glycine 0 C--O 1.215 -1.088 0 CA-C-N 115.527 -0.76 . . . . 25.0 112.503 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.7 p 68.92 154.74 0.14 Allowed Pre-proline 0 CA--C 1.563 1.458 0 C-N-CA 126.084 1.753 . . . . 25.0 112.628 -175.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.62 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 50.1 Cg_exo -62.68 1.25 1.11 Allowed 'Trans proline' 0 N--CA 1.498 1.746 0 N-CA-C 117.254 1.982 . . . . 25.0 117.254 -177.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.8 p -63.98 -18.17 22.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 118.831 2.9 . . . . 25.0 118.831 -168.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.5 p -134.8 119.1 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 117.308 2.336 . . . . 25.0 117.308 -175.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.56 36.28 91.18 Favored Glycine 0 C--O 1.211 -1.283 0 CA-C-N 115.481 -0.781 . . . . 25.0 113.945 174.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.3 t -51.98 -38.55 57.03 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 119.219 -0.42 . . . . 25.0 111.678 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -80.73 5.61 15.26 Favored 'General case' 0 C--O 1.249 1.037 0 N-CA-C 115.266 1.58 . . . . 25.0 115.266 -173.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 pp -143.15 178.4 7.73 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-O 118.029 -0.986 . . . . 25.0 109.773 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -56.71 132.75 52.94 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 114.023 1.12 . . . . 25.0 114.023 -173.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -134.33 155.66 49.85 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 114.266 1.21 . . . . 50.0 114.266 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -122.93 113.35 18.99 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 104.128 -2.545 . . . . 25.0 104.128 164.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 88.7 mt -120.74 118.35 29.83 Favored 'General case' 0 C--O 1.207 -1.139 0 CA-C-O 121.394 0.616 . . . . 25.0 110.122 -177.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -110.06 106.99 16.69 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.593 -1.262 . . . . 25.0 107.593 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.51 -171.3 47.06 Favored Glycine 0 C--O 1.244 0.73 0 N-CA-C 118.753 2.261 . . . . 25.0 118.753 -172.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.1 p -82.49 175.72 9.98 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.761 -0.72 . . . . 25.0 111.315 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 69.2 mt -90.97 -2.86 57.65 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 123.546 0.529 . . . . 25.0 110.711 173.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -95.39 -174.27 37.17 Favored Glycine 0 C--O 1.244 0.74 0 N-CA-C 110.02 -1.232 . . . . 25.0 110.02 176.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.4 t -74.91 138.89 42.71 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.676 0.621 . . . . 25.0 112.676 -177.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -145.8 152.9 40.27 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 117.806 0.276 . . . . 50.0 111.538 -178.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -98.09 128.51 44.64 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 103.0 -2.963 . . . . 25.0 103.0 166.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 34.2 mm -124.59 108.65 20.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 107.513 -1.291 . . . . 25.0 107.513 -178.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.62 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 9.6 mp -108.85 118.0 35.65 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 104.408 -2.441 . . . . 25.0 104.408 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.43 -36.5 59.19 Favored Glycine 0 CA--C 1.497 -1.078 0 CA-C-O 119.517 -0.602 . . . . 25.0 113.353 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.87 -151.81 41.44 Favored Glycine 0 CA--C 1.497 -1.091 0 C-N-CA 119.834 -1.174 . . . . 25.0 112.303 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -78.35 169.21 54.31 Favored Glycine 0 C--O 1.247 0.948 0 N-CA-C 110.262 -1.135 . . . . 25.0 110.262 -177.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.3 164.95 23.14 Favored Glycine 0 N--CA 1.432 -1.608 0 C-N-CA 120.819 -0.705 . . . . 25.0 113.507 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.63 109.85 17.18 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.104 -1.073 . . . . 25.0 108.104 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -106.8 156.64 18.45 Favored 'General case' 0 C--N 1.316 -0.873 0 O-C-N 124.252 0.97 . . . . 50.0 112.403 -170.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -127.91 95.28 4.16 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 105.368 -2.086 . . . . 25.0 105.368 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.1 mt -102.21 138.0 39.72 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 113.739 -1.573 . . . . 25.0 112.034 -170.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -134.88 103.13 5.48 Favored 'General case' 0 C--O 1.267 1.986 0 CA-C-O 121.969 0.89 . . . . 25.0 111.502 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.74 -26.91 52.67 Favored Glycine 0 C--N 1.314 -0.68 0 CA-C-N 115.257 -0.883 . . . . 25.0 114.393 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 52.39 -145.75 0.54 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.384 1.074 . . . . 25.0 111.363 -176.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.56 169.19 13.12 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 121.503 -0.748 . . . . 25.0 112.724 -175.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.67 157.29 30.14 Favored Glycine 0 C--O 1.225 -0.417 0 CA-C-N 115.14 -0.936 . . . . 25.0 111.579 -173.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -79.36 112.49 16.64 Favored 'General case' 0 C--O 1.261 1.671 0 N-CA-C 105.812 -1.921 . . . . 25.0 105.812 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -113.68 149.16 35.1 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.023 -0.671 . . . . 50.0 109.598 -171.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mp -111.31 92.86 4.2 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.922 0.889 . . . . 25.0 109.34 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.1 mp -107.09 120.99 43.6 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.479 1.289 . . . . 25.0 114.479 -170.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -123.51 139.41 54.04 Favored 'General case' 0 C--O 1.246 0.876 0 N-CA-C 107.728 -1.212 . . . . 25.0 107.728 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -90.71 -36.59 6.78 Favored Glycine 0 C--O 1.257 1.539 0 CA-C-O 118.105 -1.386 . . . . 25.0 115.588 -173.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.91 -166.42 52.98 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 118.552 1.176 . . . . 25.0 112.388 -176.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.14 148.19 22.7 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.319 -0.94 . . . . 25.0 111.412 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.53 162.57 38.01 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-O 122.518 1.066 . . . . 25.0 114.534 -176.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -88.54 127.94 35.55 Favored 'General case' 0 CA--C 1.479 -1.776 0 N-CA-C 101.692 -3.447 . . . . 25.0 101.692 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -121.87 156.93 32.25 Favored 'General case' 0 C--O 1.255 1.357 0 C-N-CA 122.74 0.416 . . . . 50.0 111.211 -170.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -119.3 125.54 49.32 Favored 'General case' 0 C--O 1.212 -0.91 0 N-CA-C 101.821 -3.4 . . . . 25.0 101.821 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -145.41 132.77 20.64 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 115.689 1.737 . . . . 25.0 115.689 -174.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 63.9 m -102.0 140.45 36.27 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.526 -0.916 . . . . 25.0 108.526 175.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.92 -44.52 4.78 Favored Glycine 0 N--CA 1.467 0.721 0 N-CA-C 109.183 -1.567 . . . . 25.0 109.183 174.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.32 -175.09 54.89 Favored Glycine 0 N--CA 1.465 0.593 0 CA-C-N 116.988 0.394 . . . . 25.0 112.648 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -60.83 155.24 19.97 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 122.701 1.238 . . . . 25.0 110.371 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.37 159.62 32.12 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 115.18 -0.918 . . . . 25.0 111.717 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.58 107.55 13.48 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 122.206 1.003 . . . . 25.0 108.445 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -95.6 162.93 13.42 Favored 'General case' 0 C--O 1.27 2.132 0 CA-C-N 115.075 -0.966 . . . . 50.0 111.137 -172.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.8 m -128.35 132.02 48.59 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 122.536 1.16 . . . . 25.0 109.002 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -122.32 129.06 51.79 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 105.3 -2.111 . . . . 25.0 105.3 175.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 26.4 mmt85 -127.13 -15.42 5.27 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 121.277 0.561 . . . . 25.0 109.953 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 60.59 174.8 0.1 Allowed 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 115.216 -0.902 . . . . 25.0 112.426 -171.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -89.92 -51.87 5.26 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 115.108 1.522 . . . . 25.0 115.108 -172.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.1 mt -141.87 174.07 10.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.906 -1.043 . . . . 25.0 109.519 -173.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.12 -27.58 63.87 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 107.725 -1.213 . . . . 25.0 107.725 171.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -72.02 -9.2 58.06 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-O 122.758 1.266 . . . . 25.0 113.447 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -94.1 141.41 28.57 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.843 1.306 . . . . 25.0 111.732 -173.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.3 t 46.85 42.58 12.23 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 113.389 -1.732 . . . . 25.0 115.347 175.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -118.7 162.03 19.12 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.423 -1.262 . . . . 25.0 111.427 -178.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -104.68 146.49 28.87 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 105.403 -2.073 . . . . 25.0 105.403 175.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.7 p -138.71 167.44 19.46 Favored Pre-proline 0 C--O 1.211 -0.932 0 N-CA-C 108.165 -1.05 . . . . 25.0 108.165 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -61.03 -20.06 65.93 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 CA-C-O 122.377 0.907 . . . . 25.0 113.234 174.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 73.1 mt -79.26 -23.58 43.55 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 119.924 -1.735 . . . . 25.0 111.13 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 147.99 -175.73 27.16 Favored Glycine 0 C--O 1.212 -1.232 0 CA-C-N 115.384 -0.825 . . . . 25.0 111.916 177.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.0 t -89.15 137.99 31.82 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 123.375 1.559 . . . . 25.0 112.485 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -117.64 17.9 14.31 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-N 114.768 -1.105 . . . . 25.0 110.532 171.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.35 138.41 49.38 Favored Glycine 0 C--N 1.338 0.661 0 CA-C-N 115.184 -0.916 . . . . 25.0 111.519 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -85.22 173.53 10.33 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 117.353 0.576 . . . . 50.0 111.745 -176.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.74 103.89 7.77 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 123.217 0.607 . . . . 25.0 112.105 -179.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.8 mt -87.02 133.75 29.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 106.579 -1.638 . . . . 25.0 106.579 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.84 -38.9 22.38 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.608 0.966 . . . . 25.0 113.608 -172.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.6 p-10 -144.79 44.32 1.37 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.787 1.032 . . . . 25.0 113.787 -167.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -61.1 131.14 49.59 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.95 1.093 . . . . 25.0 113.95 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -96.39 106.32 28.45 Favored Pre-proline 0 N--CA 1.48 1.065 0 N-CA-C 106.749 -1.575 . . . . 25.0 106.749 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -77.56 -4.29 14.47 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 N-CA-C 114.17 0.796 . . . . 25.0 114.17 -171.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 45.6 t -93.28 -41.93 9.6 Favored 'General case' 0 C--N 1.315 -0.918 0 O-C-N 124.26 0.975 . . . . 25.0 111.091 177.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -98.19 -37.15 9.81 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.979 1.474 . . . . 25.0 114.979 -172.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -87.16 168.63 13.07 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.259 0.466 . . . . 50.0 112.259 -172.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -146.04 145.84 30.74 Favored 'General case' 0 C--O 1.263 1.785 0 O-C-N 121.805 -0.559 . . . . 25.0 112.288 -178.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 75.1 mt -130.74 129.1 63.79 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 N-CA-C 109.266 -0.642 . . . . 25.0 109.266 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -91.69 141.24 28.9 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 119.771 -1.83 . . . . 25.0 107.393 174.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.7 p -134.09 -5.9 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 121.463 0.649 . . . . 25.0 111.423 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.87 -36.27 78.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.851 -0.613 . . . . 25.0 111.929 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.46 -24.69 53.9 Favored 'General case' 0 C--O 1.248 0.989 0 N-CA-C 113.91 1.078 . . . . 25.0 113.91 -178.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.88 9.4 5.37 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 115.946 1.832 . . . . 25.0 115.946 -168.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -151.08 -75.05 0.01 OUTLIER Glycine 0 C--O 1.219 -0.81 0 C-N-CA 119.868 -1.158 . . . . 25.0 115.067 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -155.39 167.74 29.4 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 109.592 -0.521 . . . . 25.0 109.592 -171.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.2 t -120.22 -39.81 2.76 Favored 'General case' 0 C--O 1.248 0.997 0 N-CA-C 108.963 -0.755 . . . . 25.0 108.963 176.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -92.04 123.15 7.11 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 109.31 -1.516 . . . . 25.0 109.31 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.16 148.81 46.99 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.254 0.55 . . . . 25.0 111.222 -177.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -83.16 -176.48 51.51 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 115.945 -0.571 . . . . 25.0 112.008 -177.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -61.94 100.2 0.15 Allowed 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 115.05 1.5 . . . . 25.0 115.05 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -141.03 -157.4 7.16 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-O 117.222 -1.876 . . . . 25.0 108.659 176.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -152.99 162.97 40.68 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 121.114 2.457 . . . . 25.0 112.566 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 51.16 44.33 28.76 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.214 1.006 . . . . 25.0 113.118 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.24 31.82 63.36 Favored Glycine 0 C--O 1.257 1.579 0 N-CA-C 111.031 -0.828 . . . . 25.0 111.031 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.6 t -139.76 174.23 10.72 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 117.719 0.759 . . . . 25.0 110.364 -177.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.7 mt -95.18 172.64 7.99 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 101.424 -3.547 . . . . 25.0 101.424 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.33 119.8 22.88 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.652 -1.24 . . . . 25.0 107.652 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.4 m -80.06 157.6 4.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.148 -0.686 . . . . 25.0 109.148 -176.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.46 160.25 40.92 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.754 -0.832 . . . . 25.0 108.754 -176.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.3 m -123.31 163.9 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 116.33 -0.395 . . . . 25.0 110.268 177.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 35.1 t -70.84 -52.44 20.33 Favored 'General case' 0 C--O 1.204 -1.325 0 N-CA-C 107.52 -1.289 . . . . 25.0 107.52 174.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -159.61 -143.79 0.1 Allowed 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 104.997 -2.223 . . . . 25.0 104.997 -178.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -69.92 -21.14 63.32 Favored 'General case' 0 C--O 1.253 1.285 0 N-CA-C 109.564 -0.532 . . . . 25.0 109.564 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -141.54 -145.44 4.55 Favored Glycine 0 C--O 1.24 0.509 0 N-CA-C 110.532 -1.027 . . . . 25.0 110.532 178.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.55 -145.13 0.33 Allowed 'General case' 0 C--O 1.245 0.843 0 C-N-CA 124.082 0.953 . . . . 25.0 109.784 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.6 mtt85 -82.09 159.06 23.5 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 113.127 0.788 . . . . 25.0 113.127 -176.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -111.3 166.28 11.23 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 104.822 -2.288 . . . . 25.0 104.822 177.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -135.65 151.4 50.18 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.997 -0.547 . . . . 25.0 111.378 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 34.4 tp -124.61 104.34 8.64 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 103.595 -2.743 . . . . 25.0 103.595 168.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -104.46 153.03 21.63 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.634 -0.712 . . . . 25.0 110.793 -172.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 43.5 t -99.5 150.87 21.77 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.397 -2.075 . . . . 25.0 105.397 170.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -119.81 25.02 10.24 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 106.534 -1.654 . . . . 25.0 106.534 -178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -116.1 134.84 54.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.367 -1.288 . . . . 25.0 109.461 174.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -134.12 150.02 51.11 Favored 'General case' 0 C--O 1.216 -0.673 0 O-C-N 125.176 1.547 . . . . 25.0 110.549 -175.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -74.52 165.13 25.72 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 124.11 0.964 . . . . 25.0 109.127 174.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.97 -15.33 62.9 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.683 0.754 . . . . 25.0 111.463 178.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -79.03 -11.34 60.0 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.614 -0.721 . . . . 25.0 112.348 174.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.58 26.26 39.54 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 120.505 -0.855 . . . . 25.0 112.162 -176.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 69.5 mt -101.07 141.97 33.19 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.386 -1.338 . . . . 25.0 107.386 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 80.1 p -149.24 -175.44 4.98 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.338 -1.356 . . . . 25.0 107.338 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -123.2 139.21 54.29 Favored 'General case' 0 C--O 1.247 0.926 0 N-CA-C 113.223 0.823 . . . . 25.0 113.223 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -152.07 153.99 35.04 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.789 -1.189 . . . . 25.0 107.789 166.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 10.5 p -148.51 143.8 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 N-CA-C 104.603 -2.369 . . . . 25.0 104.603 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -105.86 148.93 27.01 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 107.186 -1.413 . . . . 25.0 107.186 -175.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.5 mp -137.98 131.03 30.17 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 104.301 -2.481 . . . . 25.0 104.301 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -104.37 4.91 33.98 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 121.198 1.817 . . . . 25.0 114.758 -174.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -77.16 1.58 63.83 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 120.283 -0.961 . . . . 25.0 114.817 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 47.7 t0 52.84 61.68 3.07 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-O 122.08 0.943 . . . . 25.0 110.728 175.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -130.98 41.92 3.3 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.707 -1.133 . . . . 25.0 111.762 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.95 -25.18 66.63 Favored 'General case' 0 C--O 1.209 -1.051 0 C-N-CA 119.345 -0.942 . . . . 25.0 110.809 176.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.12 -32.15 70.03 Favored 'General case' 0 C--O 1.275 2.418 0 C-N-CA 124.094 0.957 . . . . 25.0 112.282 177.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -93.62 -27.31 16.66 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.734 1.013 . . . . 25.0 113.734 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 11.4 mt -62.84 139.79 58.74 Favored 'General case' 0 C--O 1.247 0.923 0 CA-C-O 121.947 0.88 . . . . 25.0 109.492 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 72.5 m -141.77 159.78 41.52 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 102.012 -3.329 . . . . 25.0 102.012 169.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -86.24 10.36 14.93 Favored 'General case' 0 C--O 1.214 -0.813 0 N-CA-C 108.107 -1.072 . . . . 25.0 108.107 -176.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -72.11 -26.23 62.05 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.692 0.758 . . . . 25.0 110.386 178.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 24.3 p30 -86.06 -1.25 57.2 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 109.694 -0.484 . . . . 25.0 109.694 176.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 37.3 mm -98.39 128.88 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 102.415 -3.18 . . . . 25.0 102.415 173.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.3 p -105.82 113.77 43.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 122.936 1.35 . . . . 25.0 111.665 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -142.42 9.12 1.82 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 112.524 -2.125 . . . . 25.0 107.379 178.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.9 51.75 1.57 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.421 1.088 . . . . 25.0 111.301 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 56.43 33.7 22.92 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.384 1.073 . . . . 25.0 113.665 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 18.2 m 65.29 -43.99 0.35 Allowed 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 117.468 2.396 . . . . 25.0 117.468 176.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -76.65 154.11 34.59 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 114.27 1.211 . . . . 25.0 114.27 -173.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -80.77 20.14 0.78 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.26 -0.882 . . . . 25.0 111.752 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.85 -25.52 56.29 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.986 -0.552 . . . . 25.0 111.833 -177.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -112.0 -161.32 0.75 Allowed 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 108.839 -0.8 . . . . 25.0 108.839 -174.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 67.49 -174.2 0.19 Allowed 'General case' 0 C--O 1.25 1.13 0 N-CA-C 115.796 1.776 . . . . 25.0 115.796 175.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 81.46 17.44 71.15 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 114.195 0.438 . . . . 25.0 114.195 175.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -98.94 109.86 22.55 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 122.466 -0.432 . . . . 25.0 110.888 -174.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -127.35 157.71 39.22 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 107.425 -1.324 . . . . 25.0 107.425 178.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -140.78 30.45 2.28 Favored Glycine 0 C--O 1.209 -1.451 0 N-CA-C 110.761 -0.935 . . . . 25.0 110.761 178.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.11 -28.38 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 CA-C-O 122.157 0.98 . . . . 25.0 110.939 -175.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.12 136.38 26.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 CA-C-O 122.167 0.984 . . . . 25.0 109.823 -177.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 161.89 157.52 8.95 Favored Glycine 0 N--CA 1.466 0.654 0 CA-C-N 114.605 -1.18 . . . . 25.0 111.951 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -149.67 141.97 24.18 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 108.584 -0.895 . . . . 25.0 108.584 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 88.6 p -159.46 171.54 19.53 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.865 0.866 . . . . 25.0 110.097 177.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 171.17 174.9 39.28 Favored Glycine 0 C--O 1.25 1.102 0 CA-C-N 118.814 0.734 . . . . 25.0 111.773 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -136.75 101.9 9.54 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 108.702 -0.851 . . . . 25.0 108.702 177.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.35 152.64 49.89 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 N-CA-C 115.471 1.296 . . . . 25.0 115.471 -174.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -121.84 151.38 40.71 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 107.805 -1.183 . . . . 25.0 107.805 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -141.51 76.84 20.27 Favored Pre-proline 0 C--O 1.24 0.599 0 CA-C-N 118.366 0.53 . . . . 25.0 110.49 176.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.11 155.48 61.29 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 118.35 -0.634 . . . . 25.0 113.404 -176.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.9 t -122.68 -3.46 8.76 Favored 'General case' 0 C--O 1.245 0.827 0 O-C-N 121.49 -0.756 . . . . 25.0 111.977 -177.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--O 1.271 2.214 0 N-CA-C 107.943 -1.132 . . . . 25.0 107.943 176.918 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.92 -0.4 . . . . 25.0 109.92 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -137.38 111.16 9.07 Favored Pre-proline 0 C--N 1.318 -0.798 0 O-C-N 121.739 -0.601 . . . . 25.0 109.624 175.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -67.84 149.65 78.22 Favored 'Trans proline' 0 C--O 1.245 0.842 0 C-N-CA 116.601 -1.799 . . . . 25.0 112.3 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.83 57.43 0.03 OUTLIER Glycine 0 C--O 1.244 0.727 0 N-CA-C 109.836 -1.306 . . . . 25.0 109.836 -177.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.7 p -63.87 131.82 29.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 122.08 0.943 . . . . 25.0 111.568 -172.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -96.61 -6.42 36.79 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 115.3 -0.864 . . . . 25.0 110.978 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.58 -152.57 13.47 Favored Glycine 0 C--O 1.244 0.762 0 CA-C-N 115.758 -0.655 . . . . 25.0 112.704 177.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 p 73.38 159.69 0.16 Allowed Pre-proline 0 CA--C 1.563 1.459 0 C-N-CA 126.343 1.857 . . . . 25.0 109.474 -177.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.441 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 30.3 Cg_exo -68.52 6.89 0.8 Allowed 'Trans proline' 0 CA--C 1.553 1.427 0 N-CA-C 116.069 1.526 . . . . 25.0 116.069 -174.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.8 p -69.01 -16.74 21.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 115.926 1.824 . . . . 25.0 115.926 -169.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.85 139.04 22.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 O-C-N 121.218 -0.927 . . . . 25.0 113.199 -174.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.87 9.09 70.02 Favored Glycine 0 N--CA 1.469 0.852 0 N-CA-C 117.586 1.794 . . . . 25.0 117.586 171.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.5 t -50.72 -43.02 57.85 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 114.272 1.212 . . . . 25.0 114.272 -169.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -77.47 7.4 5.49 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 114.167 1.173 . . . . 25.0 114.167 -176.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.33 175.28 10.21 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 120.27 -1.519 . . . . 25.0 111.221 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -56.65 125.33 21.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 123.702 0.626 . . . . 25.0 111.308 -175.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -121.94 162.83 20.36 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.981 0.734 . . . . 50.0 112.981 -173.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -130.73 114.96 16.02 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 102.518 -3.142 . . . . 25.0 102.518 163.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.0 mt -128.05 128.87 45.74 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 122.077 0.942 . . . . 25.0 109.66 -177.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 66.9 m80 -117.45 121.3 40.65 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.218 -0.901 . . . . 25.0 110.35 177.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.15 175.26 46.24 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 122.644 1.136 . . . . 25.0 115.094 -174.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.2 p -82.24 172.42 13.16 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.109 -1.046 . . . . 25.0 109.81 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.6 mt -86.79 12.09 11.7 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.176 0.512 . . . . 25.0 111.938 177.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -111.69 -172.91 19.37 Favored Glycine 0 N--CA 1.471 0.975 0 CA-C-N 114.826 -1.079 . . . . 25.0 111.581 177.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.2 t -77.16 134.02 38.79 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.013 0.745 . . . . 25.0 113.013 -178.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -148.02 163.99 35.18 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.457 -0.777 . . . . 50.0 110.853 -173.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -112.32 125.3 54.03 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 101.078 -3.675 . . . . 25.0 101.078 169.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 40.6 mm -119.13 99.95 8.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 104.92 -2.252 . . . . 25.0 104.92 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.441 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 9.4 mp -107.9 120.23 41.7 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 103.646 -2.724 . . . . 25.0 103.646 -176.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.22 -27.54 36.46 Favored Glycine 0 CA--C 1.488 -1.628 0 N-CA-C 115.264 0.866 . . . . 25.0 115.264 -171.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.74 -149.86 50.2 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 109.982 -1.247 . . . . 25.0 109.982 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.4 172.41 47.91 Favored Glycine 0 C--O 1.247 0.952 0 CA-C-N 114.901 -0.65 . . . . 25.0 114.473 -175.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.42 172.57 24.53 Favored Glycine 0 N--CA 1.439 -1.101 0 CA-C-O 119.132 -0.815 . . . . 25.0 114.281 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.8 112.78 24.72 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 104.722 -2.325 . . . . 25.0 104.722 177.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -108.96 156.35 19.81 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.052 -0.522 . . . . 50.0 110.578 -169.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -119.55 90.89 3.42 Favored 'General case' 0 C--O 1.248 1.019 0 N-CA-C 107.099 -1.445 . . . . 25.0 107.099 175.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 31.9 mt -100.81 128.63 46.77 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 113.862 -1.517 . . . . 25.0 110.869 -171.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -125.43 105.2 8.89 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.137 0.494 . . . . 25.0 112.008 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.73 -26.09 47.36 Favored Glycine 0 C--O 1.246 0.853 0 CA-C-O 116.797 -2.113 . . . . 25.0 115.929 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 52.77 -150.38 0.35 Allowed 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 119.551 1.676 . . . . 25.0 111.952 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.38 165.76 9.24 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.588 0.958 . . . . 25.0 113.588 -178.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.11 157.55 33.58 Favored Glycine 0 N--CA 1.438 -1.193 0 N-CA-C 110.097 -1.201 . . . . 25.0 110.097 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -80.87 115.29 20.28 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.52 -1.659 . . . . 25.0 106.52 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -123.56 147.55 47.18 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 119.887 -0.725 . . . . 50.0 111.166 -169.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 mp -108.65 104.57 13.9 Favored 'General case' 0 C--O 1.204 -1.308 0 N-CA-C 108.121 -1.066 . . . . 25.0 108.121 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 mp -109.21 109.83 20.88 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.784 0.802 . . . . 25.0 112.848 -174.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -118.78 96.44 5.26 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-N 113.977 -1.465 . . . . 25.0 108.101 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -59.74 -22.26 56.74 Favored Glycine 0 C--O 1.216 -0.989 0 N-CA-C 118.474 2.15 . . . . 25.0 118.474 -177.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.84 -159.07 53.79 Favored Glycine 0 C--O 1.245 0.839 0 CA-C-N 118.427 1.113 . . . . 25.0 112.444 -178.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.14 159.36 14.82 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-O 122.046 0.927 . . . . 25.0 112.524 -176.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.67 -178.32 53.3 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 114.826 -1.079 . . . . 25.0 114.229 -177.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -96.91 145.39 25.93 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 101.779 -3.415 . . . . 25.0 101.779 172.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -135.36 155.14 51.08 Favored 'General case' 0 CA--C 1.5 -0.943 0 C-N-CA 120.745 -0.382 . . . . 50.0 111.682 -170.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -109.17 122.36 47.14 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 104.994 -2.224 . . . . 25.0 104.994 174.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -142.05 136.19 29.94 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 122.466 1.126 . . . . 25.0 113.244 -176.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.7 m -113.63 133.89 55.04 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 115.169 -0.923 . . . . 25.0 110.181 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.04 -44.0 4.25 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.2 -1.16 . . . . 25.0 110.2 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.86 -161.24 52.19 Favored Glycine 0 C--O 1.252 1.234 0 C-N-CA 123.13 0.395 . . . . 25.0 113.019 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -67.25 161.82 24.03 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 122.176 -0.602 . . . . 25.0 112.296 174.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.44 167.24 41.7 Favored Glycine 0 CA--C 1.533 1.215 0 N-CA-C 111.129 -0.788 . . . . 25.0 111.129 -177.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.9 107.09 18.53 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.755 0.788 . . . . 25.0 109.711 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -102.38 153.2 20.24 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.853 -0.612 . . . . 50.0 110.479 -172.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.9 m -128.54 123.41 33.4 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-N 115.172 -0.922 . . . . 25.0 110.302 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -115.34 117.9 31.74 Favored 'General case' 0 C--O 1.21 -1.003 0 N-CA-C 108.432 -0.951 . . . . 25.0 108.432 -177.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 51.2 mtt85 -114.94 -33.41 5.44 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 113.007 0.743 . . . . 25.0 113.007 177.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 71.78 151.46 0.11 Allowed 'General case' 0 CA--C 1.551 1.017 0 O-C-N 125.195 1.559 . . . . 25.0 109.723 -173.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.74 -51.03 45.78 Favored 'General case' 0 C--O 1.24 0.576 0 O-C-N 121.015 -1.053 . . . . 25.0 113.562 -167.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.7 mt -131.8 166.6 21.21 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 121.918 0.866 . . . . 25.0 109.224 -174.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.89 -21.06 56.72 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.695 0.798 . . . . 25.0 109.341 175.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -73.8 3.27 6.8 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 115.049 1.5 . . . . 25.0 115.049 176.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -114.53 149.88 35.77 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.998 0.904 . . . . 25.0 112.202 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.2 t 55.03 46.1 24.94 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 122.903 1.335 . . . . 25.0 113.697 169.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 47.6 p-80 -134.97 -178.98 5.34 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.198 -0.91 . . . . 25.0 109.225 -175.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -122.63 145.41 48.38 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 103.823 -2.658 . . . . 25.0 103.823 175.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.8 p -133.98 167.56 22.28 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 107.129 -1.434 . . . . 25.0 107.129 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.32 -22.79 67.06 Favored 'Trans proline' 0 C--N 1.367 1.538 0 C-N-CA 116.393 -1.938 . . . . 25.0 113.693 177.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.9 -27.05 67.91 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 122.051 0.929 . . . . 25.0 111.173 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 139.5 179.05 17.2 Favored Glycine 0 C--O 1.246 0.852 0 N-CA-C 109.687 -1.365 . . . . 25.0 109.687 -171.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.6 t -81.87 150.07 27.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 123.461 1.6 . . . . 25.0 113.258 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -131.42 29.93 4.51 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 113.521 -1.672 . . . . 25.0 107.503 170.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.93 140.3 32.68 Favored Glycine 0 CA--C 1.501 -0.808 0 N-CA-C 109.144 -1.582 . . . . 25.0 109.144 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -82.03 167.91 18.36 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 118.72 -0.657 . . . . 50.0 109.517 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -124.41 114.08 19.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 118.438 0.563 . . . . 25.0 109.897 -176.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mt -100.16 127.13 53.43 Favored 'Isoleucine or valine' 0 C--O 1.25 1.122 0 N-CA-C 108.207 -1.035 . . . . 25.0 108.207 -178.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.3 mt -81.05 -44.24 18.32 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 115.292 1.59 . . . . 25.0 115.292 -173.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 57.0 p30 -133.54 44.78 2.75 Favored 'General case' 0 C--O 1.252 1.188 0 N-CA-C 113.585 0.957 . . . . 25.0 113.585 -172.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -59.24 145.23 43.64 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.351 0.66 . . . . 25.0 111.962 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -121.6 103.17 41.21 Favored Pre-proline 0 N--CA 1.473 0.695 0 CA-C-N 115.763 -0.653 . . . . 25.0 109.784 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -65.08 -12.4 34.49 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 N-CA-C 117.985 2.264 . . . . 25.0 117.985 -174.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.3 t -91.69 -32.32 15.48 Favored 'General case' 0 C--O 1.209 -1.069 0 N-CA-C 109.521 -0.548 . . . . 25.0 109.521 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -89.73 -48.23 7.4 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 113.954 1.094 . . . . 25.0 113.954 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -93.08 172.26 8.42 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.281 -1.327 . . . . 50.0 113.373 -161.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -146.64 149.95 34.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 119.343 -0.361 . . . . 25.0 110.843 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 86.2 mt -129.34 126.64 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 123.265 0.626 . . . . 25.0 109.732 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -86.44 139.63 30.73 Favored 'General case' 0 CA--C 1.502 -0.903 0 O-C-N 121.579 -0.701 . . . . 25.0 109.624 178.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.0 p -141.5 -8.3 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.173 0 CA-C-O 120.844 0.354 . . . . 25.0 110.85 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.6 t -67.42 -40.14 85.53 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 122.54 1.162 . . . . 25.0 109.495 -175.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.28 -23.61 63.85 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.407 -0.815 . . . . 25.0 111.942 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.5 mt -96.62 -65.95 0.93 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.745 1.017 . . . . 25.0 113.745 -172.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -116.24 -49.12 0.46 Allowed Glycine 0 CA--C 1.502 -0.773 0 N-CA-C 118.532 2.173 . . . . 25.0 118.532 -167.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -155.27 165.85 35.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 118.396 1.098 . . . . 25.0 111.93 -173.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.69 -24.76 3.22 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.194 0.521 . . . . 25.0 111.201 178.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -95.02 126.75 8.86 Favored Glycine 0 C--O 1.245 0.792 0 N-CA-C 110.594 -1.002 . . . . 25.0 110.594 173.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.11 140.74 57.81 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.981 0.896 . . . . 25.0 111.096 -176.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.29 -158.38 34.61 Favored Glycine 0 C--N 1.335 0.479 0 N-CA-C 110.833 -0.907 . . . . 25.0 110.833 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -67.75 140.46 56.71 Favored 'General case' 0 C--O 1.254 1.307 0 CA-C-O 122.175 0.988 . . . . 25.0 113.057 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 165.58 -172.95 41.23 Favored Glycine 0 C--O 1.253 1.292 0 N-CA-C 108.955 -1.658 . . . . 25.0 108.955 175.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -149.17 168.84 22.15 Favored 'General case' 0 C--O 1.245 0.857 0 C-N-CA 122.496 0.318 . . . . 25.0 110.294 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 56.58 36.49 27.69 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.26 1.207 . . . . 25.0 114.26 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 69.92 28.34 71.97 Favored Glycine 0 CA--C 1.538 1.513 0 N-CA-C 111.393 -0.683 . . . . 25.0 111.393 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 8.6 t -138.14 -178.32 5.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 117.383 0.591 . . . . 25.0 110.343 -175.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 87.2 mt -113.85 167.51 10.57 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 103.432 -2.803 . . . . 25.0 103.432 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.66 119.7 17.26 Favored 'General case' 0 C--O 1.257 1.465 0 C-N-CA 118.091 -1.444 . . . . 25.0 112.474 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.7 m -98.31 161.74 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 124.107 0.963 . . . . 25.0 109.151 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 54.0 p -148.73 171.11 16.75 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 118.901 -0.571 . . . . 25.0 111.621 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.5 m -120.95 162.6 19.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.473 0 N-CA-C 108.289 -1.004 . . . . 25.0 108.289 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.6 t -74.45 -53.72 9.0 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 106.121 -1.807 . . . . 25.0 106.121 170.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -159.83 -160.9 0.85 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 104.26 -2.496 . . . . 25.0 104.26 -177.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -65.56 -16.3 63.56 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 122.121 0.962 . . . . 25.0 111.877 176.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -133.52 -156.6 8.07 Favored Glycine 0 N--CA 1.469 0.851 0 N-CA-C 107.428 -2.269 . . . . 25.0 107.428 175.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.67 -142.25 0.32 Allowed 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.056 0.542 . . . . 25.0 109.7 178.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -96.21 170.21 9.42 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.296 1.221 . . . . 25.0 114.296 -168.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.36 160.72 28.68 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 105.952 -1.87 . . . . 25.0 105.952 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -134.89 153.78 51.92 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 117.536 0.153 . . . . 25.0 110.663 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 31.9 tp -127.65 120.85 28.97 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 104.848 -2.279 . . . . 25.0 104.848 172.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -121.95 153.43 38.51 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 118.405 0.548 . . . . 25.0 111.914 -172.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.6 t -102.55 147.25 27.0 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 103.654 -2.721 . . . . 25.0 103.654 171.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -115.5 19.04 15.67 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.931 -0.766 . . . . 25.0 108.931 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -110.89 143.37 41.61 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 105.521 -2.029 . . . . 25.0 105.521 171.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -141.12 157.69 44.94 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.879 0.737 . . . . 25.0 111.097 -176.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -80.16 164.6 23.18 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.332 -0.988 . . . . 25.0 108.332 175.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.72 -30.18 71.19 Favored 'General case' 0 C--O 1.221 -0.44 0 O-C-N 121.515 -0.74 . . . . 25.0 110.78 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -70.58 -5.06 26.4 Favored 'General case' 0 CA--C 1.554 1.096 0 C-N-CA 123.401 0.68 . . . . 25.0 112.342 177.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.59 7.53 84.31 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 115.66 -0.7 . . . . 25.0 111.915 -178.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 88.8 mt -73.16 136.83 44.82 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 106.595 -1.632 . . . . 25.0 106.595 174.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 94.4 p -148.92 -177.43 5.8 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 107.654 -1.239 . . . . 25.0 107.654 -175.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -128.38 132.54 48.53 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 119.426 1.012 . . . . 25.0 113.381 -175.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -152.51 156.71 39.93 Favored 'General case' 0 C--O 1.256 1.421 0 N-CA-C 107.205 -1.405 . . . . 25.0 107.205 168.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.9 p -146.66 147.38 17.94 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.804 0 N-CA-C 105.919 -1.882 . . . . 25.0 105.919 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -112.31 143.01 44.12 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.747 -0.66 . . . . 25.0 109.967 -170.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.8 mp -132.17 154.28 49.7 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.932 -1.136 . . . . 25.0 107.932 -177.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.51 0.97 10.06 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 116.992 2.219 . . . . 25.0 116.992 -177.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.3 -3.65 88.58 Favored Glycine 0 C--O 1.224 -0.493 0 C-N-CA 120.04 -1.076 . . . . 25.0 112.997 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 50.5 t0 48.74 61.41 3.1 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 122.323 1.058 . . . . 25.0 111.488 -177.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -123.3 41.48 3.46 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.282 -1.326 . . . . 25.0 107.624 175.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.53 -25.95 68.48 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 115.192 -0.913 . . . . 25.0 112.949 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.56 -23.82 64.54 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.424 0.63 . . . . 25.0 111.01 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -101.8 -0.04 34.92 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.769 -0.65 . . . . 25.0 112.031 -175.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 11.4 mt -78.0 134.39 37.83 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.111 -0.635 . . . . 25.0 109.328 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.2 m -135.54 162.27 33.14 Favored 'General case' 0 CA--C 1.492 -1.252 0 CA-C-N 114.605 -1.18 . . . . 25.0 109.036 173.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.44 -1.6 57.22 Favored 'General case' 0 C--O 1.204 -1.296 0 CA-C-O 122.624 1.202 . . . . 25.0 109.473 -177.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.36 -31.69 72.99 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.178 -1.374 . . . . 25.0 109.383 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -89.21 -7.05 56.34 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.877 1.323 . . . . 25.0 112.849 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 47.0 mm -95.93 108.13 20.68 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.012 0 N-CA-C 104.944 -2.243 . . . . 25.0 104.944 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 14.5 p -94.83 121.48 45.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 122.545 1.164 . . . . 25.0 111.695 -169.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -152.98 -3.57 0.22 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 112.968 -1.924 . . . . 25.0 112.298 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -74.55 51.36 0.46 Allowed 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.73 1.011 . . . . 25.0 113.73 -177.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 54.32 22.65 3.85 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.207 0.817 . . . . 25.0 113.207 -175.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.07 3.1 0.9 Allowed 'General case' 0 C--O 1.246 0.916 0 N-CA-C 115.247 1.573 . . . . 25.0 115.247 175.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -82.09 137.39 35.03 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.394 -0.522 . . . . 25.0 110.572 178.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -76.88 -12.37 59.95 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 109.198 -0.667 . . . . 25.0 109.198 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -82.72 42.64 0.79 Allowed 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 112.292 0.479 . . . . 25.0 112.292 176.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -154.25 175.16 13.84 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.065 0.946 . . . . 25.0 109.012 -178.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 62.3 -156.98 0.34 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.831 1.252 . . . . 25.0 111.638 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 58.33 28.72 62.21 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 121.926 -0.178 . . . . 25.0 113.269 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -106.63 98.64 8.28 Favored 'General case' 0 C--O 1.249 1.056 0 C-N-CA 123.083 0.553 . . . . 25.0 109.582 -176.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.87 145.11 47.97 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 121.636 0.731 . . . . 25.0 112.712 -178.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -121.94 29.7 5.5 Favored Glycine 0 C--O 1.222 -0.595 0 CA-C-N 115.154 -0.93 . . . . 25.0 112.342 174.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 58.1 t -70.64 -38.93 75.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 O-C-N 121.757 -0.849 . . . . 25.0 112.425 -174.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.9 133.05 30.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.832 0.825 . . . . 25.0 110.581 -175.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 170.07 153.43 8.64 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-N 114.607 -1.178 . . . . 25.0 110.892 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -150.88 143.66 24.51 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 117.854 0.827 . . . . 25.0 109.878 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.6 p -150.77 169.23 22.15 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 106.193 -1.78 . . . . 25.0 106.193 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -175.39 163.99 34.17 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 115.625 1.01 . . . . 25.0 115.625 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -137.38 83.56 25.87 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 107.815 -1.18 . . . . 25.0 107.815 175.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.17 161.23 46.76 Favored 'Trans proline' 0 C--N 1.349 0.589 0 O-C-N 121.99 0.469 . . . . 25.0 112.67 -176.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -130.67 159.79 36.2 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.937 -0.764 . . . . 25.0 108.937 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -135.73 84.48 32.77 Favored Pre-proline 0 C--O 1.246 0.87 0 C-N-CA 122.74 0.416 . . . . 25.0 112.034 -177.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.23 161.14 43.71 Favored 'Trans proline' 0 C--O 1.246 0.897 0 C-N-CA 116.995 -1.537 . . . . 25.0 113.323 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.5 t -127.78 17.27 6.85 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 122.061 0.934 . . . . 25.0 110.44 176.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 C--O 1.258 1.537 0 CA-C-O 117.349 -1.31 . . . . 25.0 109.566 178.639 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.954 0 CA-C-O 119.818 -0.134 . . . . 25.0 110.697 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -135.86 115.74 11.34 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 109.174 -0.676 . . . . 25.0 109.174 -178.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.1 147.38 48.43 Favored 'Trans proline' 0 C--O 1.24 0.587 0 C-N-CA 115.772 -2.352 . . . . 25.0 111.929 -177.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.33 56.84 0.26 Allowed Glycine 0 C--O 1.244 0.76 0 CA-C-O 119.043 -0.865 . . . . 25.0 112.803 -176.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 p -70.4 125.29 28.33 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.965 0 CA-C-O 122.08 0.943 . . . . 25.0 111.525 -176.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -100.27 4.22 44.03 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.156 -0.929 . . . . 25.0 110.732 -176.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -97.96 -145.2 18.47 Favored Glycine 0 C--O 1.24 0.513 0 N-CA-C 111.211 -0.756 . . . . 25.0 111.211 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.4 p 73.86 156.67 0.16 Allowed Pre-proline 0 N--CA 1.483 1.177 0 C-N-CA 126.508 1.923 . . . . 25.0 109.024 -176.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.521 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 32.8 Cg_exo -63.63 1.0 1.56 Allowed 'Trans proline' 0 N--CA 1.478 0.603 0 N-CA-C 116.25 1.596 . . . . 25.0 116.25 -176.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.5 p -63.8 -25.09 37.38 Favored 'Isoleucine or valine' 0 C--O 1.258 1.538 0 N-CA-C 114.786 1.402 . . . . 25.0 114.786 -171.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.8 p -130.7 135.84 59.47 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 CA-C-O 122.857 1.313 . . . . 25.0 114.477 -172.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.47 14.54 79.42 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 114.582 -1.19 . . . . 25.0 115.405 171.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.5 t -45.82 -48.67 15.67 Favored 'General case' 0 C--O 1.209 -1.043 0 N-CA-C 114.349 1.241 . . . . 25.0 114.349 -171.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -78.14 0.39 25.05 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 115.694 1.739 . . . . 25.0 115.694 -175.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.77 169.73 17.18 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.118 -0.989 . . . . 25.0 111.637 -175.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -60.07 125.87 25.32 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 124.431 1.082 . . . . 25.0 110.991 -171.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -120.46 165.7 14.59 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.725 1.38 . . . . 50.0 114.725 -176.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -128.47 101.13 6.05 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 101.967 -3.346 . . . . 25.0 101.967 163.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.3 mt -109.62 120.31 42.11 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 119.239 -0.41 . . . . 25.0 111.899 -177.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -112.9 113.45 25.52 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 123.537 0.523 . . . . 25.0 110.71 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.63 -177.72 49.42 Favored Glycine 0 N--CA 1.469 0.871 0 N-CA-C 116.534 1.374 . . . . 25.0 116.534 -172.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.9 p -76.66 172.82 12.42 Favored 'General case' 0 C--O 1.252 1.236 0 C-N-CA 123.326 0.65 . . . . 25.0 110.541 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 44.6 mt -86.15 9.89 16.11 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.314 0.578 . . . . 25.0 109.918 174.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.37 -179.4 26.01 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.926 -0.579 . . . . 25.0 111.679 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.6 t -72.09 130.4 40.82 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 122.672 0.389 . . . . 25.0 110.879 175.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -142.37 157.32 44.92 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.491 -0.559 . . . . 50.0 109.491 -177.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -94.85 123.52 38.36 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 102.942 -2.985 . . . . 25.0 102.942 160.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.1 mm -114.0 100.96 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 108.374 -0.973 . . . . 25.0 108.374 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.521 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 10.4 mp -104.93 127.47 52.78 Favored 'General case' 0 C--O 1.212 -0.88 0 N-CA-C 103.766 -2.679 . . . . 25.0 103.766 -177.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.43 -32.1 14.55 Favored Glycine 0 CA--C 1.493 -1.309 0 C-N-CA 120.167 -1.016 . . . . 25.0 113.262 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.23 -143.34 39.12 Favored Glycine 0 C--O 1.242 0.608 0 N-CA-C 110.648 -0.981 . . . . 25.0 110.648 178.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.7 164.96 53.98 Favored Glycine 0 C--O 1.248 0.988 0 N-CA-C 114.443 0.537 . . . . 25.0 114.443 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.44 164.94 33.8 Favored Glycine 0 C--O 1.248 1.025 0 N-CA-C 114.743 0.657 . . . . 25.0 114.743 175.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.19 99.5 7.83 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.34 -1.356 . . . . 25.0 107.34 173.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -94.1 152.14 18.98 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 113.665 0.987 . . . . 50.0 113.665 -175.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -117.35 96.69 5.53 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.616 -1.253 . . . . 25.0 107.616 174.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 32.7 mt -104.53 137.56 42.2 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.573 -0.739 . . . . 25.0 110.329 -168.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -128.43 97.7 4.81 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.722 -0.611 . . . . 25.0 109.509 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.57 -33.47 60.85 Favored Glycine 0 C--N 1.318 -0.425 0 N-CA-C 116.352 1.301 . . . . 25.0 116.352 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 53.3 -149.6 0.4 Allowed 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.602 1.161 . . . . 25.0 113.948 -178.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.96 161.48 30.87 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-O 121.451 0.643 . . . . 25.0 110.368 -173.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.6 158.74 31.64 Favored Glycine 0 C--O 1.246 0.879 0 N-CA-C 109.549 -1.42 . . . . 25.0 109.549 -176.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -84.67 101.49 12.22 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.222 -1.029 . . . . 25.0 108.222 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -103.38 148.0 26.41 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 113.731 1.011 . . . . 50.0 113.731 -172.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mp -108.27 107.93 18.73 Favored 'General case' 0 C--O 1.217 -0.631 0 N-CA-C 107.052 -1.462 . . . . 25.0 107.052 177.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 mp -109.21 113.43 26.26 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 122.62 1.2 . . . . 25.0 112.976 -171.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -118.15 96.55 5.38 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 105.221 -2.14 . . . . 25.0 105.221 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.56 -28.57 71.56 Favored Glycine 0 C--O 1.253 1.282 0 O-C-N 121.734 -0.604 . . . . 25.0 114.373 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.1 -157.18 52.82 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 120.748 -0.739 . . . . 25.0 112.617 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.22 154.54 12.99 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 122.407 1.099 . . . . 25.0 113.504 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.97 178.59 52.52 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 114.32 -1.309 . . . . 25.0 109.964 -177.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -96.88 143.51 27.7 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 101.345 -3.576 . . . . 25.0 101.345 176.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -130.65 153.08 49.32 Favored 'General case' 0 CA--C 1.5 -0.948 0 C-N-CA 120.065 -0.654 . . . . 50.0 110.258 -171.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -110.71 126.75 54.88 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 101.445 -3.539 . . . . 25.0 101.445 174.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -149.6 129.86 13.71 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-O 123.136 1.446 . . . . 25.0 113.956 -175.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.3 m -96.55 140.33 31.34 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.335 -1.302 . . . . 25.0 109.489 177.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.1 -40.19 4.35 Favored Glycine 0 C--O 1.242 0.632 0 N-CA-C 111.608 -0.597 . . . . 25.0 111.608 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.91 -167.39 54.05 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-O 123.298 1.499 . . . . 25.0 113.771 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -63.95 162.96 12.91 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 113.646 -1.277 . . . . 25.0 108.789 175.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.05 163.0 38.56 Favored Glycine 0 C--N 1.344 1.005 0 N-CA-C 111.644 -0.583 . . . . 25.0 111.644 -177.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.89 109.46 20.24 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 122.038 0.923 . . . . 25.0 109.214 178.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -105.49 150.8 25.0 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.462 -0.79 . . . . 50.0 111.17 -169.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.4 m -121.27 128.23 52.15 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 124.195 0.935 . . . . 25.0 111.119 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -115.38 103.23 10.59 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.39 -0.823 . . . . 25.0 110.953 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 60.9 mtt85 -109.68 -28.98 8.56 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 118.516 0.598 . . . . 25.0 110.859 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 68.22 161.65 0.19 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.391 -0.966 . . . . 25.0 108.391 -175.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.91 -37.88 23.61 Favored 'General case' 0 C--O 1.246 0.875 0 O-C-N 120.939 -1.1 . . . . 25.0 113.964 -165.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.4 mt -137.5 166.34 24.11 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.925 0.869 . . . . 25.0 111.252 -176.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.13 -28.2 57.02 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.977 1.311 . . . . 25.0 108.474 169.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -75.17 -2.98 30.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.43 -0.805 . . . . 25.0 112.123 -177.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -105.96 154.16 20.98 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 115.721 1.749 . . . . 25.0 115.721 -177.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.7 t 50.58 48.39 22.67 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.542 1.682 . . . . 25.0 115.542 174.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 35.1 p-80 -133.44 175.58 9.29 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 114.356 -1.293 . . . . 25.0 108.966 -178.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -122.97 140.37 53.09 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 105.357 -2.09 . . . . 25.0 105.357 174.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 55.3 p -128.52 171.29 8.83 Favored Pre-proline 0 N--CA 1.471 0.624 0 O-C-N 125.165 1.54 . . . . 25.0 109.564 -178.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -58.16 -22.47 56.68 Favored 'Trans proline' 0 C--N 1.364 1.347 0 CA-C-N 119.616 0.899 . . . . 25.0 113.565 174.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.1 mt -82.9 -10.78 58.65 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.605 0.594 . . . . 25.0 112.605 -176.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 143.54 -171.3 25.3 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-O 117.681 -1.621 . . . . 25.0 113.376 -177.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.2 t -102.84 147.24 27.13 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.393 1.596 . . . . 25.0 113.153 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -126.08 20.57 7.56 Favored 'General case' 0 C--O 1.263 1.771 0 CA-C-N 113.719 -1.582 . . . . 25.0 109.48 174.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.86 143.48 41.83 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 111.249 -0.74 . . . . 25.0 111.249 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -92.62 167.98 11.55 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.945 -0.738 . . . . 50.0 111.006 -172.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.57 103.44 8.43 Favored 'General case' 0 C--O 1.259 1.56 0 O-C-N 121.915 -0.491 . . . . 25.0 111.882 -171.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 mt -92.07 130.43 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-O 122.085 0.945 . . . . 25.0 108.535 -174.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.3 mt -82.58 -41.67 19.26 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 116.248 1.944 . . . . 25.0 116.248 -173.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 44.5 p-10 -139.51 53.44 1.71 Allowed 'General case' 0 C--O 1.252 1.193 0 CA-C-O 122.137 0.97 . . . . 25.0 113.594 -176.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -64.66 131.57 47.29 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 114.887 -1.051 . . . . 25.0 110.218 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -111.66 104.66 56.3 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 106.919 -1.512 . . . . 25.0 106.919 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -69.23 -12.26 33.47 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 N-CA-C 116.287 1.61 . . . . 25.0 116.287 -175.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.2 p -85.02 -16.7 39.89 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.627 -0.879 . . . . 25.0 108.627 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -108.78 -48.04 3.37 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 115.028 1.492 . . . . 25.0 115.028 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -92.08 169.13 10.88 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.218 -0.901 . . . . 50.0 112.348 -160.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -146.11 146.08 30.76 Favored 'General case' 0 C--O 1.249 1.052 0 C-N-CA 123.275 0.63 . . . . 25.0 111.812 -176.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 67.2 mt -127.73 134.87 64.52 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.051 0 N-CA-C 107.524 -1.288 . . . . 25.0 107.524 -177.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.77 139.49 30.52 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 107.446 -1.316 . . . . 25.0 107.446 174.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.3 p -137.76 -12.38 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 115.714 1.746 . . . . 25.0 115.714 -178.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.7 t -72.17 -27.57 62.67 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.709 1.14 . . . . 25.0 109.816 -177.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.31 -24.82 61.38 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.626 -1.17 . . . . 25.0 112.141 174.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 16.5 mt -107.19 -45.08 4.2 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.781 1.4 . . . . 25.0 114.781 -172.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -123.03 -66.58 0.22 Allowed Glycine 0 N--CA 1.472 1.035 0 N-CA-C 117.974 1.95 . . . . 25.0 117.974 -171.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -150.63 166.85 29.06 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 109.675 -0.491 . . . . 25.0 109.675 -170.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.7 t -118.51 -31.12 5.0 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.708 -1.133 . . . . 25.0 110.841 176.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -100.98 122.32 7.56 Favored Glycine 0 N--CA 1.462 0.373 0 N-CA-C 106.967 -2.453 . . . . 25.0 106.967 175.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.25 145.4 55.81 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-O 121.383 0.611 . . . . 25.0 111.744 -177.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -81.0 -170.97 44.11 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 115.328 -0.851 . . . . 25.0 113.773 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -64.33 132.94 51.63 Favored 'General case' 0 C--O 1.253 1.278 0 CA-C-O 121.769 0.795 . . . . 25.0 111.532 -177.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -177.95 -172.36 42.32 Favored Glycine 0 CA--C 1.539 1.59 0 N-CA-C 109.045 -1.622 . . . . 25.0 109.045 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -143.43 167.14 22.89 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 118.847 1.323 . . . . 25.0 112.017 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 55.11 42.24 30.94 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.143 1.377 . . . . 25.0 112.901 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 69.36 32.98 72.24 Favored Glycine 0 C--O 1.245 0.83 0 N-CA-C 110.097 -1.201 . . . . 25.0 110.097 176.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.5 t -146.78 166.43 26.68 Favored 'General case' 0 C--O 1.214 -0.788 0 CA-C-N 118.349 1.074 . . . . 25.0 110.573 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.5 mt -88.37 166.57 14.17 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 104.421 -2.437 . . . . 25.0 104.421 176.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.49 119.27 15.4 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-N 119.245 0.929 . . . . 25.0 110.241 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 35.4 m -85.79 162.1 2.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.047 -0.979 . . . . 25.0 110.481 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.7 m -140.86 168.41 19.87 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 110.32 -0.252 . . . . 25.0 110.32 -177.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 30.4 m -128.54 161.75 36.69 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 N-CA-C 107.223 -1.399 . . . . 25.0 107.223 175.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.2 t -72.09 -47.37 51.88 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 106.518 -1.66 . . . . 25.0 106.518 173.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -167.03 -161.51 0.43 Allowed 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 102.13 -3.285 . . . . 25.0 102.13 -176.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -68.32 -17.73 64.34 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 120.259 1.391 . . . . 25.0 112.039 -177.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -129.33 -155.04 8.37 Favored Glycine 0 N--CA 1.44 -1.048 0 N-CA-C 108.497 -1.841 . . . . 25.0 108.497 176.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 56.06 -150.68 0.42 Allowed 'General case' 0 N--CA 1.473 0.708 0 O-C-N 122.82 -0.223 . . . . 25.0 111.137 -178.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 27.8 mtt85 -77.45 158.78 29.83 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 116.851 2.167 . . . . 25.0 116.851 -169.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.0 163.36 16.03 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 113.47 -1.695 . . . . 25.0 106.591 177.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -137.51 154.32 49.88 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 118.451 0.569 . . . . 25.0 111.519 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 33.8 tp -123.56 119.63 30.48 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 105.754 -1.943 . . . . 25.0 105.754 169.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -119.24 154.9 32.69 Favored 'General case' 0 C--O 1.246 0.91 0 CA-C-O 121.712 0.768 . . . . 25.0 112.811 -173.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.1 t -103.0 153.69 19.98 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 104.666 -2.346 . . . . 25.0 104.666 169.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -120.67 9.52 10.81 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 122.346 1.069 . . . . 25.0 109.054 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -93.92 136.58 34.05 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 105.423 -2.065 . . . . 25.0 105.423 171.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -139.11 147.56 42.12 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.895 0.855 . . . . 25.0 110.057 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -73.99 159.25 32.98 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.012 -1.107 . . . . 25.0 108.012 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -61.98 -23.8 66.62 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 120.867 0.365 . . . . 25.0 110.587 177.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -75.83 -2.45 30.05 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.702 0.801 . . . . 25.0 111.934 177.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.39 15.8 70.55 Favored Glycine 0 C--O 1.238 0.351 0 C-N-CA 121.365 -0.445 . . . . 25.0 112.895 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 75.4 mt -88.87 139.48 30.42 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.529 -1.286 . . . . 25.0 107.529 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 86.8 p -148.56 176.19 10.53 Favored 'General case' 0 C--O 1.249 1.05 0 N-CA-C 108.771 -0.826 . . . . 25.0 108.771 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -122.28 131.8 54.1 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 113.439 0.903 . . . . 25.0 113.439 -176.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -150.28 154.21 37.5 Favored 'General case' 0 C--O 1.266 1.924 0 N-CA-C 107.317 -1.364 . . . . 25.0 107.317 168.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.4 p -145.73 146.79 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 106.813 -1.551 . . . . 25.0 106.813 175.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -112.1 142.45 44.53 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.533 -0.914 . . . . 25.0 108.533 -171.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.2 mp -133.78 143.96 48.74 Favored 'General case' 0 C--O 1.197 -1.685 0 N-CA-C 103.617 -2.734 . . . . 25.0 103.617 -173.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -115.88 5.56 14.07 Favored 'General case' 0 C--O 1.206 -1.225 0 N-CA-C 117.885 2.55 . . . . 25.0 117.885 -175.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.94 0.59 86.78 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 116.244 1.258 . . . . 25.0 116.244 177.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 41.8 t0 55.45 53.07 10.28 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 122.832 1.301 . . . . 25.0 110.359 178.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -118.65 38.64 3.7 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 113.455 -1.702 . . . . 25.0 108.428 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.9 -39.49 78.04 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.773 -0.648 . . . . 25.0 112.084 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.78 -19.47 62.0 Favored 'General case' 0 CA--C 1.577 2.005 0 O-C-N 121.156 -0.965 . . . . 25.0 112.545 -177.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.22 -26.42 20.1 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 116.132 -0.486 . . . . 25.0 111.805 177.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 22.0 mt -60.25 132.39 53.76 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 121.203 0.525 . . . . 25.0 109.646 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.9 m -135.22 160.96 36.73 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 107.529 -1.286 . . . . 25.0 107.529 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.83 -1.29 57.1 Favored 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 108.232 -1.025 . . . . 25.0 108.232 178.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -69.2 -30.04 68.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.884 -0.598 . . . . 25.0 110.838 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -90.44 -5.93 55.5 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.268 0.556 . . . . 25.0 111.018 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 17.0 mm -89.91 123.99 42.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 105.785 -1.932 . . . . 25.0 105.785 176.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.7 p -98.45 117.1 42.88 Favored 'Isoleucine or valine' 0 C--O 1.251 1.145 0 CA-C-O 122.831 1.301 . . . . 25.0 113.318 -175.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -143.97 0.56 1.08 Allowed 'General case' 0 C--O 1.251 1.146 0 CA-C-N 112.358 -2.201 . . . . 25.0 108.547 178.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.15 45.0 0.98 Allowed 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.009 0.374 . . . . 25.0 112.009 -178.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 53.49 37.57 26.02 Favored 'General case' 0 CA--C 1.561 1.4 0 CA-C-O 121.172 0.51 . . . . 25.0 112.363 -178.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.99 -4.32 0.2 Allowed 'General case' 0 CA--C 1.56 1.363 0 N-CA-C 115.636 1.717 . . . . 25.0 115.636 177.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -89.96 125.32 35.33 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 120.713 -1.242 . . . . 25.0 113.612 -177.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -77.22 -4.18 43.45 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 113.405 0.891 . . . . 25.0 113.405 -177.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -77.04 40.5 0.26 Allowed 'General case' 0 C--O 1.217 -0.649 0 N-CA-C 114.577 1.325 . . . . 25.0 114.577 178.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -152.93 -165.43 2.18 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.128 -0.694 . . . . 25.0 109.128 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 60.97 -167.11 0.19 Allowed 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 113.6 0.963 . . . . 25.0 113.6 174.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 82.2 15.89 73.28 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.374 -0.69 . . . . 25.0 111.374 -177.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -99.66 108.61 21.02 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.95 0.722 . . . . 25.0 112.95 -176.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -128.57 155.68 44.53 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 106.71 -1.589 . . . . 25.0 106.71 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -125.95 31.19 4.17 Favored Glycine 0 C--O 1.217 -0.945 0 CA-C-O 121.746 0.636 . . . . 25.0 111.895 175.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 92.3 t -73.45 -38.11 52.21 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 O-C-N 122.286 -0.538 . . . . 25.0 110.33 -175.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.56 137.73 23.83 Favored 'Isoleucine or valine' 0 C--O 1.258 1.532 0 CA-C-O 121.459 0.647 . . . . 25.0 110.442 -175.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 153.9 165.95 14.29 Favored Glycine 0 C--O 1.245 0.836 0 CA-C-N 115.482 -0.781 . . . . 25.0 111.991 -178.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -143.85 139.53 29.32 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 112.957 0.725 . . . . 25.0 112.957 176.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 84.4 p -142.69 179.9 6.71 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.857 -1.164 . . . . 25.0 107.857 175.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 135.5 172.96 12.86 Favored Glycine 0 C--O 1.24 0.517 0 N-CA-C 115.034 0.774 . . . . 25.0 115.034 175.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -137.04 113.54 9.75 Favored Pre-proline 0 C--O 1.26 1.608 0 CA-C-N 114.929 -0.635 . . . . 25.0 110.382 178.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -68.06 153.95 73.77 Favored 'Trans proline' 0 C--N 1.356 0.964 0 O-C-N 122.509 0.741 . . . . 25.0 110.663 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -128.36 139.52 52.34 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.772 -1.196 . . . . 25.0 107.772 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -131.52 69.11 81.64 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 112.689 0.626 . . . . 25.0 112.689 -177.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -70.26 150.25 64.88 Favored 'Trans proline' 0 C--N 1.346 0.419 0 CA-C-O 122.107 0.795 . . . . 25.0 113.016 -178.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.4 t -97.71 1.33 48.42 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.357 -0.838 . . . . 25.0 111.734 -175.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 C--O 1.253 1.281 0 CA-C-O 118.089 -0.957 . . . . 25.0 110.86 -177.429 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo . . . . . 0 CA--C 1.54 0.811 0 N-CA-C 114.262 0.832 . . . . 25.0 114.262 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.27 58.33 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.208 0 N-CA-C 108.362 -1.895 . . . . 25.0 108.362 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.1 p -60.29 132.77 25.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 123.219 1.485 . . . . 25.0 112.064 -170.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -101.26 -11.56 19.39 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.789 -1.096 . . . . 25.0 110.065 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.75 -151.63 14.46 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 114.735 -1.12 . . . . 25.0 112.61 177.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.2 p 73.08 158.17 0.16 Allowed Pre-proline 0 N--CA 1.496 1.854 0 C-N-CA 126.242 1.817 . . . . 25.0 110.187 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.416 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 37.6 Cg_exo -65.68 -0.81 4.11 Favored 'Trans proline' 0 C--N 1.349 0.602 0 N-CA-C 116.465 1.679 . . . . 25.0 116.465 -175.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.58 -19.23 20.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 114.311 1.226 . . . . 25.0 114.311 -173.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.5 p -140.45 136.05 36.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 114.096 1.147 . . . . 25.0 114.096 -174.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.44 25.57 56.57 Favored Glycine 0 C--O 1.242 0.652 0 N-CA-C 117.343 1.697 . . . . 25.0 117.343 172.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.9 t -50.09 -54.58 19.51 Favored 'General case' 0 C--O 1.22 -0.468 0 O-C-N 121.15 -1.206 . . . . 25.0 113.459 -175.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -80.17 4.64 16.79 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 116.447 2.018 . . . . 25.0 116.447 -171.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 pp -142.04 168.4 19.83 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 112.915 0.709 . . . . 25.0 112.915 -174.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -61.67 130.45 45.91 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.695 0.798 . . . . 25.0 112.03 -175.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -125.23 168.67 13.15 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 116.442 2.016 . . . . 50.0 116.442 -175.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -129.72 96.9 4.36 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 105.654 -1.98 . . . . 25.0 105.654 164.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 81.2 mt -108.92 113.03 25.59 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 112.462 0.541 . . . . 25.0 112.462 -176.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -104.38 113.69 27.42 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 108.409 -0.96 . . . . 25.0 108.409 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.47 177.85 48.79 Favored Glycine 0 CA--C 1.51 -0.23 0 N-CA-C 117.331 1.692 . . . . 25.0 117.331 -174.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.2 p -77.06 168.82 19.43 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-O 122.0 0.905 . . . . 25.0 112.501 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 77.6 mt -85.63 24.61 1.19 Allowed 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 114.624 -1.171 . . . . 25.0 111.531 176.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -128.77 179.36 16.68 Favored Glycine 0 N--CA 1.467 0.703 0 N-CA-C 110.48 -1.048 . . . . 25.0 110.48 175.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.1 t -66.53 137.41 56.77 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 117.86 0.83 . . . . 25.0 111.736 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -146.46 165.68 28.67 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 122.027 -0.421 . . . . 50.0 110.88 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -116.16 121.21 41.45 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 102.67 -3.085 . . . . 25.0 102.67 170.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 46.6 mm -117.12 129.29 73.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 107.523 -1.288 . . . . 25.0 107.523 -176.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.416 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 7.1 mp -128.77 125.18 37.31 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 105.399 -2.075 . . . . 25.0 105.399 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.14 -35.1 24.86 Favored Glycine 0 C--O 1.255 1.453 0 N-CA-C 115.698 1.039 . . . . 25.0 115.698 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.03 -148.43 44.48 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.38 -0.914 . . . . 25.0 111.434 -178.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.96 165.23 54.8 Favored Glycine 0 C--O 1.248 1.015 0 CA-C-O 122.471 1.039 . . . . 25.0 111.705 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.31 162.69 33.3 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 114.731 -0.734 . . . . 25.0 113.488 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.9 101.0 12.48 Favored 'General case' 0 C--O 1.203 -1.343 0 N-CA-C 105.022 -2.214 . . . . 25.0 105.022 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -96.82 151.62 19.49 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 115.88 -0.6 . . . . 50.0 110.536 -170.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -110.81 103.22 11.72 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 106.552 -1.647 . . . . 25.0 106.552 171.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 43.3 mt -106.3 132.12 52.72 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 124.032 0.833 . . . . 25.0 111.064 -174.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -130.15 104.26 7.21 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 121.465 0.65 . . . . 25.0 110.959 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.98 -30.23 63.65 Favored Glycine 0 N--CA 1.466 0.635 0 N-CA-C 116.165 1.226 . . . . 25.0 116.165 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 50.3 -151.35 0.2 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 118.29 1.045 . . . . 25.0 112.857 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.06 160.51 15.02 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.413 0.894 . . . . 25.0 113.413 -175.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.83 157.02 31.73 Favored Glycine 0 C--O 1.238 0.345 0 CA-C-N 114.778 -1.101 . . . . 25.0 111.192 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -80.4 102.91 9.91 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.236 -1.024 . . . . 25.0 108.236 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -106.05 157.75 17.3 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.344 0.592 . . . . 50.0 111.249 -169.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 mp -114.96 131.9 56.75 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 106.17 -1.789 . . . . 25.0 106.17 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.5 mp -132.71 127.09 34.02 Favored 'General case' 0 C--O 1.25 1.107 0 N-CA-C 115.217 1.562 . . . . 25.0 115.217 -174.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -120.04 145.16 47.1 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 107.333 -1.358 . . . . 25.0 107.333 172.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -98.3 -39.78 3.64 Favored Glycine 0 N--CA 1.465 0.618 0 C-N-CA 120.963 -0.637 . . . . 25.0 113.715 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.97 -167.74 54.71 Favored Glycine 0 N--CA 1.465 0.632 0 N-CA-C 110.107 -1.197 . . . . 25.0 110.107 -177.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.67 143.67 29.61 Favored 'General case' 0 CA--C 1.557 1.241 0 CA-C-O 121.85 0.833 . . . . 25.0 111.959 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.35 167.43 32.68 Favored Glycine 0 C--O 1.245 0.781 0 CA-C-N 115.169 -0.923 . . . . 25.0 113.365 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.94 114.05 23.24 Favored 'General case' 0 C--O 1.208 -1.124 0 N-CA-C 104.731 -2.322 . . . . 25.0 104.731 175.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -103.48 151.76 22.46 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.915 -0.584 . . . . 50.0 109.814 -173.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -116.09 122.83 46.31 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 104.869 -2.271 . . . . 25.0 104.869 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -145.42 138.52 26.28 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 117.651 2.463 . . . . 25.0 117.651 -169.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.422 ' OG ' HD12 ' A' ' 85' ' ' LEU . 73.2 m -111.13 141.12 45.05 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-N 115.332 -0.849 . . . . 25.0 108.998 176.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.13 -37.74 6.62 Favored Glycine 0 N--CA 1.44 -1.069 0 N-CA-C 110.296 -1.122 . . . . 25.0 110.296 172.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.51 -169.78 54.86 Favored Glycine 0 CA--C 1.507 -0.423 0 C-N-CA 119.941 -1.124 . . . . 25.0 113.439 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -63.51 154.95 30.82 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.604 -0.939 . . . . 25.0 111.369 176.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.75 162.66 30.06 Favored Glycine 0 C--O 1.244 0.729 0 N-CA-C 109.914 -1.274 . . . . 25.0 109.914 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.04 110.99 19.33 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.056 -1.09 . . . . 25.0 108.056 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -103.97 154.53 19.56 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.569 -0.453 . . . . 50.0 112.113 -170.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.5 m -120.22 105.71 11.22 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.438 -0.578 . . . . 25.0 109.438 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -89.1 93.65 9.66 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 105.159 -2.163 . . . . 25.0 105.159 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -92.55 -30.28 15.75 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 112.888 0.699 . . . . 25.0 112.888 -166.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 63.56 156.41 0.06 Allowed 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 124.337 1.055 . . . . 25.0 112.838 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.88 -67.51 0.7 Allowed 'General case' 0 C--O 1.252 1.203 0 N-CA-C 115.896 1.813 . . . . 25.0 115.896 -170.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.8 mt -137.92 -177.69 4.93 Favored 'General case' 0 C--O 1.216 -0.663 0 O-C-N 121.523 -0.736 . . . . 25.0 109.239 -173.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -53.24 -30.14 36.41 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.709 -0.848 . . . . 25.0 108.709 170.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -76.66 4.2 9.96 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 115.391 1.626 . . . . 25.0 115.391 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -118.09 142.15 47.72 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 118.173 0.442 . . . . 25.0 111.639 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.2 t 49.28 53.27 12.93 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 122.469 1.128 . . . . 25.0 112.272 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 31.9 p-80 -137.1 174.05 11.03 Favored 'General case' 0 C--O 1.212 -0.905 0 CA-C-N 114.754 -1.112 . . . . 25.0 109.229 -174.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -126.01 143.26 51.17 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 105.754 -1.943 . . . . 25.0 105.754 173.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.6 p -133.25 170.8 10.43 Favored Pre-proline 0 C--N 1.318 -0.778 0 N-CA-C 108.122 -1.066 . . . . 25.0 108.122 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.42 -16.79 43.9 Favored 'Trans proline' 0 C--O 1.206 -1.121 0 C-N-CA 117.09 -1.473 . . . . 25.0 114.043 177.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 88.8 mt -77.83 -29.81 50.8 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 120.101 -0.64 . . . . 25.0 110.966 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.55 -178.35 34.8 Favored Glycine 0 C--O 1.219 -0.829 0 N-CA-C 110.607 -0.997 . . . . 25.0 110.607 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t -96.43 148.06 23.19 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-O 122.755 1.264 . . . . 25.0 111.1 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -134.74 28.05 3.6 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 113.639 -1.619 . . . . 25.0 107.844 176.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.34 137.72 29.74 Favored Glycine 0 C--N 1.34 0.799 0 N-CA-C 108.861 -1.696 . . . . 25.0 108.861 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -87.58 165.09 15.72 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 121.321 -1.105 . . . . 50.0 110.393 -172.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -119.18 100.23 7.2 Favored 'General case' 0 C--O 1.257 1.454 0 CA-C-O 121.352 0.596 . . . . 25.0 111.687 -171.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.8 mt -89.26 132.88 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-O 123.011 1.386 . . . . 25.0 107.951 -175.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.422 HD12 ' OG ' ' A' ' 56' ' ' SER . 94.7 mt -83.93 -43.09 15.61 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 114.81 1.411 . . . . 25.0 114.81 -174.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -138.64 40.21 2.2 Favored 'General case' 0 C--O 1.26 1.608 0 N-CA-C 115.28 1.585 . . . . 25.0 115.28 -172.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -56.75 128.39 36.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.525 0.678 . . . . 25.0 111.914 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -97.96 108.1 44.47 Favored Pre-proline 0 N--CA 1.469 0.492 0 N-CA-C 106.911 -1.515 . . . . 25.0 106.911 175.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -72.4 -4.55 15.47 Favored 'Trans proline' 0 CA--C 1.552 1.394 0 N-CA-C 115.63 1.358 . . . . 25.0 115.63 -174.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 29.7 t -95.0 -46.75 6.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.085 0.469 . . . . 25.0 109.859 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -92.15 -40.52 10.97 Favored 'General case' 0 C--O 1.245 0.867 0 N-CA-C 114.382 1.253 . . . . 25.0 114.382 -172.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -84.87 171.52 12.15 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.695 0.76 . . . . 75.0 110.079 -173.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.63 155.62 45.71 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.606 0.763 . . . . 25.0 111.32 174.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 77.9 mt -125.44 124.34 66.77 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 106.796 -1.557 . . . . 25.0 106.796 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -86.25 150.75 24.15 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 119.728 -0.789 . . . . 25.0 109.179 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.9 p -154.64 -1.6 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 115.418 -0.81 . . . . 25.0 111.674 -176.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.2 t -66.28 -51.28 59.0 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.635 0.605 . . . . 25.0 112.635 -174.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.9 -24.35 60.83 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.886 0.699 . . . . 25.0 112.886 -176.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.56 -29.35 9.23 Favored 'General case' 0 C--O 1.212 -0.872 0 N-CA-C 118.075 2.621 . . . . 25.0 118.075 -174.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -121.69 -65.21 0.24 Allowed Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.456 -0.878 . . . . 25.0 115.03 -172.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -162.26 163.55 28.08 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 117.21 0.505 . . . . 25.0 109.759 -175.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 77.8 p -114.7 -28.79 6.99 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.557 0.536 . . . . 25.0 110.647 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -103.29 120.35 6.72 Favored Glycine 0 C--O 1.239 0.431 0 N-CA-C 110.642 -0.983 . . . . 25.0 110.642 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -67.24 151.18 47.99 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 118.865 1.333 . . . . 25.0 111.597 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -97.55 -157.33 30.48 Favored Glycine 0 CA--C 1.507 -0.435 0 CA-C-N 115.141 -0.936 . . . . 25.0 112.965 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -54.91 136.74 46.87 Favored 'General case' 0 C--O 1.245 0.868 0 N-CA-C 113.954 1.094 . . . . 25.0 113.954 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 165.94 172.43 33.29 Favored Glycine 0 C--O 1.22 -0.746 0 N-CA-C 109.457 -1.457 . . . . 25.0 109.457 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -141.18 166.68 24.11 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.022 0.911 . . . . 25.0 109.194 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 56.2 34.21 23.53 Favored 'General case' 0 CA--C 1.551 1.009 0 O-C-N 124.305 1.003 . . . . 25.0 113.127 -176.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.07 38.68 59.49 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 111.132 -0.787 . . . . 25.0 111.132 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.1 t -139.99 -174.23 3.86 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.803 0.802 . . . . 25.0 113.152 -176.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 52.2 mt -114.9 150.71 35.21 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 101.127 -3.657 . . . . 25.0 101.127 174.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.93 132.45 47.98 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-O 121.357 0.598 . . . . 25.0 110.058 -175.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 32.9 m -97.02 164.85 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 115.435 -0.802 . . . . 25.0 111.533 -176.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.8 m -139.95 164.54 29.74 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 110.313 -0.255 . . . . 25.0 110.313 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.3 m -126.78 166.31 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 107.584 -1.265 . . . . 25.0 107.584 176.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 30.3 t -81.55 -56.63 3.9 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 106.961 -1.496 . . . . 25.0 106.961 173.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -161.98 -147.59 0.13 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 105.263 -2.125 . . . . 25.0 105.263 -177.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -66.64 -21.68 66.11 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.371 0.268 . . . . 25.0 110.409 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -138.68 -150.38 5.59 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 110.385 -1.086 . . . . 25.0 110.385 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.19 -155.59 0.35 Allowed 'General case' 0 C--O 1.259 1.594 0 C-N-CA 123.053 0.541 . . . . 25.0 111.049 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 54.0 mtt85 -85.19 160.75 19.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 122.017 0.913 . . . . 25.0 113.018 -172.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 12.3 p -107.8 163.83 12.77 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 106.187 -1.783 . . . . 25.0 106.187 173.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -135.01 158.05 45.36 Favored 'General case' 0 CA--C 1.51 -0.587 0 O-C-N 123.529 0.518 . . . . 25.0 112.325 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 45.2 tp -128.7 136.17 50.23 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 103.759 -2.682 . . . . 25.0 103.759 172.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -127.44 148.81 50.29 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 122.468 1.128 . . . . 25.0 110.955 -176.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 32.4 t -101.96 146.5 27.78 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 103.874 -2.639 . . . . 25.0 103.874 168.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -108.82 10.45 26.59 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.406 0.622 . . . . 25.0 109.667 -174.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -94.45 143.51 26.35 Favored 'General case' 0 C--O 1.259 1.57 0 CA-C-N 113.608 -1.633 . . . . 25.0 108.938 167.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -149.12 156.7 42.58 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.809 -0.811 . . . . 25.0 108.809 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -70.24 160.58 31.92 Favored 'General case' 0 C--O 1.217 -0.635 0 N-CA-C 107.823 -1.177 . . . . 25.0 107.823 173.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.91 -21.53 66.51 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.401 -0.592 . . . . 25.0 109.401 175.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -79.68 -3.56 47.87 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.04 0.755 . . . . 25.0 113.04 177.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.96 24.01 46.86 Favored Glycine 0 N--CA 1.466 0.66 0 C-N-CA 121.113 -0.565 . . . . 25.0 113.42 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 35.9 mt -94.8 111.71 23.47 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.628 -1.249 . . . . 25.0 107.628 176.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 42.9 p -122.42 174.17 7.2 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 118.645 -0.693 . . . . 25.0 109.474 -174.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -116.39 126.3 53.27 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.344 0.52 . . . . 25.0 111.247 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -145.77 153.82 41.36 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 107.207 -1.405 . . . . 25.0 107.207 171.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 11.7 p -145.89 145.66 20.0 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 N-CA-C 106.77 -1.567 . . . . 25.0 106.77 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -106.16 143.82 33.74 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.884 -0.784 . . . . 25.0 108.884 -175.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mp -134.46 134.35 41.44 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.514 -1.291 . . . . 25.0 107.514 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -110.8 8.88 22.55 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 119.706 1.139 . . . . 25.0 112.668 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -78.91 -10.68 85.96 Favored Glycine 0 C--O 1.243 0.695 0 C-N-CA 119.596 -1.287 . . . . 25.0 112.57 174.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 48.4 t0 49.45 64.43 1.75 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 122.946 1.355 . . . . 25.0 112.051 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -130.52 36.54 3.93 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 106.274 -1.751 . . . . 25.0 106.274 176.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.55 -33.58 71.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.718 -1.128 . . . . 25.0 108.162 174.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.92 -11.73 49.39 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 113.302 0.852 . . . . 25.0 113.302 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -119.85 1.71 11.01 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 121.671 -0.643 . . . . 25.0 112.069 -178.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 14.9 mt -72.19 148.45 45.58 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.303 -0.559 . . . . 25.0 111.433 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 83.7 p -147.45 159.37 43.79 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 106.635 -1.617 . . . . 25.0 106.635 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.59 -1.9 52.16 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 108.698 -0.852 . . . . 25.0 108.698 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -68.84 -35.68 77.25 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.536 -0.913 . . . . 25.0 108.536 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -89.15 0.08 57.02 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.786 -0.571 . . . . 25.0 110.374 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 46.3 mm -94.85 113.74 29.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 104.251 -2.499 . . . . 25.0 104.251 174.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.7 p -98.78 101.91 12.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 124.081 1.896 . . . . 25.0 111.905 -170.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -116.78 -14.17 10.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 112.983 -1.917 . . . . 25.0 109.962 173.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -81.91 28.48 0.42 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.02 1.118 . . . . 25.0 114.02 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 55.66 33.32 21.04 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.232 0.827 . . . . 25.0 113.232 177.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.78 25.07 11.47 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.179 0.991 . . . . 25.0 112.698 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -90.01 133.76 34.63 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.594 -1.262 . . . . 25.0 107.594 174.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -112.82 23.04 13.86 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.203 0.601 . . . . 25.0 111.623 -176.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.79 -32.81 71.49 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 122.098 -0.376 . . . . 25.0 111.314 176.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -104.5 -156.13 0.56 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 123.29 0.636 . . . . 25.0 110.562 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 67.09 175.08 0.25 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.046 1.338 . . . . 25.0 113.824 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 87.04 9.1 74.39 Favored Glycine 0 C--O 1.224 -0.49 0 CA-C-N 115.757 -0.656 . . . . 25.0 112.478 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -82.84 100.06 10.1 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-O 121.197 0.522 . . . . 25.0 110.722 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -126.33 149.07 49.41 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.43 0.633 . . . . 25.0 109.849 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.91 33.89 2.4 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 110.746 -0.941 . . . . 25.0 110.746 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 45.1 t -73.6 -29.55 27.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.751 -0.724 . . . . 25.0 109.418 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 19.2 tt -57.18 134.67 21.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 N-CA-C 112.84 0.681 . . . . 25.0 112.84 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 158.02 157.59 8.53 Favored Glycine 0 C--O 1.222 -0.596 0 N-CA-C 114.681 0.632 . . . . 25.0 114.681 175.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -146.08 136.35 23.82 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 123.456 0.151 . . . . 25.0 110.639 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 53.6 p -152.73 163.96 38.68 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 106.97 -1.493 . . . . 25.0 106.97 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -167.44 162.46 36.25 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 114.738 0.655 . . . . 25.0 114.738 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -133.45 80.18 58.28 Favored Pre-proline 0 N--CA 1.468 0.432 0 N-CA-C 108.832 -0.803 . . . . 25.0 108.832 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -72.82 152.79 52.94 Favored 'Trans proline' 0 C--N 1.352 0.763 0 N-CA-C 114.889 1.073 . . . . 25.0 114.889 -171.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -111.01 157.13 20.29 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.42 -0.955 . . . . 25.0 108.42 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -132.12 75.01 75.71 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 112.722 0.638 . . . . 25.0 112.722 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.49 158.72 47.5 Favored 'Trans proline' 0 C--O 1.219 -0.46 0 CA-C-O 121.11 0.379 . . . . 25.0 112.845 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.7 t -132.32 -0.5 3.65 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.611 0.72 . . . . 25.0 111.837 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 C--O 1.247 0.922 0 N-CA-C 108.808 -0.812 . . . . 25.0 108.808 178.288 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo . . . . . 0 C--O 1.241 0.628 0 N-CA-C 115.002 1.116 . . . . 25.0 115.002 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.53 75.2 0.06 OUTLIER Glycine 0 C--O 1.22 -0.779 0 N-CA-C 108.797 -1.721 . . . . 25.0 108.797 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.456 HG22 ' H ' ' A' ' 7' ' ' GLY . 14.3 p -57.48 131.71 21.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-O 122.312 1.053 . . . . 25.0 111.59 -172.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -88.99 -15.04 35.15 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 114.616 -1.174 . . . . 25.0 110.987 -176.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.456 ' H ' HG22 ' A' ' 5' ' ' VAL . . . -88.08 -141.03 7.23 Favored Glycine 0 CA--C 1.506 -0.499 0 C-N-CA 121.263 -0.494 . . . . 25.0 114.17 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.0 p 71.85 157.31 0.16 Allowed Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 126.854 2.061 . . . . 25.0 111.179 -176.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.487 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 37.6 Cg_exo -65.49 1.39 2.15 Favored 'Trans proline' 0 C--N 1.362 1.249 0 N-CA-C 117.358 2.022 . . . . 25.0 117.358 -178.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.9 p -62.86 -19.0 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 115.486 1.661 . . . . 25.0 115.486 -172.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.6 p -146.61 136.12 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 113.917 1.08 . . . . 25.0 113.917 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.08 29.68 14.53 Favored Glycine 0 N--CA 1.462 0.422 0 N-CA-C 116.856 1.502 . . . . 25.0 116.856 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.9 t -57.25 -65.29 0.65 Allowed 'General case' 0 C--O 1.239 0.538 0 N-CA-C 114.132 1.16 . . . . 25.0 114.132 -177.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -80.35 10.2 4.88 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 114.347 1.24 . . . . 25.0 114.347 -170.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.91 174.56 10.39 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 118.912 -0.566 . . . . 25.0 110.461 -172.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -60.52 150.27 31.96 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 118.861 0.755 . . . . 25.0 111.72 -177.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -128.12 156.22 43.18 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.588 1.329 . . . . 50.0 114.588 -175.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -137.15 94.27 2.93 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 102.851 -3.018 . . . . 25.0 102.851 163.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.0 mt -120.25 111.72 18.16 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 114.483 1.29 . . . . 25.0 114.483 -173.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -98.19 104.94 17.01 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 115.744 -0.662 . . . . 25.0 111.484 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.95 179.55 52.68 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 117.584 1.794 . . . . 25.0 117.584 -173.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.0 p -74.63 169.54 17.59 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 112.246 0.461 . . . . 25.0 112.246 -177.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 51.2 mt -89.05 14.12 11.4 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.912 0.863 . . . . 25.0 110.332 175.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.67 178.77 17.79 Favored Glycine 0 C--O 1.223 -0.56 0 N-CA-C 108.638 -1.785 . . . . 25.0 108.638 175.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.7 t -70.29 140.91 52.41 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 117.356 0.578 . . . . 25.0 111.351 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -146.15 164.35 32.5 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.784 -0.821 . . . . 50.0 108.784 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -106.35 121.76 44.88 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 102.777 -3.045 . . . . 25.0 102.777 162.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.0 mm -109.18 111.31 35.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 107.487 -1.301 . . . . 25.0 107.487 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.487 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 4.4 mp -112.34 117.51 32.67 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.609 -1.256 . . . . 25.0 107.609 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.4 -27.69 38.78 Favored Glycine 0 C--O 1.206 -1.608 0 CA-C-O 119.133 -0.815 . . . . 25.0 114.425 -176.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.6 -147.08 44.76 Favored Glycine 0 C--O 1.243 0.658 0 C-N-CA 120.152 -1.023 . . . . 25.0 111.636 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.85 177.13 53.4 Favored Glycine 0 C--O 1.242 0.623 0 N-CA-C 112.054 -0.418 . . . . 25.0 112.054 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.04 166.87 29.31 Favored Glycine 0 C--N 1.316 -0.564 0 CA-C-N 115.854 -0.173 . . . . 25.0 112.906 176.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.01 105.19 13.8 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 106.875 -1.528 . . . . 25.0 106.875 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -104.81 138.84 40.47 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.772 -0.771 . . . . 50.0 111.596 -168.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -106.33 96.11 6.24 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.094 -1.817 . . . . 25.0 106.094 173.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 45.5 mt -105.65 143.51 33.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.247 -0.433 . . . . 25.0 110.454 -172.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -136.77 107.46 6.57 Favored 'General case' 0 C--O 1.248 0.983 0 CA-C-O 121.319 0.581 . . . . 25.0 110.698 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.05 -23.47 71.6 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 117.94 -1.478 . . . . 25.0 116.649 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 52.71 -159.13 0.13 Allowed 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 119.217 1.508 . . . . 25.0 111.814 -176.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.73 167.63 10.9 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 121.475 -0.765 . . . . 25.0 112.728 -175.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.75 155.77 32.24 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.963 -0.855 . . . . 25.0 110.963 -177.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -83.65 97.06 8.88 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.687 -0.856 . . . . 25.0 108.687 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -98.02 161.37 13.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.273 -0.421 . . . . 50.0 111.867 -169.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mp -119.55 131.93 55.64 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 105.549 -2.019 . . . . 25.0 105.549 175.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.4 mp -130.8 125.3 33.36 Favored 'General case' 0 C--O 1.248 0.996 0 N-CA-C 115.021 1.489 . . . . 25.0 115.021 -171.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -125.86 93.2 3.77 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.005 -1.452 . . . . 25.0 109.503 177.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.33 -27.02 70.05 Favored Glycine 0 C--N 1.342 0.874 0 C-N-CA 120.898 -0.668 . . . . 25.0 114.121 -177.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.99 -172.71 46.28 Favored Glycine 0 CA--C 1.522 0.514 0 CA-C-N 118.022 0.911 . . . . 25.0 113.106 177.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.94 148.72 16.61 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.94 0.876 . . . . 25.0 113.124 -175.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.59 159.04 35.23 Favored Glycine 0 C--O 1.219 -0.814 0 N-CA-C 110.274 -1.13 . . . . 25.0 110.274 -177.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -82.01 121.94 27.17 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 107.451 -1.314 . . . . 25.0 107.451 -177.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -112.02 161.42 16.49 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 119.537 -0.268 . . . . 50.0 111.686 -172.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.72 101.1 5.75 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 105.128 -2.175 . . . . 25.0 105.128 175.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -122.7 138.12 54.71 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 114.755 1.391 . . . . 25.0 114.755 -170.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 61.0 m -103.66 145.33 30.21 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.911 -1.144 . . . . 25.0 107.911 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.78 -33.18 6.5 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.781 -0.927 . . . . 25.0 110.781 173.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.59 -173.86 52.93 Favored Glycine 0 C--O 1.239 0.414 0 O-C-N 121.54 -0.976 . . . . 25.0 112.058 -177.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -58.1 149.49 23.5 Favored 'General case' 0 C--O 1.251 1.157 0 N-CA-C 112.108 0.41 . . . . 25.0 112.108 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.26 160.56 29.26 Favored Glycine 0 C--O 1.245 0.803 0 CA-C-O 119.588 -0.562 . . . . 25.0 111.752 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.04 106.56 12.15 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.966 0.412 . . . . 25.0 110.308 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -101.05 155.29 18.07 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.603 0.716 . . . . 50.0 110.524 -171.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.4 m -121.11 125.45 47.27 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.243 -0.889 . . . . 25.0 108.701 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -112.1 130.63 55.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.802 -1.555 . . . . 25.0 106.802 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 -122.28 -27.54 4.47 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 120.051 -0.66 . . . . 25.0 112.601 -177.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 63.92 161.77 0.11 Allowed 'General case' 0 N--CA 1.476 0.856 0 O-C-N 124.725 1.265 . . . . 25.0 112.241 -173.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.22 -50.66 10.6 Favored 'General case' 0 C--O 1.247 0.972 0 N-CA-C 114.595 1.332 . . . . 25.0 114.595 -171.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.7 mt -152.31 179.56 8.43 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.08 -0.711 . . . . 25.0 109.08 -172.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -54.26 -29.21 46.18 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.749 0.785 . . . . 25.0 110.451 167.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -69.55 -1.93 10.04 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 114.715 -1.129 . . . . 25.0 113.584 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.81 147.18 37.48 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-O 121.259 0.552 . . . . 25.0 112.385 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.1 t 43.95 60.36 2.76 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 114.471 -1.24 . . . . 25.0 113.934 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 53.5 p-80 -135.12 169.07 18.01 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 115.74 -0.664 . . . . 25.0 110.18 -175.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -116.95 142.62 46.72 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 104.034 -2.58 . . . . 25.0 104.034 171.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 94.7 p -128.0 168.92 13.8 Favored Pre-proline 0 N--CA 1.471 0.602 0 N-CA-C 105.643 -1.984 . . . . 25.0 105.643 -177.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.88 -22.34 62.11 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 117.223 -1.384 . . . . 25.0 113.272 176.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.6 mt -76.71 -18.06 58.73 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.02 0.748 . . . . 25.0 113.02 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 134.99 -176.92 19.7 Favored Glycine 0 C--N 1.31 -0.905 0 N-CA-C 110.853 -0.899 . . . . 25.0 110.853 -177.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.0 t -82.31 147.47 28.86 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 115.601 1.704 . . . . 25.0 115.601 -177.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -135.66 29.89 3.19 Favored 'General case' 0 C--O 1.249 1.031 0 CA-C-N 113.619 -1.628 . . . . 25.0 107.866 173.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.57 147.23 50.64 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 114.27 -1.332 . . . . 25.0 111.957 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -86.69 165.46 16.08 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 107.518 -1.289 . . . . 50.0 107.518 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -121.42 120.12 34.06 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 110.209 -0.293 . . . . 25.0 110.209 -176.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.5 mt -99.1 128.99 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 107.76 -1.2 . . . . 25.0 107.76 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.6 mt -85.2 -46.96 10.57 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 114.929 1.455 . . . . 25.0 114.929 -169.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 42.2 p-10 -131.56 35.59 3.82 Favored 'General case' 0 C--O 1.247 0.948 0 O-C-N 121.27 -0.894 . . . . 25.0 112.751 -175.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -51.37 140.14 17.97 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.821 -1.082 . . . . 25.0 112.323 -176.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -106.84 108.04 61.32 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 108.146 -1.057 . . . . 25.0 108.146 175.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -73.73 -2.3 12.01 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 N-CA-C 115.098 1.153 . . . . 25.0 115.098 -173.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.6 t -101.82 -36.34 8.71 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-O 121.851 0.834 . . . . 25.0 110.093 178.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -98.47 -39.33 8.81 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 113.734 1.013 . . . . 25.0 113.734 -171.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -84.66 169.98 13.78 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.783 -0.573 . . . . 75.0 110.818 -172.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.55 147.81 30.5 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 120.934 -0.307 . . . . 25.0 111.341 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.0 mt -129.33 130.05 67.47 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 N-CA-C 108.284 -1.006 . . . . 25.0 108.284 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.63 139.89 30.1 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 108.507 -0.923 . . . . 25.0 108.507 173.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.7 p -133.69 -5.48 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.237 -0.892 . . . . 25.0 111.446 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.1 t -74.22 -33.08 63.25 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.422 -0.799 . . . . 25.0 111.958 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.97 -43.15 93.59 Favored 'General case' 0 C--O 1.247 0.934 0 O-C-N 121.748 -0.595 . . . . 25.0 111.656 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.16 -13.07 15.83 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 114.853 1.427 . . . . 25.0 114.853 -172.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.68 -80.55 0.25 Allowed Glycine 0 C--O 1.22 -0.753 0 N-CA-C 116.513 1.365 . . . . 25.0 116.513 -172.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -158.14 157.52 32.91 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 117.436 0.618 . . . . 25.0 112.02 -170.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.7 t -108.37 -28.01 9.64 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 123.839 0.712 . . . . 25.0 111.23 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -92.27 106.15 3.37 Favored Glycine 0 CA--C 1.5 -0.906 0 O-C-N 121.369 -0.832 . . . . 25.0 112.288 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.75 143.39 57.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.856 0.828 . . . . 25.0 110.541 -176.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.61 -154.32 30.6 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 116.012 -0.54 . . . . 25.0 114.126 -175.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -59.24 138.19 57.69 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 113.39 0.885 . . . . 25.0 113.39 -176.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 172.73 -168.55 41.62 Favored Glycine 0 C--O 1.252 1.251 0 N-CA-C 110.079 -1.208 . . . . 25.0 110.079 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -155.98 165.49 36.29 Favored 'General case' 0 C--O 1.247 0.957 0 N-CA-C 108.018 -1.105 . . . . 25.0 108.018 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 54.44 36.65 26.06 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 114.984 1.476 . . . . 25.0 114.984 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.32 40.81 32.55 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 109.72 -1.352 . . . . 25.0 109.72 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.7 t -153.74 178.47 9.84 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 117.885 0.843 . . . . 25.0 110.848 -176.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 71.5 mt -95.89 159.78 14.8 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 104.232 -2.507 . . . . 25.0 104.232 168.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.34 130.9 44.78 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 119.711 -0.796 . . . . 25.0 109.186 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.8 m -98.72 155.72 3.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 CA-C-N 115.607 -0.724 . . . . 25.0 109.505 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 97.5 p -144.03 167.01 23.38 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.405 -0.591 . . . . 25.0 109.405 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.447 HG12 HG22 ' A' ' 123' ' ' THR . 33.3 m -120.52 161.98 19.64 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 N-CA-C 108.807 -0.812 . . . . 25.0 108.807 178.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.6 t -66.04 -51.77 55.18 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.952 -1.129 . . . . 25.0 107.952 174.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -172.04 -156.28 0.1 Allowed 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 103.261 -2.866 . . . . 25.0 103.261 -178.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -73.48 5.28 3.89 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 113.761 1.022 . . . . 25.0 113.761 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -148.86 -156.88 7.33 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 106.397 -2.681 . . . . 25.0 106.397 175.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 56.64 -164.06 0.16 Allowed 'General case' 0 CA--C 1.562 1.422 0 O-C-N 124.287 0.639 . . . . 25.0 112.527 176.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.6 mtt85 -75.09 159.22 31.94 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.788 1.033 . . . . 25.0 113.788 -170.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.447 HG22 HG12 ' A' ' 116' ' ' VAL . 0.7 OUTLIER -101.76 159.69 15.11 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 104.499 -2.408 . . . . 25.0 104.499 174.368 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -130.95 152.05 50.69 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-O 122.564 1.173 . . . . 25.0 110.681 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 39.0 tp -126.78 117.48 22.74 Favored 'General case' 0 C--O 1.245 0.853 0 N-CA-C 103.69 -2.707 . . . . 25.0 103.69 172.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -119.74 152.25 37.49 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 111.952 0.353 . . . . 25.0 111.952 -174.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.9 t -94.45 152.65 18.42 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 104.726 -2.324 . . . . 25.0 104.726 168.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -117.32 17.55 14.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.978 0.894 . . . . 25.0 109.032 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -112.56 146.81 37.89 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 105.607 -1.997 . . . . 25.0 105.607 174.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -139.45 151.87 46.57 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.236 0.541 . . . . 25.0 110.036 -175.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -72.28 160.23 32.74 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 106.305 -1.739 . . . . 25.0 106.305 175.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.36 -18.92 65.11 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.151 0.501 . . . . 25.0 110.106 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -69.36 -8.78 49.51 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.205 0.817 . . . . 25.0 113.205 173.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.17 20.45 57.25 Favored Glycine 0 C--O 1.22 -0.726 0 C-N-CA 120.169 -1.015 . . . . 25.0 110.765 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.2 mt -106.37 119.61 39.71 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.881 -0.785 . . . . 25.0 108.881 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.8 p -116.68 174.97 5.79 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 106.132 -1.803 . . . . 25.0 106.132 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -114.95 131.68 56.82 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 118.681 0.673 . . . . 25.0 110.436 -177.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -145.98 156.86 43.79 Favored 'General case' 0 C--O 1.256 1.413 0 N-CA-C 109.323 -0.621 . . . . 25.0 109.323 166.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.8 p -146.24 141.1 21.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 106.045 -1.835 . . . . 25.0 106.045 177.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -99.13 147.78 24.74 Favored 'General case' 0 C--O 1.249 1.047 0 N-CA-C 107.699 -1.223 . . . . 25.0 107.699 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.6 mp -134.42 133.38 40.45 Favored 'General case' 0 C--O 1.206 -1.186 0 N-CA-C 103.341 -2.837 . . . . 25.0 103.341 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -110.01 13.41 23.35 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 120.051 -0.66 . . . . 25.0 110.966 -177.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -79.11 -5.9 88.95 Favored Glycine 0 C--O 1.217 -0.931 0 CA-C-N 114.809 -1.087 . . . . 25.0 112.04 172.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 14.2 t0 51.5 55.11 9.9 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 114.594 1.331 . . . . 25.0 114.594 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -128.81 46.22 2.65 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.988 -0.551 . . . . 25.0 109.536 -174.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.62 -31.91 66.71 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 113.625 0.972 . . . . 25.0 113.625 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.86 -28.74 65.91 Favored 'General case' 0 CA--C 1.554 1.106 0 O-C-N 121.482 -0.761 . . . . 25.0 111.943 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -93.64 -18.28 22.34 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 112.322 0.49 . . . . 25.0 112.322 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.5 mt -66.48 123.66 20.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 122.195 0.998 . . . . 25.0 111.486 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.401 ' C ' ' H ' ' A' ' 152' ' ' ASP . 70.9 m -137.51 164.06 29.64 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 105.522 -2.029 . . . . 25.0 105.522 177.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -71.51 10.63 0.6 Allowed 'General case' 0 C--O 1.219 -0.511 0 CA-C-O 121.225 0.536 . . . . 25.0 110.866 175.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.401 ' H ' ' C ' ' A' ' 150' ' ' SER . 46.8 t0 -72.61 -30.04 64.0 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 122.631 1.205 . . . . 25.0 110.129 177.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -94.12 8.76 40.43 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.889 -1.051 . . . . 25.0 111.65 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 39.6 mm -116.49 144.67 23.64 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 105.675 -1.972 . . . . 25.0 105.675 175.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.3 p -123.66 127.34 73.92 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 CA-C-O 122.172 0.986 . . . . 25.0 110.827 174.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.85 -30.59 5.36 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 114.379 -1.282 . . . . 25.0 109.873 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -85.42 84.25 7.69 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 115.637 1.717 . . . . 25.0 115.637 -172.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 54.75 25.24 6.33 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.759 1.763 . . . . 25.0 115.759 172.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.41 17.19 4.62 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.872 1.269 . . . . 25.0 113.514 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -98.42 125.49 43.6 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-O 121.234 0.54 . . . . 25.0 110.404 -176.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -67.24 3.09 1.31 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.469 0.914 . . . . 25.0 113.469 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.73 -15.23 63.53 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.33 0.652 . . . . 25.0 111.23 176.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.79 171.06 11.21 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 113.212 0.819 . . . . 25.0 113.212 -177.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 62.93 -170.92 0.17 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.328 1.451 . . . . 25.0 113.981 177.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 77.09 20.23 75.98 Favored Glycine 0 C--O 1.247 0.953 0 CA-C-N 115.304 -0.862 . . . . 25.0 111.15 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -124.9 109.0 12.48 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.806 -0.813 . . . . 25.0 108.806 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -127.54 150.71 49.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.313 -0.995 . . . . 25.0 108.313 -177.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -123.34 40.94 1.87 Allowed Glycine 0 CA--C 1.519 0.337 0 N-CA-C 108.961 -1.656 . . . . 25.0 108.961 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 59.5 t -94.63 -31.95 4.48 Favored 'Isoleucine or valine' 0 C--O 1.251 1.171 0 C-N-CA 122.628 0.371 . . . . 25.0 110.676 -175.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.43 130.05 16.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 CA-C-O 122.705 1.24 . . . . 25.0 113.125 -174.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 151.72 155.64 7.09 Favored Glycine 0 CA--C 1.532 1.145 0 N-CA-C 108.561 -1.815 . . . . 25.0 108.561 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -153.34 147.38 25.53 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 117.849 0.825 . . . . 25.0 110.535 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 98.2 p -149.64 164.98 33.68 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.964 -1.124 . . . . 25.0 107.964 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -175.6 -170.12 38.09 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.995 -0.621 . . . . 25.0 112.369 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -152.59 99.56 2.8 Favored Pre-proline 0 C--N 1.314 -0.963 0 N-CA-C 107.819 -1.178 . . . . 25.0 107.819 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -71.02 153.58 63.07 Favored 'Trans proline' 0 C--O 1.247 0.936 0 C-N-CA 117.05 -1.5 . . . . 25.0 113.396 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -118.79 154.0 33.56 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 106.861 -1.533 . . . . 25.0 106.861 177.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -141.98 77.44 18.44 Favored Pre-proline 0 N--CA 1.47 0.529 0 CA-C-O 121.065 0.459 . . . . 25.0 111.813 -178.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -69.76 145.97 58.77 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 117.462 -1.226 . . . . 25.0 111.666 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 13.4 t -132.36 8.89 4.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.881 0.848 . . . . 25.0 109.526 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 C--N 1.324 -0.512 0 CA-C-N 115.035 -0.984 . . . . 25.0 109.708 177.656 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo . . . . . 0 CA--C 1.53 0.295 0 CA-C-O 122.414 0.922 . . . . 25.0 114.197 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.15 62.7 0.05 OUTLIER Glycine 0 C--O 1.241 0.578 0 N-CA-C 108.47 -1.852 . . . . 25.0 108.47 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.674 HG22 ' H ' ' A' ' 7' ' ' GLY . 12.2 p -48.5 131.47 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 113.512 0.93 . . . . 25.0 113.512 -172.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -100.68 12.34 37.65 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 114.95 -1.023 . . . . 25.0 110.619 -175.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.674 ' H ' HG22 ' A' ' 5' ' ' VAL . . . -116.9 -151.39 9.45 Favored Glycine 0 N--CA 1.439 -1.117 0 CA-C-N 115.797 -0.638 . . . . 25.0 112.832 -178.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 p 71.53 157.81 0.16 Allowed Pre-proline 0 CA--C 1.555 1.166 0 C-N-CA 126.292 1.837 . . . . 25.0 110.807 -177.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -67.71 6.99 0.62 Allowed 'Trans proline' 0 C--N 1.356 0.932 0 N-CA-C 117.279 1.992 . . . . 25.0 117.279 -176.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.1 p -67.99 -14.43 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 N-CA-C 114.779 1.4 . . . . 25.0 114.779 -173.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.1 p -150.24 144.41 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.269 0 N-CA-C 115.116 1.525 . . . . 25.0 115.116 -175.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.32 17.39 79.69 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 117.726 1.85 . . . . 25.0 117.726 169.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.2 t -50.45 -53.38 30.09 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 114.037 1.125 . . . . 25.0 114.037 -171.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -83.07 8.16 13.74 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 116.541 2.052 . . . . 25.0 116.541 -173.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -141.27 171.9 13.43 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 120.754 -1.216 . . . . 25.0 113.541 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -58.76 127.37 31.87 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.719 0.771 . . . . 25.0 112.478 -174.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -123.75 166.68 15.15 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 113.351 0.871 . . . . 50.0 113.351 -175.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -131.29 95.53 3.8 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 103.349 -2.834 . . . . 25.0 103.349 163.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 64.1 mt -102.99 128.7 49.72 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.15 0.5 . . . . 25.0 110.375 -177.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -124.67 116.04 21.74 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.818 0.818 . . . . 25.0 109.911 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.49 -177.69 49.55 Favored Glycine 0 N--CA 1.462 0.397 0 N-CA-C 116.867 1.507 . . . . 25.0 116.867 -174.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.8 p -84.52 172.9 11.26 Favored 'General case' 0 C--O 1.248 0.982 0 C-N-CA 124.838 1.255 . . . . 25.0 113.467 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.1 mt -87.94 36.56 0.77 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.262 0.553 . . . . 25.0 110.25 171.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -144.19 176.18 23.58 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 107.91 -2.076 . . . . 25.0 107.91 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.5 t -65.57 138.01 57.76 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 112.76 0.652 . . . . 25.0 112.76 -177.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -146.77 164.34 33.1 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.717 -0.674 . . . . 50.0 110.527 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -109.43 114.38 27.98 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 105.202 -2.148 . . . . 25.0 105.202 163.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 40.3 mm -104.1 115.64 46.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 106.764 -1.569 . . . . 25.0 106.764 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 9.8 mp -107.5 127.77 53.91 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 106.484 -1.673 . . . . 25.0 106.484 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.66 -33.08 8.69 Favored Glycine 0 C--N 1.313 -0.724 0 CA-C-O 119.297 -0.724 . . . . 25.0 112.474 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.58 -146.06 49.82 Favored Glycine 0 C--O 1.256 1.47 0 CA-C-N 118.745 1.273 . . . . 25.0 111.996 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.75 168.13 54.1 Favored Glycine 0 C--O 1.248 1.007 0 O-C-N 122.601 -0.353 . . . . 25.0 113.286 -176.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.59 169.13 35.17 Favored Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 111.581 -0.608 . . . . 25.0 111.581 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.95 118.93 25.73 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.51 -1.292 . . . . 25.0 107.51 176.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -116.57 148.47 40.86 Favored 'General case' 0 CA--C 1.511 -0.532 0 O-C-N 121.335 -0.853 . . . . 50.0 111.602 -171.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -104.8 107.38 18.32 Favored 'General case' 0 C--O 1.249 1.054 0 N-CA-C 106.42 -1.696 . . . . 25.0 106.42 171.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 64.3 mt -112.56 133.77 54.44 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 121.99 -0.444 . . . . 25.0 111.008 -175.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -131.93 107.06 8.45 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 121.449 0.642 . . . . 25.0 110.778 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.37 -26.79 50.63 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-O 119.023 -0.876 . . . . 25.0 115.095 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 51.48 -152.15 0.22 Allowed 'General case' 0 C--O 1.244 0.815 0 CA-C-N 117.716 0.758 . . . . 25.0 111.782 -175.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.37 164.29 16.47 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.768 1.025 . . . . 25.0 113.768 -175.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.22 155.43 31.69 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 114.853 -1.067 . . . . 25.0 110.859 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -79.62 102.49 8.94 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 106.665 -1.605 . . . . 25.0 106.665 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -104.85 155.24 19.09 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 121.097 0.475 . . . . 50.0 111.779 -173.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 mp -111.66 134.27 53.34 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 105.87 -1.9 . . . . 25.0 105.87 174.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.5 mp -131.73 117.63 18.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.577 0.703 . . . . 25.0 110.724 -174.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -118.14 89.94 3.23 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.978 -1.01 . . . . 25.0 109.663 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.31 -31.59 74.27 Favored Glycine 0 N--CA 1.468 0.809 0 N-CA-C 116.92 1.528 . . . . 25.0 116.92 -172.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.9 -163.94 51.33 Favored Glycine 0 C--O 1.243 0.705 0 O-C-N 121.864 -0.786 . . . . 25.0 111.269 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.21 161.53 19.09 Favored 'General case' 0 C--O 1.248 1.009 0 C-N-CA 123.051 0.541 . . . . 25.0 109.798 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.93 161.4 32.23 Favored Glycine 0 C--O 1.248 0.991 0 CA-C-O 118.941 -0.921 . . . . 25.0 111.209 177.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -80.85 121.19 25.65 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 105.785 -1.932 . . . . 25.0 105.785 177.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -111.51 152.35 27.6 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.343 -0.844 . . . . 50.0 109.855 -177.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -118.86 119.1 33.37 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 105.742 -1.948 . . . . 25.0 105.742 177.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -141.65 134.74 29.12 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 115.159 1.54 . . . . 25.0 115.159 -168.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.5 m -103.38 141.51 35.82 Favored 'General case' 0 C--O 1.249 1.032 0 N-CA-C 107.229 -1.397 . . . . 25.0 107.229 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.21 -37.36 5.97 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 108.442 -1.863 . . . . 25.0 108.442 175.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.84 -171.11 55.14 Favored Glycine 0 C--O 1.248 1.003 0 C-N-CA 120.626 -0.797 . . . . 25.0 111.859 -178.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -65.73 157.09 31.12 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 117.498 0.649 . . . . 25.0 110.061 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.46 164.86 32.0 Favored Glycine 0 C--O 1.245 0.808 0 CA-C-N 115.606 -0.725 . . . . 25.0 112.656 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.15 96.25 9.84 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 123.593 0.757 . . . . 25.0 110.319 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -90.71 159.89 16.12 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 123.462 0.705 . . . . 50.0 112.066 -170.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.1 m -125.51 125.43 43.24 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.797 -0.638 . . . . 25.0 109.385 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -114.68 89.15 3.03 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.398 -0.964 . . . . 25.0 108.398 177.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -88.84 -34.48 17.0 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 119.321 -0.371 . . . . 25.0 111.735 -175.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 66.74 160.82 0.15 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.542 1.137 . . . . 25.0 111.632 -173.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -90.83 -42.88 10.39 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 116.196 1.925 . . . . 25.0 116.196 -166.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.3 mt -140.65 170.49 15.68 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.139 0.792 . . . . 25.0 113.139 -172.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.99 -25.19 43.07 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 123.751 0.82 . . . . 25.0 110.914 175.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -79.12 -12.13 59.99 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 115.112 -0.949 . . . . 25.0 112.906 -178.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -81.73 139.55 34.81 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.412 -0.805 . . . . 25.0 112.911 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.4 t 45.91 40.06 6.27 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 116.52 2.045 . . . . 25.0 116.52 171.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -107.37 170.09 8.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.239 -1.346 . . . . 25.0 110.964 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -124.23 146.66 48.59 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 106.13 -1.804 . . . . 25.0 106.13 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 87.9 p -142.37 168.64 12.89 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 108.613 -0.884 . . . . 25.0 108.613 -177.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -61.04 -27.03 83.98 Favored 'Trans proline' 0 CA--C 1.553 1.44 0 C-N-CA 117.631 -1.112 . . . . 25.0 111.566 175.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.4 mt -65.6 -32.29 73.79 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.861 0.689 . . . . 25.0 112.861 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.53 -174.48 35.65 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 109.974 -1.25 . . . . 25.0 109.974 -176.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.8 t -105.55 144.67 31.98 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.407 1.099 . . . . 25.0 112.74 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -123.82 16.68 9.42 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.027 -1.442 . . . . 25.0 108.964 177.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -62.0 140.94 47.06 Favored Glycine 0 C--N 1.335 0.524 0 CA-C-N 115.645 -0.707 . . . . 25.0 112.649 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -87.03 170.68 11.33 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 117.858 0.829 . . . . 50.0 113.057 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.04 98.36 5.95 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.518 -0.765 . . . . 25.0 110.799 -172.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.2 mt -89.65 133.02 32.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 107.837 -1.171 . . . . 25.0 107.837 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 76.8 mt -85.5 -49.06 8.37 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 115.323 1.601 . . . . 25.0 115.323 -171.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -131.13 36.04 3.87 Favored 'General case' 0 C--O 1.247 0.953 0 CA-C-O 121.458 0.647 . . . . 25.0 112.695 -173.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -53.78 131.59 39.82 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.261 -0.882 . . . . 25.0 112.263 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -103.59 105.66 48.4 Favored Pre-proline 0 C--O 1.238 0.474 0 N-CA-C 108.185 -1.042 . . . . 25.0 108.185 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.78 -9.68 26.92 Favored 'Trans proline' 0 C--N 1.35 0.611 0 N-CA-C 116.119 1.546 . . . . 25.0 116.119 -173.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.1 t -95.9 -36.87 10.94 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.27 -0.572 . . . . 25.0 109.774 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -95.62 -38.02 10.58 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 114.001 1.111 . . . . 25.0 114.001 -173.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -87.77 172.41 9.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.403 0.62 . . . . 75.0 110.478 -173.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -145.08 148.81 34.08 Favored 'General case' 0 C--O 1.252 1.199 0 CA-C-N 116.084 -0.507 . . . . 25.0 111.739 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 85.7 mt -129.09 133.07 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 108.486 -0.931 . . . . 25.0 108.486 -176.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -85.83 149.03 25.53 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 121.694 0.759 . . . . 25.0 109.122 173.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.0 p -146.25 -13.03 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 O-C-N 121.641 -0.662 . . . . 25.0 112.75 176.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.1 t -63.48 -39.95 95.81 Favored 'General case' 0 C--O 1.219 -0.524 0 O-C-N 121.565 -0.709 . . . . 25.0 111.432 -174.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.78 -8.61 59.57 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-N 115.398 -0.819 . . . . 25.0 112.661 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.7 mt -106.18 -29.64 9.72 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.815 0.672 . . . . 25.0 112.815 -174.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.39 -71.6 0.01 OUTLIER Glycine 0 N--CA 1.465 0.574 0 N-CA-C 117.598 1.799 . . . . 25.0 117.598 -176.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -144.96 158.23 43.88 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.794 -0.817 . . . . 25.0 108.794 -170.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 41.0 t -113.55 -28.74 7.4 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 123.651 0.594 . . . . 25.0 112.286 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -100.39 119.6 6.57 Favored Glycine 0 N--CA 1.472 1.054 0 C-N-CA 121.495 -0.383 . . . . 25.0 112.323 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.29 146.4 34.36 Favored 'General case' 0 C--O 1.245 0.853 0 N-CA-C 114.065 1.135 . . . . 25.0 114.065 -174.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -95.86 -151.95 28.65 Favored Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.824 -0.703 . . . . 25.0 114.26 -177.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -59.51 131.73 51.85 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 122.446 1.117 . . . . 25.0 111.639 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 160.38 170.44 24.97 Favored Glycine 0 C--O 1.24 0.476 0 N-CA-C 107.573 -2.211 . . . . 25.0 107.573 -179.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -148.22 167.73 24.35 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 118.299 1.05 . . . . 25.0 109.4 -177.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 62.98 38.6 10.94 Favored 'General case' 0 C--O 1.248 1.011 0 C-N-CA 124.518 1.127 . . . . 25.0 111.801 -174.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 65.82 44.18 92.56 Favored Glycine 0 C--O 1.242 0.629 0 N-CA-C 109.938 -1.265 . . . . 25.0 109.938 177.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.7 t -151.58 179.76 8.1 Favored 'General case' 0 C--O 1.212 -0.873 0 O-C-N 122.391 -0.476 . . . . 25.0 111.18 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 85.1 mt -106.8 167.02 10.16 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 103.855 -2.646 . . . . 25.0 103.855 173.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.54 131.17 42.88 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 119.597 1.09 . . . . 25.0 110.21 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 18.6 m -95.44 163.47 2.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.426 -0.806 . . . . 25.0 109.838 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 80.0 p -149.03 160.09 43.63 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.538 -0.726 . . . . 25.0 110.6 -177.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 28.0 m -122.44 165.16 18.71 Favored 'Isoleucine or valine' 0 C--O 1.252 1.221 0 N-CA-C 109.727 -0.471 . . . . 25.0 109.727 -177.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.3 t -76.28 -50.75 13.55 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 122.22 1.01 . . . . 25.0 109.682 176.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -162.18 -152.77 0.25 Allowed 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 103.753 -2.684 . . . . 25.0 103.753 -176.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -73.31 -6.19 44.47 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 119.211 0.914 . . . . 25.0 110.63 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -148.21 -146.68 4.38 Favored Glycine 0 C--O 1.247 0.958 0 N-CA-C 109.922 -1.271 . . . . 25.0 109.922 174.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.25 -152.55 0.39 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.051 0.541 . . . . 25.0 112.416 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -75.71 162.37 28.28 Favored 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 113.919 1.081 . . . . 25.0 113.919 -171.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.61 158.0 21.38 Favored 'General case' 0 C--O 1.213 -0.851 0 N-CA-C 105.978 -1.86 . . . . 25.0 105.978 175.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -129.66 144.57 51.34 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 124.12 0.887 . . . . 25.0 111.419 175.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 49.4 tp -115.41 122.77 46.83 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 102.778 -3.045 . . . . 25.0 102.778 173.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -121.59 155.29 35.38 Favored 'General case' 0 C--O 1.211 -0.957 0 CA-C-O 121.39 0.614 . . . . 25.0 110.411 -173.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 41.0 t -92.04 152.57 19.91 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.49 -1.3 . . . . 25.0 107.49 171.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -123.01 19.17 10.05 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 108.539 -0.912 . . . . 25.0 108.539 175.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -118.96 139.84 51.0 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 105.223 -2.14 . . . . 25.0 105.223 170.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -139.25 165.08 28.13 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.528 0.68 . . . . 25.0 110.231 -177.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -85.68 163.96 17.95 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.021 -1.474 . . . . 25.0 107.021 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.31 -24.41 67.27 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 108.116 -1.068 . . . . 25.0 108.116 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -74.86 -5.55 44.21 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.432 -0.804 . . . . 25.0 112.472 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.75 1.23 83.06 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 120.33 -0.938 . . . . 25.0 111.811 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.8 mt -75.74 133.99 40.59 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.417 -0.586 . . . . 25.0 109.417 175.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 88.1 p -144.44 -172.71 3.85 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 106.199 -1.778 . . . . 25.0 106.199 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -131.4 141.35 49.84 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 121.293 -0.163 . . . . 25.0 110.614 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -154.45 158.81 40.52 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 106.99 -1.485 . . . . 25.0 106.99 166.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.2 p -145.23 144.37 21.53 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 N-CA-C 108.247 -1.02 . . . . 25.0 108.247 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -105.36 136.67 44.48 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 108.453 -0.943 . . . . 25.0 108.453 -177.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.1 mp -134.03 129.8 36.62 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 106.957 -1.497 . . . . 25.0 106.957 -177.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -90.96 -1.75 57.79 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 119.224 -0.99 . . . . 25.0 112.482 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -66.35 -21.24 70.23 Favored Glycine 0 C--O 1.242 0.607 0 N-CA-C 115.139 0.816 . . . . 25.0 115.139 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 29.4 t0 53.14 59.11 4.65 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 123.626 1.679 . . . . 25.0 111.324 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -120.98 41.0 3.42 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 112.217 -2.265 . . . . 25.0 107.711 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.36 -35.39 75.57 Favored 'General case' 0 C--O 1.214 -0.796 0 CA-C-N 114.961 -1.018 . . . . 25.0 113.511 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.17 -29.42 62.83 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 118.232 0.469 . . . . 25.0 110.794 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -85.21 -13.22 50.61 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 112.8 0.667 . . . . 25.0 112.8 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 14.5 mt -69.87 128.2 35.55 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.94 0.719 . . . . 25.0 112.94 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 34.4 m -138.59 161.65 36.57 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.34 -0.985 . . . . 25.0 108.34 171.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.92 4.93 5.69 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 109.5 -0.556 . . . . 25.0 109.5 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -66.75 -30.74 71.04 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.684 0.615 . . . . 25.0 110.451 177.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -91.63 -4.0 55.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.129 0.49 . . . . 25.0 111.338 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 48.2 mm -94.02 126.26 46.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 106.542 -1.651 . . . . 25.0 106.542 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.2 p -103.43 114.57 43.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 122.113 0.958 . . . . 25.0 110.827 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -156.18 -9.17 0.11 Allowed 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.729 1.751 . . . . 25.0 115.729 -177.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -88.18 71.93 9.16 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 118.855 0.752 . . . . 25.0 111.264 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 56.49 21.15 5.36 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.27 1.028 . . . . 25.0 113.347 -178.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 53.84 38.33 28.41 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.756 -0.656 . . . . 25.0 111.415 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -123.26 124.8 43.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.36 0.6 . . . . 25.0 111.332 -178.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.09 -4.28 28.02 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.726 -0.67 . . . . 25.0 112.303 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.34 -13.01 61.03 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.644 -0.502 . . . . 25.0 109.644 174.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.24 -176.31 6.26 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 122.727 0.411 . . . . 25.0 110.497 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 58.85 -162.45 0.24 Allowed 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.201 -1.363 . . . . 25.0 113.045 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.15 22.04 77.05 Favored Glycine 0 C--N 1.336 0.578 0 N-CA-C 110.945 -0.862 . . . . 25.0 110.945 -175.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -112.99 93.85 4.62 Favored 'General case' 0 C--O 1.246 0.875 0 C-N-CA 123.673 0.789 . . . . 25.0 110.535 -176.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -128.84 145.57 51.17 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 109.148 -0.686 . . . . 25.0 109.148 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -119.35 24.08 8.28 Favored Glycine 0 N--CA 1.462 0.424 0 N-CA-C 111.368 -0.693 . . . . 25.0 111.368 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 44.6 t -71.59 -30.15 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 122.083 0.944 . . . . 25.0 109.44 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.49 134.58 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 122.196 0.998 . . . . 25.0 109.211 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 154.81 152.14 6.05 Favored Glycine 0 C--O 1.242 0.611 0 CA-C-N 115.393 -0.821 . . . . 25.0 112.992 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -148.38 123.62 10.21 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.355 -0.609 . . . . 25.0 109.355 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 56.2 p -151.97 160.14 43.57 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.316 -0.994 . . . . 25.0 108.316 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 166.06 -172.8 41.52 Favored Glycine 0 C--N 1.319 -0.374 0 C-N-CA 121.252 -0.499 . . . . 25.0 112.161 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -138.99 109.3 7.67 Favored Pre-proline 0 C--O 1.244 0.766 0 N-CA-C 107.943 -1.132 . . . . 25.0 107.943 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.92 164.48 31.54 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 117.655 -1.097 . . . . 25.0 113.266 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -128.52 156.03 43.93 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.531 -0.759 . . . . 25.0 109.124 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -132.01 87.74 43.37 Favored Pre-proline 0 C--O 1.243 0.733 0 N-CA-C 108.912 -0.773 . . . . 25.0 108.912 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -71.29 156.18 59.35 Favored 'Trans proline' 0 C--N 1.353 0.8 0 N-CA-C 113.893 0.689 . . . . 25.0 113.893 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 11.8 t -123.3 -11.49 7.93 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.286 0.565 . . . . 25.0 110.927 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 10.1 p . . . . . 0 C--O 1.235 0.342 0 N-CA-C 107.654 -1.239 . . . . 25.0 107.654 177.341 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo . . . . . 0 N--CA 1.472 0.233 0 N-CA-C 113.503 0.54 . . . . 25.0 113.503 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.41 56.82 0.01 OUTLIER Glycine 0 C--O 1.225 -0.416 0 O-C-N 121.921 -0.487 . . . . 25.0 112.023 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.514 HG22 ' H ' ' A' ' 7' ' ' GLY . 7.2 p -64.42 137.71 24.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 122.027 0.917 . . . . 25.0 111.287 -176.306 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -105.66 -4.53 20.94 Favored 'General case' 0 C--O 1.242 0.661 0 O-C-N 121.742 -0.599 . . . . 25.0 110.849 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.514 ' H ' HG22 ' A' ' 5' ' ' VAL . . . -84.99 -141.54 5.51 Favored Glycine 0 C--O 1.221 -0.692 0 C-N-CA 121.492 -0.385 . . . . 25.0 113.384 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.0 p 69.78 157.8 0.15 Allowed Pre-proline 0 N--CA 1.485 1.31 0 C-N-CA 125.413 1.485 . . . . 25.0 111.61 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -72.84 3.07 4.7 Favored 'Trans proline' 0 C--N 1.353 0.774 0 N-CA-C 116.46 1.677 . . . . 25.0 116.46 -177.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.4 p -67.17 -18.15 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 116.196 1.925 . . . . 25.0 116.196 -170.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.4 p -148.27 144.28 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 CA-C-N 119.222 0.919 . . . . 25.0 113.39 -176.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.29 15.59 80.77 Favored Glycine 0 C--N 1.333 0.379 0 N-CA-C 117.18 1.632 . . . . 25.0 117.18 174.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.3 t -52.64 -48.68 66.25 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.887 1.069 . . . . 25.0 113.887 -171.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -77.72 3.82 13.11 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 115.198 1.555 . . . . 25.0 115.198 -173.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.93 168.82 18.99 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.903 1.075 . . . . 25.0 113.903 -177.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.62 129.39 41.69 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.573 0.583 . . . . 25.0 112.573 -175.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -128.52 159.88 34.07 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 115.451 1.649 . . . . 50.0 115.451 -174.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -112.86 118.1 33.97 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 104.529 -2.397 . . . . 25.0 104.529 162.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.2 mt -121.14 85.82 2.47 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.956 0.884 . . . . 25.0 111.627 -173.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -90.01 110.64 21.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.296 -0.865 . . . . 25.0 109.984 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.02 170.45 43.42 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 116.181 1.232 . . . . 25.0 116.181 -176.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.2 p -71.81 174.89 6.27 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.753 0.787 . . . . 25.0 112.989 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 73.6 mt -86.13 18.6 3.01 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.099 -0.955 . . . . 25.0 111.193 176.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.66 176.35 16.06 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.402 -1.079 . . . . 25.0 110.402 176.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.4 t -70.73 136.63 49.06 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 117.649 0.725 . . . . 25.0 110.517 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -143.51 159.32 42.64 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 120.903 0.382 . . . . 50.0 110.044 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -95.96 131.12 42.66 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 102.959 -2.978 . . . . 25.0 102.959 161.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.8 mm -121.36 121.9 65.92 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 N-CA-C 105.497 -2.038 . . . . 25.0 105.497 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.5 tt -123.45 124.0 41.92 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.066 -1.087 . . . . 25.0 108.066 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.3 -38.27 11.24 Favored Glycine 0 CA--C 1.502 -0.722 0 C-N-CA 119.947 -1.12 . . . . 25.0 113.102 -177.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 72.19 -147.25 40.73 Favored Glycine 0 C--O 1.254 1.364 0 CA-C-N 118.983 1.391 . . . . 25.0 112.018 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.95 164.78 54.63 Favored Glycine 0 C--O 1.243 0.691 0 N-CA-C 111.751 -0.54 . . . . 25.0 111.751 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.22 163.67 34.82 Favored Glycine 0 C--O 1.244 0.719 0 CA-C-O 119.462 -0.632 . . . . 25.0 113.741 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.5 103.34 11.97 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.165 -1.42 . . . . 25.0 107.165 176.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -103.32 157.63 16.89 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.471 -0.491 . . . . 50.0 110.258 -172.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -120.56 90.66 3.37 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 108.82 -0.807 . . . . 25.0 108.82 177.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.0 mp -86.06 136.5 33.21 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.035 -0.529 . . . . 25.0 110.694 -175.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -138.55 106.62 5.72 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.331 -0.618 . . . . 25.0 109.331 174.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.98 -28.17 54.85 Favored Glycine 0 N--CA 1.467 0.766 0 CA-C-O 118.011 -1.438 . . . . 25.0 116.184 -175.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 54.8 -147.99 0.49 Allowed 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 118.187 0.994 . . . . 25.0 111.428 -177.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.94 163.47 19.64 Favored 'General case' 0 C--O 1.256 1.409 0 CA-C-O 122.153 0.978 . . . . 25.0 112.495 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.05 157.63 33.66 Favored Glycine 0 CA--C 1.521 0.452 0 CA-C-N 114.358 -1.292 . . . . 25.0 110.173 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -81.77 110.96 17.57 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 105.635 -1.987 . . . . 25.0 105.635 177.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -110.6 150.81 28.44 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.934 -0.706 . . . . 50.0 110.02 -171.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 mp -112.9 95.07 5.21 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.957 0.786 . . . . 25.0 109.457 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.8 mp -100.74 116.34 32.4 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 114.963 1.468 . . . . 25.0 114.963 -170.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -118.03 111.92 19.56 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 115.3 -0.864 . . . . 25.0 109.207 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.37 -32.61 79.86 Favored Glycine 0 C--O 1.254 1.389 0 N-CA-C 117.262 1.665 . . . . 25.0 117.262 -174.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.47 -163.78 42.97 Favored Glycine 0 N--CA 1.458 0.143 0 C-N-CA 120.91 -0.662 . . . . 25.0 111.909 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.2 159.46 17.63 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.307 0.575 . . . . 25.0 112.317 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.38 173.1 47.55 Favored Glycine 0 C--O 1.227 -0.291 0 CA-C-N 115.447 -0.797 . . . . 25.0 114.113 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.54 125.26 33.65 Favored 'General case' 0 C--O 1.208 -1.112 0 N-CA-C 104.069 -2.567 . . . . 25.0 104.069 176.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -117.96 157.56 26.51 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.907 0.384 . . . . 50.0 110.967 -174.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -113.26 131.04 56.07 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 102.869 -3.011 . . . . 25.0 102.869 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -148.98 149.05 30.52 Favored 'General case' 0 C--O 1.248 0.997 0 C-N-CA 119.374 -0.93 . . . . 25.0 111.691 -175.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.19 146.76 35.61 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 109.6 -0.519 . . . . 25.0 109.6 -176.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -98.85 -42.75 2.79 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-O 118.649 -1.084 . . . . 25.0 113.445 -174.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.34 -169.6 52.79 Favored Glycine 0 C--O 1.248 0.991 0 CA-C-N 118.843 1.322 . . . . 25.0 111.534 -177.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -60.58 155.08 19.51 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.846 -0.797 . . . . 25.0 110.21 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.0 163.23 32.24 Favored Glycine 0 C--O 1.249 1.063 0 CA-C-N 115.312 -0.858 . . . . 25.0 111.036 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.75 96.09 9.15 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 123.395 0.678 . . . . 25.0 110.028 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -88.94 158.25 18.12 Favored 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 123.258 0.623 . . . . 50.0 111.622 -170.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.1 m -123.15 134.04 54.22 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.965 -0.754 . . . . 25.0 108.965 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -126.45 100.81 6.42 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.467 -1.309 . . . . 25.0 107.467 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 54.2 mtt85 -100.13 -27.67 13.42 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.552 0.945 . . . . 25.0 113.552 -178.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 67.77 162.22 0.19 Allowed 'General case' 0 CA--C 1.534 0.356 0 O-C-N 125.276 1.61 . . . . 25.0 110.386 -174.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.8 -49.56 17.73 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 116.166 1.913 . . . . 25.0 116.166 -170.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 81.8 mt -153.98 -179.65 8.06 Favored 'General case' 0 C--O 1.205 -1.251 0 O-C-N 121.45 -0.781 . . . . 25.0 109.535 -171.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -55.86 -27.1 50.07 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.635 -0.876 . . . . 25.0 108.635 167.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -71.29 -10.28 59.49 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 112.965 0.728 . . . . 25.0 112.965 -178.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -99.34 155.32 17.58 Favored 'General case' 0 C--O 1.215 -0.719 0 O-C-N 121.76 -0.588 . . . . 25.0 110.463 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.4 m 42.83 56.49 3.95 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.093 -0.958 . . . . 25.0 113.464 169.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 42.8 p-80 -134.38 168.79 18.27 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 122.02 0.914 . . . . 25.0 111.482 -174.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -125.75 138.93 53.88 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 102.992 -2.966 . . . . 25.0 102.992 173.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.5 p -134.99 172.51 7.13 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 108.316 -0.994 . . . . 25.0 108.316 -173.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -60.13 -15.73 35.74 Favored 'Trans proline' 0 CA--C 1.555 1.559 0 N-CA-C 114.782 1.032 . . . . 25.0 114.782 175.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.6 mt -85.23 -24.67 27.73 Favored 'General case' 0 C--O 1.215 -0.723 0 N-CA-C 111.8 0.296 . . . . 25.0 111.8 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.06 -165.21 30.68 Favored Glycine 0 C--O 1.21 -1.393 0 C-N-CA 120.39 -0.909 . . . . 25.0 111.618 -175.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.9 t -106.55 141.41 37.88 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 122.762 1.268 . . . . 25.0 112.089 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -132.96 32.95 3.72 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-N 114.989 -1.005 . . . . 25.0 109.73 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -73.16 160.99 54.21 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 110.481 -1.047 . . . . 25.0 110.481 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -104.46 169.79 8.27 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 117.994 0.897 . . . . 50.0 110.539 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -121.07 104.58 9.89 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.432 1.093 . . . . 25.0 110.545 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.4 mt -94.02 135.13 29.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 106.747 -1.575 . . . . 25.0 106.747 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 21.6 mt -84.48 -45.63 12.45 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.729 1.751 . . . . 25.0 115.729 -174.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -135.27 38.1 2.95 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 115.134 -0.939 . . . . 25.0 113.429 -169.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -59.26 125.07 22.13 Favored 'General case' 0 C--O 1.218 -0.605 0 N-CA-C 108.791 -0.818 . . . . 25.0 108.791 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -92.1 103.82 9.2 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.897 -0.592 . . . . 25.0 109.697 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -69.04 -4.25 13.17 Favored 'Trans proline' 0 CA--C 1.548 1.209 0 N-CA-C 115.841 1.439 . . . . 25.0 115.841 -175.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.6 t -95.78 -43.3 7.93 Favored 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 122.193 -0.317 . . . . 25.0 110.829 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -97.43 -38.08 9.75 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 113.812 1.041 . . . . 25.0 113.812 -174.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -86.81 170.57 11.58 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.729 -0.388 . . . . 75.0 110.687 -172.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -145.62 149.34 34.35 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 116.208 -0.451 . . . . 25.0 111.006 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 67.7 mt -124.92 125.83 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 107.6 -1.259 . . . . 25.0 107.6 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -89.34 136.23 33.14 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-O 122.02 0.914 . . . . 25.0 108.913 173.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 p -134.46 2.97 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 114.452 -1.249 . . . . 25.0 108.539 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.475 ' HB2' ' HA ' ' A' ' 156' ' ' PHE . 23.7 t -67.32 -47.84 69.34 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 120.722 -0.391 . . . . 25.0 111.146 -175.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.19 -36.0 82.18 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.894 0.702 . . . . 25.0 112.894 -175.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.3 -49.64 4.19 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.585 0.958 . . . . 25.0 113.585 -175.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.31 -78.8 1.32 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 116.375 1.31 . . . . 25.0 116.375 -169.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -157.06 171.37 20.58 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 117.518 0.659 . . . . 25.0 110.114 -168.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 30.6 t -105.51 -36.25 7.19 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.587 0.755 . . . . 25.0 111.451 -177.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -105.91 145.68 15.97 Favored Glycine 0 N--CA 1.468 0.819 0 CA-C-O 118.355 -1.247 . . . . 25.0 111.354 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -61.61 148.31 42.84 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-N 118.814 1.307 . . . . 25.0 110.245 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.0 -167.1 41.15 Favored Glycine 0 C--O 1.243 0.708 0 CA-C-N 114.764 -1.107 . . . . 25.0 113.309 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -65.23 142.11 58.41 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.385 -0.968 . . . . 25.0 108.385 177.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 169.9 178.2 40.77 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 108.723 -1.751 . . . . 25.0 108.723 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -138.18 168.93 18.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 118.102 0.951 . . . . 25.0 109.485 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 61.05 35.28 18.88 Favored 'General case' 0 C--O 1.253 1.241 0 O-C-N 123.958 0.786 . . . . 25.0 112.489 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 65.03 39.32 96.32 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 120.785 -0.722 . . . . 25.0 111.74 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.7 t -146.24 177.43 9.0 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.752 -0.462 . . . . 25.0 109.752 -176.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 92.5 mt -90.08 170.27 10.47 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 105.507 -2.034 . . . . 25.0 105.507 175.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.21 111.72 1.84 Allowed 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 118.575 0.625 . . . . 25.0 110.679 -177.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 17.0 m -102.57 155.19 5.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 107.078 -1.453 . . . . 25.0 107.078 174.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 83.5 p -156.46 173.52 16.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 118.316 0.507 . . . . 25.0 110.715 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.1 m -118.97 160.39 18.87 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 N-CA-C 109.245 -0.65 . . . . 25.0 109.245 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.6 t -69.71 -52.48 25.14 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.837 -1.542 . . . . 25.0 106.837 173.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -164.28 -160.74 0.55 Allowed 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 102.947 -2.983 . . . . 25.0 102.947 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -55.16 -38.87 68.85 Favored 'General case' 0 C--O 1.252 1.225 0 CA-C-N 118.078 0.399 . . . . 25.0 111.104 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.72 -156.42 13.57 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 112.073 -0.411 . . . . 25.0 112.073 176.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.87 -168.67 0.18 Allowed 'General case' 0 C--O 1.251 1.132 0 C-N-CA 124.128 0.971 . . . . 25.0 111.475 177.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 64.9 mtt85 -72.83 160.35 32.3 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.46 0.911 . . . . 25.0 113.46 -171.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -102.6 168.16 9.45 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 105.575 -2.009 . . . . 25.0 105.575 175.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -131.57 156.03 46.46 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.778 0.799 . . . . 25.0 111.961 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 52.5 tp -127.32 116.21 20.17 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 102.976 -2.972 . . . . 25.0 102.976 174.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -122.69 162.99 20.92 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 108.601 -0.889 . . . . 25.0 108.601 -173.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.0 t -140.09 144.41 36.77 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 103.123 -2.918 . . . . 25.0 103.123 172.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -102.4 12.45 36.53 Favored 'General case' 0 C--O 1.245 0.859 0 N-CA-C 109.163 -0.68 . . . . 25.0 109.163 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -81.25 135.11 35.7 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 105.192 -2.151 . . . . 25.0 105.192 172.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -141.91 147.35 36.93 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 122.367 1.08 . . . . 25.0 110.96 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.26 159.51 31.13 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.232 -1.396 . . . . 25.0 107.232 174.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.07 -20.32 66.13 Favored 'General case' 0 CA--C 1.548 0.886 0 O-C-N 121.688 -0.632 . . . . 25.0 109.665 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -77.29 -4.45 45.03 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.49 -0.777 . . . . 25.0 113.072 175.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.18 6.14 63.29 Favored Glycine 0 CA--C 1.51 -0.247 0 N-CA-C 116.571 1.388 . . . . 25.0 116.571 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 69.2 mt -86.52 120.02 27.4 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 110.313 -0.255 . . . . 25.0 110.313 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 25.6 p -119.51 176.57 5.3 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.442 0.697 . . . . 25.0 109.248 -178.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -118.1 132.06 56.38 Favored 'General case' 0 C--O 1.257 1.456 0 N-CA-C 114.126 1.158 . . . . 25.0 114.126 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -152.57 151.69 30.96 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.169 -1.048 . . . . 25.0 108.169 167.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.5 p -149.09 147.83 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 106.113 -1.81 . . . . 25.0 106.113 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -109.73 145.22 36.95 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 111.685 0.254 . . . . 25.0 111.685 -177.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mp -134.0 128.34 34.16 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.451 -1.314 . . . . 25.0 107.451 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -86.9 -12.77 46.75 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 114.905 1.446 . . . . 25.0 114.905 -173.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -75.75 -6.22 81.11 Favored Glycine 0 C--O 1.212 -1.267 0 N-CA-C 116.347 1.299 . . . . 25.0 116.347 -171.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 47.7 t0 50.87 54.11 11.82 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 122.216 1.008 . . . . 25.0 113.068 -175.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -114.35 41.44 2.3 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 107.227 -1.397 . . . . 25.0 107.227 174.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.53 -36.61 84.33 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.004 -0.998 . . . . 25.0 111.624 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -77.49 -24.04 50.18 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.105 -0.997 . . . . 25.0 111.219 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.13 -24.71 37.46 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.541 -0.754 . . . . 25.0 110.699 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 8.1 mt -63.22 139.12 58.74 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 119.8 -0.76 . . . . 25.0 111.756 177.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 92.8 p -138.27 165.74 25.95 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.543 -0.91 . . . . 25.0 108.543 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.68 -3.18 29.82 Favored 'General case' 0 C--N 1.312 -1.03 0 O-C-N 120.997 -1.064 . . . . 25.0 109.879 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -77.43 -37.0 52.59 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 120.944 -1.098 . . . . 25.0 111.398 -177.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -89.72 -5.44 57.01 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 121.138 -0.225 . . . . 25.0 111.421 -177.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 44.4 mm -99.63 122.01 50.96 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.793 0 N-CA-C 103.833 -2.654 . . . . 25.0 103.833 173.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.7 p -112.82 125.08 70.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 122.779 1.276 . . . . 25.0 111.377 -174.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.475 ' HA ' ' HB2' ' A' ' 97' ' ' SER . 1.3 p90 -141.68 -32.22 0.54 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 112.774 -2.012 . . . . 25.0 109.717 -176.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -75.47 55.41 0.81 Allowed 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.674 1.361 . . . . 25.0 114.674 -176.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 60.1 15.88 5.51 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 115.616 1.71 . . . . 25.0 115.616 175.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.4 m 65.29 -23.99 0.09 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.965 1.706 . . . . 25.0 115.599 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -58.86 125.35 23.18 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.248 0.619 . . . . 25.0 111.24 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -96.89 15.04 23.32 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.174 0.805 . . . . 25.0 113.174 -175.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.9 2.26 12.94 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.92 1.081 . . . . 25.0 113.92 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -145.87 -174.96 4.56 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.323 -1.362 . . . . 25.0 107.323 177.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 67.74 -178.24 0.21 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.442 1.097 . . . . 25.0 111.58 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 86.59 21.44 51.09 Favored Glycine 0 C--O 1.24 0.498 0 N-CA-C 109.159 -1.576 . . . . 25.0 109.159 -172.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -77.56 89.44 3.89 Favored 'General case' 0 C--O 1.247 0.96 0 C-N-CA 123.198 0.599 . . . . 25.0 111.659 -177.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -123.28 143.36 50.11 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.598 -0.889 . . . . 25.0 108.598 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -140.79 32.92 2.09 Favored Glycine 0 N--CA 1.461 0.358 0 N-CA-C 109.781 -1.328 . . . . 25.0 109.781 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 47.9 t -71.48 -35.08 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 112.03 0.382 . . . . 25.0 112.03 -175.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.27 130.19 25.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-O 121.195 0.521 . . . . 25.0 111.374 -177.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 152.58 158.67 8.6 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 109.298 -1.521 . . . . 25.0 109.298 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -151.95 144.49 24.18 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 118.625 1.213 . . . . 25.0 110.593 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 68.9 p -142.7 162.77 34.61 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 105.637 -1.986 . . . . 25.0 105.637 175.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -174.02 161.83 32.21 Favored Glycine 0 C--N 1.318 -0.427 0 C-N-CA 120.249 -0.977 . . . . 25.0 113.283 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -136.7 83.29 30.27 Favored Pre-proline 0 C--O 1.241 0.645 0 N-CA-C 108.364 -0.976 . . . . 25.0 108.364 177.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.24 161.54 45.62 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 118.15 -0.767 . . . . 25.0 112.376 -174.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -113.24 150.49 32.31 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 123.51 0.724 . . . . 25.0 110.212 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -138.17 70.73 48.03 Favored Pre-proline 0 N--CA 1.479 0.998 0 CA-C-O 120.903 0.382 . . . . 25.0 110.967 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -73.06 153.85 52.28 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 116.918 -1.588 . . . . 25.0 112.875 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.6 t -84.63 7.05 21.58 Favored 'General case' 0 C--O 1.25 1.085 0 CA-C-O 120.902 0.382 . . . . 25.0 111.658 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 C--O 1.254 1.33 0 CA-C-O 116.833 -1.556 . . . . 25.0 110.335 -177.664 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 N--CA 1.476 0.468 0 N-CA-C 114.409 0.888 . . . . 25.0 114.409 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.09 65.95 0.05 OUTLIER Glycine 0 C--O 1.222 -0.655 0 C-N-CA 121.106 -0.569 . . . . 25.0 112.489 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.7 p -61.49 132.0 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 122.742 1.258 . . . . 25.0 111.417 -176.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -91.94 -19.88 21.98 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 114.986 -1.007 . . . . 25.0 111.203 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.76 -146.13 7.78 Favored Glycine 0 C--O 1.223 -0.568 0 N-CA-C 116.899 1.52 . . . . 25.0 116.899 -175.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.7 p 73.36 155.59 0.16 Allowed Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 126.928 2.091 . . . . 25.0 110.427 -175.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -67.4 13.12 0.17 Allowed 'Trans proline' 0 CA--C 1.545 1.07 0 N-CA-C 117.386 2.033 . . . . 25.0 117.386 -175.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.55 -20.78 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 115.38 1.622 . . . . 25.0 115.38 -174.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.7 p -146.47 141.5 20.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.999 0.74 . . . . 25.0 112.999 -175.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.56 17.15 69.14 Favored Glycine 0 C--O 1.241 0.585 0 N-CA-C 118.324 2.09 . . . . 25.0 118.324 173.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.2 t -51.51 -54.6 25.56 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.517 0.932 . . . . 25.0 113.517 -174.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -82.48 12.6 4.36 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 117.535 2.42 . . . . 25.0 117.535 -174.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -147.95 170.48 17.62 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 122.038 -0.414 . . . . 25.0 111.837 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -58.3 136.24 57.32 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 112.795 0.665 . . . . 25.0 112.795 -175.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -123.0 160.79 25.54 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 116.221 1.934 . . . . 50.0 116.221 -173.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -137.23 105.36 5.69 Favored 'General case' 0 C--O 1.249 1.042 0 N-CA-C 103.795 -2.668 . . . . 25.0 103.795 160.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.6 mt -125.29 131.21 53.11 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.312 0.486 . . . . 25.0 112.312 -175.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -118.59 111.86 19.12 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 122.489 0.316 . . . . 25.0 111.839 -176.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.32 -177.9 51.38 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 117.916 1.926 . . . . 25.0 117.916 -174.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.1 p -81.55 173.32 12.5 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.051 0.94 . . . . 25.0 112.054 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.4 mt -84.56 5.89 25.95 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.748 -0.595 . . . . 25.0 111.494 174.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -100.23 -179.24 30.06 Favored Glycine 0 N--CA 1.464 0.544 0 N-CA-C 111.83 -0.508 . . . . 25.0 111.83 177.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.3 t -78.54 124.92 28.67 Favored 'General case' 0 C--O 1.24 0.585 0 O-C-N 122.121 -0.635 . . . . 25.0 110.053 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -131.36 156.24 45.86 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.899 0.38 . . . . 50.0 111.018 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -98.42 129.14 45.05 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 102.825 -3.028 . . . . 25.0 102.825 163.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.8 mm -126.59 124.48 65.3 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.56 0 N-CA-C 105.969 -1.863 . . . . 25.0 105.969 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.8 mp -125.85 121.72 34.04 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.35 -1.352 . . . . 25.0 107.35 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.23 -34.31 37.35 Favored Glycine 0 C--N 1.318 -0.424 0 C-N-CA 120.68 -0.771 . . . . 25.0 114.933 -178.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 72.31 -145.59 37.82 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 110.415 -1.074 . . . . 25.0 110.415 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -78.63 169.79 54.46 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-O 121.897 0.721 . . . . 25.0 111.352 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.77 159.92 27.52 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.574 -0.822 . . . . 25.0 113.553 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.72 104.49 13.01 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 105.629 -1.989 . . . . 25.0 105.629 176.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -103.31 148.9 25.27 Favored 'General case' 0 C--N 1.314 -0.941 0 O-C-N 121.365 -0.834 . . . . 50.0 111.073 -169.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -112.34 98.57 7.38 Favored 'General case' 0 C--O 1.246 0.92 0 N-CA-C 105.135 -2.172 . . . . 25.0 105.135 176.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 62.8 mt -106.86 133.55 51.35 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.118 -0.492 . . . . 25.0 111.532 -172.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -130.3 106.87 8.86 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 122.659 0.384 . . . . 25.0 110.166 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.12 -19.69 49.38 Favored Glycine 0 CA--C 1.534 1.279 0 N-CA-C 117.682 1.833 . . . . 25.0 117.682 -178.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 53.35 -148.18 0.46 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 118.711 1.255 . . . . 25.0 113.188 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.63 165.87 20.27 Favored 'General case' 0 C--O 1.254 1.292 0 CA-C-O 121.247 0.546 . . . . 25.0 112.087 -176.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.37 153.53 30.16 Favored Glycine 0 N--CA 1.452 -0.269 0 N-CA-C 109.629 -1.388 . . . . 25.0 109.629 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -80.07 101.03 8.48 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.644 -1.613 . . . . 25.0 106.644 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -101.8 151.65 21.81 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.801 -0.636 . . . . 50.0 111.568 -170.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.7 mp -114.0 95.8 5.49 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.591 -0.522 . . . . 25.0 109.591 177.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.7 mp -101.46 128.03 47.86 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.336 0.589 . . . . 25.0 112.103 -173.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -125.73 135.94 52.62 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 106.485 -1.672 . . . . 25.0 106.485 174.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -89.54 -41.07 5.83 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 119.778 -1.201 . . . . 25.0 114.826 -174.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.46 -166.21 50.83 Favored Glycine 0 C--O 1.238 0.353 0 CA-C-N 117.662 0.731 . . . . 25.0 112.829 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.68 149.65 21.34 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.099 0.407 . . . . 25.0 112.099 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.4 153.64 29.03 Favored Glycine 0 C--O 1.238 0.365 0 CA-C-N 115.38 -0.827 . . . . 25.0 112.837 -177.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.34 120.26 21.36 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 105.193 -2.151 . . . . 25.0 105.193 176.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -109.05 156.2 20.05 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.983 -0.377 . . . . 50.0 109.983 -172.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -123.9 117.99 26.07 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 103.928 -2.619 . . . . 25.0 103.928 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -144.23 132.28 21.63 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 116.753 2.131 . . . . 25.0 116.753 -168.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 64.3 m -100.63 135.49 41.99 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.454 -0.573 . . . . 25.0 109.454 176.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.49 -32.91 7.85 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.038 -1.225 . . . . 25.0 110.038 173.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.07 -163.01 54.5 Favored Glycine 0 C--O 1.247 0.954 0 CA-C-O 122.836 1.242 . . . . 25.0 111.805 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -67.23 161.01 25.81 Favored 'General case' 0 C--N 1.322 -0.629 0 O-C-N 121.922 -0.752 . . . . 25.0 110.108 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.44 164.42 37.15 Favored Glycine 0 CA--C 1.521 0.418 0 CA-C-N 115.757 -0.656 . . . . 25.0 111.807 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.66 92.08 8.08 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-O 122.352 1.072 . . . . 25.0 109.957 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -86.01 152.35 22.98 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.105 -0.952 . . . . 50.0 112.338 -172.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.5 m -121.93 127.99 51.02 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.899 -1.046 . . . . 25.0 109.735 -178.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -122.8 84.56 2.28 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.605 -1.257 . . . . 25.0 107.605 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 54.8 mtt85 -85.64 -21.72 28.28 Favored 'General case' 0 CA--C 1.497 -1.068 0 O-C-N 121.54 -0.725 . . . . 25.0 111.358 -178.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 68.22 159.07 0.16 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.017 1.327 . . . . 25.0 112.173 -175.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -93.62 -28.13 16.19 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 115.795 1.776 . . . . 25.0 115.795 -167.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 70.7 mt -145.91 166.02 27.22 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.39 0.515 . . . . 25.0 112.39 -171.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.33 -28.15 69.01 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.642 -0.873 . . . . 25.0 108.642 170.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -82.87 -0.19 47.09 Favored 'General case' 0 C--O 1.252 1.187 0 CA-C-N 114.363 -1.289 . . . . 25.0 113.814 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -91.0 134.65 34.32 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 121.719 -0.613 . . . . 25.0 110.145 -173.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.3 t 47.32 42.75 14.31 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 115.291 1.589 . . . . 25.0 115.291 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 15.5 p-80 -110.79 165.44 11.84 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.419 -0.81 . . . . 25.0 112.375 -174.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -116.06 142.24 47.06 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 106.805 -1.554 . . . . 25.0 106.805 176.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 82.5 p -136.27 166.56 27.03 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 108.278 -1.008 . . . . 25.0 108.278 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -61.14 -22.49 74.84 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 117.885 -0.944 . . . . 25.0 113.528 174.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 86.9 mt -76.79 -21.82 54.59 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.733 0.778 . . . . 25.0 111.174 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 150.52 175.18 22.31 Favored Glycine 0 CA--C 1.506 -0.479 0 CA-C-N 116.17 -0.468 . . . . 25.0 112.11 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.0 t -95.09 148.4 22.4 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 122.01 0.909 . . . . 25.0 111.137 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -131.55 30.82 4.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.833 -1.076 . . . . 25.0 108.448 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.0 142.03 44.34 Favored Glycine 0 C--O 1.243 0.675 0 N-CA-C 111.157 -0.777 . . . . 25.0 111.157 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -85.52 169.22 13.8 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 120.575 0.226 . . . . 50.0 110.393 -177.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -124.08 98.38 5.76 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.001 0.52 . . . . 25.0 111.468 -173.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.9 mt -85.34 132.73 31.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 107.56 -1.274 . . . . 25.0 107.56 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 98.0 mt -84.66 -44.55 13.33 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 114.894 1.442 . . . . 25.0 114.894 -169.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 57.5 p30 -134.45 38.62 3.09 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 114.799 1.407 . . . . 25.0 114.799 -174.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -57.35 129.64 42.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.703 0.763 . . . . 25.0 112.384 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -99.66 105.07 31.8 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 108.212 -1.033 . . . . 25.0 108.212 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -67.61 -16.83 47.68 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 116.228 -2.048 . . . . 25.0 115.802 -176.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.7 t -82.86 -26.66 31.41 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 120.607 0.241 . . . . 25.0 110.988 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -115.78 -33.1 5.26 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 115.432 1.641 . . . . 25.0 115.432 -173.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -91.8 167.63 12.02 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 123.432 0.457 . . . . 50.0 110.367 -170.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -144.65 145.91 31.99 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.212 0.449 . . . . 25.0 112.212 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 88.3 mt -127.41 127.83 69.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.281 -1.007 . . . . 25.0 108.281 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -91.25 148.0 22.65 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.509 -0.923 . . . . 25.0 108.509 173.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.4 p -147.79 -6.72 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 113.175 0.806 . . . . 25.0 113.175 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 26.4 t -61.44 -43.77 98.28 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.532 0.568 . . . . 25.0 112.532 -175.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.05 -28.86 54.91 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.9 1.074 . . . . 25.0 113.9 -178.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.62 -0.33 13.04 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 116.655 2.094 . . . . 25.0 116.655 -169.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -145.0 -72.45 0.02 OUTLIER Glycine 0 C--O 1.241 0.576 0 N-CA-C 116.555 1.382 . . . . 25.0 116.555 -178.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -157.98 169.25 25.01 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.597 -0.89 . . . . 25.0 108.597 -175.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 38.5 t -124.11 -39.8 2.33 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.111 0.482 . . . . 25.0 110.344 177.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -88.48 121.72 6.08 Favored Glycine 0 N--CA 1.465 0.585 0 N-CA-C 111.053 -0.819 . . . . 25.0 111.053 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -73.53 154.16 39.98 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 117.633 0.716 . . . . 25.0 111.87 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.15 -171.84 45.75 Favored Glycine 0 N--CA 1.463 0.467 0 CA-C-N 116.281 -0.418 . . . . 25.0 112.108 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -75.6 81.71 2.6 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.611 0.967 . . . . 25.0 113.611 -177.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -105.86 176.62 22.21 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 108.973 -1.651 . . . . 25.0 108.973 173.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -125.96 166.19 17.38 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 118.106 0.953 . . . . 25.0 110.683 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 54.09 36.43 24.67 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 114.083 1.142 . . . . 25.0 114.083 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 77.35 31.26 52.13 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 120.214 -0.993 . . . . 25.0 112.11 177.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.3 t -138.78 -174.37 3.82 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 117.382 0.591 . . . . 25.0 110.468 -177.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.56 161.01 15.23 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 102.294 -3.225 . . . . 25.0 102.294 173.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.78 115.01 10.48 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 118.744 0.702 . . . . 25.0 110.325 -173.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.1 m -85.3 165.1 2.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 108.112 -1.07 . . . . 25.0 108.112 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 92.0 p -150.39 162.59 40.26 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.673 -0.492 . . . . 25.0 109.673 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.5 m -115.95 164.2 12.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.698 -0.853 . . . . 25.0 108.698 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.5 t -76.55 -56.4 4.65 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.186 -1.413 . . . . 25.0 107.186 170.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -161.31 -159.94 0.68 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 103.436 -2.801 . . . . 25.0 103.436 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -66.52 -24.22 66.35 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 121.062 0.458 . . . . 25.0 110.311 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -118.86 -159.02 10.94 Favored Glycine 0 C--O 1.244 0.758 0 N-CA-C 109.661 -1.376 . . . . 25.0 109.661 176.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 59.44 -161.85 0.26 Allowed 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 112.913 0.708 . . . . 25.0 112.913 176.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 39.4 mtt85 -76.33 163.81 26.64 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.292 1.219 . . . . 25.0 114.292 -169.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.14 159.91 18.76 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 106.233 -1.766 . . . . 25.0 106.233 171.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -132.01 159.21 39.44 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.245 0.545 . . . . 25.0 110.452 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 55.7 tp -133.05 119.37 19.94 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 104.356 -2.461 . . . . 25.0 104.356 170.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -116.51 155.62 28.31 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.435 -0.58 . . . . 25.0 109.435 -175.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.4 t -100.02 149.92 22.98 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 104.272 -2.492 . . . . 25.0 104.272 166.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -116.13 9.56 14.74 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 122.089 0.947 . . . . 25.0 109.783 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -102.18 143.17 32.31 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 104.185 -2.524 . . . . 25.0 104.185 171.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -138.7 155.12 48.52 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.604 0.716 . . . . 25.0 109.802 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -75.29 160.01 30.84 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 105.543 -2.021 . . . . 25.0 105.543 175.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.7 -16.65 63.96 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.496 0.589 . . . . 25.0 111.485 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -76.13 -9.44 58.63 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.157 0.503 . . . . 25.0 112.141 174.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.69 3.29 68.81 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.483 -0.647 . . . . 25.0 111.483 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.3 mt -73.76 138.47 44.59 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.372 -0.973 . . . . 25.0 108.372 177.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.87 -178.43 6.35 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 106.848 -1.538 . . . . 25.0 106.848 -175.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -132.35 140.99 48.74 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-N 118.91 0.777 . . . . 25.0 112.995 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -153.58 156.02 37.22 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 108.06 -1.089 . . . . 25.0 108.06 170.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.5 p -146.06 143.93 21.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 N-CA-C 105.818 -1.919 . . . . 25.0 105.818 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -107.36 142.64 36.86 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.032 -1.47 . . . . 25.0 107.032 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.9 mp -131.49 127.92 38.31 Favored 'General case' 0 C--O 1.207 -1.141 0 N-CA-C 103.552 -2.759 . . . . 25.0 103.552 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -100.19 3.53 43.78 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 119.278 0.945 . . . . 25.0 113.304 -174.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -79.07 -2.28 86.8 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 120.668 -0.777 . . . . 25.0 113.775 177.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 44.8 t0 49.16 48.93 20.39 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 122.075 0.94 . . . . 25.0 112.14 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 6.7 p-80 -108.18 32.67 4.61 Favored 'General case' 0 C--O 1.249 1.03 0 CA-C-O 122.53 1.157 . . . . 25.0 108.615 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -55.1 -34.3 63.56 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.044 -0.98 . . . . 25.0 112.492 176.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.97 -12.78 61.98 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 113.275 0.842 . . . . 25.0 113.275 -178.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -116.86 -5.0 11.53 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.635 0.605 . . . . 25.0 112.635 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 16.1 mt -70.7 127.37 32.41 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.495 -0.928 . . . . 25.0 108.495 178.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 71.2 m -127.64 164.37 22.19 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.616 -1.624 . . . . 25.0 106.616 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -73.64 -1.87 20.68 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.197 -0.668 . . . . 25.0 109.197 176.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -71.33 -29.77 65.4 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 115.673 -0.694 . . . . 25.0 112.385 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -98.15 1.14 47.17 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 122.065 -0.397 . . . . 25.0 111.324 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 38.9 mm -105.5 111.36 34.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 105.535 -2.024 . . . . 25.0 105.535 175.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.8 p -98.15 115.95 39.62 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-O 123.064 1.412 . . . . 25.0 112.558 -173.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -137.36 0.51 2.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 112.98 -1.918 . . . . 25.0 110.362 174.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -81.61 43.95 0.78 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 122.752 0.421 . . . . 25.0 111.441 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 55.94 24.39 7.57 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.202 1.186 . . . . 25.0 114.202 -177.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.56 9.09 0.73 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.657 1.725 . . . . 25.0 115.657 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -79.01 134.94 36.77 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 121.353 -0.842 . . . . 25.0 110.787 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.34 -19.69 63.04 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.354 -0.61 . . . . 25.0 109.354 178.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.3 47.39 0.68 Allowed 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 121.264 0.554 . . . . 25.0 111.513 176.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -150.3 173.18 14.27 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.164 -1.421 . . . . 25.0 107.164 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 62.77 -172.1 0.16 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.64 1.176 . . . . 25.0 111.905 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 81.55 23.41 58.35 Favored Glycine 0 C--N 1.32 -0.311 0 N-CA-C 110.081 -1.207 . . . . 25.0 110.081 -176.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -121.34 101.74 7.83 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 109.38 -0.6 . . . . 25.0 109.38 -176.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -127.8 157.49 40.28 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.179 -0.674 . . . . 25.0 109.179 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -136.74 26.01 3.05 Favored Glycine 0 N--CA 1.464 0.532 0 CA-C-N 116.426 -0.352 . . . . 25.0 113.636 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 47.1 t -80.96 -31.99 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 116.915 0.357 . . . . 25.0 110.8 -177.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.15 133.67 27.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 CA-C-O 121.571 0.7 . . . . 25.0 111.135 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.38 168.0 26.85 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 108.614 -1.794 . . . . 25.0 108.614 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -146.29 143.58 29.25 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.436 1.618 . . . . 25.0 110.601 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 80.5 p -155.51 167.82 29.12 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.556 -0.905 . . . . 25.0 108.556 178.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 179.3 -179.74 48.84 Favored Glycine 0 CA--C 1.507 -0.418 0 C-N-CA 120.628 -0.796 . . . . 25.0 114.299 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -145.82 106.19 4.26 Favored Pre-proline 0 N--CA 1.468 0.456 0 N-CA-C 107.895 -1.15 . . . . 25.0 107.895 177.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -72.94 152.23 51.6 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 116.194 -2.07 . . . . 25.0 113.67 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -113.24 144.5 42.6 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.835 -1.913 . . . . 25.0 105.835 175.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -136.2 67.2 61.44 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 112.644 0.609 . . . . 25.0 112.644 -174.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -73.45 150.83 46.94 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 117.874 -0.951 . . . . 25.0 112.575 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.7 t -139.95 20.96 2.47 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 122.02 0.914 . . . . 25.0 109.803 -177.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.4 p . . . . . 0 C--O 1.248 0.975 0 CA-C-O 117.618 -1.182 . . . . 25.0 110.759 -178.19 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 C--O 1.247 0.967 0 N-CA-C 114.293 0.844 . . . . 25.0 114.293 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.9 51.52 0.06 OUTLIER Glycine 0 C--O 1.237 0.3 0 N-CA-C 109.625 -1.39 . . . . 25.0 109.625 -177.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.9 p -57.86 133.58 22.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.758 0.79 . . . . 25.0 111.03 -174.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -102.37 -8.81 20.86 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.197 -0.91 . . . . 25.0 110.204 -173.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -82.52 -141.79 4.04 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.882 -0.599 . . . . 25.0 112.413 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.5 p 69.12 159.4 0.15 Allowed Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 126.064 1.746 . . . . 25.0 110.835 -175.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -65.97 -5.06 11.28 Favored 'Trans proline' 0 N--CA 1.483 0.9 0 N-CA-C 116.64 1.746 . . . . 25.0 116.64 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.97 -4.2 4.22 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 N-CA-C 114.192 1.182 . . . . 25.0 114.192 -170.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.3 p -141.34 141.35 30.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 121.56 0.695 . . . . 25.0 111.713 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.48 18.5 73.67 Favored Glycine 0 C--N 1.336 0.577 0 N-CA-C 119.681 2.633 . . . . 25.0 119.681 171.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.2 t -51.4 -51.63 53.06 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 120.641 -1.505 . . . . 25.0 113.826 -172.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -85.85 13.94 6.67 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 115.187 1.551 . . . . 25.0 115.187 -171.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.24 168.58 19.44 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.32 0.489 . . . . 25.0 112.32 -176.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -63.93 130.86 45.79 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 118.208 0.458 . . . . 25.0 110.809 -177.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -127.0 170.09 12.66 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 116.6 2.074 . . . . 50.0 116.6 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -136.01 92.56 2.81 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 104.449 -2.426 . . . . 25.0 104.449 168.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 52.4 mt -106.95 123.28 47.95 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.385 0.884 . . . . 25.0 113.385 -173.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -111.43 114.77 28.12 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.815 -0.629 . . . . 25.0 109.401 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.07 174.71 51.21 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 116.948 1.539 . . . . 25.0 116.948 -175.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.3 p -69.47 169.69 12.01 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.504 0.669 . . . . 25.0 111.574 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 89.3 mt -87.33 16.09 5.71 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.521 -0.763 . . . . 25.0 110.905 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -120.6 -178.96 16.19 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.368 -0.693 . . . . 25.0 111.368 175.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.7 t -68.17 135.07 51.51 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 117.365 0.582 . . . . 25.0 110.924 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -144.92 166.44 25.29 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.083 0.553 . . . . 50.0 109.791 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -109.78 129.8 55.59 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 103.284 -2.858 . . . . 25.0 103.284 162.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.4 mm -119.23 121.71 67.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 108.138 -1.06 . . . . 25.0 108.138 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 9.0 mp -124.36 125.96 45.19 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 105.801 -1.926 . . . . 25.0 105.801 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.21 -26.62 27.9 Favored Glycine 0 C--O 1.246 0.904 0 N-CA-C 115.355 0.902 . . . . 25.0 115.355 -176.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.24 -147.33 47.33 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.122 -1.037 . . . . 25.0 112.003 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.31 174.3 52.21 Favored Glycine 0 C--O 1.248 0.983 0 O-C-N 122.73 -0.277 . . . . 25.0 112.889 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.49 160.92 20.99 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.597 -0.811 . . . . 25.0 113.82 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.57 92.0 8.75 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 122.526 1.155 . . . . 25.0 108.008 175.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -89.31 157.29 18.25 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.762 -1.108 . . . . 50.0 112.635 -169.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -117.35 94.99 4.77 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 107.469 -1.308 . . . . 25.0 107.469 172.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 49.6 mt -101.83 134.73 44.55 Favored 'General case' 0 C--O 1.213 -0.847 0 N-CA-C 112.614 0.598 . . . . 25.0 112.614 -172.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -131.51 106.79 8.44 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.174 0.512 . . . . 25.0 111.015 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.96 -25.61 57.51 Favored Glycine 0 C--O 1.246 0.845 0 N-CA-C 116.066 1.186 . . . . 25.0 116.066 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 49.99 -152.19 0.17 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.928 1.084 . . . . 25.0 113.928 -178.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.97 160.39 20.85 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 113.164 0.801 . . . . 25.0 113.164 -173.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.06 156.5 31.35 Favored Glycine 0 C--O 1.247 0.955 0 N-CA-C 109.591 -1.404 . . . . 25.0 109.591 -177.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 22.0 m-20 -81.42 106.08 13.1 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 107.149 -1.426 . . . . 25.0 107.149 177.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -106.84 161.8 14.37 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 120.946 0.403 . . . . 50.0 111.098 -170.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 mp -119.87 136.88 54.32 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 104.832 -2.284 . . . . 25.0 104.832 174.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 mp -136.1 125.42 24.83 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 114.49 1.293 . . . . 25.0 114.49 -172.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -125.19 137.84 54.13 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 113.968 -1.469 . . . . 25.0 107.542 174.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.48 -31.79 8.64 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.32 -0.943 . . . . 25.0 114.704 -178.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.98 -171.0 55.12 Favored Glycine 0 C--O 1.253 1.285 0 N-CA-C 110.784 -0.926 . . . . 25.0 110.784 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.6 157.11 9.61 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.956 0.884 . . . . 25.0 112.422 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.38 164.73 40.48 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-N 115.212 -0.903 . . . . 25.0 111.888 -176.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.97 123.72 33.57 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 104.7 -2.333 . . . . 25.0 104.7 176.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -113.44 157.08 22.4 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.663 0.986 . . . . 50.0 113.663 -169.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -113.2 127.08 56.07 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 103.493 -2.78 . . . . 25.0 103.493 174.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -147.83 137.3 22.43 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.901 1.074 . . . . 25.0 113.901 -176.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 62.1 m -116.04 142.59 46.6 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.02 -1.104 . . . . 25.0 108.02 176.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -93.49 -34.21 6.76 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 111.079 -0.808 . . . . 25.0 111.079 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.81 -173.25 55.33 Favored Glycine 0 C--O 1.244 0.732 0 CA-C-N 117.987 0.893 . . . . 25.0 113.462 -178.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -66.1 159.21 26.62 Favored 'General case' 0 C--O 1.241 0.612 0 O-C-N 121.455 -1.027 . . . . 25.0 109.65 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.1 156.45 32.21 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.57 -1.012 . . . . 25.0 110.57 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.97 124.09 26.33 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 109.184 -0.672 . . . . 25.0 109.184 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -116.3 151.6 35.53 Favored 'General case' 0 C--N 1.313 -0.987 0 O-C-N 121.614 -0.679 . . . . 50.0 112.08 -173.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 98.5 m -114.27 122.57 47.15 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 109.046 -0.724 . . . . 25.0 109.046 177.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -108.96 124.37 50.58 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 106.424 -1.695 . . . . 25.0 106.424 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 49.2 mtt85 -122.49 -36.68 2.89 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.121 0.785 . . . . 25.0 113.121 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 71.69 155.1 0.15 Allowed 'General case' 0 N--CA 1.475 0.817 0 O-C-N 125.07 1.481 . . . . 25.0 108.101 -169.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.52 -43.19 19.12 Favored 'General case' 0 C--N 1.318 -0.765 0 O-C-N 121.852 -0.53 . . . . 25.0 112.158 -165.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 58.6 mt -130.9 163.46 27.42 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 122.054 0.93 . . . . 25.0 111.423 -173.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -56.14 -27.56 54.56 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 114.497 -1.228 . . . . 25.0 108.868 169.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -72.71 -4.68 32.74 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 115.01 1.485 . . . . 25.0 115.01 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -99.09 153.55 18.8 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.41 -0.806 . . . . 25.0 112.894 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.9 t 43.35 48.7 5.93 Favored 'General case' 0 C--O 1.217 -0.649 0 N-CA-C 114.806 1.41 . . . . 25.0 114.806 170.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 28.0 p-80 -131.91 170.23 15.18 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.143 -0.935 . . . . 25.0 110.195 -175.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.5 ttt180 -122.55 142.65 50.39 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 105.707 -1.96 . . . . 25.0 105.707 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 77.9 p -137.55 168.95 14.4 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.207 -0.664 . . . . 25.0 109.207 -176.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -61.45 -24.23 78.02 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 CA-C-N 118.841 0.622 . . . . 25.0 113.266 175.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.2 mt -75.59 -26.49 57.92 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.542 0.687 . . . . 25.0 111.303 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.17 -174.13 32.65 Favored Glycine 0 N--CA 1.463 0.455 0 N-CA-C 110.595 -1.002 . . . . 25.0 110.595 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.8 t -103.18 149.21 24.88 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-O 122.742 1.258 . . . . 25.0 112.956 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -129.03 21.61 5.79 Favored 'General case' 0 C--O 1.252 1.2 0 CA-C-N 114.247 -1.342 . . . . 25.0 109.004 175.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.04 140.5 46.32 Favored Glycine 0 N--CA 1.473 1.105 0 O-C-N 124.549 1.156 . . . . 25.0 111.414 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -96.99 167.37 11.12 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 108.35 -0.981 . . . . 50.0 108.35 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.45 ' HG3' ' HB3' ' A' ' 140' ' ' ALA . 0.3 OUTLIER -123.89 109.32 13.45 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.135 0.791 . . . . 25.0 113.135 -175.074 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 41.5 mt -87.98 139.46 17.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 105.865 -1.902 . . . . 25.0 105.865 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.2 mt -90.9 -44.44 9.37 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 114.868 1.432 . . . . 25.0 114.868 -176.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.6 p-10 -130.13 39.51 3.66 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 116.165 1.913 . . . . 25.0 116.165 -173.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -55.99 126.84 27.64 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 122.3 -0.25 . . . . 25.0 111.114 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -97.57 104.14 19.46 Favored Pre-proline 0 N--CA 1.474 0.771 0 N-CA-C 108.878 -0.786 . . . . 25.0 108.878 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -70.67 -4.97 15.71 Favored 'Trans proline' 0 C--O 1.213 -0.757 0 N-CA-C 114.973 1.105 . . . . 25.0 114.973 -176.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.8 t -89.42 -28.71 19.56 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.087 0.47 . . . . 25.0 111.08 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -118.72 -38.28 3.13 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 115.217 1.562 . . . . 25.0 115.217 -172.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -85.76 175.01 8.94 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.714 0.635 . . . . 75.0 112.714 -172.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.72 152.26 36.31 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.182 0.808 . . . . 25.0 113.182 170.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 55.9 mt -119.03 132.03 70.1 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 N-CA-C 108.854 -0.795 . . . . 25.0 108.854 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -85.6 145.05 27.53 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 122.32 1.057 . . . . 25.0 111.458 173.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.0 p -143.19 -0.85 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 CA-C-N 114.724 -1.125 . . . . 25.0 110.085 178.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.8 t -64.76 -42.51 95.07 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.283 0.563 . . . . 25.0 111.11 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.92 -27.85 63.1 Favored 'General case' 0 C--O 1.249 1.066 0 CA-C-N 115.656 -0.702 . . . . 25.0 111.693 -177.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.0 mt -99.12 -58.07 2.02 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 114.255 1.206 . . . . 25.0 114.255 -169.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -104.33 -65.26 0.69 Allowed Glycine 0 C--O 1.242 0.643 0 N-CA-C 116.609 1.404 . . . . 25.0 116.609 -168.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -156.47 164.8 37.82 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.012 0.478 . . . . 25.0 110.451 -168.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.9 p -117.57 -19.74 9.28 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.99 0.516 . . . . 25.0 110.47 173.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -108.32 117.12 4.97 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 109.199 -1.56 . . . . 25.0 109.199 175.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -60.08 151.44 26.66 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 116.216 1.932 . . . . 25.0 116.216 -175.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.89 -169.25 36.63 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 114.856 -1.066 . . . . 25.0 114.798 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -55.8 135.46 51.76 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 113.435 0.902 . . . . 25.0 113.435 -177.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 168.4 177.68 39.62 Favored Glycine 0 C--O 1.236 0.257 0 N-CA-C 107.961 -2.056 . . . . 25.0 107.961 178.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -142.99 168.96 18.48 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.119 1.46 . . . . 25.0 109.21 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 57.8 35.74 25.77 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.737 0.815 . . . . 25.0 111.527 -177.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 69.37 36.66 78.63 Favored Glycine 0 C--N 1.32 -0.333 0 N-CA-C 111.114 -0.795 . . . . 25.0 111.114 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.3 t -140.09 177.85 7.69 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.193 -0.669 . . . . 25.0 109.193 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 84.3 mt -104.5 155.29 18.94 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 102.347 -3.205 . . . . 25.0 102.347 172.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.39 136.37 55.66 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 119.367 -0.933 . . . . 25.0 109.257 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.0 m -110.74 161.62 9.01 Favored 'Isoleucine or valine' 0 C--O 1.248 1.008 0 N-CA-C 108.89 -0.781 . . . . 25.0 108.89 -177.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 80.4 p -142.56 163.32 33.13 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 116.569 -0.287 . . . . 25.0 111.557 -177.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.2 m -116.41 160.99 15.49 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 N-CA-C 107.555 -1.276 . . . . 25.0 107.555 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.5 t -74.07 -48.78 27.49 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.739 -1.208 . . . . 25.0 107.739 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -168.09 -162.47 0.42 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 102.175 -3.268 . . . . 25.0 102.175 -178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -77.55 12.55 1.56 Allowed 'General case' 0 CA--C 1.546 0.803 0 CA-C-O 121.754 0.788 . . . . 25.0 111.746 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -150.91 -164.13 11.8 Favored Glycine 0 C--O 1.243 0.716 0 N-CA-C 107.438 -2.265 . . . . 25.0 107.438 176.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.42 -154.85 0.36 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.028 0.381 . . . . 25.0 112.028 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.8 mtt180 -84.08 166.52 17.62 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.925 0.713 . . . . 25.0 112.925 -173.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.68 165.98 12.22 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 105.584 -2.006 . . . . 25.0 105.584 174.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -134.55 158.4 44.08 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.762 0.791 . . . . 25.0 111.8 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 41.8 tp -127.08 129.27 47.66 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 103.834 -2.654 . . . . 25.0 103.834 174.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -123.6 154.21 39.62 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.327 0.584 . . . . 25.0 111.346 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.1 t -99.44 151.21 21.37 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 104.533 -2.395 . . . . 25.0 104.533 167.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -118.67 14.66 13.55 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 107.943 -1.132 . . . . 25.0 107.943 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -105.23 140.41 38.42 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 104.578 -2.378 . . . . 25.0 104.578 172.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -138.43 155.44 48.48 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 123.937 0.773 . . . . 25.0 109.64 -177.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -85.73 163.87 17.96 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.57 -0.741 . . . . 25.0 109.633 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.75 -24.0 67.48 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-O 121.444 0.64 . . . . 25.0 111.819 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -74.33 -4.13 34.44 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.754 0.65 . . . . 25.0 112.754 175.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.18 17.73 64.25 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.568 -0.825 . . . . 25.0 112.247 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.2 mt -93.69 141.95 27.91 Favored 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 107.311 -1.366 . . . . 25.0 107.311 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 63.9 p -141.49 178.41 7.46 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 106.854 -1.535 . . . . 25.0 106.854 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -123.31 133.17 54.18 Favored 'General case' 0 C--O 1.252 1.198 0 CA-C-N 118.544 0.611 . . . . 25.0 111.818 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -148.89 151.43 34.66 Favored 'General case' 0 C--O 1.25 1.103 0 N-CA-C 108.56 -0.904 . . . . 25.0 108.56 171.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.1 p -149.19 146.7 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 107.313 -1.366 . . . . 25.0 107.313 -178.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.45 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . . . -104.98 145.57 30.24 Favored 'General case' 0 C--O 1.247 0.972 0 N-CA-C 109.025 -0.732 . . . . 25.0 109.025 -177.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.9 mp -135.45 120.31 18.52 Favored 'General case' 0 C--O 1.211 -0.921 0 N-CA-C 105.1 -2.185 . . . . 25.0 105.1 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -88.06 -13.1 42.36 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 118.302 2.704 . . . . 25.0 118.302 -169.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -78.36 9.0 36.6 Favored Glycine 0 CA--C 1.535 1.332 0 N-CA-C 117.009 1.563 . . . . 25.0 117.009 -175.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 39.9 t0 48.46 51.14 15.78 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 122.716 1.246 . . . . 25.0 112.957 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 12.0 p-80 -110.97 31.97 5.63 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.753 -1.203 . . . . 25.0 107.753 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.29 -38.43 83.59 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 115.232 -0.895 . . . . 25.0 110.968 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.42 -22.41 66.95 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.101 0.56 . . . . 25.0 112.111 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -98.23 -10.71 23.6 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.037 0.754 . . . . 25.0 113.037 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 13.9 mt -66.1 145.85 55.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.776 0.798 . . . . 25.0 112.214 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 72.1 m -142.97 157.34 44.65 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.853 -1.165 . . . . 25.0 107.853 177.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -81.4 9.04 7.88 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.451 0.3 . . . . 25.0 110.424 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -92.72 -22.87 19.14 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.857 0.36 . . . . 25.0 110.071 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -99.17 20.63 13.14 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 122.79 1.281 . . . . 25.0 109.048 173.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 39.8 mm -122.04 130.01 74.92 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 N-CA-C 101.753 -3.425 . . . . 25.0 101.753 170.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.2 p -108.64 128.34 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 119.35 0.977 . . . . 25.0 110.948 -172.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -167.17 -24.64 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.885 -1.052 . . . . 25.0 113.376 -176.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -82.16 80.63 8.33 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.719 -0.613 . . . . 25.0 110.802 -172.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 59.22 8.61 1.13 Allowed 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 115.326 1.602 . . . . 25.0 115.326 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 m 66.37 -37.87 0.29 Allowed 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 116.59 2.07 . . . . 25.0 116.59 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -65.3 138.07 57.95 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 122.009 -0.432 . . . . 25.0 111.414 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.0 -6.22 31.88 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 121.009 0.433 . . . . 25.0 110.83 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.85 -13.7 61.75 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 116.175 -0.466 . . . . 25.0 111.083 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -102.88 160.33 14.7 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 109.764 -0.458 . . . . 25.0 109.764 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 56.56 -163.52 0.16 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.945 1.461 . . . . 25.0 114.945 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 90.43 15.97 56.11 Favored Glycine 0 N--CA 1.459 0.207 0 N-CA-C 114.662 0.625 . . . . 25.0 114.662 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -83.41 115.9 22.25 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 117.271 0.535 . . . . 25.0 111.696 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -110.68 134.12 52.73 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.133 -0.691 . . . . 25.0 109.133 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.8 45.78 0.7 Allowed Glycine 0 C--O 1.224 -0.505 0 N-CA-C 111.513 -0.635 . . . . 25.0 111.513 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 43.1 t -84.46 -32.01 7.8 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 CA-C-O 121.678 0.752 . . . . 25.0 109.619 -177.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.68 135.4 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 CA-C-O 121.713 0.768 . . . . 25.0 112.082 -176.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 161.84 133.88 1.55 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.622 -1.391 . . . . 25.0 109.622 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -148.49 152.12 36.35 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 117.393 0.597 . . . . 25.0 110.941 -177.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 51.2 p -155.41 166.54 33.22 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.365 -0.976 . . . . 25.0 108.365 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 161.67 146.99 4.83 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 121.179 -0.534 . . . . 25.0 113.707 176.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -98.56 110.15 55.73 Favored Pre-proline 0 C--O 1.247 0.957 0 C-N-CA 123.599 0.76 . . . . 25.0 109.512 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.59 150.13 79.76 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 116.936 -1.576 . . . . 25.0 111.853 176.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -110.3 141.46 43.27 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 109.662 -0.496 . . . . 25.0 109.662 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -130.41 79.29 72.7 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-O 120.955 0.407 . . . . 25.0 111.81 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.3 157.81 52.82 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 N-CA-C 114.066 0.756 . . . . 25.0 114.066 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.8 t -99.04 -17.4 18.28 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.248 -0.649 . . . . 25.0 109.248 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 12.0 p . . . . . 0 C--O 1.246 0.894 0 CA-C-O 117.338 -1.315 . . . . 25.0 108.473 173.411 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo . . . . . 0 C--O 1.234 0.302 0 N-CA-C 115.691 1.381 . . . . 25.0 115.691 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.27 51.76 0.29 Allowed Glycine 0 C--O 1.211 -1.3 0 N-CA-C 106.807 -2.517 . . . . 25.0 106.807 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.6 p -55.35 125.83 11.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 N-CA-C 114.564 1.32 . . . . 25.0 114.564 -172.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -105.64 11.2 32.52 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-O 122.189 0.995 . . . . 25.0 109.555 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -94.31 -155.73 31.85 Favored Glycine 0 N--CA 1.447 -0.625 0 O-C-N 121.38 -0.825 . . . . 25.0 113.704 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.0 p 70.18 158.2 0.16 Allowed Pre-proline 0 N--CA 1.486 1.343 0 C-N-CA 126.08 1.752 . . . . 25.0 112.518 -176.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.444 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 35.2 Cg_exo -66.2 -0.78 4.5 Favored 'Trans proline' 0 C--N 1.358 1.073 0 N-CA-C 116.957 1.868 . . . . 25.0 116.957 -174.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.1 p -65.56 -11.28 11.9 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 N-CA-C 115.91 1.818 . . . . 25.0 115.91 -171.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.8 p -146.42 127.2 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 N-CA-C 114.713 1.375 . . . . 25.0 114.713 -176.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.26 18.66 71.53 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 118.148 2.019 . . . . 25.0 118.148 173.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.7 t -50.86 -37.33 42.67 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 115.331 1.604 . . . . 25.0 115.331 -174.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -75.12 2.43 10.77 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 114.88 1.437 . . . . 25.0 114.88 -175.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.25 173.22 11.72 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 118.971 0.805 . . . . 25.0 110.598 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -51.11 128.41 21.7 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 112.886 0.698 . . . . 25.0 112.886 -177.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -129.91 159.4 36.75 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.39 0.885 . . . . 50.0 113.39 -173.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -125.9 95.98 4.6 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 105.353 -2.092 . . . . 25.0 105.353 165.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 80.9 mt -103.57 108.49 19.78 Favored 'General case' 0 C--O 1.212 -0.895 0 N-CA-C 112.976 0.732 . . . . 25.0 112.976 -176.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -98.82 109.75 22.46 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.962 -0.563 . . . . 25.0 109.596 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.0 172.53 51.63 Favored Glycine 0 C--O 1.219 -0.813 0 N-CA-C 115.893 1.117 . . . . 25.0 115.893 -175.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.8 p -72.31 175.76 5.86 Favored 'General case' 0 C--O 1.246 0.889 0 C-N-CA 123.656 0.782 . . . . 25.0 111.404 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 66.6 mt -87.91 16.73 5.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.52 0.676 . . . . 25.0 110.712 174.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.91 179.5 17.94 Favored Glycine 0 N--CA 1.461 0.331 0 N-CA-C 110.029 -1.228 . . . . 25.0 110.029 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.8 t -74.39 133.24 42.47 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.818 0.447 . . . . 25.0 110.454 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -144.54 166.56 24.81 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.453 0.701 . . . . 50.0 109.495 -177.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -110.37 121.89 46.39 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 104.839 -2.282 . . . . 25.0 104.839 164.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.0 mm -111.03 122.41 65.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 107.1 -1.445 . . . . 25.0 107.1 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.444 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 10.9 mp -119.58 122.72 42.22 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.467 -0.938 . . . . 25.0 108.467 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.17 -37.48 32.18 Favored Glycine 0 CA--C 1.496 -1.115 0 CA-C-O 117.888 -1.506 . . . . 25.0 116.074 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.64 -150.21 51.79 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 119.498 1.649 . . . . 25.0 112.357 -177.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.04 168.79 47.02 Favored Glycine 0 CA--C 1.526 0.776 0 O-C-N 121.855 -0.791 . . . . 25.0 114.12 -178.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.05 167.03 29.65 Favored Glycine 0 C--O 1.246 0.871 0 C-N-CA 121.378 -0.439 . . . . 25.0 113.391 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.44 101.25 12.46 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 106.601 -1.629 . . . . 25.0 106.601 177.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -96.32 152.16 18.84 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 113.255 0.835 . . . . 50.0 113.255 -169.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -119.06 88.42 2.93 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 107.531 -1.285 . . . . 25.0 107.531 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 52.4 mt -97.41 143.77 27.81 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.581 -0.736 . . . . 25.0 110.437 -169.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -137.21 106.65 6.11 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 121.905 -0.497 . . . . 25.0 111.497 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.62 -30.1 53.78 Favored Glycine 0 N--CA 1.466 0.659 0 CA-C-O 118.721 -1.044 . . . . 25.0 113.667 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 50.46 -149.71 0.27 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 117.865 0.832 . . . . 25.0 111.51 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.49 163.09 27.54 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.933 0.873 . . . . 25.0 112.736 -174.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.72 156.65 31.64 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 110.514 -1.034 . . . . 25.0 110.514 -174.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -86.82 100.57 12.63 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.213 -1.403 . . . . 25.0 107.213 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -102.84 152.0 21.78 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.23 -0.896 . . . . 50.0 112.955 -169.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mp -110.72 122.79 48.69 Favored 'General case' 0 C--O 1.217 -0.605 0 N-CA-C 107.005 -1.479 . . . . 25.0 107.005 176.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.9 mp -123.21 130.85 53.32 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 114.598 1.332 . . . . 25.0 114.598 -172.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -121.65 143.44 49.33 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.563 1.545 . . . . 25.0 109.011 175.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.76 -37.6 3.16 Favored Glycine 0 C--O 1.242 0.621 0 N-CA-C 115.296 0.878 . . . . 25.0 115.296 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.03 -168.38 54.71 Favored Glycine 0 C--O 1.246 0.885 0 CA-C-N 117.868 0.834 . . . . 25.0 111.974 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.61 151.72 23.98 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.196 -1.179 . . . . 25.0 112.427 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.99 162.13 38.19 Favored Glycine 0 N--CA 1.466 0.698 0 CA-C-N 115.353 -0.84 . . . . 25.0 111.693 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.74 122.71 29.01 Favored 'General case' 0 C--O 1.212 -0.892 0 N-CA-C 105.255 -2.128 . . . . 25.0 105.255 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -114.42 156.71 24.0 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 122.017 0.913 . . . . 50.0 110.526 -172.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -114.88 122.29 45.86 Favored 'General case' 0 C--O 1.218 -0.595 0 N-CA-C 102.305 -3.22 . . . . 25.0 102.305 177.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -142.19 131.01 22.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 119.165 0.893 . . . . 25.0 113.194 -175.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.99 142.03 34.78 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 115.722 -0.672 . . . . 25.0 109.26 177.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.91 -40.57 5.53 Favored Glycine 0 C--O 1.246 0.868 0 N-CA-C 109.294 -1.522 . . . . 25.0 109.294 175.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.0 -172.97 55.05 Favored Glycine 0 C--O 1.244 0.77 0 C-N-CA 120.278 -0.963 . . . . 25.0 112.786 -176.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -64.07 159.02 21.18 Favored 'General case' 0 C--O 1.251 1.142 0 O-C-N 122.178 -0.601 . . . . 25.0 110.864 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.75 161.87 37.24 Favored Glycine 0 C--O 1.247 0.91 0 CA-C-N 115.141 -0.936 . . . . 25.0 111.413 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.95 105.74 14.19 Favored 'General case' 0 C--O 1.217 -0.649 0 N-CA-C 107.807 -1.183 . . . . 25.0 107.807 -178.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -99.54 156.74 16.89 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 122.666 0.387 . . . . 50.0 111.826 -172.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 47.8 m -123.71 111.52 16.27 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.82 0.819 . . . . 25.0 110.09 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -88.39 96.46 10.6 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 104.917 -2.253 . . . . 25.0 104.917 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.4 mmt85 -81.22 -37.69 28.21 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.595 0.591 . . . . 25.0 112.595 -174.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 64.36 149.3 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 O-C-N 125.882 1.989 . . . . 25.0 111.998 -172.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.32 -59.99 2.56 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 114.995 1.48 . . . . 25.0 114.995 -168.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 48.7 mt -135.52 175.65 9.39 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 108.286 -1.005 . . . . 25.0 108.286 -170.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.62 -27.81 42.23 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.019 0.928 . . . . 25.0 110.838 171.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -76.06 -7.38 54.56 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 115.114 1.524 . . . . 25.0 115.114 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -90.16 136.49 33.01 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.325 -0.859 . . . . 25.0 112.84 -174.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.0 t 43.97 44.16 5.83 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 116.312 1.967 . . . . 25.0 116.312 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -113.66 173.91 6.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.886 -1.052 . . . . 25.0 112.18 -177.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -125.69 139.93 53.13 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 104.076 -2.565 . . . . 25.0 104.076 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 57.7 p -134.27 169.47 13.8 Favored Pre-proline 0 C--O 1.214 -0.786 0 N-CA-C 108.501 -0.925 . . . . 25.0 108.501 -176.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -61.91 -15.82 45.51 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 120.399 0.733 . . . . 25.0 112.764 176.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 89.7 mt -84.76 -31.48 23.95 Favored 'General case' 0 C--O 1.245 0.819 0 O-C-N 121.622 -0.674 . . . . 25.0 111.077 177.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.34 177.47 32.46 Favored Glycine 0 CA--C 1.503 -0.716 0 C-N-CA 121.108 -0.567 . . . . 25.0 112.761 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.2 t -88.49 146.8 24.98 Favored 'General case' 0 C--O 1.253 1.255 0 CA-C-O 121.983 0.896 . . . . 25.0 112.127 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -135.1 32.58 3.16 Favored 'General case' 0 C--O 1.254 1.331 0 CA-C-N 113.8 -1.545 . . . . 25.0 108.371 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -64.91 137.38 38.68 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 109.541 -1.424 . . . . 25.0 109.541 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -87.49 168.59 12.96 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 117.699 0.75 . . . . 50.0 110.659 -177.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -118.25 107.46 13.93 Favored 'General case' 0 C--O 1.245 0.847 0 O-C-N 123.789 0.681 . . . . 25.0 111.44 -175.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 52.7 mt -86.93 131.39 35.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 107.05 -1.463 . . . . 25.0 107.05 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.0 mt -75.88 -49.57 17.51 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 116.175 1.917 . . . . 25.0 116.175 -173.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -137.78 41.59 2.33 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.537 0.684 . . . . 25.0 112.282 -169.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -56.51 138.61 51.5 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.902 0.858 . . . . 25.0 110.72 -176.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -105.84 99.19 20.91 Favored Pre-proline 0 C--O 1.215 -0.74 0 N-CA-C 109.224 -0.658 . . . . 25.0 109.224 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -67.53 1.6 3.01 Favored 'Trans proline' 0 C--N 1.358 1.034 0 N-CA-C 115.39 1.265 . . . . 25.0 115.39 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.5 t -103.89 -42.27 5.64 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 117.515 0.143 . . . . 25.0 110.795 175.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -99.39 -36.99 9.41 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 115.15 1.537 . . . . 25.0 115.15 -175.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -85.08 170.74 12.64 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.028 -0.73 . . . . 75.0 109.028 -171.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -146.42 158.04 43.84 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.953 0.901 . . . . 25.0 110.363 177.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 64.9 mt -130.34 134.84 61.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.91 -0.774 . . . . 25.0 108.91 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -90.12 148.48 22.98 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 122.197 0.999 . . . . 25.0 109.367 175.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.5 p -153.55 -9.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 114.803 -1.09 . . . . 25.0 110.841 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.8 t -60.82 -39.71 90.04 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.036 0.446 . . . . 25.0 111.358 -178.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -86.48 -7.87 58.05 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 115.084 1.513 . . . . 25.0 115.084 -176.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.78 0.28 1.78 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 116.074 1.879 . . . . 25.0 116.074 -172.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -143.26 -69.38 0.02 OUTLIER Glycine 0 N--CA 1.467 0.76 0 N-CA-C 116.094 1.198 . . . . 25.0 116.094 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -156.03 163.81 39.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 117.467 0.634 . . . . 25.0 110.174 -174.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 30.8 t -112.71 -34.15 5.89 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 122.034 0.921 . . . . 25.0 110.552 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -107.12 137.38 13.93 Favored Glycine 0 C--O 1.223 -0.587 0 N-CA-C 107.824 -2.111 . . . . 25.0 107.824 176.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.88 151.39 45.74 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 118.936 -1.106 . . . . 25.0 109.269 -177.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -92.37 -164.11 38.11 Favored Glycine 0 C--O 1.222 -0.645 0 CA-C-N 115.839 -0.619 . . . . 25.0 112.04 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -53.59 129.04 31.45 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.798 0.809 . . . . 25.0 111.801 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 174.99 -176.47 47.14 Favored Glycine 0 C--O 1.215 -1.051 0 N-CA-C 109.928 -1.269 . . . . 25.0 109.928 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -155.94 167.62 29.81 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 118.451 1.126 . . . . 25.0 111.09 -178.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 53.92 43.7 30.5 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 124.319 1.048 . . . . 25.0 112.65 -178.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 68.94 30.24 72.34 Favored Glycine 0 C--O 1.219 -0.796 0 CA-C-N 115.291 -0.868 . . . . 25.0 112.864 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.406 ' HA ' ' H ' ' A' ' 151' ' ' ALA . 6.2 t -142.51 171.69 13.72 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 118.316 1.058 . . . . 25.0 111.722 -177.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 83.6 mt -90.42 164.1 14.42 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 103.329 -2.841 . . . . 25.0 103.329 171.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.68 110.36 7.91 Favored 'General case' 0 C--O 1.252 1.226 0 N-CA-C 107.753 -1.203 . . . . 25.0 107.753 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 18.7 m -71.89 162.7 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-N 115.349 -0.841 . . . . 25.0 109.587 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 29.5 m -145.8 169.78 17.85 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 120.292 -0.563 . . . . 25.0 109.883 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 34.9 m -121.77 164.38 18.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 108.738 -0.838 . . . . 25.0 108.738 177.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.8 t -76.14 -48.64 19.84 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.319 -1.363 . . . . 25.0 107.319 170.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -165.73 -170.42 1.79 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 101.502 -3.518 . . . . 25.0 101.502 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -69.85 -2.84 13.38 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 119.164 0.893 . . . . 25.0 112.856 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -137.35 -160.94 8.75 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 106.204 -2.759 . . . . 25.0 106.204 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.16 -160.34 0.28 Allowed 'General case' 0 C--O 1.249 1.062 0 CA-C-N 117.865 0.832 . . . . 25.0 111.093 177.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 47.0 mtt85 -71.08 166.86 20.51 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 122.279 1.038 . . . . 25.0 112.975 -171.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.1 p -114.15 165.92 12.16 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 105.74 -1.948 . . . . 25.0 105.74 173.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -133.55 153.56 51.55 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 121.14 0.495 . . . . 25.0 111.772 -177.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 28.2 tp -128.01 118.92 24.4 Favored 'General case' 0 C--O 1.25 1.099 0 N-CA-C 103.684 -2.709 . . . . 25.0 103.684 171.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -115.23 145.17 42.69 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 115.829 -0.623 . . . . 25.0 112.298 -174.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.9 t -99.71 147.83 25.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 105.221 -2.14 . . . . 25.0 105.221 168.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -114.79 11.48 16.76 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.889 1.328 . . . . 25.0 108.456 -177.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -93.62 141.17 28.78 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 105.53 -2.026 . . . . 25.0 105.53 174.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -140.83 150.34 43.16 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 122.055 0.931 . . . . 25.0 109.81 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -76.6 167.01 22.59 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.331 -1.304 . . . . 25.0 108.791 177.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.96 -32.39 73.7 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.591 -0.892 . . . . 25.0 108.591 176.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -65.42 -9.28 23.95 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 114.423 1.268 . . . . 25.0 114.423 174.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.57 21.85 61.23 Favored Glycine 0 C--O 1.241 0.581 0 N-CA-C 109.453 -1.459 . . . . 25.0 109.453 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.5 mt -92.05 136.8 32.88 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 106.092 -1.818 . . . . 25.0 106.092 175.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.6 p -141.55 -179.7 6.31 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.867 -1.16 . . . . 25.0 107.867 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -127.94 131.77 49.3 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 119.085 -1.046 . . . . 25.0 113.222 -178.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -147.61 153.95 40.04 Favored 'General case' 0 C--O 1.26 1.619 0 N-CA-C 106.818 -1.549 . . . . 25.0 106.818 168.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.1 p -142.12 146.6 22.42 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 106.93 -1.508 . . . . 25.0 106.93 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -103.2 140.93 36.72 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 107.094 -1.447 . . . . 25.0 107.094 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.2 mp -129.42 131.2 46.72 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 105.177 -2.157 . . . . 25.0 105.177 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -108.9 15.83 23.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.142 0.973 . . . . 25.0 110.541 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -72.91 -8.42 73.2 Favored Glycine 0 C--O 1.238 0.386 0 CA-C-N 114.761 -1.109 . . . . 25.0 110.719 171.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 40.0 t0 51.08 55.92 8.79 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.585 0.707 . . . . 25.0 112.445 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -133.14 43.55 2.93 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-O 122.178 0.989 . . . . 25.0 109.913 -174.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.66 -31.03 64.0 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 121.633 -0.667 . . . . 25.0 111.061 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.74 -14.83 61.63 Favored 'General case' 0 C--O 1.256 1.399 0 N-CA-C 112.406 0.521 . . . . 25.0 112.406 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -109.48 -10.72 14.87 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.108 0.48 . . . . 25.0 111.743 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 29.7 mt -73.69 126.21 29.8 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 123.193 1.473 . . . . 25.0 112.562 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 68.0 m -127.96 158.72 37.08 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 105.553 -2.017 . . . . 25.0 105.553 175.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.406 ' H ' ' HA ' ' A' ' 111' ' ' SER . . . -80.13 -3.57 49.38 Favored 'General case' 0 C--O 1.211 -0.95 0 CA-C-N 115.854 -0.612 . . . . 25.0 110.418 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -67.1 -35.98 80.97 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 117.69 0.223 . . . . 25.0 111.297 -173.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -75.89 -11.44 59.97 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 120.307 -0.557 . . . . 25.0 110.597 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 22.5 mm -83.91 119.9 33.89 Favored 'Isoleucine or valine' 0 C--O 1.247 0.957 0 N-CA-C 106.449 -1.685 . . . . 25.0 106.449 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.6 p -95.94 109.37 22.59 Favored 'Isoleucine or valine' 0 C--O 1.253 1.247 0 CA-C-O 123.044 1.402 . . . . 25.0 113.797 -174.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -145.21 -12.92 0.53 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.649 -1.614 . . . . 25.0 112.185 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -76.75 54.19 0.96 Allowed 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 113.302 0.853 . . . . 25.0 113.302 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 57.87 27.65 14.92 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 113.784 1.031 . . . . 25.0 113.784 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 55.98 0.65 0.06 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 119.361 3.097 . . . . 25.0 119.361 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -88.12 134.23 33.81 Favored 'General case' 0 C--N 1.314 -0.962 0 O-C-N 121.255 -0.903 . . . . 25.0 110.758 -176.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -68.84 -14.28 62.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.918 -0.583 . . . . 25.0 109.578 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.11 -28.1 69.39 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.121 0.486 . . . . 25.0 111.626 177.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.1 162.06 28.86 Favored 'General case' 0 C--O 1.251 1.138 0 CA-C-O 121.264 0.555 . . . . 25.0 111.822 -177.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 61.38 -157.38 0.34 Allowed 'General case' 0 C--O 1.242 0.663 0 CA-C-N 114.629 -1.169 . . . . 25.0 112.619 177.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 90.95 -1.25 77.57 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.597 -0.335 . . . . 25.0 112.429 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -104.32 115.28 30.1 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.779 -0.823 . . . . 25.0 108.779 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -123.53 139.94 53.51 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.274 -0.639 . . . . 25.0 109.274 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -113.93 26.0 10.33 Favored Glycine 0 C--O 1.241 0.59 0 N-CA-C 112.314 -0.314 . . . . 25.0 112.314 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 52.3 t -79.18 -37.27 19.08 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 N-CA-C 109.463 -0.569 . . . . 25.0 109.463 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.43 135.64 24.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.629 0.728 . . . . 25.0 111.238 -175.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 133.58 141.78 4.62 Favored Glycine 0 C--O 1.247 0.969 0 N-CA-C 110.935 -0.866 . . . . 25.0 110.935 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -151.72 161.12 43.2 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.272 -0.64 . . . . 25.0 109.272 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 84.7 p -152.91 165.67 34.74 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 107.732 -1.21 . . . . 25.0 107.732 176.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -177.31 -171.13 40.52 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 119.887 -1.149 . . . . 25.0 112.114 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -138.78 92.54 11.22 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 117.587 0.693 . . . . 25.0 110.96 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.12 161.67 40.38 Favored 'Trans proline' 0 C--O 1.232 0.209 0 O-C-N 122.801 0.895 . . . . 25.0 112.115 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -134.64 151.43 51.04 Favored 'General case' 0 CA--C 1.508 -0.638 0 C-N-CA 123.535 0.734 . . . . 25.0 109.772 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -122.86 75.1 47.7 Favored Pre-proline 0 N--CA 1.481 1.084 0 CA-C-O 121.399 0.619 . . . . 25.0 110.842 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -77.44 160.33 32.16 Favored 'Trans proline' 0 CA--C 1.513 -0.526 0 C-N-CA 116.787 -1.675 . . . . 25.0 112.533 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 12.2 t -125.64 -4.9 7.06 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.211 -0.904 . . . . 25.0 110.741 174.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 6.3 p . . . . . 0 C--O 1.246 0.871 0 N-CA-C 109.61 -0.515 . . . . 25.0 109.61 176.72 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo . . . . . 0 C--O 1.234 0.283 0 N-CA-C 113.097 0.384 . . . . 25.0 113.097 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -150.25 44.49 0.7 Allowed Glycine 0 CA--C 1.536 1.352 0 N-CA-C 114.533 0.573 . . . . 25.0 114.533 -177.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.498 HG22 ' H ' ' A' ' 7' ' ' GLY . 7.9 p -52.51 129.94 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 114.776 1.398 . . . . 25.0 114.776 -176.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -93.49 -7.71 43.58 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.838 -1.073 . . . . 25.0 111.536 -178.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.498 ' H ' HG22 ' A' ' 5' ' ' VAL . . . -81.93 -149.5 7.47 Favored Glycine 0 CA--C 1.507 -0.464 0 CA-C-N 115.597 -0.729 . . . . 25.0 114.344 179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.2 p 71.94 156.43 0.16 Allowed Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 126.266 1.826 . . . . 25.0 110.581 -173.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.61 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 24.6 Cg_exo -69.27 -0.21 6.19 Favored 'Trans proline' 0 C--N 1.354 0.849 0 N-CA-C 114.846 1.056 . . . . 25.0 114.846 -175.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.8 p -66.9 -14.43 18.03 Favored 'Isoleucine or valine' 0 C--O 1.248 0.983 0 N-CA-C 113.954 1.094 . . . . 25.0 113.954 -171.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.4 p -133.57 132.12 57.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 N-CA-C 113.758 1.022 . . . . 25.0 113.758 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.7 13.62 74.97 Favored Glycine 0 C--O 1.246 0.888 0 N-CA-C 118.642 2.217 . . . . 25.0 118.642 171.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.3 t -51.2 -41.78 60.46 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.153 1.168 . . . . 25.0 114.153 -171.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -78.61 4.96 12.09 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 116.243 1.942 . . . . 25.0 116.243 -174.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.93 176.94 9.11 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 118.832 -0.604 . . . . 25.0 111.438 -177.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -57.64 133.28 55.17 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.339 0.59 . . . . 25.0 111.585 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -130.18 157.27 42.93 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.539 0.941 . . . . 50.0 113.539 -173.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -132.25 73.08 1.51 Allowed 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 106.738 -1.578 . . . . 25.0 106.738 169.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.6 mt -91.48 125.8 36.35 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 114.366 1.247 . . . . 25.0 114.366 -174.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -110.1 109.93 20.64 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 116.327 -0.397 . . . . 25.0 110.901 176.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -80.62 176.61 54.62 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 115.855 1.102 . . . . 25.0 115.855 -175.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.7 p -69.08 170.76 9.36 Favored 'General case' 0 C--O 1.256 1.444 0 C-N-CA 123.885 0.874 . . . . 25.0 110.361 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 48.6 mt -87.06 20.82 2.53 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.657 -0.702 . . . . 25.0 110.769 170.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -128.62 -174.01 13.61 Favored Glycine 0 C--O 1.223 -0.56 0 CA-C-O 118.615 -1.103 . . . . 25.0 112.505 176.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.9 t -71.08 133.1 46.01 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 113.857 1.058 . . . . 25.0 113.857 -176.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -145.18 158.52 43.8 Favored 'General case' 0 C--O 1.219 -0.541 0 O-C-N 123.211 0.32 . . . . 50.0 111.682 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -99.61 134.15 42.91 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 103.352 -2.833 . . . . 25.0 103.352 162.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.9 mm -128.41 117.92 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 105.676 -1.972 . . . . 25.0 105.676 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.61 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 8.3 mp -115.55 116.19 27.74 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 106.888 -1.523 . . . . 25.0 106.888 178.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.76 -36.11 90.72 Favored Glycine 0 CA--C 1.502 -0.779 0 C-N-CA 120.567 -0.825 . . . . 25.0 115.062 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.34 -147.21 45.37 Favored Glycine 0 C--O 1.254 1.39 0 C-N-CA 120.813 -0.708 . . . . 25.0 112.027 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.99 165.66 54.74 Favored Glycine 0 C--O 1.249 1.039 0 N-CA-C 111.847 -0.501 . . . . 25.0 111.847 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.84 162.96 28.94 Favored Glycine 0 C--N 1.316 -0.546 0 N-CA-C 114.967 0.747 . . . . 25.0 114.967 174.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.78 106.65 16.47 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 106.524 -1.658 . . . . 25.0 106.524 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -103.58 155.3 18.65 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 112.892 0.701 . . . . 50.0 112.892 -169.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -122.77 93.7 4.05 Favored 'General case' 0 C--O 1.246 0.906 0 N-CA-C 106.277 -1.749 . . . . 25.0 106.277 176.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.8 mt -101.21 140.09 35.98 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 114.881 -1.054 . . . . 25.0 111.356 -170.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -135.64 102.73 5.19 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.563 -0.532 . . . . 25.0 109.563 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.56 -20.7 59.57 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 116.463 1.345 . . . . 25.0 116.463 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 50.29 -150.51 0.23 Allowed 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 119.548 1.674 . . . . 25.0 115.126 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.68 162.2 13.62 Favored 'General case' 0 CA--C 1.552 1.041 0 O-C-N 120.908 -1.12 . . . . 25.0 112.752 -177.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.86 156.12 28.25 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 114.828 -1.078 . . . . 25.0 111.574 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -77.91 106.6 9.86 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 106.943 -1.503 . . . . 25.0 106.943 173.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -111.93 151.83 28.74 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 121.577 -0.702 . . . . 50.0 110.649 -170.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mp -116.13 94.82 4.81 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.966 -1.124 . . . . 25.0 107.966 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 mp -99.25 127.01 45.19 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.701 0.8 . . . . 25.0 112.912 -175.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -124.4 148.81 47.32 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 104.35 -2.463 . . . . 25.0 104.35 175.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.47 -39.37 3.46 Favored Glycine 0 N--CA 1.462 0.432 0 N-CA-C 116.193 1.237 . . . . 25.0 116.193 -175.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.38 -175.55 48.77 Favored Glycine 0 C--O 1.243 0.718 0 N-CA-C 110.266 -1.134 . . . . 25.0 110.266 -177.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.01 149.14 12.31 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 112.752 0.649 . . . . 25.0 112.752 -178.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.41 153.47 29.6 Favored Glycine 0 N--CA 1.46 0.251 0 N-CA-C 111.017 -0.833 . . . . 25.0 111.017 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.5 125.38 29.28 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 104.222 -2.511 . . . . 25.0 104.222 177.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -109.65 153.12 24.68 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.328 -0.619 . . . . 50.0 109.328 -173.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -116.02 122.62 45.74 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 102.409 -3.182 . . . . 25.0 102.409 177.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -145.41 130.86 18.72 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 114.707 1.373 . . . . 25.0 114.707 -171.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.0 m -107.44 132.25 53.4 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 105.99 -1.855 . . . . 25.0 105.99 176.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -91.57 -27.53 17.15 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 111.581 -0.607 . . . . 25.0 111.581 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.21 -169.41 54.91 Favored Glycine 0 N--CA 1.466 0.648 0 CA-C-N 118.022 0.911 . . . . 25.0 113.704 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -66.2 163.41 17.84 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.903 -0.763 . . . . 25.0 110.956 177.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.44 160.29 36.39 Favored Glycine 0 C--O 1.25 1.124 0 CA-C-O 119.897 -0.391 . . . . 25.0 112.678 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.33 102.3 6.7 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.631 0.729 . . . . 25.0 109.853 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -94.85 154.1 17.4 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.773 -0.649 . . . . 50.0 111.545 -174.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.5 m -121.96 127.91 50.9 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.054 -1.461 . . . . 25.0 107.054 -177.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -116.8 82.09 1.74 Allowed 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 106.992 -1.484 . . . . 25.0 106.992 176.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.71 -27.27 40.66 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-N 115.634 -0.712 . . . . 25.0 110.946 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 66.98 153.84 0.09 Allowed 'General case' 0 N--CA 1.479 1.018 0 O-C-N 125.678 1.861 . . . . 25.0 112.112 -172.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.06 -50.8 8.67 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.917 1.08 . . . . 25.0 113.917 -166.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 46.6 mt -130.4 168.86 16.29 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-O 121.372 0.605 . . . . 25.0 109.564 -172.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.17 -28.47 53.09 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.977 0.911 . . . . 25.0 110.585 173.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -75.4 -12.88 60.34 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 115.576 1.695 . . . . 25.0 115.576 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -73.26 134.74 44.35 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.026 1.121 . . . . 25.0 114.026 -174.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.3 t 50.22 42.56 25.62 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 114.759 -1.109 . . . . 25.0 113.655 176.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -107.75 162.45 13.97 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.135 -0.484 . . . . 25.0 111.623 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -122.9 144.6 49.11 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 103.799 -2.667 . . . . 25.0 103.799 177.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 99.3 p -140.12 172.08 6.86 Favored Pre-proline 0 C--N 1.325 -0.478 0 C-N-CA 123.71 0.804 . . . . 25.0 108.963 -173.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -61.1 -19.26 62.56 Favored 'Trans proline' 0 C--N 1.354 0.829 0 O-C-N 122.653 0.817 . . . . 25.0 113.592 174.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.0 mt -79.36 -23.62 43.23 Favored 'General case' 0 C--O 1.245 0.857 0 N-CA-C 113.037 0.754 . . . . 25.0 113.037 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 148.51 -172.35 28.73 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 116.216 -0.447 . . . . 25.0 112.09 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.7 t -101.23 137.71 39.22 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.734 0.778 . . . . 25.0 111.859 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -122.63 29.93 6.68 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.22 -1.355 . . . . 25.0 107.694 173.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.91 146.56 50.43 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 109.765 -1.334 . . . . 25.0 109.765 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -95.84 163.66 13.07 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.41 -1.053 . . . . 50.0 110.316 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -126.04 104.06 8.07 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 111.992 0.367 . . . . 25.0 111.992 -170.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 21.6 mt -86.47 135.1 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 107.206 -1.405 . . . . 25.0 107.206 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.3 mt -89.02 -42.49 11.73 Favored 'General case' 0 C--O 1.21 -0.991 0 N-CA-C 114.77 1.396 . . . . 25.0 114.77 -175.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 46.8 p-10 -127.62 41.17 3.56 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.989 1.477 . . . . 25.0 114.989 -172.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -60.23 142.76 54.02 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 113.399 0.889 . . . . 25.0 113.399 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -117.1 100.13 53.11 Favored Pre-proline 0 N--CA 1.476 0.835 0 N-CA-C 108.948 -0.76 . . . . 25.0 108.948 177.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.9 1.66 4.32 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 N-CA-C 117.129 1.934 . . . . 25.0 117.129 -172.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.6 t -100.7 -35.84 9.33 Favored 'General case' 0 CA--C 1.554 1.099 0 O-C-N 121.763 -0.585 . . . . 25.0 110.753 175.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -98.86 -39.14 8.74 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 114.281 1.215 . . . . 25.0 114.281 -177.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -83.48 163.69 20.34 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.973 -0.558 . . . . 75.0 110.525 -172.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -142.26 146.14 34.82 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.003 0.814 . . . . 25.0 112.486 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 80.1 mt -125.96 131.92 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 107.753 -1.203 . . . . 25.0 107.753 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -88.29 144.5 26.38 Favored 'General case' 0 C--O 1.214 -0.814 0 O-C-N 120.958 -1.089 . . . . 25.0 110.185 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.4 p -146.69 4.42 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.359 0 CA-C-N 115.232 -0.894 . . . . 25.0 110.242 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.2 t -55.67 -57.72 10.8 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 112.9 0.704 . . . . 25.0 112.9 -173.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.44 -14.1 57.46 Favored 'General case' 0 C--O 1.256 1.404 0 N-CA-C 112.445 0.535 . . . . 25.0 112.445 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.9 mt -89.44 -52.91 4.79 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.285 0.564 . . . . 25.0 112.299 -175.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -109.03 -65.2 0.56 Allowed Glycine 0 CA--C 1.506 -0.523 0 N-CA-C 116.637 1.415 . . . . 25.0 116.637 -171.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -157.84 169.31 24.89 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 117.003 0.401 . . . . 25.0 111.353 -171.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.0 t -109.52 -23.6 11.41 Favored 'General case' 0 CA--C 1.557 1.233 0 O-C-N 123.869 0.731 . . . . 25.0 111.977 177.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -120.4 145.03 17.42 Favored Glycine 0 C--O 1.235 0.173 0 N-CA-C 105.593 -3.003 . . . . 25.0 105.593 172.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -58.28 154.0 14.23 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.095 1.146 . . . . 25.0 114.095 -173.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -90.17 -166.2 41.16 Favored Glycine 0 C--O 1.223 -0.59 0 CA-C-N 115.272 -0.876 . . . . 25.0 112.989 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -57.04 131.38 49.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.356 0.598 . . . . 25.0 112.202 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 160.41 178.1 34.1 Favored Glycine 0 N--CA 1.466 0.698 0 N-CA-C 107.054 -2.418 . . . . 25.0 107.054 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -141.76 166.72 23.95 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.932 1.366 . . . . 25.0 110.321 -175.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 55.04 34.23 22.04 Favored 'General case' 0 C--O 1.26 1.627 0 C-N-CA 123.392 0.677 . . . . 25.0 112.038 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.09 41.3 54.56 Favored Glycine 0 C--O 1.216 -1.018 0 N-CA-C 111.269 -0.732 . . . . 25.0 111.269 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.5 t -142.95 175.87 9.51 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.887 -0.782 . . . . 25.0 108.887 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 82.6 mt -106.48 164.65 11.88 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 105.655 -1.98 . . . . 25.0 105.655 173.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.418 ' HB3' ' CE1' ' A' ' 128' ' ' TYR . . . -72.89 120.5 18.6 Favored 'General case' 0 C--O 1.245 0.85 0 N-CA-C 108.302 -0.999 . . . . 25.0 108.302 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.9 m -89.71 158.36 2.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.874 -0.788 . . . . 25.0 108.874 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.4 m -132.98 154.09 50.82 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.038 -0.727 . . . . 25.0 109.038 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.3 m -120.33 160.38 20.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 108.633 -0.877 . . . . 25.0 108.633 177.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 17.2 t -75.84 -47.4 25.72 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 105.828 -1.915 . . . . 25.0 105.828 170.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -173.86 -162.52 0.15 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 101.229 -3.619 . . . . 25.0 101.229 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -61.02 -35.93 78.17 Favored 'General case' 0 C--O 1.246 0.88 0 CA-C-N 118.157 0.435 . . . . 25.0 111.088 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -103.01 -154.05 24.48 Favored Glycine 0 C--O 1.225 -0.463 0 CA-C-O 121.574 0.541 . . . . 25.0 112.293 176.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.91 -138.75 0.4 Allowed 'General case' 0 C--O 1.237 0.435 0 C-N-CA 122.75 0.42 . . . . 25.0 111.747 174.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 33.7 mtt85 -105.48 167.05 10.01 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 121.679 -0.638 . . . . 25.0 112.188 -174.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.28 165.58 13.28 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 105.402 -2.073 . . . . 25.0 105.402 177.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -138.45 152.65 48.52 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.767 -0.827 . . . . 25.0 108.767 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 27.0 tp -128.75 114.8 17.04 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 105.1 -2.185 . . . . 25.0 105.1 175.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -116.97 151.18 37.26 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 122.588 1.185 . . . . 25.0 112.101 -171.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.1 t -93.77 142.55 27.24 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 104.543 -2.392 . . . . 25.0 104.543 171.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.418 ' CE1' ' HB3' ' A' ' 113' ' ' ALA . 62.7 m-85 -115.6 11.08 15.74 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 122.539 1.161 . . . . 25.0 108.207 176.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -91.1 136.1 33.32 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 105.258 -2.127 . . . . 25.0 105.258 168.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -131.5 152.43 50.73 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-O 121.892 0.853 . . . . 25.0 110.433 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -86.54 166.72 15.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.392 -1.276 . . . . 25.0 109.382 -176.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -61.38 -32.14 72.05 Favored 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 122.676 0.39 . . . . 25.0 111.192 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -76.6 -4.54 43.46 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.325 0.861 . . . . 25.0 113.325 175.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.01 13.64 63.98 Favored Glycine 0 CA--C 1.501 -0.838 0 C-N-CA 120.919 -0.657 . . . . 25.0 112.176 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 65.7 mt -83.47 158.3 22.1 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 106.472 -1.677 . . . . 25.0 106.472 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.6 p -154.56 177.77 10.83 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 104.851 -2.278 . . . . 25.0 104.851 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -127.77 137.55 52.46 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-O 119.044 -0.503 . . . . 25.0 110.199 -176.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -152.56 153.49 33.52 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 118.996 0.816 . . . . 25.0 109.071 171.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.2 p -143.7 142.05 25.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 106.792 -1.559 . . . . 25.0 106.792 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -100.31 146.76 26.55 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.361 -0.977 . . . . 25.0 108.361 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.0 mp -137.48 132.76 33.78 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 104.669 -2.345 . . . . 25.0 104.669 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -101.82 12.16 37.49 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 121.26 1.845 . . . . 25.0 115.803 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -73.81 -14.91 79.7 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.398 -0.906 . . . . 25.0 113.081 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 42.2 t0 53.26 43.0 32.07 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 123.826 1.774 . . . . 25.0 110.902 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -109.55 41.1 1.73 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 113.547 -1.661 . . . . 25.0 107.606 -176.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.94 -29.95 63.59 Favored 'General case' 0 C--O 1.209 -1.047 0 CA-C-N 113.923 -1.49 . . . . 25.0 113.293 177.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.58 -31.66 57.66 Favored 'General case' 0 C--N 1.319 -0.756 0 O-C-N 120.285 -1.51 . . . . 25.0 112.135 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -77.27 -29.83 54.03 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.975 0.731 . . . . 25.0 112.975 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 15.9 mt -60.91 129.9 43.78 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 122.65 1.214 . . . . 25.0 110.413 -176.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.9 m -138.73 163.8 31.21 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 104.999 -2.222 . . . . 25.0 104.999 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.04 4.47 17.0 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 118.562 0.619 . . . . 25.0 109.734 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -75.01 -29.86 60.98 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.39 -0.823 . . . . 25.0 111.662 -177.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -87.32 -8.74 56.35 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 122.092 -0.38 . . . . 25.0 110.8 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 40.6 mm -91.95 132.78 35.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 104.609 -2.367 . . . . 25.0 104.609 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.4 p -115.11 132.76 63.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 122.053 0.93 . . . . 25.0 111.496 -175.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -155.33 -34.13 0.09 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 114.701 1.371 . . . . 25.0 114.701 -174.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.33 60.43 5.58 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 113.234 0.827 . . . . 25.0 113.234 -173.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 58.75 21.17 8.63 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.843 1.053 . . . . 25.0 113.843 176.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.65 11.52 2.44 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 114.675 1.361 . . . . 25.0 114.675 175.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -89.87 129.59 36.21 Favored 'General case' 0 C--O 1.238 0.448 0 O-C-N 121.999 -0.438 . . . . 25.0 110.304 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -66.69 -15.29 63.4 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.376 0.608 . . . . 25.0 111.07 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.7 -19.08 64.35 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 121.699 -0.626 . . . . 25.0 112.269 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.48 157.4 22.42 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 111.982 0.364 . . . . 25.0 111.982 -178.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 56.59 -163.79 0.16 Allowed 'General case' 0 CA--C 1.549 0.933 0 O-C-N 124.434 1.084 . . . . 25.0 113.417 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 97.67 0.98 58.96 Favored Glycine 0 N--CA 1.465 0.628 0 N-CA-C 114.94 0.736 . . . . 25.0 114.94 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -75.85 110.87 10.64 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 117.239 0.519 . . . . 25.0 111.193 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -129.85 155.44 46.0 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.553 0.341 . . . . 25.0 111.01 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -136.44 39.86 1.59 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.096 -1.202 . . . . 25.0 110.096 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 60.8 t -73.99 -36.21 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 109.76 -0.459 . . . . 25.0 109.76 -176.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.4 130.93 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-O 121.684 0.754 . . . . 25.0 111.639 -177.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 139.0 155.25 6.61 Favored Glycine 0 C--O 1.247 0.929 0 CA-C-N 115.336 -0.847 . . . . 25.0 111.741 -178.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -163.2 170.72 17.32 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 108.731 -0.84 . . . . 25.0 108.731 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 77.4 p -150.58 168.73 23.4 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 105.826 -1.916 . . . . 25.0 105.826 173.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -159.04 140.68 7.03 Favored Glycine 0 CA--C 1.501 -0.808 0 C-N-CA 119.728 -1.225 . . . . 25.0 115.062 177.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -131.64 80.16 67.08 Favored Pre-proline 0 C--O 1.24 0.561 0 N-CA-C 106.998 -1.482 . . . . 25.0 106.998 177.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -68.75 155.33 69.09 Favored 'Trans proline' 0 C--O 1.236 0.406 0 N-CA-C 113.582 0.57 . . . . 25.0 113.582 -174.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -120.66 151.96 38.81 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 106.871 -1.529 . . . . 25.0 106.871 -177.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -143.47 64.85 14.19 Favored Pre-proline 0 C--O 1.248 0.997 0 N-CA-C 115.559 1.689 . . . . 25.0 115.559 -178.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -71.53 151.28 58.71 Favored 'Trans proline' 0 C--O 1.244 0.814 0 C-N-CA 116.969 -1.554 . . . . 25.0 111.345 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 11.5 t -137.63 22.68 2.91 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.397 0.618 . . . . 25.0 110.919 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 C--O 1.247 0.944 0 CA-C-O 116.874 -1.536 . . . . 25.0 110.825 -179.665 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo . . . . . 0 CA--C 1.536 0.607 0 CA-C-O 121.516 0.548 . . . . 25.0 113.268 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.88 46.39 0.04 OUTLIER Glycine 0 CA--C 1.522 0.511 0 CA-C-N 115.427 -0.806 . . . . 25.0 111.11 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.1 p -57.54 133.85 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 CA-C-O 121.497 0.665 . . . . 25.0 109.997 -175.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -99.76 -11.57 20.71 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.703 -0.68 . . . . 25.0 109.742 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.33 -147.55 8.43 Favored Glycine 0 CA--C 1.501 -0.836 0 CA-C-N 115.621 -0.718 . . . . 25.0 113.028 177.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.2 p 71.3 159.09 0.16 Allowed Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 125.632 1.573 . . . . 25.0 111.135 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.551 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 31.2 Cg_exo -66.19 1.76 2.25 Favored 'Trans proline' 0 C--N 1.351 0.67 0 N-CA-C 117.406 2.041 . . . . 25.0 117.406 -175.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.3 p -63.98 -24.06 34.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 115.735 1.754 . . . . 25.0 115.735 -168.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.6 p -145.93 140.43 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 114.233 1.197 . . . . 25.0 114.233 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.85 10.0 86.53 Favored Glycine 0 N--CA 1.466 0.678 0 CA-C-N 114.753 -1.112 . . . . 25.0 115.434 171.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.6 t -50.95 -39.3 54.71 Favored 'General case' 0 C--O 1.21 -1.025 0 N-CA-C 114.075 1.139 . . . . 25.0 114.075 -170.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -81.71 8.07 10.9 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 115.044 1.498 . . . . 25.0 115.044 -175.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -142.99 173.96 11.09 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 118.852 -0.594 . . . . 25.0 111.459 176.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -58.79 124.12 18.72 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 115.314 1.598 . . . . 25.0 115.314 -173.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -124.32 164.47 19.54 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.611 1.708 . . . . 50.0 115.611 -175.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -130.85 77.03 1.76 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 107.469 -1.308 . . . . 25.0 107.469 169.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.1 mt -90.74 120.24 31.62 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.861 1.06 . . . . 25.0 113.861 -175.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -110.9 124.54 52.29 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 122.799 0.44 . . . . 25.0 110.69 178.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.45 172.72 41.52 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-O 122.626 1.126 . . . . 25.0 114.973 -176.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.8 p -84.97 175.44 9.06 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.037 -1.081 . . . . 25.0 110.484 175.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 66.2 mt -79.42 4.22 16.11 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.507 0.723 . . . . 25.0 112.733 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.61 177.78 24.82 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 119.438 -0.646 . . . . 25.0 113.879 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.1 t -70.14 129.98 40.85 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 117.303 0.552 . . . . 25.0 111.995 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -145.51 159.36 43.22 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.129 -0.357 . . . . 50.0 110.774 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -94.33 138.97 31.68 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 106.119 -1.808 . . . . 25.0 106.119 164.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.3 mm -129.69 105.99 12.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 105.49 -2.041 . . . . 25.0 105.49 178.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.551 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 8.9 mp -105.57 117.45 34.06 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.735 -0.839 . . . . 25.0 108.735 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.64 -42.54 62.44 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.196 -1.002 . . . . 25.0 114.303 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.8 -149.55 48.12 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 120.277 -0.963 . . . . 25.0 112.53 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.46 168.16 52.91 Favored Glycine 0 C--O 1.247 0.929 0 CA-C-O 122.001 0.778 . . . . 25.0 114.25 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.85 167.22 26.47 Favored Glycine 0 C--O 1.24 0.47 0 N-CA-C 111.954 -0.458 . . . . 25.0 111.954 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.06 120.15 28.03 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 105.773 -1.936 . . . . 25.0 105.773 176.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -115.09 154.74 28.35 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 120.41 -0.516 . . . . 50.0 111.984 -172.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -118.86 90.63 3.37 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 107.068 -1.456 . . . . 25.0 107.068 177.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.4 mt -98.4 138.22 35.95 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 123.078 0.551 . . . . 25.0 111.876 -171.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -135.31 105.78 6.42 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 118.554 0.616 . . . . 25.0 111.537 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.27 -30.65 45.02 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 115.316 0.887 . . . . 25.0 115.316 -175.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 53.93 -150.1 0.4 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.058 0.943 . . . . 25.0 112.289 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.36 162.9 24.3 Favored 'General case' 0 C--O 1.254 1.305 0 O-C-N 121.072 -1.018 . . . . 25.0 112.353 -175.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.75 159.04 32.54 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 114.922 -1.036 . . . . 25.0 111.71 -177.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -81.02 102.78 10.41 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.058 -1.089 . . . . 25.0 108.058 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -106.04 150.07 26.09 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.521 0.677 . . . . 50.0 112.72 -170.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 mp -113.05 89.37 3.06 Favored 'General case' 0 C--O 1.217 -0.626 0 N-CA-C 108.436 -0.95 . . . . 25.0 108.436 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.9 mp -92.75 129.67 38.61 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.303 0.482 . . . . 25.0 112.303 -176.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -127.1 146.61 50.32 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 104.516 -2.402 . . . . 25.0 104.516 175.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -98.19 -33.74 5.61 Favored Glycine 0 N--CA 1.466 0.689 0 N-CA-C 117.253 1.661 . . . . 25.0 117.253 -176.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.94 -162.19 52.66 Favored Glycine 0 C--O 1.257 1.587 0 N-CA-C 110.608 -0.997 . . . . 25.0 110.608 -174.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.68 161.79 7.39 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.674 0.75 . . . . 25.0 112.758 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.4 170.95 37.94 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 115.07 -0.968 . . . . 25.0 113.683 174.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.72 124.03 30.46 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 106.28 -1.748 . . . . 25.0 106.28 177.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -115.56 152.36 33.19 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 120.979 0.418 . . . . 50.0 111.593 -175.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -115.09 129.53 56.71 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 103.879 -2.637 . . . . 25.0 103.879 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -148.41 127.45 12.8 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 115.884 1.809 . . . . 25.0 115.884 -174.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.9 m -99.37 134.2 42.57 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.481 -0.781 . . . . 25.0 108.899 172.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.03 -33.95 9.25 Favored Glycine 0 C--O 1.244 0.777 0 C-N-CA 120.07 -1.062 . . . . 25.0 112.681 175.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.6 -169.39 54.73 Favored Glycine 0 C--O 1.255 1.442 0 CA-C-O 122.54 1.078 . . . . 25.0 115.111 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -67.75 162.45 23.83 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.375 -1.073 . . . . 25.0 110.605 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.77 164.48 39.63 Favored Glycine 0 C--O 1.244 0.761 0 N-CA-C 111.218 -0.753 . . . . 25.0 111.218 -177.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.74 105.13 16.05 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 109.619 -0.511 . . . . 25.0 109.619 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -99.15 151.71 20.68 Favored 'General case' 0 C--O 1.215 -0.73 0 CA-C-N 115.691 -0.686 . . . . 50.0 110.531 -170.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 58.9 m -121.64 126.67 49.58 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.925 -0.769 . . . . 25.0 108.925 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -114.36 87.59 2.67 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.615 -1.254 . . . . 25.0 107.615 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 30.8 mtt85 -85.87 -23.22 27.17 Favored 'General case' 0 CA--C 1.505 -0.763 0 O-C-N 121.602 -0.686 . . . . 25.0 112.661 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 67.75 142.6 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 O-C-N 125.161 1.538 . . . . 25.0 112.876 -174.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.28 -52.91 10.89 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 114.791 1.404 . . . . 25.0 114.791 -163.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 98.0 mt -135.82 176.53 8.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.308 1.051 . . . . 25.0 110.04 -176.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.58 -28.41 32.03 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.104 -0.953 . . . . 25.0 112.362 173.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -77.91 -10.83 59.77 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 114.707 1.373 . . . . 25.0 114.707 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.15 138.4 41.99 Favored 'General case' 0 C--O 1.213 -0.844 0 O-C-N 120.845 -1.159 . . . . 25.0 111.709 -175.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.8 t 45.61 39.42 4.9 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-N 113.682 -1.599 . . . . 25.0 114.005 173.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -104.31 167.31 9.83 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.097 -0.956 . . . . 25.0 109.434 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -127.47 143.84 51.14 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 104.791 -2.3 . . . . 25.0 104.791 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.6 p -135.9 166.76 25.86 Favored Pre-proline 0 C--N 1.315 -0.904 0 N-CA-C 108.021 -1.103 . . . . 25.0 108.021 -176.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -63.04 -23.48 73.81 Favored 'Trans proline' 0 C--N 1.353 0.774 0 CA-C-N 118.917 0.649 . . . . 25.0 112.68 175.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 73.7 mt -72.85 -23.85 60.81 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.418 0.628 . . . . 25.0 111.036 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 149.23 177.49 23.41 Favored Glycine 0 CA--C 1.5 -0.847 0 N-CA-C 111.028 -0.829 . . . . 25.0 111.028 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.3 t -97.59 155.12 17.12 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 118.072 0.936 . . . . 25.0 112.765 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -136.36 24.78 3.21 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 106.622 -1.621 . . . . 25.0 106.622 175.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.53 146.33 48.49 Favored Glycine 0 C--O 1.218 -0.865 0 CA-C-O 118.885 -0.953 . . . . 25.0 111.733 178.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -98.37 166.27 11.46 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 118.11 0.955 . . . . 50.0 112.311 -177.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -124.11 99.82 6.42 Favored 'General case' 0 C--O 1.253 1.26 0 O-C-N 123.593 0.558 . . . . 25.0 111.844 -172.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.8 mt -84.19 135.49 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 106.082 -1.821 . . . . 25.0 106.082 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.424 ' HA ' ' HG2' ' A' ' 142' ' ' GLU . 12.9 mt -89.99 -45.13 9.39 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 115.607 1.706 . . . . 25.0 115.607 -171.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -131.23 32.11 4.3 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.816 1.043 . . . . 25.0 113.816 -170.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -51.25 138.97 19.74 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.795 1.035 . . . . 25.0 113.795 -175.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -107.93 106.93 59.62 Favored Pre-proline 0 C--O 1.235 0.329 0 N-CA-C 108.293 -1.003 . . . . 25.0 108.293 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -69.8 -8.17 22.93 Favored 'Trans proline' 0 CA--C 1.547 1.161 0 N-CA-C 117.743 2.17 . . . . 25.0 117.743 -174.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.8 t -96.84 -35.81 10.81 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-O 120.481 0.181 . . . . 25.0 111.41 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -98.83 -37.66 9.35 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 113.349 0.87 . . . . 25.0 113.349 -173.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -86.59 167.0 14.96 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.922 0.391 . . . . 75.0 110.551 -173.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -145.59 149.09 33.91 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 109.356 -0.609 . . . . 25.0 109.356 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 68.5 mt -125.51 133.21 69.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 108.05 -1.093 . . . . 25.0 108.05 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -95.59 144.33 26.13 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.754 -1.202 . . . . 25.0 107.754 174.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.1 p -143.41 -10.16 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.722 -0.672 . . . . 25.0 111.612 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 39.0 t -58.85 -42.6 89.74 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.416 0.895 . . . . 25.0 113.416 -175.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.54 -20.82 61.98 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 113.977 1.102 . . . . 25.0 113.977 -176.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.79 -45.38 1.9 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 116.436 2.013 . . . . 25.0 116.436 -170.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -94.74 -75.57 1.29 Allowed Glycine 0 N--CA 1.463 0.47 0 C-N-CA 119.999 -1.096 . . . . 25.0 113.099 -175.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -148.75 167.09 26.51 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.068 -0.716 . . . . 25.0 109.068 -175.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.8 t -124.38 -27.96 3.7 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.453 0.644 . . . . 25.0 110.362 176.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -101.0 120.14 6.78 Favored Glycine 0 N--CA 1.466 0.691 0 N-CA-C 108.294 -1.922 . . . . 25.0 108.294 172.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -66.24 150.4 48.87 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 119.776 1.788 . . . . 25.0 109.55 -176.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -102.57 -146.33 17.4 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-O 122.755 1.197 . . . . 25.0 115.723 -173.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -60.01 134.35 56.96 Favored 'General case' 0 C--O 1.251 1.16 0 CA-C-N 113.605 -1.298 . . . . 25.0 112.238 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 159.28 -176.98 36.01 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 123.28 0.363 . . . . 25.0 112.504 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -144.57 179.07 7.52 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 109.609 -0.515 . . . . 25.0 109.609 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 56.74 32.85 21.93 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 113.967 1.099 . . . . 25.0 113.967 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 69.06 29.7 72.24 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 109.964 -1.254 . . . . 25.0 109.964 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.8 t -143.32 174.3 10.85 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.373 0.606 . . . . 25.0 109.69 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 5.5 mp -92.7 161.82 14.39 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 103.337 -2.838 . . . . 25.0 103.337 173.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.84 118.01 10.49 Favored 'General case' 0 C--O 1.269 2.087 0 CA-C-N 118.953 0.797 . . . . 25.0 112.196 -172.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 26.4 m -79.75 162.05 3.9 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 CA-C-O 121.56 0.695 . . . . 25.0 109.363 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 56.1 m -145.88 171.3 15.01 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.714 -0.847 . . . . 25.0 108.714 -177.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 34.0 m -125.17 162.68 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 109.156 -0.683 . . . . 25.0 109.156 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 40.2 t -80.92 -40.17 25.01 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.464 -1.68 . . . . 25.0 106.464 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -174.27 -163.49 0.16 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 102.628 -3.101 . . . . 25.0 102.628 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -63.63 -23.76 67.51 Favored 'General case' 0 C--O 1.248 1.013 0 N-CA-C 112.39 0.515 . . . . 25.0 112.39 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -121.6 -153.61 9.0 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 109.499 -1.441 . . . . 25.0 109.499 175.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.83 -154.01 0.37 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 122.859 0.464 . . . . 25.0 110.295 175.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.0 mtt85 -81.46 160.29 24.03 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 114.43 1.27 . . . . 25.0 114.43 -173.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.1 p -105.21 162.62 13.25 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 105.642 -1.985 . . . . 25.0 105.642 172.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -130.27 150.68 51.4 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.394 0.616 . . . . 25.0 112.175 -177.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 64.8 tp -127.53 120.05 27.39 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 104.022 -2.584 . . . . 25.0 104.022 171.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -118.41 146.19 44.63 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.686 0.624 . . . . 25.0 112.686 -171.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.2 t -89.15 147.94 23.93 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 106.201 -1.778 . . . . 25.0 106.201 167.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -116.5 -0.04 12.59 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.624 -1.251 . . . . 25.0 107.624 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -86.0 137.43 32.72 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 104.085 -2.561 . . . . 25.0 104.085 169.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -146.2 158.42 43.88 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 124.697 1.248 . . . . 25.0 109.38 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -80.6 160.61 25.06 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.733 -1.122 . . . . 25.0 107.976 175.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.47 -22.37 66.94 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 122.002 -0.436 . . . . 25.0 110.625 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -69.41 -11.82 61.14 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 113.455 0.909 . . . . 25.0 113.455 174.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.63 16.14 57.18 Favored Glycine 0 C--O 1.22 -0.781 0 N-CA-C 111.64 -0.584 . . . . 25.0 111.64 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.3 mt -88.66 130.21 35.35 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.985 -1.117 . . . . 25.0 107.985 178.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 72.7 p -138.95 -179.69 5.98 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.477 -0.564 . . . . 25.0 109.477 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -122.13 133.11 54.76 Favored 'General case' 0 C--O 1.257 1.453 0 CA-C-O 119.177 -0.44 . . . . 25.0 110.452 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.4 pt-20 -145.91 152.17 39.02 Favored 'General case' 0 C--O 1.247 0.956 0 N-CA-C 108.293 -1.002 . . . . 25.0 108.293 171.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.8 p -145.85 139.82 21.31 Favored 'Isoleucine or valine' 0 C--O 1.248 0.985 0 N-CA-C 106.712 -1.588 . . . . 25.0 106.712 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -103.41 147.6 26.93 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 107.704 -1.221 . . . . 25.0 107.704 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.7 mp -136.61 129.96 31.55 Favored 'General case' 0 C--O 1.208 -1.132 0 N-CA-C 105.186 -2.153 . . . . 25.0 105.186 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.424 ' HG2' ' HA ' ' A' ' 85' ' ' LEU . 17.4 pt-20 -99.66 6.54 45.62 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 119.889 1.222 . . . . 25.0 112.158 -175.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -71.1 -12.35 71.71 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.718 -0.753 . . . . 25.0 112.275 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 38.7 t0 53.53 54.86 9.4 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.915 0.864 . . . . 25.0 111.371 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -126.94 39.63 3.88 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.56 -1.2 . . . . 25.0 109.129 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.74 -37.01 82.66 Favored 'General case' 0 C--O 1.214 -0.791 0 O-C-N 121.792 -0.567 . . . . 25.0 111.673 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.16 -10.29 59.46 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 121.53 -0.731 . . . . 25.0 112.085 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -98.12 -26.13 14.68 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 111.789 0.292 . . . . 25.0 111.789 175.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.0 mt -62.69 136.06 57.69 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 122.581 1.181 . . . . 25.0 111.357 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.5 m -135.81 164.26 28.32 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 105.558 -2.016 . . . . 25.0 105.558 171.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -77.05 8.38 3.94 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.71 0.29 . . . . 25.0 110.716 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -65.66 -39.34 91.26 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.301 0.482 . . . . 25.0 112.301 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -81.54 -10.41 59.46 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.075 -0.966 . . . . 25.0 111.079 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 13.4 mm -91.27 126.1 43.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 106.312 -1.736 . . . . 25.0 106.312 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.0 p -103.05 122.77 55.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 O-C-N 120.996 -1.065 . . . . 25.0 111.555 -177.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -157.22 -16.05 0.09 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 114.684 -1.144 . . . . 25.0 113.563 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.96 61.48 6.45 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 121.878 -0.514 . . . . 25.0 111.261 -172.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 55.44 15.39 1.42 Allowed 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 115.94 1.83 . . . . 25.0 115.94 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 64.76 -21.82 0.08 Allowed 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 116.557 2.058 . . . . 25.0 116.557 176.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -70.64 116.48 11.01 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.917 -1.114 . . . . 25.0 110.201 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.42 -5.7 44.0 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 113.238 0.829 . . . . 25.0 113.238 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.24 -20.11 65.62 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.316 0.579 . . . . 25.0 110.811 177.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -90.99 -162.26 0.89 Allowed 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.588 -0.733 . . . . 25.0 111.198 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 60.79 -160.45 0.3 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.138 0.975 . . . . 25.0 113.106 176.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 79.98 24.05 60.51 Favored Glycine 0 C--O 1.228 -0.263 0 C-N-CA 121.367 -0.444 . . . . 25.0 112.272 -178.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -97.37 93.49 6.52 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.791 -0.829 . . . . 25.0 109.788 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -121.86 152.67 39.33 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.249 0.547 . . . . 25.0 109.834 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -140.5 33.77 2.03 Favored Glycine 0 CA--C 1.51 -0.251 0 CA-C-O 122.281 0.934 . . . . 25.0 111.173 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 61.3 t -82.69 -35.79 12.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 O-C-N 122.221 -0.576 . . . . 25.0 110.675 -176.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -53.27 137.84 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 115.843 -0.617 . . . . 25.0 111.246 -178.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 140.35 155.3 6.5 Favored Glycine 0 C--O 1.245 0.784 0 CA-C-N 115.843 -0.617 . . . . 25.0 112.759 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -155.94 143.67 19.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.565 0.683 . . . . 25.0 110.077 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 87.1 p -154.13 163.67 39.74 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 122.477 0.311 . . . . 25.0 110.916 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 172.41 -179.25 44.09 Favored Glycine 0 N--CA 1.47 0.956 0 N-CA-C 110.982 -0.847 . . . . 25.0 110.982 176.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -138.99 113.06 8.25 Favored Pre-proline 0 C--O 1.248 0.98 0 CA-C-N 118.152 0.976 . . . . 25.0 110.917 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.82 169.06 23.01 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 N-CA-C 115.365 1.256 . . . . 25.0 115.365 -177.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -122.49 149.02 44.46 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.078 -0.712 . . . . 25.0 109.078 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -138.49 73.78 41.62 Favored Pre-proline 0 N--CA 1.472 0.641 0 C-N-CA 123.349 0.66 . . . . 25.0 110.372 175.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -76.4 155.2 36.51 Favored 'Trans proline' 0 N--CA 1.478 0.577 0 C-N-CA 118.448 -0.568 . . . . 25.0 113.29 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.7 t -96.08 -2.16 47.21 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 121.951 -0.468 . . . . 25.0 111.965 -177.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 C--O 1.257 1.496 0 CA-C-O 118.554 -0.736 . . . . 25.0 110.017 -177.827 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo . . . . . 0 CA--C 1.538 0.677 0 CA-C-O 120.677 0.199 . . . . 25.0 112.194 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.64 60.67 0.03 OUTLIER Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.993 -0.623 . . . . 25.0 111.899 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.57 HG22 ' H ' ' A' ' 7' ' ' GLY . 7.1 p -55.84 134.68 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 122.504 1.145 . . . . 25.0 111.217 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -101.99 0.31 34.97 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 121.556 0.693 . . . . 25.0 111.045 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.57 ' H ' HG22 ' A' ' 5' ' ' VAL . . . -92.08 -147.96 21.6 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.499 -0.773 . . . . 25.0 113.694 176.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.8 p 69.98 155.59 0.15 Allowed Pre-proline 0 N--CA 1.489 1.521 0 C-N-CA 126.011 1.724 . . . . 25.0 111.226 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -73.89 4.68 3.96 Favored 'Trans proline' 0 C--O 1.24 0.625 0 C-N-CA 121.631 1.554 . . . . 25.0 115.318 -177.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.0 p -54.18 -31.5 21.98 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 N-CA-C 116.02 1.859 . . . . 25.0 116.02 -170.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.0 p -148.26 152.83 12.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 O-C-N 120.943 -1.098 . . . . 25.0 111.01 -177.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.91 7.32 88.44 Favored Glycine 0 N--CA 1.468 0.788 0 N-CA-C 115.425 0.93 . . . . 25.0 115.425 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.2 t -56.65 -40.4 75.39 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 113.914 1.079 . . . . 25.0 113.914 -172.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -78.87 10.17 3.6 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 116.41 2.004 . . . . 25.0 116.41 -175.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.59 169.74 18.97 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 119.205 -0.426 . . . . 25.0 110.545 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -51.0 139.01 18.34 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 118.664 0.666 . . . . 25.0 111.892 -177.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -131.0 161.93 30.88 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.436 1.273 . . . . 50.0 114.436 -175.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -133.87 96.15 3.6 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 104.682 -2.34 . . . . 25.0 104.682 163.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 97.5 mt -112.01 126.26 54.95 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 121.341 0.591 . . . . 25.0 111.213 -176.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -119.72 117.19 27.6 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.226 -0.897 . . . . 25.0 109.753 -176.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.58 177.29 51.38 Favored Glycine 0 CA--C 1.502 -0.763 0 N-CA-C 116.063 1.185 . . . . 25.0 116.063 -175.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.7 p -79.81 174.26 11.76 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 114.302 -0.949 . . . . 25.0 111.407 178.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 77.3 mt -87.3 18.3 3.85 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 121.551 -0.718 . . . . 25.0 111.336 175.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -123.92 179.4 16.15 Favored Glycine 0 CA--C 1.502 -0.76 0 N-CA-C 111.475 -0.65 . . . . 25.0 111.475 177.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.2 t -67.29 134.09 50.92 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.146 0.424 . . . . 25.0 112.146 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -147.02 171.96 14.47 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 123.402 0.681 . . . . 50.0 111.843 -176.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -119.34 126.77 52.21 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.802 -1.555 . . . . 25.0 106.802 166.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.9 mm -123.75 130.41 74.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 106.652 -1.61 . . . . 25.0 106.652 -178.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.6 tt -134.78 123.93 24.36 Favored 'General case' 0 C--O 1.21 -1.012 0 N-CA-C 106.761 -1.57 . . . . 25.0 106.761 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.2 -34.33 37.41 Favored Glycine 0 CA--C 1.497 -1.051 0 N-CA-C 116.22 1.248 . . . . 25.0 116.22 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.38 -143.91 38.13 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.465 -0.874 . . . . 25.0 110.99 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.44 165.9 54.72 Favored Glycine 0 CA--C 1.498 -1.014 0 CA-C-O 122.672 1.151 . . . . 25.0 113.201 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.14 167.28 30.38 Favored Glycine 0 N--CA 1.459 0.212 0 CA-C-N 114.837 -0.682 . . . . 25.0 113.495 178.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.11 111.61 19.48 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 106.498 -1.667 . . . . 25.0 106.498 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -109.36 152.55 25.16 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 113.67 0.989 . . . . 50.0 113.67 -171.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -114.7 105.14 12.7 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 106.816 -1.549 . . . . 25.0 106.816 171.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 58.1 mt -110.8 133.6 53.22 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.221 0.452 . . . . 25.0 112.221 -174.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -131.71 110.59 11.0 Favored 'General case' 0 C--N 1.316 -0.875 0 O-C-N 121.224 -0.922 . . . . 25.0 112.99 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.25 -29.72 29.93 Favored Glycine 0 C--O 1.242 0.601 0 N-CA-C 117.713 1.845 . . . . 25.0 117.713 -174.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 53.01 -154.42 0.22 Allowed 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.683 0.994 . . . . 25.0 113.683 -177.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.93 160.3 15.1 Favored 'General case' 0 C--O 1.258 1.515 0 N-CA-C 112.306 0.484 . . . . 25.0 112.306 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.63 152.11 27.94 Favored Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 110.316 -1.113 . . . . 25.0 110.316 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -78.95 119.04 21.54 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 106.385 -1.709 . . . . 25.0 106.385 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -119.18 151.77 37.76 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 111.797 0.295 . . . . 50.0 111.797 -172.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.82 127.77 48.48 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 107.089 -1.449 . . . . 25.0 107.089 170.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.7 mp -127.37 121.34 30.71 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 122.015 0.912 . . . . 25.0 112.747 -176.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -118.93 135.14 54.74 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 108.553 -0.906 . . . . 25.0 108.553 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.61 -38.5 5.54 Favored Glycine 0 CA--C 1.498 -0.987 0 O-C-N 120.137 -1.602 . . . . 25.0 113.519 -174.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.83 -166.67 50.68 Favored Glycine 0 C--O 1.246 0.884 0 CA-C-O 121.947 0.748 . . . . 25.0 111.396 -177.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.91 157.94 14.22 Favored 'General case' 0 C--O 1.248 1.003 0 C-N-CA 123.241 0.617 . . . . 25.0 111.631 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.41 165.38 32.47 Favored Glycine 0 N--CA 1.466 0.695 0 CA-C-N 116.063 -0.517 . . . . 25.0 114.009 178.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.58 122.86 28.64 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 105.286 -2.116 . . . . 25.0 105.286 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -114.24 156.99 23.32 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.625 -0.509 . . . . 50.0 109.625 -175.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -124.19 122.95 39.17 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 106.382 -1.71 . . . . 25.0 106.382 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -146.38 139.89 25.95 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 116.728 2.121 . . . . 25.0 116.728 -170.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 70.3 m -108.31 143.33 37.33 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 114.958 -1.019 . . . . 25.0 108.473 175.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.9 -32.24 6.93 Favored Glycine 0 C--N 1.323 -0.173 0 N-CA-C 109.005 -1.638 . . . . 25.0 109.005 175.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.45 -174.88 54.52 Favored Glycine 0 CA--C 1.502 -0.741 0 C-N-CA 119.599 -1.286 . . . . 25.0 112.834 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -62.62 159.04 16.81 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.794 -0.827 . . . . 25.0 110.84 177.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.34 156.52 32.72 Favored Glycine 0 C--O 1.224 -0.487 0 CA-C-N 114.875 -1.057 . . . . 25.0 111.089 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.62 108.36 14.19 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.934 -1.136 . . . . 25.0 107.934 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -101.08 159.93 14.81 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.31 -0.859 . . . . 50.0 110.969 -172.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 57.4 m -124.67 119.09 28.01 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 109.102 -0.703 . . . . 25.0 109.102 177.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -99.65 83.94 2.86 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 106.589 -1.634 . . . . 25.0 106.589 175.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -83.16 -20.86 33.92 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.277 -0.874 . . . . 25.0 111.229 -173.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 61.91 160.6 0.07 Allowed 'General case' 0 CA--C 1.547 0.845 0 O-C-N 124.858 1.349 . . . . 25.0 112.181 -176.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -93.45 -70.39 0.7 Allowed 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.81 1.041 . . . . 25.0 113.81 -168.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.1 mt -116.48 175.17 5.68 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.68 0.753 . . . . 25.0 111.482 -171.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.94 -32.34 32.7 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.484 0.714 . . . . 25.0 111.435 176.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -80.02 -6.94 58.5 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.52 0.933 . . . . 25.0 113.52 -174.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.68 127.89 34.51 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 122.087 0.946 . . . . 25.0 111.594 -177.066 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.1 t 49.94 39.56 18.91 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 115.63 1.715 . . . . 25.0 115.63 173.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -103.59 160.94 14.31 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.722 -1.126 . . . . 25.0 110.12 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -115.09 139.91 49.5 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 104.056 -2.572 . . . . 25.0 104.056 176.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 62.8 p -124.29 166.0 21.7 Favored Pre-proline 0 C--N 1.317 -0.824 0 N-CA-C 108.623 -0.881 . . . . 25.0 108.623 -175.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -65.07 -19.5 63.41 Favored 'Trans proline' 0 C--O 1.245 0.861 0 C-N-CA 117.769 -1.02 . . . . 25.0 112.702 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 81.2 mt -76.17 -29.65 57.79 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.283 0.563 . . . . 25.0 112.181 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 160.76 179.15 35.33 Favored Glycine 0 N--CA 1.472 1.044 0 CA-C-O 118.412 -1.216 . . . . 25.0 110.182 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.4 t -98.02 148.78 23.15 Favored 'General case' 0 C--O 1.251 1.146 0 CA-C-N 118.884 1.342 . . . . 25.0 113.034 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -130.29 28.95 4.93 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-N 114.643 -1.162 . . . . 25.0 108.156 174.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.51 146.92 50.27 Favored Glycine 0 N--CA 1.463 0.455 0 N-CA-C 109.073 -1.611 . . . . 25.0 109.073 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -93.69 166.29 12.29 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 117.343 0.571 . . . . 50.0 111.405 -176.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.92 104.6 9.95 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 122.656 0.383 . . . . 25.0 111.65 -173.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.0 mt -91.16 135.7 26.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 107.889 -1.152 . . . . 25.0 107.889 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.446 ' HA ' ' HG2' ' A' ' 142' ' ' GLU . 85.5 mt -88.32 -56.57 3.26 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.539 0.94 . . . . 25.0 113.539 -174.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -124.61 39.37 3.99 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.672 0.99 . . . . 25.0 113.672 -171.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -55.53 138.77 45.9 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.76 0.79 . . . . 25.0 111.665 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -105.85 102.75 40.62 Favored Pre-proline 0 N--CA 1.469 0.497 0 N-CA-C 108.804 -0.813 . . . . 25.0 108.804 177.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -67.74 -6.7 17.46 Favored 'Trans proline' 0 C--N 1.359 1.087 0 N-CA-C 116.31 1.619 . . . . 25.0 116.31 -174.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.9 t -97.48 -42.87 7.51 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.005 0.522 . . . . 25.0 109.97 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -96.31 -43.11 7.83 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 113.283 0.845 . . . . 25.0 113.283 -171.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -82.44 164.81 20.73 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 121.472 -0.767 . . . . 75.0 110.336 -173.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -142.05 152.07 43.01 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.9 -0.591 . . . . 25.0 111.347 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 77.5 mt -126.49 131.92 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 107.63 -1.248 . . . . 25.0 107.63 -177.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -93.2 151.03 20.07 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 108.526 -0.916 . . . . 25.0 108.526 174.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 p -150.41 -3.91 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 N-CA-C 112.834 0.679 . . . . 25.0 112.834 -175.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.6 t -60.68 -48.49 81.54 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.831 1.048 . . . . 25.0 113.831 -173.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.54 -31.63 60.14 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.158 0.799 . . . . 25.0 113.158 -177.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.55 -22.95 16.24 Favored 'General case' 0 C--O 1.246 0.881 0 N-CA-C 115.919 1.822 . . . . 25.0 115.919 -173.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -134.11 -72.76 0.08 OUTLIER Glycine 0 CA--C 1.53 1.024 0 N-CA-C 116.102 1.201 . . . . 25.0 116.102 -174.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -154.57 167.06 31.38 Favored 'General case' 0 C--O 1.211 -0.926 0 CA-C-N 117.471 0.636 . . . . 25.0 109.438 -173.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 30.9 t -120.45 -47.77 2.33 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.191 -1.04 . . . . 25.0 108.191 176.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.15 120.9 5.37 Favored Glycine 0 CA--C 1.501 -0.814 0 N-CA-C 108.588 -1.805 . . . . 25.0 108.588 175.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -68.41 158.13 34.3 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 117.302 0.551 . . . . 25.0 111.744 -175.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -100.51 -160.31 27.99 Favored Glycine 0 N--CA 1.457 0.073 0 N-CA-C 115.109 0.804 . . . . 25.0 115.109 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -48.35 134.7 14.64 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.681 -0.76 . . . . 25.0 112.794 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 158.98 -175.07 35.99 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 108.676 -1.769 . . . . 25.0 108.676 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -152.9 168.21 26.54 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 118.694 1.247 . . . . 25.0 108.343 -177.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 52.59 39.04 27.41 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.85 1.056 . . . . 25.0 113.85 -177.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 69.47 35.1 74.83 Favored Glycine 0 C--O 1.245 0.801 0 N-CA-C 110.751 -0.939 . . . . 25.0 110.751 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.603 ' HA ' ' H ' ' A' ' 151' ' ' ALA . 7.6 t -136.97 176.57 8.59 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 121.623 -0.928 . . . . 25.0 109.905 -178.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.1 mt -110.34 164.58 12.54 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 102.47 -3.159 . . . . 25.0 102.47 176.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.63 120.98 23.33 Favored 'General case' 0 C--O 1.258 1.509 0 N-CA-C 108.063 -1.088 . . . . 25.0 108.063 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.7 m -80.23 159.32 4.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 C-N-CA 122.86 0.464 . . . . 25.0 111.374 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 73.3 m -134.83 163.0 30.81 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.438 -0.949 . . . . 25.0 108.438 177.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.0 m -124.37 165.51 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.362 0 N-CA-C 107.544 -1.28 . . . . 25.0 107.544 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.6 t -80.13 -49.07 12.23 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 106.574 -1.639 . . . . 25.0 106.574 173.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -161.57 -161.99 0.84 Allowed 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 101.941 -3.355 . . . . 25.0 101.941 174.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -67.09 -0.22 3.11 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.498 0.666 . . . . 25.0 112.536 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -142.64 -155.72 6.53 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 108.786 -1.726 . . . . 25.0 108.786 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 53.32 -145.86 0.57 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.116 0.784 . . . . 25.0 113.116 176.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.4 mtt85 -75.89 174.04 10.42 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.934 0.873 . . . . 25.0 113.336 -173.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.26 163.19 29.86 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 105.342 -2.095 . . . . 25.0 105.342 176.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -136.92 155.1 50.17 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.703 -0.48 . . . . 25.0 109.703 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 29.7 tp -125.43 127.17 46.1 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.161 -1.792 . . . . 25.0 106.161 171.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -126.37 151.51 47.53 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.386 0.513 . . . . 25.0 112.386 -171.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 84.0 p -88.63 150.01 23.25 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 105.115 -2.18 . . . . 25.0 105.115 169.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -117.33 27.78 8.88 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 105.621 -1.992 . . . . 25.0 105.621 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -122.88 141.67 51.63 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 112.578 -2.101 . . . . 25.0 106.468 174.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -138.41 153.83 48.9 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 124.221 0.95 . . . . 25.0 111.465 -178.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -77.96 160.29 28.29 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.498 -1.297 . . . . 25.0 107.498 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.73 -20.07 65.45 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-O 122.505 1.145 . . . . 25.0 109.142 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -74.12 -12.3 60.56 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 114.682 -1.145 . . . . 25.0 113.549 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.25 9.02 67.8 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 115.888 -0.596 . . . . 25.0 113.776 -178.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 63.0 mt -83.33 147.53 27.88 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 108.128 -1.064 . . . . 25.0 108.128 174.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 69.6 p -149.76 179.57 7.91 Favored 'General case' 0 C--O 1.248 0.976 0 N-CA-C 107.642 -1.244 . . . . 25.0 107.642 177.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -123.8 135.61 53.9 Favored 'General case' 0 C--O 1.253 1.268 0 CA-C-N 118.871 0.76 . . . . 25.0 111.76 -176.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -151.41 154.97 37.67 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.756 -1.572 . . . . 25.0 106.756 171.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.69 139.39 19.66 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 105.771 -1.937 . . . . 25.0 105.771 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -101.53 143.92 30.93 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 107.685 -1.228 . . . . 25.0 107.685 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mp -136.5 139.13 42.06 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 106.29 -1.744 . . . . 25.0 106.29 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.446 ' HG2' ' HA ' ' A' ' 85' ' ' LEU . 12.9 pt-20 -110.15 11.65 23.66 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.992 1.269 . . . . 25.0 110.603 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -68.41 -19.82 72.95 Favored Glycine 0 CA--C 1.499 -0.944 0 CA-C-N 115.218 -0.901 . . . . 25.0 111.006 173.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.1 t0 54.74 51.69 13.39 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 122.999 1.381 . . . . 25.0 110.733 175.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -121.63 42.75 3.02 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 113.513 -1.676 . . . . 25.0 108.151 -175.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -55.84 -31.59 62.85 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 114.596 -1.184 . . . . 25.0 112.462 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -77.18 -29.43 54.42 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 118.678 0.672 . . . . 25.0 111.878 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.55 -20.33 26.6 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 120.574 -0.45 . . . . 25.0 111.799 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 22.2 mt -62.12 136.54 57.99 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 121.082 0.468 . . . . 25.0 111.088 177.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 70.3 m -144.7 161.5 39.05 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 107.541 -1.281 . . . . 25.0 107.541 175.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.603 ' H ' ' HA ' ' A' ' 111' ' ' SER . . . -79.74 -0.09 32.83 Favored 'General case' 0 C--O 1.206 -1.206 0 N-CA-C 107.367 -1.346 . . . . 25.0 107.367 177.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -74.09 -26.77 60.55 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.372 -0.831 . . . . 25.0 110.788 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -89.66 -6.72 55.89 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.591 -0.693 . . . . 25.0 109.524 176.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 49.1 mm -90.22 136.6 23.46 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.621 0 N-CA-C 103.708 -2.701 . . . . 25.0 103.708 173.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.9 p -116.39 128.93 73.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 122.656 1.217 . . . . 25.0 110.861 -176.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -158.05 -17.13 0.08 Allowed 'General case' 0 C--O 1.211 -0.937 0 CA-C-N 113.95 -1.477 . . . . 25.0 113.121 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.75 43.34 0.91 Allowed 'General case' 0 C--O 1.246 0.897 0 O-C-N 121.454 -0.779 . . . . 25.0 112.183 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 58.17 29.09 17.42 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.891 0.877 . . . . 25.0 112.964 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.4 m 51.53 37.26 19.09 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 122.334 1.064 . . . . 25.0 111.342 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -76.36 123.81 26.53 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.71 1.004 . . . . 25.0 113.71 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.82 -18.32 60.47 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.29 -0.868 . . . . 25.0 112.719 177.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -81.07 -21.5 39.97 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 122.305 -0.247 . . . . 25.0 110.596 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.45 177.56 8.89 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.835 0.454 . . . . 25.0 111.108 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 63.47 178.66 0.16 Allowed 'General case' 0 CA--C 1.547 0.861 0 O-C-N 124.682 1.239 . . . . 25.0 113.939 176.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 82.04 22.63 58.97 Favored Glycine 0 C--O 1.237 0.294 0 CA-C-N 115.296 -0.865 . . . . 25.0 111.141 -177.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -106.99 104.79 14.55 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 112.338 0.496 . . . . 25.0 112.338 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -130.29 151.59 50.63 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 107.62 -1.252 . . . . 25.0 107.62 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -135.57 33.72 2.38 Favored Glycine 0 CA--C 1.502 -0.761 0 N-CA-C 110.802 -0.919 . . . . 25.0 110.802 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 54.6 t -79.53 -27.27 12.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 CA-C-O 121.939 0.876 . . . . 25.0 108.774 -176.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -53.86 134.39 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 CA-C-N 114.485 -1.234 . . . . 25.0 113.025 -174.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 141.12 150.66 5.43 Favored Glycine 0 C--O 1.246 0.895 0 N-CA-C 109.5 -1.44 . . . . 25.0 109.5 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -142.86 145.36 33.07 Favored 'General case' 0 C--O 1.252 1.232 0 O-C-N 122.197 -0.59 . . . . 25.0 111.249 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 13.3 p -150.72 154.77 38.0 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.725 0.774 . . . . 25.0 111.306 175.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 176.71 166.74 34.27 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 115.138 -0.937 . . . . 25.0 113.85 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -133.55 111.07 12.53 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 107.312 -1.366 . . . . 25.0 107.312 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.88 160.91 39.92 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 116.879 -1.614 . . . . 25.0 113.137 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -119.15 147.02 44.65 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.032 -1.099 . . . . 25.0 108.032 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -143.74 73.11 17.08 Favored Pre-proline 0 C--O 1.251 1.171 0 O-C-N 123.536 0.523 . . . . 25.0 111.198 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -69.9 164.07 36.06 Favored 'Trans proline' 0 C--O 1.249 1.031 0 N-CA-C 113.857 0.676 . . . . 25.0 113.857 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 12.6 t -125.66 8.68 7.62 Favored 'General case' 0 C--O 1.256 1.414 0 N-CA-C 109.652 -0.499 . . . . 25.0 109.652 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 C--O 1.245 0.853 0 N-CA-C 108.565 -0.902 . . . . 25.0 108.565 178.043 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo . . . . . 0 CA--C 1.531 0.356 0 N-CA-C 113.856 0.675 . . . . 25.0 113.856 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -163.66 31.64 0.27 Allowed Glycine 0 CA--C 1.521 0.417 0 CA-C-O 119.429 -0.651 . . . . 25.0 112.26 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.5 p -60.35 133.11 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 122.027 0.918 . . . . 25.0 111.194 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -99.07 -18.57 17.67 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.647 -0.706 . . . . 25.0 112.197 -177.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.79 -134.11 3.84 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-O 121.715 0.62 . . . . 25.0 114.56 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.9 p 69.08 156.64 0.15 Allowed Pre-proline 0 N--CA 1.483 1.208 0 C-N-CA 125.858 1.663 . . . . 25.0 110.392 -173.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.425 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 32.4 Cg_exo -65.9 0.11 3.43 Favored 'Trans proline' 0 N--CA 1.485 1.008 0 N-CA-C 117.707 2.156 . . . . 25.0 117.707 -173.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.6 p -68.01 -22.14 27.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 114.787 1.403 . . . . 25.0 114.787 -172.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.2 p -128.1 121.57 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 117.329 2.344 . . . . 25.0 117.329 -171.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.05 20.6 79.06 Favored Glycine 0 C--O 1.224 -0.47 0 N-CA-C 117.423 1.729 . . . . 25.0 117.423 173.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.2 t -50.07 -37.87 35.56 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 114.726 1.38 . . . . 25.0 114.726 -174.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -80.74 13.61 2.52 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 114.649 1.352 . . . . 25.0 114.649 -176.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -149.63 171.22 17.02 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.531 -0.73 . . . . 25.0 110.542 176.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.76 121.57 14.32 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.293 0.637 . . . . 25.0 111.538 -173.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -120.72 169.69 10.16 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 115.296 1.591 . . . . 50.0 115.296 -173.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -123.35 114.55 20.32 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 103.775 -2.676 . . . . 25.0 103.775 160.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 82.3 mt -120.04 102.57 8.63 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.536 0.684 . . . . 25.0 111.761 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -93.4 121.8 35.16 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.709 -0.678 . . . . 25.0 109.837 177.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.15 -174.29 47.67 Favored Glycine 0 N--CA 1.464 0.565 0 N-CA-C 115.245 0.858 . . . . 25.0 115.245 -178.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.7 p -91.67 173.71 7.73 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.778 0.831 . . . . 25.0 112.404 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 75.4 mt -83.67 12.41 5.88 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.356 0.873 . . . . 25.0 113.356 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.85 179.31 20.04 Favored Glycine 0 N--CA 1.462 0.378 0 CA-C-N 116.284 -0.416 . . . . 25.0 112.175 178.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.5 t -71.48 130.93 42.51 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 122.701 0.4 . . . . 25.0 110.635 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -143.41 165.89 26.29 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 123.265 0.353 . . . . 50.0 111.527 -174.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -111.11 125.49 53.83 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 106.108 -1.812 . . . . 25.0 106.108 166.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.0 mm -115.49 129.22 72.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 107.043 -1.465 . . . . 25.0 107.043 -177.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.425 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 1.0 OUTLIER -129.27 123.33 31.63 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 105.418 -2.067 . . . . 25.0 105.418 179.677 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.54 -36.32 23.53 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 114.969 0.747 . . . . 25.0 114.969 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.52 -149.03 50.42 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.268 -0.733 . . . . 25.0 111.268 -176.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -78.41 170.47 54.84 Favored Glycine 0 C--O 1.257 1.585 0 O-C-N 121.728 -0.866 . . . . 25.0 112.061 -176.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.34 165.06 33.83 Favored Glycine 0 C--N 1.316 -0.557 0 CA-C-O 119.639 -0.534 . . . . 25.0 112.91 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.14 101.07 13.14 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.053 -1.091 . . . . 25.0 108.053 178.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -98.48 153.57 18.51 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.915 0.709 . . . . 50.0 112.915 -168.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -115.15 99.85 7.73 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 105.745 -1.946 . . . . 25.0 105.745 175.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 33.2 mt -104.26 137.82 41.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.798 -1.092 . . . . 25.0 111.571 -171.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -133.77 99.42 4.46 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.925 0.713 . . . . 25.0 112.925 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.38 -35.2 63.47 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-O 118.342 -1.255 . . . . 25.0 115.8 -177.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 55.17 -154.47 0.29 Allowed 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 118.814 1.307 . . . . 25.0 113.672 -178.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.97 160.13 15.56 Favored 'General case' 0 C--O 1.249 1.034 0 N-CA-C 113.486 0.921 . . . . 25.0 113.486 -176.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.12 159.93 33.51 Favored Glycine 0 C--O 1.223 -0.546 0 CA-C-N 115.187 -0.915 . . . . 25.0 111.451 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -82.15 115.5 21.29 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 104.688 -2.338 . . . . 25.0 104.688 177.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -116.67 154.33 30.76 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.758 -0.377 . . . . 50.0 110.514 -171.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 mp -114.05 133.08 55.76 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 105.792 -1.929 . . . . 25.0 105.792 174.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.6 mp -133.28 128.92 36.84 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 113.967 1.099 . . . . 25.0 113.967 -173.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -129.92 135.13 47.99 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.181 -1.414 . . . . 25.0 107.181 177.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -93.36 -40.65 4.73 Favored Glycine 0 N--CA 1.475 1.26 0 N-CA-C 115.409 0.924 . . . . 25.0 115.409 -175.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.34 -174.92 55.22 Favored Glycine 0 C--O 1.24 0.491 0 N-CA-C 110.88 -0.888 . . . . 25.0 110.88 -176.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.83 154.06 9.88 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.328 0.585 . . . . 25.0 109.911 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.1 150.66 24.12 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.493 -0.776 . . . . 25.0 112.028 -176.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -74.92 127.87 34.23 Favored 'General case' 0 C--O 1.212 -0.92 0 N-CA-C 104.737 -2.32 . . . . 25.0 104.737 176.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -117.68 150.94 38.22 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 121.707 -0.62 . . . . 50.0 111.046 -174.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -112.76 121.56 45.09 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 103.764 -2.68 . . . . 25.0 103.764 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -144.7 131.5 20.16 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 117.743 2.497 . . . . 25.0 117.743 -171.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.3 m -99.45 141.19 32.55 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-N 115.8 -0.637 . . . . 25.0 109.534 174.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -94.72 -35.71 5.8 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 110.443 -1.063 . . . . 25.0 110.443 172.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.17 -176.33 51.74 Favored Glycine 0 N--CA 1.465 0.62 0 CA-C-N 118.198 0.999 . . . . 25.0 113.373 -178.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -59.51 156.1 13.92 Favored 'General case' 0 C--O 1.246 0.884 0 O-C-N 121.595 -0.944 . . . . 25.0 110.724 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.01 162.54 34.63 Favored Glycine 0 C--O 1.246 0.903 0 N-CA-C 108.943 -1.663 . . . . 25.0 108.943 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.95 121.32 26.36 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 106.842 -1.54 . . . . 25.0 106.842 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -112.0 152.19 28.41 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.184 0.516 . . . . 50.0 110.17 -175.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.5 m -117.47 110.31 17.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.851 0.834 . . . . 25.0 110.329 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -94.21 119.94 33.75 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 106.032 -1.84 . . . . 25.0 106.032 176.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.9 mmt85 -114.5 -32.25 5.96 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.967 -0.561 . . . . 25.0 112.339 -177.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 68.09 148.53 0.06 Allowed 'General case' 0 CA--C 1.55 0.948 0 O-C-N 124.741 1.275 . . . . 25.0 110.667 -174.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.16 -34.98 21.99 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 114.822 1.416 . . . . 25.0 114.822 -165.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 70.5 mt -132.25 161.66 32.9 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.1 0.476 . . . . 25.0 110.602 -172.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.83 -31.35 66.55 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 107.095 -1.446 . . . . 25.0 107.095 169.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -87.69 9.34 21.82 Favored 'General case' 0 C--O 1.254 1.31 0 N-CA-C 115.571 1.693 . . . . 25.0 115.571 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -94.7 141.54 28.5 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.034 -1.042 . . . . 25.0 110.101 -177.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.8 t 47.32 50.48 14.48 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 114.556 1.317 . . . . 25.0 114.556 -178.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 31.0 p-80 -114.35 169.54 8.96 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.47 -0.786 . . . . 25.0 111.403 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -121.45 148.79 43.97 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 104.621 -2.362 . . . . 25.0 104.621 173.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 92.4 p -139.59 170.96 8.74 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 107.299 -1.371 . . . . 25.0 107.299 -177.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -62.79 -20.45 71.21 Favored 'Trans proline' 0 C--N 1.361 1.185 0 CA-C-N 119.044 0.694 . . . . 25.0 113.087 174.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 80.9 mt -73.64 -27.5 61.3 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 121.748 -0.595 . . . . 25.0 110.91 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.91 -177.95 30.29 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.683 -0.967 . . . . 25.0 110.683 -174.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.3 t -101.7 141.73 34.12 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 122.811 1.291 . . . . 25.0 111.54 -178.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -127.71 27.36 5.77 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 114.678 -1.146 . . . . 25.0 109.167 176.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.2 145.17 45.77 Favored Glycine 0 N--CA 1.462 0.39 0 O-C-N 124.07 0.856 . . . . 25.0 112.124 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -85.33 170.1 13.09 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 122.694 -0.297 . . . . 50.0 111.321 -177.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -128.11 105.95 8.72 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.694 0.798 . . . . 25.0 111.394 -174.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.0 mt -87.82 133.91 29.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 121.853 0.835 . . . . 25.0 108.789 -178.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.448 ' HA ' ' HG2' ' A' ' 142' ' ' GLU . 85.0 mt -85.1 -43.93 13.45 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 116.401 2.001 . . . . 25.0 116.401 -172.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -137.67 40.16 2.39 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.09 1.144 . . . . 25.0 114.09 -173.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -55.97 132.21 49.29 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.579 -0.737 . . . . 25.0 112.287 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -102.37 105.43 43.36 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 106.011 -1.848 . . . . 25.0 106.011 174.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -70.48 -4.39 14.42 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 N-CA-C 116.622 1.739 . . . . 25.0 116.622 -172.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.3 t -97.29 -45.62 6.42 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.201 0.524 . . . . 25.0 111.079 174.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -82.53 -41.26 19.88 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.357 0.873 . . . . 25.0 113.357 -174.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -84.95 165.44 17.61 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.694 -0.484 . . . . 75.0 109.694 -169.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -140.73 146.24 37.5 Favored 'General case' 0 C--O 1.246 0.874 0 N-CA-C 108.523 -0.917 . . . . 25.0 108.523 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 76.5 mt -128.66 126.52 65.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 107.926 -1.138 . . . . 25.0 107.926 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -80.91 148.14 30.0 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.809 0.814 . . . . 25.0 110.361 172.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.0 p -143.32 -7.91 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.317 -0.856 . . . . 25.0 110.628 176.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.8 t -63.92 -41.16 97.73 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.282 0.563 . . . . 25.0 111.943 -173.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.62 -4.61 57.97 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.028 0.751 . . . . 25.0 113.028 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 11.9 mt -115.04 -38.25 3.93 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.989 1.477 . . . . 25.0 114.989 -169.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -136.42 -54.68 0.06 OUTLIER Glycine 0 C--O 1.24 0.477 0 N-CA-C 117.644 1.818 . . . . 25.0 117.644 -174.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -155.04 164.02 39.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 117.569 0.684 . . . . 25.0 109.826 -174.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 45.8 t -121.26 -25.53 5.23 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 124.12 0.887 . . . . 25.0 109.018 173.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -100.65 121.59 7.29 Favored Glycine 0 N--CA 1.464 0.565 0 N-CA-C 107.615 -2.194 . . . . 25.0 107.615 172.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.68 146.49 53.72 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 118.565 1.183 . . . . 25.0 113.246 -174.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -80.85 -175.19 49.45 Favored Glycine 0 C--N 1.32 -0.316 0 CA-C-N 115.349 -0.841 . . . . 25.0 114.415 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -60.84 142.62 56.01 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 121.196 0.522 . . . . 25.0 111.701 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 166.83 -171.94 41.84 Favored Glycine 0 C--O 1.245 0.787 0 N-CA-C 109.363 -1.495 . . . . 25.0 109.363 -177.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -141.52 165.25 28.0 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.833 1.317 . . . . 25.0 111.465 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 57.52 33.9 23.88 Favored 'General case' 0 C--O 1.246 0.878 0 O-C-N 124.454 1.096 . . . . 25.0 113.541 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 74.56 39.32 41.81 Favored Glycine 0 C--O 1.222 -0.653 0 N-CA-C 109.969 -1.252 . . . . 25.0 109.969 177.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 11.1 t -148.6 167.64 24.92 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 108.998 -0.741 . . . . 25.0 108.998 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.4 mt -84.78 159.91 20.36 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 103.069 -2.937 . . . . 25.0 103.069 169.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.66 128.9 38.03 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 119.291 -0.964 . . . . 25.0 109.158 178.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.9 m -91.48 159.23 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 109.65 -0.5 . . . . 25.0 109.65 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.19 164.71 26.77 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 110.169 -0.308 . . . . 25.0 110.169 -177.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.4 m -118.58 162.64 16.5 Favored 'Isoleucine or valine' 0 C--O 1.25 1.08 0 N-CA-C 106.726 -1.583 . . . . 25.0 106.726 175.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.8 t -83.06 -51.23 7.72 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 106.295 -1.743 . . . . 25.0 106.295 170.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -166.69 -164.58 0.66 Allowed 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 100.825 -3.768 . . . . 25.0 100.825 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -68.12 -25.07 65.11 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 119.173 0.897 . . . . 25.0 110.658 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -106.9 -164.64 22.3 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 108.17 -1.972 . . . . 25.0 108.17 174.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 56.18 -162.79 0.17 Allowed 'General case' 0 C--O 1.248 0.976 0 N-CA-C 113.538 0.94 . . . . 25.0 113.538 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 64.3 mtt85 -79.24 169.29 18.35 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.755 1.02 . . . . 25.0 113.755 -168.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.7 p -115.3 165.56 12.82 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 105.111 -2.181 . . . . 25.0 105.111 174.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -134.73 157.97 45.33 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 121.404 0.621 . . . . 25.0 111.357 -177.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 51.1 tp -130.13 113.97 15.15 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 103.781 -2.674 . . . . 25.0 103.781 171.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -116.13 148.67 40.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.979 0.419 . . . . 25.0 110.19 -174.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 43.0 t -97.27 147.18 24.4 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 106.061 -1.829 . . . . 25.0 106.061 171.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -116.9 17.28 15.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.562 0.696 . . . . 25.0 110.532 -177.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -107.8 140.06 41.45 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 104.674 -2.343 . . . . 25.0 104.674 172.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -140.04 154.65 47.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.698 0.761 . . . . 25.0 112.404 -176.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -75.03 166.22 24.01 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.924 -1.035 . . . . 25.0 109.318 177.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.83 -25.27 66.35 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 108.443 -0.947 . . . . 25.0 108.443 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -74.02 -5.37 41.0 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.372 -0.831 . . . . 25.0 112.995 175.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.32 10.48 77.47 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 121.299 -0.477 . . . . 25.0 112.619 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.5 mt -83.8 134.03 34.74 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 122.288 -0.536 . . . . 25.0 109.663 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 59.8 p -138.69 176.89 8.3 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 106.605 -1.628 . . . . 25.0 106.605 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -125.64 134.46 51.87 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 120.328 -0.549 . . . . 25.0 110.349 -175.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -152.76 152.93 32.22 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 108.979 -0.749 . . . . 25.0 108.979 171.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 13.0 p -145.23 143.78 21.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 106.244 -1.762 . . . . 25.0 106.244 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -102.45 146.14 28.53 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 107.081 -1.452 . . . . 25.0 107.081 -177.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.5 mp -132.19 134.98 46.0 Favored 'General case' 0 C--O 1.201 -1.479 0 N-CA-C 104.908 -2.256 . . . . 25.0 104.908 177.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.448 ' HG2' ' HA ' ' A' ' 85' ' ' LEU . 8.7 pt-20 -103.18 10.55 37.73 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 119.923 1.238 . . . . 25.0 111.059 -178.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.7 -10.2 66.92 Favored Glycine 0 N--CA 1.458 0.164 0 C-N-CA 120.952 -0.642 . . . . 25.0 113.57 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 37.9 t0 53.09 40.9 31.98 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 123.327 1.536 . . . . 25.0 110.557 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -115.92 38.29 3.38 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.053 -1.43 . . . . 25.0 109.811 -179.115 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.28 -32.57 68.54 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.067 0.766 . . . . 25.0 113.067 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.14 -28.49 62.27 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.017 0.377 . . . . 25.0 112.017 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -85.49 -29.56 24.17 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-N 116.744 -0.207 . . . . 25.0 111.041 -177.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 29.4 mt -59.35 139.5 56.97 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-O 122.431 1.11 . . . . 25.0 112.581 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.4 m -143.06 160.43 40.39 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.3 -1.741 . . . . 25.0 106.3 176.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.64 3.76 15.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.17 0.509 . . . . 25.0 109.987 176.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -68.38 -29.59 68.33 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.174 -0.466 . . . . 25.0 110.307 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -92.07 1.63 57.08 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.39 0.614 . . . . 25.0 110.867 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 31.4 mm -101.02 125.42 54.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.821 0 N-CA-C 104.821 -2.289 . . . . 25.0 104.821 178.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.74 119.4 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 122.934 1.35 . . . . 25.0 112.14 -174.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -156.0 -20.76 0.1 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 113.248 -1.797 . . . . 25.0 110.908 177.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -76.11 52.18 0.71 Allowed 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.211 1.189 . . . . 25.0 114.211 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 63.68 11.37 5.74 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 115.229 1.566 . . . . 25.0 115.229 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.5 m 64.96 -59.2 0.25 Allowed 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 116.686 2.106 . . . . 25.0 116.686 176.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -64.27 137.91 58.17 Favored 'General case' 0 C--O 1.244 0.772 0 O-C-N 121.946 -0.471 . . . . 25.0 111.381 -175.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -81.69 61.09 4.92 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 113.349 0.87 . . . . 25.0 113.349 -176.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.04 -37.02 78.35 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.77 -0.826 . . . . 25.0 108.77 177.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -135.87 -104.73 0.21 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.534 -0.757 . . . . 25.0 109.702 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 55.71 -159.7 0.2 Allowed 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.247 1.019 . . . . 25.0 111.17 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 63.44 25.83 68.99 Favored Glycine 0 C--O 1.218 -0.863 0 C-N-CA 121.227 -0.511 . . . . 25.0 112.648 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -82.54 94.94 7.59 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.596 0.712 . . . . 25.0 110.647 -174.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -125.32 150.73 46.87 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 108.493 -0.929 . . . . 25.0 108.493 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -146.0 32.0 1.57 Allowed Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 109.125 -1.59 . . . . 25.0 109.125 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 39.9 t -65.34 -37.66 80.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 109.99 -0.374 . . . . 25.0 109.99 -175.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.8 128.65 21.09 Favored 'Isoleucine or valine' 0 C--O 1.244 0.8 0 CA-C-O 122.197 0.999 . . . . 25.0 110.913 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 158.58 146.27 4.48 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 109.082 -1.607 . . . . 25.0 109.082 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -141.09 154.57 46.0 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-N 117.503 0.652 . . . . 25.0 111.159 -176.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 93.7 p -149.86 158.24 43.98 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.339 -1.356 . . . . 25.0 107.339 176.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 178.79 174.27 44.86 Favored Glycine 0 C--O 1.241 0.541 0 C-N-CA 120.06 -1.067 . . . . 25.0 113.578 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -152.9 85.49 4.33 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 107.728 -1.212 . . . . 25.0 107.728 178.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.42 150.28 75.58 Favored 'Trans proline' 0 C--N 1.354 0.818 0 O-C-N 122.015 0.481 . . . . 25.0 112.054 -177.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -114.81 154.51 28.46 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.201 -0.454 . . . . 25.0 110.575 -174.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -136.32 61.16 37.19 Favored Pre-proline 0 C--O 1.25 1.087 0 N-CA-C 113.225 0.824 . . . . 25.0 113.225 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -71.97 160.27 48.08 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 115.623 -2.451 . . . . 25.0 112.498 177.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.9 t -120.22 -15.75 8.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.017 -0.538 . . . . 25.0 111.181 -177.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.746 -0.645 . . . . 25.0 110.763 177.266 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo . . . . . 0 N--CA 1.48 0.7 0 N-CA-C 113.692 0.612 . . . . 25.0 113.692 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -178.02 54.04 0.1 OUTLIER Glycine 0 C--O 1.224 -0.528 0 N-CA-C 110.557 -1.017 . . . . 25.0 110.557 -178.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.4 p -60.52 132.41 25.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 122.261 1.029 . . . . 25.0 112.346 -174.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -103.11 -6.14 22.54 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.397 -1.274 . . . . 25.0 110.482 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.97 -148.12 4.91 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 116.36 -0.382 . . . . 25.0 112.717 178.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.4 p 68.39 159.85 0.15 Allowed Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 125.974 1.71 . . . . 25.0 112.204 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -66.52 1.3 2.7 Favored 'Trans proline' 0 C--N 1.359 1.122 0 N-CA-C 116.634 1.744 . . . . 25.0 116.634 -176.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.3 p -68.53 -18.98 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 N-CA-C 115.24 1.57 . . . . 25.0 115.24 -170.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.3 p -146.92 143.64 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 113.288 0.848 . . . . 25.0 113.288 -177.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.32 13.68 81.44 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 115.607 1.003 . . . . 25.0 115.607 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.2 t -54.21 -50.95 65.94 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 122.337 -0.508 . . . . 25.0 111.459 -173.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -86.8 19.26 3.03 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 114.758 1.392 . . . . 25.0 114.758 -172.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -152.39 170.83 19.13 Favored 'General case' 0 CA--C 1.561 1.397 0 O-C-N 121.653 -0.654 . . . . 25.0 111.391 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -59.38 134.18 56.77 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 112.47 0.544 . . . . 25.0 112.47 -175.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -121.54 163.22 19.22 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 115.575 1.694 . . . . 50.0 115.575 -173.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -138.08 87.04 2.21 Favored 'General case' 0 C--O 1.249 1.043 0 N-CA-C 102.857 -3.016 . . . . 25.0 102.857 164.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 89.2 mt -102.65 122.6 44.75 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 117.764 0.256 . . . . 25.0 111.551 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -110.75 122.88 48.91 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 123.61 0.568 . . . . 25.0 110.257 -179.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.99 176.65 40.95 Favored Glycine 0 CA--C 1.54 1.646 0 C-N-CA 120.59 -0.814 . . . . 25.0 114.349 -178.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.1 p -87.43 179.33 6.59 Favored 'General case' 0 C--O 1.256 1.429 0 C-N-CA 123.581 0.752 . . . . 25.0 110.981 177.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 51.7 mt -82.48 13.96 3.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.232 -0.895 . . . . 25.0 112.736 175.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.4 176.04 20.7 Favored Glycine 0 C--O 1.242 0.597 0 CA-C-N 115.479 -0.782 . . . . 25.0 111.834 177.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.3 t -78.07 131.35 37.27 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 121.85 -0.794 . . . . 25.0 108.884 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -142.65 153.58 43.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.308 0.575 . . . . 50.0 110.545 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -87.52 133.97 33.69 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 102.809 -3.034 . . . . 25.0 102.809 164.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 34.6 mm -127.04 116.69 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 105.292 -2.114 . . . . 25.0 105.292 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.1 tt -122.36 122.22 38.53 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.462 -1.31 . . . . 25.0 107.462 -177.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.21 -38.71 28.84 Favored Glycine 0 N--CA 1.445 -0.733 0 O-C-N 123.986 0.804 . . . . 25.0 114.71 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.66 -147.48 38.66 Favored Glycine 0 C--O 1.241 0.552 0 O-C-N 121.485 -1.009 . . . . 25.0 110.991 -176.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.37 165.02 54.77 Favored Glycine 0 CA--C 1.505 -0.588 0 CA-C-O 121.181 0.323 . . . . 25.0 112.762 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.57 167.27 36.46 Favored Glycine 0 C--O 1.236 0.274 0 C-N-CA 121.024 -0.608 . . . . 25.0 113.875 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.7 107.68 15.51 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.282 -1.007 . . . . 25.0 108.282 177.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -106.4 147.56 29.12 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.086 0.773 . . . . 50.0 113.086 -170.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -113.34 107.03 15.31 Favored 'General case' 0 C--O 1.249 1.073 0 N-CA-C 107.343 -1.354 . . . . 25.0 107.343 172.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 53.6 mt -111.39 133.51 53.64 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 116.161 -0.472 . . . . 25.0 110.613 -171.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -128.83 107.3 9.53 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.483 0.659 . . . . 25.0 111.715 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.71 -34.12 28.78 Favored Glycine 0 N--CA 1.463 0.489 0 N-CA-C 116.732 1.453 . . . . 25.0 116.732 -175.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 55.48 -153.5 0.33 Allowed 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 118.374 1.087 . . . . 25.0 111.959 -173.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.83 164.53 9.97 Favored 'General case' 0 C--O 1.252 1.193 0 N-CA-C 112.798 0.666 . . . . 25.0 112.798 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.67 155.19 31.66 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 115.279 -0.873 . . . . 25.0 111.351 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -78.59 98.54 6.19 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 106.99 -1.485 . . . . 25.0 106.99 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -100.24 151.42 21.47 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 122.032 -0.417 . . . . 50.0 110.183 -171.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.9 mp -113.16 90.6 3.39 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.767 -0.827 . . . . 25.0 108.767 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.4 mp -92.92 125.24 37.42 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 112.14 0.422 . . . . 25.0 112.14 -172.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -122.79 132.76 54.36 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 106.937 -1.505 . . . . 25.0 106.937 173.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.1 -38.76 8.32 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 119.715 -1.231 . . . . 25.0 115.028 -177.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.71 -171.83 51.44 Favored Glycine 0 C--O 1.223 -0.546 0 O-C-N 121.824 -0.81 . . . . 25.0 111.612 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.34 149.48 12.96 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.533 0.683 . . . . 25.0 110.935 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.35 166.93 42.35 Favored Glycine 0 C--N 1.332 0.327 0 CA-C-N 115.482 -0.781 . . . . 25.0 111.939 -178.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.71 129.23 34.86 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 105.16 -2.163 . . . . 25.0 105.16 176.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -120.85 154.16 36.18 Favored 'General case' 0 C--O 1.251 1.153 0 O-C-N 121.733 -0.605 . . . . 50.0 111.656 -175.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -116.57 128.3 55.29 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 103.607 -2.738 . . . . 25.0 103.607 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -147.76 141.58 25.74 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 115.831 1.789 . . . . 25.0 115.831 -174.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.6 m -109.3 138.02 46.29 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.194 -1.409 . . . . 25.0 107.194 176.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.03 -38.57 5.69 Favored Glycine 0 C--N 1.317 -0.512 0 N-CA-C 111.06 -0.816 . . . . 25.0 111.06 174.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.52 -170.37 54.54 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 118.749 1.274 . . . . 25.0 111.992 -177.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -64.15 161.63 15.95 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.088 0.471 . . . . 25.0 111.419 176.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.99 164.06 40.01 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-N 115.503 -0.771 . . . . 25.0 111.724 -176.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.13 106.5 16.63 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.129 -1.063 . . . . 25.0 108.129 -177.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -97.04 156.65 16.27 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 112.548 0.573 . . . . 50.0 112.548 -170.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 57.1 m -122.63 125.66 46.09 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.524 -0.917 . . . . 25.0 108.524 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -120.51 85.57 2.41 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.942 -0.762 . . . . 25.0 108.942 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -89.12 -23.95 22.36 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 112.313 0.486 . . . . 25.0 112.313 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 66.41 162.02 0.16 Allowed 'General case' 0 CA--C 1.548 0.898 0 O-C-N 125.212 1.57 . . . . 25.0 108.595 -171.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.13 -46.1 21.54 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 115.663 1.727 . . . . 25.0 115.663 -165.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.9 mt -144.12 169.28 18.15 Favored 'General case' 0 C--O 1.197 -1.691 0 C-N-CA 123.008 0.523 . . . . 25.0 111.246 -169.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.68 -32.69 30.8 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.574 -0.739 . . . . 25.0 110.571 169.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -80.99 1.44 31.2 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.732 1.382 . . . . 25.0 114.732 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -104.16 142.58 34.25 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.95 0.722 . . . . 25.0 112.95 -175.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.9 t 51.87 54.38 10.99 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 115.142 1.534 . . . . 25.0 115.142 177.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 36.9 p-80 -132.13 170.64 14.71 Favored 'General case' 0 C--O 1.208 -1.111 0 CA-C-N 116.441 -0.345 . . . . 25.0 111.884 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -118.07 144.92 45.21 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 106.696 -1.594 . . . . 25.0 106.696 178.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.9 p -133.31 164.83 41.17 Favored Pre-proline 0 C--O 1.244 0.797 0 N-CA-C 108.443 -0.947 . . . . 25.0 108.443 178.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -64.66 -15.84 52.16 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 117.504 -1.198 . . . . 25.0 113.436 174.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 87.9 mt -82.34 -21.51 35.96 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.075 -0.511 . . . . 25.0 111.817 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.77 171.77 24.13 Favored Glycine 0 C--O 1.219 -0.839 0 N-CA-C 109.875 -1.29 . . . . 25.0 109.875 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.1 t -101.13 147.88 25.72 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 122.659 1.218 . . . . 25.0 112.91 178.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -131.21 21.45 4.84 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.235 -0.893 . . . . 25.0 110.647 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.2 152.04 51.7 Favored Glycine 0 N--CA 1.473 1.164 0 N-CA-C 109.572 -1.411 . . . . 25.0 109.572 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -96.94 171.34 8.56 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 118.529 1.165 . . . . 50.0 110.536 -174.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.439 ' HG3' ' HB3' ' A' ' 140' ' ' ALA . 0.0 OUTLIER -126.85 108.5 11.06 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 121.931 -0.481 . . . . 25.0 112.231 -175.228 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.3 mt -89.39 138.68 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 109.212 -0.662 . . . . 25.0 109.212 -176.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.419 ' HA ' ' HG2' ' A' ' 142' ' ' GLU . 76.9 mt -86.33 -52.62 5.51 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 115.77 1.767 . . . . 25.0 115.77 -175.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -127.82 32.46 4.95 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 113.982 1.105 . . . . 25.0 113.982 -168.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -52.94 143.33 17.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.423 -1.262 . . . . 25.0 114.029 -175.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -118.17 103.35 49.78 Favored Pre-proline 0 C--O 1.237 0.398 0 C-N-CA 123.032 0.533 . . . . 25.0 111.333 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.23 -13.21 35.6 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 N-CA-C 114.549 0.942 . . . . 25.0 114.549 -175.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.0 t -81.26 -39.33 25.45 Favored 'General case' 0 C--O 1.245 0.836 0 N-CA-C 108.737 -0.838 . . . . 25.0 108.737 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -95.33 -43.53 7.99 Favored 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 117.196 2.295 . . . . 25.0 117.196 -175.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -90.19 172.75 8.58 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.572 -1.195 . . . . 75.0 112.03 -162.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -142.81 147.32 35.28 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 112.36 0.504 . . . . 25.0 112.36 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 90.7 mt -127.35 128.78 70.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 108.604 -0.887 . . . . 25.0 108.604 -178.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -86.62 148.6 25.41 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 122.124 0.964 . . . . 25.0 111.617 174.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.41 HG11 ' CZ ' ' A' ' 101' ' ' PHE . 8.4 p -146.75 -2.8 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 115.566 -0.743 . . . . 25.0 111.043 175.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 44.9 t -60.97 -44.57 97.15 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.662 0.744 . . . . 25.0 111.464 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.82 -28.53 58.33 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.372 -0.831 . . . . 25.0 112.074 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.6 mt -92.09 -41.61 10.4 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 116.288 1.958 . . . . 25.0 116.288 -171.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -138.54 -48.12 0.06 OUTLIER Glycine 0 N--CA 1.463 0.491 0 N-CA-C 118.156 2.022 . . . . 25.0 118.156 -172.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.41 ' CZ ' HG11 ' A' ' 96' ' ' VAL . 50.2 p90 -160.14 153.03 21.45 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 118.579 1.19 . . . . 25.0 112.714 -172.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 25.2 t -109.15 -16.94 13.98 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.511 -0.552 . . . . 25.0 109.511 178.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -121.46 132.61 9.12 Favored Glycine 0 N--CA 1.47 0.912 0 N-CA-C 108.363 -1.895 . . . . 25.0 108.363 176.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -68.15 156.0 38.43 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.963 1.468 . . . . 25.0 114.963 -172.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -101.77 -161.25 26.79 Favored Glycine 0 N--CA 1.464 0.53 0 O-C-N 121.583 -0.698 . . . . 25.0 112.828 -177.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -54.57 138.99 39.62 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 113.482 0.919 . . . . 25.0 113.482 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 168.72 -176.42 42.98 Favored Glycine 0 C--O 1.227 -0.292 0 CA-C-N 115.242 -0.89 . . . . 25.0 110.995 177.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -146.56 165.93 28.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.573 0.687 . . . . 25.0 109.283 -177.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 54.99 34.02 21.5 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 114.449 1.277 . . . . 25.0 114.449 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.62 25.39 65.35 Favored Glycine 0 N--CA 1.465 0.617 0 N-CA-C 111.159 -0.776 . . . . 25.0 111.159 177.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.428 ' HA ' ' H ' ' A' ' 151' ' ' ALA . 4.8 t -136.64 176.4 8.74 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 109.01 -0.737 . . . . 25.0 109.01 -178.06 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 69.7 mt -89.48 164.89 14.63 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 104.056 -2.572 . . . . 25.0 104.056 169.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.66 108.12 4.24 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 122.199 1.0 . . . . 25.0 109.894 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 18.0 m -73.16 160.34 5.36 Favored 'Isoleucine or valine' 0 C--O 1.247 0.968 0 N-CA-C 108.893 -0.78 . . . . 25.0 108.893 -177.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.47 168.87 20.8 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 110.382 -0.229 . . . . 25.0 110.382 -176.057 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.6 m -124.97 160.09 30.76 Favored 'Isoleucine or valine' 0 C--O 1.251 1.138 0 O-C-N 121.876 -0.515 . . . . 25.0 110.222 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.6 t -73.5 -49.12 28.3 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.692 -1.225 . . . . 25.0 107.692 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -168.94 -160.59 0.28 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 103.854 -2.647 . . . . 25.0 103.854 -177.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -72.82 -0.08 12.41 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 121.291 -0.88 . . . . 25.0 111.987 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -143.63 -157.79 7.31 Favored Glycine 0 C--O 1.241 0.575 0 N-CA-C 108.007 -2.037 . . . . 25.0 108.007 177.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.65 -153.59 0.37 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.184 0.809 . . . . 25.0 113.184 178.109 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.4 mtt85 -80.72 161.58 24.52 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 113.496 0.924 . . . . 25.0 113.496 -172.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.64 164.58 11.68 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 105.827 -1.916 . . . . 25.0 105.827 171.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -128.77 155.92 44.38 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 121.603 0.716 . . . . 25.0 110.357 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 29.8 tp -132.5 115.92 16.11 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 102.705 -3.072 . . . . 25.0 102.705 169.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -116.7 153.49 32.26 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 112.638 0.607 . . . . 25.0 112.638 -174.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 33.4 t -97.25 149.66 21.8 Favored 'General case' 0 C--O 1.215 -0.721 0 N-CA-C 103.889 -2.634 . . . . 25.0 103.889 168.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -119.35 10.17 11.85 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 124.828 1.33 . . . . 25.0 109.581 -178.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -97.95 152.78 18.89 Favored 'General case' 0 C--O 1.251 1.154 0 CA-C-N 114.291 -1.322 . . . . 25.0 107.504 171.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -142.88 160.4 40.41 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 122.234 1.016 . . . . 25.0 112.537 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -75.18 165.07 25.77 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 106.277 -1.749 . . . . 25.0 106.277 172.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.62 -22.83 67.11 Favored 'General case' 0 C--O 1.248 0.999 0 CA-C-O 122.287 1.042 . . . . 25.0 109.374 176.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -80.27 -6.78 58.47 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.859 -1.064 . . . . 25.0 112.788 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.59 2.53 72.72 Favored Glycine 0 C--O 1.223 -0.58 0 N-CA-C 114.419 0.528 . . . . 25.0 114.419 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.9 mt -72.68 137.17 45.83 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.83 -1.174 . . . . 25.0 107.83 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 88.7 p -140.25 -179.88 6.24 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 109.461 -0.57 . . . . 25.0 109.461 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -122.84 140.2 53.2 Favored 'General case' 0 C--O 1.247 0.951 0 O-C-N 121.926 -0.484 . . . . 25.0 111.717 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -156.97 155.49 31.38 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 107.476 -1.305 . . . . 25.0 107.476 170.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.8 p -148.78 147.07 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 N-CA-C 105.12 -2.178 . . . . 25.0 105.12 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.439 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . . . -115.38 149.64 37.63 Favored 'General case' 0 C--O 1.254 1.305 0 N-CA-C 109.306 -0.627 . . . . 25.0 109.306 -175.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mp -139.15 129.22 25.18 Favored 'General case' 0 C--O 1.205 -1.254 0 N-CA-C 107.522 -1.288 . . . . 25.0 107.522 -175.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.419 ' HG2' ' HA ' ' A' ' 85' ' ' LEU . 6.9 pt-20 -86.33 0.77 53.21 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.347 -0.941 . . . . 25.0 113.058 -177.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -65.17 -17.84 64.17 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 116.033 1.173 . . . . 25.0 116.033 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 38.5 t0 54.4 45.77 26.43 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 122.423 1.106 . . . . 25.0 112.199 -178.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -122.05 43.37 2.88 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 113.993 -1.458 . . . . 25.0 109.418 -174.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -52.63 -37.51 58.58 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 113.995 1.109 . . . . 25.0 113.995 178.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.59 -28.18 63.64 Favored 'General case' 0 C--O 1.248 0.996 0 CA-C-N 118.923 0.783 . . . . 25.0 111.473 -178.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.56 -27.47 34.33 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 121.413 0.625 . . . . 25.0 112.377 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 46.1 mt -66.6 128.58 36.79 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 119.87 -0.732 . . . . 25.0 110.337 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.9 m -131.15 160.93 33.31 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.176 -1.416 . . . . 25.0 107.176 177.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.428 ' H ' ' HA ' ' A' ' 111' ' ' SER . . . -79.51 1.37 26.02 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 107.619 -1.252 . . . . 25.0 107.619 177.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -68.47 -30.8 69.73 Favored 'General case' 0 N--CA 1.437 -1.106 0 O-C-N 123.465 0.478 . . . . 25.0 111.803 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -91.31 -10.41 41.43 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.733 -0.469 . . . . 25.0 109.733 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 26.9 mm -83.75 136.01 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 104.435 -2.432 . . . . 25.0 104.435 175.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.9 p -113.51 126.35 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 O-C-N 120.47 -1.394 . . . . 25.0 110.965 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -153.77 -30.43 0.12 Allowed 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 114.38 -1.282 . . . . 25.0 112.743 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -82.77 69.84 9.64 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 112.849 0.685 . . . . 25.0 112.849 -175.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 54.37 20.77 2.87 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.871 1.063 . . . . 25.0 113.871 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.12 17.95 4.89 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.705 0.802 . . . . 25.0 111.721 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -98.57 131.55 44.69 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.553 0.341 . . . . 25.0 110.976 -174.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.4 -10.33 58.78 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.957 0.725 . . . . 25.0 112.957 -176.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.07 -32.3 72.83 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.221 0.452 . . . . 25.0 112.221 -178.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.71 162.97 26.58 Favored 'General case' 0 C--O 1.247 0.961 0 N-CA-C 111.978 0.362 . . . . 25.0 111.978 -175.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 57.59 -169.81 0.11 Allowed 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 114.034 1.124 . . . . 25.0 114.034 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 90.83 2.18 72.41 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.787 -0.721 . . . . 25.0 113.789 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -102.48 115.29 30.28 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.841 -1.17 . . . . 25.0 107.841 176.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -134.47 161.78 34.09 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.287 -1.005 . . . . 25.0 108.287 -177.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -135.11 27.34 3.16 Favored Glycine 0 C--O 1.242 0.606 0 N-CA-C 110.419 -1.072 . . . . 25.0 110.419 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 47.7 t -70.2 -34.83 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.32 0.648 . . . . 25.0 110.355 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -58.36 133.69 23.32 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 CA-C-O 121.727 0.775 . . . . 25.0 111.735 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 156.81 160.18 9.93 Favored Glycine 0 C--N 1.336 0.564 0 N-CA-C 110.757 -0.937 . . . . 25.0 110.757 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -136.37 152.42 50.62 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 122.382 -0.481 . . . . 25.0 110.031 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 54.5 p -148.71 159.16 44.38 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.239 0.542 . . . . 25.0 110.0 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -179.93 168.77 39.25 Favored Glycine 0 N--CA 1.461 0.318 0 O-C-N 121.677 -0.639 . . . . 25.0 113.717 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -154.23 114.19 2.5 Favored Pre-proline 0 C--O 1.246 0.908 0 N-CA-C 107.767 -1.197 . . . . 25.0 107.767 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -68.84 157.05 63.4 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 117.304 -1.331 . . . . 25.0 112.559 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -117.75 146.67 43.62 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 108.208 -1.034 . . . . 25.0 108.208 177.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -140.15 64.27 25.9 Favored Pre-proline 0 N--CA 1.478 0.969 0 N-CA-C 112.405 0.52 . . . . 25.0 112.405 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.21 161.39 32.26 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 117.579 -1.147 . . . . 25.0 112.616 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 15.2 t -119.17 2.91 11.43 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 116.328 -0.396 . . . . 25.0 110.894 177.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 C--O 1.254 1.307 0 CA-C-O 117.494 -1.241 . . . . 25.0 111.283 178.829 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo . . . . . 0 CA--C 1.527 0.174 0 N-CA-C 112.653 0.213 . . . . 25.0 112.653 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.79 36.34 0.22 Allowed Glycine 0 N--CA 1.473 1.107 0 C-N-CA 121.173 -0.537 . . . . 25.0 113.838 -177.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.429 HG12 ' H ' ' A' ' 5' ' ' VAL . 0.9 OUTLIER -50.03 119.6 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 114.119 1.155 . . . . 25.0 114.119 -175.523 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -93.43 8.5 40.29 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 122.176 0.989 . . . . 25.0 108.341 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.92 -152.67 17.71 Favored Glycine 0 C--O 1.22 -0.742 0 CA-C-N 115.865 -0.607 . . . . 25.0 113.993 176.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.6 p 69.13 158.19 0.15 Allowed Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 125.988 1.715 . . . . 25.0 112.048 -174.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -69.7 22.77 0.17 Allowed 'Trans proline' 0 C--N 1.359 1.098 0 N-CA-C 118.803 2.578 . . . . 25.0 118.803 -176.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.07 -25.76 17.07 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.504 0 N-CA-C 114.516 1.302 . . . . 25.0 114.516 -171.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.6 p -146.69 145.76 19.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 CA-C-N 119.644 1.111 . . . . 25.0 112.223 -175.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.2 24.15 41.69 Favored Glycine 0 N--CA 1.466 0.681 0 N-CA-C 118.719 2.247 . . . . 25.0 118.719 172.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.7 t -49.49 -66.11 0.45 Allowed 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 118.641 1.22 . . . . 25.0 112.719 -175.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -86.49 17.83 3.62 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 115.588 1.699 . . . . 25.0 115.588 -167.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.16 168.75 19.07 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 120.821 -1.175 . . . . 25.0 110.927 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -68.9 132.22 46.37 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.233 0.54 . . . . 25.0 110.848 -175.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -123.67 160.46 27.14 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.896 1.443 . . . . 50.0 114.896 -174.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -124.38 99.03 6.01 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 104.492 -2.41 . . . . 25.0 104.492 161.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 87.1 mt -108.44 109.72 21.07 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 111.664 0.246 . . . . 25.0 111.664 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -103.18 117.12 33.81 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.498 -0.556 . . . . 25.0 109.498 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.78 -171.59 46.04 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 117.644 1.818 . . . . 25.0 117.644 -168.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.439 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 81.8 p -87.1 169.02 12.76 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.561 0.744 . . . . 25.0 109.102 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 68.7 mt -86.54 11.28 13.03 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.23 -0.441 . . . . 25.0 111.464 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -112.26 175.78 17.35 Favored Glycine 0 N--CA 1.461 0.357 0 N-CA-C 109.115 -1.594 . . . . 25.0 109.115 177.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.3 t -66.33 140.74 58.12 Favored 'General case' 0 C--O 1.207 -1.143 0 CA-C-N 117.978 0.889 . . . . 25.0 110.745 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.439 ' CD ' ' H ' ' A' ' 22' ' ' THR . 26.2 mt-10 -149.11 156.99 43.03 Favored 'General case' 0 C--O 1.246 0.895 0 C-N-CA 122.917 0.487 . . . . 50.0 110.106 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -89.93 138.23 31.67 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 104.544 -2.391 . . . . 25.0 104.544 161.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.5 mm -126.62 92.98 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 106.042 -1.836 . . . . 25.0 106.042 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 11.0 mp -104.5 120.96 42.46 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 104.652 -2.351 . . . . 25.0 104.652 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.27 -26.39 36.69 Favored Glycine 0 CA--C 1.505 -0.586 0 CA-C-O 119.729 -0.484 . . . . 25.0 112.051 -174.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.6 -149.24 46.49 Favored Glycine 0 C--O 1.249 1.077 0 N-CA-C 110.165 -1.174 . . . . 25.0 110.165 -173.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.49 179.12 40.82 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-O 123.059 1.366 . . . . 25.0 112.475 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.97 164.19 19.97 Favored Glycine 0 C--O 1.248 0.976 0 CA-C-N 114.207 -0.996 . . . . 25.0 114.266 179.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.56 100.02 12.11 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 106.722 -1.584 . . . . 25.0 106.722 176.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -96.83 156.36 16.38 Favored 'General case' 0 C--O 1.214 -0.783 0 C-N-CA 120.207 -0.597 . . . . 50.0 112.148 -170.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -115.61 91.26 3.55 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 106.233 -1.766 . . . . 25.0 106.233 174.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 70.0 mt -97.77 136.19 38.46 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-N 114.024 -1.444 . . . . 25.0 112.613 -172.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -131.64 95.14 3.66 Favored 'General case' 0 C--O 1.252 1.189 0 CA-C-O 121.53 0.681 . . . . 25.0 111.743 -176.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.88 -27.13 69.49 Favored Glycine 0 CA--C 1.521 0.426 0 CA-C-O 119.118 -0.823 . . . . 25.0 113.926 -176.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 48.79 -148.25 0.24 Allowed 'General case' 0 C--O 1.243 0.721 0 C-N-CA 124.405 1.082 . . . . 25.0 111.852 -176.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.91 159.58 34.41 Favored 'General case' 0 C--O 1.25 1.11 0 CA-C-O 121.69 0.757 . . . . 25.0 111.633 -177.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.33 156.64 21.49 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.51 -1.036 . . . . 25.0 110.51 -175.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -86.45 90.15 8.12 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.516 -0.92 . . . . 25.0 108.516 176.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -90.57 160.28 16.02 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.028 -0.987 . . . . 50.0 112.43 -170.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 tp -124.27 99.69 6.34 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.378 -0.971 . . . . 25.0 108.378 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.3 mp -101.83 117.83 35.66 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 116.016 1.858 . . . . 25.0 116.016 -166.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -122.23 101.62 7.63 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.117 -0.947 . . . . 25.0 109.137 174.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.42 -29.17 70.88 Favored Glycine 0 CA--C 1.523 0.585 0 O-C-N 120.141 -1.599 . . . . 25.0 112.769 -177.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.57 -168.08 54.1 Favored Glycine 0 N--CA 1.471 1.029 0 N-CA-C 108.938 -1.665 . . . . 25.0 108.938 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.86 151.89 33.27 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.86 0.689 . . . . 25.0 112.86 -175.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.79 165.98 33.12 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 115.847 1.099 . . . . 25.0 115.847 -175.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.415 ' HD2' ' HA ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -91.03 105.84 18.1 Favored 'General case' 0 C--O 1.212 -0.893 0 N-CA-C 105.667 -1.975 . . . . 25.0 105.667 176.293 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -99.98 151.45 21.33 Favored 'General case' 0 CA--C 1.483 -1.63 0 O-C-N 123.879 0.737 . . . . 50.0 112.093 -168.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -112.03 125.36 53.99 Favored 'General case' 0 C--O 1.211 -0.955 0 N-CA-C 103.374 -2.825 . . . . 25.0 103.374 177.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -149.31 132.68 16.56 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 122.348 1.07 . . . . 25.0 113.27 -174.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 71.5 m -96.77 136.11 37.78 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 106.979 -1.489 . . . . 25.0 106.979 173.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -88.06 -40.94 6.42 Favored Glycine 0 CA--C 1.499 -0.909 0 N-CA-C 110.357 -1.097 . . . . 25.0 110.357 174.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.62 -171.64 54.09 Favored Glycine 0 C--O 1.252 1.228 0 CA-C-O 122.633 1.129 . . . . 25.0 113.402 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -63.01 163.09 10.33 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 121.661 -0.905 . . . . 25.0 110.225 176.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.91 164.52 40.3 Favored Glycine 0 C--O 1.243 0.684 0 CA-C-O 118.554 -1.137 . . . . 25.0 112.514 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.51 113.24 20.11 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.967 -0.753 . . . . 25.0 108.967 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -104.9 154.41 20.11 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 121.541 -0.724 . . . . 50.0 110.576 -177.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.3 m -120.58 129.08 53.61 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 106.271 -1.751 . . . . 25.0 106.271 177.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -115.38 128.7 56.24 Favored 'General case' 0 C--O 1.207 -1.153 0 N-CA-C 104.827 -2.286 . . . . 25.0 104.827 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 61.9 mtt85 -133.41 -29.88 1.35 Allowed 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 113.393 0.886 . . . . 25.0 113.393 174.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 68.23 163.03 0.21 Allowed 'General case' 0 CA--C 1.537 0.459 0 O-C-N 124.794 1.309 . . . . 25.0 110.201 -172.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.22 -41.34 49.58 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.473 1.657 . . . . 25.0 115.473 -165.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 66.5 mt -136.53 170.39 16.14 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 115.217 1.562 . . . . 25.0 115.217 -171.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.09 -28.33 64.5 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.13 -1.396 . . . . 25.0 109.198 168.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -81.29 6.98 12.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.161 -1.381 . . . . 25.0 114.423 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -111.32 152.96 26.64 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.119 -1.613 . . . . 25.0 113.237 -174.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.6 t 41.27 50.77 3.48 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 117.897 2.554 . . . . 25.0 117.897 -178.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 24.5 p-80 -125.43 161.28 27.43 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 114.411 -1.268 . . . . 25.0 112.237 -176.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -109.37 138.72 45.29 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 104.859 -2.275 . . . . 25.0 104.859 174.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.4 p -122.6 172.14 5.66 Favored Pre-proline 0 C--N 1.322 -0.629 0 O-C-N 124.129 0.893 . . . . 25.0 109.975 -178.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -61.94 -23.97 76.45 Favored 'Trans proline' 0 C--O 1.254 1.315 0 C-N-CA 117.707 -1.062 . . . . 25.0 112.639 174.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 75.1 mt -78.22 -29.03 48.07 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.339 0.496 . . . . 25.0 112.339 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.23 -179.6 32.88 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.08 -1.208 . . . . 25.0 110.08 -172.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.5 t -98.12 151.42 20.41 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.106 1.15 . . . . 25.0 114.106 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.415 ' HA ' ' HD2' ' A' ' 52' ' ' ARG . 72.7 m-85 -135.47 29.73 3.26 Favored 'General case' 0 C--O 1.251 1.166 0 CA-C-N 114.419 -1.264 . . . . 25.0 108.889 175.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.53 146.8 42.77 Favored Glycine 0 C--N 1.335 0.476 0 O-C-N 124.102 0.876 . . . . 25.0 112.138 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -84.2 169.46 14.76 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 122.543 -0.387 . . . . 50.0 111.647 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -128.78 108.22 10.28 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 110.166 -0.309 . . . . 25.0 110.166 -176.48 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.5 mt -98.13 135.67 31.91 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 N-CA-C 107.618 -1.253 . . . . 25.0 107.618 -177.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.6 mt -84.83 -41.19 16.3 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 115.723 1.749 . . . . 25.0 115.723 -171.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.9 p-10 -137.22 39.07 2.51 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.991 1.108 . . . . 25.0 113.991 -172.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -58.24 132.89 54.94 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.126 -0.943 . . . . 25.0 110.655 -177.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -113.7 106.25 54.03 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 108.375 -0.972 . . . . 25.0 108.375 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.1 -16.64 56.08 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 N-CA-C 116.338 1.63 . . . . 25.0 116.338 -173.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.7 t -88.33 -29.11 20.57 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.895 0.378 . . . . 25.0 111.374 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -93.44 -48.93 6.17 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.609 0.719 . . . . 25.0 111.575 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -96.56 165.5 12.13 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 114.169 -1.378 . . . . 50.0 110.92 -159.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -142.18 151.54 42.3 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 113.921 1.082 . . . . 25.0 113.921 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 75.3 mt -126.51 123.54 63.43 Favored 'Isoleucine or valine' 0 C--O 1.247 0.969 0 N-CA-C 107.55 -1.278 . . . . 25.0 107.55 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -81.58 147.35 29.65 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 122.257 1.027 . . . . 25.0 108.363 173.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -155.63 -12.02 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 115.232 -0.895 . . . . 25.0 112.45 -179.028 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.6 t -62.67 -38.34 89.95 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 120.738 -1.226 . . . . 25.0 110.237 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.65 -21.0 56.05 Favored 'General case' 0 CA--C 1.555 1.149 0 N-CA-C 114.812 1.412 . . . . 25.0 114.812 -176.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.39 0.63 2.81 Favored 'General case' 0 CA--C 1.556 1.176 0 N-CA-C 117.61 2.448 . . . . 25.0 117.61 -170.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -143.32 -67.05 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 119.021 0.828 . . . . 25.0 115.012 177.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -160.11 164.92 32.64 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.99 0.9 . . . . 25.0 110.992 -174.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.8 t -119.48 -26.76 5.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.773 -1.103 . . . . 25.0 110.521 174.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -93.95 120.68 6.39 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 118.718 -1.046 . . . . 25.0 112.699 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -65.93 157.17 31.37 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.442 1.621 . . . . 25.0 112.356 178.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -90.7 -172.03 43.88 Favored Glycine 0 C--N 1.32 -0.332 0 CA-C-O 118.88 -0.956 . . . . 25.0 112.263 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -79.54 83.1 5.57 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 118.646 1.223 . . . . 25.0 112.111 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.06 -175.43 17.96 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 108.348 -1.901 . . . . 25.0 108.348 168.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -127.05 160.7 30.34 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.971 1.385 . . . . 25.0 111.879 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 51.83 47.24 25.18 Favored 'General case' 0 C--O 1.266 1.951 0 N-CA-C 114.946 1.462 . . . . 25.0 114.946 -176.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.26 48.69 36.96 Favored Glycine 0 N--CA 1.48 1.591 0 N-CA-C 109.253 -1.539 . . . . 25.0 109.253 176.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.5 t -148.33 173.84 12.64 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 117.838 0.819 . . . . 25.0 111.905 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.7 mp -105.36 168.57 8.99 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 101.816 -3.402 . . . . 25.0 101.816 173.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.55 135.48 39.27 Favored 'General case' 0 C--O 1.254 1.31 0 C-N-CA 117.915 -1.514 . . . . 25.0 108.009 -176.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.7 m -102.35 163.58 3.42 Favored 'Isoleucine or valine' 0 C--O 1.248 0.997 0 CA-C-O 118.524 -0.75 . . . . 25.0 109.165 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.0 p -149.78 163.41 38.05 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-N 118.514 0.597 . . . . 25.0 112.247 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 28.0 m -115.89 160.82 15.05 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 N-CA-C 105.787 -1.931 . . . . 25.0 105.787 176.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.9 t -78.76 -42.67 27.42 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 107.055 -1.461 . . . . 25.0 107.055 176.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -168.31 -169.13 1.03 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 103.78 -2.674 . . . . 25.0 103.78 -175.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -59.76 -24.78 64.35 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.662 0.601 . . . . 25.0 112.534 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -126.9 -147.38 6.72 Favored Glycine 0 C--O 1.252 1.231 0 N-CA-C 111.114 -0.795 . . . . 25.0 111.114 174.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 53.72 -142.69 0.78 Allowed 'General case' 0 C--O 1.246 0.872 0 N-CA-C 113.891 1.071 . . . . 25.0 113.891 -179.012 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.7 mtt85 -91.39 162.83 14.42 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 114.716 1.376 . . . . 25.0 114.716 -170.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.5 p -113.08 162.48 15.88 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 104.73 -2.322 . . . . 25.0 104.73 176.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -132.7 156.14 47.55 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 109.245 -0.65 . . . . 25.0 109.245 -175.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 33.6 tp -135.16 127.66 30.6 Favored 'General case' 0 C--O 1.251 1.17 0 N-CA-C 102.695 -3.076 . . . . 25.0 102.695 171.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -128.65 159.6 35.07 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 115.787 -0.642 . . . . 25.0 112.673 -170.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.2 t -94.64 149.77 20.91 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.295 -1.372 . . . . 25.0 107.295 171.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -119.82 24.15 10.7 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 106.93 -1.507 . . . . 25.0 106.93 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -125.91 135.88 52.41 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 106.364 -1.717 . . . . 25.0 106.364 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -139.39 156.31 47.07 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 122.558 1.17 . . . . 25.0 109.672 -172.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -74.08 159.35 32.75 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-N 114.782 -1.099 . . . . 25.0 109.225 173.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.29 -20.64 66.5 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.733 -0.604 . . . . 25.0 109.789 173.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -69.89 -12.27 61.49 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 118.675 -0.678 . . . . 25.0 112.502 175.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.13 22.93 46.75 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 111.51 -0.636 . . . . 25.0 111.51 -177.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.7 mt -100.18 141.01 33.6 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 107.636 -1.246 . . . . 25.0 107.636 177.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 59.7 p -147.61 171.43 15.61 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 106.789 -1.56 . . . . 25.0 106.789 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -115.76 138.38 51.18 Favored 'General case' 0 C--O 1.257 1.453 0 CA-C-N 118.667 0.667 . . . . 25.0 112.624 -173.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -152.63 153.21 32.87 Favored 'General case' 0 C--O 1.248 1.02 0 CA-C-O 121.717 0.77 . . . . 25.0 110.088 172.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.9 p -145.03 143.79 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.784 0 N-CA-C 105.858 -1.904 . . . . 25.0 105.858 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -107.86 142.69 37.55 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.41 -1.329 . . . . 25.0 107.41 -176.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.6 mp -131.13 137.13 48.9 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.489 -1.3 . . . . 25.0 107.489 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -109.71 7.29 24.27 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 121.251 1.841 . . . . 25.0 115.858 -176.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -76.9 4.94 51.45 Favored Glycine 0 N--CA 1.469 0.894 0 N-CA-C 116.322 1.289 . . . . 25.0 116.322 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 46.6 t0 51.34 51.94 15.83 Favored 'General case' 0 C--O 1.256 1.43 0 C-N-CA 124.046 0.939 . . . . 25.0 111.875 176.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -129.84 29.83 4.94 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 124.849 1.26 . . . . 25.0 110.714 -174.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.85 -31.98 70.26 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 119.275 -0.97 . . . . 25.0 111.52 176.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.6 -20.95 66.12 Favored 'General case' 0 C--O 1.251 1.171 0 CA-C-N 118.777 0.717 . . . . 25.0 111.349 177.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -95.67 -27.77 15.13 Favored 'General case' 0 C--O 1.259 1.603 0 N-CA-C 114.048 1.129 . . . . 25.0 114.048 176.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 74.6 mt -58.39 137.36 57.31 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 114.126 1.158 . . . . 25.0 114.126 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 62.7 m -137.15 167.15 22.1 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 105.642 -1.985 . . . . 25.0 105.642 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -77.45 -2.88 37.52 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 120.458 -1.401 . . . . 25.0 111.324 174.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -68.42 -29.09 67.68 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.777 -0.577 . . . . 25.0 112.353 -176.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -87.02 -2.48 58.66 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.882 -0.599 . . . . 25.0 111.209 174.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 36.7 mm -96.64 127.32 48.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 104.679 -2.341 . . . . 25.0 104.679 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.1 p -105.42 104.4 16.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 124.063 1.887 . . . . 25.0 114.78 -174.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -141.81 -1.1 1.29 Allowed 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 112.625 -2.079 . . . . 25.0 111.091 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -80.91 53.5 1.97 Allowed 'General case' 0 CA--C 1.549 0.905 0 O-C-N 121.151 -0.968 . . . . 25.0 112.603 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 58.85 18.07 5.8 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 114.434 1.272 . . . . 25.0 114.434 -175.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.58 -39.88 0.39 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 118.264 2.69 . . . . 25.0 118.264 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -70.81 150.01 46.27 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-O 121.388 0.613 . . . . 25.0 110.622 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -80.3 19.93 0.72 Allowed 'General case' 0 C--O 1.218 -0.564 0 C-N-CA 124.09 0.956 . . . . 25.0 112.32 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.74 -21.78 66.84 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 115.487 1.662 . . . . 25.0 115.487 -177.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -140.28 -160.59 1.09 Allowed 'General case' 0 CA--C 1.547 0.862 0 CA-C-O 121.567 0.699 . . . . 25.0 111.37 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 64.21 -171.11 0.18 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 115.359 1.614 . . . . 25.0 115.359 177.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 81.38 24.38 56.87 Favored Glycine 0 C--O 1.225 -0.456 0 CA-C-O 122.985 1.325 . . . . 25.0 110.515 -175.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -98.7 114.59 27.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.444 -0.878 . . . . 25.0 109.165 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -123.68 143.22 50.39 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 108.532 -0.914 . . . . 25.0 108.532 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -111.07 16.83 27.45 Favored Glycine 0 C--O 1.225 -0.432 0 N-CA-C 112.155 -0.378 . . . . 25.0 112.155 -177.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 49.0 t -68.59 -37.33 77.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.697 -0.252 . . . . 25.0 111.297 -174.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.0 133.31 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-O 121.599 0.714 . . . . 25.0 111.57 -176.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 149.04 159.01 8.33 Favored Glycine 0 N--CA 1.463 0.435 0 N-CA-C 110.058 -1.217 . . . . 25.0 110.058 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -151.69 153.04 33.6 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-O 122.285 1.04 . . . . 25.0 111.338 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 92.6 p -165.34 163.11 19.95 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 105.074 -2.195 . . . . 25.0 105.074 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 174.7 159.84 21.7 Favored Glycine 0 C--O 1.245 0.803 0 C-N-CA 119.963 -1.113 . . . . 25.0 114.241 174.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -116.86 110.75 41.58 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 109.047 -0.724 . . . . 25.0 109.047 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.37 169.5 21.83 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 116.328 -1.981 . . . . 25.0 114.335 -175.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -124.57 140.95 52.47 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.368 -0.975 . . . . 25.0 108.368 175.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -143.66 73.47 17.1 Favored Pre-proline 0 N--CA 1.487 1.383 0 CA-C-O 121.11 0.481 . . . . 25.0 111.75 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -67.99 152.89 76.36 Favored 'Trans proline' 0 C--O 1.242 0.682 0 N-CA-C 114.062 0.755 . . . . 25.0 114.062 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.6 t -124.05 11.05 8.86 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.712 -0.676 . . . . 25.0 109.363 -176.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.257 1.457 0 N-CA-C 109.157 -0.683 . . . . 25.0 109.157 178.717 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo . . . . . 0 C--O 1.243 0.749 0 N-CA-C 114.297 0.845 . . . . 25.0 114.297 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -163.83 49.76 0.3 Allowed Glycine 0 N--CA 1.467 0.759 0 N-CA-C 108.467 -1.853 . . . . 25.0 108.467 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.447 HG22 ' H ' ' A' ' 7' ' ' GLY . 9.2 p -54.58 128.87 15.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-O 122.918 1.342 . . . . 25.0 110.495 -175.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -101.19 -1.63 33.36 Favored 'General case' 0 C--O 1.252 1.226 0 O-C-N 121.289 -0.882 . . . . 25.0 110.389 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.447 ' H ' HG22 ' A' ' 5' ' ' VAL . . . -86.48 -142.55 6.99 Favored Glycine 0 C--O 1.241 0.539 0 CA-C-N 116.421 -0.354 . . . . 25.0 112.79 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.0 p 68.43 157.75 0.15 Allowed Pre-proline 0 N--CA 1.486 1.353 0 C-N-CA 125.811 1.644 . . . . 25.0 111.739 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.577 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 25.5 Cg_exo -71.1 -2.35 10.97 Favored 'Trans proline' 0 C--N 1.354 0.86 0 N-CA-C 116.046 1.518 . . . . 25.0 116.046 -172.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.6 p -65.04 -13.59 15.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 115.974 1.842 . . . . 25.0 115.974 -171.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.3 p -139.69 134.94 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 114.693 1.368 . . . . 25.0 114.693 -177.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.6 13.18 83.21 Favored Glycine 0 N--CA 1.466 0.665 0 N-CA-C 117.026 1.57 . . . . 25.0 117.026 174.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.7 t -47.12 -49.74 21.5 Favored 'General case' 0 C--O 1.209 -1.028 0 CA-C-N 118.98 1.39 . . . . 25.0 113.279 -168.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -78.61 6.91 7.68 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 116.85 2.167 . . . . 25.0 116.85 -174.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 pp -142.57 169.52 17.42 Favored 'General case' 0 C--O 1.203 -1.352 0 O-C-N 121.277 -0.889 . . . . 25.0 111.428 -177.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -61.5 128.47 36.44 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 113.139 0.792 . . . . 25.0 113.139 -174.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -130.08 167.15 18.78 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 114.081 1.141 . . . . 50.0 114.081 -175.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -125.34 107.73 10.98 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 104.008 -2.59 . . . . 25.0 104.008 169.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.3 mt -122.66 114.43 20.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 119.069 0.85 . . . . 25.0 110.143 -175.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -108.22 121.94 45.91 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.618 -0.882 . . . . 25.0 108.618 173.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.2 -177.89 47.33 Favored Glycine 0 N--CA 1.471 1.026 0 N-CA-C 115.063 0.785 . . . . 25.0 115.063 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.4 p -81.02 178.11 8.63 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.021 0.928 . . . . 25.0 111.229 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 79.7 mt -90.31 13.55 15.08 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.193 0.52 . . . . 25.0 110.103 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.77 -177.09 20.64 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.455 -0.658 . . . . 25.0 111.455 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.8 t -75.38 129.4 37.29 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.128 1.159 . . . . 25.0 114.128 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -145.01 159.82 42.34 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.045 -1.034 . . . . 50.0 112.998 -174.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -98.66 120.97 39.99 Favored 'General case' 0 C--O 1.26 1.608 0 N-CA-C 105.498 -2.038 . . . . 25.0 105.498 164.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.1 mm -115.98 107.88 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 N-CA-C 105.291 -2.115 . . . . 25.0 105.291 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.577 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 9.2 mp -115.89 132.11 56.74 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 105.084 -2.191 . . . . 25.0 105.084 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.89 -33.94 9.4 Favored Glycine 0 CA--C 1.483 -1.962 0 N-CA-C 114.72 0.648 . . . . 25.0 114.72 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 72.94 -145.59 36.81 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 111.793 -0.523 . . . . 25.0 111.793 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.39 163.13 52.76 Favored Glycine 0 N--CA 1.438 -1.185 0 CA-C-O 121.783 0.657 . . . . 25.0 113.569 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.24 166.76 41.44 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.216 -0.754 . . . . 25.0 111.216 177.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.38 112.08 20.02 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.045 -1.094 . . . . 25.0 108.045 176.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -107.09 157.7 17.63 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 113.662 0.986 . . . . 50.0 113.662 -172.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -117.93 87.17 2.66 Favored 'General case' 0 C--O 1.255 1.386 0 N-CA-C 106.668 -1.604 . . . . 25.0 106.668 178.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 53.6 mt -96.34 137.99 34.61 Favored 'General case' 0 C--O 1.207 -1.141 0 CA-C-N 115.572 -0.74 . . . . 25.0 112.07 -174.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -131.34 112.77 13.04 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 107.117 -1.438 . . . . 25.0 107.117 177.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -92.14 -22.68 29.3 Favored Glycine 0 CA--C 1.507 -0.453 0 CA-C-O 118.877 -0.957 . . . . 25.0 115.455 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 51.12 -147.47 0.41 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.127 0.971 . . . . 25.0 113.303 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.34 165.03 19.51 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 123.313 1.53 . . . . 25.0 112.326 -177.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.11 157.12 32.79 Favored Glycine 0 C--O 1.246 0.869 0 CA-C-N 113.876 -1.511 . . . . 25.0 111.253 -176.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.2 m-20 -78.29 114.81 17.53 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 103.853 -2.647 . . . . 25.0 103.853 177.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -119.78 160.13 23.2 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.986 -0.746 . . . . 50.0 108.986 -172.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.0 mp -111.12 124.56 52.42 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 104.31 -2.478 . . . . 25.0 104.31 171.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.59 100.89 7.26 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 121.875 -0.516 . . . . 25.0 111.991 -175.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -117.74 103.73 10.28 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.971 -1.122 . . . . 25.0 107.971 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.86 -24.53 68.42 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 116.88 1.512 . . . . 25.0 116.88 -177.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.39 -168.09 51.28 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 118.371 -1.238 . . . . 25.0 111.036 -178.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.41 153.86 3.78 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.55 1.315 . . . . 25.0 114.55 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.03 171.78 47.82 Favored Glycine 0 CA--C 1.502 -0.74 0 O-C-N 124.6 1.187 . . . . 25.0 110.406 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.08 156.18 27.18 Favored 'General case' 0 C--O 1.203 -1.35 1 N-CA-C 99.922 -4.103 . . . . 25.0 99.922 173.258 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -144.77 156.61 44.14 Favored 'General case' 0 C--O 1.247 0.948 0 C-N-CA 120.437 -0.505 . . . . 50.0 110.821 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -119.91 121.38 38.88 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 103.33 -2.841 . . . . 25.0 103.33 174.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.7 130.72 26.33 Favored 'General case' 0 C--O 1.211 -0.921 0 N-CA-C 113.916 1.08 . . . . 25.0 113.916 -171.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.29 126.84 52.55 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.157 -0.965 . . . . 25.0 108.816 -178.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -80.85 -48.43 6.14 Favored Glycine 0 C--O 1.247 0.916 0 C-N-CA 119.94 -1.124 . . . . 25.0 112.624 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.63 -167.8 53.22 Favored Glycine 0 CA--C 1.535 1.339 0 O-C-N 122.414 -0.462 . . . . 25.0 114.244 -177.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -67.12 159.77 28.17 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 121.274 -1.133 . . . . 25.0 111.086 177.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.21 156.99 33.12 Favored Glycine 0 C--O 1.242 0.599 0 N-CA-C 110.538 -1.025 . . . . 25.0 110.538 -177.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.81 98.64 5.64 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 122.121 0.962 . . . . 25.0 110.853 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -89.21 155.94 19.09 Favored 'General case' 0 C--O 1.252 1.21 0 CA-C-N 114.391 -1.277 . . . . 50.0 112.587 -174.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 46.8 m -128.12 125.23 38.76 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.156 0.503 . . . . 25.0 110.025 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -113.32 103.16 11.04 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.914 -0.772 . . . . 25.0 108.914 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 24.6 mmt85 -105.0 -30.32 9.86 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-N 115.916 -0.584 . . . . 25.0 110.052 -178.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 64.75 165.79 0.16 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.88 1.272 . . . . 25.0 110.437 -171.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -87.13 -38.77 16.15 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.862 0.69 . . . . 25.0 112.862 -168.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.1 mt -136.03 161.6 35.23 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 122.089 0.947 . . . . 25.0 111.538 -173.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.93 -25.68 63.67 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 114.894 -1.048 . . . . 25.0 109.051 172.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -78.06 3.09 15.81 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.389 -1.278 . . . . 25.0 114.171 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -95.57 148.52 22.42 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 115.386 1.625 . . . . 25.0 115.386 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.6 t 53.23 39.41 29.67 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.871 1.434 . . . . 25.0 114.871 173.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 27.2 p-80 -114.7 163.67 15.12 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.326 -0.852 . . . . 25.0 112.737 -175.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -110.49 142.89 41.63 Favored 'General case' 0 C--O 1.208 -1.097 0 N-CA-C 103.564 -2.754 . . . . 25.0 103.564 173.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 97.5 p -135.32 170.07 12.09 Favored Pre-proline 0 CA--C 1.512 -0.506 0 N-CA-C 107.039 -1.467 . . . . 25.0 107.039 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -62.48 -18.78 65.07 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 CA-C-N 119.385 0.816 . . . . 25.0 113.32 173.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.4 mt -77.82 -24.29 48.77 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.304 0.573 . . . . 25.0 111.822 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 144.68 -176.95 23.52 Favored Glycine 0 C--O 1.25 1.117 0 N-CA-C 110.155 -1.178 . . . . 25.0 110.155 -178.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.4 t -84.13 147.29 27.42 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 122.788 1.28 . . . . 25.0 112.193 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -133.94 27.32 3.91 Favored 'General case' 0 C--O 1.256 1.409 0 N-CA-C 105.731 -1.952 . . . . 25.0 105.731 169.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.16 143.95 42.08 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 114.323 -1.308 . . . . 25.0 110.545 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -87.65 166.69 14.5 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.493 -0.928 . . . . 50.0 108.493 -174.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -130.06 117.43 19.99 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 107.466 -1.309 . . . . 25.0 107.466 -175.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.0 mt -100.42 135.83 34.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 106.906 -1.516 . . . . 25.0 106.906 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.413 ' HA ' ' HG2' ' A' ' 142' ' ' GLU . 92.6 mt -79.49 -55.64 4.9 Favored 'General case' 0 C--O 1.217 -0.608 0 C-N-CA 124.037 0.935 . . . . 25.0 112.938 -173.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 -132.12 51.07 2.18 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-O 122.749 1.262 . . . . 25.0 113.309 -175.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -61.76 143.52 56.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.773 -1.103 . . . . 25.0 108.933 175.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -125.11 107.06 28.09 Favored Pre-proline 0 CA--C 1.505 -0.756 0 N-CA-C 107.392 -1.336 . . . . 25.0 107.392 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.37 -9.68 26.42 Favored 'Trans proline' 0 CA--C 1.555 1.552 0 N-CA-C 117.538 2.092 . . . . 25.0 117.538 -172.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.6 t -76.76 -37.24 56.25 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.603 -0.888 . . . . 25.0 108.603 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -111.37 -33.71 6.33 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 115.522 1.675 . . . . 25.0 115.522 -171.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -90.36 152.0 21.2 Favored 'General case' 0 C--O 1.212 -0.869 0 CA-C-N 117.908 0.322 . . . . 50.0 110.429 -170.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -129.34 141.97 50.94 Favored 'General case' 0 C--O 1.26 1.623 0 CA-C-O 119.141 -0.456 . . . . 25.0 110.126 -174.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 77.0 mt -125.52 133.12 69.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.277 -0.638 . . . . 25.0 109.277 178.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.55 141.59 28.42 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.884 -0.784 . . . . 25.0 108.884 172.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.6 p -139.65 -4.66 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.096 -0.956 . . . . 25.0 112.193 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.3 t -73.17 -31.46 64.25 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.962 -0.755 . . . . 25.0 108.962 -177.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.85 -36.73 80.84 Favored 'General case' 0 C--O 1.254 1.298 0 CA-C-N 115.641 -0.709 . . . . 25.0 112.713 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.79 -29.63 8.98 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 117.354 2.353 . . . . 25.0 117.354 -170.073 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -124.26 -72.44 0.23 Allowed Glycine 0 CA--C 1.5 -0.87 0 N-CA-C 117.931 1.932 . . . . 25.0 117.931 -168.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -154.61 172.76 17.33 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 109.705 -0.48 . . . . 25.0 109.705 -167.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.9 t -128.0 -20.26 3.85 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 112.065 0.394 . . . . 25.0 112.065 174.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -97.59 126.95 9.05 Favored Glycine 0 N--CA 1.488 2.136 0 O-C-N 121.421 -0.799 . . . . 25.0 112.703 176.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.63 151.14 47.94 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.618 0.599 . . . . 25.0 112.618 178.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -88.46 -173.26 47.1 Favored Glycine 0 C--O 1.223 -0.563 0 N-CA-C 114.771 0.668 . . . . 25.0 114.771 -175.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -76.11 82.36 2.94 Favored 'General case' 0 C--O 1.258 1.505 0 CA-C-N 118.919 1.36 . . . . 25.0 110.874 -178.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -115.62 -172.85 17.18 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 109.214 -1.554 . . . . 25.0 109.214 174.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -143.03 168.35 19.92 Favored 'General case' 0 C--O 1.241 0.632 0 O-C-N 121.815 -0.815 . . . . 25.0 110.301 175.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 58.38 32.11 21.71 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.776 1.23 . . . . 25.0 113.76 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 80.54 23.41 60.44 Favored Glycine 0 C--N 1.316 -0.581 0 CA-C-O 118.863 -0.965 . . . . 25.0 111.55 176.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.2 t -132.79 169.65 16.41 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 119.04 1.42 . . . . 25.0 109.671 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.4 mp -88.6 163.46 15.83 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 103.302 -2.851 . . . . 25.0 103.302 171.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.42 122.55 19.19 Favored 'General case' 0 C--O 1.257 1.468 0 C-N-CA 119.081 -1.047 . . . . 25.0 111.141 -176.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.9 m -90.75 160.73 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 107.032 -1.47 . . . . 25.0 107.032 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 60.0 p -147.81 166.28 28.04 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 123.918 0.761 . . . . 25.0 109.45 -177.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 22.0 m -117.64 166.81 11.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 107.629 -1.248 . . . . 25.0 107.629 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.8 t -74.66 -55.08 6.27 Favored 'General case' 0 C--O 1.216 -0.69 0 N-CA-C 106.828 -1.545 . . . . 25.0 106.828 169.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -159.6 -158.34 0.65 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 105.216 -2.142 . . . . 25.0 105.216 -176.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -61.15 -33.36 73.29 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 120.153 -0.619 . . . . 25.0 109.793 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -119.34 -148.51 8.3 Favored Glycine 0 C--O 1.244 0.77 0 N-CA-C 109.647 -1.381 . . . . 25.0 109.647 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.89 -144.18 0.53 Allowed 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 113.893 1.072 . . . . 25.0 113.893 177.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.9 mtt85 -82.33 167.29 18.71 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.994 0.902 . . . . 25.0 112.704 -171.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.86 161.43 18.25 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 105.524 -2.028 . . . . 25.0 105.524 171.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.431 ' CE2' ' HB2' ' A' ' 140' ' ' ALA . 31.8 m-85 -137.01 145.9 44.66 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 108.704 -0.85 . . . . 25.0 108.704 -177.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 43.0 tp -125.15 125.95 44.49 Favored 'General case' 0 C--O 1.257 1.499 0 N-CA-C 103.427 -2.805 . . . . 25.0 103.427 177.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -121.77 154.75 36.54 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.262 -0.881 . . . . 25.0 109.379 -173.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 37.6 t -99.47 155.42 17.57 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 106.023 -1.843 . . . . 25.0 106.023 169.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -122.38 13.71 10.29 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.834 0.35 . . . . 25.0 111.116 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -106.63 132.49 52.56 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 106.646 -1.612 . . . . 25.0 106.646 171.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -128.13 153.21 47.1 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-O 122.699 1.238 . . . . 25.0 109.08 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -79.51 165.5 22.94 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.692 -1.14 . . . . 25.0 111.198 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.94 -34.31 67.87 Favored 'General case' 0 C--O 1.21 -0.978 0 CA-C-O 122.218 1.009 . . . . 25.0 109.024 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -72.46 -2.34 19.17 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 115.25 1.574 . . . . 25.0 115.25 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.87 7.82 85.14 Favored Glycine 0 N--CA 1.471 1.012 0 CA-C-O 122.353 0.974 . . . . 25.0 113.15 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 41.3 mt -84.32 139.28 32.4 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.436 -1.038 . . . . 25.0 109.798 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 95.2 p -147.81 -179.55 6.98 Favored 'General case' 0 C--O 1.249 1.066 0 N-CA-C 107.351 -1.352 . . . . 25.0 107.351 -177.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -119.47 136.52 54.28 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.608 -0.837 . . . . 25.0 112.955 -178.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -147.74 148.7 31.26 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.876 -1.157 . . . . 25.0 107.876 167.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.3 p -145.33 148.28 17.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 105.381 -2.081 . . . . 25.0 105.381 175.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.431 ' HB2' ' CE2' ' A' ' 124' ' ' TYR . . . -108.44 148.13 30.62 Favored 'General case' 0 C--O 1.264 1.861 0 N-CA-C 108.593 -0.892 . . . . 25.0 108.593 -179.096 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.8 mp -139.0 124.07 18.95 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 105.067 -2.197 . . . . 25.0 105.067 -177.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.413 ' HG2' ' HA ' ' A' ' 85' ' ' LEU . 17.9 pt-20 -103.99 9.22 36.66 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 120.832 1.651 . . . . 25.0 113.625 -171.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -69.38 -16.34 71.31 Favored Glycine 0 N--CA 1.459 0.176 0 C-N-CA 120.515 -0.85 . . . . 25.0 112.805 175.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 31.2 t0 58.01 58.33 3.63 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 122.039 0.924 . . . . 25.0 111.982 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -124.26 42.02 3.35 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.394 -1.276 . . . . 25.0 109.229 -177.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.51 -34.48 72.66 Favored 'General case' 0 C--O 1.206 -1.234 0 N-CA-C 113.466 0.913 . . . . 25.0 113.466 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.49 -23.75 62.73 Favored 'General case' 0 C--O 1.254 1.293 0 CA-C-N 119.358 0.981 . . . . 25.0 112.067 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -89.84 -25.41 21.05 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 113.75 1.019 . . . . 25.0 113.75 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 11.8 mt -63.33 126.41 27.36 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.196 -0.911 . . . . 25.0 111.108 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 39.8 m -135.06 157.62 46.46 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 107.633 -1.247 . . . . 25.0 107.633 174.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.08 -2.56 24.92 Favored 'General case' 0 C--N 1.349 0.551 0 N-CA-C 112.656 0.613 . . . . 25.0 112.656 -176.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.27 -30.73 71.63 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.462 0.649 . . . . 25.0 110.115 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -90.22 0.67 57.09 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 112.619 0.6 . . . . 25.0 112.619 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 34.7 mm -105.33 122.87 59.17 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 N-CA-C 103.985 -2.598 . . . . 25.0 103.985 175.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 14.8 p -105.64 119.98 55.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 O-C-N 120.885 -1.134 . . . . 25.0 113.611 -176.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -148.84 18.51 1.0 Allowed 'General case' 0 C--O 1.243 0.759 0 CA-C-N 112.757 -2.02 . . . . 25.0 108.465 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -102.47 41.89 1.19 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.729 0.776 . . . . 25.0 111.187 -175.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 55.22 25.79 7.71 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 114.431 1.271 . . . . 25.0 114.431 -173.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.8 m 64.75 -10.63 0.15 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.581 1.696 . . . . 25.0 115.581 176.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -72.35 139.98 48.21 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.761 -1.212 . . . . 25.0 109.389 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -91.4 4.78 51.62 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.748 -0.66 . . . . 25.0 110.465 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.03 16.66 0.12 Allowed 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.639 0.776 . . . . 25.0 112.994 177.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -144.02 -158.32 0.87 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 107.913 -1.143 . . . . 25.0 107.913 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 60.58 178.69 0.1 Allowed 'General case' 0 CA--C 1.555 1.144 0 N-CA-C 114.333 1.234 . . . . 25.0 114.333 176.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.74 24.17 75.02 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 115.876 -0.602 . . . . 25.0 112.898 -176.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -91.26 114.72 27.32 Favored 'General case' 0 C--N 1.316 -0.858 0 O-C-N 122.399 -0.471 . . . . 25.0 112.168 -175.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.48 144.08 48.9 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.309 0.576 . . . . 25.0 109.624 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -145.92 33.55 1.5 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.894 -0.882 . . . . 25.0 110.894 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.3 t -93.85 -29.79 4.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 113.288 0.847 . . . . 25.0 113.288 -172.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.01 132.82 27.86 Favored 'Isoleucine or valine' 0 C--O 1.248 0.98 0 CA-C-N 115.337 -0.847 . . . . 25.0 112.229 -174.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 168.58 159.61 14.61 Favored Glycine 0 N--CA 1.48 1.597 0 N-CA-C 110.227 -1.149 . . . . 25.0 110.227 175.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -147.68 146.71 29.39 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 119.264 1.532 . . . . 25.0 112.161 -176.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 93.1 p -155.22 174.71 14.82 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 106.217 -1.771 . . . . 25.0 106.217 177.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -177.52 167.21 38.11 Favored Glycine 0 C--N 1.309 -0.936 0 C-N-CA 120.104 -1.046 . . . . 25.0 114.854 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 11.9 tp-100 -146.12 81.03 9.93 Favored Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 108.229 -1.026 . . . . 25.0 108.229 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -70.6 151.66 64.41 Favored 'Trans proline' 0 CA--C 1.509 -0.736 0 C-N-CA 121.054 1.17 . . . . 25.0 113.071 -173.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -107.38 147.32 30.51 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.413 -0.812 . . . . 25.0 111.004 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -144.76 75.57 14.45 Favored Pre-proline 0 C--N 1.312 -1.045 0 O-C-N 124.191 0.932 . . . . 25.0 110.414 177.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -72.97 169.62 21.74 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 121.587 1.525 . . . . 25.0 113.255 -175.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.5 t -120.02 2.46 10.97 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 116.417 -0.356 . . . . 25.0 110.358 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 C--O 1.249 1.059 0 CA-C-O 116.707 -1.616 . . . . 25.0 110.817 -178.605 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 CA--C 1.542 0.904 0 N-CA-C 113.877 0.683 . . . . 25.0 113.877 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.79 59.69 0.03 OUTLIER Glycine 0 CA--C 1.524 0.612 0 C-N-CA 121.052 -0.594 . . . . 25.0 111.816 -176.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.8 p -63.9 132.82 29.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 121.734 0.778 . . . . 25.0 110.05 -173.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -91.02 -15.4 29.68 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 119.622 -0.831 . . . . 25.0 110.789 -178.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.28 -147.13 3.87 Favored Glycine 0 C--O 1.207 -1.55 0 N-CA-C 115.952 1.141 . . . . 25.0 115.952 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.7 p 77.96 156.9 0.15 Allowed Pre-proline 0 CA--C 1.558 1.274 0 C-N-CA 126.832 2.053 . . . . 25.0 110.408 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.659 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 50.1 Cg_exo -62.55 -3.36 4.25 Favored 'Trans proline' 0 C--N 1.362 1.249 0 N-CA-C 117.761 2.177 . . . . 25.0 117.761 -175.012 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.6 p -63.65 -17.67 20.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 114.757 1.391 . . . . 25.0 114.757 -173.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.5 p -142.44 140.95 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-O 122.554 1.168 . . . . 25.0 113.373 -178.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.32 16.03 80.9 Favored Glycine 0 C--O 1.226 -0.344 0 N-CA-C 118.248 2.059 . . . . 25.0 118.248 175.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.2 t -46.21 -58.96 3.2 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 114.15 1.167 . . . . 25.0 114.15 -175.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -78.24 3.14 16.14 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 116.076 1.88 . . . . 25.0 116.076 -169.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.28 171.82 13.62 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.456 -0.778 . . . . 25.0 111.82 -172.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -58.9 135.32 57.52 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.149 0.58 . . . . 25.0 112.534 -177.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -128.52 163.35 25.15 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 113.537 0.94 . . . . 50.0 113.537 -174.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -136.53 108.66 7.22 Favored 'General case' 0 C--O 1.255 1.348 0 N-CA-C 101.683 -3.451 . . . . 25.0 101.683 161.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 89.7 mt -126.0 126.13 43.8 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.909 0.861 . . . . 25.0 110.46 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -114.69 134.6 54.95 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 107.507 -1.294 . . . . 25.0 107.507 178.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -106.14 178.39 22.75 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 115.294 0.878 . . . . 25.0 115.294 -173.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.5 p -79.86 175.41 10.65 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-O 121.856 0.836 . . . . 25.0 112.558 178.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 39.0 mt -83.6 10.54 8.91 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 113.25 0.833 . . . . 25.0 113.25 176.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.07 178.35 25.63 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 123.073 0.368 . . . . 25.0 112.208 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.2 t -74.68 128.66 36.11 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.888 0.475 . . . . 25.0 110.92 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -143.96 151.18 39.41 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.006 0.431 . . . . 50.0 110.542 -174.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -94.36 125.59 39.09 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 102.546 -3.131 . . . . 25.0 102.546 168.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.3 mm -119.02 103.86 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.018 0 N-CA-C 107.257 -1.386 . . . . 25.0 107.257 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.659 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 9.8 mp -100.69 131.55 46.53 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 104.06 -2.57 . . . . 25.0 104.06 177.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.86 -29.83 14.63 Favored Glycine 0 C--N 1.313 -0.745 0 CA-C-N 114.907 -1.042 . . . . 25.0 113.086 176.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.04 -148.7 50.63 Favored Glycine 0 N--CA 1.466 0.685 0 C-N-CA 120.293 -0.956 . . . . 25.0 112.278 -178.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.7 170.68 52.57 Favored Glycine 0 C--O 1.247 0.929 0 CA-C-N 118.219 1.01 . . . . 25.0 113.096 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.25 162.51 23.84 Favored Glycine 0 C--O 1.256 1.525 0 O-C-N 124.035 0.491 . . . . 25.0 114.225 176.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.08 108.58 11.47 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 106.678 -1.601 . . . . 25.0 106.678 177.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -107.57 149.33 28.15 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.992 -0.744 . . . . 50.0 108.992 -173.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -116.61 105.14 12.11 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 106.856 -1.535 . . . . 25.0 106.856 171.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 80.8 mt -111.37 129.11 56.11 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.58 -0.736 . . . . 25.0 112.568 -170.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -125.11 102.48 7.51 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-O 121.802 0.81 . . . . 25.0 110.449 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.45 -29.43 61.87 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-O 118.742 -1.032 . . . . 25.0 115.204 -176.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 53.54 -156.11 0.2 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.09 0.956 . . . . 25.0 112.461 -177.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.19 166.77 9.19 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.098 -1.001 . . . . 25.0 112.767 -175.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.29 160.0 34.26 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 108.239 -1.944 . . . . 25.0 108.239 -176.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -85.73 106.36 16.93 Favored 'General case' 0 C--O 1.251 1.151 0 O-C-N 122.125 -0.633 . . . . 25.0 109.387 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -109.43 144.4 37.71 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.84 -0.744 . . . . 50.0 111.677 -168.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 mp -105.65 92.89 4.37 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.274 -0.876 . . . . 25.0 108.873 177.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 mp -97.3 113.98 25.68 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-O 121.894 0.854 . . . . 25.0 111.783 -174.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -117.41 94.76 4.68 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 106.709 -1.589 . . . . 25.0 106.709 178.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -57.2 -20.53 36.03 Favored Glycine 0 N--CA 1.473 1.133 0 CA-C-O 118.478 -1.179 . . . . 25.0 115.198 -175.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.98 -168.86 49.73 Favored Glycine 0 C--O 1.249 1.06 0 CA-C-N 119.163 1.482 . . . . 25.0 110.531 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.74 153.07 11.22 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 114.805 -0.697 . . . . 25.0 112.49 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.82 177.1 45.31 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.588 -0.733 . . . . 25.0 111.876 178.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -97.34 132.24 43.26 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 105.779 -1.934 . . . . 25.0 105.779 176.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -125.62 159.78 31.29 Favored 'General case' 0 CA--C 1.485 -1.542 0 CA-C-O 118.851 -0.595 . . . . 50.0 110.743 -172.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -121.67 121.97 38.55 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 103.399 -2.815 . . . . 25.0 103.399 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -146.73 131.4 17.87 Favored 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 116.402 2.001 . . . . 25.0 116.402 -167.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 27.5 m -100.54 141.45 33.37 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.33 0.586 . . . . 25.0 112.26 176.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.96 -35.09 5.2 Favored Glycine 0 C--O 1.206 -1.597 0 O-C-N 121.499 -0.751 . . . . 25.0 111.887 177.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.92 -167.91 50.66 Favored Glycine 0 C--O 1.245 0.83 0 O-C-N 121.644 -0.915 . . . . 25.0 113.776 -177.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -59.83 161.51 6.33 Favored 'General case' 0 C--O 1.251 1.156 0 O-C-N 121.204 -1.174 . . . . 25.0 110.672 176.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.76 167.3 36.31 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 115.215 -0.902 . . . . 25.0 113.195 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.82 93.9 9.62 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 122.102 0.953 . . . . 25.0 110.931 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.14 153.44 22.06 Favored 'General case' 0 C--O 1.247 0.927 0 CA-C-N 115.302 -0.863 . . . . 50.0 111.651 -170.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.453 HG22 ' HG3' ' A' ' 65' ' ' ARG . 24.3 m -125.27 116.52 22.08 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 122.314 1.055 . . . . 25.0 109.685 178.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -104.38 102.55 12.21 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.714 -1.217 . . . . 25.0 107.714 177.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.453 ' HG3' HG22 ' A' ' 63' ' ' THR . 97.1 mtt180 -106.75 -23.14 12.5 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 113.541 0.941 . . . . 25.0 113.541 -177.239 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 67.79 160.46 0.17 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.508 1.523 . . . . 25.0 112.13 -176.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.72 -45.49 14.36 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 115.345 1.609 . . . . 25.0 115.345 -168.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 65.4 mt -139.23 169.56 17.54 Favored 'General case' 0 C--O 1.207 -1.137 0 CA-C-O 121.43 0.633 . . . . 25.0 111.925 -174.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.78 -23.95 32.84 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.273 0.629 . . . . 25.0 110.76 171.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -80.35 -6.63 58.3 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.307 1.043 . . . . 25.0 113.745 -177.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -90.13 152.77 20.97 Favored 'General case' 0 C--O 1.213 -0.831 0 N-CA-C 113.658 0.984 . . . . 25.0 113.658 176.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.8 t 45.14 48.77 9.86 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.702 1.601 . . . . 25.0 113.807 165.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -135.83 165.8 24.77 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 115.178 -0.919 . . . . 25.0 111.162 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 59.2 ttt180 -112.89 136.42 52.56 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 105.375 -2.083 . . . . 25.0 105.375 176.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 81.2 p -126.28 171.17 8.29 Favored Pre-proline 0 C--N 1.325 -0.467 0 C-N-CA 125.023 1.329 . . . . 25.0 108.167 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.22 -24.6 68.04 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 117.828 -0.981 . . . . 25.0 113.618 177.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 38.1 mt -71.89 -27.31 62.75 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 112.997 0.739 . . . . 25.0 112.997 177.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 145.56 -176.41 24.57 Favored Glycine 0 C--O 1.213 -1.195 0 N-CA-C 111.019 -0.832 . . . . 25.0 111.019 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 15.2 t -86.07 146.32 26.68 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 122.817 1.294 . . . . 25.0 112.6 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -127.28 28.7 5.68 Favored 'General case' 0 C--O 1.246 0.896 0 C-N-CA 125.432 1.493 . . . . 25.0 107.316 169.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -62.22 143.9 48.88 Favored Glycine 0 C--N 1.34 0.802 0 N-CA-C 110.57 -1.012 . . . . 25.0 110.57 178.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -92.05 163.11 14.09 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 120.277 -0.569 . . . . 50.0 110.944 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.75 110.06 15.01 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.178 0.299 . . . . 25.0 110.485 -175.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 30.3 mt -91.7 136.59 24.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.094 -1.076 . . . . 25.0 108.094 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.6 mt -83.64 -42.8 16.28 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 114.457 1.281 . . . . 25.0 114.457 -172.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 47.3 p-10 -137.86 38.82 2.38 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.46 1.282 . . . . 25.0 114.46 -169.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -56.24 139.06 49.16 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.041 0.386 . . . . 25.0 112.041 -177.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -116.16 101.52 53.87 Favored Pre-proline 0 C--O 1.248 0.98 0 N-CA-C 108.012 -1.107 . . . . 25.0 108.012 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.03 -9.16 25.59 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 N-CA-C 114.643 0.978 . . . . 25.0 114.643 -172.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.6 t -80.41 -45.02 18.35 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-O 121.228 0.537 . . . . 25.0 109.724 177.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -95.91 -39.23 9.9 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 115.006 1.484 . . . . 25.0 115.006 -173.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -89.3 173.06 8.6 Favored 'General case' 0 C--O 1.218 -0.585 0 CA-C-N 115.837 -0.619 . . . . 75.0 110.542 -167.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -151.77 152.85 33.23 Favored 'General case' 0 C--O 1.26 1.652 0 CA-C-N 116.214 -0.448 . . . . 25.0 110.509 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 45.6 mt -129.03 132.04 67.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 109.346 -0.613 . . . . 25.0 109.346 -178.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -84.85 150.61 24.88 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 123.039 1.399 . . . . 25.0 108.831 174.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.2 p -150.17 -9.5 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.333 0 O-C-N 121.18 -0.95 . . . . 25.0 112.155 176.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.437 ' HB2' ' HA ' ' A' ' 156' ' ' PHE . 31.5 t -61.15 -47.16 87.48 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.657 0.741 . . . . 25.0 109.731 -175.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.29 -43.15 67.7 Favored 'General case' 0 C--O 1.251 1.158 0 N-CA-C 114.451 1.278 . . . . 25.0 114.451 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.47 -3.87 20.45 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 116.094 1.887 . . . . 25.0 116.094 -169.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -139.77 -72.53 0.04 OUTLIER Glycine 0 CA--C 1.533 1.185 0 N-CA-C 118.312 2.085 . . . . 25.0 118.312 -176.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -158.05 170.61 21.91 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 119.058 1.429 . . . . 25.0 109.543 -175.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.9 t -121.45 -33.54 3.62 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 112.453 0.538 . . . . 25.0 112.453 172.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -91.89 129.1 9.67 Favored Glycine 0 N--CA 1.466 0.694 0 O-C-N 120.754 -1.217 . . . . 25.0 110.309 177.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -69.61 148.25 49.61 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 118.374 1.087 . . . . 25.0 111.645 -177.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -81.67 -167.9 39.83 Favored Glycine 0 C--O 1.223 -0.572 0 CA-C-N 115.894 -0.594 . . . . 25.0 112.375 -176.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -79.53 70.5 6.0 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.305 0.854 . . . . 25.0 113.305 -176.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -105.69 -168.29 23.51 Favored Glycine 0 C--O 1.211 -1.282 0 N-CA-C 107.873 -2.091 . . . . 25.0 107.873 172.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -138.26 164.54 28.97 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 120.023 1.912 . . . . 25.0 109.425 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 54.78 35.63 24.54 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 122.944 0.498 . . . . 25.0 111.563 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.09 39.57 73.04 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 120.64 -1.288 . . . . 25.0 112.312 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 8.4 t -135.6 -178.75 5.26 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 117.778 0.789 . . . . 25.0 109.82 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 85.2 mt -101.07 164.88 11.59 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 102.149 -3.278 . . . . 25.0 102.149 173.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.04 111.95 10.79 Favored 'General case' 0 C--O 1.267 1.996 0 CA-C-O 123.119 1.438 . . . . 25.0 107.32 -178.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.8 m -70.25 153.11 8.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 N-CA-C 108.348 -0.982 . . . . 25.0 108.348 -176.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.39 162.29 33.46 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.852 -1.155 . . . . 25.0 110.526 -175.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.7 m -127.65 161.92 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 108.631 -0.878 . . . . 25.0 108.631 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.6 t -82.03 -50.75 8.74 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 105.67 -1.974 . . . . 25.0 105.67 172.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -166.21 -162.84 0.56 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 100.666 -3.827 . . . . 25.0 100.666 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -67.28 -19.21 65.46 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 109.258 -0.645 . . . . 25.0 109.258 -178.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -119.81 -153.01 9.15 Favored Glycine 0 C--O 1.238 0.393 0 N-CA-C 111.115 -0.794 . . . . 25.0 111.115 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 56.91 -132.23 1.48 Allowed 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 112.806 0.669 . . . . 25.0 112.806 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.4 mtt85 -103.5 157.42 17.05 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.425 0.898 . . . . 25.0 113.425 -173.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.31 158.66 16.47 Favored 'General case' 0 C--O 1.253 1.249 0 N-CA-C 105.952 -1.87 . . . . 25.0 105.952 171.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -130.1 160.05 34.91 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.39 -0.967 . . . . 25.0 108.39 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 30.5 tp -132.87 102.81 5.78 Favored 'General case' 0 C--O 1.216 -0.684 0 N-CA-C 103.132 -2.914 . . . . 25.0 103.132 171.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -103.77 151.93 22.47 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.353 0.597 . . . . 25.0 109.947 -172.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 41.5 t -92.03 154.74 18.57 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 104.225 -2.509 . . . . 25.0 104.225 171.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -126.76 26.33 6.23 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 122.874 1.321 . . . . 25.0 108.415 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -117.14 147.07 42.76 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 103.592 -2.744 . . . . 25.0 103.592 171.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -149.16 151.52 34.49 Favored 'General case' 0 C--O 1.217 -0.654 0 O-C-N 124.158 0.911 . . . . 25.0 110.662 -175.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -77.09 164.58 25.57 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 124.091 0.957 . . . . 25.0 110.033 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.11 -19.72 64.86 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.742 -0.599 . . . . 25.0 112.181 -175.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -75.99 -9.02 58.27 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 122.526 0.331 . . . . 25.0 111.543 176.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 92.2 14.07 56.53 Favored Glycine 0 C--O 1.219 -0.805 0 CA-C-O 121.963 0.757 . . . . 25.0 112.573 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.0 mt -83.92 137.48 33.63 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 121.323 -1.104 . . . . 25.0 109.663 178.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 84.4 p -145.73 174.48 11.17 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.482 -0.562 . . . . 25.0 109.482 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -115.95 141.6 47.89 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 118.273 0.488 . . . . 25.0 111.649 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -150.93 156.42 41.15 Favored 'General case' 0 C--O 1.251 1.145 0 N-CA-C 106.343 -1.725 . . . . 25.0 106.343 169.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 13.4 p -146.96 147.69 17.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 104.933 -2.247 . . . . 25.0 104.933 173.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -107.59 141.95 38.27 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.018 -1.475 . . . . 25.0 107.018 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.2 mp -131.39 125.24 32.12 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 103.363 -2.828 . . . . 25.0 103.363 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -104.87 15.22 28.2 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 120.395 -1.441 . . . . 25.0 111.698 -173.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -83.95 4.41 82.93 Favored Glycine 0 C--O 1.241 0.57 0 CA-C-N 114.994 -1.003 . . . . 25.0 114.732 177.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 28.2 t0 49.34 47.04 22.78 Favored 'General case' 0 C--O 1.252 1.202 0 N-CA-C 114.586 1.328 . . . . 25.0 114.586 175.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -122.88 41.08 3.54 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.24 -0.891 . . . . 25.0 111.272 -175.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.67 -29.62 64.78 Favored 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 113.685 0.994 . . . . 25.0 113.685 173.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.99 -17.77 62.63 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 119.506 1.048 . . . . 25.0 110.371 -177.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -102.1 -8.48 21.37 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 113.341 0.867 . . . . 25.0 113.341 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.9 mt -79.37 133.66 36.58 Favored 'General case' 0 C--O 1.207 -1.161 0 C-N-CA 120.33 -0.548 . . . . 25.0 109.806 -176.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.0 m -141.32 165.81 26.5 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 106.932 -1.507 . . . . 25.0 106.932 172.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -81.79 4.02 23.68 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 121.733 0.778 . . . . 25.0 109.865 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -66.37 -31.31 72.0 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.119 -1.4 . . . . 25.0 110.656 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -94.16 0.35 55.73 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 112.14 0.422 . . . . 25.0 112.14 177.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 26.3 mm -99.33 123.45 52.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 N-CA-C 104.329 -2.471 . . . . 25.0 104.329 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.1 p -100.71 119.36 48.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 122.592 1.187 . . . . 25.0 113.281 -172.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.437 ' HA ' ' HB2' ' A' ' 97' ' ' SER . 9.3 p90 -149.63 -12.25 0.29 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 112.835 -1.984 . . . . 25.0 111.567 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.43 53.01 2.37 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 121.086 -1.009 . . . . 25.0 113.231 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 60.42 25.98 15.55 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 115.857 1.799 . . . . 25.0 115.857 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 m 65.63 -45.13 0.38 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 117.887 2.551 . . . . 25.0 117.887 177.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.19 120.13 13.25 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 121.439 -0.788 . . . . 25.0 110.44 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -79.14 31.09 0.21 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.439 0.903 . . . . 25.0 113.439 -174.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.62 -2.8 15.48 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 112.756 0.65 . . . . 25.0 112.756 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -151.52 -176.42 5.59 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 123.793 0.683 . . . . 25.0 110.596 -176.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 63.72 -166.65 0.22 Allowed 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 114.026 1.121 . . . . 25.0 114.026 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.36 25.89 67.2 Favored Glycine 0 CA--C 1.535 1.322 0 N-CA-C 111.372 -0.691 . . . . 25.0 111.372 -177.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -92.54 134.49 34.93 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.668 -0.864 . . . . 25.0 108.668 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -129.39 141.04 51.15 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 107.704 -1.221 . . . . 25.0 107.704 176.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -126.85 38.38 2.19 Favored Glycine 0 N--CA 1.464 0.501 0 CA-C-O 122.371 0.984 . . . . 25.0 111.26 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 26.3 t -84.25 -28.5 7.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 O-C-N 121.945 -0.738 . . . . 25.0 110.546 -174.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.39 133.18 24.78 Favored 'Isoleucine or valine' 0 C--O 1.26 1.607 0 CA-C-O 122.872 1.32 . . . . 25.0 111.071 -178.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 164.99 156.72 9.21 Favored Glycine 0 C--O 1.239 0.441 0 CA-C-N 115.076 -0.966 . . . . 25.0 112.277 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -151.02 142.81 23.78 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 121.621 -0.929 . . . . 25.0 110.482 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 59.0 p -149.96 163.53 37.85 Favored 'General case' 0 C--O 1.248 1.003 0 N-CA-C 106.484 -1.673 . . . . 25.0 106.484 176.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.53 -174.33 40.44 Favored Glycine 0 C--O 1.246 0.859 0 C-N-CA 120.415 -0.898 . . . . 25.0 114.322 176.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -154.4 86.39 3.65 Favored Pre-proline 0 C--O 1.252 1.198 0 C-N-CA 123.449 0.699 . . . . 25.0 109.533 -178.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -69.28 160.55 49.39 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 117.703 -1.065 . . . . 25.0 112.568 -176.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -131.16 155.27 47.3 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 124.446 1.091 . . . . 25.0 108.066 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -141.43 80.49 16.33 Favored Pre-proline 0 C--O 1.245 0.819 0 CA-C-N 118.387 0.539 . . . . 25.0 112.088 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.74 135.53 28.35 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 118.169 -0.754 . . . . 25.0 112.146 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.9 t -88.81 -4.41 58.5 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 112.822 0.675 . . . . 25.0 112.822 -177.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 3.7 p . . . . . 0 C--O 1.254 1.297 0 CA-C-O 118.213 -0.898 . . . . 25.0 109.671 179.959 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo . . . . . 0 CA--C 1.541 0.832 0 CA-C-O 121.358 0.482 . . . . 25.0 113.215 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.14 49.32 0.08 OUTLIER Glycine 0 N--CA 1.473 1.157 0 N-CA-C 110.961 -0.855 . . . . 25.0 110.961 178.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.42 HG22 ' H ' ' A' ' 7' ' ' GLY . 2.9 p -55.41 132.06 18.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 123.657 0.783 . . . . 25.0 112.048 -176.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -98.06 -2.05 41.11 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.366 -0.834 . . . . 25.0 110.302 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.42 ' H ' HG22 ' A' ' 5' ' ' VAL . . . -85.03 -145.11 7.32 Favored Glycine 0 C--O 1.206 -1.624 0 CA-C-N 116.032 -0.531 . . . . 25.0 113.336 177.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.0 p 67.76 153.97 0.13 Allowed Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 126.006 1.723 . . . . 25.0 112.672 -173.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.618 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 47.0 Cg_exo -61.91 -3.91 4.25 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.74 2.293 . . . . 25.0 116.148 -178.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.3 p -63.66 -16.63 18.68 Favored 'Isoleucine or valine' 0 C--O 1.248 0.986 0 N-CA-C 116.85 2.167 . . . . 25.0 116.85 -167.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.8 p -143.82 131.76 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 113.341 0.867 . . . . 25.0 113.341 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.87 19.88 56.9 Favored Glycine 0 N--CA 1.469 0.855 0 N-CA-C 117.592 1.797 . . . . 25.0 117.592 176.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.9 t -47.68 -56.76 6.58 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 117.985 0.893 . . . . 25.0 112.346 -176.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -75.19 -1.99 25.84 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 115.496 1.665 . . . . 25.0 115.496 -170.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -137.57 174.64 10.38 Favored 'General case' 0 C--O 1.207 -1.158 0 CA-C-N 116.234 -0.439 . . . . 25.0 111.784 -171.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.27 144.1 47.28 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-O 122.276 1.036 . . . . 25.0 109.135 -175.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -131.06 150.25 52.23 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 114.632 -1.167 . . . . 50.0 113.018 -176.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -131.22 105.03 7.4 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 100.541 -3.874 . . . . 25.0 100.541 165.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 89.0 mt -127.95 132.72 49.22 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 109.734 -0.469 . . . . 25.0 109.734 -175.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -120.0 115.9 24.67 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.272 -1.381 . . . . 25.0 107.272 -178.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -80.5 176.38 54.67 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 116.554 1.382 . . . . 25.0 116.554 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.5 p -82.33 175.8 9.96 Favored 'General case' 0 C--O 1.251 1.132 0 C-N-CA 124.349 1.06 . . . . 25.0 110.582 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 82.3 mt -80.65 4.46 18.63 Favored 'General case' 0 N--CA 1.463 0.198 0 O-C-N 121.99 -0.443 . . . . 25.0 111.334 174.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -95.85 -176.0 36.66 Favored Glycine 0 C--O 1.226 -0.39 0 CA-C-O 121.374 0.43 . . . . 25.0 112.063 -178.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.6 t -82.12 131.1 35.24 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 109.18 -0.674 . . . . 25.0 109.18 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -145.57 159.89 42.45 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.756 0.788 . . . . 50.0 109.203 -177.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -100.82 131.94 46.46 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 104.773 -2.306 . . . . 25.0 104.773 165.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.4 mm -120.29 103.75 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 N-CA-C 106.736 -1.579 . . . . 25.0 106.736 178.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.618 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 5.3 mp -105.78 128.39 53.68 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 104.427 -2.435 . . . . 25.0 104.427 -178.173 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.95 -32.19 11.2 Favored Glycine 0 C--N 1.307 -1.049 0 N-CA-C 117.447 1.739 . . . . 25.0 117.447 -177.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.91 -147.14 49.18 Favored Glycine 0 C--O 1.243 0.659 0 CA-C-N 118.934 1.367 . . . . 25.0 111.944 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.95 175.61 50.25 Favored Glycine 0 C--O 1.244 0.768 0 O-C-N 121.734 -0.862 . . . . 25.0 112.837 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.26 160.73 12.51 Favored Glycine 0 C--O 1.256 1.529 0 C-N-CA 120.329 -0.939 . . . . 25.0 111.523 175.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.7 113.02 20.99 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 105.565 -2.013 . . . . 25.0 105.565 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -105.0 154.08 20.59 Favored 'General case' 0 C--O 1.251 1.156 0 N-CA-C 113.211 0.819 . . . . 50.0 113.211 -172.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -121.36 92.61 3.79 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 107.093 -1.447 . . . . 25.0 107.093 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 34.5 mt -108.3 137.3 46.49 Favored 'General case' 0 C--O 1.203 -1.364 0 N-CA-C 114.455 1.28 . . . . 25.0 114.455 -169.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -131.71 117.6 18.84 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.299 0.571 . . . . 25.0 111.719 -179.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -87.92 -24.7 34.27 Favored Glycine 0 C--O 1.245 0.831 0 CA-C-O 117.247 -1.863 . . . . 25.0 116.78 -178.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 53.14 -153.36 0.25 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.978 1.389 . . . . 25.0 112.068 -177.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.71 167.22 15.74 Favored 'General case' 0 C--O 1.249 1.055 0 O-C-N 120.615 -1.303 . . . . 25.0 111.376 -178.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.5 158.52 31.67 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 114.993 -1.003 . . . . 25.0 111.606 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -85.71 94.29 9.07 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 107.385 -1.339 . . . . 25.0 107.385 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -99.38 159.83 14.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.175 -0.921 . . . . 50.0 110.588 -170.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 mp -120.38 106.37 11.79 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 108.529 -0.915 . . . . 25.0 108.529 174.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 mp -111.7 106.15 14.86 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 113.05 0.759 . . . . 25.0 113.05 -172.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -118.99 92.41 3.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.736 -1.12 . . . . 25.0 108.986 -177.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.38 -12.42 32.17 Favored Glycine 0 N--CA 1.467 0.719 0 N-CA-C 118.366 2.106 . . . . 25.0 118.366 -177.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 61.48 -162.45 24.76 Favored Glycine 0 N--CA 1.462 0.399 0 CA-C-N 119.546 1.673 . . . . 25.0 113.853 177.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.69 158.86 1.21 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 114.227 1.195 . . . . 25.0 114.227 -177.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.93 179.46 51.78 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 115.138 -0.937 . . . . 25.0 112.809 -177.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.79 141.62 29.03 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 101.498 -3.519 . . . . 25.0 101.498 176.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -133.53 158.12 43.93 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.57 -0.9 . . . . 50.0 108.57 -175.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -124.01 120.09 31.42 Favored 'General case' 0 C--O 1.212 -0.906 0 N-CA-C 107.766 -1.198 . . . . 25.0 107.766 173.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -141.64 132.48 25.84 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 115.644 1.72 . . . . 25.0 115.644 -169.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 63.9 m -95.22 140.98 29.36 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 123.278 0.631 . . . . 25.0 109.752 175.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.39 -39.18 4.54 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 107.9 -2.08 . . . . 25.0 107.9 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.03 -164.38 52.87 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 117.997 0.898 . . . . 25.0 113.387 -177.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.0 158.73 15.72 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.03 0.532 . . . . 25.0 110.202 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.97 157.85 26.24 Favored Glycine 0 N--CA 1.476 1.324 0 N-CA-C 111.502 -0.639 . . . . 25.0 111.502 175.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.0 110.91 8.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.627 1.203 . . . . 25.0 111.915 -176.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -104.86 155.22 19.12 Favored 'General case' 0 C--O 1.25 1.123 0 CA-C-N 114.625 -1.17 . . . . 50.0 109.505 -173.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 88.0 m -125.33 131.01 53.1 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.418 0.687 . . . . 25.0 110.444 -177.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -124.31 104.05 8.57 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 108.015 -1.105 . . . . 25.0 108.015 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 54.5 mtt85 -115.09 -16.59 11.59 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 121.669 -0.645 . . . . 25.0 111.531 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 62.44 164.22 0.1 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.692 1.597 . . . . 25.0 111.571 -175.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.15 -39.49 48.99 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 114.317 1.228 . . . . 25.0 114.317 -172.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.7 mt -135.37 164.81 26.91 Favored 'General case' 0 C--O 1.207 -1.149 0 C-N-CA 123.114 0.566 . . . . 25.0 112.341 -170.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -17.97 64.2 Favored 'General case' 0 C--O 1.209 -1.067 0 N-CA-C 108.386 -0.968 . . . . 25.0 108.386 170.191 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -82.53 6.06 18.74 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.811 1.041 . . . . 25.0 113.811 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -111.22 151.81 27.83 Favored 'General case' 0 C--O 1.213 -0.849 0 N-CA-C 115.798 1.777 . . . . 25.0 115.798 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.0 t 54.91 36.32 26.45 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 113.712 -1.586 . . . . 25.0 112.975 175.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 24.0 p-80 -121.05 167.65 12.39 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.869 -1.06 . . . . 25.0 112.507 -173.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 -123.44 140.99 52.44 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 106.748 -1.575 . . . . 25.0 106.748 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.6 p -133.94 173.29 6.01 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 107.949 -1.13 . . . . 25.0 107.949 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -61.39 -25.68 80.36 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 115.831 -2.313 . . . . 25.0 112.999 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 68.6 mt -68.77 -27.09 65.59 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.533 0.682 . . . . 25.0 111.916 -178.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.53 -173.83 32.94 Favored Glycine 0 CA--C 1.498 -0.995 0 N-CA-C 110.414 -1.074 . . . . 25.0 110.414 -177.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.1 t -100.41 148.02 25.19 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.487 1.137 . . . . 25.0 111.345 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -134.09 31.0 3.59 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 114.622 -1.172 . . . . 25.0 108.496 172.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.56 148.94 50.28 Favored Glycine 0 C--O 1.249 1.057 0 CA-C-N 114.085 -1.416 . . . . 25.0 109.578 176.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -91.8 167.18 12.34 Favored 'General case' 0 C--N 1.314 -0.961 0 O-C-N 121.888 -0.772 . . . . 50.0 110.133 -176.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -120.75 111.34 17.47 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.575 0.75 . . . . 25.0 109.989 -177.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.8 mt -97.32 129.36 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-O 121.676 0.75 . . . . 25.0 109.021 -177.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 81.4 mt -83.78 -41.71 17.29 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 115.717 1.747 . . . . 25.0 115.717 -170.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.4 p-10 -140.45 45.63 1.83 Allowed 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.755 1.391 . . . . 25.0 114.755 -176.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -55.83 129.92 41.42 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 122.241 1.02 . . . . 25.0 112.943 -178.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -91.97 105.11 12.39 Favored Pre-proline 0 C--O 1.246 0.872 0 CA-C-N 114.231 -1.35 . . . . 25.0 108.081 174.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.38 3.93 3.79 Favored 'Trans proline' 0 C--O 1.205 -1.143 0 N-CA-C 115.779 1.415 . . . . 25.0 115.779 -173.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.2 t -110.83 -43.8 3.74 Favored 'General case' 0 C--O 1.253 1.281 0 O-C-N 121.809 -0.557 . . . . 25.0 111.259 176.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -87.26 -38.66 16.11 Favored 'General case' 0 C--O 1.241 0.624 0 O-C-N 123.51 0.506 . . . . 25.0 110.58 -172.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -88.43 158.44 18.36 Favored 'General case' 0 CA--C 1.552 1.048 0 N-CA-C 112.271 0.471 . . . . 50.0 112.271 -170.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -137.81 147.89 45.0 Favored 'General case' 0 C--O 1.252 1.201 0 N-CA-C 113.859 1.059 . . . . 25.0 113.859 -175.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 68.2 mt -131.81 130.39 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 108.773 -0.825 . . . . 25.0 108.773 -175.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -90.05 147.44 23.65 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.047 -1.033 . . . . 25.0 108.927 171.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.0 p -141.35 -5.02 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 115.484 -0.78 . . . . 25.0 109.417 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.0 t -65.65 -41.96 91.94 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 121.294 0.569 . . . . 25.0 111.313 -170.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.91 -34.3 57.72 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 119.937 -0.705 . . . . 25.0 112.855 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.97 -3.25 18.98 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 116.502 2.038 . . . . 25.0 116.502 -169.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -142.58 -74.08 0.03 OUTLIER Glycine 0 C--O 1.214 -1.124 0 CA-C-O 119.256 -0.747 . . . . 25.0 114.561 -178.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -160.23 165.16 32.0 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 117.814 0.807 . . . . 25.0 112.007 -173.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.9 t -121.27 -10.9 8.88 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 121.0 0.429 . . . . 25.0 112.1 176.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.43 133.41 11.07 Favored Glycine 0 N--CA 1.467 0.722 0 N-CA-C 108.613 -1.795 . . . . 25.0 108.613 170.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.15 150.11 42.45 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-N 117.314 0.557 . . . . 25.0 112.172 -175.012 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -86.06 -177.7 49.96 Favored Glycine 0 C--O 1.223 -0.545 0 O-C-N 122.125 -0.36 . . . . 25.0 113.1 -174.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -63.81 101.15 0.34 Allowed 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.624 0.602 . . . . 25.0 112.624 -175.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -150.85 -165.62 12.94 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.006 -1.237 . . . . 25.0 110.006 175.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -148.43 165.88 29.8 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 119.645 1.722 . . . . 25.0 113.164 -177.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 58.94 33.97 23.35 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.464 1.283 . . . . 25.0 114.464 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 77.36 30.54 53.89 Favored Glycine 0 N--CA 1.465 0.617 0 C-N-CA 119.857 -1.163 . . . . 25.0 110.27 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.6 t -143.61 168.63 19.42 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 121.32 -1.106 . . . . 25.0 108.965 -178.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.8 mt -93.02 172.24 8.44 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 106.144 -1.799 . . . . 25.0 106.144 175.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.58 118.95 19.75 Favored 'General case' 0 C--O 1.254 1.323 0 CA-C-N 119.446 1.021 . . . . 25.0 110.099 177.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.8 m -87.85 159.15 3.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 109.45 -0.574 . . . . 25.0 109.45 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 99.4 p -147.0 163.69 35.42 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 108.77 -0.826 . . . . 25.0 108.77 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.5 m -126.02 165.89 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 N-CA-C 107.532 -1.284 . . . . 25.0 107.532 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.1 t -74.49 -49.32 22.65 Favored 'General case' 0 C--O 1.255 1.346 0 N-CA-C 104.251 -2.5 . . . . 25.0 104.251 173.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -168.8 -170.89 1.25 Allowed 'General case' 0 C--O 1.207 -1.133 1 N-CA-C 99.201 -4.37 . . . . 25.0 99.201 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -60.23 -20.46 58.95 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 119.175 0.898 . . . . 25.0 111.912 -178.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.22 -151.45 9.68 Favored Glycine 0 C--O 1.216 -1.02 0 N-CA-C 110.602 -0.999 . . . . 25.0 110.602 176.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 54.66 -133.75 1.66 Allowed 'General case' 0 N--CA 1.465 0.325 0 O-C-N 124.066 0.51 . . . . 25.0 112.094 -179.07 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 22.8 mtt85 -105.37 155.53 19.03 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 112.473 0.546 . . . . 25.0 112.473 -174.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.3 p -103.3 163.01 12.52 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.173 -2.528 . . . . 25.0 104.173 175.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.493 ' CE2' ' HB2' ' A' ' 140' ' ' ALA . 57.8 m-85 -141.33 149.86 41.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 118.63 0.65 . . . . 25.0 111.328 -176.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 55.8 tp -124.57 128.21 48.56 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 105.298 -2.112 . . . . 25.0 105.298 177.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -126.15 155.75 41.21 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 122.597 1.189 . . . . 25.0 112.218 -172.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 32.3 t -90.96 158.28 16.81 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 103.481 -2.785 . . . . 25.0 103.481 168.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -129.69 17.08 5.82 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 106.773 -1.566 . . . . 25.0 106.773 176.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -115.44 144.78 43.31 Favored 'General case' 0 C--O 1.25 1.125 0 CA-C-N 112.525 -2.125 . . . . 25.0 106.667 173.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -144.52 168.18 20.74 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.334 0.587 . . . . 25.0 110.18 -178.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -97.13 161.35 13.86 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.946 -1.131 . . . . 25.0 107.946 176.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.22 -26.72 68.64 Favored 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 109.647 -0.501 . . . . 25.0 109.647 -176.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -67.26 -7.16 22.06 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 112.929 0.715 . . . . 25.0 112.929 174.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.89 22.18 53.63 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 121.84 0.689 . . . . 25.0 113.404 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 78.1 mt -90.99 133.48 35.25 Favored 'General case' 0 CA--C 1.506 -0.728 0 O-C-N 121.899 -0.766 . . . . 25.0 109.951 177.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 66.3 p -141.43 -179.46 6.15 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.414 -1.328 . . . . 25.0 107.414 178.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -124.77 136.26 53.7 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 119.614 -0.232 . . . . 25.0 111.221 -178.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -149.15 152.53 36.24 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 106.622 -1.622 . . . . 25.0 106.622 166.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.5 p -144.63 144.65 21.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 105.004 -2.221 . . . . 25.0 105.004 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.493 ' HB2' ' CE2' ' A' ' 124' ' ' TYR . . . -105.54 142.98 34.35 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.963 -1.495 . . . . 25.0 106.963 -176.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.8 mp -130.77 132.66 45.42 Favored 'General case' 0 C--O 1.195 -1.81 0 N-CA-C 105.404 -2.073 . . . . 25.0 105.404 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -105.35 6.19 32.46 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 119.646 -1.909 . . . . 25.0 114.195 -174.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -87.34 8.66 76.12 Favored Glycine 0 CA--C 1.542 1.765 0 C-N-CA 120.753 -0.737 . . . . 25.0 113.415 -179.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 35.7 t0 43.98 57.36 4.2 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 114.7 1.371 . . . . 25.0 114.7 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -123.82 36.16 4.69 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-N 114.95 -1.023 . . . . 25.0 109.284 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.97 -33.32 68.74 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.348 -0.387 . . . . 25.0 112.027 174.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.36 -22.91 62.73 Favored 'General case' 0 C--O 1.255 1.374 0 O-C-N 121.297 -0.877 . . . . 25.0 112.442 178.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.5 -15.92 20.35 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 112.333 0.494 . . . . 25.0 112.333 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 12.9 mt -64.59 139.02 58.72 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 123.009 1.385 . . . . 25.0 112.265 176.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 57.8 m -143.52 154.7 43.89 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 106.66 -1.607 . . . . 25.0 106.66 177.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.05 -2.93 29.61 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.657 0.614 . . . . 25.0 112.657 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -67.0 -31.55 72.19 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 108.366 -0.975 . . . . 25.0 108.366 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -85.6 -5.03 59.32 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 120.377 -0.529 . . . . 25.0 112.309 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 48.3 mm -97.27 122.79 49.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 104.481 -2.414 . . . . 25.0 104.481 176.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.1 p -103.2 112.93 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-O 123.12 1.438 . . . . 25.0 113.568 -174.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -142.0 -7.21 0.94 Allowed 'General case' 0 C--O 1.251 1.158 0 CA-C-N 112.656 -2.066 . . . . 25.0 111.782 176.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -85.86 50.61 2.01 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.56 0.948 . . . . 25.0 113.56 -176.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 60.09 20.06 9.28 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.456 2.021 . . . . 25.0 116.456 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.0 -21.28 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 119.886 3.291 . . . . 25.0 119.886 174.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -70.0 139.8 52.82 Favored 'General case' 0 N--CA 1.444 -0.746 0 O-C-N 121.606 -0.684 . . . . 25.0 110.196 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -75.25 -1.83 25.27 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.462 0.912 . . . . 25.0 113.462 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.29 34.97 0.21 Allowed 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.883 0.849 . . . . 25.0 111.164 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -145.66 -171.59 3.72 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.267 -0.879 . . . . 25.0 108.921 -175.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 59.65 -168.98 0.15 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.632 1.573 . . . . 25.0 113.083 175.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 80.18 6.2 89.31 Favored Glycine 0 C--O 1.25 1.145 0 CA-C-O 121.682 0.601 . . . . 25.0 114.418 -173.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -81.86 69.73 8.61 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.868 0.867 . . . . 25.0 111.364 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -125.01 141.15 52.31 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 122.853 0.461 . . . . 25.0 111.297 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -142.67 44.76 0.95 Allowed Glycine 0 CA--C 1.527 0.784 0 O-C-N 124.222 0.951 . . . . 25.0 112.097 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 45.6 t -70.87 -37.26 67.67 Favored 'Isoleucine or valine' 0 C--O 1.251 1.143 0 O-C-N 121.758 -0.848 . . . . 25.0 111.684 -178.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.11 136.47 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-O 122.245 1.022 . . . . 25.0 111.645 -177.453 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 166.84 170.38 31.66 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 109.22 -1.552 . . . . 25.0 109.22 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -146.55 148.8 32.54 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.855 0.836 . . . . 25.0 110.721 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 95.2 p -158.42 169.93 23.35 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-N 114.782 -1.099 . . . . 25.0 110.169 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 150.58 167.12 14.19 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 116.289 1.276 . . . . 25.0 116.289 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -136.66 95.0 12.82 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 124.948 1.299 . . . . 25.0 107.618 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.86 158.29 57.97 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 119.809 0.339 . . . . 25.0 112.094 -178.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -114.03 154.75 27.15 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 107.951 -1.129 . . . . 25.0 107.951 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -127.2 67.88 71.55 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 115.574 -0.739 . . . . 25.0 110.818 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -72.15 158.19 52.55 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 CA-C-O 122.945 1.144 . . . . 25.0 112.25 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.2 t -132.48 27.52 4.39 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 105.828 -1.915 . . . . 25.0 105.828 172.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 C--O 1.25 1.115 0 CA-C-N 113.876 -1.511 . . . . 25.0 111.821 179.056 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo . . . . . 0 CA--C 1.515 -0.464 0 N-CA-C 113.531 0.55 . . . . 25.0 113.531 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.64 46.1 0.04 OUTLIER Glycine 0 N--CA 1.472 1.087 0 CA-C-O 117.539 -1.701 . . . . 25.0 110.474 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -51.67 120.89 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 O-C-N 125.592 1.407 . . . . 25.0 113.0 -176.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -92.29 -8.59 44.75 Favored 'General case' 0 C--O 1.259 1.557 0 CA-C-N 113.516 -1.675 . . . . 25.0 110.899 -173.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.01 -137.17 3.34 Favored Glycine 0 C--N 1.298 -1.567 0 O-C-N 124.01 0.819 . . . . 25.0 113.403 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.7 p 65.69 156.34 0.13 Allowed Pre-proline 0 N--CA 1.498 1.966 0 C-N-CA 126.225 1.81 . . . . 25.0 111.665 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.582 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 47.3 Cg_exo -64.23 -3.31 5.98 Favored 'Trans proline' 0 C--N 1.364 1.344 0 N-CA-C 118.17 2.335 . . . . 25.0 118.17 -177.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 p -68.74 -9.92 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 116.822 2.156 . . . . 25.0 116.822 -173.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.7 p -138.87 133.02 40.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 113.547 0.943 . . . . 25.0 113.547 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.11 15.8 74.66 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 118.093 1.997 . . . . 25.0 118.093 172.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 89.4 p -54.75 -35.21 63.51 Favored 'General case' 0 CA--C 1.565 1.549 0 O-C-N 120.776 -1.426 . . . . 25.0 113.815 -170.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -78.22 3.81 14.33 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 117.576 2.435 . . . . 25.0 117.576 -175.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.4 pp -149.98 177.64 9.67 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 123.181 0.592 . . . . 25.0 110.478 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -59.32 128.7 38.39 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 112.548 0.573 . . . . 25.0 112.548 -174.111 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -125.9 160.61 29.48 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 114.298 1.222 . . . . 50.0 114.298 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -124.24 97.39 5.3 Favored 'General case' 0 C--O 1.279 2.639 0 N-CA-C 106.237 -1.764 . . . . 25.0 106.237 159.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.4 mt -104.44 128.68 52.39 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.932 0.872 . . . . 25.0 112.691 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -115.67 120.47 39.48 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 109.114 -0.699 . . . . 25.0 109.114 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.83 173.88 40.35 Favored Glycine 0 N--CA 1.472 1.083 0 N-CA-C 120.238 2.855 . . . . 25.0 120.238 -178.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.5 p -71.72 174.42 6.84 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.521 1.153 . . . . 25.0 113.06 175.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.5 mt -93.5 16.85 12.61 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.483 -0.78 . . . . 25.0 109.904 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -119.24 -177.62 16.48 Favored Glycine 0 C--O 1.24 0.494 0 N-CA-C 109.479 -1.448 . . . . 25.0 109.479 174.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.7 t -68.45 133.92 49.36 Favored 'General case' 0 C--O 1.253 1.278 0 C-N-CA 123.347 0.659 . . . . 25.0 111.483 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -144.98 160.5 41.25 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.974 -1.121 . . . . 50.0 107.974 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -104.27 124.55 49.35 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 104.916 -2.253 . . . . 25.0 104.916 163.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.0 mm -114.84 128.65 71.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 N-CA-C 106.378 -1.712 . . . . 25.0 106.378 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.582 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 4.4 mp -126.9 124.46 39.6 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 102.942 -2.985 . . . . 25.0 102.942 178.461 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.32 -30.87 56.24 Favored Glycine 0 N--CA 1.483 1.777 0 N-CA-C 114.625 0.61 . . . . 25.0 114.625 176.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.5 -149.56 48.59 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 118.781 1.29 . . . . 25.0 111.352 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -79.14 170.43 54.57 Favored Glycine 0 C--N 1.298 -1.561 0 N-CA-C 109.362 -1.495 . . . . 25.0 109.362 -177.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.82 167.98 41.92 Favored Glycine 0 C--N 1.307 -1.032 0 N-CA-C 110.861 -0.896 . . . . 25.0 110.861 177.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.91 102.97 15.58 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.53 1.132 . . . . 25.0 108.319 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -102.78 147.25 27.09 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 122.589 1.185 . . . . 50.0 111.381 -167.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -118.16 92.29 3.79 Favored 'General case' 0 C--O 1.285 2.934 0 N-CA-C 107.477 -1.305 . . . . 25.0 107.477 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 23.3 mt -102.69 140.37 37.05 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.558 0.947 . . . . 25.0 113.558 -169.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -134.31 106.18 6.98 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.633 -0.877 . . . . 25.0 108.633 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.38 -17.75 63.79 Favored Glycine 0 N--CA 1.476 1.354 0 N-CA-C 115.86 1.104 . . . . 25.0 115.86 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 47.93 -149.64 0.16 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 119.335 1.568 . . . . 25.0 113.939 -177.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.98 163.1 25.36 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-N 115.633 -0.712 . . . . 25.0 112.918 -173.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.5 160.62 35.97 Favored Glycine 0 C--O 1.252 1.258 0 O-C-N 124.979 1.424 . . . . 25.0 113.672 -175.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -81.59 102.53 10.7 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.901 -1.148 . . . . 25.0 107.901 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -109.69 152.95 24.96 Favored 'General case' 0 CA--C 1.505 -0.754 0 C-N-CA 119.48 -0.888 . . . . 50.0 110.92 -169.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.44 120.79 43.15 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 105.15 -2.167 . . . . 25.0 105.15 177.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.8 mp -124.14 121.3 34.75 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.275 1.213 . . . . 25.0 114.275 -176.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -116.08 148.02 40.68 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 113.801 -1.545 . . . . 25.0 106.888 174.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.15 -34.32 4.87 Favored Glycine 0 N--CA 1.476 1.333 0 N-CA-C 116.173 1.229 . . . . 25.0 116.173 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.72 -171.38 53.5 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-O 123.593 1.663 . . . . 25.0 110.335 -177.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.28 149.64 16.01 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 114.253 -0.973 . . . . 25.0 112.422 -176.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.56 168.32 44.47 Favored Glycine 0 CA--C 1.496 -1.155 0 CA-C-O 118.31 -1.272 . . . . 25.0 111.723 -176.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.49 134.32 33.62 Favored 'General case' 0 C--O 1.209 -1.07 0 N-CA-C 101.637 -3.468 . . . . 25.0 101.637 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -123.1 157.71 32.25 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 109.655 -0.498 . . . . 50.0 109.655 -174.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -120.73 127.59 52.15 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 101.994 -3.336 . . . . 25.0 101.994 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -149.48 135.04 18.51 Favored 'General case' 0 C--O 1.2 -1.507 0 N-CA-C 116.493 2.034 . . . . 25.0 116.493 -174.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.2 m -99.55 145.6 27.33 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.995 -1.002 . . . . 25.0 110.228 171.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.92 -34.54 5.4 Favored Glycine 0 C--O 1.215 -1.076 0 N-CA-C 108.779 -1.728 . . . . 25.0 108.779 173.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.69 -165.1 53.56 Favored Glycine 0 C--O 1.217 -0.946 0 CA-C-O 122.009 0.783 . . . . 25.0 111.659 -177.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -71.16 156.06 40.02 Favored 'General case' 0 C--O 1.258 1.53 0 CA-C-O 121.938 0.875 . . . . 25.0 109.344 178.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.54 161.45 33.61 Favored Glycine 0 C--O 1.258 1.605 0 CA-C-O 117.982 -1.454 . . . . 25.0 110.121 -175.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.75 112.29 17.99 Favored 'General case' 0 C--O 1.2 -1.532 0 O-C-N 124.697 0.881 . . . . 25.0 109.428 177.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -104.15 153.4 20.98 Favored 'General case' 0 CA--C 1.487 -1.462 0 CA-C-N 116.58 -0.282 . . . . 50.0 110.901 -174.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 79.5 m -116.36 122.54 45.17 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 107.843 -1.169 . . . . 25.0 107.843 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -108.13 89.26 2.94 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 104.137 -2.542 . . . . 25.0 104.137 177.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -92.12 -25.84 18.55 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 114.822 -1.081 . . . . 25.0 111.626 -174.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 66.86 150.03 0.06 Allowed 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.477 1.511 . . . . 25.0 112.198 -175.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.65 -43.36 31.61 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 117.061 2.245 . . . . 25.0 117.061 -165.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.4 mt -142.9 173.57 11.43 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.572 -0.899 . . . . 25.0 108.572 -165.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.55 -30.23 69.64 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-N 115.179 -0.919 . . . . 25.0 110.125 167.166 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -78.17 -6.59 55.27 Favored 'General case' 0 C--O 1.263 1.796 0 N-CA-C 114.539 1.311 . . . . 25.0 114.539 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -90.59 151.17 21.43 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 121.209 -0.932 . . . . 25.0 109.499 -172.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.8 t 29.1 47.05 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 117.569 2.433 . . . . 25.0 117.569 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 -119.15 178.63 4.44 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.56 -0.746 . . . . 25.0 109.532 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -126.84 140.17 52.55 Favored 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 107.963 -1.125 . . . . 25.0 107.963 176.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 84.1 p -129.81 166.1 28.52 Favored Pre-proline 0 C--O 1.189 -2.108 0 N-CA-C 108.216 -1.031 . . . . 25.0 108.216 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -64.68 -24.58 62.25 Favored 'Trans proline' 0 C--O 1.243 0.735 0 C-N-CA 115.667 -2.422 . . . . 25.0 112.677 178.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 31.7 mt -65.64 -38.99 90.94 Favored 'General case' 0 C--O 1.201 -1.498 0 CA-C-O 121.826 0.822 . . . . 25.0 112.459 178.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 171.46 167.29 31.48 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 115.001 -1.0 . . . . 25.0 111.383 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.8 t -86.42 149.64 24.86 Favored 'General case' 0 C--N 1.353 0.751 0 CA-C-O 124.425 2.059 . . . . 25.0 110.855 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -132.83 28.09 4.24 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 112.337 -2.21 . . . . 25.0 111.355 175.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.74 140.41 36.59 Favored Glycine 0 N--CA 1.474 1.231 0 CA-C-O 122.31 0.95 . . . . 25.0 111.917 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -91.18 169.39 10.88 Favored 'General case' 0 C--O 1.249 1.067 0 O-C-N 119.884 -1.95 . . . . 50.0 111.998 -176.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -122.18 97.4 5.46 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.662 0.785 . . . . 25.0 110.936 -170.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 22.1 mt -84.41 132.7 30.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 N-CA-C 106.92 -1.511 . . . . 25.0 106.92 -178.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.448 ' HA ' ' HG2' ' A' ' 142' ' ' GLU . 90.4 mt -87.47 -43.81 11.78 Favored 'General case' 0 C--O 1.253 1.289 0 N-CA-C 115.774 1.768 . . . . 25.0 115.774 -172.024 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 54.0 p-10 -137.78 44.55 2.2 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.539 0.57 . . . . 25.0 112.539 -174.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -57.28 138.55 54.64 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.823 1.249 . . . . 25.0 111.971 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -106.16 105.5 54.02 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 106.807 -1.553 . . . . 25.0 106.807 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -68.05 -5.4 14.59 Favored 'Trans proline' 0 C--O 1.199 -1.427 0 N-CA-C 117.703 2.155 . . . . 25.0 117.703 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 37.7 t -99.87 -38.78 8.5 Favored 'General case' 0 CA--C 1.557 1.213 0 CA-C-O 120.815 0.341 . . . . 25.0 110.921 177.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -93.45 -42.3 9.33 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-N 116.668 -0.242 . . . . 25.0 111.578 -174.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -87.56 167.66 13.74 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 115.134 -0.939 . . . . 50.0 109.516 -170.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -139.99 151.11 45.23 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 122.977 0.511 . . . . 25.0 110.733 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 86.0 mt -124.93 133.71 68.78 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.596 0 N-CA-C 107.945 -1.131 . . . . 25.0 107.945 177.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -100.15 154.53 18.37 Favored 'General case' 0 C--O 1.212 -0.914 0 N-CA-C 107.896 -1.15 . . . . 25.0 107.896 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.8 p -154.33 2.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 121.467 -0.771 . . . . 25.0 111.448 -176.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 11.0 t -62.74 -45.97 90.26 Favored 'General case' 0 C--O 1.258 1.546 0 N-CA-C 115.464 1.653 . . . . 25.0 115.464 -173.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.63 -42.01 22.88 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.9 -0.591 . . . . 25.0 111.07 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.37 -8.32 48.33 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 117.136 2.273 . . . . 25.0 117.136 -172.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -140.44 -72.07 0.04 OUTLIER Glycine 0 C--N 1.337 0.613 0 N-CA-C 116.72 1.448 . . . . 25.0 116.72 -176.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -160.63 168.61 24.57 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 108.283 -1.006 . . . . 25.0 108.283 -176.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.0 t -127.73 -30.99 2.48 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.8 0.81 . . . . 25.0 111.925 175.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -94.06 121.36 6.65 Favored Glycine 0 CA--C 1.483 -1.968 0 N-CA-C 107.467 -2.253 . . . . 25.0 107.467 175.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.82 146.07 47.61 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.038 -0.581 . . . . 25.0 111.813 -178.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -102.68 -160.3 25.81 Favored Glycine 0 C--O 1.244 0.727 0 CA-C-O 122.415 1.008 . . . . 25.0 114.539 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -56.48 139.36 49.51 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 122.262 1.03 . . . . 25.0 113.673 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 164.28 -175.67 40.32 Favored Glycine 0 C--O 1.25 1.141 0 N-CA-C 110.15 -1.18 . . . . 25.0 110.15 -177.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -146.61 165.26 30.07 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.834 1.317 . . . . 25.0 110.995 -177.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 56.4 37.38 28.78 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 113.243 0.831 . . . . 25.0 113.243 177.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 79.02 32.6 39.23 Favored Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.204 -1.474 . . . . 25.0 110.945 176.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.7 t -148.59 179.72 7.6 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 120.02 1.91 . . . . 25.0 110.682 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 65.4 mt -90.52 168.58 11.72 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 104.519 -2.401 . . . . 25.0 104.519 168.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.77 121.94 20.72 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 108.07 -1.085 . . . . 25.0 108.07 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 28.9 m -93.86 162.37 2.42 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 O-C-N 125.081 1.488 . . . . 25.0 108.945 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.4 p -148.93 163.84 36.28 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.414 0.894 . . . . 25.0 113.414 -177.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.8 m -120.91 167.69 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 106.729 -1.582 . . . . 25.0 106.729 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 37.4 t -75.51 -55.07 6.03 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 106.615 -1.624 . . . . 25.0 106.615 173.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -165.6 -150.95 0.13 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 103.854 -2.647 . . . . 25.0 103.854 -176.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -69.39 -15.08 63.23 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 122.44 1.114 . . . . 25.0 111.114 -176.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -140.09 -155.24 6.51 Favored Glycine 0 C--O 1.258 1.606 0 CA-C-O 117.391 -1.783 . . . . 25.0 110.895 178.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 68.01 -150.25 0.16 Allowed 'General case' 0 C--O 1.247 0.973 0 C-N-CA 125.113 1.365 . . . . 25.0 111.061 177.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 46.6 mtt85 -93.16 168.8 10.87 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-O 122.062 0.934 . . . . 25.0 111.419 -174.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 8.4 p -109.97 165.38 11.77 Favored 'General case' 0 C--O 1.251 1.146 0 N-CA-C 104.023 -2.584 . . . . 25.0 104.023 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -133.01 156.71 46.86 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-O 123.817 1.77 . . . . 25.0 110.056 175.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 59.9 tp -128.41 127.93 43.51 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 104.212 -2.514 . . . . 25.0 104.212 170.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -125.37 152.79 44.32 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.067 -0.716 . . . . 25.0 109.067 -172.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 41.1 t -96.07 149.88 21.11 Favored 'General case' 0 C--O 1.248 0.987 0 N-CA-C 106.039 -1.837 . . . . 25.0 106.039 171.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -115.31 19.74 15.34 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 122.551 1.167 . . . . 25.0 107.957 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -115.12 149.78 37.04 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 106.635 -1.617 . . . . 25.0 106.635 176.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -149.55 153.01 36.48 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 124.062 0.851 . . . . 25.0 111.516 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -83.18 162.35 21.27 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.509 -1.293 . . . . 25.0 107.509 177.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.99 -20.49 66.52 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 118.418 0.554 . . . . 25.0 111.381 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -82.39 -1.25 49.4 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 112.736 0.643 . . . . 25.0 112.736 176.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.26 14.4 68.95 Favored Glycine 0 CA--C 1.497 -1.035 0 O-C-N 124.112 0.882 . . . . 25.0 111.728 177.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 80.9 mt -83.87 139.16 32.81 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.634 -1.617 . . . . 25.0 106.634 177.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 61.4 p -149.85 -177.1 5.71 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 116.331 -1.795 . . . . 25.0 106.349 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -133.04 133.97 43.76 Favored 'General case' 0 C--O 1.274 2.39 0 N-CA-C 115.055 1.502 . . . . 25.0 115.055 -176.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -144.09 156.4 44.34 Favored 'General case' 0 C--O 1.269 2.114 0 N-CA-C 109.316 -0.624 . . . . 25.0 109.316 169.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.9 p -144.76 144.6 21.85 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 N-CA-C 107.252 -1.388 . . . . 25.0 107.252 -178.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -112.04 138.56 48.52 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 118.992 0.814 . . . . 25.0 110.445 -177.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.6 mp -130.4 135.37 47.95 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.741 -0.837 . . . . 25.0 108.741 -175.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.448 ' HG2' ' HA ' ' A' ' 85' ' ' LEU . 17.4 pt-20 -102.3 7.83 40.53 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 117.918 -1.513 . . . . 25.0 111.622 -176.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -73.44 -6.4 70.3 Favored Glycine 0 C--O 1.216 -1.021 0 O-C-N 124.3 1.0 . . . . 25.0 113.121 178.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 49.1 t0 49.98 47.22 23.6 Favored 'General case' 0 C--O 1.262 1.743 0 CA-C-O 122.051 0.929 . . . . 25.0 111.689 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.17 35.49 4.76 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 107.279 -1.378 . . . . 25.0 107.279 -178.207 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.4 -32.21 69.96 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 121.007 0.432 . . . . 25.0 110.093 172.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.27 -11.45 60.72 Favored 'General case' 0 C--O 1.26 1.647 0 C-N-CA 119.834 -0.746 . . . . 25.0 111.675 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -110.21 -1.08 17.55 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 113.852 1.056 . . . . 25.0 113.852 174.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 20.6 mt -79.25 120.94 24.44 Favored 'General case' 0 C--O 1.248 0.997 0 O-C-N 123.831 0.707 . . . . 25.0 111.636 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 71.8 m -135.56 160.45 38.46 Favored 'General case' 0 N--CA 1.4 -2.972 0 CA-C-N 114.405 -1.27 . . . . 25.0 108.292 176.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -68.1 -7.53 30.39 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 122.47 1.129 . . . . 25.0 110.474 -177.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -61.14 -27.22 68.24 Favored 'General case' 0 C--O 1.208 -1.106 0 CA-C-N 114.426 -1.261 . . . . 25.0 109.131 177.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -103.1 -1.89 28.36 Favored 'General case' 0 C--O 1.26 1.613 0 N-CA-C 114.509 1.3 . . . . 25.0 114.509 176.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 23.1 mm -101.08 114.88 41.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 104.931 -2.248 . . . . 25.0 104.931 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 13.7 p -97.78 110.72 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 119.735 -1.853 . . . . 25.0 113.86 -168.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -151.07 -4.04 0.31 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 113.083 -1.871 . . . . 25.0 113.824 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -84.96 58.65 5.14 Favored 'General case' 0 C--N 1.346 0.443 0 N-CA-C 113.574 0.953 . . . . 25.0 113.574 -175.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 52.35 26.62 4.21 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 116.854 2.168 . . . . 25.0 116.854 178.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.11 -6.23 0.11 Allowed 'General case' 0 CA--C 1.564 1.502 0 N-CA-C 117.244 2.313 . . . . 25.0 117.244 178.112 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -65.75 133.72 51.63 Favored 'General case' 0 CA--C 1.551 0.991 0 O-C-N 121.442 -0.786 . . . . 25.0 111.174 -176.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.3 -18.74 61.17 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.02 0.528 . . . . 25.0 109.674 175.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -77.87 -8.44 58.08 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.83 -0.433 . . . . 25.0 109.83 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.37 168.84 18.88 Favored 'General case' 0 C--O 1.252 1.227 0 CA-C-O 121.159 0.504 . . . . 25.0 110.73 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 51.58 -155.56 0.15 Allowed 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 115.175 1.546 . . . . 25.0 115.175 177.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.95 16.37 74.7 Favored Glycine 0 C--O 1.247 0.93 0 N-CA-C 114.936 0.734 . . . . 25.0 114.936 -178.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -101.55 97.66 8.07 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 124.388 0.699 . . . . 25.0 109.834 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.25 136.96 54.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 122.273 1.035 . . . . 25.0 111.768 -176.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -140.11 28.18 2.5 Favored Glycine 0 C--N 1.336 0.583 0 N-CA-C 109.251 -1.54 . . . . 25.0 109.251 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 60.4 t -74.85 -37.76 42.6 Favored 'Isoleucine or valine' 0 C--O 1.251 1.147 0 N-CA-C 108.451 -0.944 . . . . 25.0 108.451 -177.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.63 128.02 16.44 Favored 'Isoleucine or valine' 0 C--O 1.246 0.872 0 O-C-N 124.57 1.169 . . . . 25.0 111.009 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 166.16 167.29 26.58 Favored Glycine 0 N--CA 1.43 -1.731 0 CA-C-N 114.046 -1.434 . . . . 25.0 110.836 -177.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -149.91 139.64 21.74 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.196 -1.038 . . . . 25.0 108.196 -176.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 85.0 p -154.74 158.07 38.99 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.128 -1.064 . . . . 25.0 108.128 177.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 159.58 161.08 10.93 Favored Glycine 0 C--O 1.24 0.472 0 N-CA-C 116.097 1.199 . . . . 25.0 116.097 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 -105.16 107.37 58.77 Favored Pre-proline 0 C--O 1.251 1.162 0 CA-C-O 121.022 0.439 . . . . 25.0 109.871 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -71.04 163.17 40.16 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 116.636 -1.776 . . . . 25.0 111.892 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -129.85 154.82 46.89 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 106.82 -1.548 . . . . 25.0 106.82 -178.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -140.3 69.12 33.54 Favored Pre-proline 0 C--N 1.306 -1.297 0 O-C-N 121.694 -0.629 . . . . 25.0 109.579 -178.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.19 139.45 42.24 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 116.382 -1.946 . . . . 25.0 112.921 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 15.3 t -93.52 -14.95 26.01 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.217 -0.901 . . . . 25.0 111.501 -176.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 10.7 p . . . . . 0 C--O 1.258 1.55 0 N-CA-C 107.592 -1.262 . . . . 25.0 107.592 179.373 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 CA--C 1.511 -0.643 0 CA-C-O 121.494 0.539 . . . . 25.0 112.968 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -155.2 61.64 0.36 Allowed Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 107.764 -2.134 . . . . 25.0 107.764 177.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.415 HG12 ' H ' ' A' ' 5' ' ' VAL . 1.4 p -54.76 126.49 11.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 124.158 0.983 . . . . 25.0 110.236 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -100.54 8.96 43.15 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.506 -0.77 . . . . 25.0 110.841 -178.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -90.25 -146.95 16.68 Favored Glycine 0 C--O 1.215 -1.088 0 CA-C-N 115.527 -0.76 . . . . 25.0 112.503 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.7 p 68.92 154.74 0.14 Allowed Pre-proline 0 CA--C 1.563 1.458 0 C-N-CA 126.084 1.753 . . . . 25.0 112.628 -175.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.673 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 50.1 Cg_exo -62.68 1.25 1.11 Allowed 'Trans proline' 0 N--CA 1.498 1.746 0 N-CA-C 117.254 1.982 . . . . 25.0 117.254 -177.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.8 p -63.98 -18.17 22.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 118.831 2.9 . . . . 25.0 118.831 -168.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.5 p -134.8 119.1 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 117.308 2.336 . . . . 25.0 117.308 -175.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.56 36.28 91.18 Favored Glycine 0 C--O 1.211 -1.283 0 CA-C-N 115.481 -0.781 . . . . 25.0 113.945 174.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.3 t -51.98 -38.55 57.03 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 119.219 -0.42 . . . . 25.0 111.678 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -80.73 5.61 15.26 Favored 'General case' 0 C--O 1.249 1.037 0 N-CA-C 115.266 1.58 . . . . 25.0 115.266 -173.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 pp -143.15 178.4 7.73 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-O 118.029 -0.986 . . . . 25.0 109.773 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -56.71 132.75 52.94 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 114.023 1.12 . . . . 25.0 114.023 -173.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -134.33 155.66 49.85 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 114.266 1.21 . . . . 50.0 114.266 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -122.93 113.35 18.99 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 104.128 -2.545 . . . . 25.0 104.128 164.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 88.7 mt -120.74 118.35 29.83 Favored 'General case' 0 C--O 1.207 -1.139 0 CA-C-O 121.394 0.616 . . . . 25.0 110.122 -177.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -110.06 106.99 16.69 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.593 -1.262 . . . . 25.0 107.593 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.51 -171.3 47.06 Favored Glycine 0 C--O 1.244 0.73 0 N-CA-C 118.753 2.261 . . . . 25.0 118.753 -172.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.1 p -82.49 175.72 9.98 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.761 -0.72 . . . . 25.0 111.315 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 69.2 mt -90.97 -2.86 57.65 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 123.546 0.529 . . . . 25.0 110.711 173.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -95.39 -174.27 37.17 Favored Glycine 0 C--O 1.244 0.74 0 N-CA-C 110.02 -1.232 . . . . 25.0 110.02 176.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.4 t -74.91 138.89 42.71 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.676 0.621 . . . . 25.0 112.676 -177.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -145.8 152.9 40.27 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 117.806 0.276 . . . . 50.0 111.538 -178.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -98.09 128.51 44.64 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 103.0 -2.963 . . . . 25.0 103.0 166.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 34.2 mm -124.59 108.65 20.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 107.513 -1.291 . . . . 25.0 107.513 -178.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.673 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 9.6 mp -108.85 118.0 35.65 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 104.408 -2.441 . . . . 25.0 104.408 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.43 -36.5 59.19 Favored Glycine 0 CA--C 1.497 -1.078 0 CA-C-O 119.517 -0.602 . . . . 25.0 113.353 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.87 -151.81 41.44 Favored Glycine 0 CA--C 1.497 -1.091 0 C-N-CA 119.834 -1.174 . . . . 25.0 112.303 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -78.35 169.21 54.31 Favored Glycine 0 C--O 1.247 0.948 0 N-CA-C 110.262 -1.135 . . . . 25.0 110.262 -177.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.3 164.95 23.14 Favored Glycine 0 N--CA 1.432 -1.608 0 C-N-CA 120.819 -0.705 . . . . 25.0 113.507 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.63 109.85 17.18 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.104 -1.073 . . . . 25.0 108.104 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -106.8 156.64 18.45 Favored 'General case' 0 C--N 1.316 -0.873 0 O-C-N 124.252 0.97 . . . . 50.0 112.403 -170.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -127.91 95.28 4.16 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 105.368 -2.086 . . . . 25.0 105.368 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.1 mt -102.21 138.0 39.72 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 113.739 -1.573 . . . . 25.0 112.034 -170.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -134.88 103.13 5.48 Favored 'General case' 0 C--O 1.267 1.986 0 CA-C-O 121.969 0.89 . . . . 25.0 111.502 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.74 -26.91 52.67 Favored Glycine 0 C--N 1.314 -0.68 0 CA-C-N 115.257 -0.883 . . . . 25.0 114.393 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 52.39 -145.75 0.54 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.384 1.074 . . . . 25.0 111.363 -176.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.56 169.19 13.12 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 121.503 -0.748 . . . . 25.0 112.724 -175.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.67 157.29 30.14 Favored Glycine 0 C--O 1.225 -0.417 0 CA-C-N 115.14 -0.936 . . . . 25.0 111.579 -173.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -79.36 112.49 16.64 Favored 'General case' 0 C--O 1.261 1.671 0 N-CA-C 105.812 -1.921 . . . . 25.0 105.812 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -113.68 149.16 35.1 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.023 -0.671 . . . . 50.0 109.598 -171.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mp -111.31 92.86 4.2 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.922 0.889 . . . . 25.0 109.34 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.1 mp -107.09 120.99 43.6 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.479 1.289 . . . . 25.0 114.479 -170.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -123.51 139.41 54.04 Favored 'General case' 0 C--O 1.246 0.876 0 N-CA-C 107.728 -1.212 . . . . 25.0 107.728 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -90.71 -36.59 6.78 Favored Glycine 0 C--O 1.257 1.539 0 CA-C-O 118.105 -1.386 . . . . 25.0 115.588 -173.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.91 -166.42 52.98 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 118.552 1.176 . . . . 25.0 112.388 -176.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.14 148.19 22.7 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.319 -0.94 . . . . 25.0 111.412 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.53 162.57 38.01 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-O 122.518 1.066 . . . . 25.0 114.534 -176.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -88.54 127.94 35.55 Favored 'General case' 0 CA--C 1.479 -1.776 0 N-CA-C 101.692 -3.447 . . . . 25.0 101.692 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -121.87 156.93 32.25 Favored 'General case' 0 C--O 1.255 1.357 0 C-N-CA 122.74 0.416 . . . . 50.0 111.211 -170.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -119.3 125.54 49.32 Favored 'General case' 0 C--O 1.212 -0.91 0 N-CA-C 101.821 -3.4 . . . . 25.0 101.821 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -145.41 132.77 20.64 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 115.689 1.737 . . . . 25.0 115.689 -174.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 63.9 m -102.0 140.45 36.27 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.526 -0.916 . . . . 25.0 108.526 175.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.92 -44.52 4.78 Favored Glycine 0 N--CA 1.467 0.721 0 N-CA-C 109.183 -1.567 . . . . 25.0 109.183 174.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.32 -175.09 54.89 Favored Glycine 0 N--CA 1.465 0.593 0 CA-C-N 116.988 0.394 . . . . 25.0 112.648 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -60.83 155.24 19.97 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 122.701 1.238 . . . . 25.0 110.371 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.37 159.62 32.12 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 115.18 -0.918 . . . . 25.0 111.717 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.58 107.55 13.48 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 122.206 1.003 . . . . 25.0 108.445 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -95.6 162.93 13.42 Favored 'General case' 0 C--O 1.27 2.132 0 CA-C-N 115.075 -0.966 . . . . 50.0 111.137 -172.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.8 m -128.35 132.02 48.59 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 122.536 1.16 . . . . 25.0 109.002 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -122.32 129.06 51.79 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 105.3 -2.111 . . . . 25.0 105.3 175.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.403 ' HD3' ' HB3' ' A' ' 95' ' ' ASP . 26.4 mmt85 -127.13 -15.42 5.27 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 121.277 0.561 . . . . 25.0 109.953 179.219 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 60.59 174.8 0.1 Allowed 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 115.216 -0.902 . . . . 25.0 112.426 -171.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -89.92 -51.87 5.26 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 115.108 1.522 . . . . 25.0 115.108 -172.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.1 mt -141.87 174.07 10.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.906 -1.043 . . . . 25.0 109.519 -173.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.12 -27.58 63.87 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 107.725 -1.213 . . . . 25.0 107.725 171.226 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -72.02 -9.2 58.06 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-O 122.758 1.266 . . . . 25.0 113.447 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -94.1 141.41 28.57 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.843 1.306 . . . . 25.0 111.732 -173.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.3 t 46.85 42.58 12.23 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 113.389 -1.732 . . . . 25.0 115.347 175.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -118.7 162.03 19.12 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.423 -1.262 . . . . 25.0 111.427 -178.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -104.68 146.49 28.87 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 105.403 -2.073 . . . . 25.0 105.403 175.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.7 p -138.71 167.44 19.46 Favored Pre-proline 0 C--O 1.211 -0.932 0 N-CA-C 108.165 -1.05 . . . . 25.0 108.165 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -61.03 -20.06 65.93 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 CA-C-O 122.377 0.907 . . . . 25.0 113.234 174.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 73.1 mt -79.26 -23.58 43.55 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 119.924 -1.735 . . . . 25.0 111.13 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 147.99 -175.73 27.16 Favored Glycine 0 C--O 1.212 -1.232 0 CA-C-N 115.384 -0.825 . . . . 25.0 111.916 177.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.0 t -89.15 137.99 31.82 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 123.375 1.559 . . . . 25.0 112.485 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -117.64 17.9 14.31 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-N 114.768 -1.105 . . . . 25.0 110.532 171.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.35 138.41 49.38 Favored Glycine 0 C--N 1.338 0.661 0 CA-C-N 115.184 -0.916 . . . . 25.0 111.519 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -85.22 173.53 10.33 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 117.353 0.576 . . . . 50.0 111.745 -176.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.74 103.89 7.77 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 123.217 0.607 . . . . 25.0 112.105 -179.14 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.8 mt -87.02 133.75 29.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 106.579 -1.638 . . . . 25.0 106.579 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.84 -38.9 22.38 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.608 0.966 . . . . 25.0 113.608 -172.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.6 p-10 -144.79 44.32 1.37 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.787 1.032 . . . . 25.0 113.787 -167.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -61.1 131.14 49.59 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.95 1.093 . . . . 25.0 113.95 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -96.39 106.32 28.45 Favored Pre-proline 0 N--CA 1.48 1.065 0 N-CA-C 106.749 -1.575 . . . . 25.0 106.749 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -77.56 -4.29 14.47 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 N-CA-C 114.17 0.796 . . . . 25.0 114.17 -171.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 45.6 t -93.28 -41.93 9.6 Favored 'General case' 0 C--N 1.315 -0.918 0 O-C-N 124.26 0.975 . . . . 25.0 111.091 177.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -98.19 -37.15 9.81 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.979 1.474 . . . . 25.0 114.979 -172.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -87.16 168.63 13.07 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.259 0.466 . . . . 50.0 112.259 -172.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -146.04 145.84 30.74 Favored 'General case' 0 C--O 1.263 1.785 0 O-C-N 121.805 -0.559 . . . . 25.0 112.288 -178.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 75.1 mt -130.74 129.1 63.79 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 N-CA-C 109.266 -0.642 . . . . 25.0 109.266 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.403 ' HB3' ' HD3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -91.69 141.24 28.9 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 119.771 -1.83 . . . . 25.0 107.393 174.928 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.7 p -134.09 -5.9 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 121.463 0.649 . . . . 25.0 111.423 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.87 -36.27 78.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.851 -0.613 . . . . 25.0 111.929 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.46 -24.69 53.9 Favored 'General case' 0 C--O 1.248 0.989 0 N-CA-C 113.91 1.078 . . . . 25.0 113.91 -178.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.88 9.4 5.37 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 115.946 1.832 . . . . 25.0 115.946 -168.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -151.08 -75.05 0.01 OUTLIER Glycine 0 C--O 1.219 -0.81 0 C-N-CA 119.868 -1.158 . . . . 25.0 115.067 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -155.39 167.74 29.4 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 109.592 -0.521 . . . . 25.0 109.592 -171.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.2 t -120.22 -39.81 2.76 Favored 'General case' 0 C--O 1.248 0.997 0 N-CA-C 108.963 -0.755 . . . . 25.0 108.963 176.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -92.04 123.15 7.11 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 109.31 -1.516 . . . . 25.0 109.31 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.16 148.81 46.99 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.254 0.55 . . . . 25.0 111.222 -177.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -83.16 -176.48 51.51 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 115.945 -0.571 . . . . 25.0 112.008 -177.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -61.94 100.2 0.15 Allowed 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 115.05 1.5 . . . . 25.0 115.05 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -141.03 -157.4 7.16 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-O 117.222 -1.876 . . . . 25.0 108.659 176.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -152.99 162.97 40.68 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 121.114 2.457 . . . . 25.0 112.566 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 51.16 44.33 28.76 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.214 1.006 . . . . 25.0 113.118 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.24 31.82 63.36 Favored Glycine 0 C--O 1.257 1.579 0 N-CA-C 111.031 -0.828 . . . . 25.0 111.031 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.6 t -139.76 174.23 10.72 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 117.719 0.759 . . . . 25.0 110.364 -177.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.7 mt -95.18 172.64 7.99 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 101.424 -3.547 . . . . 25.0 101.424 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.33 119.8 22.88 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.652 -1.24 . . . . 25.0 107.652 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.4 m -80.06 157.6 4.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.148 -0.686 . . . . 25.0 109.148 -176.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.46 160.25 40.92 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.754 -0.832 . . . . 25.0 108.754 -176.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.502 HG12 HG22 ' A' ' 123' ' ' THR . 16.3 m -123.31 163.9 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 116.33 -0.395 . . . . 25.0 110.268 177.226 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 35.1 t -70.84 -52.44 20.33 Favored 'General case' 0 C--O 1.204 -1.325 0 N-CA-C 107.52 -1.289 . . . . 25.0 107.52 174.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -159.61 -143.79 0.1 Allowed 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 104.997 -2.223 . . . . 25.0 104.997 -178.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -69.92 -21.14 63.32 Favored 'General case' 0 C--O 1.253 1.285 0 N-CA-C 109.564 -0.532 . . . . 25.0 109.564 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -141.54 -145.44 4.55 Favored Glycine 0 C--O 1.24 0.509 0 N-CA-C 110.532 -1.027 . . . . 25.0 110.532 178.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.55 -145.13 0.33 Allowed 'General case' 0 C--O 1.245 0.843 0 C-N-CA 124.082 0.953 . . . . 25.0 109.784 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.6 mtt85 -82.09 159.06 23.5 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 113.127 0.788 . . . . 25.0 113.127 -176.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.502 HG22 HG12 ' A' ' 116' ' ' VAL . 0.5 OUTLIER -111.3 166.28 11.23 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 104.822 -2.288 . . . . 25.0 104.822 177.404 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -135.65 151.4 50.18 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.997 -0.547 . . . . 25.0 111.378 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 34.4 tp -124.61 104.34 8.64 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 103.595 -2.743 . . . . 25.0 103.595 168.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -104.46 153.03 21.63 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.634 -0.712 . . . . 25.0 110.793 -172.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 43.5 t -99.5 150.87 21.77 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.397 -2.075 . . . . 25.0 105.397 170.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -119.81 25.02 10.24 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 106.534 -1.654 . . . . 25.0 106.534 -178.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -116.1 134.84 54.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.367 -1.288 . . . . 25.0 109.461 174.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -134.12 150.02 51.11 Favored 'General case' 0 C--O 1.216 -0.673 0 O-C-N 125.176 1.547 . . . . 25.0 110.549 -175.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -74.52 165.13 25.72 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 124.11 0.964 . . . . 25.0 109.127 174.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.97 -15.33 62.9 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.683 0.754 . . . . 25.0 111.463 178.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -79.03 -11.34 60.0 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.614 -0.721 . . . . 25.0 112.348 174.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.58 26.26 39.54 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 120.505 -0.855 . . . . 25.0 112.162 -176.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 69.5 mt -101.07 141.97 33.19 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.386 -1.338 . . . . 25.0 107.386 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 80.1 p -149.24 -175.44 4.98 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.338 -1.356 . . . . 25.0 107.338 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -123.2 139.21 54.29 Favored 'General case' 0 C--O 1.247 0.926 0 N-CA-C 113.223 0.823 . . . . 25.0 113.223 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -152.07 153.99 35.04 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.789 -1.189 . . . . 25.0 107.789 166.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 10.5 p -148.51 143.8 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 N-CA-C 104.603 -2.369 . . . . 25.0 104.603 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -105.86 148.93 27.01 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 107.186 -1.413 . . . . 25.0 107.186 -175.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.5 mp -137.98 131.03 30.17 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 104.301 -2.481 . . . . 25.0 104.301 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -104.37 4.91 33.98 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 121.198 1.817 . . . . 25.0 114.758 -174.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -77.16 1.58 63.83 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 120.283 -0.961 . . . . 25.0 114.817 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 47.7 t0 52.84 61.68 3.07 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-O 122.08 0.943 . . . . 25.0 110.728 175.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -130.98 41.92 3.3 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.707 -1.133 . . . . 25.0 111.762 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.95 -25.18 66.63 Favored 'General case' 0 C--O 1.209 -1.051 0 C-N-CA 119.345 -0.942 . . . . 25.0 110.809 176.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.12 -32.15 70.03 Favored 'General case' 0 C--O 1.275 2.418 0 C-N-CA 124.094 0.957 . . . . 25.0 112.282 177.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -93.62 -27.31 16.66 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.734 1.013 . . . . 25.0 113.734 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 11.4 mt -62.84 139.79 58.74 Favored 'General case' 0 C--O 1.247 0.923 0 CA-C-O 121.947 0.88 . . . . 25.0 109.492 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 72.5 m -141.77 159.78 41.52 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 102.012 -3.329 . . . . 25.0 102.012 169.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -86.24 10.36 14.93 Favored 'General case' 0 C--O 1.214 -0.813 0 N-CA-C 108.107 -1.072 . . . . 25.0 108.107 -176.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -72.11 -26.23 62.05 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.692 0.758 . . . . 25.0 110.386 178.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 24.3 p30 -86.06 -1.25 57.2 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 109.694 -0.484 . . . . 25.0 109.694 176.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 37.3 mm -98.39 128.88 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 102.415 -3.18 . . . . 25.0 102.415 173.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.3 p -105.82 113.77 43.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 122.936 1.35 . . . . 25.0 111.665 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -142.42 9.12 1.82 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 112.524 -2.125 . . . . 25.0 107.379 178.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.9 51.75 1.57 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.421 1.088 . . . . 25.0 111.301 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 56.43 33.7 22.92 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.384 1.073 . . . . 25.0 113.665 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 18.2 m 65.29 -43.99 0.35 Allowed 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 117.468 2.396 . . . . 25.0 117.468 176.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -76.65 154.11 34.59 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 114.27 1.211 . . . . 25.0 114.27 -173.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -80.77 20.14 0.78 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.26 -0.882 . . . . 25.0 111.752 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.85 -25.52 56.29 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.986 -0.552 . . . . 25.0 111.833 -177.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -112.0 -161.32 0.75 Allowed 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 108.839 -0.8 . . . . 25.0 108.839 -174.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 67.49 -174.2 0.19 Allowed 'General case' 0 C--O 1.25 1.13 0 N-CA-C 115.796 1.776 . . . . 25.0 115.796 175.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 81.46 17.44 71.15 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 114.195 0.438 . . . . 25.0 114.195 175.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -98.94 109.86 22.55 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 122.466 -0.432 . . . . 25.0 110.888 -174.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -127.35 157.71 39.22 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 107.425 -1.324 . . . . 25.0 107.425 178.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -140.78 30.45 2.28 Favored Glycine 0 C--O 1.209 -1.451 0 N-CA-C 110.761 -0.935 . . . . 25.0 110.761 178.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.11 -28.38 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 CA-C-O 122.157 0.98 . . . . 25.0 110.939 -175.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.12 136.38 26.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 CA-C-O 122.167 0.984 . . . . 25.0 109.823 -177.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 161.89 157.52 8.95 Favored Glycine 0 N--CA 1.466 0.654 0 CA-C-N 114.605 -1.18 . . . . 25.0 111.951 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -149.67 141.97 24.18 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 108.584 -0.895 . . . . 25.0 108.584 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 88.6 p -159.46 171.54 19.53 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.865 0.866 . . . . 25.0 110.097 177.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 171.17 174.9 39.28 Favored Glycine 0 C--O 1.25 1.102 0 CA-C-N 118.814 0.734 . . . . 25.0 111.773 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -136.75 101.9 9.54 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 108.702 -0.851 . . . . 25.0 108.702 177.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.35 152.64 49.89 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 N-CA-C 115.471 1.296 . . . . 25.0 115.471 -174.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -121.84 151.38 40.71 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 107.805 -1.183 . . . . 25.0 107.805 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -141.51 76.84 20.27 Favored Pre-proline 0 C--O 1.24 0.599 0 CA-C-N 118.366 0.53 . . . . 25.0 110.49 176.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.11 155.48 61.29 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 118.35 -0.634 . . . . 25.0 113.404 -176.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.9 t -122.68 -3.46 8.76 Favored 'General case' 0 C--O 1.245 0.827 0 O-C-N 121.49 -0.756 . . . . 25.0 111.977 -177.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--O 1.271 2.214 0 N-CA-C 107.943 -1.132 . . . . 25.0 107.943 176.918 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo . . . . . 0 C--O 1.245 0.842 0 CA-C-O 120.713 0.214 . . . . 25.0 112.3 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.83 57.43 0.03 OUTLIER Glycine 0 C--O 1.244 0.727 0 N-CA-C 109.836 -1.306 . . . . 25.0 109.836 -177.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.475 HG22 ' H ' ' A' ' 7' ' ' GLY . 7.7 p -63.87 131.82 29.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 122.08 0.943 . . . . 25.0 111.568 -172.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -96.61 -6.42 36.79 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 115.3 -0.864 . . . . 25.0 110.978 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.475 ' H ' HG22 ' A' ' 5' ' ' VAL . . . -83.58 -152.57 13.47 Favored Glycine 0 C--O 1.244 0.762 0 CA-C-N 115.758 -0.655 . . . . 25.0 112.704 177.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 p 73.38 159.69 0.16 Allowed Pre-proline 0 CA--C 1.563 1.459 0 C-N-CA 126.343 1.857 . . . . 25.0 109.474 -177.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.455 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 30.3 Cg_exo -68.52 6.89 0.8 Allowed 'Trans proline' 0 CA--C 1.553 1.427 0 N-CA-C 116.069 1.526 . . . . 25.0 116.069 -174.005 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.8 p -69.01 -16.74 21.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 115.926 1.824 . . . . 25.0 115.926 -169.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.85 139.04 22.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 O-C-N 121.218 -0.927 . . . . 25.0 113.199 -174.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.87 9.09 70.02 Favored Glycine 0 N--CA 1.469 0.852 0 N-CA-C 117.586 1.794 . . . . 25.0 117.586 171.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.5 t -50.72 -43.02 57.85 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 114.272 1.212 . . . . 25.0 114.272 -169.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -77.47 7.4 5.49 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 114.167 1.173 . . . . 25.0 114.167 -176.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.33 175.28 10.21 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 120.27 -1.519 . . . . 25.0 111.221 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -56.65 125.33 21.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 123.702 0.626 . . . . 25.0 111.308 -175.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -121.94 162.83 20.36 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.981 0.734 . . . . 50.0 112.981 -173.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -130.73 114.96 16.02 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 102.518 -3.142 . . . . 25.0 102.518 163.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.0 mt -128.05 128.87 45.74 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 122.077 0.942 . . . . 25.0 109.66 -177.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -117.45 121.3 40.65 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.218 -0.901 . . . . 25.0 110.35 177.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.15 175.26 46.24 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 122.644 1.136 . . . . 25.0 115.094 -174.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.2 p -82.24 172.42 13.16 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.109 -1.046 . . . . 25.0 109.81 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.6 mt -86.79 12.09 11.7 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.176 0.512 . . . . 25.0 111.938 177.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -111.69 -172.91 19.37 Favored Glycine 0 N--CA 1.471 0.975 0 CA-C-N 114.826 -1.079 . . . . 25.0 111.581 177.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.2 t -77.16 134.02 38.79 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.013 0.745 . . . . 25.0 113.013 -178.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -148.02 163.99 35.18 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.457 -0.777 . . . . 50.0 110.853 -173.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -112.32 125.3 54.03 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 101.078 -3.675 . . . . 25.0 101.078 169.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 40.6 mm -119.13 99.95 8.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 104.92 -2.252 . . . . 25.0 104.92 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.455 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 9.4 mp -107.9 120.23 41.7 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 103.646 -2.724 . . . . 25.0 103.646 -176.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.22 -27.54 36.46 Favored Glycine 0 CA--C 1.488 -1.628 0 N-CA-C 115.264 0.866 . . . . 25.0 115.264 -171.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.74 -149.86 50.2 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 109.982 -1.247 . . . . 25.0 109.982 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.4 172.41 47.91 Favored Glycine 0 C--O 1.247 0.952 0 CA-C-N 114.901 -0.65 . . . . 25.0 114.473 -175.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.42 172.57 24.53 Favored Glycine 0 N--CA 1.439 -1.101 0 CA-C-O 119.132 -0.815 . . . . 25.0 114.281 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.8 112.78 24.72 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 104.722 -2.325 . . . . 25.0 104.722 177.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -108.96 156.35 19.81 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.052 -0.522 . . . . 50.0 110.578 -169.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -119.55 90.89 3.42 Favored 'General case' 0 C--O 1.248 1.019 0 N-CA-C 107.099 -1.445 . . . . 25.0 107.099 175.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 31.9 mt -100.81 128.63 46.77 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 113.862 -1.517 . . . . 25.0 110.869 -171.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -125.43 105.2 8.89 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.137 0.494 . . . . 25.0 112.008 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.73 -26.09 47.36 Favored Glycine 0 C--O 1.246 0.853 0 CA-C-O 116.797 -2.113 . . . . 25.0 115.929 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 52.77 -150.38 0.35 Allowed 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 119.551 1.676 . . . . 25.0 111.952 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.38 165.76 9.24 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.588 0.958 . . . . 25.0 113.588 -178.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.11 157.55 33.58 Favored Glycine 0 N--CA 1.438 -1.193 0 N-CA-C 110.097 -1.201 . . . . 25.0 110.097 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -80.87 115.29 20.28 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.52 -1.659 . . . . 25.0 106.52 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -123.56 147.55 47.18 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 119.887 -0.725 . . . . 50.0 111.166 -169.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 mp -108.65 104.57 13.9 Favored 'General case' 0 C--O 1.204 -1.308 0 N-CA-C 108.121 -1.066 . . . . 25.0 108.121 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 mp -109.21 109.83 20.88 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.784 0.802 . . . . 25.0 112.848 -174.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -118.78 96.44 5.26 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-N 113.977 -1.465 . . . . 25.0 108.101 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -59.74 -22.26 56.74 Favored Glycine 0 C--O 1.216 -0.989 0 N-CA-C 118.474 2.15 . . . . 25.0 118.474 -177.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.84 -159.07 53.79 Favored Glycine 0 C--O 1.245 0.839 0 CA-C-N 118.427 1.113 . . . . 25.0 112.444 -178.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.14 159.36 14.82 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-O 122.046 0.927 . . . . 25.0 112.524 -176.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.67 -178.32 53.3 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 114.826 -1.079 . . . . 25.0 114.229 -177.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -96.91 145.39 25.93 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 101.779 -3.415 . . . . 25.0 101.779 172.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -135.36 155.14 51.08 Favored 'General case' 0 CA--C 1.5 -0.943 0 C-N-CA 120.745 -0.382 . . . . 50.0 111.682 -170.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -109.17 122.36 47.14 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 104.994 -2.224 . . . . 25.0 104.994 174.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -142.05 136.19 29.94 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 122.466 1.126 . . . . 25.0 113.244 -176.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.7 m -113.63 133.89 55.04 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 115.169 -0.923 . . . . 25.0 110.181 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.04 -44.0 4.25 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.2 -1.16 . . . . 25.0 110.2 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.86 -161.24 52.19 Favored Glycine 0 C--O 1.252 1.234 0 C-N-CA 123.13 0.395 . . . . 25.0 113.019 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -67.25 161.82 24.03 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 122.176 -0.602 . . . . 25.0 112.296 174.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.44 167.24 41.7 Favored Glycine 0 CA--C 1.533 1.215 0 N-CA-C 111.129 -0.788 . . . . 25.0 111.129 -177.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.9 107.09 18.53 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.755 0.788 . . . . 25.0 109.711 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -102.38 153.2 20.24 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.853 -0.612 . . . . 50.0 110.479 -172.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.9 m -128.54 123.41 33.4 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-N 115.172 -0.922 . . . . 25.0 110.302 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -115.34 117.9 31.74 Favored 'General case' 0 C--O 1.21 -1.003 0 N-CA-C 108.432 -0.951 . . . . 25.0 108.432 -177.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 51.2 mtt85 -114.94 -33.41 5.44 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 113.007 0.743 . . . . 25.0 113.007 177.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 71.78 151.46 0.11 Allowed 'General case' 0 CA--C 1.551 1.017 0 O-C-N 125.195 1.559 . . . . 25.0 109.723 -173.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.74 -51.03 45.78 Favored 'General case' 0 C--O 1.24 0.576 0 O-C-N 121.015 -1.053 . . . . 25.0 113.562 -167.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.7 mt -131.8 166.6 21.21 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 121.918 0.866 . . . . 25.0 109.224 -174.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.89 -21.06 56.72 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.695 0.798 . . . . 25.0 109.341 175.289 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -73.8 3.27 6.8 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 115.049 1.5 . . . . 25.0 115.049 176.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -114.53 149.88 35.77 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.998 0.904 . . . . 25.0 112.202 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.2 t 55.03 46.1 24.94 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 122.903 1.335 . . . . 25.0 113.697 169.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 47.6 p-80 -134.97 -178.98 5.34 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.198 -0.91 . . . . 25.0 109.225 -175.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -122.63 145.41 48.38 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 103.823 -2.658 . . . . 25.0 103.823 175.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.8 p -133.98 167.56 22.28 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 107.129 -1.434 . . . . 25.0 107.129 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.32 -22.79 67.06 Favored 'Trans proline' 0 C--N 1.367 1.538 0 C-N-CA 116.393 -1.938 . . . . 25.0 113.693 177.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.9 -27.05 67.91 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 122.051 0.929 . . . . 25.0 111.173 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 139.5 179.05 17.2 Favored Glycine 0 C--O 1.246 0.852 0 N-CA-C 109.687 -1.365 . . . . 25.0 109.687 -171.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.6 t -81.87 150.07 27.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 123.461 1.6 . . . . 25.0 113.258 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -131.42 29.93 4.51 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 113.521 -1.672 . . . . 25.0 107.503 170.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.93 140.3 32.68 Favored Glycine 0 CA--C 1.501 -0.808 0 N-CA-C 109.144 -1.582 . . . . 25.0 109.144 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -82.03 167.91 18.36 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 118.72 -0.657 . . . . 50.0 109.517 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -124.41 114.08 19.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 118.438 0.563 . . . . 25.0 109.897 -176.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mt -100.16 127.13 53.43 Favored 'Isoleucine or valine' 0 C--O 1.25 1.122 0 N-CA-C 108.207 -1.035 . . . . 25.0 108.207 -178.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.3 mt -81.05 -44.24 18.32 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 115.292 1.59 . . . . 25.0 115.292 -173.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 57.0 p30 -133.54 44.78 2.75 Favored 'General case' 0 C--O 1.252 1.188 0 N-CA-C 113.585 0.957 . . . . 25.0 113.585 -172.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -59.24 145.23 43.64 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.351 0.66 . . . . 25.0 111.962 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -121.6 103.17 41.21 Favored Pre-proline 0 N--CA 1.473 0.695 0 CA-C-N 115.763 -0.653 . . . . 25.0 109.784 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -65.08 -12.4 34.49 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 N-CA-C 117.985 2.264 . . . . 25.0 117.985 -174.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.3 t -91.69 -32.32 15.48 Favored 'General case' 0 C--O 1.209 -1.069 0 N-CA-C 109.521 -0.548 . . . . 25.0 109.521 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -89.73 -48.23 7.4 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 113.954 1.094 . . . . 25.0 113.954 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -93.08 172.26 8.42 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.281 -1.327 . . . . 50.0 113.373 -161.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -146.64 149.95 34.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 119.343 -0.361 . . . . 25.0 110.843 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 86.2 mt -129.34 126.64 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 123.265 0.626 . . . . 25.0 109.732 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -86.44 139.63 30.73 Favored 'General case' 0 CA--C 1.502 -0.903 0 O-C-N 121.579 -0.701 . . . . 25.0 109.624 178.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.0 p -141.5 -8.3 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.173 0 CA-C-O 120.844 0.354 . . . . 25.0 110.85 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.6 t -67.42 -40.14 85.53 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 122.54 1.162 . . . . 25.0 109.495 -175.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.28 -23.61 63.85 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.407 -0.815 . . . . 25.0 111.942 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.5 mt -96.62 -65.95 0.93 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.745 1.017 . . . . 25.0 113.745 -172.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -116.24 -49.12 0.46 Allowed Glycine 0 CA--C 1.502 -0.773 0 N-CA-C 118.532 2.173 . . . . 25.0 118.532 -167.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -155.27 165.85 35.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 118.396 1.098 . . . . 25.0 111.93 -173.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.69 -24.76 3.22 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.194 0.521 . . . . 25.0 111.201 178.061 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -95.02 126.75 8.86 Favored Glycine 0 C--O 1.245 0.792 0 N-CA-C 110.594 -1.002 . . . . 25.0 110.594 173.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.11 140.74 57.81 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.981 0.896 . . . . 25.0 111.096 -176.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.29 -158.38 34.61 Favored Glycine 0 C--N 1.335 0.479 0 N-CA-C 110.833 -0.907 . . . . 25.0 110.833 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -67.75 140.46 56.71 Favored 'General case' 0 C--O 1.254 1.307 0 CA-C-O 122.175 0.988 . . . . 25.0 113.057 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 165.58 -172.95 41.23 Favored Glycine 0 C--O 1.253 1.292 0 N-CA-C 108.955 -1.658 . . . . 25.0 108.955 175.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -149.17 168.84 22.15 Favored 'General case' 0 C--O 1.245 0.857 0 C-N-CA 122.496 0.318 . . . . 25.0 110.294 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 56.58 36.49 27.69 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.26 1.207 . . . . 25.0 114.26 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 69.92 28.34 71.97 Favored Glycine 0 CA--C 1.538 1.513 0 N-CA-C 111.393 -0.683 . . . . 25.0 111.393 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 8.6 t -138.14 -178.32 5.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 117.383 0.591 . . . . 25.0 110.343 -175.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 87.2 mt -113.85 167.51 10.57 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 103.432 -2.803 . . . . 25.0 103.432 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.66 119.7 17.26 Favored 'General case' 0 C--O 1.257 1.465 0 C-N-CA 118.091 -1.444 . . . . 25.0 112.474 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.7 m -98.31 161.74 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 124.107 0.963 . . . . 25.0 109.151 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 54.0 p -148.73 171.11 16.75 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 118.901 -0.571 . . . . 25.0 111.621 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.5 m -120.95 162.6 19.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.473 0 N-CA-C 108.289 -1.004 . . . . 25.0 108.289 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.6 t -74.45 -53.72 9.0 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 106.121 -1.807 . . . . 25.0 106.121 170.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -159.83 -160.9 0.85 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 104.26 -2.496 . . . . 25.0 104.26 -177.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -65.56 -16.3 63.56 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 122.121 0.962 . . . . 25.0 111.877 176.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -133.52 -156.6 8.07 Favored Glycine 0 N--CA 1.469 0.851 0 N-CA-C 107.428 -2.269 . . . . 25.0 107.428 175.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.67 -142.25 0.32 Allowed 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.056 0.542 . . . . 25.0 109.7 178.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -96.21 170.21 9.42 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.296 1.221 . . . . 25.0 114.296 -168.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.36 160.72 28.68 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 105.952 -1.87 . . . . 25.0 105.952 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -134.89 153.78 51.92 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 117.536 0.153 . . . . 25.0 110.663 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 31.9 tp -127.65 120.85 28.97 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 104.848 -2.279 . . . . 25.0 104.848 172.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -121.95 153.43 38.51 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 118.405 0.548 . . . . 25.0 111.914 -172.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.6 t -102.55 147.25 27.0 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 103.654 -2.721 . . . . 25.0 103.654 171.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -115.5 19.04 15.67 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.931 -0.766 . . . . 25.0 108.931 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -110.89 143.37 41.61 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 105.521 -2.029 . . . . 25.0 105.521 171.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -141.12 157.69 44.94 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.879 0.737 . . . . 25.0 111.097 -176.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -80.16 164.6 23.18 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.332 -0.988 . . . . 25.0 108.332 175.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.72 -30.18 71.19 Favored 'General case' 0 C--O 1.221 -0.44 0 O-C-N 121.515 -0.74 . . . . 25.0 110.78 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -70.58 -5.06 26.4 Favored 'General case' 0 CA--C 1.554 1.096 0 C-N-CA 123.401 0.68 . . . . 25.0 112.342 177.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.59 7.53 84.31 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 115.66 -0.7 . . . . 25.0 111.915 -178.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 88.8 mt -73.16 136.83 44.82 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 106.595 -1.632 . . . . 25.0 106.595 174.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 94.4 p -148.92 -177.43 5.8 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 107.654 -1.239 . . . . 25.0 107.654 -175.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -128.38 132.54 48.53 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 119.426 1.012 . . . . 25.0 113.381 -175.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -152.51 156.71 39.93 Favored 'General case' 0 C--O 1.256 1.421 0 N-CA-C 107.205 -1.405 . . . . 25.0 107.205 168.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.9 p -146.66 147.38 17.94 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.804 0 N-CA-C 105.919 -1.882 . . . . 25.0 105.919 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -112.31 143.01 44.12 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.747 -0.66 . . . . 25.0 109.967 -170.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.8 mp -132.17 154.28 49.7 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.932 -1.136 . . . . 25.0 107.932 -177.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.51 0.97 10.06 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 116.992 2.219 . . . . 25.0 116.992 -177.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.3 -3.65 88.58 Favored Glycine 0 C--O 1.224 -0.493 0 C-N-CA 120.04 -1.076 . . . . 25.0 112.997 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 50.5 t0 48.74 61.41 3.1 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 122.323 1.058 . . . . 25.0 111.488 -177.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -123.3 41.48 3.46 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.282 -1.326 . . . . 25.0 107.624 175.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.53 -25.95 68.48 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 115.192 -0.913 . . . . 25.0 112.949 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.56 -23.82 64.54 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.424 0.63 . . . . 25.0 111.01 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -101.8 -0.04 34.92 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.769 -0.65 . . . . 25.0 112.031 -175.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 11.4 mt -78.0 134.39 37.83 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.111 -0.635 . . . . 25.0 109.328 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.2 m -135.54 162.27 33.14 Favored 'General case' 0 CA--C 1.492 -1.252 0 CA-C-N 114.605 -1.18 . . . . 25.0 109.036 173.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.44 -1.6 57.22 Favored 'General case' 0 C--O 1.204 -1.296 0 CA-C-O 122.624 1.202 . . . . 25.0 109.473 -177.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.36 -31.69 72.99 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.178 -1.374 . . . . 25.0 109.383 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -89.21 -7.05 56.34 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.877 1.323 . . . . 25.0 112.849 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 47.0 mm -95.93 108.13 20.68 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.012 0 N-CA-C 104.944 -2.243 . . . . 25.0 104.944 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 14.5 p -94.83 121.48 45.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 122.545 1.164 . . . . 25.0 111.695 -169.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -152.98 -3.57 0.22 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 112.968 -1.924 . . . . 25.0 112.298 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -74.55 51.36 0.46 Allowed 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.73 1.011 . . . . 25.0 113.73 -177.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 54.32 22.65 3.85 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.207 0.817 . . . . 25.0 113.207 -175.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.07 3.1 0.9 Allowed 'General case' 0 C--O 1.246 0.916 0 N-CA-C 115.247 1.573 . . . . 25.0 115.247 175.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -82.09 137.39 35.03 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.394 -0.522 . . . . 25.0 110.572 178.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -76.88 -12.37 59.95 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 109.198 -0.667 . . . . 25.0 109.198 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -82.72 42.64 0.79 Allowed 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 112.292 0.479 . . . . 25.0 112.292 176.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -154.25 175.16 13.84 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.065 0.946 . . . . 25.0 109.012 -178.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 62.3 -156.98 0.34 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.831 1.252 . . . . 25.0 111.638 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 58.33 28.72 62.21 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 121.926 -0.178 . . . . 25.0 113.269 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -106.63 98.64 8.28 Favored 'General case' 0 C--O 1.249 1.056 0 C-N-CA 123.083 0.553 . . . . 25.0 109.582 -176.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.87 145.11 47.97 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 121.636 0.731 . . . . 25.0 112.712 -178.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -121.94 29.7 5.5 Favored Glycine 0 C--O 1.222 -0.595 0 CA-C-N 115.154 -0.93 . . . . 25.0 112.342 174.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 58.1 t -70.64 -38.93 75.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 O-C-N 121.757 -0.849 . . . . 25.0 112.425 -174.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.9 133.05 30.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.832 0.825 . . . . 25.0 110.581 -175.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 170.07 153.43 8.64 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-N 114.607 -1.178 . . . . 25.0 110.892 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -150.88 143.66 24.51 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 117.854 0.827 . . . . 25.0 109.878 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.6 p -150.77 169.23 22.15 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 106.193 -1.78 . . . . 25.0 106.193 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -175.39 163.99 34.17 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 115.625 1.01 . . . . 25.0 115.625 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -137.38 83.56 25.87 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 107.815 -1.18 . . . . 25.0 107.815 175.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.17 161.23 46.76 Favored 'Trans proline' 0 C--N 1.349 0.589 0 O-C-N 121.99 0.469 . . . . 25.0 112.67 -176.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -130.67 159.79 36.2 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.937 -0.764 . . . . 25.0 108.937 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -135.73 84.48 32.77 Favored Pre-proline 0 C--O 1.246 0.87 0 C-N-CA 122.74 0.416 . . . . 25.0 112.034 -177.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.23 161.14 43.71 Favored 'Trans proline' 0 C--O 1.246 0.897 0 C-N-CA 116.995 -1.537 . . . . 25.0 113.323 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.5 t -127.78 17.27 6.85 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 122.061 0.934 . . . . 25.0 110.44 176.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 C--O 1.258 1.537 0 CA-C-O 117.349 -1.31 . . . . 25.0 109.566 178.639 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 C--O 1.24 0.587 0 CA-C-O 121.85 0.688 . . . . 25.0 111.929 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.33 56.84 0.26 Allowed Glycine 0 C--O 1.244 0.76 0 CA-C-O 119.043 -0.865 . . . . 25.0 112.803 -176.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.408 HG22 ' H ' ' A' ' 7' ' ' GLY . 5.9 p -70.4 125.29 28.33 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.965 0 CA-C-O 122.08 0.943 . . . . 25.0 111.525 -176.062 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -100.27 4.22 44.03 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.156 -0.929 . . . . 25.0 110.732 -176.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.408 ' H ' HG22 ' A' ' 5' ' ' VAL . . . -97.96 -145.2 18.47 Favored Glycine 0 C--O 1.24 0.513 0 N-CA-C 111.211 -0.756 . . . . 25.0 111.211 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.4 p 73.86 156.67 0.16 Allowed Pre-proline 0 N--CA 1.483 1.177 0 C-N-CA 126.508 1.923 . . . . 25.0 109.024 -176.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.549 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 32.8 Cg_exo -63.63 1.0 1.56 Allowed 'Trans proline' 0 N--CA 1.478 0.603 0 N-CA-C 116.25 1.596 . . . . 25.0 116.25 -176.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.5 p -63.8 -25.09 37.38 Favored 'Isoleucine or valine' 0 C--O 1.258 1.538 0 N-CA-C 114.786 1.402 . . . . 25.0 114.786 -171.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.8 p -130.7 135.84 59.47 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 CA-C-O 122.857 1.313 . . . . 25.0 114.477 -172.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.47 14.54 79.42 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 114.582 -1.19 . . . . 25.0 115.405 171.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.5 t -45.82 -48.67 15.67 Favored 'General case' 0 C--O 1.209 -1.043 0 N-CA-C 114.349 1.241 . . . . 25.0 114.349 -171.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -78.14 0.39 25.05 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 115.694 1.739 . . . . 25.0 115.694 -175.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.77 169.73 17.18 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.118 -0.989 . . . . 25.0 111.637 -175.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -60.07 125.87 25.32 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 124.431 1.082 . . . . 25.0 110.991 -171.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -120.46 165.7 14.59 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.725 1.38 . . . . 50.0 114.725 -176.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -128.47 101.13 6.05 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 101.967 -3.346 . . . . 25.0 101.967 163.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.3 mt -109.62 120.31 42.11 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 119.239 -0.41 . . . . 25.0 111.899 -177.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -112.9 113.45 25.52 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 123.537 0.523 . . . . 25.0 110.71 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.63 -177.72 49.42 Favored Glycine 0 N--CA 1.469 0.871 0 N-CA-C 116.534 1.374 . . . . 25.0 116.534 -172.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.9 p -76.66 172.82 12.42 Favored 'General case' 0 C--O 1.252 1.236 0 C-N-CA 123.326 0.65 . . . . 25.0 110.541 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 44.6 mt -86.15 9.89 16.11 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.314 0.578 . . . . 25.0 109.918 174.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.37 -179.4 26.01 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.926 -0.579 . . . . 25.0 111.679 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.6 t -72.09 130.4 40.82 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 122.672 0.389 . . . . 25.0 110.879 175.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -142.37 157.32 44.92 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.491 -0.559 . . . . 50.0 109.491 -177.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -94.85 123.52 38.36 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 102.942 -2.985 . . . . 25.0 102.942 160.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.1 mm -114.0 100.96 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 108.374 -0.973 . . . . 25.0 108.374 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.549 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 10.4 mp -104.93 127.47 52.78 Favored 'General case' 0 C--O 1.212 -0.88 0 N-CA-C 103.766 -2.679 . . . . 25.0 103.766 -177.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.43 -32.1 14.55 Favored Glycine 0 CA--C 1.493 -1.309 0 C-N-CA 120.167 -1.016 . . . . 25.0 113.262 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.23 -143.34 39.12 Favored Glycine 0 C--O 1.242 0.608 0 N-CA-C 110.648 -0.981 . . . . 25.0 110.648 178.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.7 164.96 53.98 Favored Glycine 0 C--O 1.248 0.988 0 N-CA-C 114.443 0.537 . . . . 25.0 114.443 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.44 164.94 33.8 Favored Glycine 0 C--O 1.248 1.025 0 N-CA-C 114.743 0.657 . . . . 25.0 114.743 175.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.19 99.5 7.83 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.34 -1.356 . . . . 25.0 107.34 173.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -94.1 152.14 18.98 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 113.665 0.987 . . . . 50.0 113.665 -175.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -117.35 96.69 5.53 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.616 -1.253 . . . . 25.0 107.616 174.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 32.7 mt -104.53 137.56 42.2 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.573 -0.739 . . . . 25.0 110.329 -168.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -128.43 97.7 4.81 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.722 -0.611 . . . . 25.0 109.509 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.57 -33.47 60.85 Favored Glycine 0 C--N 1.318 -0.425 0 N-CA-C 116.352 1.301 . . . . 25.0 116.352 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 53.3 -149.6 0.4 Allowed 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.602 1.161 . . . . 25.0 113.948 -178.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.96 161.48 30.87 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-O 121.451 0.643 . . . . 25.0 110.368 -173.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.6 158.74 31.64 Favored Glycine 0 C--O 1.246 0.879 0 N-CA-C 109.549 -1.42 . . . . 25.0 109.549 -176.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -84.67 101.49 12.22 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.222 -1.029 . . . . 25.0 108.222 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -103.38 148.0 26.41 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 113.731 1.011 . . . . 50.0 113.731 -172.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mp -108.27 107.93 18.73 Favored 'General case' 0 C--O 1.217 -0.631 0 N-CA-C 107.052 -1.462 . . . . 25.0 107.052 177.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 mp -109.21 113.43 26.26 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 122.62 1.2 . . . . 25.0 112.976 -171.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -118.15 96.55 5.38 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 105.221 -2.14 . . . . 25.0 105.221 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.56 -28.57 71.56 Favored Glycine 0 C--O 1.253 1.282 0 O-C-N 121.734 -0.604 . . . . 25.0 114.373 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.1 -157.18 52.82 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 120.748 -0.739 . . . . 25.0 112.617 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.22 154.54 12.99 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 122.407 1.099 . . . . 25.0 113.504 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.97 178.59 52.52 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 114.32 -1.309 . . . . 25.0 109.964 -177.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -96.88 143.51 27.7 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 101.345 -3.576 . . . . 25.0 101.345 176.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -130.65 153.08 49.32 Favored 'General case' 0 CA--C 1.5 -0.948 0 C-N-CA 120.065 -0.654 . . . . 50.0 110.258 -171.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -110.71 126.75 54.88 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 101.445 -3.539 . . . . 25.0 101.445 174.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -149.6 129.86 13.71 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-O 123.136 1.446 . . . . 25.0 113.956 -175.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.3 m -96.55 140.33 31.34 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.335 -1.302 . . . . 25.0 109.489 177.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.1 -40.19 4.35 Favored Glycine 0 C--O 1.242 0.632 0 N-CA-C 111.608 -0.597 . . . . 25.0 111.608 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.91 -167.39 54.05 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-O 123.298 1.499 . . . . 25.0 113.771 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -63.95 162.96 12.91 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 113.646 -1.277 . . . . 25.0 108.789 175.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.05 163.0 38.56 Favored Glycine 0 C--N 1.344 1.005 0 N-CA-C 111.644 -0.583 . . . . 25.0 111.644 -177.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.89 109.46 20.24 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 122.038 0.923 . . . . 25.0 109.214 178.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -105.49 150.8 25.0 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.462 -0.79 . . . . 50.0 111.17 -169.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.4 m -121.27 128.23 52.15 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 124.195 0.935 . . . . 25.0 111.119 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -115.38 103.23 10.59 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.39 -0.823 . . . . 25.0 110.953 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 60.9 mtt85 -109.68 -28.98 8.56 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 118.516 0.598 . . . . 25.0 110.859 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 68.22 161.65 0.19 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.391 -0.966 . . . . 25.0 108.391 -175.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.91 -37.88 23.61 Favored 'General case' 0 C--O 1.246 0.875 0 O-C-N 120.939 -1.1 . . . . 25.0 113.964 -165.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.4 mt -137.5 166.34 24.11 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.925 0.869 . . . . 25.0 111.252 -176.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.13 -28.2 57.02 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.977 1.311 . . . . 25.0 108.474 169.207 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -75.17 -2.98 30.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.43 -0.805 . . . . 25.0 112.123 -177.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -105.96 154.16 20.98 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 115.721 1.749 . . . . 25.0 115.721 -177.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.7 t 50.58 48.39 22.67 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.542 1.682 . . . . 25.0 115.542 174.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 35.1 p-80 -133.44 175.58 9.29 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 114.356 -1.293 . . . . 25.0 108.966 -178.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -122.97 140.37 53.09 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 105.357 -2.09 . . . . 25.0 105.357 174.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 55.3 p -128.52 171.29 8.83 Favored Pre-proline 0 N--CA 1.471 0.624 0 O-C-N 125.165 1.54 . . . . 25.0 109.564 -178.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -58.16 -22.47 56.68 Favored 'Trans proline' 0 C--N 1.364 1.347 0 CA-C-N 119.616 0.899 . . . . 25.0 113.565 174.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.1 mt -82.9 -10.78 58.65 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.605 0.594 . . . . 25.0 112.605 -176.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 143.54 -171.3 25.3 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-O 117.681 -1.621 . . . . 25.0 113.376 -177.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.2 t -102.84 147.24 27.13 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.393 1.596 . . . . 25.0 113.153 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -126.08 20.57 7.56 Favored 'General case' 0 C--O 1.263 1.771 0 CA-C-N 113.719 -1.582 . . . . 25.0 109.48 174.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.86 143.48 41.83 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 111.249 -0.74 . . . . 25.0 111.249 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -92.62 167.98 11.55 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.945 -0.738 . . . . 50.0 111.006 -172.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.57 103.44 8.43 Favored 'General case' 0 C--O 1.259 1.56 0 O-C-N 121.915 -0.491 . . . . 25.0 111.882 -171.182 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 mt -92.07 130.43 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-O 122.085 0.945 . . . . 25.0 108.535 -174.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.3 mt -82.58 -41.67 19.26 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 116.248 1.944 . . . . 25.0 116.248 -173.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 44.5 p-10 -139.51 53.44 1.71 Allowed 'General case' 0 C--O 1.252 1.193 0 CA-C-O 122.137 0.97 . . . . 25.0 113.594 -176.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -64.66 131.57 47.29 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 114.887 -1.051 . . . . 25.0 110.218 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -111.66 104.66 56.3 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 106.919 -1.512 . . . . 25.0 106.919 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -69.23 -12.26 33.47 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 N-CA-C 116.287 1.61 . . . . 25.0 116.287 -175.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.2 p -85.02 -16.7 39.89 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.627 -0.879 . . . . 25.0 108.627 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -108.78 -48.04 3.37 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 115.028 1.492 . . . . 25.0 115.028 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -92.08 169.13 10.88 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.218 -0.901 . . . . 50.0 112.348 -160.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -146.11 146.08 30.76 Favored 'General case' 0 C--O 1.249 1.052 0 C-N-CA 123.275 0.63 . . . . 25.0 111.812 -176.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 67.2 mt -127.73 134.87 64.52 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.051 0 N-CA-C 107.524 -1.288 . . . . 25.0 107.524 -177.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.77 139.49 30.52 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 107.446 -1.316 . . . . 25.0 107.446 174.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.3 p -137.76 -12.38 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 115.714 1.746 . . . . 25.0 115.714 -178.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.7 t -72.17 -27.57 62.67 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.709 1.14 . . . . 25.0 109.816 -177.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.31 -24.82 61.38 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.626 -1.17 . . . . 25.0 112.141 174.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 16.5 mt -107.19 -45.08 4.2 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.781 1.4 . . . . 25.0 114.781 -172.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -123.03 -66.58 0.22 Allowed Glycine 0 N--CA 1.472 1.035 0 N-CA-C 117.974 1.95 . . . . 25.0 117.974 -171.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -150.63 166.85 29.06 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 109.675 -0.491 . . . . 25.0 109.675 -170.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.7 t -118.51 -31.12 5.0 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.708 -1.133 . . . . 25.0 110.841 176.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -100.98 122.32 7.56 Favored Glycine 0 N--CA 1.462 0.373 0 N-CA-C 106.967 -2.453 . . . . 25.0 106.967 175.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.25 145.4 55.81 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-O 121.383 0.611 . . . . 25.0 111.744 -177.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -81.0 -170.97 44.11 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 115.328 -0.851 . . . . 25.0 113.773 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -64.33 132.94 51.63 Favored 'General case' 0 C--O 1.253 1.278 0 CA-C-O 121.769 0.795 . . . . 25.0 111.532 -177.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -177.95 -172.36 42.32 Favored Glycine 0 CA--C 1.539 1.59 0 N-CA-C 109.045 -1.622 . . . . 25.0 109.045 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -143.43 167.14 22.89 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 118.847 1.323 . . . . 25.0 112.017 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 55.11 42.24 30.94 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.143 1.377 . . . . 25.0 112.901 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 69.36 32.98 72.24 Favored Glycine 0 C--O 1.245 0.83 0 N-CA-C 110.097 -1.201 . . . . 25.0 110.097 176.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.5 t -146.78 166.43 26.68 Favored 'General case' 0 C--O 1.214 -0.788 0 CA-C-N 118.349 1.074 . . . . 25.0 110.573 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.5 mt -88.37 166.57 14.17 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 104.421 -2.437 . . . . 25.0 104.421 176.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.49 119.27 15.4 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-N 119.245 0.929 . . . . 25.0 110.241 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 35.4 m -85.79 162.1 2.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.047 -0.979 . . . . 25.0 110.481 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.7 m -140.86 168.41 19.87 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 110.32 -0.252 . . . . 25.0 110.32 -177.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 30.4 m -128.54 161.75 36.69 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 N-CA-C 107.223 -1.399 . . . . 25.0 107.223 175.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.2 t -72.09 -47.37 51.88 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 106.518 -1.66 . . . . 25.0 106.518 173.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -167.03 -161.51 0.43 Allowed 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 102.13 -3.285 . . . . 25.0 102.13 -176.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -68.32 -17.73 64.34 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 120.259 1.391 . . . . 25.0 112.039 -177.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -129.33 -155.04 8.37 Favored Glycine 0 N--CA 1.44 -1.048 0 N-CA-C 108.497 -1.841 . . . . 25.0 108.497 176.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 56.06 -150.68 0.42 Allowed 'General case' 0 N--CA 1.473 0.708 0 O-C-N 122.82 -0.223 . . . . 25.0 111.137 -178.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 27.8 mtt85 -77.45 158.78 29.83 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 116.851 2.167 . . . . 25.0 116.851 -169.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.0 163.36 16.03 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 113.47 -1.695 . . . . 25.0 106.591 177.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -137.51 154.32 49.88 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 118.451 0.569 . . . . 25.0 111.519 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 33.8 tp -123.56 119.63 30.48 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 105.754 -1.943 . . . . 25.0 105.754 169.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -119.24 154.9 32.69 Favored 'General case' 0 C--O 1.246 0.91 0 CA-C-O 121.712 0.768 . . . . 25.0 112.811 -173.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.1 t -103.0 153.69 19.98 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 104.666 -2.346 . . . . 25.0 104.666 169.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -120.67 9.52 10.81 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 122.346 1.069 . . . . 25.0 109.054 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -93.92 136.58 34.05 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 105.423 -2.065 . . . . 25.0 105.423 171.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -139.11 147.56 42.12 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.895 0.855 . . . . 25.0 110.057 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -73.99 159.25 32.98 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.012 -1.107 . . . . 25.0 108.012 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -61.98 -23.8 66.62 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 120.867 0.365 . . . . 25.0 110.587 177.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -75.83 -2.45 30.05 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.702 0.801 . . . . 25.0 111.934 177.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.39 15.8 70.55 Favored Glycine 0 C--O 1.238 0.351 0 C-N-CA 121.365 -0.445 . . . . 25.0 112.895 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 75.4 mt -88.87 139.48 30.42 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.529 -1.286 . . . . 25.0 107.529 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 86.8 p -148.56 176.19 10.53 Favored 'General case' 0 C--O 1.249 1.05 0 N-CA-C 108.771 -0.826 . . . . 25.0 108.771 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -122.28 131.8 54.1 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 113.439 0.903 . . . . 25.0 113.439 -176.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -150.28 154.21 37.5 Favored 'General case' 0 C--O 1.266 1.924 0 N-CA-C 107.317 -1.364 . . . . 25.0 107.317 168.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.4 p -145.73 146.79 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 106.813 -1.551 . . . . 25.0 106.813 175.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -112.1 142.45 44.53 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.533 -0.914 . . . . 25.0 108.533 -171.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.2 mp -133.78 143.96 48.74 Favored 'General case' 0 C--O 1.197 -1.685 0 N-CA-C 103.617 -2.734 . . . . 25.0 103.617 -173.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -115.88 5.56 14.07 Favored 'General case' 0 C--O 1.206 -1.225 0 N-CA-C 117.885 2.55 . . . . 25.0 117.885 -175.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.94 0.59 86.78 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 116.244 1.258 . . . . 25.0 116.244 177.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 41.8 t0 55.45 53.07 10.28 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 122.832 1.301 . . . . 25.0 110.359 178.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -118.65 38.64 3.7 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 113.455 -1.702 . . . . 25.0 108.428 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.9 -39.49 78.04 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.773 -0.648 . . . . 25.0 112.084 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.78 -19.47 62.0 Favored 'General case' 0 CA--C 1.577 2.005 0 O-C-N 121.156 -0.965 . . . . 25.0 112.545 -177.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.22 -26.42 20.1 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 116.132 -0.486 . . . . 25.0 111.805 177.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 22.0 mt -60.25 132.39 53.76 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 121.203 0.525 . . . . 25.0 109.646 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.9 m -135.22 160.96 36.73 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 107.529 -1.286 . . . . 25.0 107.529 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.83 -1.29 57.1 Favored 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 108.232 -1.025 . . . . 25.0 108.232 178.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -69.2 -30.04 68.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.884 -0.598 . . . . 25.0 110.838 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -90.44 -5.93 55.5 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.268 0.556 . . . . 25.0 111.018 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 17.0 mm -89.91 123.99 42.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 105.785 -1.932 . . . . 25.0 105.785 176.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.7 p -98.45 117.1 42.88 Favored 'Isoleucine or valine' 0 C--O 1.251 1.145 0 CA-C-O 122.831 1.301 . . . . 25.0 113.318 -175.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -143.97 0.56 1.08 Allowed 'General case' 0 C--O 1.251 1.146 0 CA-C-N 112.358 -2.201 . . . . 25.0 108.547 178.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.15 45.0 0.98 Allowed 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.009 0.374 . . . . 25.0 112.009 -178.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 53.49 37.57 26.02 Favored 'General case' 0 CA--C 1.561 1.4 0 CA-C-O 121.172 0.51 . . . . 25.0 112.363 -178.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.99 -4.32 0.2 Allowed 'General case' 0 CA--C 1.56 1.363 0 N-CA-C 115.636 1.717 . . . . 25.0 115.636 177.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -89.96 125.32 35.33 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 120.713 -1.242 . . . . 25.0 113.612 -177.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -77.22 -4.18 43.45 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 113.405 0.891 . . . . 25.0 113.405 -177.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -77.04 40.5 0.26 Allowed 'General case' 0 C--O 1.217 -0.649 0 N-CA-C 114.577 1.325 . . . . 25.0 114.577 178.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -152.93 -165.43 2.18 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.128 -0.694 . . . . 25.0 109.128 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 60.97 -167.11 0.19 Allowed 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 113.6 0.963 . . . . 25.0 113.6 174.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 82.2 15.89 73.28 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.374 -0.69 . . . . 25.0 111.374 -177.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -99.66 108.61 21.02 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.95 0.722 . . . . 25.0 112.95 -176.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -128.57 155.68 44.53 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 106.71 -1.589 . . . . 25.0 106.71 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -125.95 31.19 4.17 Favored Glycine 0 C--O 1.217 -0.945 0 CA-C-O 121.746 0.636 . . . . 25.0 111.895 175.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 92.3 t -73.45 -38.11 52.21 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 O-C-N 122.286 -0.538 . . . . 25.0 110.33 -175.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.56 137.73 23.83 Favored 'Isoleucine or valine' 0 C--O 1.258 1.532 0 CA-C-O 121.459 0.647 . . . . 25.0 110.442 -175.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 153.9 165.95 14.29 Favored Glycine 0 C--O 1.245 0.836 0 CA-C-N 115.482 -0.781 . . . . 25.0 111.991 -178.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -143.85 139.53 29.32 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 112.957 0.725 . . . . 25.0 112.957 176.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 84.4 p -142.69 179.9 6.71 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.857 -1.164 . . . . 25.0 107.857 175.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 135.5 172.96 12.86 Favored Glycine 0 C--O 1.24 0.517 0 N-CA-C 115.034 0.774 . . . . 25.0 115.034 175.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -137.04 113.54 9.75 Favored Pre-proline 0 C--O 1.26 1.608 0 CA-C-N 114.929 -0.635 . . . . 25.0 110.382 178.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -68.06 153.95 73.77 Favored 'Trans proline' 0 C--N 1.356 0.964 0 O-C-N 122.509 0.741 . . . . 25.0 110.663 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -128.36 139.52 52.34 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.772 -1.196 . . . . 25.0 107.772 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -131.52 69.11 81.64 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 112.689 0.626 . . . . 25.0 112.689 -177.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -70.26 150.25 64.88 Favored 'Trans proline' 0 C--N 1.346 0.419 0 CA-C-O 122.107 0.795 . . . . 25.0 113.016 -178.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.4 t -97.71 1.33 48.42 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.357 -0.838 . . . . 25.0 111.734 -175.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 C--O 1.253 1.281 0 CA-C-O 118.089 -0.957 . . . . 25.0 110.86 -177.429 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 110.193 -0.299 . . . . 25.0 110.193 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -141.05 113.0 6.84 Favored Pre-proline 0 C--O 1.245 0.867 0 N-CA-C 112.965 0.728 . . . . 25.0 112.965 -178.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.39 157.09 45.62 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 116.537 -1.842 . . . . 25.0 114.262 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.27 58.33 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.208 0 N-CA-C 108.362 -1.895 . . . . 25.0 108.362 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.1 p -60.29 132.77 25.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 123.219 1.485 . . . . 25.0 112.064 -170.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -101.26 -11.56 19.39 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.789 -1.096 . . . . 25.0 110.065 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.75 -151.63 14.46 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 114.735 -1.12 . . . . 25.0 112.61 177.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.2 p 73.08 158.17 0.16 Allowed Pre-proline 0 N--CA 1.496 1.854 0 C-N-CA 126.242 1.817 . . . . 25.0 110.187 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.416 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 37.6 Cg_exo -65.68 -0.81 4.11 Favored 'Trans proline' 0 C--N 1.349 0.602 0 N-CA-C 116.465 1.679 . . . . 25.0 116.465 -175.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.58 -19.23 20.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 114.311 1.226 . . . . 25.0 114.311 -173.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.5 p -140.45 136.05 36.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 114.096 1.147 . . . . 25.0 114.096 -174.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.44 25.57 56.57 Favored Glycine 0 C--O 1.242 0.652 0 N-CA-C 117.343 1.697 . . . . 25.0 117.343 172.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.9 t -50.09 -54.58 19.51 Favored 'General case' 0 C--O 1.22 -0.468 0 O-C-N 121.15 -1.206 . . . . 25.0 113.459 -175.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -80.17 4.64 16.79 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 116.447 2.018 . . . . 25.0 116.447 -171.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 pp -142.04 168.4 19.83 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 112.915 0.709 . . . . 25.0 112.915 -174.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -61.67 130.45 45.91 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.695 0.798 . . . . 25.0 112.03 -175.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -125.23 168.67 13.15 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 116.442 2.016 . . . . 50.0 116.442 -175.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -129.72 96.9 4.36 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 105.654 -1.98 . . . . 25.0 105.654 164.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 81.2 mt -108.92 113.03 25.59 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 112.462 0.541 . . . . 25.0 112.462 -176.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -104.38 113.69 27.42 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 108.409 -0.96 . . . . 25.0 108.409 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.47 177.85 48.79 Favored Glycine 0 CA--C 1.51 -0.23 0 N-CA-C 117.331 1.692 . . . . 25.0 117.331 -174.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.2 p -77.06 168.82 19.43 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-O 122.0 0.905 . . . . 25.0 112.501 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 77.6 mt -85.63 24.61 1.19 Allowed 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 114.624 -1.171 . . . . 25.0 111.531 176.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -128.77 179.36 16.68 Favored Glycine 0 N--CA 1.467 0.703 0 N-CA-C 110.48 -1.048 . . . . 25.0 110.48 175.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.1 t -66.53 137.41 56.77 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 117.86 0.83 . . . . 25.0 111.736 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -146.46 165.68 28.67 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 122.027 -0.421 . . . . 50.0 110.88 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -116.16 121.21 41.45 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 102.67 -3.085 . . . . 25.0 102.67 170.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 46.6 mm -117.12 129.29 73.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 107.523 -1.288 . . . . 25.0 107.523 -176.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.416 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 7.1 mp -128.77 125.18 37.31 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 105.399 -2.075 . . . . 25.0 105.399 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.14 -35.1 24.86 Favored Glycine 0 C--O 1.255 1.453 0 N-CA-C 115.698 1.039 . . . . 25.0 115.698 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.03 -148.43 44.48 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.38 -0.914 . . . . 25.0 111.434 -178.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.96 165.23 54.8 Favored Glycine 0 C--O 1.248 1.015 0 CA-C-O 122.471 1.039 . . . . 25.0 111.705 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.31 162.69 33.3 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 114.731 -0.734 . . . . 25.0 113.488 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.9 101.0 12.48 Favored 'General case' 0 C--O 1.203 -1.343 0 N-CA-C 105.022 -2.214 . . . . 25.0 105.022 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -96.82 151.62 19.49 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 115.88 -0.6 . . . . 50.0 110.536 -170.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -110.81 103.22 11.72 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 106.552 -1.647 . . . . 25.0 106.552 171.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 43.3 mt -106.3 132.12 52.72 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 124.032 0.833 . . . . 25.0 111.064 -174.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -130.15 104.26 7.21 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 121.465 0.65 . . . . 25.0 110.959 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.98 -30.23 63.65 Favored Glycine 0 N--CA 1.466 0.635 0 N-CA-C 116.165 1.226 . . . . 25.0 116.165 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 50.3 -151.35 0.2 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 118.29 1.045 . . . . 25.0 112.857 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.06 160.51 15.02 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.413 0.894 . . . . 25.0 113.413 -175.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.83 157.02 31.73 Favored Glycine 0 C--O 1.238 0.345 0 CA-C-N 114.778 -1.101 . . . . 25.0 111.192 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -80.4 102.91 9.91 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.236 -1.024 . . . . 25.0 108.236 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -106.05 157.75 17.3 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.344 0.592 . . . . 50.0 111.249 -169.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 mp -114.96 131.9 56.75 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 106.17 -1.789 . . . . 25.0 106.17 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.5 mp -132.71 127.09 34.02 Favored 'General case' 0 C--O 1.25 1.107 0 N-CA-C 115.217 1.562 . . . . 25.0 115.217 -174.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -120.04 145.16 47.1 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 107.333 -1.358 . . . . 25.0 107.333 172.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -98.3 -39.78 3.64 Favored Glycine 0 N--CA 1.465 0.618 0 C-N-CA 120.963 -0.637 . . . . 25.0 113.715 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.97 -167.74 54.71 Favored Glycine 0 N--CA 1.465 0.632 0 N-CA-C 110.107 -1.197 . . . . 25.0 110.107 -177.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.67 143.67 29.61 Favored 'General case' 0 CA--C 1.557 1.241 0 CA-C-O 121.85 0.833 . . . . 25.0 111.959 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.35 167.43 32.68 Favored Glycine 0 C--O 1.245 0.781 0 CA-C-N 115.169 -0.923 . . . . 25.0 113.365 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.94 114.05 23.24 Favored 'General case' 0 C--O 1.208 -1.124 0 N-CA-C 104.731 -2.322 . . . . 25.0 104.731 175.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -103.48 151.76 22.46 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.915 -0.584 . . . . 50.0 109.814 -173.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -116.09 122.83 46.31 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 104.869 -2.271 . . . . 25.0 104.869 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -145.42 138.52 26.28 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 117.651 2.463 . . . . 25.0 117.651 -169.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.422 ' OG ' HD12 ' A' ' 85' ' ' LEU . 73.2 m -111.13 141.12 45.05 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-N 115.332 -0.849 . . . . 25.0 108.998 176.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.13 -37.74 6.62 Favored Glycine 0 N--CA 1.44 -1.069 0 N-CA-C 110.296 -1.122 . . . . 25.0 110.296 172.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.51 -169.78 54.86 Favored Glycine 0 CA--C 1.507 -0.423 0 C-N-CA 119.941 -1.124 . . . . 25.0 113.439 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -63.51 154.95 30.82 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.604 -0.939 . . . . 25.0 111.369 176.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.75 162.66 30.06 Favored Glycine 0 C--O 1.244 0.729 0 N-CA-C 109.914 -1.274 . . . . 25.0 109.914 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.04 110.99 19.33 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.056 -1.09 . . . . 25.0 108.056 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -103.97 154.53 19.56 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.569 -0.453 . . . . 50.0 112.113 -170.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.5 m -120.22 105.71 11.22 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.438 -0.578 . . . . 25.0 109.438 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -89.1 93.65 9.66 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 105.159 -2.163 . . . . 25.0 105.159 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -92.55 -30.28 15.75 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 112.888 0.699 . . . . 25.0 112.888 -166.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 63.56 156.41 0.06 Allowed 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 124.337 1.055 . . . . 25.0 112.838 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.88 -67.51 0.7 Allowed 'General case' 0 C--O 1.252 1.203 0 N-CA-C 115.896 1.813 . . . . 25.0 115.896 -170.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.8 mt -137.92 -177.69 4.93 Favored 'General case' 0 C--O 1.216 -0.663 0 O-C-N 121.523 -0.736 . . . . 25.0 109.239 -173.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -53.24 -30.14 36.41 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.709 -0.848 . . . . 25.0 108.709 170.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -76.66 4.2 9.96 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 115.391 1.626 . . . . 25.0 115.391 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -118.09 142.15 47.72 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 118.173 0.442 . . . . 25.0 111.639 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.2 t 49.28 53.27 12.93 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 122.469 1.128 . . . . 25.0 112.272 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 31.9 p-80 -137.1 174.05 11.03 Favored 'General case' 0 C--O 1.212 -0.905 0 CA-C-N 114.754 -1.112 . . . . 25.0 109.229 -174.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -126.01 143.26 51.17 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 105.754 -1.943 . . . . 25.0 105.754 173.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.6 p -133.25 170.8 10.43 Favored Pre-proline 0 C--N 1.318 -0.778 0 N-CA-C 108.122 -1.066 . . . . 25.0 108.122 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.42 -16.79 43.9 Favored 'Trans proline' 0 C--O 1.206 -1.121 0 C-N-CA 117.09 -1.473 . . . . 25.0 114.043 177.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 88.8 mt -77.83 -29.81 50.8 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 120.101 -0.64 . . . . 25.0 110.966 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.55 -178.35 34.8 Favored Glycine 0 C--O 1.219 -0.829 0 N-CA-C 110.607 -0.997 . . . . 25.0 110.607 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t -96.43 148.06 23.19 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-O 122.755 1.264 . . . . 25.0 111.1 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -134.74 28.05 3.6 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 113.639 -1.619 . . . . 25.0 107.844 176.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.34 137.72 29.74 Favored Glycine 0 C--N 1.34 0.799 0 N-CA-C 108.861 -1.696 . . . . 25.0 108.861 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -87.58 165.09 15.72 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 121.321 -1.105 . . . . 50.0 110.393 -172.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -119.18 100.23 7.2 Favored 'General case' 0 C--O 1.257 1.454 0 CA-C-O 121.352 0.596 . . . . 25.0 111.687 -171.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.8 mt -89.26 132.88 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-O 123.011 1.386 . . . . 25.0 107.951 -175.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.422 HD12 ' OG ' ' A' ' 56' ' ' SER . 94.7 mt -83.93 -43.09 15.61 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 114.81 1.411 . . . . 25.0 114.81 -174.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -138.64 40.21 2.2 Favored 'General case' 0 C--O 1.26 1.608 0 N-CA-C 115.28 1.585 . . . . 25.0 115.28 -172.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -56.75 128.39 36.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.525 0.678 . . . . 25.0 111.914 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -97.96 108.1 44.47 Favored Pre-proline 0 N--CA 1.469 0.492 0 N-CA-C 106.911 -1.515 . . . . 25.0 106.911 175.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -72.4 -4.55 15.47 Favored 'Trans proline' 0 CA--C 1.552 1.394 0 N-CA-C 115.63 1.358 . . . . 25.0 115.63 -174.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 29.7 t -95.0 -46.75 6.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.085 0.469 . . . . 25.0 109.859 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -92.15 -40.52 10.97 Favored 'General case' 0 C--O 1.245 0.867 0 N-CA-C 114.382 1.253 . . . . 25.0 114.382 -172.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -84.87 171.52 12.15 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.695 0.76 . . . . 75.0 110.079 -173.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.63 155.62 45.71 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.606 0.763 . . . . 25.0 111.32 174.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 77.9 mt -125.44 124.34 66.77 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 106.796 -1.557 . . . . 25.0 106.796 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -86.25 150.75 24.15 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 119.728 -0.789 . . . . 25.0 109.179 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.9 p -154.64 -1.6 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 115.418 -0.81 . . . . 25.0 111.674 -176.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.2 t -66.28 -51.28 59.0 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.635 0.605 . . . . 25.0 112.635 -174.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.9 -24.35 60.83 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.886 0.699 . . . . 25.0 112.886 -176.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.56 -29.35 9.23 Favored 'General case' 0 C--O 1.212 -0.872 0 N-CA-C 118.075 2.621 . . . . 25.0 118.075 -174.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -121.69 -65.21 0.24 Allowed Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.456 -0.878 . . . . 25.0 115.03 -172.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -162.26 163.55 28.08 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 117.21 0.505 . . . . 25.0 109.759 -175.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 77.8 p -114.7 -28.79 6.99 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.557 0.536 . . . . 25.0 110.647 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -103.29 120.35 6.72 Favored Glycine 0 C--O 1.239 0.431 0 N-CA-C 110.642 -0.983 . . . . 25.0 110.642 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -67.24 151.18 47.99 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 118.865 1.333 . . . . 25.0 111.597 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -97.55 -157.33 30.48 Favored Glycine 0 CA--C 1.507 -0.435 0 CA-C-N 115.141 -0.936 . . . . 25.0 112.965 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -54.91 136.74 46.87 Favored 'General case' 0 C--O 1.245 0.868 0 N-CA-C 113.954 1.094 . . . . 25.0 113.954 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 165.94 172.43 33.29 Favored Glycine 0 C--O 1.22 -0.746 0 N-CA-C 109.457 -1.457 . . . . 25.0 109.457 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -141.18 166.68 24.11 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.022 0.911 . . . . 25.0 109.194 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 56.2 34.21 23.53 Favored 'General case' 0 CA--C 1.551 1.009 0 O-C-N 124.305 1.003 . . . . 25.0 113.127 -176.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.07 38.68 59.49 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 111.132 -0.787 . . . . 25.0 111.132 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.1 t -139.99 -174.23 3.86 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.803 0.802 . . . . 25.0 113.152 -176.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 52.2 mt -114.9 150.71 35.21 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 101.127 -3.657 . . . . 25.0 101.127 174.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.93 132.45 47.98 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-O 121.357 0.598 . . . . 25.0 110.058 -175.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 32.9 m -97.02 164.85 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 115.435 -0.802 . . . . 25.0 111.533 -176.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.8 m -139.95 164.54 29.74 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 110.313 -0.255 . . . . 25.0 110.313 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.3 m -126.78 166.31 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 107.584 -1.265 . . . . 25.0 107.584 176.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 30.3 t -81.55 -56.63 3.9 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 106.961 -1.496 . . . . 25.0 106.961 173.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -161.98 -147.59 0.13 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 105.263 -2.125 . . . . 25.0 105.263 -177.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -66.64 -21.68 66.11 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.371 0.268 . . . . 25.0 110.409 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -138.68 -150.38 5.59 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 110.385 -1.086 . . . . 25.0 110.385 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.19 -155.59 0.35 Allowed 'General case' 0 C--O 1.259 1.594 0 C-N-CA 123.053 0.541 . . . . 25.0 111.049 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 54.0 mtt85 -85.19 160.75 19.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 122.017 0.913 . . . . 25.0 113.018 -172.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 12.3 p -107.8 163.83 12.77 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 106.187 -1.783 . . . . 25.0 106.187 173.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -135.01 158.05 45.36 Favored 'General case' 0 CA--C 1.51 -0.587 0 O-C-N 123.529 0.518 . . . . 25.0 112.325 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 45.2 tp -128.7 136.17 50.23 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 103.759 -2.682 . . . . 25.0 103.759 172.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -127.44 148.81 50.29 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 122.468 1.128 . . . . 25.0 110.955 -176.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 32.4 t -101.96 146.5 27.78 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 103.874 -2.639 . . . . 25.0 103.874 168.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -108.82 10.45 26.59 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.406 0.622 . . . . 25.0 109.667 -174.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -94.45 143.51 26.35 Favored 'General case' 0 C--O 1.259 1.57 0 CA-C-N 113.608 -1.633 . . . . 25.0 108.938 167.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -149.12 156.7 42.58 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.809 -0.811 . . . . 25.0 108.809 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -70.24 160.58 31.92 Favored 'General case' 0 C--O 1.217 -0.635 0 N-CA-C 107.823 -1.177 . . . . 25.0 107.823 173.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.91 -21.53 66.51 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.401 -0.592 . . . . 25.0 109.401 175.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -79.68 -3.56 47.87 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.04 0.755 . . . . 25.0 113.04 177.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.96 24.01 46.86 Favored Glycine 0 N--CA 1.466 0.66 0 C-N-CA 121.113 -0.565 . . . . 25.0 113.42 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 35.9 mt -94.8 111.71 23.47 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.628 -1.249 . . . . 25.0 107.628 176.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 42.9 p -122.42 174.17 7.2 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 118.645 -0.693 . . . . 25.0 109.474 -174.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -116.39 126.3 53.27 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.344 0.52 . . . . 25.0 111.247 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -145.77 153.82 41.36 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 107.207 -1.405 . . . . 25.0 107.207 171.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 11.7 p -145.89 145.66 20.0 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 N-CA-C 106.77 -1.567 . . . . 25.0 106.77 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -106.16 143.82 33.74 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.884 -0.784 . . . . 25.0 108.884 -175.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mp -134.46 134.35 41.44 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.514 -1.291 . . . . 25.0 107.514 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -110.8 8.88 22.55 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 119.706 1.139 . . . . 25.0 112.668 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -78.91 -10.68 85.96 Favored Glycine 0 C--O 1.243 0.695 0 C-N-CA 119.596 -1.287 . . . . 25.0 112.57 174.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 48.4 t0 49.45 64.43 1.75 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 122.946 1.355 . . . . 25.0 112.051 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -130.52 36.54 3.93 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 106.274 -1.751 . . . . 25.0 106.274 176.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.55 -33.58 71.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.718 -1.128 . . . . 25.0 108.162 174.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.92 -11.73 49.39 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 113.302 0.852 . . . . 25.0 113.302 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -119.85 1.71 11.01 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 121.671 -0.643 . . . . 25.0 112.069 -178.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 14.9 mt -72.19 148.45 45.58 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.303 -0.559 . . . . 25.0 111.433 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 83.7 p -147.45 159.37 43.79 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 106.635 -1.617 . . . . 25.0 106.635 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.59 -1.9 52.16 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 108.698 -0.852 . . . . 25.0 108.698 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -68.84 -35.68 77.25 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.536 -0.913 . . . . 25.0 108.536 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -89.15 0.08 57.02 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.786 -0.571 . . . . 25.0 110.374 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 46.3 mm -94.85 113.74 29.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 104.251 -2.499 . . . . 25.0 104.251 174.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.7 p -98.78 101.91 12.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 124.081 1.896 . . . . 25.0 111.905 -170.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -116.78 -14.17 10.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 112.983 -1.917 . . . . 25.0 109.962 173.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -81.91 28.48 0.42 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.02 1.118 . . . . 25.0 114.02 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 55.66 33.32 21.04 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.232 0.827 . . . . 25.0 113.232 177.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.78 25.07 11.47 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.179 0.991 . . . . 25.0 112.698 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -90.01 133.76 34.63 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.594 -1.262 . . . . 25.0 107.594 174.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -112.82 23.04 13.86 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.203 0.601 . . . . 25.0 111.623 -176.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.79 -32.81 71.49 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 122.098 -0.376 . . . . 25.0 111.314 176.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -104.5 -156.13 0.56 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 123.29 0.636 . . . . 25.0 110.562 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 67.09 175.08 0.25 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.046 1.338 . . . . 25.0 113.824 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 87.04 9.1 74.39 Favored Glycine 0 C--O 1.224 -0.49 0 CA-C-N 115.757 -0.656 . . . . 25.0 112.478 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -82.84 100.06 10.1 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-O 121.197 0.522 . . . . 25.0 110.722 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -126.33 149.07 49.41 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.43 0.633 . . . . 25.0 109.849 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.91 33.89 2.4 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 110.746 -0.941 . . . . 25.0 110.746 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 45.1 t -73.6 -29.55 27.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.751 -0.724 . . . . 25.0 109.418 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 19.2 tt -57.18 134.67 21.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 N-CA-C 112.84 0.681 . . . . 25.0 112.84 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 158.02 157.59 8.53 Favored Glycine 0 C--O 1.222 -0.596 0 N-CA-C 114.681 0.632 . . . . 25.0 114.681 175.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -146.08 136.35 23.82 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 123.456 0.151 . . . . 25.0 110.639 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 53.6 p -152.73 163.96 38.68 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 106.97 -1.493 . . . . 25.0 106.97 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -167.44 162.46 36.25 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 114.738 0.655 . . . . 25.0 114.738 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -133.45 80.18 58.28 Favored Pre-proline 0 N--CA 1.468 0.432 0 N-CA-C 108.832 -0.803 . . . . 25.0 108.832 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -72.82 152.79 52.94 Favored 'Trans proline' 0 C--N 1.352 0.763 0 N-CA-C 114.889 1.073 . . . . 25.0 114.889 -171.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -111.01 157.13 20.29 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.42 -0.955 . . . . 25.0 108.42 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -132.12 75.01 75.71 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 112.722 0.638 . . . . 25.0 112.722 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.49 158.72 47.5 Favored 'Trans proline' 0 C--O 1.219 -0.46 0 CA-C-O 121.11 0.379 . . . . 25.0 112.845 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.7 t -132.32 -0.5 3.65 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.611 0.72 . . . . 25.0 111.837 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 C--O 1.247 0.922 0 N-CA-C 108.808 -0.812 . . . . 25.0 108.808 178.288 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.695 0.76 . . . . 25.0 110.481 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -127.46 91.82 44.94 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 108.643 -0.873 . . . . 25.0 108.643 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -70.51 153.98 65.09 Favored 'Trans proline' 0 C--O 1.241 0.628 0 N-CA-C 115.002 1.116 . . . . 25.0 115.002 -175.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.53 75.2 0.06 OUTLIER Glycine 0 C--O 1.22 -0.779 0 N-CA-C 108.797 -1.721 . . . . 25.0 108.797 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.456 HG22 ' H ' ' A' ' 7' ' ' GLY . 14.3 p -57.48 131.71 21.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-O 122.312 1.053 . . . . 25.0 111.59 -172.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -88.99 -15.04 35.15 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 114.616 -1.174 . . . . 25.0 110.987 -176.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.456 ' H ' HG22 ' A' ' 5' ' ' VAL . . . -88.08 -141.03 7.23 Favored Glycine 0 CA--C 1.506 -0.499 0 C-N-CA 121.263 -0.494 . . . . 25.0 114.17 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.0 p 71.85 157.31 0.16 Allowed Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 126.854 2.061 . . . . 25.0 111.179 -176.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.487 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 37.6 Cg_exo -65.49 1.39 2.15 Favored 'Trans proline' 0 C--N 1.362 1.249 0 N-CA-C 117.358 2.022 . . . . 25.0 117.358 -178.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.9 p -62.86 -19.0 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 115.486 1.661 . . . . 25.0 115.486 -172.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.6 p -146.61 136.12 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 113.917 1.08 . . . . 25.0 113.917 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.08 29.68 14.53 Favored Glycine 0 N--CA 1.462 0.422 0 N-CA-C 116.856 1.502 . . . . 25.0 116.856 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.9 t -57.25 -65.29 0.65 Allowed 'General case' 0 C--O 1.239 0.538 0 N-CA-C 114.132 1.16 . . . . 25.0 114.132 -177.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -80.35 10.2 4.88 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 114.347 1.24 . . . . 25.0 114.347 -170.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.91 174.56 10.39 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 118.912 -0.566 . . . . 25.0 110.461 -172.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -60.52 150.27 31.96 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 118.861 0.755 . . . . 25.0 111.72 -177.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -128.12 156.22 43.18 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.588 1.329 . . . . 50.0 114.588 -175.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -137.15 94.27 2.93 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 102.851 -3.018 . . . . 25.0 102.851 163.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.0 mt -120.25 111.72 18.16 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 114.483 1.29 . . . . 25.0 114.483 -173.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -98.19 104.94 17.01 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 115.744 -0.662 . . . . 25.0 111.484 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.95 179.55 52.68 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 117.584 1.794 . . . . 25.0 117.584 -173.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.0 p -74.63 169.54 17.59 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 112.246 0.461 . . . . 25.0 112.246 -177.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 51.2 mt -89.05 14.12 11.4 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.912 0.863 . . . . 25.0 110.332 175.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.67 178.77 17.79 Favored Glycine 0 C--O 1.223 -0.56 0 N-CA-C 108.638 -1.785 . . . . 25.0 108.638 175.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.7 t -70.29 140.91 52.41 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 117.356 0.578 . . . . 25.0 111.351 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -146.15 164.35 32.5 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.784 -0.821 . . . . 50.0 108.784 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -106.35 121.76 44.88 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 102.777 -3.045 . . . . 25.0 102.777 162.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.0 mm -109.18 111.31 35.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 107.487 -1.301 . . . . 25.0 107.487 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.487 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 4.4 mp -112.34 117.51 32.67 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.609 -1.256 . . . . 25.0 107.609 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.4 -27.69 38.78 Favored Glycine 0 C--O 1.206 -1.608 0 CA-C-O 119.133 -0.815 . . . . 25.0 114.425 -176.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.6 -147.08 44.76 Favored Glycine 0 C--O 1.243 0.658 0 C-N-CA 120.152 -1.023 . . . . 25.0 111.636 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.85 177.13 53.4 Favored Glycine 0 C--O 1.242 0.623 0 N-CA-C 112.054 -0.418 . . . . 25.0 112.054 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.04 166.87 29.31 Favored Glycine 0 C--N 1.316 -0.564 0 CA-C-N 115.854 -0.173 . . . . 25.0 112.906 176.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.01 105.19 13.8 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 106.875 -1.528 . . . . 25.0 106.875 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -104.81 138.84 40.47 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.772 -0.771 . . . . 50.0 111.596 -168.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -106.33 96.11 6.24 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.094 -1.817 . . . . 25.0 106.094 173.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 45.5 mt -105.65 143.51 33.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.247 -0.433 . . . . 25.0 110.454 -172.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -136.77 107.46 6.57 Favored 'General case' 0 C--O 1.248 0.983 0 CA-C-O 121.319 0.581 . . . . 25.0 110.698 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.05 -23.47 71.6 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 117.94 -1.478 . . . . 25.0 116.649 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 52.71 -159.13 0.13 Allowed 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 119.217 1.508 . . . . 25.0 111.814 -176.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.73 167.63 10.9 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 121.475 -0.765 . . . . 25.0 112.728 -175.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.75 155.77 32.24 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.963 -0.855 . . . . 25.0 110.963 -177.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -83.65 97.06 8.88 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.687 -0.856 . . . . 25.0 108.687 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -98.02 161.37 13.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.273 -0.421 . . . . 50.0 111.867 -169.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mp -119.55 131.93 55.64 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 105.549 -2.019 . . . . 25.0 105.549 175.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.4 mp -130.8 125.3 33.36 Favored 'General case' 0 C--O 1.248 0.996 0 N-CA-C 115.021 1.489 . . . . 25.0 115.021 -171.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -125.86 93.2 3.77 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.005 -1.452 . . . . 25.0 109.503 177.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.33 -27.02 70.05 Favored Glycine 0 C--N 1.342 0.874 0 C-N-CA 120.898 -0.668 . . . . 25.0 114.121 -177.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.99 -172.71 46.28 Favored Glycine 0 CA--C 1.522 0.514 0 CA-C-N 118.022 0.911 . . . . 25.0 113.106 177.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.94 148.72 16.61 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.94 0.876 . . . . 25.0 113.124 -175.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.59 159.04 35.23 Favored Glycine 0 C--O 1.219 -0.814 0 N-CA-C 110.274 -1.13 . . . . 25.0 110.274 -177.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -82.01 121.94 27.17 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 107.451 -1.314 . . . . 25.0 107.451 -177.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -112.02 161.42 16.49 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 119.537 -0.268 . . . . 50.0 111.686 -172.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.72 101.1 5.75 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 105.128 -2.175 . . . . 25.0 105.128 175.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -122.7 138.12 54.71 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 114.755 1.391 . . . . 25.0 114.755 -170.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 61.0 m -103.66 145.33 30.21 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.911 -1.144 . . . . 25.0 107.911 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.78 -33.18 6.5 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.781 -0.927 . . . . 25.0 110.781 173.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.59 -173.86 52.93 Favored Glycine 0 C--O 1.239 0.414 0 O-C-N 121.54 -0.976 . . . . 25.0 112.058 -177.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -58.1 149.49 23.5 Favored 'General case' 0 C--O 1.251 1.157 0 N-CA-C 112.108 0.41 . . . . 25.0 112.108 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.26 160.56 29.26 Favored Glycine 0 C--O 1.245 0.803 0 CA-C-O 119.588 -0.562 . . . . 25.0 111.752 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.04 106.56 12.15 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.966 0.412 . . . . 25.0 110.308 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -101.05 155.29 18.07 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.603 0.716 . . . . 50.0 110.524 -171.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.4 m -121.11 125.45 47.27 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.243 -0.889 . . . . 25.0 108.701 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -112.1 130.63 55.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.802 -1.555 . . . . 25.0 106.802 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 -122.28 -27.54 4.47 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 120.051 -0.66 . . . . 25.0 112.601 -177.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 63.92 161.77 0.11 Allowed 'General case' 0 N--CA 1.476 0.856 0 O-C-N 124.725 1.265 . . . . 25.0 112.241 -173.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.22 -50.66 10.6 Favored 'General case' 0 C--O 1.247 0.972 0 N-CA-C 114.595 1.332 . . . . 25.0 114.595 -171.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.7 mt -152.31 179.56 8.43 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.08 -0.711 . . . . 25.0 109.08 -172.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -54.26 -29.21 46.18 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.749 0.785 . . . . 25.0 110.451 167.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -69.55 -1.93 10.04 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 114.715 -1.129 . . . . 25.0 113.584 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.81 147.18 37.48 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-O 121.259 0.552 . . . . 25.0 112.385 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.1 t 43.95 60.36 2.76 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 114.471 -1.24 . . . . 25.0 113.934 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 53.5 p-80 -135.12 169.07 18.01 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 115.74 -0.664 . . . . 25.0 110.18 -175.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -116.95 142.62 46.72 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 104.034 -2.58 . . . . 25.0 104.034 171.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 94.7 p -128.0 168.92 13.8 Favored Pre-proline 0 N--CA 1.471 0.602 0 N-CA-C 105.643 -1.984 . . . . 25.0 105.643 -177.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.88 -22.34 62.11 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 117.223 -1.384 . . . . 25.0 113.272 176.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.6 mt -76.71 -18.06 58.73 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.02 0.748 . . . . 25.0 113.02 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 134.99 -176.92 19.7 Favored Glycine 0 C--N 1.31 -0.905 0 N-CA-C 110.853 -0.899 . . . . 25.0 110.853 -177.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.0 t -82.31 147.47 28.86 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 115.601 1.704 . . . . 25.0 115.601 -177.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -135.66 29.89 3.19 Favored 'General case' 0 C--O 1.249 1.031 0 CA-C-N 113.619 -1.628 . . . . 25.0 107.866 173.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.57 147.23 50.64 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 114.27 -1.332 . . . . 25.0 111.957 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -86.69 165.46 16.08 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 107.518 -1.289 . . . . 50.0 107.518 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -121.42 120.12 34.06 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 110.209 -0.293 . . . . 25.0 110.209 -176.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.5 mt -99.1 128.99 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 107.76 -1.2 . . . . 25.0 107.76 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.6 mt -85.2 -46.96 10.57 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 114.929 1.455 . . . . 25.0 114.929 -169.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 42.2 p-10 -131.56 35.59 3.82 Favored 'General case' 0 C--O 1.247 0.948 0 O-C-N 121.27 -0.894 . . . . 25.0 112.751 -175.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -51.37 140.14 17.97 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.821 -1.082 . . . . 25.0 112.323 -176.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -106.84 108.04 61.32 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 108.146 -1.057 . . . . 25.0 108.146 175.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -73.73 -2.3 12.01 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 N-CA-C 115.098 1.153 . . . . 25.0 115.098 -173.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.6 t -101.82 -36.34 8.71 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-O 121.851 0.834 . . . . 25.0 110.093 178.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -98.47 -39.33 8.81 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 113.734 1.013 . . . . 25.0 113.734 -171.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -84.66 169.98 13.78 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.783 -0.573 . . . . 75.0 110.818 -172.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.55 147.81 30.5 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 120.934 -0.307 . . . . 25.0 111.341 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.0 mt -129.33 130.05 67.47 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 N-CA-C 108.284 -1.006 . . . . 25.0 108.284 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.63 139.89 30.1 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 108.507 -0.923 . . . . 25.0 108.507 173.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.7 p -133.69 -5.48 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.237 -0.892 . . . . 25.0 111.446 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.1 t -74.22 -33.08 63.25 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.422 -0.799 . . . . 25.0 111.958 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.97 -43.15 93.59 Favored 'General case' 0 C--O 1.247 0.934 0 O-C-N 121.748 -0.595 . . . . 25.0 111.656 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.16 -13.07 15.83 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 114.853 1.427 . . . . 25.0 114.853 -172.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.68 -80.55 0.25 Allowed Glycine 0 C--O 1.22 -0.753 0 N-CA-C 116.513 1.365 . . . . 25.0 116.513 -172.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -158.14 157.52 32.91 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 117.436 0.618 . . . . 25.0 112.02 -170.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.7 t -108.37 -28.01 9.64 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 123.839 0.712 . . . . 25.0 111.23 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -92.27 106.15 3.37 Favored Glycine 0 CA--C 1.5 -0.906 0 O-C-N 121.369 -0.832 . . . . 25.0 112.288 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.75 143.39 57.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.856 0.828 . . . . 25.0 110.541 -176.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.61 -154.32 30.6 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 116.012 -0.54 . . . . 25.0 114.126 -175.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -59.24 138.19 57.69 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 113.39 0.885 . . . . 25.0 113.39 -176.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 172.73 -168.55 41.62 Favored Glycine 0 C--O 1.252 1.251 0 N-CA-C 110.079 -1.208 . . . . 25.0 110.079 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -155.98 165.49 36.29 Favored 'General case' 0 C--O 1.247 0.957 0 N-CA-C 108.018 -1.105 . . . . 25.0 108.018 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 54.44 36.65 26.06 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 114.984 1.476 . . . . 25.0 114.984 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.32 40.81 32.55 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 109.72 -1.352 . . . . 25.0 109.72 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.7 t -153.74 178.47 9.84 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 117.885 0.843 . . . . 25.0 110.848 -176.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 71.5 mt -95.89 159.78 14.8 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 104.232 -2.507 . . . . 25.0 104.232 168.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.34 130.9 44.78 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 119.711 -0.796 . . . . 25.0 109.186 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.8 m -98.72 155.72 3.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 CA-C-N 115.607 -0.724 . . . . 25.0 109.505 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 97.5 p -144.03 167.01 23.38 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.405 -0.591 . . . . 25.0 109.405 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.447 HG12 HG22 ' A' ' 123' ' ' THR . 33.3 m -120.52 161.98 19.64 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 N-CA-C 108.807 -0.812 . . . . 25.0 108.807 178.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.6 t -66.04 -51.77 55.18 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.952 -1.129 . . . . 25.0 107.952 174.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -172.04 -156.28 0.1 Allowed 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 103.261 -2.866 . . . . 25.0 103.261 -178.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -73.48 5.28 3.89 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 113.761 1.022 . . . . 25.0 113.761 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -148.86 -156.88 7.33 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 106.397 -2.681 . . . . 25.0 106.397 175.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 56.64 -164.06 0.16 Allowed 'General case' 0 CA--C 1.562 1.422 0 O-C-N 124.287 0.639 . . . . 25.0 112.527 176.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.6 mtt85 -75.09 159.22 31.94 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.788 1.033 . . . . 25.0 113.788 -170.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.447 HG22 HG12 ' A' ' 116' ' ' VAL . 0.7 OUTLIER -101.76 159.69 15.11 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 104.499 -2.408 . . . . 25.0 104.499 174.368 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -130.95 152.05 50.69 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-O 122.564 1.173 . . . . 25.0 110.681 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 39.0 tp -126.78 117.48 22.74 Favored 'General case' 0 C--O 1.245 0.853 0 N-CA-C 103.69 -2.707 . . . . 25.0 103.69 172.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -119.74 152.25 37.49 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 111.952 0.353 . . . . 25.0 111.952 -174.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.9 t -94.45 152.65 18.42 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 104.726 -2.324 . . . . 25.0 104.726 168.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -117.32 17.55 14.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.978 0.894 . . . . 25.0 109.032 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -112.56 146.81 37.89 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 105.607 -1.997 . . . . 25.0 105.607 174.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -139.45 151.87 46.57 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.236 0.541 . . . . 25.0 110.036 -175.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -72.28 160.23 32.74 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 106.305 -1.739 . . . . 25.0 106.305 175.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.36 -18.92 65.11 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.151 0.501 . . . . 25.0 110.106 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -69.36 -8.78 49.51 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.205 0.817 . . . . 25.0 113.205 173.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.17 20.45 57.25 Favored Glycine 0 C--O 1.22 -0.726 0 C-N-CA 120.169 -1.015 . . . . 25.0 110.765 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.2 mt -106.37 119.61 39.71 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.881 -0.785 . . . . 25.0 108.881 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.8 p -116.68 174.97 5.79 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 106.132 -1.803 . . . . 25.0 106.132 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -114.95 131.68 56.82 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 118.681 0.673 . . . . 25.0 110.436 -177.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -145.98 156.86 43.79 Favored 'General case' 0 C--O 1.256 1.413 0 N-CA-C 109.323 -0.621 . . . . 25.0 109.323 166.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.8 p -146.24 141.1 21.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 106.045 -1.835 . . . . 25.0 106.045 177.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -99.13 147.78 24.74 Favored 'General case' 0 C--O 1.249 1.047 0 N-CA-C 107.699 -1.223 . . . . 25.0 107.699 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.6 mp -134.42 133.38 40.45 Favored 'General case' 0 C--O 1.206 -1.186 0 N-CA-C 103.341 -2.837 . . . . 25.0 103.341 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -110.01 13.41 23.35 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 120.051 -0.66 . . . . 25.0 110.966 -177.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -79.11 -5.9 88.95 Favored Glycine 0 C--O 1.217 -0.931 0 CA-C-N 114.809 -1.087 . . . . 25.0 112.04 172.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 14.2 t0 51.5 55.11 9.9 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 114.594 1.331 . . . . 25.0 114.594 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -128.81 46.22 2.65 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.988 -0.551 . . . . 25.0 109.536 -174.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.62 -31.91 66.71 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 113.625 0.972 . . . . 25.0 113.625 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.86 -28.74 65.91 Favored 'General case' 0 CA--C 1.554 1.106 0 O-C-N 121.482 -0.761 . . . . 25.0 111.943 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -93.64 -18.28 22.34 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 112.322 0.49 . . . . 25.0 112.322 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.5 mt -66.48 123.66 20.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 122.195 0.998 . . . . 25.0 111.486 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.401 ' C ' ' H ' ' A' ' 152' ' ' ASP . 70.9 m -137.51 164.06 29.64 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 105.522 -2.029 . . . . 25.0 105.522 177.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -71.51 10.63 0.6 Allowed 'General case' 0 C--O 1.219 -0.511 0 CA-C-O 121.225 0.536 . . . . 25.0 110.866 175.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.401 ' H ' ' C ' ' A' ' 150' ' ' SER . 46.8 t0 -72.61 -30.04 64.0 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 122.631 1.205 . . . . 25.0 110.129 177.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -94.12 8.76 40.43 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.889 -1.051 . . . . 25.0 111.65 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 39.6 mm -116.49 144.67 23.64 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 105.675 -1.972 . . . . 25.0 105.675 175.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.3 p -123.66 127.34 73.92 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 CA-C-O 122.172 0.986 . . . . 25.0 110.827 174.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.85 -30.59 5.36 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 114.379 -1.282 . . . . 25.0 109.873 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -85.42 84.25 7.69 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 115.637 1.717 . . . . 25.0 115.637 -172.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 54.75 25.24 6.33 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.759 1.763 . . . . 25.0 115.759 172.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.41 17.19 4.62 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.872 1.269 . . . . 25.0 113.514 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -98.42 125.49 43.6 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-O 121.234 0.54 . . . . 25.0 110.404 -176.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -67.24 3.09 1.31 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.469 0.914 . . . . 25.0 113.469 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.73 -15.23 63.53 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.33 0.652 . . . . 25.0 111.23 176.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.79 171.06 11.21 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 113.212 0.819 . . . . 25.0 113.212 -177.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 62.93 -170.92 0.17 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.328 1.451 . . . . 25.0 113.981 177.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 77.09 20.23 75.98 Favored Glycine 0 C--O 1.247 0.953 0 CA-C-N 115.304 -0.862 . . . . 25.0 111.15 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -124.9 109.0 12.48 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.806 -0.813 . . . . 25.0 108.806 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -127.54 150.71 49.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.313 -0.995 . . . . 25.0 108.313 -177.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -123.34 40.94 1.87 Allowed Glycine 0 CA--C 1.519 0.337 0 N-CA-C 108.961 -1.656 . . . . 25.0 108.961 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 59.5 t -94.63 -31.95 4.48 Favored 'Isoleucine or valine' 0 C--O 1.251 1.171 0 C-N-CA 122.628 0.371 . . . . 25.0 110.676 -175.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.43 130.05 16.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 CA-C-O 122.705 1.24 . . . . 25.0 113.125 -174.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 151.72 155.64 7.09 Favored Glycine 0 CA--C 1.532 1.145 0 N-CA-C 108.561 -1.815 . . . . 25.0 108.561 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -153.34 147.38 25.53 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 117.849 0.825 . . . . 25.0 110.535 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 98.2 p -149.64 164.98 33.68 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.964 -1.124 . . . . 25.0 107.964 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -175.6 -170.12 38.09 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.995 -0.621 . . . . 25.0 112.369 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -152.59 99.56 2.8 Favored Pre-proline 0 C--N 1.314 -0.963 0 N-CA-C 107.819 -1.178 . . . . 25.0 107.819 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -71.02 153.58 63.07 Favored 'Trans proline' 0 C--O 1.247 0.936 0 C-N-CA 117.05 -1.5 . . . . 25.0 113.396 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -118.79 154.0 33.56 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 106.861 -1.533 . . . . 25.0 106.861 177.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -141.98 77.44 18.44 Favored Pre-proline 0 N--CA 1.47 0.529 0 CA-C-O 121.065 0.459 . . . . 25.0 111.813 -178.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -69.76 145.97 58.77 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 117.462 -1.226 . . . . 25.0 111.666 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 13.4 t -132.36 8.89 4.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.881 0.848 . . . . 25.0 109.526 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 C--N 1.324 -0.512 0 CA-C-N 115.035 -0.984 . . . . 25.0 109.708 177.656 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.727 0.298 . . . . 25.0 110.357 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -116.66 91.57 34.97 Favored Pre-proline 0 N--CA 1.479 1.002 0 N-CA-C 108.446 -0.946 . . . . 25.0 108.446 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -71.86 150.46 55.51 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 117.088 -1.475 . . . . 25.0 114.197 -175.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.15 62.7 0.05 OUTLIER Glycine 0 C--O 1.241 0.578 0 N-CA-C 108.47 -1.852 . . . . 25.0 108.47 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.674 HG22 ' H ' ' A' ' 7' ' ' GLY . 12.2 p -48.5 131.47 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 113.512 0.93 . . . . 25.0 113.512 -172.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -100.68 12.34 37.65 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 114.95 -1.023 . . . . 25.0 110.619 -175.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.674 ' H ' HG22 ' A' ' 5' ' ' VAL . . . -116.9 -151.39 9.45 Favored Glycine 0 N--CA 1.439 -1.117 0 CA-C-N 115.797 -0.638 . . . . 25.0 112.832 -178.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 p 71.53 157.81 0.16 Allowed Pre-proline 0 CA--C 1.555 1.166 0 C-N-CA 126.292 1.837 . . . . 25.0 110.807 -177.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -67.71 6.99 0.62 Allowed 'Trans proline' 0 C--N 1.356 0.932 0 N-CA-C 117.279 1.992 . . . . 25.0 117.279 -176.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.1 p -67.99 -14.43 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 N-CA-C 114.779 1.4 . . . . 25.0 114.779 -173.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.1 p -150.24 144.41 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.269 0 N-CA-C 115.116 1.525 . . . . 25.0 115.116 -175.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.32 17.39 79.69 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 117.726 1.85 . . . . 25.0 117.726 169.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.2 t -50.45 -53.38 30.09 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 114.037 1.125 . . . . 25.0 114.037 -171.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -83.07 8.16 13.74 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 116.541 2.052 . . . . 25.0 116.541 -173.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -141.27 171.9 13.43 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 120.754 -1.216 . . . . 25.0 113.541 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -58.76 127.37 31.87 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.719 0.771 . . . . 25.0 112.478 -174.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -123.75 166.68 15.15 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 113.351 0.871 . . . . 50.0 113.351 -175.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -131.29 95.53 3.8 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 103.349 -2.834 . . . . 25.0 103.349 163.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 64.1 mt -102.99 128.7 49.72 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.15 0.5 . . . . 25.0 110.375 -177.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -124.67 116.04 21.74 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.818 0.818 . . . . 25.0 109.911 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.49 -177.69 49.55 Favored Glycine 0 N--CA 1.462 0.397 0 N-CA-C 116.867 1.507 . . . . 25.0 116.867 -174.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.8 p -84.52 172.9 11.26 Favored 'General case' 0 C--O 1.248 0.982 0 C-N-CA 124.838 1.255 . . . . 25.0 113.467 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.1 mt -87.94 36.56 0.77 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.262 0.553 . . . . 25.0 110.25 171.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -144.19 176.18 23.58 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 107.91 -2.076 . . . . 25.0 107.91 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.5 t -65.57 138.01 57.76 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 112.76 0.652 . . . . 25.0 112.76 -177.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -146.77 164.34 33.1 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.717 -0.674 . . . . 50.0 110.527 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -109.43 114.38 27.98 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 105.202 -2.148 . . . . 25.0 105.202 163.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 40.3 mm -104.1 115.64 46.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 106.764 -1.569 . . . . 25.0 106.764 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 9.8 mp -107.5 127.77 53.91 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 106.484 -1.673 . . . . 25.0 106.484 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.66 -33.08 8.69 Favored Glycine 0 C--N 1.313 -0.724 0 CA-C-O 119.297 -0.724 . . . . 25.0 112.474 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.58 -146.06 49.82 Favored Glycine 0 C--O 1.256 1.47 0 CA-C-N 118.745 1.273 . . . . 25.0 111.996 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.75 168.13 54.1 Favored Glycine 0 C--O 1.248 1.007 0 O-C-N 122.601 -0.353 . . . . 25.0 113.286 -176.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.59 169.13 35.17 Favored Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 111.581 -0.608 . . . . 25.0 111.581 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.95 118.93 25.73 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.51 -1.292 . . . . 25.0 107.51 176.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -116.57 148.47 40.86 Favored 'General case' 0 CA--C 1.511 -0.532 0 O-C-N 121.335 -0.853 . . . . 50.0 111.602 -171.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -104.8 107.38 18.32 Favored 'General case' 0 C--O 1.249 1.054 0 N-CA-C 106.42 -1.696 . . . . 25.0 106.42 171.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 64.3 mt -112.56 133.77 54.44 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 121.99 -0.444 . . . . 25.0 111.008 -175.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -131.93 107.06 8.45 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 121.449 0.642 . . . . 25.0 110.778 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.37 -26.79 50.63 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-O 119.023 -0.876 . . . . 25.0 115.095 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 51.48 -152.15 0.22 Allowed 'General case' 0 C--O 1.244 0.815 0 CA-C-N 117.716 0.758 . . . . 25.0 111.782 -175.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.37 164.29 16.47 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.768 1.025 . . . . 25.0 113.768 -175.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.22 155.43 31.69 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 114.853 -1.067 . . . . 25.0 110.859 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -79.62 102.49 8.94 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 106.665 -1.605 . . . . 25.0 106.665 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -104.85 155.24 19.09 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 121.097 0.475 . . . . 50.0 111.779 -173.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 mp -111.66 134.27 53.34 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 105.87 -1.9 . . . . 25.0 105.87 174.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.5 mp -131.73 117.63 18.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.577 0.703 . . . . 25.0 110.724 -174.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -118.14 89.94 3.23 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.978 -1.01 . . . . 25.0 109.663 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.31 -31.59 74.27 Favored Glycine 0 N--CA 1.468 0.809 0 N-CA-C 116.92 1.528 . . . . 25.0 116.92 -172.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.9 -163.94 51.33 Favored Glycine 0 C--O 1.243 0.705 0 O-C-N 121.864 -0.786 . . . . 25.0 111.269 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.21 161.53 19.09 Favored 'General case' 0 C--O 1.248 1.009 0 C-N-CA 123.051 0.541 . . . . 25.0 109.798 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.93 161.4 32.23 Favored Glycine 0 C--O 1.248 0.991 0 CA-C-O 118.941 -0.921 . . . . 25.0 111.209 177.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -80.85 121.19 25.65 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 105.785 -1.932 . . . . 25.0 105.785 177.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -111.51 152.35 27.6 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.343 -0.844 . . . . 50.0 109.855 -177.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -118.86 119.1 33.37 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 105.742 -1.948 . . . . 25.0 105.742 177.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -141.65 134.74 29.12 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 115.159 1.54 . . . . 25.0 115.159 -168.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.5 m -103.38 141.51 35.82 Favored 'General case' 0 C--O 1.249 1.032 0 N-CA-C 107.229 -1.397 . . . . 25.0 107.229 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.21 -37.36 5.97 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 108.442 -1.863 . . . . 25.0 108.442 175.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.84 -171.11 55.14 Favored Glycine 0 C--O 1.248 1.003 0 C-N-CA 120.626 -0.797 . . . . 25.0 111.859 -178.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -65.73 157.09 31.12 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 117.498 0.649 . . . . 25.0 110.061 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.46 164.86 32.0 Favored Glycine 0 C--O 1.245 0.808 0 CA-C-N 115.606 -0.725 . . . . 25.0 112.656 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.15 96.25 9.84 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 123.593 0.757 . . . . 25.0 110.319 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -90.71 159.89 16.12 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 123.462 0.705 . . . . 50.0 112.066 -170.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.1 m -125.51 125.43 43.24 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.797 -0.638 . . . . 25.0 109.385 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -114.68 89.15 3.03 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.398 -0.964 . . . . 25.0 108.398 177.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -88.84 -34.48 17.0 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 119.321 -0.371 . . . . 25.0 111.735 -175.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 66.74 160.82 0.15 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.542 1.137 . . . . 25.0 111.632 -173.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -90.83 -42.88 10.39 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 116.196 1.925 . . . . 25.0 116.196 -166.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.3 mt -140.65 170.49 15.68 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.139 0.792 . . . . 25.0 113.139 -172.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.99 -25.19 43.07 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 123.751 0.82 . . . . 25.0 110.914 175.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -79.12 -12.13 59.99 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 115.112 -0.949 . . . . 25.0 112.906 -178.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -81.73 139.55 34.81 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.412 -0.805 . . . . 25.0 112.911 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.4 t 45.91 40.06 6.27 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 116.52 2.045 . . . . 25.0 116.52 171.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -107.37 170.09 8.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.239 -1.346 . . . . 25.0 110.964 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -124.23 146.66 48.59 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 106.13 -1.804 . . . . 25.0 106.13 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 87.9 p -142.37 168.64 12.89 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 108.613 -0.884 . . . . 25.0 108.613 -177.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -61.04 -27.03 83.98 Favored 'Trans proline' 0 CA--C 1.553 1.44 0 C-N-CA 117.631 -1.112 . . . . 25.0 111.566 175.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.4 mt -65.6 -32.29 73.79 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.861 0.689 . . . . 25.0 112.861 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.53 -174.48 35.65 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 109.974 -1.25 . . . . 25.0 109.974 -176.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.8 t -105.55 144.67 31.98 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.407 1.099 . . . . 25.0 112.74 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -123.82 16.68 9.42 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.027 -1.442 . . . . 25.0 108.964 177.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -62.0 140.94 47.06 Favored Glycine 0 C--N 1.335 0.524 0 CA-C-N 115.645 -0.707 . . . . 25.0 112.649 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -87.03 170.68 11.33 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 117.858 0.829 . . . . 50.0 113.057 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.04 98.36 5.95 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.518 -0.765 . . . . 25.0 110.799 -172.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.2 mt -89.65 133.02 32.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 107.837 -1.171 . . . . 25.0 107.837 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 76.8 mt -85.5 -49.06 8.37 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 115.323 1.601 . . . . 25.0 115.323 -171.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -131.13 36.04 3.87 Favored 'General case' 0 C--O 1.247 0.953 0 CA-C-O 121.458 0.647 . . . . 25.0 112.695 -173.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -53.78 131.59 39.82 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.261 -0.882 . . . . 25.0 112.263 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -103.59 105.66 48.4 Favored Pre-proline 0 C--O 1.238 0.474 0 N-CA-C 108.185 -1.042 . . . . 25.0 108.185 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.78 -9.68 26.92 Favored 'Trans proline' 0 C--N 1.35 0.611 0 N-CA-C 116.119 1.546 . . . . 25.0 116.119 -173.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.1 t -95.9 -36.87 10.94 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.27 -0.572 . . . . 25.0 109.774 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -95.62 -38.02 10.58 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 114.001 1.111 . . . . 25.0 114.001 -173.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -87.77 172.41 9.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.403 0.62 . . . . 75.0 110.478 -173.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -145.08 148.81 34.08 Favored 'General case' 0 C--O 1.252 1.199 0 CA-C-N 116.084 -0.507 . . . . 25.0 111.739 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 85.7 mt -129.09 133.07 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 108.486 -0.931 . . . . 25.0 108.486 -176.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -85.83 149.03 25.53 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 121.694 0.759 . . . . 25.0 109.122 173.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.0 p -146.25 -13.03 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 O-C-N 121.641 -0.662 . . . . 25.0 112.75 176.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.1 t -63.48 -39.95 95.81 Favored 'General case' 0 C--O 1.219 -0.524 0 O-C-N 121.565 -0.709 . . . . 25.0 111.432 -174.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.78 -8.61 59.57 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-N 115.398 -0.819 . . . . 25.0 112.661 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.7 mt -106.18 -29.64 9.72 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.815 0.672 . . . . 25.0 112.815 -174.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.39 -71.6 0.01 OUTLIER Glycine 0 N--CA 1.465 0.574 0 N-CA-C 117.598 1.799 . . . . 25.0 117.598 -176.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -144.96 158.23 43.88 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.794 -0.817 . . . . 25.0 108.794 -170.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 41.0 t -113.55 -28.74 7.4 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 123.651 0.594 . . . . 25.0 112.286 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -100.39 119.6 6.57 Favored Glycine 0 N--CA 1.472 1.054 0 C-N-CA 121.495 -0.383 . . . . 25.0 112.323 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.29 146.4 34.36 Favored 'General case' 0 C--O 1.245 0.853 0 N-CA-C 114.065 1.135 . . . . 25.0 114.065 -174.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -95.86 -151.95 28.65 Favored Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.824 -0.703 . . . . 25.0 114.26 -177.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -59.51 131.73 51.85 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 122.446 1.117 . . . . 25.0 111.639 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 160.38 170.44 24.97 Favored Glycine 0 C--O 1.24 0.476 0 N-CA-C 107.573 -2.211 . . . . 25.0 107.573 -179.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -148.22 167.73 24.35 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 118.299 1.05 . . . . 25.0 109.4 -177.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 62.98 38.6 10.94 Favored 'General case' 0 C--O 1.248 1.011 0 C-N-CA 124.518 1.127 . . . . 25.0 111.801 -174.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 65.82 44.18 92.56 Favored Glycine 0 C--O 1.242 0.629 0 N-CA-C 109.938 -1.265 . . . . 25.0 109.938 177.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.7 t -151.58 179.76 8.1 Favored 'General case' 0 C--O 1.212 -0.873 0 O-C-N 122.391 -0.476 . . . . 25.0 111.18 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 85.1 mt -106.8 167.02 10.16 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 103.855 -2.646 . . . . 25.0 103.855 173.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.54 131.17 42.88 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 119.597 1.09 . . . . 25.0 110.21 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 18.6 m -95.44 163.47 2.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.426 -0.806 . . . . 25.0 109.838 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 80.0 p -149.03 160.09 43.63 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.538 -0.726 . . . . 25.0 110.6 -177.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 28.0 m -122.44 165.16 18.71 Favored 'Isoleucine or valine' 0 C--O 1.252 1.221 0 N-CA-C 109.727 -0.471 . . . . 25.0 109.727 -177.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.3 t -76.28 -50.75 13.55 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 122.22 1.01 . . . . 25.0 109.682 176.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -162.18 -152.77 0.25 Allowed 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 103.753 -2.684 . . . . 25.0 103.753 -176.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -73.31 -6.19 44.47 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 119.211 0.914 . . . . 25.0 110.63 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -148.21 -146.68 4.38 Favored Glycine 0 C--O 1.247 0.958 0 N-CA-C 109.922 -1.271 . . . . 25.0 109.922 174.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.25 -152.55 0.39 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.051 0.541 . . . . 25.0 112.416 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -75.71 162.37 28.28 Favored 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 113.919 1.081 . . . . 25.0 113.919 -171.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.61 158.0 21.38 Favored 'General case' 0 C--O 1.213 -0.851 0 N-CA-C 105.978 -1.86 . . . . 25.0 105.978 175.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -129.66 144.57 51.34 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 124.12 0.887 . . . . 25.0 111.419 175.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 49.4 tp -115.41 122.77 46.83 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 102.778 -3.045 . . . . 25.0 102.778 173.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -121.59 155.29 35.38 Favored 'General case' 0 C--O 1.211 -0.957 0 CA-C-O 121.39 0.614 . . . . 25.0 110.411 -173.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 41.0 t -92.04 152.57 19.91 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.49 -1.3 . . . . 25.0 107.49 171.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -123.01 19.17 10.05 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 108.539 -0.912 . . . . 25.0 108.539 175.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -118.96 139.84 51.0 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 105.223 -2.14 . . . . 25.0 105.223 170.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -139.25 165.08 28.13 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.528 0.68 . . . . 25.0 110.231 -177.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -85.68 163.96 17.95 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.021 -1.474 . . . . 25.0 107.021 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.31 -24.41 67.27 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 108.116 -1.068 . . . . 25.0 108.116 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -74.86 -5.55 44.21 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.432 -0.804 . . . . 25.0 112.472 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.75 1.23 83.06 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 120.33 -0.938 . . . . 25.0 111.811 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.8 mt -75.74 133.99 40.59 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.417 -0.586 . . . . 25.0 109.417 175.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 88.1 p -144.44 -172.71 3.85 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 106.199 -1.778 . . . . 25.0 106.199 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -131.4 141.35 49.84 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 121.293 -0.163 . . . . 25.0 110.614 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -154.45 158.81 40.52 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 106.99 -1.485 . . . . 25.0 106.99 166.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.2 p -145.23 144.37 21.53 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 N-CA-C 108.247 -1.02 . . . . 25.0 108.247 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -105.36 136.67 44.48 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 108.453 -0.943 . . . . 25.0 108.453 -177.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.1 mp -134.03 129.8 36.62 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 106.957 -1.497 . . . . 25.0 106.957 -177.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -90.96 -1.75 57.79 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 119.224 -0.99 . . . . 25.0 112.482 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -66.35 -21.24 70.23 Favored Glycine 0 C--O 1.242 0.607 0 N-CA-C 115.139 0.816 . . . . 25.0 115.139 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 29.4 t0 53.14 59.11 4.65 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 123.626 1.679 . . . . 25.0 111.324 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -120.98 41.0 3.42 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 112.217 -2.265 . . . . 25.0 107.711 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.36 -35.39 75.57 Favored 'General case' 0 C--O 1.214 -0.796 0 CA-C-N 114.961 -1.018 . . . . 25.0 113.511 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.17 -29.42 62.83 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 118.232 0.469 . . . . 25.0 110.794 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -85.21 -13.22 50.61 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 112.8 0.667 . . . . 25.0 112.8 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 14.5 mt -69.87 128.2 35.55 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.94 0.719 . . . . 25.0 112.94 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 34.4 m -138.59 161.65 36.57 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.34 -0.985 . . . . 25.0 108.34 171.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.92 4.93 5.69 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 109.5 -0.556 . . . . 25.0 109.5 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -66.75 -30.74 71.04 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.684 0.615 . . . . 25.0 110.451 177.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -91.63 -4.0 55.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.129 0.49 . . . . 25.0 111.338 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 48.2 mm -94.02 126.26 46.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 106.542 -1.651 . . . . 25.0 106.542 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.2 p -103.43 114.57 43.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 122.113 0.958 . . . . 25.0 110.827 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -156.18 -9.17 0.11 Allowed 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.729 1.751 . . . . 25.0 115.729 -177.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -88.18 71.93 9.16 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 118.855 0.752 . . . . 25.0 111.264 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 56.49 21.15 5.36 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.27 1.028 . . . . 25.0 113.347 -178.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 53.84 38.33 28.41 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.756 -0.656 . . . . 25.0 111.415 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -123.26 124.8 43.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.36 0.6 . . . . 25.0 111.332 -178.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.09 -4.28 28.02 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.726 -0.67 . . . . 25.0 112.303 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.34 -13.01 61.03 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.644 -0.502 . . . . 25.0 109.644 174.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.24 -176.31 6.26 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 122.727 0.411 . . . . 25.0 110.497 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 58.85 -162.45 0.24 Allowed 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.201 -1.363 . . . . 25.0 113.045 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.15 22.04 77.05 Favored Glycine 0 C--N 1.336 0.578 0 N-CA-C 110.945 -0.862 . . . . 25.0 110.945 -175.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -112.99 93.85 4.62 Favored 'General case' 0 C--O 1.246 0.875 0 C-N-CA 123.673 0.789 . . . . 25.0 110.535 -176.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -128.84 145.57 51.17 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 109.148 -0.686 . . . . 25.0 109.148 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -119.35 24.08 8.28 Favored Glycine 0 N--CA 1.462 0.424 0 N-CA-C 111.368 -0.693 . . . . 25.0 111.368 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 44.6 t -71.59 -30.15 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 122.083 0.944 . . . . 25.0 109.44 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.49 134.58 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 122.196 0.998 . . . . 25.0 109.211 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 154.81 152.14 6.05 Favored Glycine 0 C--O 1.242 0.611 0 CA-C-N 115.393 -0.821 . . . . 25.0 112.992 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -148.38 123.62 10.21 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.355 -0.609 . . . . 25.0 109.355 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 56.2 p -151.97 160.14 43.57 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.316 -0.994 . . . . 25.0 108.316 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 166.06 -172.8 41.52 Favored Glycine 0 C--N 1.319 -0.374 0 C-N-CA 121.252 -0.499 . . . . 25.0 112.161 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -138.99 109.3 7.67 Favored Pre-proline 0 C--O 1.244 0.766 0 N-CA-C 107.943 -1.132 . . . . 25.0 107.943 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.92 164.48 31.54 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 117.655 -1.097 . . . . 25.0 113.266 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -128.52 156.03 43.93 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.531 -0.759 . . . . 25.0 109.124 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -132.01 87.74 43.37 Favored Pre-proline 0 C--O 1.243 0.733 0 N-CA-C 108.912 -0.773 . . . . 25.0 108.912 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -71.29 156.18 59.35 Favored 'Trans proline' 0 C--N 1.353 0.8 0 N-CA-C 113.893 0.689 . . . . 25.0 113.893 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 11.8 t -123.3 -11.49 7.93 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.286 0.565 . . . . 25.0 110.927 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 10.1 p . . . . . 0 C--O 1.235 0.342 0 N-CA-C 107.654 -1.239 . . . . 25.0 107.654 177.341 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.456 0.17 . . . . 25.0 110.67 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -140.21 114.2 7.57 Favored Pre-proline 0 C--O 1.248 0.998 0 N-CA-C 108.184 -1.043 . . . . 25.0 108.184 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.02 167.04 28.41 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 118.119 -0.787 . . . . 25.0 113.503 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.41 56.82 0.01 OUTLIER Glycine 0 C--O 1.225 -0.416 0 O-C-N 121.921 -0.487 . . . . 25.0 112.023 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.514 HG22 ' H ' ' A' ' 7' ' ' GLY . 7.2 p -64.42 137.71 24.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 122.027 0.917 . . . . 25.0 111.287 -176.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -105.66 -4.53 20.94 Favored 'General case' 0 C--O 1.242 0.661 0 O-C-N 121.742 -0.599 . . . . 25.0 110.849 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.514 ' H ' HG22 ' A' ' 5' ' ' VAL . . . -84.99 -141.54 5.51 Favored Glycine 0 C--O 1.221 -0.692 0 C-N-CA 121.492 -0.385 . . . . 25.0 113.384 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.0 p 69.78 157.8 0.15 Allowed Pre-proline 0 N--CA 1.485 1.31 0 C-N-CA 125.413 1.485 . . . . 25.0 111.61 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -72.84 3.07 4.7 Favored 'Trans proline' 0 C--N 1.353 0.774 0 N-CA-C 116.46 1.677 . . . . 25.0 116.46 -177.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.4 p -67.17 -18.15 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 116.196 1.925 . . . . 25.0 116.196 -170.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.4 p -148.27 144.28 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 CA-C-N 119.222 0.919 . . . . 25.0 113.39 -176.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.29 15.59 80.77 Favored Glycine 0 C--N 1.333 0.379 0 N-CA-C 117.18 1.632 . . . . 25.0 117.18 174.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.3 t -52.64 -48.68 66.25 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.887 1.069 . . . . 25.0 113.887 -171.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -77.72 3.82 13.11 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 115.198 1.555 . . . . 25.0 115.198 -173.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.93 168.82 18.99 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.903 1.075 . . . . 25.0 113.903 -177.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.62 129.39 41.69 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.573 0.583 . . . . 25.0 112.573 -175.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -128.52 159.88 34.07 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 115.451 1.649 . . . . 50.0 115.451 -174.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -112.86 118.1 33.97 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 104.529 -2.397 . . . . 25.0 104.529 162.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.2 mt -121.14 85.82 2.47 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.956 0.884 . . . . 25.0 111.627 -173.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -90.01 110.64 21.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.296 -0.865 . . . . 25.0 109.984 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.02 170.45 43.42 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 116.181 1.232 . . . . 25.0 116.181 -176.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.2 p -71.81 174.89 6.27 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.753 0.787 . . . . 25.0 112.989 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 73.6 mt -86.13 18.6 3.01 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.099 -0.955 . . . . 25.0 111.193 176.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.66 176.35 16.06 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.402 -1.079 . . . . 25.0 110.402 176.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.4 t -70.73 136.63 49.06 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 117.649 0.725 . . . . 25.0 110.517 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -143.51 159.32 42.64 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 120.903 0.382 . . . . 50.0 110.044 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -95.96 131.12 42.66 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 102.959 -2.978 . . . . 25.0 102.959 161.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.8 mm -121.36 121.9 65.92 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 N-CA-C 105.497 -2.038 . . . . 25.0 105.497 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.5 tt -123.45 124.0 41.92 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.066 -1.087 . . . . 25.0 108.066 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.3 -38.27 11.24 Favored Glycine 0 CA--C 1.502 -0.722 0 C-N-CA 119.947 -1.12 . . . . 25.0 113.102 -177.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 72.19 -147.25 40.73 Favored Glycine 0 C--O 1.254 1.364 0 CA-C-N 118.983 1.391 . . . . 25.0 112.018 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.95 164.78 54.63 Favored Glycine 0 C--O 1.243 0.691 0 N-CA-C 111.751 -0.54 . . . . 25.0 111.751 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.22 163.67 34.82 Favored Glycine 0 C--O 1.244 0.719 0 CA-C-O 119.462 -0.632 . . . . 25.0 113.741 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.5 103.34 11.97 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.165 -1.42 . . . . 25.0 107.165 176.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -103.32 157.63 16.89 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.471 -0.491 . . . . 50.0 110.258 -172.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -120.56 90.66 3.37 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 108.82 -0.807 . . . . 25.0 108.82 177.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.0 mp -86.06 136.5 33.21 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.035 -0.529 . . . . 25.0 110.694 -175.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -138.55 106.62 5.72 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.331 -0.618 . . . . 25.0 109.331 174.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.98 -28.17 54.85 Favored Glycine 0 N--CA 1.467 0.766 0 CA-C-O 118.011 -1.438 . . . . 25.0 116.184 -175.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 54.8 -147.99 0.49 Allowed 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 118.187 0.994 . . . . 25.0 111.428 -177.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.94 163.47 19.64 Favored 'General case' 0 C--O 1.256 1.409 0 CA-C-O 122.153 0.978 . . . . 25.0 112.495 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.05 157.63 33.66 Favored Glycine 0 CA--C 1.521 0.452 0 CA-C-N 114.358 -1.292 . . . . 25.0 110.173 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -81.77 110.96 17.57 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 105.635 -1.987 . . . . 25.0 105.635 177.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -110.6 150.81 28.44 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.934 -0.706 . . . . 50.0 110.02 -171.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 mp -112.9 95.07 5.21 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.957 0.786 . . . . 25.0 109.457 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.8 mp -100.74 116.34 32.4 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 114.963 1.468 . . . . 25.0 114.963 -170.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -118.03 111.92 19.56 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 115.3 -0.864 . . . . 25.0 109.207 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.37 -32.61 79.86 Favored Glycine 0 C--O 1.254 1.389 0 N-CA-C 117.262 1.665 . . . . 25.0 117.262 -174.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.47 -163.78 42.97 Favored Glycine 0 N--CA 1.458 0.143 0 C-N-CA 120.91 -0.662 . . . . 25.0 111.909 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.2 159.46 17.63 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.307 0.575 . . . . 25.0 112.317 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.38 173.1 47.55 Favored Glycine 0 C--O 1.227 -0.291 0 CA-C-N 115.447 -0.797 . . . . 25.0 114.113 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.54 125.26 33.65 Favored 'General case' 0 C--O 1.208 -1.112 0 N-CA-C 104.069 -2.567 . . . . 25.0 104.069 176.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -117.96 157.56 26.51 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.907 0.384 . . . . 50.0 110.967 -174.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -113.26 131.04 56.07 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 102.869 -3.011 . . . . 25.0 102.869 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -148.98 149.05 30.52 Favored 'General case' 0 C--O 1.248 0.997 0 C-N-CA 119.374 -0.93 . . . . 25.0 111.691 -175.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.19 146.76 35.61 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 109.6 -0.519 . . . . 25.0 109.6 -176.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -98.85 -42.75 2.79 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-O 118.649 -1.084 . . . . 25.0 113.445 -174.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.34 -169.6 52.79 Favored Glycine 0 C--O 1.248 0.991 0 CA-C-N 118.843 1.322 . . . . 25.0 111.534 -177.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -60.58 155.08 19.51 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.846 -0.797 . . . . 25.0 110.21 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.0 163.23 32.24 Favored Glycine 0 C--O 1.249 1.063 0 CA-C-N 115.312 -0.858 . . . . 25.0 111.036 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.75 96.09 9.15 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 123.395 0.678 . . . . 25.0 110.028 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -88.94 158.25 18.12 Favored 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 123.258 0.623 . . . . 50.0 111.622 -170.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.1 m -123.15 134.04 54.22 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.965 -0.754 . . . . 25.0 108.965 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -126.45 100.81 6.42 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.467 -1.309 . . . . 25.0 107.467 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 54.2 mtt85 -100.13 -27.67 13.42 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.552 0.945 . . . . 25.0 113.552 -178.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 67.77 162.22 0.19 Allowed 'General case' 0 CA--C 1.534 0.356 0 O-C-N 125.276 1.61 . . . . 25.0 110.386 -174.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.8 -49.56 17.73 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 116.166 1.913 . . . . 25.0 116.166 -170.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 81.8 mt -153.98 -179.65 8.06 Favored 'General case' 0 C--O 1.205 -1.251 0 O-C-N 121.45 -0.781 . . . . 25.0 109.535 -171.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -55.86 -27.1 50.07 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.635 -0.876 . . . . 25.0 108.635 167.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -71.29 -10.28 59.49 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 112.965 0.728 . . . . 25.0 112.965 -178.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -99.34 155.32 17.58 Favored 'General case' 0 C--O 1.215 -0.719 0 O-C-N 121.76 -0.588 . . . . 25.0 110.463 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.4 m 42.83 56.49 3.95 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.093 -0.958 . . . . 25.0 113.464 169.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 42.8 p-80 -134.38 168.79 18.27 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 122.02 0.914 . . . . 25.0 111.482 -174.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -125.75 138.93 53.88 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 102.992 -2.966 . . . . 25.0 102.992 173.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.5 p -134.99 172.51 7.13 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 108.316 -0.994 . . . . 25.0 108.316 -173.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -60.13 -15.73 35.74 Favored 'Trans proline' 0 CA--C 1.555 1.559 0 N-CA-C 114.782 1.032 . . . . 25.0 114.782 175.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.6 mt -85.23 -24.67 27.73 Favored 'General case' 0 C--O 1.215 -0.723 0 N-CA-C 111.8 0.296 . . . . 25.0 111.8 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.06 -165.21 30.68 Favored Glycine 0 C--O 1.21 -1.393 0 C-N-CA 120.39 -0.909 . . . . 25.0 111.618 -175.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.9 t -106.55 141.41 37.88 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 122.762 1.268 . . . . 25.0 112.089 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -132.96 32.95 3.72 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-N 114.989 -1.005 . . . . 25.0 109.73 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -73.16 160.99 54.21 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 110.481 -1.047 . . . . 25.0 110.481 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -104.46 169.79 8.27 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 117.994 0.897 . . . . 50.0 110.539 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -121.07 104.58 9.89 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.432 1.093 . . . . 25.0 110.545 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.4 mt -94.02 135.13 29.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 106.747 -1.575 . . . . 25.0 106.747 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 21.6 mt -84.48 -45.63 12.45 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.729 1.751 . . . . 25.0 115.729 -174.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -135.27 38.1 2.95 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 115.134 -0.939 . . . . 25.0 113.429 -169.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -59.26 125.07 22.13 Favored 'General case' 0 C--O 1.218 -0.605 0 N-CA-C 108.791 -0.818 . . . . 25.0 108.791 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -92.1 103.82 9.2 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.897 -0.592 . . . . 25.0 109.697 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -69.04 -4.25 13.17 Favored 'Trans proline' 0 CA--C 1.548 1.209 0 N-CA-C 115.841 1.439 . . . . 25.0 115.841 -175.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.6 t -95.78 -43.3 7.93 Favored 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 122.193 -0.317 . . . . 25.0 110.829 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -97.43 -38.08 9.75 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 113.812 1.041 . . . . 25.0 113.812 -174.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -86.81 170.57 11.58 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.729 -0.388 . . . . 75.0 110.687 -172.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -145.62 149.34 34.35 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 116.208 -0.451 . . . . 25.0 111.006 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 67.7 mt -124.92 125.83 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 107.6 -1.259 . . . . 25.0 107.6 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -89.34 136.23 33.14 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-O 122.02 0.914 . . . . 25.0 108.913 173.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 p -134.46 2.97 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 114.452 -1.249 . . . . 25.0 108.539 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.475 ' HB2' ' HA ' ' A' ' 156' ' ' PHE . 23.7 t -67.32 -47.84 69.34 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 120.722 -0.391 . . . . 25.0 111.146 -175.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.19 -36.0 82.18 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.894 0.702 . . . . 25.0 112.894 -175.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.3 -49.64 4.19 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.585 0.958 . . . . 25.0 113.585 -175.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.31 -78.8 1.32 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 116.375 1.31 . . . . 25.0 116.375 -169.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -157.06 171.37 20.58 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 117.518 0.659 . . . . 25.0 110.114 -168.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 30.6 t -105.51 -36.25 7.19 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.587 0.755 . . . . 25.0 111.451 -177.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -105.91 145.68 15.97 Favored Glycine 0 N--CA 1.468 0.819 0 CA-C-O 118.355 -1.247 . . . . 25.0 111.354 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -61.61 148.31 42.84 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-N 118.814 1.307 . . . . 25.0 110.245 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.0 -167.1 41.15 Favored Glycine 0 C--O 1.243 0.708 0 CA-C-N 114.764 -1.107 . . . . 25.0 113.309 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -65.23 142.11 58.41 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.385 -0.968 . . . . 25.0 108.385 177.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 169.9 178.2 40.77 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 108.723 -1.751 . . . . 25.0 108.723 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -138.18 168.93 18.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 118.102 0.951 . . . . 25.0 109.485 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 61.05 35.28 18.88 Favored 'General case' 0 C--O 1.253 1.241 0 O-C-N 123.958 0.786 . . . . 25.0 112.489 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 65.03 39.32 96.32 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 120.785 -0.722 . . . . 25.0 111.74 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.7 t -146.24 177.43 9.0 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.752 -0.462 . . . . 25.0 109.752 -176.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 92.5 mt -90.08 170.27 10.47 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 105.507 -2.034 . . . . 25.0 105.507 175.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.21 111.72 1.84 Allowed 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 118.575 0.625 . . . . 25.0 110.679 -177.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 17.0 m -102.57 155.19 5.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 107.078 -1.453 . . . . 25.0 107.078 174.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 83.5 p -156.46 173.52 16.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 118.316 0.507 . . . . 25.0 110.715 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.1 m -118.97 160.39 18.87 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 N-CA-C 109.245 -0.65 . . . . 25.0 109.245 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.6 t -69.71 -52.48 25.14 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.837 -1.542 . . . . 25.0 106.837 173.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -164.28 -160.74 0.55 Allowed 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 102.947 -2.983 . . . . 25.0 102.947 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -55.16 -38.87 68.85 Favored 'General case' 0 C--O 1.252 1.225 0 CA-C-N 118.078 0.399 . . . . 25.0 111.104 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.72 -156.42 13.57 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 112.073 -0.411 . . . . 25.0 112.073 176.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.87 -168.67 0.18 Allowed 'General case' 0 C--O 1.251 1.132 0 C-N-CA 124.128 0.971 . . . . 25.0 111.475 177.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 64.9 mtt85 -72.83 160.35 32.3 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.46 0.911 . . . . 25.0 113.46 -171.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -102.6 168.16 9.45 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 105.575 -2.009 . . . . 25.0 105.575 175.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -131.57 156.03 46.46 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.778 0.799 . . . . 25.0 111.961 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 52.5 tp -127.32 116.21 20.17 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 102.976 -2.972 . . . . 25.0 102.976 174.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -122.69 162.99 20.92 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 108.601 -0.889 . . . . 25.0 108.601 -173.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.0 t -140.09 144.41 36.77 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 103.123 -2.918 . . . . 25.0 103.123 172.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -102.4 12.45 36.53 Favored 'General case' 0 C--O 1.245 0.859 0 N-CA-C 109.163 -0.68 . . . . 25.0 109.163 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -81.25 135.11 35.7 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 105.192 -2.151 . . . . 25.0 105.192 172.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -141.91 147.35 36.93 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 122.367 1.08 . . . . 25.0 110.96 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.26 159.51 31.13 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.232 -1.396 . . . . 25.0 107.232 174.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.07 -20.32 66.13 Favored 'General case' 0 CA--C 1.548 0.886 0 O-C-N 121.688 -0.632 . . . . 25.0 109.665 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -77.29 -4.45 45.03 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.49 -0.777 . . . . 25.0 113.072 175.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.18 6.14 63.29 Favored Glycine 0 CA--C 1.51 -0.247 0 N-CA-C 116.571 1.388 . . . . 25.0 116.571 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 69.2 mt -86.52 120.02 27.4 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 110.313 -0.255 . . . . 25.0 110.313 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 25.6 p -119.51 176.57 5.3 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.442 0.697 . . . . 25.0 109.248 -178.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -118.1 132.06 56.38 Favored 'General case' 0 C--O 1.257 1.456 0 N-CA-C 114.126 1.158 . . . . 25.0 114.126 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -152.57 151.69 30.96 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.169 -1.048 . . . . 25.0 108.169 167.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.5 p -149.09 147.83 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 106.113 -1.81 . . . . 25.0 106.113 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -109.73 145.22 36.95 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 111.685 0.254 . . . . 25.0 111.685 -177.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mp -134.0 128.34 34.16 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.451 -1.314 . . . . 25.0 107.451 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -86.9 -12.77 46.75 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 114.905 1.446 . . . . 25.0 114.905 -173.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -75.75 -6.22 81.11 Favored Glycine 0 C--O 1.212 -1.267 0 N-CA-C 116.347 1.299 . . . . 25.0 116.347 -171.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 47.7 t0 50.87 54.11 11.82 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 122.216 1.008 . . . . 25.0 113.068 -175.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -114.35 41.44 2.3 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 107.227 -1.397 . . . . 25.0 107.227 174.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.53 -36.61 84.33 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.004 -0.998 . . . . 25.0 111.624 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -77.49 -24.04 50.18 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.105 -0.997 . . . . 25.0 111.219 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.13 -24.71 37.46 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.541 -0.754 . . . . 25.0 110.699 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 8.1 mt -63.22 139.12 58.74 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 119.8 -0.76 . . . . 25.0 111.756 177.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 92.8 p -138.27 165.74 25.95 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.543 -0.91 . . . . 25.0 108.543 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.68 -3.18 29.82 Favored 'General case' 0 C--N 1.312 -1.03 0 O-C-N 120.997 -1.064 . . . . 25.0 109.879 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -77.43 -37.0 52.59 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 120.944 -1.098 . . . . 25.0 111.398 -177.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -89.72 -5.44 57.01 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 121.138 -0.225 . . . . 25.0 111.421 -177.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 44.4 mm -99.63 122.01 50.96 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.793 0 N-CA-C 103.833 -2.654 . . . . 25.0 103.833 173.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.7 p -112.82 125.08 70.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 122.779 1.276 . . . . 25.0 111.377 -174.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.475 ' HA ' ' HB2' ' A' ' 97' ' ' SER . 1.3 p90 -141.68 -32.22 0.54 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 112.774 -2.012 . . . . 25.0 109.717 -176.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -75.47 55.41 0.81 Allowed 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.674 1.361 . . . . 25.0 114.674 -176.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 60.1 15.88 5.51 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 115.616 1.71 . . . . 25.0 115.616 175.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.4 m 65.29 -23.99 0.09 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.965 1.706 . . . . 25.0 115.599 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -58.86 125.35 23.18 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.248 0.619 . . . . 25.0 111.24 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -96.89 15.04 23.32 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.174 0.805 . . . . 25.0 113.174 -175.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.9 2.26 12.94 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.92 1.081 . . . . 25.0 113.92 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -145.87 -174.96 4.56 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.323 -1.362 . . . . 25.0 107.323 177.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 67.74 -178.24 0.21 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.442 1.097 . . . . 25.0 111.58 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 86.59 21.44 51.09 Favored Glycine 0 C--O 1.24 0.498 0 N-CA-C 109.159 -1.576 . . . . 25.0 109.159 -172.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -77.56 89.44 3.89 Favored 'General case' 0 C--O 1.247 0.96 0 C-N-CA 123.198 0.599 . . . . 25.0 111.659 -177.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -123.28 143.36 50.11 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.598 -0.889 . . . . 25.0 108.598 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -140.79 32.92 2.09 Favored Glycine 0 N--CA 1.461 0.358 0 N-CA-C 109.781 -1.328 . . . . 25.0 109.781 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 47.9 t -71.48 -35.08 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 112.03 0.382 . . . . 25.0 112.03 -175.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.27 130.19 25.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-O 121.195 0.521 . . . . 25.0 111.374 -177.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 152.58 158.67 8.6 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 109.298 -1.521 . . . . 25.0 109.298 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -151.95 144.49 24.18 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 118.625 1.213 . . . . 25.0 110.593 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 68.9 p -142.7 162.77 34.61 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 105.637 -1.986 . . . . 25.0 105.637 175.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -174.02 161.83 32.21 Favored Glycine 0 C--N 1.318 -0.427 0 C-N-CA 120.249 -0.977 . . . . 25.0 113.283 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -136.7 83.29 30.27 Favored Pre-proline 0 C--O 1.241 0.645 0 N-CA-C 108.364 -0.976 . . . . 25.0 108.364 177.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.24 161.54 45.62 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 118.15 -0.767 . . . . 25.0 112.376 -174.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -113.24 150.49 32.31 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 123.51 0.724 . . . . 25.0 110.212 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -138.17 70.73 48.03 Favored Pre-proline 0 N--CA 1.479 0.998 0 CA-C-O 120.903 0.382 . . . . 25.0 110.967 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -73.06 153.85 52.28 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 116.918 -1.588 . . . . 25.0 112.875 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.6 t -84.63 7.05 21.58 Favored 'General case' 0 C--O 1.25 1.085 0 CA-C-O 120.902 0.382 . . . . 25.0 111.658 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 C--O 1.254 1.33 0 CA-C-O 116.833 -1.556 . . . . 25.0 110.335 -177.664 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.452 0 N-CA-C 110.158 -0.312 . . . . 25.0 110.158 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -129.35 112.51 18.12 Favored Pre-proline 0 C--O 1.254 1.311 0 N-CA-C 108.062 -1.088 . . . . 25.0 108.062 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.71 149.67 67.51 Favored 'Trans proline' 0 N--CA 1.476 0.468 0 C-N-CA 116.882 -1.612 . . . . 25.0 114.409 -177.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.09 65.95 0.05 OUTLIER Glycine 0 C--O 1.222 -0.655 0 C-N-CA 121.106 -0.569 . . . . 25.0 112.489 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.7 p -61.49 132.0 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 122.742 1.258 . . . . 25.0 111.417 -176.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -91.94 -19.88 21.98 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 114.986 -1.007 . . . . 25.0 111.203 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.76 -146.13 7.78 Favored Glycine 0 C--O 1.223 -0.568 0 N-CA-C 116.899 1.52 . . . . 25.0 116.899 -175.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.7 p 73.36 155.59 0.16 Allowed Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 126.928 2.091 . . . . 25.0 110.427 -175.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -67.4 13.12 0.17 Allowed 'Trans proline' 0 CA--C 1.545 1.07 0 N-CA-C 117.386 2.033 . . . . 25.0 117.386 -175.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.55 -20.78 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 115.38 1.622 . . . . 25.0 115.38 -174.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.7 p -146.47 141.5 20.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.999 0.74 . . . . 25.0 112.999 -175.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.56 17.15 69.14 Favored Glycine 0 C--O 1.241 0.585 0 N-CA-C 118.324 2.09 . . . . 25.0 118.324 173.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.2 t -51.51 -54.6 25.56 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.517 0.932 . . . . 25.0 113.517 -174.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -82.48 12.6 4.36 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 117.535 2.42 . . . . 25.0 117.535 -174.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -147.95 170.48 17.62 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 122.038 -0.414 . . . . 25.0 111.837 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -58.3 136.24 57.32 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 112.795 0.665 . . . . 25.0 112.795 -175.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -123.0 160.79 25.54 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 116.221 1.934 . . . . 50.0 116.221 -173.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -137.23 105.36 5.69 Favored 'General case' 0 C--O 1.249 1.042 0 N-CA-C 103.795 -2.668 . . . . 25.0 103.795 160.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.6 mt -125.29 131.21 53.11 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.312 0.486 . . . . 25.0 112.312 -175.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -118.59 111.86 19.12 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 122.489 0.316 . . . . 25.0 111.839 -176.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.32 -177.9 51.38 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 117.916 1.926 . . . . 25.0 117.916 -174.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.1 p -81.55 173.32 12.5 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.051 0.94 . . . . 25.0 112.054 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.4 mt -84.56 5.89 25.95 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.748 -0.595 . . . . 25.0 111.494 174.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -100.23 -179.24 30.06 Favored Glycine 0 N--CA 1.464 0.544 0 N-CA-C 111.83 -0.508 . . . . 25.0 111.83 177.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.3 t -78.54 124.92 28.67 Favored 'General case' 0 C--O 1.24 0.585 0 O-C-N 122.121 -0.635 . . . . 25.0 110.053 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -131.36 156.24 45.86 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.899 0.38 . . . . 50.0 111.018 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -98.42 129.14 45.05 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 102.825 -3.028 . . . . 25.0 102.825 163.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.8 mm -126.59 124.48 65.3 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.56 0 N-CA-C 105.969 -1.863 . . . . 25.0 105.969 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.8 mp -125.85 121.72 34.04 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.35 -1.352 . . . . 25.0 107.35 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.23 -34.31 37.35 Favored Glycine 0 C--N 1.318 -0.424 0 C-N-CA 120.68 -0.771 . . . . 25.0 114.933 -178.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 72.31 -145.59 37.82 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 110.415 -1.074 . . . . 25.0 110.415 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -78.63 169.79 54.46 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-O 121.897 0.721 . . . . 25.0 111.352 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.77 159.92 27.52 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.574 -0.822 . . . . 25.0 113.553 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.72 104.49 13.01 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 105.629 -1.989 . . . . 25.0 105.629 176.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -103.31 148.9 25.27 Favored 'General case' 0 C--N 1.314 -0.941 0 O-C-N 121.365 -0.834 . . . . 50.0 111.073 -169.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -112.34 98.57 7.38 Favored 'General case' 0 C--O 1.246 0.92 0 N-CA-C 105.135 -2.172 . . . . 25.0 105.135 176.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 62.8 mt -106.86 133.55 51.35 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.118 -0.492 . . . . 25.0 111.532 -172.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -130.3 106.87 8.86 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 122.659 0.384 . . . . 25.0 110.166 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.12 -19.69 49.38 Favored Glycine 0 CA--C 1.534 1.279 0 N-CA-C 117.682 1.833 . . . . 25.0 117.682 -178.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 53.35 -148.18 0.46 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 118.711 1.255 . . . . 25.0 113.188 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.63 165.87 20.27 Favored 'General case' 0 C--O 1.254 1.292 0 CA-C-O 121.247 0.546 . . . . 25.0 112.087 -176.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.37 153.53 30.16 Favored Glycine 0 N--CA 1.452 -0.269 0 N-CA-C 109.629 -1.388 . . . . 25.0 109.629 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -80.07 101.03 8.48 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.644 -1.613 . . . . 25.0 106.644 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -101.8 151.65 21.81 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.801 -0.636 . . . . 50.0 111.568 -170.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.7 mp -114.0 95.8 5.49 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.591 -0.522 . . . . 25.0 109.591 177.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.7 mp -101.46 128.03 47.86 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.336 0.589 . . . . 25.0 112.103 -173.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -125.73 135.94 52.62 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 106.485 -1.672 . . . . 25.0 106.485 174.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -89.54 -41.07 5.83 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 119.778 -1.201 . . . . 25.0 114.826 -174.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.46 -166.21 50.83 Favored Glycine 0 C--O 1.238 0.353 0 CA-C-N 117.662 0.731 . . . . 25.0 112.829 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.68 149.65 21.34 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.099 0.407 . . . . 25.0 112.099 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.4 153.64 29.03 Favored Glycine 0 C--O 1.238 0.365 0 CA-C-N 115.38 -0.827 . . . . 25.0 112.837 -177.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.34 120.26 21.36 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 105.193 -2.151 . . . . 25.0 105.193 176.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -109.05 156.2 20.05 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.983 -0.377 . . . . 50.0 109.983 -172.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -123.9 117.99 26.07 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 103.928 -2.619 . . . . 25.0 103.928 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -144.23 132.28 21.63 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 116.753 2.131 . . . . 25.0 116.753 -168.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 64.3 m -100.63 135.49 41.99 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.454 -0.573 . . . . 25.0 109.454 176.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.49 -32.91 7.85 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.038 -1.225 . . . . 25.0 110.038 173.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.07 -163.01 54.5 Favored Glycine 0 C--O 1.247 0.954 0 CA-C-O 122.836 1.242 . . . . 25.0 111.805 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -67.23 161.01 25.81 Favored 'General case' 0 C--N 1.322 -0.629 0 O-C-N 121.922 -0.752 . . . . 25.0 110.108 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.44 164.42 37.15 Favored Glycine 0 CA--C 1.521 0.418 0 CA-C-N 115.757 -0.656 . . . . 25.0 111.807 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.66 92.08 8.08 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-O 122.352 1.072 . . . . 25.0 109.957 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -86.01 152.35 22.98 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.105 -0.952 . . . . 50.0 112.338 -172.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.5 m -121.93 127.99 51.02 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.899 -1.046 . . . . 25.0 109.735 -178.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -122.8 84.56 2.28 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.605 -1.257 . . . . 25.0 107.605 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 54.8 mtt85 -85.64 -21.72 28.28 Favored 'General case' 0 CA--C 1.497 -1.068 0 O-C-N 121.54 -0.725 . . . . 25.0 111.358 -178.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 68.22 159.07 0.16 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.017 1.327 . . . . 25.0 112.173 -175.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -93.62 -28.13 16.19 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 115.795 1.776 . . . . 25.0 115.795 -167.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 70.7 mt -145.91 166.02 27.22 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.39 0.515 . . . . 25.0 112.39 -171.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.33 -28.15 69.01 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.642 -0.873 . . . . 25.0 108.642 170.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -82.87 -0.19 47.09 Favored 'General case' 0 C--O 1.252 1.187 0 CA-C-N 114.363 -1.289 . . . . 25.0 113.814 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -91.0 134.65 34.32 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 121.719 -0.613 . . . . 25.0 110.145 -173.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.3 t 47.32 42.75 14.31 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 115.291 1.589 . . . . 25.0 115.291 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 15.5 p-80 -110.79 165.44 11.84 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.419 -0.81 . . . . 25.0 112.375 -174.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -116.06 142.24 47.06 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 106.805 -1.554 . . . . 25.0 106.805 176.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 82.5 p -136.27 166.56 27.03 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 108.278 -1.008 . . . . 25.0 108.278 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -61.14 -22.49 74.84 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 117.885 -0.944 . . . . 25.0 113.528 174.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 86.9 mt -76.79 -21.82 54.59 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.733 0.778 . . . . 25.0 111.174 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 150.52 175.18 22.31 Favored Glycine 0 CA--C 1.506 -0.479 0 CA-C-N 116.17 -0.468 . . . . 25.0 112.11 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.0 t -95.09 148.4 22.4 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 122.01 0.909 . . . . 25.0 111.137 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -131.55 30.82 4.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.833 -1.076 . . . . 25.0 108.448 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.0 142.03 44.34 Favored Glycine 0 C--O 1.243 0.675 0 N-CA-C 111.157 -0.777 . . . . 25.0 111.157 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -85.52 169.22 13.8 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 120.575 0.226 . . . . 50.0 110.393 -177.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -124.08 98.38 5.76 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.001 0.52 . . . . 25.0 111.468 -173.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.9 mt -85.34 132.73 31.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 107.56 -1.274 . . . . 25.0 107.56 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 98.0 mt -84.66 -44.55 13.33 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 114.894 1.442 . . . . 25.0 114.894 -169.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 57.5 p30 -134.45 38.62 3.09 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 114.799 1.407 . . . . 25.0 114.799 -174.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -57.35 129.64 42.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.703 0.763 . . . . 25.0 112.384 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -99.66 105.07 31.8 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 108.212 -1.033 . . . . 25.0 108.212 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -67.61 -16.83 47.68 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 116.228 -2.048 . . . . 25.0 115.802 -176.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.7 t -82.86 -26.66 31.41 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 120.607 0.241 . . . . 25.0 110.988 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -115.78 -33.1 5.26 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 115.432 1.641 . . . . 25.0 115.432 -173.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -91.8 167.63 12.02 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 123.432 0.457 . . . . 50.0 110.367 -170.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -144.65 145.91 31.99 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.212 0.449 . . . . 25.0 112.212 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 88.3 mt -127.41 127.83 69.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.281 -1.007 . . . . 25.0 108.281 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -91.25 148.0 22.65 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.509 -0.923 . . . . 25.0 108.509 173.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.4 p -147.79 -6.72 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 113.175 0.806 . . . . 25.0 113.175 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 26.4 t -61.44 -43.77 98.28 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.532 0.568 . . . . 25.0 112.532 -175.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.05 -28.86 54.91 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.9 1.074 . . . . 25.0 113.9 -178.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.62 -0.33 13.04 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 116.655 2.094 . . . . 25.0 116.655 -169.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -145.0 -72.45 0.02 OUTLIER Glycine 0 C--O 1.241 0.576 0 N-CA-C 116.555 1.382 . . . . 25.0 116.555 -178.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -157.98 169.25 25.01 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.597 -0.89 . . . . 25.0 108.597 -175.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 38.5 t -124.11 -39.8 2.33 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.111 0.482 . . . . 25.0 110.344 177.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -88.48 121.72 6.08 Favored Glycine 0 N--CA 1.465 0.585 0 N-CA-C 111.053 -0.819 . . . . 25.0 111.053 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -73.53 154.16 39.98 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 117.633 0.716 . . . . 25.0 111.87 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.15 -171.84 45.75 Favored Glycine 0 N--CA 1.463 0.467 0 CA-C-N 116.281 -0.418 . . . . 25.0 112.108 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -75.6 81.71 2.6 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.611 0.967 . . . . 25.0 113.611 -177.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -105.86 176.62 22.21 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 108.973 -1.651 . . . . 25.0 108.973 173.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -125.96 166.19 17.38 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 118.106 0.953 . . . . 25.0 110.683 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 54.09 36.43 24.67 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 114.083 1.142 . . . . 25.0 114.083 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 77.35 31.26 52.13 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 120.214 -0.993 . . . . 25.0 112.11 177.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.3 t -138.78 -174.37 3.82 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 117.382 0.591 . . . . 25.0 110.468 -177.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.56 161.01 15.23 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 102.294 -3.225 . . . . 25.0 102.294 173.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.78 115.01 10.48 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 118.744 0.702 . . . . 25.0 110.325 -173.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.1 m -85.3 165.1 2.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 108.112 -1.07 . . . . 25.0 108.112 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 92.0 p -150.39 162.59 40.26 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.673 -0.492 . . . . 25.0 109.673 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.5 m -115.95 164.2 12.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.698 -0.853 . . . . 25.0 108.698 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.5 t -76.55 -56.4 4.65 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.186 -1.413 . . . . 25.0 107.186 170.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -161.31 -159.94 0.68 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 103.436 -2.801 . . . . 25.0 103.436 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -66.52 -24.22 66.35 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 121.062 0.458 . . . . 25.0 110.311 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -118.86 -159.02 10.94 Favored Glycine 0 C--O 1.244 0.758 0 N-CA-C 109.661 -1.376 . . . . 25.0 109.661 176.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 59.44 -161.85 0.26 Allowed 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 112.913 0.708 . . . . 25.0 112.913 176.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 39.4 mtt85 -76.33 163.81 26.64 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.292 1.219 . . . . 25.0 114.292 -169.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.14 159.91 18.76 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 106.233 -1.766 . . . . 25.0 106.233 171.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -132.01 159.21 39.44 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.245 0.545 . . . . 25.0 110.452 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 55.7 tp -133.05 119.37 19.94 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 104.356 -2.461 . . . . 25.0 104.356 170.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -116.51 155.62 28.31 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.435 -0.58 . . . . 25.0 109.435 -175.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.4 t -100.02 149.92 22.98 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 104.272 -2.492 . . . . 25.0 104.272 166.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -116.13 9.56 14.74 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 122.089 0.947 . . . . 25.0 109.783 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -102.18 143.17 32.31 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 104.185 -2.524 . . . . 25.0 104.185 171.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -138.7 155.12 48.52 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.604 0.716 . . . . 25.0 109.802 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -75.29 160.01 30.84 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 105.543 -2.021 . . . . 25.0 105.543 175.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.7 -16.65 63.96 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.496 0.589 . . . . 25.0 111.485 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -76.13 -9.44 58.63 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.157 0.503 . . . . 25.0 112.141 174.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.69 3.29 68.81 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.483 -0.647 . . . . 25.0 111.483 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.3 mt -73.76 138.47 44.59 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.372 -0.973 . . . . 25.0 108.372 177.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.87 -178.43 6.35 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 106.848 -1.538 . . . . 25.0 106.848 -175.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -132.35 140.99 48.74 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-N 118.91 0.777 . . . . 25.0 112.995 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -153.58 156.02 37.22 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 108.06 -1.089 . . . . 25.0 108.06 170.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.5 p -146.06 143.93 21.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 N-CA-C 105.818 -1.919 . . . . 25.0 105.818 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -107.36 142.64 36.86 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.032 -1.47 . . . . 25.0 107.032 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.9 mp -131.49 127.92 38.31 Favored 'General case' 0 C--O 1.207 -1.141 0 N-CA-C 103.552 -2.759 . . . . 25.0 103.552 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -100.19 3.53 43.78 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 119.278 0.945 . . . . 25.0 113.304 -174.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -79.07 -2.28 86.8 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 120.668 -0.777 . . . . 25.0 113.775 177.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 44.8 t0 49.16 48.93 20.39 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 122.075 0.94 . . . . 25.0 112.14 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 6.7 p-80 -108.18 32.67 4.61 Favored 'General case' 0 C--O 1.249 1.03 0 CA-C-O 122.53 1.157 . . . . 25.0 108.615 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -55.1 -34.3 63.56 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.044 -0.98 . . . . 25.0 112.492 176.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.97 -12.78 61.98 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 113.275 0.842 . . . . 25.0 113.275 -178.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -116.86 -5.0 11.53 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.635 0.605 . . . . 25.0 112.635 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 16.1 mt -70.7 127.37 32.41 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.495 -0.928 . . . . 25.0 108.495 178.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 71.2 m -127.64 164.37 22.19 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.616 -1.624 . . . . 25.0 106.616 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -73.64 -1.87 20.68 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.197 -0.668 . . . . 25.0 109.197 176.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -71.33 -29.77 65.4 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 115.673 -0.694 . . . . 25.0 112.385 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -98.15 1.14 47.17 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 122.065 -0.397 . . . . 25.0 111.324 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 38.9 mm -105.5 111.36 34.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 105.535 -2.024 . . . . 25.0 105.535 175.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.8 p -98.15 115.95 39.62 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-O 123.064 1.412 . . . . 25.0 112.558 -173.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -137.36 0.51 2.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 112.98 -1.918 . . . . 25.0 110.362 174.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -81.61 43.95 0.78 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 122.752 0.421 . . . . 25.0 111.441 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 55.94 24.39 7.57 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.202 1.186 . . . . 25.0 114.202 -177.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.56 9.09 0.73 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.657 1.725 . . . . 25.0 115.657 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -79.01 134.94 36.77 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 121.353 -0.842 . . . . 25.0 110.787 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.34 -19.69 63.04 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.354 -0.61 . . . . 25.0 109.354 178.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.3 47.39 0.68 Allowed 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 121.264 0.554 . . . . 25.0 111.513 176.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -150.3 173.18 14.27 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.164 -1.421 . . . . 25.0 107.164 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 62.77 -172.1 0.16 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.64 1.176 . . . . 25.0 111.905 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 81.55 23.41 58.35 Favored Glycine 0 C--N 1.32 -0.311 0 N-CA-C 110.081 -1.207 . . . . 25.0 110.081 -176.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -121.34 101.74 7.83 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 109.38 -0.6 . . . . 25.0 109.38 -176.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -127.8 157.49 40.28 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.179 -0.674 . . . . 25.0 109.179 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -136.74 26.01 3.05 Favored Glycine 0 N--CA 1.464 0.532 0 CA-C-N 116.426 -0.352 . . . . 25.0 113.636 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 47.1 t -80.96 -31.99 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 116.915 0.357 . . . . 25.0 110.8 -177.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.15 133.67 27.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 CA-C-O 121.571 0.7 . . . . 25.0 111.135 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.38 168.0 26.85 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 108.614 -1.794 . . . . 25.0 108.614 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -146.29 143.58 29.25 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.436 1.618 . . . . 25.0 110.601 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 80.5 p -155.51 167.82 29.12 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.556 -0.905 . . . . 25.0 108.556 178.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 179.3 -179.74 48.84 Favored Glycine 0 CA--C 1.507 -0.418 0 C-N-CA 120.628 -0.796 . . . . 25.0 114.299 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -145.82 106.19 4.26 Favored Pre-proline 0 N--CA 1.468 0.456 0 N-CA-C 107.895 -1.15 . . . . 25.0 107.895 177.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -72.94 152.23 51.6 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 116.194 -2.07 . . . . 25.0 113.67 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -113.24 144.5 42.6 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.835 -1.913 . . . . 25.0 105.835 175.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -136.2 67.2 61.44 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 112.644 0.609 . . . . 25.0 112.644 -174.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -73.45 150.83 46.94 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 117.874 -0.951 . . . . 25.0 112.575 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.7 t -139.95 20.96 2.47 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 122.02 0.914 . . . . 25.0 109.803 -177.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.4 p . . . . . 0 C--O 1.248 0.975 0 CA-C-O 117.618 -1.182 . . . . 25.0 110.759 -178.19 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.784 0 N-CA-C 110.025 -0.361 . . . . 25.0 110.025 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -123.54 118.23 27.51 Favored Pre-proline 0 C--O 1.241 0.65 0 O-C-N 123.296 0.372 . . . . 25.0 110.652 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.37 142.75 46.01 Favored 'Trans proline' 0 C--O 1.247 0.967 0 C-N-CA 116.726 -1.716 . . . . 25.0 114.293 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.9 51.52 0.06 OUTLIER Glycine 0 C--O 1.237 0.3 0 N-CA-C 109.625 -1.39 . . . . 25.0 109.625 -177.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.9 p -57.86 133.58 22.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.758 0.79 . . . . 25.0 111.03 -174.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -102.37 -8.81 20.86 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.197 -0.91 . . . . 25.0 110.204 -173.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -82.52 -141.79 4.04 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.882 -0.599 . . . . 25.0 112.413 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.5 p 69.12 159.4 0.15 Allowed Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 126.064 1.746 . . . . 25.0 110.835 -175.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -65.97 -5.06 11.28 Favored 'Trans proline' 0 N--CA 1.483 0.9 0 N-CA-C 116.64 1.746 . . . . 25.0 116.64 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.97 -4.2 4.22 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 N-CA-C 114.192 1.182 . . . . 25.0 114.192 -170.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.3 p -141.34 141.35 30.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 121.56 0.695 . . . . 25.0 111.713 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.48 18.5 73.67 Favored Glycine 0 C--N 1.336 0.577 0 N-CA-C 119.681 2.633 . . . . 25.0 119.681 171.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.2 t -51.4 -51.63 53.06 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 120.641 -1.505 . . . . 25.0 113.826 -172.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -85.85 13.94 6.67 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 115.187 1.551 . . . . 25.0 115.187 -171.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.24 168.58 19.44 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.32 0.489 . . . . 25.0 112.32 -176.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -63.93 130.86 45.79 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 118.208 0.458 . . . . 25.0 110.809 -177.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -127.0 170.09 12.66 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 116.6 2.074 . . . . 50.0 116.6 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -136.01 92.56 2.81 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 104.449 -2.426 . . . . 25.0 104.449 168.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 52.4 mt -106.95 123.28 47.95 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.385 0.884 . . . . 25.0 113.385 -173.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -111.43 114.77 28.12 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.815 -0.629 . . . . 25.0 109.401 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.07 174.71 51.21 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 116.948 1.539 . . . . 25.0 116.948 -175.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.3 p -69.47 169.69 12.01 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.504 0.669 . . . . 25.0 111.574 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 89.3 mt -87.33 16.09 5.71 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.521 -0.763 . . . . 25.0 110.905 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -120.6 -178.96 16.19 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.368 -0.693 . . . . 25.0 111.368 175.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.7 t -68.17 135.07 51.51 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 117.365 0.582 . . . . 25.0 110.924 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -144.92 166.44 25.29 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.083 0.553 . . . . 50.0 109.791 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -109.78 129.8 55.59 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 103.284 -2.858 . . . . 25.0 103.284 162.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.4 mm -119.23 121.71 67.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 108.138 -1.06 . . . . 25.0 108.138 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 9.0 mp -124.36 125.96 45.19 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 105.801 -1.926 . . . . 25.0 105.801 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.21 -26.62 27.9 Favored Glycine 0 C--O 1.246 0.904 0 N-CA-C 115.355 0.902 . . . . 25.0 115.355 -176.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.24 -147.33 47.33 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.122 -1.037 . . . . 25.0 112.003 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.31 174.3 52.21 Favored Glycine 0 C--O 1.248 0.983 0 O-C-N 122.73 -0.277 . . . . 25.0 112.889 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.49 160.92 20.99 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.597 -0.811 . . . . 25.0 113.82 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.57 92.0 8.75 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 122.526 1.155 . . . . 25.0 108.008 175.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -89.31 157.29 18.25 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.762 -1.108 . . . . 50.0 112.635 -169.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -117.35 94.99 4.77 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 107.469 -1.308 . . . . 25.0 107.469 172.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 49.6 mt -101.83 134.73 44.55 Favored 'General case' 0 C--O 1.213 -0.847 0 N-CA-C 112.614 0.598 . . . . 25.0 112.614 -172.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -131.51 106.79 8.44 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.174 0.512 . . . . 25.0 111.015 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.96 -25.61 57.51 Favored Glycine 0 C--O 1.246 0.845 0 N-CA-C 116.066 1.186 . . . . 25.0 116.066 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 49.99 -152.19 0.17 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.928 1.084 . . . . 25.0 113.928 -178.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.97 160.39 20.85 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 113.164 0.801 . . . . 25.0 113.164 -173.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.06 156.5 31.35 Favored Glycine 0 C--O 1.247 0.955 0 N-CA-C 109.591 -1.404 . . . . 25.0 109.591 -177.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 22.0 m-20 -81.42 106.08 13.1 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 107.149 -1.426 . . . . 25.0 107.149 177.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -106.84 161.8 14.37 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 120.946 0.403 . . . . 50.0 111.098 -170.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 mp -119.87 136.88 54.32 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 104.832 -2.284 . . . . 25.0 104.832 174.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 mp -136.1 125.42 24.83 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 114.49 1.293 . . . . 25.0 114.49 -172.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -125.19 137.84 54.13 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 113.968 -1.469 . . . . 25.0 107.542 174.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.48 -31.79 8.64 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.32 -0.943 . . . . 25.0 114.704 -178.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.98 -171.0 55.12 Favored Glycine 0 C--O 1.253 1.285 0 N-CA-C 110.784 -0.926 . . . . 25.0 110.784 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.6 157.11 9.61 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.956 0.884 . . . . 25.0 112.422 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.38 164.73 40.48 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-N 115.212 -0.903 . . . . 25.0 111.888 -176.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.97 123.72 33.57 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 104.7 -2.333 . . . . 25.0 104.7 176.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -113.44 157.08 22.4 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.663 0.986 . . . . 50.0 113.663 -169.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -113.2 127.08 56.07 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 103.493 -2.78 . . . . 25.0 103.493 174.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -147.83 137.3 22.43 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.901 1.074 . . . . 25.0 113.901 -176.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 62.1 m -116.04 142.59 46.6 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.02 -1.104 . . . . 25.0 108.02 176.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -93.49 -34.21 6.76 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 111.079 -0.808 . . . . 25.0 111.079 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.81 -173.25 55.33 Favored Glycine 0 C--O 1.244 0.732 0 CA-C-N 117.987 0.893 . . . . 25.0 113.462 -178.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -66.1 159.21 26.62 Favored 'General case' 0 C--O 1.241 0.612 0 O-C-N 121.455 -1.027 . . . . 25.0 109.65 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.1 156.45 32.21 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.57 -1.012 . . . . 25.0 110.57 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.97 124.09 26.33 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 109.184 -0.672 . . . . 25.0 109.184 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -116.3 151.6 35.53 Favored 'General case' 0 C--N 1.313 -0.987 0 O-C-N 121.614 -0.679 . . . . 50.0 112.08 -173.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 98.5 m -114.27 122.57 47.15 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 109.046 -0.724 . . . . 25.0 109.046 177.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -108.96 124.37 50.58 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 106.424 -1.695 . . . . 25.0 106.424 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 49.2 mtt85 -122.49 -36.68 2.89 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.121 0.785 . . . . 25.0 113.121 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 71.69 155.1 0.15 Allowed 'General case' 0 N--CA 1.475 0.817 0 O-C-N 125.07 1.481 . . . . 25.0 108.101 -169.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.52 -43.19 19.12 Favored 'General case' 0 C--N 1.318 -0.765 0 O-C-N 121.852 -0.53 . . . . 25.0 112.158 -165.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 58.6 mt -130.9 163.46 27.42 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 122.054 0.93 . . . . 25.0 111.423 -173.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -56.14 -27.56 54.56 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 114.497 -1.228 . . . . 25.0 108.868 169.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -72.71 -4.68 32.74 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 115.01 1.485 . . . . 25.0 115.01 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -99.09 153.55 18.8 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.41 -0.806 . . . . 25.0 112.894 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.9 t 43.35 48.7 5.93 Favored 'General case' 0 C--O 1.217 -0.649 0 N-CA-C 114.806 1.41 . . . . 25.0 114.806 170.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 28.0 p-80 -131.91 170.23 15.18 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.143 -0.935 . . . . 25.0 110.195 -175.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.5 ttt180 -122.55 142.65 50.39 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 105.707 -1.96 . . . . 25.0 105.707 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 77.9 p -137.55 168.95 14.4 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.207 -0.664 . . . . 25.0 109.207 -176.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -61.45 -24.23 78.02 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 CA-C-N 118.841 0.622 . . . . 25.0 113.266 175.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.2 mt -75.59 -26.49 57.92 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.542 0.687 . . . . 25.0 111.303 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.17 -174.13 32.65 Favored Glycine 0 N--CA 1.463 0.455 0 N-CA-C 110.595 -1.002 . . . . 25.0 110.595 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.8 t -103.18 149.21 24.88 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-O 122.742 1.258 . . . . 25.0 112.956 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -129.03 21.61 5.79 Favored 'General case' 0 C--O 1.252 1.2 0 CA-C-N 114.247 -1.342 . . . . 25.0 109.004 175.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.04 140.5 46.32 Favored Glycine 0 N--CA 1.473 1.105 0 O-C-N 124.549 1.156 . . . . 25.0 111.414 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -96.99 167.37 11.12 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 108.35 -0.981 . . . . 50.0 108.35 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.45 ' HG3' ' HB3' ' A' ' 140' ' ' ALA . 0.3 OUTLIER -123.89 109.32 13.45 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.135 0.791 . . . . 25.0 113.135 -175.074 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 41.5 mt -87.98 139.46 17.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 105.865 -1.902 . . . . 25.0 105.865 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.2 mt -90.9 -44.44 9.37 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 114.868 1.432 . . . . 25.0 114.868 -176.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.6 p-10 -130.13 39.51 3.66 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 116.165 1.913 . . . . 25.0 116.165 -173.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -55.99 126.84 27.64 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 122.3 -0.25 . . . . 25.0 111.114 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -97.57 104.14 19.46 Favored Pre-proline 0 N--CA 1.474 0.771 0 N-CA-C 108.878 -0.786 . . . . 25.0 108.878 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -70.67 -4.97 15.71 Favored 'Trans proline' 0 C--O 1.213 -0.757 0 N-CA-C 114.973 1.105 . . . . 25.0 114.973 -176.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.8 t -89.42 -28.71 19.56 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.087 0.47 . . . . 25.0 111.08 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -118.72 -38.28 3.13 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 115.217 1.562 . . . . 25.0 115.217 -172.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -85.76 175.01 8.94 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.714 0.635 . . . . 75.0 112.714 -172.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.72 152.26 36.31 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.182 0.808 . . . . 25.0 113.182 170.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 55.9 mt -119.03 132.03 70.1 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 N-CA-C 108.854 -0.795 . . . . 25.0 108.854 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -85.6 145.05 27.53 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 122.32 1.057 . . . . 25.0 111.458 173.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.0 p -143.19 -0.85 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 CA-C-N 114.724 -1.125 . . . . 25.0 110.085 178.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.8 t -64.76 -42.51 95.07 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.283 0.563 . . . . 25.0 111.11 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.92 -27.85 63.1 Favored 'General case' 0 C--O 1.249 1.066 0 CA-C-N 115.656 -0.702 . . . . 25.0 111.693 -177.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.0 mt -99.12 -58.07 2.02 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 114.255 1.206 . . . . 25.0 114.255 -169.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -104.33 -65.26 0.69 Allowed Glycine 0 C--O 1.242 0.643 0 N-CA-C 116.609 1.404 . . . . 25.0 116.609 -168.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -156.47 164.8 37.82 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.012 0.478 . . . . 25.0 110.451 -168.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.9 p -117.57 -19.74 9.28 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.99 0.516 . . . . 25.0 110.47 173.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -108.32 117.12 4.97 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 109.199 -1.56 . . . . 25.0 109.199 175.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -60.08 151.44 26.66 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 116.216 1.932 . . . . 25.0 116.216 -175.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.89 -169.25 36.63 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 114.856 -1.066 . . . . 25.0 114.798 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -55.8 135.46 51.76 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 113.435 0.902 . . . . 25.0 113.435 -177.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 168.4 177.68 39.62 Favored Glycine 0 C--O 1.236 0.257 0 N-CA-C 107.961 -2.056 . . . . 25.0 107.961 178.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -142.99 168.96 18.48 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.119 1.46 . . . . 25.0 109.21 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 57.8 35.74 25.77 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.737 0.815 . . . . 25.0 111.527 -177.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 69.37 36.66 78.63 Favored Glycine 0 C--N 1.32 -0.333 0 N-CA-C 111.114 -0.795 . . . . 25.0 111.114 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.3 t -140.09 177.85 7.69 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.193 -0.669 . . . . 25.0 109.193 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 84.3 mt -104.5 155.29 18.94 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 102.347 -3.205 . . . . 25.0 102.347 172.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.39 136.37 55.66 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 119.367 -0.933 . . . . 25.0 109.257 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.0 m -110.74 161.62 9.01 Favored 'Isoleucine or valine' 0 C--O 1.248 1.008 0 N-CA-C 108.89 -0.781 . . . . 25.0 108.89 -177.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 80.4 p -142.56 163.32 33.13 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 116.569 -0.287 . . . . 25.0 111.557 -177.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.2 m -116.41 160.99 15.49 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 N-CA-C 107.555 -1.276 . . . . 25.0 107.555 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.5 t -74.07 -48.78 27.49 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.739 -1.208 . . . . 25.0 107.739 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -168.09 -162.47 0.42 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 102.175 -3.268 . . . . 25.0 102.175 -178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -77.55 12.55 1.56 Allowed 'General case' 0 CA--C 1.546 0.803 0 CA-C-O 121.754 0.788 . . . . 25.0 111.746 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -150.91 -164.13 11.8 Favored Glycine 0 C--O 1.243 0.716 0 N-CA-C 107.438 -2.265 . . . . 25.0 107.438 176.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.42 -154.85 0.36 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.028 0.381 . . . . 25.0 112.028 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.8 mtt180 -84.08 166.52 17.62 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.925 0.713 . . . . 25.0 112.925 -173.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.68 165.98 12.22 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 105.584 -2.006 . . . . 25.0 105.584 174.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -134.55 158.4 44.08 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.762 0.791 . . . . 25.0 111.8 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 41.8 tp -127.08 129.27 47.66 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 103.834 -2.654 . . . . 25.0 103.834 174.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -123.6 154.21 39.62 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.327 0.584 . . . . 25.0 111.346 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.1 t -99.44 151.21 21.37 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 104.533 -2.395 . . . . 25.0 104.533 167.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -118.67 14.66 13.55 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 107.943 -1.132 . . . . 25.0 107.943 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -105.23 140.41 38.42 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 104.578 -2.378 . . . . 25.0 104.578 172.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -138.43 155.44 48.48 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 123.937 0.773 . . . . 25.0 109.64 -177.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -85.73 163.87 17.96 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.57 -0.741 . . . . 25.0 109.633 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.75 -24.0 67.48 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-O 121.444 0.64 . . . . 25.0 111.819 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -74.33 -4.13 34.44 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.754 0.65 . . . . 25.0 112.754 175.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.18 17.73 64.25 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.568 -0.825 . . . . 25.0 112.247 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.2 mt -93.69 141.95 27.91 Favored 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 107.311 -1.366 . . . . 25.0 107.311 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 63.9 p -141.49 178.41 7.46 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 106.854 -1.535 . . . . 25.0 106.854 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -123.31 133.17 54.18 Favored 'General case' 0 C--O 1.252 1.198 0 CA-C-N 118.544 0.611 . . . . 25.0 111.818 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -148.89 151.43 34.66 Favored 'General case' 0 C--O 1.25 1.103 0 N-CA-C 108.56 -0.904 . . . . 25.0 108.56 171.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.1 p -149.19 146.7 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 107.313 -1.366 . . . . 25.0 107.313 -178.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.45 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . . . -104.98 145.57 30.24 Favored 'General case' 0 C--O 1.247 0.972 0 N-CA-C 109.025 -0.732 . . . . 25.0 109.025 -177.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.9 mp -135.45 120.31 18.52 Favored 'General case' 0 C--O 1.211 -0.921 0 N-CA-C 105.1 -2.185 . . . . 25.0 105.1 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -88.06 -13.1 42.36 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 118.302 2.704 . . . . 25.0 118.302 -169.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -78.36 9.0 36.6 Favored Glycine 0 CA--C 1.535 1.332 0 N-CA-C 117.009 1.563 . . . . 25.0 117.009 -175.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 39.9 t0 48.46 51.14 15.78 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 122.716 1.246 . . . . 25.0 112.957 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 12.0 p-80 -110.97 31.97 5.63 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.753 -1.203 . . . . 25.0 107.753 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.29 -38.43 83.59 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 115.232 -0.895 . . . . 25.0 110.968 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.42 -22.41 66.95 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.101 0.56 . . . . 25.0 112.111 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -98.23 -10.71 23.6 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.037 0.754 . . . . 25.0 113.037 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 13.9 mt -66.1 145.85 55.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.776 0.798 . . . . 25.0 112.214 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 72.1 m -142.97 157.34 44.65 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.853 -1.165 . . . . 25.0 107.853 177.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -81.4 9.04 7.88 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.451 0.3 . . . . 25.0 110.424 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -92.72 -22.87 19.14 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.857 0.36 . . . . 25.0 110.071 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -99.17 20.63 13.14 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 122.79 1.281 . . . . 25.0 109.048 173.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 39.8 mm -122.04 130.01 74.92 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 N-CA-C 101.753 -3.425 . . . . 25.0 101.753 170.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.2 p -108.64 128.34 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 119.35 0.977 . . . . 25.0 110.948 -172.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -167.17 -24.64 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.885 -1.052 . . . . 25.0 113.376 -176.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -82.16 80.63 8.33 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.719 -0.613 . . . . 25.0 110.802 -172.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 59.22 8.61 1.13 Allowed 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 115.326 1.602 . . . . 25.0 115.326 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 m 66.37 -37.87 0.29 Allowed 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 116.59 2.07 . . . . 25.0 116.59 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -65.3 138.07 57.95 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 122.009 -0.432 . . . . 25.0 111.414 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.0 -6.22 31.88 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 121.009 0.433 . . . . 25.0 110.83 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.85 -13.7 61.75 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 116.175 -0.466 . . . . 25.0 111.083 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -102.88 160.33 14.7 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 109.764 -0.458 . . . . 25.0 109.764 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 56.56 -163.52 0.16 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.945 1.461 . . . . 25.0 114.945 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 90.43 15.97 56.11 Favored Glycine 0 N--CA 1.459 0.207 0 N-CA-C 114.662 0.625 . . . . 25.0 114.662 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -83.41 115.9 22.25 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 117.271 0.535 . . . . 25.0 111.696 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -110.68 134.12 52.73 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.133 -0.691 . . . . 25.0 109.133 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.8 45.78 0.7 Allowed Glycine 0 C--O 1.224 -0.505 0 N-CA-C 111.513 -0.635 . . . . 25.0 111.513 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 43.1 t -84.46 -32.01 7.8 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 CA-C-O 121.678 0.752 . . . . 25.0 109.619 -177.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.68 135.4 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 CA-C-O 121.713 0.768 . . . . 25.0 112.082 -176.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 161.84 133.88 1.55 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.622 -1.391 . . . . 25.0 109.622 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -148.49 152.12 36.35 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 117.393 0.597 . . . . 25.0 110.941 -177.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 51.2 p -155.41 166.54 33.22 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.365 -0.976 . . . . 25.0 108.365 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 161.67 146.99 4.83 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 121.179 -0.534 . . . . 25.0 113.707 176.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -98.56 110.15 55.73 Favored Pre-proline 0 C--O 1.247 0.957 0 C-N-CA 123.599 0.76 . . . . 25.0 109.512 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.59 150.13 79.76 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 116.936 -1.576 . . . . 25.0 111.853 176.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -110.3 141.46 43.27 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 109.662 -0.496 . . . . 25.0 109.662 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -130.41 79.29 72.7 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-O 120.955 0.407 . . . . 25.0 111.81 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.3 157.81 52.82 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 N-CA-C 114.066 0.756 . . . . 25.0 114.066 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.8 t -99.04 -17.4 18.28 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.248 -0.649 . . . . 25.0 109.248 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 12.0 p . . . . . 0 C--O 1.246 0.894 0 CA-C-O 117.338 -1.315 . . . . 25.0 108.473 173.411 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 119.791 -0.147 . . . . 25.0 110.67 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -104.9 91.45 4.34 Favored Pre-proline 0 C--O 1.244 0.791 0 C-N-CA 123.679 0.792 . . . . 25.0 110.24 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -68.75 135.28 32.49 Favored 'Trans proline' 0 C--N 1.349 0.586 0 N-CA-C 115.691 1.381 . . . . 25.0 115.691 -174.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.27 51.76 0.29 Allowed Glycine 0 C--O 1.211 -1.3 0 N-CA-C 106.807 -2.517 . . . . 25.0 106.807 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.6 p -55.35 125.83 11.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 N-CA-C 114.564 1.32 . . . . 25.0 114.564 -172.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -105.64 11.2 32.52 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-O 122.189 0.995 . . . . 25.0 109.555 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -94.31 -155.73 31.85 Favored Glycine 0 N--CA 1.447 -0.625 0 O-C-N 121.38 -0.825 . . . . 25.0 113.704 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.0 p 70.18 158.2 0.16 Allowed Pre-proline 0 N--CA 1.486 1.343 0 C-N-CA 126.08 1.752 . . . . 25.0 112.518 -176.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.444 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 35.2 Cg_exo -66.2 -0.78 4.5 Favored 'Trans proline' 0 C--N 1.358 1.073 0 N-CA-C 116.957 1.868 . . . . 25.0 116.957 -174.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.1 p -65.56 -11.28 11.9 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 N-CA-C 115.91 1.818 . . . . 25.0 115.91 -171.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.8 p -146.42 127.2 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 N-CA-C 114.713 1.375 . . . . 25.0 114.713 -176.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.26 18.66 71.53 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 118.148 2.019 . . . . 25.0 118.148 173.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.7 t -50.86 -37.33 42.67 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 115.331 1.604 . . . . 25.0 115.331 -174.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -75.12 2.43 10.77 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 114.88 1.437 . . . . 25.0 114.88 -175.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.25 173.22 11.72 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 118.971 0.805 . . . . 25.0 110.598 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -51.11 128.41 21.7 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 112.886 0.698 . . . . 25.0 112.886 -177.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -129.91 159.4 36.75 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.39 0.885 . . . . 50.0 113.39 -173.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -125.9 95.98 4.6 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 105.353 -2.092 . . . . 25.0 105.353 165.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 80.9 mt -103.57 108.49 19.78 Favored 'General case' 0 C--O 1.212 -0.895 0 N-CA-C 112.976 0.732 . . . . 25.0 112.976 -176.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -98.82 109.75 22.46 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.962 -0.563 . . . . 25.0 109.596 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.0 172.53 51.63 Favored Glycine 0 C--O 1.219 -0.813 0 N-CA-C 115.893 1.117 . . . . 25.0 115.893 -175.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.8 p -72.31 175.76 5.86 Favored 'General case' 0 C--O 1.246 0.889 0 C-N-CA 123.656 0.782 . . . . 25.0 111.404 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 66.6 mt -87.91 16.73 5.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.52 0.676 . . . . 25.0 110.712 174.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.91 179.5 17.94 Favored Glycine 0 N--CA 1.461 0.331 0 N-CA-C 110.029 -1.228 . . . . 25.0 110.029 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.8 t -74.39 133.24 42.47 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.818 0.447 . . . . 25.0 110.454 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -144.54 166.56 24.81 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.453 0.701 . . . . 50.0 109.495 -177.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -110.37 121.89 46.39 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 104.839 -2.282 . . . . 25.0 104.839 164.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.0 mm -111.03 122.41 65.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 107.1 -1.445 . . . . 25.0 107.1 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.444 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 10.9 mp -119.58 122.72 42.22 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.467 -0.938 . . . . 25.0 108.467 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.17 -37.48 32.18 Favored Glycine 0 CA--C 1.496 -1.115 0 CA-C-O 117.888 -1.506 . . . . 25.0 116.074 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.64 -150.21 51.79 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 119.498 1.649 . . . . 25.0 112.357 -177.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.04 168.79 47.02 Favored Glycine 0 CA--C 1.526 0.776 0 O-C-N 121.855 -0.791 . . . . 25.0 114.12 -178.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.05 167.03 29.65 Favored Glycine 0 C--O 1.246 0.871 0 C-N-CA 121.378 -0.439 . . . . 25.0 113.391 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.44 101.25 12.46 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 106.601 -1.629 . . . . 25.0 106.601 177.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -96.32 152.16 18.84 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 113.255 0.835 . . . . 50.0 113.255 -169.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -119.06 88.42 2.93 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 107.531 -1.285 . . . . 25.0 107.531 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 52.4 mt -97.41 143.77 27.81 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.581 -0.736 . . . . 25.0 110.437 -169.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -137.21 106.65 6.11 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 121.905 -0.497 . . . . 25.0 111.497 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.62 -30.1 53.78 Favored Glycine 0 N--CA 1.466 0.659 0 CA-C-O 118.721 -1.044 . . . . 25.0 113.667 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 50.46 -149.71 0.27 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 117.865 0.832 . . . . 25.0 111.51 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.49 163.09 27.54 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.933 0.873 . . . . 25.0 112.736 -174.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.72 156.65 31.64 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 110.514 -1.034 . . . . 25.0 110.514 -174.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -86.82 100.57 12.63 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.213 -1.403 . . . . 25.0 107.213 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -102.84 152.0 21.78 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.23 -0.896 . . . . 50.0 112.955 -169.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mp -110.72 122.79 48.69 Favored 'General case' 0 C--O 1.217 -0.605 0 N-CA-C 107.005 -1.479 . . . . 25.0 107.005 176.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.9 mp -123.21 130.85 53.32 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 114.598 1.332 . . . . 25.0 114.598 -172.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -121.65 143.44 49.33 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.563 1.545 . . . . 25.0 109.011 175.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.76 -37.6 3.16 Favored Glycine 0 C--O 1.242 0.621 0 N-CA-C 115.296 0.878 . . . . 25.0 115.296 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.03 -168.38 54.71 Favored Glycine 0 C--O 1.246 0.885 0 CA-C-N 117.868 0.834 . . . . 25.0 111.974 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.61 151.72 23.98 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.196 -1.179 . . . . 25.0 112.427 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.99 162.13 38.19 Favored Glycine 0 N--CA 1.466 0.698 0 CA-C-N 115.353 -0.84 . . . . 25.0 111.693 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.74 122.71 29.01 Favored 'General case' 0 C--O 1.212 -0.892 0 N-CA-C 105.255 -2.128 . . . . 25.0 105.255 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -114.42 156.71 24.0 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 122.017 0.913 . . . . 50.0 110.526 -172.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -114.88 122.29 45.86 Favored 'General case' 0 C--O 1.218 -0.595 0 N-CA-C 102.305 -3.22 . . . . 25.0 102.305 177.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -142.19 131.01 22.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 119.165 0.893 . . . . 25.0 113.194 -175.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.99 142.03 34.78 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 115.722 -0.672 . . . . 25.0 109.26 177.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.91 -40.57 5.53 Favored Glycine 0 C--O 1.246 0.868 0 N-CA-C 109.294 -1.522 . . . . 25.0 109.294 175.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.0 -172.97 55.05 Favored Glycine 0 C--O 1.244 0.77 0 C-N-CA 120.278 -0.963 . . . . 25.0 112.786 -176.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -64.07 159.02 21.18 Favored 'General case' 0 C--O 1.251 1.142 0 O-C-N 122.178 -0.601 . . . . 25.0 110.864 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.75 161.87 37.24 Favored Glycine 0 C--O 1.247 0.91 0 CA-C-N 115.141 -0.936 . . . . 25.0 111.413 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.95 105.74 14.19 Favored 'General case' 0 C--O 1.217 -0.649 0 N-CA-C 107.807 -1.183 . . . . 25.0 107.807 -178.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -99.54 156.74 16.89 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 122.666 0.387 . . . . 50.0 111.826 -172.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 47.8 m -123.71 111.52 16.27 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.82 0.819 . . . . 25.0 110.09 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -88.39 96.46 10.6 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 104.917 -2.253 . . . . 25.0 104.917 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.4 mmt85 -81.22 -37.69 28.21 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.595 0.591 . . . . 25.0 112.595 -174.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 64.36 149.3 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 O-C-N 125.882 1.989 . . . . 25.0 111.998 -172.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.32 -59.99 2.56 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 114.995 1.48 . . . . 25.0 114.995 -168.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 48.7 mt -135.52 175.65 9.39 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 108.286 -1.005 . . . . 25.0 108.286 -170.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.62 -27.81 42.23 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.019 0.928 . . . . 25.0 110.838 171.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -76.06 -7.38 54.56 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 115.114 1.524 . . . . 25.0 115.114 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -90.16 136.49 33.01 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.325 -0.859 . . . . 25.0 112.84 -174.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.0 t 43.97 44.16 5.83 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 116.312 1.967 . . . . 25.0 116.312 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -113.66 173.91 6.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.886 -1.052 . . . . 25.0 112.18 -177.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -125.69 139.93 53.13 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 104.076 -2.565 . . . . 25.0 104.076 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 57.7 p -134.27 169.47 13.8 Favored Pre-proline 0 C--O 1.214 -0.786 0 N-CA-C 108.501 -0.925 . . . . 25.0 108.501 -176.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -61.91 -15.82 45.51 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 120.399 0.733 . . . . 25.0 112.764 176.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 89.7 mt -84.76 -31.48 23.95 Favored 'General case' 0 C--O 1.245 0.819 0 O-C-N 121.622 -0.674 . . . . 25.0 111.077 177.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.34 177.47 32.46 Favored Glycine 0 CA--C 1.503 -0.716 0 C-N-CA 121.108 -0.567 . . . . 25.0 112.761 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.2 t -88.49 146.8 24.98 Favored 'General case' 0 C--O 1.253 1.255 0 CA-C-O 121.983 0.896 . . . . 25.0 112.127 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -135.1 32.58 3.16 Favored 'General case' 0 C--O 1.254 1.331 0 CA-C-N 113.8 -1.545 . . . . 25.0 108.371 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -64.91 137.38 38.68 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 109.541 -1.424 . . . . 25.0 109.541 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -87.49 168.59 12.96 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 117.699 0.75 . . . . 50.0 110.659 -177.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -118.25 107.46 13.93 Favored 'General case' 0 C--O 1.245 0.847 0 O-C-N 123.789 0.681 . . . . 25.0 111.44 -175.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 52.7 mt -86.93 131.39 35.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 107.05 -1.463 . . . . 25.0 107.05 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.0 mt -75.88 -49.57 17.51 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 116.175 1.917 . . . . 25.0 116.175 -173.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -137.78 41.59 2.33 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.537 0.684 . . . . 25.0 112.282 -169.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -56.51 138.61 51.5 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.902 0.858 . . . . 25.0 110.72 -176.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -105.84 99.19 20.91 Favored Pre-proline 0 C--O 1.215 -0.74 0 N-CA-C 109.224 -0.658 . . . . 25.0 109.224 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -67.53 1.6 3.01 Favored 'Trans proline' 0 C--N 1.358 1.034 0 N-CA-C 115.39 1.265 . . . . 25.0 115.39 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.5 t -103.89 -42.27 5.64 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 117.515 0.143 . . . . 25.0 110.795 175.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -99.39 -36.99 9.41 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 115.15 1.537 . . . . 25.0 115.15 -175.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -85.08 170.74 12.64 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.028 -0.73 . . . . 75.0 109.028 -171.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -146.42 158.04 43.84 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.953 0.901 . . . . 25.0 110.363 177.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 64.9 mt -130.34 134.84 61.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.91 -0.774 . . . . 25.0 108.91 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -90.12 148.48 22.98 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 122.197 0.999 . . . . 25.0 109.367 175.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.5 p -153.55 -9.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 114.803 -1.09 . . . . 25.0 110.841 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.8 t -60.82 -39.71 90.04 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.036 0.446 . . . . 25.0 111.358 -178.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -86.48 -7.87 58.05 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 115.084 1.513 . . . . 25.0 115.084 -176.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.78 0.28 1.78 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 116.074 1.879 . . . . 25.0 116.074 -172.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -143.26 -69.38 0.02 OUTLIER Glycine 0 N--CA 1.467 0.76 0 N-CA-C 116.094 1.198 . . . . 25.0 116.094 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -156.03 163.81 39.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 117.467 0.634 . . . . 25.0 110.174 -174.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 30.8 t -112.71 -34.15 5.89 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 122.034 0.921 . . . . 25.0 110.552 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -107.12 137.38 13.93 Favored Glycine 0 C--O 1.223 -0.587 0 N-CA-C 107.824 -2.111 . . . . 25.0 107.824 176.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.88 151.39 45.74 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 118.936 -1.106 . . . . 25.0 109.269 -177.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -92.37 -164.11 38.11 Favored Glycine 0 C--O 1.222 -0.645 0 CA-C-N 115.839 -0.619 . . . . 25.0 112.04 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -53.59 129.04 31.45 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.798 0.809 . . . . 25.0 111.801 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 174.99 -176.47 47.14 Favored Glycine 0 C--O 1.215 -1.051 0 N-CA-C 109.928 -1.269 . . . . 25.0 109.928 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -155.94 167.62 29.81 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 118.451 1.126 . . . . 25.0 111.09 -178.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 53.92 43.7 30.5 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 124.319 1.048 . . . . 25.0 112.65 -178.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 68.94 30.24 72.34 Favored Glycine 0 C--O 1.219 -0.796 0 CA-C-N 115.291 -0.868 . . . . 25.0 112.864 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.406 ' HA ' ' H ' ' A' ' 151' ' ' ALA . 6.2 t -142.51 171.69 13.72 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 118.316 1.058 . . . . 25.0 111.722 -177.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 83.6 mt -90.42 164.1 14.42 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 103.329 -2.841 . . . . 25.0 103.329 171.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.68 110.36 7.91 Favored 'General case' 0 C--O 1.252 1.226 0 N-CA-C 107.753 -1.203 . . . . 25.0 107.753 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 18.7 m -71.89 162.7 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-N 115.349 -0.841 . . . . 25.0 109.587 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 29.5 m -145.8 169.78 17.85 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 120.292 -0.563 . . . . 25.0 109.883 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 34.9 m -121.77 164.38 18.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 108.738 -0.838 . . . . 25.0 108.738 177.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.8 t -76.14 -48.64 19.84 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.319 -1.363 . . . . 25.0 107.319 170.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -165.73 -170.42 1.79 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 101.502 -3.518 . . . . 25.0 101.502 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -69.85 -2.84 13.38 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 119.164 0.893 . . . . 25.0 112.856 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -137.35 -160.94 8.75 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 106.204 -2.759 . . . . 25.0 106.204 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.16 -160.34 0.28 Allowed 'General case' 0 C--O 1.249 1.062 0 CA-C-N 117.865 0.832 . . . . 25.0 111.093 177.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 47.0 mtt85 -71.08 166.86 20.51 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 122.279 1.038 . . . . 25.0 112.975 -171.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.1 p -114.15 165.92 12.16 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 105.74 -1.948 . . . . 25.0 105.74 173.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -133.55 153.56 51.55 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 121.14 0.495 . . . . 25.0 111.772 -177.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 28.2 tp -128.01 118.92 24.4 Favored 'General case' 0 C--O 1.25 1.099 0 N-CA-C 103.684 -2.709 . . . . 25.0 103.684 171.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -115.23 145.17 42.69 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 115.829 -0.623 . . . . 25.0 112.298 -174.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.9 t -99.71 147.83 25.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 105.221 -2.14 . . . . 25.0 105.221 168.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -114.79 11.48 16.76 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.889 1.328 . . . . 25.0 108.456 -177.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -93.62 141.17 28.78 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 105.53 -2.026 . . . . 25.0 105.53 174.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -140.83 150.34 43.16 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 122.055 0.931 . . . . 25.0 109.81 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -76.6 167.01 22.59 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.331 -1.304 . . . . 25.0 108.791 177.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.96 -32.39 73.7 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.591 -0.892 . . . . 25.0 108.591 176.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -65.42 -9.28 23.95 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 114.423 1.268 . . . . 25.0 114.423 174.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.57 21.85 61.23 Favored Glycine 0 C--O 1.241 0.581 0 N-CA-C 109.453 -1.459 . . . . 25.0 109.453 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.5 mt -92.05 136.8 32.88 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 106.092 -1.818 . . . . 25.0 106.092 175.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.6 p -141.55 -179.7 6.31 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.867 -1.16 . . . . 25.0 107.867 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -127.94 131.77 49.3 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 119.085 -1.046 . . . . 25.0 113.222 -178.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -147.61 153.95 40.04 Favored 'General case' 0 C--O 1.26 1.619 0 N-CA-C 106.818 -1.549 . . . . 25.0 106.818 168.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.1 p -142.12 146.6 22.42 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 106.93 -1.508 . . . . 25.0 106.93 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -103.2 140.93 36.72 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 107.094 -1.447 . . . . 25.0 107.094 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.2 mp -129.42 131.2 46.72 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 105.177 -2.157 . . . . 25.0 105.177 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -108.9 15.83 23.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.142 0.973 . . . . 25.0 110.541 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -72.91 -8.42 73.2 Favored Glycine 0 C--O 1.238 0.386 0 CA-C-N 114.761 -1.109 . . . . 25.0 110.719 171.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 40.0 t0 51.08 55.92 8.79 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.585 0.707 . . . . 25.0 112.445 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -133.14 43.55 2.93 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-O 122.178 0.989 . . . . 25.0 109.913 -174.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.66 -31.03 64.0 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 121.633 -0.667 . . . . 25.0 111.061 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.74 -14.83 61.63 Favored 'General case' 0 C--O 1.256 1.399 0 N-CA-C 112.406 0.521 . . . . 25.0 112.406 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -109.48 -10.72 14.87 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.108 0.48 . . . . 25.0 111.743 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 29.7 mt -73.69 126.21 29.8 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 123.193 1.473 . . . . 25.0 112.562 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 68.0 m -127.96 158.72 37.08 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 105.553 -2.017 . . . . 25.0 105.553 175.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.406 ' H ' ' HA ' ' A' ' 111' ' ' SER . . . -80.13 -3.57 49.38 Favored 'General case' 0 C--O 1.211 -0.95 0 CA-C-N 115.854 -0.612 . . . . 25.0 110.418 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -67.1 -35.98 80.97 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 117.69 0.223 . . . . 25.0 111.297 -173.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -75.89 -11.44 59.97 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 120.307 -0.557 . . . . 25.0 110.597 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 22.5 mm -83.91 119.9 33.89 Favored 'Isoleucine or valine' 0 C--O 1.247 0.957 0 N-CA-C 106.449 -1.685 . . . . 25.0 106.449 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.6 p -95.94 109.37 22.59 Favored 'Isoleucine or valine' 0 C--O 1.253 1.247 0 CA-C-O 123.044 1.402 . . . . 25.0 113.797 -174.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -145.21 -12.92 0.53 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.649 -1.614 . . . . 25.0 112.185 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -76.75 54.19 0.96 Allowed 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 113.302 0.853 . . . . 25.0 113.302 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 57.87 27.65 14.92 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 113.784 1.031 . . . . 25.0 113.784 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 55.98 0.65 0.06 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 119.361 3.097 . . . . 25.0 119.361 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -88.12 134.23 33.81 Favored 'General case' 0 C--N 1.314 -0.962 0 O-C-N 121.255 -0.903 . . . . 25.0 110.758 -176.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -68.84 -14.28 62.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.918 -0.583 . . . . 25.0 109.578 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.11 -28.1 69.39 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.121 0.486 . . . . 25.0 111.626 177.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.1 162.06 28.86 Favored 'General case' 0 C--O 1.251 1.138 0 CA-C-O 121.264 0.555 . . . . 25.0 111.822 -177.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 61.38 -157.38 0.34 Allowed 'General case' 0 C--O 1.242 0.663 0 CA-C-N 114.629 -1.169 . . . . 25.0 112.619 177.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 90.95 -1.25 77.57 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.597 -0.335 . . . . 25.0 112.429 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -104.32 115.28 30.1 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.779 -0.823 . . . . 25.0 108.779 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -123.53 139.94 53.51 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.274 -0.639 . . . . 25.0 109.274 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -113.93 26.0 10.33 Favored Glycine 0 C--O 1.241 0.59 0 N-CA-C 112.314 -0.314 . . . . 25.0 112.314 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 52.3 t -79.18 -37.27 19.08 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 N-CA-C 109.463 -0.569 . . . . 25.0 109.463 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.43 135.64 24.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.629 0.728 . . . . 25.0 111.238 -175.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 133.58 141.78 4.62 Favored Glycine 0 C--O 1.247 0.969 0 N-CA-C 110.935 -0.866 . . . . 25.0 110.935 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -151.72 161.12 43.2 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.272 -0.64 . . . . 25.0 109.272 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 84.7 p -152.91 165.67 34.74 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 107.732 -1.21 . . . . 25.0 107.732 176.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -177.31 -171.13 40.52 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 119.887 -1.149 . . . . 25.0 112.114 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -138.78 92.54 11.22 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 117.587 0.693 . . . . 25.0 110.96 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.12 161.67 40.38 Favored 'Trans proline' 0 C--O 1.232 0.209 0 O-C-N 122.801 0.895 . . . . 25.0 112.115 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -134.64 151.43 51.04 Favored 'General case' 0 CA--C 1.508 -0.638 0 C-N-CA 123.535 0.734 . . . . 25.0 109.772 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -122.86 75.1 47.7 Favored Pre-proline 0 N--CA 1.481 1.084 0 CA-C-O 121.399 0.619 . . . . 25.0 110.842 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -77.44 160.33 32.16 Favored 'Trans proline' 0 CA--C 1.513 -0.526 0 C-N-CA 116.787 -1.675 . . . . 25.0 112.533 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 12.2 t -125.64 -4.9 7.06 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.211 -0.904 . . . . 25.0 110.741 174.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 6.3 p . . . . . 0 C--O 1.246 0.871 0 N-CA-C 109.61 -0.515 . . . . 25.0 109.61 176.72 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.866 0 CA-C-O 120.442 0.163 . . . . 25.0 110.573 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -150.28 101.72 3.15 Favored Pre-proline 0 C--N 1.33 -0.246 0 C-N-CA 122.236 0.214 . . . . 25.0 110.637 177.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.74 147.07 74.82 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 118.594 0.533 . . . . 25.0 113.097 -175.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -150.25 44.49 0.7 Allowed Glycine 0 CA--C 1.536 1.352 0 N-CA-C 114.533 0.573 . . . . 25.0 114.533 -177.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.498 HG22 ' H ' ' A' ' 7' ' ' GLY . 7.9 p -52.51 129.94 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 114.776 1.398 . . . . 25.0 114.776 -176.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -93.49 -7.71 43.58 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.838 -1.073 . . . . 25.0 111.536 -178.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.498 ' H ' HG22 ' A' ' 5' ' ' VAL . . . -81.93 -149.5 7.47 Favored Glycine 0 CA--C 1.507 -0.464 0 CA-C-N 115.597 -0.729 . . . . 25.0 114.344 179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.2 p 71.94 156.43 0.16 Allowed Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 126.266 1.826 . . . . 25.0 110.581 -173.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.61 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 24.6 Cg_exo -69.27 -0.21 6.19 Favored 'Trans proline' 0 C--N 1.354 0.849 0 N-CA-C 114.846 1.056 . . . . 25.0 114.846 -175.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.8 p -66.9 -14.43 18.03 Favored 'Isoleucine or valine' 0 C--O 1.248 0.983 0 N-CA-C 113.954 1.094 . . . . 25.0 113.954 -171.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.4 p -133.57 132.12 57.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 N-CA-C 113.758 1.022 . . . . 25.0 113.758 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.7 13.62 74.97 Favored Glycine 0 C--O 1.246 0.888 0 N-CA-C 118.642 2.217 . . . . 25.0 118.642 171.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.3 t -51.2 -41.78 60.46 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.153 1.168 . . . . 25.0 114.153 -171.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -78.61 4.96 12.09 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 116.243 1.942 . . . . 25.0 116.243 -174.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.93 176.94 9.11 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 118.832 -0.604 . . . . 25.0 111.438 -177.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -57.64 133.28 55.17 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.339 0.59 . . . . 25.0 111.585 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -130.18 157.27 42.93 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.539 0.941 . . . . 50.0 113.539 -173.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -132.25 73.08 1.51 Allowed 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 106.738 -1.578 . . . . 25.0 106.738 169.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.6 mt -91.48 125.8 36.35 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 114.366 1.247 . . . . 25.0 114.366 -174.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -110.1 109.93 20.64 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 116.327 -0.397 . . . . 25.0 110.901 176.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -80.62 176.61 54.62 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 115.855 1.102 . . . . 25.0 115.855 -175.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.7 p -69.08 170.76 9.36 Favored 'General case' 0 C--O 1.256 1.444 0 C-N-CA 123.885 0.874 . . . . 25.0 110.361 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 48.6 mt -87.06 20.82 2.53 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.657 -0.702 . . . . 25.0 110.769 170.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -128.62 -174.01 13.61 Favored Glycine 0 C--O 1.223 -0.56 0 CA-C-O 118.615 -1.103 . . . . 25.0 112.505 176.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.9 t -71.08 133.1 46.01 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 113.857 1.058 . . . . 25.0 113.857 -176.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -145.18 158.52 43.8 Favored 'General case' 0 C--O 1.219 -0.541 0 O-C-N 123.211 0.32 . . . . 50.0 111.682 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -99.61 134.15 42.91 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 103.352 -2.833 . . . . 25.0 103.352 162.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.9 mm -128.41 117.92 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 105.676 -1.972 . . . . 25.0 105.676 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.61 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 8.3 mp -115.55 116.19 27.74 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 106.888 -1.523 . . . . 25.0 106.888 178.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.76 -36.11 90.72 Favored Glycine 0 CA--C 1.502 -0.779 0 C-N-CA 120.567 -0.825 . . . . 25.0 115.062 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.34 -147.21 45.37 Favored Glycine 0 C--O 1.254 1.39 0 C-N-CA 120.813 -0.708 . . . . 25.0 112.027 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.99 165.66 54.74 Favored Glycine 0 C--O 1.249 1.039 0 N-CA-C 111.847 -0.501 . . . . 25.0 111.847 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.84 162.96 28.94 Favored Glycine 0 C--N 1.316 -0.546 0 N-CA-C 114.967 0.747 . . . . 25.0 114.967 174.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.78 106.65 16.47 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 106.524 -1.658 . . . . 25.0 106.524 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -103.58 155.3 18.65 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 112.892 0.701 . . . . 50.0 112.892 -169.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -122.77 93.7 4.05 Favored 'General case' 0 C--O 1.246 0.906 0 N-CA-C 106.277 -1.749 . . . . 25.0 106.277 176.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.8 mt -101.21 140.09 35.98 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 114.881 -1.054 . . . . 25.0 111.356 -170.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -135.64 102.73 5.19 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.563 -0.532 . . . . 25.0 109.563 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.56 -20.7 59.57 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 116.463 1.345 . . . . 25.0 116.463 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 50.29 -150.51 0.23 Allowed 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 119.548 1.674 . . . . 25.0 115.126 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.68 162.2 13.62 Favored 'General case' 0 CA--C 1.552 1.041 0 O-C-N 120.908 -1.12 . . . . 25.0 112.752 -177.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.86 156.12 28.25 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 114.828 -1.078 . . . . 25.0 111.574 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -77.91 106.6 9.86 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 106.943 -1.503 . . . . 25.0 106.943 173.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -111.93 151.83 28.74 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 121.577 -0.702 . . . . 50.0 110.649 -170.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mp -116.13 94.82 4.81 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.966 -1.124 . . . . 25.0 107.966 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 mp -99.25 127.01 45.19 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.701 0.8 . . . . 25.0 112.912 -175.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -124.4 148.81 47.32 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 104.35 -2.463 . . . . 25.0 104.35 175.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.47 -39.37 3.46 Favored Glycine 0 N--CA 1.462 0.432 0 N-CA-C 116.193 1.237 . . . . 25.0 116.193 -175.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.38 -175.55 48.77 Favored Glycine 0 C--O 1.243 0.718 0 N-CA-C 110.266 -1.134 . . . . 25.0 110.266 -177.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.01 149.14 12.31 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 112.752 0.649 . . . . 25.0 112.752 -178.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.41 153.47 29.6 Favored Glycine 0 N--CA 1.46 0.251 0 N-CA-C 111.017 -0.833 . . . . 25.0 111.017 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.5 125.38 29.28 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 104.222 -2.511 . . . . 25.0 104.222 177.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -109.65 153.12 24.68 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.328 -0.619 . . . . 50.0 109.328 -173.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -116.02 122.62 45.74 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 102.409 -3.182 . . . . 25.0 102.409 177.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -145.41 130.86 18.72 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 114.707 1.373 . . . . 25.0 114.707 -171.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.0 m -107.44 132.25 53.4 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 105.99 -1.855 . . . . 25.0 105.99 176.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -91.57 -27.53 17.15 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 111.581 -0.607 . . . . 25.0 111.581 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.21 -169.41 54.91 Favored Glycine 0 N--CA 1.466 0.648 0 CA-C-N 118.022 0.911 . . . . 25.0 113.704 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -66.2 163.41 17.84 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.903 -0.763 . . . . 25.0 110.956 177.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.44 160.29 36.39 Favored Glycine 0 C--O 1.25 1.124 0 CA-C-O 119.897 -0.391 . . . . 25.0 112.678 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.33 102.3 6.7 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.631 0.729 . . . . 25.0 109.853 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -94.85 154.1 17.4 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.773 -0.649 . . . . 50.0 111.545 -174.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.5 m -121.96 127.91 50.9 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.054 -1.461 . . . . 25.0 107.054 -177.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -116.8 82.09 1.74 Allowed 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 106.992 -1.484 . . . . 25.0 106.992 176.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.71 -27.27 40.66 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-N 115.634 -0.712 . . . . 25.0 110.946 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 66.98 153.84 0.09 Allowed 'General case' 0 N--CA 1.479 1.018 0 O-C-N 125.678 1.861 . . . . 25.0 112.112 -172.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.06 -50.8 8.67 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.917 1.08 . . . . 25.0 113.917 -166.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 46.6 mt -130.4 168.86 16.29 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-O 121.372 0.605 . . . . 25.0 109.564 -172.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.17 -28.47 53.09 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.977 0.911 . . . . 25.0 110.585 173.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -75.4 -12.88 60.34 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 115.576 1.695 . . . . 25.0 115.576 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -73.26 134.74 44.35 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.026 1.121 . . . . 25.0 114.026 -174.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.3 t 50.22 42.56 25.62 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 114.759 -1.109 . . . . 25.0 113.655 176.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -107.75 162.45 13.97 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.135 -0.484 . . . . 25.0 111.623 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -122.9 144.6 49.11 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 103.799 -2.667 . . . . 25.0 103.799 177.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 99.3 p -140.12 172.08 6.86 Favored Pre-proline 0 C--N 1.325 -0.478 0 C-N-CA 123.71 0.804 . . . . 25.0 108.963 -173.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -61.1 -19.26 62.56 Favored 'Trans proline' 0 C--N 1.354 0.829 0 O-C-N 122.653 0.817 . . . . 25.0 113.592 174.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.0 mt -79.36 -23.62 43.23 Favored 'General case' 0 C--O 1.245 0.857 0 N-CA-C 113.037 0.754 . . . . 25.0 113.037 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 148.51 -172.35 28.73 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 116.216 -0.447 . . . . 25.0 112.09 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.7 t -101.23 137.71 39.22 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.734 0.778 . . . . 25.0 111.859 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -122.63 29.93 6.68 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.22 -1.355 . . . . 25.0 107.694 173.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.91 146.56 50.43 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 109.765 -1.334 . . . . 25.0 109.765 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -95.84 163.66 13.07 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.41 -1.053 . . . . 50.0 110.316 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -126.04 104.06 8.07 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 111.992 0.367 . . . . 25.0 111.992 -170.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 21.6 mt -86.47 135.1 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 107.206 -1.405 . . . . 25.0 107.206 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.3 mt -89.02 -42.49 11.73 Favored 'General case' 0 C--O 1.21 -0.991 0 N-CA-C 114.77 1.396 . . . . 25.0 114.77 -175.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 46.8 p-10 -127.62 41.17 3.56 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.989 1.477 . . . . 25.0 114.989 -172.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -60.23 142.76 54.02 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 113.399 0.889 . . . . 25.0 113.399 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -117.1 100.13 53.11 Favored Pre-proline 0 N--CA 1.476 0.835 0 N-CA-C 108.948 -0.76 . . . . 25.0 108.948 177.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.9 1.66 4.32 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 N-CA-C 117.129 1.934 . . . . 25.0 117.129 -172.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.6 t -100.7 -35.84 9.33 Favored 'General case' 0 CA--C 1.554 1.099 0 O-C-N 121.763 -0.585 . . . . 25.0 110.753 175.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -98.86 -39.14 8.74 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 114.281 1.215 . . . . 25.0 114.281 -177.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -83.48 163.69 20.34 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.973 -0.558 . . . . 75.0 110.525 -172.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -142.26 146.14 34.82 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.003 0.814 . . . . 25.0 112.486 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 80.1 mt -125.96 131.92 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 107.753 -1.203 . . . . 25.0 107.753 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -88.29 144.5 26.38 Favored 'General case' 0 C--O 1.214 -0.814 0 O-C-N 120.958 -1.089 . . . . 25.0 110.185 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.4 p -146.69 4.42 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.359 0 CA-C-N 115.232 -0.894 . . . . 25.0 110.242 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.2 t -55.67 -57.72 10.8 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 112.9 0.704 . . . . 25.0 112.9 -173.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.44 -14.1 57.46 Favored 'General case' 0 C--O 1.256 1.404 0 N-CA-C 112.445 0.535 . . . . 25.0 112.445 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.9 mt -89.44 -52.91 4.79 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.285 0.564 . . . . 25.0 112.299 -175.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -109.03 -65.2 0.56 Allowed Glycine 0 CA--C 1.506 -0.523 0 N-CA-C 116.637 1.415 . . . . 25.0 116.637 -171.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -157.84 169.31 24.89 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 117.003 0.401 . . . . 25.0 111.353 -171.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.0 t -109.52 -23.6 11.41 Favored 'General case' 0 CA--C 1.557 1.233 0 O-C-N 123.869 0.731 . . . . 25.0 111.977 177.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -120.4 145.03 17.42 Favored Glycine 0 C--O 1.235 0.173 0 N-CA-C 105.593 -3.003 . . . . 25.0 105.593 172.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -58.28 154.0 14.23 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.095 1.146 . . . . 25.0 114.095 -173.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -90.17 -166.2 41.16 Favored Glycine 0 C--O 1.223 -0.59 0 CA-C-N 115.272 -0.876 . . . . 25.0 112.989 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -57.04 131.38 49.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.356 0.598 . . . . 25.0 112.202 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 160.41 178.1 34.1 Favored Glycine 0 N--CA 1.466 0.698 0 N-CA-C 107.054 -2.418 . . . . 25.0 107.054 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -141.76 166.72 23.95 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.932 1.366 . . . . 25.0 110.321 -175.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 55.04 34.23 22.04 Favored 'General case' 0 C--O 1.26 1.627 0 C-N-CA 123.392 0.677 . . . . 25.0 112.038 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.09 41.3 54.56 Favored Glycine 0 C--O 1.216 -1.018 0 N-CA-C 111.269 -0.732 . . . . 25.0 111.269 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.5 t -142.95 175.87 9.51 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.887 -0.782 . . . . 25.0 108.887 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 82.6 mt -106.48 164.65 11.88 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 105.655 -1.98 . . . . 25.0 105.655 173.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.418 ' HB3' ' CE1' ' A' ' 128' ' ' TYR . . . -72.89 120.5 18.6 Favored 'General case' 0 C--O 1.245 0.85 0 N-CA-C 108.302 -0.999 . . . . 25.0 108.302 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.9 m -89.71 158.36 2.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.874 -0.788 . . . . 25.0 108.874 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.4 m -132.98 154.09 50.82 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.038 -0.727 . . . . 25.0 109.038 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.3 m -120.33 160.38 20.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 108.633 -0.877 . . . . 25.0 108.633 177.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 17.2 t -75.84 -47.4 25.72 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 105.828 -1.915 . . . . 25.0 105.828 170.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -173.86 -162.52 0.15 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 101.229 -3.619 . . . . 25.0 101.229 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -61.02 -35.93 78.17 Favored 'General case' 0 C--O 1.246 0.88 0 CA-C-N 118.157 0.435 . . . . 25.0 111.088 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -103.01 -154.05 24.48 Favored Glycine 0 C--O 1.225 -0.463 0 CA-C-O 121.574 0.541 . . . . 25.0 112.293 176.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.91 -138.75 0.4 Allowed 'General case' 0 C--O 1.237 0.435 0 C-N-CA 122.75 0.42 . . . . 25.0 111.747 174.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 33.7 mtt85 -105.48 167.05 10.01 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 121.679 -0.638 . . . . 25.0 112.188 -174.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.28 165.58 13.28 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 105.402 -2.073 . . . . 25.0 105.402 177.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -138.45 152.65 48.52 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.767 -0.827 . . . . 25.0 108.767 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 27.0 tp -128.75 114.8 17.04 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 105.1 -2.185 . . . . 25.0 105.1 175.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -116.97 151.18 37.26 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 122.588 1.185 . . . . 25.0 112.101 -171.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.1 t -93.77 142.55 27.24 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 104.543 -2.392 . . . . 25.0 104.543 171.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.418 ' CE1' ' HB3' ' A' ' 113' ' ' ALA . 62.7 m-85 -115.6 11.08 15.74 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 122.539 1.161 . . . . 25.0 108.207 176.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -91.1 136.1 33.32 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 105.258 -2.127 . . . . 25.0 105.258 168.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -131.5 152.43 50.73 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-O 121.892 0.853 . . . . 25.0 110.433 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -86.54 166.72 15.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.392 -1.276 . . . . 25.0 109.382 -176.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -61.38 -32.14 72.05 Favored 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 122.676 0.39 . . . . 25.0 111.192 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -76.6 -4.54 43.46 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.325 0.861 . . . . 25.0 113.325 175.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.01 13.64 63.98 Favored Glycine 0 CA--C 1.501 -0.838 0 C-N-CA 120.919 -0.657 . . . . 25.0 112.176 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 65.7 mt -83.47 158.3 22.1 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 106.472 -1.677 . . . . 25.0 106.472 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.6 p -154.56 177.77 10.83 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 104.851 -2.278 . . . . 25.0 104.851 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -127.77 137.55 52.46 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-O 119.044 -0.503 . . . . 25.0 110.199 -176.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -152.56 153.49 33.52 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 118.996 0.816 . . . . 25.0 109.071 171.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.2 p -143.7 142.05 25.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 106.792 -1.559 . . . . 25.0 106.792 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -100.31 146.76 26.55 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.361 -0.977 . . . . 25.0 108.361 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.0 mp -137.48 132.76 33.78 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 104.669 -2.345 . . . . 25.0 104.669 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -101.82 12.16 37.49 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 121.26 1.845 . . . . 25.0 115.803 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -73.81 -14.91 79.7 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.398 -0.906 . . . . 25.0 113.081 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 42.2 t0 53.26 43.0 32.07 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 123.826 1.774 . . . . 25.0 110.902 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -109.55 41.1 1.73 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 113.547 -1.661 . . . . 25.0 107.606 -176.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.94 -29.95 63.59 Favored 'General case' 0 C--O 1.209 -1.047 0 CA-C-N 113.923 -1.49 . . . . 25.0 113.293 177.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.58 -31.66 57.66 Favored 'General case' 0 C--N 1.319 -0.756 0 O-C-N 120.285 -1.51 . . . . 25.0 112.135 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -77.27 -29.83 54.03 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.975 0.731 . . . . 25.0 112.975 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 15.9 mt -60.91 129.9 43.78 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 122.65 1.214 . . . . 25.0 110.413 -176.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.9 m -138.73 163.8 31.21 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 104.999 -2.222 . . . . 25.0 104.999 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.04 4.47 17.0 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 118.562 0.619 . . . . 25.0 109.734 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -75.01 -29.86 60.98 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.39 -0.823 . . . . 25.0 111.662 -177.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -87.32 -8.74 56.35 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 122.092 -0.38 . . . . 25.0 110.8 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 40.6 mm -91.95 132.78 35.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 104.609 -2.367 . . . . 25.0 104.609 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.4 p -115.11 132.76 63.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 122.053 0.93 . . . . 25.0 111.496 -175.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -155.33 -34.13 0.09 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 114.701 1.371 . . . . 25.0 114.701 -174.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.33 60.43 5.58 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 113.234 0.827 . . . . 25.0 113.234 -173.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 58.75 21.17 8.63 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.843 1.053 . . . . 25.0 113.843 176.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.65 11.52 2.44 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 114.675 1.361 . . . . 25.0 114.675 175.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -89.87 129.59 36.21 Favored 'General case' 0 C--O 1.238 0.448 0 O-C-N 121.999 -0.438 . . . . 25.0 110.304 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -66.69 -15.29 63.4 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.376 0.608 . . . . 25.0 111.07 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.7 -19.08 64.35 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 121.699 -0.626 . . . . 25.0 112.269 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.48 157.4 22.42 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 111.982 0.364 . . . . 25.0 111.982 -178.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 56.59 -163.79 0.16 Allowed 'General case' 0 CA--C 1.549 0.933 0 O-C-N 124.434 1.084 . . . . 25.0 113.417 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 97.67 0.98 58.96 Favored Glycine 0 N--CA 1.465 0.628 0 N-CA-C 114.94 0.736 . . . . 25.0 114.94 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -75.85 110.87 10.64 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 117.239 0.519 . . . . 25.0 111.193 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -129.85 155.44 46.0 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.553 0.341 . . . . 25.0 111.01 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -136.44 39.86 1.59 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.096 -1.202 . . . . 25.0 110.096 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 60.8 t -73.99 -36.21 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 109.76 -0.459 . . . . 25.0 109.76 -176.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.4 130.93 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-O 121.684 0.754 . . . . 25.0 111.639 -177.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 139.0 155.25 6.61 Favored Glycine 0 C--O 1.247 0.929 0 CA-C-N 115.336 -0.847 . . . . 25.0 111.741 -178.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -163.2 170.72 17.32 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 108.731 -0.84 . . . . 25.0 108.731 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 77.4 p -150.58 168.73 23.4 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 105.826 -1.916 . . . . 25.0 105.826 173.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -159.04 140.68 7.03 Favored Glycine 0 CA--C 1.501 -0.808 0 C-N-CA 119.728 -1.225 . . . . 25.0 115.062 177.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -131.64 80.16 67.08 Favored Pre-proline 0 C--O 1.24 0.561 0 N-CA-C 106.998 -1.482 . . . . 25.0 106.998 177.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -68.75 155.33 69.09 Favored 'Trans proline' 0 C--O 1.236 0.406 0 N-CA-C 113.582 0.57 . . . . 25.0 113.582 -174.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -120.66 151.96 38.81 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 106.871 -1.529 . . . . 25.0 106.871 -177.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -143.47 64.85 14.19 Favored Pre-proline 0 C--O 1.248 0.997 0 N-CA-C 115.559 1.689 . . . . 25.0 115.559 -178.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -71.53 151.28 58.71 Favored 'Trans proline' 0 C--O 1.244 0.814 0 C-N-CA 116.969 -1.554 . . . . 25.0 111.345 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 11.5 t -137.63 22.68 2.91 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.397 0.618 . . . . 25.0 110.919 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 C--O 1.247 0.944 0 CA-C-O 116.874 -1.536 . . . . 25.0 110.825 -179.665 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.971 0 N-CA-C 109.914 -0.402 . . . . 25.0 109.914 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -128.04 121.05 21.61 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 107.357 -1.349 . . . . 25.0 107.357 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.51 146.65 68.69 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 115.069 -2.82 . . . . 25.0 113.268 -175.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.88 46.39 0.04 OUTLIER Glycine 0 CA--C 1.522 0.511 0 CA-C-N 115.427 -0.806 . . . . 25.0 111.11 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.1 p -57.54 133.85 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 CA-C-O 121.497 0.665 . . . . 25.0 109.997 -175.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -99.76 -11.57 20.71 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.703 -0.68 . . . . 25.0 109.742 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.33 -147.55 8.43 Favored Glycine 0 CA--C 1.501 -0.836 0 CA-C-N 115.621 -0.718 . . . . 25.0 113.028 177.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.2 p 71.3 159.09 0.16 Allowed Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 125.632 1.573 . . . . 25.0 111.135 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.551 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 31.2 Cg_exo -66.19 1.76 2.25 Favored 'Trans proline' 0 C--N 1.351 0.67 0 N-CA-C 117.406 2.041 . . . . 25.0 117.406 -175.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.3 p -63.98 -24.06 34.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 115.735 1.754 . . . . 25.0 115.735 -168.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.6 p -145.93 140.43 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 114.233 1.197 . . . . 25.0 114.233 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.85 10.0 86.53 Favored Glycine 0 N--CA 1.466 0.678 0 CA-C-N 114.753 -1.112 . . . . 25.0 115.434 171.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.6 t -50.95 -39.3 54.71 Favored 'General case' 0 C--O 1.21 -1.025 0 N-CA-C 114.075 1.139 . . . . 25.0 114.075 -170.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -81.71 8.07 10.9 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 115.044 1.498 . . . . 25.0 115.044 -175.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -142.99 173.96 11.09 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 118.852 -0.594 . . . . 25.0 111.459 176.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -58.79 124.12 18.72 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 115.314 1.598 . . . . 25.0 115.314 -173.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -124.32 164.47 19.54 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.611 1.708 . . . . 50.0 115.611 -175.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -130.85 77.03 1.76 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 107.469 -1.308 . . . . 25.0 107.469 169.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.1 mt -90.74 120.24 31.62 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.861 1.06 . . . . 25.0 113.861 -175.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -110.9 124.54 52.29 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 122.799 0.44 . . . . 25.0 110.69 178.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.45 172.72 41.52 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-O 122.626 1.126 . . . . 25.0 114.973 -176.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.8 p -84.97 175.44 9.06 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.037 -1.081 . . . . 25.0 110.484 175.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 66.2 mt -79.42 4.22 16.11 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.507 0.723 . . . . 25.0 112.733 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.61 177.78 24.82 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 119.438 -0.646 . . . . 25.0 113.879 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.1 t -70.14 129.98 40.85 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 117.303 0.552 . . . . 25.0 111.995 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -145.51 159.36 43.22 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.129 -0.357 . . . . 50.0 110.774 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -94.33 138.97 31.68 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 106.119 -1.808 . . . . 25.0 106.119 164.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.3 mm -129.69 105.99 12.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 105.49 -2.041 . . . . 25.0 105.49 178.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.551 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 8.9 mp -105.57 117.45 34.06 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.735 -0.839 . . . . 25.0 108.735 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.64 -42.54 62.44 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.196 -1.002 . . . . 25.0 114.303 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.8 -149.55 48.12 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 120.277 -0.963 . . . . 25.0 112.53 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.46 168.16 52.91 Favored Glycine 0 C--O 1.247 0.929 0 CA-C-O 122.001 0.778 . . . . 25.0 114.25 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.85 167.22 26.47 Favored Glycine 0 C--O 1.24 0.47 0 N-CA-C 111.954 -0.458 . . . . 25.0 111.954 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.06 120.15 28.03 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 105.773 -1.936 . . . . 25.0 105.773 176.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -115.09 154.74 28.35 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 120.41 -0.516 . . . . 50.0 111.984 -172.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -118.86 90.63 3.37 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 107.068 -1.456 . . . . 25.0 107.068 177.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.4 mt -98.4 138.22 35.95 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 123.078 0.551 . . . . 25.0 111.876 -171.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -135.31 105.78 6.42 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 118.554 0.616 . . . . 25.0 111.537 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.27 -30.65 45.02 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 115.316 0.887 . . . . 25.0 115.316 -175.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 53.93 -150.1 0.4 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.058 0.943 . . . . 25.0 112.289 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.36 162.9 24.3 Favored 'General case' 0 C--O 1.254 1.305 0 O-C-N 121.072 -1.018 . . . . 25.0 112.353 -175.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.75 159.04 32.54 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 114.922 -1.036 . . . . 25.0 111.71 -177.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -81.02 102.78 10.41 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.058 -1.089 . . . . 25.0 108.058 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -106.04 150.07 26.09 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.521 0.677 . . . . 50.0 112.72 -170.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 mp -113.05 89.37 3.06 Favored 'General case' 0 C--O 1.217 -0.626 0 N-CA-C 108.436 -0.95 . . . . 25.0 108.436 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.9 mp -92.75 129.67 38.61 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.303 0.482 . . . . 25.0 112.303 -176.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -127.1 146.61 50.32 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 104.516 -2.402 . . . . 25.0 104.516 175.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -98.19 -33.74 5.61 Favored Glycine 0 N--CA 1.466 0.689 0 N-CA-C 117.253 1.661 . . . . 25.0 117.253 -176.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.94 -162.19 52.66 Favored Glycine 0 C--O 1.257 1.587 0 N-CA-C 110.608 -0.997 . . . . 25.0 110.608 -174.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.68 161.79 7.39 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.674 0.75 . . . . 25.0 112.758 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.4 170.95 37.94 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 115.07 -0.968 . . . . 25.0 113.683 174.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.72 124.03 30.46 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 106.28 -1.748 . . . . 25.0 106.28 177.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -115.56 152.36 33.19 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 120.979 0.418 . . . . 50.0 111.593 -175.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -115.09 129.53 56.71 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 103.879 -2.637 . . . . 25.0 103.879 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -148.41 127.45 12.8 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 115.884 1.809 . . . . 25.0 115.884 -174.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.9 m -99.37 134.2 42.57 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.481 -0.781 . . . . 25.0 108.899 172.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.03 -33.95 9.25 Favored Glycine 0 C--O 1.244 0.777 0 C-N-CA 120.07 -1.062 . . . . 25.0 112.681 175.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.6 -169.39 54.73 Favored Glycine 0 C--O 1.255 1.442 0 CA-C-O 122.54 1.078 . . . . 25.0 115.111 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -67.75 162.45 23.83 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.375 -1.073 . . . . 25.0 110.605 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.77 164.48 39.63 Favored Glycine 0 C--O 1.244 0.761 0 N-CA-C 111.218 -0.753 . . . . 25.0 111.218 -177.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.74 105.13 16.05 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 109.619 -0.511 . . . . 25.0 109.619 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -99.15 151.71 20.68 Favored 'General case' 0 C--O 1.215 -0.73 0 CA-C-N 115.691 -0.686 . . . . 50.0 110.531 -170.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 58.9 m -121.64 126.67 49.58 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.925 -0.769 . . . . 25.0 108.925 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -114.36 87.59 2.67 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.615 -1.254 . . . . 25.0 107.615 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 30.8 mtt85 -85.87 -23.22 27.17 Favored 'General case' 0 CA--C 1.505 -0.763 0 O-C-N 121.602 -0.686 . . . . 25.0 112.661 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 67.75 142.6 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 O-C-N 125.161 1.538 . . . . 25.0 112.876 -174.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.28 -52.91 10.89 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 114.791 1.404 . . . . 25.0 114.791 -163.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 98.0 mt -135.82 176.53 8.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.308 1.051 . . . . 25.0 110.04 -176.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.58 -28.41 32.03 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.104 -0.953 . . . . 25.0 112.362 173.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -77.91 -10.83 59.77 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 114.707 1.373 . . . . 25.0 114.707 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.15 138.4 41.99 Favored 'General case' 0 C--O 1.213 -0.844 0 O-C-N 120.845 -1.159 . . . . 25.0 111.709 -175.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.8 t 45.61 39.42 4.9 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-N 113.682 -1.599 . . . . 25.0 114.005 173.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -104.31 167.31 9.83 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.097 -0.956 . . . . 25.0 109.434 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -127.47 143.84 51.14 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 104.791 -2.3 . . . . 25.0 104.791 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.6 p -135.9 166.76 25.86 Favored Pre-proline 0 C--N 1.315 -0.904 0 N-CA-C 108.021 -1.103 . . . . 25.0 108.021 -176.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -63.04 -23.48 73.81 Favored 'Trans proline' 0 C--N 1.353 0.774 0 CA-C-N 118.917 0.649 . . . . 25.0 112.68 175.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 73.7 mt -72.85 -23.85 60.81 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.418 0.628 . . . . 25.0 111.036 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 149.23 177.49 23.41 Favored Glycine 0 CA--C 1.5 -0.847 0 N-CA-C 111.028 -0.829 . . . . 25.0 111.028 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.3 t -97.59 155.12 17.12 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 118.072 0.936 . . . . 25.0 112.765 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -136.36 24.78 3.21 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 106.622 -1.621 . . . . 25.0 106.622 175.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.53 146.33 48.49 Favored Glycine 0 C--O 1.218 -0.865 0 CA-C-O 118.885 -0.953 . . . . 25.0 111.733 178.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -98.37 166.27 11.46 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 118.11 0.955 . . . . 50.0 112.311 -177.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -124.11 99.82 6.42 Favored 'General case' 0 C--O 1.253 1.26 0 O-C-N 123.593 0.558 . . . . 25.0 111.844 -172.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.8 mt -84.19 135.49 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 106.082 -1.821 . . . . 25.0 106.082 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.424 ' HA ' ' HG2' ' A' ' 142' ' ' GLU . 12.9 mt -89.99 -45.13 9.39 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 115.607 1.706 . . . . 25.0 115.607 -171.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -131.23 32.11 4.3 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.816 1.043 . . . . 25.0 113.816 -170.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -51.25 138.97 19.74 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.795 1.035 . . . . 25.0 113.795 -175.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -107.93 106.93 59.62 Favored Pre-proline 0 C--O 1.235 0.329 0 N-CA-C 108.293 -1.003 . . . . 25.0 108.293 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -69.8 -8.17 22.93 Favored 'Trans proline' 0 CA--C 1.547 1.161 0 N-CA-C 117.743 2.17 . . . . 25.0 117.743 -174.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.8 t -96.84 -35.81 10.81 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-O 120.481 0.181 . . . . 25.0 111.41 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -98.83 -37.66 9.35 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 113.349 0.87 . . . . 25.0 113.349 -173.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -86.59 167.0 14.96 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.922 0.391 . . . . 75.0 110.551 -173.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -145.59 149.09 33.91 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 109.356 -0.609 . . . . 25.0 109.356 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 68.5 mt -125.51 133.21 69.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 108.05 -1.093 . . . . 25.0 108.05 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -95.59 144.33 26.13 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.754 -1.202 . . . . 25.0 107.754 174.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.1 p -143.41 -10.16 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.722 -0.672 . . . . 25.0 111.612 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 39.0 t -58.85 -42.6 89.74 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.416 0.895 . . . . 25.0 113.416 -175.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.54 -20.82 61.98 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 113.977 1.102 . . . . 25.0 113.977 -176.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.79 -45.38 1.9 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 116.436 2.013 . . . . 25.0 116.436 -170.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -94.74 -75.57 1.29 Allowed Glycine 0 N--CA 1.463 0.47 0 C-N-CA 119.999 -1.096 . . . . 25.0 113.099 -175.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -148.75 167.09 26.51 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.068 -0.716 . . . . 25.0 109.068 -175.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.8 t -124.38 -27.96 3.7 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.453 0.644 . . . . 25.0 110.362 176.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -101.0 120.14 6.78 Favored Glycine 0 N--CA 1.466 0.691 0 N-CA-C 108.294 -1.922 . . . . 25.0 108.294 172.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -66.24 150.4 48.87 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 119.776 1.788 . . . . 25.0 109.55 -176.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -102.57 -146.33 17.4 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-O 122.755 1.197 . . . . 25.0 115.723 -173.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -60.01 134.35 56.96 Favored 'General case' 0 C--O 1.251 1.16 0 CA-C-N 113.605 -1.298 . . . . 25.0 112.238 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 159.28 -176.98 36.01 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 123.28 0.363 . . . . 25.0 112.504 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -144.57 179.07 7.52 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 109.609 -0.515 . . . . 25.0 109.609 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 56.74 32.85 21.93 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 113.967 1.099 . . . . 25.0 113.967 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 69.06 29.7 72.24 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 109.964 -1.254 . . . . 25.0 109.964 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.8 t -143.32 174.3 10.85 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.373 0.606 . . . . 25.0 109.69 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 5.5 mp -92.7 161.82 14.39 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 103.337 -2.838 . . . . 25.0 103.337 173.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.84 118.01 10.49 Favored 'General case' 0 C--O 1.269 2.087 0 CA-C-N 118.953 0.797 . . . . 25.0 112.196 -172.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 26.4 m -79.75 162.05 3.9 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 CA-C-O 121.56 0.695 . . . . 25.0 109.363 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 56.1 m -145.88 171.3 15.01 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.714 -0.847 . . . . 25.0 108.714 -177.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 34.0 m -125.17 162.68 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 109.156 -0.683 . . . . 25.0 109.156 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 40.2 t -80.92 -40.17 25.01 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.464 -1.68 . . . . 25.0 106.464 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -174.27 -163.49 0.16 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 102.628 -3.101 . . . . 25.0 102.628 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -63.63 -23.76 67.51 Favored 'General case' 0 C--O 1.248 1.013 0 N-CA-C 112.39 0.515 . . . . 25.0 112.39 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -121.6 -153.61 9.0 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 109.499 -1.441 . . . . 25.0 109.499 175.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.83 -154.01 0.37 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 122.859 0.464 . . . . 25.0 110.295 175.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.0 mtt85 -81.46 160.29 24.03 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 114.43 1.27 . . . . 25.0 114.43 -173.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.1 p -105.21 162.62 13.25 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 105.642 -1.985 . . . . 25.0 105.642 172.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -130.27 150.68 51.4 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.394 0.616 . . . . 25.0 112.175 -177.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 64.8 tp -127.53 120.05 27.39 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 104.022 -2.584 . . . . 25.0 104.022 171.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -118.41 146.19 44.63 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.686 0.624 . . . . 25.0 112.686 -171.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.2 t -89.15 147.94 23.93 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 106.201 -1.778 . . . . 25.0 106.201 167.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -116.5 -0.04 12.59 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.624 -1.251 . . . . 25.0 107.624 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -86.0 137.43 32.72 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 104.085 -2.561 . . . . 25.0 104.085 169.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -146.2 158.42 43.88 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 124.697 1.248 . . . . 25.0 109.38 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -80.6 160.61 25.06 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.733 -1.122 . . . . 25.0 107.976 175.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.47 -22.37 66.94 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 122.002 -0.436 . . . . 25.0 110.625 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -69.41 -11.82 61.14 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 113.455 0.909 . . . . 25.0 113.455 174.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.63 16.14 57.18 Favored Glycine 0 C--O 1.22 -0.781 0 N-CA-C 111.64 -0.584 . . . . 25.0 111.64 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.3 mt -88.66 130.21 35.35 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.985 -1.117 . . . . 25.0 107.985 178.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 72.7 p -138.95 -179.69 5.98 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.477 -0.564 . . . . 25.0 109.477 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -122.13 133.11 54.76 Favored 'General case' 0 C--O 1.257 1.453 0 CA-C-O 119.177 -0.44 . . . . 25.0 110.452 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.4 pt-20 -145.91 152.17 39.02 Favored 'General case' 0 C--O 1.247 0.956 0 N-CA-C 108.293 -1.002 . . . . 25.0 108.293 171.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.8 p -145.85 139.82 21.31 Favored 'Isoleucine or valine' 0 C--O 1.248 0.985 0 N-CA-C 106.712 -1.588 . . . . 25.0 106.712 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -103.41 147.6 26.93 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 107.704 -1.221 . . . . 25.0 107.704 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.7 mp -136.61 129.96 31.55 Favored 'General case' 0 C--O 1.208 -1.132 0 N-CA-C 105.186 -2.153 . . . . 25.0 105.186 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.424 ' HG2' ' HA ' ' A' ' 85' ' ' LEU . 17.4 pt-20 -99.66 6.54 45.62 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 119.889 1.222 . . . . 25.0 112.158 -175.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -71.1 -12.35 71.71 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.718 -0.753 . . . . 25.0 112.275 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 38.7 t0 53.53 54.86 9.4 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.915 0.864 . . . . 25.0 111.371 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -126.94 39.63 3.88 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.56 -1.2 . . . . 25.0 109.129 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.74 -37.01 82.66 Favored 'General case' 0 C--O 1.214 -0.791 0 O-C-N 121.792 -0.567 . . . . 25.0 111.673 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.16 -10.29 59.46 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 121.53 -0.731 . . . . 25.0 112.085 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -98.12 -26.13 14.68 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 111.789 0.292 . . . . 25.0 111.789 175.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.0 mt -62.69 136.06 57.69 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 122.581 1.181 . . . . 25.0 111.357 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.5 m -135.81 164.26 28.32 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 105.558 -2.016 . . . . 25.0 105.558 171.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -77.05 8.38 3.94 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.71 0.29 . . . . 25.0 110.716 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -65.66 -39.34 91.26 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.301 0.482 . . . . 25.0 112.301 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -81.54 -10.41 59.46 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.075 -0.966 . . . . 25.0 111.079 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 13.4 mm -91.27 126.1 43.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 106.312 -1.736 . . . . 25.0 106.312 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.0 p -103.05 122.77 55.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 O-C-N 120.996 -1.065 . . . . 25.0 111.555 -177.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -157.22 -16.05 0.09 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 114.684 -1.144 . . . . 25.0 113.563 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.96 61.48 6.45 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 121.878 -0.514 . . . . 25.0 111.261 -172.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 55.44 15.39 1.42 Allowed 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 115.94 1.83 . . . . 25.0 115.94 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 64.76 -21.82 0.08 Allowed 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 116.557 2.058 . . . . 25.0 116.557 176.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -70.64 116.48 11.01 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.917 -1.114 . . . . 25.0 110.201 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.42 -5.7 44.0 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 113.238 0.829 . . . . 25.0 113.238 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.24 -20.11 65.62 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.316 0.579 . . . . 25.0 110.811 177.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -90.99 -162.26 0.89 Allowed 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.588 -0.733 . . . . 25.0 111.198 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 60.79 -160.45 0.3 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.138 0.975 . . . . 25.0 113.106 176.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 79.98 24.05 60.51 Favored Glycine 0 C--O 1.228 -0.263 0 C-N-CA 121.367 -0.444 . . . . 25.0 112.272 -178.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -97.37 93.49 6.52 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.791 -0.829 . . . . 25.0 109.788 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -121.86 152.67 39.33 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.249 0.547 . . . . 25.0 109.834 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -140.5 33.77 2.03 Favored Glycine 0 CA--C 1.51 -0.251 0 CA-C-O 122.281 0.934 . . . . 25.0 111.173 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 61.3 t -82.69 -35.79 12.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 O-C-N 122.221 -0.576 . . . . 25.0 110.675 -176.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -53.27 137.84 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 115.843 -0.617 . . . . 25.0 111.246 -178.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 140.35 155.3 6.5 Favored Glycine 0 C--O 1.245 0.784 0 CA-C-N 115.843 -0.617 . . . . 25.0 112.759 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -155.94 143.67 19.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.565 0.683 . . . . 25.0 110.077 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 87.1 p -154.13 163.67 39.74 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 122.477 0.311 . . . . 25.0 110.916 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 172.41 -179.25 44.09 Favored Glycine 0 N--CA 1.47 0.956 0 N-CA-C 110.982 -0.847 . . . . 25.0 110.982 176.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -138.99 113.06 8.25 Favored Pre-proline 0 C--O 1.248 0.98 0 CA-C-N 118.152 0.976 . . . . 25.0 110.917 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.82 169.06 23.01 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 N-CA-C 115.365 1.256 . . . . 25.0 115.365 -177.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -122.49 149.02 44.46 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.078 -0.712 . . . . 25.0 109.078 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -138.49 73.78 41.62 Favored Pre-proline 0 N--CA 1.472 0.641 0 C-N-CA 123.349 0.66 . . . . 25.0 110.372 175.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -76.4 155.2 36.51 Favored 'Trans proline' 0 N--CA 1.478 0.577 0 C-N-CA 118.448 -0.568 . . . . 25.0 113.29 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.7 t -96.08 -2.16 47.21 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 121.951 -0.468 . . . . 25.0 111.965 -177.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 C--O 1.257 1.496 0 CA-C-O 118.554 -0.736 . . . . 25.0 110.017 -177.827 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 109.557 -0.535 . . . . 25.0 109.557 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -102.95 115.22 64.51 Favored Pre-proline 0 C--O 1.25 1.081 0 N-CA-C 110.029 -0.36 . . . . 25.0 110.029 178.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -67.98 146.39 71.09 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 117.223 -1.385 . . . . 25.0 112.194 -177.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.64 60.67 0.03 OUTLIER Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.993 -0.623 . . . . 25.0 111.899 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.57 HG22 ' H ' ' A' ' 7' ' ' GLY . 7.1 p -55.84 134.68 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 122.504 1.145 . . . . 25.0 111.217 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -101.99 0.31 34.97 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 121.556 0.693 . . . . 25.0 111.045 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.57 ' H ' HG22 ' A' ' 5' ' ' VAL . . . -92.08 -147.96 21.6 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.499 -0.773 . . . . 25.0 113.694 176.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.8 p 69.98 155.59 0.15 Allowed Pre-proline 0 N--CA 1.489 1.521 0 C-N-CA 126.011 1.724 . . . . 25.0 111.226 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -73.89 4.68 3.96 Favored 'Trans proline' 0 C--O 1.24 0.625 0 C-N-CA 121.631 1.554 . . . . 25.0 115.318 -177.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.0 p -54.18 -31.5 21.98 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 N-CA-C 116.02 1.859 . . . . 25.0 116.02 -170.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.0 p -148.26 152.83 12.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 O-C-N 120.943 -1.098 . . . . 25.0 111.01 -177.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.91 7.32 88.44 Favored Glycine 0 N--CA 1.468 0.788 0 N-CA-C 115.425 0.93 . . . . 25.0 115.425 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.2 t -56.65 -40.4 75.39 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 113.914 1.079 . . . . 25.0 113.914 -172.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -78.87 10.17 3.6 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 116.41 2.004 . . . . 25.0 116.41 -175.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.59 169.74 18.97 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 119.205 -0.426 . . . . 25.0 110.545 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -51.0 139.01 18.34 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 118.664 0.666 . . . . 25.0 111.892 -177.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -131.0 161.93 30.88 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.436 1.273 . . . . 50.0 114.436 -175.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -133.87 96.15 3.6 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 104.682 -2.34 . . . . 25.0 104.682 163.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 97.5 mt -112.01 126.26 54.95 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 121.341 0.591 . . . . 25.0 111.213 -176.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -119.72 117.19 27.6 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.226 -0.897 . . . . 25.0 109.753 -176.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.58 177.29 51.38 Favored Glycine 0 CA--C 1.502 -0.763 0 N-CA-C 116.063 1.185 . . . . 25.0 116.063 -175.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.7 p -79.81 174.26 11.76 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 114.302 -0.949 . . . . 25.0 111.407 178.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 77.3 mt -87.3 18.3 3.85 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 121.551 -0.718 . . . . 25.0 111.336 175.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -123.92 179.4 16.15 Favored Glycine 0 CA--C 1.502 -0.76 0 N-CA-C 111.475 -0.65 . . . . 25.0 111.475 177.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.2 t -67.29 134.09 50.92 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.146 0.424 . . . . 25.0 112.146 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -147.02 171.96 14.47 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 123.402 0.681 . . . . 50.0 111.843 -176.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -119.34 126.77 52.21 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.802 -1.555 . . . . 25.0 106.802 166.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.9 mm -123.75 130.41 74.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 106.652 -1.61 . . . . 25.0 106.652 -178.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.6 tt -134.78 123.93 24.36 Favored 'General case' 0 C--O 1.21 -1.012 0 N-CA-C 106.761 -1.57 . . . . 25.0 106.761 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.2 -34.33 37.41 Favored Glycine 0 CA--C 1.497 -1.051 0 N-CA-C 116.22 1.248 . . . . 25.0 116.22 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.38 -143.91 38.13 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.465 -0.874 . . . . 25.0 110.99 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.44 165.9 54.72 Favored Glycine 0 CA--C 1.498 -1.014 0 CA-C-O 122.672 1.151 . . . . 25.0 113.201 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.14 167.28 30.38 Favored Glycine 0 N--CA 1.459 0.212 0 CA-C-N 114.837 -0.682 . . . . 25.0 113.495 178.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.11 111.61 19.48 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 106.498 -1.667 . . . . 25.0 106.498 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -109.36 152.55 25.16 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 113.67 0.989 . . . . 50.0 113.67 -171.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -114.7 105.14 12.7 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 106.816 -1.549 . . . . 25.0 106.816 171.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 58.1 mt -110.8 133.6 53.22 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.221 0.452 . . . . 25.0 112.221 -174.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -131.71 110.59 11.0 Favored 'General case' 0 C--N 1.316 -0.875 0 O-C-N 121.224 -0.922 . . . . 25.0 112.99 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.25 -29.72 29.93 Favored Glycine 0 C--O 1.242 0.601 0 N-CA-C 117.713 1.845 . . . . 25.0 117.713 -174.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 53.01 -154.42 0.22 Allowed 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.683 0.994 . . . . 25.0 113.683 -177.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.93 160.3 15.1 Favored 'General case' 0 C--O 1.258 1.515 0 N-CA-C 112.306 0.484 . . . . 25.0 112.306 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.63 152.11 27.94 Favored Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 110.316 -1.113 . . . . 25.0 110.316 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -78.95 119.04 21.54 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 106.385 -1.709 . . . . 25.0 106.385 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -119.18 151.77 37.76 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 111.797 0.295 . . . . 50.0 111.797 -172.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.82 127.77 48.48 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 107.089 -1.449 . . . . 25.0 107.089 170.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.7 mp -127.37 121.34 30.71 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 122.015 0.912 . . . . 25.0 112.747 -176.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -118.93 135.14 54.74 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 108.553 -0.906 . . . . 25.0 108.553 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.61 -38.5 5.54 Favored Glycine 0 CA--C 1.498 -0.987 0 O-C-N 120.137 -1.602 . . . . 25.0 113.519 -174.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.83 -166.67 50.68 Favored Glycine 0 C--O 1.246 0.884 0 CA-C-O 121.947 0.748 . . . . 25.0 111.396 -177.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.91 157.94 14.22 Favored 'General case' 0 C--O 1.248 1.003 0 C-N-CA 123.241 0.617 . . . . 25.0 111.631 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.41 165.38 32.47 Favored Glycine 0 N--CA 1.466 0.695 0 CA-C-N 116.063 -0.517 . . . . 25.0 114.009 178.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.58 122.86 28.64 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 105.286 -2.116 . . . . 25.0 105.286 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -114.24 156.99 23.32 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.625 -0.509 . . . . 50.0 109.625 -175.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -124.19 122.95 39.17 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 106.382 -1.71 . . . . 25.0 106.382 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -146.38 139.89 25.95 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 116.728 2.121 . . . . 25.0 116.728 -170.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 70.3 m -108.31 143.33 37.33 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 114.958 -1.019 . . . . 25.0 108.473 175.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.9 -32.24 6.93 Favored Glycine 0 C--N 1.323 -0.173 0 N-CA-C 109.005 -1.638 . . . . 25.0 109.005 175.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.45 -174.88 54.52 Favored Glycine 0 CA--C 1.502 -0.741 0 C-N-CA 119.599 -1.286 . . . . 25.0 112.834 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -62.62 159.04 16.81 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.794 -0.827 . . . . 25.0 110.84 177.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.34 156.52 32.72 Favored Glycine 0 C--O 1.224 -0.487 0 CA-C-N 114.875 -1.057 . . . . 25.0 111.089 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.62 108.36 14.19 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.934 -1.136 . . . . 25.0 107.934 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -101.08 159.93 14.81 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.31 -0.859 . . . . 50.0 110.969 -172.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 57.4 m -124.67 119.09 28.01 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 109.102 -0.703 . . . . 25.0 109.102 177.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -99.65 83.94 2.86 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 106.589 -1.634 . . . . 25.0 106.589 175.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -83.16 -20.86 33.92 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.277 -0.874 . . . . 25.0 111.229 -173.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 61.91 160.6 0.07 Allowed 'General case' 0 CA--C 1.547 0.845 0 O-C-N 124.858 1.349 . . . . 25.0 112.181 -176.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -93.45 -70.39 0.7 Allowed 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.81 1.041 . . . . 25.0 113.81 -168.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.1 mt -116.48 175.17 5.68 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.68 0.753 . . . . 25.0 111.482 -171.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.94 -32.34 32.7 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.484 0.714 . . . . 25.0 111.435 176.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -80.02 -6.94 58.5 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.52 0.933 . . . . 25.0 113.52 -174.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.68 127.89 34.51 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 122.087 0.946 . . . . 25.0 111.594 -177.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.1 t 49.94 39.56 18.91 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 115.63 1.715 . . . . 25.0 115.63 173.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -103.59 160.94 14.31 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.722 -1.126 . . . . 25.0 110.12 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -115.09 139.91 49.5 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 104.056 -2.572 . . . . 25.0 104.056 176.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 62.8 p -124.29 166.0 21.7 Favored Pre-proline 0 C--N 1.317 -0.824 0 N-CA-C 108.623 -0.881 . . . . 25.0 108.623 -175.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -65.07 -19.5 63.41 Favored 'Trans proline' 0 C--O 1.245 0.861 0 C-N-CA 117.769 -1.02 . . . . 25.0 112.702 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 81.2 mt -76.17 -29.65 57.79 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.283 0.563 . . . . 25.0 112.181 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 160.76 179.15 35.33 Favored Glycine 0 N--CA 1.472 1.044 0 CA-C-O 118.412 -1.216 . . . . 25.0 110.182 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.4 t -98.02 148.78 23.15 Favored 'General case' 0 C--O 1.251 1.146 0 CA-C-N 118.884 1.342 . . . . 25.0 113.034 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -130.29 28.95 4.93 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-N 114.643 -1.162 . . . . 25.0 108.156 174.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.51 146.92 50.27 Favored Glycine 0 N--CA 1.463 0.455 0 N-CA-C 109.073 -1.611 . . . . 25.0 109.073 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -93.69 166.29 12.29 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 117.343 0.571 . . . . 50.0 111.405 -176.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.92 104.6 9.95 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 122.656 0.383 . . . . 25.0 111.65 -173.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.0 mt -91.16 135.7 26.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 107.889 -1.152 . . . . 25.0 107.889 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.446 ' HA ' ' HG2' ' A' ' 142' ' ' GLU . 85.5 mt -88.32 -56.57 3.26 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.539 0.94 . . . . 25.0 113.539 -174.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -124.61 39.37 3.99 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.672 0.99 . . . . 25.0 113.672 -171.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -55.53 138.77 45.9 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.76 0.79 . . . . 25.0 111.665 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -105.85 102.75 40.62 Favored Pre-proline 0 N--CA 1.469 0.497 0 N-CA-C 108.804 -0.813 . . . . 25.0 108.804 177.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -67.74 -6.7 17.46 Favored 'Trans proline' 0 C--N 1.359 1.087 0 N-CA-C 116.31 1.619 . . . . 25.0 116.31 -174.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.9 t -97.48 -42.87 7.51 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.005 0.522 . . . . 25.0 109.97 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -96.31 -43.11 7.83 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 113.283 0.845 . . . . 25.0 113.283 -171.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -82.44 164.81 20.73 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 121.472 -0.767 . . . . 75.0 110.336 -173.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -142.05 152.07 43.01 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.9 -0.591 . . . . 25.0 111.347 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 77.5 mt -126.49 131.92 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 107.63 -1.248 . . . . 25.0 107.63 -177.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -93.2 151.03 20.07 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 108.526 -0.916 . . . . 25.0 108.526 174.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 p -150.41 -3.91 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 N-CA-C 112.834 0.679 . . . . 25.0 112.834 -175.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.6 t -60.68 -48.49 81.54 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.831 1.048 . . . . 25.0 113.831 -173.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.54 -31.63 60.14 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.158 0.799 . . . . 25.0 113.158 -177.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.55 -22.95 16.24 Favored 'General case' 0 C--O 1.246 0.881 0 N-CA-C 115.919 1.822 . . . . 25.0 115.919 -173.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -134.11 -72.76 0.08 OUTLIER Glycine 0 CA--C 1.53 1.024 0 N-CA-C 116.102 1.201 . . . . 25.0 116.102 -174.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -154.57 167.06 31.38 Favored 'General case' 0 C--O 1.211 -0.926 0 CA-C-N 117.471 0.636 . . . . 25.0 109.438 -173.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 30.9 t -120.45 -47.77 2.33 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.191 -1.04 . . . . 25.0 108.191 176.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.15 120.9 5.37 Favored Glycine 0 CA--C 1.501 -0.814 0 N-CA-C 108.588 -1.805 . . . . 25.0 108.588 175.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -68.41 158.13 34.3 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 117.302 0.551 . . . . 25.0 111.744 -175.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -100.51 -160.31 27.99 Favored Glycine 0 N--CA 1.457 0.073 0 N-CA-C 115.109 0.804 . . . . 25.0 115.109 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -48.35 134.7 14.64 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.681 -0.76 . . . . 25.0 112.794 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 158.98 -175.07 35.99 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 108.676 -1.769 . . . . 25.0 108.676 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -152.9 168.21 26.54 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 118.694 1.247 . . . . 25.0 108.343 -177.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 52.59 39.04 27.41 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.85 1.056 . . . . 25.0 113.85 -177.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 69.47 35.1 74.83 Favored Glycine 0 C--O 1.245 0.801 0 N-CA-C 110.751 -0.939 . . . . 25.0 110.751 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.603 ' HA ' ' H ' ' A' ' 151' ' ' ALA . 7.6 t -136.97 176.57 8.59 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 121.623 -0.928 . . . . 25.0 109.905 -178.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.1 mt -110.34 164.58 12.54 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 102.47 -3.159 . . . . 25.0 102.47 176.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.63 120.98 23.33 Favored 'General case' 0 C--O 1.258 1.509 0 N-CA-C 108.063 -1.088 . . . . 25.0 108.063 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.7 m -80.23 159.32 4.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 C-N-CA 122.86 0.464 . . . . 25.0 111.374 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 73.3 m -134.83 163.0 30.81 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.438 -0.949 . . . . 25.0 108.438 177.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.0 m -124.37 165.51 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.362 0 N-CA-C 107.544 -1.28 . . . . 25.0 107.544 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.6 t -80.13 -49.07 12.23 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 106.574 -1.639 . . . . 25.0 106.574 173.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -161.57 -161.99 0.84 Allowed 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 101.941 -3.355 . . . . 25.0 101.941 174.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -67.09 -0.22 3.11 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.498 0.666 . . . . 25.0 112.536 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -142.64 -155.72 6.53 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 108.786 -1.726 . . . . 25.0 108.786 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 53.32 -145.86 0.57 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.116 0.784 . . . . 25.0 113.116 176.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.4 mtt85 -75.89 174.04 10.42 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.934 0.873 . . . . 25.0 113.336 -173.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.26 163.19 29.86 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 105.342 -2.095 . . . . 25.0 105.342 176.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -136.92 155.1 50.17 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.703 -0.48 . . . . 25.0 109.703 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 29.7 tp -125.43 127.17 46.1 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.161 -1.792 . . . . 25.0 106.161 171.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -126.37 151.51 47.53 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.386 0.513 . . . . 25.0 112.386 -171.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 84.0 p -88.63 150.01 23.25 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 105.115 -2.18 . . . . 25.0 105.115 169.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -117.33 27.78 8.88 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 105.621 -1.992 . . . . 25.0 105.621 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -122.88 141.67 51.63 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 112.578 -2.101 . . . . 25.0 106.468 174.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -138.41 153.83 48.9 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 124.221 0.95 . . . . 25.0 111.465 -178.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -77.96 160.29 28.29 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.498 -1.297 . . . . 25.0 107.498 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.73 -20.07 65.45 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-O 122.505 1.145 . . . . 25.0 109.142 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -74.12 -12.3 60.56 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 114.682 -1.145 . . . . 25.0 113.549 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.25 9.02 67.8 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 115.888 -0.596 . . . . 25.0 113.776 -178.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 63.0 mt -83.33 147.53 27.88 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 108.128 -1.064 . . . . 25.0 108.128 174.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 69.6 p -149.76 179.57 7.91 Favored 'General case' 0 C--O 1.248 0.976 0 N-CA-C 107.642 -1.244 . . . . 25.0 107.642 177.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -123.8 135.61 53.9 Favored 'General case' 0 C--O 1.253 1.268 0 CA-C-N 118.871 0.76 . . . . 25.0 111.76 -176.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -151.41 154.97 37.67 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.756 -1.572 . . . . 25.0 106.756 171.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.69 139.39 19.66 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 105.771 -1.937 . . . . 25.0 105.771 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -101.53 143.92 30.93 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 107.685 -1.228 . . . . 25.0 107.685 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mp -136.5 139.13 42.06 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 106.29 -1.744 . . . . 25.0 106.29 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.446 ' HG2' ' HA ' ' A' ' 85' ' ' LEU . 12.9 pt-20 -110.15 11.65 23.66 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.992 1.269 . . . . 25.0 110.603 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -68.41 -19.82 72.95 Favored Glycine 0 CA--C 1.499 -0.944 0 CA-C-N 115.218 -0.901 . . . . 25.0 111.006 173.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.1 t0 54.74 51.69 13.39 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 122.999 1.381 . . . . 25.0 110.733 175.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -121.63 42.75 3.02 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 113.513 -1.676 . . . . 25.0 108.151 -175.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -55.84 -31.59 62.85 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 114.596 -1.184 . . . . 25.0 112.462 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -77.18 -29.43 54.42 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 118.678 0.672 . . . . 25.0 111.878 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.55 -20.33 26.6 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 120.574 -0.45 . . . . 25.0 111.799 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 22.2 mt -62.12 136.54 57.99 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 121.082 0.468 . . . . 25.0 111.088 177.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 70.3 m -144.7 161.5 39.05 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 107.541 -1.281 . . . . 25.0 107.541 175.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.603 ' H ' ' HA ' ' A' ' 111' ' ' SER . . . -79.74 -0.09 32.83 Favored 'General case' 0 C--O 1.206 -1.206 0 N-CA-C 107.367 -1.346 . . . . 25.0 107.367 177.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -74.09 -26.77 60.55 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.372 -0.831 . . . . 25.0 110.788 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -89.66 -6.72 55.89 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.591 -0.693 . . . . 25.0 109.524 176.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 49.1 mm -90.22 136.6 23.46 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.621 0 N-CA-C 103.708 -2.701 . . . . 25.0 103.708 173.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.9 p -116.39 128.93 73.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 122.656 1.217 . . . . 25.0 110.861 -176.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -158.05 -17.13 0.08 Allowed 'General case' 0 C--O 1.211 -0.937 0 CA-C-N 113.95 -1.477 . . . . 25.0 113.121 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.75 43.34 0.91 Allowed 'General case' 0 C--O 1.246 0.897 0 O-C-N 121.454 -0.779 . . . . 25.0 112.183 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 58.17 29.09 17.42 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.891 0.877 . . . . 25.0 112.964 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.4 m 51.53 37.26 19.09 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 122.334 1.064 . . . . 25.0 111.342 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -76.36 123.81 26.53 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.71 1.004 . . . . 25.0 113.71 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.82 -18.32 60.47 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.29 -0.868 . . . . 25.0 112.719 177.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -81.07 -21.5 39.97 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 122.305 -0.247 . . . . 25.0 110.596 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.45 177.56 8.89 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.835 0.454 . . . . 25.0 111.108 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 63.47 178.66 0.16 Allowed 'General case' 0 CA--C 1.547 0.861 0 O-C-N 124.682 1.239 . . . . 25.0 113.939 176.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 82.04 22.63 58.97 Favored Glycine 0 C--O 1.237 0.294 0 CA-C-N 115.296 -0.865 . . . . 25.0 111.141 -177.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -106.99 104.79 14.55 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 112.338 0.496 . . . . 25.0 112.338 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -130.29 151.59 50.63 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 107.62 -1.252 . . . . 25.0 107.62 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -135.57 33.72 2.38 Favored Glycine 0 CA--C 1.502 -0.761 0 N-CA-C 110.802 -0.919 . . . . 25.0 110.802 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 54.6 t -79.53 -27.27 12.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 CA-C-O 121.939 0.876 . . . . 25.0 108.774 -176.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -53.86 134.39 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 CA-C-N 114.485 -1.234 . . . . 25.0 113.025 -174.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 141.12 150.66 5.43 Favored Glycine 0 C--O 1.246 0.895 0 N-CA-C 109.5 -1.44 . . . . 25.0 109.5 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -142.86 145.36 33.07 Favored 'General case' 0 C--O 1.252 1.232 0 O-C-N 122.197 -0.59 . . . . 25.0 111.249 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 13.3 p -150.72 154.77 38.0 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.725 0.774 . . . . 25.0 111.306 175.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 176.71 166.74 34.27 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 115.138 -0.937 . . . . 25.0 113.85 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -133.55 111.07 12.53 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 107.312 -1.366 . . . . 25.0 107.312 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.88 160.91 39.92 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 116.879 -1.614 . . . . 25.0 113.137 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -119.15 147.02 44.65 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.032 -1.099 . . . . 25.0 108.032 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -143.74 73.11 17.08 Favored Pre-proline 0 C--O 1.251 1.171 0 O-C-N 123.536 0.523 . . . . 25.0 111.198 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -69.9 164.07 36.06 Favored 'Trans proline' 0 C--O 1.249 1.031 0 N-CA-C 113.857 0.676 . . . . 25.0 113.857 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 12.6 t -125.66 8.68 7.62 Favored 'General case' 0 C--O 1.256 1.414 0 N-CA-C 109.652 -0.499 . . . . 25.0 109.652 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 C--O 1.245 0.853 0 N-CA-C 108.565 -0.902 . . . . 25.0 108.565 178.043 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 120.776 0.322 . . . . 25.0 110.36 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -135.73 115.51 11.41 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 107.463 -1.31 . . . . 25.0 107.463 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -69.33 144.24 55.63 Favored 'Trans proline' 0 CA--C 1.531 0.356 0 C-N-CA 116.407 -1.929 . . . . 25.0 113.856 -176.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -163.66 31.64 0.27 Allowed Glycine 0 CA--C 1.521 0.417 0 CA-C-O 119.429 -0.651 . . . . 25.0 112.26 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.5 p -60.35 133.11 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 122.027 0.918 . . . . 25.0 111.194 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -99.07 -18.57 17.67 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.647 -0.706 . . . . 25.0 112.197 -177.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.79 -134.11 3.84 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-O 121.715 0.62 . . . . 25.0 114.56 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.9 p 69.08 156.64 0.15 Allowed Pre-proline 0 N--CA 1.483 1.208 0 C-N-CA 125.858 1.663 . . . . 25.0 110.392 -173.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.425 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 32.4 Cg_exo -65.9 0.11 3.43 Favored 'Trans proline' 0 N--CA 1.485 1.008 0 N-CA-C 117.707 2.156 . . . . 25.0 117.707 -173.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.6 p -68.01 -22.14 27.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 114.787 1.403 . . . . 25.0 114.787 -172.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.2 p -128.1 121.57 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 117.329 2.344 . . . . 25.0 117.329 -171.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.05 20.6 79.06 Favored Glycine 0 C--O 1.224 -0.47 0 N-CA-C 117.423 1.729 . . . . 25.0 117.423 173.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.2 t -50.07 -37.87 35.56 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 114.726 1.38 . . . . 25.0 114.726 -174.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -80.74 13.61 2.52 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 114.649 1.352 . . . . 25.0 114.649 -176.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -149.63 171.22 17.02 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.531 -0.73 . . . . 25.0 110.542 176.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.76 121.57 14.32 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.293 0.637 . . . . 25.0 111.538 -173.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -120.72 169.69 10.16 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 115.296 1.591 . . . . 50.0 115.296 -173.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -123.35 114.55 20.32 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 103.775 -2.676 . . . . 25.0 103.775 160.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 82.3 mt -120.04 102.57 8.63 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.536 0.684 . . . . 25.0 111.761 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -93.4 121.8 35.16 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.709 -0.678 . . . . 25.0 109.837 177.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.15 -174.29 47.67 Favored Glycine 0 N--CA 1.464 0.565 0 N-CA-C 115.245 0.858 . . . . 25.0 115.245 -178.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.7 p -91.67 173.71 7.73 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.778 0.831 . . . . 25.0 112.404 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 75.4 mt -83.67 12.41 5.88 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.356 0.873 . . . . 25.0 113.356 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.85 179.31 20.04 Favored Glycine 0 N--CA 1.462 0.378 0 CA-C-N 116.284 -0.416 . . . . 25.0 112.175 178.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.5 t -71.48 130.93 42.51 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 122.701 0.4 . . . . 25.0 110.635 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -143.41 165.89 26.29 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 123.265 0.353 . . . . 50.0 111.527 -174.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -111.11 125.49 53.83 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 106.108 -1.812 . . . . 25.0 106.108 166.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.0 mm -115.49 129.22 72.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 107.043 -1.465 . . . . 25.0 107.043 -177.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.425 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 1.0 OUTLIER -129.27 123.33 31.63 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 105.418 -2.067 . . . . 25.0 105.418 179.677 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.54 -36.32 23.53 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 114.969 0.747 . . . . 25.0 114.969 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.52 -149.03 50.42 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.268 -0.733 . . . . 25.0 111.268 -176.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -78.41 170.47 54.84 Favored Glycine 0 C--O 1.257 1.585 0 O-C-N 121.728 -0.866 . . . . 25.0 112.061 -176.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.34 165.06 33.83 Favored Glycine 0 C--N 1.316 -0.557 0 CA-C-O 119.639 -0.534 . . . . 25.0 112.91 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.14 101.07 13.14 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.053 -1.091 . . . . 25.0 108.053 178.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -98.48 153.57 18.51 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.915 0.709 . . . . 50.0 112.915 -168.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -115.15 99.85 7.73 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 105.745 -1.946 . . . . 25.0 105.745 175.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 33.2 mt -104.26 137.82 41.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.798 -1.092 . . . . 25.0 111.571 -171.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -133.77 99.42 4.46 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.925 0.713 . . . . 25.0 112.925 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.38 -35.2 63.47 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-O 118.342 -1.255 . . . . 25.0 115.8 -177.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 55.17 -154.47 0.29 Allowed 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 118.814 1.307 . . . . 25.0 113.672 -178.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.97 160.13 15.56 Favored 'General case' 0 C--O 1.249 1.034 0 N-CA-C 113.486 0.921 . . . . 25.0 113.486 -176.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.12 159.93 33.51 Favored Glycine 0 C--O 1.223 -0.546 0 CA-C-N 115.187 -0.915 . . . . 25.0 111.451 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -82.15 115.5 21.29 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 104.688 -2.338 . . . . 25.0 104.688 177.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -116.67 154.33 30.76 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.758 -0.377 . . . . 50.0 110.514 -171.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 mp -114.05 133.08 55.76 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 105.792 -1.929 . . . . 25.0 105.792 174.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.6 mp -133.28 128.92 36.84 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 113.967 1.099 . . . . 25.0 113.967 -173.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -129.92 135.13 47.99 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.181 -1.414 . . . . 25.0 107.181 177.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -93.36 -40.65 4.73 Favored Glycine 0 N--CA 1.475 1.26 0 N-CA-C 115.409 0.924 . . . . 25.0 115.409 -175.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.34 -174.92 55.22 Favored Glycine 0 C--O 1.24 0.491 0 N-CA-C 110.88 -0.888 . . . . 25.0 110.88 -176.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.83 154.06 9.88 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.328 0.585 . . . . 25.0 109.911 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.1 150.66 24.12 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.493 -0.776 . . . . 25.0 112.028 -176.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -74.92 127.87 34.23 Favored 'General case' 0 C--O 1.212 -0.92 0 N-CA-C 104.737 -2.32 . . . . 25.0 104.737 176.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -117.68 150.94 38.22 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 121.707 -0.62 . . . . 50.0 111.046 -174.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -112.76 121.56 45.09 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 103.764 -2.68 . . . . 25.0 103.764 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -144.7 131.5 20.16 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 117.743 2.497 . . . . 25.0 117.743 -171.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.3 m -99.45 141.19 32.55 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-N 115.8 -0.637 . . . . 25.0 109.534 174.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -94.72 -35.71 5.8 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 110.443 -1.063 . . . . 25.0 110.443 172.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.17 -176.33 51.74 Favored Glycine 0 N--CA 1.465 0.62 0 CA-C-N 118.198 0.999 . . . . 25.0 113.373 -178.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -59.51 156.1 13.92 Favored 'General case' 0 C--O 1.246 0.884 0 O-C-N 121.595 -0.944 . . . . 25.0 110.724 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.01 162.54 34.63 Favored Glycine 0 C--O 1.246 0.903 0 N-CA-C 108.943 -1.663 . . . . 25.0 108.943 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.95 121.32 26.36 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 106.842 -1.54 . . . . 25.0 106.842 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -112.0 152.19 28.41 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.184 0.516 . . . . 50.0 110.17 -175.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.5 m -117.47 110.31 17.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.851 0.834 . . . . 25.0 110.329 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -94.21 119.94 33.75 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 106.032 -1.84 . . . . 25.0 106.032 176.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.9 mmt85 -114.5 -32.25 5.96 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.967 -0.561 . . . . 25.0 112.339 -177.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 68.09 148.53 0.06 Allowed 'General case' 0 CA--C 1.55 0.948 0 O-C-N 124.741 1.275 . . . . 25.0 110.667 -174.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.16 -34.98 21.99 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 114.822 1.416 . . . . 25.0 114.822 -165.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 70.5 mt -132.25 161.66 32.9 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.1 0.476 . . . . 25.0 110.602 -172.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.83 -31.35 66.55 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 107.095 -1.446 . . . . 25.0 107.095 169.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -87.69 9.34 21.82 Favored 'General case' 0 C--O 1.254 1.31 0 N-CA-C 115.571 1.693 . . . . 25.0 115.571 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -94.7 141.54 28.5 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.034 -1.042 . . . . 25.0 110.101 -177.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.8 t 47.32 50.48 14.48 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 114.556 1.317 . . . . 25.0 114.556 -178.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 31.0 p-80 -114.35 169.54 8.96 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.47 -0.786 . . . . 25.0 111.403 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -121.45 148.79 43.97 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 104.621 -2.362 . . . . 25.0 104.621 173.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 92.4 p -139.59 170.96 8.74 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 107.299 -1.371 . . . . 25.0 107.299 -177.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -62.79 -20.45 71.21 Favored 'Trans proline' 0 C--N 1.361 1.185 0 CA-C-N 119.044 0.694 . . . . 25.0 113.087 174.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 80.9 mt -73.64 -27.5 61.3 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 121.748 -0.595 . . . . 25.0 110.91 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.91 -177.95 30.29 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.683 -0.967 . . . . 25.0 110.683 -174.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.3 t -101.7 141.73 34.12 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 122.811 1.291 . . . . 25.0 111.54 -178.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -127.71 27.36 5.77 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 114.678 -1.146 . . . . 25.0 109.167 176.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.2 145.17 45.77 Favored Glycine 0 N--CA 1.462 0.39 0 O-C-N 124.07 0.856 . . . . 25.0 112.124 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -85.33 170.1 13.09 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 122.694 -0.297 . . . . 50.0 111.321 -177.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -128.11 105.95 8.72 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.694 0.798 . . . . 25.0 111.394 -174.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.0 mt -87.82 133.91 29.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 121.853 0.835 . . . . 25.0 108.789 -178.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.448 ' HA ' ' HG2' ' A' ' 142' ' ' GLU . 85.0 mt -85.1 -43.93 13.45 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 116.401 2.001 . . . . 25.0 116.401 -172.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -137.67 40.16 2.39 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.09 1.144 . . . . 25.0 114.09 -173.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -55.97 132.21 49.29 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.579 -0.737 . . . . 25.0 112.287 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -102.37 105.43 43.36 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 106.011 -1.848 . . . . 25.0 106.011 174.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -70.48 -4.39 14.42 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 N-CA-C 116.622 1.739 . . . . 25.0 116.622 -172.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.3 t -97.29 -45.62 6.42 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.201 0.524 . . . . 25.0 111.079 174.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -82.53 -41.26 19.88 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.357 0.873 . . . . 25.0 113.357 -174.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -84.95 165.44 17.61 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.694 -0.484 . . . . 75.0 109.694 -169.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -140.73 146.24 37.5 Favored 'General case' 0 C--O 1.246 0.874 0 N-CA-C 108.523 -0.917 . . . . 25.0 108.523 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 76.5 mt -128.66 126.52 65.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 107.926 -1.138 . . . . 25.0 107.926 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -80.91 148.14 30.0 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.809 0.814 . . . . 25.0 110.361 172.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.0 p -143.32 -7.91 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.317 -0.856 . . . . 25.0 110.628 176.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.8 t -63.92 -41.16 97.73 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.282 0.563 . . . . 25.0 111.943 -173.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.62 -4.61 57.97 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.028 0.751 . . . . 25.0 113.028 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 11.9 mt -115.04 -38.25 3.93 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.989 1.477 . . . . 25.0 114.989 -169.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -136.42 -54.68 0.06 OUTLIER Glycine 0 C--O 1.24 0.477 0 N-CA-C 117.644 1.818 . . . . 25.0 117.644 -174.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -155.04 164.02 39.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 117.569 0.684 . . . . 25.0 109.826 -174.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 45.8 t -121.26 -25.53 5.23 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 124.12 0.887 . . . . 25.0 109.018 173.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -100.65 121.59 7.29 Favored Glycine 0 N--CA 1.464 0.565 0 N-CA-C 107.615 -2.194 . . . . 25.0 107.615 172.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.68 146.49 53.72 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 118.565 1.183 . . . . 25.0 113.246 -174.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -80.85 -175.19 49.45 Favored Glycine 0 C--N 1.32 -0.316 0 CA-C-N 115.349 -0.841 . . . . 25.0 114.415 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -60.84 142.62 56.01 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 121.196 0.522 . . . . 25.0 111.701 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 166.83 -171.94 41.84 Favored Glycine 0 C--O 1.245 0.787 0 N-CA-C 109.363 -1.495 . . . . 25.0 109.363 -177.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -141.52 165.25 28.0 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.833 1.317 . . . . 25.0 111.465 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 57.52 33.9 23.88 Favored 'General case' 0 C--O 1.246 0.878 0 O-C-N 124.454 1.096 . . . . 25.0 113.541 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 74.56 39.32 41.81 Favored Glycine 0 C--O 1.222 -0.653 0 N-CA-C 109.969 -1.252 . . . . 25.0 109.969 177.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 11.1 t -148.6 167.64 24.92 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 108.998 -0.741 . . . . 25.0 108.998 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.4 mt -84.78 159.91 20.36 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 103.069 -2.937 . . . . 25.0 103.069 169.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.66 128.9 38.03 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 119.291 -0.964 . . . . 25.0 109.158 178.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.9 m -91.48 159.23 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 109.65 -0.5 . . . . 25.0 109.65 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.19 164.71 26.77 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 110.169 -0.308 . . . . 25.0 110.169 -177.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.4 m -118.58 162.64 16.5 Favored 'Isoleucine or valine' 0 C--O 1.25 1.08 0 N-CA-C 106.726 -1.583 . . . . 25.0 106.726 175.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.8 t -83.06 -51.23 7.72 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 106.295 -1.743 . . . . 25.0 106.295 170.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -166.69 -164.58 0.66 Allowed 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 100.825 -3.768 . . . . 25.0 100.825 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -68.12 -25.07 65.11 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 119.173 0.897 . . . . 25.0 110.658 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -106.9 -164.64 22.3 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 108.17 -1.972 . . . . 25.0 108.17 174.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 56.18 -162.79 0.17 Allowed 'General case' 0 C--O 1.248 0.976 0 N-CA-C 113.538 0.94 . . . . 25.0 113.538 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 64.3 mtt85 -79.24 169.29 18.35 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.755 1.02 . . . . 25.0 113.755 -168.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.7 p -115.3 165.56 12.82 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 105.111 -2.181 . . . . 25.0 105.111 174.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -134.73 157.97 45.33 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 121.404 0.621 . . . . 25.0 111.357 -177.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 51.1 tp -130.13 113.97 15.15 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 103.781 -2.674 . . . . 25.0 103.781 171.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -116.13 148.67 40.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.979 0.419 . . . . 25.0 110.19 -174.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 43.0 t -97.27 147.18 24.4 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 106.061 -1.829 . . . . 25.0 106.061 171.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -116.9 17.28 15.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.562 0.696 . . . . 25.0 110.532 -177.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -107.8 140.06 41.45 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 104.674 -2.343 . . . . 25.0 104.674 172.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -140.04 154.65 47.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.698 0.761 . . . . 25.0 112.404 -176.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -75.03 166.22 24.01 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.924 -1.035 . . . . 25.0 109.318 177.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.83 -25.27 66.35 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 108.443 -0.947 . . . . 25.0 108.443 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -74.02 -5.37 41.0 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.372 -0.831 . . . . 25.0 112.995 175.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.32 10.48 77.47 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 121.299 -0.477 . . . . 25.0 112.619 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.5 mt -83.8 134.03 34.74 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 122.288 -0.536 . . . . 25.0 109.663 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 59.8 p -138.69 176.89 8.3 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 106.605 -1.628 . . . . 25.0 106.605 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -125.64 134.46 51.87 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 120.328 -0.549 . . . . 25.0 110.349 -175.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -152.76 152.93 32.22 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 108.979 -0.749 . . . . 25.0 108.979 171.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 13.0 p -145.23 143.78 21.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 106.244 -1.762 . . . . 25.0 106.244 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -102.45 146.14 28.53 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 107.081 -1.452 . . . . 25.0 107.081 -177.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.5 mp -132.19 134.98 46.0 Favored 'General case' 0 C--O 1.201 -1.479 0 N-CA-C 104.908 -2.256 . . . . 25.0 104.908 177.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.448 ' HG2' ' HA ' ' A' ' 85' ' ' LEU . 8.7 pt-20 -103.18 10.55 37.73 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 119.923 1.238 . . . . 25.0 111.059 -178.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.7 -10.2 66.92 Favored Glycine 0 N--CA 1.458 0.164 0 C-N-CA 120.952 -0.642 . . . . 25.0 113.57 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 37.9 t0 53.09 40.9 31.98 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 123.327 1.536 . . . . 25.0 110.557 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -115.92 38.29 3.38 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.053 -1.43 . . . . 25.0 109.811 -179.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.28 -32.57 68.54 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.067 0.766 . . . . 25.0 113.067 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.14 -28.49 62.27 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.017 0.377 . . . . 25.0 112.017 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -85.49 -29.56 24.17 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-N 116.744 -0.207 . . . . 25.0 111.041 -177.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 29.4 mt -59.35 139.5 56.97 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-O 122.431 1.11 . . . . 25.0 112.581 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.4 m -143.06 160.43 40.39 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.3 -1.741 . . . . 25.0 106.3 176.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.64 3.76 15.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.17 0.509 . . . . 25.0 109.987 176.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -68.38 -29.59 68.33 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.174 -0.466 . . . . 25.0 110.307 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -92.07 1.63 57.08 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.39 0.614 . . . . 25.0 110.867 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 31.4 mm -101.02 125.42 54.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.821 0 N-CA-C 104.821 -2.289 . . . . 25.0 104.821 178.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.74 119.4 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 122.934 1.35 . . . . 25.0 112.14 -174.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -156.0 -20.76 0.1 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 113.248 -1.797 . . . . 25.0 110.908 177.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -76.11 52.18 0.71 Allowed 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.211 1.189 . . . . 25.0 114.211 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 63.68 11.37 5.74 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 115.229 1.566 . . . . 25.0 115.229 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.5 m 64.96 -59.2 0.25 Allowed 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 116.686 2.106 . . . . 25.0 116.686 176.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -64.27 137.91 58.17 Favored 'General case' 0 C--O 1.244 0.772 0 O-C-N 121.946 -0.471 . . . . 25.0 111.381 -175.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -81.69 61.09 4.92 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 113.349 0.87 . . . . 25.0 113.349 -176.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.04 -37.02 78.35 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.77 -0.826 . . . . 25.0 108.77 177.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -135.87 -104.73 0.21 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.534 -0.757 . . . . 25.0 109.702 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 55.71 -159.7 0.2 Allowed 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.247 1.019 . . . . 25.0 111.17 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 63.44 25.83 68.99 Favored Glycine 0 C--O 1.218 -0.863 0 C-N-CA 121.227 -0.511 . . . . 25.0 112.648 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -82.54 94.94 7.59 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.596 0.712 . . . . 25.0 110.647 -174.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -125.32 150.73 46.87 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 108.493 -0.929 . . . . 25.0 108.493 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -146.0 32.0 1.57 Allowed Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 109.125 -1.59 . . . . 25.0 109.125 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 39.9 t -65.34 -37.66 80.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 109.99 -0.374 . . . . 25.0 109.99 -175.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.8 128.65 21.09 Favored 'Isoleucine or valine' 0 C--O 1.244 0.8 0 CA-C-O 122.197 0.999 . . . . 25.0 110.913 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 158.58 146.27 4.48 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 109.082 -1.607 . . . . 25.0 109.082 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -141.09 154.57 46.0 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-N 117.503 0.652 . . . . 25.0 111.159 -176.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 93.7 p -149.86 158.24 43.98 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.339 -1.356 . . . . 25.0 107.339 176.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 178.79 174.27 44.86 Favored Glycine 0 C--O 1.241 0.541 0 C-N-CA 120.06 -1.067 . . . . 25.0 113.578 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -152.9 85.49 4.33 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 107.728 -1.212 . . . . 25.0 107.728 178.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.42 150.28 75.58 Favored 'Trans proline' 0 C--N 1.354 0.818 0 O-C-N 122.015 0.481 . . . . 25.0 112.054 -177.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -114.81 154.51 28.46 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.201 -0.454 . . . . 25.0 110.575 -174.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -136.32 61.16 37.19 Favored Pre-proline 0 C--O 1.25 1.087 0 N-CA-C 113.225 0.824 . . . . 25.0 113.225 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -71.97 160.27 48.08 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 115.623 -2.451 . . . . 25.0 112.498 177.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.9 t -120.22 -15.75 8.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.017 -0.538 . . . . 25.0 111.181 -177.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.746 -0.645 . . . . 25.0 110.763 177.266 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 110.428 -0.212 . . . . 25.0 110.428 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -138.89 107.73 7.56 Favored Pre-proline 0 C--O 1.243 0.716 0 C-N-CA 122.533 0.333 . . . . 25.0 110.659 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.9 154.19 71.37 Favored 'Trans proline' 0 N--CA 1.48 0.7 0 N-CA-C 113.692 0.612 . . . . 25.0 113.692 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -178.02 54.04 0.1 OUTLIER Glycine 0 C--O 1.224 -0.528 0 N-CA-C 110.557 -1.017 . . . . 25.0 110.557 -178.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.4 p -60.52 132.41 25.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 122.261 1.029 . . . . 25.0 112.346 -174.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -103.11 -6.14 22.54 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.397 -1.274 . . . . 25.0 110.482 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.97 -148.12 4.91 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 116.36 -0.382 . . . . 25.0 112.717 178.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.4 p 68.39 159.85 0.15 Allowed Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 125.974 1.71 . . . . 25.0 112.204 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -66.52 1.3 2.7 Favored 'Trans proline' 0 C--N 1.359 1.122 0 N-CA-C 116.634 1.744 . . . . 25.0 116.634 -176.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.3 p -68.53 -18.98 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 N-CA-C 115.24 1.57 . . . . 25.0 115.24 -170.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.3 p -146.92 143.64 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 113.288 0.848 . . . . 25.0 113.288 -177.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.32 13.68 81.44 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 115.607 1.003 . . . . 25.0 115.607 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.2 t -54.21 -50.95 65.94 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 122.337 -0.508 . . . . 25.0 111.459 -173.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -86.8 19.26 3.03 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 114.758 1.392 . . . . 25.0 114.758 -172.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -152.39 170.83 19.13 Favored 'General case' 0 CA--C 1.561 1.397 0 O-C-N 121.653 -0.654 . . . . 25.0 111.391 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -59.38 134.18 56.77 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 112.47 0.544 . . . . 25.0 112.47 -175.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -121.54 163.22 19.22 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 115.575 1.694 . . . . 50.0 115.575 -173.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -138.08 87.04 2.21 Favored 'General case' 0 C--O 1.249 1.043 0 N-CA-C 102.857 -3.016 . . . . 25.0 102.857 164.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 89.2 mt -102.65 122.6 44.75 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 117.764 0.256 . . . . 25.0 111.551 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -110.75 122.88 48.91 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 123.61 0.568 . . . . 25.0 110.257 -179.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.99 176.65 40.95 Favored Glycine 0 CA--C 1.54 1.646 0 C-N-CA 120.59 -0.814 . . . . 25.0 114.349 -178.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.1 p -87.43 179.33 6.59 Favored 'General case' 0 C--O 1.256 1.429 0 C-N-CA 123.581 0.752 . . . . 25.0 110.981 177.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 51.7 mt -82.48 13.96 3.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.232 -0.895 . . . . 25.0 112.736 175.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.4 176.04 20.7 Favored Glycine 0 C--O 1.242 0.597 0 CA-C-N 115.479 -0.782 . . . . 25.0 111.834 177.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.3 t -78.07 131.35 37.27 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 121.85 -0.794 . . . . 25.0 108.884 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -142.65 153.58 43.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.308 0.575 . . . . 50.0 110.545 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -87.52 133.97 33.69 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 102.809 -3.034 . . . . 25.0 102.809 164.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 34.6 mm -127.04 116.69 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 105.292 -2.114 . . . . 25.0 105.292 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.1 tt -122.36 122.22 38.53 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.462 -1.31 . . . . 25.0 107.462 -177.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.21 -38.71 28.84 Favored Glycine 0 N--CA 1.445 -0.733 0 O-C-N 123.986 0.804 . . . . 25.0 114.71 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.66 -147.48 38.66 Favored Glycine 0 C--O 1.241 0.552 0 O-C-N 121.485 -1.009 . . . . 25.0 110.991 -176.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.37 165.02 54.77 Favored Glycine 0 CA--C 1.505 -0.588 0 CA-C-O 121.181 0.323 . . . . 25.0 112.762 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.57 167.27 36.46 Favored Glycine 0 C--O 1.236 0.274 0 C-N-CA 121.024 -0.608 . . . . 25.0 113.875 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.7 107.68 15.51 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.282 -1.007 . . . . 25.0 108.282 177.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -106.4 147.56 29.12 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.086 0.773 . . . . 50.0 113.086 -170.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -113.34 107.03 15.31 Favored 'General case' 0 C--O 1.249 1.073 0 N-CA-C 107.343 -1.354 . . . . 25.0 107.343 172.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 53.6 mt -111.39 133.51 53.64 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 116.161 -0.472 . . . . 25.0 110.613 -171.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -128.83 107.3 9.53 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.483 0.659 . . . . 25.0 111.715 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.71 -34.12 28.78 Favored Glycine 0 N--CA 1.463 0.489 0 N-CA-C 116.732 1.453 . . . . 25.0 116.732 -175.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 55.48 -153.5 0.33 Allowed 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 118.374 1.087 . . . . 25.0 111.959 -173.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.83 164.53 9.97 Favored 'General case' 0 C--O 1.252 1.193 0 N-CA-C 112.798 0.666 . . . . 25.0 112.798 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.67 155.19 31.66 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 115.279 -0.873 . . . . 25.0 111.351 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -78.59 98.54 6.19 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 106.99 -1.485 . . . . 25.0 106.99 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -100.24 151.42 21.47 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 122.032 -0.417 . . . . 50.0 110.183 -171.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.9 mp -113.16 90.6 3.39 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.767 -0.827 . . . . 25.0 108.767 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.4 mp -92.92 125.24 37.42 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 112.14 0.422 . . . . 25.0 112.14 -172.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -122.79 132.76 54.36 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 106.937 -1.505 . . . . 25.0 106.937 173.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.1 -38.76 8.32 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 119.715 -1.231 . . . . 25.0 115.028 -177.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.71 -171.83 51.44 Favored Glycine 0 C--O 1.223 -0.546 0 O-C-N 121.824 -0.81 . . . . 25.0 111.612 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.34 149.48 12.96 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.533 0.683 . . . . 25.0 110.935 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.35 166.93 42.35 Favored Glycine 0 C--N 1.332 0.327 0 CA-C-N 115.482 -0.781 . . . . 25.0 111.939 -178.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.71 129.23 34.86 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 105.16 -2.163 . . . . 25.0 105.16 176.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -120.85 154.16 36.18 Favored 'General case' 0 C--O 1.251 1.153 0 O-C-N 121.733 -0.605 . . . . 50.0 111.656 -175.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -116.57 128.3 55.29 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 103.607 -2.738 . . . . 25.0 103.607 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -147.76 141.58 25.74 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 115.831 1.789 . . . . 25.0 115.831 -174.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.6 m -109.3 138.02 46.29 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.194 -1.409 . . . . 25.0 107.194 176.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.03 -38.57 5.69 Favored Glycine 0 C--N 1.317 -0.512 0 N-CA-C 111.06 -0.816 . . . . 25.0 111.06 174.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.52 -170.37 54.54 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 118.749 1.274 . . . . 25.0 111.992 -177.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -64.15 161.63 15.95 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.088 0.471 . . . . 25.0 111.419 176.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.99 164.06 40.01 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-N 115.503 -0.771 . . . . 25.0 111.724 -176.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.13 106.5 16.63 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.129 -1.063 . . . . 25.0 108.129 -177.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -97.04 156.65 16.27 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 112.548 0.573 . . . . 50.0 112.548 -170.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 57.1 m -122.63 125.66 46.09 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.524 -0.917 . . . . 25.0 108.524 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -120.51 85.57 2.41 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.942 -0.762 . . . . 25.0 108.942 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -89.12 -23.95 22.36 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 112.313 0.486 . . . . 25.0 112.313 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 66.41 162.02 0.16 Allowed 'General case' 0 CA--C 1.548 0.898 0 O-C-N 125.212 1.57 . . . . 25.0 108.595 -171.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.13 -46.1 21.54 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 115.663 1.727 . . . . 25.0 115.663 -165.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.9 mt -144.12 169.28 18.15 Favored 'General case' 0 C--O 1.197 -1.691 0 C-N-CA 123.008 0.523 . . . . 25.0 111.246 -169.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.68 -32.69 30.8 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.574 -0.739 . . . . 25.0 110.571 169.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -80.99 1.44 31.2 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.732 1.382 . . . . 25.0 114.732 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -104.16 142.58 34.25 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.95 0.722 . . . . 25.0 112.95 -175.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.9 t 51.87 54.38 10.99 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 115.142 1.534 . . . . 25.0 115.142 177.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 36.9 p-80 -132.13 170.64 14.71 Favored 'General case' 0 C--O 1.208 -1.111 0 CA-C-N 116.441 -0.345 . . . . 25.0 111.884 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -118.07 144.92 45.21 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 106.696 -1.594 . . . . 25.0 106.696 178.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.9 p -133.31 164.83 41.17 Favored Pre-proline 0 C--O 1.244 0.797 0 N-CA-C 108.443 -0.947 . . . . 25.0 108.443 178.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -64.66 -15.84 52.16 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 117.504 -1.198 . . . . 25.0 113.436 174.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 87.9 mt -82.34 -21.51 35.96 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.075 -0.511 . . . . 25.0 111.817 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.77 171.77 24.13 Favored Glycine 0 C--O 1.219 -0.839 0 N-CA-C 109.875 -1.29 . . . . 25.0 109.875 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.1 t -101.13 147.88 25.72 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 122.659 1.218 . . . . 25.0 112.91 178.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -131.21 21.45 4.84 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.235 -0.893 . . . . 25.0 110.647 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.2 152.04 51.7 Favored Glycine 0 N--CA 1.473 1.164 0 N-CA-C 109.572 -1.411 . . . . 25.0 109.572 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -96.94 171.34 8.56 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 118.529 1.165 . . . . 50.0 110.536 -174.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.439 ' HG3' ' HB3' ' A' ' 140' ' ' ALA . 0.0 OUTLIER -126.85 108.5 11.06 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 121.931 -0.481 . . . . 25.0 112.231 -175.228 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.3 mt -89.39 138.68 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 109.212 -0.662 . . . . 25.0 109.212 -176.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.419 ' HA ' ' HG2' ' A' ' 142' ' ' GLU . 76.9 mt -86.33 -52.62 5.51 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 115.77 1.767 . . . . 25.0 115.77 -175.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -127.82 32.46 4.95 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 113.982 1.105 . . . . 25.0 113.982 -168.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -52.94 143.33 17.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.423 -1.262 . . . . 25.0 114.029 -175.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -118.17 103.35 49.78 Favored Pre-proline 0 C--O 1.237 0.398 0 C-N-CA 123.032 0.533 . . . . 25.0 111.333 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.23 -13.21 35.6 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 N-CA-C 114.549 0.942 . . . . 25.0 114.549 -175.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.0 t -81.26 -39.33 25.45 Favored 'General case' 0 C--O 1.245 0.836 0 N-CA-C 108.737 -0.838 . . . . 25.0 108.737 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -95.33 -43.53 7.99 Favored 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 117.196 2.295 . . . . 25.0 117.196 -175.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -90.19 172.75 8.58 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.572 -1.195 . . . . 75.0 112.03 -162.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -142.81 147.32 35.28 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 112.36 0.504 . . . . 25.0 112.36 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 90.7 mt -127.35 128.78 70.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 108.604 -0.887 . . . . 25.0 108.604 -178.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -86.62 148.6 25.41 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 122.124 0.964 . . . . 25.0 111.617 174.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.41 HG11 ' CZ ' ' A' ' 101' ' ' PHE . 8.4 p -146.75 -2.8 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 115.566 -0.743 . . . . 25.0 111.043 175.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 44.9 t -60.97 -44.57 97.15 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.662 0.744 . . . . 25.0 111.464 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.82 -28.53 58.33 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.372 -0.831 . . . . 25.0 112.074 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.6 mt -92.09 -41.61 10.4 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 116.288 1.958 . . . . 25.0 116.288 -171.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -138.54 -48.12 0.06 OUTLIER Glycine 0 N--CA 1.463 0.491 0 N-CA-C 118.156 2.022 . . . . 25.0 118.156 -172.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.41 ' CZ ' HG11 ' A' ' 96' ' ' VAL . 50.2 p90 -160.14 153.03 21.45 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 118.579 1.19 . . . . 25.0 112.714 -172.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 25.2 t -109.15 -16.94 13.98 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.511 -0.552 . . . . 25.0 109.511 178.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -121.46 132.61 9.12 Favored Glycine 0 N--CA 1.47 0.912 0 N-CA-C 108.363 -1.895 . . . . 25.0 108.363 176.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -68.15 156.0 38.43 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.963 1.468 . . . . 25.0 114.963 -172.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -101.77 -161.25 26.79 Favored Glycine 0 N--CA 1.464 0.53 0 O-C-N 121.583 -0.698 . . . . 25.0 112.828 -177.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -54.57 138.99 39.62 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 113.482 0.919 . . . . 25.0 113.482 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 168.72 -176.42 42.98 Favored Glycine 0 C--O 1.227 -0.292 0 CA-C-N 115.242 -0.89 . . . . 25.0 110.995 177.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -146.56 165.93 28.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.573 0.687 . . . . 25.0 109.283 -177.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 54.99 34.02 21.5 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 114.449 1.277 . . . . 25.0 114.449 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.62 25.39 65.35 Favored Glycine 0 N--CA 1.465 0.617 0 N-CA-C 111.159 -0.776 . . . . 25.0 111.159 177.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.428 ' HA ' ' H ' ' A' ' 151' ' ' ALA . 4.8 t -136.64 176.4 8.74 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 109.01 -0.737 . . . . 25.0 109.01 -178.06 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 69.7 mt -89.48 164.89 14.63 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 104.056 -2.572 . . . . 25.0 104.056 169.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.66 108.12 4.24 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 122.199 1.0 . . . . 25.0 109.894 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 18.0 m -73.16 160.34 5.36 Favored 'Isoleucine or valine' 0 C--O 1.247 0.968 0 N-CA-C 108.893 -0.78 . . . . 25.0 108.893 -177.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.47 168.87 20.8 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 110.382 -0.229 . . . . 25.0 110.382 -176.057 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.6 m -124.97 160.09 30.76 Favored 'Isoleucine or valine' 0 C--O 1.251 1.138 0 O-C-N 121.876 -0.515 . . . . 25.0 110.222 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.6 t -73.5 -49.12 28.3 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.692 -1.225 . . . . 25.0 107.692 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -168.94 -160.59 0.28 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 103.854 -2.647 . . . . 25.0 103.854 -177.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -72.82 -0.08 12.41 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 121.291 -0.88 . . . . 25.0 111.987 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -143.63 -157.79 7.31 Favored Glycine 0 C--O 1.241 0.575 0 N-CA-C 108.007 -2.037 . . . . 25.0 108.007 177.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.65 -153.59 0.37 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.184 0.809 . . . . 25.0 113.184 178.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.4 mtt85 -80.72 161.58 24.52 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 113.496 0.924 . . . . 25.0 113.496 -172.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.64 164.58 11.68 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 105.827 -1.916 . . . . 25.0 105.827 171.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -128.77 155.92 44.38 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 121.603 0.716 . . . . 25.0 110.357 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 29.8 tp -132.5 115.92 16.11 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 102.705 -3.072 . . . . 25.0 102.705 169.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -116.7 153.49 32.26 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 112.638 0.607 . . . . 25.0 112.638 -174.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 33.4 t -97.25 149.66 21.8 Favored 'General case' 0 C--O 1.215 -0.721 0 N-CA-C 103.889 -2.634 . . . . 25.0 103.889 168.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -119.35 10.17 11.85 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 124.828 1.33 . . . . 25.0 109.581 -178.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -97.95 152.78 18.89 Favored 'General case' 0 C--O 1.251 1.154 0 CA-C-N 114.291 -1.322 . . . . 25.0 107.504 171.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -142.88 160.4 40.41 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 122.234 1.016 . . . . 25.0 112.537 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -75.18 165.07 25.77 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 106.277 -1.749 . . . . 25.0 106.277 172.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.62 -22.83 67.11 Favored 'General case' 0 C--O 1.248 0.999 0 CA-C-O 122.287 1.042 . . . . 25.0 109.374 176.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -80.27 -6.78 58.47 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.859 -1.064 . . . . 25.0 112.788 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.59 2.53 72.72 Favored Glycine 0 C--O 1.223 -0.58 0 N-CA-C 114.419 0.528 . . . . 25.0 114.419 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.9 mt -72.68 137.17 45.83 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.83 -1.174 . . . . 25.0 107.83 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 88.7 p -140.25 -179.88 6.24 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 109.461 -0.57 . . . . 25.0 109.461 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -122.84 140.2 53.2 Favored 'General case' 0 C--O 1.247 0.951 0 O-C-N 121.926 -0.484 . . . . 25.0 111.717 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -156.97 155.49 31.38 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 107.476 -1.305 . . . . 25.0 107.476 170.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.8 p -148.78 147.07 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 N-CA-C 105.12 -2.178 . . . . 25.0 105.12 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.439 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . . . -115.38 149.64 37.63 Favored 'General case' 0 C--O 1.254 1.305 0 N-CA-C 109.306 -0.627 . . . . 25.0 109.306 -175.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mp -139.15 129.22 25.18 Favored 'General case' 0 C--O 1.205 -1.254 0 N-CA-C 107.522 -1.288 . . . . 25.0 107.522 -175.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.419 ' HG2' ' HA ' ' A' ' 85' ' ' LEU . 6.9 pt-20 -86.33 0.77 53.21 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.347 -0.941 . . . . 25.0 113.058 -177.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -65.17 -17.84 64.17 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 116.033 1.173 . . . . 25.0 116.033 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 38.5 t0 54.4 45.77 26.43 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 122.423 1.106 . . . . 25.0 112.199 -178.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -122.05 43.37 2.88 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 113.993 -1.458 . . . . 25.0 109.418 -174.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -52.63 -37.51 58.58 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 113.995 1.109 . . . . 25.0 113.995 178.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.59 -28.18 63.64 Favored 'General case' 0 C--O 1.248 0.996 0 CA-C-N 118.923 0.783 . . . . 25.0 111.473 -178.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.56 -27.47 34.33 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 121.413 0.625 . . . . 25.0 112.377 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 46.1 mt -66.6 128.58 36.79 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 119.87 -0.732 . . . . 25.0 110.337 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.9 m -131.15 160.93 33.31 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.176 -1.416 . . . . 25.0 107.176 177.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.428 ' H ' ' HA ' ' A' ' 111' ' ' SER . . . -79.51 1.37 26.02 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 107.619 -1.252 . . . . 25.0 107.619 177.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -68.47 -30.8 69.73 Favored 'General case' 0 N--CA 1.437 -1.106 0 O-C-N 123.465 0.478 . . . . 25.0 111.803 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -91.31 -10.41 41.43 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.733 -0.469 . . . . 25.0 109.733 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 26.9 mm -83.75 136.01 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 104.435 -2.432 . . . . 25.0 104.435 175.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.9 p -113.51 126.35 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 O-C-N 120.47 -1.394 . . . . 25.0 110.965 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -153.77 -30.43 0.12 Allowed 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 114.38 -1.282 . . . . 25.0 112.743 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -82.77 69.84 9.64 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 112.849 0.685 . . . . 25.0 112.849 -175.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 54.37 20.77 2.87 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.871 1.063 . . . . 25.0 113.871 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.12 17.95 4.89 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.705 0.802 . . . . 25.0 111.721 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -98.57 131.55 44.69 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.553 0.341 . . . . 25.0 110.976 -174.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.4 -10.33 58.78 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.957 0.725 . . . . 25.0 112.957 -176.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.07 -32.3 72.83 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.221 0.452 . . . . 25.0 112.221 -178.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.71 162.97 26.58 Favored 'General case' 0 C--O 1.247 0.961 0 N-CA-C 111.978 0.362 . . . . 25.0 111.978 -175.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 57.59 -169.81 0.11 Allowed 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 114.034 1.124 . . . . 25.0 114.034 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 90.83 2.18 72.41 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.787 -0.721 . . . . 25.0 113.789 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -102.48 115.29 30.28 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.841 -1.17 . . . . 25.0 107.841 176.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -134.47 161.78 34.09 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.287 -1.005 . . . . 25.0 108.287 -177.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -135.11 27.34 3.16 Favored Glycine 0 C--O 1.242 0.606 0 N-CA-C 110.419 -1.072 . . . . 25.0 110.419 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 47.7 t -70.2 -34.83 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.32 0.648 . . . . 25.0 110.355 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -58.36 133.69 23.32 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 CA-C-O 121.727 0.775 . . . . 25.0 111.735 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 156.81 160.18 9.93 Favored Glycine 0 C--N 1.336 0.564 0 N-CA-C 110.757 -0.937 . . . . 25.0 110.757 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -136.37 152.42 50.62 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 122.382 -0.481 . . . . 25.0 110.031 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 54.5 p -148.71 159.16 44.38 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.239 0.542 . . . . 25.0 110.0 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -179.93 168.77 39.25 Favored Glycine 0 N--CA 1.461 0.318 0 O-C-N 121.677 -0.639 . . . . 25.0 113.717 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -154.23 114.19 2.5 Favored Pre-proline 0 C--O 1.246 0.908 0 N-CA-C 107.767 -1.197 . . . . 25.0 107.767 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -68.84 157.05 63.4 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 117.304 -1.331 . . . . 25.0 112.559 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -117.75 146.67 43.62 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 108.208 -1.034 . . . . 25.0 108.208 177.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -140.15 64.27 25.9 Favored Pre-proline 0 N--CA 1.478 0.969 0 N-CA-C 112.405 0.52 . . . . 25.0 112.405 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.21 161.39 32.26 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 117.579 -1.147 . . . . 25.0 112.616 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 15.2 t -119.17 2.91 11.43 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 116.328 -0.396 . . . . 25.0 110.894 177.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 C--O 1.254 1.307 0 CA-C-O 117.494 -1.241 . . . . 25.0 111.283 178.829 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 121.429 0.633 . . . . 25.0 109.906 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -148.76 113.82 3.7 Favored Pre-proline 0 N--CA 1.477 0.893 0 O-C-N 121.626 -0.671 . . . . 25.0 109.901 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -70.18 147.22 59.7 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 117.65 -1.1 . . . . 25.0 112.653 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.79 36.34 0.22 Allowed Glycine 0 N--CA 1.473 1.107 0 C-N-CA 121.173 -0.537 . . . . 25.0 113.838 -177.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.429 HG12 ' H ' ' A' ' 5' ' ' VAL . 0.9 OUTLIER -50.03 119.6 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 114.119 1.155 . . . . 25.0 114.119 -175.523 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -93.43 8.5 40.29 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 122.176 0.989 . . . . 25.0 108.341 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.92 -152.67 17.71 Favored Glycine 0 C--O 1.22 -0.742 0 CA-C-N 115.865 -0.607 . . . . 25.0 113.993 176.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.6 p 69.13 158.19 0.15 Allowed Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 125.988 1.715 . . . . 25.0 112.048 -174.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -69.7 22.77 0.17 Allowed 'Trans proline' 0 C--N 1.359 1.098 0 N-CA-C 118.803 2.578 . . . . 25.0 118.803 -176.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.07 -25.76 17.07 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.504 0 N-CA-C 114.516 1.302 . . . . 25.0 114.516 -171.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.6 p -146.69 145.76 19.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 CA-C-N 119.644 1.111 . . . . 25.0 112.223 -175.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.2 24.15 41.69 Favored Glycine 0 N--CA 1.466 0.681 0 N-CA-C 118.719 2.247 . . . . 25.0 118.719 172.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.7 t -49.49 -66.11 0.45 Allowed 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 118.641 1.22 . . . . 25.0 112.719 -175.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -86.49 17.83 3.62 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 115.588 1.699 . . . . 25.0 115.588 -167.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.16 168.75 19.07 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 120.821 -1.175 . . . . 25.0 110.927 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -68.9 132.22 46.37 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.233 0.54 . . . . 25.0 110.848 -175.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -123.67 160.46 27.14 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.896 1.443 . . . . 50.0 114.896 -174.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -124.38 99.03 6.01 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 104.492 -2.41 . . . . 25.0 104.492 161.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 87.1 mt -108.44 109.72 21.07 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 111.664 0.246 . . . . 25.0 111.664 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -103.18 117.12 33.81 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.498 -0.556 . . . . 25.0 109.498 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.78 -171.59 46.04 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 117.644 1.818 . . . . 25.0 117.644 -168.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.439 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 81.8 p -87.1 169.02 12.76 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.561 0.744 . . . . 25.0 109.102 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 68.7 mt -86.54 11.28 13.03 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.23 -0.441 . . . . 25.0 111.464 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -112.26 175.78 17.35 Favored Glycine 0 N--CA 1.461 0.357 0 N-CA-C 109.115 -1.594 . . . . 25.0 109.115 177.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.3 t -66.33 140.74 58.12 Favored 'General case' 0 C--O 1.207 -1.143 0 CA-C-N 117.978 0.889 . . . . 25.0 110.745 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.439 ' CD ' ' H ' ' A' ' 22' ' ' THR . 26.2 mt-10 -149.11 156.99 43.03 Favored 'General case' 0 C--O 1.246 0.895 0 C-N-CA 122.917 0.487 . . . . 50.0 110.106 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -89.93 138.23 31.67 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 104.544 -2.391 . . . . 25.0 104.544 161.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.5 mm -126.62 92.98 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 106.042 -1.836 . . . . 25.0 106.042 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 11.0 mp -104.5 120.96 42.46 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 104.652 -2.351 . . . . 25.0 104.652 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.27 -26.39 36.69 Favored Glycine 0 CA--C 1.505 -0.586 0 CA-C-O 119.729 -0.484 . . . . 25.0 112.051 -174.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.6 -149.24 46.49 Favored Glycine 0 C--O 1.249 1.077 0 N-CA-C 110.165 -1.174 . . . . 25.0 110.165 -173.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.49 179.12 40.82 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-O 123.059 1.366 . . . . 25.0 112.475 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.97 164.19 19.97 Favored Glycine 0 C--O 1.248 0.976 0 CA-C-N 114.207 -0.996 . . . . 25.0 114.266 179.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.56 100.02 12.11 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 106.722 -1.584 . . . . 25.0 106.722 176.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -96.83 156.36 16.38 Favored 'General case' 0 C--O 1.214 -0.783 0 C-N-CA 120.207 -0.597 . . . . 50.0 112.148 -170.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -115.61 91.26 3.55 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 106.233 -1.766 . . . . 25.0 106.233 174.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 70.0 mt -97.77 136.19 38.46 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-N 114.024 -1.444 . . . . 25.0 112.613 -172.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -131.64 95.14 3.66 Favored 'General case' 0 C--O 1.252 1.189 0 CA-C-O 121.53 0.681 . . . . 25.0 111.743 -176.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.88 -27.13 69.49 Favored Glycine 0 CA--C 1.521 0.426 0 CA-C-O 119.118 -0.823 . . . . 25.0 113.926 -176.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 48.79 -148.25 0.24 Allowed 'General case' 0 C--O 1.243 0.721 0 C-N-CA 124.405 1.082 . . . . 25.0 111.852 -176.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.91 159.58 34.41 Favored 'General case' 0 C--O 1.25 1.11 0 CA-C-O 121.69 0.757 . . . . 25.0 111.633 -177.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.33 156.64 21.49 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.51 -1.036 . . . . 25.0 110.51 -175.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -86.45 90.15 8.12 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.516 -0.92 . . . . 25.0 108.516 176.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -90.57 160.28 16.02 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.028 -0.987 . . . . 50.0 112.43 -170.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 tp -124.27 99.69 6.34 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.378 -0.971 . . . . 25.0 108.378 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.3 mp -101.83 117.83 35.66 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 116.016 1.858 . . . . 25.0 116.016 -166.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -122.23 101.62 7.63 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.117 -0.947 . . . . 25.0 109.137 174.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.42 -29.17 70.88 Favored Glycine 0 CA--C 1.523 0.585 0 O-C-N 120.141 -1.599 . . . . 25.0 112.769 -177.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.57 -168.08 54.1 Favored Glycine 0 N--CA 1.471 1.029 0 N-CA-C 108.938 -1.665 . . . . 25.0 108.938 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.86 151.89 33.27 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.86 0.689 . . . . 25.0 112.86 -175.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.79 165.98 33.12 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 115.847 1.099 . . . . 25.0 115.847 -175.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.415 ' HD2' ' HA ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -91.03 105.84 18.1 Favored 'General case' 0 C--O 1.212 -0.893 0 N-CA-C 105.667 -1.975 . . . . 25.0 105.667 176.293 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -99.98 151.45 21.33 Favored 'General case' 0 CA--C 1.483 -1.63 0 O-C-N 123.879 0.737 . . . . 50.0 112.093 -168.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -112.03 125.36 53.99 Favored 'General case' 0 C--O 1.211 -0.955 0 N-CA-C 103.374 -2.825 . . . . 25.0 103.374 177.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -149.31 132.68 16.56 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 122.348 1.07 . . . . 25.0 113.27 -174.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 71.5 m -96.77 136.11 37.78 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 106.979 -1.489 . . . . 25.0 106.979 173.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -88.06 -40.94 6.42 Favored Glycine 0 CA--C 1.499 -0.909 0 N-CA-C 110.357 -1.097 . . . . 25.0 110.357 174.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.62 -171.64 54.09 Favored Glycine 0 C--O 1.252 1.228 0 CA-C-O 122.633 1.129 . . . . 25.0 113.402 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -63.01 163.09 10.33 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 121.661 -0.905 . . . . 25.0 110.225 176.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.91 164.52 40.3 Favored Glycine 0 C--O 1.243 0.684 0 CA-C-O 118.554 -1.137 . . . . 25.0 112.514 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.51 113.24 20.11 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.967 -0.753 . . . . 25.0 108.967 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -104.9 154.41 20.11 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 121.541 -0.724 . . . . 50.0 110.576 -177.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.3 m -120.58 129.08 53.61 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 106.271 -1.751 . . . . 25.0 106.271 177.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -115.38 128.7 56.24 Favored 'General case' 0 C--O 1.207 -1.153 0 N-CA-C 104.827 -2.286 . . . . 25.0 104.827 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 61.9 mtt85 -133.41 -29.88 1.35 Allowed 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 113.393 0.886 . . . . 25.0 113.393 174.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 68.23 163.03 0.21 Allowed 'General case' 0 CA--C 1.537 0.459 0 O-C-N 124.794 1.309 . . . . 25.0 110.201 -172.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.22 -41.34 49.58 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.473 1.657 . . . . 25.0 115.473 -165.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 66.5 mt -136.53 170.39 16.14 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 115.217 1.562 . . . . 25.0 115.217 -171.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.09 -28.33 64.5 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.13 -1.396 . . . . 25.0 109.198 168.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -81.29 6.98 12.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.161 -1.381 . . . . 25.0 114.423 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -111.32 152.96 26.64 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.119 -1.613 . . . . 25.0 113.237 -174.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.6 t 41.27 50.77 3.48 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 117.897 2.554 . . . . 25.0 117.897 -178.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 24.5 p-80 -125.43 161.28 27.43 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 114.411 -1.268 . . . . 25.0 112.237 -176.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -109.37 138.72 45.29 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 104.859 -2.275 . . . . 25.0 104.859 174.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.4 p -122.6 172.14 5.66 Favored Pre-proline 0 C--N 1.322 -0.629 0 O-C-N 124.129 0.893 . . . . 25.0 109.975 -178.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -61.94 -23.97 76.45 Favored 'Trans proline' 0 C--O 1.254 1.315 0 C-N-CA 117.707 -1.062 . . . . 25.0 112.639 174.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 75.1 mt -78.22 -29.03 48.07 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.339 0.496 . . . . 25.0 112.339 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.23 -179.6 32.88 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.08 -1.208 . . . . 25.0 110.08 -172.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.5 t -98.12 151.42 20.41 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.106 1.15 . . . . 25.0 114.106 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.415 ' HA ' ' HD2' ' A' ' 52' ' ' ARG . 72.7 m-85 -135.47 29.73 3.26 Favored 'General case' 0 C--O 1.251 1.166 0 CA-C-N 114.419 -1.264 . . . . 25.0 108.889 175.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.53 146.8 42.77 Favored Glycine 0 C--N 1.335 0.476 0 O-C-N 124.102 0.876 . . . . 25.0 112.138 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -84.2 169.46 14.76 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 122.543 -0.387 . . . . 50.0 111.647 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -128.78 108.22 10.28 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 110.166 -0.309 . . . . 25.0 110.166 -176.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.5 mt -98.13 135.67 31.91 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 N-CA-C 107.618 -1.253 . . . . 25.0 107.618 -177.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.6 mt -84.83 -41.19 16.3 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 115.723 1.749 . . . . 25.0 115.723 -171.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.9 p-10 -137.22 39.07 2.51 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.991 1.108 . . . . 25.0 113.991 -172.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -58.24 132.89 54.94 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.126 -0.943 . . . . 25.0 110.655 -177.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -113.7 106.25 54.03 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 108.375 -0.972 . . . . 25.0 108.375 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.1 -16.64 56.08 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 N-CA-C 116.338 1.63 . . . . 25.0 116.338 -173.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.7 t -88.33 -29.11 20.57 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.895 0.378 . . . . 25.0 111.374 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -93.44 -48.93 6.17 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.609 0.719 . . . . 25.0 111.575 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -96.56 165.5 12.13 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 114.169 -1.378 . . . . 50.0 110.92 -159.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -142.18 151.54 42.3 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 113.921 1.082 . . . . 25.0 113.921 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 75.3 mt -126.51 123.54 63.43 Favored 'Isoleucine or valine' 0 C--O 1.247 0.969 0 N-CA-C 107.55 -1.278 . . . . 25.0 107.55 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -81.58 147.35 29.65 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 122.257 1.027 . . . . 25.0 108.363 173.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -155.63 -12.02 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 115.232 -0.895 . . . . 25.0 112.45 -179.028 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.6 t -62.67 -38.34 89.95 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 120.738 -1.226 . . . . 25.0 110.237 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.65 -21.0 56.05 Favored 'General case' 0 CA--C 1.555 1.149 0 N-CA-C 114.812 1.412 . . . . 25.0 114.812 -176.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.39 0.63 2.81 Favored 'General case' 0 CA--C 1.556 1.176 0 N-CA-C 117.61 2.448 . . . . 25.0 117.61 -170.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -143.32 -67.05 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 119.021 0.828 . . . . 25.0 115.012 177.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -160.11 164.92 32.64 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.99 0.9 . . . . 25.0 110.992 -174.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.8 t -119.48 -26.76 5.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.773 -1.103 . . . . 25.0 110.521 174.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -93.95 120.68 6.39 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 118.718 -1.046 . . . . 25.0 112.699 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -65.93 157.17 31.37 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.442 1.621 . . . . 25.0 112.356 178.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -90.7 -172.03 43.88 Favored Glycine 0 C--N 1.32 -0.332 0 CA-C-O 118.88 -0.956 . . . . 25.0 112.263 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -79.54 83.1 5.57 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 118.646 1.223 . . . . 25.0 112.111 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.06 -175.43 17.96 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 108.348 -1.901 . . . . 25.0 108.348 168.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -127.05 160.7 30.34 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.971 1.385 . . . . 25.0 111.879 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 51.83 47.24 25.18 Favored 'General case' 0 C--O 1.266 1.951 0 N-CA-C 114.946 1.462 . . . . 25.0 114.946 -176.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.26 48.69 36.96 Favored Glycine 0 N--CA 1.48 1.591 0 N-CA-C 109.253 -1.539 . . . . 25.0 109.253 176.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.5 t -148.33 173.84 12.64 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 117.838 0.819 . . . . 25.0 111.905 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.7 mp -105.36 168.57 8.99 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 101.816 -3.402 . . . . 25.0 101.816 173.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.55 135.48 39.27 Favored 'General case' 0 C--O 1.254 1.31 0 C-N-CA 117.915 -1.514 . . . . 25.0 108.009 -176.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.7 m -102.35 163.58 3.42 Favored 'Isoleucine or valine' 0 C--O 1.248 0.997 0 CA-C-O 118.524 -0.75 . . . . 25.0 109.165 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.0 p -149.78 163.41 38.05 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-N 118.514 0.597 . . . . 25.0 112.247 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 28.0 m -115.89 160.82 15.05 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 N-CA-C 105.787 -1.931 . . . . 25.0 105.787 176.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.9 t -78.76 -42.67 27.42 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 107.055 -1.461 . . . . 25.0 107.055 176.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -168.31 -169.13 1.03 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 103.78 -2.674 . . . . 25.0 103.78 -175.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -59.76 -24.78 64.35 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.662 0.601 . . . . 25.0 112.534 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -126.9 -147.38 6.72 Favored Glycine 0 C--O 1.252 1.231 0 N-CA-C 111.114 -0.795 . . . . 25.0 111.114 174.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 53.72 -142.69 0.78 Allowed 'General case' 0 C--O 1.246 0.872 0 N-CA-C 113.891 1.071 . . . . 25.0 113.891 -179.012 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.7 mtt85 -91.39 162.83 14.42 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 114.716 1.376 . . . . 25.0 114.716 -170.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.5 p -113.08 162.48 15.88 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 104.73 -2.322 . . . . 25.0 104.73 176.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -132.7 156.14 47.55 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 109.245 -0.65 . . . . 25.0 109.245 -175.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 33.6 tp -135.16 127.66 30.6 Favored 'General case' 0 C--O 1.251 1.17 0 N-CA-C 102.695 -3.076 . . . . 25.0 102.695 171.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -128.65 159.6 35.07 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 115.787 -0.642 . . . . 25.0 112.673 -170.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.2 t -94.64 149.77 20.91 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.295 -1.372 . . . . 25.0 107.295 171.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -119.82 24.15 10.7 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 106.93 -1.507 . . . . 25.0 106.93 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -125.91 135.88 52.41 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 106.364 -1.717 . . . . 25.0 106.364 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -139.39 156.31 47.07 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 122.558 1.17 . . . . 25.0 109.672 -172.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -74.08 159.35 32.75 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-N 114.782 -1.099 . . . . 25.0 109.225 173.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.29 -20.64 66.5 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.733 -0.604 . . . . 25.0 109.789 173.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -69.89 -12.27 61.49 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 118.675 -0.678 . . . . 25.0 112.502 175.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.13 22.93 46.75 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 111.51 -0.636 . . . . 25.0 111.51 -177.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.7 mt -100.18 141.01 33.6 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 107.636 -1.246 . . . . 25.0 107.636 177.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 59.7 p -147.61 171.43 15.61 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 106.789 -1.56 . . . . 25.0 106.789 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -115.76 138.38 51.18 Favored 'General case' 0 C--O 1.257 1.453 0 CA-C-N 118.667 0.667 . . . . 25.0 112.624 -173.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -152.63 153.21 32.87 Favored 'General case' 0 C--O 1.248 1.02 0 CA-C-O 121.717 0.77 . . . . 25.0 110.088 172.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.9 p -145.03 143.79 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.784 0 N-CA-C 105.858 -1.904 . . . . 25.0 105.858 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -107.86 142.69 37.55 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.41 -1.329 . . . . 25.0 107.41 -176.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.6 mp -131.13 137.13 48.9 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.489 -1.3 . . . . 25.0 107.489 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -109.71 7.29 24.27 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 121.251 1.841 . . . . 25.0 115.858 -176.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -76.9 4.94 51.45 Favored Glycine 0 N--CA 1.469 0.894 0 N-CA-C 116.322 1.289 . . . . 25.0 116.322 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 46.6 t0 51.34 51.94 15.83 Favored 'General case' 0 C--O 1.256 1.43 0 C-N-CA 124.046 0.939 . . . . 25.0 111.875 176.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -129.84 29.83 4.94 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 124.849 1.26 . . . . 25.0 110.714 -174.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.85 -31.98 70.26 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 119.275 -0.97 . . . . 25.0 111.52 176.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.6 -20.95 66.12 Favored 'General case' 0 C--O 1.251 1.171 0 CA-C-N 118.777 0.717 . . . . 25.0 111.349 177.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -95.67 -27.77 15.13 Favored 'General case' 0 C--O 1.259 1.603 0 N-CA-C 114.048 1.129 . . . . 25.0 114.048 176.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 74.6 mt -58.39 137.36 57.31 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 114.126 1.158 . . . . 25.0 114.126 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 62.7 m -137.15 167.15 22.1 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 105.642 -1.985 . . . . 25.0 105.642 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -77.45 -2.88 37.52 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 120.458 -1.401 . . . . 25.0 111.324 174.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -68.42 -29.09 67.68 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.777 -0.577 . . . . 25.0 112.353 -176.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -87.02 -2.48 58.66 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.882 -0.599 . . . . 25.0 111.209 174.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 36.7 mm -96.64 127.32 48.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 104.679 -2.341 . . . . 25.0 104.679 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.1 p -105.42 104.4 16.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 124.063 1.887 . . . . 25.0 114.78 -174.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -141.81 -1.1 1.29 Allowed 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 112.625 -2.079 . . . . 25.0 111.091 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -80.91 53.5 1.97 Allowed 'General case' 0 CA--C 1.549 0.905 0 O-C-N 121.151 -0.968 . . . . 25.0 112.603 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 58.85 18.07 5.8 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 114.434 1.272 . . . . 25.0 114.434 -175.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.58 -39.88 0.39 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 118.264 2.69 . . . . 25.0 118.264 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -70.81 150.01 46.27 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-O 121.388 0.613 . . . . 25.0 110.622 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -80.3 19.93 0.72 Allowed 'General case' 0 C--O 1.218 -0.564 0 C-N-CA 124.09 0.956 . . . . 25.0 112.32 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.74 -21.78 66.84 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 115.487 1.662 . . . . 25.0 115.487 -177.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -140.28 -160.59 1.09 Allowed 'General case' 0 CA--C 1.547 0.862 0 CA-C-O 121.567 0.699 . . . . 25.0 111.37 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 64.21 -171.11 0.18 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 115.359 1.614 . . . . 25.0 115.359 177.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 81.38 24.38 56.87 Favored Glycine 0 C--O 1.225 -0.456 0 CA-C-O 122.985 1.325 . . . . 25.0 110.515 -175.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -98.7 114.59 27.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.444 -0.878 . . . . 25.0 109.165 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -123.68 143.22 50.39 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 108.532 -0.914 . . . . 25.0 108.532 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -111.07 16.83 27.45 Favored Glycine 0 C--O 1.225 -0.432 0 N-CA-C 112.155 -0.378 . . . . 25.0 112.155 -177.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 49.0 t -68.59 -37.33 77.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.697 -0.252 . . . . 25.0 111.297 -174.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.0 133.31 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-O 121.599 0.714 . . . . 25.0 111.57 -176.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 149.04 159.01 8.33 Favored Glycine 0 N--CA 1.463 0.435 0 N-CA-C 110.058 -1.217 . . . . 25.0 110.058 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -151.69 153.04 33.6 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-O 122.285 1.04 . . . . 25.0 111.338 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 92.6 p -165.34 163.11 19.95 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 105.074 -2.195 . . . . 25.0 105.074 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 174.7 159.84 21.7 Favored Glycine 0 C--O 1.245 0.803 0 C-N-CA 119.963 -1.113 . . . . 25.0 114.241 174.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -116.86 110.75 41.58 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 109.047 -0.724 . . . . 25.0 109.047 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.37 169.5 21.83 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 116.328 -1.981 . . . . 25.0 114.335 -175.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -124.57 140.95 52.47 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.368 -0.975 . . . . 25.0 108.368 175.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -143.66 73.47 17.1 Favored Pre-proline 0 N--CA 1.487 1.383 0 CA-C-O 121.11 0.481 . . . . 25.0 111.75 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -67.99 152.89 76.36 Favored 'Trans proline' 0 C--O 1.242 0.682 0 N-CA-C 114.062 0.755 . . . . 25.0 114.062 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.6 t -124.05 11.05 8.86 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.712 -0.676 . . . . 25.0 109.363 -176.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.257 1.457 0 N-CA-C 109.157 -0.683 . . . . 25.0 109.157 178.717 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.526 3.327 0 N-CA-C 110.156 -0.313 . . . . 25.0 110.156 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -140.86 100.12 6.63 Favored Pre-proline 0 N--CA 1.486 1.358 0 O-C-N 121.788 -0.57 . . . . 25.0 109.512 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -71.16 142.9 42.88 Favored 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 117.02 -1.52 . . . . 25.0 114.297 -177.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -163.83 49.76 0.3 Allowed Glycine 0 N--CA 1.467 0.759 0 N-CA-C 108.467 -1.853 . . . . 25.0 108.467 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.447 HG22 ' H ' ' A' ' 7' ' ' GLY . 9.2 p -54.58 128.87 15.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-O 122.918 1.342 . . . . 25.0 110.495 -175.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -101.19 -1.63 33.36 Favored 'General case' 0 C--O 1.252 1.226 0 O-C-N 121.289 -0.882 . . . . 25.0 110.389 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.447 ' H ' HG22 ' A' ' 5' ' ' VAL . . . -86.48 -142.55 6.99 Favored Glycine 0 C--O 1.241 0.539 0 CA-C-N 116.421 -0.354 . . . . 25.0 112.79 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.0 p 68.43 157.75 0.15 Allowed Pre-proline 0 N--CA 1.486 1.353 0 C-N-CA 125.811 1.644 . . . . 25.0 111.739 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.577 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 25.5 Cg_exo -71.1 -2.35 10.97 Favored 'Trans proline' 0 C--N 1.354 0.86 0 N-CA-C 116.046 1.518 . . . . 25.0 116.046 -172.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.6 p -65.04 -13.59 15.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 115.974 1.842 . . . . 25.0 115.974 -171.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.3 p -139.69 134.94 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 114.693 1.368 . . . . 25.0 114.693 -177.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.6 13.18 83.21 Favored Glycine 0 N--CA 1.466 0.665 0 N-CA-C 117.026 1.57 . . . . 25.0 117.026 174.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.7 t -47.12 -49.74 21.5 Favored 'General case' 0 C--O 1.209 -1.028 0 CA-C-N 118.98 1.39 . . . . 25.0 113.279 -168.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -78.61 6.91 7.68 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 116.85 2.167 . . . . 25.0 116.85 -174.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 pp -142.57 169.52 17.42 Favored 'General case' 0 C--O 1.203 -1.352 0 O-C-N 121.277 -0.889 . . . . 25.0 111.428 -177.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -61.5 128.47 36.44 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 113.139 0.792 . . . . 25.0 113.139 -174.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -130.08 167.15 18.78 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 114.081 1.141 . . . . 50.0 114.081 -175.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -125.34 107.73 10.98 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 104.008 -2.59 . . . . 25.0 104.008 169.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.3 mt -122.66 114.43 20.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 119.069 0.85 . . . . 25.0 110.143 -175.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -108.22 121.94 45.91 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.618 -0.882 . . . . 25.0 108.618 173.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.2 -177.89 47.33 Favored Glycine 0 N--CA 1.471 1.026 0 N-CA-C 115.063 0.785 . . . . 25.0 115.063 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.4 p -81.02 178.11 8.63 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.021 0.928 . . . . 25.0 111.229 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 79.7 mt -90.31 13.55 15.08 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.193 0.52 . . . . 25.0 110.103 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.77 -177.09 20.64 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.455 -0.658 . . . . 25.0 111.455 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.8 t -75.38 129.4 37.29 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.128 1.159 . . . . 25.0 114.128 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -145.01 159.82 42.34 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.045 -1.034 . . . . 50.0 112.998 -174.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -98.66 120.97 39.99 Favored 'General case' 0 C--O 1.26 1.608 0 N-CA-C 105.498 -2.038 . . . . 25.0 105.498 164.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.1 mm -115.98 107.88 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 N-CA-C 105.291 -2.115 . . . . 25.0 105.291 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.577 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 9.2 mp -115.89 132.11 56.74 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 105.084 -2.191 . . . . 25.0 105.084 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.89 -33.94 9.4 Favored Glycine 0 CA--C 1.483 -1.962 0 N-CA-C 114.72 0.648 . . . . 25.0 114.72 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 72.94 -145.59 36.81 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 111.793 -0.523 . . . . 25.0 111.793 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.39 163.13 52.76 Favored Glycine 0 N--CA 1.438 -1.185 0 CA-C-O 121.783 0.657 . . . . 25.0 113.569 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.24 166.76 41.44 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.216 -0.754 . . . . 25.0 111.216 177.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.38 112.08 20.02 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.045 -1.094 . . . . 25.0 108.045 176.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -107.09 157.7 17.63 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 113.662 0.986 . . . . 50.0 113.662 -172.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -117.93 87.17 2.66 Favored 'General case' 0 C--O 1.255 1.386 0 N-CA-C 106.668 -1.604 . . . . 25.0 106.668 178.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 53.6 mt -96.34 137.99 34.61 Favored 'General case' 0 C--O 1.207 -1.141 0 CA-C-N 115.572 -0.74 . . . . 25.0 112.07 -174.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -131.34 112.77 13.04 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 107.117 -1.438 . . . . 25.0 107.117 177.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -92.14 -22.68 29.3 Favored Glycine 0 CA--C 1.507 -0.453 0 CA-C-O 118.877 -0.957 . . . . 25.0 115.455 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 51.12 -147.47 0.41 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.127 0.971 . . . . 25.0 113.303 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.34 165.03 19.51 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 123.313 1.53 . . . . 25.0 112.326 -177.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.11 157.12 32.79 Favored Glycine 0 C--O 1.246 0.869 0 CA-C-N 113.876 -1.511 . . . . 25.0 111.253 -176.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.2 m-20 -78.29 114.81 17.53 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 103.853 -2.647 . . . . 25.0 103.853 177.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -119.78 160.13 23.2 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.986 -0.746 . . . . 50.0 108.986 -172.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.0 mp -111.12 124.56 52.42 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 104.31 -2.478 . . . . 25.0 104.31 171.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.59 100.89 7.26 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 121.875 -0.516 . . . . 25.0 111.991 -175.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -117.74 103.73 10.28 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.971 -1.122 . . . . 25.0 107.971 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.86 -24.53 68.42 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 116.88 1.512 . . . . 25.0 116.88 -177.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.39 -168.09 51.28 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 118.371 -1.238 . . . . 25.0 111.036 -178.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.41 153.86 3.78 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.55 1.315 . . . . 25.0 114.55 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.03 171.78 47.82 Favored Glycine 0 CA--C 1.502 -0.74 0 O-C-N 124.6 1.187 . . . . 25.0 110.406 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.08 156.18 27.18 Favored 'General case' 0 C--O 1.203 -1.35 1 N-CA-C 99.922 -4.103 . . . . 25.0 99.922 173.258 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -144.77 156.61 44.14 Favored 'General case' 0 C--O 1.247 0.948 0 C-N-CA 120.437 -0.505 . . . . 50.0 110.821 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -119.91 121.38 38.88 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 103.33 -2.841 . . . . 25.0 103.33 174.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.7 130.72 26.33 Favored 'General case' 0 C--O 1.211 -0.921 0 N-CA-C 113.916 1.08 . . . . 25.0 113.916 -171.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.29 126.84 52.55 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.157 -0.965 . . . . 25.0 108.816 -178.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -80.85 -48.43 6.14 Favored Glycine 0 C--O 1.247 0.916 0 C-N-CA 119.94 -1.124 . . . . 25.0 112.624 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.63 -167.8 53.22 Favored Glycine 0 CA--C 1.535 1.339 0 O-C-N 122.414 -0.462 . . . . 25.0 114.244 -177.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -67.12 159.77 28.17 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 121.274 -1.133 . . . . 25.0 111.086 177.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.21 156.99 33.12 Favored Glycine 0 C--O 1.242 0.599 0 N-CA-C 110.538 -1.025 . . . . 25.0 110.538 -177.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.81 98.64 5.64 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 122.121 0.962 . . . . 25.0 110.853 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -89.21 155.94 19.09 Favored 'General case' 0 C--O 1.252 1.21 0 CA-C-N 114.391 -1.277 . . . . 50.0 112.587 -174.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 46.8 m -128.12 125.23 38.76 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.156 0.503 . . . . 25.0 110.025 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -113.32 103.16 11.04 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.914 -0.772 . . . . 25.0 108.914 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 24.6 mmt85 -105.0 -30.32 9.86 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-N 115.916 -0.584 . . . . 25.0 110.052 -178.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 64.75 165.79 0.16 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.88 1.272 . . . . 25.0 110.437 -171.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -87.13 -38.77 16.15 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.862 0.69 . . . . 25.0 112.862 -168.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.1 mt -136.03 161.6 35.23 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 122.089 0.947 . . . . 25.0 111.538 -173.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.93 -25.68 63.67 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 114.894 -1.048 . . . . 25.0 109.051 172.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -78.06 3.09 15.81 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.389 -1.278 . . . . 25.0 114.171 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -95.57 148.52 22.42 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 115.386 1.625 . . . . 25.0 115.386 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.6 t 53.23 39.41 29.67 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.871 1.434 . . . . 25.0 114.871 173.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 27.2 p-80 -114.7 163.67 15.12 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.326 -0.852 . . . . 25.0 112.737 -175.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -110.49 142.89 41.63 Favored 'General case' 0 C--O 1.208 -1.097 0 N-CA-C 103.564 -2.754 . . . . 25.0 103.564 173.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 97.5 p -135.32 170.07 12.09 Favored Pre-proline 0 CA--C 1.512 -0.506 0 N-CA-C 107.039 -1.467 . . . . 25.0 107.039 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -62.48 -18.78 65.07 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 CA-C-N 119.385 0.816 . . . . 25.0 113.32 173.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.4 mt -77.82 -24.29 48.77 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.304 0.573 . . . . 25.0 111.822 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 144.68 -176.95 23.52 Favored Glycine 0 C--O 1.25 1.117 0 N-CA-C 110.155 -1.178 . . . . 25.0 110.155 -178.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.4 t -84.13 147.29 27.42 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 122.788 1.28 . . . . 25.0 112.193 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -133.94 27.32 3.91 Favored 'General case' 0 C--O 1.256 1.409 0 N-CA-C 105.731 -1.952 . . . . 25.0 105.731 169.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.16 143.95 42.08 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 114.323 -1.308 . . . . 25.0 110.545 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -87.65 166.69 14.5 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.493 -0.928 . . . . 50.0 108.493 -174.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -130.06 117.43 19.99 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 107.466 -1.309 . . . . 25.0 107.466 -175.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.0 mt -100.42 135.83 34.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 106.906 -1.516 . . . . 25.0 106.906 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.413 ' HA ' ' HG2' ' A' ' 142' ' ' GLU . 92.6 mt -79.49 -55.64 4.9 Favored 'General case' 0 C--O 1.217 -0.608 0 C-N-CA 124.037 0.935 . . . . 25.0 112.938 -173.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 -132.12 51.07 2.18 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-O 122.749 1.262 . . . . 25.0 113.309 -175.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -61.76 143.52 56.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.773 -1.103 . . . . 25.0 108.933 175.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -125.11 107.06 28.09 Favored Pre-proline 0 CA--C 1.505 -0.756 0 N-CA-C 107.392 -1.336 . . . . 25.0 107.392 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.37 -9.68 26.42 Favored 'Trans proline' 0 CA--C 1.555 1.552 0 N-CA-C 117.538 2.092 . . . . 25.0 117.538 -172.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.6 t -76.76 -37.24 56.25 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.603 -0.888 . . . . 25.0 108.603 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -111.37 -33.71 6.33 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 115.522 1.675 . . . . 25.0 115.522 -171.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -90.36 152.0 21.2 Favored 'General case' 0 C--O 1.212 -0.869 0 CA-C-N 117.908 0.322 . . . . 50.0 110.429 -170.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -129.34 141.97 50.94 Favored 'General case' 0 C--O 1.26 1.623 0 CA-C-O 119.141 -0.456 . . . . 25.0 110.126 -174.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 77.0 mt -125.52 133.12 69.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.277 -0.638 . . . . 25.0 109.277 178.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.55 141.59 28.42 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.884 -0.784 . . . . 25.0 108.884 172.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.6 p -139.65 -4.66 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.096 -0.956 . . . . 25.0 112.193 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.3 t -73.17 -31.46 64.25 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.962 -0.755 . . . . 25.0 108.962 -177.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.85 -36.73 80.84 Favored 'General case' 0 C--O 1.254 1.298 0 CA-C-N 115.641 -0.709 . . . . 25.0 112.713 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.79 -29.63 8.98 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 117.354 2.353 . . . . 25.0 117.354 -170.073 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -124.26 -72.44 0.23 Allowed Glycine 0 CA--C 1.5 -0.87 0 N-CA-C 117.931 1.932 . . . . 25.0 117.931 -168.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -154.61 172.76 17.33 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 109.705 -0.48 . . . . 25.0 109.705 -167.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.9 t -128.0 -20.26 3.85 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 112.065 0.394 . . . . 25.0 112.065 174.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -97.59 126.95 9.05 Favored Glycine 0 N--CA 1.488 2.136 0 O-C-N 121.421 -0.799 . . . . 25.0 112.703 176.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.63 151.14 47.94 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.618 0.599 . . . . 25.0 112.618 178.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -88.46 -173.26 47.1 Favored Glycine 0 C--O 1.223 -0.563 0 N-CA-C 114.771 0.668 . . . . 25.0 114.771 -175.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -76.11 82.36 2.94 Favored 'General case' 0 C--O 1.258 1.505 0 CA-C-N 118.919 1.36 . . . . 25.0 110.874 -178.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -115.62 -172.85 17.18 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 109.214 -1.554 . . . . 25.0 109.214 174.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -143.03 168.35 19.92 Favored 'General case' 0 C--O 1.241 0.632 0 O-C-N 121.815 -0.815 . . . . 25.0 110.301 175.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 58.38 32.11 21.71 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.776 1.23 . . . . 25.0 113.76 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 80.54 23.41 60.44 Favored Glycine 0 C--N 1.316 -0.581 0 CA-C-O 118.863 -0.965 . . . . 25.0 111.55 176.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.2 t -132.79 169.65 16.41 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 119.04 1.42 . . . . 25.0 109.671 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.4 mp -88.6 163.46 15.83 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 103.302 -2.851 . . . . 25.0 103.302 171.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.42 122.55 19.19 Favored 'General case' 0 C--O 1.257 1.468 0 C-N-CA 119.081 -1.047 . . . . 25.0 111.141 -176.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.9 m -90.75 160.73 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 107.032 -1.47 . . . . 25.0 107.032 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 60.0 p -147.81 166.28 28.04 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 123.918 0.761 . . . . 25.0 109.45 -177.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 22.0 m -117.64 166.81 11.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 107.629 -1.248 . . . . 25.0 107.629 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.8 t -74.66 -55.08 6.27 Favored 'General case' 0 C--O 1.216 -0.69 0 N-CA-C 106.828 -1.545 . . . . 25.0 106.828 169.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -159.6 -158.34 0.65 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 105.216 -2.142 . . . . 25.0 105.216 -176.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -61.15 -33.36 73.29 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 120.153 -0.619 . . . . 25.0 109.793 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -119.34 -148.51 8.3 Favored Glycine 0 C--O 1.244 0.77 0 N-CA-C 109.647 -1.381 . . . . 25.0 109.647 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.89 -144.18 0.53 Allowed 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 113.893 1.072 . . . . 25.0 113.893 177.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.9 mtt85 -82.33 167.29 18.71 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.994 0.902 . . . . 25.0 112.704 -171.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.86 161.43 18.25 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 105.524 -2.028 . . . . 25.0 105.524 171.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.431 ' CE2' ' HB2' ' A' ' 140' ' ' ALA . 31.8 m-85 -137.01 145.9 44.66 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 108.704 -0.85 . . . . 25.0 108.704 -177.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 43.0 tp -125.15 125.95 44.49 Favored 'General case' 0 C--O 1.257 1.499 0 N-CA-C 103.427 -2.805 . . . . 25.0 103.427 177.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -121.77 154.75 36.54 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.262 -0.881 . . . . 25.0 109.379 -173.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 37.6 t -99.47 155.42 17.57 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 106.023 -1.843 . . . . 25.0 106.023 169.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -122.38 13.71 10.29 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.834 0.35 . . . . 25.0 111.116 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -106.63 132.49 52.56 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 106.646 -1.612 . . . . 25.0 106.646 171.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -128.13 153.21 47.1 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-O 122.699 1.238 . . . . 25.0 109.08 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -79.51 165.5 22.94 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.692 -1.14 . . . . 25.0 111.198 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.94 -34.31 67.87 Favored 'General case' 0 C--O 1.21 -0.978 0 CA-C-O 122.218 1.009 . . . . 25.0 109.024 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -72.46 -2.34 19.17 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 115.25 1.574 . . . . 25.0 115.25 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.87 7.82 85.14 Favored Glycine 0 N--CA 1.471 1.012 0 CA-C-O 122.353 0.974 . . . . 25.0 113.15 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 41.3 mt -84.32 139.28 32.4 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.436 -1.038 . . . . 25.0 109.798 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 95.2 p -147.81 -179.55 6.98 Favored 'General case' 0 C--O 1.249 1.066 0 N-CA-C 107.351 -1.352 . . . . 25.0 107.351 -177.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -119.47 136.52 54.28 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.608 -0.837 . . . . 25.0 112.955 -178.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -147.74 148.7 31.26 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.876 -1.157 . . . . 25.0 107.876 167.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.3 p -145.33 148.28 17.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 105.381 -2.081 . . . . 25.0 105.381 175.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.431 ' HB2' ' CE2' ' A' ' 124' ' ' TYR . . . -108.44 148.13 30.62 Favored 'General case' 0 C--O 1.264 1.861 0 N-CA-C 108.593 -0.892 . . . . 25.0 108.593 -179.096 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.8 mp -139.0 124.07 18.95 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 105.067 -2.197 . . . . 25.0 105.067 -177.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.413 ' HG2' ' HA ' ' A' ' 85' ' ' LEU . 17.9 pt-20 -103.99 9.22 36.66 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 120.832 1.651 . . . . 25.0 113.625 -171.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -69.38 -16.34 71.31 Favored Glycine 0 N--CA 1.459 0.176 0 C-N-CA 120.515 -0.85 . . . . 25.0 112.805 175.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 31.2 t0 58.01 58.33 3.63 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 122.039 0.924 . . . . 25.0 111.982 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -124.26 42.02 3.35 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.394 -1.276 . . . . 25.0 109.229 -177.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.51 -34.48 72.66 Favored 'General case' 0 C--O 1.206 -1.234 0 N-CA-C 113.466 0.913 . . . . 25.0 113.466 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.49 -23.75 62.73 Favored 'General case' 0 C--O 1.254 1.293 0 CA-C-N 119.358 0.981 . . . . 25.0 112.067 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -89.84 -25.41 21.05 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 113.75 1.019 . . . . 25.0 113.75 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 11.8 mt -63.33 126.41 27.36 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.196 -0.911 . . . . 25.0 111.108 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 39.8 m -135.06 157.62 46.46 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 107.633 -1.247 . . . . 25.0 107.633 174.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.08 -2.56 24.92 Favored 'General case' 0 C--N 1.349 0.551 0 N-CA-C 112.656 0.613 . . . . 25.0 112.656 -176.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.27 -30.73 71.63 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.462 0.649 . . . . 25.0 110.115 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -90.22 0.67 57.09 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 112.619 0.6 . . . . 25.0 112.619 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 34.7 mm -105.33 122.87 59.17 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 N-CA-C 103.985 -2.598 . . . . 25.0 103.985 175.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 14.8 p -105.64 119.98 55.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 O-C-N 120.885 -1.134 . . . . 25.0 113.611 -176.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -148.84 18.51 1.0 Allowed 'General case' 0 C--O 1.243 0.759 0 CA-C-N 112.757 -2.02 . . . . 25.0 108.465 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -102.47 41.89 1.19 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.729 0.776 . . . . 25.0 111.187 -175.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 55.22 25.79 7.71 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 114.431 1.271 . . . . 25.0 114.431 -173.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.8 m 64.75 -10.63 0.15 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.581 1.696 . . . . 25.0 115.581 176.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -72.35 139.98 48.21 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.761 -1.212 . . . . 25.0 109.389 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -91.4 4.78 51.62 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.748 -0.66 . . . . 25.0 110.465 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.03 16.66 0.12 Allowed 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.639 0.776 . . . . 25.0 112.994 177.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -144.02 -158.32 0.87 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 107.913 -1.143 . . . . 25.0 107.913 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 60.58 178.69 0.1 Allowed 'General case' 0 CA--C 1.555 1.144 0 N-CA-C 114.333 1.234 . . . . 25.0 114.333 176.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.74 24.17 75.02 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 115.876 -0.602 . . . . 25.0 112.898 -176.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -91.26 114.72 27.32 Favored 'General case' 0 C--N 1.316 -0.858 0 O-C-N 122.399 -0.471 . . . . 25.0 112.168 -175.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.48 144.08 48.9 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.309 0.576 . . . . 25.0 109.624 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -145.92 33.55 1.5 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.894 -0.882 . . . . 25.0 110.894 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.3 t -93.85 -29.79 4.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 113.288 0.847 . . . . 25.0 113.288 -172.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.01 132.82 27.86 Favored 'Isoleucine or valine' 0 C--O 1.248 0.98 0 CA-C-N 115.337 -0.847 . . . . 25.0 112.229 -174.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 168.58 159.61 14.61 Favored Glycine 0 N--CA 1.48 1.597 0 N-CA-C 110.227 -1.149 . . . . 25.0 110.227 175.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -147.68 146.71 29.39 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 119.264 1.532 . . . . 25.0 112.161 -176.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 93.1 p -155.22 174.71 14.82 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 106.217 -1.771 . . . . 25.0 106.217 177.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -177.52 167.21 38.11 Favored Glycine 0 C--N 1.309 -0.936 0 C-N-CA 120.104 -1.046 . . . . 25.0 114.854 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 11.9 tp-100 -146.12 81.03 9.93 Favored Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 108.229 -1.026 . . . . 25.0 108.229 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -70.6 151.66 64.41 Favored 'Trans proline' 0 CA--C 1.509 -0.736 0 C-N-CA 121.054 1.17 . . . . 25.0 113.071 -173.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -107.38 147.32 30.51 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.413 -0.812 . . . . 25.0 111.004 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -144.76 75.57 14.45 Favored Pre-proline 0 C--N 1.312 -1.045 0 O-C-N 124.191 0.932 . . . . 25.0 110.414 177.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -72.97 169.62 21.74 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 121.587 1.525 . . . . 25.0 113.255 -175.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.5 t -120.02 2.46 10.97 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 116.417 -0.356 . . . . 25.0 110.358 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 C--O 1.249 1.059 0 CA-C-O 116.707 -1.616 . . . . 25.0 110.817 -178.605 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 110.038 -0.356 . . . . 25.0 110.038 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -139.99 118.94 8.72 Favored Pre-proline 0 C--N 1.317 -0.834 0 O-C-N 123.703 0.627 . . . . 25.0 111.061 -178.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.03 151.96 56.48 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 117.256 -1.363 . . . . 25.0 113.877 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.79 59.69 0.03 OUTLIER Glycine 0 CA--C 1.524 0.612 0 C-N-CA 121.052 -0.594 . . . . 25.0 111.816 -176.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.8 p -63.9 132.82 29.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 121.734 0.778 . . . . 25.0 110.05 -173.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -91.02 -15.4 29.68 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 119.622 -0.831 . . . . 25.0 110.789 -178.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.28 -147.13 3.87 Favored Glycine 0 C--O 1.207 -1.55 0 N-CA-C 115.952 1.141 . . . . 25.0 115.952 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.7 p 77.96 156.9 0.15 Allowed Pre-proline 0 CA--C 1.558 1.274 0 C-N-CA 126.832 2.053 . . . . 25.0 110.408 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.659 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 50.1 Cg_exo -62.55 -3.36 4.25 Favored 'Trans proline' 0 C--N 1.362 1.249 0 N-CA-C 117.761 2.177 . . . . 25.0 117.761 -175.012 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.6 p -63.65 -17.67 20.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 114.757 1.391 . . . . 25.0 114.757 -173.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.5 p -142.44 140.95 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-O 122.554 1.168 . . . . 25.0 113.373 -178.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.32 16.03 80.9 Favored Glycine 0 C--O 1.226 -0.344 0 N-CA-C 118.248 2.059 . . . . 25.0 118.248 175.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.2 t -46.21 -58.96 3.2 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 114.15 1.167 . . . . 25.0 114.15 -175.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -78.24 3.14 16.14 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 116.076 1.88 . . . . 25.0 116.076 -169.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.28 171.82 13.62 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.456 -0.778 . . . . 25.0 111.82 -172.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -58.9 135.32 57.52 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.149 0.58 . . . . 25.0 112.534 -177.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -128.52 163.35 25.15 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 113.537 0.94 . . . . 50.0 113.537 -174.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -136.53 108.66 7.22 Favored 'General case' 0 C--O 1.255 1.348 0 N-CA-C 101.683 -3.451 . . . . 25.0 101.683 161.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 89.7 mt -126.0 126.13 43.8 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.909 0.861 . . . . 25.0 110.46 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -114.69 134.6 54.95 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 107.507 -1.294 . . . . 25.0 107.507 178.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -106.14 178.39 22.75 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 115.294 0.878 . . . . 25.0 115.294 -173.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.5 p -79.86 175.41 10.65 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-O 121.856 0.836 . . . . 25.0 112.558 178.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 39.0 mt -83.6 10.54 8.91 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 113.25 0.833 . . . . 25.0 113.25 176.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.07 178.35 25.63 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 123.073 0.368 . . . . 25.0 112.208 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.2 t -74.68 128.66 36.11 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.888 0.475 . . . . 25.0 110.92 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -143.96 151.18 39.41 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.006 0.431 . . . . 50.0 110.542 -174.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -94.36 125.59 39.09 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 102.546 -3.131 . . . . 25.0 102.546 168.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.3 mm -119.02 103.86 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.018 0 N-CA-C 107.257 -1.386 . . . . 25.0 107.257 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.659 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 9.8 mp -100.69 131.55 46.53 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 104.06 -2.57 . . . . 25.0 104.06 177.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.86 -29.83 14.63 Favored Glycine 0 C--N 1.313 -0.745 0 CA-C-N 114.907 -1.042 . . . . 25.0 113.086 176.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.04 -148.7 50.63 Favored Glycine 0 N--CA 1.466 0.685 0 C-N-CA 120.293 -0.956 . . . . 25.0 112.278 -178.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.7 170.68 52.57 Favored Glycine 0 C--O 1.247 0.929 0 CA-C-N 118.219 1.01 . . . . 25.0 113.096 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.25 162.51 23.84 Favored Glycine 0 C--O 1.256 1.525 0 O-C-N 124.035 0.491 . . . . 25.0 114.225 176.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.08 108.58 11.47 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 106.678 -1.601 . . . . 25.0 106.678 177.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -107.57 149.33 28.15 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.992 -0.744 . . . . 50.0 108.992 -173.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -116.61 105.14 12.11 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 106.856 -1.535 . . . . 25.0 106.856 171.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 80.8 mt -111.37 129.11 56.11 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.58 -0.736 . . . . 25.0 112.568 -170.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -125.11 102.48 7.51 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-O 121.802 0.81 . . . . 25.0 110.449 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.45 -29.43 61.87 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-O 118.742 -1.032 . . . . 25.0 115.204 -176.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 53.54 -156.11 0.2 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.09 0.956 . . . . 25.0 112.461 -177.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.19 166.77 9.19 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.098 -1.001 . . . . 25.0 112.767 -175.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.29 160.0 34.26 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 108.239 -1.944 . . . . 25.0 108.239 -176.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -85.73 106.36 16.93 Favored 'General case' 0 C--O 1.251 1.151 0 O-C-N 122.125 -0.633 . . . . 25.0 109.387 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -109.43 144.4 37.71 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.84 -0.744 . . . . 50.0 111.677 -168.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 mp -105.65 92.89 4.37 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.274 -0.876 . . . . 25.0 108.873 177.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 mp -97.3 113.98 25.68 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-O 121.894 0.854 . . . . 25.0 111.783 -174.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -117.41 94.76 4.68 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 106.709 -1.589 . . . . 25.0 106.709 178.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -57.2 -20.53 36.03 Favored Glycine 0 N--CA 1.473 1.133 0 CA-C-O 118.478 -1.179 . . . . 25.0 115.198 -175.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.98 -168.86 49.73 Favored Glycine 0 C--O 1.249 1.06 0 CA-C-N 119.163 1.482 . . . . 25.0 110.531 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.74 153.07 11.22 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 114.805 -0.697 . . . . 25.0 112.49 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.82 177.1 45.31 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.588 -0.733 . . . . 25.0 111.876 178.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -97.34 132.24 43.26 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 105.779 -1.934 . . . . 25.0 105.779 176.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -125.62 159.78 31.29 Favored 'General case' 0 CA--C 1.485 -1.542 0 CA-C-O 118.851 -0.595 . . . . 50.0 110.743 -172.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -121.67 121.97 38.55 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 103.399 -2.815 . . . . 25.0 103.399 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -146.73 131.4 17.87 Favored 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 116.402 2.001 . . . . 25.0 116.402 -167.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 27.5 m -100.54 141.45 33.37 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.33 0.586 . . . . 25.0 112.26 176.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.96 -35.09 5.2 Favored Glycine 0 C--O 1.206 -1.597 0 O-C-N 121.499 -0.751 . . . . 25.0 111.887 177.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.92 -167.91 50.66 Favored Glycine 0 C--O 1.245 0.83 0 O-C-N 121.644 -0.915 . . . . 25.0 113.776 -177.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -59.83 161.51 6.33 Favored 'General case' 0 C--O 1.251 1.156 0 O-C-N 121.204 -1.174 . . . . 25.0 110.672 176.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.76 167.3 36.31 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 115.215 -0.902 . . . . 25.0 113.195 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.82 93.9 9.62 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 122.102 0.953 . . . . 25.0 110.931 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.14 153.44 22.06 Favored 'General case' 0 C--O 1.247 0.927 0 CA-C-N 115.302 -0.863 . . . . 50.0 111.651 -170.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.453 HG22 ' HG3' ' A' ' 65' ' ' ARG . 24.3 m -125.27 116.52 22.08 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 122.314 1.055 . . . . 25.0 109.685 178.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -104.38 102.55 12.21 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.714 -1.217 . . . . 25.0 107.714 177.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.453 ' HG3' HG22 ' A' ' 63' ' ' THR . 97.1 mtt180 -106.75 -23.14 12.5 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 113.541 0.941 . . . . 25.0 113.541 -177.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 67.79 160.46 0.17 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.508 1.523 . . . . 25.0 112.13 -176.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.72 -45.49 14.36 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 115.345 1.609 . . . . 25.0 115.345 -168.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 65.4 mt -139.23 169.56 17.54 Favored 'General case' 0 C--O 1.207 -1.137 0 CA-C-O 121.43 0.633 . . . . 25.0 111.925 -174.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.78 -23.95 32.84 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.273 0.629 . . . . 25.0 110.76 171.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -80.35 -6.63 58.3 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.307 1.043 . . . . 25.0 113.745 -177.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -90.13 152.77 20.97 Favored 'General case' 0 C--O 1.213 -0.831 0 N-CA-C 113.658 0.984 . . . . 25.0 113.658 176.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.8 t 45.14 48.77 9.86 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.702 1.601 . . . . 25.0 113.807 165.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -135.83 165.8 24.77 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 115.178 -0.919 . . . . 25.0 111.162 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 59.2 ttt180 -112.89 136.42 52.56 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 105.375 -2.083 . . . . 25.0 105.375 176.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 81.2 p -126.28 171.17 8.29 Favored Pre-proline 0 C--N 1.325 -0.467 0 C-N-CA 125.023 1.329 . . . . 25.0 108.167 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.22 -24.6 68.04 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 117.828 -0.981 . . . . 25.0 113.618 177.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 38.1 mt -71.89 -27.31 62.75 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 112.997 0.739 . . . . 25.0 112.997 177.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 145.56 -176.41 24.57 Favored Glycine 0 C--O 1.213 -1.195 0 N-CA-C 111.019 -0.832 . . . . 25.0 111.019 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 15.2 t -86.07 146.32 26.68 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 122.817 1.294 . . . . 25.0 112.6 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -127.28 28.7 5.68 Favored 'General case' 0 C--O 1.246 0.896 0 C-N-CA 125.432 1.493 . . . . 25.0 107.316 169.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -62.22 143.9 48.88 Favored Glycine 0 C--N 1.34 0.802 0 N-CA-C 110.57 -1.012 . . . . 25.0 110.57 178.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -92.05 163.11 14.09 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 120.277 -0.569 . . . . 50.0 110.944 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.75 110.06 15.01 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.178 0.299 . . . . 25.0 110.485 -175.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 30.3 mt -91.7 136.59 24.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.094 -1.076 . . . . 25.0 108.094 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.6 mt -83.64 -42.8 16.28 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 114.457 1.281 . . . . 25.0 114.457 -172.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 47.3 p-10 -137.86 38.82 2.38 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.46 1.282 . . . . 25.0 114.46 -169.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -56.24 139.06 49.16 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.041 0.386 . . . . 25.0 112.041 -177.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -116.16 101.52 53.87 Favored Pre-proline 0 C--O 1.248 0.98 0 N-CA-C 108.012 -1.107 . . . . 25.0 108.012 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.03 -9.16 25.59 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 N-CA-C 114.643 0.978 . . . . 25.0 114.643 -172.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.6 t -80.41 -45.02 18.35 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-O 121.228 0.537 . . . . 25.0 109.724 177.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -95.91 -39.23 9.9 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 115.006 1.484 . . . . 25.0 115.006 -173.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -89.3 173.06 8.6 Favored 'General case' 0 C--O 1.218 -0.585 0 CA-C-N 115.837 -0.619 . . . . 75.0 110.542 -167.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -151.77 152.85 33.23 Favored 'General case' 0 C--O 1.26 1.652 0 CA-C-N 116.214 -0.448 . . . . 25.0 110.509 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 45.6 mt -129.03 132.04 67.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 109.346 -0.613 . . . . 25.0 109.346 -178.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -84.85 150.61 24.88 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 123.039 1.399 . . . . 25.0 108.831 174.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.2 p -150.17 -9.5 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.333 0 O-C-N 121.18 -0.95 . . . . 25.0 112.155 176.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.437 ' HB2' ' HA ' ' A' ' 156' ' ' PHE . 31.5 t -61.15 -47.16 87.48 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.657 0.741 . . . . 25.0 109.731 -175.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.29 -43.15 67.7 Favored 'General case' 0 C--O 1.251 1.158 0 N-CA-C 114.451 1.278 . . . . 25.0 114.451 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.47 -3.87 20.45 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 116.094 1.887 . . . . 25.0 116.094 -169.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -139.77 -72.53 0.04 OUTLIER Glycine 0 CA--C 1.533 1.185 0 N-CA-C 118.312 2.085 . . . . 25.0 118.312 -176.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -158.05 170.61 21.91 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 119.058 1.429 . . . . 25.0 109.543 -175.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.9 t -121.45 -33.54 3.62 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 112.453 0.538 . . . . 25.0 112.453 172.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -91.89 129.1 9.67 Favored Glycine 0 N--CA 1.466 0.694 0 O-C-N 120.754 -1.217 . . . . 25.0 110.309 177.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -69.61 148.25 49.61 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 118.374 1.087 . . . . 25.0 111.645 -177.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -81.67 -167.9 39.83 Favored Glycine 0 C--O 1.223 -0.572 0 CA-C-N 115.894 -0.594 . . . . 25.0 112.375 -176.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -79.53 70.5 6.0 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.305 0.854 . . . . 25.0 113.305 -176.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -105.69 -168.29 23.51 Favored Glycine 0 C--O 1.211 -1.282 0 N-CA-C 107.873 -2.091 . . . . 25.0 107.873 172.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -138.26 164.54 28.97 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 120.023 1.912 . . . . 25.0 109.425 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 54.78 35.63 24.54 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 122.944 0.498 . . . . 25.0 111.563 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.09 39.57 73.04 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 120.64 -1.288 . . . . 25.0 112.312 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 8.4 t -135.6 -178.75 5.26 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 117.778 0.789 . . . . 25.0 109.82 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 85.2 mt -101.07 164.88 11.59 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 102.149 -3.278 . . . . 25.0 102.149 173.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.04 111.95 10.79 Favored 'General case' 0 C--O 1.267 1.996 0 CA-C-O 123.119 1.438 . . . . 25.0 107.32 -178.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.8 m -70.25 153.11 8.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 N-CA-C 108.348 -0.982 . . . . 25.0 108.348 -176.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.39 162.29 33.46 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.852 -1.155 . . . . 25.0 110.526 -175.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.7 m -127.65 161.92 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 108.631 -0.878 . . . . 25.0 108.631 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.6 t -82.03 -50.75 8.74 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 105.67 -1.974 . . . . 25.0 105.67 172.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -166.21 -162.84 0.56 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 100.666 -3.827 . . . . 25.0 100.666 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -67.28 -19.21 65.46 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 109.258 -0.645 . . . . 25.0 109.258 -178.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -119.81 -153.01 9.15 Favored Glycine 0 C--O 1.238 0.393 0 N-CA-C 111.115 -0.794 . . . . 25.0 111.115 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 56.91 -132.23 1.48 Allowed 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 112.806 0.669 . . . . 25.0 112.806 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.4 mtt85 -103.5 157.42 17.05 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.425 0.898 . . . . 25.0 113.425 -173.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.31 158.66 16.47 Favored 'General case' 0 C--O 1.253 1.249 0 N-CA-C 105.952 -1.87 . . . . 25.0 105.952 171.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -130.1 160.05 34.91 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.39 -0.967 . . . . 25.0 108.39 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 30.5 tp -132.87 102.81 5.78 Favored 'General case' 0 C--O 1.216 -0.684 0 N-CA-C 103.132 -2.914 . . . . 25.0 103.132 171.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -103.77 151.93 22.47 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.353 0.597 . . . . 25.0 109.947 -172.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 41.5 t -92.03 154.74 18.57 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 104.225 -2.509 . . . . 25.0 104.225 171.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -126.76 26.33 6.23 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 122.874 1.321 . . . . 25.0 108.415 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -117.14 147.07 42.76 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 103.592 -2.744 . . . . 25.0 103.592 171.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -149.16 151.52 34.49 Favored 'General case' 0 C--O 1.217 -0.654 0 O-C-N 124.158 0.911 . . . . 25.0 110.662 -175.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -77.09 164.58 25.57 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 124.091 0.957 . . . . 25.0 110.033 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.11 -19.72 64.86 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.742 -0.599 . . . . 25.0 112.181 -175.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -75.99 -9.02 58.27 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 122.526 0.331 . . . . 25.0 111.543 176.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 92.2 14.07 56.53 Favored Glycine 0 C--O 1.219 -0.805 0 CA-C-O 121.963 0.757 . . . . 25.0 112.573 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.0 mt -83.92 137.48 33.63 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 121.323 -1.104 . . . . 25.0 109.663 178.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 84.4 p -145.73 174.48 11.17 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.482 -0.562 . . . . 25.0 109.482 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -115.95 141.6 47.89 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 118.273 0.488 . . . . 25.0 111.649 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -150.93 156.42 41.15 Favored 'General case' 0 C--O 1.251 1.145 0 N-CA-C 106.343 -1.725 . . . . 25.0 106.343 169.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 13.4 p -146.96 147.69 17.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 104.933 -2.247 . . . . 25.0 104.933 173.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -107.59 141.95 38.27 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.018 -1.475 . . . . 25.0 107.018 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.2 mp -131.39 125.24 32.12 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 103.363 -2.828 . . . . 25.0 103.363 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -104.87 15.22 28.2 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 120.395 -1.441 . . . . 25.0 111.698 -173.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -83.95 4.41 82.93 Favored Glycine 0 C--O 1.241 0.57 0 CA-C-N 114.994 -1.003 . . . . 25.0 114.732 177.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 28.2 t0 49.34 47.04 22.78 Favored 'General case' 0 C--O 1.252 1.202 0 N-CA-C 114.586 1.328 . . . . 25.0 114.586 175.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -122.88 41.08 3.54 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.24 -0.891 . . . . 25.0 111.272 -175.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.67 -29.62 64.78 Favored 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 113.685 0.994 . . . . 25.0 113.685 173.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.99 -17.77 62.63 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 119.506 1.048 . . . . 25.0 110.371 -177.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -102.1 -8.48 21.37 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 113.341 0.867 . . . . 25.0 113.341 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.9 mt -79.37 133.66 36.58 Favored 'General case' 0 C--O 1.207 -1.161 0 C-N-CA 120.33 -0.548 . . . . 25.0 109.806 -176.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.0 m -141.32 165.81 26.5 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 106.932 -1.507 . . . . 25.0 106.932 172.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -81.79 4.02 23.68 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 121.733 0.778 . . . . 25.0 109.865 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -66.37 -31.31 72.0 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.119 -1.4 . . . . 25.0 110.656 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -94.16 0.35 55.73 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 112.14 0.422 . . . . 25.0 112.14 177.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 26.3 mm -99.33 123.45 52.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 N-CA-C 104.329 -2.471 . . . . 25.0 104.329 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.1 p -100.71 119.36 48.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 122.592 1.187 . . . . 25.0 113.281 -172.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.437 ' HA ' ' HB2' ' A' ' 97' ' ' SER . 9.3 p90 -149.63 -12.25 0.29 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 112.835 -1.984 . . . . 25.0 111.567 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.43 53.01 2.37 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 121.086 -1.009 . . . . 25.0 113.231 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 60.42 25.98 15.55 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 115.857 1.799 . . . . 25.0 115.857 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 m 65.63 -45.13 0.38 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 117.887 2.551 . . . . 25.0 117.887 177.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.19 120.13 13.25 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 121.439 -0.788 . . . . 25.0 110.44 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -79.14 31.09 0.21 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.439 0.903 . . . . 25.0 113.439 -174.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.62 -2.8 15.48 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 112.756 0.65 . . . . 25.0 112.756 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -151.52 -176.42 5.59 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 123.793 0.683 . . . . 25.0 110.596 -176.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 63.72 -166.65 0.22 Allowed 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 114.026 1.121 . . . . 25.0 114.026 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.36 25.89 67.2 Favored Glycine 0 CA--C 1.535 1.322 0 N-CA-C 111.372 -0.691 . . . . 25.0 111.372 -177.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -92.54 134.49 34.93 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.668 -0.864 . . . . 25.0 108.668 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -129.39 141.04 51.15 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 107.704 -1.221 . . . . 25.0 107.704 176.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -126.85 38.38 2.19 Favored Glycine 0 N--CA 1.464 0.501 0 CA-C-O 122.371 0.984 . . . . 25.0 111.26 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 26.3 t -84.25 -28.5 7.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 O-C-N 121.945 -0.738 . . . . 25.0 110.546 -174.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.39 133.18 24.78 Favored 'Isoleucine or valine' 0 C--O 1.26 1.607 0 CA-C-O 122.872 1.32 . . . . 25.0 111.071 -178.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 164.99 156.72 9.21 Favored Glycine 0 C--O 1.239 0.441 0 CA-C-N 115.076 -0.966 . . . . 25.0 112.277 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -151.02 142.81 23.78 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 121.621 -0.929 . . . . 25.0 110.482 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 59.0 p -149.96 163.53 37.85 Favored 'General case' 0 C--O 1.248 1.003 0 N-CA-C 106.484 -1.673 . . . . 25.0 106.484 176.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.53 -174.33 40.44 Favored Glycine 0 C--O 1.246 0.859 0 C-N-CA 120.415 -0.898 . . . . 25.0 114.322 176.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -154.4 86.39 3.65 Favored Pre-proline 0 C--O 1.252 1.198 0 C-N-CA 123.449 0.699 . . . . 25.0 109.533 -178.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -69.28 160.55 49.39 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 117.703 -1.065 . . . . 25.0 112.568 -176.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -131.16 155.27 47.3 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 124.446 1.091 . . . . 25.0 108.066 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -141.43 80.49 16.33 Favored Pre-proline 0 C--O 1.245 0.819 0 CA-C-N 118.387 0.539 . . . . 25.0 112.088 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.74 135.53 28.35 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 118.169 -0.754 . . . . 25.0 112.146 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.9 t -88.81 -4.41 58.5 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 112.822 0.675 . . . . 25.0 112.822 -177.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 3.7 p . . . . . 0 C--O 1.254 1.297 0 CA-C-O 118.213 -0.898 . . . . 25.0 109.671 179.959 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 110.425 -0.213 . . . . 25.0 110.425 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -147.63 129.6 7.51 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-O 121.238 0.542 . . . . 25.0 109.727 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.89 147.24 43.67 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 117.444 -1.238 . . . . 25.0 113.215 -174.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.14 49.32 0.08 OUTLIER Glycine 0 N--CA 1.473 1.157 0 N-CA-C 110.961 -0.855 . . . . 25.0 110.961 178.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.42 HG22 ' H ' ' A' ' 7' ' ' GLY . 2.9 p -55.41 132.06 18.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 123.657 0.783 . . . . 25.0 112.048 -176.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -98.06 -2.05 41.11 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.366 -0.834 . . . . 25.0 110.302 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.42 ' H ' HG22 ' A' ' 5' ' ' VAL . . . -85.03 -145.11 7.32 Favored Glycine 0 C--O 1.206 -1.624 0 CA-C-N 116.032 -0.531 . . . . 25.0 113.336 177.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.0 p 67.76 153.97 0.13 Allowed Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 126.006 1.723 . . . . 25.0 112.672 -173.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.618 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 47.0 Cg_exo -61.91 -3.91 4.25 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.74 2.293 . . . . 25.0 116.148 -178.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.3 p -63.66 -16.63 18.68 Favored 'Isoleucine or valine' 0 C--O 1.248 0.986 0 N-CA-C 116.85 2.167 . . . . 25.0 116.85 -167.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.8 p -143.82 131.76 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 113.341 0.867 . . . . 25.0 113.341 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.87 19.88 56.9 Favored Glycine 0 N--CA 1.469 0.855 0 N-CA-C 117.592 1.797 . . . . 25.0 117.592 176.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.9 t -47.68 -56.76 6.58 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 117.985 0.893 . . . . 25.0 112.346 -176.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -75.19 -1.99 25.84 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 115.496 1.665 . . . . 25.0 115.496 -170.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -137.57 174.64 10.38 Favored 'General case' 0 C--O 1.207 -1.158 0 CA-C-N 116.234 -0.439 . . . . 25.0 111.784 -171.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.27 144.1 47.28 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-O 122.276 1.036 . . . . 25.0 109.135 -175.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -131.06 150.25 52.23 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 114.632 -1.167 . . . . 50.0 113.018 -176.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -131.22 105.03 7.4 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 100.541 -3.874 . . . . 25.0 100.541 165.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 89.0 mt -127.95 132.72 49.22 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 109.734 -0.469 . . . . 25.0 109.734 -175.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -120.0 115.9 24.67 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.272 -1.381 . . . . 25.0 107.272 -178.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -80.5 176.38 54.67 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 116.554 1.382 . . . . 25.0 116.554 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.5 p -82.33 175.8 9.96 Favored 'General case' 0 C--O 1.251 1.132 0 C-N-CA 124.349 1.06 . . . . 25.0 110.582 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 82.3 mt -80.65 4.46 18.63 Favored 'General case' 0 N--CA 1.463 0.198 0 O-C-N 121.99 -0.443 . . . . 25.0 111.334 174.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -95.85 -176.0 36.66 Favored Glycine 0 C--O 1.226 -0.39 0 CA-C-O 121.374 0.43 . . . . 25.0 112.063 -178.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.6 t -82.12 131.1 35.24 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 109.18 -0.674 . . . . 25.0 109.18 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -145.57 159.89 42.45 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.756 0.788 . . . . 50.0 109.203 -177.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -100.82 131.94 46.46 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 104.773 -2.306 . . . . 25.0 104.773 165.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.4 mm -120.29 103.75 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 N-CA-C 106.736 -1.579 . . . . 25.0 106.736 178.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.618 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 5.3 mp -105.78 128.39 53.68 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 104.427 -2.435 . . . . 25.0 104.427 -178.173 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.95 -32.19 11.2 Favored Glycine 0 C--N 1.307 -1.049 0 N-CA-C 117.447 1.739 . . . . 25.0 117.447 -177.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.91 -147.14 49.18 Favored Glycine 0 C--O 1.243 0.659 0 CA-C-N 118.934 1.367 . . . . 25.0 111.944 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.95 175.61 50.25 Favored Glycine 0 C--O 1.244 0.768 0 O-C-N 121.734 -0.862 . . . . 25.0 112.837 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.26 160.73 12.51 Favored Glycine 0 C--O 1.256 1.529 0 C-N-CA 120.329 -0.939 . . . . 25.0 111.523 175.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.7 113.02 20.99 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 105.565 -2.013 . . . . 25.0 105.565 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -105.0 154.08 20.59 Favored 'General case' 0 C--O 1.251 1.156 0 N-CA-C 113.211 0.819 . . . . 50.0 113.211 -172.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -121.36 92.61 3.79 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 107.093 -1.447 . . . . 25.0 107.093 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 34.5 mt -108.3 137.3 46.49 Favored 'General case' 0 C--O 1.203 -1.364 0 N-CA-C 114.455 1.28 . . . . 25.0 114.455 -169.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -131.71 117.6 18.84 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.299 0.571 . . . . 25.0 111.719 -179.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -87.92 -24.7 34.27 Favored Glycine 0 C--O 1.245 0.831 0 CA-C-O 117.247 -1.863 . . . . 25.0 116.78 -178.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 53.14 -153.36 0.25 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.978 1.389 . . . . 25.0 112.068 -177.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.71 167.22 15.74 Favored 'General case' 0 C--O 1.249 1.055 0 O-C-N 120.615 -1.303 . . . . 25.0 111.376 -178.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.5 158.52 31.67 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 114.993 -1.003 . . . . 25.0 111.606 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -85.71 94.29 9.07 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 107.385 -1.339 . . . . 25.0 107.385 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -99.38 159.83 14.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.175 -0.921 . . . . 50.0 110.588 -170.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 mp -120.38 106.37 11.79 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 108.529 -0.915 . . . . 25.0 108.529 174.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 mp -111.7 106.15 14.86 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 113.05 0.759 . . . . 25.0 113.05 -172.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -118.99 92.41 3.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.736 -1.12 . . . . 25.0 108.986 -177.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.38 -12.42 32.17 Favored Glycine 0 N--CA 1.467 0.719 0 N-CA-C 118.366 2.106 . . . . 25.0 118.366 -177.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 61.48 -162.45 24.76 Favored Glycine 0 N--CA 1.462 0.399 0 CA-C-N 119.546 1.673 . . . . 25.0 113.853 177.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.69 158.86 1.21 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 114.227 1.195 . . . . 25.0 114.227 -177.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.93 179.46 51.78 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 115.138 -0.937 . . . . 25.0 112.809 -177.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.79 141.62 29.03 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 101.498 -3.519 . . . . 25.0 101.498 176.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -133.53 158.12 43.93 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.57 -0.9 . . . . 50.0 108.57 -175.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -124.01 120.09 31.42 Favored 'General case' 0 C--O 1.212 -0.906 0 N-CA-C 107.766 -1.198 . . . . 25.0 107.766 173.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -141.64 132.48 25.84 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 115.644 1.72 . . . . 25.0 115.644 -169.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 63.9 m -95.22 140.98 29.36 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 123.278 0.631 . . . . 25.0 109.752 175.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.39 -39.18 4.54 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 107.9 -2.08 . . . . 25.0 107.9 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.03 -164.38 52.87 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 117.997 0.898 . . . . 25.0 113.387 -177.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.0 158.73 15.72 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.03 0.532 . . . . 25.0 110.202 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.97 157.85 26.24 Favored Glycine 0 N--CA 1.476 1.324 0 N-CA-C 111.502 -0.639 . . . . 25.0 111.502 175.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.0 110.91 8.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.627 1.203 . . . . 25.0 111.915 -176.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -104.86 155.22 19.12 Favored 'General case' 0 C--O 1.25 1.123 0 CA-C-N 114.625 -1.17 . . . . 50.0 109.505 -173.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 88.0 m -125.33 131.01 53.1 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.418 0.687 . . . . 25.0 110.444 -177.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -124.31 104.05 8.57 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 108.015 -1.105 . . . . 25.0 108.015 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 54.5 mtt85 -115.09 -16.59 11.59 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 121.669 -0.645 . . . . 25.0 111.531 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 62.44 164.22 0.1 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.692 1.597 . . . . 25.0 111.571 -175.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.15 -39.49 48.99 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 114.317 1.228 . . . . 25.0 114.317 -172.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.7 mt -135.37 164.81 26.91 Favored 'General case' 0 C--O 1.207 -1.149 0 C-N-CA 123.114 0.566 . . . . 25.0 112.341 -170.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -17.97 64.2 Favored 'General case' 0 C--O 1.209 -1.067 0 N-CA-C 108.386 -0.968 . . . . 25.0 108.386 170.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -82.53 6.06 18.74 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.811 1.041 . . . . 25.0 113.811 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -111.22 151.81 27.83 Favored 'General case' 0 C--O 1.213 -0.849 0 N-CA-C 115.798 1.777 . . . . 25.0 115.798 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.0 t 54.91 36.32 26.45 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 113.712 -1.586 . . . . 25.0 112.975 175.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 24.0 p-80 -121.05 167.65 12.39 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.869 -1.06 . . . . 25.0 112.507 -173.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 -123.44 140.99 52.44 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 106.748 -1.575 . . . . 25.0 106.748 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.6 p -133.94 173.29 6.01 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 107.949 -1.13 . . . . 25.0 107.949 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -61.39 -25.68 80.36 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 115.831 -2.313 . . . . 25.0 112.999 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 68.6 mt -68.77 -27.09 65.59 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.533 0.682 . . . . 25.0 111.916 -178.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.53 -173.83 32.94 Favored Glycine 0 CA--C 1.498 -0.995 0 N-CA-C 110.414 -1.074 . . . . 25.0 110.414 -177.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.1 t -100.41 148.02 25.19 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.487 1.137 . . . . 25.0 111.345 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -134.09 31.0 3.59 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 114.622 -1.172 . . . . 25.0 108.496 172.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.56 148.94 50.28 Favored Glycine 0 C--O 1.249 1.057 0 CA-C-N 114.085 -1.416 . . . . 25.0 109.578 176.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -91.8 167.18 12.34 Favored 'General case' 0 C--N 1.314 -0.961 0 O-C-N 121.888 -0.772 . . . . 50.0 110.133 -176.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -120.75 111.34 17.47 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.575 0.75 . . . . 25.0 109.989 -177.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.8 mt -97.32 129.36 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-O 121.676 0.75 . . . . 25.0 109.021 -177.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 81.4 mt -83.78 -41.71 17.29 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 115.717 1.747 . . . . 25.0 115.717 -170.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.4 p-10 -140.45 45.63 1.83 Allowed 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.755 1.391 . . . . 25.0 114.755 -176.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -55.83 129.92 41.42 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 122.241 1.02 . . . . 25.0 112.943 -178.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -91.97 105.11 12.39 Favored Pre-proline 0 C--O 1.246 0.872 0 CA-C-N 114.231 -1.35 . . . . 25.0 108.081 174.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.38 3.93 3.79 Favored 'Trans proline' 0 C--O 1.205 -1.143 0 N-CA-C 115.779 1.415 . . . . 25.0 115.779 -173.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.2 t -110.83 -43.8 3.74 Favored 'General case' 0 C--O 1.253 1.281 0 O-C-N 121.809 -0.557 . . . . 25.0 111.259 176.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -87.26 -38.66 16.11 Favored 'General case' 0 C--O 1.241 0.624 0 O-C-N 123.51 0.506 . . . . 25.0 110.58 -172.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -88.43 158.44 18.36 Favored 'General case' 0 CA--C 1.552 1.048 0 N-CA-C 112.271 0.471 . . . . 50.0 112.271 -170.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -137.81 147.89 45.0 Favored 'General case' 0 C--O 1.252 1.201 0 N-CA-C 113.859 1.059 . . . . 25.0 113.859 -175.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 68.2 mt -131.81 130.39 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 108.773 -0.825 . . . . 25.0 108.773 -175.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -90.05 147.44 23.65 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.047 -1.033 . . . . 25.0 108.927 171.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.0 p -141.35 -5.02 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 115.484 -0.78 . . . . 25.0 109.417 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.0 t -65.65 -41.96 91.94 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 121.294 0.569 . . . . 25.0 111.313 -170.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.91 -34.3 57.72 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 119.937 -0.705 . . . . 25.0 112.855 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.97 -3.25 18.98 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 116.502 2.038 . . . . 25.0 116.502 -169.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -142.58 -74.08 0.03 OUTLIER Glycine 0 C--O 1.214 -1.124 0 CA-C-O 119.256 -0.747 . . . . 25.0 114.561 -178.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -160.23 165.16 32.0 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 117.814 0.807 . . . . 25.0 112.007 -173.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.9 t -121.27 -10.9 8.88 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 121.0 0.429 . . . . 25.0 112.1 176.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.43 133.41 11.07 Favored Glycine 0 N--CA 1.467 0.722 0 N-CA-C 108.613 -1.795 . . . . 25.0 108.613 170.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.15 150.11 42.45 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-N 117.314 0.557 . . . . 25.0 112.172 -175.012 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -86.06 -177.7 49.96 Favored Glycine 0 C--O 1.223 -0.545 0 O-C-N 122.125 -0.36 . . . . 25.0 113.1 -174.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -63.81 101.15 0.34 Allowed 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.624 0.602 . . . . 25.0 112.624 -175.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -150.85 -165.62 12.94 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.006 -1.237 . . . . 25.0 110.006 175.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -148.43 165.88 29.8 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 119.645 1.722 . . . . 25.0 113.164 -177.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 58.94 33.97 23.35 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.464 1.283 . . . . 25.0 114.464 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 77.36 30.54 53.89 Favored Glycine 0 N--CA 1.465 0.617 0 C-N-CA 119.857 -1.163 . . . . 25.0 110.27 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.6 t -143.61 168.63 19.42 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 121.32 -1.106 . . . . 25.0 108.965 -178.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.8 mt -93.02 172.24 8.44 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 106.144 -1.799 . . . . 25.0 106.144 175.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.58 118.95 19.75 Favored 'General case' 0 C--O 1.254 1.323 0 CA-C-N 119.446 1.021 . . . . 25.0 110.099 177.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.8 m -87.85 159.15 3.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 109.45 -0.574 . . . . 25.0 109.45 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 99.4 p -147.0 163.69 35.42 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 108.77 -0.826 . . . . 25.0 108.77 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.5 m -126.02 165.89 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 N-CA-C 107.532 -1.284 . . . . 25.0 107.532 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.1 t -74.49 -49.32 22.65 Favored 'General case' 0 C--O 1.255 1.346 0 N-CA-C 104.251 -2.5 . . . . 25.0 104.251 173.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -168.8 -170.89 1.25 Allowed 'General case' 0 C--O 1.207 -1.133 1 N-CA-C 99.201 -4.37 . . . . 25.0 99.201 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -60.23 -20.46 58.95 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 119.175 0.898 . . . . 25.0 111.912 -178.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.22 -151.45 9.68 Favored Glycine 0 C--O 1.216 -1.02 0 N-CA-C 110.602 -0.999 . . . . 25.0 110.602 176.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 54.66 -133.75 1.66 Allowed 'General case' 0 N--CA 1.465 0.325 0 O-C-N 124.066 0.51 . . . . 25.0 112.094 -179.07 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 22.8 mtt85 -105.37 155.53 19.03 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 112.473 0.546 . . . . 25.0 112.473 -174.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.3 p -103.3 163.01 12.52 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.173 -2.528 . . . . 25.0 104.173 175.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.493 ' CE2' ' HB2' ' A' ' 140' ' ' ALA . 57.8 m-85 -141.33 149.86 41.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 118.63 0.65 . . . . 25.0 111.328 -176.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 55.8 tp -124.57 128.21 48.56 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 105.298 -2.112 . . . . 25.0 105.298 177.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -126.15 155.75 41.21 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 122.597 1.189 . . . . 25.0 112.218 -172.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 32.3 t -90.96 158.28 16.81 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 103.481 -2.785 . . . . 25.0 103.481 168.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -129.69 17.08 5.82 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 106.773 -1.566 . . . . 25.0 106.773 176.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -115.44 144.78 43.31 Favored 'General case' 0 C--O 1.25 1.125 0 CA-C-N 112.525 -2.125 . . . . 25.0 106.667 173.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -144.52 168.18 20.74 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.334 0.587 . . . . 25.0 110.18 -178.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -97.13 161.35 13.86 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.946 -1.131 . . . . 25.0 107.946 176.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.22 -26.72 68.64 Favored 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 109.647 -0.501 . . . . 25.0 109.647 -176.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -67.26 -7.16 22.06 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 112.929 0.715 . . . . 25.0 112.929 174.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.89 22.18 53.63 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 121.84 0.689 . . . . 25.0 113.404 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 78.1 mt -90.99 133.48 35.25 Favored 'General case' 0 CA--C 1.506 -0.728 0 O-C-N 121.899 -0.766 . . . . 25.0 109.951 177.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 66.3 p -141.43 -179.46 6.15 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.414 -1.328 . . . . 25.0 107.414 178.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -124.77 136.26 53.7 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 119.614 -0.232 . . . . 25.0 111.221 -178.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -149.15 152.53 36.24 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 106.622 -1.622 . . . . 25.0 106.622 166.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.5 p -144.63 144.65 21.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 105.004 -2.221 . . . . 25.0 105.004 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.493 ' HB2' ' CE2' ' A' ' 124' ' ' TYR . . . -105.54 142.98 34.35 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.963 -1.495 . . . . 25.0 106.963 -176.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.8 mp -130.77 132.66 45.42 Favored 'General case' 0 C--O 1.195 -1.81 0 N-CA-C 105.404 -2.073 . . . . 25.0 105.404 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -105.35 6.19 32.46 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 119.646 -1.909 . . . . 25.0 114.195 -174.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -87.34 8.66 76.12 Favored Glycine 0 CA--C 1.542 1.765 0 C-N-CA 120.753 -0.737 . . . . 25.0 113.415 -179.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 35.7 t0 43.98 57.36 4.2 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 114.7 1.371 . . . . 25.0 114.7 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -123.82 36.16 4.69 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-N 114.95 -1.023 . . . . 25.0 109.284 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.97 -33.32 68.74 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.348 -0.387 . . . . 25.0 112.027 174.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.36 -22.91 62.73 Favored 'General case' 0 C--O 1.255 1.374 0 O-C-N 121.297 -0.877 . . . . 25.0 112.442 178.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.5 -15.92 20.35 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 112.333 0.494 . . . . 25.0 112.333 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 12.9 mt -64.59 139.02 58.72 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 123.009 1.385 . . . . 25.0 112.265 176.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 57.8 m -143.52 154.7 43.89 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 106.66 -1.607 . . . . 25.0 106.66 177.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.05 -2.93 29.61 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.657 0.614 . . . . 25.0 112.657 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -67.0 -31.55 72.19 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 108.366 -0.975 . . . . 25.0 108.366 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -85.6 -5.03 59.32 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 120.377 -0.529 . . . . 25.0 112.309 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 48.3 mm -97.27 122.79 49.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 104.481 -2.414 . . . . 25.0 104.481 176.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.1 p -103.2 112.93 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-O 123.12 1.438 . . . . 25.0 113.568 -174.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -142.0 -7.21 0.94 Allowed 'General case' 0 C--O 1.251 1.158 0 CA-C-N 112.656 -2.066 . . . . 25.0 111.782 176.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -85.86 50.61 2.01 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.56 0.948 . . . . 25.0 113.56 -176.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 60.09 20.06 9.28 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.456 2.021 . . . . 25.0 116.456 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.0 -21.28 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 119.886 3.291 . . . . 25.0 119.886 174.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -70.0 139.8 52.82 Favored 'General case' 0 N--CA 1.444 -0.746 0 O-C-N 121.606 -0.684 . . . . 25.0 110.196 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -75.25 -1.83 25.27 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.462 0.912 . . . . 25.0 113.462 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.29 34.97 0.21 Allowed 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.883 0.849 . . . . 25.0 111.164 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -145.66 -171.59 3.72 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.267 -0.879 . . . . 25.0 108.921 -175.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 59.65 -168.98 0.15 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.632 1.573 . . . . 25.0 113.083 175.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 80.18 6.2 89.31 Favored Glycine 0 C--O 1.25 1.145 0 CA-C-O 121.682 0.601 . . . . 25.0 114.418 -173.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -81.86 69.73 8.61 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.868 0.867 . . . . 25.0 111.364 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -125.01 141.15 52.31 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 122.853 0.461 . . . . 25.0 111.297 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -142.67 44.76 0.95 Allowed Glycine 0 CA--C 1.527 0.784 0 O-C-N 124.222 0.951 . . . . 25.0 112.097 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 45.6 t -70.87 -37.26 67.67 Favored 'Isoleucine or valine' 0 C--O 1.251 1.143 0 O-C-N 121.758 -0.848 . . . . 25.0 111.684 -178.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.11 136.47 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-O 122.245 1.022 . . . . 25.0 111.645 -177.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 166.84 170.38 31.66 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 109.22 -1.552 . . . . 25.0 109.22 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -146.55 148.8 32.54 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.855 0.836 . . . . 25.0 110.721 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 95.2 p -158.42 169.93 23.35 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-N 114.782 -1.099 . . . . 25.0 110.169 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 150.58 167.12 14.19 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 116.289 1.276 . . . . 25.0 116.289 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -136.66 95.0 12.82 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 124.948 1.299 . . . . 25.0 107.618 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.86 158.29 57.97 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 119.809 0.339 . . . . 25.0 112.094 -178.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -114.03 154.75 27.15 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 107.951 -1.129 . . . . 25.0 107.951 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -127.2 67.88 71.55 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 115.574 -0.739 . . . . 25.0 110.818 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -72.15 158.19 52.55 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 CA-C-O 122.945 1.144 . . . . 25.0 112.25 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.2 t -132.48 27.52 4.39 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 105.828 -1.915 . . . . 25.0 105.828 172.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 C--O 1.25 1.115 0 CA-C-N 113.876 -1.511 . . . . 25.0 111.821 179.056 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.34 0 N-CA-C 110.506 -0.183 . . . . 25.0 110.506 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -103.39 112.37 65.64 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 119.404 -0.331 . . . . 25.0 111.451 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -69.66 140.08 42.17 Favored 'Trans proline' 0 C--N 1.324 -0.724 0 N-CA-C 113.531 0.55 . . . . 25.0 113.531 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.64 46.1 0.04 OUTLIER Glycine 0 N--CA 1.472 1.087 0 CA-C-O 117.539 -1.701 . . . . 25.0 110.474 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -51.67 120.89 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 O-C-N 125.592 1.407 . . . . 25.0 113.0 -176.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -92.29 -8.59 44.75 Favored 'General case' 0 C--O 1.259 1.557 0 CA-C-N 113.516 -1.675 . . . . 25.0 110.899 -173.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.01 -137.17 3.34 Favored Glycine 0 C--N 1.298 -1.567 0 O-C-N 124.01 0.819 . . . . 25.0 113.403 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.7 p 65.69 156.34 0.13 Allowed Pre-proline 0 N--CA 1.498 1.966 0 C-N-CA 126.225 1.81 . . . . 25.0 111.665 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.582 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 47.3 Cg_exo -64.23 -3.31 5.98 Favored 'Trans proline' 0 C--N 1.364 1.344 0 N-CA-C 118.17 2.335 . . . . 25.0 118.17 -177.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 p -68.74 -9.92 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 116.822 2.156 . . . . 25.0 116.822 -173.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.7 p -138.87 133.02 40.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 113.547 0.943 . . . . 25.0 113.547 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.11 15.8 74.66 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 118.093 1.997 . . . . 25.0 118.093 172.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 89.4 p -54.75 -35.21 63.51 Favored 'General case' 0 CA--C 1.565 1.549 0 O-C-N 120.776 -1.426 . . . . 25.0 113.815 -170.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -78.22 3.81 14.33 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 117.576 2.435 . . . . 25.0 117.576 -175.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.4 pp -149.98 177.64 9.67 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 123.181 0.592 . . . . 25.0 110.478 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -59.32 128.7 38.39 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 112.548 0.573 . . . . 25.0 112.548 -174.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -125.9 160.61 29.48 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 114.298 1.222 . . . . 50.0 114.298 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -124.24 97.39 5.3 Favored 'General case' 0 C--O 1.279 2.639 0 N-CA-C 106.237 -1.764 . . . . 25.0 106.237 159.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.4 mt -104.44 128.68 52.39 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.932 0.872 . . . . 25.0 112.691 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -115.67 120.47 39.48 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 109.114 -0.699 . . . . 25.0 109.114 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.83 173.88 40.35 Favored Glycine 0 N--CA 1.472 1.083 0 N-CA-C 120.238 2.855 . . . . 25.0 120.238 -178.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.5 p -71.72 174.42 6.84 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.521 1.153 . . . . 25.0 113.06 175.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.5 mt -93.5 16.85 12.61 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.483 -0.78 . . . . 25.0 109.904 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -119.24 -177.62 16.48 Favored Glycine 0 C--O 1.24 0.494 0 N-CA-C 109.479 -1.448 . . . . 25.0 109.479 174.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.7 t -68.45 133.92 49.36 Favored 'General case' 0 C--O 1.253 1.278 0 C-N-CA 123.347 0.659 . . . . 25.0 111.483 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -144.98 160.5 41.25 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.974 -1.121 . . . . 50.0 107.974 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -104.27 124.55 49.35 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 104.916 -2.253 . . . . 25.0 104.916 163.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.0 mm -114.84 128.65 71.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 N-CA-C 106.378 -1.712 . . . . 25.0 106.378 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.582 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 4.4 mp -126.9 124.46 39.6 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 102.942 -2.985 . . . . 25.0 102.942 178.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.32 -30.87 56.24 Favored Glycine 0 N--CA 1.483 1.777 0 N-CA-C 114.625 0.61 . . . . 25.0 114.625 176.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.5 -149.56 48.59 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 118.781 1.29 . . . . 25.0 111.352 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -79.14 170.43 54.57 Favored Glycine 0 C--N 1.298 -1.561 0 N-CA-C 109.362 -1.495 . . . . 25.0 109.362 -177.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.82 167.98 41.92 Favored Glycine 0 C--N 1.307 -1.032 0 N-CA-C 110.861 -0.896 . . . . 25.0 110.861 177.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.91 102.97 15.58 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.53 1.132 . . . . 25.0 108.319 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -102.78 147.25 27.09 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 122.589 1.185 . . . . 50.0 111.381 -167.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -118.16 92.29 3.79 Favored 'General case' 0 C--O 1.285 2.934 0 N-CA-C 107.477 -1.305 . . . . 25.0 107.477 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 23.3 mt -102.69 140.37 37.05 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.558 0.947 . . . . 25.0 113.558 -169.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -134.31 106.18 6.98 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.633 -0.877 . . . . 25.0 108.633 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.38 -17.75 63.79 Favored Glycine 0 N--CA 1.476 1.354 0 N-CA-C 115.86 1.104 . . . . 25.0 115.86 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 47.93 -149.64 0.16 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 119.335 1.568 . . . . 25.0 113.939 -177.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.98 163.1 25.36 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-N 115.633 -0.712 . . . . 25.0 112.918 -173.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.5 160.62 35.97 Favored Glycine 0 C--O 1.252 1.258 0 O-C-N 124.979 1.424 . . . . 25.0 113.672 -175.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -81.59 102.53 10.7 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.901 -1.148 . . . . 25.0 107.901 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -109.69 152.95 24.96 Favored 'General case' 0 CA--C 1.505 -0.754 0 C-N-CA 119.48 -0.888 . . . . 50.0 110.92 -169.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.44 120.79 43.15 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 105.15 -2.167 . . . . 25.0 105.15 177.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.8 mp -124.14 121.3 34.75 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.275 1.213 . . . . 25.0 114.275 -176.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -116.08 148.02 40.68 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 113.801 -1.545 . . . . 25.0 106.888 174.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.15 -34.32 4.87 Favored Glycine 0 N--CA 1.476 1.333 0 N-CA-C 116.173 1.229 . . . . 25.0 116.173 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.72 -171.38 53.5 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-O 123.593 1.663 . . . . 25.0 110.335 -177.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.28 149.64 16.01 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 114.253 -0.973 . . . . 25.0 112.422 -176.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.56 168.32 44.47 Favored Glycine 0 CA--C 1.496 -1.155 0 CA-C-O 118.31 -1.272 . . . . 25.0 111.723 -176.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.49 134.32 33.62 Favored 'General case' 0 C--O 1.209 -1.07 0 N-CA-C 101.637 -3.468 . . . . 25.0 101.637 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -123.1 157.71 32.25 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 109.655 -0.498 . . . . 50.0 109.655 -174.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -120.73 127.59 52.15 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 101.994 -3.336 . . . . 25.0 101.994 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -149.48 135.04 18.51 Favored 'General case' 0 C--O 1.2 -1.507 0 N-CA-C 116.493 2.034 . . . . 25.0 116.493 -174.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.2 m -99.55 145.6 27.33 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.995 -1.002 . . . . 25.0 110.228 171.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.92 -34.54 5.4 Favored Glycine 0 C--O 1.215 -1.076 0 N-CA-C 108.779 -1.728 . . . . 25.0 108.779 173.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.69 -165.1 53.56 Favored Glycine 0 C--O 1.217 -0.946 0 CA-C-O 122.009 0.783 . . . . 25.0 111.659 -177.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -71.16 156.06 40.02 Favored 'General case' 0 C--O 1.258 1.53 0 CA-C-O 121.938 0.875 . . . . 25.0 109.344 178.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.54 161.45 33.61 Favored Glycine 0 C--O 1.258 1.605 0 CA-C-O 117.982 -1.454 . . . . 25.0 110.121 -175.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.75 112.29 17.99 Favored 'General case' 0 C--O 1.2 -1.532 0 O-C-N 124.697 0.881 . . . . 25.0 109.428 177.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -104.15 153.4 20.98 Favored 'General case' 0 CA--C 1.487 -1.462 0 CA-C-N 116.58 -0.282 . . . . 50.0 110.901 -174.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 79.5 m -116.36 122.54 45.17 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 107.843 -1.169 . . . . 25.0 107.843 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -108.13 89.26 2.94 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 104.137 -2.542 . . . . 25.0 104.137 177.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -92.12 -25.84 18.55 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 114.822 -1.081 . . . . 25.0 111.626 -174.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 66.86 150.03 0.06 Allowed 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.477 1.511 . . . . 25.0 112.198 -175.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.65 -43.36 31.61 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 117.061 2.245 . . . . 25.0 117.061 -165.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.4 mt -142.9 173.57 11.43 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.572 -0.899 . . . . 25.0 108.572 -165.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.55 -30.23 69.64 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-N 115.179 -0.919 . . . . 25.0 110.125 167.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -78.17 -6.59 55.27 Favored 'General case' 0 C--O 1.263 1.796 0 N-CA-C 114.539 1.311 . . . . 25.0 114.539 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -90.59 151.17 21.43 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 121.209 -0.932 . . . . 25.0 109.499 -172.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.8 t 29.1 47.05 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 117.569 2.433 . . . . 25.0 117.569 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 -119.15 178.63 4.44 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.56 -0.746 . . . . 25.0 109.532 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -126.84 140.17 52.55 Favored 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 107.963 -1.125 . . . . 25.0 107.963 176.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 84.1 p -129.81 166.1 28.52 Favored Pre-proline 0 C--O 1.189 -2.108 0 N-CA-C 108.216 -1.031 . . . . 25.0 108.216 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -64.68 -24.58 62.25 Favored 'Trans proline' 0 C--O 1.243 0.735 0 C-N-CA 115.667 -2.422 . . . . 25.0 112.677 178.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 31.7 mt -65.64 -38.99 90.94 Favored 'General case' 0 C--O 1.201 -1.498 0 CA-C-O 121.826 0.822 . . . . 25.0 112.459 178.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 171.46 167.29 31.48 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 115.001 -1.0 . . . . 25.0 111.383 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.8 t -86.42 149.64 24.86 Favored 'General case' 0 C--N 1.353 0.751 0 CA-C-O 124.425 2.059 . . . . 25.0 110.855 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -132.83 28.09 4.24 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 112.337 -2.21 . . . . 25.0 111.355 175.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.74 140.41 36.59 Favored Glycine 0 N--CA 1.474 1.231 0 CA-C-O 122.31 0.95 . . . . 25.0 111.917 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -91.18 169.39 10.88 Favored 'General case' 0 C--O 1.249 1.067 0 O-C-N 119.884 -1.95 . . . . 50.0 111.998 -176.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -122.18 97.4 5.46 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.662 0.785 . . . . 25.0 110.936 -170.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 22.1 mt -84.41 132.7 30.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 N-CA-C 106.92 -1.511 . . . . 25.0 106.92 -178.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.448 ' HA ' ' HG2' ' A' ' 142' ' ' GLU . 90.4 mt -87.47 -43.81 11.78 Favored 'General case' 0 C--O 1.253 1.289 0 N-CA-C 115.774 1.768 . . . . 25.0 115.774 -172.024 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 54.0 p-10 -137.78 44.55 2.2 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.539 0.57 . . . . 25.0 112.539 -174.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -57.28 138.55 54.64 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.823 1.249 . . . . 25.0 111.971 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -106.16 105.5 54.02 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 106.807 -1.553 . . . . 25.0 106.807 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -68.05 -5.4 14.59 Favored 'Trans proline' 0 C--O 1.199 -1.427 0 N-CA-C 117.703 2.155 . . . . 25.0 117.703 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 37.7 t -99.87 -38.78 8.5 Favored 'General case' 0 CA--C 1.557 1.213 0 CA-C-O 120.815 0.341 . . . . 25.0 110.921 177.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -93.45 -42.3 9.33 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-N 116.668 -0.242 . . . . 25.0 111.578 -174.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -87.56 167.66 13.74 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 115.134 -0.939 . . . . 50.0 109.516 -170.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -139.99 151.11 45.23 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 122.977 0.511 . . . . 25.0 110.733 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 86.0 mt -124.93 133.71 68.78 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.596 0 N-CA-C 107.945 -1.131 . . . . 25.0 107.945 177.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -100.15 154.53 18.37 Favored 'General case' 0 C--O 1.212 -0.914 0 N-CA-C 107.896 -1.15 . . . . 25.0 107.896 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.8 p -154.33 2.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 121.467 -0.771 . . . . 25.0 111.448 -176.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 11.0 t -62.74 -45.97 90.26 Favored 'General case' 0 C--O 1.258 1.546 0 N-CA-C 115.464 1.653 . . . . 25.0 115.464 -173.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.63 -42.01 22.88 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.9 -0.591 . . . . 25.0 111.07 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.37 -8.32 48.33 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 117.136 2.273 . . . . 25.0 117.136 -172.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -140.44 -72.07 0.04 OUTLIER Glycine 0 C--N 1.337 0.613 0 N-CA-C 116.72 1.448 . . . . 25.0 116.72 -176.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -160.63 168.61 24.57 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 108.283 -1.006 . . . . 25.0 108.283 -176.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.0 t -127.73 -30.99 2.48 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.8 0.81 . . . . 25.0 111.925 175.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -94.06 121.36 6.65 Favored Glycine 0 CA--C 1.483 -1.968 0 N-CA-C 107.467 -2.253 . . . . 25.0 107.467 175.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.82 146.07 47.61 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.038 -0.581 . . . . 25.0 111.813 -178.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -102.68 -160.3 25.81 Favored Glycine 0 C--O 1.244 0.727 0 CA-C-O 122.415 1.008 . . . . 25.0 114.539 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -56.48 139.36 49.51 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 122.262 1.03 . . . . 25.0 113.673 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 164.28 -175.67 40.32 Favored Glycine 0 C--O 1.25 1.141 0 N-CA-C 110.15 -1.18 . . . . 25.0 110.15 -177.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -146.61 165.26 30.07 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.834 1.317 . . . . 25.0 110.995 -177.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 56.4 37.38 28.78 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 113.243 0.831 . . . . 25.0 113.243 177.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 79.02 32.6 39.23 Favored Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.204 -1.474 . . . . 25.0 110.945 176.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.7 t -148.59 179.72 7.6 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 120.02 1.91 . . . . 25.0 110.682 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 65.4 mt -90.52 168.58 11.72 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 104.519 -2.401 . . . . 25.0 104.519 168.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.77 121.94 20.72 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 108.07 -1.085 . . . . 25.0 108.07 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 28.9 m -93.86 162.37 2.42 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 O-C-N 125.081 1.488 . . . . 25.0 108.945 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.4 p -148.93 163.84 36.28 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.414 0.894 . . . . 25.0 113.414 -177.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.8 m -120.91 167.69 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 106.729 -1.582 . . . . 25.0 106.729 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 37.4 t -75.51 -55.07 6.03 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 106.615 -1.624 . . . . 25.0 106.615 173.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -165.6 -150.95 0.13 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 103.854 -2.647 . . . . 25.0 103.854 -176.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -69.39 -15.08 63.23 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 122.44 1.114 . . . . 25.0 111.114 -176.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -140.09 -155.24 6.51 Favored Glycine 0 C--O 1.258 1.606 0 CA-C-O 117.391 -1.783 . . . . 25.0 110.895 178.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 68.01 -150.25 0.16 Allowed 'General case' 0 C--O 1.247 0.973 0 C-N-CA 125.113 1.365 . . . . 25.0 111.061 177.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 46.6 mtt85 -93.16 168.8 10.87 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-O 122.062 0.934 . . . . 25.0 111.419 -174.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 8.4 p -109.97 165.38 11.77 Favored 'General case' 0 C--O 1.251 1.146 0 N-CA-C 104.023 -2.584 . . . . 25.0 104.023 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -133.01 156.71 46.86 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-O 123.817 1.77 . . . . 25.0 110.056 175.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 59.9 tp -128.41 127.93 43.51 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 104.212 -2.514 . . . . 25.0 104.212 170.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -125.37 152.79 44.32 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.067 -0.716 . . . . 25.0 109.067 -172.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 41.1 t -96.07 149.88 21.11 Favored 'General case' 0 C--O 1.248 0.987 0 N-CA-C 106.039 -1.837 . . . . 25.0 106.039 171.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -115.31 19.74 15.34 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 122.551 1.167 . . . . 25.0 107.957 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -115.12 149.78 37.04 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 106.635 -1.617 . . . . 25.0 106.635 176.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -149.55 153.01 36.48 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 124.062 0.851 . . . . 25.0 111.516 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -83.18 162.35 21.27 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.509 -1.293 . . . . 25.0 107.509 177.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.99 -20.49 66.52 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 118.418 0.554 . . . . 25.0 111.381 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -82.39 -1.25 49.4 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 112.736 0.643 . . . . 25.0 112.736 176.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.26 14.4 68.95 Favored Glycine 0 CA--C 1.497 -1.035 0 O-C-N 124.112 0.882 . . . . 25.0 111.728 177.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 80.9 mt -83.87 139.16 32.81 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.634 -1.617 . . . . 25.0 106.634 177.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 61.4 p -149.85 -177.1 5.71 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 116.331 -1.795 . . . . 25.0 106.349 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -133.04 133.97 43.76 Favored 'General case' 0 C--O 1.274 2.39 0 N-CA-C 115.055 1.502 . . . . 25.0 115.055 -176.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -144.09 156.4 44.34 Favored 'General case' 0 C--O 1.269 2.114 0 N-CA-C 109.316 -0.624 . . . . 25.0 109.316 169.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.9 p -144.76 144.6 21.85 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 N-CA-C 107.252 -1.388 . . . . 25.0 107.252 -178.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -112.04 138.56 48.52 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 118.992 0.814 . . . . 25.0 110.445 -177.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.6 mp -130.4 135.37 47.95 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.741 -0.837 . . . . 25.0 108.741 -175.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.448 ' HG2' ' HA ' ' A' ' 85' ' ' LEU . 17.4 pt-20 -102.3 7.83 40.53 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 117.918 -1.513 . . . . 25.0 111.622 -176.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -73.44 -6.4 70.3 Favored Glycine 0 C--O 1.216 -1.021 0 O-C-N 124.3 1.0 . . . . 25.0 113.121 178.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 49.1 t0 49.98 47.22 23.6 Favored 'General case' 0 C--O 1.262 1.743 0 CA-C-O 122.051 0.929 . . . . 25.0 111.689 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.17 35.49 4.76 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 107.279 -1.378 . . . . 25.0 107.279 -178.207 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.4 -32.21 69.96 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 121.007 0.432 . . . . 25.0 110.093 172.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.27 -11.45 60.72 Favored 'General case' 0 C--O 1.26 1.647 0 C-N-CA 119.834 -0.746 . . . . 25.0 111.675 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -110.21 -1.08 17.55 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 113.852 1.056 . . . . 25.0 113.852 174.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 20.6 mt -79.25 120.94 24.44 Favored 'General case' 0 C--O 1.248 0.997 0 O-C-N 123.831 0.707 . . . . 25.0 111.636 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 71.8 m -135.56 160.45 38.46 Favored 'General case' 0 N--CA 1.4 -2.972 0 CA-C-N 114.405 -1.27 . . . . 25.0 108.292 176.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -68.1 -7.53 30.39 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 122.47 1.129 . . . . 25.0 110.474 -177.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -61.14 -27.22 68.24 Favored 'General case' 0 C--O 1.208 -1.106 0 CA-C-N 114.426 -1.261 . . . . 25.0 109.131 177.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -103.1 -1.89 28.36 Favored 'General case' 0 C--O 1.26 1.613 0 N-CA-C 114.509 1.3 . . . . 25.0 114.509 176.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 23.1 mm -101.08 114.88 41.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 104.931 -2.248 . . . . 25.0 104.931 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 13.7 p -97.78 110.72 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 119.735 -1.853 . . . . 25.0 113.86 -168.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -151.07 -4.04 0.31 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 113.083 -1.871 . . . . 25.0 113.824 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -84.96 58.65 5.14 Favored 'General case' 0 C--N 1.346 0.443 0 N-CA-C 113.574 0.953 . . . . 25.0 113.574 -175.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 52.35 26.62 4.21 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 116.854 2.168 . . . . 25.0 116.854 178.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.11 -6.23 0.11 Allowed 'General case' 0 CA--C 1.564 1.502 0 N-CA-C 117.244 2.313 . . . . 25.0 117.244 178.112 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -65.75 133.72 51.63 Favored 'General case' 0 CA--C 1.551 0.991 0 O-C-N 121.442 -0.786 . . . . 25.0 111.174 -176.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.3 -18.74 61.17 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.02 0.528 . . . . 25.0 109.674 175.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -77.87 -8.44 58.08 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.83 -0.433 . . . . 25.0 109.83 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.37 168.84 18.88 Favored 'General case' 0 C--O 1.252 1.227 0 CA-C-O 121.159 0.504 . . . . 25.0 110.73 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 51.58 -155.56 0.15 Allowed 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 115.175 1.546 . . . . 25.0 115.175 177.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.95 16.37 74.7 Favored Glycine 0 C--O 1.247 0.93 0 N-CA-C 114.936 0.734 . . . . 25.0 114.936 -178.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -101.55 97.66 8.07 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 124.388 0.699 . . . . 25.0 109.834 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.25 136.96 54.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 122.273 1.035 . . . . 25.0 111.768 -176.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -140.11 28.18 2.5 Favored Glycine 0 C--N 1.336 0.583 0 N-CA-C 109.251 -1.54 . . . . 25.0 109.251 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 60.4 t -74.85 -37.76 42.6 Favored 'Isoleucine or valine' 0 C--O 1.251 1.147 0 N-CA-C 108.451 -0.944 . . . . 25.0 108.451 -177.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.63 128.02 16.44 Favored 'Isoleucine or valine' 0 C--O 1.246 0.872 0 O-C-N 124.57 1.169 . . . . 25.0 111.009 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 166.16 167.29 26.58 Favored Glycine 0 N--CA 1.43 -1.731 0 CA-C-N 114.046 -1.434 . . . . 25.0 110.836 -177.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -149.91 139.64 21.74 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.196 -1.038 . . . . 25.0 108.196 -176.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 85.0 p -154.74 158.07 38.99 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.128 -1.064 . . . . 25.0 108.128 177.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 159.58 161.08 10.93 Favored Glycine 0 C--O 1.24 0.472 0 N-CA-C 116.097 1.199 . . . . 25.0 116.097 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 -105.16 107.37 58.77 Favored Pre-proline 0 C--O 1.251 1.162 0 CA-C-O 121.022 0.439 . . . . 25.0 109.871 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -71.04 163.17 40.16 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 116.636 -1.776 . . . . 25.0 111.892 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -129.85 154.82 46.89 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 106.82 -1.548 . . . . 25.0 106.82 -178.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -140.3 69.12 33.54 Favored Pre-proline 0 C--N 1.306 -1.297 0 O-C-N 121.694 -0.629 . . . . 25.0 109.579 -178.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.19 139.45 42.24 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 116.382 -1.946 . . . . 25.0 112.921 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 15.3 t -93.52 -14.95 26.01 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.217 -0.901 . . . . 25.0 111.501 -176.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 10.7 p . . . . . 0 C--O 1.258 1.55 0 N-CA-C 107.592 -1.262 . . . . 25.0 107.592 179.373 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.933 0 CA-C-O 121.978 0.894 . . . . 25.0 110.781 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -143.61 101.79 5.04 Favored Pre-proline 0 C--O 1.241 0.638 0 N-CA-C 106.869 -1.53 . . . . 25.0 106.869 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.85 139.84 28.08 Favored 'Trans proline' 0 CA--C 1.511 -0.643 0 C-N-CA 116.258 -2.028 . . . . 25.0 112.968 -171.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -155.2 61.64 0.36 Allowed Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 107.764 -2.134 . . . . 25.0 107.764 177.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.415 HG12 ' H ' ' A' ' 5' ' ' VAL . 1.4 p -54.76 126.49 11.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 124.158 0.983 . . . . 25.0 110.236 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -100.54 8.96 43.15 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.506 -0.77 . . . . 25.0 110.841 -178.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -90.25 -146.95 16.68 Favored Glycine 0 C--O 1.215 -1.088 0 CA-C-N 115.527 -0.76 . . . . 25.0 112.503 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.7 p 68.92 154.74 0.14 Allowed Pre-proline 0 CA--C 1.563 1.458 0 C-N-CA 126.084 1.753 . . . . 25.0 112.628 -175.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.673 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 50.1 Cg_exo -62.68 1.25 1.11 Allowed 'Trans proline' 0 N--CA 1.498 1.746 0 N-CA-C 117.254 1.982 . . . . 25.0 117.254 -177.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.8 p -63.98 -18.17 22.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 118.831 2.9 . . . . 25.0 118.831 -168.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.5 p -134.8 119.1 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 117.308 2.336 . . . . 25.0 117.308 -175.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.56 36.28 91.18 Favored Glycine 0 C--O 1.211 -1.283 0 CA-C-N 115.481 -0.781 . . . . 25.0 113.945 174.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.3 t -51.98 -38.55 57.03 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 119.219 -0.42 . . . . 25.0 111.678 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -80.73 5.61 15.26 Favored 'General case' 0 C--O 1.249 1.037 0 N-CA-C 115.266 1.58 . . . . 25.0 115.266 -173.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 pp -143.15 178.4 7.73 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-O 118.029 -0.986 . . . . 25.0 109.773 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -56.71 132.75 52.94 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 114.023 1.12 . . . . 25.0 114.023 -173.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -134.33 155.66 49.85 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 114.266 1.21 . . . . 50.0 114.266 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -122.93 113.35 18.99 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 104.128 -2.545 . . . . 25.0 104.128 164.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 88.7 mt -120.74 118.35 29.83 Favored 'General case' 0 C--O 1.207 -1.139 0 CA-C-O 121.394 0.616 . . . . 25.0 110.122 -177.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -110.06 106.99 16.69 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.593 -1.262 . . . . 25.0 107.593 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.51 -171.3 47.06 Favored Glycine 0 C--O 1.244 0.73 0 N-CA-C 118.753 2.261 . . . . 25.0 118.753 -172.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.1 p -82.49 175.72 9.98 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.761 -0.72 . . . . 25.0 111.315 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 69.2 mt -90.97 -2.86 57.65 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 123.546 0.529 . . . . 25.0 110.711 173.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -95.39 -174.27 37.17 Favored Glycine 0 C--O 1.244 0.74 0 N-CA-C 110.02 -1.232 . . . . 25.0 110.02 176.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.4 t -74.91 138.89 42.71 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.676 0.621 . . . . 25.0 112.676 -177.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -145.8 152.9 40.27 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 117.806 0.276 . . . . 50.0 111.538 -178.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -98.09 128.51 44.64 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 103.0 -2.963 . . . . 25.0 103.0 166.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 34.2 mm -124.59 108.65 20.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 107.513 -1.291 . . . . 25.0 107.513 -178.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.673 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 9.6 mp -108.85 118.0 35.65 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 104.408 -2.441 . . . . 25.0 104.408 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.43 -36.5 59.19 Favored Glycine 0 CA--C 1.497 -1.078 0 CA-C-O 119.517 -0.602 . . . . 25.0 113.353 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.87 -151.81 41.44 Favored Glycine 0 CA--C 1.497 -1.091 0 C-N-CA 119.834 -1.174 . . . . 25.0 112.303 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -78.35 169.21 54.31 Favored Glycine 0 C--O 1.247 0.948 0 N-CA-C 110.262 -1.135 . . . . 25.0 110.262 -177.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.3 164.95 23.14 Favored Glycine 0 N--CA 1.432 -1.608 0 C-N-CA 120.819 -0.705 . . . . 25.0 113.507 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.63 109.85 17.18 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.104 -1.073 . . . . 25.0 108.104 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -106.8 156.64 18.45 Favored 'General case' 0 C--N 1.316 -0.873 0 O-C-N 124.252 0.97 . . . . 50.0 112.403 -170.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -127.91 95.28 4.16 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 105.368 -2.086 . . . . 25.0 105.368 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.1 mt -102.21 138.0 39.72 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 113.739 -1.573 . . . . 25.0 112.034 -170.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -134.88 103.13 5.48 Favored 'General case' 0 C--O 1.267 1.986 0 CA-C-O 121.969 0.89 . . . . 25.0 111.502 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.74 -26.91 52.67 Favored Glycine 0 C--N 1.314 -0.68 0 CA-C-N 115.257 -0.883 . . . . 25.0 114.393 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 52.39 -145.75 0.54 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.384 1.074 . . . . 25.0 111.363 -176.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.56 169.19 13.12 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 121.503 -0.748 . . . . 25.0 112.724 -175.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.67 157.29 30.14 Favored Glycine 0 C--O 1.225 -0.417 0 CA-C-N 115.14 -0.936 . . . . 25.0 111.579 -173.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -79.36 112.49 16.64 Favored 'General case' 0 C--O 1.261 1.671 0 N-CA-C 105.812 -1.921 . . . . 25.0 105.812 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -113.68 149.16 35.1 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.023 -0.671 . . . . 50.0 109.598 -171.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mp -111.31 92.86 4.2 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.922 0.889 . . . . 25.0 109.34 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.1 mp -107.09 120.99 43.6 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.479 1.289 . . . . 25.0 114.479 -170.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -123.51 139.41 54.04 Favored 'General case' 0 C--O 1.246 0.876 0 N-CA-C 107.728 -1.212 . . . . 25.0 107.728 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -90.71 -36.59 6.78 Favored Glycine 0 C--O 1.257 1.539 0 CA-C-O 118.105 -1.386 . . . . 25.0 115.588 -173.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.91 -166.42 52.98 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 118.552 1.176 . . . . 25.0 112.388 -176.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.14 148.19 22.7 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.319 -0.94 . . . . 25.0 111.412 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.53 162.57 38.01 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-O 122.518 1.066 . . . . 25.0 114.534 -176.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -88.54 127.94 35.55 Favored 'General case' 0 CA--C 1.479 -1.776 0 N-CA-C 101.692 -3.447 . . . . 25.0 101.692 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -121.87 156.93 32.25 Favored 'General case' 0 C--O 1.255 1.357 0 C-N-CA 122.74 0.416 . . . . 50.0 111.211 -170.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -119.3 125.54 49.32 Favored 'General case' 0 C--O 1.212 -0.91 0 N-CA-C 101.821 -3.4 . . . . 25.0 101.821 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -145.41 132.77 20.64 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 115.689 1.737 . . . . 25.0 115.689 -174.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 63.9 m -102.0 140.45 36.27 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.526 -0.916 . . . . 25.0 108.526 175.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.92 -44.52 4.78 Favored Glycine 0 N--CA 1.467 0.721 0 N-CA-C 109.183 -1.567 . . . . 25.0 109.183 174.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.32 -175.09 54.89 Favored Glycine 0 N--CA 1.465 0.593 0 CA-C-N 116.988 0.394 . . . . 25.0 112.648 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -60.83 155.24 19.97 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 122.701 1.238 . . . . 25.0 110.371 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.37 159.62 32.12 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 115.18 -0.918 . . . . 25.0 111.717 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.58 107.55 13.48 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 122.206 1.003 . . . . 25.0 108.445 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -95.6 162.93 13.42 Favored 'General case' 0 C--O 1.27 2.132 0 CA-C-N 115.075 -0.966 . . . . 50.0 111.137 -172.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.8 m -128.35 132.02 48.59 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 122.536 1.16 . . . . 25.0 109.002 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -122.32 129.06 51.79 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 105.3 -2.111 . . . . 25.0 105.3 175.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.403 ' HD3' ' HB3' ' A' ' 95' ' ' ASP . 26.4 mmt85 -127.13 -15.42 5.27 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 121.277 0.561 . . . . 25.0 109.953 179.219 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 60.59 174.8 0.1 Allowed 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 115.216 -0.902 . . . . 25.0 112.426 -171.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -89.92 -51.87 5.26 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 115.108 1.522 . . . . 25.0 115.108 -172.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.1 mt -141.87 174.07 10.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.906 -1.043 . . . . 25.0 109.519 -173.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.12 -27.58 63.87 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 107.725 -1.213 . . . . 25.0 107.725 171.226 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -72.02 -9.2 58.06 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-O 122.758 1.266 . . . . 25.0 113.447 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -94.1 141.41 28.57 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.843 1.306 . . . . 25.0 111.732 -173.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.3 t 46.85 42.58 12.23 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 113.389 -1.732 . . . . 25.0 115.347 175.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -118.7 162.03 19.12 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.423 -1.262 . . . . 25.0 111.427 -178.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -104.68 146.49 28.87 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 105.403 -2.073 . . . . 25.0 105.403 175.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.7 p -138.71 167.44 19.46 Favored Pre-proline 0 C--O 1.211 -0.932 0 N-CA-C 108.165 -1.05 . . . . 25.0 108.165 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -61.03 -20.06 65.93 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 CA-C-O 122.377 0.907 . . . . 25.0 113.234 174.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 73.1 mt -79.26 -23.58 43.55 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 119.924 -1.735 . . . . 25.0 111.13 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 147.99 -175.73 27.16 Favored Glycine 0 C--O 1.212 -1.232 0 CA-C-N 115.384 -0.825 . . . . 25.0 111.916 177.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.0 t -89.15 137.99 31.82 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 123.375 1.559 . . . . 25.0 112.485 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -117.64 17.9 14.31 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-N 114.768 -1.105 . . . . 25.0 110.532 171.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.35 138.41 49.38 Favored Glycine 0 C--N 1.338 0.661 0 CA-C-N 115.184 -0.916 . . . . 25.0 111.519 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -85.22 173.53 10.33 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 117.353 0.576 . . . . 50.0 111.745 -176.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.74 103.89 7.77 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 123.217 0.607 . . . . 25.0 112.105 -179.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.8 mt -87.02 133.75 29.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 106.579 -1.638 . . . . 25.0 106.579 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.84 -38.9 22.38 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.608 0.966 . . . . 25.0 113.608 -172.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.6 p-10 -144.79 44.32 1.37 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.787 1.032 . . . . 25.0 113.787 -167.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -61.1 131.14 49.59 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.95 1.093 . . . . 25.0 113.95 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -96.39 106.32 28.45 Favored Pre-proline 0 N--CA 1.48 1.065 0 N-CA-C 106.749 -1.575 . . . . 25.0 106.749 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -77.56 -4.29 14.47 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 N-CA-C 114.17 0.796 . . . . 25.0 114.17 -171.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 45.6 t -93.28 -41.93 9.6 Favored 'General case' 0 C--N 1.315 -0.918 0 O-C-N 124.26 0.975 . . . . 25.0 111.091 177.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -98.19 -37.15 9.81 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.979 1.474 . . . . 25.0 114.979 -172.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -87.16 168.63 13.07 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.259 0.466 . . . . 50.0 112.259 -172.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -146.04 145.84 30.74 Favored 'General case' 0 C--O 1.263 1.785 0 O-C-N 121.805 -0.559 . . . . 25.0 112.288 -178.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 75.1 mt -130.74 129.1 63.79 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 N-CA-C 109.266 -0.642 . . . . 25.0 109.266 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.403 ' HB3' ' HD3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -91.69 141.24 28.9 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 119.771 -1.83 . . . . 25.0 107.393 174.928 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.7 p -134.09 -5.9 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 121.463 0.649 . . . . 25.0 111.423 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.87 -36.27 78.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.851 -0.613 . . . . 25.0 111.929 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.46 -24.69 53.9 Favored 'General case' 0 C--O 1.248 0.989 0 N-CA-C 113.91 1.078 . . . . 25.0 113.91 -178.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.88 9.4 5.37 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 115.946 1.832 . . . . 25.0 115.946 -168.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -151.08 -75.05 0.01 OUTLIER Glycine 0 C--O 1.219 -0.81 0 C-N-CA 119.868 -1.158 . . . . 25.0 115.067 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -155.39 167.74 29.4 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 109.592 -0.521 . . . . 25.0 109.592 -171.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.2 t -120.22 -39.81 2.76 Favored 'General case' 0 C--O 1.248 0.997 0 N-CA-C 108.963 -0.755 . . . . 25.0 108.963 176.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -92.04 123.15 7.11 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 109.31 -1.516 . . . . 25.0 109.31 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.16 148.81 46.99 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.254 0.55 . . . . 25.0 111.222 -177.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -83.16 -176.48 51.51 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 115.945 -0.571 . . . . 25.0 112.008 -177.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -61.94 100.2 0.15 Allowed 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 115.05 1.5 . . . . 25.0 115.05 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -141.03 -157.4 7.16 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-O 117.222 -1.876 . . . . 25.0 108.659 176.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -152.99 162.97 40.68 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 121.114 2.457 . . . . 25.0 112.566 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 51.16 44.33 28.76 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.214 1.006 . . . . 25.0 113.118 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.24 31.82 63.36 Favored Glycine 0 C--O 1.257 1.579 0 N-CA-C 111.031 -0.828 . . . . 25.0 111.031 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.6 t -139.76 174.23 10.72 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 117.719 0.759 . . . . 25.0 110.364 -177.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.7 mt -95.18 172.64 7.99 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 101.424 -3.547 . . . . 25.0 101.424 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.33 119.8 22.88 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.652 -1.24 . . . . 25.0 107.652 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.4 m -80.06 157.6 4.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.148 -0.686 . . . . 25.0 109.148 -176.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.46 160.25 40.92 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.754 -0.832 . . . . 25.0 108.754 -176.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.502 HG12 HG22 ' A' ' 123' ' ' THR . 16.3 m -123.31 163.9 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 116.33 -0.395 . . . . 25.0 110.268 177.226 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 35.1 t -70.84 -52.44 20.33 Favored 'General case' 0 C--O 1.204 -1.325 0 N-CA-C 107.52 -1.289 . . . . 25.0 107.52 174.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -159.61 -143.79 0.1 Allowed 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 104.997 -2.223 . . . . 25.0 104.997 -178.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -69.92 -21.14 63.32 Favored 'General case' 0 C--O 1.253 1.285 0 N-CA-C 109.564 -0.532 . . . . 25.0 109.564 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -141.54 -145.44 4.55 Favored Glycine 0 C--O 1.24 0.509 0 N-CA-C 110.532 -1.027 . . . . 25.0 110.532 178.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.55 -145.13 0.33 Allowed 'General case' 0 C--O 1.245 0.843 0 C-N-CA 124.082 0.953 . . . . 25.0 109.784 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.6 mtt85 -82.09 159.06 23.5 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 113.127 0.788 . . . . 25.0 113.127 -176.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.502 HG22 HG12 ' A' ' 116' ' ' VAL . 0.5 OUTLIER -111.3 166.28 11.23 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 104.822 -2.288 . . . . 25.0 104.822 177.404 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -135.65 151.4 50.18 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.997 -0.547 . . . . 25.0 111.378 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 34.4 tp -124.61 104.34 8.64 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 103.595 -2.743 . . . . 25.0 103.595 168.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -104.46 153.03 21.63 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.634 -0.712 . . . . 25.0 110.793 -172.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 43.5 t -99.5 150.87 21.77 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.397 -2.075 . . . . 25.0 105.397 170.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -119.81 25.02 10.24 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 106.534 -1.654 . . . . 25.0 106.534 -178.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -116.1 134.84 54.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.367 -1.288 . . . . 25.0 109.461 174.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -134.12 150.02 51.11 Favored 'General case' 0 C--O 1.216 -0.673 0 O-C-N 125.176 1.547 . . . . 25.0 110.549 -175.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -74.52 165.13 25.72 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 124.11 0.964 . . . . 25.0 109.127 174.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.97 -15.33 62.9 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.683 0.754 . . . . 25.0 111.463 178.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -79.03 -11.34 60.0 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.614 -0.721 . . . . 25.0 112.348 174.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.58 26.26 39.54 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 120.505 -0.855 . . . . 25.0 112.162 -176.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 69.5 mt -101.07 141.97 33.19 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.386 -1.338 . . . . 25.0 107.386 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 80.1 p -149.24 -175.44 4.98 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.338 -1.356 . . . . 25.0 107.338 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -123.2 139.21 54.29 Favored 'General case' 0 C--O 1.247 0.926 0 N-CA-C 113.223 0.823 . . . . 25.0 113.223 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -152.07 153.99 35.04 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.789 -1.189 . . . . 25.0 107.789 166.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 10.5 p -148.51 143.8 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 N-CA-C 104.603 -2.369 . . . . 25.0 104.603 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -105.86 148.93 27.01 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 107.186 -1.413 . . . . 25.0 107.186 -175.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.5 mp -137.98 131.03 30.17 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 104.301 -2.481 . . . . 25.0 104.301 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -104.37 4.91 33.98 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 121.198 1.817 . . . . 25.0 114.758 -174.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -77.16 1.58 63.83 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 120.283 -0.961 . . . . 25.0 114.817 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 47.7 t0 52.84 61.68 3.07 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-O 122.08 0.943 . . . . 25.0 110.728 175.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -130.98 41.92 3.3 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.707 -1.133 . . . . 25.0 111.762 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.95 -25.18 66.63 Favored 'General case' 0 C--O 1.209 -1.051 0 C-N-CA 119.345 -0.942 . . . . 25.0 110.809 176.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.12 -32.15 70.03 Favored 'General case' 0 C--O 1.275 2.418 0 C-N-CA 124.094 0.957 . . . . 25.0 112.282 177.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -93.62 -27.31 16.66 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.734 1.013 . . . . 25.0 113.734 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 11.4 mt -62.84 139.79 58.74 Favored 'General case' 0 C--O 1.247 0.923 0 CA-C-O 121.947 0.88 . . . . 25.0 109.492 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 72.5 m -141.77 159.78 41.52 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 102.012 -3.329 . . . . 25.0 102.012 169.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -86.24 10.36 14.93 Favored 'General case' 0 C--O 1.214 -0.813 0 N-CA-C 108.107 -1.072 . . . . 25.0 108.107 -176.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -72.11 -26.23 62.05 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.692 0.758 . . . . 25.0 110.386 178.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 24.3 p30 -86.06 -1.25 57.2 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 109.694 -0.484 . . . . 25.0 109.694 176.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 37.3 mm -98.39 128.88 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 102.415 -3.18 . . . . 25.0 102.415 173.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.3 p -105.82 113.77 43.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 122.936 1.35 . . . . 25.0 111.665 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -142.42 9.12 1.82 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 112.524 -2.125 . . . . 25.0 107.379 178.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.9 51.75 1.57 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.421 1.088 . . . . 25.0 111.301 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 56.43 33.7 22.92 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.384 1.073 . . . . 25.0 113.665 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 18.2 m 65.29 -43.99 0.35 Allowed 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 117.468 2.396 . . . . 25.0 117.468 176.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -76.65 154.11 34.59 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 114.27 1.211 . . . . 25.0 114.27 -173.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -80.77 20.14 0.78 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.26 -0.882 . . . . 25.0 111.752 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.85 -25.52 56.29 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.986 -0.552 . . . . 25.0 111.833 -177.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -112.0 -161.32 0.75 Allowed 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 108.839 -0.8 . . . . 25.0 108.839 -174.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 67.49 -174.2 0.19 Allowed 'General case' 0 C--O 1.25 1.13 0 N-CA-C 115.796 1.776 . . . . 25.0 115.796 175.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 81.46 17.44 71.15 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 114.195 0.438 . . . . 25.0 114.195 175.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -98.94 109.86 22.55 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 122.466 -0.432 . . . . 25.0 110.888 -174.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -127.35 157.71 39.22 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 107.425 -1.324 . . . . 25.0 107.425 178.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -140.78 30.45 2.28 Favored Glycine 0 C--O 1.209 -1.451 0 N-CA-C 110.761 -0.935 . . . . 25.0 110.761 178.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.11 -28.38 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 CA-C-O 122.157 0.98 . . . . 25.0 110.939 -175.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.12 136.38 26.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 CA-C-O 122.167 0.984 . . . . 25.0 109.823 -177.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 161.89 157.52 8.95 Favored Glycine 0 N--CA 1.466 0.654 0 CA-C-N 114.605 -1.18 . . . . 25.0 111.951 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -149.67 141.97 24.18 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 108.584 -0.895 . . . . 25.0 108.584 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 88.6 p -159.46 171.54 19.53 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.865 0.866 . . . . 25.0 110.097 177.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 171.17 174.9 39.28 Favored Glycine 0 C--O 1.25 1.102 0 CA-C-N 118.814 0.734 . . . . 25.0 111.773 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -136.75 101.9 9.54 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 108.702 -0.851 . . . . 25.0 108.702 177.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.35 152.64 49.89 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 N-CA-C 115.471 1.296 . . . . 25.0 115.471 -174.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -121.84 151.38 40.71 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 107.805 -1.183 . . . . 25.0 107.805 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -141.51 76.84 20.27 Favored Pre-proline 0 C--O 1.24 0.599 0 CA-C-N 118.366 0.53 . . . . 25.0 110.49 176.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.11 155.48 61.29 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 118.35 -0.634 . . . . 25.0 113.404 -176.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.9 t -122.68 -3.46 8.76 Favored 'General case' 0 C--O 1.245 0.827 0 O-C-N 121.49 -0.756 . . . . 25.0 111.977 -177.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--O 1.271 2.214 0 N-CA-C 107.943 -1.132 . . . . 25.0 107.943 176.918 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.92 -0.4 . . . . 25.0 109.92 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -137.38 111.16 9.07 Favored Pre-proline 0 C--N 1.318 -0.798 0 O-C-N 121.739 -0.601 . . . . 25.0 109.624 175.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -67.84 149.65 78.22 Favored 'Trans proline' 0 C--O 1.245 0.842 0 C-N-CA 116.601 -1.799 . . . . 25.0 112.3 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.83 57.43 0.03 OUTLIER Glycine 0 C--O 1.244 0.727 0 N-CA-C 109.836 -1.306 . . . . 25.0 109.836 -177.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.475 HG22 ' H ' ' A' ' 7' ' ' GLY . 7.7 p -63.87 131.82 29.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 122.08 0.943 . . . . 25.0 111.568 -172.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -96.61 -6.42 36.79 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 115.3 -0.864 . . . . 25.0 110.978 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.475 ' H ' HG22 ' A' ' 5' ' ' VAL . . . -83.58 -152.57 13.47 Favored Glycine 0 C--O 1.244 0.762 0 CA-C-N 115.758 -0.655 . . . . 25.0 112.704 177.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 p 73.38 159.69 0.16 Allowed Pre-proline 0 CA--C 1.563 1.459 0 C-N-CA 126.343 1.857 . . . . 25.0 109.474 -177.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.455 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 30.3 Cg_exo -68.52 6.89 0.8 Allowed 'Trans proline' 0 CA--C 1.553 1.427 0 N-CA-C 116.069 1.526 . . . . 25.0 116.069 -174.005 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.8 p -69.01 -16.74 21.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 115.926 1.824 . . . . 25.0 115.926 -169.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.85 139.04 22.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 O-C-N 121.218 -0.927 . . . . 25.0 113.199 -174.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.87 9.09 70.02 Favored Glycine 0 N--CA 1.469 0.852 0 N-CA-C 117.586 1.794 . . . . 25.0 117.586 171.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.5 t -50.72 -43.02 57.85 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 114.272 1.212 . . . . 25.0 114.272 -169.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -77.47 7.4 5.49 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 114.167 1.173 . . . . 25.0 114.167 -176.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.33 175.28 10.21 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 120.27 -1.519 . . . . 25.0 111.221 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -56.65 125.33 21.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 123.702 0.626 . . . . 25.0 111.308 -175.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -121.94 162.83 20.36 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.981 0.734 . . . . 50.0 112.981 -173.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -130.73 114.96 16.02 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 102.518 -3.142 . . . . 25.0 102.518 163.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.0 mt -128.05 128.87 45.74 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 122.077 0.942 . . . . 25.0 109.66 -177.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -117.45 121.3 40.65 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.218 -0.901 . . . . 25.0 110.35 177.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.15 175.26 46.24 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 122.644 1.136 . . . . 25.0 115.094 -174.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.2 p -82.24 172.42 13.16 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.109 -1.046 . . . . 25.0 109.81 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.6 mt -86.79 12.09 11.7 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.176 0.512 . . . . 25.0 111.938 177.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -111.69 -172.91 19.37 Favored Glycine 0 N--CA 1.471 0.975 0 CA-C-N 114.826 -1.079 . . . . 25.0 111.581 177.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.2 t -77.16 134.02 38.79 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.013 0.745 . . . . 25.0 113.013 -178.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -148.02 163.99 35.18 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.457 -0.777 . . . . 50.0 110.853 -173.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -112.32 125.3 54.03 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 101.078 -3.675 . . . . 25.0 101.078 169.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 40.6 mm -119.13 99.95 8.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 104.92 -2.252 . . . . 25.0 104.92 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.455 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 9.4 mp -107.9 120.23 41.7 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 103.646 -2.724 . . . . 25.0 103.646 -176.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.22 -27.54 36.46 Favored Glycine 0 CA--C 1.488 -1.628 0 N-CA-C 115.264 0.866 . . . . 25.0 115.264 -171.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.74 -149.86 50.2 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 109.982 -1.247 . . . . 25.0 109.982 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.4 172.41 47.91 Favored Glycine 0 C--O 1.247 0.952 0 CA-C-N 114.901 -0.65 . . . . 25.0 114.473 -175.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.42 172.57 24.53 Favored Glycine 0 N--CA 1.439 -1.101 0 CA-C-O 119.132 -0.815 . . . . 25.0 114.281 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.8 112.78 24.72 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 104.722 -2.325 . . . . 25.0 104.722 177.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -108.96 156.35 19.81 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.052 -0.522 . . . . 50.0 110.578 -169.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -119.55 90.89 3.42 Favored 'General case' 0 C--O 1.248 1.019 0 N-CA-C 107.099 -1.445 . . . . 25.0 107.099 175.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 31.9 mt -100.81 128.63 46.77 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 113.862 -1.517 . . . . 25.0 110.869 -171.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -125.43 105.2 8.89 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.137 0.494 . . . . 25.0 112.008 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.73 -26.09 47.36 Favored Glycine 0 C--O 1.246 0.853 0 CA-C-O 116.797 -2.113 . . . . 25.0 115.929 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 52.77 -150.38 0.35 Allowed 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 119.551 1.676 . . . . 25.0 111.952 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.38 165.76 9.24 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.588 0.958 . . . . 25.0 113.588 -178.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.11 157.55 33.58 Favored Glycine 0 N--CA 1.438 -1.193 0 N-CA-C 110.097 -1.201 . . . . 25.0 110.097 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -80.87 115.29 20.28 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.52 -1.659 . . . . 25.0 106.52 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -123.56 147.55 47.18 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 119.887 -0.725 . . . . 50.0 111.166 -169.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 mp -108.65 104.57 13.9 Favored 'General case' 0 C--O 1.204 -1.308 0 N-CA-C 108.121 -1.066 . . . . 25.0 108.121 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 mp -109.21 109.83 20.88 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.784 0.802 . . . . 25.0 112.848 -174.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -118.78 96.44 5.26 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-N 113.977 -1.465 . . . . 25.0 108.101 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -59.74 -22.26 56.74 Favored Glycine 0 C--O 1.216 -0.989 0 N-CA-C 118.474 2.15 . . . . 25.0 118.474 -177.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.84 -159.07 53.79 Favored Glycine 0 C--O 1.245 0.839 0 CA-C-N 118.427 1.113 . . . . 25.0 112.444 -178.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.14 159.36 14.82 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-O 122.046 0.927 . . . . 25.0 112.524 -176.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.67 -178.32 53.3 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 114.826 -1.079 . . . . 25.0 114.229 -177.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -96.91 145.39 25.93 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 101.779 -3.415 . . . . 25.0 101.779 172.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -135.36 155.14 51.08 Favored 'General case' 0 CA--C 1.5 -0.943 0 C-N-CA 120.745 -0.382 . . . . 50.0 111.682 -170.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -109.17 122.36 47.14 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 104.994 -2.224 . . . . 25.0 104.994 174.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -142.05 136.19 29.94 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 122.466 1.126 . . . . 25.0 113.244 -176.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.7 m -113.63 133.89 55.04 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 115.169 -0.923 . . . . 25.0 110.181 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.04 -44.0 4.25 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.2 -1.16 . . . . 25.0 110.2 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.86 -161.24 52.19 Favored Glycine 0 C--O 1.252 1.234 0 C-N-CA 123.13 0.395 . . . . 25.0 113.019 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -67.25 161.82 24.03 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 122.176 -0.602 . . . . 25.0 112.296 174.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.44 167.24 41.7 Favored Glycine 0 CA--C 1.533 1.215 0 N-CA-C 111.129 -0.788 . . . . 25.0 111.129 -177.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.9 107.09 18.53 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.755 0.788 . . . . 25.0 109.711 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -102.38 153.2 20.24 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.853 -0.612 . . . . 50.0 110.479 -172.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.9 m -128.54 123.41 33.4 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-N 115.172 -0.922 . . . . 25.0 110.302 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -115.34 117.9 31.74 Favored 'General case' 0 C--O 1.21 -1.003 0 N-CA-C 108.432 -0.951 . . . . 25.0 108.432 -177.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 51.2 mtt85 -114.94 -33.41 5.44 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 113.007 0.743 . . . . 25.0 113.007 177.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 71.78 151.46 0.11 Allowed 'General case' 0 CA--C 1.551 1.017 0 O-C-N 125.195 1.559 . . . . 25.0 109.723 -173.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.74 -51.03 45.78 Favored 'General case' 0 C--O 1.24 0.576 0 O-C-N 121.015 -1.053 . . . . 25.0 113.562 -167.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.7 mt -131.8 166.6 21.21 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 121.918 0.866 . . . . 25.0 109.224 -174.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.89 -21.06 56.72 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.695 0.798 . . . . 25.0 109.341 175.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -73.8 3.27 6.8 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 115.049 1.5 . . . . 25.0 115.049 176.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -114.53 149.88 35.77 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.998 0.904 . . . . 25.0 112.202 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.2 t 55.03 46.1 24.94 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 122.903 1.335 . . . . 25.0 113.697 169.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 47.6 p-80 -134.97 -178.98 5.34 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.198 -0.91 . . . . 25.0 109.225 -175.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -122.63 145.41 48.38 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 103.823 -2.658 . . . . 25.0 103.823 175.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.8 p -133.98 167.56 22.28 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 107.129 -1.434 . . . . 25.0 107.129 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.32 -22.79 67.06 Favored 'Trans proline' 0 C--N 1.367 1.538 0 C-N-CA 116.393 -1.938 . . . . 25.0 113.693 177.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.9 -27.05 67.91 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 122.051 0.929 . . . . 25.0 111.173 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 139.5 179.05 17.2 Favored Glycine 0 C--O 1.246 0.852 0 N-CA-C 109.687 -1.365 . . . . 25.0 109.687 -171.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.6 t -81.87 150.07 27.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 123.461 1.6 . . . . 25.0 113.258 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -131.42 29.93 4.51 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 113.521 -1.672 . . . . 25.0 107.503 170.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.93 140.3 32.68 Favored Glycine 0 CA--C 1.501 -0.808 0 N-CA-C 109.144 -1.582 . . . . 25.0 109.144 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -82.03 167.91 18.36 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 118.72 -0.657 . . . . 50.0 109.517 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -124.41 114.08 19.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 118.438 0.563 . . . . 25.0 109.897 -176.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mt -100.16 127.13 53.43 Favored 'Isoleucine or valine' 0 C--O 1.25 1.122 0 N-CA-C 108.207 -1.035 . . . . 25.0 108.207 -178.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.3 mt -81.05 -44.24 18.32 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 115.292 1.59 . . . . 25.0 115.292 -173.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 57.0 p30 -133.54 44.78 2.75 Favored 'General case' 0 C--O 1.252 1.188 0 N-CA-C 113.585 0.957 . . . . 25.0 113.585 -172.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -59.24 145.23 43.64 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.351 0.66 . . . . 25.0 111.962 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -121.6 103.17 41.21 Favored Pre-proline 0 N--CA 1.473 0.695 0 CA-C-N 115.763 -0.653 . . . . 25.0 109.784 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -65.08 -12.4 34.49 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 N-CA-C 117.985 2.264 . . . . 25.0 117.985 -174.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.3 t -91.69 -32.32 15.48 Favored 'General case' 0 C--O 1.209 -1.069 0 N-CA-C 109.521 -0.548 . . . . 25.0 109.521 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -89.73 -48.23 7.4 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 113.954 1.094 . . . . 25.0 113.954 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -93.08 172.26 8.42 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.281 -1.327 . . . . 50.0 113.373 -161.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -146.64 149.95 34.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 119.343 -0.361 . . . . 25.0 110.843 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 86.2 mt -129.34 126.64 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 123.265 0.626 . . . . 25.0 109.732 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -86.44 139.63 30.73 Favored 'General case' 0 CA--C 1.502 -0.903 0 O-C-N 121.579 -0.701 . . . . 25.0 109.624 178.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.0 p -141.5 -8.3 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.173 0 CA-C-O 120.844 0.354 . . . . 25.0 110.85 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.6 t -67.42 -40.14 85.53 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 122.54 1.162 . . . . 25.0 109.495 -175.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.28 -23.61 63.85 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.407 -0.815 . . . . 25.0 111.942 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.5 mt -96.62 -65.95 0.93 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.745 1.017 . . . . 25.0 113.745 -172.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -116.24 -49.12 0.46 Allowed Glycine 0 CA--C 1.502 -0.773 0 N-CA-C 118.532 2.173 . . . . 25.0 118.532 -167.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -155.27 165.85 35.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 118.396 1.098 . . . . 25.0 111.93 -173.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.69 -24.76 3.22 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.194 0.521 . . . . 25.0 111.201 178.061 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -95.02 126.75 8.86 Favored Glycine 0 C--O 1.245 0.792 0 N-CA-C 110.594 -1.002 . . . . 25.0 110.594 173.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.11 140.74 57.81 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.981 0.896 . . . . 25.0 111.096 -176.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.29 -158.38 34.61 Favored Glycine 0 C--N 1.335 0.479 0 N-CA-C 110.833 -0.907 . . . . 25.0 110.833 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -67.75 140.46 56.71 Favored 'General case' 0 C--O 1.254 1.307 0 CA-C-O 122.175 0.988 . . . . 25.0 113.057 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 165.58 -172.95 41.23 Favored Glycine 0 C--O 1.253 1.292 0 N-CA-C 108.955 -1.658 . . . . 25.0 108.955 175.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -149.17 168.84 22.15 Favored 'General case' 0 C--O 1.245 0.857 0 C-N-CA 122.496 0.318 . . . . 25.0 110.294 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 56.58 36.49 27.69 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.26 1.207 . . . . 25.0 114.26 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 69.92 28.34 71.97 Favored Glycine 0 CA--C 1.538 1.513 0 N-CA-C 111.393 -0.683 . . . . 25.0 111.393 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 8.6 t -138.14 -178.32 5.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 117.383 0.591 . . . . 25.0 110.343 -175.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 87.2 mt -113.85 167.51 10.57 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 103.432 -2.803 . . . . 25.0 103.432 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.66 119.7 17.26 Favored 'General case' 0 C--O 1.257 1.465 0 C-N-CA 118.091 -1.444 . . . . 25.0 112.474 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.7 m -98.31 161.74 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 124.107 0.963 . . . . 25.0 109.151 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 54.0 p -148.73 171.11 16.75 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 118.901 -0.571 . . . . 25.0 111.621 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.5 m -120.95 162.6 19.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.473 0 N-CA-C 108.289 -1.004 . . . . 25.0 108.289 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.6 t -74.45 -53.72 9.0 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 106.121 -1.807 . . . . 25.0 106.121 170.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -159.83 -160.9 0.85 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 104.26 -2.496 . . . . 25.0 104.26 -177.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -65.56 -16.3 63.56 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 122.121 0.962 . . . . 25.0 111.877 176.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -133.52 -156.6 8.07 Favored Glycine 0 N--CA 1.469 0.851 0 N-CA-C 107.428 -2.269 . . . . 25.0 107.428 175.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.67 -142.25 0.32 Allowed 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.056 0.542 . . . . 25.0 109.7 178.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -96.21 170.21 9.42 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.296 1.221 . . . . 25.0 114.296 -168.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.36 160.72 28.68 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 105.952 -1.87 . . . . 25.0 105.952 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -134.89 153.78 51.92 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 117.536 0.153 . . . . 25.0 110.663 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 31.9 tp -127.65 120.85 28.97 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 104.848 -2.279 . . . . 25.0 104.848 172.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -121.95 153.43 38.51 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 118.405 0.548 . . . . 25.0 111.914 -172.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.6 t -102.55 147.25 27.0 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 103.654 -2.721 . . . . 25.0 103.654 171.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -115.5 19.04 15.67 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.931 -0.766 . . . . 25.0 108.931 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -110.89 143.37 41.61 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 105.521 -2.029 . . . . 25.0 105.521 171.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -141.12 157.69 44.94 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.879 0.737 . . . . 25.0 111.097 -176.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -80.16 164.6 23.18 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.332 -0.988 . . . . 25.0 108.332 175.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.72 -30.18 71.19 Favored 'General case' 0 C--O 1.221 -0.44 0 O-C-N 121.515 -0.74 . . . . 25.0 110.78 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -70.58 -5.06 26.4 Favored 'General case' 0 CA--C 1.554 1.096 0 C-N-CA 123.401 0.68 . . . . 25.0 112.342 177.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.59 7.53 84.31 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 115.66 -0.7 . . . . 25.0 111.915 -178.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 88.8 mt -73.16 136.83 44.82 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 106.595 -1.632 . . . . 25.0 106.595 174.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 94.4 p -148.92 -177.43 5.8 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 107.654 -1.239 . . . . 25.0 107.654 -175.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -128.38 132.54 48.53 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 119.426 1.012 . . . . 25.0 113.381 -175.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -152.51 156.71 39.93 Favored 'General case' 0 C--O 1.256 1.421 0 N-CA-C 107.205 -1.405 . . . . 25.0 107.205 168.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.9 p -146.66 147.38 17.94 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.804 0 N-CA-C 105.919 -1.882 . . . . 25.0 105.919 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -112.31 143.01 44.12 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.747 -0.66 . . . . 25.0 109.967 -170.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.8 mp -132.17 154.28 49.7 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.932 -1.136 . . . . 25.0 107.932 -177.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.51 0.97 10.06 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 116.992 2.219 . . . . 25.0 116.992 -177.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.3 -3.65 88.58 Favored Glycine 0 C--O 1.224 -0.493 0 C-N-CA 120.04 -1.076 . . . . 25.0 112.997 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 50.5 t0 48.74 61.41 3.1 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 122.323 1.058 . . . . 25.0 111.488 -177.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -123.3 41.48 3.46 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.282 -1.326 . . . . 25.0 107.624 175.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.53 -25.95 68.48 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 115.192 -0.913 . . . . 25.0 112.949 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.56 -23.82 64.54 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.424 0.63 . . . . 25.0 111.01 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -101.8 -0.04 34.92 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.769 -0.65 . . . . 25.0 112.031 -175.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 11.4 mt -78.0 134.39 37.83 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.111 -0.635 . . . . 25.0 109.328 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.2 m -135.54 162.27 33.14 Favored 'General case' 0 CA--C 1.492 -1.252 0 CA-C-N 114.605 -1.18 . . . . 25.0 109.036 173.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.44 -1.6 57.22 Favored 'General case' 0 C--O 1.204 -1.296 0 CA-C-O 122.624 1.202 . . . . 25.0 109.473 -177.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.36 -31.69 72.99 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.178 -1.374 . . . . 25.0 109.383 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -89.21 -7.05 56.34 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.877 1.323 . . . . 25.0 112.849 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 47.0 mm -95.93 108.13 20.68 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.012 0 N-CA-C 104.944 -2.243 . . . . 25.0 104.944 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 14.5 p -94.83 121.48 45.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 122.545 1.164 . . . . 25.0 111.695 -169.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -152.98 -3.57 0.22 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 112.968 -1.924 . . . . 25.0 112.298 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -74.55 51.36 0.46 Allowed 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.73 1.011 . . . . 25.0 113.73 -177.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 54.32 22.65 3.85 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.207 0.817 . . . . 25.0 113.207 -175.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.07 3.1 0.9 Allowed 'General case' 0 C--O 1.246 0.916 0 N-CA-C 115.247 1.573 . . . . 25.0 115.247 175.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -82.09 137.39 35.03 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.394 -0.522 . . . . 25.0 110.572 178.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -76.88 -12.37 59.95 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 109.198 -0.667 . . . . 25.0 109.198 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -82.72 42.64 0.79 Allowed 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 112.292 0.479 . . . . 25.0 112.292 176.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -154.25 175.16 13.84 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.065 0.946 . . . . 25.0 109.012 -178.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 62.3 -156.98 0.34 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.831 1.252 . . . . 25.0 111.638 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 58.33 28.72 62.21 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 121.926 -0.178 . . . . 25.0 113.269 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -106.63 98.64 8.28 Favored 'General case' 0 C--O 1.249 1.056 0 C-N-CA 123.083 0.553 . . . . 25.0 109.582 -176.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.87 145.11 47.97 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 121.636 0.731 . . . . 25.0 112.712 -178.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -121.94 29.7 5.5 Favored Glycine 0 C--O 1.222 -0.595 0 CA-C-N 115.154 -0.93 . . . . 25.0 112.342 174.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 58.1 t -70.64 -38.93 75.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 O-C-N 121.757 -0.849 . . . . 25.0 112.425 -174.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.9 133.05 30.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.832 0.825 . . . . 25.0 110.581 -175.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 170.07 153.43 8.64 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-N 114.607 -1.178 . . . . 25.0 110.892 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -150.88 143.66 24.51 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 117.854 0.827 . . . . 25.0 109.878 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.6 p -150.77 169.23 22.15 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 106.193 -1.78 . . . . 25.0 106.193 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -175.39 163.99 34.17 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 115.625 1.01 . . . . 25.0 115.625 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -137.38 83.56 25.87 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 107.815 -1.18 . . . . 25.0 107.815 175.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.17 161.23 46.76 Favored 'Trans proline' 0 C--N 1.349 0.589 0 O-C-N 121.99 0.469 . . . . 25.0 112.67 -176.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -130.67 159.79 36.2 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.937 -0.764 . . . . 25.0 108.937 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -135.73 84.48 32.77 Favored Pre-proline 0 C--O 1.246 0.87 0 C-N-CA 122.74 0.416 . . . . 25.0 112.034 -177.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.23 161.14 43.71 Favored 'Trans proline' 0 C--O 1.246 0.897 0 C-N-CA 116.995 -1.537 . . . . 25.0 113.323 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.5 t -127.78 17.27 6.85 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 122.061 0.934 . . . . 25.0 110.44 176.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 C--O 1.258 1.537 0 CA-C-O 117.349 -1.31 . . . . 25.0 109.566 178.639 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.954 0 CA-C-O 119.818 -0.134 . . . . 25.0 110.697 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -135.86 115.74 11.34 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 109.174 -0.676 . . . . 25.0 109.174 -178.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.1 147.38 48.43 Favored 'Trans proline' 0 C--O 1.24 0.587 0 C-N-CA 115.772 -2.352 . . . . 25.0 111.929 -177.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.33 56.84 0.26 Allowed Glycine 0 C--O 1.244 0.76 0 CA-C-O 119.043 -0.865 . . . . 25.0 112.803 -176.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.408 HG22 ' H ' ' A' ' 7' ' ' GLY . 5.9 p -70.4 125.29 28.33 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.965 0 CA-C-O 122.08 0.943 . . . . 25.0 111.525 -176.062 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -100.27 4.22 44.03 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.156 -0.929 . . . . 25.0 110.732 -176.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.408 ' H ' HG22 ' A' ' 5' ' ' VAL . . . -97.96 -145.2 18.47 Favored Glycine 0 C--O 1.24 0.513 0 N-CA-C 111.211 -0.756 . . . . 25.0 111.211 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.4 p 73.86 156.67 0.16 Allowed Pre-proline 0 N--CA 1.483 1.177 0 C-N-CA 126.508 1.923 . . . . 25.0 109.024 -176.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.549 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 32.8 Cg_exo -63.63 1.0 1.56 Allowed 'Trans proline' 0 N--CA 1.478 0.603 0 N-CA-C 116.25 1.596 . . . . 25.0 116.25 -176.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.5 p -63.8 -25.09 37.38 Favored 'Isoleucine or valine' 0 C--O 1.258 1.538 0 N-CA-C 114.786 1.402 . . . . 25.0 114.786 -171.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.8 p -130.7 135.84 59.47 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 CA-C-O 122.857 1.313 . . . . 25.0 114.477 -172.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.47 14.54 79.42 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 114.582 -1.19 . . . . 25.0 115.405 171.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.5 t -45.82 -48.67 15.67 Favored 'General case' 0 C--O 1.209 -1.043 0 N-CA-C 114.349 1.241 . . . . 25.0 114.349 -171.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -78.14 0.39 25.05 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 115.694 1.739 . . . . 25.0 115.694 -175.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.77 169.73 17.18 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.118 -0.989 . . . . 25.0 111.637 -175.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -60.07 125.87 25.32 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 124.431 1.082 . . . . 25.0 110.991 -171.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -120.46 165.7 14.59 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.725 1.38 . . . . 50.0 114.725 -176.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -128.47 101.13 6.05 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 101.967 -3.346 . . . . 25.0 101.967 163.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.3 mt -109.62 120.31 42.11 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 119.239 -0.41 . . . . 25.0 111.899 -177.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -112.9 113.45 25.52 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 123.537 0.523 . . . . 25.0 110.71 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.63 -177.72 49.42 Favored Glycine 0 N--CA 1.469 0.871 0 N-CA-C 116.534 1.374 . . . . 25.0 116.534 -172.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.9 p -76.66 172.82 12.42 Favored 'General case' 0 C--O 1.252 1.236 0 C-N-CA 123.326 0.65 . . . . 25.0 110.541 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 44.6 mt -86.15 9.89 16.11 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.314 0.578 . . . . 25.0 109.918 174.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.37 -179.4 26.01 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.926 -0.579 . . . . 25.0 111.679 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.6 t -72.09 130.4 40.82 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 122.672 0.389 . . . . 25.0 110.879 175.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -142.37 157.32 44.92 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.491 -0.559 . . . . 50.0 109.491 -177.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -94.85 123.52 38.36 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 102.942 -2.985 . . . . 25.0 102.942 160.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.1 mm -114.0 100.96 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 108.374 -0.973 . . . . 25.0 108.374 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.549 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 10.4 mp -104.93 127.47 52.78 Favored 'General case' 0 C--O 1.212 -0.88 0 N-CA-C 103.766 -2.679 . . . . 25.0 103.766 -177.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.43 -32.1 14.55 Favored Glycine 0 CA--C 1.493 -1.309 0 C-N-CA 120.167 -1.016 . . . . 25.0 113.262 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.23 -143.34 39.12 Favored Glycine 0 C--O 1.242 0.608 0 N-CA-C 110.648 -0.981 . . . . 25.0 110.648 178.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.7 164.96 53.98 Favored Glycine 0 C--O 1.248 0.988 0 N-CA-C 114.443 0.537 . . . . 25.0 114.443 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.44 164.94 33.8 Favored Glycine 0 C--O 1.248 1.025 0 N-CA-C 114.743 0.657 . . . . 25.0 114.743 175.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.19 99.5 7.83 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.34 -1.356 . . . . 25.0 107.34 173.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -94.1 152.14 18.98 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 113.665 0.987 . . . . 50.0 113.665 -175.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -117.35 96.69 5.53 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.616 -1.253 . . . . 25.0 107.616 174.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 32.7 mt -104.53 137.56 42.2 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.573 -0.739 . . . . 25.0 110.329 -168.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -128.43 97.7 4.81 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.722 -0.611 . . . . 25.0 109.509 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.57 -33.47 60.85 Favored Glycine 0 C--N 1.318 -0.425 0 N-CA-C 116.352 1.301 . . . . 25.0 116.352 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 53.3 -149.6 0.4 Allowed 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.602 1.161 . . . . 25.0 113.948 -178.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.96 161.48 30.87 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-O 121.451 0.643 . . . . 25.0 110.368 -173.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.6 158.74 31.64 Favored Glycine 0 C--O 1.246 0.879 0 N-CA-C 109.549 -1.42 . . . . 25.0 109.549 -176.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -84.67 101.49 12.22 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.222 -1.029 . . . . 25.0 108.222 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -103.38 148.0 26.41 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 113.731 1.011 . . . . 50.0 113.731 -172.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mp -108.27 107.93 18.73 Favored 'General case' 0 C--O 1.217 -0.631 0 N-CA-C 107.052 -1.462 . . . . 25.0 107.052 177.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 mp -109.21 113.43 26.26 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 122.62 1.2 . . . . 25.0 112.976 -171.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -118.15 96.55 5.38 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 105.221 -2.14 . . . . 25.0 105.221 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.56 -28.57 71.56 Favored Glycine 0 C--O 1.253 1.282 0 O-C-N 121.734 -0.604 . . . . 25.0 114.373 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.1 -157.18 52.82 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 120.748 -0.739 . . . . 25.0 112.617 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.22 154.54 12.99 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 122.407 1.099 . . . . 25.0 113.504 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.97 178.59 52.52 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 114.32 -1.309 . . . . 25.0 109.964 -177.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -96.88 143.51 27.7 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 101.345 -3.576 . . . . 25.0 101.345 176.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -130.65 153.08 49.32 Favored 'General case' 0 CA--C 1.5 -0.948 0 C-N-CA 120.065 -0.654 . . . . 50.0 110.258 -171.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -110.71 126.75 54.88 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 101.445 -3.539 . . . . 25.0 101.445 174.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -149.6 129.86 13.71 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-O 123.136 1.446 . . . . 25.0 113.956 -175.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.3 m -96.55 140.33 31.34 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.335 -1.302 . . . . 25.0 109.489 177.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.1 -40.19 4.35 Favored Glycine 0 C--O 1.242 0.632 0 N-CA-C 111.608 -0.597 . . . . 25.0 111.608 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.91 -167.39 54.05 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-O 123.298 1.499 . . . . 25.0 113.771 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -63.95 162.96 12.91 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 113.646 -1.277 . . . . 25.0 108.789 175.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.05 163.0 38.56 Favored Glycine 0 C--N 1.344 1.005 0 N-CA-C 111.644 -0.583 . . . . 25.0 111.644 -177.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.89 109.46 20.24 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 122.038 0.923 . . . . 25.0 109.214 178.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -105.49 150.8 25.0 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.462 -0.79 . . . . 50.0 111.17 -169.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.4 m -121.27 128.23 52.15 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 124.195 0.935 . . . . 25.0 111.119 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -115.38 103.23 10.59 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.39 -0.823 . . . . 25.0 110.953 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 60.9 mtt85 -109.68 -28.98 8.56 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 118.516 0.598 . . . . 25.0 110.859 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 68.22 161.65 0.19 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.391 -0.966 . . . . 25.0 108.391 -175.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.91 -37.88 23.61 Favored 'General case' 0 C--O 1.246 0.875 0 O-C-N 120.939 -1.1 . . . . 25.0 113.964 -165.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.4 mt -137.5 166.34 24.11 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.925 0.869 . . . . 25.0 111.252 -176.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.13 -28.2 57.02 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.977 1.311 . . . . 25.0 108.474 169.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -75.17 -2.98 30.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.43 -0.805 . . . . 25.0 112.123 -177.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -105.96 154.16 20.98 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 115.721 1.749 . . . . 25.0 115.721 -177.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.7 t 50.58 48.39 22.67 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.542 1.682 . . . . 25.0 115.542 174.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 35.1 p-80 -133.44 175.58 9.29 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 114.356 -1.293 . . . . 25.0 108.966 -178.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -122.97 140.37 53.09 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 105.357 -2.09 . . . . 25.0 105.357 174.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 55.3 p -128.52 171.29 8.83 Favored Pre-proline 0 N--CA 1.471 0.624 0 O-C-N 125.165 1.54 . . . . 25.0 109.564 -178.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -58.16 -22.47 56.68 Favored 'Trans proline' 0 C--N 1.364 1.347 0 CA-C-N 119.616 0.899 . . . . 25.0 113.565 174.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.1 mt -82.9 -10.78 58.65 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.605 0.594 . . . . 25.0 112.605 -176.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 143.54 -171.3 25.3 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-O 117.681 -1.621 . . . . 25.0 113.376 -177.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.2 t -102.84 147.24 27.13 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.393 1.596 . . . . 25.0 113.153 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -126.08 20.57 7.56 Favored 'General case' 0 C--O 1.263 1.771 0 CA-C-N 113.719 -1.582 . . . . 25.0 109.48 174.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.86 143.48 41.83 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 111.249 -0.74 . . . . 25.0 111.249 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -92.62 167.98 11.55 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.945 -0.738 . . . . 50.0 111.006 -172.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.57 103.44 8.43 Favored 'General case' 0 C--O 1.259 1.56 0 O-C-N 121.915 -0.491 . . . . 25.0 111.882 -171.182 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 mt -92.07 130.43 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-O 122.085 0.945 . . . . 25.0 108.535 -174.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.3 mt -82.58 -41.67 19.26 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 116.248 1.944 . . . . 25.0 116.248 -173.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 44.5 p-10 -139.51 53.44 1.71 Allowed 'General case' 0 C--O 1.252 1.193 0 CA-C-O 122.137 0.97 . . . . 25.0 113.594 -176.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -64.66 131.57 47.29 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 114.887 -1.051 . . . . 25.0 110.218 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -111.66 104.66 56.3 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 106.919 -1.512 . . . . 25.0 106.919 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -69.23 -12.26 33.47 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 N-CA-C 116.287 1.61 . . . . 25.0 116.287 -175.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.2 p -85.02 -16.7 39.89 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.627 -0.879 . . . . 25.0 108.627 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -108.78 -48.04 3.37 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 115.028 1.492 . . . . 25.0 115.028 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -92.08 169.13 10.88 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.218 -0.901 . . . . 50.0 112.348 -160.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -146.11 146.08 30.76 Favored 'General case' 0 C--O 1.249 1.052 0 C-N-CA 123.275 0.63 . . . . 25.0 111.812 -176.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 67.2 mt -127.73 134.87 64.52 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.051 0 N-CA-C 107.524 -1.288 . . . . 25.0 107.524 -177.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.77 139.49 30.52 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 107.446 -1.316 . . . . 25.0 107.446 174.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.3 p -137.76 -12.38 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 115.714 1.746 . . . . 25.0 115.714 -178.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.7 t -72.17 -27.57 62.67 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.709 1.14 . . . . 25.0 109.816 -177.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.31 -24.82 61.38 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.626 -1.17 . . . . 25.0 112.141 174.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 16.5 mt -107.19 -45.08 4.2 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.781 1.4 . . . . 25.0 114.781 -172.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -123.03 -66.58 0.22 Allowed Glycine 0 N--CA 1.472 1.035 0 N-CA-C 117.974 1.95 . . . . 25.0 117.974 -171.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -150.63 166.85 29.06 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 109.675 -0.491 . . . . 25.0 109.675 -170.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.7 t -118.51 -31.12 5.0 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.708 -1.133 . . . . 25.0 110.841 176.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -100.98 122.32 7.56 Favored Glycine 0 N--CA 1.462 0.373 0 N-CA-C 106.967 -2.453 . . . . 25.0 106.967 175.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.25 145.4 55.81 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-O 121.383 0.611 . . . . 25.0 111.744 -177.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -81.0 -170.97 44.11 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 115.328 -0.851 . . . . 25.0 113.773 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -64.33 132.94 51.63 Favored 'General case' 0 C--O 1.253 1.278 0 CA-C-O 121.769 0.795 . . . . 25.0 111.532 -177.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -177.95 -172.36 42.32 Favored Glycine 0 CA--C 1.539 1.59 0 N-CA-C 109.045 -1.622 . . . . 25.0 109.045 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -143.43 167.14 22.89 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 118.847 1.323 . . . . 25.0 112.017 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 55.11 42.24 30.94 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.143 1.377 . . . . 25.0 112.901 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 69.36 32.98 72.24 Favored Glycine 0 C--O 1.245 0.83 0 N-CA-C 110.097 -1.201 . . . . 25.0 110.097 176.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.5 t -146.78 166.43 26.68 Favored 'General case' 0 C--O 1.214 -0.788 0 CA-C-N 118.349 1.074 . . . . 25.0 110.573 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.5 mt -88.37 166.57 14.17 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 104.421 -2.437 . . . . 25.0 104.421 176.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.49 119.27 15.4 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-N 119.245 0.929 . . . . 25.0 110.241 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 35.4 m -85.79 162.1 2.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.047 -0.979 . . . . 25.0 110.481 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.7 m -140.86 168.41 19.87 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 110.32 -0.252 . . . . 25.0 110.32 -177.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 30.4 m -128.54 161.75 36.69 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 N-CA-C 107.223 -1.399 . . . . 25.0 107.223 175.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.2 t -72.09 -47.37 51.88 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 106.518 -1.66 . . . . 25.0 106.518 173.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -167.03 -161.51 0.43 Allowed 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 102.13 -3.285 . . . . 25.0 102.13 -176.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -68.32 -17.73 64.34 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 120.259 1.391 . . . . 25.0 112.039 -177.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -129.33 -155.04 8.37 Favored Glycine 0 N--CA 1.44 -1.048 0 N-CA-C 108.497 -1.841 . . . . 25.0 108.497 176.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 56.06 -150.68 0.42 Allowed 'General case' 0 N--CA 1.473 0.708 0 O-C-N 122.82 -0.223 . . . . 25.0 111.137 -178.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 27.8 mtt85 -77.45 158.78 29.83 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 116.851 2.167 . . . . 25.0 116.851 -169.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.0 163.36 16.03 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 113.47 -1.695 . . . . 25.0 106.591 177.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -137.51 154.32 49.88 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 118.451 0.569 . . . . 25.0 111.519 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 33.8 tp -123.56 119.63 30.48 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 105.754 -1.943 . . . . 25.0 105.754 169.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -119.24 154.9 32.69 Favored 'General case' 0 C--O 1.246 0.91 0 CA-C-O 121.712 0.768 . . . . 25.0 112.811 -173.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.1 t -103.0 153.69 19.98 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 104.666 -2.346 . . . . 25.0 104.666 169.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -120.67 9.52 10.81 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 122.346 1.069 . . . . 25.0 109.054 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -93.92 136.58 34.05 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 105.423 -2.065 . . . . 25.0 105.423 171.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -139.11 147.56 42.12 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.895 0.855 . . . . 25.0 110.057 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -73.99 159.25 32.98 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.012 -1.107 . . . . 25.0 108.012 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -61.98 -23.8 66.62 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 120.867 0.365 . . . . 25.0 110.587 177.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -75.83 -2.45 30.05 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.702 0.801 . . . . 25.0 111.934 177.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.39 15.8 70.55 Favored Glycine 0 C--O 1.238 0.351 0 C-N-CA 121.365 -0.445 . . . . 25.0 112.895 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 75.4 mt -88.87 139.48 30.42 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.529 -1.286 . . . . 25.0 107.529 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 86.8 p -148.56 176.19 10.53 Favored 'General case' 0 C--O 1.249 1.05 0 N-CA-C 108.771 -0.826 . . . . 25.0 108.771 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -122.28 131.8 54.1 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 113.439 0.903 . . . . 25.0 113.439 -176.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -150.28 154.21 37.5 Favored 'General case' 0 C--O 1.266 1.924 0 N-CA-C 107.317 -1.364 . . . . 25.0 107.317 168.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.4 p -145.73 146.79 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 106.813 -1.551 . . . . 25.0 106.813 175.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -112.1 142.45 44.53 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.533 -0.914 . . . . 25.0 108.533 -171.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.2 mp -133.78 143.96 48.74 Favored 'General case' 0 C--O 1.197 -1.685 0 N-CA-C 103.617 -2.734 . . . . 25.0 103.617 -173.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -115.88 5.56 14.07 Favored 'General case' 0 C--O 1.206 -1.225 0 N-CA-C 117.885 2.55 . . . . 25.0 117.885 -175.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.94 0.59 86.78 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 116.244 1.258 . . . . 25.0 116.244 177.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 41.8 t0 55.45 53.07 10.28 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 122.832 1.301 . . . . 25.0 110.359 178.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -118.65 38.64 3.7 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 113.455 -1.702 . . . . 25.0 108.428 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.9 -39.49 78.04 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.773 -0.648 . . . . 25.0 112.084 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.78 -19.47 62.0 Favored 'General case' 0 CA--C 1.577 2.005 0 O-C-N 121.156 -0.965 . . . . 25.0 112.545 -177.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.22 -26.42 20.1 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 116.132 -0.486 . . . . 25.0 111.805 177.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 22.0 mt -60.25 132.39 53.76 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 121.203 0.525 . . . . 25.0 109.646 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.9 m -135.22 160.96 36.73 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 107.529 -1.286 . . . . 25.0 107.529 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.83 -1.29 57.1 Favored 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 108.232 -1.025 . . . . 25.0 108.232 178.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -69.2 -30.04 68.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.884 -0.598 . . . . 25.0 110.838 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -90.44 -5.93 55.5 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.268 0.556 . . . . 25.0 111.018 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 17.0 mm -89.91 123.99 42.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 105.785 -1.932 . . . . 25.0 105.785 176.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.7 p -98.45 117.1 42.88 Favored 'Isoleucine or valine' 0 C--O 1.251 1.145 0 CA-C-O 122.831 1.301 . . . . 25.0 113.318 -175.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -143.97 0.56 1.08 Allowed 'General case' 0 C--O 1.251 1.146 0 CA-C-N 112.358 -2.201 . . . . 25.0 108.547 178.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.15 45.0 0.98 Allowed 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.009 0.374 . . . . 25.0 112.009 -178.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 53.49 37.57 26.02 Favored 'General case' 0 CA--C 1.561 1.4 0 CA-C-O 121.172 0.51 . . . . 25.0 112.363 -178.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.99 -4.32 0.2 Allowed 'General case' 0 CA--C 1.56 1.363 0 N-CA-C 115.636 1.717 . . . . 25.0 115.636 177.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -89.96 125.32 35.33 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 120.713 -1.242 . . . . 25.0 113.612 -177.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -77.22 -4.18 43.45 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 113.405 0.891 . . . . 25.0 113.405 -177.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -77.04 40.5 0.26 Allowed 'General case' 0 C--O 1.217 -0.649 0 N-CA-C 114.577 1.325 . . . . 25.0 114.577 178.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -152.93 -165.43 2.18 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.128 -0.694 . . . . 25.0 109.128 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 60.97 -167.11 0.19 Allowed 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 113.6 0.963 . . . . 25.0 113.6 174.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 82.2 15.89 73.28 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.374 -0.69 . . . . 25.0 111.374 -177.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -99.66 108.61 21.02 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.95 0.722 . . . . 25.0 112.95 -176.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -128.57 155.68 44.53 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 106.71 -1.589 . . . . 25.0 106.71 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -125.95 31.19 4.17 Favored Glycine 0 C--O 1.217 -0.945 0 CA-C-O 121.746 0.636 . . . . 25.0 111.895 175.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 92.3 t -73.45 -38.11 52.21 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 O-C-N 122.286 -0.538 . . . . 25.0 110.33 -175.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.56 137.73 23.83 Favored 'Isoleucine or valine' 0 C--O 1.258 1.532 0 CA-C-O 121.459 0.647 . . . . 25.0 110.442 -175.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 153.9 165.95 14.29 Favored Glycine 0 C--O 1.245 0.836 0 CA-C-N 115.482 -0.781 . . . . 25.0 111.991 -178.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -143.85 139.53 29.32 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 112.957 0.725 . . . . 25.0 112.957 176.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 84.4 p -142.69 179.9 6.71 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.857 -1.164 . . . . 25.0 107.857 175.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 135.5 172.96 12.86 Favored Glycine 0 C--O 1.24 0.517 0 N-CA-C 115.034 0.774 . . . . 25.0 115.034 175.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -137.04 113.54 9.75 Favored Pre-proline 0 C--O 1.26 1.608 0 CA-C-N 114.929 -0.635 . . . . 25.0 110.382 178.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -68.06 153.95 73.77 Favored 'Trans proline' 0 C--N 1.356 0.964 0 O-C-N 122.509 0.741 . . . . 25.0 110.663 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -128.36 139.52 52.34 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.772 -1.196 . . . . 25.0 107.772 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -131.52 69.11 81.64 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 112.689 0.626 . . . . 25.0 112.689 -177.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -70.26 150.25 64.88 Favored 'Trans proline' 0 C--N 1.346 0.419 0 CA-C-O 122.107 0.795 . . . . 25.0 113.016 -178.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.4 t -97.71 1.33 48.42 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.357 -0.838 . . . . 25.0 111.734 -175.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 C--O 1.253 1.281 0 CA-C-O 118.089 -0.957 . . . . 25.0 110.86 -177.429 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo . . . . . 0 CA--C 1.54 0.811 0 N-CA-C 114.262 0.832 . . . . 25.0 114.262 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.27 58.33 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.208 0 N-CA-C 108.362 -1.895 . . . . 25.0 108.362 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.1 p -60.29 132.77 25.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 123.219 1.485 . . . . 25.0 112.064 -170.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -101.26 -11.56 19.39 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.789 -1.096 . . . . 25.0 110.065 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.75 -151.63 14.46 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 114.735 -1.12 . . . . 25.0 112.61 177.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.2 p 73.08 158.17 0.16 Allowed Pre-proline 0 N--CA 1.496 1.854 0 C-N-CA 126.242 1.817 . . . . 25.0 110.187 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.416 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 37.6 Cg_exo -65.68 -0.81 4.11 Favored 'Trans proline' 0 C--N 1.349 0.602 0 N-CA-C 116.465 1.679 . . . . 25.0 116.465 -175.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.58 -19.23 20.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 114.311 1.226 . . . . 25.0 114.311 -173.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.5 p -140.45 136.05 36.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 114.096 1.147 . . . . 25.0 114.096 -174.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.44 25.57 56.57 Favored Glycine 0 C--O 1.242 0.652 0 N-CA-C 117.343 1.697 . . . . 25.0 117.343 172.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.9 t -50.09 -54.58 19.51 Favored 'General case' 0 C--O 1.22 -0.468 0 O-C-N 121.15 -1.206 . . . . 25.0 113.459 -175.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -80.17 4.64 16.79 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 116.447 2.018 . . . . 25.0 116.447 -171.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 pp -142.04 168.4 19.83 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 112.915 0.709 . . . . 25.0 112.915 -174.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -61.67 130.45 45.91 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.695 0.798 . . . . 25.0 112.03 -175.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -125.23 168.67 13.15 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 116.442 2.016 . . . . 50.0 116.442 -175.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -129.72 96.9 4.36 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 105.654 -1.98 . . . . 25.0 105.654 164.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 81.2 mt -108.92 113.03 25.59 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 112.462 0.541 . . . . 25.0 112.462 -176.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -104.38 113.69 27.42 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 108.409 -0.96 . . . . 25.0 108.409 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.47 177.85 48.79 Favored Glycine 0 CA--C 1.51 -0.23 0 N-CA-C 117.331 1.692 . . . . 25.0 117.331 -174.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.2 p -77.06 168.82 19.43 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-O 122.0 0.905 . . . . 25.0 112.501 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 77.6 mt -85.63 24.61 1.19 Allowed 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 114.624 -1.171 . . . . 25.0 111.531 176.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -128.77 179.36 16.68 Favored Glycine 0 N--CA 1.467 0.703 0 N-CA-C 110.48 -1.048 . . . . 25.0 110.48 175.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.1 t -66.53 137.41 56.77 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 117.86 0.83 . . . . 25.0 111.736 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -146.46 165.68 28.67 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 122.027 -0.421 . . . . 50.0 110.88 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -116.16 121.21 41.45 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 102.67 -3.085 . . . . 25.0 102.67 170.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 46.6 mm -117.12 129.29 73.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 107.523 -1.288 . . . . 25.0 107.523 -176.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.416 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 7.1 mp -128.77 125.18 37.31 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 105.399 -2.075 . . . . 25.0 105.399 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.14 -35.1 24.86 Favored Glycine 0 C--O 1.255 1.453 0 N-CA-C 115.698 1.039 . . . . 25.0 115.698 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.03 -148.43 44.48 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.38 -0.914 . . . . 25.0 111.434 -178.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.96 165.23 54.8 Favored Glycine 0 C--O 1.248 1.015 0 CA-C-O 122.471 1.039 . . . . 25.0 111.705 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.31 162.69 33.3 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 114.731 -0.734 . . . . 25.0 113.488 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.9 101.0 12.48 Favored 'General case' 0 C--O 1.203 -1.343 0 N-CA-C 105.022 -2.214 . . . . 25.0 105.022 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -96.82 151.62 19.49 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 115.88 -0.6 . . . . 50.0 110.536 -170.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -110.81 103.22 11.72 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 106.552 -1.647 . . . . 25.0 106.552 171.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 43.3 mt -106.3 132.12 52.72 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 124.032 0.833 . . . . 25.0 111.064 -174.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -130.15 104.26 7.21 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 121.465 0.65 . . . . 25.0 110.959 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.98 -30.23 63.65 Favored Glycine 0 N--CA 1.466 0.635 0 N-CA-C 116.165 1.226 . . . . 25.0 116.165 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 50.3 -151.35 0.2 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 118.29 1.045 . . . . 25.0 112.857 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.06 160.51 15.02 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.413 0.894 . . . . 25.0 113.413 -175.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.83 157.02 31.73 Favored Glycine 0 C--O 1.238 0.345 0 CA-C-N 114.778 -1.101 . . . . 25.0 111.192 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -80.4 102.91 9.91 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.236 -1.024 . . . . 25.0 108.236 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -106.05 157.75 17.3 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.344 0.592 . . . . 50.0 111.249 -169.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 mp -114.96 131.9 56.75 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 106.17 -1.789 . . . . 25.0 106.17 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.5 mp -132.71 127.09 34.02 Favored 'General case' 0 C--O 1.25 1.107 0 N-CA-C 115.217 1.562 . . . . 25.0 115.217 -174.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -120.04 145.16 47.1 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 107.333 -1.358 . . . . 25.0 107.333 172.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -98.3 -39.78 3.64 Favored Glycine 0 N--CA 1.465 0.618 0 C-N-CA 120.963 -0.637 . . . . 25.0 113.715 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.97 -167.74 54.71 Favored Glycine 0 N--CA 1.465 0.632 0 N-CA-C 110.107 -1.197 . . . . 25.0 110.107 -177.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.67 143.67 29.61 Favored 'General case' 0 CA--C 1.557 1.241 0 CA-C-O 121.85 0.833 . . . . 25.0 111.959 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.35 167.43 32.68 Favored Glycine 0 C--O 1.245 0.781 0 CA-C-N 115.169 -0.923 . . . . 25.0 113.365 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.94 114.05 23.24 Favored 'General case' 0 C--O 1.208 -1.124 0 N-CA-C 104.731 -2.322 . . . . 25.0 104.731 175.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -103.48 151.76 22.46 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.915 -0.584 . . . . 50.0 109.814 -173.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -116.09 122.83 46.31 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 104.869 -2.271 . . . . 25.0 104.869 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -145.42 138.52 26.28 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 117.651 2.463 . . . . 25.0 117.651 -169.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.422 ' OG ' HD12 ' A' ' 85' ' ' LEU . 73.2 m -111.13 141.12 45.05 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-N 115.332 -0.849 . . . . 25.0 108.998 176.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.13 -37.74 6.62 Favored Glycine 0 N--CA 1.44 -1.069 0 N-CA-C 110.296 -1.122 . . . . 25.0 110.296 172.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.51 -169.78 54.86 Favored Glycine 0 CA--C 1.507 -0.423 0 C-N-CA 119.941 -1.124 . . . . 25.0 113.439 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -63.51 154.95 30.82 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.604 -0.939 . . . . 25.0 111.369 176.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.75 162.66 30.06 Favored Glycine 0 C--O 1.244 0.729 0 N-CA-C 109.914 -1.274 . . . . 25.0 109.914 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.04 110.99 19.33 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.056 -1.09 . . . . 25.0 108.056 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -103.97 154.53 19.56 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.569 -0.453 . . . . 50.0 112.113 -170.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.5 m -120.22 105.71 11.22 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.438 -0.578 . . . . 25.0 109.438 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -89.1 93.65 9.66 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 105.159 -2.163 . . . . 25.0 105.159 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -92.55 -30.28 15.75 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 112.888 0.699 . . . . 25.0 112.888 -166.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 63.56 156.41 0.06 Allowed 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 124.337 1.055 . . . . 25.0 112.838 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.88 -67.51 0.7 Allowed 'General case' 0 C--O 1.252 1.203 0 N-CA-C 115.896 1.813 . . . . 25.0 115.896 -170.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.8 mt -137.92 -177.69 4.93 Favored 'General case' 0 C--O 1.216 -0.663 0 O-C-N 121.523 -0.736 . . . . 25.0 109.239 -173.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -53.24 -30.14 36.41 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.709 -0.848 . . . . 25.0 108.709 170.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -76.66 4.2 9.96 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 115.391 1.626 . . . . 25.0 115.391 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -118.09 142.15 47.72 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 118.173 0.442 . . . . 25.0 111.639 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.2 t 49.28 53.27 12.93 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 122.469 1.128 . . . . 25.0 112.272 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 31.9 p-80 -137.1 174.05 11.03 Favored 'General case' 0 C--O 1.212 -0.905 0 CA-C-N 114.754 -1.112 . . . . 25.0 109.229 -174.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -126.01 143.26 51.17 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 105.754 -1.943 . . . . 25.0 105.754 173.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.6 p -133.25 170.8 10.43 Favored Pre-proline 0 C--N 1.318 -0.778 0 N-CA-C 108.122 -1.066 . . . . 25.0 108.122 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.42 -16.79 43.9 Favored 'Trans proline' 0 C--O 1.206 -1.121 0 C-N-CA 117.09 -1.473 . . . . 25.0 114.043 177.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 88.8 mt -77.83 -29.81 50.8 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 120.101 -0.64 . . . . 25.0 110.966 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.55 -178.35 34.8 Favored Glycine 0 C--O 1.219 -0.829 0 N-CA-C 110.607 -0.997 . . . . 25.0 110.607 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t -96.43 148.06 23.19 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-O 122.755 1.264 . . . . 25.0 111.1 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -134.74 28.05 3.6 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 113.639 -1.619 . . . . 25.0 107.844 176.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.34 137.72 29.74 Favored Glycine 0 C--N 1.34 0.799 0 N-CA-C 108.861 -1.696 . . . . 25.0 108.861 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -87.58 165.09 15.72 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 121.321 -1.105 . . . . 50.0 110.393 -172.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -119.18 100.23 7.2 Favored 'General case' 0 C--O 1.257 1.454 0 CA-C-O 121.352 0.596 . . . . 25.0 111.687 -171.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.8 mt -89.26 132.88 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-O 123.011 1.386 . . . . 25.0 107.951 -175.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.422 HD12 ' OG ' ' A' ' 56' ' ' SER . 94.7 mt -83.93 -43.09 15.61 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 114.81 1.411 . . . . 25.0 114.81 -174.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -138.64 40.21 2.2 Favored 'General case' 0 C--O 1.26 1.608 0 N-CA-C 115.28 1.585 . . . . 25.0 115.28 -172.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -56.75 128.39 36.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.525 0.678 . . . . 25.0 111.914 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -97.96 108.1 44.47 Favored Pre-proline 0 N--CA 1.469 0.492 0 N-CA-C 106.911 -1.515 . . . . 25.0 106.911 175.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -72.4 -4.55 15.47 Favored 'Trans proline' 0 CA--C 1.552 1.394 0 N-CA-C 115.63 1.358 . . . . 25.0 115.63 -174.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 29.7 t -95.0 -46.75 6.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.085 0.469 . . . . 25.0 109.859 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -92.15 -40.52 10.97 Favored 'General case' 0 C--O 1.245 0.867 0 N-CA-C 114.382 1.253 . . . . 25.0 114.382 -172.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -84.87 171.52 12.15 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.695 0.76 . . . . 75.0 110.079 -173.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.63 155.62 45.71 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.606 0.763 . . . . 25.0 111.32 174.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 77.9 mt -125.44 124.34 66.77 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 106.796 -1.557 . . . . 25.0 106.796 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -86.25 150.75 24.15 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 119.728 -0.789 . . . . 25.0 109.179 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.9 p -154.64 -1.6 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 115.418 -0.81 . . . . 25.0 111.674 -176.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.2 t -66.28 -51.28 59.0 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.635 0.605 . . . . 25.0 112.635 -174.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.9 -24.35 60.83 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.886 0.699 . . . . 25.0 112.886 -176.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.56 -29.35 9.23 Favored 'General case' 0 C--O 1.212 -0.872 0 N-CA-C 118.075 2.621 . . . . 25.0 118.075 -174.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -121.69 -65.21 0.24 Allowed Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.456 -0.878 . . . . 25.0 115.03 -172.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -162.26 163.55 28.08 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 117.21 0.505 . . . . 25.0 109.759 -175.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 77.8 p -114.7 -28.79 6.99 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.557 0.536 . . . . 25.0 110.647 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -103.29 120.35 6.72 Favored Glycine 0 C--O 1.239 0.431 0 N-CA-C 110.642 -0.983 . . . . 25.0 110.642 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -67.24 151.18 47.99 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 118.865 1.333 . . . . 25.0 111.597 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -97.55 -157.33 30.48 Favored Glycine 0 CA--C 1.507 -0.435 0 CA-C-N 115.141 -0.936 . . . . 25.0 112.965 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -54.91 136.74 46.87 Favored 'General case' 0 C--O 1.245 0.868 0 N-CA-C 113.954 1.094 . . . . 25.0 113.954 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 165.94 172.43 33.29 Favored Glycine 0 C--O 1.22 -0.746 0 N-CA-C 109.457 -1.457 . . . . 25.0 109.457 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -141.18 166.68 24.11 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.022 0.911 . . . . 25.0 109.194 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 56.2 34.21 23.53 Favored 'General case' 0 CA--C 1.551 1.009 0 O-C-N 124.305 1.003 . . . . 25.0 113.127 -176.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.07 38.68 59.49 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 111.132 -0.787 . . . . 25.0 111.132 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.1 t -139.99 -174.23 3.86 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.803 0.802 . . . . 25.0 113.152 -176.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 52.2 mt -114.9 150.71 35.21 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 101.127 -3.657 . . . . 25.0 101.127 174.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.93 132.45 47.98 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-O 121.357 0.598 . . . . 25.0 110.058 -175.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 32.9 m -97.02 164.85 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 115.435 -0.802 . . . . 25.0 111.533 -176.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.8 m -139.95 164.54 29.74 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 110.313 -0.255 . . . . 25.0 110.313 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.3 m -126.78 166.31 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 107.584 -1.265 . . . . 25.0 107.584 176.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 30.3 t -81.55 -56.63 3.9 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 106.961 -1.496 . . . . 25.0 106.961 173.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -161.98 -147.59 0.13 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 105.263 -2.125 . . . . 25.0 105.263 -177.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -66.64 -21.68 66.11 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.371 0.268 . . . . 25.0 110.409 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -138.68 -150.38 5.59 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 110.385 -1.086 . . . . 25.0 110.385 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.19 -155.59 0.35 Allowed 'General case' 0 C--O 1.259 1.594 0 C-N-CA 123.053 0.541 . . . . 25.0 111.049 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 54.0 mtt85 -85.19 160.75 19.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 122.017 0.913 . . . . 25.0 113.018 -172.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 12.3 p -107.8 163.83 12.77 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 106.187 -1.783 . . . . 25.0 106.187 173.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -135.01 158.05 45.36 Favored 'General case' 0 CA--C 1.51 -0.587 0 O-C-N 123.529 0.518 . . . . 25.0 112.325 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 45.2 tp -128.7 136.17 50.23 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 103.759 -2.682 . . . . 25.0 103.759 172.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -127.44 148.81 50.29 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 122.468 1.128 . . . . 25.0 110.955 -176.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 32.4 t -101.96 146.5 27.78 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 103.874 -2.639 . . . . 25.0 103.874 168.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -108.82 10.45 26.59 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.406 0.622 . . . . 25.0 109.667 -174.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -94.45 143.51 26.35 Favored 'General case' 0 C--O 1.259 1.57 0 CA-C-N 113.608 -1.633 . . . . 25.0 108.938 167.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -149.12 156.7 42.58 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.809 -0.811 . . . . 25.0 108.809 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -70.24 160.58 31.92 Favored 'General case' 0 C--O 1.217 -0.635 0 N-CA-C 107.823 -1.177 . . . . 25.0 107.823 173.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.91 -21.53 66.51 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.401 -0.592 . . . . 25.0 109.401 175.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -79.68 -3.56 47.87 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.04 0.755 . . . . 25.0 113.04 177.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.96 24.01 46.86 Favored Glycine 0 N--CA 1.466 0.66 0 C-N-CA 121.113 -0.565 . . . . 25.0 113.42 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 35.9 mt -94.8 111.71 23.47 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.628 -1.249 . . . . 25.0 107.628 176.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 42.9 p -122.42 174.17 7.2 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 118.645 -0.693 . . . . 25.0 109.474 -174.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -116.39 126.3 53.27 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.344 0.52 . . . . 25.0 111.247 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -145.77 153.82 41.36 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 107.207 -1.405 . . . . 25.0 107.207 171.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 11.7 p -145.89 145.66 20.0 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 N-CA-C 106.77 -1.567 . . . . 25.0 106.77 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -106.16 143.82 33.74 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.884 -0.784 . . . . 25.0 108.884 -175.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mp -134.46 134.35 41.44 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.514 -1.291 . . . . 25.0 107.514 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -110.8 8.88 22.55 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 119.706 1.139 . . . . 25.0 112.668 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -78.91 -10.68 85.96 Favored Glycine 0 C--O 1.243 0.695 0 C-N-CA 119.596 -1.287 . . . . 25.0 112.57 174.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 48.4 t0 49.45 64.43 1.75 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 122.946 1.355 . . . . 25.0 112.051 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -130.52 36.54 3.93 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 106.274 -1.751 . . . . 25.0 106.274 176.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.55 -33.58 71.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.718 -1.128 . . . . 25.0 108.162 174.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.92 -11.73 49.39 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 113.302 0.852 . . . . 25.0 113.302 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -119.85 1.71 11.01 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 121.671 -0.643 . . . . 25.0 112.069 -178.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 14.9 mt -72.19 148.45 45.58 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.303 -0.559 . . . . 25.0 111.433 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 83.7 p -147.45 159.37 43.79 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 106.635 -1.617 . . . . 25.0 106.635 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.59 -1.9 52.16 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 108.698 -0.852 . . . . 25.0 108.698 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -68.84 -35.68 77.25 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.536 -0.913 . . . . 25.0 108.536 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -89.15 0.08 57.02 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.786 -0.571 . . . . 25.0 110.374 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 46.3 mm -94.85 113.74 29.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 104.251 -2.499 . . . . 25.0 104.251 174.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.7 p -98.78 101.91 12.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 124.081 1.896 . . . . 25.0 111.905 -170.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -116.78 -14.17 10.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 112.983 -1.917 . . . . 25.0 109.962 173.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -81.91 28.48 0.42 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.02 1.118 . . . . 25.0 114.02 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 55.66 33.32 21.04 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.232 0.827 . . . . 25.0 113.232 177.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.78 25.07 11.47 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.179 0.991 . . . . 25.0 112.698 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -90.01 133.76 34.63 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.594 -1.262 . . . . 25.0 107.594 174.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -112.82 23.04 13.86 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.203 0.601 . . . . 25.0 111.623 -176.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.79 -32.81 71.49 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 122.098 -0.376 . . . . 25.0 111.314 176.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -104.5 -156.13 0.56 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 123.29 0.636 . . . . 25.0 110.562 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 67.09 175.08 0.25 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.046 1.338 . . . . 25.0 113.824 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 87.04 9.1 74.39 Favored Glycine 0 C--O 1.224 -0.49 0 CA-C-N 115.757 -0.656 . . . . 25.0 112.478 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -82.84 100.06 10.1 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-O 121.197 0.522 . . . . 25.0 110.722 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -126.33 149.07 49.41 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.43 0.633 . . . . 25.0 109.849 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.91 33.89 2.4 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 110.746 -0.941 . . . . 25.0 110.746 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 45.1 t -73.6 -29.55 27.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.751 -0.724 . . . . 25.0 109.418 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 19.2 tt -57.18 134.67 21.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 N-CA-C 112.84 0.681 . . . . 25.0 112.84 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 158.02 157.59 8.53 Favored Glycine 0 C--O 1.222 -0.596 0 N-CA-C 114.681 0.632 . . . . 25.0 114.681 175.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -146.08 136.35 23.82 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 123.456 0.151 . . . . 25.0 110.639 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 53.6 p -152.73 163.96 38.68 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 106.97 -1.493 . . . . 25.0 106.97 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -167.44 162.46 36.25 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 114.738 0.655 . . . . 25.0 114.738 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -133.45 80.18 58.28 Favored Pre-proline 0 N--CA 1.468 0.432 0 N-CA-C 108.832 -0.803 . . . . 25.0 108.832 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -72.82 152.79 52.94 Favored 'Trans proline' 0 C--N 1.352 0.763 0 N-CA-C 114.889 1.073 . . . . 25.0 114.889 -171.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -111.01 157.13 20.29 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.42 -0.955 . . . . 25.0 108.42 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -132.12 75.01 75.71 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 112.722 0.638 . . . . 25.0 112.722 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.49 158.72 47.5 Favored 'Trans proline' 0 C--O 1.219 -0.46 0 CA-C-O 121.11 0.379 . . . . 25.0 112.845 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.7 t -132.32 -0.5 3.65 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.611 0.72 . . . . 25.0 111.837 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 C--O 1.247 0.922 0 N-CA-C 108.808 -0.812 . . . . 25.0 108.808 178.288 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo . . . . . 0 C--O 1.241 0.628 0 N-CA-C 115.002 1.116 . . . . 25.0 115.002 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.53 75.2 0.06 OUTLIER Glycine 0 C--O 1.22 -0.779 0 N-CA-C 108.797 -1.721 . . . . 25.0 108.797 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.456 HG22 ' H ' ' A' ' 7' ' ' GLY . 14.3 p -57.48 131.71 21.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-O 122.312 1.053 . . . . 25.0 111.59 -172.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -88.99 -15.04 35.15 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 114.616 -1.174 . . . . 25.0 110.987 -176.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.456 ' H ' HG22 ' A' ' 5' ' ' VAL . . . -88.08 -141.03 7.23 Favored Glycine 0 CA--C 1.506 -0.499 0 C-N-CA 121.263 -0.494 . . . . 25.0 114.17 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.0 p 71.85 157.31 0.16 Allowed Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 126.854 2.061 . . . . 25.0 111.179 -176.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.487 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 37.6 Cg_exo -65.49 1.39 2.15 Favored 'Trans proline' 0 C--N 1.362 1.249 0 N-CA-C 117.358 2.022 . . . . 25.0 117.358 -178.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.9 p -62.86 -19.0 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 115.486 1.661 . . . . 25.0 115.486 -172.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.6 p -146.61 136.12 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 113.917 1.08 . . . . 25.0 113.917 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.08 29.68 14.53 Favored Glycine 0 N--CA 1.462 0.422 0 N-CA-C 116.856 1.502 . . . . 25.0 116.856 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.9 t -57.25 -65.29 0.65 Allowed 'General case' 0 C--O 1.239 0.538 0 N-CA-C 114.132 1.16 . . . . 25.0 114.132 -177.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -80.35 10.2 4.88 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 114.347 1.24 . . . . 25.0 114.347 -170.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.91 174.56 10.39 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 118.912 -0.566 . . . . 25.0 110.461 -172.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -60.52 150.27 31.96 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 118.861 0.755 . . . . 25.0 111.72 -177.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -128.12 156.22 43.18 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.588 1.329 . . . . 50.0 114.588 -175.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -137.15 94.27 2.93 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 102.851 -3.018 . . . . 25.0 102.851 163.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.0 mt -120.25 111.72 18.16 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 114.483 1.29 . . . . 25.0 114.483 -173.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -98.19 104.94 17.01 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 115.744 -0.662 . . . . 25.0 111.484 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.95 179.55 52.68 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 117.584 1.794 . . . . 25.0 117.584 -173.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.0 p -74.63 169.54 17.59 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 112.246 0.461 . . . . 25.0 112.246 -177.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 51.2 mt -89.05 14.12 11.4 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.912 0.863 . . . . 25.0 110.332 175.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.67 178.77 17.79 Favored Glycine 0 C--O 1.223 -0.56 0 N-CA-C 108.638 -1.785 . . . . 25.0 108.638 175.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.7 t -70.29 140.91 52.41 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 117.356 0.578 . . . . 25.0 111.351 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -146.15 164.35 32.5 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.784 -0.821 . . . . 50.0 108.784 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -106.35 121.76 44.88 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 102.777 -3.045 . . . . 25.0 102.777 162.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.0 mm -109.18 111.31 35.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 107.487 -1.301 . . . . 25.0 107.487 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.487 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 4.4 mp -112.34 117.51 32.67 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.609 -1.256 . . . . 25.0 107.609 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.4 -27.69 38.78 Favored Glycine 0 C--O 1.206 -1.608 0 CA-C-O 119.133 -0.815 . . . . 25.0 114.425 -176.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.6 -147.08 44.76 Favored Glycine 0 C--O 1.243 0.658 0 C-N-CA 120.152 -1.023 . . . . 25.0 111.636 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.85 177.13 53.4 Favored Glycine 0 C--O 1.242 0.623 0 N-CA-C 112.054 -0.418 . . . . 25.0 112.054 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.04 166.87 29.31 Favored Glycine 0 C--N 1.316 -0.564 0 CA-C-N 115.854 -0.173 . . . . 25.0 112.906 176.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.01 105.19 13.8 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 106.875 -1.528 . . . . 25.0 106.875 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -104.81 138.84 40.47 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.772 -0.771 . . . . 50.0 111.596 -168.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -106.33 96.11 6.24 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.094 -1.817 . . . . 25.0 106.094 173.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 45.5 mt -105.65 143.51 33.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.247 -0.433 . . . . 25.0 110.454 -172.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -136.77 107.46 6.57 Favored 'General case' 0 C--O 1.248 0.983 0 CA-C-O 121.319 0.581 . . . . 25.0 110.698 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.05 -23.47 71.6 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 117.94 -1.478 . . . . 25.0 116.649 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 52.71 -159.13 0.13 Allowed 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 119.217 1.508 . . . . 25.0 111.814 -176.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.73 167.63 10.9 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 121.475 -0.765 . . . . 25.0 112.728 -175.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.75 155.77 32.24 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.963 -0.855 . . . . 25.0 110.963 -177.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -83.65 97.06 8.88 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.687 -0.856 . . . . 25.0 108.687 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -98.02 161.37 13.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.273 -0.421 . . . . 50.0 111.867 -169.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mp -119.55 131.93 55.64 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 105.549 -2.019 . . . . 25.0 105.549 175.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.4 mp -130.8 125.3 33.36 Favored 'General case' 0 C--O 1.248 0.996 0 N-CA-C 115.021 1.489 . . . . 25.0 115.021 -171.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -125.86 93.2 3.77 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.005 -1.452 . . . . 25.0 109.503 177.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.33 -27.02 70.05 Favored Glycine 0 C--N 1.342 0.874 0 C-N-CA 120.898 -0.668 . . . . 25.0 114.121 -177.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.99 -172.71 46.28 Favored Glycine 0 CA--C 1.522 0.514 0 CA-C-N 118.022 0.911 . . . . 25.0 113.106 177.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.94 148.72 16.61 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.94 0.876 . . . . 25.0 113.124 -175.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.59 159.04 35.23 Favored Glycine 0 C--O 1.219 -0.814 0 N-CA-C 110.274 -1.13 . . . . 25.0 110.274 -177.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -82.01 121.94 27.17 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 107.451 -1.314 . . . . 25.0 107.451 -177.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -112.02 161.42 16.49 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 119.537 -0.268 . . . . 50.0 111.686 -172.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.72 101.1 5.75 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 105.128 -2.175 . . . . 25.0 105.128 175.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -122.7 138.12 54.71 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 114.755 1.391 . . . . 25.0 114.755 -170.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 61.0 m -103.66 145.33 30.21 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.911 -1.144 . . . . 25.0 107.911 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.78 -33.18 6.5 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.781 -0.927 . . . . 25.0 110.781 173.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.59 -173.86 52.93 Favored Glycine 0 C--O 1.239 0.414 0 O-C-N 121.54 -0.976 . . . . 25.0 112.058 -177.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -58.1 149.49 23.5 Favored 'General case' 0 C--O 1.251 1.157 0 N-CA-C 112.108 0.41 . . . . 25.0 112.108 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.26 160.56 29.26 Favored Glycine 0 C--O 1.245 0.803 0 CA-C-O 119.588 -0.562 . . . . 25.0 111.752 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.04 106.56 12.15 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.966 0.412 . . . . 25.0 110.308 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -101.05 155.29 18.07 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.603 0.716 . . . . 50.0 110.524 -171.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.4 m -121.11 125.45 47.27 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.243 -0.889 . . . . 25.0 108.701 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -112.1 130.63 55.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.802 -1.555 . . . . 25.0 106.802 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 -122.28 -27.54 4.47 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 120.051 -0.66 . . . . 25.0 112.601 -177.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 63.92 161.77 0.11 Allowed 'General case' 0 N--CA 1.476 0.856 0 O-C-N 124.725 1.265 . . . . 25.0 112.241 -173.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.22 -50.66 10.6 Favored 'General case' 0 C--O 1.247 0.972 0 N-CA-C 114.595 1.332 . . . . 25.0 114.595 -171.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.7 mt -152.31 179.56 8.43 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.08 -0.711 . . . . 25.0 109.08 -172.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -54.26 -29.21 46.18 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.749 0.785 . . . . 25.0 110.451 167.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -69.55 -1.93 10.04 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 114.715 -1.129 . . . . 25.0 113.584 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.81 147.18 37.48 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-O 121.259 0.552 . . . . 25.0 112.385 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.1 t 43.95 60.36 2.76 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 114.471 -1.24 . . . . 25.0 113.934 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 53.5 p-80 -135.12 169.07 18.01 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 115.74 -0.664 . . . . 25.0 110.18 -175.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -116.95 142.62 46.72 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 104.034 -2.58 . . . . 25.0 104.034 171.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 94.7 p -128.0 168.92 13.8 Favored Pre-proline 0 N--CA 1.471 0.602 0 N-CA-C 105.643 -1.984 . . . . 25.0 105.643 -177.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.88 -22.34 62.11 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 117.223 -1.384 . . . . 25.0 113.272 176.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.6 mt -76.71 -18.06 58.73 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.02 0.748 . . . . 25.0 113.02 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 134.99 -176.92 19.7 Favored Glycine 0 C--N 1.31 -0.905 0 N-CA-C 110.853 -0.899 . . . . 25.0 110.853 -177.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.0 t -82.31 147.47 28.86 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 115.601 1.704 . . . . 25.0 115.601 -177.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -135.66 29.89 3.19 Favored 'General case' 0 C--O 1.249 1.031 0 CA-C-N 113.619 -1.628 . . . . 25.0 107.866 173.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.57 147.23 50.64 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 114.27 -1.332 . . . . 25.0 111.957 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -86.69 165.46 16.08 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 107.518 -1.289 . . . . 50.0 107.518 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -121.42 120.12 34.06 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 110.209 -0.293 . . . . 25.0 110.209 -176.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.5 mt -99.1 128.99 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 107.76 -1.2 . . . . 25.0 107.76 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.6 mt -85.2 -46.96 10.57 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 114.929 1.455 . . . . 25.0 114.929 -169.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 42.2 p-10 -131.56 35.59 3.82 Favored 'General case' 0 C--O 1.247 0.948 0 O-C-N 121.27 -0.894 . . . . 25.0 112.751 -175.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -51.37 140.14 17.97 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.821 -1.082 . . . . 25.0 112.323 -176.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -106.84 108.04 61.32 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 108.146 -1.057 . . . . 25.0 108.146 175.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -73.73 -2.3 12.01 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 N-CA-C 115.098 1.153 . . . . 25.0 115.098 -173.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.6 t -101.82 -36.34 8.71 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-O 121.851 0.834 . . . . 25.0 110.093 178.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -98.47 -39.33 8.81 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 113.734 1.013 . . . . 25.0 113.734 -171.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -84.66 169.98 13.78 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.783 -0.573 . . . . 75.0 110.818 -172.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.55 147.81 30.5 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 120.934 -0.307 . . . . 25.0 111.341 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.0 mt -129.33 130.05 67.47 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 N-CA-C 108.284 -1.006 . . . . 25.0 108.284 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.63 139.89 30.1 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 108.507 -0.923 . . . . 25.0 108.507 173.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.7 p -133.69 -5.48 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.237 -0.892 . . . . 25.0 111.446 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.1 t -74.22 -33.08 63.25 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.422 -0.799 . . . . 25.0 111.958 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.97 -43.15 93.59 Favored 'General case' 0 C--O 1.247 0.934 0 O-C-N 121.748 -0.595 . . . . 25.0 111.656 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.16 -13.07 15.83 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 114.853 1.427 . . . . 25.0 114.853 -172.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.68 -80.55 0.25 Allowed Glycine 0 C--O 1.22 -0.753 0 N-CA-C 116.513 1.365 . . . . 25.0 116.513 -172.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -158.14 157.52 32.91 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 117.436 0.618 . . . . 25.0 112.02 -170.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.7 t -108.37 -28.01 9.64 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 123.839 0.712 . . . . 25.0 111.23 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -92.27 106.15 3.37 Favored Glycine 0 CA--C 1.5 -0.906 0 O-C-N 121.369 -0.832 . . . . 25.0 112.288 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.75 143.39 57.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.856 0.828 . . . . 25.0 110.541 -176.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.61 -154.32 30.6 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 116.012 -0.54 . . . . 25.0 114.126 -175.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -59.24 138.19 57.69 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 113.39 0.885 . . . . 25.0 113.39 -176.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 172.73 -168.55 41.62 Favored Glycine 0 C--O 1.252 1.251 0 N-CA-C 110.079 -1.208 . . . . 25.0 110.079 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -155.98 165.49 36.29 Favored 'General case' 0 C--O 1.247 0.957 0 N-CA-C 108.018 -1.105 . . . . 25.0 108.018 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 54.44 36.65 26.06 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 114.984 1.476 . . . . 25.0 114.984 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.32 40.81 32.55 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 109.72 -1.352 . . . . 25.0 109.72 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.7 t -153.74 178.47 9.84 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 117.885 0.843 . . . . 25.0 110.848 -176.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 71.5 mt -95.89 159.78 14.8 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 104.232 -2.507 . . . . 25.0 104.232 168.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.34 130.9 44.78 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 119.711 -0.796 . . . . 25.0 109.186 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.8 m -98.72 155.72 3.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 CA-C-N 115.607 -0.724 . . . . 25.0 109.505 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 97.5 p -144.03 167.01 23.38 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.405 -0.591 . . . . 25.0 109.405 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.447 HG12 HG22 ' A' ' 123' ' ' THR . 33.3 m -120.52 161.98 19.64 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 N-CA-C 108.807 -0.812 . . . . 25.0 108.807 178.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.6 t -66.04 -51.77 55.18 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.952 -1.129 . . . . 25.0 107.952 174.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -172.04 -156.28 0.1 Allowed 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 103.261 -2.866 . . . . 25.0 103.261 -178.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -73.48 5.28 3.89 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 113.761 1.022 . . . . 25.0 113.761 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -148.86 -156.88 7.33 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 106.397 -2.681 . . . . 25.0 106.397 175.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 56.64 -164.06 0.16 Allowed 'General case' 0 CA--C 1.562 1.422 0 O-C-N 124.287 0.639 . . . . 25.0 112.527 176.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.6 mtt85 -75.09 159.22 31.94 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.788 1.033 . . . . 25.0 113.788 -170.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.447 HG22 HG12 ' A' ' 116' ' ' VAL . 0.7 OUTLIER -101.76 159.69 15.11 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 104.499 -2.408 . . . . 25.0 104.499 174.368 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -130.95 152.05 50.69 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-O 122.564 1.173 . . . . 25.0 110.681 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 39.0 tp -126.78 117.48 22.74 Favored 'General case' 0 C--O 1.245 0.853 0 N-CA-C 103.69 -2.707 . . . . 25.0 103.69 172.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -119.74 152.25 37.49 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 111.952 0.353 . . . . 25.0 111.952 -174.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.9 t -94.45 152.65 18.42 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 104.726 -2.324 . . . . 25.0 104.726 168.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -117.32 17.55 14.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.978 0.894 . . . . 25.0 109.032 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -112.56 146.81 37.89 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 105.607 -1.997 . . . . 25.0 105.607 174.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -139.45 151.87 46.57 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.236 0.541 . . . . 25.0 110.036 -175.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -72.28 160.23 32.74 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 106.305 -1.739 . . . . 25.0 106.305 175.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.36 -18.92 65.11 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.151 0.501 . . . . 25.0 110.106 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -69.36 -8.78 49.51 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.205 0.817 . . . . 25.0 113.205 173.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.17 20.45 57.25 Favored Glycine 0 C--O 1.22 -0.726 0 C-N-CA 120.169 -1.015 . . . . 25.0 110.765 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.2 mt -106.37 119.61 39.71 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.881 -0.785 . . . . 25.0 108.881 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.8 p -116.68 174.97 5.79 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 106.132 -1.803 . . . . 25.0 106.132 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -114.95 131.68 56.82 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 118.681 0.673 . . . . 25.0 110.436 -177.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -145.98 156.86 43.79 Favored 'General case' 0 C--O 1.256 1.413 0 N-CA-C 109.323 -0.621 . . . . 25.0 109.323 166.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.8 p -146.24 141.1 21.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 106.045 -1.835 . . . . 25.0 106.045 177.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -99.13 147.78 24.74 Favored 'General case' 0 C--O 1.249 1.047 0 N-CA-C 107.699 -1.223 . . . . 25.0 107.699 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.6 mp -134.42 133.38 40.45 Favored 'General case' 0 C--O 1.206 -1.186 0 N-CA-C 103.341 -2.837 . . . . 25.0 103.341 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -110.01 13.41 23.35 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 120.051 -0.66 . . . . 25.0 110.966 -177.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -79.11 -5.9 88.95 Favored Glycine 0 C--O 1.217 -0.931 0 CA-C-N 114.809 -1.087 . . . . 25.0 112.04 172.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 14.2 t0 51.5 55.11 9.9 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 114.594 1.331 . . . . 25.0 114.594 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -128.81 46.22 2.65 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.988 -0.551 . . . . 25.0 109.536 -174.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.62 -31.91 66.71 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 113.625 0.972 . . . . 25.0 113.625 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.86 -28.74 65.91 Favored 'General case' 0 CA--C 1.554 1.106 0 O-C-N 121.482 -0.761 . . . . 25.0 111.943 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -93.64 -18.28 22.34 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 112.322 0.49 . . . . 25.0 112.322 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.5 mt -66.48 123.66 20.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 122.195 0.998 . . . . 25.0 111.486 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.401 ' C ' ' H ' ' A' ' 152' ' ' ASP . 70.9 m -137.51 164.06 29.64 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 105.522 -2.029 . . . . 25.0 105.522 177.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -71.51 10.63 0.6 Allowed 'General case' 0 C--O 1.219 -0.511 0 CA-C-O 121.225 0.536 . . . . 25.0 110.866 175.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.401 ' H ' ' C ' ' A' ' 150' ' ' SER . 46.8 t0 -72.61 -30.04 64.0 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 122.631 1.205 . . . . 25.0 110.129 177.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -94.12 8.76 40.43 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.889 -1.051 . . . . 25.0 111.65 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 39.6 mm -116.49 144.67 23.64 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 105.675 -1.972 . . . . 25.0 105.675 175.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.3 p -123.66 127.34 73.92 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 CA-C-O 122.172 0.986 . . . . 25.0 110.827 174.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.85 -30.59 5.36 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 114.379 -1.282 . . . . 25.0 109.873 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -85.42 84.25 7.69 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 115.637 1.717 . . . . 25.0 115.637 -172.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 54.75 25.24 6.33 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.759 1.763 . . . . 25.0 115.759 172.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.41 17.19 4.62 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.872 1.269 . . . . 25.0 113.514 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -98.42 125.49 43.6 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-O 121.234 0.54 . . . . 25.0 110.404 -176.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -67.24 3.09 1.31 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.469 0.914 . . . . 25.0 113.469 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.73 -15.23 63.53 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.33 0.652 . . . . 25.0 111.23 176.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.79 171.06 11.21 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 113.212 0.819 . . . . 25.0 113.212 -177.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 62.93 -170.92 0.17 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.328 1.451 . . . . 25.0 113.981 177.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 77.09 20.23 75.98 Favored Glycine 0 C--O 1.247 0.953 0 CA-C-N 115.304 -0.862 . . . . 25.0 111.15 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -124.9 109.0 12.48 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.806 -0.813 . . . . 25.0 108.806 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -127.54 150.71 49.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.313 -0.995 . . . . 25.0 108.313 -177.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -123.34 40.94 1.87 Allowed Glycine 0 CA--C 1.519 0.337 0 N-CA-C 108.961 -1.656 . . . . 25.0 108.961 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 59.5 t -94.63 -31.95 4.48 Favored 'Isoleucine or valine' 0 C--O 1.251 1.171 0 C-N-CA 122.628 0.371 . . . . 25.0 110.676 -175.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.43 130.05 16.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 CA-C-O 122.705 1.24 . . . . 25.0 113.125 -174.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 151.72 155.64 7.09 Favored Glycine 0 CA--C 1.532 1.145 0 N-CA-C 108.561 -1.815 . . . . 25.0 108.561 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -153.34 147.38 25.53 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 117.849 0.825 . . . . 25.0 110.535 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 98.2 p -149.64 164.98 33.68 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.964 -1.124 . . . . 25.0 107.964 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -175.6 -170.12 38.09 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.995 -0.621 . . . . 25.0 112.369 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -152.59 99.56 2.8 Favored Pre-proline 0 C--N 1.314 -0.963 0 N-CA-C 107.819 -1.178 . . . . 25.0 107.819 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -71.02 153.58 63.07 Favored 'Trans proline' 0 C--O 1.247 0.936 0 C-N-CA 117.05 -1.5 . . . . 25.0 113.396 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -118.79 154.0 33.56 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 106.861 -1.533 . . . . 25.0 106.861 177.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -141.98 77.44 18.44 Favored Pre-proline 0 N--CA 1.47 0.529 0 CA-C-O 121.065 0.459 . . . . 25.0 111.813 -178.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -69.76 145.97 58.77 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 117.462 -1.226 . . . . 25.0 111.666 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 13.4 t -132.36 8.89 4.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.881 0.848 . . . . 25.0 109.526 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 C--N 1.324 -0.512 0 CA-C-N 115.035 -0.984 . . . . 25.0 109.708 177.656 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo . . . . . 0 CA--C 1.53 0.295 0 CA-C-O 122.414 0.922 . . . . 25.0 114.197 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.15 62.7 0.05 OUTLIER Glycine 0 C--O 1.241 0.578 0 N-CA-C 108.47 -1.852 . . . . 25.0 108.47 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.674 HG22 ' H ' ' A' ' 7' ' ' GLY . 12.2 p -48.5 131.47 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 113.512 0.93 . . . . 25.0 113.512 -172.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -100.68 12.34 37.65 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 114.95 -1.023 . . . . 25.0 110.619 -175.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.674 ' H ' HG22 ' A' ' 5' ' ' VAL . . . -116.9 -151.39 9.45 Favored Glycine 0 N--CA 1.439 -1.117 0 CA-C-N 115.797 -0.638 . . . . 25.0 112.832 -178.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 p 71.53 157.81 0.16 Allowed Pre-proline 0 CA--C 1.555 1.166 0 C-N-CA 126.292 1.837 . . . . 25.0 110.807 -177.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -67.71 6.99 0.62 Allowed 'Trans proline' 0 C--N 1.356 0.932 0 N-CA-C 117.279 1.992 . . . . 25.0 117.279 -176.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.1 p -67.99 -14.43 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 N-CA-C 114.779 1.4 . . . . 25.0 114.779 -173.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.1 p -150.24 144.41 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.269 0 N-CA-C 115.116 1.525 . . . . 25.0 115.116 -175.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.32 17.39 79.69 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 117.726 1.85 . . . . 25.0 117.726 169.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.2 t -50.45 -53.38 30.09 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 114.037 1.125 . . . . 25.0 114.037 -171.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -83.07 8.16 13.74 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 116.541 2.052 . . . . 25.0 116.541 -173.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -141.27 171.9 13.43 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 120.754 -1.216 . . . . 25.0 113.541 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -58.76 127.37 31.87 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.719 0.771 . . . . 25.0 112.478 -174.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -123.75 166.68 15.15 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 113.351 0.871 . . . . 50.0 113.351 -175.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -131.29 95.53 3.8 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 103.349 -2.834 . . . . 25.0 103.349 163.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 64.1 mt -102.99 128.7 49.72 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.15 0.5 . . . . 25.0 110.375 -177.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -124.67 116.04 21.74 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.818 0.818 . . . . 25.0 109.911 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.49 -177.69 49.55 Favored Glycine 0 N--CA 1.462 0.397 0 N-CA-C 116.867 1.507 . . . . 25.0 116.867 -174.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.8 p -84.52 172.9 11.26 Favored 'General case' 0 C--O 1.248 0.982 0 C-N-CA 124.838 1.255 . . . . 25.0 113.467 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.1 mt -87.94 36.56 0.77 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.262 0.553 . . . . 25.0 110.25 171.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -144.19 176.18 23.58 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 107.91 -2.076 . . . . 25.0 107.91 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.5 t -65.57 138.01 57.76 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 112.76 0.652 . . . . 25.0 112.76 -177.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -146.77 164.34 33.1 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.717 -0.674 . . . . 50.0 110.527 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -109.43 114.38 27.98 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 105.202 -2.148 . . . . 25.0 105.202 163.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 40.3 mm -104.1 115.64 46.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 106.764 -1.569 . . . . 25.0 106.764 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 9.8 mp -107.5 127.77 53.91 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 106.484 -1.673 . . . . 25.0 106.484 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.66 -33.08 8.69 Favored Glycine 0 C--N 1.313 -0.724 0 CA-C-O 119.297 -0.724 . . . . 25.0 112.474 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.58 -146.06 49.82 Favored Glycine 0 C--O 1.256 1.47 0 CA-C-N 118.745 1.273 . . . . 25.0 111.996 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.75 168.13 54.1 Favored Glycine 0 C--O 1.248 1.007 0 O-C-N 122.601 -0.353 . . . . 25.0 113.286 -176.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.59 169.13 35.17 Favored Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 111.581 -0.608 . . . . 25.0 111.581 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.95 118.93 25.73 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.51 -1.292 . . . . 25.0 107.51 176.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -116.57 148.47 40.86 Favored 'General case' 0 CA--C 1.511 -0.532 0 O-C-N 121.335 -0.853 . . . . 50.0 111.602 -171.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -104.8 107.38 18.32 Favored 'General case' 0 C--O 1.249 1.054 0 N-CA-C 106.42 -1.696 . . . . 25.0 106.42 171.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 64.3 mt -112.56 133.77 54.44 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 121.99 -0.444 . . . . 25.0 111.008 -175.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -131.93 107.06 8.45 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 121.449 0.642 . . . . 25.0 110.778 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.37 -26.79 50.63 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-O 119.023 -0.876 . . . . 25.0 115.095 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 51.48 -152.15 0.22 Allowed 'General case' 0 C--O 1.244 0.815 0 CA-C-N 117.716 0.758 . . . . 25.0 111.782 -175.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.37 164.29 16.47 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.768 1.025 . . . . 25.0 113.768 -175.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.22 155.43 31.69 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 114.853 -1.067 . . . . 25.0 110.859 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -79.62 102.49 8.94 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 106.665 -1.605 . . . . 25.0 106.665 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -104.85 155.24 19.09 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 121.097 0.475 . . . . 50.0 111.779 -173.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 mp -111.66 134.27 53.34 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 105.87 -1.9 . . . . 25.0 105.87 174.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.5 mp -131.73 117.63 18.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.577 0.703 . . . . 25.0 110.724 -174.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -118.14 89.94 3.23 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.978 -1.01 . . . . 25.0 109.663 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.31 -31.59 74.27 Favored Glycine 0 N--CA 1.468 0.809 0 N-CA-C 116.92 1.528 . . . . 25.0 116.92 -172.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.9 -163.94 51.33 Favored Glycine 0 C--O 1.243 0.705 0 O-C-N 121.864 -0.786 . . . . 25.0 111.269 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.21 161.53 19.09 Favored 'General case' 0 C--O 1.248 1.009 0 C-N-CA 123.051 0.541 . . . . 25.0 109.798 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.93 161.4 32.23 Favored Glycine 0 C--O 1.248 0.991 0 CA-C-O 118.941 -0.921 . . . . 25.0 111.209 177.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -80.85 121.19 25.65 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 105.785 -1.932 . . . . 25.0 105.785 177.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -111.51 152.35 27.6 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.343 -0.844 . . . . 50.0 109.855 -177.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -118.86 119.1 33.37 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 105.742 -1.948 . . . . 25.0 105.742 177.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -141.65 134.74 29.12 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 115.159 1.54 . . . . 25.0 115.159 -168.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.5 m -103.38 141.51 35.82 Favored 'General case' 0 C--O 1.249 1.032 0 N-CA-C 107.229 -1.397 . . . . 25.0 107.229 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.21 -37.36 5.97 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 108.442 -1.863 . . . . 25.0 108.442 175.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.84 -171.11 55.14 Favored Glycine 0 C--O 1.248 1.003 0 C-N-CA 120.626 -0.797 . . . . 25.0 111.859 -178.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -65.73 157.09 31.12 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 117.498 0.649 . . . . 25.0 110.061 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.46 164.86 32.0 Favored Glycine 0 C--O 1.245 0.808 0 CA-C-N 115.606 -0.725 . . . . 25.0 112.656 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.15 96.25 9.84 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 123.593 0.757 . . . . 25.0 110.319 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -90.71 159.89 16.12 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 123.462 0.705 . . . . 50.0 112.066 -170.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.1 m -125.51 125.43 43.24 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.797 -0.638 . . . . 25.0 109.385 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -114.68 89.15 3.03 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.398 -0.964 . . . . 25.0 108.398 177.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -88.84 -34.48 17.0 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 119.321 -0.371 . . . . 25.0 111.735 -175.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 66.74 160.82 0.15 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.542 1.137 . . . . 25.0 111.632 -173.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -90.83 -42.88 10.39 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 116.196 1.925 . . . . 25.0 116.196 -166.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.3 mt -140.65 170.49 15.68 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.139 0.792 . . . . 25.0 113.139 -172.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.99 -25.19 43.07 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 123.751 0.82 . . . . 25.0 110.914 175.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -79.12 -12.13 59.99 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 115.112 -0.949 . . . . 25.0 112.906 -178.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -81.73 139.55 34.81 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.412 -0.805 . . . . 25.0 112.911 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.4 t 45.91 40.06 6.27 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 116.52 2.045 . . . . 25.0 116.52 171.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -107.37 170.09 8.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.239 -1.346 . . . . 25.0 110.964 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -124.23 146.66 48.59 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 106.13 -1.804 . . . . 25.0 106.13 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 87.9 p -142.37 168.64 12.89 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 108.613 -0.884 . . . . 25.0 108.613 -177.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -61.04 -27.03 83.98 Favored 'Trans proline' 0 CA--C 1.553 1.44 0 C-N-CA 117.631 -1.112 . . . . 25.0 111.566 175.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.4 mt -65.6 -32.29 73.79 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.861 0.689 . . . . 25.0 112.861 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.53 -174.48 35.65 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 109.974 -1.25 . . . . 25.0 109.974 -176.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.8 t -105.55 144.67 31.98 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.407 1.099 . . . . 25.0 112.74 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -123.82 16.68 9.42 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.027 -1.442 . . . . 25.0 108.964 177.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -62.0 140.94 47.06 Favored Glycine 0 C--N 1.335 0.524 0 CA-C-N 115.645 -0.707 . . . . 25.0 112.649 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -87.03 170.68 11.33 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 117.858 0.829 . . . . 50.0 113.057 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.04 98.36 5.95 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.518 -0.765 . . . . 25.0 110.799 -172.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.2 mt -89.65 133.02 32.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 107.837 -1.171 . . . . 25.0 107.837 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 76.8 mt -85.5 -49.06 8.37 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 115.323 1.601 . . . . 25.0 115.323 -171.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -131.13 36.04 3.87 Favored 'General case' 0 C--O 1.247 0.953 0 CA-C-O 121.458 0.647 . . . . 25.0 112.695 -173.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -53.78 131.59 39.82 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.261 -0.882 . . . . 25.0 112.263 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -103.59 105.66 48.4 Favored Pre-proline 0 C--O 1.238 0.474 0 N-CA-C 108.185 -1.042 . . . . 25.0 108.185 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.78 -9.68 26.92 Favored 'Trans proline' 0 C--N 1.35 0.611 0 N-CA-C 116.119 1.546 . . . . 25.0 116.119 -173.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.1 t -95.9 -36.87 10.94 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.27 -0.572 . . . . 25.0 109.774 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -95.62 -38.02 10.58 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 114.001 1.111 . . . . 25.0 114.001 -173.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -87.77 172.41 9.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.403 0.62 . . . . 75.0 110.478 -173.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -145.08 148.81 34.08 Favored 'General case' 0 C--O 1.252 1.199 0 CA-C-N 116.084 -0.507 . . . . 25.0 111.739 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 85.7 mt -129.09 133.07 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 108.486 -0.931 . . . . 25.0 108.486 -176.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -85.83 149.03 25.53 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 121.694 0.759 . . . . 25.0 109.122 173.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.0 p -146.25 -13.03 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 O-C-N 121.641 -0.662 . . . . 25.0 112.75 176.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.1 t -63.48 -39.95 95.81 Favored 'General case' 0 C--O 1.219 -0.524 0 O-C-N 121.565 -0.709 . . . . 25.0 111.432 -174.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.78 -8.61 59.57 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-N 115.398 -0.819 . . . . 25.0 112.661 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.7 mt -106.18 -29.64 9.72 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.815 0.672 . . . . 25.0 112.815 -174.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.39 -71.6 0.01 OUTLIER Glycine 0 N--CA 1.465 0.574 0 N-CA-C 117.598 1.799 . . . . 25.0 117.598 -176.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -144.96 158.23 43.88 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.794 -0.817 . . . . 25.0 108.794 -170.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 41.0 t -113.55 -28.74 7.4 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 123.651 0.594 . . . . 25.0 112.286 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -100.39 119.6 6.57 Favored Glycine 0 N--CA 1.472 1.054 0 C-N-CA 121.495 -0.383 . . . . 25.0 112.323 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.29 146.4 34.36 Favored 'General case' 0 C--O 1.245 0.853 0 N-CA-C 114.065 1.135 . . . . 25.0 114.065 -174.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -95.86 -151.95 28.65 Favored Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.824 -0.703 . . . . 25.0 114.26 -177.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -59.51 131.73 51.85 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 122.446 1.117 . . . . 25.0 111.639 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 160.38 170.44 24.97 Favored Glycine 0 C--O 1.24 0.476 0 N-CA-C 107.573 -2.211 . . . . 25.0 107.573 -179.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -148.22 167.73 24.35 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 118.299 1.05 . . . . 25.0 109.4 -177.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 62.98 38.6 10.94 Favored 'General case' 0 C--O 1.248 1.011 0 C-N-CA 124.518 1.127 . . . . 25.0 111.801 -174.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 65.82 44.18 92.56 Favored Glycine 0 C--O 1.242 0.629 0 N-CA-C 109.938 -1.265 . . . . 25.0 109.938 177.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.7 t -151.58 179.76 8.1 Favored 'General case' 0 C--O 1.212 -0.873 0 O-C-N 122.391 -0.476 . . . . 25.0 111.18 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 85.1 mt -106.8 167.02 10.16 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 103.855 -2.646 . . . . 25.0 103.855 173.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.54 131.17 42.88 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 119.597 1.09 . . . . 25.0 110.21 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 18.6 m -95.44 163.47 2.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.426 -0.806 . . . . 25.0 109.838 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 80.0 p -149.03 160.09 43.63 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.538 -0.726 . . . . 25.0 110.6 -177.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 28.0 m -122.44 165.16 18.71 Favored 'Isoleucine or valine' 0 C--O 1.252 1.221 0 N-CA-C 109.727 -0.471 . . . . 25.0 109.727 -177.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.3 t -76.28 -50.75 13.55 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 122.22 1.01 . . . . 25.0 109.682 176.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -162.18 -152.77 0.25 Allowed 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 103.753 -2.684 . . . . 25.0 103.753 -176.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -73.31 -6.19 44.47 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 119.211 0.914 . . . . 25.0 110.63 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -148.21 -146.68 4.38 Favored Glycine 0 C--O 1.247 0.958 0 N-CA-C 109.922 -1.271 . . . . 25.0 109.922 174.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.25 -152.55 0.39 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.051 0.541 . . . . 25.0 112.416 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -75.71 162.37 28.28 Favored 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 113.919 1.081 . . . . 25.0 113.919 -171.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.61 158.0 21.38 Favored 'General case' 0 C--O 1.213 -0.851 0 N-CA-C 105.978 -1.86 . . . . 25.0 105.978 175.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -129.66 144.57 51.34 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 124.12 0.887 . . . . 25.0 111.419 175.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 49.4 tp -115.41 122.77 46.83 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 102.778 -3.045 . . . . 25.0 102.778 173.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -121.59 155.29 35.38 Favored 'General case' 0 C--O 1.211 -0.957 0 CA-C-O 121.39 0.614 . . . . 25.0 110.411 -173.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 41.0 t -92.04 152.57 19.91 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.49 -1.3 . . . . 25.0 107.49 171.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -123.01 19.17 10.05 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 108.539 -0.912 . . . . 25.0 108.539 175.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -118.96 139.84 51.0 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 105.223 -2.14 . . . . 25.0 105.223 170.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -139.25 165.08 28.13 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.528 0.68 . . . . 25.0 110.231 -177.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -85.68 163.96 17.95 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.021 -1.474 . . . . 25.0 107.021 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.31 -24.41 67.27 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 108.116 -1.068 . . . . 25.0 108.116 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -74.86 -5.55 44.21 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.432 -0.804 . . . . 25.0 112.472 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.75 1.23 83.06 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 120.33 -0.938 . . . . 25.0 111.811 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.8 mt -75.74 133.99 40.59 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.417 -0.586 . . . . 25.0 109.417 175.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 88.1 p -144.44 -172.71 3.85 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 106.199 -1.778 . . . . 25.0 106.199 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -131.4 141.35 49.84 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 121.293 -0.163 . . . . 25.0 110.614 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -154.45 158.81 40.52 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 106.99 -1.485 . . . . 25.0 106.99 166.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.2 p -145.23 144.37 21.53 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 N-CA-C 108.247 -1.02 . . . . 25.0 108.247 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -105.36 136.67 44.48 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 108.453 -0.943 . . . . 25.0 108.453 -177.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.1 mp -134.03 129.8 36.62 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 106.957 -1.497 . . . . 25.0 106.957 -177.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -90.96 -1.75 57.79 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 119.224 -0.99 . . . . 25.0 112.482 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -66.35 -21.24 70.23 Favored Glycine 0 C--O 1.242 0.607 0 N-CA-C 115.139 0.816 . . . . 25.0 115.139 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 29.4 t0 53.14 59.11 4.65 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 123.626 1.679 . . . . 25.0 111.324 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -120.98 41.0 3.42 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 112.217 -2.265 . . . . 25.0 107.711 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.36 -35.39 75.57 Favored 'General case' 0 C--O 1.214 -0.796 0 CA-C-N 114.961 -1.018 . . . . 25.0 113.511 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.17 -29.42 62.83 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 118.232 0.469 . . . . 25.0 110.794 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -85.21 -13.22 50.61 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 112.8 0.667 . . . . 25.0 112.8 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 14.5 mt -69.87 128.2 35.55 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.94 0.719 . . . . 25.0 112.94 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 34.4 m -138.59 161.65 36.57 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.34 -0.985 . . . . 25.0 108.34 171.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.92 4.93 5.69 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 109.5 -0.556 . . . . 25.0 109.5 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -66.75 -30.74 71.04 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.684 0.615 . . . . 25.0 110.451 177.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -91.63 -4.0 55.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.129 0.49 . . . . 25.0 111.338 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 48.2 mm -94.02 126.26 46.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 106.542 -1.651 . . . . 25.0 106.542 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.2 p -103.43 114.57 43.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 122.113 0.958 . . . . 25.0 110.827 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -156.18 -9.17 0.11 Allowed 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.729 1.751 . . . . 25.0 115.729 -177.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -88.18 71.93 9.16 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 118.855 0.752 . . . . 25.0 111.264 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 56.49 21.15 5.36 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.27 1.028 . . . . 25.0 113.347 -178.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 53.84 38.33 28.41 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.756 -0.656 . . . . 25.0 111.415 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -123.26 124.8 43.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.36 0.6 . . . . 25.0 111.332 -178.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.09 -4.28 28.02 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.726 -0.67 . . . . 25.0 112.303 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.34 -13.01 61.03 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.644 -0.502 . . . . 25.0 109.644 174.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.24 -176.31 6.26 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 122.727 0.411 . . . . 25.0 110.497 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 58.85 -162.45 0.24 Allowed 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.201 -1.363 . . . . 25.0 113.045 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.15 22.04 77.05 Favored Glycine 0 C--N 1.336 0.578 0 N-CA-C 110.945 -0.862 . . . . 25.0 110.945 -175.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -112.99 93.85 4.62 Favored 'General case' 0 C--O 1.246 0.875 0 C-N-CA 123.673 0.789 . . . . 25.0 110.535 -176.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -128.84 145.57 51.17 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 109.148 -0.686 . . . . 25.0 109.148 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -119.35 24.08 8.28 Favored Glycine 0 N--CA 1.462 0.424 0 N-CA-C 111.368 -0.693 . . . . 25.0 111.368 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 44.6 t -71.59 -30.15 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 122.083 0.944 . . . . 25.0 109.44 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.49 134.58 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 122.196 0.998 . . . . 25.0 109.211 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 154.81 152.14 6.05 Favored Glycine 0 C--O 1.242 0.611 0 CA-C-N 115.393 -0.821 . . . . 25.0 112.992 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -148.38 123.62 10.21 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.355 -0.609 . . . . 25.0 109.355 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 56.2 p -151.97 160.14 43.57 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.316 -0.994 . . . . 25.0 108.316 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 166.06 -172.8 41.52 Favored Glycine 0 C--N 1.319 -0.374 0 C-N-CA 121.252 -0.499 . . . . 25.0 112.161 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -138.99 109.3 7.67 Favored Pre-proline 0 C--O 1.244 0.766 0 N-CA-C 107.943 -1.132 . . . . 25.0 107.943 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.92 164.48 31.54 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 117.655 -1.097 . . . . 25.0 113.266 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -128.52 156.03 43.93 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.531 -0.759 . . . . 25.0 109.124 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -132.01 87.74 43.37 Favored Pre-proline 0 C--O 1.243 0.733 0 N-CA-C 108.912 -0.773 . . . . 25.0 108.912 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -71.29 156.18 59.35 Favored 'Trans proline' 0 C--N 1.353 0.8 0 N-CA-C 113.893 0.689 . . . . 25.0 113.893 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 11.8 t -123.3 -11.49 7.93 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.286 0.565 . . . . 25.0 110.927 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 10.1 p . . . . . 0 C--O 1.235 0.342 0 N-CA-C 107.654 -1.239 . . . . 25.0 107.654 177.341 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo . . . . . 0 N--CA 1.472 0.233 0 N-CA-C 113.503 0.54 . . . . 25.0 113.503 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.41 56.82 0.01 OUTLIER Glycine 0 C--O 1.225 -0.416 0 O-C-N 121.921 -0.487 . . . . 25.0 112.023 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.514 HG22 ' H ' ' A' ' 7' ' ' GLY . 7.2 p -64.42 137.71 24.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 122.027 0.917 . . . . 25.0 111.287 -176.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -105.66 -4.53 20.94 Favored 'General case' 0 C--O 1.242 0.661 0 O-C-N 121.742 -0.599 . . . . 25.0 110.849 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.514 ' H ' HG22 ' A' ' 5' ' ' VAL . . . -84.99 -141.54 5.51 Favored Glycine 0 C--O 1.221 -0.692 0 C-N-CA 121.492 -0.385 . . . . 25.0 113.384 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.0 p 69.78 157.8 0.15 Allowed Pre-proline 0 N--CA 1.485 1.31 0 C-N-CA 125.413 1.485 . . . . 25.0 111.61 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -72.84 3.07 4.7 Favored 'Trans proline' 0 C--N 1.353 0.774 0 N-CA-C 116.46 1.677 . . . . 25.0 116.46 -177.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.4 p -67.17 -18.15 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 116.196 1.925 . . . . 25.0 116.196 -170.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.4 p -148.27 144.28 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 CA-C-N 119.222 0.919 . . . . 25.0 113.39 -176.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.29 15.59 80.77 Favored Glycine 0 C--N 1.333 0.379 0 N-CA-C 117.18 1.632 . . . . 25.0 117.18 174.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.3 t -52.64 -48.68 66.25 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.887 1.069 . . . . 25.0 113.887 -171.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -77.72 3.82 13.11 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 115.198 1.555 . . . . 25.0 115.198 -173.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.93 168.82 18.99 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.903 1.075 . . . . 25.0 113.903 -177.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.62 129.39 41.69 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.573 0.583 . . . . 25.0 112.573 -175.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -128.52 159.88 34.07 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 115.451 1.649 . . . . 50.0 115.451 -174.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -112.86 118.1 33.97 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 104.529 -2.397 . . . . 25.0 104.529 162.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.2 mt -121.14 85.82 2.47 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.956 0.884 . . . . 25.0 111.627 -173.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -90.01 110.64 21.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.296 -0.865 . . . . 25.0 109.984 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.02 170.45 43.42 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 116.181 1.232 . . . . 25.0 116.181 -176.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.2 p -71.81 174.89 6.27 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.753 0.787 . . . . 25.0 112.989 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 73.6 mt -86.13 18.6 3.01 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.099 -0.955 . . . . 25.0 111.193 176.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.66 176.35 16.06 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.402 -1.079 . . . . 25.0 110.402 176.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.4 t -70.73 136.63 49.06 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 117.649 0.725 . . . . 25.0 110.517 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -143.51 159.32 42.64 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 120.903 0.382 . . . . 50.0 110.044 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -95.96 131.12 42.66 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 102.959 -2.978 . . . . 25.0 102.959 161.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.8 mm -121.36 121.9 65.92 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 N-CA-C 105.497 -2.038 . . . . 25.0 105.497 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.5 tt -123.45 124.0 41.92 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.066 -1.087 . . . . 25.0 108.066 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.3 -38.27 11.24 Favored Glycine 0 CA--C 1.502 -0.722 0 C-N-CA 119.947 -1.12 . . . . 25.0 113.102 -177.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 72.19 -147.25 40.73 Favored Glycine 0 C--O 1.254 1.364 0 CA-C-N 118.983 1.391 . . . . 25.0 112.018 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.95 164.78 54.63 Favored Glycine 0 C--O 1.243 0.691 0 N-CA-C 111.751 -0.54 . . . . 25.0 111.751 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.22 163.67 34.82 Favored Glycine 0 C--O 1.244 0.719 0 CA-C-O 119.462 -0.632 . . . . 25.0 113.741 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.5 103.34 11.97 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.165 -1.42 . . . . 25.0 107.165 176.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -103.32 157.63 16.89 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.471 -0.491 . . . . 50.0 110.258 -172.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -120.56 90.66 3.37 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 108.82 -0.807 . . . . 25.0 108.82 177.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.0 mp -86.06 136.5 33.21 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.035 -0.529 . . . . 25.0 110.694 -175.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -138.55 106.62 5.72 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.331 -0.618 . . . . 25.0 109.331 174.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.98 -28.17 54.85 Favored Glycine 0 N--CA 1.467 0.766 0 CA-C-O 118.011 -1.438 . . . . 25.0 116.184 -175.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 54.8 -147.99 0.49 Allowed 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 118.187 0.994 . . . . 25.0 111.428 -177.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.94 163.47 19.64 Favored 'General case' 0 C--O 1.256 1.409 0 CA-C-O 122.153 0.978 . . . . 25.0 112.495 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.05 157.63 33.66 Favored Glycine 0 CA--C 1.521 0.452 0 CA-C-N 114.358 -1.292 . . . . 25.0 110.173 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -81.77 110.96 17.57 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 105.635 -1.987 . . . . 25.0 105.635 177.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -110.6 150.81 28.44 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.934 -0.706 . . . . 50.0 110.02 -171.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 mp -112.9 95.07 5.21 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.957 0.786 . . . . 25.0 109.457 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.8 mp -100.74 116.34 32.4 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 114.963 1.468 . . . . 25.0 114.963 -170.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -118.03 111.92 19.56 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 115.3 -0.864 . . . . 25.0 109.207 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.37 -32.61 79.86 Favored Glycine 0 C--O 1.254 1.389 0 N-CA-C 117.262 1.665 . . . . 25.0 117.262 -174.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.47 -163.78 42.97 Favored Glycine 0 N--CA 1.458 0.143 0 C-N-CA 120.91 -0.662 . . . . 25.0 111.909 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.2 159.46 17.63 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.307 0.575 . . . . 25.0 112.317 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.38 173.1 47.55 Favored Glycine 0 C--O 1.227 -0.291 0 CA-C-N 115.447 -0.797 . . . . 25.0 114.113 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.54 125.26 33.65 Favored 'General case' 0 C--O 1.208 -1.112 0 N-CA-C 104.069 -2.567 . . . . 25.0 104.069 176.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -117.96 157.56 26.51 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.907 0.384 . . . . 50.0 110.967 -174.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -113.26 131.04 56.07 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 102.869 -3.011 . . . . 25.0 102.869 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -148.98 149.05 30.52 Favored 'General case' 0 C--O 1.248 0.997 0 C-N-CA 119.374 -0.93 . . . . 25.0 111.691 -175.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.19 146.76 35.61 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 109.6 -0.519 . . . . 25.0 109.6 -176.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -98.85 -42.75 2.79 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-O 118.649 -1.084 . . . . 25.0 113.445 -174.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.34 -169.6 52.79 Favored Glycine 0 C--O 1.248 0.991 0 CA-C-N 118.843 1.322 . . . . 25.0 111.534 -177.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -60.58 155.08 19.51 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.846 -0.797 . . . . 25.0 110.21 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.0 163.23 32.24 Favored Glycine 0 C--O 1.249 1.063 0 CA-C-N 115.312 -0.858 . . . . 25.0 111.036 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.75 96.09 9.15 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 123.395 0.678 . . . . 25.0 110.028 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -88.94 158.25 18.12 Favored 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 123.258 0.623 . . . . 50.0 111.622 -170.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.1 m -123.15 134.04 54.22 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.965 -0.754 . . . . 25.0 108.965 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -126.45 100.81 6.42 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.467 -1.309 . . . . 25.0 107.467 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 54.2 mtt85 -100.13 -27.67 13.42 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.552 0.945 . . . . 25.0 113.552 -178.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 67.77 162.22 0.19 Allowed 'General case' 0 CA--C 1.534 0.356 0 O-C-N 125.276 1.61 . . . . 25.0 110.386 -174.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.8 -49.56 17.73 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 116.166 1.913 . . . . 25.0 116.166 -170.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 81.8 mt -153.98 -179.65 8.06 Favored 'General case' 0 C--O 1.205 -1.251 0 O-C-N 121.45 -0.781 . . . . 25.0 109.535 -171.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -55.86 -27.1 50.07 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.635 -0.876 . . . . 25.0 108.635 167.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -71.29 -10.28 59.49 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 112.965 0.728 . . . . 25.0 112.965 -178.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -99.34 155.32 17.58 Favored 'General case' 0 C--O 1.215 -0.719 0 O-C-N 121.76 -0.588 . . . . 25.0 110.463 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.4 m 42.83 56.49 3.95 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.093 -0.958 . . . . 25.0 113.464 169.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 42.8 p-80 -134.38 168.79 18.27 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 122.02 0.914 . . . . 25.0 111.482 -174.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -125.75 138.93 53.88 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 102.992 -2.966 . . . . 25.0 102.992 173.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.5 p -134.99 172.51 7.13 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 108.316 -0.994 . . . . 25.0 108.316 -173.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -60.13 -15.73 35.74 Favored 'Trans proline' 0 CA--C 1.555 1.559 0 N-CA-C 114.782 1.032 . . . . 25.0 114.782 175.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.6 mt -85.23 -24.67 27.73 Favored 'General case' 0 C--O 1.215 -0.723 0 N-CA-C 111.8 0.296 . . . . 25.0 111.8 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.06 -165.21 30.68 Favored Glycine 0 C--O 1.21 -1.393 0 C-N-CA 120.39 -0.909 . . . . 25.0 111.618 -175.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.9 t -106.55 141.41 37.88 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 122.762 1.268 . . . . 25.0 112.089 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -132.96 32.95 3.72 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-N 114.989 -1.005 . . . . 25.0 109.73 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -73.16 160.99 54.21 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 110.481 -1.047 . . . . 25.0 110.481 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -104.46 169.79 8.27 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 117.994 0.897 . . . . 50.0 110.539 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -121.07 104.58 9.89 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.432 1.093 . . . . 25.0 110.545 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.4 mt -94.02 135.13 29.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 106.747 -1.575 . . . . 25.0 106.747 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 21.6 mt -84.48 -45.63 12.45 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.729 1.751 . . . . 25.0 115.729 -174.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -135.27 38.1 2.95 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 115.134 -0.939 . . . . 25.0 113.429 -169.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -59.26 125.07 22.13 Favored 'General case' 0 C--O 1.218 -0.605 0 N-CA-C 108.791 -0.818 . . . . 25.0 108.791 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -92.1 103.82 9.2 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.897 -0.592 . . . . 25.0 109.697 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -69.04 -4.25 13.17 Favored 'Trans proline' 0 CA--C 1.548 1.209 0 N-CA-C 115.841 1.439 . . . . 25.0 115.841 -175.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.6 t -95.78 -43.3 7.93 Favored 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 122.193 -0.317 . . . . 25.0 110.829 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -97.43 -38.08 9.75 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 113.812 1.041 . . . . 25.0 113.812 -174.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -86.81 170.57 11.58 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.729 -0.388 . . . . 75.0 110.687 -172.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -145.62 149.34 34.35 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 116.208 -0.451 . . . . 25.0 111.006 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 67.7 mt -124.92 125.83 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 107.6 -1.259 . . . . 25.0 107.6 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -89.34 136.23 33.14 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-O 122.02 0.914 . . . . 25.0 108.913 173.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 p -134.46 2.97 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 114.452 -1.249 . . . . 25.0 108.539 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.475 ' HB2' ' HA ' ' A' ' 156' ' ' PHE . 23.7 t -67.32 -47.84 69.34 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 120.722 -0.391 . . . . 25.0 111.146 -175.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.19 -36.0 82.18 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.894 0.702 . . . . 25.0 112.894 -175.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.3 -49.64 4.19 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.585 0.958 . . . . 25.0 113.585 -175.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.31 -78.8 1.32 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 116.375 1.31 . . . . 25.0 116.375 -169.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -157.06 171.37 20.58 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 117.518 0.659 . . . . 25.0 110.114 -168.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 30.6 t -105.51 -36.25 7.19 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.587 0.755 . . . . 25.0 111.451 -177.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -105.91 145.68 15.97 Favored Glycine 0 N--CA 1.468 0.819 0 CA-C-O 118.355 -1.247 . . . . 25.0 111.354 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -61.61 148.31 42.84 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-N 118.814 1.307 . . . . 25.0 110.245 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.0 -167.1 41.15 Favored Glycine 0 C--O 1.243 0.708 0 CA-C-N 114.764 -1.107 . . . . 25.0 113.309 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -65.23 142.11 58.41 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.385 -0.968 . . . . 25.0 108.385 177.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 169.9 178.2 40.77 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 108.723 -1.751 . . . . 25.0 108.723 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -138.18 168.93 18.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 118.102 0.951 . . . . 25.0 109.485 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 61.05 35.28 18.88 Favored 'General case' 0 C--O 1.253 1.241 0 O-C-N 123.958 0.786 . . . . 25.0 112.489 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 65.03 39.32 96.32 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 120.785 -0.722 . . . . 25.0 111.74 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.7 t -146.24 177.43 9.0 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.752 -0.462 . . . . 25.0 109.752 -176.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 92.5 mt -90.08 170.27 10.47 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 105.507 -2.034 . . . . 25.0 105.507 175.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.21 111.72 1.84 Allowed 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 118.575 0.625 . . . . 25.0 110.679 -177.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 17.0 m -102.57 155.19 5.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 107.078 -1.453 . . . . 25.0 107.078 174.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 83.5 p -156.46 173.52 16.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 118.316 0.507 . . . . 25.0 110.715 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.1 m -118.97 160.39 18.87 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 N-CA-C 109.245 -0.65 . . . . 25.0 109.245 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.6 t -69.71 -52.48 25.14 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.837 -1.542 . . . . 25.0 106.837 173.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -164.28 -160.74 0.55 Allowed 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 102.947 -2.983 . . . . 25.0 102.947 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -55.16 -38.87 68.85 Favored 'General case' 0 C--O 1.252 1.225 0 CA-C-N 118.078 0.399 . . . . 25.0 111.104 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.72 -156.42 13.57 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 112.073 -0.411 . . . . 25.0 112.073 176.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.87 -168.67 0.18 Allowed 'General case' 0 C--O 1.251 1.132 0 C-N-CA 124.128 0.971 . . . . 25.0 111.475 177.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 64.9 mtt85 -72.83 160.35 32.3 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.46 0.911 . . . . 25.0 113.46 -171.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -102.6 168.16 9.45 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 105.575 -2.009 . . . . 25.0 105.575 175.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -131.57 156.03 46.46 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.778 0.799 . . . . 25.0 111.961 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 52.5 tp -127.32 116.21 20.17 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 102.976 -2.972 . . . . 25.0 102.976 174.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -122.69 162.99 20.92 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 108.601 -0.889 . . . . 25.0 108.601 -173.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.0 t -140.09 144.41 36.77 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 103.123 -2.918 . . . . 25.0 103.123 172.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -102.4 12.45 36.53 Favored 'General case' 0 C--O 1.245 0.859 0 N-CA-C 109.163 -0.68 . . . . 25.0 109.163 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -81.25 135.11 35.7 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 105.192 -2.151 . . . . 25.0 105.192 172.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -141.91 147.35 36.93 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 122.367 1.08 . . . . 25.0 110.96 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.26 159.51 31.13 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.232 -1.396 . . . . 25.0 107.232 174.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.07 -20.32 66.13 Favored 'General case' 0 CA--C 1.548 0.886 0 O-C-N 121.688 -0.632 . . . . 25.0 109.665 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -77.29 -4.45 45.03 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.49 -0.777 . . . . 25.0 113.072 175.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.18 6.14 63.29 Favored Glycine 0 CA--C 1.51 -0.247 0 N-CA-C 116.571 1.388 . . . . 25.0 116.571 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 69.2 mt -86.52 120.02 27.4 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 110.313 -0.255 . . . . 25.0 110.313 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 25.6 p -119.51 176.57 5.3 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.442 0.697 . . . . 25.0 109.248 -178.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -118.1 132.06 56.38 Favored 'General case' 0 C--O 1.257 1.456 0 N-CA-C 114.126 1.158 . . . . 25.0 114.126 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -152.57 151.69 30.96 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.169 -1.048 . . . . 25.0 108.169 167.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.5 p -149.09 147.83 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 106.113 -1.81 . . . . 25.0 106.113 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -109.73 145.22 36.95 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 111.685 0.254 . . . . 25.0 111.685 -177.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mp -134.0 128.34 34.16 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.451 -1.314 . . . . 25.0 107.451 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -86.9 -12.77 46.75 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 114.905 1.446 . . . . 25.0 114.905 -173.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -75.75 -6.22 81.11 Favored Glycine 0 C--O 1.212 -1.267 0 N-CA-C 116.347 1.299 . . . . 25.0 116.347 -171.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 47.7 t0 50.87 54.11 11.82 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 122.216 1.008 . . . . 25.0 113.068 -175.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 14.5 p80 -114.35 41.44 2.3 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 107.227 -1.397 . . . . 25.0 107.227 174.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.53 -36.61 84.33 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.004 -0.998 . . . . 25.0 111.624 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -77.49 -24.04 50.18 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.105 -0.997 . . . . 25.0 111.219 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.13 -24.71 37.46 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.541 -0.754 . . . . 25.0 110.699 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 8.1 mt -63.22 139.12 58.74 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 119.8 -0.76 . . . . 25.0 111.756 177.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 92.8 p -138.27 165.74 25.95 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.543 -0.91 . . . . 25.0 108.543 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.68 -3.18 29.82 Favored 'General case' 0 C--N 1.312 -1.03 0 O-C-N 120.997 -1.064 . . . . 25.0 109.879 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -77.43 -37.0 52.59 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 120.944 -1.098 . . . . 25.0 111.398 -177.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -89.72 -5.44 57.01 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 121.138 -0.225 . . . . 25.0 111.421 -177.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 44.4 mm -99.63 122.01 50.96 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.793 0 N-CA-C 103.833 -2.654 . . . . 25.0 103.833 173.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.7 p -112.82 125.08 70.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 122.779 1.276 . . . . 25.0 111.377 -174.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.475 ' HA ' ' HB2' ' A' ' 97' ' ' SER . 1.3 p90 -141.68 -32.22 0.54 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 112.774 -2.012 . . . . 25.0 109.717 -176.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -75.47 55.41 0.81 Allowed 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.674 1.361 . . . . 25.0 114.674 -176.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 60.1 15.88 5.51 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 115.616 1.71 . . . . 25.0 115.616 175.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.4 m 65.29 -23.99 0.09 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.965 1.706 . . . . 25.0 115.599 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -58.86 125.35 23.18 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.248 0.619 . . . . 25.0 111.24 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -96.89 15.04 23.32 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.174 0.805 . . . . 25.0 113.174 -175.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.9 2.26 12.94 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.92 1.081 . . . . 25.0 113.92 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -145.87 -174.96 4.56 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.323 -1.362 . . . . 25.0 107.323 177.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 67.74 -178.24 0.21 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.442 1.097 . . . . 25.0 111.58 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 86.59 21.44 51.09 Favored Glycine 0 C--O 1.24 0.498 0 N-CA-C 109.159 -1.576 . . . . 25.0 109.159 -172.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -77.56 89.44 3.89 Favored 'General case' 0 C--O 1.247 0.96 0 C-N-CA 123.198 0.599 . . . . 25.0 111.659 -177.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -123.28 143.36 50.11 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.598 -0.889 . . . . 25.0 108.598 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -140.79 32.92 2.09 Favored Glycine 0 N--CA 1.461 0.358 0 N-CA-C 109.781 -1.328 . . . . 25.0 109.781 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 47.9 t -71.48 -35.08 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 112.03 0.382 . . . . 25.0 112.03 -175.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.27 130.19 25.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-O 121.195 0.521 . . . . 25.0 111.374 -177.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 152.58 158.67 8.6 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 109.298 -1.521 . . . . 25.0 109.298 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -151.95 144.49 24.18 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 118.625 1.213 . . . . 25.0 110.593 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 68.9 p -142.7 162.77 34.61 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 105.637 -1.986 . . . . 25.0 105.637 175.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -174.02 161.83 32.21 Favored Glycine 0 C--N 1.318 -0.427 0 C-N-CA 120.249 -0.977 . . . . 25.0 113.283 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -136.7 83.29 30.27 Favored Pre-proline 0 C--O 1.241 0.645 0 N-CA-C 108.364 -0.976 . . . . 25.0 108.364 177.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.24 161.54 45.62 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 118.15 -0.767 . . . . 25.0 112.376 -174.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -113.24 150.49 32.31 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 123.51 0.724 . . . . 25.0 110.212 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -138.17 70.73 48.03 Favored Pre-proline 0 N--CA 1.479 0.998 0 CA-C-O 120.903 0.382 . . . . 25.0 110.967 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -73.06 153.85 52.28 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 116.918 -1.588 . . . . 25.0 112.875 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.6 t -84.63 7.05 21.58 Favored 'General case' 0 C--O 1.25 1.085 0 CA-C-O 120.902 0.382 . . . . 25.0 111.658 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 C--O 1.254 1.33 0 CA-C-O 116.833 -1.556 . . . . 25.0 110.335 -177.664 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 N--CA 1.476 0.468 0 N-CA-C 114.409 0.888 . . . . 25.0 114.409 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.09 65.95 0.05 OUTLIER Glycine 0 C--O 1.222 -0.655 0 C-N-CA 121.106 -0.569 . . . . 25.0 112.489 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.7 p -61.49 132.0 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 122.742 1.258 . . . . 25.0 111.417 -176.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -91.94 -19.88 21.98 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 114.986 -1.007 . . . . 25.0 111.203 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.76 -146.13 7.78 Favored Glycine 0 C--O 1.223 -0.568 0 N-CA-C 116.899 1.52 . . . . 25.0 116.899 -175.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.7 p 73.36 155.59 0.16 Allowed Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 126.928 2.091 . . . . 25.0 110.427 -175.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -67.4 13.12 0.17 Allowed 'Trans proline' 0 CA--C 1.545 1.07 0 N-CA-C 117.386 2.033 . . . . 25.0 117.386 -175.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.55 -20.78 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 115.38 1.622 . . . . 25.0 115.38 -174.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.7 p -146.47 141.5 20.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.999 0.74 . . . . 25.0 112.999 -175.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.56 17.15 69.14 Favored Glycine 0 C--O 1.241 0.585 0 N-CA-C 118.324 2.09 . . . . 25.0 118.324 173.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.2 t -51.51 -54.6 25.56 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.517 0.932 . . . . 25.0 113.517 -174.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -82.48 12.6 4.36 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 117.535 2.42 . . . . 25.0 117.535 -174.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -147.95 170.48 17.62 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 122.038 -0.414 . . . . 25.0 111.837 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -58.3 136.24 57.32 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 112.795 0.665 . . . . 25.0 112.795 -175.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -123.0 160.79 25.54 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 116.221 1.934 . . . . 50.0 116.221 -173.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -137.23 105.36 5.69 Favored 'General case' 0 C--O 1.249 1.042 0 N-CA-C 103.795 -2.668 . . . . 25.0 103.795 160.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.6 mt -125.29 131.21 53.11 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.312 0.486 . . . . 25.0 112.312 -175.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -118.59 111.86 19.12 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 122.489 0.316 . . . . 25.0 111.839 -176.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.32 -177.9 51.38 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 117.916 1.926 . . . . 25.0 117.916 -174.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.1 p -81.55 173.32 12.5 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.051 0.94 . . . . 25.0 112.054 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.4 mt -84.56 5.89 25.95 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.748 -0.595 . . . . 25.0 111.494 174.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -100.23 -179.24 30.06 Favored Glycine 0 N--CA 1.464 0.544 0 N-CA-C 111.83 -0.508 . . . . 25.0 111.83 177.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.3 t -78.54 124.92 28.67 Favored 'General case' 0 C--O 1.24 0.585 0 O-C-N 122.121 -0.635 . . . . 25.0 110.053 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -131.36 156.24 45.86 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.899 0.38 . . . . 50.0 111.018 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -98.42 129.14 45.05 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 102.825 -3.028 . . . . 25.0 102.825 163.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.8 mm -126.59 124.48 65.3 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.56 0 N-CA-C 105.969 -1.863 . . . . 25.0 105.969 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.8 mp -125.85 121.72 34.04 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.35 -1.352 . . . . 25.0 107.35 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.23 -34.31 37.35 Favored Glycine 0 C--N 1.318 -0.424 0 C-N-CA 120.68 -0.771 . . . . 25.0 114.933 -178.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 72.31 -145.59 37.82 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 110.415 -1.074 . . . . 25.0 110.415 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -78.63 169.79 54.46 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-O 121.897 0.721 . . . . 25.0 111.352 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.77 159.92 27.52 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.574 -0.822 . . . . 25.0 113.553 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.72 104.49 13.01 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 105.629 -1.989 . . . . 25.0 105.629 176.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -103.31 148.9 25.27 Favored 'General case' 0 C--N 1.314 -0.941 0 O-C-N 121.365 -0.834 . . . . 50.0 111.073 -169.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -112.34 98.57 7.38 Favored 'General case' 0 C--O 1.246 0.92 0 N-CA-C 105.135 -2.172 . . . . 25.0 105.135 176.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 62.8 mt -106.86 133.55 51.35 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.118 -0.492 . . . . 25.0 111.532 -172.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -130.3 106.87 8.86 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 122.659 0.384 . . . . 25.0 110.166 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.12 -19.69 49.38 Favored Glycine 0 CA--C 1.534 1.279 0 N-CA-C 117.682 1.833 . . . . 25.0 117.682 -178.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 53.35 -148.18 0.46 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 118.711 1.255 . . . . 25.0 113.188 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.63 165.87 20.27 Favored 'General case' 0 C--O 1.254 1.292 0 CA-C-O 121.247 0.546 . . . . 25.0 112.087 -176.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.37 153.53 30.16 Favored Glycine 0 N--CA 1.452 -0.269 0 N-CA-C 109.629 -1.388 . . . . 25.0 109.629 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -80.07 101.03 8.48 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.644 -1.613 . . . . 25.0 106.644 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -101.8 151.65 21.81 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.801 -0.636 . . . . 50.0 111.568 -170.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.7 mp -114.0 95.8 5.49 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.591 -0.522 . . . . 25.0 109.591 177.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.7 mp -101.46 128.03 47.86 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.336 0.589 . . . . 25.0 112.103 -173.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -125.73 135.94 52.62 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 106.485 -1.672 . . . . 25.0 106.485 174.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -89.54 -41.07 5.83 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 119.778 -1.201 . . . . 25.0 114.826 -174.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.46 -166.21 50.83 Favored Glycine 0 C--O 1.238 0.353 0 CA-C-N 117.662 0.731 . . . . 25.0 112.829 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.68 149.65 21.34 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.099 0.407 . . . . 25.0 112.099 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.4 153.64 29.03 Favored Glycine 0 C--O 1.238 0.365 0 CA-C-N 115.38 -0.827 . . . . 25.0 112.837 -177.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.34 120.26 21.36 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 105.193 -2.151 . . . . 25.0 105.193 176.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -109.05 156.2 20.05 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.983 -0.377 . . . . 50.0 109.983 -172.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -123.9 117.99 26.07 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 103.928 -2.619 . . . . 25.0 103.928 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -144.23 132.28 21.63 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 116.753 2.131 . . . . 25.0 116.753 -168.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 64.3 m -100.63 135.49 41.99 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.454 -0.573 . . . . 25.0 109.454 176.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.49 -32.91 7.85 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.038 -1.225 . . . . 25.0 110.038 173.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.07 -163.01 54.5 Favored Glycine 0 C--O 1.247 0.954 0 CA-C-O 122.836 1.242 . . . . 25.0 111.805 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -67.23 161.01 25.81 Favored 'General case' 0 C--N 1.322 -0.629 0 O-C-N 121.922 -0.752 . . . . 25.0 110.108 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.44 164.42 37.15 Favored Glycine 0 CA--C 1.521 0.418 0 CA-C-N 115.757 -0.656 . . . . 25.0 111.807 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.66 92.08 8.08 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-O 122.352 1.072 . . . . 25.0 109.957 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -86.01 152.35 22.98 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.105 -0.952 . . . . 50.0 112.338 -172.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.5 m -121.93 127.99 51.02 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.899 -1.046 . . . . 25.0 109.735 -178.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -122.8 84.56 2.28 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.605 -1.257 . . . . 25.0 107.605 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 54.8 mtt85 -85.64 -21.72 28.28 Favored 'General case' 0 CA--C 1.497 -1.068 0 O-C-N 121.54 -0.725 . . . . 25.0 111.358 -178.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 68.22 159.07 0.16 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.017 1.327 . . . . 25.0 112.173 -175.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -93.62 -28.13 16.19 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 115.795 1.776 . . . . 25.0 115.795 -167.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 70.7 mt -145.91 166.02 27.22 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.39 0.515 . . . . 25.0 112.39 -171.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.33 -28.15 69.01 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.642 -0.873 . . . . 25.0 108.642 170.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -82.87 -0.19 47.09 Favored 'General case' 0 C--O 1.252 1.187 0 CA-C-N 114.363 -1.289 . . . . 25.0 113.814 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -91.0 134.65 34.32 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 121.719 -0.613 . . . . 25.0 110.145 -173.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.3 t 47.32 42.75 14.31 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 115.291 1.589 . . . . 25.0 115.291 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 15.5 p-80 -110.79 165.44 11.84 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.419 -0.81 . . . . 25.0 112.375 -174.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -116.06 142.24 47.06 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 106.805 -1.554 . . . . 25.0 106.805 176.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 82.5 p -136.27 166.56 27.03 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 108.278 -1.008 . . . . 25.0 108.278 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -61.14 -22.49 74.84 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 117.885 -0.944 . . . . 25.0 113.528 174.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 86.9 mt -76.79 -21.82 54.59 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.733 0.778 . . . . 25.0 111.174 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 150.52 175.18 22.31 Favored Glycine 0 CA--C 1.506 -0.479 0 CA-C-N 116.17 -0.468 . . . . 25.0 112.11 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.0 t -95.09 148.4 22.4 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 122.01 0.909 . . . . 25.0 111.137 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -131.55 30.82 4.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.833 -1.076 . . . . 25.0 108.448 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.0 142.03 44.34 Favored Glycine 0 C--O 1.243 0.675 0 N-CA-C 111.157 -0.777 . . . . 25.0 111.157 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -85.52 169.22 13.8 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 120.575 0.226 . . . . 50.0 110.393 -177.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -124.08 98.38 5.76 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.001 0.52 . . . . 25.0 111.468 -173.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.9 mt -85.34 132.73 31.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 107.56 -1.274 . . . . 25.0 107.56 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 98.0 mt -84.66 -44.55 13.33 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 114.894 1.442 . . . . 25.0 114.894 -169.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 57.5 p30 -134.45 38.62 3.09 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 114.799 1.407 . . . . 25.0 114.799 -174.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -57.35 129.64 42.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.703 0.763 . . . . 25.0 112.384 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -99.66 105.07 31.8 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 108.212 -1.033 . . . . 25.0 108.212 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -67.61 -16.83 47.68 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 116.228 -2.048 . . . . 25.0 115.802 -176.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.7 t -82.86 -26.66 31.41 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 120.607 0.241 . . . . 25.0 110.988 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -115.78 -33.1 5.26 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 115.432 1.641 . . . . 25.0 115.432 -173.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -91.8 167.63 12.02 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 123.432 0.457 . . . . 50.0 110.367 -170.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -144.65 145.91 31.99 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.212 0.449 . . . . 25.0 112.212 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 88.3 mt -127.41 127.83 69.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.281 -1.007 . . . . 25.0 108.281 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -91.25 148.0 22.65 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.509 -0.923 . . . . 25.0 108.509 173.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.4 p -147.79 -6.72 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 113.175 0.806 . . . . 25.0 113.175 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 26.4 t -61.44 -43.77 98.28 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.532 0.568 . . . . 25.0 112.532 -175.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.05 -28.86 54.91 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.9 1.074 . . . . 25.0 113.9 -178.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.62 -0.33 13.04 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 116.655 2.094 . . . . 25.0 116.655 -169.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -145.0 -72.45 0.02 OUTLIER Glycine 0 C--O 1.241 0.576 0 N-CA-C 116.555 1.382 . . . . 25.0 116.555 -178.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -157.98 169.25 25.01 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.597 -0.89 . . . . 25.0 108.597 -175.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 38.5 t -124.11 -39.8 2.33 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.111 0.482 . . . . 25.0 110.344 177.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -88.48 121.72 6.08 Favored Glycine 0 N--CA 1.465 0.585 0 N-CA-C 111.053 -0.819 . . . . 25.0 111.053 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -73.53 154.16 39.98 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 117.633 0.716 . . . . 25.0 111.87 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.15 -171.84 45.75 Favored Glycine 0 N--CA 1.463 0.467 0 CA-C-N 116.281 -0.418 . . . . 25.0 112.108 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -75.6 81.71 2.6 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.611 0.967 . . . . 25.0 113.611 -177.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -105.86 176.62 22.21 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 108.973 -1.651 . . . . 25.0 108.973 173.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -125.96 166.19 17.38 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 118.106 0.953 . . . . 25.0 110.683 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 54.09 36.43 24.67 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 114.083 1.142 . . . . 25.0 114.083 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 77.35 31.26 52.13 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 120.214 -0.993 . . . . 25.0 112.11 177.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.3 t -138.78 -174.37 3.82 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 117.382 0.591 . . . . 25.0 110.468 -177.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.56 161.01 15.23 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 102.294 -3.225 . . . . 25.0 102.294 173.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.78 115.01 10.48 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 118.744 0.702 . . . . 25.0 110.325 -173.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.1 m -85.3 165.1 2.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 108.112 -1.07 . . . . 25.0 108.112 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 92.0 p -150.39 162.59 40.26 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.673 -0.492 . . . . 25.0 109.673 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.5 m -115.95 164.2 12.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.698 -0.853 . . . . 25.0 108.698 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.5 t -76.55 -56.4 4.65 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.186 -1.413 . . . . 25.0 107.186 170.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -161.31 -159.94 0.68 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 103.436 -2.801 . . . . 25.0 103.436 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -66.52 -24.22 66.35 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 121.062 0.458 . . . . 25.0 110.311 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -118.86 -159.02 10.94 Favored Glycine 0 C--O 1.244 0.758 0 N-CA-C 109.661 -1.376 . . . . 25.0 109.661 176.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 59.44 -161.85 0.26 Allowed 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 112.913 0.708 . . . . 25.0 112.913 176.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 39.4 mtt85 -76.33 163.81 26.64 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.292 1.219 . . . . 25.0 114.292 -169.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.14 159.91 18.76 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 106.233 -1.766 . . . . 25.0 106.233 171.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -132.01 159.21 39.44 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.245 0.545 . . . . 25.0 110.452 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 55.7 tp -133.05 119.37 19.94 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 104.356 -2.461 . . . . 25.0 104.356 170.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -116.51 155.62 28.31 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.435 -0.58 . . . . 25.0 109.435 -175.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.4 t -100.02 149.92 22.98 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 104.272 -2.492 . . . . 25.0 104.272 166.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -116.13 9.56 14.74 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 122.089 0.947 . . . . 25.0 109.783 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -102.18 143.17 32.31 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 104.185 -2.524 . . . . 25.0 104.185 171.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -138.7 155.12 48.52 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.604 0.716 . . . . 25.0 109.802 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -75.29 160.01 30.84 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 105.543 -2.021 . . . . 25.0 105.543 175.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.7 -16.65 63.96 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.496 0.589 . . . . 25.0 111.485 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -76.13 -9.44 58.63 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.157 0.503 . . . . 25.0 112.141 174.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.69 3.29 68.81 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.483 -0.647 . . . . 25.0 111.483 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.3 mt -73.76 138.47 44.59 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.372 -0.973 . . . . 25.0 108.372 177.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.87 -178.43 6.35 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 106.848 -1.538 . . . . 25.0 106.848 -175.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -132.35 140.99 48.74 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-N 118.91 0.777 . . . . 25.0 112.995 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -153.58 156.02 37.22 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 108.06 -1.089 . . . . 25.0 108.06 170.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.5 p -146.06 143.93 21.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 N-CA-C 105.818 -1.919 . . . . 25.0 105.818 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -107.36 142.64 36.86 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.032 -1.47 . . . . 25.0 107.032 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.413 HD22 ' HE1' ' A' ' 145' ' ' HIS . 2.9 mp -131.49 127.92 38.31 Favored 'General case' 0 C--O 1.207 -1.141 0 N-CA-C 103.552 -2.759 . . . . 25.0 103.552 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -100.19 3.53 43.78 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 119.278 0.945 . . . . 25.0 113.304 -174.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -79.07 -2.28 86.8 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 120.668 -0.777 . . . . 25.0 113.775 177.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 44.8 t0 49.16 48.93 20.39 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 122.075 0.94 . . . . 25.0 112.14 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . 0.413 ' HE1' HD22 ' A' ' 141' ' ' LEU . 5.0 p80 -108.18 32.67 4.61 Favored 'General case' 0 C--O 1.249 1.03 0 CA-C-O 122.53 1.157 . . . . 25.0 108.615 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -55.1 -34.3 63.56 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.044 -0.98 . . . . 25.0 112.492 176.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.97 -12.78 61.98 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 113.275 0.842 . . . . 25.0 113.275 -178.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -116.86 -5.0 11.53 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.635 0.605 . . . . 25.0 112.635 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 16.1 mt -70.7 127.37 32.41 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.495 -0.928 . . . . 25.0 108.495 178.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 71.2 m -127.64 164.37 22.19 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.616 -1.624 . . . . 25.0 106.616 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -73.64 -1.87 20.68 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.197 -0.668 . . . . 25.0 109.197 176.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -71.33 -29.77 65.4 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 115.673 -0.694 . . . . 25.0 112.385 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -98.15 1.14 47.17 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 122.065 -0.397 . . . . 25.0 111.324 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 38.9 mm -105.5 111.36 34.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 105.535 -2.024 . . . . 25.0 105.535 175.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.8 p -98.15 115.95 39.62 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-O 123.064 1.412 . . . . 25.0 112.558 -173.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -137.36 0.51 2.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 112.98 -1.918 . . . . 25.0 110.362 174.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -81.61 43.95 0.78 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 122.752 0.421 . . . . 25.0 111.441 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 55.94 24.39 7.57 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.202 1.186 . . . . 25.0 114.202 -177.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.56 9.09 0.73 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.657 1.725 . . . . 25.0 115.657 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -79.01 134.94 36.77 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 121.353 -0.842 . . . . 25.0 110.787 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.34 -19.69 63.04 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.354 -0.61 . . . . 25.0 109.354 178.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.3 47.39 0.68 Allowed 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 121.264 0.554 . . . . 25.0 111.513 176.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -150.3 173.18 14.27 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.164 -1.421 . . . . 25.0 107.164 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 62.77 -172.1 0.16 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.64 1.176 . . . . 25.0 111.905 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 81.55 23.41 58.35 Favored Glycine 0 C--N 1.32 -0.311 0 N-CA-C 110.081 -1.207 . . . . 25.0 110.081 -176.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -121.34 101.74 7.83 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 109.38 -0.6 . . . . 25.0 109.38 -176.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -127.8 157.49 40.28 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.179 -0.674 . . . . 25.0 109.179 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -136.74 26.01 3.05 Favored Glycine 0 N--CA 1.464 0.532 0 CA-C-N 116.426 -0.352 . . . . 25.0 113.636 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 47.1 t -80.96 -31.99 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 116.915 0.357 . . . . 25.0 110.8 -177.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.15 133.67 27.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 CA-C-O 121.571 0.7 . . . . 25.0 111.135 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.38 168.0 26.85 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 108.614 -1.794 . . . . 25.0 108.614 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -146.29 143.58 29.25 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.436 1.618 . . . . 25.0 110.601 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 80.5 p -155.51 167.82 29.12 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.556 -0.905 . . . . 25.0 108.556 178.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 179.3 -179.74 48.84 Favored Glycine 0 CA--C 1.507 -0.418 0 C-N-CA 120.628 -0.796 . . . . 25.0 114.299 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -145.82 106.19 4.26 Favored Pre-proline 0 N--CA 1.468 0.456 0 N-CA-C 107.895 -1.15 . . . . 25.0 107.895 177.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -72.94 152.23 51.6 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 116.194 -2.07 . . . . 25.0 113.67 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -113.24 144.5 42.6 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.835 -1.913 . . . . 25.0 105.835 175.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -136.2 67.2 61.44 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 112.644 0.609 . . . . 25.0 112.644 -174.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -73.45 150.83 46.94 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 117.874 -0.951 . . . . 25.0 112.575 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.7 t -139.95 20.96 2.47 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 122.02 0.914 . . . . 25.0 109.803 -177.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.4 p . . . . . 0 C--O 1.248 0.975 0 CA-C-O 117.618 -1.182 . . . . 25.0 110.759 -178.19 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 C--O 1.247 0.967 0 N-CA-C 114.293 0.844 . . . . 25.0 114.293 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.9 51.52 0.06 OUTLIER Glycine 0 C--O 1.237 0.3 0 N-CA-C 109.625 -1.39 . . . . 25.0 109.625 -177.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.9 p -57.86 133.58 22.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.758 0.79 . . . . 25.0 111.03 -174.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -102.37 -8.81 20.86 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.197 -0.91 . . . . 25.0 110.204 -173.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -82.52 -141.79 4.04 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.882 -0.599 . . . . 25.0 112.413 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.5 p 69.12 159.4 0.15 Allowed Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 126.064 1.746 . . . . 25.0 110.835 -175.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -65.97 -5.06 11.28 Favored 'Trans proline' 0 N--CA 1.483 0.9 0 N-CA-C 116.64 1.746 . . . . 25.0 116.64 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.97 -4.2 4.22 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 N-CA-C 114.192 1.182 . . . . 25.0 114.192 -170.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.3 p -141.34 141.35 30.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 121.56 0.695 . . . . 25.0 111.713 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.48 18.5 73.67 Favored Glycine 0 C--N 1.336 0.577 0 N-CA-C 119.681 2.633 . . . . 25.0 119.681 171.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.2 t -51.4 -51.63 53.06 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 120.641 -1.505 . . . . 25.0 113.826 -172.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -85.85 13.94 6.67 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 115.187 1.551 . . . . 25.0 115.187 -171.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.24 168.58 19.44 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.32 0.489 . . . . 25.0 112.32 -176.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -63.93 130.86 45.79 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 118.208 0.458 . . . . 25.0 110.809 -177.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -127.0 170.09 12.66 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 116.6 2.074 . . . . 50.0 116.6 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -136.01 92.56 2.81 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 104.449 -2.426 . . . . 25.0 104.449 168.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 52.4 mt -106.95 123.28 47.95 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.385 0.884 . . . . 25.0 113.385 -173.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -111.43 114.77 28.12 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.815 -0.629 . . . . 25.0 109.401 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.07 174.71 51.21 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 116.948 1.539 . . . . 25.0 116.948 -175.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.3 p -69.47 169.69 12.01 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.504 0.669 . . . . 25.0 111.574 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 89.3 mt -87.33 16.09 5.71 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.521 -0.763 . . . . 25.0 110.905 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -120.6 -178.96 16.19 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.368 -0.693 . . . . 25.0 111.368 175.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.7 t -68.17 135.07 51.51 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 117.365 0.582 . . . . 25.0 110.924 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -144.92 166.44 25.29 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.083 0.553 . . . . 50.0 109.791 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -109.78 129.8 55.59 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 103.284 -2.858 . . . . 25.0 103.284 162.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.4 mm -119.23 121.71 67.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 108.138 -1.06 . . . . 25.0 108.138 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 9.0 mp -124.36 125.96 45.19 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 105.801 -1.926 . . . . 25.0 105.801 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.21 -26.62 27.9 Favored Glycine 0 C--O 1.246 0.904 0 N-CA-C 115.355 0.902 . . . . 25.0 115.355 -176.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.24 -147.33 47.33 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.122 -1.037 . . . . 25.0 112.003 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.31 174.3 52.21 Favored Glycine 0 C--O 1.248 0.983 0 O-C-N 122.73 -0.277 . . . . 25.0 112.889 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.49 160.92 20.99 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.597 -0.811 . . . . 25.0 113.82 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.57 92.0 8.75 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 122.526 1.155 . . . . 25.0 108.008 175.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -89.31 157.29 18.25 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.762 -1.108 . . . . 50.0 112.635 -169.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -117.35 94.99 4.77 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 107.469 -1.308 . . . . 25.0 107.469 172.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 49.6 mt -101.83 134.73 44.55 Favored 'General case' 0 C--O 1.213 -0.847 0 N-CA-C 112.614 0.598 . . . . 25.0 112.614 -172.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -131.51 106.79 8.44 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.174 0.512 . . . . 25.0 111.015 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.96 -25.61 57.51 Favored Glycine 0 C--O 1.246 0.845 0 N-CA-C 116.066 1.186 . . . . 25.0 116.066 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 49.99 -152.19 0.17 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.928 1.084 . . . . 25.0 113.928 -178.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.97 160.39 20.85 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 113.164 0.801 . . . . 25.0 113.164 -173.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.06 156.5 31.35 Favored Glycine 0 C--O 1.247 0.955 0 N-CA-C 109.591 -1.404 . . . . 25.0 109.591 -177.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 22.0 m-20 -81.42 106.08 13.1 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 107.149 -1.426 . . . . 25.0 107.149 177.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -106.84 161.8 14.37 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 120.946 0.403 . . . . 50.0 111.098 -170.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 mp -119.87 136.88 54.32 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 104.832 -2.284 . . . . 25.0 104.832 174.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 mp -136.1 125.42 24.83 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 114.49 1.293 . . . . 25.0 114.49 -172.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -125.19 137.84 54.13 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 113.968 -1.469 . . . . 25.0 107.542 174.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.48 -31.79 8.64 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.32 -0.943 . . . . 25.0 114.704 -178.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.98 -171.0 55.12 Favored Glycine 0 C--O 1.253 1.285 0 N-CA-C 110.784 -0.926 . . . . 25.0 110.784 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.6 157.11 9.61 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.956 0.884 . . . . 25.0 112.422 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.38 164.73 40.48 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-N 115.212 -0.903 . . . . 25.0 111.888 -176.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.97 123.72 33.57 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 104.7 -2.333 . . . . 25.0 104.7 176.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -113.44 157.08 22.4 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.663 0.986 . . . . 50.0 113.663 -169.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -113.2 127.08 56.07 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 103.493 -2.78 . . . . 25.0 103.493 174.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -147.83 137.3 22.43 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.901 1.074 . . . . 25.0 113.901 -176.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 62.1 m -116.04 142.59 46.6 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.02 -1.104 . . . . 25.0 108.02 176.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -93.49 -34.21 6.76 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 111.079 -0.808 . . . . 25.0 111.079 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.81 -173.25 55.33 Favored Glycine 0 C--O 1.244 0.732 0 CA-C-N 117.987 0.893 . . . . 25.0 113.462 -178.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -66.1 159.21 26.62 Favored 'General case' 0 C--O 1.241 0.612 0 O-C-N 121.455 -1.027 . . . . 25.0 109.65 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.1 156.45 32.21 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.57 -1.012 . . . . 25.0 110.57 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.97 124.09 26.33 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 109.184 -0.672 . . . . 25.0 109.184 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -116.3 151.6 35.53 Favored 'General case' 0 C--N 1.313 -0.987 0 O-C-N 121.614 -0.679 . . . . 50.0 112.08 -173.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 98.5 m -114.27 122.57 47.15 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 109.046 -0.724 . . . . 25.0 109.046 177.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -108.96 124.37 50.58 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 106.424 -1.695 . . . . 25.0 106.424 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 49.2 mtt85 -122.49 -36.68 2.89 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.121 0.785 . . . . 25.0 113.121 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 71.69 155.1 0.15 Allowed 'General case' 0 N--CA 1.475 0.817 0 O-C-N 125.07 1.481 . . . . 25.0 108.101 -169.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.52 -43.19 19.12 Favored 'General case' 0 C--N 1.318 -0.765 0 O-C-N 121.852 -0.53 . . . . 25.0 112.158 -165.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 58.6 mt -130.9 163.46 27.42 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 122.054 0.93 . . . . 25.0 111.423 -173.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -56.14 -27.56 54.56 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 114.497 -1.228 . . . . 25.0 108.868 169.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -72.71 -4.68 32.74 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 115.01 1.485 . . . . 25.0 115.01 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -99.09 153.55 18.8 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.41 -0.806 . . . . 25.0 112.894 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.9 t 43.35 48.7 5.93 Favored 'General case' 0 C--O 1.217 -0.649 0 N-CA-C 114.806 1.41 . . . . 25.0 114.806 170.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 28.0 p-80 -131.91 170.23 15.18 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.143 -0.935 . . . . 25.0 110.195 -175.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.5 ttt180 -122.55 142.65 50.39 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 105.707 -1.96 . . . . 25.0 105.707 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 77.9 p -137.55 168.95 14.4 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.207 -0.664 . . . . 25.0 109.207 -176.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -61.45 -24.23 78.02 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 CA-C-N 118.841 0.622 . . . . 25.0 113.266 175.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.2 mt -75.59 -26.49 57.92 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.542 0.687 . . . . 25.0 111.303 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.17 -174.13 32.65 Favored Glycine 0 N--CA 1.463 0.455 0 N-CA-C 110.595 -1.002 . . . . 25.0 110.595 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.8 t -103.18 149.21 24.88 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-O 122.742 1.258 . . . . 25.0 112.956 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -129.03 21.61 5.79 Favored 'General case' 0 C--O 1.252 1.2 0 CA-C-N 114.247 -1.342 . . . . 25.0 109.004 175.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.04 140.5 46.32 Favored Glycine 0 N--CA 1.473 1.105 0 O-C-N 124.549 1.156 . . . . 25.0 111.414 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -96.99 167.37 11.12 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 108.35 -0.981 . . . . 50.0 108.35 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.45 ' HG3' ' HB3' ' A' ' 140' ' ' ALA . 0.3 OUTLIER -123.89 109.32 13.45 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.135 0.791 . . . . 25.0 113.135 -175.074 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 41.5 mt -87.98 139.46 17.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 105.865 -1.902 . . . . 25.0 105.865 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.2 mt -90.9 -44.44 9.37 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 114.868 1.432 . . . . 25.0 114.868 -176.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.6 p-10 -130.13 39.51 3.66 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 116.165 1.913 . . . . 25.0 116.165 -173.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -55.99 126.84 27.64 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 122.3 -0.25 . . . . 25.0 111.114 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -97.57 104.14 19.46 Favored Pre-proline 0 N--CA 1.474 0.771 0 N-CA-C 108.878 -0.786 . . . . 25.0 108.878 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -70.67 -4.97 15.71 Favored 'Trans proline' 0 C--O 1.213 -0.757 0 N-CA-C 114.973 1.105 . . . . 25.0 114.973 -176.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.8 t -89.42 -28.71 19.56 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.087 0.47 . . . . 25.0 111.08 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -118.72 -38.28 3.13 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 115.217 1.562 . . . . 25.0 115.217 -172.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -85.76 175.01 8.94 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.714 0.635 . . . . 75.0 112.714 -172.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.72 152.26 36.31 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.182 0.808 . . . . 25.0 113.182 170.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 55.9 mt -119.03 132.03 70.1 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 N-CA-C 108.854 -0.795 . . . . 25.0 108.854 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -85.6 145.05 27.53 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 122.32 1.057 . . . . 25.0 111.458 173.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.0 p -143.19 -0.85 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 CA-C-N 114.724 -1.125 . . . . 25.0 110.085 178.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.8 t -64.76 -42.51 95.07 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.283 0.563 . . . . 25.0 111.11 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.92 -27.85 63.1 Favored 'General case' 0 C--O 1.249 1.066 0 CA-C-N 115.656 -0.702 . . . . 25.0 111.693 -177.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.0 mt -99.12 -58.07 2.02 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 114.255 1.206 . . . . 25.0 114.255 -169.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -104.33 -65.26 0.69 Allowed Glycine 0 C--O 1.242 0.643 0 N-CA-C 116.609 1.404 . . . . 25.0 116.609 -168.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -156.47 164.8 37.82 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.012 0.478 . . . . 25.0 110.451 -168.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.9 p -117.57 -19.74 9.28 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.99 0.516 . . . . 25.0 110.47 173.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -108.32 117.12 4.97 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 109.199 -1.56 . . . . 25.0 109.199 175.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -60.08 151.44 26.66 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 116.216 1.932 . . . . 25.0 116.216 -175.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.89 -169.25 36.63 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 114.856 -1.066 . . . . 25.0 114.798 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -55.8 135.46 51.76 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 113.435 0.902 . . . . 25.0 113.435 -177.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 168.4 177.68 39.62 Favored Glycine 0 C--O 1.236 0.257 0 N-CA-C 107.961 -2.056 . . . . 25.0 107.961 178.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -142.99 168.96 18.48 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.119 1.46 . . . . 25.0 109.21 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 57.8 35.74 25.77 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.737 0.815 . . . . 25.0 111.527 -177.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 69.37 36.66 78.63 Favored Glycine 0 C--N 1.32 -0.333 0 N-CA-C 111.114 -0.795 . . . . 25.0 111.114 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.3 t -140.09 177.85 7.69 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.193 -0.669 . . . . 25.0 109.193 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 84.3 mt -104.5 155.29 18.94 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 102.347 -3.205 . . . . 25.0 102.347 172.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.39 136.37 55.66 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 119.367 -0.933 . . . . 25.0 109.257 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.0 m -110.74 161.62 9.01 Favored 'Isoleucine or valine' 0 C--O 1.248 1.008 0 N-CA-C 108.89 -0.781 . . . . 25.0 108.89 -177.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 80.4 p -142.56 163.32 33.13 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 116.569 -0.287 . . . . 25.0 111.557 -177.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.2 m -116.41 160.99 15.49 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 N-CA-C 107.555 -1.276 . . . . 25.0 107.555 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.5 t -74.07 -48.78 27.49 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.739 -1.208 . . . . 25.0 107.739 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -168.09 -162.47 0.42 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 102.175 -3.268 . . . . 25.0 102.175 -178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -77.55 12.55 1.56 Allowed 'General case' 0 CA--C 1.546 0.803 0 CA-C-O 121.754 0.788 . . . . 25.0 111.746 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -150.91 -164.13 11.8 Favored Glycine 0 C--O 1.243 0.716 0 N-CA-C 107.438 -2.265 . . . . 25.0 107.438 176.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.42 -154.85 0.36 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.028 0.381 . . . . 25.0 112.028 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.8 mtt180 -84.08 166.52 17.62 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.925 0.713 . . . . 25.0 112.925 -173.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.68 165.98 12.22 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 105.584 -2.006 . . . . 25.0 105.584 174.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -134.55 158.4 44.08 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.762 0.791 . . . . 25.0 111.8 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 41.8 tp -127.08 129.27 47.66 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 103.834 -2.654 . . . . 25.0 103.834 174.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -123.6 154.21 39.62 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.327 0.584 . . . . 25.0 111.346 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.1 t -99.44 151.21 21.37 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 104.533 -2.395 . . . . 25.0 104.533 167.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -118.67 14.66 13.55 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 107.943 -1.132 . . . . 25.0 107.943 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -105.23 140.41 38.42 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 104.578 -2.378 . . . . 25.0 104.578 172.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -138.43 155.44 48.48 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 123.937 0.773 . . . . 25.0 109.64 -177.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -85.73 163.87 17.96 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.57 -0.741 . . . . 25.0 109.633 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.75 -24.0 67.48 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-O 121.444 0.64 . . . . 25.0 111.819 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -74.33 -4.13 34.44 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.754 0.65 . . . . 25.0 112.754 175.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.18 17.73 64.25 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.568 -0.825 . . . . 25.0 112.247 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.2 mt -93.69 141.95 27.91 Favored 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 107.311 -1.366 . . . . 25.0 107.311 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 63.9 p -141.49 178.41 7.46 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 106.854 -1.535 . . . . 25.0 106.854 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -123.31 133.17 54.18 Favored 'General case' 0 C--O 1.252 1.198 0 CA-C-N 118.544 0.611 . . . . 25.0 111.818 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -148.89 151.43 34.66 Favored 'General case' 0 C--O 1.25 1.103 0 N-CA-C 108.56 -0.904 . . . . 25.0 108.56 171.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.1 p -149.19 146.7 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 107.313 -1.366 . . . . 25.0 107.313 -178.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.45 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . . . -104.98 145.57 30.24 Favored 'General case' 0 C--O 1.247 0.972 0 N-CA-C 109.025 -0.732 . . . . 25.0 109.025 -177.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.9 mp -135.45 120.31 18.52 Favored 'General case' 0 C--O 1.211 -0.921 0 N-CA-C 105.1 -2.185 . . . . 25.0 105.1 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -88.06 -13.1 42.36 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 118.302 2.704 . . . . 25.0 118.302 -169.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -78.36 9.0 36.6 Favored Glycine 0 CA--C 1.535 1.332 0 N-CA-C 117.009 1.563 . . . . 25.0 117.009 -175.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 39.9 t0 48.46 51.14 15.78 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 122.716 1.246 . . . . 25.0 112.957 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -110.97 31.97 5.63 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.753 -1.203 . . . . 25.0 107.753 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.29 -38.43 83.59 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 115.232 -0.895 . . . . 25.0 110.968 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.42 -22.41 66.95 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.101 0.56 . . . . 25.0 112.111 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -98.23 -10.71 23.6 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.037 0.754 . . . . 25.0 113.037 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 13.9 mt -66.1 145.85 55.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.776 0.798 . . . . 25.0 112.214 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 72.1 m -142.97 157.34 44.65 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.853 -1.165 . . . . 25.0 107.853 177.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -81.4 9.04 7.88 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.451 0.3 . . . . 25.0 110.424 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -92.72 -22.87 19.14 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.857 0.36 . . . . 25.0 110.071 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -99.17 20.63 13.14 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 122.79 1.281 . . . . 25.0 109.048 173.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 39.8 mm -122.04 130.01 74.92 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 N-CA-C 101.753 -3.425 . . . . 25.0 101.753 170.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.2 p -108.64 128.34 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 119.35 0.977 . . . . 25.0 110.948 -172.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -167.17 -24.64 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.885 -1.052 . . . . 25.0 113.376 -176.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -82.16 80.63 8.33 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.719 -0.613 . . . . 25.0 110.802 -172.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 59.22 8.61 1.13 Allowed 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 115.326 1.602 . . . . 25.0 115.326 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 m 66.37 -37.87 0.29 Allowed 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 116.59 2.07 . . . . 25.0 116.59 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -65.3 138.07 57.95 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 122.009 -0.432 . . . . 25.0 111.414 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.0 -6.22 31.88 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 121.009 0.433 . . . . 25.0 110.83 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.85 -13.7 61.75 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 116.175 -0.466 . . . . 25.0 111.083 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -102.88 160.33 14.7 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 109.764 -0.458 . . . . 25.0 109.764 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 56.56 -163.52 0.16 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.945 1.461 . . . . 25.0 114.945 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 90.43 15.97 56.11 Favored Glycine 0 N--CA 1.459 0.207 0 N-CA-C 114.662 0.625 . . . . 25.0 114.662 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -83.41 115.9 22.25 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 117.271 0.535 . . . . 25.0 111.696 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -110.68 134.12 52.73 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.133 -0.691 . . . . 25.0 109.133 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.8 45.78 0.7 Allowed Glycine 0 C--O 1.224 -0.505 0 N-CA-C 111.513 -0.635 . . . . 25.0 111.513 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 43.1 t -84.46 -32.01 7.8 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 CA-C-O 121.678 0.752 . . . . 25.0 109.619 -177.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.68 135.4 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 CA-C-O 121.713 0.768 . . . . 25.0 112.082 -176.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 161.84 133.88 1.55 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.622 -1.391 . . . . 25.0 109.622 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -148.49 152.12 36.35 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 117.393 0.597 . . . . 25.0 110.941 -177.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 51.2 p -155.41 166.54 33.22 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.365 -0.976 . . . . 25.0 108.365 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 161.67 146.99 4.83 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 121.179 -0.534 . . . . 25.0 113.707 176.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -98.56 110.15 55.73 Favored Pre-proline 0 C--O 1.247 0.957 0 C-N-CA 123.599 0.76 . . . . 25.0 109.512 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.59 150.13 79.76 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 116.936 -1.576 . . . . 25.0 111.853 176.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -110.3 141.46 43.27 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 109.662 -0.496 . . . . 25.0 109.662 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -130.41 79.29 72.7 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-O 120.955 0.407 . . . . 25.0 111.81 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.3 157.81 52.82 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 N-CA-C 114.066 0.756 . . . . 25.0 114.066 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.8 t -99.04 -17.4 18.28 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.248 -0.649 . . . . 25.0 109.248 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 12.0 p . . . . . 0 C--O 1.246 0.894 0 CA-C-O 117.338 -1.315 . . . . 25.0 108.473 173.411 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo . . . . . 0 C--O 1.234 0.302 0 N-CA-C 115.691 1.381 . . . . 25.0 115.691 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.27 51.76 0.29 Allowed Glycine 0 C--O 1.211 -1.3 0 N-CA-C 106.807 -2.517 . . . . 25.0 106.807 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.6 p -55.35 125.83 11.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 N-CA-C 114.564 1.32 . . . . 25.0 114.564 -172.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -105.64 11.2 32.52 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-O 122.189 0.995 . . . . 25.0 109.555 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -94.31 -155.73 31.85 Favored Glycine 0 N--CA 1.447 -0.625 0 O-C-N 121.38 -0.825 . . . . 25.0 113.704 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.0 p 70.18 158.2 0.16 Allowed Pre-proline 0 N--CA 1.486 1.343 0 C-N-CA 126.08 1.752 . . . . 25.0 112.518 -176.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.444 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 35.2 Cg_exo -66.2 -0.78 4.5 Favored 'Trans proline' 0 C--N 1.358 1.073 0 N-CA-C 116.957 1.868 . . . . 25.0 116.957 -174.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.1 p -65.56 -11.28 11.9 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 N-CA-C 115.91 1.818 . . . . 25.0 115.91 -171.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.8 p -146.42 127.2 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 N-CA-C 114.713 1.375 . . . . 25.0 114.713 -176.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.26 18.66 71.53 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 118.148 2.019 . . . . 25.0 118.148 173.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.7 t -50.86 -37.33 42.67 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 115.331 1.604 . . . . 25.0 115.331 -174.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -75.12 2.43 10.77 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 114.88 1.437 . . . . 25.0 114.88 -175.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.25 173.22 11.72 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 118.971 0.805 . . . . 25.0 110.598 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -51.11 128.41 21.7 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 112.886 0.698 . . . . 25.0 112.886 -177.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -129.91 159.4 36.75 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.39 0.885 . . . . 50.0 113.39 -173.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -125.9 95.98 4.6 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 105.353 -2.092 . . . . 25.0 105.353 165.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 80.9 mt -103.57 108.49 19.78 Favored 'General case' 0 C--O 1.212 -0.895 0 N-CA-C 112.976 0.732 . . . . 25.0 112.976 -176.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -98.82 109.75 22.46 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.962 -0.563 . . . . 25.0 109.596 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.0 172.53 51.63 Favored Glycine 0 C--O 1.219 -0.813 0 N-CA-C 115.893 1.117 . . . . 25.0 115.893 -175.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.8 p -72.31 175.76 5.86 Favored 'General case' 0 C--O 1.246 0.889 0 C-N-CA 123.656 0.782 . . . . 25.0 111.404 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 66.6 mt -87.91 16.73 5.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.52 0.676 . . . . 25.0 110.712 174.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.91 179.5 17.94 Favored Glycine 0 N--CA 1.461 0.331 0 N-CA-C 110.029 -1.228 . . . . 25.0 110.029 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.8 t -74.39 133.24 42.47 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.818 0.447 . . . . 25.0 110.454 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -144.54 166.56 24.81 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.453 0.701 . . . . 50.0 109.495 -177.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -110.37 121.89 46.39 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 104.839 -2.282 . . . . 25.0 104.839 164.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.0 mm -111.03 122.41 65.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 107.1 -1.445 . . . . 25.0 107.1 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.444 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 10.9 mp -119.58 122.72 42.22 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.467 -0.938 . . . . 25.0 108.467 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.17 -37.48 32.18 Favored Glycine 0 CA--C 1.496 -1.115 0 CA-C-O 117.888 -1.506 . . . . 25.0 116.074 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.64 -150.21 51.79 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 119.498 1.649 . . . . 25.0 112.357 -177.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.04 168.79 47.02 Favored Glycine 0 CA--C 1.526 0.776 0 O-C-N 121.855 -0.791 . . . . 25.0 114.12 -178.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.05 167.03 29.65 Favored Glycine 0 C--O 1.246 0.871 0 C-N-CA 121.378 -0.439 . . . . 25.0 113.391 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.44 101.25 12.46 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 106.601 -1.629 . . . . 25.0 106.601 177.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -96.32 152.16 18.84 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 113.255 0.835 . . . . 50.0 113.255 -169.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -119.06 88.42 2.93 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 107.531 -1.285 . . . . 25.0 107.531 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 52.4 mt -97.41 143.77 27.81 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.581 -0.736 . . . . 25.0 110.437 -169.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -137.21 106.65 6.11 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 121.905 -0.497 . . . . 25.0 111.497 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.62 -30.1 53.78 Favored Glycine 0 N--CA 1.466 0.659 0 CA-C-O 118.721 -1.044 . . . . 25.0 113.667 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 50.46 -149.71 0.27 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 117.865 0.832 . . . . 25.0 111.51 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.49 163.09 27.54 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.933 0.873 . . . . 25.0 112.736 -174.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.72 156.65 31.64 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 110.514 -1.034 . . . . 25.0 110.514 -174.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -86.82 100.57 12.63 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.213 -1.403 . . . . 25.0 107.213 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -102.84 152.0 21.78 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.23 -0.896 . . . . 50.0 112.955 -169.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mp -110.72 122.79 48.69 Favored 'General case' 0 C--O 1.217 -0.605 0 N-CA-C 107.005 -1.479 . . . . 25.0 107.005 176.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.9 mp -123.21 130.85 53.32 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 114.598 1.332 . . . . 25.0 114.598 -172.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -121.65 143.44 49.33 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.563 1.545 . . . . 25.0 109.011 175.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.76 -37.6 3.16 Favored Glycine 0 C--O 1.242 0.621 0 N-CA-C 115.296 0.878 . . . . 25.0 115.296 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.03 -168.38 54.71 Favored Glycine 0 C--O 1.246 0.885 0 CA-C-N 117.868 0.834 . . . . 25.0 111.974 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.61 151.72 23.98 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.196 -1.179 . . . . 25.0 112.427 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.99 162.13 38.19 Favored Glycine 0 N--CA 1.466 0.698 0 CA-C-N 115.353 -0.84 . . . . 25.0 111.693 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.74 122.71 29.01 Favored 'General case' 0 C--O 1.212 -0.892 0 N-CA-C 105.255 -2.128 . . . . 25.0 105.255 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -114.42 156.71 24.0 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 122.017 0.913 . . . . 50.0 110.526 -172.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -114.88 122.29 45.86 Favored 'General case' 0 C--O 1.218 -0.595 0 N-CA-C 102.305 -3.22 . . . . 25.0 102.305 177.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -142.19 131.01 22.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 119.165 0.893 . . . . 25.0 113.194 -175.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.99 142.03 34.78 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 115.722 -0.672 . . . . 25.0 109.26 177.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.91 -40.57 5.53 Favored Glycine 0 C--O 1.246 0.868 0 N-CA-C 109.294 -1.522 . . . . 25.0 109.294 175.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.0 -172.97 55.05 Favored Glycine 0 C--O 1.244 0.77 0 C-N-CA 120.278 -0.963 . . . . 25.0 112.786 -176.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -64.07 159.02 21.18 Favored 'General case' 0 C--O 1.251 1.142 0 O-C-N 122.178 -0.601 . . . . 25.0 110.864 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.75 161.87 37.24 Favored Glycine 0 C--O 1.247 0.91 0 CA-C-N 115.141 -0.936 . . . . 25.0 111.413 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.95 105.74 14.19 Favored 'General case' 0 C--O 1.217 -0.649 0 N-CA-C 107.807 -1.183 . . . . 25.0 107.807 -178.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -99.54 156.74 16.89 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 122.666 0.387 . . . . 50.0 111.826 -172.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 47.8 m -123.71 111.52 16.27 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.82 0.819 . . . . 25.0 110.09 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -88.39 96.46 10.6 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 104.917 -2.253 . . . . 25.0 104.917 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.4 mmt85 -81.22 -37.69 28.21 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.595 0.591 . . . . 25.0 112.595 -174.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 64.36 149.3 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 O-C-N 125.882 1.989 . . . . 25.0 111.998 -172.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.32 -59.99 2.56 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 114.995 1.48 . . . . 25.0 114.995 -168.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 48.7 mt -135.52 175.65 9.39 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 108.286 -1.005 . . . . 25.0 108.286 -170.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.62 -27.81 42.23 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.019 0.928 . . . . 25.0 110.838 171.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -76.06 -7.38 54.56 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 115.114 1.524 . . . . 25.0 115.114 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -90.16 136.49 33.01 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.325 -0.859 . . . . 25.0 112.84 -174.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.0 t 43.97 44.16 5.83 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 116.312 1.967 . . . . 25.0 116.312 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -113.66 173.91 6.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.886 -1.052 . . . . 25.0 112.18 -177.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -125.69 139.93 53.13 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 104.076 -2.565 . . . . 25.0 104.076 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 57.7 p -134.27 169.47 13.8 Favored Pre-proline 0 C--O 1.214 -0.786 0 N-CA-C 108.501 -0.925 . . . . 25.0 108.501 -176.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -61.91 -15.82 45.51 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 120.399 0.733 . . . . 25.0 112.764 176.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 89.7 mt -84.76 -31.48 23.95 Favored 'General case' 0 C--O 1.245 0.819 0 O-C-N 121.622 -0.674 . . . . 25.0 111.077 177.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.34 177.47 32.46 Favored Glycine 0 CA--C 1.503 -0.716 0 C-N-CA 121.108 -0.567 . . . . 25.0 112.761 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.2 t -88.49 146.8 24.98 Favored 'General case' 0 C--O 1.253 1.255 0 CA-C-O 121.983 0.896 . . . . 25.0 112.127 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -135.1 32.58 3.16 Favored 'General case' 0 C--O 1.254 1.331 0 CA-C-N 113.8 -1.545 . . . . 25.0 108.371 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -64.91 137.38 38.68 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 109.541 -1.424 . . . . 25.0 109.541 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -87.49 168.59 12.96 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 117.699 0.75 . . . . 50.0 110.659 -177.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -118.25 107.46 13.93 Favored 'General case' 0 C--O 1.245 0.847 0 O-C-N 123.789 0.681 . . . . 25.0 111.44 -175.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 52.7 mt -86.93 131.39 35.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 107.05 -1.463 . . . . 25.0 107.05 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.0 mt -75.88 -49.57 17.51 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 116.175 1.917 . . . . 25.0 116.175 -173.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -137.78 41.59 2.33 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.537 0.684 . . . . 25.0 112.282 -169.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -56.51 138.61 51.5 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.902 0.858 . . . . 25.0 110.72 -176.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -105.84 99.19 20.91 Favored Pre-proline 0 C--O 1.215 -0.74 0 N-CA-C 109.224 -0.658 . . . . 25.0 109.224 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -67.53 1.6 3.01 Favored 'Trans proline' 0 C--N 1.358 1.034 0 N-CA-C 115.39 1.265 . . . . 25.0 115.39 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.5 t -103.89 -42.27 5.64 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 117.515 0.143 . . . . 25.0 110.795 175.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -99.39 -36.99 9.41 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 115.15 1.537 . . . . 25.0 115.15 -175.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -85.08 170.74 12.64 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.028 -0.73 . . . . 75.0 109.028 -171.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -146.42 158.04 43.84 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.953 0.901 . . . . 25.0 110.363 177.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 64.9 mt -130.34 134.84 61.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.91 -0.774 . . . . 25.0 108.91 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -90.12 148.48 22.98 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 122.197 0.999 . . . . 25.0 109.367 175.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.5 p -153.55 -9.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 114.803 -1.09 . . . . 25.0 110.841 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.8 t -60.82 -39.71 90.04 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.036 0.446 . . . . 25.0 111.358 -178.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -86.48 -7.87 58.05 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 115.084 1.513 . . . . 25.0 115.084 -176.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.78 0.28 1.78 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 116.074 1.879 . . . . 25.0 116.074 -172.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -143.26 -69.38 0.02 OUTLIER Glycine 0 N--CA 1.467 0.76 0 N-CA-C 116.094 1.198 . . . . 25.0 116.094 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -156.03 163.81 39.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 117.467 0.634 . . . . 25.0 110.174 -174.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 30.8 t -112.71 -34.15 5.89 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 122.034 0.921 . . . . 25.0 110.552 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -107.12 137.38 13.93 Favored Glycine 0 C--O 1.223 -0.587 0 N-CA-C 107.824 -2.111 . . . . 25.0 107.824 176.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.88 151.39 45.74 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 118.936 -1.106 . . . . 25.0 109.269 -177.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -92.37 -164.11 38.11 Favored Glycine 0 C--O 1.222 -0.645 0 CA-C-N 115.839 -0.619 . . . . 25.0 112.04 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -53.59 129.04 31.45 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.798 0.809 . . . . 25.0 111.801 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 174.99 -176.47 47.14 Favored Glycine 0 C--O 1.215 -1.051 0 N-CA-C 109.928 -1.269 . . . . 25.0 109.928 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -155.94 167.62 29.81 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 118.451 1.126 . . . . 25.0 111.09 -178.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 53.92 43.7 30.5 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 124.319 1.048 . . . . 25.0 112.65 -178.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 68.94 30.24 72.34 Favored Glycine 0 C--O 1.219 -0.796 0 CA-C-N 115.291 -0.868 . . . . 25.0 112.864 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.406 ' HA ' ' H ' ' A' ' 151' ' ' ALA . 6.2 t -142.51 171.69 13.72 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 118.316 1.058 . . . . 25.0 111.722 -177.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 83.6 mt -90.42 164.1 14.42 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 103.329 -2.841 . . . . 25.0 103.329 171.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.68 110.36 7.91 Favored 'General case' 0 C--O 1.252 1.226 0 N-CA-C 107.753 -1.203 . . . . 25.0 107.753 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 18.7 m -71.89 162.7 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-N 115.349 -0.841 . . . . 25.0 109.587 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 29.5 m -145.8 169.78 17.85 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 120.292 -0.563 . . . . 25.0 109.883 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 34.9 m -121.77 164.38 18.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 108.738 -0.838 . . . . 25.0 108.738 177.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.8 t -76.14 -48.64 19.84 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.319 -1.363 . . . . 25.0 107.319 170.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -165.73 -170.42 1.79 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 101.502 -3.518 . . . . 25.0 101.502 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -69.85 -2.84 13.38 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 119.164 0.893 . . . . 25.0 112.856 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -137.35 -160.94 8.75 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 106.204 -2.759 . . . . 25.0 106.204 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.16 -160.34 0.28 Allowed 'General case' 0 C--O 1.249 1.062 0 CA-C-N 117.865 0.832 . . . . 25.0 111.093 177.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 47.0 mtt85 -71.08 166.86 20.51 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 122.279 1.038 . . . . 25.0 112.975 -171.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.1 p -114.15 165.92 12.16 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 105.74 -1.948 . . . . 25.0 105.74 173.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -133.55 153.56 51.55 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 121.14 0.495 . . . . 25.0 111.772 -177.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 28.2 tp -128.01 118.92 24.4 Favored 'General case' 0 C--O 1.25 1.099 0 N-CA-C 103.684 -2.709 . . . . 25.0 103.684 171.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -115.23 145.17 42.69 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 115.829 -0.623 . . . . 25.0 112.298 -174.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.9 t -99.71 147.83 25.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 105.221 -2.14 . . . . 25.0 105.221 168.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -114.79 11.48 16.76 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.889 1.328 . . . . 25.0 108.456 -177.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -93.62 141.17 28.78 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 105.53 -2.026 . . . . 25.0 105.53 174.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -140.83 150.34 43.16 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 122.055 0.931 . . . . 25.0 109.81 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -76.6 167.01 22.59 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.331 -1.304 . . . . 25.0 108.791 177.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.96 -32.39 73.7 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.591 -0.892 . . . . 25.0 108.591 176.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -65.42 -9.28 23.95 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 114.423 1.268 . . . . 25.0 114.423 174.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.57 21.85 61.23 Favored Glycine 0 C--O 1.241 0.581 0 N-CA-C 109.453 -1.459 . . . . 25.0 109.453 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.5 mt -92.05 136.8 32.88 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 106.092 -1.818 . . . . 25.0 106.092 175.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.6 p -141.55 -179.7 6.31 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.867 -1.16 . . . . 25.0 107.867 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -127.94 131.77 49.3 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 119.085 -1.046 . . . . 25.0 113.222 -178.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -147.61 153.95 40.04 Favored 'General case' 0 C--O 1.26 1.619 0 N-CA-C 106.818 -1.549 . . . . 25.0 106.818 168.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.1 p -142.12 146.6 22.42 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 106.93 -1.508 . . . . 25.0 106.93 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -103.2 140.93 36.72 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 107.094 -1.447 . . . . 25.0 107.094 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.2 mp -129.42 131.2 46.72 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 105.177 -2.157 . . . . 25.0 105.177 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -108.9 15.83 23.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.142 0.973 . . . . 25.0 110.541 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -72.91 -8.42 73.2 Favored Glycine 0 C--O 1.238 0.386 0 CA-C-N 114.761 -1.109 . . . . 25.0 110.719 171.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 40.0 t0 51.08 55.92 8.79 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.585 0.707 . . . . 25.0 112.445 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -133.14 43.55 2.93 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-O 122.178 0.989 . . . . 25.0 109.913 -174.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.66 -31.03 64.0 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 121.633 -0.667 . . . . 25.0 111.061 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.74 -14.83 61.63 Favored 'General case' 0 C--O 1.256 1.399 0 N-CA-C 112.406 0.521 . . . . 25.0 112.406 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -109.48 -10.72 14.87 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.108 0.48 . . . . 25.0 111.743 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 29.7 mt -73.69 126.21 29.8 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 123.193 1.473 . . . . 25.0 112.562 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 68.0 m -127.96 158.72 37.08 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 105.553 -2.017 . . . . 25.0 105.553 175.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.406 ' H ' ' HA ' ' A' ' 111' ' ' SER . . . -80.13 -3.57 49.38 Favored 'General case' 0 C--O 1.211 -0.95 0 CA-C-N 115.854 -0.612 . . . . 25.0 110.418 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -67.1 -35.98 80.97 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 117.69 0.223 . . . . 25.0 111.297 -173.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -75.89 -11.44 59.97 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 120.307 -0.557 . . . . 25.0 110.597 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 22.5 mm -83.91 119.9 33.89 Favored 'Isoleucine or valine' 0 C--O 1.247 0.957 0 N-CA-C 106.449 -1.685 . . . . 25.0 106.449 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.6 p -95.94 109.37 22.59 Favored 'Isoleucine or valine' 0 C--O 1.253 1.247 0 CA-C-O 123.044 1.402 . . . . 25.0 113.797 -174.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -145.21 -12.92 0.53 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.649 -1.614 . . . . 25.0 112.185 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -76.75 54.19 0.96 Allowed 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 113.302 0.853 . . . . 25.0 113.302 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 57.87 27.65 14.92 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 113.784 1.031 . . . . 25.0 113.784 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 55.98 0.65 0.06 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 119.361 3.097 . . . . 25.0 119.361 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -88.12 134.23 33.81 Favored 'General case' 0 C--N 1.314 -0.962 0 O-C-N 121.255 -0.903 . . . . 25.0 110.758 -176.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -68.84 -14.28 62.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.918 -0.583 . . . . 25.0 109.578 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.11 -28.1 69.39 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.121 0.486 . . . . 25.0 111.626 177.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.1 162.06 28.86 Favored 'General case' 0 C--O 1.251 1.138 0 CA-C-O 121.264 0.555 . . . . 25.0 111.822 -177.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 61.38 -157.38 0.34 Allowed 'General case' 0 C--O 1.242 0.663 0 CA-C-N 114.629 -1.169 . . . . 25.0 112.619 177.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 90.95 -1.25 77.57 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.597 -0.335 . . . . 25.0 112.429 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -104.32 115.28 30.1 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.779 -0.823 . . . . 25.0 108.779 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -123.53 139.94 53.51 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.274 -0.639 . . . . 25.0 109.274 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -113.93 26.0 10.33 Favored Glycine 0 C--O 1.241 0.59 0 N-CA-C 112.314 -0.314 . . . . 25.0 112.314 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 52.3 t -79.18 -37.27 19.08 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 N-CA-C 109.463 -0.569 . . . . 25.0 109.463 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.43 135.64 24.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.629 0.728 . . . . 25.0 111.238 -175.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 133.58 141.78 4.62 Favored Glycine 0 C--O 1.247 0.969 0 N-CA-C 110.935 -0.866 . . . . 25.0 110.935 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -151.72 161.12 43.2 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.272 -0.64 . . . . 25.0 109.272 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 84.7 p -152.91 165.67 34.74 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 107.732 -1.21 . . . . 25.0 107.732 176.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -177.31 -171.13 40.52 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 119.887 -1.149 . . . . 25.0 112.114 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -138.78 92.54 11.22 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 117.587 0.693 . . . . 25.0 110.96 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.12 161.67 40.38 Favored 'Trans proline' 0 C--O 1.232 0.209 0 O-C-N 122.801 0.895 . . . . 25.0 112.115 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -134.64 151.43 51.04 Favored 'General case' 0 CA--C 1.508 -0.638 0 C-N-CA 123.535 0.734 . . . . 25.0 109.772 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -122.86 75.1 47.7 Favored Pre-proline 0 N--CA 1.481 1.084 0 CA-C-O 121.399 0.619 . . . . 25.0 110.842 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -77.44 160.33 32.16 Favored 'Trans proline' 0 CA--C 1.513 -0.526 0 C-N-CA 116.787 -1.675 . . . . 25.0 112.533 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 12.2 t -125.64 -4.9 7.06 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.211 -0.904 . . . . 25.0 110.741 174.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 6.3 p . . . . . 0 C--O 1.246 0.871 0 N-CA-C 109.61 -0.515 . . . . 25.0 109.61 176.72 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo . . . . . 0 C--O 1.234 0.283 0 N-CA-C 113.097 0.384 . . . . 25.0 113.097 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -150.25 44.49 0.7 Allowed Glycine 0 CA--C 1.536 1.352 0 N-CA-C 114.533 0.573 . . . . 25.0 114.533 -177.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.498 HG22 ' H ' ' A' ' 7' ' ' GLY . 7.9 p -52.51 129.94 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 114.776 1.398 . . . . 25.0 114.776 -176.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -93.49 -7.71 43.58 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.838 -1.073 . . . . 25.0 111.536 -178.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.498 ' H ' HG22 ' A' ' 5' ' ' VAL . . . -81.93 -149.5 7.47 Favored Glycine 0 CA--C 1.507 -0.464 0 CA-C-N 115.597 -0.729 . . . . 25.0 114.344 179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.2 p 71.94 156.43 0.16 Allowed Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 126.266 1.826 . . . . 25.0 110.581 -173.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.61 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 24.6 Cg_exo -69.27 -0.21 6.19 Favored 'Trans proline' 0 C--N 1.354 0.849 0 N-CA-C 114.846 1.056 . . . . 25.0 114.846 -175.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.8 p -66.9 -14.43 18.03 Favored 'Isoleucine or valine' 0 C--O 1.248 0.983 0 N-CA-C 113.954 1.094 . . . . 25.0 113.954 -171.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.4 p -133.57 132.12 57.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 N-CA-C 113.758 1.022 . . . . 25.0 113.758 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.7 13.62 74.97 Favored Glycine 0 C--O 1.246 0.888 0 N-CA-C 118.642 2.217 . . . . 25.0 118.642 171.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.3 t -51.2 -41.78 60.46 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.153 1.168 . . . . 25.0 114.153 -171.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -78.61 4.96 12.09 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 116.243 1.942 . . . . 25.0 116.243 -174.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.93 176.94 9.11 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 118.832 -0.604 . . . . 25.0 111.438 -177.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -57.64 133.28 55.17 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.339 0.59 . . . . 25.0 111.585 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -130.18 157.27 42.93 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.539 0.941 . . . . 50.0 113.539 -173.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -132.25 73.08 1.51 Allowed 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 106.738 -1.578 . . . . 25.0 106.738 169.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.6 mt -91.48 125.8 36.35 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 114.366 1.247 . . . . 25.0 114.366 -174.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -110.1 109.93 20.64 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 116.327 -0.397 . . . . 25.0 110.901 176.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -80.62 176.61 54.62 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 115.855 1.102 . . . . 25.0 115.855 -175.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.7 p -69.08 170.76 9.36 Favored 'General case' 0 C--O 1.256 1.444 0 C-N-CA 123.885 0.874 . . . . 25.0 110.361 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 48.6 mt -87.06 20.82 2.53 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.657 -0.702 . . . . 25.0 110.769 170.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -128.62 -174.01 13.61 Favored Glycine 0 C--O 1.223 -0.56 0 CA-C-O 118.615 -1.103 . . . . 25.0 112.505 176.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.9 t -71.08 133.1 46.01 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 113.857 1.058 . . . . 25.0 113.857 -176.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -145.18 158.52 43.8 Favored 'General case' 0 C--O 1.219 -0.541 0 O-C-N 123.211 0.32 . . . . 50.0 111.682 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -99.61 134.15 42.91 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 103.352 -2.833 . . . . 25.0 103.352 162.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.9 mm -128.41 117.92 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 105.676 -1.972 . . . . 25.0 105.676 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.61 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 8.3 mp -115.55 116.19 27.74 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 106.888 -1.523 . . . . 25.0 106.888 178.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.76 -36.11 90.72 Favored Glycine 0 CA--C 1.502 -0.779 0 C-N-CA 120.567 -0.825 . . . . 25.0 115.062 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.34 -147.21 45.37 Favored Glycine 0 C--O 1.254 1.39 0 C-N-CA 120.813 -0.708 . . . . 25.0 112.027 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.99 165.66 54.74 Favored Glycine 0 C--O 1.249 1.039 0 N-CA-C 111.847 -0.501 . . . . 25.0 111.847 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.84 162.96 28.94 Favored Glycine 0 C--N 1.316 -0.546 0 N-CA-C 114.967 0.747 . . . . 25.0 114.967 174.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.78 106.65 16.47 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 106.524 -1.658 . . . . 25.0 106.524 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -103.58 155.3 18.65 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 112.892 0.701 . . . . 50.0 112.892 -169.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -122.77 93.7 4.05 Favored 'General case' 0 C--O 1.246 0.906 0 N-CA-C 106.277 -1.749 . . . . 25.0 106.277 176.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.8 mt -101.21 140.09 35.98 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 114.881 -1.054 . . . . 25.0 111.356 -170.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -135.64 102.73 5.19 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.563 -0.532 . . . . 25.0 109.563 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.56 -20.7 59.57 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 116.463 1.345 . . . . 25.0 116.463 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 50.29 -150.51 0.23 Allowed 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 119.548 1.674 . . . . 25.0 115.126 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.68 162.2 13.62 Favored 'General case' 0 CA--C 1.552 1.041 0 O-C-N 120.908 -1.12 . . . . 25.0 112.752 -177.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.86 156.12 28.25 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 114.828 -1.078 . . . . 25.0 111.574 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -77.91 106.6 9.86 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 106.943 -1.503 . . . . 25.0 106.943 173.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -111.93 151.83 28.74 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 121.577 -0.702 . . . . 50.0 110.649 -170.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mp -116.13 94.82 4.81 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.966 -1.124 . . . . 25.0 107.966 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 mp -99.25 127.01 45.19 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.701 0.8 . . . . 25.0 112.912 -175.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -124.4 148.81 47.32 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 104.35 -2.463 . . . . 25.0 104.35 175.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.47 -39.37 3.46 Favored Glycine 0 N--CA 1.462 0.432 0 N-CA-C 116.193 1.237 . . . . 25.0 116.193 -175.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.38 -175.55 48.77 Favored Glycine 0 C--O 1.243 0.718 0 N-CA-C 110.266 -1.134 . . . . 25.0 110.266 -177.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.01 149.14 12.31 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 112.752 0.649 . . . . 25.0 112.752 -178.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.41 153.47 29.6 Favored Glycine 0 N--CA 1.46 0.251 0 N-CA-C 111.017 -0.833 . . . . 25.0 111.017 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.5 125.38 29.28 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 104.222 -2.511 . . . . 25.0 104.222 177.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -109.65 153.12 24.68 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.328 -0.619 . . . . 50.0 109.328 -173.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -116.02 122.62 45.74 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 102.409 -3.182 . . . . 25.0 102.409 177.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -145.41 130.86 18.72 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 114.707 1.373 . . . . 25.0 114.707 -171.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.0 m -107.44 132.25 53.4 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 105.99 -1.855 . . . . 25.0 105.99 176.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -91.57 -27.53 17.15 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 111.581 -0.607 . . . . 25.0 111.581 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.21 -169.41 54.91 Favored Glycine 0 N--CA 1.466 0.648 0 CA-C-N 118.022 0.911 . . . . 25.0 113.704 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -66.2 163.41 17.84 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.903 -0.763 . . . . 25.0 110.956 177.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.44 160.29 36.39 Favored Glycine 0 C--O 1.25 1.124 0 CA-C-O 119.897 -0.391 . . . . 25.0 112.678 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.33 102.3 6.7 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.631 0.729 . . . . 25.0 109.853 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -94.85 154.1 17.4 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.773 -0.649 . . . . 50.0 111.545 -174.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.5 m -121.96 127.91 50.9 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.054 -1.461 . . . . 25.0 107.054 -177.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -116.8 82.09 1.74 Allowed 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 106.992 -1.484 . . . . 25.0 106.992 176.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.71 -27.27 40.66 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-N 115.634 -0.712 . . . . 25.0 110.946 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 66.98 153.84 0.09 Allowed 'General case' 0 N--CA 1.479 1.018 0 O-C-N 125.678 1.861 . . . . 25.0 112.112 -172.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.06 -50.8 8.67 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.917 1.08 . . . . 25.0 113.917 -166.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 46.6 mt -130.4 168.86 16.29 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-O 121.372 0.605 . . . . 25.0 109.564 -172.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.17 -28.47 53.09 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.977 0.911 . . . . 25.0 110.585 173.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -75.4 -12.88 60.34 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 115.576 1.695 . . . . 25.0 115.576 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -73.26 134.74 44.35 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.026 1.121 . . . . 25.0 114.026 -174.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.3 t 50.22 42.56 25.62 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 114.759 -1.109 . . . . 25.0 113.655 176.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -107.75 162.45 13.97 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.135 -0.484 . . . . 25.0 111.623 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -122.9 144.6 49.11 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 103.799 -2.667 . . . . 25.0 103.799 177.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 99.3 p -140.12 172.08 6.86 Favored Pre-proline 0 C--N 1.325 -0.478 0 C-N-CA 123.71 0.804 . . . . 25.0 108.963 -173.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -61.1 -19.26 62.56 Favored 'Trans proline' 0 C--N 1.354 0.829 0 O-C-N 122.653 0.817 . . . . 25.0 113.592 174.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.0 mt -79.36 -23.62 43.23 Favored 'General case' 0 C--O 1.245 0.857 0 N-CA-C 113.037 0.754 . . . . 25.0 113.037 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 148.51 -172.35 28.73 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 116.216 -0.447 . . . . 25.0 112.09 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.7 t -101.23 137.71 39.22 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.734 0.778 . . . . 25.0 111.859 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -122.63 29.93 6.68 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.22 -1.355 . . . . 25.0 107.694 173.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.91 146.56 50.43 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 109.765 -1.334 . . . . 25.0 109.765 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -95.84 163.66 13.07 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.41 -1.053 . . . . 50.0 110.316 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -126.04 104.06 8.07 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 111.992 0.367 . . . . 25.0 111.992 -170.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 21.6 mt -86.47 135.1 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 107.206 -1.405 . . . . 25.0 107.206 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.3 mt -89.02 -42.49 11.73 Favored 'General case' 0 C--O 1.21 -0.991 0 N-CA-C 114.77 1.396 . . . . 25.0 114.77 -175.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 46.8 p-10 -127.62 41.17 3.56 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.989 1.477 . . . . 25.0 114.989 -172.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -60.23 142.76 54.02 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 113.399 0.889 . . . . 25.0 113.399 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -117.1 100.13 53.11 Favored Pre-proline 0 N--CA 1.476 0.835 0 N-CA-C 108.948 -0.76 . . . . 25.0 108.948 177.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.9 1.66 4.32 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 N-CA-C 117.129 1.934 . . . . 25.0 117.129 -172.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.6 t -100.7 -35.84 9.33 Favored 'General case' 0 CA--C 1.554 1.099 0 O-C-N 121.763 -0.585 . . . . 25.0 110.753 175.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -98.86 -39.14 8.74 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 114.281 1.215 . . . . 25.0 114.281 -177.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -83.48 163.69 20.34 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.973 -0.558 . . . . 75.0 110.525 -172.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -142.26 146.14 34.82 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.003 0.814 . . . . 25.0 112.486 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 80.1 mt -125.96 131.92 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 107.753 -1.203 . . . . 25.0 107.753 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -88.29 144.5 26.38 Favored 'General case' 0 C--O 1.214 -0.814 0 O-C-N 120.958 -1.089 . . . . 25.0 110.185 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.4 p -146.69 4.42 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.359 0 CA-C-N 115.232 -0.894 . . . . 25.0 110.242 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.2 t -55.67 -57.72 10.8 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 112.9 0.704 . . . . 25.0 112.9 -173.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.44 -14.1 57.46 Favored 'General case' 0 C--O 1.256 1.404 0 N-CA-C 112.445 0.535 . . . . 25.0 112.445 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.9 mt -89.44 -52.91 4.79 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.285 0.564 . . . . 25.0 112.299 -175.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -109.03 -65.2 0.56 Allowed Glycine 0 CA--C 1.506 -0.523 0 N-CA-C 116.637 1.415 . . . . 25.0 116.637 -171.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -157.84 169.31 24.89 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 117.003 0.401 . . . . 25.0 111.353 -171.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.0 t -109.52 -23.6 11.41 Favored 'General case' 0 CA--C 1.557 1.233 0 O-C-N 123.869 0.731 . . . . 25.0 111.977 177.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -120.4 145.03 17.42 Favored Glycine 0 C--O 1.235 0.173 0 N-CA-C 105.593 -3.003 . . . . 25.0 105.593 172.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -58.28 154.0 14.23 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.095 1.146 . . . . 25.0 114.095 -173.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -90.17 -166.2 41.16 Favored Glycine 0 C--O 1.223 -0.59 0 CA-C-N 115.272 -0.876 . . . . 25.0 112.989 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -57.04 131.38 49.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.356 0.598 . . . . 25.0 112.202 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 160.41 178.1 34.1 Favored Glycine 0 N--CA 1.466 0.698 0 N-CA-C 107.054 -2.418 . . . . 25.0 107.054 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -141.76 166.72 23.95 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.932 1.366 . . . . 25.0 110.321 -175.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 55.04 34.23 22.04 Favored 'General case' 0 C--O 1.26 1.627 0 C-N-CA 123.392 0.677 . . . . 25.0 112.038 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.09 41.3 54.56 Favored Glycine 0 C--O 1.216 -1.018 0 N-CA-C 111.269 -0.732 . . . . 25.0 111.269 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.5 t -142.95 175.87 9.51 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.887 -0.782 . . . . 25.0 108.887 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 82.6 mt -106.48 164.65 11.88 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 105.655 -1.98 . . . . 25.0 105.655 173.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.418 ' HB3' ' CE1' ' A' ' 128' ' ' TYR . . . -72.89 120.5 18.6 Favored 'General case' 0 C--O 1.245 0.85 0 N-CA-C 108.302 -0.999 . . . . 25.0 108.302 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.9 m -89.71 158.36 2.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.874 -0.788 . . . . 25.0 108.874 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.4 m -132.98 154.09 50.82 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.038 -0.727 . . . . 25.0 109.038 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.3 m -120.33 160.38 20.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 108.633 -0.877 . . . . 25.0 108.633 177.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 17.2 t -75.84 -47.4 25.72 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 105.828 -1.915 . . . . 25.0 105.828 170.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -173.86 -162.52 0.15 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 101.229 -3.619 . . . . 25.0 101.229 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -61.02 -35.93 78.17 Favored 'General case' 0 C--O 1.246 0.88 0 CA-C-N 118.157 0.435 . . . . 25.0 111.088 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -103.01 -154.05 24.48 Favored Glycine 0 C--O 1.225 -0.463 0 CA-C-O 121.574 0.541 . . . . 25.0 112.293 176.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.91 -138.75 0.4 Allowed 'General case' 0 C--O 1.237 0.435 0 C-N-CA 122.75 0.42 . . . . 25.0 111.747 174.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 33.7 mtt85 -105.48 167.05 10.01 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 121.679 -0.638 . . . . 25.0 112.188 -174.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.28 165.58 13.28 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 105.402 -2.073 . . . . 25.0 105.402 177.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -138.45 152.65 48.52 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.767 -0.827 . . . . 25.0 108.767 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 27.0 tp -128.75 114.8 17.04 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 105.1 -2.185 . . . . 25.0 105.1 175.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -116.97 151.18 37.26 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 122.588 1.185 . . . . 25.0 112.101 -171.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.1 t -93.77 142.55 27.24 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 104.543 -2.392 . . . . 25.0 104.543 171.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.418 ' CE1' ' HB3' ' A' ' 113' ' ' ALA . 62.7 m-85 -115.6 11.08 15.74 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 122.539 1.161 . . . . 25.0 108.207 176.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -91.1 136.1 33.32 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 105.258 -2.127 . . . . 25.0 105.258 168.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -131.5 152.43 50.73 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-O 121.892 0.853 . . . . 25.0 110.433 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -86.54 166.72 15.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.392 -1.276 . . . . 25.0 109.382 -176.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -61.38 -32.14 72.05 Favored 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 122.676 0.39 . . . . 25.0 111.192 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -76.6 -4.54 43.46 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.325 0.861 . . . . 25.0 113.325 175.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.01 13.64 63.98 Favored Glycine 0 CA--C 1.501 -0.838 0 C-N-CA 120.919 -0.657 . . . . 25.0 112.176 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 65.7 mt -83.47 158.3 22.1 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 106.472 -1.677 . . . . 25.0 106.472 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.6 p -154.56 177.77 10.83 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 104.851 -2.278 . . . . 25.0 104.851 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -127.77 137.55 52.46 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-O 119.044 -0.503 . . . . 25.0 110.199 -176.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -152.56 153.49 33.52 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 118.996 0.816 . . . . 25.0 109.071 171.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.2 p -143.7 142.05 25.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 106.792 -1.559 . . . . 25.0 106.792 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -100.31 146.76 26.55 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.361 -0.977 . . . . 25.0 108.361 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.0 mp -137.48 132.76 33.78 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 104.669 -2.345 . . . . 25.0 104.669 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -101.82 12.16 37.49 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 121.26 1.845 . . . . 25.0 115.803 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -73.81 -14.91 79.7 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.398 -0.906 . . . . 25.0 113.081 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 42.2 t0 53.26 43.0 32.07 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 123.826 1.774 . . . . 25.0 110.902 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -109.55 41.1 1.73 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 113.547 -1.661 . . . . 25.0 107.606 -176.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.94 -29.95 63.59 Favored 'General case' 0 C--O 1.209 -1.047 0 CA-C-N 113.923 -1.49 . . . . 25.0 113.293 177.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.58 -31.66 57.66 Favored 'General case' 0 C--N 1.319 -0.756 0 O-C-N 120.285 -1.51 . . . . 25.0 112.135 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -77.27 -29.83 54.03 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.975 0.731 . . . . 25.0 112.975 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 15.9 mt -60.91 129.9 43.78 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 122.65 1.214 . . . . 25.0 110.413 -176.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.9 m -138.73 163.8 31.21 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 104.999 -2.222 . . . . 25.0 104.999 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.04 4.47 17.0 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 118.562 0.619 . . . . 25.0 109.734 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -75.01 -29.86 60.98 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.39 -0.823 . . . . 25.0 111.662 -177.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -87.32 -8.74 56.35 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 122.092 -0.38 . . . . 25.0 110.8 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 40.6 mm -91.95 132.78 35.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 104.609 -2.367 . . . . 25.0 104.609 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.4 p -115.11 132.76 63.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 122.053 0.93 . . . . 25.0 111.496 -175.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -155.33 -34.13 0.09 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 114.701 1.371 . . . . 25.0 114.701 -174.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.33 60.43 5.58 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 113.234 0.827 . . . . 25.0 113.234 -173.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 58.75 21.17 8.63 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.843 1.053 . . . . 25.0 113.843 176.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.65 11.52 2.44 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 114.675 1.361 . . . . 25.0 114.675 175.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -89.87 129.59 36.21 Favored 'General case' 0 C--O 1.238 0.448 0 O-C-N 121.999 -0.438 . . . . 25.0 110.304 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -66.69 -15.29 63.4 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.376 0.608 . . . . 25.0 111.07 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.7 -19.08 64.35 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 121.699 -0.626 . . . . 25.0 112.269 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.48 157.4 22.42 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 111.982 0.364 . . . . 25.0 111.982 -178.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 56.59 -163.79 0.16 Allowed 'General case' 0 CA--C 1.549 0.933 0 O-C-N 124.434 1.084 . . . . 25.0 113.417 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 97.67 0.98 58.96 Favored Glycine 0 N--CA 1.465 0.628 0 N-CA-C 114.94 0.736 . . . . 25.0 114.94 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -75.85 110.87 10.64 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 117.239 0.519 . . . . 25.0 111.193 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -129.85 155.44 46.0 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.553 0.341 . . . . 25.0 111.01 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -136.44 39.86 1.59 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.096 -1.202 . . . . 25.0 110.096 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 60.8 t -73.99 -36.21 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 109.76 -0.459 . . . . 25.0 109.76 -176.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.4 130.93 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-O 121.684 0.754 . . . . 25.0 111.639 -177.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 139.0 155.25 6.61 Favored Glycine 0 C--O 1.247 0.929 0 CA-C-N 115.336 -0.847 . . . . 25.0 111.741 -178.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -163.2 170.72 17.32 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 108.731 -0.84 . . . . 25.0 108.731 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 77.4 p -150.58 168.73 23.4 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 105.826 -1.916 . . . . 25.0 105.826 173.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -159.04 140.68 7.03 Favored Glycine 0 CA--C 1.501 -0.808 0 C-N-CA 119.728 -1.225 . . . . 25.0 115.062 177.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -131.64 80.16 67.08 Favored Pre-proline 0 C--O 1.24 0.561 0 N-CA-C 106.998 -1.482 . . . . 25.0 106.998 177.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -68.75 155.33 69.09 Favored 'Trans proline' 0 C--O 1.236 0.406 0 N-CA-C 113.582 0.57 . . . . 25.0 113.582 -174.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -120.66 151.96 38.81 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 106.871 -1.529 . . . . 25.0 106.871 -177.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -143.47 64.85 14.19 Favored Pre-proline 0 C--O 1.248 0.997 0 N-CA-C 115.559 1.689 . . . . 25.0 115.559 -178.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -71.53 151.28 58.71 Favored 'Trans proline' 0 C--O 1.244 0.814 0 C-N-CA 116.969 -1.554 . . . . 25.0 111.345 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 11.5 t -137.63 22.68 2.91 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.397 0.618 . . . . 25.0 110.919 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 C--O 1.247 0.944 0 CA-C-O 116.874 -1.536 . . . . 25.0 110.825 -179.665 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo . . . . . 0 CA--C 1.536 0.607 0 CA-C-O 121.516 0.548 . . . . 25.0 113.268 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.88 46.39 0.04 OUTLIER Glycine 0 CA--C 1.522 0.511 0 CA-C-N 115.427 -0.806 . . . . 25.0 111.11 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.1 p -57.54 133.85 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 CA-C-O 121.497 0.665 . . . . 25.0 109.997 -175.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -99.76 -11.57 20.71 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.703 -0.68 . . . . 25.0 109.742 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.33 -147.55 8.43 Favored Glycine 0 CA--C 1.501 -0.836 0 CA-C-N 115.621 -0.718 . . . . 25.0 113.028 177.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.2 p 71.3 159.09 0.16 Allowed Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 125.632 1.573 . . . . 25.0 111.135 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.551 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 31.2 Cg_exo -66.19 1.76 2.25 Favored 'Trans proline' 0 C--N 1.351 0.67 0 N-CA-C 117.406 2.041 . . . . 25.0 117.406 -175.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.3 p -63.98 -24.06 34.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 115.735 1.754 . . . . 25.0 115.735 -168.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.6 p -145.93 140.43 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 114.233 1.197 . . . . 25.0 114.233 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.85 10.0 86.53 Favored Glycine 0 N--CA 1.466 0.678 0 CA-C-N 114.753 -1.112 . . . . 25.0 115.434 171.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.6 t -50.95 -39.3 54.71 Favored 'General case' 0 C--O 1.21 -1.025 0 N-CA-C 114.075 1.139 . . . . 25.0 114.075 -170.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -81.71 8.07 10.9 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 115.044 1.498 . . . . 25.0 115.044 -175.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -142.99 173.96 11.09 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 118.852 -0.594 . . . . 25.0 111.459 176.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -58.79 124.12 18.72 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 115.314 1.598 . . . . 25.0 115.314 -173.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -124.32 164.47 19.54 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.611 1.708 . . . . 50.0 115.611 -175.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -130.85 77.03 1.76 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 107.469 -1.308 . . . . 25.0 107.469 169.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.1 mt -90.74 120.24 31.62 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.861 1.06 . . . . 25.0 113.861 -175.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -110.9 124.54 52.29 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 122.799 0.44 . . . . 25.0 110.69 178.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.45 172.72 41.52 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-O 122.626 1.126 . . . . 25.0 114.973 -176.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.8 p -84.97 175.44 9.06 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.037 -1.081 . . . . 25.0 110.484 175.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 66.2 mt -79.42 4.22 16.11 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.507 0.723 . . . . 25.0 112.733 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.61 177.78 24.82 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 119.438 -0.646 . . . . 25.0 113.879 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.1 t -70.14 129.98 40.85 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 117.303 0.552 . . . . 25.0 111.995 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -145.51 159.36 43.22 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.129 -0.357 . . . . 50.0 110.774 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -94.33 138.97 31.68 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 106.119 -1.808 . . . . 25.0 106.119 164.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.3 mm -129.69 105.99 12.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 105.49 -2.041 . . . . 25.0 105.49 178.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.551 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 8.9 mp -105.57 117.45 34.06 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.735 -0.839 . . . . 25.0 108.735 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.64 -42.54 62.44 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.196 -1.002 . . . . 25.0 114.303 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.8 -149.55 48.12 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 120.277 -0.963 . . . . 25.0 112.53 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.46 168.16 52.91 Favored Glycine 0 C--O 1.247 0.929 0 CA-C-O 122.001 0.778 . . . . 25.0 114.25 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.85 167.22 26.47 Favored Glycine 0 C--O 1.24 0.47 0 N-CA-C 111.954 -0.458 . . . . 25.0 111.954 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.06 120.15 28.03 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 105.773 -1.936 . . . . 25.0 105.773 176.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -115.09 154.74 28.35 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 120.41 -0.516 . . . . 50.0 111.984 -172.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -118.86 90.63 3.37 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 107.068 -1.456 . . . . 25.0 107.068 177.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.4 mt -98.4 138.22 35.95 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 123.078 0.551 . . . . 25.0 111.876 -171.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -135.31 105.78 6.42 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 118.554 0.616 . . . . 25.0 111.537 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.27 -30.65 45.02 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 115.316 0.887 . . . . 25.0 115.316 -175.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 53.93 -150.1 0.4 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.058 0.943 . . . . 25.0 112.289 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.36 162.9 24.3 Favored 'General case' 0 C--O 1.254 1.305 0 O-C-N 121.072 -1.018 . . . . 25.0 112.353 -175.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.75 159.04 32.54 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 114.922 -1.036 . . . . 25.0 111.71 -177.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -81.02 102.78 10.41 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.058 -1.089 . . . . 25.0 108.058 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -106.04 150.07 26.09 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.521 0.677 . . . . 50.0 112.72 -170.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 mp -113.05 89.37 3.06 Favored 'General case' 0 C--O 1.217 -0.626 0 N-CA-C 108.436 -0.95 . . . . 25.0 108.436 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.9 mp -92.75 129.67 38.61 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.303 0.482 . . . . 25.0 112.303 -176.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -127.1 146.61 50.32 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 104.516 -2.402 . . . . 25.0 104.516 175.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -98.19 -33.74 5.61 Favored Glycine 0 N--CA 1.466 0.689 0 N-CA-C 117.253 1.661 . . . . 25.0 117.253 -176.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.94 -162.19 52.66 Favored Glycine 0 C--O 1.257 1.587 0 N-CA-C 110.608 -0.997 . . . . 25.0 110.608 -174.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.68 161.79 7.39 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.674 0.75 . . . . 25.0 112.758 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.4 170.95 37.94 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 115.07 -0.968 . . . . 25.0 113.683 174.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.72 124.03 30.46 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 106.28 -1.748 . . . . 25.0 106.28 177.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -115.56 152.36 33.19 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 120.979 0.418 . . . . 50.0 111.593 -175.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -115.09 129.53 56.71 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 103.879 -2.637 . . . . 25.0 103.879 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -148.41 127.45 12.8 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 115.884 1.809 . . . . 25.0 115.884 -174.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.9 m -99.37 134.2 42.57 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.481 -0.781 . . . . 25.0 108.899 172.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.03 -33.95 9.25 Favored Glycine 0 C--O 1.244 0.777 0 C-N-CA 120.07 -1.062 . . . . 25.0 112.681 175.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.6 -169.39 54.73 Favored Glycine 0 C--O 1.255 1.442 0 CA-C-O 122.54 1.078 . . . . 25.0 115.111 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -67.75 162.45 23.83 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.375 -1.073 . . . . 25.0 110.605 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.77 164.48 39.63 Favored Glycine 0 C--O 1.244 0.761 0 N-CA-C 111.218 -0.753 . . . . 25.0 111.218 -177.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.74 105.13 16.05 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 109.619 -0.511 . . . . 25.0 109.619 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -99.15 151.71 20.68 Favored 'General case' 0 C--O 1.215 -0.73 0 CA-C-N 115.691 -0.686 . . . . 50.0 110.531 -170.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 58.9 m -121.64 126.67 49.58 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.925 -0.769 . . . . 25.0 108.925 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -114.36 87.59 2.67 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.615 -1.254 . . . . 25.0 107.615 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 30.8 mtt85 -85.87 -23.22 27.17 Favored 'General case' 0 CA--C 1.505 -0.763 0 O-C-N 121.602 -0.686 . . . . 25.0 112.661 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 67.75 142.6 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 O-C-N 125.161 1.538 . . . . 25.0 112.876 -174.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.28 -52.91 10.89 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 114.791 1.404 . . . . 25.0 114.791 -163.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 98.0 mt -135.82 176.53 8.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.308 1.051 . . . . 25.0 110.04 -176.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.58 -28.41 32.03 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.104 -0.953 . . . . 25.0 112.362 173.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -77.91 -10.83 59.77 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 114.707 1.373 . . . . 25.0 114.707 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.15 138.4 41.99 Favored 'General case' 0 C--O 1.213 -0.844 0 O-C-N 120.845 -1.159 . . . . 25.0 111.709 -175.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.8 t 45.61 39.42 4.9 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-N 113.682 -1.599 . . . . 25.0 114.005 173.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -104.31 167.31 9.83 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.097 -0.956 . . . . 25.0 109.434 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -127.47 143.84 51.14 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 104.791 -2.3 . . . . 25.0 104.791 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.6 p -135.9 166.76 25.86 Favored Pre-proline 0 C--N 1.315 -0.904 0 N-CA-C 108.021 -1.103 . . . . 25.0 108.021 -176.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -63.04 -23.48 73.81 Favored 'Trans proline' 0 C--N 1.353 0.774 0 CA-C-N 118.917 0.649 . . . . 25.0 112.68 175.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 73.7 mt -72.85 -23.85 60.81 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.418 0.628 . . . . 25.0 111.036 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 149.23 177.49 23.41 Favored Glycine 0 CA--C 1.5 -0.847 0 N-CA-C 111.028 -0.829 . . . . 25.0 111.028 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.3 t -97.59 155.12 17.12 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 118.072 0.936 . . . . 25.0 112.765 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -136.36 24.78 3.21 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 106.622 -1.621 . . . . 25.0 106.622 175.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.53 146.33 48.49 Favored Glycine 0 C--O 1.218 -0.865 0 CA-C-O 118.885 -0.953 . . . . 25.0 111.733 178.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -98.37 166.27 11.46 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 118.11 0.955 . . . . 50.0 112.311 -177.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -124.11 99.82 6.42 Favored 'General case' 0 C--O 1.253 1.26 0 O-C-N 123.593 0.558 . . . . 25.0 111.844 -172.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.8 mt -84.19 135.49 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 106.082 -1.821 . . . . 25.0 106.082 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.424 ' HA ' ' HG2' ' A' ' 142' ' ' GLU . 12.9 mt -89.99 -45.13 9.39 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 115.607 1.706 . . . . 25.0 115.607 -171.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -131.23 32.11 4.3 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.816 1.043 . . . . 25.0 113.816 -170.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -51.25 138.97 19.74 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.795 1.035 . . . . 25.0 113.795 -175.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -107.93 106.93 59.62 Favored Pre-proline 0 C--O 1.235 0.329 0 N-CA-C 108.293 -1.003 . . . . 25.0 108.293 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -69.8 -8.17 22.93 Favored 'Trans proline' 0 CA--C 1.547 1.161 0 N-CA-C 117.743 2.17 . . . . 25.0 117.743 -174.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.8 t -96.84 -35.81 10.81 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-O 120.481 0.181 . . . . 25.0 111.41 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -98.83 -37.66 9.35 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 113.349 0.87 . . . . 25.0 113.349 -173.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -86.59 167.0 14.96 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.922 0.391 . . . . 75.0 110.551 -173.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -145.59 149.09 33.91 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 109.356 -0.609 . . . . 25.0 109.356 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 68.5 mt -125.51 133.21 69.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 108.05 -1.093 . . . . 25.0 108.05 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -95.59 144.33 26.13 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.754 -1.202 . . . . 25.0 107.754 174.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.1 p -143.41 -10.16 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.722 -0.672 . . . . 25.0 111.612 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 39.0 t -58.85 -42.6 89.74 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.416 0.895 . . . . 25.0 113.416 -175.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.54 -20.82 61.98 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 113.977 1.102 . . . . 25.0 113.977 -176.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.79 -45.38 1.9 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 116.436 2.013 . . . . 25.0 116.436 -170.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -94.74 -75.57 1.29 Allowed Glycine 0 N--CA 1.463 0.47 0 C-N-CA 119.999 -1.096 . . . . 25.0 113.099 -175.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -148.75 167.09 26.51 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.068 -0.716 . . . . 25.0 109.068 -175.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.8 t -124.38 -27.96 3.7 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.453 0.644 . . . . 25.0 110.362 176.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -101.0 120.14 6.78 Favored Glycine 0 N--CA 1.466 0.691 0 N-CA-C 108.294 -1.922 . . . . 25.0 108.294 172.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -66.24 150.4 48.87 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 119.776 1.788 . . . . 25.0 109.55 -176.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -102.57 -146.33 17.4 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-O 122.755 1.197 . . . . 25.0 115.723 -173.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -60.01 134.35 56.96 Favored 'General case' 0 C--O 1.251 1.16 0 CA-C-N 113.605 -1.298 . . . . 25.0 112.238 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 159.28 -176.98 36.01 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 123.28 0.363 . . . . 25.0 112.504 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -144.57 179.07 7.52 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 109.609 -0.515 . . . . 25.0 109.609 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 56.74 32.85 21.93 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 113.967 1.099 . . . . 25.0 113.967 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 69.06 29.7 72.24 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 109.964 -1.254 . . . . 25.0 109.964 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.8 t -143.32 174.3 10.85 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.373 0.606 . . . . 25.0 109.69 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 5.5 mp -92.7 161.82 14.39 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 103.337 -2.838 . . . . 25.0 103.337 173.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.84 118.01 10.49 Favored 'General case' 0 C--O 1.269 2.087 0 CA-C-N 118.953 0.797 . . . . 25.0 112.196 -172.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 26.4 m -79.75 162.05 3.9 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 CA-C-O 121.56 0.695 . . . . 25.0 109.363 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 56.1 m -145.88 171.3 15.01 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.714 -0.847 . . . . 25.0 108.714 -177.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 34.0 m -125.17 162.68 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 109.156 -0.683 . . . . 25.0 109.156 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 40.2 t -80.92 -40.17 25.01 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.464 -1.68 . . . . 25.0 106.464 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -174.27 -163.49 0.16 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 102.628 -3.101 . . . . 25.0 102.628 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -63.63 -23.76 67.51 Favored 'General case' 0 C--O 1.248 1.013 0 N-CA-C 112.39 0.515 . . . . 25.0 112.39 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -121.6 -153.61 9.0 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 109.499 -1.441 . . . . 25.0 109.499 175.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.83 -154.01 0.37 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 122.859 0.464 . . . . 25.0 110.295 175.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.0 mtt85 -81.46 160.29 24.03 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 114.43 1.27 . . . . 25.0 114.43 -173.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.1 p -105.21 162.62 13.25 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 105.642 -1.985 . . . . 25.0 105.642 172.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -130.27 150.68 51.4 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.394 0.616 . . . . 25.0 112.175 -177.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 64.8 tp -127.53 120.05 27.39 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 104.022 -2.584 . . . . 25.0 104.022 171.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -118.41 146.19 44.63 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.686 0.624 . . . . 25.0 112.686 -171.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.2 t -89.15 147.94 23.93 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 106.201 -1.778 . . . . 25.0 106.201 167.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -116.5 -0.04 12.59 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.624 -1.251 . . . . 25.0 107.624 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -86.0 137.43 32.72 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 104.085 -2.561 . . . . 25.0 104.085 169.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -146.2 158.42 43.88 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 124.697 1.248 . . . . 25.0 109.38 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -80.6 160.61 25.06 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.733 -1.122 . . . . 25.0 107.976 175.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.47 -22.37 66.94 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 122.002 -0.436 . . . . 25.0 110.625 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -69.41 -11.82 61.14 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 113.455 0.909 . . . . 25.0 113.455 174.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.63 16.14 57.18 Favored Glycine 0 C--O 1.22 -0.781 0 N-CA-C 111.64 -0.584 . . . . 25.0 111.64 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.3 mt -88.66 130.21 35.35 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.985 -1.117 . . . . 25.0 107.985 178.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 72.7 p -138.95 -179.69 5.98 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.477 -0.564 . . . . 25.0 109.477 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -122.13 133.11 54.76 Favored 'General case' 0 C--O 1.257 1.453 0 CA-C-O 119.177 -0.44 . . . . 25.0 110.452 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.4 pt-20 -145.91 152.17 39.02 Favored 'General case' 0 C--O 1.247 0.956 0 N-CA-C 108.293 -1.002 . . . . 25.0 108.293 171.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.8 p -145.85 139.82 21.31 Favored 'Isoleucine or valine' 0 C--O 1.248 0.985 0 N-CA-C 106.712 -1.588 . . . . 25.0 106.712 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -103.41 147.6 26.93 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 107.704 -1.221 . . . . 25.0 107.704 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.7 mp -136.61 129.96 31.55 Favored 'General case' 0 C--O 1.208 -1.132 0 N-CA-C 105.186 -2.153 . . . . 25.0 105.186 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.424 ' HG2' ' HA ' ' A' ' 85' ' ' LEU . 17.4 pt-20 -99.66 6.54 45.62 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 119.889 1.222 . . . . 25.0 112.158 -175.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -71.1 -12.35 71.71 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.718 -0.753 . . . . 25.0 112.275 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 38.7 t0 53.53 54.86 9.4 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.915 0.864 . . . . 25.0 111.371 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -126.94 39.63 3.88 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.56 -1.2 . . . . 25.0 109.129 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.74 -37.01 82.66 Favored 'General case' 0 C--O 1.214 -0.791 0 O-C-N 121.792 -0.567 . . . . 25.0 111.673 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.16 -10.29 59.46 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 121.53 -0.731 . . . . 25.0 112.085 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -98.12 -26.13 14.68 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 111.789 0.292 . . . . 25.0 111.789 175.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.0 mt -62.69 136.06 57.69 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 122.581 1.181 . . . . 25.0 111.357 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.5 m -135.81 164.26 28.32 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 105.558 -2.016 . . . . 25.0 105.558 171.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -77.05 8.38 3.94 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.71 0.29 . . . . 25.0 110.716 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -65.66 -39.34 91.26 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.301 0.482 . . . . 25.0 112.301 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -81.54 -10.41 59.46 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.075 -0.966 . . . . 25.0 111.079 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 13.4 mm -91.27 126.1 43.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 106.312 -1.736 . . . . 25.0 106.312 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.0 p -103.05 122.77 55.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 O-C-N 120.996 -1.065 . . . . 25.0 111.555 -177.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -157.22 -16.05 0.09 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 114.684 -1.144 . . . . 25.0 113.563 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.96 61.48 6.45 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 121.878 -0.514 . . . . 25.0 111.261 -172.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 55.44 15.39 1.42 Allowed 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 115.94 1.83 . . . . 25.0 115.94 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 64.76 -21.82 0.08 Allowed 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 116.557 2.058 . . . . 25.0 116.557 176.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -70.64 116.48 11.01 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.917 -1.114 . . . . 25.0 110.201 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.42 -5.7 44.0 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 113.238 0.829 . . . . 25.0 113.238 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.24 -20.11 65.62 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.316 0.579 . . . . 25.0 110.811 177.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -90.99 -162.26 0.89 Allowed 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.588 -0.733 . . . . 25.0 111.198 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 60.79 -160.45 0.3 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.138 0.975 . . . . 25.0 113.106 176.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 79.98 24.05 60.51 Favored Glycine 0 C--O 1.228 -0.263 0 C-N-CA 121.367 -0.444 . . . . 25.0 112.272 -178.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -97.37 93.49 6.52 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.791 -0.829 . . . . 25.0 109.788 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -121.86 152.67 39.33 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.249 0.547 . . . . 25.0 109.834 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -140.5 33.77 2.03 Favored Glycine 0 CA--C 1.51 -0.251 0 CA-C-O 122.281 0.934 . . . . 25.0 111.173 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 61.3 t -82.69 -35.79 12.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 O-C-N 122.221 -0.576 . . . . 25.0 110.675 -176.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -53.27 137.84 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 115.843 -0.617 . . . . 25.0 111.246 -178.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 140.35 155.3 6.5 Favored Glycine 0 C--O 1.245 0.784 0 CA-C-N 115.843 -0.617 . . . . 25.0 112.759 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -155.94 143.67 19.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.565 0.683 . . . . 25.0 110.077 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 87.1 p -154.13 163.67 39.74 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 122.477 0.311 . . . . 25.0 110.916 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 172.41 -179.25 44.09 Favored Glycine 0 N--CA 1.47 0.956 0 N-CA-C 110.982 -0.847 . . . . 25.0 110.982 176.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -138.99 113.06 8.25 Favored Pre-proline 0 C--O 1.248 0.98 0 CA-C-N 118.152 0.976 . . . . 25.0 110.917 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.82 169.06 23.01 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 N-CA-C 115.365 1.256 . . . . 25.0 115.365 -177.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -122.49 149.02 44.46 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.078 -0.712 . . . . 25.0 109.078 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -138.49 73.78 41.62 Favored Pre-proline 0 N--CA 1.472 0.641 0 C-N-CA 123.349 0.66 . . . . 25.0 110.372 175.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -76.4 155.2 36.51 Favored 'Trans proline' 0 N--CA 1.478 0.577 0 C-N-CA 118.448 -0.568 . . . . 25.0 113.29 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.7 t -96.08 -2.16 47.21 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 121.951 -0.468 . . . . 25.0 111.965 -177.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 C--O 1.257 1.496 0 CA-C-O 118.554 -0.736 . . . . 25.0 110.017 -177.827 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo . . . . . 0 CA--C 1.538 0.677 0 CA-C-O 120.677 0.199 . . . . 25.0 112.194 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.64 60.67 0.03 OUTLIER Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.993 -0.623 . . . . 25.0 111.899 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.57 HG22 ' H ' ' A' ' 7' ' ' GLY . 7.1 p -55.84 134.68 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 122.504 1.145 . . . . 25.0 111.217 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -101.99 0.31 34.97 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 121.556 0.693 . . . . 25.0 111.045 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.57 ' H ' HG22 ' A' ' 5' ' ' VAL . . . -92.08 -147.96 21.6 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.499 -0.773 . . . . 25.0 113.694 176.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.8 p 69.98 155.59 0.15 Allowed Pre-proline 0 N--CA 1.489 1.521 0 C-N-CA 126.011 1.724 . . . . 25.0 111.226 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -73.89 4.68 3.96 Favored 'Trans proline' 0 C--O 1.24 0.625 0 C-N-CA 121.631 1.554 . . . . 25.0 115.318 -177.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.0 p -54.18 -31.5 21.98 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 N-CA-C 116.02 1.859 . . . . 25.0 116.02 -170.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.0 p -148.26 152.83 12.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 O-C-N 120.943 -1.098 . . . . 25.0 111.01 -177.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.91 7.32 88.44 Favored Glycine 0 N--CA 1.468 0.788 0 N-CA-C 115.425 0.93 . . . . 25.0 115.425 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.2 t -56.65 -40.4 75.39 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 113.914 1.079 . . . . 25.0 113.914 -172.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -78.87 10.17 3.6 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 116.41 2.004 . . . . 25.0 116.41 -175.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.59 169.74 18.97 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 119.205 -0.426 . . . . 25.0 110.545 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -51.0 139.01 18.34 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 118.664 0.666 . . . . 25.0 111.892 -177.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -131.0 161.93 30.88 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.436 1.273 . . . . 50.0 114.436 -175.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -133.87 96.15 3.6 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 104.682 -2.34 . . . . 25.0 104.682 163.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 97.5 mt -112.01 126.26 54.95 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 121.341 0.591 . . . . 25.0 111.213 -176.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -119.72 117.19 27.6 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.226 -0.897 . . . . 25.0 109.753 -176.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.58 177.29 51.38 Favored Glycine 0 CA--C 1.502 -0.763 0 N-CA-C 116.063 1.185 . . . . 25.0 116.063 -175.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.7 p -79.81 174.26 11.76 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 114.302 -0.949 . . . . 25.0 111.407 178.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 77.3 mt -87.3 18.3 3.85 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 121.551 -0.718 . . . . 25.0 111.336 175.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -123.92 179.4 16.15 Favored Glycine 0 CA--C 1.502 -0.76 0 N-CA-C 111.475 -0.65 . . . . 25.0 111.475 177.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.2 t -67.29 134.09 50.92 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.146 0.424 . . . . 25.0 112.146 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -147.02 171.96 14.47 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 123.402 0.681 . . . . 50.0 111.843 -176.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -119.34 126.77 52.21 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.802 -1.555 . . . . 25.0 106.802 166.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.9 mm -123.75 130.41 74.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 106.652 -1.61 . . . . 25.0 106.652 -178.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.6 tt -134.78 123.93 24.36 Favored 'General case' 0 C--O 1.21 -1.012 0 N-CA-C 106.761 -1.57 . . . . 25.0 106.761 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.2 -34.33 37.41 Favored Glycine 0 CA--C 1.497 -1.051 0 N-CA-C 116.22 1.248 . . . . 25.0 116.22 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.38 -143.91 38.13 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.465 -0.874 . . . . 25.0 110.99 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.44 165.9 54.72 Favored Glycine 0 CA--C 1.498 -1.014 0 CA-C-O 122.672 1.151 . . . . 25.0 113.201 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.14 167.28 30.38 Favored Glycine 0 N--CA 1.459 0.212 0 CA-C-N 114.837 -0.682 . . . . 25.0 113.495 178.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.11 111.61 19.48 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 106.498 -1.667 . . . . 25.0 106.498 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -109.36 152.55 25.16 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 113.67 0.989 . . . . 50.0 113.67 -171.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -114.7 105.14 12.7 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 106.816 -1.549 . . . . 25.0 106.816 171.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 58.1 mt -110.8 133.6 53.22 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.221 0.452 . . . . 25.0 112.221 -174.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -131.71 110.59 11.0 Favored 'General case' 0 C--N 1.316 -0.875 0 O-C-N 121.224 -0.922 . . . . 25.0 112.99 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.25 -29.72 29.93 Favored Glycine 0 C--O 1.242 0.601 0 N-CA-C 117.713 1.845 . . . . 25.0 117.713 -174.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 53.01 -154.42 0.22 Allowed 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.683 0.994 . . . . 25.0 113.683 -177.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.93 160.3 15.1 Favored 'General case' 0 C--O 1.258 1.515 0 N-CA-C 112.306 0.484 . . . . 25.0 112.306 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.63 152.11 27.94 Favored Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 110.316 -1.113 . . . . 25.0 110.316 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -78.95 119.04 21.54 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 106.385 -1.709 . . . . 25.0 106.385 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -119.18 151.77 37.76 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 111.797 0.295 . . . . 50.0 111.797 -172.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.82 127.77 48.48 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 107.089 -1.449 . . . . 25.0 107.089 170.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.7 mp -127.37 121.34 30.71 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 122.015 0.912 . . . . 25.0 112.747 -176.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -118.93 135.14 54.74 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 108.553 -0.906 . . . . 25.0 108.553 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.61 -38.5 5.54 Favored Glycine 0 CA--C 1.498 -0.987 0 O-C-N 120.137 -1.602 . . . . 25.0 113.519 -174.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.83 -166.67 50.68 Favored Glycine 0 C--O 1.246 0.884 0 CA-C-O 121.947 0.748 . . . . 25.0 111.396 -177.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.91 157.94 14.22 Favored 'General case' 0 C--O 1.248 1.003 0 C-N-CA 123.241 0.617 . . . . 25.0 111.631 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.41 165.38 32.47 Favored Glycine 0 N--CA 1.466 0.695 0 CA-C-N 116.063 -0.517 . . . . 25.0 114.009 178.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.58 122.86 28.64 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 105.286 -2.116 . . . . 25.0 105.286 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -114.24 156.99 23.32 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.625 -0.509 . . . . 50.0 109.625 -175.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -124.19 122.95 39.17 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 106.382 -1.71 . . . . 25.0 106.382 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -146.38 139.89 25.95 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 116.728 2.121 . . . . 25.0 116.728 -170.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 70.3 m -108.31 143.33 37.33 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 114.958 -1.019 . . . . 25.0 108.473 175.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.9 -32.24 6.93 Favored Glycine 0 C--N 1.323 -0.173 0 N-CA-C 109.005 -1.638 . . . . 25.0 109.005 175.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.45 -174.88 54.52 Favored Glycine 0 CA--C 1.502 -0.741 0 C-N-CA 119.599 -1.286 . . . . 25.0 112.834 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -62.62 159.04 16.81 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.794 -0.827 . . . . 25.0 110.84 177.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.34 156.52 32.72 Favored Glycine 0 C--O 1.224 -0.487 0 CA-C-N 114.875 -1.057 . . . . 25.0 111.089 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.62 108.36 14.19 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.934 -1.136 . . . . 25.0 107.934 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -101.08 159.93 14.81 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.31 -0.859 . . . . 50.0 110.969 -172.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 57.4 m -124.67 119.09 28.01 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 109.102 -0.703 . . . . 25.0 109.102 177.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -99.65 83.94 2.86 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 106.589 -1.634 . . . . 25.0 106.589 175.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -83.16 -20.86 33.92 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.277 -0.874 . . . . 25.0 111.229 -173.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 61.91 160.6 0.07 Allowed 'General case' 0 CA--C 1.547 0.845 0 O-C-N 124.858 1.349 . . . . 25.0 112.181 -176.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -93.45 -70.39 0.7 Allowed 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.81 1.041 . . . . 25.0 113.81 -168.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.1 mt -116.48 175.17 5.68 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.68 0.753 . . . . 25.0 111.482 -171.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.94 -32.34 32.7 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.484 0.714 . . . . 25.0 111.435 176.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -80.02 -6.94 58.5 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.52 0.933 . . . . 25.0 113.52 -174.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.68 127.89 34.51 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 122.087 0.946 . . . . 25.0 111.594 -177.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.1 t 49.94 39.56 18.91 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 115.63 1.715 . . . . 25.0 115.63 173.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -103.59 160.94 14.31 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.722 -1.126 . . . . 25.0 110.12 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -115.09 139.91 49.5 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 104.056 -2.572 . . . . 25.0 104.056 176.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 62.8 p -124.29 166.0 21.7 Favored Pre-proline 0 C--N 1.317 -0.824 0 N-CA-C 108.623 -0.881 . . . . 25.0 108.623 -175.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -65.07 -19.5 63.41 Favored 'Trans proline' 0 C--O 1.245 0.861 0 C-N-CA 117.769 -1.02 . . . . 25.0 112.702 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 81.2 mt -76.17 -29.65 57.79 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.283 0.563 . . . . 25.0 112.181 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 160.76 179.15 35.33 Favored Glycine 0 N--CA 1.472 1.044 0 CA-C-O 118.412 -1.216 . . . . 25.0 110.182 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.4 t -98.02 148.78 23.15 Favored 'General case' 0 C--O 1.251 1.146 0 CA-C-N 118.884 1.342 . . . . 25.0 113.034 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -130.29 28.95 4.93 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-N 114.643 -1.162 . . . . 25.0 108.156 174.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.51 146.92 50.27 Favored Glycine 0 N--CA 1.463 0.455 0 N-CA-C 109.073 -1.611 . . . . 25.0 109.073 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -93.69 166.29 12.29 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 117.343 0.571 . . . . 50.0 111.405 -176.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.92 104.6 9.95 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 122.656 0.383 . . . . 25.0 111.65 -173.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.0 mt -91.16 135.7 26.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 107.889 -1.152 . . . . 25.0 107.889 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.446 ' HA ' ' HG2' ' A' ' 142' ' ' GLU . 85.5 mt -88.32 -56.57 3.26 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.539 0.94 . . . . 25.0 113.539 -174.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -124.61 39.37 3.99 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.672 0.99 . . . . 25.0 113.672 -171.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -55.53 138.77 45.9 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.76 0.79 . . . . 25.0 111.665 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -105.85 102.75 40.62 Favored Pre-proline 0 N--CA 1.469 0.497 0 N-CA-C 108.804 -0.813 . . . . 25.0 108.804 177.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -67.74 -6.7 17.46 Favored 'Trans proline' 0 C--N 1.359 1.087 0 N-CA-C 116.31 1.619 . . . . 25.0 116.31 -174.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.9 t -97.48 -42.87 7.51 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.005 0.522 . . . . 25.0 109.97 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -96.31 -43.11 7.83 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 113.283 0.845 . . . . 25.0 113.283 -171.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -82.44 164.81 20.73 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 121.472 -0.767 . . . . 75.0 110.336 -173.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -142.05 152.07 43.01 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.9 -0.591 . . . . 25.0 111.347 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 77.5 mt -126.49 131.92 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 107.63 -1.248 . . . . 25.0 107.63 -177.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -93.2 151.03 20.07 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 108.526 -0.916 . . . . 25.0 108.526 174.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 p -150.41 -3.91 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 N-CA-C 112.834 0.679 . . . . 25.0 112.834 -175.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.6 t -60.68 -48.49 81.54 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.831 1.048 . . . . 25.0 113.831 -173.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.54 -31.63 60.14 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.158 0.799 . . . . 25.0 113.158 -177.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.55 -22.95 16.24 Favored 'General case' 0 C--O 1.246 0.881 0 N-CA-C 115.919 1.822 . . . . 25.0 115.919 -173.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -134.11 -72.76 0.08 OUTLIER Glycine 0 CA--C 1.53 1.024 0 N-CA-C 116.102 1.201 . . . . 25.0 116.102 -174.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -154.57 167.06 31.38 Favored 'General case' 0 C--O 1.211 -0.926 0 CA-C-N 117.471 0.636 . . . . 25.0 109.438 -173.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 30.9 t -120.45 -47.77 2.33 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.191 -1.04 . . . . 25.0 108.191 176.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.15 120.9 5.37 Favored Glycine 0 CA--C 1.501 -0.814 0 N-CA-C 108.588 -1.805 . . . . 25.0 108.588 175.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -68.41 158.13 34.3 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 117.302 0.551 . . . . 25.0 111.744 -175.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -100.51 -160.31 27.99 Favored Glycine 0 N--CA 1.457 0.073 0 N-CA-C 115.109 0.804 . . . . 25.0 115.109 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -48.35 134.7 14.64 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.681 -0.76 . . . . 25.0 112.794 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 158.98 -175.07 35.99 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 108.676 -1.769 . . . . 25.0 108.676 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -152.9 168.21 26.54 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 118.694 1.247 . . . . 25.0 108.343 -177.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 52.59 39.04 27.41 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.85 1.056 . . . . 25.0 113.85 -177.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 69.47 35.1 74.83 Favored Glycine 0 C--O 1.245 0.801 0 N-CA-C 110.751 -0.939 . . . . 25.0 110.751 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.603 ' HA ' ' H ' ' A' ' 151' ' ' ALA . 7.6 t -136.97 176.57 8.59 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 121.623 -0.928 . . . . 25.0 109.905 -178.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.1 mt -110.34 164.58 12.54 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 102.47 -3.159 . . . . 25.0 102.47 176.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.63 120.98 23.33 Favored 'General case' 0 C--O 1.258 1.509 0 N-CA-C 108.063 -1.088 . . . . 25.0 108.063 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.7 m -80.23 159.32 4.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 C-N-CA 122.86 0.464 . . . . 25.0 111.374 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 73.3 m -134.83 163.0 30.81 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.438 -0.949 . . . . 25.0 108.438 177.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.0 m -124.37 165.51 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.362 0 N-CA-C 107.544 -1.28 . . . . 25.0 107.544 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.6 t -80.13 -49.07 12.23 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 106.574 -1.639 . . . . 25.0 106.574 173.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -161.57 -161.99 0.84 Allowed 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 101.941 -3.355 . . . . 25.0 101.941 174.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -67.09 -0.22 3.11 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.498 0.666 . . . . 25.0 112.536 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -142.64 -155.72 6.53 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 108.786 -1.726 . . . . 25.0 108.786 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 53.32 -145.86 0.57 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.116 0.784 . . . . 25.0 113.116 176.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.4 mtt85 -75.89 174.04 10.42 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.934 0.873 . . . . 25.0 113.336 -173.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.26 163.19 29.86 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 105.342 -2.095 . . . . 25.0 105.342 176.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -136.92 155.1 50.17 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.703 -0.48 . . . . 25.0 109.703 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 29.7 tp -125.43 127.17 46.1 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.161 -1.792 . . . . 25.0 106.161 171.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -126.37 151.51 47.53 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.386 0.513 . . . . 25.0 112.386 -171.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 84.0 p -88.63 150.01 23.25 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 105.115 -2.18 . . . . 25.0 105.115 169.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -117.33 27.78 8.88 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 105.621 -1.992 . . . . 25.0 105.621 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -122.88 141.67 51.63 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 112.578 -2.101 . . . . 25.0 106.468 174.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -138.41 153.83 48.9 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 124.221 0.95 . . . . 25.0 111.465 -178.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -77.96 160.29 28.29 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.498 -1.297 . . . . 25.0 107.498 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.73 -20.07 65.45 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-O 122.505 1.145 . . . . 25.0 109.142 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -74.12 -12.3 60.56 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 114.682 -1.145 . . . . 25.0 113.549 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.25 9.02 67.8 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 115.888 -0.596 . . . . 25.0 113.776 -178.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 63.0 mt -83.33 147.53 27.88 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 108.128 -1.064 . . . . 25.0 108.128 174.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 69.6 p -149.76 179.57 7.91 Favored 'General case' 0 C--O 1.248 0.976 0 N-CA-C 107.642 -1.244 . . . . 25.0 107.642 177.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -123.8 135.61 53.9 Favored 'General case' 0 C--O 1.253 1.268 0 CA-C-N 118.871 0.76 . . . . 25.0 111.76 -176.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -151.41 154.97 37.67 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.756 -1.572 . . . . 25.0 106.756 171.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.69 139.39 19.66 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 105.771 -1.937 . . . . 25.0 105.771 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -101.53 143.92 30.93 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 107.685 -1.228 . . . . 25.0 107.685 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mp -136.5 139.13 42.06 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 106.29 -1.744 . . . . 25.0 106.29 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.446 ' HG2' ' HA ' ' A' ' 85' ' ' LEU . 12.9 pt-20 -110.15 11.65 23.66 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.992 1.269 . . . . 25.0 110.603 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -68.41 -19.82 72.95 Favored Glycine 0 CA--C 1.499 -0.944 0 CA-C-N 115.218 -0.901 . . . . 25.0 111.006 173.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.1 t0 54.74 51.69 13.39 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 122.999 1.381 . . . . 25.0 110.733 175.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -121.63 42.75 3.02 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 113.513 -1.676 . . . . 25.0 108.151 -175.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -55.84 -31.59 62.85 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 114.596 -1.184 . . . . 25.0 112.462 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -77.18 -29.43 54.42 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 118.678 0.672 . . . . 25.0 111.878 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.55 -20.33 26.6 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 120.574 -0.45 . . . . 25.0 111.799 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 22.2 mt -62.12 136.54 57.99 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 121.082 0.468 . . . . 25.0 111.088 177.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 70.3 m -144.7 161.5 39.05 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 107.541 -1.281 . . . . 25.0 107.541 175.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.603 ' H ' ' HA ' ' A' ' 111' ' ' SER . . . -79.74 -0.09 32.83 Favored 'General case' 0 C--O 1.206 -1.206 0 N-CA-C 107.367 -1.346 . . . . 25.0 107.367 177.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -74.09 -26.77 60.55 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.372 -0.831 . . . . 25.0 110.788 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -89.66 -6.72 55.89 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.591 -0.693 . . . . 25.0 109.524 176.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 49.1 mm -90.22 136.6 23.46 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.621 0 N-CA-C 103.708 -2.701 . . . . 25.0 103.708 173.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.9 p -116.39 128.93 73.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 122.656 1.217 . . . . 25.0 110.861 -176.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -158.05 -17.13 0.08 Allowed 'General case' 0 C--O 1.211 -0.937 0 CA-C-N 113.95 -1.477 . . . . 25.0 113.121 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.75 43.34 0.91 Allowed 'General case' 0 C--O 1.246 0.897 0 O-C-N 121.454 -0.779 . . . . 25.0 112.183 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 58.17 29.09 17.42 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.891 0.877 . . . . 25.0 112.964 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.4 m 51.53 37.26 19.09 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 122.334 1.064 . . . . 25.0 111.342 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -76.36 123.81 26.53 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.71 1.004 . . . . 25.0 113.71 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.82 -18.32 60.47 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.29 -0.868 . . . . 25.0 112.719 177.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -81.07 -21.5 39.97 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 122.305 -0.247 . . . . 25.0 110.596 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.45 177.56 8.89 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.835 0.454 . . . . 25.0 111.108 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 63.47 178.66 0.16 Allowed 'General case' 0 CA--C 1.547 0.861 0 O-C-N 124.682 1.239 . . . . 25.0 113.939 176.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 82.04 22.63 58.97 Favored Glycine 0 C--O 1.237 0.294 0 CA-C-N 115.296 -0.865 . . . . 25.0 111.141 -177.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -106.99 104.79 14.55 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 112.338 0.496 . . . . 25.0 112.338 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -130.29 151.59 50.63 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 107.62 -1.252 . . . . 25.0 107.62 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -135.57 33.72 2.38 Favored Glycine 0 CA--C 1.502 -0.761 0 N-CA-C 110.802 -0.919 . . . . 25.0 110.802 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 54.6 t -79.53 -27.27 12.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 CA-C-O 121.939 0.876 . . . . 25.0 108.774 -176.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -53.86 134.39 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 CA-C-N 114.485 -1.234 . . . . 25.0 113.025 -174.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 141.12 150.66 5.43 Favored Glycine 0 C--O 1.246 0.895 0 N-CA-C 109.5 -1.44 . . . . 25.0 109.5 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -142.86 145.36 33.07 Favored 'General case' 0 C--O 1.252 1.232 0 O-C-N 122.197 -0.59 . . . . 25.0 111.249 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 13.3 p -150.72 154.77 38.0 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.725 0.774 . . . . 25.0 111.306 175.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 176.71 166.74 34.27 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 115.138 -0.937 . . . . 25.0 113.85 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -133.55 111.07 12.53 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 107.312 -1.366 . . . . 25.0 107.312 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.88 160.91 39.92 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 116.879 -1.614 . . . . 25.0 113.137 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -119.15 147.02 44.65 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.032 -1.099 . . . . 25.0 108.032 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -143.74 73.11 17.08 Favored Pre-proline 0 C--O 1.251 1.171 0 O-C-N 123.536 0.523 . . . . 25.0 111.198 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -69.9 164.07 36.06 Favored 'Trans proline' 0 C--O 1.249 1.031 0 N-CA-C 113.857 0.676 . . . . 25.0 113.857 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 12.6 t -125.66 8.68 7.62 Favored 'General case' 0 C--O 1.256 1.414 0 N-CA-C 109.652 -0.499 . . . . 25.0 109.652 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 C--O 1.245 0.853 0 N-CA-C 108.565 -0.902 . . . . 25.0 108.565 178.043 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo . . . . . 0 CA--C 1.531 0.356 0 N-CA-C 113.856 0.675 . . . . 25.0 113.856 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -163.66 31.64 0.27 Allowed Glycine 0 CA--C 1.521 0.417 0 CA-C-O 119.429 -0.651 . . . . 25.0 112.26 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.5 p -60.35 133.11 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 122.027 0.918 . . . . 25.0 111.194 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -99.07 -18.57 17.67 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.647 -0.706 . . . . 25.0 112.197 -177.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.79 -134.11 3.84 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-O 121.715 0.62 . . . . 25.0 114.56 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.9 p 69.08 156.64 0.15 Allowed Pre-proline 0 N--CA 1.483 1.208 0 C-N-CA 125.858 1.663 . . . . 25.0 110.392 -173.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.425 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 32.4 Cg_exo -65.9 0.11 3.43 Favored 'Trans proline' 0 N--CA 1.485 1.008 0 N-CA-C 117.707 2.156 . . . . 25.0 117.707 -173.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.6 p -68.01 -22.14 27.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 114.787 1.403 . . . . 25.0 114.787 -172.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.2 p -128.1 121.57 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 117.329 2.344 . . . . 25.0 117.329 -171.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.05 20.6 79.06 Favored Glycine 0 C--O 1.224 -0.47 0 N-CA-C 117.423 1.729 . . . . 25.0 117.423 173.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.2 t -50.07 -37.87 35.56 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 114.726 1.38 . . . . 25.0 114.726 -174.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -80.74 13.61 2.52 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 114.649 1.352 . . . . 25.0 114.649 -176.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -149.63 171.22 17.02 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.531 -0.73 . . . . 25.0 110.542 176.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.76 121.57 14.32 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.293 0.637 . . . . 25.0 111.538 -173.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -120.72 169.69 10.16 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 115.296 1.591 . . . . 50.0 115.296 -173.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -123.35 114.55 20.32 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 103.775 -2.676 . . . . 25.0 103.775 160.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 82.3 mt -120.04 102.57 8.63 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.536 0.684 . . . . 25.0 111.761 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -93.4 121.8 35.16 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.709 -0.678 . . . . 25.0 109.837 177.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.15 -174.29 47.67 Favored Glycine 0 N--CA 1.464 0.565 0 N-CA-C 115.245 0.858 . . . . 25.0 115.245 -178.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.7 p -91.67 173.71 7.73 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.778 0.831 . . . . 25.0 112.404 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 75.4 mt -83.67 12.41 5.88 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.356 0.873 . . . . 25.0 113.356 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.85 179.31 20.04 Favored Glycine 0 N--CA 1.462 0.378 0 CA-C-N 116.284 -0.416 . . . . 25.0 112.175 178.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.5 t -71.48 130.93 42.51 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 122.701 0.4 . . . . 25.0 110.635 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -143.41 165.89 26.29 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 123.265 0.353 . . . . 50.0 111.527 -174.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -111.11 125.49 53.83 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 106.108 -1.812 . . . . 25.0 106.108 166.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.0 mm -115.49 129.22 72.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 107.043 -1.465 . . . . 25.0 107.043 -177.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.425 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 1.0 OUTLIER -129.27 123.33 31.63 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 105.418 -2.067 . . . . 25.0 105.418 179.677 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.54 -36.32 23.53 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 114.969 0.747 . . . . 25.0 114.969 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.52 -149.03 50.42 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.268 -0.733 . . . . 25.0 111.268 -176.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -78.41 170.47 54.84 Favored Glycine 0 C--O 1.257 1.585 0 O-C-N 121.728 -0.866 . . . . 25.0 112.061 -176.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.34 165.06 33.83 Favored Glycine 0 C--N 1.316 -0.557 0 CA-C-O 119.639 -0.534 . . . . 25.0 112.91 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.14 101.07 13.14 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.053 -1.091 . . . . 25.0 108.053 178.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -98.48 153.57 18.51 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.915 0.709 . . . . 50.0 112.915 -168.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -115.15 99.85 7.73 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 105.745 -1.946 . . . . 25.0 105.745 175.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 33.2 mt -104.26 137.82 41.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.798 -1.092 . . . . 25.0 111.571 -171.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -133.77 99.42 4.46 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.925 0.713 . . . . 25.0 112.925 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.38 -35.2 63.47 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-O 118.342 -1.255 . . . . 25.0 115.8 -177.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 55.17 -154.47 0.29 Allowed 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 118.814 1.307 . . . . 25.0 113.672 -178.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.97 160.13 15.56 Favored 'General case' 0 C--O 1.249 1.034 0 N-CA-C 113.486 0.921 . . . . 25.0 113.486 -176.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.12 159.93 33.51 Favored Glycine 0 C--O 1.223 -0.546 0 CA-C-N 115.187 -0.915 . . . . 25.0 111.451 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -82.15 115.5 21.29 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 104.688 -2.338 . . . . 25.0 104.688 177.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -116.67 154.33 30.76 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.758 -0.377 . . . . 50.0 110.514 -171.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 mp -114.05 133.08 55.76 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 105.792 -1.929 . . . . 25.0 105.792 174.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.6 mp -133.28 128.92 36.84 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 113.967 1.099 . . . . 25.0 113.967 -173.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -129.92 135.13 47.99 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.181 -1.414 . . . . 25.0 107.181 177.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -93.36 -40.65 4.73 Favored Glycine 0 N--CA 1.475 1.26 0 N-CA-C 115.409 0.924 . . . . 25.0 115.409 -175.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.34 -174.92 55.22 Favored Glycine 0 C--O 1.24 0.491 0 N-CA-C 110.88 -0.888 . . . . 25.0 110.88 -176.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.83 154.06 9.88 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.328 0.585 . . . . 25.0 109.911 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.1 150.66 24.12 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.493 -0.776 . . . . 25.0 112.028 -176.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -74.92 127.87 34.23 Favored 'General case' 0 C--O 1.212 -0.92 0 N-CA-C 104.737 -2.32 . . . . 25.0 104.737 176.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -117.68 150.94 38.22 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 121.707 -0.62 . . . . 50.0 111.046 -174.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -112.76 121.56 45.09 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 103.764 -2.68 . . . . 25.0 103.764 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -144.7 131.5 20.16 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 117.743 2.497 . . . . 25.0 117.743 -171.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.3 m -99.45 141.19 32.55 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-N 115.8 -0.637 . . . . 25.0 109.534 174.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -94.72 -35.71 5.8 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 110.443 -1.063 . . . . 25.0 110.443 172.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.17 -176.33 51.74 Favored Glycine 0 N--CA 1.465 0.62 0 CA-C-N 118.198 0.999 . . . . 25.0 113.373 -178.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -59.51 156.1 13.92 Favored 'General case' 0 C--O 1.246 0.884 0 O-C-N 121.595 -0.944 . . . . 25.0 110.724 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.01 162.54 34.63 Favored Glycine 0 C--O 1.246 0.903 0 N-CA-C 108.943 -1.663 . . . . 25.0 108.943 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.95 121.32 26.36 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 106.842 -1.54 . . . . 25.0 106.842 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -112.0 152.19 28.41 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.184 0.516 . . . . 50.0 110.17 -175.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.5 m -117.47 110.31 17.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.851 0.834 . . . . 25.0 110.329 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -94.21 119.94 33.75 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 106.032 -1.84 . . . . 25.0 106.032 176.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.9 mmt85 -114.5 -32.25 5.96 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.967 -0.561 . . . . 25.0 112.339 -177.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 68.09 148.53 0.06 Allowed 'General case' 0 CA--C 1.55 0.948 0 O-C-N 124.741 1.275 . . . . 25.0 110.667 -174.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.16 -34.98 21.99 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 114.822 1.416 . . . . 25.0 114.822 -165.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 70.5 mt -132.25 161.66 32.9 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.1 0.476 . . . . 25.0 110.602 -172.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.83 -31.35 66.55 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 107.095 -1.446 . . . . 25.0 107.095 169.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -87.69 9.34 21.82 Favored 'General case' 0 C--O 1.254 1.31 0 N-CA-C 115.571 1.693 . . . . 25.0 115.571 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -94.7 141.54 28.5 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.034 -1.042 . . . . 25.0 110.101 -177.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.8 t 47.32 50.48 14.48 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 114.556 1.317 . . . . 25.0 114.556 -178.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 31.0 p-80 -114.35 169.54 8.96 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.47 -0.786 . . . . 25.0 111.403 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -121.45 148.79 43.97 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 104.621 -2.362 . . . . 25.0 104.621 173.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 92.4 p -139.59 170.96 8.74 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 107.299 -1.371 . . . . 25.0 107.299 -177.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -62.79 -20.45 71.21 Favored 'Trans proline' 0 C--N 1.361 1.185 0 CA-C-N 119.044 0.694 . . . . 25.0 113.087 174.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 80.9 mt -73.64 -27.5 61.3 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 121.748 -0.595 . . . . 25.0 110.91 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.91 -177.95 30.29 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.683 -0.967 . . . . 25.0 110.683 -174.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.3 t -101.7 141.73 34.12 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 122.811 1.291 . . . . 25.0 111.54 -178.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -127.71 27.36 5.77 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 114.678 -1.146 . . . . 25.0 109.167 176.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.2 145.17 45.77 Favored Glycine 0 N--CA 1.462 0.39 0 O-C-N 124.07 0.856 . . . . 25.0 112.124 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -85.33 170.1 13.09 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 122.694 -0.297 . . . . 50.0 111.321 -177.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -128.11 105.95 8.72 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.694 0.798 . . . . 25.0 111.394 -174.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.0 mt -87.82 133.91 29.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 121.853 0.835 . . . . 25.0 108.789 -178.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.448 ' HA ' ' HG2' ' A' ' 142' ' ' GLU . 85.0 mt -85.1 -43.93 13.45 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 116.401 2.001 . . . . 25.0 116.401 -172.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -137.67 40.16 2.39 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.09 1.144 . . . . 25.0 114.09 -173.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -55.97 132.21 49.29 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.579 -0.737 . . . . 25.0 112.287 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -102.37 105.43 43.36 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 106.011 -1.848 . . . . 25.0 106.011 174.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -70.48 -4.39 14.42 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 N-CA-C 116.622 1.739 . . . . 25.0 116.622 -172.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.3 t -97.29 -45.62 6.42 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.201 0.524 . . . . 25.0 111.079 174.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -82.53 -41.26 19.88 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.357 0.873 . . . . 25.0 113.357 -174.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -84.95 165.44 17.61 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.694 -0.484 . . . . 75.0 109.694 -169.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -140.73 146.24 37.5 Favored 'General case' 0 C--O 1.246 0.874 0 N-CA-C 108.523 -0.917 . . . . 25.0 108.523 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 76.5 mt -128.66 126.52 65.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 107.926 -1.138 . . . . 25.0 107.926 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -80.91 148.14 30.0 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.809 0.814 . . . . 25.0 110.361 172.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.0 p -143.32 -7.91 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.317 -0.856 . . . . 25.0 110.628 176.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.8 t -63.92 -41.16 97.73 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.282 0.563 . . . . 25.0 111.943 -173.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.62 -4.61 57.97 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.028 0.751 . . . . 25.0 113.028 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 11.9 mt -115.04 -38.25 3.93 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.989 1.477 . . . . 25.0 114.989 -169.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -136.42 -54.68 0.06 OUTLIER Glycine 0 C--O 1.24 0.477 0 N-CA-C 117.644 1.818 . . . . 25.0 117.644 -174.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -155.04 164.02 39.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 117.569 0.684 . . . . 25.0 109.826 -174.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 45.8 t -121.26 -25.53 5.23 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 124.12 0.887 . . . . 25.0 109.018 173.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -100.65 121.59 7.29 Favored Glycine 0 N--CA 1.464 0.565 0 N-CA-C 107.615 -2.194 . . . . 25.0 107.615 172.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.68 146.49 53.72 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 118.565 1.183 . . . . 25.0 113.246 -174.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -80.85 -175.19 49.45 Favored Glycine 0 C--N 1.32 -0.316 0 CA-C-N 115.349 -0.841 . . . . 25.0 114.415 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -60.84 142.62 56.01 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 121.196 0.522 . . . . 25.0 111.701 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 166.83 -171.94 41.84 Favored Glycine 0 C--O 1.245 0.787 0 N-CA-C 109.363 -1.495 . . . . 25.0 109.363 -177.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -141.52 165.25 28.0 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.833 1.317 . . . . 25.0 111.465 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 57.52 33.9 23.88 Favored 'General case' 0 C--O 1.246 0.878 0 O-C-N 124.454 1.096 . . . . 25.0 113.541 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 74.56 39.32 41.81 Favored Glycine 0 C--O 1.222 -0.653 0 N-CA-C 109.969 -1.252 . . . . 25.0 109.969 177.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 11.1 t -148.6 167.64 24.92 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 108.998 -0.741 . . . . 25.0 108.998 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.4 mt -84.78 159.91 20.36 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 103.069 -2.937 . . . . 25.0 103.069 169.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.66 128.9 38.03 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 119.291 -0.964 . . . . 25.0 109.158 178.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.9 m -91.48 159.23 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 109.65 -0.5 . . . . 25.0 109.65 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.19 164.71 26.77 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 110.169 -0.308 . . . . 25.0 110.169 -177.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.4 m -118.58 162.64 16.5 Favored 'Isoleucine or valine' 0 C--O 1.25 1.08 0 N-CA-C 106.726 -1.583 . . . . 25.0 106.726 175.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.8 t -83.06 -51.23 7.72 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 106.295 -1.743 . . . . 25.0 106.295 170.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -166.69 -164.58 0.66 Allowed 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 100.825 -3.768 . . . . 25.0 100.825 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -68.12 -25.07 65.11 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 119.173 0.897 . . . . 25.0 110.658 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -106.9 -164.64 22.3 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 108.17 -1.972 . . . . 25.0 108.17 174.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 56.18 -162.79 0.17 Allowed 'General case' 0 C--O 1.248 0.976 0 N-CA-C 113.538 0.94 . . . . 25.0 113.538 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 64.3 mtt85 -79.24 169.29 18.35 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.755 1.02 . . . . 25.0 113.755 -168.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.7 p -115.3 165.56 12.82 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 105.111 -2.181 . . . . 25.0 105.111 174.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -134.73 157.97 45.33 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 121.404 0.621 . . . . 25.0 111.357 -177.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 51.1 tp -130.13 113.97 15.15 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 103.781 -2.674 . . . . 25.0 103.781 171.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -116.13 148.67 40.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.979 0.419 . . . . 25.0 110.19 -174.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 43.0 t -97.27 147.18 24.4 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 106.061 -1.829 . . . . 25.0 106.061 171.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -116.9 17.28 15.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.562 0.696 . . . . 25.0 110.532 -177.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -107.8 140.06 41.45 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 104.674 -2.343 . . . . 25.0 104.674 172.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -140.04 154.65 47.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.698 0.761 . . . . 25.0 112.404 -176.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -75.03 166.22 24.01 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.924 -1.035 . . . . 25.0 109.318 177.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.83 -25.27 66.35 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 108.443 -0.947 . . . . 25.0 108.443 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -74.02 -5.37 41.0 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.372 -0.831 . . . . 25.0 112.995 175.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.32 10.48 77.47 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 121.299 -0.477 . . . . 25.0 112.619 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.5 mt -83.8 134.03 34.74 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 122.288 -0.536 . . . . 25.0 109.663 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 59.8 p -138.69 176.89 8.3 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 106.605 -1.628 . . . . 25.0 106.605 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -125.64 134.46 51.87 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 120.328 -0.549 . . . . 25.0 110.349 -175.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -152.76 152.93 32.22 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 108.979 -0.749 . . . . 25.0 108.979 171.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 13.0 p -145.23 143.78 21.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 106.244 -1.762 . . . . 25.0 106.244 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -102.45 146.14 28.53 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 107.081 -1.452 . . . . 25.0 107.081 -177.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.5 mp -132.19 134.98 46.0 Favored 'General case' 0 C--O 1.201 -1.479 0 N-CA-C 104.908 -2.256 . . . . 25.0 104.908 177.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.448 ' HG2' ' HA ' ' A' ' 85' ' ' LEU . 8.7 pt-20 -103.18 10.55 37.73 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 119.923 1.238 . . . . 25.0 111.059 -178.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.7 -10.2 66.92 Favored Glycine 0 N--CA 1.458 0.164 0 C-N-CA 120.952 -0.642 . . . . 25.0 113.57 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 37.9 t0 53.09 40.9 31.98 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 123.327 1.536 . . . . 25.0 110.557 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -115.92 38.29 3.38 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.053 -1.43 . . . . 25.0 109.811 -179.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.28 -32.57 68.54 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.067 0.766 . . . . 25.0 113.067 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.14 -28.49 62.27 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.017 0.377 . . . . 25.0 112.017 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -85.49 -29.56 24.17 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-N 116.744 -0.207 . . . . 25.0 111.041 -177.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 29.4 mt -59.35 139.5 56.97 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-O 122.431 1.11 . . . . 25.0 112.581 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.4 m -143.06 160.43 40.39 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.3 -1.741 . . . . 25.0 106.3 176.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.64 3.76 15.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.17 0.509 . . . . 25.0 109.987 176.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -68.38 -29.59 68.33 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.174 -0.466 . . . . 25.0 110.307 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -92.07 1.63 57.08 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.39 0.614 . . . . 25.0 110.867 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 31.4 mm -101.02 125.42 54.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.821 0 N-CA-C 104.821 -2.289 . . . . 25.0 104.821 178.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.74 119.4 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 122.934 1.35 . . . . 25.0 112.14 -174.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -156.0 -20.76 0.1 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 113.248 -1.797 . . . . 25.0 110.908 177.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -76.11 52.18 0.71 Allowed 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.211 1.189 . . . . 25.0 114.211 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 63.68 11.37 5.74 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 115.229 1.566 . . . . 25.0 115.229 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.5 m 64.96 -59.2 0.25 Allowed 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 116.686 2.106 . . . . 25.0 116.686 176.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -64.27 137.91 58.17 Favored 'General case' 0 C--O 1.244 0.772 0 O-C-N 121.946 -0.471 . . . . 25.0 111.381 -175.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -81.69 61.09 4.92 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 113.349 0.87 . . . . 25.0 113.349 -176.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.04 -37.02 78.35 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.77 -0.826 . . . . 25.0 108.77 177.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -135.87 -104.73 0.21 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.534 -0.757 . . . . 25.0 109.702 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 55.71 -159.7 0.2 Allowed 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.247 1.019 . . . . 25.0 111.17 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 63.44 25.83 68.99 Favored Glycine 0 C--O 1.218 -0.863 0 C-N-CA 121.227 -0.511 . . . . 25.0 112.648 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -82.54 94.94 7.59 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.596 0.712 . . . . 25.0 110.647 -174.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -125.32 150.73 46.87 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 108.493 -0.929 . . . . 25.0 108.493 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -146.0 32.0 1.57 Allowed Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 109.125 -1.59 . . . . 25.0 109.125 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 39.9 t -65.34 -37.66 80.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 109.99 -0.374 . . . . 25.0 109.99 -175.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.8 128.65 21.09 Favored 'Isoleucine or valine' 0 C--O 1.244 0.8 0 CA-C-O 122.197 0.999 . . . . 25.0 110.913 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 158.58 146.27 4.48 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 109.082 -1.607 . . . . 25.0 109.082 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -141.09 154.57 46.0 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-N 117.503 0.652 . . . . 25.0 111.159 -176.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 93.7 p -149.86 158.24 43.98 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.339 -1.356 . . . . 25.0 107.339 176.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 178.79 174.27 44.86 Favored Glycine 0 C--O 1.241 0.541 0 C-N-CA 120.06 -1.067 . . . . 25.0 113.578 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -152.9 85.49 4.33 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 107.728 -1.212 . . . . 25.0 107.728 178.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.42 150.28 75.58 Favored 'Trans proline' 0 C--N 1.354 0.818 0 O-C-N 122.015 0.481 . . . . 25.0 112.054 -177.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -114.81 154.51 28.46 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.201 -0.454 . . . . 25.0 110.575 -174.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -136.32 61.16 37.19 Favored Pre-proline 0 C--O 1.25 1.087 0 N-CA-C 113.225 0.824 . . . . 25.0 113.225 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -71.97 160.27 48.08 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 115.623 -2.451 . . . . 25.0 112.498 177.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.9 t -120.22 -15.75 8.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.017 -0.538 . . . . 25.0 111.181 -177.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.746 -0.645 . . . . 25.0 110.763 177.266 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo . . . . . 0 N--CA 1.48 0.7 0 N-CA-C 113.692 0.612 . . . . 25.0 113.692 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -178.02 54.04 0.1 OUTLIER Glycine 0 C--O 1.224 -0.528 0 N-CA-C 110.557 -1.017 . . . . 25.0 110.557 -178.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.4 p -60.52 132.41 25.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 122.261 1.029 . . . . 25.0 112.346 -174.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -103.11 -6.14 22.54 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.397 -1.274 . . . . 25.0 110.482 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.97 -148.12 4.91 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 116.36 -0.382 . . . . 25.0 112.717 178.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.4 p 68.39 159.85 0.15 Allowed Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 125.974 1.71 . . . . 25.0 112.204 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -66.52 1.3 2.7 Favored 'Trans proline' 0 C--N 1.359 1.122 0 N-CA-C 116.634 1.744 . . . . 25.0 116.634 -176.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.3 p -68.53 -18.98 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 N-CA-C 115.24 1.57 . . . . 25.0 115.24 -170.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.3 p -146.92 143.64 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 113.288 0.848 . . . . 25.0 113.288 -177.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.32 13.68 81.44 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 115.607 1.003 . . . . 25.0 115.607 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.2 t -54.21 -50.95 65.94 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 122.337 -0.508 . . . . 25.0 111.459 -173.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -86.8 19.26 3.03 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 114.758 1.392 . . . . 25.0 114.758 -172.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -152.39 170.83 19.13 Favored 'General case' 0 CA--C 1.561 1.397 0 O-C-N 121.653 -0.654 . . . . 25.0 111.391 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -59.38 134.18 56.77 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 112.47 0.544 . . . . 25.0 112.47 -175.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -121.54 163.22 19.22 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 115.575 1.694 . . . . 50.0 115.575 -173.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -138.08 87.04 2.21 Favored 'General case' 0 C--O 1.249 1.043 0 N-CA-C 102.857 -3.016 . . . . 25.0 102.857 164.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 89.2 mt -102.65 122.6 44.75 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 117.764 0.256 . . . . 25.0 111.551 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -110.75 122.88 48.91 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 123.61 0.568 . . . . 25.0 110.257 -179.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.99 176.65 40.95 Favored Glycine 0 CA--C 1.54 1.646 0 C-N-CA 120.59 -0.814 . . . . 25.0 114.349 -178.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.1 p -87.43 179.33 6.59 Favored 'General case' 0 C--O 1.256 1.429 0 C-N-CA 123.581 0.752 . . . . 25.0 110.981 177.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 51.7 mt -82.48 13.96 3.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.232 -0.895 . . . . 25.0 112.736 175.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.4 176.04 20.7 Favored Glycine 0 C--O 1.242 0.597 0 CA-C-N 115.479 -0.782 . . . . 25.0 111.834 177.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.3 t -78.07 131.35 37.27 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 121.85 -0.794 . . . . 25.0 108.884 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -142.65 153.58 43.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.308 0.575 . . . . 50.0 110.545 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -87.52 133.97 33.69 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 102.809 -3.034 . . . . 25.0 102.809 164.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 34.6 mm -127.04 116.69 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 105.292 -2.114 . . . . 25.0 105.292 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.1 tt -122.36 122.22 38.53 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.462 -1.31 . . . . 25.0 107.462 -177.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.21 -38.71 28.84 Favored Glycine 0 N--CA 1.445 -0.733 0 O-C-N 123.986 0.804 . . . . 25.0 114.71 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.66 -147.48 38.66 Favored Glycine 0 C--O 1.241 0.552 0 O-C-N 121.485 -1.009 . . . . 25.0 110.991 -176.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.37 165.02 54.77 Favored Glycine 0 CA--C 1.505 -0.588 0 CA-C-O 121.181 0.323 . . . . 25.0 112.762 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.57 167.27 36.46 Favored Glycine 0 C--O 1.236 0.274 0 C-N-CA 121.024 -0.608 . . . . 25.0 113.875 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.7 107.68 15.51 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.282 -1.007 . . . . 25.0 108.282 177.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -106.4 147.56 29.12 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.086 0.773 . . . . 50.0 113.086 -170.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -113.34 107.03 15.31 Favored 'General case' 0 C--O 1.249 1.073 0 N-CA-C 107.343 -1.354 . . . . 25.0 107.343 172.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 53.6 mt -111.39 133.51 53.64 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 116.161 -0.472 . . . . 25.0 110.613 -171.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -128.83 107.3 9.53 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.483 0.659 . . . . 25.0 111.715 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.71 -34.12 28.78 Favored Glycine 0 N--CA 1.463 0.489 0 N-CA-C 116.732 1.453 . . . . 25.0 116.732 -175.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 55.48 -153.5 0.33 Allowed 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 118.374 1.087 . . . . 25.0 111.959 -173.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.83 164.53 9.97 Favored 'General case' 0 C--O 1.252 1.193 0 N-CA-C 112.798 0.666 . . . . 25.0 112.798 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.67 155.19 31.66 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 115.279 -0.873 . . . . 25.0 111.351 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -78.59 98.54 6.19 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 106.99 -1.485 . . . . 25.0 106.99 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -100.24 151.42 21.47 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 122.032 -0.417 . . . . 50.0 110.183 -171.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.9 mp -113.16 90.6 3.39 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.767 -0.827 . . . . 25.0 108.767 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.4 mp -92.92 125.24 37.42 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 112.14 0.422 . . . . 25.0 112.14 -172.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -122.79 132.76 54.36 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 106.937 -1.505 . . . . 25.0 106.937 173.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.1 -38.76 8.32 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 119.715 -1.231 . . . . 25.0 115.028 -177.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.71 -171.83 51.44 Favored Glycine 0 C--O 1.223 -0.546 0 O-C-N 121.824 -0.81 . . . . 25.0 111.612 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.34 149.48 12.96 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.533 0.683 . . . . 25.0 110.935 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.35 166.93 42.35 Favored Glycine 0 C--N 1.332 0.327 0 CA-C-N 115.482 -0.781 . . . . 25.0 111.939 -178.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.71 129.23 34.86 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 105.16 -2.163 . . . . 25.0 105.16 176.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -120.85 154.16 36.18 Favored 'General case' 0 C--O 1.251 1.153 0 O-C-N 121.733 -0.605 . . . . 50.0 111.656 -175.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -116.57 128.3 55.29 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 103.607 -2.738 . . . . 25.0 103.607 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -147.76 141.58 25.74 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 115.831 1.789 . . . . 25.0 115.831 -174.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.6 m -109.3 138.02 46.29 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.194 -1.409 . . . . 25.0 107.194 176.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.03 -38.57 5.69 Favored Glycine 0 C--N 1.317 -0.512 0 N-CA-C 111.06 -0.816 . . . . 25.0 111.06 174.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.52 -170.37 54.54 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 118.749 1.274 . . . . 25.0 111.992 -177.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -64.15 161.63 15.95 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.088 0.471 . . . . 25.0 111.419 176.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.99 164.06 40.01 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-N 115.503 -0.771 . . . . 25.0 111.724 -176.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.13 106.5 16.63 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.129 -1.063 . . . . 25.0 108.129 -177.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -97.04 156.65 16.27 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 112.548 0.573 . . . . 50.0 112.548 -170.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 57.1 m -122.63 125.66 46.09 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.524 -0.917 . . . . 25.0 108.524 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -120.51 85.57 2.41 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.942 -0.762 . . . . 25.0 108.942 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -89.12 -23.95 22.36 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 112.313 0.486 . . . . 25.0 112.313 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 66.41 162.02 0.16 Allowed 'General case' 0 CA--C 1.548 0.898 0 O-C-N 125.212 1.57 . . . . 25.0 108.595 -171.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.13 -46.1 21.54 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 115.663 1.727 . . . . 25.0 115.663 -165.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.9 mt -144.12 169.28 18.15 Favored 'General case' 0 C--O 1.197 -1.691 0 C-N-CA 123.008 0.523 . . . . 25.0 111.246 -169.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.68 -32.69 30.8 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.574 -0.739 . . . . 25.0 110.571 169.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -80.99 1.44 31.2 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.732 1.382 . . . . 25.0 114.732 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -104.16 142.58 34.25 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.95 0.722 . . . . 25.0 112.95 -175.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.9 t 51.87 54.38 10.99 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 115.142 1.534 . . . . 25.0 115.142 177.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 36.9 p-80 -132.13 170.64 14.71 Favored 'General case' 0 C--O 1.208 -1.111 0 CA-C-N 116.441 -0.345 . . . . 25.0 111.884 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -118.07 144.92 45.21 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 106.696 -1.594 . . . . 25.0 106.696 178.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.9 p -133.31 164.83 41.17 Favored Pre-proline 0 C--O 1.244 0.797 0 N-CA-C 108.443 -0.947 . . . . 25.0 108.443 178.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -64.66 -15.84 52.16 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 117.504 -1.198 . . . . 25.0 113.436 174.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 87.9 mt -82.34 -21.51 35.96 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.075 -0.511 . . . . 25.0 111.817 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.77 171.77 24.13 Favored Glycine 0 C--O 1.219 -0.839 0 N-CA-C 109.875 -1.29 . . . . 25.0 109.875 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.1 t -101.13 147.88 25.72 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 122.659 1.218 . . . . 25.0 112.91 178.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -131.21 21.45 4.84 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.235 -0.893 . . . . 25.0 110.647 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.2 152.04 51.7 Favored Glycine 0 N--CA 1.473 1.164 0 N-CA-C 109.572 -1.411 . . . . 25.0 109.572 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -96.94 171.34 8.56 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 118.529 1.165 . . . . 50.0 110.536 -174.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.439 ' HG3' ' HB3' ' A' ' 140' ' ' ALA . 0.0 OUTLIER -126.85 108.5 11.06 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 121.931 -0.481 . . . . 25.0 112.231 -175.228 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.3 mt -89.39 138.68 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 109.212 -0.662 . . . . 25.0 109.212 -176.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.419 ' HA ' ' HG2' ' A' ' 142' ' ' GLU . 76.9 mt -86.33 -52.62 5.51 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 115.77 1.767 . . . . 25.0 115.77 -175.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -127.82 32.46 4.95 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 113.982 1.105 . . . . 25.0 113.982 -168.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -52.94 143.33 17.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.423 -1.262 . . . . 25.0 114.029 -175.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -118.17 103.35 49.78 Favored Pre-proline 0 C--O 1.237 0.398 0 C-N-CA 123.032 0.533 . . . . 25.0 111.333 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.23 -13.21 35.6 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 N-CA-C 114.549 0.942 . . . . 25.0 114.549 -175.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.0 t -81.26 -39.33 25.45 Favored 'General case' 0 C--O 1.245 0.836 0 N-CA-C 108.737 -0.838 . . . . 25.0 108.737 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -95.33 -43.53 7.99 Favored 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 117.196 2.295 . . . . 25.0 117.196 -175.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -90.19 172.75 8.58 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.572 -1.195 . . . . 75.0 112.03 -162.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -142.81 147.32 35.28 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 112.36 0.504 . . . . 25.0 112.36 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 90.7 mt -127.35 128.78 70.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 108.604 -0.887 . . . . 25.0 108.604 -178.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -86.62 148.6 25.41 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 122.124 0.964 . . . . 25.0 111.617 174.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.41 HG11 ' CZ ' ' A' ' 101' ' ' PHE . 8.4 p -146.75 -2.8 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 115.566 -0.743 . . . . 25.0 111.043 175.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 44.9 t -60.97 -44.57 97.15 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.662 0.744 . . . . 25.0 111.464 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.82 -28.53 58.33 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.372 -0.831 . . . . 25.0 112.074 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.6 mt -92.09 -41.61 10.4 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 116.288 1.958 . . . . 25.0 116.288 -171.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -138.54 -48.12 0.06 OUTLIER Glycine 0 N--CA 1.463 0.491 0 N-CA-C 118.156 2.022 . . . . 25.0 118.156 -172.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.41 ' CZ ' HG11 ' A' ' 96' ' ' VAL . 50.2 p90 -160.14 153.03 21.45 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 118.579 1.19 . . . . 25.0 112.714 -172.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 25.2 t -109.15 -16.94 13.98 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.511 -0.552 . . . . 25.0 109.511 178.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -121.46 132.61 9.12 Favored Glycine 0 N--CA 1.47 0.912 0 N-CA-C 108.363 -1.895 . . . . 25.0 108.363 176.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -68.15 156.0 38.43 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.963 1.468 . . . . 25.0 114.963 -172.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -101.77 -161.25 26.79 Favored Glycine 0 N--CA 1.464 0.53 0 O-C-N 121.583 -0.698 . . . . 25.0 112.828 -177.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -54.57 138.99 39.62 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 113.482 0.919 . . . . 25.0 113.482 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 168.72 -176.42 42.98 Favored Glycine 0 C--O 1.227 -0.292 0 CA-C-N 115.242 -0.89 . . . . 25.0 110.995 177.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -146.56 165.93 28.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.573 0.687 . . . . 25.0 109.283 -177.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 54.99 34.02 21.5 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 114.449 1.277 . . . . 25.0 114.449 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.62 25.39 65.35 Favored Glycine 0 N--CA 1.465 0.617 0 N-CA-C 111.159 -0.776 . . . . 25.0 111.159 177.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.428 ' HA ' ' H ' ' A' ' 151' ' ' ALA . 4.8 t -136.64 176.4 8.74 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 109.01 -0.737 . . . . 25.0 109.01 -178.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 69.7 mt -89.48 164.89 14.63 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 104.056 -2.572 . . . . 25.0 104.056 169.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.66 108.12 4.24 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 122.199 1.0 . . . . 25.0 109.894 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 18.0 m -73.16 160.34 5.36 Favored 'Isoleucine or valine' 0 C--O 1.247 0.968 0 N-CA-C 108.893 -0.78 . . . . 25.0 108.893 -177.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.47 168.87 20.8 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 110.382 -0.229 . . . . 25.0 110.382 -176.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.6 m -124.97 160.09 30.76 Favored 'Isoleucine or valine' 0 C--O 1.251 1.138 0 O-C-N 121.876 -0.515 . . . . 25.0 110.222 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.6 t -73.5 -49.12 28.3 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.692 -1.225 . . . . 25.0 107.692 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -168.94 -160.59 0.28 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 103.854 -2.647 . . . . 25.0 103.854 -177.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -72.82 -0.08 12.41 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 121.291 -0.88 . . . . 25.0 111.987 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -143.63 -157.79 7.31 Favored Glycine 0 C--O 1.241 0.575 0 N-CA-C 108.007 -2.037 . . . . 25.0 108.007 177.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.65 -153.59 0.37 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.184 0.809 . . . . 25.0 113.184 178.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.4 mtt85 -80.72 161.58 24.52 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 113.496 0.924 . . . . 25.0 113.496 -172.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.64 164.58 11.68 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 105.827 -1.916 . . . . 25.0 105.827 171.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -128.77 155.92 44.38 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 121.603 0.716 . . . . 25.0 110.357 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 29.8 tp -132.5 115.92 16.11 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 102.705 -3.072 . . . . 25.0 102.705 169.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -116.7 153.49 32.26 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 112.638 0.607 . . . . 25.0 112.638 -174.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 33.4 t -97.25 149.66 21.8 Favored 'General case' 0 C--O 1.215 -0.721 0 N-CA-C 103.889 -2.634 . . . . 25.0 103.889 168.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -119.35 10.17 11.85 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 124.828 1.33 . . . . 25.0 109.581 -178.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -97.95 152.78 18.89 Favored 'General case' 0 C--O 1.251 1.154 0 CA-C-N 114.291 -1.322 . . . . 25.0 107.504 171.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -142.88 160.4 40.41 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 122.234 1.016 . . . . 25.0 112.537 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -75.18 165.07 25.77 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 106.277 -1.749 . . . . 25.0 106.277 172.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.62 -22.83 67.11 Favored 'General case' 0 C--O 1.248 0.999 0 CA-C-O 122.287 1.042 . . . . 25.0 109.374 176.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -80.27 -6.78 58.47 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.859 -1.064 . . . . 25.0 112.788 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.59 2.53 72.72 Favored Glycine 0 C--O 1.223 -0.58 0 N-CA-C 114.419 0.528 . . . . 25.0 114.419 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.9 mt -72.68 137.17 45.83 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.83 -1.174 . . . . 25.0 107.83 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 88.7 p -140.25 -179.88 6.24 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 109.461 -0.57 . . . . 25.0 109.461 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -122.84 140.2 53.2 Favored 'General case' 0 C--O 1.247 0.951 0 O-C-N 121.926 -0.484 . . . . 25.0 111.717 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -156.97 155.49 31.38 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 107.476 -1.305 . . . . 25.0 107.476 170.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.8 p -148.78 147.07 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 N-CA-C 105.12 -2.178 . . . . 25.0 105.12 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.439 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . . . -115.38 149.64 37.63 Favored 'General case' 0 C--O 1.254 1.305 0 N-CA-C 109.306 -0.627 . . . . 25.0 109.306 -175.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mp -139.15 129.22 25.18 Favored 'General case' 0 C--O 1.205 -1.254 0 N-CA-C 107.522 -1.288 . . . . 25.0 107.522 -175.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.419 ' HG2' ' HA ' ' A' ' 85' ' ' LEU . 6.9 pt-20 -86.33 0.77 53.21 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.347 -0.941 . . . . 25.0 113.058 -177.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -65.17 -17.84 64.17 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 116.033 1.173 . . . . 25.0 116.033 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 38.5 t0 54.4 45.77 26.43 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 122.423 1.106 . . . . 25.0 112.199 -178.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -122.05 43.37 2.88 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 113.993 -1.458 . . . . 25.0 109.418 -174.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -52.63 -37.51 58.58 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 113.995 1.109 . . . . 25.0 113.995 178.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.59 -28.18 63.64 Favored 'General case' 0 C--O 1.248 0.996 0 CA-C-N 118.923 0.783 . . . . 25.0 111.473 -178.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.56 -27.47 34.33 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 121.413 0.625 . . . . 25.0 112.377 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 46.1 mt -66.6 128.58 36.79 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 119.87 -0.732 . . . . 25.0 110.337 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.9 m -131.15 160.93 33.31 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.176 -1.416 . . . . 25.0 107.176 177.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.428 ' H ' ' HA ' ' A' ' 111' ' ' SER . . . -79.51 1.37 26.02 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 107.619 -1.252 . . . . 25.0 107.619 177.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -68.47 -30.8 69.73 Favored 'General case' 0 N--CA 1.437 -1.106 0 O-C-N 123.465 0.478 . . . . 25.0 111.803 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -91.31 -10.41 41.43 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.733 -0.469 . . . . 25.0 109.733 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 26.9 mm -83.75 136.01 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 104.435 -2.432 . . . . 25.0 104.435 175.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.9 p -113.51 126.35 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 O-C-N 120.47 -1.394 . . . . 25.0 110.965 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -153.77 -30.43 0.12 Allowed 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 114.38 -1.282 . . . . 25.0 112.743 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -82.77 69.84 9.64 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 112.849 0.685 . . . . 25.0 112.849 -175.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 54.37 20.77 2.87 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.871 1.063 . . . . 25.0 113.871 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.12 17.95 4.89 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.705 0.802 . . . . 25.0 111.721 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -98.57 131.55 44.69 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.553 0.341 . . . . 25.0 110.976 -174.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.4 -10.33 58.78 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.957 0.725 . . . . 25.0 112.957 -176.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.07 -32.3 72.83 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.221 0.452 . . . . 25.0 112.221 -178.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.71 162.97 26.58 Favored 'General case' 0 C--O 1.247 0.961 0 N-CA-C 111.978 0.362 . . . . 25.0 111.978 -175.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 57.59 -169.81 0.11 Allowed 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 114.034 1.124 . . . . 25.0 114.034 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 90.83 2.18 72.41 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.787 -0.721 . . . . 25.0 113.789 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -102.48 115.29 30.28 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.841 -1.17 . . . . 25.0 107.841 176.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -134.47 161.78 34.09 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.287 -1.005 . . . . 25.0 108.287 -177.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -135.11 27.34 3.16 Favored Glycine 0 C--O 1.242 0.606 0 N-CA-C 110.419 -1.072 . . . . 25.0 110.419 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 47.7 t -70.2 -34.83 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.32 0.648 . . . . 25.0 110.355 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -58.36 133.69 23.32 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 CA-C-O 121.727 0.775 . . . . 25.0 111.735 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 156.81 160.18 9.93 Favored Glycine 0 C--N 1.336 0.564 0 N-CA-C 110.757 -0.937 . . . . 25.0 110.757 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -136.37 152.42 50.62 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 122.382 -0.481 . . . . 25.0 110.031 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 54.5 p -148.71 159.16 44.38 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.239 0.542 . . . . 25.0 110.0 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -179.93 168.77 39.25 Favored Glycine 0 N--CA 1.461 0.318 0 O-C-N 121.677 -0.639 . . . . 25.0 113.717 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -154.23 114.19 2.5 Favored Pre-proline 0 C--O 1.246 0.908 0 N-CA-C 107.767 -1.197 . . . . 25.0 107.767 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -68.84 157.05 63.4 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 117.304 -1.331 . . . . 25.0 112.559 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -117.75 146.67 43.62 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 108.208 -1.034 . . . . 25.0 108.208 177.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -140.15 64.27 25.9 Favored Pre-proline 0 N--CA 1.478 0.969 0 N-CA-C 112.405 0.52 . . . . 25.0 112.405 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.21 161.39 32.26 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 117.579 -1.147 . . . . 25.0 112.616 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 15.2 t -119.17 2.91 11.43 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 116.328 -0.396 . . . . 25.0 110.894 177.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 C--O 1.254 1.307 0 CA-C-O 117.494 -1.241 . . . . 25.0 111.283 178.829 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo . . . . . 0 CA--C 1.527 0.174 0 N-CA-C 112.653 0.213 . . . . 25.0 112.653 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.79 36.34 0.22 Allowed Glycine 0 N--CA 1.473 1.107 0 C-N-CA 121.173 -0.537 . . . . 25.0 113.838 -177.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.429 HG12 ' H ' ' A' ' 5' ' ' VAL . 0.9 OUTLIER -50.03 119.6 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 114.119 1.155 . . . . 25.0 114.119 -175.523 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -93.43 8.5 40.29 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 122.176 0.989 . . . . 25.0 108.341 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.92 -152.67 17.71 Favored Glycine 0 C--O 1.22 -0.742 0 CA-C-N 115.865 -0.607 . . . . 25.0 113.993 176.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.6 p 69.13 158.19 0.15 Allowed Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 125.988 1.715 . . . . 25.0 112.048 -174.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -69.7 22.77 0.17 Allowed 'Trans proline' 0 C--N 1.359 1.098 0 N-CA-C 118.803 2.578 . . . . 25.0 118.803 -176.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.07 -25.76 17.07 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.504 0 N-CA-C 114.516 1.302 . . . . 25.0 114.516 -171.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.6 p -146.69 145.76 19.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 CA-C-N 119.644 1.111 . . . . 25.0 112.223 -175.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.2 24.15 41.69 Favored Glycine 0 N--CA 1.466 0.681 0 N-CA-C 118.719 2.247 . . . . 25.0 118.719 172.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.7 t -49.49 -66.11 0.45 Allowed 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 118.641 1.22 . . . . 25.0 112.719 -175.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -86.49 17.83 3.62 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 115.588 1.699 . . . . 25.0 115.588 -167.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.16 168.75 19.07 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 120.821 -1.175 . . . . 25.0 110.927 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -68.9 132.22 46.37 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.233 0.54 . . . . 25.0 110.848 -175.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -123.67 160.46 27.14 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.896 1.443 . . . . 50.0 114.896 -174.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -124.38 99.03 6.01 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 104.492 -2.41 . . . . 25.0 104.492 161.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 87.1 mt -108.44 109.72 21.07 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 111.664 0.246 . . . . 25.0 111.664 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -103.18 117.12 33.81 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.498 -0.556 . . . . 25.0 109.498 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.78 -171.59 46.04 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 117.644 1.818 . . . . 25.0 117.644 -168.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.439 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 81.8 p -87.1 169.02 12.76 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.561 0.744 . . . . 25.0 109.102 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 68.7 mt -86.54 11.28 13.03 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.23 -0.441 . . . . 25.0 111.464 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -112.26 175.78 17.35 Favored Glycine 0 N--CA 1.461 0.357 0 N-CA-C 109.115 -1.594 . . . . 25.0 109.115 177.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.3 t -66.33 140.74 58.12 Favored 'General case' 0 C--O 1.207 -1.143 0 CA-C-N 117.978 0.889 . . . . 25.0 110.745 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.439 ' CD ' ' H ' ' A' ' 22' ' ' THR . 26.2 mt-10 -149.11 156.99 43.03 Favored 'General case' 0 C--O 1.246 0.895 0 C-N-CA 122.917 0.487 . . . . 50.0 110.106 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -89.93 138.23 31.67 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 104.544 -2.391 . . . . 25.0 104.544 161.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.5 mm -126.62 92.98 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 106.042 -1.836 . . . . 25.0 106.042 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 11.0 mp -104.5 120.96 42.46 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 104.652 -2.351 . . . . 25.0 104.652 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.27 -26.39 36.69 Favored Glycine 0 CA--C 1.505 -0.586 0 CA-C-O 119.729 -0.484 . . . . 25.0 112.051 -174.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.6 -149.24 46.49 Favored Glycine 0 C--O 1.249 1.077 0 N-CA-C 110.165 -1.174 . . . . 25.0 110.165 -173.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.49 179.12 40.82 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-O 123.059 1.366 . . . . 25.0 112.475 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.97 164.19 19.97 Favored Glycine 0 C--O 1.248 0.976 0 CA-C-N 114.207 -0.996 . . . . 25.0 114.266 179.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.56 100.02 12.11 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 106.722 -1.584 . . . . 25.0 106.722 176.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -96.83 156.36 16.38 Favored 'General case' 0 C--O 1.214 -0.783 0 C-N-CA 120.207 -0.597 . . . . 50.0 112.148 -170.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -115.61 91.26 3.55 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 106.233 -1.766 . . . . 25.0 106.233 174.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 70.0 mt -97.77 136.19 38.46 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-N 114.024 -1.444 . . . . 25.0 112.613 -172.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -131.64 95.14 3.66 Favored 'General case' 0 C--O 1.252 1.189 0 CA-C-O 121.53 0.681 . . . . 25.0 111.743 -176.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.88 -27.13 69.49 Favored Glycine 0 CA--C 1.521 0.426 0 CA-C-O 119.118 -0.823 . . . . 25.0 113.926 -176.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 48.79 -148.25 0.24 Allowed 'General case' 0 C--O 1.243 0.721 0 C-N-CA 124.405 1.082 . . . . 25.0 111.852 -176.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.91 159.58 34.41 Favored 'General case' 0 C--O 1.25 1.11 0 CA-C-O 121.69 0.757 . . . . 25.0 111.633 -177.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.33 156.64 21.49 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.51 -1.036 . . . . 25.0 110.51 -175.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -86.45 90.15 8.12 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.516 -0.92 . . . . 25.0 108.516 176.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -90.57 160.28 16.02 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.028 -0.987 . . . . 50.0 112.43 -170.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 tp -124.27 99.69 6.34 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.378 -0.971 . . . . 25.0 108.378 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.3 mp -101.83 117.83 35.66 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 116.016 1.858 . . . . 25.0 116.016 -166.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -122.23 101.62 7.63 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.117 -0.947 . . . . 25.0 109.137 174.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.42 -29.17 70.88 Favored Glycine 0 CA--C 1.523 0.585 0 O-C-N 120.141 -1.599 . . . . 25.0 112.769 -177.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.57 -168.08 54.1 Favored Glycine 0 N--CA 1.471 1.029 0 N-CA-C 108.938 -1.665 . . . . 25.0 108.938 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.86 151.89 33.27 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.86 0.689 . . . . 25.0 112.86 -175.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.79 165.98 33.12 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 115.847 1.099 . . . . 25.0 115.847 -175.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.415 ' HD2' ' HA ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -91.03 105.84 18.1 Favored 'General case' 0 C--O 1.212 -0.893 0 N-CA-C 105.667 -1.975 . . . . 25.0 105.667 176.293 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -99.98 151.45 21.33 Favored 'General case' 0 CA--C 1.483 -1.63 0 O-C-N 123.879 0.737 . . . . 50.0 112.093 -168.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -112.03 125.36 53.99 Favored 'General case' 0 C--O 1.211 -0.955 0 N-CA-C 103.374 -2.825 . . . . 25.0 103.374 177.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -149.31 132.68 16.56 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 122.348 1.07 . . . . 25.0 113.27 -174.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 71.5 m -96.77 136.11 37.78 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 106.979 -1.489 . . . . 25.0 106.979 173.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -88.06 -40.94 6.42 Favored Glycine 0 CA--C 1.499 -0.909 0 N-CA-C 110.357 -1.097 . . . . 25.0 110.357 174.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.62 -171.64 54.09 Favored Glycine 0 C--O 1.252 1.228 0 CA-C-O 122.633 1.129 . . . . 25.0 113.402 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -63.01 163.09 10.33 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 121.661 -0.905 . . . . 25.0 110.225 176.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.91 164.52 40.3 Favored Glycine 0 C--O 1.243 0.684 0 CA-C-O 118.554 -1.137 . . . . 25.0 112.514 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.51 113.24 20.11 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.967 -0.753 . . . . 25.0 108.967 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -104.9 154.41 20.11 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 121.541 -0.724 . . . . 50.0 110.576 -177.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.3 m -120.58 129.08 53.61 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 106.271 -1.751 . . . . 25.0 106.271 177.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -115.38 128.7 56.24 Favored 'General case' 0 C--O 1.207 -1.153 0 N-CA-C 104.827 -2.286 . . . . 25.0 104.827 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 61.9 mtt85 -133.41 -29.88 1.35 Allowed 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 113.393 0.886 . . . . 25.0 113.393 174.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 68.23 163.03 0.21 Allowed 'General case' 0 CA--C 1.537 0.459 0 O-C-N 124.794 1.309 . . . . 25.0 110.201 -172.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.22 -41.34 49.58 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.473 1.657 . . . . 25.0 115.473 -165.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 66.5 mt -136.53 170.39 16.14 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 115.217 1.562 . . . . 25.0 115.217 -171.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.09 -28.33 64.5 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.13 -1.396 . . . . 25.0 109.198 168.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -81.29 6.98 12.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.161 -1.381 . . . . 25.0 114.423 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -111.32 152.96 26.64 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.119 -1.613 . . . . 25.0 113.237 -174.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.6 t 41.27 50.77 3.48 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 117.897 2.554 . . . . 25.0 117.897 -178.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 24.5 p-80 -125.43 161.28 27.43 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 114.411 -1.268 . . . . 25.0 112.237 -176.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -109.37 138.72 45.29 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 104.859 -2.275 . . . . 25.0 104.859 174.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.4 p -122.6 172.14 5.66 Favored Pre-proline 0 C--N 1.322 -0.629 0 O-C-N 124.129 0.893 . . . . 25.0 109.975 -178.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -61.94 -23.97 76.45 Favored 'Trans proline' 0 C--O 1.254 1.315 0 C-N-CA 117.707 -1.062 . . . . 25.0 112.639 174.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 75.1 mt -78.22 -29.03 48.07 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.339 0.496 . . . . 25.0 112.339 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.23 -179.6 32.88 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.08 -1.208 . . . . 25.0 110.08 -172.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.5 t -98.12 151.42 20.41 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.106 1.15 . . . . 25.0 114.106 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.415 ' HA ' ' HD2' ' A' ' 52' ' ' ARG . 72.7 m-85 -135.47 29.73 3.26 Favored 'General case' 0 C--O 1.251 1.166 0 CA-C-N 114.419 -1.264 . . . . 25.0 108.889 175.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.53 146.8 42.77 Favored Glycine 0 C--N 1.335 0.476 0 O-C-N 124.102 0.876 . . . . 25.0 112.138 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -84.2 169.46 14.76 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 122.543 -0.387 . . . . 50.0 111.647 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -128.78 108.22 10.28 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 110.166 -0.309 . . . . 25.0 110.166 -176.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.5 mt -98.13 135.67 31.91 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 N-CA-C 107.618 -1.253 . . . . 25.0 107.618 -177.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.6 mt -84.83 -41.19 16.3 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 115.723 1.749 . . . . 25.0 115.723 -171.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.9 p-10 -137.22 39.07 2.51 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.991 1.108 . . . . 25.0 113.991 -172.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -58.24 132.89 54.94 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.126 -0.943 . . . . 25.0 110.655 -177.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -113.7 106.25 54.03 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 108.375 -0.972 . . . . 25.0 108.375 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.1 -16.64 56.08 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 N-CA-C 116.338 1.63 . . . . 25.0 116.338 -173.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.7 t -88.33 -29.11 20.57 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.895 0.378 . . . . 25.0 111.374 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -93.44 -48.93 6.17 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.609 0.719 . . . . 25.0 111.575 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -96.56 165.5 12.13 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 114.169 -1.378 . . . . 50.0 110.92 -159.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -142.18 151.54 42.3 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 113.921 1.082 . . . . 25.0 113.921 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 75.3 mt -126.51 123.54 63.43 Favored 'Isoleucine or valine' 0 C--O 1.247 0.969 0 N-CA-C 107.55 -1.278 . . . . 25.0 107.55 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -81.58 147.35 29.65 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 122.257 1.027 . . . . 25.0 108.363 173.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -155.63 -12.02 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 115.232 -0.895 . . . . 25.0 112.45 -179.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.6 t -62.67 -38.34 89.95 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 120.738 -1.226 . . . . 25.0 110.237 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.65 -21.0 56.05 Favored 'General case' 0 CA--C 1.555 1.149 0 N-CA-C 114.812 1.412 . . . . 25.0 114.812 -176.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.39 0.63 2.81 Favored 'General case' 0 CA--C 1.556 1.176 0 N-CA-C 117.61 2.448 . . . . 25.0 117.61 -170.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -143.32 -67.05 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 119.021 0.828 . . . . 25.0 115.012 177.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -160.11 164.92 32.64 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.99 0.9 . . . . 25.0 110.992 -174.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.8 t -119.48 -26.76 5.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.773 -1.103 . . . . 25.0 110.521 174.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -93.95 120.68 6.39 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 118.718 -1.046 . . . . 25.0 112.699 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -65.93 157.17 31.37 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.442 1.621 . . . . 25.0 112.356 178.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -90.7 -172.03 43.88 Favored Glycine 0 C--N 1.32 -0.332 0 CA-C-O 118.88 -0.956 . . . . 25.0 112.263 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -79.54 83.1 5.57 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 118.646 1.223 . . . . 25.0 112.111 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.06 -175.43 17.96 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 108.348 -1.901 . . . . 25.0 108.348 168.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -127.05 160.7 30.34 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.971 1.385 . . . . 25.0 111.879 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 51.83 47.24 25.18 Favored 'General case' 0 C--O 1.266 1.951 0 N-CA-C 114.946 1.462 . . . . 25.0 114.946 -176.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.26 48.69 36.96 Favored Glycine 0 N--CA 1.48 1.591 0 N-CA-C 109.253 -1.539 . . . . 25.0 109.253 176.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.5 t -148.33 173.84 12.64 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 117.838 0.819 . . . . 25.0 111.905 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.7 mp -105.36 168.57 8.99 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 101.816 -3.402 . . . . 25.0 101.816 173.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.55 135.48 39.27 Favored 'General case' 0 C--O 1.254 1.31 0 C-N-CA 117.915 -1.514 . . . . 25.0 108.009 -176.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.7 m -102.35 163.58 3.42 Favored 'Isoleucine or valine' 0 C--O 1.248 0.997 0 CA-C-O 118.524 -0.75 . . . . 25.0 109.165 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.0 p -149.78 163.41 38.05 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-N 118.514 0.597 . . . . 25.0 112.247 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 28.0 m -115.89 160.82 15.05 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 N-CA-C 105.787 -1.931 . . . . 25.0 105.787 176.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.9 t -78.76 -42.67 27.42 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 107.055 -1.461 . . . . 25.0 107.055 176.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -168.31 -169.13 1.03 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 103.78 -2.674 . . . . 25.0 103.78 -175.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -59.76 -24.78 64.35 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.662 0.601 . . . . 25.0 112.534 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -126.9 -147.38 6.72 Favored Glycine 0 C--O 1.252 1.231 0 N-CA-C 111.114 -0.795 . . . . 25.0 111.114 174.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 53.72 -142.69 0.78 Allowed 'General case' 0 C--O 1.246 0.872 0 N-CA-C 113.891 1.071 . . . . 25.0 113.891 -179.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.7 mtt85 -91.39 162.83 14.42 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 114.716 1.376 . . . . 25.0 114.716 -170.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.5 p -113.08 162.48 15.88 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 104.73 -2.322 . . . . 25.0 104.73 176.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -132.7 156.14 47.55 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 109.245 -0.65 . . . . 25.0 109.245 -175.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 33.6 tp -135.16 127.66 30.6 Favored 'General case' 0 C--O 1.251 1.17 0 N-CA-C 102.695 -3.076 . . . . 25.0 102.695 171.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -128.65 159.6 35.07 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 115.787 -0.642 . . . . 25.0 112.673 -170.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.2 t -94.64 149.77 20.91 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.295 -1.372 . . . . 25.0 107.295 171.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -119.82 24.15 10.7 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 106.93 -1.507 . . . . 25.0 106.93 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -125.91 135.88 52.41 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 106.364 -1.717 . . . . 25.0 106.364 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -139.39 156.31 47.07 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 122.558 1.17 . . . . 25.0 109.672 -172.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -74.08 159.35 32.75 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-N 114.782 -1.099 . . . . 25.0 109.225 173.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.29 -20.64 66.5 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.733 -0.604 . . . . 25.0 109.789 173.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -69.89 -12.27 61.49 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 118.675 -0.678 . . . . 25.0 112.502 175.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.13 22.93 46.75 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 111.51 -0.636 . . . . 25.0 111.51 -177.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.7 mt -100.18 141.01 33.6 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 107.636 -1.246 . . . . 25.0 107.636 177.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 59.7 p -147.61 171.43 15.61 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 106.789 -1.56 . . . . 25.0 106.789 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -115.76 138.38 51.18 Favored 'General case' 0 C--O 1.257 1.453 0 CA-C-N 118.667 0.667 . . . . 25.0 112.624 -173.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -152.63 153.21 32.87 Favored 'General case' 0 C--O 1.248 1.02 0 CA-C-O 121.717 0.77 . . . . 25.0 110.088 172.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.9 p -145.03 143.79 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.784 0 N-CA-C 105.858 -1.904 . . . . 25.0 105.858 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -107.86 142.69 37.55 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.41 -1.329 . . . . 25.0 107.41 -176.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.6 mp -131.13 137.13 48.9 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.489 -1.3 . . . . 25.0 107.489 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -109.71 7.29 24.27 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 121.251 1.841 . . . . 25.0 115.858 -176.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -76.9 4.94 51.45 Favored Glycine 0 N--CA 1.469 0.894 0 N-CA-C 116.322 1.289 . . . . 25.0 116.322 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 46.6 t0 51.34 51.94 15.83 Favored 'General case' 0 C--O 1.256 1.43 0 C-N-CA 124.046 0.939 . . . . 25.0 111.875 176.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -129.84 29.83 4.94 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 124.849 1.26 . . . . 25.0 110.714 -174.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.85 -31.98 70.26 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 119.275 -0.97 . . . . 25.0 111.52 176.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.6 -20.95 66.12 Favored 'General case' 0 C--O 1.251 1.171 0 CA-C-N 118.777 0.717 . . . . 25.0 111.349 177.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -95.67 -27.77 15.13 Favored 'General case' 0 C--O 1.259 1.603 0 N-CA-C 114.048 1.129 . . . . 25.0 114.048 176.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 74.6 mt -58.39 137.36 57.31 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 114.126 1.158 . . . . 25.0 114.126 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 62.7 m -137.15 167.15 22.1 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 105.642 -1.985 . . . . 25.0 105.642 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -77.45 -2.88 37.52 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 120.458 -1.401 . . . . 25.0 111.324 174.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -68.42 -29.09 67.68 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.777 -0.577 . . . . 25.0 112.353 -176.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -87.02 -2.48 58.66 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.882 -0.599 . . . . 25.0 111.209 174.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 36.7 mm -96.64 127.32 48.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 104.679 -2.341 . . . . 25.0 104.679 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.1 p -105.42 104.4 16.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 124.063 1.887 . . . . 25.0 114.78 -174.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -141.81 -1.1 1.29 Allowed 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 112.625 -2.079 . . . . 25.0 111.091 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -80.91 53.5 1.97 Allowed 'General case' 0 CA--C 1.549 0.905 0 O-C-N 121.151 -0.968 . . . . 25.0 112.603 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 58.85 18.07 5.8 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 114.434 1.272 . . . . 25.0 114.434 -175.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.58 -39.88 0.39 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 118.264 2.69 . . . . 25.0 118.264 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -70.81 150.01 46.27 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-O 121.388 0.613 . . . . 25.0 110.622 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -80.3 19.93 0.72 Allowed 'General case' 0 C--O 1.218 -0.564 0 C-N-CA 124.09 0.956 . . . . 25.0 112.32 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.74 -21.78 66.84 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 115.487 1.662 . . . . 25.0 115.487 -177.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -140.28 -160.59 1.09 Allowed 'General case' 0 CA--C 1.547 0.862 0 CA-C-O 121.567 0.699 . . . . 25.0 111.37 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 64.21 -171.11 0.18 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 115.359 1.614 . . . . 25.0 115.359 177.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 81.38 24.38 56.87 Favored Glycine 0 C--O 1.225 -0.456 0 CA-C-O 122.985 1.325 . . . . 25.0 110.515 -175.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -98.7 114.59 27.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.444 -0.878 . . . . 25.0 109.165 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -123.68 143.22 50.39 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 108.532 -0.914 . . . . 25.0 108.532 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -111.07 16.83 27.45 Favored Glycine 0 C--O 1.225 -0.432 0 N-CA-C 112.155 -0.378 . . . . 25.0 112.155 -177.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 49.0 t -68.59 -37.33 77.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.697 -0.252 . . . . 25.0 111.297 -174.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.0 133.31 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-O 121.599 0.714 . . . . 25.0 111.57 -176.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 149.04 159.01 8.33 Favored Glycine 0 N--CA 1.463 0.435 0 N-CA-C 110.058 -1.217 . . . . 25.0 110.058 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -151.69 153.04 33.6 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-O 122.285 1.04 . . . . 25.0 111.338 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 92.6 p -165.34 163.11 19.95 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 105.074 -2.195 . . . . 25.0 105.074 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 174.7 159.84 21.7 Favored Glycine 0 C--O 1.245 0.803 0 C-N-CA 119.963 -1.113 . . . . 25.0 114.241 174.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -116.86 110.75 41.58 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 109.047 -0.724 . . . . 25.0 109.047 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.37 169.5 21.83 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 116.328 -1.981 . . . . 25.0 114.335 -175.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -124.57 140.95 52.47 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.368 -0.975 . . . . 25.0 108.368 175.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -143.66 73.47 17.1 Favored Pre-proline 0 N--CA 1.487 1.383 0 CA-C-O 121.11 0.481 . . . . 25.0 111.75 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -67.99 152.89 76.36 Favored 'Trans proline' 0 C--O 1.242 0.682 0 N-CA-C 114.062 0.755 . . . . 25.0 114.062 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.6 t -124.05 11.05 8.86 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.712 -0.676 . . . . 25.0 109.363 -176.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.257 1.457 0 N-CA-C 109.157 -0.683 . . . . 25.0 109.157 178.717 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo . . . . . 0 C--O 1.243 0.749 0 N-CA-C 114.297 0.845 . . . . 25.0 114.297 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -163.83 49.76 0.3 Allowed Glycine 0 N--CA 1.467 0.759 0 N-CA-C 108.467 -1.853 . . . . 25.0 108.467 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.447 HG22 ' H ' ' A' ' 7' ' ' GLY . 9.2 p -54.58 128.87 15.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-O 122.918 1.342 . . . . 25.0 110.495 -175.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -101.19 -1.63 33.36 Favored 'General case' 0 C--O 1.252 1.226 0 O-C-N 121.289 -0.882 . . . . 25.0 110.389 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.447 ' H ' HG22 ' A' ' 5' ' ' VAL . . . -86.48 -142.55 6.99 Favored Glycine 0 C--O 1.241 0.539 0 CA-C-N 116.421 -0.354 . . . . 25.0 112.79 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.0 p 68.43 157.75 0.15 Allowed Pre-proline 0 N--CA 1.486 1.353 0 C-N-CA 125.811 1.644 . . . . 25.0 111.739 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.577 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 25.5 Cg_exo -71.1 -2.35 10.97 Favored 'Trans proline' 0 C--N 1.354 0.86 0 N-CA-C 116.046 1.518 . . . . 25.0 116.046 -172.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.6 p -65.04 -13.59 15.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 115.974 1.842 . . . . 25.0 115.974 -171.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.3 p -139.69 134.94 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 114.693 1.368 . . . . 25.0 114.693 -177.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.6 13.18 83.21 Favored Glycine 0 N--CA 1.466 0.665 0 N-CA-C 117.026 1.57 . . . . 25.0 117.026 174.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.7 t -47.12 -49.74 21.5 Favored 'General case' 0 C--O 1.209 -1.028 0 CA-C-N 118.98 1.39 . . . . 25.0 113.279 -168.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -78.61 6.91 7.68 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 116.85 2.167 . . . . 25.0 116.85 -174.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 pp -142.57 169.52 17.42 Favored 'General case' 0 C--O 1.203 -1.352 0 O-C-N 121.277 -0.889 . . . . 25.0 111.428 -177.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -61.5 128.47 36.44 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 113.139 0.792 . . . . 25.0 113.139 -174.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -130.08 167.15 18.78 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 114.081 1.141 . . . . 50.0 114.081 -175.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -125.34 107.73 10.98 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 104.008 -2.59 . . . . 25.0 104.008 169.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.3 mt -122.66 114.43 20.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 119.069 0.85 . . . . 25.0 110.143 -175.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -108.22 121.94 45.91 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.618 -0.882 . . . . 25.0 108.618 173.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.2 -177.89 47.33 Favored Glycine 0 N--CA 1.471 1.026 0 N-CA-C 115.063 0.785 . . . . 25.0 115.063 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.4 p -81.02 178.11 8.63 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.021 0.928 . . . . 25.0 111.229 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 79.7 mt -90.31 13.55 15.08 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.193 0.52 . . . . 25.0 110.103 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.77 -177.09 20.64 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.455 -0.658 . . . . 25.0 111.455 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.8 t -75.38 129.4 37.29 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.128 1.159 . . . . 25.0 114.128 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -145.01 159.82 42.34 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.045 -1.034 . . . . 50.0 112.998 -174.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -98.66 120.97 39.99 Favored 'General case' 0 C--O 1.26 1.608 0 N-CA-C 105.498 -2.038 . . . . 25.0 105.498 164.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.1 mm -115.98 107.88 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 N-CA-C 105.291 -2.115 . . . . 25.0 105.291 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.577 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 9.2 mp -115.89 132.11 56.74 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 105.084 -2.191 . . . . 25.0 105.084 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.89 -33.94 9.4 Favored Glycine 0 CA--C 1.483 -1.962 0 N-CA-C 114.72 0.648 . . . . 25.0 114.72 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 72.94 -145.59 36.81 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 111.793 -0.523 . . . . 25.0 111.793 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.39 163.13 52.76 Favored Glycine 0 N--CA 1.438 -1.185 0 CA-C-O 121.783 0.657 . . . . 25.0 113.569 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.24 166.76 41.44 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.216 -0.754 . . . . 25.0 111.216 177.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.38 112.08 20.02 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.045 -1.094 . . . . 25.0 108.045 176.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -107.09 157.7 17.63 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 113.662 0.986 . . . . 50.0 113.662 -172.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -117.93 87.17 2.66 Favored 'General case' 0 C--O 1.255 1.386 0 N-CA-C 106.668 -1.604 . . . . 25.0 106.668 178.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 53.6 mt -96.34 137.99 34.61 Favored 'General case' 0 C--O 1.207 -1.141 0 CA-C-N 115.572 -0.74 . . . . 25.0 112.07 -174.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -131.34 112.77 13.04 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 107.117 -1.438 . . . . 25.0 107.117 177.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -92.14 -22.68 29.3 Favored Glycine 0 CA--C 1.507 -0.453 0 CA-C-O 118.877 -0.957 . . . . 25.0 115.455 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 51.12 -147.47 0.41 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.127 0.971 . . . . 25.0 113.303 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.34 165.03 19.51 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 123.313 1.53 . . . . 25.0 112.326 -177.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.11 157.12 32.79 Favored Glycine 0 C--O 1.246 0.869 0 CA-C-N 113.876 -1.511 . . . . 25.0 111.253 -176.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.2 m-20 -78.29 114.81 17.53 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 103.853 -2.647 . . . . 25.0 103.853 177.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -119.78 160.13 23.2 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.986 -0.746 . . . . 50.0 108.986 -172.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.0 mp -111.12 124.56 52.42 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 104.31 -2.478 . . . . 25.0 104.31 171.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.59 100.89 7.26 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 121.875 -0.516 . . . . 25.0 111.991 -175.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -117.74 103.73 10.28 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.971 -1.122 . . . . 25.0 107.971 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.86 -24.53 68.42 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 116.88 1.512 . . . . 25.0 116.88 -177.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.39 -168.09 51.28 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 118.371 -1.238 . . . . 25.0 111.036 -178.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.41 153.86 3.78 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.55 1.315 . . . . 25.0 114.55 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.03 171.78 47.82 Favored Glycine 0 CA--C 1.502 -0.74 0 O-C-N 124.6 1.187 . . . . 25.0 110.406 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.08 156.18 27.18 Favored 'General case' 0 C--O 1.203 -1.35 1 N-CA-C 99.922 -4.103 . . . . 25.0 99.922 173.258 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -144.77 156.61 44.14 Favored 'General case' 0 C--O 1.247 0.948 0 C-N-CA 120.437 -0.505 . . . . 50.0 110.821 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -119.91 121.38 38.88 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 103.33 -2.841 . . . . 25.0 103.33 174.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.7 130.72 26.33 Favored 'General case' 0 C--O 1.211 -0.921 0 N-CA-C 113.916 1.08 . . . . 25.0 113.916 -171.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.29 126.84 52.55 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.157 -0.965 . . . . 25.0 108.816 -178.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -80.85 -48.43 6.14 Favored Glycine 0 C--O 1.247 0.916 0 C-N-CA 119.94 -1.124 . . . . 25.0 112.624 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.63 -167.8 53.22 Favored Glycine 0 CA--C 1.535 1.339 0 O-C-N 122.414 -0.462 . . . . 25.0 114.244 -177.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -67.12 159.77 28.17 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 121.274 -1.133 . . . . 25.0 111.086 177.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.21 156.99 33.12 Favored Glycine 0 C--O 1.242 0.599 0 N-CA-C 110.538 -1.025 . . . . 25.0 110.538 -177.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.81 98.64 5.64 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 122.121 0.962 . . . . 25.0 110.853 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -89.21 155.94 19.09 Favored 'General case' 0 C--O 1.252 1.21 0 CA-C-N 114.391 -1.277 . . . . 50.0 112.587 -174.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 46.8 m -128.12 125.23 38.76 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.156 0.503 . . . . 25.0 110.025 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -113.32 103.16 11.04 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.914 -0.772 . . . . 25.0 108.914 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 24.6 mmt85 -105.0 -30.32 9.86 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-N 115.916 -0.584 . . . . 25.0 110.052 -178.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 64.75 165.79 0.16 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.88 1.272 . . . . 25.0 110.437 -171.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -87.13 -38.77 16.15 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.862 0.69 . . . . 25.0 112.862 -168.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.1 mt -136.03 161.6 35.23 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 122.089 0.947 . . . . 25.0 111.538 -173.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.93 -25.68 63.67 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 114.894 -1.048 . . . . 25.0 109.051 172.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -78.06 3.09 15.81 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.389 -1.278 . . . . 25.0 114.171 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -95.57 148.52 22.42 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 115.386 1.625 . . . . 25.0 115.386 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.6 t 53.23 39.41 29.67 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.871 1.434 . . . . 25.0 114.871 173.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 27.2 p-80 -114.7 163.67 15.12 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.326 -0.852 . . . . 25.0 112.737 -175.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -110.49 142.89 41.63 Favored 'General case' 0 C--O 1.208 -1.097 0 N-CA-C 103.564 -2.754 . . . . 25.0 103.564 173.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 97.5 p -135.32 170.07 12.09 Favored Pre-proline 0 CA--C 1.512 -0.506 0 N-CA-C 107.039 -1.467 . . . . 25.0 107.039 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -62.48 -18.78 65.07 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 CA-C-N 119.385 0.816 . . . . 25.0 113.32 173.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.4 mt -77.82 -24.29 48.77 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.304 0.573 . . . . 25.0 111.822 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 144.68 -176.95 23.52 Favored Glycine 0 C--O 1.25 1.117 0 N-CA-C 110.155 -1.178 . . . . 25.0 110.155 -178.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.4 t -84.13 147.29 27.42 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 122.788 1.28 . . . . 25.0 112.193 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -133.94 27.32 3.91 Favored 'General case' 0 C--O 1.256 1.409 0 N-CA-C 105.731 -1.952 . . . . 25.0 105.731 169.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.16 143.95 42.08 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 114.323 -1.308 . . . . 25.0 110.545 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -87.65 166.69 14.5 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.493 -0.928 . . . . 50.0 108.493 -174.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -130.06 117.43 19.99 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 107.466 -1.309 . . . . 25.0 107.466 -175.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.0 mt -100.42 135.83 34.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 106.906 -1.516 . . . . 25.0 106.906 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.413 ' HA ' ' HG2' ' A' ' 142' ' ' GLU . 92.6 mt -79.49 -55.64 4.9 Favored 'General case' 0 C--O 1.217 -0.608 0 C-N-CA 124.037 0.935 . . . . 25.0 112.938 -173.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 -132.12 51.07 2.18 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-O 122.749 1.262 . . . . 25.0 113.309 -175.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -61.76 143.52 56.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.773 -1.103 . . . . 25.0 108.933 175.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -125.11 107.06 28.09 Favored Pre-proline 0 CA--C 1.505 -0.756 0 N-CA-C 107.392 -1.336 . . . . 25.0 107.392 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.37 -9.68 26.42 Favored 'Trans proline' 0 CA--C 1.555 1.552 0 N-CA-C 117.538 2.092 . . . . 25.0 117.538 -172.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.6 t -76.76 -37.24 56.25 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.603 -0.888 . . . . 25.0 108.603 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -111.37 -33.71 6.33 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 115.522 1.675 . . . . 25.0 115.522 -171.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -90.36 152.0 21.2 Favored 'General case' 0 C--O 1.212 -0.869 0 CA-C-N 117.908 0.322 . . . . 50.0 110.429 -170.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -129.34 141.97 50.94 Favored 'General case' 0 C--O 1.26 1.623 0 CA-C-O 119.141 -0.456 . . . . 25.0 110.126 -174.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 77.0 mt -125.52 133.12 69.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.277 -0.638 . . . . 25.0 109.277 178.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.55 141.59 28.42 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.884 -0.784 . . . . 25.0 108.884 172.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.6 p -139.65 -4.66 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.096 -0.956 . . . . 25.0 112.193 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.3 t -73.17 -31.46 64.25 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.962 -0.755 . . . . 25.0 108.962 -177.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.85 -36.73 80.84 Favored 'General case' 0 C--O 1.254 1.298 0 CA-C-N 115.641 -0.709 . . . . 25.0 112.713 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.79 -29.63 8.98 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 117.354 2.353 . . . . 25.0 117.354 -170.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -124.26 -72.44 0.23 Allowed Glycine 0 CA--C 1.5 -0.87 0 N-CA-C 117.931 1.932 . . . . 25.0 117.931 -168.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -154.61 172.76 17.33 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 109.705 -0.48 . . . . 25.0 109.705 -167.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.9 t -128.0 -20.26 3.85 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 112.065 0.394 . . . . 25.0 112.065 174.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -97.59 126.95 9.05 Favored Glycine 0 N--CA 1.488 2.136 0 O-C-N 121.421 -0.799 . . . . 25.0 112.703 176.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.63 151.14 47.94 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.618 0.599 . . . . 25.0 112.618 178.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -88.46 -173.26 47.1 Favored Glycine 0 C--O 1.223 -0.563 0 N-CA-C 114.771 0.668 . . . . 25.0 114.771 -175.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -76.11 82.36 2.94 Favored 'General case' 0 C--O 1.258 1.505 0 CA-C-N 118.919 1.36 . . . . 25.0 110.874 -178.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -115.62 -172.85 17.18 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 109.214 -1.554 . . . . 25.0 109.214 174.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -143.03 168.35 19.92 Favored 'General case' 0 C--O 1.241 0.632 0 O-C-N 121.815 -0.815 . . . . 25.0 110.301 175.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 58.38 32.11 21.71 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.776 1.23 . . . . 25.0 113.76 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 80.54 23.41 60.44 Favored Glycine 0 C--N 1.316 -0.581 0 CA-C-O 118.863 -0.965 . . . . 25.0 111.55 176.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.2 t -132.79 169.65 16.41 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 119.04 1.42 . . . . 25.0 109.671 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.4 mp -88.6 163.46 15.83 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 103.302 -2.851 . . . . 25.0 103.302 171.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.42 122.55 19.19 Favored 'General case' 0 C--O 1.257 1.468 0 C-N-CA 119.081 -1.047 . . . . 25.0 111.141 -176.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.9 m -90.75 160.73 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 107.032 -1.47 . . . . 25.0 107.032 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 60.0 p -147.81 166.28 28.04 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 123.918 0.761 . . . . 25.0 109.45 -177.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 22.0 m -117.64 166.81 11.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 107.629 -1.248 . . . . 25.0 107.629 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.8 t -74.66 -55.08 6.27 Favored 'General case' 0 C--O 1.216 -0.69 0 N-CA-C 106.828 -1.545 . . . . 25.0 106.828 169.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -159.6 -158.34 0.65 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 105.216 -2.142 . . . . 25.0 105.216 -176.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -61.15 -33.36 73.29 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 120.153 -0.619 . . . . 25.0 109.793 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -119.34 -148.51 8.3 Favored Glycine 0 C--O 1.244 0.77 0 N-CA-C 109.647 -1.381 . . . . 25.0 109.647 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.89 -144.18 0.53 Allowed 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 113.893 1.072 . . . . 25.0 113.893 177.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.9 mtt85 -82.33 167.29 18.71 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.994 0.902 . . . . 25.0 112.704 -171.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.86 161.43 18.25 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 105.524 -2.028 . . . . 25.0 105.524 171.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.431 ' CE2' ' HB2' ' A' ' 140' ' ' ALA . 31.8 m-85 -137.01 145.9 44.66 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 108.704 -0.85 . . . . 25.0 108.704 -177.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 43.0 tp -125.15 125.95 44.49 Favored 'General case' 0 C--O 1.257 1.499 0 N-CA-C 103.427 -2.805 . . . . 25.0 103.427 177.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -121.77 154.75 36.54 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.262 -0.881 . . . . 25.0 109.379 -173.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 37.6 t -99.47 155.42 17.57 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 106.023 -1.843 . . . . 25.0 106.023 169.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -122.38 13.71 10.29 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.834 0.35 . . . . 25.0 111.116 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -106.63 132.49 52.56 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 106.646 -1.612 . . . . 25.0 106.646 171.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -128.13 153.21 47.1 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-O 122.699 1.238 . . . . 25.0 109.08 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -79.51 165.5 22.94 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.692 -1.14 . . . . 25.0 111.198 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.94 -34.31 67.87 Favored 'General case' 0 C--O 1.21 -0.978 0 CA-C-O 122.218 1.009 . . . . 25.0 109.024 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -72.46 -2.34 19.17 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 115.25 1.574 . . . . 25.0 115.25 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.87 7.82 85.14 Favored Glycine 0 N--CA 1.471 1.012 0 CA-C-O 122.353 0.974 . . . . 25.0 113.15 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 41.3 mt -84.32 139.28 32.4 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.436 -1.038 . . . . 25.0 109.798 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 95.2 p -147.81 -179.55 6.98 Favored 'General case' 0 C--O 1.249 1.066 0 N-CA-C 107.351 -1.352 . . . . 25.0 107.351 -177.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -119.47 136.52 54.28 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.608 -0.837 . . . . 25.0 112.955 -178.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -147.74 148.7 31.26 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.876 -1.157 . . . . 25.0 107.876 167.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.3 p -145.33 148.28 17.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 105.381 -2.081 . . . . 25.0 105.381 175.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.431 ' HB2' ' CE2' ' A' ' 124' ' ' TYR . . . -108.44 148.13 30.62 Favored 'General case' 0 C--O 1.264 1.861 0 N-CA-C 108.593 -0.892 . . . . 25.0 108.593 -179.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.8 mp -139.0 124.07 18.95 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 105.067 -2.197 . . . . 25.0 105.067 -177.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.413 ' HG2' ' HA ' ' A' ' 85' ' ' LEU . 17.9 pt-20 -103.99 9.22 36.66 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 120.832 1.651 . . . . 25.0 113.625 -171.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -69.38 -16.34 71.31 Favored Glycine 0 N--CA 1.459 0.176 0 C-N-CA 120.515 -0.85 . . . . 25.0 112.805 175.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 31.2 t0 58.01 58.33 3.63 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 122.039 0.924 . . . . 25.0 111.982 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -124.26 42.02 3.35 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.394 -1.276 . . . . 25.0 109.229 -177.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.51 -34.48 72.66 Favored 'General case' 0 C--O 1.206 -1.234 0 N-CA-C 113.466 0.913 . . . . 25.0 113.466 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.49 -23.75 62.73 Favored 'General case' 0 C--O 1.254 1.293 0 CA-C-N 119.358 0.981 . . . . 25.0 112.067 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -89.84 -25.41 21.05 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 113.75 1.019 . . . . 25.0 113.75 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 11.8 mt -63.33 126.41 27.36 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.196 -0.911 . . . . 25.0 111.108 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 39.8 m -135.06 157.62 46.46 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 107.633 -1.247 . . . . 25.0 107.633 174.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.08 -2.56 24.92 Favored 'General case' 0 C--N 1.349 0.551 0 N-CA-C 112.656 0.613 . . . . 25.0 112.656 -176.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.27 -30.73 71.63 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.462 0.649 . . . . 25.0 110.115 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -90.22 0.67 57.09 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 112.619 0.6 . . . . 25.0 112.619 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 34.7 mm -105.33 122.87 59.17 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 N-CA-C 103.985 -2.598 . . . . 25.0 103.985 175.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 14.8 p -105.64 119.98 55.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 O-C-N 120.885 -1.134 . . . . 25.0 113.611 -176.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -148.84 18.51 1.0 Allowed 'General case' 0 C--O 1.243 0.759 0 CA-C-N 112.757 -2.02 . . . . 25.0 108.465 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -102.47 41.89 1.19 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.729 0.776 . . . . 25.0 111.187 -175.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 55.22 25.79 7.71 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 114.431 1.271 . . . . 25.0 114.431 -173.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.8 m 64.75 -10.63 0.15 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.581 1.696 . . . . 25.0 115.581 176.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -72.35 139.98 48.21 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.761 -1.212 . . . . 25.0 109.389 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -91.4 4.78 51.62 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.748 -0.66 . . . . 25.0 110.465 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.03 16.66 0.12 Allowed 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.639 0.776 . . . . 25.0 112.994 177.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -144.02 -158.32 0.87 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 107.913 -1.143 . . . . 25.0 107.913 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 60.58 178.69 0.1 Allowed 'General case' 0 CA--C 1.555 1.144 0 N-CA-C 114.333 1.234 . . . . 25.0 114.333 176.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.74 24.17 75.02 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 115.876 -0.602 . . . . 25.0 112.898 -176.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -91.26 114.72 27.32 Favored 'General case' 0 C--N 1.316 -0.858 0 O-C-N 122.399 -0.471 . . . . 25.0 112.168 -175.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.48 144.08 48.9 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.309 0.576 . . . . 25.0 109.624 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -145.92 33.55 1.5 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.894 -0.882 . . . . 25.0 110.894 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.3 t -93.85 -29.79 4.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 113.288 0.847 . . . . 25.0 113.288 -172.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.01 132.82 27.86 Favored 'Isoleucine or valine' 0 C--O 1.248 0.98 0 CA-C-N 115.337 -0.847 . . . . 25.0 112.229 -174.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 168.58 159.61 14.61 Favored Glycine 0 N--CA 1.48 1.597 0 N-CA-C 110.227 -1.149 . . . . 25.0 110.227 175.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -147.68 146.71 29.39 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 119.264 1.532 . . . . 25.0 112.161 -176.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 93.1 p -155.22 174.71 14.82 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 106.217 -1.771 . . . . 25.0 106.217 177.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -177.52 167.21 38.11 Favored Glycine 0 C--N 1.309 -0.936 0 C-N-CA 120.104 -1.046 . . . . 25.0 114.854 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 11.9 tp-100 -146.12 81.03 9.93 Favored Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 108.229 -1.026 . . . . 25.0 108.229 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -70.6 151.66 64.41 Favored 'Trans proline' 0 CA--C 1.509 -0.736 0 C-N-CA 121.054 1.17 . . . . 25.0 113.071 -173.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -107.38 147.32 30.51 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.413 -0.812 . . . . 25.0 111.004 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -144.76 75.57 14.45 Favored Pre-proline 0 C--N 1.312 -1.045 0 O-C-N 124.191 0.932 . . . . 25.0 110.414 177.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -72.97 169.62 21.74 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 121.587 1.525 . . . . 25.0 113.255 -175.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.5 t -120.02 2.46 10.97 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 116.417 -0.356 . . . . 25.0 110.358 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 C--O 1.249 1.059 0 CA-C-O 116.707 -1.616 . . . . 25.0 110.817 -178.605 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 CA--C 1.542 0.904 0 N-CA-C 113.877 0.683 . . . . 25.0 113.877 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.79 59.69 0.03 OUTLIER Glycine 0 CA--C 1.524 0.612 0 C-N-CA 121.052 -0.594 . . . . 25.0 111.816 -176.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.8 p -63.9 132.82 29.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 121.734 0.778 . . . . 25.0 110.05 -173.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -91.02 -15.4 29.68 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 119.622 -0.831 . . . . 25.0 110.789 -178.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.28 -147.13 3.87 Favored Glycine 0 C--O 1.207 -1.55 0 N-CA-C 115.952 1.141 . . . . 25.0 115.952 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.7 p 77.96 156.9 0.15 Allowed Pre-proline 0 CA--C 1.558 1.274 0 C-N-CA 126.832 2.053 . . . . 25.0 110.408 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.659 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 50.1 Cg_exo -62.55 -3.36 4.25 Favored 'Trans proline' 0 C--N 1.362 1.249 0 N-CA-C 117.761 2.177 . . . . 25.0 117.761 -175.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.6 p -63.65 -17.67 20.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 114.757 1.391 . . . . 25.0 114.757 -173.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.5 p -142.44 140.95 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-O 122.554 1.168 . . . . 25.0 113.373 -178.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.32 16.03 80.9 Favored Glycine 0 C--O 1.226 -0.344 0 N-CA-C 118.248 2.059 . . . . 25.0 118.248 175.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.2 t -46.21 -58.96 3.2 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 114.15 1.167 . . . . 25.0 114.15 -175.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -78.24 3.14 16.14 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 116.076 1.88 . . . . 25.0 116.076 -169.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.28 171.82 13.62 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.456 -0.778 . . . . 25.0 111.82 -172.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -58.9 135.32 57.52 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.149 0.58 . . . . 25.0 112.534 -177.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -128.52 163.35 25.15 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 113.537 0.94 . . . . 50.0 113.537 -174.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -136.53 108.66 7.22 Favored 'General case' 0 C--O 1.255 1.348 0 N-CA-C 101.683 -3.451 . . . . 25.0 101.683 161.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 89.7 mt -126.0 126.13 43.8 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.909 0.861 . . . . 25.0 110.46 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -114.69 134.6 54.95 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 107.507 -1.294 . . . . 25.0 107.507 178.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -106.14 178.39 22.75 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 115.294 0.878 . . . . 25.0 115.294 -173.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.5 p -79.86 175.41 10.65 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-O 121.856 0.836 . . . . 25.0 112.558 178.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 39.0 mt -83.6 10.54 8.91 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 113.25 0.833 . . . . 25.0 113.25 176.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.07 178.35 25.63 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 123.073 0.368 . . . . 25.0 112.208 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.2 t -74.68 128.66 36.11 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.888 0.475 . . . . 25.0 110.92 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -143.96 151.18 39.41 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.006 0.431 . . . . 50.0 110.542 -174.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -94.36 125.59 39.09 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 102.546 -3.131 . . . . 25.0 102.546 168.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.3 mm -119.02 103.86 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.018 0 N-CA-C 107.257 -1.386 . . . . 25.0 107.257 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.659 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 9.8 mp -100.69 131.55 46.53 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 104.06 -2.57 . . . . 25.0 104.06 177.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.86 -29.83 14.63 Favored Glycine 0 C--N 1.313 -0.745 0 CA-C-N 114.907 -1.042 . . . . 25.0 113.086 176.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.04 -148.7 50.63 Favored Glycine 0 N--CA 1.466 0.685 0 C-N-CA 120.293 -0.956 . . . . 25.0 112.278 -178.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.7 170.68 52.57 Favored Glycine 0 C--O 1.247 0.929 0 CA-C-N 118.219 1.01 . . . . 25.0 113.096 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.25 162.51 23.84 Favored Glycine 0 C--O 1.256 1.525 0 O-C-N 124.035 0.491 . . . . 25.0 114.225 176.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.08 108.58 11.47 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 106.678 -1.601 . . . . 25.0 106.678 177.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -107.57 149.33 28.15 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.992 -0.744 . . . . 50.0 108.992 -173.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -116.61 105.14 12.11 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 106.856 -1.535 . . . . 25.0 106.856 171.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 80.8 mt -111.37 129.11 56.11 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.58 -0.736 . . . . 25.0 112.568 -170.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -125.11 102.48 7.51 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-O 121.802 0.81 . . . . 25.0 110.449 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.45 -29.43 61.87 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-O 118.742 -1.032 . . . . 25.0 115.204 -176.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 53.54 -156.11 0.2 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.09 0.956 . . . . 25.0 112.461 -177.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.19 166.77 9.19 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.098 -1.001 . . . . 25.0 112.767 -175.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.29 160.0 34.26 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 108.239 -1.944 . . . . 25.0 108.239 -176.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -85.73 106.36 16.93 Favored 'General case' 0 C--O 1.251 1.151 0 O-C-N 122.125 -0.633 . . . . 25.0 109.387 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -109.43 144.4 37.71 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.84 -0.744 . . . . 50.0 111.677 -168.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 mp -105.65 92.89 4.37 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.274 -0.876 . . . . 25.0 108.873 177.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 mp -97.3 113.98 25.68 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-O 121.894 0.854 . . . . 25.0 111.783 -174.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -117.41 94.76 4.68 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 106.709 -1.589 . . . . 25.0 106.709 178.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -57.2 -20.53 36.03 Favored Glycine 0 N--CA 1.473 1.133 0 CA-C-O 118.478 -1.179 . . . . 25.0 115.198 -175.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.98 -168.86 49.73 Favored Glycine 0 C--O 1.249 1.06 0 CA-C-N 119.163 1.482 . . . . 25.0 110.531 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.74 153.07 11.22 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 114.805 -0.697 . . . . 25.0 112.49 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.82 177.1 45.31 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.588 -0.733 . . . . 25.0 111.876 178.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -97.34 132.24 43.26 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 105.779 -1.934 . . . . 25.0 105.779 176.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -125.62 159.78 31.29 Favored 'General case' 0 CA--C 1.485 -1.542 0 CA-C-O 118.851 -0.595 . . . . 50.0 110.743 -172.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -121.67 121.97 38.55 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 103.399 -2.815 . . . . 25.0 103.399 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -146.73 131.4 17.87 Favored 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 116.402 2.001 . . . . 25.0 116.402 -167.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 27.5 m -100.54 141.45 33.37 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.33 0.586 . . . . 25.0 112.26 176.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.96 -35.09 5.2 Favored Glycine 0 C--O 1.206 -1.597 0 O-C-N 121.499 -0.751 . . . . 25.0 111.887 177.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.92 -167.91 50.66 Favored Glycine 0 C--O 1.245 0.83 0 O-C-N 121.644 -0.915 . . . . 25.0 113.776 -177.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -59.83 161.51 6.33 Favored 'General case' 0 C--O 1.251 1.156 0 O-C-N 121.204 -1.174 . . . . 25.0 110.672 176.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.76 167.3 36.31 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 115.215 -0.902 . . . . 25.0 113.195 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.82 93.9 9.62 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 122.102 0.953 . . . . 25.0 110.931 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.14 153.44 22.06 Favored 'General case' 0 C--O 1.247 0.927 0 CA-C-N 115.302 -0.863 . . . . 50.0 111.651 -170.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.453 HG22 ' HG3' ' A' ' 65' ' ' ARG . 24.3 m -125.27 116.52 22.08 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 122.314 1.055 . . . . 25.0 109.685 178.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -104.38 102.55 12.21 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.714 -1.217 . . . . 25.0 107.714 177.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.453 ' HG3' HG22 ' A' ' 63' ' ' THR . 97.1 mtt180 -106.75 -23.14 12.5 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 113.541 0.941 . . . . 25.0 113.541 -177.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 67.79 160.46 0.17 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.508 1.523 . . . . 25.0 112.13 -176.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.72 -45.49 14.36 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 115.345 1.609 . . . . 25.0 115.345 -168.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 65.4 mt -139.23 169.56 17.54 Favored 'General case' 0 C--O 1.207 -1.137 0 CA-C-O 121.43 0.633 . . . . 25.0 111.925 -174.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.78 -23.95 32.84 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.273 0.629 . . . . 25.0 110.76 171.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -80.35 -6.63 58.3 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.307 1.043 . . . . 25.0 113.745 -177.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -90.13 152.77 20.97 Favored 'General case' 0 C--O 1.213 -0.831 0 N-CA-C 113.658 0.984 . . . . 25.0 113.658 176.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.8 t 45.14 48.77 9.86 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.702 1.601 . . . . 25.0 113.807 165.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -135.83 165.8 24.77 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 115.178 -0.919 . . . . 25.0 111.162 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 59.2 ttt180 -112.89 136.42 52.56 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 105.375 -2.083 . . . . 25.0 105.375 176.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 81.2 p -126.28 171.17 8.29 Favored Pre-proline 0 C--N 1.325 -0.467 0 C-N-CA 125.023 1.329 . . . . 25.0 108.167 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.22 -24.6 68.04 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 117.828 -0.981 . . . . 25.0 113.618 177.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 38.1 mt -71.89 -27.31 62.75 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 112.997 0.739 . . . . 25.0 112.997 177.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 145.56 -176.41 24.57 Favored Glycine 0 C--O 1.213 -1.195 0 N-CA-C 111.019 -0.832 . . . . 25.0 111.019 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 15.2 t -86.07 146.32 26.68 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 122.817 1.294 . . . . 25.0 112.6 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -127.28 28.7 5.68 Favored 'General case' 0 C--O 1.246 0.896 0 C-N-CA 125.432 1.493 . . . . 25.0 107.316 169.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -62.22 143.9 48.88 Favored Glycine 0 C--N 1.34 0.802 0 N-CA-C 110.57 -1.012 . . . . 25.0 110.57 178.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -92.05 163.11 14.09 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 120.277 -0.569 . . . . 50.0 110.944 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.75 110.06 15.01 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.178 0.299 . . . . 25.0 110.485 -175.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 30.3 mt -91.7 136.59 24.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.094 -1.076 . . . . 25.0 108.094 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.6 mt -83.64 -42.8 16.28 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 114.457 1.281 . . . . 25.0 114.457 -172.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 47.3 p-10 -137.86 38.82 2.38 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.46 1.282 . . . . 25.0 114.46 -169.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -56.24 139.06 49.16 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.041 0.386 . . . . 25.0 112.041 -177.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -116.16 101.52 53.87 Favored Pre-proline 0 C--O 1.248 0.98 0 N-CA-C 108.012 -1.107 . . . . 25.0 108.012 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.03 -9.16 25.59 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 N-CA-C 114.643 0.978 . . . . 25.0 114.643 -172.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.6 t -80.41 -45.02 18.35 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-O 121.228 0.537 . . . . 25.0 109.724 177.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -95.91 -39.23 9.9 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 115.006 1.484 . . . . 25.0 115.006 -173.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -89.3 173.06 8.6 Favored 'General case' 0 C--O 1.218 -0.585 0 CA-C-N 115.837 -0.619 . . . . 75.0 110.542 -167.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -151.77 152.85 33.23 Favored 'General case' 0 C--O 1.26 1.652 0 CA-C-N 116.214 -0.448 . . . . 25.0 110.509 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 45.6 mt -129.03 132.04 67.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 109.346 -0.613 . . . . 25.0 109.346 -178.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -84.85 150.61 24.88 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 123.039 1.399 . . . . 25.0 108.831 174.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.2 p -150.17 -9.5 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.333 0 O-C-N 121.18 -0.95 . . . . 25.0 112.155 176.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.437 ' HB2' ' HA ' ' A' ' 156' ' ' PHE . 31.5 t -61.15 -47.16 87.48 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.657 0.741 . . . . 25.0 109.731 -175.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.29 -43.15 67.7 Favored 'General case' 0 C--O 1.251 1.158 0 N-CA-C 114.451 1.278 . . . . 25.0 114.451 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.47 -3.87 20.45 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 116.094 1.887 . . . . 25.0 116.094 -169.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -139.77 -72.53 0.04 OUTLIER Glycine 0 CA--C 1.533 1.185 0 N-CA-C 118.312 2.085 . . . . 25.0 118.312 -176.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -158.05 170.61 21.91 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 119.058 1.429 . . . . 25.0 109.543 -175.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.9 t -121.45 -33.54 3.62 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 112.453 0.538 . . . . 25.0 112.453 172.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -91.89 129.1 9.67 Favored Glycine 0 N--CA 1.466 0.694 0 O-C-N 120.754 -1.217 . . . . 25.0 110.309 177.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -69.61 148.25 49.61 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 118.374 1.087 . . . . 25.0 111.645 -177.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -81.67 -167.9 39.83 Favored Glycine 0 C--O 1.223 -0.572 0 CA-C-N 115.894 -0.594 . . . . 25.0 112.375 -176.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -79.53 70.5 6.0 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.305 0.854 . . . . 25.0 113.305 -176.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -105.69 -168.29 23.51 Favored Glycine 0 C--O 1.211 -1.282 0 N-CA-C 107.873 -2.091 . . . . 25.0 107.873 172.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -138.26 164.54 28.97 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 120.023 1.912 . . . . 25.0 109.425 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 54.78 35.63 24.54 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 122.944 0.498 . . . . 25.0 111.563 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.09 39.57 73.04 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 120.64 -1.288 . . . . 25.0 112.312 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 8.4 t -135.6 -178.75 5.26 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 117.778 0.789 . . . . 25.0 109.82 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 85.2 mt -101.07 164.88 11.59 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 102.149 -3.278 . . . . 25.0 102.149 173.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.04 111.95 10.79 Favored 'General case' 0 C--O 1.267 1.996 0 CA-C-O 123.119 1.438 . . . . 25.0 107.32 -178.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.8 m -70.25 153.11 8.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 N-CA-C 108.348 -0.982 . . . . 25.0 108.348 -176.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.39 162.29 33.46 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.852 -1.155 . . . . 25.0 110.526 -175.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.7 m -127.65 161.92 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 108.631 -0.878 . . . . 25.0 108.631 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.6 t -82.03 -50.75 8.74 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 105.67 -1.974 . . . . 25.0 105.67 172.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -166.21 -162.84 0.56 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 100.666 -3.827 . . . . 25.0 100.666 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -67.28 -19.21 65.46 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 109.258 -0.645 . . . . 25.0 109.258 -178.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -119.81 -153.01 9.15 Favored Glycine 0 C--O 1.238 0.393 0 N-CA-C 111.115 -0.794 . . . . 25.0 111.115 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 56.91 -132.23 1.48 Allowed 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 112.806 0.669 . . . . 25.0 112.806 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.4 mtt85 -103.5 157.42 17.05 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.425 0.898 . . . . 25.0 113.425 -173.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.31 158.66 16.47 Favored 'General case' 0 C--O 1.253 1.249 0 N-CA-C 105.952 -1.87 . . . . 25.0 105.952 171.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -130.1 160.05 34.91 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.39 -0.967 . . . . 25.0 108.39 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 30.5 tp -132.87 102.81 5.78 Favored 'General case' 0 C--O 1.216 -0.684 0 N-CA-C 103.132 -2.914 . . . . 25.0 103.132 171.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -103.77 151.93 22.47 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.353 0.597 . . . . 25.0 109.947 -172.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 41.5 t -92.03 154.74 18.57 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 104.225 -2.509 . . . . 25.0 104.225 171.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -126.76 26.33 6.23 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 122.874 1.321 . . . . 25.0 108.415 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -117.14 147.07 42.76 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 103.592 -2.744 . . . . 25.0 103.592 171.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -149.16 151.52 34.49 Favored 'General case' 0 C--O 1.217 -0.654 0 O-C-N 124.158 0.911 . . . . 25.0 110.662 -175.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -77.09 164.58 25.57 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 124.091 0.957 . . . . 25.0 110.033 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.11 -19.72 64.86 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.742 -0.599 . . . . 25.0 112.181 -175.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -75.99 -9.02 58.27 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 122.526 0.331 . . . . 25.0 111.543 176.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 92.2 14.07 56.53 Favored Glycine 0 C--O 1.219 -0.805 0 CA-C-O 121.963 0.757 . . . . 25.0 112.573 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.0 mt -83.92 137.48 33.63 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 121.323 -1.104 . . . . 25.0 109.663 178.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 84.4 p -145.73 174.48 11.17 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.482 -0.562 . . . . 25.0 109.482 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -115.95 141.6 47.89 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 118.273 0.488 . . . . 25.0 111.649 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -150.93 156.42 41.15 Favored 'General case' 0 C--O 1.251 1.145 0 N-CA-C 106.343 -1.725 . . . . 25.0 106.343 169.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 13.4 p -146.96 147.69 17.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 104.933 -2.247 . . . . 25.0 104.933 173.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -107.59 141.95 38.27 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.018 -1.475 . . . . 25.0 107.018 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.2 mp -131.39 125.24 32.12 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 103.363 -2.828 . . . . 25.0 103.363 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -104.87 15.22 28.2 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 120.395 -1.441 . . . . 25.0 111.698 -173.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -83.95 4.41 82.93 Favored Glycine 0 C--O 1.241 0.57 0 CA-C-N 114.994 -1.003 . . . . 25.0 114.732 177.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 28.2 t0 49.34 47.04 22.78 Favored 'General case' 0 C--O 1.252 1.202 0 N-CA-C 114.586 1.328 . . . . 25.0 114.586 175.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -122.88 41.08 3.54 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.24 -0.891 . . . . 25.0 111.272 -175.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.67 -29.62 64.78 Favored 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 113.685 0.994 . . . . 25.0 113.685 173.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.99 -17.77 62.63 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 119.506 1.048 . . . . 25.0 110.371 -177.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -102.1 -8.48 21.37 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 113.341 0.867 . . . . 25.0 113.341 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.9 mt -79.37 133.66 36.58 Favored 'General case' 0 C--O 1.207 -1.161 0 C-N-CA 120.33 -0.548 . . . . 25.0 109.806 -176.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.0 m -141.32 165.81 26.5 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 106.932 -1.507 . . . . 25.0 106.932 172.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -81.79 4.02 23.68 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 121.733 0.778 . . . . 25.0 109.865 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -66.37 -31.31 72.0 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.119 -1.4 . . . . 25.0 110.656 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -94.16 0.35 55.73 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 112.14 0.422 . . . . 25.0 112.14 177.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 26.3 mm -99.33 123.45 52.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 N-CA-C 104.329 -2.471 . . . . 25.0 104.329 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.1 p -100.71 119.36 48.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 122.592 1.187 . . . . 25.0 113.281 -172.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.437 ' HA ' ' HB2' ' A' ' 97' ' ' SER . 9.3 p90 -149.63 -12.25 0.29 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 112.835 -1.984 . . . . 25.0 111.567 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.43 53.01 2.37 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 121.086 -1.009 . . . . 25.0 113.231 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 60.42 25.98 15.55 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 115.857 1.799 . . . . 25.0 115.857 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 m 65.63 -45.13 0.38 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 117.887 2.551 . . . . 25.0 117.887 177.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.19 120.13 13.25 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 121.439 -0.788 . . . . 25.0 110.44 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -79.14 31.09 0.21 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.439 0.903 . . . . 25.0 113.439 -174.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.62 -2.8 15.48 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 112.756 0.65 . . . . 25.0 112.756 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -151.52 -176.42 5.59 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 123.793 0.683 . . . . 25.0 110.596 -176.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 63.72 -166.65 0.22 Allowed 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 114.026 1.121 . . . . 25.0 114.026 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.36 25.89 67.2 Favored Glycine 0 CA--C 1.535 1.322 0 N-CA-C 111.372 -0.691 . . . . 25.0 111.372 -177.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -92.54 134.49 34.93 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.668 -0.864 . . . . 25.0 108.668 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -129.39 141.04 51.15 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 107.704 -1.221 . . . . 25.0 107.704 176.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -126.85 38.38 2.19 Favored Glycine 0 N--CA 1.464 0.501 0 CA-C-O 122.371 0.984 . . . . 25.0 111.26 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 26.3 t -84.25 -28.5 7.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 O-C-N 121.945 -0.738 . . . . 25.0 110.546 -174.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.39 133.18 24.78 Favored 'Isoleucine or valine' 0 C--O 1.26 1.607 0 CA-C-O 122.872 1.32 . . . . 25.0 111.071 -178.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 164.99 156.72 9.21 Favored Glycine 0 C--O 1.239 0.441 0 CA-C-N 115.076 -0.966 . . . . 25.0 112.277 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -151.02 142.81 23.78 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 121.621 -0.929 . . . . 25.0 110.482 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 59.0 p -149.96 163.53 37.85 Favored 'General case' 0 C--O 1.248 1.003 0 N-CA-C 106.484 -1.673 . . . . 25.0 106.484 176.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.53 -174.33 40.44 Favored Glycine 0 C--O 1.246 0.859 0 C-N-CA 120.415 -0.898 . . . . 25.0 114.322 176.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -154.4 86.39 3.65 Favored Pre-proline 0 C--O 1.252 1.198 0 C-N-CA 123.449 0.699 . . . . 25.0 109.533 -178.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -69.28 160.55 49.39 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 117.703 -1.065 . . . . 25.0 112.568 -176.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -131.16 155.27 47.3 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 124.446 1.091 . . . . 25.0 108.066 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -141.43 80.49 16.33 Favored Pre-proline 0 C--O 1.245 0.819 0 CA-C-N 118.387 0.539 . . . . 25.0 112.088 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.74 135.53 28.35 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 118.169 -0.754 . . . . 25.0 112.146 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.9 t -88.81 -4.41 58.5 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 112.822 0.675 . . . . 25.0 112.822 -177.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 3.7 p . . . . . 0 C--O 1.254 1.297 0 CA-C-O 118.213 -0.898 . . . . 25.0 109.671 179.959 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo . . . . . 0 CA--C 1.541 0.832 0 CA-C-O 121.358 0.482 . . . . 25.0 113.215 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.14 49.32 0.08 OUTLIER Glycine 0 N--CA 1.473 1.157 0 N-CA-C 110.961 -0.855 . . . . 25.0 110.961 178.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.42 HG22 ' H ' ' A' ' 7' ' ' GLY . 2.9 p -55.41 132.06 18.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 123.657 0.783 . . . . 25.0 112.048 -176.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -98.06 -2.05 41.11 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.366 -0.834 . . . . 25.0 110.302 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.42 ' H ' HG22 ' A' ' 5' ' ' VAL . . . -85.03 -145.11 7.32 Favored Glycine 0 C--O 1.206 -1.624 0 CA-C-N 116.032 -0.531 . . . . 25.0 113.336 177.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.0 p 67.76 153.97 0.13 Allowed Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 126.006 1.723 . . . . 25.0 112.672 -173.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.618 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 47.0 Cg_exo -61.91 -3.91 4.25 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.74 2.293 . . . . 25.0 116.148 -178.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.3 p -63.66 -16.63 18.68 Favored 'Isoleucine or valine' 0 C--O 1.248 0.986 0 N-CA-C 116.85 2.167 . . . . 25.0 116.85 -167.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.8 p -143.82 131.76 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 113.341 0.867 . . . . 25.0 113.341 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.87 19.88 56.9 Favored Glycine 0 N--CA 1.469 0.855 0 N-CA-C 117.592 1.797 . . . . 25.0 117.592 176.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.9 t -47.68 -56.76 6.58 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 117.985 0.893 . . . . 25.0 112.346 -176.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -75.19 -1.99 25.84 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 115.496 1.665 . . . . 25.0 115.496 -170.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -137.57 174.64 10.38 Favored 'General case' 0 C--O 1.207 -1.158 0 CA-C-N 116.234 -0.439 . . . . 25.0 111.784 -171.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.27 144.1 47.28 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-O 122.276 1.036 . . . . 25.0 109.135 -175.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -131.06 150.25 52.23 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 114.632 -1.167 . . . . 50.0 113.018 -176.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -131.22 105.03 7.4 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 100.541 -3.874 . . . . 25.0 100.541 165.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 89.0 mt -127.95 132.72 49.22 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 109.734 -0.469 . . . . 25.0 109.734 -175.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -120.0 115.9 24.67 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.272 -1.381 . . . . 25.0 107.272 -178.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -80.5 176.38 54.67 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 116.554 1.382 . . . . 25.0 116.554 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.5 p -82.33 175.8 9.96 Favored 'General case' 0 C--O 1.251 1.132 0 C-N-CA 124.349 1.06 . . . . 25.0 110.582 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 82.3 mt -80.65 4.46 18.63 Favored 'General case' 0 N--CA 1.463 0.198 0 O-C-N 121.99 -0.443 . . . . 25.0 111.334 174.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -95.85 -176.0 36.66 Favored Glycine 0 C--O 1.226 -0.39 0 CA-C-O 121.374 0.43 . . . . 25.0 112.063 -178.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.6 t -82.12 131.1 35.24 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 109.18 -0.674 . . . . 25.0 109.18 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -145.57 159.89 42.45 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.756 0.788 . . . . 50.0 109.203 -177.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -100.82 131.94 46.46 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 104.773 -2.306 . . . . 25.0 104.773 165.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.4 mm -120.29 103.75 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 N-CA-C 106.736 -1.579 . . . . 25.0 106.736 178.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.618 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 5.3 mp -105.78 128.39 53.68 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 104.427 -2.435 . . . . 25.0 104.427 -178.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.95 -32.19 11.2 Favored Glycine 0 C--N 1.307 -1.049 0 N-CA-C 117.447 1.739 . . . . 25.0 117.447 -177.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.91 -147.14 49.18 Favored Glycine 0 C--O 1.243 0.659 0 CA-C-N 118.934 1.367 . . . . 25.0 111.944 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.95 175.61 50.25 Favored Glycine 0 C--O 1.244 0.768 0 O-C-N 121.734 -0.862 . . . . 25.0 112.837 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.26 160.73 12.51 Favored Glycine 0 C--O 1.256 1.529 0 C-N-CA 120.329 -0.939 . . . . 25.0 111.523 175.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.7 113.02 20.99 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 105.565 -2.013 . . . . 25.0 105.565 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -105.0 154.08 20.59 Favored 'General case' 0 C--O 1.251 1.156 0 N-CA-C 113.211 0.819 . . . . 50.0 113.211 -172.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -121.36 92.61 3.79 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 107.093 -1.447 . . . . 25.0 107.093 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 34.5 mt -108.3 137.3 46.49 Favored 'General case' 0 C--O 1.203 -1.364 0 N-CA-C 114.455 1.28 . . . . 25.0 114.455 -169.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -131.71 117.6 18.84 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.299 0.571 . . . . 25.0 111.719 -179.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -87.92 -24.7 34.27 Favored Glycine 0 C--O 1.245 0.831 0 CA-C-O 117.247 -1.863 . . . . 25.0 116.78 -178.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 53.14 -153.36 0.25 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.978 1.389 . . . . 25.0 112.068 -177.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.71 167.22 15.74 Favored 'General case' 0 C--O 1.249 1.055 0 O-C-N 120.615 -1.303 . . . . 25.0 111.376 -178.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.5 158.52 31.67 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 114.993 -1.003 . . . . 25.0 111.606 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -85.71 94.29 9.07 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 107.385 -1.339 . . . . 25.0 107.385 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -99.38 159.83 14.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.175 -0.921 . . . . 50.0 110.588 -170.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 mp -120.38 106.37 11.79 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 108.529 -0.915 . . . . 25.0 108.529 174.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 mp -111.7 106.15 14.86 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 113.05 0.759 . . . . 25.0 113.05 -172.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -118.99 92.41 3.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.736 -1.12 . . . . 25.0 108.986 -177.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.38 -12.42 32.17 Favored Glycine 0 N--CA 1.467 0.719 0 N-CA-C 118.366 2.106 . . . . 25.0 118.366 -177.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 61.48 -162.45 24.76 Favored Glycine 0 N--CA 1.462 0.399 0 CA-C-N 119.546 1.673 . . . . 25.0 113.853 177.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.69 158.86 1.21 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 114.227 1.195 . . . . 25.0 114.227 -177.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.93 179.46 51.78 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 115.138 -0.937 . . . . 25.0 112.809 -177.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.79 141.62 29.03 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 101.498 -3.519 . . . . 25.0 101.498 176.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -133.53 158.12 43.93 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.57 -0.9 . . . . 50.0 108.57 -175.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -124.01 120.09 31.42 Favored 'General case' 0 C--O 1.212 -0.906 0 N-CA-C 107.766 -1.198 . . . . 25.0 107.766 173.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -141.64 132.48 25.84 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 115.644 1.72 . . . . 25.0 115.644 -169.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 63.9 m -95.22 140.98 29.36 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 123.278 0.631 . . . . 25.0 109.752 175.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.39 -39.18 4.54 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 107.9 -2.08 . . . . 25.0 107.9 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.03 -164.38 52.87 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 117.997 0.898 . . . . 25.0 113.387 -177.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.0 158.73 15.72 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.03 0.532 . . . . 25.0 110.202 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.97 157.85 26.24 Favored Glycine 0 N--CA 1.476 1.324 0 N-CA-C 111.502 -0.639 . . . . 25.0 111.502 175.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.0 110.91 8.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.627 1.203 . . . . 25.0 111.915 -176.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -104.86 155.22 19.12 Favored 'General case' 0 C--O 1.25 1.123 0 CA-C-N 114.625 -1.17 . . . . 50.0 109.505 -173.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 88.0 m -125.33 131.01 53.1 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.418 0.687 . . . . 25.0 110.444 -177.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -124.31 104.05 8.57 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 108.015 -1.105 . . . . 25.0 108.015 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 54.5 mtt85 -115.09 -16.59 11.59 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 121.669 -0.645 . . . . 25.0 111.531 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 62.44 164.22 0.1 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.692 1.597 . . . . 25.0 111.571 -175.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.15 -39.49 48.99 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 114.317 1.228 . . . . 25.0 114.317 -172.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.7 mt -135.37 164.81 26.91 Favored 'General case' 0 C--O 1.207 -1.149 0 C-N-CA 123.114 0.566 . . . . 25.0 112.341 -170.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -17.97 64.2 Favored 'General case' 0 C--O 1.209 -1.067 0 N-CA-C 108.386 -0.968 . . . . 25.0 108.386 170.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -82.53 6.06 18.74 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.811 1.041 . . . . 25.0 113.811 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -111.22 151.81 27.83 Favored 'General case' 0 C--O 1.213 -0.849 0 N-CA-C 115.798 1.777 . . . . 25.0 115.798 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.0 t 54.91 36.32 26.45 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 113.712 -1.586 . . . . 25.0 112.975 175.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 24.0 p-80 -121.05 167.65 12.39 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.869 -1.06 . . . . 25.0 112.507 -173.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 -123.44 140.99 52.44 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 106.748 -1.575 . . . . 25.0 106.748 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.6 p -133.94 173.29 6.01 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 107.949 -1.13 . . . . 25.0 107.949 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -61.39 -25.68 80.36 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 115.831 -2.313 . . . . 25.0 112.999 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 68.6 mt -68.77 -27.09 65.59 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.533 0.682 . . . . 25.0 111.916 -178.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.53 -173.83 32.94 Favored Glycine 0 CA--C 1.498 -0.995 0 N-CA-C 110.414 -1.074 . . . . 25.0 110.414 -177.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.1 t -100.41 148.02 25.19 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.487 1.137 . . . . 25.0 111.345 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -134.09 31.0 3.59 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 114.622 -1.172 . . . . 25.0 108.496 172.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.56 148.94 50.28 Favored Glycine 0 C--O 1.249 1.057 0 CA-C-N 114.085 -1.416 . . . . 25.0 109.578 176.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -91.8 167.18 12.34 Favored 'General case' 0 C--N 1.314 -0.961 0 O-C-N 121.888 -0.772 . . . . 50.0 110.133 -176.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -120.75 111.34 17.47 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.575 0.75 . . . . 25.0 109.989 -177.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.8 mt -97.32 129.36 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-O 121.676 0.75 . . . . 25.0 109.021 -177.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 81.4 mt -83.78 -41.71 17.29 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 115.717 1.747 . . . . 25.0 115.717 -170.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.4 p-10 -140.45 45.63 1.83 Allowed 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.755 1.391 . . . . 25.0 114.755 -176.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -55.83 129.92 41.42 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 122.241 1.02 . . . . 25.0 112.943 -178.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -91.97 105.11 12.39 Favored Pre-proline 0 C--O 1.246 0.872 0 CA-C-N 114.231 -1.35 . . . . 25.0 108.081 174.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.38 3.93 3.79 Favored 'Trans proline' 0 C--O 1.205 -1.143 0 N-CA-C 115.779 1.415 . . . . 25.0 115.779 -173.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.2 t -110.83 -43.8 3.74 Favored 'General case' 0 C--O 1.253 1.281 0 O-C-N 121.809 -0.557 . . . . 25.0 111.259 176.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -87.26 -38.66 16.11 Favored 'General case' 0 C--O 1.241 0.624 0 O-C-N 123.51 0.506 . . . . 25.0 110.58 -172.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -88.43 158.44 18.36 Favored 'General case' 0 CA--C 1.552 1.048 0 N-CA-C 112.271 0.471 . . . . 50.0 112.271 -170.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -137.81 147.89 45.0 Favored 'General case' 0 C--O 1.252 1.201 0 N-CA-C 113.859 1.059 . . . . 25.0 113.859 -175.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 68.2 mt -131.81 130.39 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 108.773 -0.825 . . . . 25.0 108.773 -175.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -90.05 147.44 23.65 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.047 -1.033 . . . . 25.0 108.927 171.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.0 p -141.35 -5.02 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 115.484 -0.78 . . . . 25.0 109.417 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.0 t -65.65 -41.96 91.94 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 121.294 0.569 . . . . 25.0 111.313 -170.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.91 -34.3 57.72 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 119.937 -0.705 . . . . 25.0 112.855 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.97 -3.25 18.98 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 116.502 2.038 . . . . 25.0 116.502 -169.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -142.58 -74.08 0.03 OUTLIER Glycine 0 C--O 1.214 -1.124 0 CA-C-O 119.256 -0.747 . . . . 25.0 114.561 -178.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -160.23 165.16 32.0 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 117.814 0.807 . . . . 25.0 112.007 -173.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.9 t -121.27 -10.9 8.88 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 121.0 0.429 . . . . 25.0 112.1 176.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.43 133.41 11.07 Favored Glycine 0 N--CA 1.467 0.722 0 N-CA-C 108.613 -1.795 . . . . 25.0 108.613 170.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.15 150.11 42.45 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-N 117.314 0.557 . . . . 25.0 112.172 -175.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -86.06 -177.7 49.96 Favored Glycine 0 C--O 1.223 -0.545 0 O-C-N 122.125 -0.36 . . . . 25.0 113.1 -174.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -63.81 101.15 0.34 Allowed 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.624 0.602 . . . . 25.0 112.624 -175.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -150.85 -165.62 12.94 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.006 -1.237 . . . . 25.0 110.006 175.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -148.43 165.88 29.8 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 119.645 1.722 . . . . 25.0 113.164 -177.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 58.94 33.97 23.35 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.464 1.283 . . . . 25.0 114.464 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 77.36 30.54 53.89 Favored Glycine 0 N--CA 1.465 0.617 0 C-N-CA 119.857 -1.163 . . . . 25.0 110.27 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.6 t -143.61 168.63 19.42 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 121.32 -1.106 . . . . 25.0 108.965 -178.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.8 mt -93.02 172.24 8.44 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 106.144 -1.799 . . . . 25.0 106.144 175.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.58 118.95 19.75 Favored 'General case' 0 C--O 1.254 1.323 0 CA-C-N 119.446 1.021 . . . . 25.0 110.099 177.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.8 m -87.85 159.15 3.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 109.45 -0.574 . . . . 25.0 109.45 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 99.4 p -147.0 163.69 35.42 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 108.77 -0.826 . . . . 25.0 108.77 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.5 m -126.02 165.89 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 N-CA-C 107.532 -1.284 . . . . 25.0 107.532 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.1 t -74.49 -49.32 22.65 Favored 'General case' 0 C--O 1.255 1.346 0 N-CA-C 104.251 -2.5 . . . . 25.0 104.251 173.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -168.8 -170.89 1.25 Allowed 'General case' 0 C--O 1.207 -1.133 1 N-CA-C 99.201 -4.37 . . . . 25.0 99.201 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -60.23 -20.46 58.95 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 119.175 0.898 . . . . 25.0 111.912 -178.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.22 -151.45 9.68 Favored Glycine 0 C--O 1.216 -1.02 0 N-CA-C 110.602 -0.999 . . . . 25.0 110.602 176.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 54.66 -133.75 1.66 Allowed 'General case' 0 N--CA 1.465 0.325 0 O-C-N 124.066 0.51 . . . . 25.0 112.094 -179.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 22.8 mtt85 -105.37 155.53 19.03 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 112.473 0.546 . . . . 25.0 112.473 -174.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.3 p -103.3 163.01 12.52 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.173 -2.528 . . . . 25.0 104.173 175.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.493 ' CE2' ' HB2' ' A' ' 140' ' ' ALA . 57.8 m-85 -141.33 149.86 41.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 118.63 0.65 . . . . 25.0 111.328 -176.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 55.8 tp -124.57 128.21 48.56 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 105.298 -2.112 . . . . 25.0 105.298 177.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -126.15 155.75 41.21 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 122.597 1.189 . . . . 25.0 112.218 -172.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 32.3 t -90.96 158.28 16.81 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 103.481 -2.785 . . . . 25.0 103.481 168.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -129.69 17.08 5.82 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 106.773 -1.566 . . . . 25.0 106.773 176.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -115.44 144.78 43.31 Favored 'General case' 0 C--O 1.25 1.125 0 CA-C-N 112.525 -2.125 . . . . 25.0 106.667 173.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -144.52 168.18 20.74 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.334 0.587 . . . . 25.0 110.18 -178.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -97.13 161.35 13.86 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.946 -1.131 . . . . 25.0 107.946 176.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.22 -26.72 68.64 Favored 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 109.647 -0.501 . . . . 25.0 109.647 -176.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -67.26 -7.16 22.06 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 112.929 0.715 . . . . 25.0 112.929 174.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.89 22.18 53.63 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 121.84 0.689 . . . . 25.0 113.404 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 78.1 mt -90.99 133.48 35.25 Favored 'General case' 0 CA--C 1.506 -0.728 0 O-C-N 121.899 -0.766 . . . . 25.0 109.951 177.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 66.3 p -141.43 -179.46 6.15 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.414 -1.328 . . . . 25.0 107.414 178.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -124.77 136.26 53.7 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 119.614 -0.232 . . . . 25.0 111.221 -178.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -149.15 152.53 36.24 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 106.622 -1.622 . . . . 25.0 106.622 166.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.5 p -144.63 144.65 21.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 105.004 -2.221 . . . . 25.0 105.004 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.493 ' HB2' ' CE2' ' A' ' 124' ' ' TYR . . . -105.54 142.98 34.35 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.963 -1.495 . . . . 25.0 106.963 -176.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.8 mp -130.77 132.66 45.42 Favored 'General case' 0 C--O 1.195 -1.81 0 N-CA-C 105.404 -2.073 . . . . 25.0 105.404 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -105.35 6.19 32.46 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 119.646 -1.909 . . . . 25.0 114.195 -174.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -87.34 8.66 76.12 Favored Glycine 0 CA--C 1.542 1.765 0 C-N-CA 120.753 -0.737 . . . . 25.0 113.415 -179.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 35.7 t0 43.98 57.36 4.2 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 114.7 1.371 . . . . 25.0 114.7 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -123.82 36.16 4.69 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-N 114.95 -1.023 . . . . 25.0 109.284 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.97 -33.32 68.74 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.348 -0.387 . . . . 25.0 112.027 174.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.36 -22.91 62.73 Favored 'General case' 0 C--O 1.255 1.374 0 O-C-N 121.297 -0.877 . . . . 25.0 112.442 178.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.5 -15.92 20.35 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 112.333 0.494 . . . . 25.0 112.333 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 12.9 mt -64.59 139.02 58.72 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 123.009 1.385 . . . . 25.0 112.265 176.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 57.8 m -143.52 154.7 43.89 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 106.66 -1.607 . . . . 25.0 106.66 177.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.05 -2.93 29.61 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.657 0.614 . . . . 25.0 112.657 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -67.0 -31.55 72.19 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 108.366 -0.975 . . . . 25.0 108.366 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -85.6 -5.03 59.32 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 120.377 -0.529 . . . . 25.0 112.309 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 48.3 mm -97.27 122.79 49.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 104.481 -2.414 . . . . 25.0 104.481 176.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.1 p -103.2 112.93 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-O 123.12 1.438 . . . . 25.0 113.568 -174.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -142.0 -7.21 0.94 Allowed 'General case' 0 C--O 1.251 1.158 0 CA-C-N 112.656 -2.066 . . . . 25.0 111.782 176.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -85.86 50.61 2.01 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.56 0.948 . . . . 25.0 113.56 -176.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 60.09 20.06 9.28 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.456 2.021 . . . . 25.0 116.456 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.0 -21.28 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 119.886 3.291 . . . . 25.0 119.886 174.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -70.0 139.8 52.82 Favored 'General case' 0 N--CA 1.444 -0.746 0 O-C-N 121.606 -0.684 . . . . 25.0 110.196 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -75.25 -1.83 25.27 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.462 0.912 . . . . 25.0 113.462 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.29 34.97 0.21 Allowed 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.883 0.849 . . . . 25.0 111.164 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -145.66 -171.59 3.72 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.267 -0.879 . . . . 25.0 108.921 -175.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 59.65 -168.98 0.15 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.632 1.573 . . . . 25.0 113.083 175.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 80.18 6.2 89.31 Favored Glycine 0 C--O 1.25 1.145 0 CA-C-O 121.682 0.601 . . . . 25.0 114.418 -173.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -81.86 69.73 8.61 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.868 0.867 . . . . 25.0 111.364 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -125.01 141.15 52.31 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 122.853 0.461 . . . . 25.0 111.297 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -142.67 44.76 0.95 Allowed Glycine 0 CA--C 1.527 0.784 0 O-C-N 124.222 0.951 . . . . 25.0 112.097 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 45.6 t -70.87 -37.26 67.67 Favored 'Isoleucine or valine' 0 C--O 1.251 1.143 0 O-C-N 121.758 -0.848 . . . . 25.0 111.684 -178.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.11 136.47 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-O 122.245 1.022 . . . . 25.0 111.645 -177.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 166.84 170.38 31.66 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 109.22 -1.552 . . . . 25.0 109.22 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -146.55 148.8 32.54 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.855 0.836 . . . . 25.0 110.721 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 95.2 p -158.42 169.93 23.35 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-N 114.782 -1.099 . . . . 25.0 110.169 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 150.58 167.12 14.19 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 116.289 1.276 . . . . 25.0 116.289 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -136.66 95.0 12.82 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 124.948 1.299 . . . . 25.0 107.618 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.86 158.29 57.97 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 119.809 0.339 . . . . 25.0 112.094 -178.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -114.03 154.75 27.15 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 107.951 -1.129 . . . . 25.0 107.951 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -127.2 67.88 71.55 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 115.574 -0.739 . . . . 25.0 110.818 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -72.15 158.19 52.55 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 CA-C-O 122.945 1.144 . . . . 25.0 112.25 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.2 t -132.48 27.52 4.39 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 105.828 -1.915 . . . . 25.0 105.828 172.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 C--O 1.25 1.115 0 CA-C-N 113.876 -1.511 . . . . 25.0 111.821 179.056 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo . . . . . 0 CA--C 1.515 -0.464 0 N-CA-C 113.531 0.55 . . . . 25.0 113.531 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.64 46.1 0.04 OUTLIER Glycine 0 N--CA 1.472 1.087 0 CA-C-O 117.539 -1.701 . . . . 25.0 110.474 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -51.67 120.89 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 O-C-N 125.592 1.407 . . . . 25.0 113.0 -176.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -92.29 -8.59 44.75 Favored 'General case' 0 C--O 1.259 1.557 0 CA-C-N 113.516 -1.675 . . . . 25.0 110.899 -173.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.01 -137.17 3.34 Favored Glycine 0 C--N 1.298 -1.567 0 O-C-N 124.01 0.819 . . . . 25.0 113.403 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.7 p 65.69 156.34 0.13 Allowed Pre-proline 0 N--CA 1.498 1.966 0 C-N-CA 126.225 1.81 . . . . 25.0 111.665 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.582 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 47.3 Cg_exo -64.23 -3.31 5.98 Favored 'Trans proline' 0 C--N 1.364 1.344 0 N-CA-C 118.17 2.335 . . . . 25.0 118.17 -177.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 p -68.74 -9.92 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 116.822 2.156 . . . . 25.0 116.822 -173.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.7 p -138.87 133.02 40.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 113.547 0.943 . . . . 25.0 113.547 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.11 15.8 74.66 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 118.093 1.997 . . . . 25.0 118.093 172.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 89.4 p -54.75 -35.21 63.51 Favored 'General case' 0 CA--C 1.565 1.549 0 O-C-N 120.776 -1.426 . . . . 25.0 113.815 -170.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -78.22 3.81 14.33 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 117.576 2.435 . . . . 25.0 117.576 -175.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.4 pp -149.98 177.64 9.67 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 123.181 0.592 . . . . 25.0 110.478 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -59.32 128.7 38.39 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 112.548 0.573 . . . . 25.0 112.548 -174.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -125.9 160.61 29.48 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 114.298 1.222 . . . . 50.0 114.298 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -124.24 97.39 5.3 Favored 'General case' 0 C--O 1.279 2.639 0 N-CA-C 106.237 -1.764 . . . . 25.0 106.237 159.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.4 mt -104.44 128.68 52.39 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.932 0.872 . . . . 25.0 112.691 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -115.67 120.47 39.48 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 109.114 -0.699 . . . . 25.0 109.114 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.83 173.88 40.35 Favored Glycine 0 N--CA 1.472 1.083 0 N-CA-C 120.238 2.855 . . . . 25.0 120.238 -178.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.5 p -71.72 174.42 6.84 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.521 1.153 . . . . 25.0 113.06 175.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.5 mt -93.5 16.85 12.61 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.483 -0.78 . . . . 25.0 109.904 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -119.24 -177.62 16.48 Favored Glycine 0 C--O 1.24 0.494 0 N-CA-C 109.479 -1.448 . . . . 25.0 109.479 174.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.7 t -68.45 133.92 49.36 Favored 'General case' 0 C--O 1.253 1.278 0 C-N-CA 123.347 0.659 . . . . 25.0 111.483 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -144.98 160.5 41.25 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.974 -1.121 . . . . 50.0 107.974 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -104.27 124.55 49.35 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 104.916 -2.253 . . . . 25.0 104.916 163.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.0 mm -114.84 128.65 71.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 N-CA-C 106.378 -1.712 . . . . 25.0 106.378 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.582 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 4.4 mp -126.9 124.46 39.6 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 102.942 -2.985 . . . . 25.0 102.942 178.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.32 -30.87 56.24 Favored Glycine 0 N--CA 1.483 1.777 0 N-CA-C 114.625 0.61 . . . . 25.0 114.625 176.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.5 -149.56 48.59 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 118.781 1.29 . . . . 25.0 111.352 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -79.14 170.43 54.57 Favored Glycine 0 C--N 1.298 -1.561 0 N-CA-C 109.362 -1.495 . . . . 25.0 109.362 -177.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.82 167.98 41.92 Favored Glycine 0 C--N 1.307 -1.032 0 N-CA-C 110.861 -0.896 . . . . 25.0 110.861 177.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.91 102.97 15.58 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.53 1.132 . . . . 25.0 108.319 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -102.78 147.25 27.09 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 122.589 1.185 . . . . 50.0 111.381 -167.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -118.16 92.29 3.79 Favored 'General case' 0 C--O 1.285 2.934 0 N-CA-C 107.477 -1.305 . . . . 25.0 107.477 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 23.3 mt -102.69 140.37 37.05 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.558 0.947 . . . . 25.0 113.558 -169.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -134.31 106.18 6.98 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.633 -0.877 . . . . 25.0 108.633 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.38 -17.75 63.79 Favored Glycine 0 N--CA 1.476 1.354 0 N-CA-C 115.86 1.104 . . . . 25.0 115.86 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 47.93 -149.64 0.16 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 119.335 1.568 . . . . 25.0 113.939 -177.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.98 163.1 25.36 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-N 115.633 -0.712 . . . . 25.0 112.918 -173.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.5 160.62 35.97 Favored Glycine 0 C--O 1.252 1.258 0 O-C-N 124.979 1.424 . . . . 25.0 113.672 -175.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -81.59 102.53 10.7 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.901 -1.148 . . . . 25.0 107.901 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -109.69 152.95 24.96 Favored 'General case' 0 CA--C 1.505 -0.754 0 C-N-CA 119.48 -0.888 . . . . 50.0 110.92 -169.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.44 120.79 43.15 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 105.15 -2.167 . . . . 25.0 105.15 177.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.8 mp -124.14 121.3 34.75 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.275 1.213 . . . . 25.0 114.275 -176.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -116.08 148.02 40.68 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 113.801 -1.545 . . . . 25.0 106.888 174.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.15 -34.32 4.87 Favored Glycine 0 N--CA 1.476 1.333 0 N-CA-C 116.173 1.229 . . . . 25.0 116.173 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.72 -171.38 53.5 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-O 123.593 1.663 . . . . 25.0 110.335 -177.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.28 149.64 16.01 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 114.253 -0.973 . . . . 25.0 112.422 -176.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.56 168.32 44.47 Favored Glycine 0 CA--C 1.496 -1.155 0 CA-C-O 118.31 -1.272 . . . . 25.0 111.723 -176.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.49 134.32 33.62 Favored 'General case' 0 C--O 1.209 -1.07 0 N-CA-C 101.637 -3.468 . . . . 25.0 101.637 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -123.1 157.71 32.25 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 109.655 -0.498 . . . . 50.0 109.655 -174.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -120.73 127.59 52.15 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 101.994 -3.336 . . . . 25.0 101.994 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -149.48 135.04 18.51 Favored 'General case' 0 C--O 1.2 -1.507 0 N-CA-C 116.493 2.034 . . . . 25.0 116.493 -174.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.2 m -99.55 145.6 27.33 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.995 -1.002 . . . . 25.0 110.228 171.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.92 -34.54 5.4 Favored Glycine 0 C--O 1.215 -1.076 0 N-CA-C 108.779 -1.728 . . . . 25.0 108.779 173.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.69 -165.1 53.56 Favored Glycine 0 C--O 1.217 -0.946 0 CA-C-O 122.009 0.783 . . . . 25.0 111.659 -177.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -71.16 156.06 40.02 Favored 'General case' 0 C--O 1.258 1.53 0 CA-C-O 121.938 0.875 . . . . 25.0 109.344 178.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.54 161.45 33.61 Favored Glycine 0 C--O 1.258 1.605 0 CA-C-O 117.982 -1.454 . . . . 25.0 110.121 -175.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.75 112.29 17.99 Favored 'General case' 0 C--O 1.2 -1.532 0 O-C-N 124.697 0.881 . . . . 25.0 109.428 177.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -104.15 153.4 20.98 Favored 'General case' 0 CA--C 1.487 -1.462 0 CA-C-N 116.58 -0.282 . . . . 50.0 110.901 -174.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 79.5 m -116.36 122.54 45.17 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 107.843 -1.169 . . . . 25.0 107.843 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -108.13 89.26 2.94 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 104.137 -2.542 . . . . 25.0 104.137 177.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -92.12 -25.84 18.55 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 114.822 -1.081 . . . . 25.0 111.626 -174.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 66.86 150.03 0.06 Allowed 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.477 1.511 . . . . 25.0 112.198 -175.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.65 -43.36 31.61 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 117.061 2.245 . . . . 25.0 117.061 -165.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.4 mt -142.9 173.57 11.43 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.572 -0.899 . . . . 25.0 108.572 -165.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.55 -30.23 69.64 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-N 115.179 -0.919 . . . . 25.0 110.125 167.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -78.17 -6.59 55.27 Favored 'General case' 0 C--O 1.263 1.796 0 N-CA-C 114.539 1.311 . . . . 25.0 114.539 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -90.59 151.17 21.43 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 121.209 -0.932 . . . . 25.0 109.499 -172.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.8 t 29.1 47.05 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 117.569 2.433 . . . . 25.0 117.569 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 -119.15 178.63 4.44 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.56 -0.746 . . . . 25.0 109.532 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -126.84 140.17 52.55 Favored 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 107.963 -1.125 . . . . 25.0 107.963 176.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 84.1 p -129.81 166.1 28.52 Favored Pre-proline 0 C--O 1.189 -2.108 0 N-CA-C 108.216 -1.031 . . . . 25.0 108.216 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -64.68 -24.58 62.25 Favored 'Trans proline' 0 C--O 1.243 0.735 0 C-N-CA 115.667 -2.422 . . . . 25.0 112.677 178.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 31.7 mt -65.64 -38.99 90.94 Favored 'General case' 0 C--O 1.201 -1.498 0 CA-C-O 121.826 0.822 . . . . 25.0 112.459 178.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 171.46 167.29 31.48 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 115.001 -1.0 . . . . 25.0 111.383 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.8 t -86.42 149.64 24.86 Favored 'General case' 0 C--N 1.353 0.751 0 CA-C-O 124.425 2.059 . . . . 25.0 110.855 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -132.83 28.09 4.24 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 112.337 -2.21 . . . . 25.0 111.355 175.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.74 140.41 36.59 Favored Glycine 0 N--CA 1.474 1.231 0 CA-C-O 122.31 0.95 . . . . 25.0 111.917 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -91.18 169.39 10.88 Favored 'General case' 0 C--O 1.249 1.067 0 O-C-N 119.884 -1.95 . . . . 50.0 111.998 -176.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -122.18 97.4 5.46 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.662 0.785 . . . . 25.0 110.936 -170.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 22.1 mt -84.41 132.7 30.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 N-CA-C 106.92 -1.511 . . . . 25.0 106.92 -178.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.448 ' HA ' ' HG2' ' A' ' 142' ' ' GLU . 90.4 mt -87.47 -43.81 11.78 Favored 'General case' 0 C--O 1.253 1.289 0 N-CA-C 115.774 1.768 . . . . 25.0 115.774 -172.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 54.0 p-10 -137.78 44.55 2.2 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.539 0.57 . . . . 25.0 112.539 -174.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -57.28 138.55 54.64 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.823 1.249 . . . . 25.0 111.971 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -106.16 105.5 54.02 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 106.807 -1.553 . . . . 25.0 106.807 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -68.05 -5.4 14.59 Favored 'Trans proline' 0 C--O 1.199 -1.427 0 N-CA-C 117.703 2.155 . . . . 25.0 117.703 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 37.7 t -99.87 -38.78 8.5 Favored 'General case' 0 CA--C 1.557 1.213 0 CA-C-O 120.815 0.341 . . . . 25.0 110.921 177.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -93.45 -42.3 9.33 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-N 116.668 -0.242 . . . . 25.0 111.578 -174.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -87.56 167.66 13.74 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 115.134 -0.939 . . . . 50.0 109.516 -170.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -139.99 151.11 45.23 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 122.977 0.511 . . . . 25.0 110.733 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 86.0 mt -124.93 133.71 68.78 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.596 0 N-CA-C 107.945 -1.131 . . . . 25.0 107.945 177.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -100.15 154.53 18.37 Favored 'General case' 0 C--O 1.212 -0.914 0 N-CA-C 107.896 -1.15 . . . . 25.0 107.896 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.8 p -154.33 2.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 121.467 -0.771 . . . . 25.0 111.448 -176.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 11.0 t -62.74 -45.97 90.26 Favored 'General case' 0 C--O 1.258 1.546 0 N-CA-C 115.464 1.653 . . . . 25.0 115.464 -173.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.63 -42.01 22.88 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.9 -0.591 . . . . 25.0 111.07 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.37 -8.32 48.33 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 117.136 2.273 . . . . 25.0 117.136 -172.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -140.44 -72.07 0.04 OUTLIER Glycine 0 C--N 1.337 0.613 0 N-CA-C 116.72 1.448 . . . . 25.0 116.72 -176.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -160.63 168.61 24.57 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 108.283 -1.006 . . . . 25.0 108.283 -176.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.0 t -127.73 -30.99 2.48 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.8 0.81 . . . . 25.0 111.925 175.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -94.06 121.36 6.65 Favored Glycine 0 CA--C 1.483 -1.968 0 N-CA-C 107.467 -2.253 . . . . 25.0 107.467 175.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.82 146.07 47.61 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.038 -0.581 . . . . 25.0 111.813 -178.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -102.68 -160.3 25.81 Favored Glycine 0 C--O 1.244 0.727 0 CA-C-O 122.415 1.008 . . . . 25.0 114.539 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -56.48 139.36 49.51 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 122.262 1.03 . . . . 25.0 113.673 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 164.28 -175.67 40.32 Favored Glycine 0 C--O 1.25 1.141 0 N-CA-C 110.15 -1.18 . . . . 25.0 110.15 -177.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -146.61 165.26 30.07 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.834 1.317 . . . . 25.0 110.995 -177.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 56.4 37.38 28.78 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 113.243 0.831 . . . . 25.0 113.243 177.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 79.02 32.6 39.23 Favored Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.204 -1.474 . . . . 25.0 110.945 176.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.7 t -148.59 179.72 7.6 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 120.02 1.91 . . . . 25.0 110.682 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 65.4 mt -90.52 168.58 11.72 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 104.519 -2.401 . . . . 25.0 104.519 168.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.77 121.94 20.72 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 108.07 -1.085 . . . . 25.0 108.07 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 28.9 m -93.86 162.37 2.42 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 O-C-N 125.081 1.488 . . . . 25.0 108.945 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.4 p -148.93 163.84 36.28 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.414 0.894 . . . . 25.0 113.414 -177.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.8 m -120.91 167.69 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 106.729 -1.582 . . . . 25.0 106.729 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 37.4 t -75.51 -55.07 6.03 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 106.615 -1.624 . . . . 25.0 106.615 173.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -165.6 -150.95 0.13 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 103.854 -2.647 . . . . 25.0 103.854 -176.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -69.39 -15.08 63.23 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 122.44 1.114 . . . . 25.0 111.114 -176.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -140.09 -155.24 6.51 Favored Glycine 0 C--O 1.258 1.606 0 CA-C-O 117.391 -1.783 . . . . 25.0 110.895 178.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 68.01 -150.25 0.16 Allowed 'General case' 0 C--O 1.247 0.973 0 C-N-CA 125.113 1.365 . . . . 25.0 111.061 177.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 46.6 mtt85 -93.16 168.8 10.87 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-O 122.062 0.934 . . . . 25.0 111.419 -174.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 8.4 p -109.97 165.38 11.77 Favored 'General case' 0 C--O 1.251 1.146 0 N-CA-C 104.023 -2.584 . . . . 25.0 104.023 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -133.01 156.71 46.86 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-O 123.817 1.77 . . . . 25.0 110.056 175.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 59.9 tp -128.41 127.93 43.51 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 104.212 -2.514 . . . . 25.0 104.212 170.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -125.37 152.79 44.32 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.067 -0.716 . . . . 25.0 109.067 -172.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 41.1 t -96.07 149.88 21.11 Favored 'General case' 0 C--O 1.248 0.987 0 N-CA-C 106.039 -1.837 . . . . 25.0 106.039 171.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -115.31 19.74 15.34 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 122.551 1.167 . . . . 25.0 107.957 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -115.12 149.78 37.04 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 106.635 -1.617 . . . . 25.0 106.635 176.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -149.55 153.01 36.48 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 124.062 0.851 . . . . 25.0 111.516 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -83.18 162.35 21.27 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.509 -1.293 . . . . 25.0 107.509 177.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.99 -20.49 66.52 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 118.418 0.554 . . . . 25.0 111.381 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -82.39 -1.25 49.4 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 112.736 0.643 . . . . 25.0 112.736 176.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.26 14.4 68.95 Favored Glycine 0 CA--C 1.497 -1.035 0 O-C-N 124.112 0.882 . . . . 25.0 111.728 177.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 80.9 mt -83.87 139.16 32.81 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.634 -1.617 . . . . 25.0 106.634 177.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 61.4 p -149.85 -177.1 5.71 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 116.331 -1.795 . . . . 25.0 106.349 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -133.04 133.97 43.76 Favored 'General case' 0 C--O 1.274 2.39 0 N-CA-C 115.055 1.502 . . . . 25.0 115.055 -176.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -144.09 156.4 44.34 Favored 'General case' 0 C--O 1.269 2.114 0 N-CA-C 109.316 -0.624 . . . . 25.0 109.316 169.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.9 p -144.76 144.6 21.85 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 N-CA-C 107.252 -1.388 . . . . 25.0 107.252 -178.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -112.04 138.56 48.52 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 118.992 0.814 . . . . 25.0 110.445 -177.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.6 mp -130.4 135.37 47.95 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.741 -0.837 . . . . 25.0 108.741 -175.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.448 ' HG2' ' HA ' ' A' ' 85' ' ' LEU . 17.4 pt-20 -102.3 7.83 40.53 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 117.918 -1.513 . . . . 25.0 111.622 -176.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -73.44 -6.4 70.3 Favored Glycine 0 C--O 1.216 -1.021 0 O-C-N 124.3 1.0 . . . . 25.0 113.121 178.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 49.1 t0 49.98 47.22 23.6 Favored 'General case' 0 C--O 1.262 1.743 0 CA-C-O 122.051 0.929 . . . . 25.0 111.689 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -125.17 35.49 4.76 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 107.279 -1.378 . . . . 25.0 107.279 -178.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.4 -32.21 69.96 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 121.007 0.432 . . . . 25.0 110.093 172.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.27 -11.45 60.72 Favored 'General case' 0 C--O 1.26 1.647 0 C-N-CA 119.834 -0.746 . . . . 25.0 111.675 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -110.21 -1.08 17.55 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 113.852 1.056 . . . . 25.0 113.852 174.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 20.6 mt -79.25 120.94 24.44 Favored 'General case' 0 C--O 1.248 0.997 0 O-C-N 123.831 0.707 . . . . 25.0 111.636 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 71.8 m -135.56 160.45 38.46 Favored 'General case' 0 N--CA 1.4 -2.972 0 CA-C-N 114.405 -1.27 . . . . 25.0 108.292 176.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -68.1 -7.53 30.39 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 122.47 1.129 . . . . 25.0 110.474 -177.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -61.14 -27.22 68.24 Favored 'General case' 0 C--O 1.208 -1.106 0 CA-C-N 114.426 -1.261 . . . . 25.0 109.131 177.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -103.1 -1.89 28.36 Favored 'General case' 0 C--O 1.26 1.613 0 N-CA-C 114.509 1.3 . . . . 25.0 114.509 176.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 23.1 mm -101.08 114.88 41.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 104.931 -2.248 . . . . 25.0 104.931 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 13.7 p -97.78 110.72 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 119.735 -1.853 . . . . 25.0 113.86 -168.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -151.07 -4.04 0.31 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 113.083 -1.871 . . . . 25.0 113.824 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -84.96 58.65 5.14 Favored 'General case' 0 C--N 1.346 0.443 0 N-CA-C 113.574 0.953 . . . . 25.0 113.574 -175.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 52.35 26.62 4.21 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 116.854 2.168 . . . . 25.0 116.854 178.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.11 -6.23 0.11 Allowed 'General case' 0 CA--C 1.564 1.502 0 N-CA-C 117.244 2.313 . . . . 25.0 117.244 178.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -65.75 133.72 51.63 Favored 'General case' 0 CA--C 1.551 0.991 0 O-C-N 121.442 -0.786 . . . . 25.0 111.174 -176.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.3 -18.74 61.17 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.02 0.528 . . . . 25.0 109.674 175.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -77.87 -8.44 58.08 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.83 -0.433 . . . . 25.0 109.83 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.37 168.84 18.88 Favored 'General case' 0 C--O 1.252 1.227 0 CA-C-O 121.159 0.504 . . . . 25.0 110.73 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 51.58 -155.56 0.15 Allowed 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 115.175 1.546 . . . . 25.0 115.175 177.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.95 16.37 74.7 Favored Glycine 0 C--O 1.247 0.93 0 N-CA-C 114.936 0.734 . . . . 25.0 114.936 -178.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -101.55 97.66 8.07 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 124.388 0.699 . . . . 25.0 109.834 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.25 136.96 54.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 122.273 1.035 . . . . 25.0 111.768 -176.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -140.11 28.18 2.5 Favored Glycine 0 C--N 1.336 0.583 0 N-CA-C 109.251 -1.54 . . . . 25.0 109.251 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 60.4 t -74.85 -37.76 42.6 Favored 'Isoleucine or valine' 0 C--O 1.251 1.147 0 N-CA-C 108.451 -0.944 . . . . 25.0 108.451 -177.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.63 128.02 16.44 Favored 'Isoleucine or valine' 0 C--O 1.246 0.872 0 O-C-N 124.57 1.169 . . . . 25.0 111.009 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 166.16 167.29 26.58 Favored Glycine 0 N--CA 1.43 -1.731 0 CA-C-N 114.046 -1.434 . . . . 25.0 110.836 -177.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -149.91 139.64 21.74 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.196 -1.038 . . . . 25.0 108.196 -176.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 85.0 p -154.74 158.07 38.99 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.128 -1.064 . . . . 25.0 108.128 177.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 159.58 161.08 10.93 Favored Glycine 0 C--O 1.24 0.472 0 N-CA-C 116.097 1.199 . . . . 25.0 116.097 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 -105.16 107.37 58.77 Favored Pre-proline 0 C--O 1.251 1.162 0 CA-C-O 121.022 0.439 . . . . 25.0 109.871 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -71.04 163.17 40.16 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 116.636 -1.776 . . . . 25.0 111.892 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -129.85 154.82 46.89 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 106.82 -1.548 . . . . 25.0 106.82 -178.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -140.3 69.12 33.54 Favored Pre-proline 0 C--N 1.306 -1.297 0 O-C-N 121.694 -0.629 . . . . 25.0 109.579 -178.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.19 139.45 42.24 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 116.382 -1.946 . . . . 25.0 112.921 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 15.3 t -93.52 -14.95 26.01 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.217 -0.901 . . . . 25.0 111.501 -176.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 10.7 p . . . . . 0 C--O 1.258 1.55 0 N-CA-C 107.592 -1.262 . . . . 25.0 107.592 179.373 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 CA--C 1.511 -0.643 0 CA-C-O 121.494 0.539 . . . . 25.0 112.968 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -155.2 61.64 0.36 Allowed Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 107.764 -2.134 . . . . 25.0 107.764 177.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.415 HG12 ' H ' ' A' ' 5' ' ' VAL . 1.4 p -54.76 126.49 11.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 124.158 0.983 . . . . 25.0 110.236 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -100.54 8.96 43.15 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.506 -0.77 . . . . 25.0 110.841 -178.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -90.25 -146.95 16.68 Favored Glycine 0 C--O 1.215 -1.088 0 CA-C-N 115.527 -0.76 . . . . 25.0 112.503 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.7 p 68.92 154.74 0.14 Allowed Pre-proline 0 CA--C 1.563 1.458 0 C-N-CA 126.084 1.753 . . . . 25.0 112.628 -175.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.673 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 50.1 Cg_exo -62.68 1.25 1.11 Allowed 'Trans proline' 0 N--CA 1.498 1.746 0 N-CA-C 117.254 1.982 . . . . 25.0 117.254 -177.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.8 p -63.98 -18.17 22.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 118.831 2.9 . . . . 25.0 118.831 -168.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.5 p -134.8 119.1 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 117.308 2.336 . . . . 25.0 117.308 -175.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.56 36.28 91.18 Favored Glycine 0 C--O 1.211 -1.283 0 CA-C-N 115.481 -0.781 . . . . 25.0 113.945 174.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.3 t -51.98 -38.55 57.03 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 119.219 -0.42 . . . . 25.0 111.678 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -80.73 5.61 15.26 Favored 'General case' 0 C--O 1.249 1.037 0 N-CA-C 115.266 1.58 . . . . 25.0 115.266 -173.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 pp -143.15 178.4 7.73 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-O 118.029 -0.986 . . . . 25.0 109.773 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -56.71 132.75 52.94 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 114.023 1.12 . . . . 25.0 114.023 -173.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -134.33 155.66 49.85 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 114.266 1.21 . . . . 50.0 114.266 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -122.93 113.35 18.99 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 104.128 -2.545 . . . . 25.0 104.128 164.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 88.7 mt -120.74 118.35 29.83 Favored 'General case' 0 C--O 1.207 -1.139 0 CA-C-O 121.394 0.616 . . . . 25.0 110.122 -177.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -110.06 106.99 16.69 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.593 -1.262 . . . . 25.0 107.593 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.51 -171.3 47.06 Favored Glycine 0 C--O 1.244 0.73 0 N-CA-C 118.753 2.261 . . . . 25.0 118.753 -172.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.1 p -82.49 175.72 9.98 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.761 -0.72 . . . . 25.0 111.315 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 69.2 mt -90.97 -2.86 57.65 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 123.546 0.529 . . . . 25.0 110.711 173.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -95.39 -174.27 37.17 Favored Glycine 0 C--O 1.244 0.74 0 N-CA-C 110.02 -1.232 . . . . 25.0 110.02 176.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.4 t -74.91 138.89 42.71 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.676 0.621 . . . . 25.0 112.676 -177.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -145.8 152.9 40.27 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 117.806 0.276 . . . . 50.0 111.538 -178.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -98.09 128.51 44.64 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 103.0 -2.963 . . . . 25.0 103.0 166.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 34.2 mm -124.59 108.65 20.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 107.513 -1.291 . . . . 25.0 107.513 -178.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.673 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 9.6 mp -108.85 118.0 35.65 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 104.408 -2.441 . . . . 25.0 104.408 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.43 -36.5 59.19 Favored Glycine 0 CA--C 1.497 -1.078 0 CA-C-O 119.517 -0.602 . . . . 25.0 113.353 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.87 -151.81 41.44 Favored Glycine 0 CA--C 1.497 -1.091 0 C-N-CA 119.834 -1.174 . . . . 25.0 112.303 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -78.35 169.21 54.31 Favored Glycine 0 C--O 1.247 0.948 0 N-CA-C 110.262 -1.135 . . . . 25.0 110.262 -177.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.3 164.95 23.14 Favored Glycine 0 N--CA 1.432 -1.608 0 C-N-CA 120.819 -0.705 . . . . 25.0 113.507 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.63 109.85 17.18 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.104 -1.073 . . . . 25.0 108.104 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -106.8 156.64 18.45 Favored 'General case' 0 C--N 1.316 -0.873 0 O-C-N 124.252 0.97 . . . . 50.0 112.403 -170.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -127.91 95.28 4.16 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 105.368 -2.086 . . . . 25.0 105.368 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.1 mt -102.21 138.0 39.72 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 113.739 -1.573 . . . . 25.0 112.034 -170.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -134.88 103.13 5.48 Favored 'General case' 0 C--O 1.267 1.986 0 CA-C-O 121.969 0.89 . . . . 25.0 111.502 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.74 -26.91 52.67 Favored Glycine 0 C--N 1.314 -0.68 0 CA-C-N 115.257 -0.883 . . . . 25.0 114.393 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 52.39 -145.75 0.54 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.384 1.074 . . . . 25.0 111.363 -176.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.56 169.19 13.12 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 121.503 -0.748 . . . . 25.0 112.724 -175.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.67 157.29 30.14 Favored Glycine 0 C--O 1.225 -0.417 0 CA-C-N 115.14 -0.936 . . . . 25.0 111.579 -173.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -79.36 112.49 16.64 Favored 'General case' 0 C--O 1.261 1.671 0 N-CA-C 105.812 -1.921 . . . . 25.0 105.812 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -113.68 149.16 35.1 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.023 -0.671 . . . . 50.0 109.598 -171.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mp -111.31 92.86 4.2 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.922 0.889 . . . . 25.0 109.34 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.1 mp -107.09 120.99 43.6 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.479 1.289 . . . . 25.0 114.479 -170.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -123.51 139.41 54.04 Favored 'General case' 0 C--O 1.246 0.876 0 N-CA-C 107.728 -1.212 . . . . 25.0 107.728 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -90.71 -36.59 6.78 Favored Glycine 0 C--O 1.257 1.539 0 CA-C-O 118.105 -1.386 . . . . 25.0 115.588 -173.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.91 -166.42 52.98 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 118.552 1.176 . . . . 25.0 112.388 -176.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.14 148.19 22.7 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.319 -0.94 . . . . 25.0 111.412 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.53 162.57 38.01 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-O 122.518 1.066 . . . . 25.0 114.534 -176.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -88.54 127.94 35.55 Favored 'General case' 0 CA--C 1.479 -1.776 0 N-CA-C 101.692 -3.447 . . . . 25.0 101.692 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -121.87 156.93 32.25 Favored 'General case' 0 C--O 1.255 1.357 0 C-N-CA 122.74 0.416 . . . . 50.0 111.211 -170.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -119.3 125.54 49.32 Favored 'General case' 0 C--O 1.212 -0.91 0 N-CA-C 101.821 -3.4 . . . . 25.0 101.821 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -145.41 132.77 20.64 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 115.689 1.737 . . . . 25.0 115.689 -174.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 63.9 m -102.0 140.45 36.27 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.526 -0.916 . . . . 25.0 108.526 175.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.92 -44.52 4.78 Favored Glycine 0 N--CA 1.467 0.721 0 N-CA-C 109.183 -1.567 . . . . 25.0 109.183 174.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.32 -175.09 54.89 Favored Glycine 0 N--CA 1.465 0.593 0 CA-C-N 116.988 0.394 . . . . 25.0 112.648 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -60.83 155.24 19.97 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 122.701 1.238 . . . . 25.0 110.371 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.37 159.62 32.12 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 115.18 -0.918 . . . . 25.0 111.717 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.58 107.55 13.48 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 122.206 1.003 . . . . 25.0 108.445 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -95.6 162.93 13.42 Favored 'General case' 0 C--O 1.27 2.132 0 CA-C-N 115.075 -0.966 . . . . 50.0 111.137 -172.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.8 m -128.35 132.02 48.59 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 122.536 1.16 . . . . 25.0 109.002 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -122.32 129.06 51.79 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 105.3 -2.111 . . . . 25.0 105.3 175.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.403 ' HD3' ' HB3' ' A' ' 95' ' ' ASP . 26.4 mmt85 -127.13 -15.42 5.27 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 121.277 0.561 . . . . 25.0 109.953 179.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 60.59 174.8 0.1 Allowed 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 115.216 -0.902 . . . . 25.0 112.426 -171.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -89.92 -51.87 5.26 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 115.108 1.522 . . . . 25.0 115.108 -172.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.1 mt -141.87 174.07 10.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.906 -1.043 . . . . 25.0 109.519 -173.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.12 -27.58 63.87 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 107.725 -1.213 . . . . 25.0 107.725 171.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -72.02 -9.2 58.06 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-O 122.758 1.266 . . . . 25.0 113.447 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -94.1 141.41 28.57 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.843 1.306 . . . . 25.0 111.732 -173.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.3 t 46.85 42.58 12.23 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 113.389 -1.732 . . . . 25.0 115.347 175.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -118.7 162.03 19.12 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.423 -1.262 . . . . 25.0 111.427 -178.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -104.68 146.49 28.87 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 105.403 -2.073 . . . . 25.0 105.403 175.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.7 p -138.71 167.44 19.46 Favored Pre-proline 0 C--O 1.211 -0.932 0 N-CA-C 108.165 -1.05 . . . . 25.0 108.165 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -61.03 -20.06 65.93 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 CA-C-O 122.377 0.907 . . . . 25.0 113.234 174.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 73.1 mt -79.26 -23.58 43.55 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 119.924 -1.735 . . . . 25.0 111.13 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 147.99 -175.73 27.16 Favored Glycine 0 C--O 1.212 -1.232 0 CA-C-N 115.384 -0.825 . . . . 25.0 111.916 177.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.0 t -89.15 137.99 31.82 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 123.375 1.559 . . . . 25.0 112.485 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -117.64 17.9 14.31 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-N 114.768 -1.105 . . . . 25.0 110.532 171.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.35 138.41 49.38 Favored Glycine 0 C--N 1.338 0.661 0 CA-C-N 115.184 -0.916 . . . . 25.0 111.519 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -85.22 173.53 10.33 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 117.353 0.576 . . . . 50.0 111.745 -176.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.74 103.89 7.77 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 123.217 0.607 . . . . 25.0 112.105 -179.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.8 mt -87.02 133.75 29.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 106.579 -1.638 . . . . 25.0 106.579 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.84 -38.9 22.38 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.608 0.966 . . . . 25.0 113.608 -172.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.6 p-10 -144.79 44.32 1.37 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.787 1.032 . . . . 25.0 113.787 -167.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -61.1 131.14 49.59 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.95 1.093 . . . . 25.0 113.95 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -96.39 106.32 28.45 Favored Pre-proline 0 N--CA 1.48 1.065 0 N-CA-C 106.749 -1.575 . . . . 25.0 106.749 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -77.56 -4.29 14.47 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 N-CA-C 114.17 0.796 . . . . 25.0 114.17 -171.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 45.6 t -93.28 -41.93 9.6 Favored 'General case' 0 C--N 1.315 -0.918 0 O-C-N 124.26 0.975 . . . . 25.0 111.091 177.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -98.19 -37.15 9.81 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.979 1.474 . . . . 25.0 114.979 -172.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -87.16 168.63 13.07 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.259 0.466 . . . . 50.0 112.259 -172.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -146.04 145.84 30.74 Favored 'General case' 0 C--O 1.263 1.785 0 O-C-N 121.805 -0.559 . . . . 25.0 112.288 -178.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 75.1 mt -130.74 129.1 63.79 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 N-CA-C 109.266 -0.642 . . . . 25.0 109.266 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.403 ' HB3' ' HD3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -91.69 141.24 28.9 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 119.771 -1.83 . . . . 25.0 107.393 174.928 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.7 p -134.09 -5.9 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 121.463 0.649 . . . . 25.0 111.423 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.87 -36.27 78.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.851 -0.613 . . . . 25.0 111.929 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.46 -24.69 53.9 Favored 'General case' 0 C--O 1.248 0.989 0 N-CA-C 113.91 1.078 . . . . 25.0 113.91 -178.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.88 9.4 5.37 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 115.946 1.832 . . . . 25.0 115.946 -168.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -151.08 -75.05 0.01 OUTLIER Glycine 0 C--O 1.219 -0.81 0 C-N-CA 119.868 -1.158 . . . . 25.0 115.067 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -155.39 167.74 29.4 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 109.592 -0.521 . . . . 25.0 109.592 -171.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.2 t -120.22 -39.81 2.76 Favored 'General case' 0 C--O 1.248 0.997 0 N-CA-C 108.963 -0.755 . . . . 25.0 108.963 176.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -92.04 123.15 7.11 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 109.31 -1.516 . . . . 25.0 109.31 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.16 148.81 46.99 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.254 0.55 . . . . 25.0 111.222 -177.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -83.16 -176.48 51.51 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 115.945 -0.571 . . . . 25.0 112.008 -177.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -61.94 100.2 0.15 Allowed 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 115.05 1.5 . . . . 25.0 115.05 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -141.03 -157.4 7.16 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-O 117.222 -1.876 . . . . 25.0 108.659 176.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -152.99 162.97 40.68 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 121.114 2.457 . . . . 25.0 112.566 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 51.16 44.33 28.76 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.214 1.006 . . . . 25.0 113.118 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.24 31.82 63.36 Favored Glycine 0 C--O 1.257 1.579 0 N-CA-C 111.031 -0.828 . . . . 25.0 111.031 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.6 t -139.76 174.23 10.72 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 117.719 0.759 . . . . 25.0 110.364 -177.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.7 mt -95.18 172.64 7.99 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 101.424 -3.547 . . . . 25.0 101.424 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.33 119.8 22.88 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.652 -1.24 . . . . 25.0 107.652 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.4 m -80.06 157.6 4.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.148 -0.686 . . . . 25.0 109.148 -176.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.46 160.25 40.92 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.754 -0.832 . . . . 25.0 108.754 -176.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.502 HG12 HG22 ' A' ' 123' ' ' THR . 16.3 m -123.31 163.9 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 116.33 -0.395 . . . . 25.0 110.268 177.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 35.1 t -70.84 -52.44 20.33 Favored 'General case' 0 C--O 1.204 -1.325 0 N-CA-C 107.52 -1.289 . . . . 25.0 107.52 174.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -159.61 -143.79 0.1 Allowed 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 104.997 -2.223 . . . . 25.0 104.997 -178.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -69.92 -21.14 63.32 Favored 'General case' 0 C--O 1.253 1.285 0 N-CA-C 109.564 -0.532 . . . . 25.0 109.564 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -141.54 -145.44 4.55 Favored Glycine 0 C--O 1.24 0.509 0 N-CA-C 110.532 -1.027 . . . . 25.0 110.532 178.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.55 -145.13 0.33 Allowed 'General case' 0 C--O 1.245 0.843 0 C-N-CA 124.082 0.953 . . . . 25.0 109.784 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.6 mtt85 -82.09 159.06 23.5 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 113.127 0.788 . . . . 25.0 113.127 -176.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.502 HG22 HG12 ' A' ' 116' ' ' VAL . 0.5 OUTLIER -111.3 166.28 11.23 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 104.822 -2.288 . . . . 25.0 104.822 177.404 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -135.65 151.4 50.18 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.997 -0.547 . . . . 25.0 111.378 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 34.4 tp -124.61 104.34 8.64 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 103.595 -2.743 . . . . 25.0 103.595 168.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -104.46 153.03 21.63 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.634 -0.712 . . . . 25.0 110.793 -172.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 43.5 t -99.5 150.87 21.77 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.397 -2.075 . . . . 25.0 105.397 170.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -119.81 25.02 10.24 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 106.534 -1.654 . . . . 25.0 106.534 -178.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -116.1 134.84 54.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.367 -1.288 . . . . 25.0 109.461 174.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -134.12 150.02 51.11 Favored 'General case' 0 C--O 1.216 -0.673 0 O-C-N 125.176 1.547 . . . . 25.0 110.549 -175.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -74.52 165.13 25.72 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 124.11 0.964 . . . . 25.0 109.127 174.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.97 -15.33 62.9 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.683 0.754 . . . . 25.0 111.463 178.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -79.03 -11.34 60.0 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.614 -0.721 . . . . 25.0 112.348 174.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.58 26.26 39.54 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 120.505 -0.855 . . . . 25.0 112.162 -176.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 69.5 mt -101.07 141.97 33.19 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.386 -1.338 . . . . 25.0 107.386 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 80.1 p -149.24 -175.44 4.98 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.338 -1.356 . . . . 25.0 107.338 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -123.2 139.21 54.29 Favored 'General case' 0 C--O 1.247 0.926 0 N-CA-C 113.223 0.823 . . . . 25.0 113.223 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -152.07 153.99 35.04 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.789 -1.189 . . . . 25.0 107.789 166.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 10.5 p -148.51 143.8 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 N-CA-C 104.603 -2.369 . . . . 25.0 104.603 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -105.86 148.93 27.01 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 107.186 -1.413 . . . . 25.0 107.186 -175.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.5 mp -137.98 131.03 30.17 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 104.301 -2.481 . . . . 25.0 104.301 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -104.37 4.91 33.98 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 121.198 1.817 . . . . 25.0 114.758 -174.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -77.16 1.58 63.83 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 120.283 -0.961 . . . . 25.0 114.817 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 47.7 t0 52.84 61.68 3.07 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-O 122.08 0.943 . . . . 25.0 110.728 175.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -130.98 41.92 3.3 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.707 -1.133 . . . . 25.0 111.762 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.95 -25.18 66.63 Favored 'General case' 0 C--O 1.209 -1.051 0 C-N-CA 119.345 -0.942 . . . . 25.0 110.809 176.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.12 -32.15 70.03 Favored 'General case' 0 C--O 1.275 2.418 0 C-N-CA 124.094 0.957 . . . . 25.0 112.282 177.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -93.62 -27.31 16.66 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.734 1.013 . . . . 25.0 113.734 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 11.4 mt -62.84 139.79 58.74 Favored 'General case' 0 C--O 1.247 0.923 0 CA-C-O 121.947 0.88 . . . . 25.0 109.492 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 72.5 m -141.77 159.78 41.52 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 102.012 -3.329 . . . . 25.0 102.012 169.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -86.24 10.36 14.93 Favored 'General case' 0 C--O 1.214 -0.813 0 N-CA-C 108.107 -1.072 . . . . 25.0 108.107 -176.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -72.11 -26.23 62.05 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.692 0.758 . . . . 25.0 110.386 178.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 24.3 p30 -86.06 -1.25 57.2 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 109.694 -0.484 . . . . 25.0 109.694 176.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 37.3 mm -98.39 128.88 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 102.415 -3.18 . . . . 25.0 102.415 173.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.3 p -105.82 113.77 43.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 122.936 1.35 . . . . 25.0 111.665 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -142.42 9.12 1.82 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 112.524 -2.125 . . . . 25.0 107.379 178.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.9 51.75 1.57 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.421 1.088 . . . . 25.0 111.301 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 56.43 33.7 22.92 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.384 1.073 . . . . 25.0 113.665 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 18.2 m 65.29 -43.99 0.35 Allowed 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 117.468 2.396 . . . . 25.0 117.468 176.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -76.65 154.11 34.59 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 114.27 1.211 . . . . 25.0 114.27 -173.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -80.77 20.14 0.78 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.26 -0.882 . . . . 25.0 111.752 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.85 -25.52 56.29 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.986 -0.552 . . . . 25.0 111.833 -177.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -112.0 -161.32 0.75 Allowed 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 108.839 -0.8 . . . . 25.0 108.839 -174.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 67.49 -174.2 0.19 Allowed 'General case' 0 C--O 1.25 1.13 0 N-CA-C 115.796 1.776 . . . . 25.0 115.796 175.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 81.46 17.44 71.15 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 114.195 0.438 . . . . 25.0 114.195 175.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -98.94 109.86 22.55 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 122.466 -0.432 . . . . 25.0 110.888 -174.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -127.35 157.71 39.22 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 107.425 -1.324 . . . . 25.0 107.425 178.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -140.78 30.45 2.28 Favored Glycine 0 C--O 1.209 -1.451 0 N-CA-C 110.761 -0.935 . . . . 25.0 110.761 178.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.11 -28.38 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 CA-C-O 122.157 0.98 . . . . 25.0 110.939 -175.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.12 136.38 26.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 CA-C-O 122.167 0.984 . . . . 25.0 109.823 -177.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 161.89 157.52 8.95 Favored Glycine 0 N--CA 1.466 0.654 0 CA-C-N 114.605 -1.18 . . . . 25.0 111.951 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -149.67 141.97 24.18 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 108.584 -0.895 . . . . 25.0 108.584 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 88.6 p -159.46 171.54 19.53 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.865 0.866 . . . . 25.0 110.097 177.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 171.17 174.9 39.28 Favored Glycine 0 C--O 1.25 1.102 0 CA-C-N 118.814 0.734 . . . . 25.0 111.773 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -136.75 101.9 9.54 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 108.702 -0.851 . . . . 25.0 108.702 177.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.35 152.64 49.89 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 N-CA-C 115.471 1.296 . . . . 25.0 115.471 -174.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -121.84 151.38 40.71 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 107.805 -1.183 . . . . 25.0 107.805 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -141.51 76.84 20.27 Favored Pre-proline 0 C--O 1.24 0.599 0 CA-C-N 118.366 0.53 . . . . 25.0 110.49 176.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.11 155.48 61.29 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 118.35 -0.634 . . . . 25.0 113.404 -176.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.9 t -122.68 -3.46 8.76 Favored 'General case' 0 C--O 1.245 0.827 0 O-C-N 121.49 -0.756 . . . . 25.0 111.977 -177.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--O 1.271 2.214 0 N-CA-C 107.943 -1.132 . . . . 25.0 107.943 176.918 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo . . . . . 0 C--O 1.245 0.842 0 CA-C-O 120.713 0.214 . . . . 25.0 112.3 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.83 57.43 0.03 OUTLIER Glycine 0 C--O 1.244 0.727 0 N-CA-C 109.836 -1.306 . . . . 25.0 109.836 -177.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.475 HG22 ' H ' ' A' ' 7' ' ' GLY . 7.7 p -63.87 131.82 29.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 122.08 0.943 . . . . 25.0 111.568 -172.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -96.61 -6.42 36.79 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 115.3 -0.864 . . . . 25.0 110.978 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.475 ' H ' HG22 ' A' ' 5' ' ' VAL . . . -83.58 -152.57 13.47 Favored Glycine 0 C--O 1.244 0.762 0 CA-C-N 115.758 -0.655 . . . . 25.0 112.704 177.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 p 73.38 159.69 0.16 Allowed Pre-proline 0 CA--C 1.563 1.459 0 C-N-CA 126.343 1.857 . . . . 25.0 109.474 -177.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.455 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 30.3 Cg_exo -68.52 6.89 0.8 Allowed 'Trans proline' 0 CA--C 1.553 1.427 0 N-CA-C 116.069 1.526 . . . . 25.0 116.069 -174.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.8 p -69.01 -16.74 21.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 115.926 1.824 . . . . 25.0 115.926 -169.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.85 139.04 22.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 O-C-N 121.218 -0.927 . . . . 25.0 113.199 -174.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.87 9.09 70.02 Favored Glycine 0 N--CA 1.469 0.852 0 N-CA-C 117.586 1.794 . . . . 25.0 117.586 171.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.5 t -50.72 -43.02 57.85 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 114.272 1.212 . . . . 25.0 114.272 -169.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -77.47 7.4 5.49 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 114.167 1.173 . . . . 25.0 114.167 -176.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.33 175.28 10.21 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 120.27 -1.519 . . . . 25.0 111.221 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -56.65 125.33 21.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 123.702 0.626 . . . . 25.0 111.308 -175.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -121.94 162.83 20.36 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.981 0.734 . . . . 50.0 112.981 -173.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -130.73 114.96 16.02 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 102.518 -3.142 . . . . 25.0 102.518 163.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.0 mt -128.05 128.87 45.74 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 122.077 0.942 . . . . 25.0 109.66 -177.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 66.9 m80 -117.45 121.3 40.65 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.218 -0.901 . . . . 25.0 110.35 177.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.15 175.26 46.24 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 122.644 1.136 . . . . 25.0 115.094 -174.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.2 p -82.24 172.42 13.16 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.109 -1.046 . . . . 25.0 109.81 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.6 mt -86.79 12.09 11.7 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.176 0.512 . . . . 25.0 111.938 177.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -111.69 -172.91 19.37 Favored Glycine 0 N--CA 1.471 0.975 0 CA-C-N 114.826 -1.079 . . . . 25.0 111.581 177.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.2 t -77.16 134.02 38.79 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.013 0.745 . . . . 25.0 113.013 -178.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -148.02 163.99 35.18 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.457 -0.777 . . . . 50.0 110.853 -173.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -112.32 125.3 54.03 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 101.078 -3.675 . . . . 25.0 101.078 169.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 40.6 mm -119.13 99.95 8.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 104.92 -2.252 . . . . 25.0 104.92 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.455 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 9.4 mp -107.9 120.23 41.7 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 103.646 -2.724 . . . . 25.0 103.646 -176.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.22 -27.54 36.46 Favored Glycine 0 CA--C 1.488 -1.628 0 N-CA-C 115.264 0.866 . . . . 25.0 115.264 -171.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.74 -149.86 50.2 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 109.982 -1.247 . . . . 25.0 109.982 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.4 172.41 47.91 Favored Glycine 0 C--O 1.247 0.952 0 CA-C-N 114.901 -0.65 . . . . 25.0 114.473 -175.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.42 172.57 24.53 Favored Glycine 0 N--CA 1.439 -1.101 0 CA-C-O 119.132 -0.815 . . . . 25.0 114.281 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.8 112.78 24.72 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 104.722 -2.325 . . . . 25.0 104.722 177.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -108.96 156.35 19.81 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.052 -0.522 . . . . 50.0 110.578 -169.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -119.55 90.89 3.42 Favored 'General case' 0 C--O 1.248 1.019 0 N-CA-C 107.099 -1.445 . . . . 25.0 107.099 175.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 31.9 mt -100.81 128.63 46.77 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 113.862 -1.517 . . . . 25.0 110.869 -171.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -125.43 105.2 8.89 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.137 0.494 . . . . 25.0 112.008 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.73 -26.09 47.36 Favored Glycine 0 C--O 1.246 0.853 0 CA-C-O 116.797 -2.113 . . . . 25.0 115.929 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 52.77 -150.38 0.35 Allowed 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 119.551 1.676 . . . . 25.0 111.952 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.38 165.76 9.24 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.588 0.958 . . . . 25.0 113.588 -178.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.11 157.55 33.58 Favored Glycine 0 N--CA 1.438 -1.193 0 N-CA-C 110.097 -1.201 . . . . 25.0 110.097 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -80.87 115.29 20.28 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.52 -1.659 . . . . 25.0 106.52 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -123.56 147.55 47.18 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 119.887 -0.725 . . . . 50.0 111.166 -169.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 mp -108.65 104.57 13.9 Favored 'General case' 0 C--O 1.204 -1.308 0 N-CA-C 108.121 -1.066 . . . . 25.0 108.121 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 mp -109.21 109.83 20.88 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.784 0.802 . . . . 25.0 112.848 -174.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -118.78 96.44 5.26 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-N 113.977 -1.465 . . . . 25.0 108.101 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -59.74 -22.26 56.74 Favored Glycine 0 C--O 1.216 -0.989 0 N-CA-C 118.474 2.15 . . . . 25.0 118.474 -177.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.84 -159.07 53.79 Favored Glycine 0 C--O 1.245 0.839 0 CA-C-N 118.427 1.113 . . . . 25.0 112.444 -178.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.14 159.36 14.82 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-O 122.046 0.927 . . . . 25.0 112.524 -176.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.67 -178.32 53.3 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 114.826 -1.079 . . . . 25.0 114.229 -177.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -96.91 145.39 25.93 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 101.779 -3.415 . . . . 25.0 101.779 172.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -135.36 155.14 51.08 Favored 'General case' 0 CA--C 1.5 -0.943 0 C-N-CA 120.745 -0.382 . . . . 50.0 111.682 -170.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -109.17 122.36 47.14 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 104.994 -2.224 . . . . 25.0 104.994 174.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -142.05 136.19 29.94 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 122.466 1.126 . . . . 25.0 113.244 -176.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.7 m -113.63 133.89 55.04 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 115.169 -0.923 . . . . 25.0 110.181 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.04 -44.0 4.25 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.2 -1.16 . . . . 25.0 110.2 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.86 -161.24 52.19 Favored Glycine 0 C--O 1.252 1.234 0 C-N-CA 123.13 0.395 . . . . 25.0 113.019 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -67.25 161.82 24.03 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 122.176 -0.602 . . . . 25.0 112.296 174.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.44 167.24 41.7 Favored Glycine 0 CA--C 1.533 1.215 0 N-CA-C 111.129 -0.788 . . . . 25.0 111.129 -177.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.9 107.09 18.53 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.755 0.788 . . . . 25.0 109.711 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -102.38 153.2 20.24 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.853 -0.612 . . . . 50.0 110.479 -172.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.9 m -128.54 123.41 33.4 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-N 115.172 -0.922 . . . . 25.0 110.302 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -115.34 117.9 31.74 Favored 'General case' 0 C--O 1.21 -1.003 0 N-CA-C 108.432 -0.951 . . . . 25.0 108.432 -177.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 51.2 mtt85 -114.94 -33.41 5.44 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 113.007 0.743 . . . . 25.0 113.007 177.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 71.78 151.46 0.11 Allowed 'General case' 0 CA--C 1.551 1.017 0 O-C-N 125.195 1.559 . . . . 25.0 109.723 -173.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.74 -51.03 45.78 Favored 'General case' 0 C--O 1.24 0.576 0 O-C-N 121.015 -1.053 . . . . 25.0 113.562 -167.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.7 mt -131.8 166.6 21.21 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 121.918 0.866 . . . . 25.0 109.224 -174.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.89 -21.06 56.72 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.695 0.798 . . . . 25.0 109.341 175.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -73.8 3.27 6.8 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 115.049 1.5 . . . . 25.0 115.049 176.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -114.53 149.88 35.77 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.998 0.904 . . . . 25.0 112.202 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.2 t 55.03 46.1 24.94 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 122.903 1.335 . . . . 25.0 113.697 169.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 47.6 p-80 -134.97 -178.98 5.34 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.198 -0.91 . . . . 25.0 109.225 -175.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -122.63 145.41 48.38 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 103.823 -2.658 . . . . 25.0 103.823 175.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.8 p -133.98 167.56 22.28 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 107.129 -1.434 . . . . 25.0 107.129 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.32 -22.79 67.06 Favored 'Trans proline' 0 C--N 1.367 1.538 0 C-N-CA 116.393 -1.938 . . . . 25.0 113.693 177.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.9 -27.05 67.91 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 122.051 0.929 . . . . 25.0 111.173 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 139.5 179.05 17.2 Favored Glycine 0 C--O 1.246 0.852 0 N-CA-C 109.687 -1.365 . . . . 25.0 109.687 -171.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.6 t -81.87 150.07 27.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 123.461 1.6 . . . . 25.0 113.258 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -131.42 29.93 4.51 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 113.521 -1.672 . . . . 25.0 107.503 170.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.93 140.3 32.68 Favored Glycine 0 CA--C 1.501 -0.808 0 N-CA-C 109.144 -1.582 . . . . 25.0 109.144 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -82.03 167.91 18.36 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 118.72 -0.657 . . . . 50.0 109.517 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -124.41 114.08 19.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 118.438 0.563 . . . . 25.0 109.897 -176.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mt -100.16 127.13 53.43 Favored 'Isoleucine or valine' 0 C--O 1.25 1.122 0 N-CA-C 108.207 -1.035 . . . . 25.0 108.207 -178.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.3 mt -81.05 -44.24 18.32 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 115.292 1.59 . . . . 25.0 115.292 -173.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 57.0 p30 -133.54 44.78 2.75 Favored 'General case' 0 C--O 1.252 1.188 0 N-CA-C 113.585 0.957 . . . . 25.0 113.585 -172.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -59.24 145.23 43.64 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.351 0.66 . . . . 25.0 111.962 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -121.6 103.17 41.21 Favored Pre-proline 0 N--CA 1.473 0.695 0 CA-C-N 115.763 -0.653 . . . . 25.0 109.784 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -65.08 -12.4 34.49 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 N-CA-C 117.985 2.264 . . . . 25.0 117.985 -174.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.3 t -91.69 -32.32 15.48 Favored 'General case' 0 C--O 1.209 -1.069 0 N-CA-C 109.521 -0.548 . . . . 25.0 109.521 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -89.73 -48.23 7.4 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 113.954 1.094 . . . . 25.0 113.954 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -93.08 172.26 8.42 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.281 -1.327 . . . . 50.0 113.373 -161.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -146.64 149.95 34.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 119.343 -0.361 . . . . 25.0 110.843 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 86.2 mt -129.34 126.64 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 123.265 0.626 . . . . 25.0 109.732 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -86.44 139.63 30.73 Favored 'General case' 0 CA--C 1.502 -0.903 0 O-C-N 121.579 -0.701 . . . . 25.0 109.624 178.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.0 p -141.5 -8.3 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.173 0 CA-C-O 120.844 0.354 . . . . 25.0 110.85 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.6 t -67.42 -40.14 85.53 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 122.54 1.162 . . . . 25.0 109.495 -175.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.28 -23.61 63.85 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.407 -0.815 . . . . 25.0 111.942 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.5 mt -96.62 -65.95 0.93 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.745 1.017 . . . . 25.0 113.745 -172.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -116.24 -49.12 0.46 Allowed Glycine 0 CA--C 1.502 -0.773 0 N-CA-C 118.532 2.173 . . . . 25.0 118.532 -167.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -155.27 165.85 35.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 118.396 1.098 . . . . 25.0 111.93 -173.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.69 -24.76 3.22 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.194 0.521 . . . . 25.0 111.201 178.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -95.02 126.75 8.86 Favored Glycine 0 C--O 1.245 0.792 0 N-CA-C 110.594 -1.002 . . . . 25.0 110.594 173.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.11 140.74 57.81 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.981 0.896 . . . . 25.0 111.096 -176.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.29 -158.38 34.61 Favored Glycine 0 C--N 1.335 0.479 0 N-CA-C 110.833 -0.907 . . . . 25.0 110.833 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -67.75 140.46 56.71 Favored 'General case' 0 C--O 1.254 1.307 0 CA-C-O 122.175 0.988 . . . . 25.0 113.057 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 165.58 -172.95 41.23 Favored Glycine 0 C--O 1.253 1.292 0 N-CA-C 108.955 -1.658 . . . . 25.0 108.955 175.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -149.17 168.84 22.15 Favored 'General case' 0 C--O 1.245 0.857 0 C-N-CA 122.496 0.318 . . . . 25.0 110.294 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 56.58 36.49 27.69 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.26 1.207 . . . . 25.0 114.26 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 69.92 28.34 71.97 Favored Glycine 0 CA--C 1.538 1.513 0 N-CA-C 111.393 -0.683 . . . . 25.0 111.393 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 8.6 t -138.14 -178.32 5.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 117.383 0.591 . . . . 25.0 110.343 -175.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 87.2 mt -113.85 167.51 10.57 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 103.432 -2.803 . . . . 25.0 103.432 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.66 119.7 17.26 Favored 'General case' 0 C--O 1.257 1.465 0 C-N-CA 118.091 -1.444 . . . . 25.0 112.474 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.7 m -98.31 161.74 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 124.107 0.963 . . . . 25.0 109.151 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 54.0 p -148.73 171.11 16.75 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 118.901 -0.571 . . . . 25.0 111.621 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.5 m -120.95 162.6 19.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.473 0 N-CA-C 108.289 -1.004 . . . . 25.0 108.289 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.6 t -74.45 -53.72 9.0 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 106.121 -1.807 . . . . 25.0 106.121 170.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -159.83 -160.9 0.85 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 104.26 -2.496 . . . . 25.0 104.26 -177.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -65.56 -16.3 63.56 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 122.121 0.962 . . . . 25.0 111.877 176.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -133.52 -156.6 8.07 Favored Glycine 0 N--CA 1.469 0.851 0 N-CA-C 107.428 -2.269 . . . . 25.0 107.428 175.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.67 -142.25 0.32 Allowed 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.056 0.542 . . . . 25.0 109.7 178.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -96.21 170.21 9.42 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.296 1.221 . . . . 25.0 114.296 -168.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.36 160.72 28.68 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 105.952 -1.87 . . . . 25.0 105.952 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -134.89 153.78 51.92 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 117.536 0.153 . . . . 25.0 110.663 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 31.9 tp -127.65 120.85 28.97 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 104.848 -2.279 . . . . 25.0 104.848 172.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -121.95 153.43 38.51 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 118.405 0.548 . . . . 25.0 111.914 -172.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.6 t -102.55 147.25 27.0 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 103.654 -2.721 . . . . 25.0 103.654 171.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -115.5 19.04 15.67 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.931 -0.766 . . . . 25.0 108.931 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -110.89 143.37 41.61 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 105.521 -2.029 . . . . 25.0 105.521 171.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -141.12 157.69 44.94 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.879 0.737 . . . . 25.0 111.097 -176.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -80.16 164.6 23.18 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.332 -0.988 . . . . 25.0 108.332 175.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.72 -30.18 71.19 Favored 'General case' 0 C--O 1.221 -0.44 0 O-C-N 121.515 -0.74 . . . . 25.0 110.78 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -70.58 -5.06 26.4 Favored 'General case' 0 CA--C 1.554 1.096 0 C-N-CA 123.401 0.68 . . . . 25.0 112.342 177.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.59 7.53 84.31 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 115.66 -0.7 . . . . 25.0 111.915 -178.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 88.8 mt -73.16 136.83 44.82 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 106.595 -1.632 . . . . 25.0 106.595 174.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 94.4 p -148.92 -177.43 5.8 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 107.654 -1.239 . . . . 25.0 107.654 -175.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -128.38 132.54 48.53 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 119.426 1.012 . . . . 25.0 113.381 -175.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -152.51 156.71 39.93 Favored 'General case' 0 C--O 1.256 1.421 0 N-CA-C 107.205 -1.405 . . . . 25.0 107.205 168.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.9 p -146.66 147.38 17.94 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.804 0 N-CA-C 105.919 -1.882 . . . . 25.0 105.919 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -112.31 143.01 44.12 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.747 -0.66 . . . . 25.0 109.967 -170.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.8 mp -132.17 154.28 49.7 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.932 -1.136 . . . . 25.0 107.932 -177.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.51 0.97 10.06 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 116.992 2.219 . . . . 25.0 116.992 -177.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.3 -3.65 88.58 Favored Glycine 0 C--O 1.224 -0.493 0 C-N-CA 120.04 -1.076 . . . . 25.0 112.997 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 50.5 t0 48.74 61.41 3.1 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 122.323 1.058 . . . . 25.0 111.488 -177.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -123.3 41.48 3.46 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.282 -1.326 . . . . 25.0 107.624 175.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.53 -25.95 68.48 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 115.192 -0.913 . . . . 25.0 112.949 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.56 -23.82 64.54 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.424 0.63 . . . . 25.0 111.01 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -101.8 -0.04 34.92 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.769 -0.65 . . . . 25.0 112.031 -175.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 11.4 mt -78.0 134.39 37.83 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.111 -0.635 . . . . 25.0 109.328 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.2 m -135.54 162.27 33.14 Favored 'General case' 0 CA--C 1.492 -1.252 0 CA-C-N 114.605 -1.18 . . . . 25.0 109.036 173.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.44 -1.6 57.22 Favored 'General case' 0 C--O 1.204 -1.296 0 CA-C-O 122.624 1.202 . . . . 25.0 109.473 -177.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.36 -31.69 72.99 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.178 -1.374 . . . . 25.0 109.383 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -89.21 -7.05 56.34 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.877 1.323 . . . . 25.0 112.849 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 47.0 mm -95.93 108.13 20.68 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.012 0 N-CA-C 104.944 -2.243 . . . . 25.0 104.944 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 14.5 p -94.83 121.48 45.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 122.545 1.164 . . . . 25.0 111.695 -169.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -152.98 -3.57 0.22 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 112.968 -1.924 . . . . 25.0 112.298 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -74.55 51.36 0.46 Allowed 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.73 1.011 . . . . 25.0 113.73 -177.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 54.32 22.65 3.85 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.207 0.817 . . . . 25.0 113.207 -175.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.07 3.1 0.9 Allowed 'General case' 0 C--O 1.246 0.916 0 N-CA-C 115.247 1.573 . . . . 25.0 115.247 175.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -82.09 137.39 35.03 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.394 -0.522 . . . . 25.0 110.572 178.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -76.88 -12.37 59.95 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 109.198 -0.667 . . . . 25.0 109.198 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -82.72 42.64 0.79 Allowed 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 112.292 0.479 . . . . 25.0 112.292 176.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -154.25 175.16 13.84 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.065 0.946 . . . . 25.0 109.012 -178.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 62.3 -156.98 0.34 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.831 1.252 . . . . 25.0 111.638 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 58.33 28.72 62.21 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 121.926 -0.178 . . . . 25.0 113.269 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -106.63 98.64 8.28 Favored 'General case' 0 C--O 1.249 1.056 0 C-N-CA 123.083 0.553 . . . . 25.0 109.582 -176.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.87 145.11 47.97 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 121.636 0.731 . . . . 25.0 112.712 -178.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -121.94 29.7 5.5 Favored Glycine 0 C--O 1.222 -0.595 0 CA-C-N 115.154 -0.93 . . . . 25.0 112.342 174.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 58.1 t -70.64 -38.93 75.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 O-C-N 121.757 -0.849 . . . . 25.0 112.425 -174.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.9 133.05 30.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.832 0.825 . . . . 25.0 110.581 -175.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 170.07 153.43 8.64 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-N 114.607 -1.178 . . . . 25.0 110.892 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -150.88 143.66 24.51 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 117.854 0.827 . . . . 25.0 109.878 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.6 p -150.77 169.23 22.15 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 106.193 -1.78 . . . . 25.0 106.193 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -175.39 163.99 34.17 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 115.625 1.01 . . . . 25.0 115.625 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -137.38 83.56 25.87 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 107.815 -1.18 . . . . 25.0 107.815 175.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.17 161.23 46.76 Favored 'Trans proline' 0 C--N 1.349 0.589 0 O-C-N 121.99 0.469 . . . . 25.0 112.67 -176.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -130.67 159.79 36.2 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.937 -0.764 . . . . 25.0 108.937 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -135.73 84.48 32.77 Favored Pre-proline 0 C--O 1.246 0.87 0 C-N-CA 122.74 0.416 . . . . 25.0 112.034 -177.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.23 161.14 43.71 Favored 'Trans proline' 0 C--O 1.246 0.897 0 C-N-CA 116.995 -1.537 . . . . 25.0 113.323 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.5 t -127.78 17.27 6.85 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 122.061 0.934 . . . . 25.0 110.44 176.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 C--O 1.258 1.537 0 CA-C-O 117.349 -1.31 . . . . 25.0 109.566 178.639 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 C--O 1.24 0.587 0 CA-C-O 121.85 0.688 . . . . 25.0 111.929 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.33 56.84 0.26 Allowed Glycine 0 C--O 1.244 0.76 0 CA-C-O 119.043 -0.865 . . . . 25.0 112.803 -176.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.408 HG22 ' H ' ' A' ' 7' ' ' GLY . 5.9 p -70.4 125.29 28.33 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.965 0 CA-C-O 122.08 0.943 . . . . 25.0 111.525 -176.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -100.27 4.22 44.03 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.156 -0.929 . . . . 25.0 110.732 -176.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.408 ' H ' HG22 ' A' ' 5' ' ' VAL . . . -97.96 -145.2 18.47 Favored Glycine 0 C--O 1.24 0.513 0 N-CA-C 111.211 -0.756 . . . . 25.0 111.211 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.4 p 73.86 156.67 0.16 Allowed Pre-proline 0 N--CA 1.483 1.177 0 C-N-CA 126.508 1.923 . . . . 25.0 109.024 -176.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.549 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 32.8 Cg_exo -63.63 1.0 1.56 Allowed 'Trans proline' 0 N--CA 1.478 0.603 0 N-CA-C 116.25 1.596 . . . . 25.0 116.25 -176.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.5 p -63.8 -25.09 37.38 Favored 'Isoleucine or valine' 0 C--O 1.258 1.538 0 N-CA-C 114.786 1.402 . . . . 25.0 114.786 -171.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.8 p -130.7 135.84 59.47 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 CA-C-O 122.857 1.313 . . . . 25.0 114.477 -172.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.47 14.54 79.42 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 114.582 -1.19 . . . . 25.0 115.405 171.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.5 t -45.82 -48.67 15.67 Favored 'General case' 0 C--O 1.209 -1.043 0 N-CA-C 114.349 1.241 . . . . 25.0 114.349 -171.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -78.14 0.39 25.05 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 115.694 1.739 . . . . 25.0 115.694 -175.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.77 169.73 17.18 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.118 -0.989 . . . . 25.0 111.637 -175.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -60.07 125.87 25.32 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 124.431 1.082 . . . . 25.0 110.991 -171.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -120.46 165.7 14.59 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.725 1.38 . . . . 50.0 114.725 -176.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -128.47 101.13 6.05 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 101.967 -3.346 . . . . 25.0 101.967 163.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.3 mt -109.62 120.31 42.11 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 119.239 -0.41 . . . . 25.0 111.899 -177.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -112.9 113.45 25.52 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 123.537 0.523 . . . . 25.0 110.71 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.63 -177.72 49.42 Favored Glycine 0 N--CA 1.469 0.871 0 N-CA-C 116.534 1.374 . . . . 25.0 116.534 -172.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.9 p -76.66 172.82 12.42 Favored 'General case' 0 C--O 1.252 1.236 0 C-N-CA 123.326 0.65 . . . . 25.0 110.541 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 44.6 mt -86.15 9.89 16.11 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.314 0.578 . . . . 25.0 109.918 174.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.37 -179.4 26.01 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.926 -0.579 . . . . 25.0 111.679 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.6 t -72.09 130.4 40.82 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 122.672 0.389 . . . . 25.0 110.879 175.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -142.37 157.32 44.92 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.491 -0.559 . . . . 50.0 109.491 -177.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -94.85 123.52 38.36 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 102.942 -2.985 . . . . 25.0 102.942 160.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.1 mm -114.0 100.96 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 108.374 -0.973 . . . . 25.0 108.374 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.549 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 10.4 mp -104.93 127.47 52.78 Favored 'General case' 0 C--O 1.212 -0.88 0 N-CA-C 103.766 -2.679 . . . . 25.0 103.766 -177.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.43 -32.1 14.55 Favored Glycine 0 CA--C 1.493 -1.309 0 C-N-CA 120.167 -1.016 . . . . 25.0 113.262 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.23 -143.34 39.12 Favored Glycine 0 C--O 1.242 0.608 0 N-CA-C 110.648 -0.981 . . . . 25.0 110.648 178.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.7 164.96 53.98 Favored Glycine 0 C--O 1.248 0.988 0 N-CA-C 114.443 0.537 . . . . 25.0 114.443 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.44 164.94 33.8 Favored Glycine 0 C--O 1.248 1.025 0 N-CA-C 114.743 0.657 . . . . 25.0 114.743 175.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.19 99.5 7.83 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.34 -1.356 . . . . 25.0 107.34 173.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -94.1 152.14 18.98 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 113.665 0.987 . . . . 50.0 113.665 -175.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -117.35 96.69 5.53 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.616 -1.253 . . . . 25.0 107.616 174.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 32.7 mt -104.53 137.56 42.2 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.573 -0.739 . . . . 25.0 110.329 -168.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -128.43 97.7 4.81 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.722 -0.611 . . . . 25.0 109.509 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.57 -33.47 60.85 Favored Glycine 0 C--N 1.318 -0.425 0 N-CA-C 116.352 1.301 . . . . 25.0 116.352 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 53.3 -149.6 0.4 Allowed 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.602 1.161 . . . . 25.0 113.948 -178.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.96 161.48 30.87 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-O 121.451 0.643 . . . . 25.0 110.368 -173.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.6 158.74 31.64 Favored Glycine 0 C--O 1.246 0.879 0 N-CA-C 109.549 -1.42 . . . . 25.0 109.549 -176.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -84.67 101.49 12.22 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.222 -1.029 . . . . 25.0 108.222 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -103.38 148.0 26.41 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 113.731 1.011 . . . . 50.0 113.731 -172.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mp -108.27 107.93 18.73 Favored 'General case' 0 C--O 1.217 -0.631 0 N-CA-C 107.052 -1.462 . . . . 25.0 107.052 177.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 mp -109.21 113.43 26.26 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 122.62 1.2 . . . . 25.0 112.976 -171.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -118.15 96.55 5.38 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 105.221 -2.14 . . . . 25.0 105.221 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.56 -28.57 71.56 Favored Glycine 0 C--O 1.253 1.282 0 O-C-N 121.734 -0.604 . . . . 25.0 114.373 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.1 -157.18 52.82 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 120.748 -0.739 . . . . 25.0 112.617 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.22 154.54 12.99 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 122.407 1.099 . . . . 25.0 113.504 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.97 178.59 52.52 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 114.32 -1.309 . . . . 25.0 109.964 -177.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -96.88 143.51 27.7 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 101.345 -3.576 . . . . 25.0 101.345 176.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -130.65 153.08 49.32 Favored 'General case' 0 CA--C 1.5 -0.948 0 C-N-CA 120.065 -0.654 . . . . 50.0 110.258 -171.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -110.71 126.75 54.88 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 101.445 -3.539 . . . . 25.0 101.445 174.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -149.6 129.86 13.71 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-O 123.136 1.446 . . . . 25.0 113.956 -175.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.3 m -96.55 140.33 31.34 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.335 -1.302 . . . . 25.0 109.489 177.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.1 -40.19 4.35 Favored Glycine 0 C--O 1.242 0.632 0 N-CA-C 111.608 -0.597 . . . . 25.0 111.608 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.91 -167.39 54.05 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-O 123.298 1.499 . . . . 25.0 113.771 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -63.95 162.96 12.91 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 113.646 -1.277 . . . . 25.0 108.789 175.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.05 163.0 38.56 Favored Glycine 0 C--N 1.344 1.005 0 N-CA-C 111.644 -0.583 . . . . 25.0 111.644 -177.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.89 109.46 20.24 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 122.038 0.923 . . . . 25.0 109.214 178.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -105.49 150.8 25.0 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.462 -0.79 . . . . 50.0 111.17 -169.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.4 m -121.27 128.23 52.15 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 124.195 0.935 . . . . 25.0 111.119 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -115.38 103.23 10.59 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.39 -0.823 . . . . 25.0 110.953 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 60.9 mtt85 -109.68 -28.98 8.56 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 118.516 0.598 . . . . 25.0 110.859 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 68.22 161.65 0.19 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.391 -0.966 . . . . 25.0 108.391 -175.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.91 -37.88 23.61 Favored 'General case' 0 C--O 1.246 0.875 0 O-C-N 120.939 -1.1 . . . . 25.0 113.964 -165.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.4 mt -137.5 166.34 24.11 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.925 0.869 . . . . 25.0 111.252 -176.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.13 -28.2 57.02 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.977 1.311 . . . . 25.0 108.474 169.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -75.17 -2.98 30.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.43 -0.805 . . . . 25.0 112.123 -177.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -105.96 154.16 20.98 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 115.721 1.749 . . . . 25.0 115.721 -177.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.7 t 50.58 48.39 22.67 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.542 1.682 . . . . 25.0 115.542 174.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 35.1 p-80 -133.44 175.58 9.29 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 114.356 -1.293 . . . . 25.0 108.966 -178.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -122.97 140.37 53.09 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 105.357 -2.09 . . . . 25.0 105.357 174.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 55.3 p -128.52 171.29 8.83 Favored Pre-proline 0 N--CA 1.471 0.624 0 O-C-N 125.165 1.54 . . . . 25.0 109.564 -178.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -58.16 -22.47 56.68 Favored 'Trans proline' 0 C--N 1.364 1.347 0 CA-C-N 119.616 0.899 . . . . 25.0 113.565 174.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.1 mt -82.9 -10.78 58.65 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.605 0.594 . . . . 25.0 112.605 -176.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 143.54 -171.3 25.3 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-O 117.681 -1.621 . . . . 25.0 113.376 -177.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.2 t -102.84 147.24 27.13 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.393 1.596 . . . . 25.0 113.153 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -126.08 20.57 7.56 Favored 'General case' 0 C--O 1.263 1.771 0 CA-C-N 113.719 -1.582 . . . . 25.0 109.48 174.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.86 143.48 41.83 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 111.249 -0.74 . . . . 25.0 111.249 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -92.62 167.98 11.55 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.945 -0.738 . . . . 50.0 111.006 -172.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.57 103.44 8.43 Favored 'General case' 0 C--O 1.259 1.56 0 O-C-N 121.915 -0.491 . . . . 25.0 111.882 -171.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 mt -92.07 130.43 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-O 122.085 0.945 . . . . 25.0 108.535 -174.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.3 mt -82.58 -41.67 19.26 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 116.248 1.944 . . . . 25.0 116.248 -173.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 44.5 p-10 -139.51 53.44 1.71 Allowed 'General case' 0 C--O 1.252 1.193 0 CA-C-O 122.137 0.97 . . . . 25.0 113.594 -176.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -64.66 131.57 47.29 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 114.887 -1.051 . . . . 25.0 110.218 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -111.66 104.66 56.3 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 106.919 -1.512 . . . . 25.0 106.919 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -69.23 -12.26 33.47 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 N-CA-C 116.287 1.61 . . . . 25.0 116.287 -175.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.2 p -85.02 -16.7 39.89 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.627 -0.879 . . . . 25.0 108.627 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -108.78 -48.04 3.37 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 115.028 1.492 . . . . 25.0 115.028 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -92.08 169.13 10.88 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.218 -0.901 . . . . 50.0 112.348 -160.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -146.11 146.08 30.76 Favored 'General case' 0 C--O 1.249 1.052 0 C-N-CA 123.275 0.63 . . . . 25.0 111.812 -176.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 67.2 mt -127.73 134.87 64.52 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.051 0 N-CA-C 107.524 -1.288 . . . . 25.0 107.524 -177.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.77 139.49 30.52 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 107.446 -1.316 . . . . 25.0 107.446 174.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.3 p -137.76 -12.38 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 115.714 1.746 . . . . 25.0 115.714 -178.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.7 t -72.17 -27.57 62.67 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.709 1.14 . . . . 25.0 109.816 -177.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.31 -24.82 61.38 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.626 -1.17 . . . . 25.0 112.141 174.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 16.5 mt -107.19 -45.08 4.2 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.781 1.4 . . . . 25.0 114.781 -172.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -123.03 -66.58 0.22 Allowed Glycine 0 N--CA 1.472 1.035 0 N-CA-C 117.974 1.95 . . . . 25.0 117.974 -171.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -150.63 166.85 29.06 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 109.675 -0.491 . . . . 25.0 109.675 -170.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.7 t -118.51 -31.12 5.0 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.708 -1.133 . . . . 25.0 110.841 176.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -100.98 122.32 7.56 Favored Glycine 0 N--CA 1.462 0.373 0 N-CA-C 106.967 -2.453 . . . . 25.0 106.967 175.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.25 145.4 55.81 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-O 121.383 0.611 . . . . 25.0 111.744 -177.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -81.0 -170.97 44.11 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 115.328 -0.851 . . . . 25.0 113.773 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -64.33 132.94 51.63 Favored 'General case' 0 C--O 1.253 1.278 0 CA-C-O 121.769 0.795 . . . . 25.0 111.532 -177.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -177.95 -172.36 42.32 Favored Glycine 0 CA--C 1.539 1.59 0 N-CA-C 109.045 -1.622 . . . . 25.0 109.045 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -143.43 167.14 22.89 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 118.847 1.323 . . . . 25.0 112.017 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 55.11 42.24 30.94 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.143 1.377 . . . . 25.0 112.901 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 69.36 32.98 72.24 Favored Glycine 0 C--O 1.245 0.83 0 N-CA-C 110.097 -1.201 . . . . 25.0 110.097 176.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.5 t -146.78 166.43 26.68 Favored 'General case' 0 C--O 1.214 -0.788 0 CA-C-N 118.349 1.074 . . . . 25.0 110.573 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.5 mt -88.37 166.57 14.17 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 104.421 -2.437 . . . . 25.0 104.421 176.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.49 119.27 15.4 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-N 119.245 0.929 . . . . 25.0 110.241 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 35.4 m -85.79 162.1 2.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.047 -0.979 . . . . 25.0 110.481 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.7 m -140.86 168.41 19.87 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 110.32 -0.252 . . . . 25.0 110.32 -177.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 30.4 m -128.54 161.75 36.69 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 N-CA-C 107.223 -1.399 . . . . 25.0 107.223 175.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.2 t -72.09 -47.37 51.88 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 106.518 -1.66 . . . . 25.0 106.518 173.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -167.03 -161.51 0.43 Allowed 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 102.13 -3.285 . . . . 25.0 102.13 -176.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -68.32 -17.73 64.34 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 120.259 1.391 . . . . 25.0 112.039 -177.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -129.33 -155.04 8.37 Favored Glycine 0 N--CA 1.44 -1.048 0 N-CA-C 108.497 -1.841 . . . . 25.0 108.497 176.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 56.06 -150.68 0.42 Allowed 'General case' 0 N--CA 1.473 0.708 0 O-C-N 122.82 -0.223 . . . . 25.0 111.137 -178.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 27.8 mtt85 -77.45 158.78 29.83 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 116.851 2.167 . . . . 25.0 116.851 -169.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.0 163.36 16.03 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 113.47 -1.695 . . . . 25.0 106.591 177.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -137.51 154.32 49.88 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 118.451 0.569 . . . . 25.0 111.519 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 33.8 tp -123.56 119.63 30.48 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 105.754 -1.943 . . . . 25.0 105.754 169.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -119.24 154.9 32.69 Favored 'General case' 0 C--O 1.246 0.91 0 CA-C-O 121.712 0.768 . . . . 25.0 112.811 -173.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.1 t -103.0 153.69 19.98 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 104.666 -2.346 . . . . 25.0 104.666 169.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -120.67 9.52 10.81 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 122.346 1.069 . . . . 25.0 109.054 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -93.92 136.58 34.05 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 105.423 -2.065 . . . . 25.0 105.423 171.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -139.11 147.56 42.12 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.895 0.855 . . . . 25.0 110.057 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -73.99 159.25 32.98 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.012 -1.107 . . . . 25.0 108.012 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -61.98 -23.8 66.62 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 120.867 0.365 . . . . 25.0 110.587 177.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -75.83 -2.45 30.05 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.702 0.801 . . . . 25.0 111.934 177.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.39 15.8 70.55 Favored Glycine 0 C--O 1.238 0.351 0 C-N-CA 121.365 -0.445 . . . . 25.0 112.895 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 75.4 mt -88.87 139.48 30.42 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.529 -1.286 . . . . 25.0 107.529 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 86.8 p -148.56 176.19 10.53 Favored 'General case' 0 C--O 1.249 1.05 0 N-CA-C 108.771 -0.826 . . . . 25.0 108.771 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -122.28 131.8 54.1 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 113.439 0.903 . . . . 25.0 113.439 -176.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -150.28 154.21 37.5 Favored 'General case' 0 C--O 1.266 1.924 0 N-CA-C 107.317 -1.364 . . . . 25.0 107.317 168.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.4 p -145.73 146.79 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 106.813 -1.551 . . . . 25.0 106.813 175.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -112.1 142.45 44.53 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.533 -0.914 . . . . 25.0 108.533 -171.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.2 mp -133.78 143.96 48.74 Favored 'General case' 0 C--O 1.197 -1.685 0 N-CA-C 103.617 -2.734 . . . . 25.0 103.617 -173.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -115.88 5.56 14.07 Favored 'General case' 0 C--O 1.206 -1.225 0 N-CA-C 117.885 2.55 . . . . 25.0 117.885 -175.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.94 0.59 86.78 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 116.244 1.258 . . . . 25.0 116.244 177.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 41.8 t0 55.45 53.07 10.28 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 122.832 1.301 . . . . 25.0 110.359 178.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -118.65 38.64 3.7 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 113.455 -1.702 . . . . 25.0 108.428 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.9 -39.49 78.04 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.773 -0.648 . . . . 25.0 112.084 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.78 -19.47 62.0 Favored 'General case' 0 CA--C 1.577 2.005 0 O-C-N 121.156 -0.965 . . . . 25.0 112.545 -177.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.22 -26.42 20.1 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 116.132 -0.486 . . . . 25.0 111.805 177.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 22.0 mt -60.25 132.39 53.76 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 121.203 0.525 . . . . 25.0 109.646 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.9 m -135.22 160.96 36.73 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 107.529 -1.286 . . . . 25.0 107.529 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.83 -1.29 57.1 Favored 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 108.232 -1.025 . . . . 25.0 108.232 178.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -69.2 -30.04 68.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.884 -0.598 . . . . 25.0 110.838 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -90.44 -5.93 55.5 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.268 0.556 . . . . 25.0 111.018 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 17.0 mm -89.91 123.99 42.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 105.785 -1.932 . . . . 25.0 105.785 176.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.7 p -98.45 117.1 42.88 Favored 'Isoleucine or valine' 0 C--O 1.251 1.145 0 CA-C-O 122.831 1.301 . . . . 25.0 113.318 -175.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -143.97 0.56 1.08 Allowed 'General case' 0 C--O 1.251 1.146 0 CA-C-N 112.358 -2.201 . . . . 25.0 108.547 178.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.15 45.0 0.98 Allowed 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.009 0.374 . . . . 25.0 112.009 -178.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 53.49 37.57 26.02 Favored 'General case' 0 CA--C 1.561 1.4 0 CA-C-O 121.172 0.51 . . . . 25.0 112.363 -178.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.99 -4.32 0.2 Allowed 'General case' 0 CA--C 1.56 1.363 0 N-CA-C 115.636 1.717 . . . . 25.0 115.636 177.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -89.96 125.32 35.33 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 120.713 -1.242 . . . . 25.0 113.612 -177.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -77.22 -4.18 43.45 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 113.405 0.891 . . . . 25.0 113.405 -177.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -77.04 40.5 0.26 Allowed 'General case' 0 C--O 1.217 -0.649 0 N-CA-C 114.577 1.325 . . . . 25.0 114.577 178.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -152.93 -165.43 2.18 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.128 -0.694 . . . . 25.0 109.128 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 60.97 -167.11 0.19 Allowed 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 113.6 0.963 . . . . 25.0 113.6 174.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 82.2 15.89 73.28 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.374 -0.69 . . . . 25.0 111.374 -177.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -99.66 108.61 21.02 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.95 0.722 . . . . 25.0 112.95 -176.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -128.57 155.68 44.53 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 106.71 -1.589 . . . . 25.0 106.71 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -125.95 31.19 4.17 Favored Glycine 0 C--O 1.217 -0.945 0 CA-C-O 121.746 0.636 . . . . 25.0 111.895 175.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 92.3 t -73.45 -38.11 52.21 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 O-C-N 122.286 -0.538 . . . . 25.0 110.33 -175.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.56 137.73 23.83 Favored 'Isoleucine or valine' 0 C--O 1.258 1.532 0 CA-C-O 121.459 0.647 . . . . 25.0 110.442 -175.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 153.9 165.95 14.29 Favored Glycine 0 C--O 1.245 0.836 0 CA-C-N 115.482 -0.781 . . . . 25.0 111.991 -178.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -143.85 139.53 29.32 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 112.957 0.725 . . . . 25.0 112.957 176.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 84.4 p -142.69 179.9 6.71 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.857 -1.164 . . . . 25.0 107.857 175.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 135.5 172.96 12.86 Favored Glycine 0 C--O 1.24 0.517 0 N-CA-C 115.034 0.774 . . . . 25.0 115.034 175.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -137.04 113.54 9.75 Favored Pre-proline 0 C--O 1.26 1.608 0 CA-C-N 114.929 -0.635 . . . . 25.0 110.382 178.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -68.06 153.95 73.77 Favored 'Trans proline' 0 C--N 1.356 0.964 0 O-C-N 122.509 0.741 . . . . 25.0 110.663 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -128.36 139.52 52.34 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.772 -1.196 . . . . 25.0 107.772 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -131.52 69.11 81.64 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 112.689 0.626 . . . . 25.0 112.689 -177.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -70.26 150.25 64.88 Favored 'Trans proline' 0 C--N 1.346 0.419 0 CA-C-O 122.107 0.795 . . . . 25.0 113.016 -178.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.4 t -97.71 1.33 48.42 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.357 -0.838 . . . . 25.0 111.734 -175.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 C--O 1.253 1.281 0 CA-C-O 118.089 -0.957 . . . . 25.0 110.86 -177.429 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 110.193 -0.299 . . . . 25.0 110.193 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -141.05 113.0 6.84 Favored Pre-proline 0 C--O 1.245 0.867 0 N-CA-C 112.965 0.728 . . . . 25.0 112.965 -178.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.39 157.09 45.62 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 116.537 -1.842 . . . . 25.0 114.262 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.27 58.33 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.208 0 N-CA-C 108.362 -1.895 . . . . 25.0 108.362 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.1 p -60.29 132.77 25.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 123.219 1.485 . . . . 25.0 112.064 -170.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -101.26 -11.56 19.39 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.789 -1.096 . . . . 25.0 110.065 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.75 -151.63 14.46 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 114.735 -1.12 . . . . 25.0 112.61 177.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.2 p 73.08 158.17 0.16 Allowed Pre-proline 0 N--CA 1.496 1.854 0 C-N-CA 126.242 1.817 . . . . 25.0 110.187 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.416 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 37.6 Cg_exo -65.68 -0.81 4.11 Favored 'Trans proline' 0 C--N 1.349 0.602 0 N-CA-C 116.465 1.679 . . . . 25.0 116.465 -175.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.58 -19.23 20.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 114.311 1.226 . . . . 25.0 114.311 -173.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.5 p -140.45 136.05 36.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 114.096 1.147 . . . . 25.0 114.096 -174.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.44 25.57 56.57 Favored Glycine 0 C--O 1.242 0.652 0 N-CA-C 117.343 1.697 . . . . 25.0 117.343 172.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.9 t -50.09 -54.58 19.51 Favored 'General case' 0 C--O 1.22 -0.468 0 O-C-N 121.15 -1.206 . . . . 25.0 113.459 -175.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -80.17 4.64 16.79 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 116.447 2.018 . . . . 25.0 116.447 -171.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 pp -142.04 168.4 19.83 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 112.915 0.709 . . . . 25.0 112.915 -174.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -61.67 130.45 45.91 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.695 0.798 . . . . 25.0 112.03 -175.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -125.23 168.67 13.15 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 116.442 2.016 . . . . 50.0 116.442 -175.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -129.72 96.9 4.36 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 105.654 -1.98 . . . . 25.0 105.654 164.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 81.2 mt -108.92 113.03 25.59 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 112.462 0.541 . . . . 25.0 112.462 -176.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -104.38 113.69 27.42 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 108.409 -0.96 . . . . 25.0 108.409 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.47 177.85 48.79 Favored Glycine 0 CA--C 1.51 -0.23 0 N-CA-C 117.331 1.692 . . . . 25.0 117.331 -174.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.2 p -77.06 168.82 19.43 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-O 122.0 0.905 . . . . 25.0 112.501 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 77.6 mt -85.63 24.61 1.19 Allowed 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 114.624 -1.171 . . . . 25.0 111.531 176.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -128.77 179.36 16.68 Favored Glycine 0 N--CA 1.467 0.703 0 N-CA-C 110.48 -1.048 . . . . 25.0 110.48 175.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.1 t -66.53 137.41 56.77 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 117.86 0.83 . . . . 25.0 111.736 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -146.46 165.68 28.67 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 122.027 -0.421 . . . . 50.0 110.88 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -116.16 121.21 41.45 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 102.67 -3.085 . . . . 25.0 102.67 170.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 46.6 mm -117.12 129.29 73.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 107.523 -1.288 . . . . 25.0 107.523 -176.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.416 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 7.1 mp -128.77 125.18 37.31 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 105.399 -2.075 . . . . 25.0 105.399 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.14 -35.1 24.86 Favored Glycine 0 C--O 1.255 1.453 0 N-CA-C 115.698 1.039 . . . . 25.0 115.698 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.03 -148.43 44.48 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.38 -0.914 . . . . 25.0 111.434 -178.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.96 165.23 54.8 Favored Glycine 0 C--O 1.248 1.015 0 CA-C-O 122.471 1.039 . . . . 25.0 111.705 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.31 162.69 33.3 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 114.731 -0.734 . . . . 25.0 113.488 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.9 101.0 12.48 Favored 'General case' 0 C--O 1.203 -1.343 0 N-CA-C 105.022 -2.214 . . . . 25.0 105.022 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -96.82 151.62 19.49 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 115.88 -0.6 . . . . 50.0 110.536 -170.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -110.81 103.22 11.72 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 106.552 -1.647 . . . . 25.0 106.552 171.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 43.3 mt -106.3 132.12 52.72 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 124.032 0.833 . . . . 25.0 111.064 -174.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -130.15 104.26 7.21 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 121.465 0.65 . . . . 25.0 110.959 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.98 -30.23 63.65 Favored Glycine 0 N--CA 1.466 0.635 0 N-CA-C 116.165 1.226 . . . . 25.0 116.165 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 50.3 -151.35 0.2 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 118.29 1.045 . . . . 25.0 112.857 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.06 160.51 15.02 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.413 0.894 . . . . 25.0 113.413 -175.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.83 157.02 31.73 Favored Glycine 0 C--O 1.238 0.345 0 CA-C-N 114.778 -1.101 . . . . 25.0 111.192 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -80.4 102.91 9.91 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.236 -1.024 . . . . 25.0 108.236 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -106.05 157.75 17.3 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.344 0.592 . . . . 50.0 111.249 -169.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 mp -114.96 131.9 56.75 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 106.17 -1.789 . . . . 25.0 106.17 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.5 mp -132.71 127.09 34.02 Favored 'General case' 0 C--O 1.25 1.107 0 N-CA-C 115.217 1.562 . . . . 25.0 115.217 -174.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -120.04 145.16 47.1 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 107.333 -1.358 . . . . 25.0 107.333 172.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -98.3 -39.78 3.64 Favored Glycine 0 N--CA 1.465 0.618 0 C-N-CA 120.963 -0.637 . . . . 25.0 113.715 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.97 -167.74 54.71 Favored Glycine 0 N--CA 1.465 0.632 0 N-CA-C 110.107 -1.197 . . . . 25.0 110.107 -177.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.67 143.67 29.61 Favored 'General case' 0 CA--C 1.557 1.241 0 CA-C-O 121.85 0.833 . . . . 25.0 111.959 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.35 167.43 32.68 Favored Glycine 0 C--O 1.245 0.781 0 CA-C-N 115.169 -0.923 . . . . 25.0 113.365 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.94 114.05 23.24 Favored 'General case' 0 C--O 1.208 -1.124 0 N-CA-C 104.731 -2.322 . . . . 25.0 104.731 175.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -103.48 151.76 22.46 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.915 -0.584 . . . . 50.0 109.814 -173.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -116.09 122.83 46.31 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 104.869 -2.271 . . . . 25.0 104.869 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -145.42 138.52 26.28 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 117.651 2.463 . . . . 25.0 117.651 -169.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.422 ' OG ' HD12 ' A' ' 85' ' ' LEU . 73.2 m -111.13 141.12 45.05 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-N 115.332 -0.849 . . . . 25.0 108.998 176.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.13 -37.74 6.62 Favored Glycine 0 N--CA 1.44 -1.069 0 N-CA-C 110.296 -1.122 . . . . 25.0 110.296 172.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.51 -169.78 54.86 Favored Glycine 0 CA--C 1.507 -0.423 0 C-N-CA 119.941 -1.124 . . . . 25.0 113.439 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -63.51 154.95 30.82 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.604 -0.939 . . . . 25.0 111.369 176.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.75 162.66 30.06 Favored Glycine 0 C--O 1.244 0.729 0 N-CA-C 109.914 -1.274 . . . . 25.0 109.914 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.04 110.99 19.33 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.056 -1.09 . . . . 25.0 108.056 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -103.97 154.53 19.56 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.569 -0.453 . . . . 50.0 112.113 -170.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.5 m -120.22 105.71 11.22 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.438 -0.578 . . . . 25.0 109.438 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -89.1 93.65 9.66 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 105.159 -2.163 . . . . 25.0 105.159 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -92.55 -30.28 15.75 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 112.888 0.699 . . . . 25.0 112.888 -166.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 63.56 156.41 0.06 Allowed 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 124.337 1.055 . . . . 25.0 112.838 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.88 -67.51 0.7 Allowed 'General case' 0 C--O 1.252 1.203 0 N-CA-C 115.896 1.813 . . . . 25.0 115.896 -170.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.8 mt -137.92 -177.69 4.93 Favored 'General case' 0 C--O 1.216 -0.663 0 O-C-N 121.523 -0.736 . . . . 25.0 109.239 -173.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -53.24 -30.14 36.41 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.709 -0.848 . . . . 25.0 108.709 170.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -76.66 4.2 9.96 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 115.391 1.626 . . . . 25.0 115.391 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -118.09 142.15 47.72 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 118.173 0.442 . . . . 25.0 111.639 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.2 t 49.28 53.27 12.93 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 122.469 1.128 . . . . 25.0 112.272 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 31.9 p-80 -137.1 174.05 11.03 Favored 'General case' 0 C--O 1.212 -0.905 0 CA-C-N 114.754 -1.112 . . . . 25.0 109.229 -174.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -126.01 143.26 51.17 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 105.754 -1.943 . . . . 25.0 105.754 173.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.6 p -133.25 170.8 10.43 Favored Pre-proline 0 C--N 1.318 -0.778 0 N-CA-C 108.122 -1.066 . . . . 25.0 108.122 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.42 -16.79 43.9 Favored 'Trans proline' 0 C--O 1.206 -1.121 0 C-N-CA 117.09 -1.473 . . . . 25.0 114.043 177.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 88.8 mt -77.83 -29.81 50.8 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 120.101 -0.64 . . . . 25.0 110.966 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.55 -178.35 34.8 Favored Glycine 0 C--O 1.219 -0.829 0 N-CA-C 110.607 -0.997 . . . . 25.0 110.607 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t -96.43 148.06 23.19 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-O 122.755 1.264 . . . . 25.0 111.1 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -134.74 28.05 3.6 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 113.639 -1.619 . . . . 25.0 107.844 176.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.34 137.72 29.74 Favored Glycine 0 C--N 1.34 0.799 0 N-CA-C 108.861 -1.696 . . . . 25.0 108.861 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -87.58 165.09 15.72 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 121.321 -1.105 . . . . 50.0 110.393 -172.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -119.18 100.23 7.2 Favored 'General case' 0 C--O 1.257 1.454 0 CA-C-O 121.352 0.596 . . . . 25.0 111.687 -171.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.8 mt -89.26 132.88 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-O 123.011 1.386 . . . . 25.0 107.951 -175.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.422 HD12 ' OG ' ' A' ' 56' ' ' SER . 94.7 mt -83.93 -43.09 15.61 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 114.81 1.411 . . . . 25.0 114.81 -174.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -138.64 40.21 2.2 Favored 'General case' 0 C--O 1.26 1.608 0 N-CA-C 115.28 1.585 . . . . 25.0 115.28 -172.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -56.75 128.39 36.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.525 0.678 . . . . 25.0 111.914 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -97.96 108.1 44.47 Favored Pre-proline 0 N--CA 1.469 0.492 0 N-CA-C 106.911 -1.515 . . . . 25.0 106.911 175.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -72.4 -4.55 15.47 Favored 'Trans proline' 0 CA--C 1.552 1.394 0 N-CA-C 115.63 1.358 . . . . 25.0 115.63 -174.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 29.7 t -95.0 -46.75 6.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.085 0.469 . . . . 25.0 109.859 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -92.15 -40.52 10.97 Favored 'General case' 0 C--O 1.245 0.867 0 N-CA-C 114.382 1.253 . . . . 25.0 114.382 -172.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -84.87 171.52 12.15 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.695 0.76 . . . . 75.0 110.079 -173.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.63 155.62 45.71 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.606 0.763 . . . . 25.0 111.32 174.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 77.9 mt -125.44 124.34 66.77 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 106.796 -1.557 . . . . 25.0 106.796 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -86.25 150.75 24.15 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 119.728 -0.789 . . . . 25.0 109.179 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.9 p -154.64 -1.6 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 115.418 -0.81 . . . . 25.0 111.674 -176.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.2 t -66.28 -51.28 59.0 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.635 0.605 . . . . 25.0 112.635 -174.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.9 -24.35 60.83 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.886 0.699 . . . . 25.0 112.886 -176.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.56 -29.35 9.23 Favored 'General case' 0 C--O 1.212 -0.872 0 N-CA-C 118.075 2.621 . . . . 25.0 118.075 -174.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -121.69 -65.21 0.24 Allowed Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.456 -0.878 . . . . 25.0 115.03 -172.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -162.26 163.55 28.08 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 117.21 0.505 . . . . 25.0 109.759 -175.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 77.8 p -114.7 -28.79 6.99 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.557 0.536 . . . . 25.0 110.647 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -103.29 120.35 6.72 Favored Glycine 0 C--O 1.239 0.431 0 N-CA-C 110.642 -0.983 . . . . 25.0 110.642 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -67.24 151.18 47.99 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 118.865 1.333 . . . . 25.0 111.597 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -97.55 -157.33 30.48 Favored Glycine 0 CA--C 1.507 -0.435 0 CA-C-N 115.141 -0.936 . . . . 25.0 112.965 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -54.91 136.74 46.87 Favored 'General case' 0 C--O 1.245 0.868 0 N-CA-C 113.954 1.094 . . . . 25.0 113.954 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 165.94 172.43 33.29 Favored Glycine 0 C--O 1.22 -0.746 0 N-CA-C 109.457 -1.457 . . . . 25.0 109.457 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -141.18 166.68 24.11 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.022 0.911 . . . . 25.0 109.194 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 56.2 34.21 23.53 Favored 'General case' 0 CA--C 1.551 1.009 0 O-C-N 124.305 1.003 . . . . 25.0 113.127 -176.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.07 38.68 59.49 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 111.132 -0.787 . . . . 25.0 111.132 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.1 t -139.99 -174.23 3.86 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.803 0.802 . . . . 25.0 113.152 -176.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 52.2 mt -114.9 150.71 35.21 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 101.127 -3.657 . . . . 25.0 101.127 174.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.93 132.45 47.98 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-O 121.357 0.598 . . . . 25.0 110.058 -175.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 32.9 m -97.02 164.85 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 115.435 -0.802 . . . . 25.0 111.533 -176.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.8 m -139.95 164.54 29.74 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 110.313 -0.255 . . . . 25.0 110.313 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.3 m -126.78 166.31 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 107.584 -1.265 . . . . 25.0 107.584 176.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 30.3 t -81.55 -56.63 3.9 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 106.961 -1.496 . . . . 25.0 106.961 173.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -161.98 -147.59 0.13 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 105.263 -2.125 . . . . 25.0 105.263 -177.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -66.64 -21.68 66.11 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.371 0.268 . . . . 25.0 110.409 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -138.68 -150.38 5.59 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 110.385 -1.086 . . . . 25.0 110.385 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.19 -155.59 0.35 Allowed 'General case' 0 C--O 1.259 1.594 0 C-N-CA 123.053 0.541 . . . . 25.0 111.049 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 54.0 mtt85 -85.19 160.75 19.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 122.017 0.913 . . . . 25.0 113.018 -172.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 12.3 p -107.8 163.83 12.77 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 106.187 -1.783 . . . . 25.0 106.187 173.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -135.01 158.05 45.36 Favored 'General case' 0 CA--C 1.51 -0.587 0 O-C-N 123.529 0.518 . . . . 25.0 112.325 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 45.2 tp -128.7 136.17 50.23 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 103.759 -2.682 . . . . 25.0 103.759 172.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -127.44 148.81 50.29 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 122.468 1.128 . . . . 25.0 110.955 -176.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 32.4 t -101.96 146.5 27.78 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 103.874 -2.639 . . . . 25.0 103.874 168.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -108.82 10.45 26.59 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.406 0.622 . . . . 25.0 109.667 -174.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -94.45 143.51 26.35 Favored 'General case' 0 C--O 1.259 1.57 0 CA-C-N 113.608 -1.633 . . . . 25.0 108.938 167.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -149.12 156.7 42.58 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.809 -0.811 . . . . 25.0 108.809 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -70.24 160.58 31.92 Favored 'General case' 0 C--O 1.217 -0.635 0 N-CA-C 107.823 -1.177 . . . . 25.0 107.823 173.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.91 -21.53 66.51 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.401 -0.592 . . . . 25.0 109.401 175.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -79.68 -3.56 47.87 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.04 0.755 . . . . 25.0 113.04 177.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.96 24.01 46.86 Favored Glycine 0 N--CA 1.466 0.66 0 C-N-CA 121.113 -0.565 . . . . 25.0 113.42 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 35.9 mt -94.8 111.71 23.47 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.628 -1.249 . . . . 25.0 107.628 176.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 42.9 p -122.42 174.17 7.2 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 118.645 -0.693 . . . . 25.0 109.474 -174.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -116.39 126.3 53.27 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.344 0.52 . . . . 25.0 111.247 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -145.77 153.82 41.36 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 107.207 -1.405 . . . . 25.0 107.207 171.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 11.7 p -145.89 145.66 20.0 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 N-CA-C 106.77 -1.567 . . . . 25.0 106.77 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -106.16 143.82 33.74 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.884 -0.784 . . . . 25.0 108.884 -175.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mp -134.46 134.35 41.44 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.514 -1.291 . . . . 25.0 107.514 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -110.8 8.88 22.55 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 119.706 1.139 . . . . 25.0 112.668 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -78.91 -10.68 85.96 Favored Glycine 0 C--O 1.243 0.695 0 C-N-CA 119.596 -1.287 . . . . 25.0 112.57 174.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 48.4 t0 49.45 64.43 1.75 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 122.946 1.355 . . . . 25.0 112.051 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -130.52 36.54 3.93 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 106.274 -1.751 . . . . 25.0 106.274 176.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.55 -33.58 71.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.718 -1.128 . . . . 25.0 108.162 174.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.92 -11.73 49.39 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 113.302 0.852 . . . . 25.0 113.302 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -119.85 1.71 11.01 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 121.671 -0.643 . . . . 25.0 112.069 -178.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 14.9 mt -72.19 148.45 45.58 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.303 -0.559 . . . . 25.0 111.433 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 83.7 p -147.45 159.37 43.79 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 106.635 -1.617 . . . . 25.0 106.635 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.59 -1.9 52.16 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 108.698 -0.852 . . . . 25.0 108.698 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -68.84 -35.68 77.25 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.536 -0.913 . . . . 25.0 108.536 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -89.15 0.08 57.02 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.786 -0.571 . . . . 25.0 110.374 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 46.3 mm -94.85 113.74 29.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 104.251 -2.499 . . . . 25.0 104.251 174.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.7 p -98.78 101.91 12.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 124.081 1.896 . . . . 25.0 111.905 -170.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -116.78 -14.17 10.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 112.983 -1.917 . . . . 25.0 109.962 173.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -81.91 28.48 0.42 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.02 1.118 . . . . 25.0 114.02 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 55.66 33.32 21.04 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.232 0.827 . . . . 25.0 113.232 177.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.78 25.07 11.47 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.179 0.991 . . . . 25.0 112.698 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -90.01 133.76 34.63 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.594 -1.262 . . . . 25.0 107.594 174.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -112.82 23.04 13.86 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.203 0.601 . . . . 25.0 111.623 -176.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.79 -32.81 71.49 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 122.098 -0.376 . . . . 25.0 111.314 176.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -104.5 -156.13 0.56 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 123.29 0.636 . . . . 25.0 110.562 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 67.09 175.08 0.25 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.046 1.338 . . . . 25.0 113.824 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 87.04 9.1 74.39 Favored Glycine 0 C--O 1.224 -0.49 0 CA-C-N 115.757 -0.656 . . . . 25.0 112.478 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -82.84 100.06 10.1 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-O 121.197 0.522 . . . . 25.0 110.722 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -126.33 149.07 49.41 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.43 0.633 . . . . 25.0 109.849 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.91 33.89 2.4 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 110.746 -0.941 . . . . 25.0 110.746 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 45.1 t -73.6 -29.55 27.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.751 -0.724 . . . . 25.0 109.418 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 19.2 tt -57.18 134.67 21.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 N-CA-C 112.84 0.681 . . . . 25.0 112.84 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 158.02 157.59 8.53 Favored Glycine 0 C--O 1.222 -0.596 0 N-CA-C 114.681 0.632 . . . . 25.0 114.681 175.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -146.08 136.35 23.82 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 123.456 0.151 . . . . 25.0 110.639 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 53.6 p -152.73 163.96 38.68 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 106.97 -1.493 . . . . 25.0 106.97 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -167.44 162.46 36.25 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 114.738 0.655 . . . . 25.0 114.738 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -133.45 80.18 58.28 Favored Pre-proline 0 N--CA 1.468 0.432 0 N-CA-C 108.832 -0.803 . . . . 25.0 108.832 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -72.82 152.79 52.94 Favored 'Trans proline' 0 C--N 1.352 0.763 0 N-CA-C 114.889 1.073 . . . . 25.0 114.889 -171.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -111.01 157.13 20.29 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.42 -0.955 . . . . 25.0 108.42 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -132.12 75.01 75.71 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 112.722 0.638 . . . . 25.0 112.722 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.49 158.72 47.5 Favored 'Trans proline' 0 C--O 1.219 -0.46 0 CA-C-O 121.11 0.379 . . . . 25.0 112.845 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.7 t -132.32 -0.5 3.65 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.611 0.72 . . . . 25.0 111.837 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 C--O 1.247 0.922 0 N-CA-C 108.808 -0.812 . . . . 25.0 108.808 178.288 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.695 0.76 . . . . 25.0 110.481 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -127.46 91.82 44.94 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 108.643 -0.873 . . . . 25.0 108.643 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -70.51 153.98 65.09 Favored 'Trans proline' 0 C--O 1.241 0.628 0 N-CA-C 115.002 1.116 . . . . 25.0 115.002 -175.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.53 75.2 0.06 OUTLIER Glycine 0 C--O 1.22 -0.779 0 N-CA-C 108.797 -1.721 . . . . 25.0 108.797 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.456 HG22 ' H ' ' A' ' 7' ' ' GLY . 14.3 p -57.48 131.71 21.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-O 122.312 1.053 . . . . 25.0 111.59 -172.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -88.99 -15.04 35.15 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 114.616 -1.174 . . . . 25.0 110.987 -176.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.456 ' H ' HG22 ' A' ' 5' ' ' VAL . . . -88.08 -141.03 7.23 Favored Glycine 0 CA--C 1.506 -0.499 0 C-N-CA 121.263 -0.494 . . . . 25.0 114.17 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.0 p 71.85 157.31 0.16 Allowed Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 126.854 2.061 . . . . 25.0 111.179 -176.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.487 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 37.6 Cg_exo -65.49 1.39 2.15 Favored 'Trans proline' 0 C--N 1.362 1.249 0 N-CA-C 117.358 2.022 . . . . 25.0 117.358 -178.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.9 p -62.86 -19.0 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 115.486 1.661 . . . . 25.0 115.486 -172.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.6 p -146.61 136.12 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 113.917 1.08 . . . . 25.0 113.917 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.08 29.68 14.53 Favored Glycine 0 N--CA 1.462 0.422 0 N-CA-C 116.856 1.502 . . . . 25.0 116.856 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.9 t -57.25 -65.29 0.65 Allowed 'General case' 0 C--O 1.239 0.538 0 N-CA-C 114.132 1.16 . . . . 25.0 114.132 -177.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -80.35 10.2 4.88 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 114.347 1.24 . . . . 25.0 114.347 -170.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.91 174.56 10.39 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 118.912 -0.566 . . . . 25.0 110.461 -172.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -60.52 150.27 31.96 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 118.861 0.755 . . . . 25.0 111.72 -177.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -128.12 156.22 43.18 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.588 1.329 . . . . 50.0 114.588 -175.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -137.15 94.27 2.93 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 102.851 -3.018 . . . . 25.0 102.851 163.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.0 mt -120.25 111.72 18.16 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 114.483 1.29 . . . . 25.0 114.483 -173.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -98.19 104.94 17.01 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 115.744 -0.662 . . . . 25.0 111.484 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.95 179.55 52.68 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 117.584 1.794 . . . . 25.0 117.584 -173.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.0 p -74.63 169.54 17.59 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 112.246 0.461 . . . . 25.0 112.246 -177.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 51.2 mt -89.05 14.12 11.4 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.912 0.863 . . . . 25.0 110.332 175.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.67 178.77 17.79 Favored Glycine 0 C--O 1.223 -0.56 0 N-CA-C 108.638 -1.785 . . . . 25.0 108.638 175.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.7 t -70.29 140.91 52.41 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 117.356 0.578 . . . . 25.0 111.351 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -146.15 164.35 32.5 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.784 -0.821 . . . . 50.0 108.784 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -106.35 121.76 44.88 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 102.777 -3.045 . . . . 25.0 102.777 162.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.0 mm -109.18 111.31 35.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 107.487 -1.301 . . . . 25.0 107.487 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.487 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 4.4 mp -112.34 117.51 32.67 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.609 -1.256 . . . . 25.0 107.609 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.4 -27.69 38.78 Favored Glycine 0 C--O 1.206 -1.608 0 CA-C-O 119.133 -0.815 . . . . 25.0 114.425 -176.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.6 -147.08 44.76 Favored Glycine 0 C--O 1.243 0.658 0 C-N-CA 120.152 -1.023 . . . . 25.0 111.636 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.85 177.13 53.4 Favored Glycine 0 C--O 1.242 0.623 0 N-CA-C 112.054 -0.418 . . . . 25.0 112.054 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.04 166.87 29.31 Favored Glycine 0 C--N 1.316 -0.564 0 CA-C-N 115.854 -0.173 . . . . 25.0 112.906 176.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.01 105.19 13.8 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 106.875 -1.528 . . . . 25.0 106.875 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -104.81 138.84 40.47 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.772 -0.771 . . . . 50.0 111.596 -168.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -106.33 96.11 6.24 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.094 -1.817 . . . . 25.0 106.094 173.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 45.5 mt -105.65 143.51 33.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.247 -0.433 . . . . 25.0 110.454 -172.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -136.77 107.46 6.57 Favored 'General case' 0 C--O 1.248 0.983 0 CA-C-O 121.319 0.581 . . . . 25.0 110.698 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.05 -23.47 71.6 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 117.94 -1.478 . . . . 25.0 116.649 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 52.71 -159.13 0.13 Allowed 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 119.217 1.508 . . . . 25.0 111.814 -176.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.73 167.63 10.9 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 121.475 -0.765 . . . . 25.0 112.728 -175.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.75 155.77 32.24 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.963 -0.855 . . . . 25.0 110.963 -177.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -83.65 97.06 8.88 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.687 -0.856 . . . . 25.0 108.687 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -98.02 161.37 13.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.273 -0.421 . . . . 50.0 111.867 -169.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mp -119.55 131.93 55.64 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 105.549 -2.019 . . . . 25.0 105.549 175.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.4 mp -130.8 125.3 33.36 Favored 'General case' 0 C--O 1.248 0.996 0 N-CA-C 115.021 1.489 . . . . 25.0 115.021 -171.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -125.86 93.2 3.77 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.005 -1.452 . . . . 25.0 109.503 177.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.33 -27.02 70.05 Favored Glycine 0 C--N 1.342 0.874 0 C-N-CA 120.898 -0.668 . . . . 25.0 114.121 -177.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.99 -172.71 46.28 Favored Glycine 0 CA--C 1.522 0.514 0 CA-C-N 118.022 0.911 . . . . 25.0 113.106 177.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.94 148.72 16.61 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.94 0.876 . . . . 25.0 113.124 -175.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.59 159.04 35.23 Favored Glycine 0 C--O 1.219 -0.814 0 N-CA-C 110.274 -1.13 . . . . 25.0 110.274 -177.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -82.01 121.94 27.17 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 107.451 -1.314 . . . . 25.0 107.451 -177.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -112.02 161.42 16.49 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 119.537 -0.268 . . . . 50.0 111.686 -172.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.72 101.1 5.75 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 105.128 -2.175 . . . . 25.0 105.128 175.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -122.7 138.12 54.71 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 114.755 1.391 . . . . 25.0 114.755 -170.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 61.0 m -103.66 145.33 30.21 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.911 -1.144 . . . . 25.0 107.911 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.78 -33.18 6.5 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.781 -0.927 . . . . 25.0 110.781 173.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.59 -173.86 52.93 Favored Glycine 0 C--O 1.239 0.414 0 O-C-N 121.54 -0.976 . . . . 25.0 112.058 -177.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -58.1 149.49 23.5 Favored 'General case' 0 C--O 1.251 1.157 0 N-CA-C 112.108 0.41 . . . . 25.0 112.108 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.26 160.56 29.26 Favored Glycine 0 C--O 1.245 0.803 0 CA-C-O 119.588 -0.562 . . . . 25.0 111.752 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.04 106.56 12.15 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.966 0.412 . . . . 25.0 110.308 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -101.05 155.29 18.07 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.603 0.716 . . . . 50.0 110.524 -171.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.4 m -121.11 125.45 47.27 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.243 -0.889 . . . . 25.0 108.701 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -112.1 130.63 55.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.802 -1.555 . . . . 25.0 106.802 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 -122.28 -27.54 4.47 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 120.051 -0.66 . . . . 25.0 112.601 -177.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 63.92 161.77 0.11 Allowed 'General case' 0 N--CA 1.476 0.856 0 O-C-N 124.725 1.265 . . . . 25.0 112.241 -173.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.22 -50.66 10.6 Favored 'General case' 0 C--O 1.247 0.972 0 N-CA-C 114.595 1.332 . . . . 25.0 114.595 -171.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.7 mt -152.31 179.56 8.43 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.08 -0.711 . . . . 25.0 109.08 -172.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -54.26 -29.21 46.18 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.749 0.785 . . . . 25.0 110.451 167.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -69.55 -1.93 10.04 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 114.715 -1.129 . . . . 25.0 113.584 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.81 147.18 37.48 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-O 121.259 0.552 . . . . 25.0 112.385 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.1 t 43.95 60.36 2.76 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 114.471 -1.24 . . . . 25.0 113.934 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 53.5 p-80 -135.12 169.07 18.01 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 115.74 -0.664 . . . . 25.0 110.18 -175.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -116.95 142.62 46.72 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 104.034 -2.58 . . . . 25.0 104.034 171.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 94.7 p -128.0 168.92 13.8 Favored Pre-proline 0 N--CA 1.471 0.602 0 N-CA-C 105.643 -1.984 . . . . 25.0 105.643 -177.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.88 -22.34 62.11 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 117.223 -1.384 . . . . 25.0 113.272 176.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.6 mt -76.71 -18.06 58.73 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.02 0.748 . . . . 25.0 113.02 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 134.99 -176.92 19.7 Favored Glycine 0 C--N 1.31 -0.905 0 N-CA-C 110.853 -0.899 . . . . 25.0 110.853 -177.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.0 t -82.31 147.47 28.86 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 115.601 1.704 . . . . 25.0 115.601 -177.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -135.66 29.89 3.19 Favored 'General case' 0 C--O 1.249 1.031 0 CA-C-N 113.619 -1.628 . . . . 25.0 107.866 173.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.57 147.23 50.64 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 114.27 -1.332 . . . . 25.0 111.957 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -86.69 165.46 16.08 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 107.518 -1.289 . . . . 50.0 107.518 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -121.42 120.12 34.06 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 110.209 -0.293 . . . . 25.0 110.209 -176.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.5 mt -99.1 128.99 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 107.76 -1.2 . . . . 25.0 107.76 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.6 mt -85.2 -46.96 10.57 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 114.929 1.455 . . . . 25.0 114.929 -169.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 42.2 p-10 -131.56 35.59 3.82 Favored 'General case' 0 C--O 1.247 0.948 0 O-C-N 121.27 -0.894 . . . . 25.0 112.751 -175.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -51.37 140.14 17.97 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.821 -1.082 . . . . 25.0 112.323 -176.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -106.84 108.04 61.32 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 108.146 -1.057 . . . . 25.0 108.146 175.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -73.73 -2.3 12.01 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 N-CA-C 115.098 1.153 . . . . 25.0 115.098 -173.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.6 t -101.82 -36.34 8.71 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-O 121.851 0.834 . . . . 25.0 110.093 178.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -98.47 -39.33 8.81 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 113.734 1.013 . . . . 25.0 113.734 -171.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -84.66 169.98 13.78 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.783 -0.573 . . . . 75.0 110.818 -172.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.55 147.81 30.5 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 120.934 -0.307 . . . . 25.0 111.341 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.0 mt -129.33 130.05 67.47 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 N-CA-C 108.284 -1.006 . . . . 25.0 108.284 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.63 139.89 30.1 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 108.507 -0.923 . . . . 25.0 108.507 173.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.7 p -133.69 -5.48 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.237 -0.892 . . . . 25.0 111.446 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.1 t -74.22 -33.08 63.25 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.422 -0.799 . . . . 25.0 111.958 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.97 -43.15 93.59 Favored 'General case' 0 C--O 1.247 0.934 0 O-C-N 121.748 -0.595 . . . . 25.0 111.656 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.16 -13.07 15.83 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 114.853 1.427 . . . . 25.0 114.853 -172.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.68 -80.55 0.25 Allowed Glycine 0 C--O 1.22 -0.753 0 N-CA-C 116.513 1.365 . . . . 25.0 116.513 -172.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -158.14 157.52 32.91 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 117.436 0.618 . . . . 25.0 112.02 -170.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.7 t -108.37 -28.01 9.64 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 123.839 0.712 . . . . 25.0 111.23 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -92.27 106.15 3.37 Favored Glycine 0 CA--C 1.5 -0.906 0 O-C-N 121.369 -0.832 . . . . 25.0 112.288 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.75 143.39 57.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.856 0.828 . . . . 25.0 110.541 -176.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.61 -154.32 30.6 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 116.012 -0.54 . . . . 25.0 114.126 -175.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -59.24 138.19 57.69 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 113.39 0.885 . . . . 25.0 113.39 -176.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 172.73 -168.55 41.62 Favored Glycine 0 C--O 1.252 1.251 0 N-CA-C 110.079 -1.208 . . . . 25.0 110.079 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -155.98 165.49 36.29 Favored 'General case' 0 C--O 1.247 0.957 0 N-CA-C 108.018 -1.105 . . . . 25.0 108.018 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 54.44 36.65 26.06 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 114.984 1.476 . . . . 25.0 114.984 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.32 40.81 32.55 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 109.72 -1.352 . . . . 25.0 109.72 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.7 t -153.74 178.47 9.84 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 117.885 0.843 . . . . 25.0 110.848 -176.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 71.5 mt -95.89 159.78 14.8 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 104.232 -2.507 . . . . 25.0 104.232 168.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.34 130.9 44.78 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 119.711 -0.796 . . . . 25.0 109.186 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.8 m -98.72 155.72 3.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 CA-C-N 115.607 -0.724 . . . . 25.0 109.505 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 97.5 p -144.03 167.01 23.38 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.405 -0.591 . . . . 25.0 109.405 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.447 HG12 HG22 ' A' ' 123' ' ' THR . 33.3 m -120.52 161.98 19.64 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 N-CA-C 108.807 -0.812 . . . . 25.0 108.807 178.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.6 t -66.04 -51.77 55.18 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.952 -1.129 . . . . 25.0 107.952 174.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -172.04 -156.28 0.1 Allowed 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 103.261 -2.866 . . . . 25.0 103.261 -178.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -73.48 5.28 3.89 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 113.761 1.022 . . . . 25.0 113.761 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -148.86 -156.88 7.33 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 106.397 -2.681 . . . . 25.0 106.397 175.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 56.64 -164.06 0.16 Allowed 'General case' 0 CA--C 1.562 1.422 0 O-C-N 124.287 0.639 . . . . 25.0 112.527 176.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.6 mtt85 -75.09 159.22 31.94 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.788 1.033 . . . . 25.0 113.788 -170.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.447 HG22 HG12 ' A' ' 116' ' ' VAL . 0.7 OUTLIER -101.76 159.69 15.11 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 104.499 -2.408 . . . . 25.0 104.499 174.368 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -130.95 152.05 50.69 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-O 122.564 1.173 . . . . 25.0 110.681 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 39.0 tp -126.78 117.48 22.74 Favored 'General case' 0 C--O 1.245 0.853 0 N-CA-C 103.69 -2.707 . . . . 25.0 103.69 172.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -119.74 152.25 37.49 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 111.952 0.353 . . . . 25.0 111.952 -174.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.9 t -94.45 152.65 18.42 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 104.726 -2.324 . . . . 25.0 104.726 168.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -117.32 17.55 14.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.978 0.894 . . . . 25.0 109.032 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -112.56 146.81 37.89 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 105.607 -1.997 . . . . 25.0 105.607 174.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -139.45 151.87 46.57 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.236 0.541 . . . . 25.0 110.036 -175.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -72.28 160.23 32.74 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 106.305 -1.739 . . . . 25.0 106.305 175.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.36 -18.92 65.11 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.151 0.501 . . . . 25.0 110.106 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -69.36 -8.78 49.51 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.205 0.817 . . . . 25.0 113.205 173.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.17 20.45 57.25 Favored Glycine 0 C--O 1.22 -0.726 0 C-N-CA 120.169 -1.015 . . . . 25.0 110.765 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.2 mt -106.37 119.61 39.71 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.881 -0.785 . . . . 25.0 108.881 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.8 p -116.68 174.97 5.79 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 106.132 -1.803 . . . . 25.0 106.132 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -114.95 131.68 56.82 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 118.681 0.673 . . . . 25.0 110.436 -177.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -145.98 156.86 43.79 Favored 'General case' 0 C--O 1.256 1.413 0 N-CA-C 109.323 -0.621 . . . . 25.0 109.323 166.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.8 p -146.24 141.1 21.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 106.045 -1.835 . . . . 25.0 106.045 177.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -99.13 147.78 24.74 Favored 'General case' 0 C--O 1.249 1.047 0 N-CA-C 107.699 -1.223 . . . . 25.0 107.699 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.6 mp -134.42 133.38 40.45 Favored 'General case' 0 C--O 1.206 -1.186 0 N-CA-C 103.341 -2.837 . . . . 25.0 103.341 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -110.01 13.41 23.35 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 120.051 -0.66 . . . . 25.0 110.966 -177.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -79.11 -5.9 88.95 Favored Glycine 0 C--O 1.217 -0.931 0 CA-C-N 114.809 -1.087 . . . . 25.0 112.04 172.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 14.2 t0 51.5 55.11 9.9 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 114.594 1.331 . . . . 25.0 114.594 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -128.81 46.22 2.65 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.988 -0.551 . . . . 25.0 109.536 -174.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.62 -31.91 66.71 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 113.625 0.972 . . . . 25.0 113.625 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.86 -28.74 65.91 Favored 'General case' 0 CA--C 1.554 1.106 0 O-C-N 121.482 -0.761 . . . . 25.0 111.943 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -93.64 -18.28 22.34 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 112.322 0.49 . . . . 25.0 112.322 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.5 mt -66.48 123.66 20.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 122.195 0.998 . . . . 25.0 111.486 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.401 ' C ' ' H ' ' A' ' 152' ' ' ASP . 70.9 m -137.51 164.06 29.64 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 105.522 -2.029 . . . . 25.0 105.522 177.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -71.51 10.63 0.6 Allowed 'General case' 0 C--O 1.219 -0.511 0 CA-C-O 121.225 0.536 . . . . 25.0 110.866 175.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.401 ' H ' ' C ' ' A' ' 150' ' ' SER . 46.8 t0 -72.61 -30.04 64.0 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 122.631 1.205 . . . . 25.0 110.129 177.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -94.12 8.76 40.43 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.889 -1.051 . . . . 25.0 111.65 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 39.6 mm -116.49 144.67 23.64 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 105.675 -1.972 . . . . 25.0 105.675 175.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.3 p -123.66 127.34 73.92 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 CA-C-O 122.172 0.986 . . . . 25.0 110.827 174.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.85 -30.59 5.36 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 114.379 -1.282 . . . . 25.0 109.873 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -85.42 84.25 7.69 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 115.637 1.717 . . . . 25.0 115.637 -172.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 54.75 25.24 6.33 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.759 1.763 . . . . 25.0 115.759 172.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.41 17.19 4.62 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.872 1.269 . . . . 25.0 113.514 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -98.42 125.49 43.6 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-O 121.234 0.54 . . . . 25.0 110.404 -176.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -67.24 3.09 1.31 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.469 0.914 . . . . 25.0 113.469 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.73 -15.23 63.53 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.33 0.652 . . . . 25.0 111.23 176.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.79 171.06 11.21 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 113.212 0.819 . . . . 25.0 113.212 -177.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 62.93 -170.92 0.17 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.328 1.451 . . . . 25.0 113.981 177.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 77.09 20.23 75.98 Favored Glycine 0 C--O 1.247 0.953 0 CA-C-N 115.304 -0.862 . . . . 25.0 111.15 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -124.9 109.0 12.48 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.806 -0.813 . . . . 25.0 108.806 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -127.54 150.71 49.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.313 -0.995 . . . . 25.0 108.313 -177.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -123.34 40.94 1.87 Allowed Glycine 0 CA--C 1.519 0.337 0 N-CA-C 108.961 -1.656 . . . . 25.0 108.961 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 59.5 t -94.63 -31.95 4.48 Favored 'Isoleucine or valine' 0 C--O 1.251 1.171 0 C-N-CA 122.628 0.371 . . . . 25.0 110.676 -175.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.43 130.05 16.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 CA-C-O 122.705 1.24 . . . . 25.0 113.125 -174.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 151.72 155.64 7.09 Favored Glycine 0 CA--C 1.532 1.145 0 N-CA-C 108.561 -1.815 . . . . 25.0 108.561 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -153.34 147.38 25.53 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 117.849 0.825 . . . . 25.0 110.535 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 98.2 p -149.64 164.98 33.68 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.964 -1.124 . . . . 25.0 107.964 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -175.6 -170.12 38.09 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.995 -0.621 . . . . 25.0 112.369 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -152.59 99.56 2.8 Favored Pre-proline 0 C--N 1.314 -0.963 0 N-CA-C 107.819 -1.178 . . . . 25.0 107.819 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -71.02 153.58 63.07 Favored 'Trans proline' 0 C--O 1.247 0.936 0 C-N-CA 117.05 -1.5 . . . . 25.0 113.396 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -118.79 154.0 33.56 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 106.861 -1.533 . . . . 25.0 106.861 177.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -141.98 77.44 18.44 Favored Pre-proline 0 N--CA 1.47 0.529 0 CA-C-O 121.065 0.459 . . . . 25.0 111.813 -178.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -69.76 145.97 58.77 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 117.462 -1.226 . . . . 25.0 111.666 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 13.4 t -132.36 8.89 4.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.881 0.848 . . . . 25.0 109.526 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 C--N 1.324 -0.512 0 CA-C-N 115.035 -0.984 . . . . 25.0 109.708 177.656 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.727 0.298 . . . . 25.0 110.357 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -116.66 91.57 34.97 Favored Pre-proline 0 N--CA 1.479 1.002 0 N-CA-C 108.446 -0.946 . . . . 25.0 108.446 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -71.86 150.46 55.51 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 117.088 -1.475 . . . . 25.0 114.197 -175.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.15 62.7 0.05 OUTLIER Glycine 0 C--O 1.241 0.578 0 N-CA-C 108.47 -1.852 . . . . 25.0 108.47 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.674 HG22 ' H ' ' A' ' 7' ' ' GLY . 12.2 p -48.5 131.47 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 113.512 0.93 . . . . 25.0 113.512 -172.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -100.68 12.34 37.65 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 114.95 -1.023 . . . . 25.0 110.619 -175.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.674 ' H ' HG22 ' A' ' 5' ' ' VAL . . . -116.9 -151.39 9.45 Favored Glycine 0 N--CA 1.439 -1.117 0 CA-C-N 115.797 -0.638 . . . . 25.0 112.832 -178.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 p 71.53 157.81 0.16 Allowed Pre-proline 0 CA--C 1.555 1.166 0 C-N-CA 126.292 1.837 . . . . 25.0 110.807 -177.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -67.71 6.99 0.62 Allowed 'Trans proline' 0 C--N 1.356 0.932 0 N-CA-C 117.279 1.992 . . . . 25.0 117.279 -176.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.1 p -67.99 -14.43 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 N-CA-C 114.779 1.4 . . . . 25.0 114.779 -173.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.1 p -150.24 144.41 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.269 0 N-CA-C 115.116 1.525 . . . . 25.0 115.116 -175.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.32 17.39 79.69 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 117.726 1.85 . . . . 25.0 117.726 169.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.2 t -50.45 -53.38 30.09 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 114.037 1.125 . . . . 25.0 114.037 -171.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -83.07 8.16 13.74 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 116.541 2.052 . . . . 25.0 116.541 -173.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -141.27 171.9 13.43 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 120.754 -1.216 . . . . 25.0 113.541 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -58.76 127.37 31.87 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.719 0.771 . . . . 25.0 112.478 -174.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -123.75 166.68 15.15 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 113.351 0.871 . . . . 50.0 113.351 -175.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -131.29 95.53 3.8 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 103.349 -2.834 . . . . 25.0 103.349 163.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 64.1 mt -102.99 128.7 49.72 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.15 0.5 . . . . 25.0 110.375 -177.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -124.67 116.04 21.74 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.818 0.818 . . . . 25.0 109.911 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.49 -177.69 49.55 Favored Glycine 0 N--CA 1.462 0.397 0 N-CA-C 116.867 1.507 . . . . 25.0 116.867 -174.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.8 p -84.52 172.9 11.26 Favored 'General case' 0 C--O 1.248 0.982 0 C-N-CA 124.838 1.255 . . . . 25.0 113.467 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.1 mt -87.94 36.56 0.77 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.262 0.553 . . . . 25.0 110.25 171.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -144.19 176.18 23.58 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 107.91 -2.076 . . . . 25.0 107.91 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.5 t -65.57 138.01 57.76 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 112.76 0.652 . . . . 25.0 112.76 -177.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -146.77 164.34 33.1 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.717 -0.674 . . . . 50.0 110.527 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -109.43 114.38 27.98 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 105.202 -2.148 . . . . 25.0 105.202 163.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 40.3 mm -104.1 115.64 46.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 106.764 -1.569 . . . . 25.0 106.764 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 9.8 mp -107.5 127.77 53.91 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 106.484 -1.673 . . . . 25.0 106.484 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.66 -33.08 8.69 Favored Glycine 0 C--N 1.313 -0.724 0 CA-C-O 119.297 -0.724 . . . . 25.0 112.474 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.58 -146.06 49.82 Favored Glycine 0 C--O 1.256 1.47 0 CA-C-N 118.745 1.273 . . . . 25.0 111.996 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.75 168.13 54.1 Favored Glycine 0 C--O 1.248 1.007 0 O-C-N 122.601 -0.353 . . . . 25.0 113.286 -176.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.59 169.13 35.17 Favored Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 111.581 -0.608 . . . . 25.0 111.581 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.95 118.93 25.73 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.51 -1.292 . . . . 25.0 107.51 176.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -116.57 148.47 40.86 Favored 'General case' 0 CA--C 1.511 -0.532 0 O-C-N 121.335 -0.853 . . . . 50.0 111.602 -171.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -104.8 107.38 18.32 Favored 'General case' 0 C--O 1.249 1.054 0 N-CA-C 106.42 -1.696 . . . . 25.0 106.42 171.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 64.3 mt -112.56 133.77 54.44 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 121.99 -0.444 . . . . 25.0 111.008 -175.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -131.93 107.06 8.45 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 121.449 0.642 . . . . 25.0 110.778 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.37 -26.79 50.63 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-O 119.023 -0.876 . . . . 25.0 115.095 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 51.48 -152.15 0.22 Allowed 'General case' 0 C--O 1.244 0.815 0 CA-C-N 117.716 0.758 . . . . 25.0 111.782 -175.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.37 164.29 16.47 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.768 1.025 . . . . 25.0 113.768 -175.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.22 155.43 31.69 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 114.853 -1.067 . . . . 25.0 110.859 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -79.62 102.49 8.94 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 106.665 -1.605 . . . . 25.0 106.665 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -104.85 155.24 19.09 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 121.097 0.475 . . . . 50.0 111.779 -173.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 mp -111.66 134.27 53.34 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 105.87 -1.9 . . . . 25.0 105.87 174.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.5 mp -131.73 117.63 18.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.577 0.703 . . . . 25.0 110.724 -174.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -118.14 89.94 3.23 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.978 -1.01 . . . . 25.0 109.663 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.31 -31.59 74.27 Favored Glycine 0 N--CA 1.468 0.809 0 N-CA-C 116.92 1.528 . . . . 25.0 116.92 -172.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.9 -163.94 51.33 Favored Glycine 0 C--O 1.243 0.705 0 O-C-N 121.864 -0.786 . . . . 25.0 111.269 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.21 161.53 19.09 Favored 'General case' 0 C--O 1.248 1.009 0 C-N-CA 123.051 0.541 . . . . 25.0 109.798 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.93 161.4 32.23 Favored Glycine 0 C--O 1.248 0.991 0 CA-C-O 118.941 -0.921 . . . . 25.0 111.209 177.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -80.85 121.19 25.65 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 105.785 -1.932 . . . . 25.0 105.785 177.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -111.51 152.35 27.6 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.343 -0.844 . . . . 50.0 109.855 -177.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -118.86 119.1 33.37 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 105.742 -1.948 . . . . 25.0 105.742 177.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -141.65 134.74 29.12 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 115.159 1.54 . . . . 25.0 115.159 -168.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.5 m -103.38 141.51 35.82 Favored 'General case' 0 C--O 1.249 1.032 0 N-CA-C 107.229 -1.397 . . . . 25.0 107.229 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.21 -37.36 5.97 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 108.442 -1.863 . . . . 25.0 108.442 175.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.84 -171.11 55.14 Favored Glycine 0 C--O 1.248 1.003 0 C-N-CA 120.626 -0.797 . . . . 25.0 111.859 -178.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -65.73 157.09 31.12 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 117.498 0.649 . . . . 25.0 110.061 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.46 164.86 32.0 Favored Glycine 0 C--O 1.245 0.808 0 CA-C-N 115.606 -0.725 . . . . 25.0 112.656 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.15 96.25 9.84 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 123.593 0.757 . . . . 25.0 110.319 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -90.71 159.89 16.12 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 123.462 0.705 . . . . 50.0 112.066 -170.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.1 m -125.51 125.43 43.24 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.797 -0.638 . . . . 25.0 109.385 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -114.68 89.15 3.03 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.398 -0.964 . . . . 25.0 108.398 177.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -88.84 -34.48 17.0 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 119.321 -0.371 . . . . 25.0 111.735 -175.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 66.74 160.82 0.15 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.542 1.137 . . . . 25.0 111.632 -173.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -90.83 -42.88 10.39 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 116.196 1.925 . . . . 25.0 116.196 -166.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.3 mt -140.65 170.49 15.68 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.139 0.792 . . . . 25.0 113.139 -172.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.99 -25.19 43.07 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 123.751 0.82 . . . . 25.0 110.914 175.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -79.12 -12.13 59.99 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 115.112 -0.949 . . . . 25.0 112.906 -178.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -81.73 139.55 34.81 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.412 -0.805 . . . . 25.0 112.911 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.4 t 45.91 40.06 6.27 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 116.52 2.045 . . . . 25.0 116.52 171.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -107.37 170.09 8.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.239 -1.346 . . . . 25.0 110.964 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -124.23 146.66 48.59 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 106.13 -1.804 . . . . 25.0 106.13 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 87.9 p -142.37 168.64 12.89 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 108.613 -0.884 . . . . 25.0 108.613 -177.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -61.04 -27.03 83.98 Favored 'Trans proline' 0 CA--C 1.553 1.44 0 C-N-CA 117.631 -1.112 . . . . 25.0 111.566 175.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.4 mt -65.6 -32.29 73.79 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.861 0.689 . . . . 25.0 112.861 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.53 -174.48 35.65 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 109.974 -1.25 . . . . 25.0 109.974 -176.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.8 t -105.55 144.67 31.98 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.407 1.099 . . . . 25.0 112.74 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -123.82 16.68 9.42 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.027 -1.442 . . . . 25.0 108.964 177.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -62.0 140.94 47.06 Favored Glycine 0 C--N 1.335 0.524 0 CA-C-N 115.645 -0.707 . . . . 25.0 112.649 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -87.03 170.68 11.33 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 117.858 0.829 . . . . 50.0 113.057 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.04 98.36 5.95 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.518 -0.765 . . . . 25.0 110.799 -172.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.2 mt -89.65 133.02 32.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 107.837 -1.171 . . . . 25.0 107.837 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 76.8 mt -85.5 -49.06 8.37 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 115.323 1.601 . . . . 25.0 115.323 -171.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -131.13 36.04 3.87 Favored 'General case' 0 C--O 1.247 0.953 0 CA-C-O 121.458 0.647 . . . . 25.0 112.695 -173.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -53.78 131.59 39.82 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.261 -0.882 . . . . 25.0 112.263 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -103.59 105.66 48.4 Favored Pre-proline 0 C--O 1.238 0.474 0 N-CA-C 108.185 -1.042 . . . . 25.0 108.185 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.78 -9.68 26.92 Favored 'Trans proline' 0 C--N 1.35 0.611 0 N-CA-C 116.119 1.546 . . . . 25.0 116.119 -173.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.1 t -95.9 -36.87 10.94 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.27 -0.572 . . . . 25.0 109.774 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -95.62 -38.02 10.58 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 114.001 1.111 . . . . 25.0 114.001 -173.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -87.77 172.41 9.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.403 0.62 . . . . 75.0 110.478 -173.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -145.08 148.81 34.08 Favored 'General case' 0 C--O 1.252 1.199 0 CA-C-N 116.084 -0.507 . . . . 25.0 111.739 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 85.7 mt -129.09 133.07 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 108.486 -0.931 . . . . 25.0 108.486 -176.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -85.83 149.03 25.53 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 121.694 0.759 . . . . 25.0 109.122 173.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.0 p -146.25 -13.03 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 O-C-N 121.641 -0.662 . . . . 25.0 112.75 176.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.1 t -63.48 -39.95 95.81 Favored 'General case' 0 C--O 1.219 -0.524 0 O-C-N 121.565 -0.709 . . . . 25.0 111.432 -174.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.78 -8.61 59.57 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-N 115.398 -0.819 . . . . 25.0 112.661 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.7 mt -106.18 -29.64 9.72 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.815 0.672 . . . . 25.0 112.815 -174.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.39 -71.6 0.01 OUTLIER Glycine 0 N--CA 1.465 0.574 0 N-CA-C 117.598 1.799 . . . . 25.0 117.598 -176.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -144.96 158.23 43.88 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.794 -0.817 . . . . 25.0 108.794 -170.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 41.0 t -113.55 -28.74 7.4 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 123.651 0.594 . . . . 25.0 112.286 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -100.39 119.6 6.57 Favored Glycine 0 N--CA 1.472 1.054 0 C-N-CA 121.495 -0.383 . . . . 25.0 112.323 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.29 146.4 34.36 Favored 'General case' 0 C--O 1.245 0.853 0 N-CA-C 114.065 1.135 . . . . 25.0 114.065 -174.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -95.86 -151.95 28.65 Favored Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.824 -0.703 . . . . 25.0 114.26 -177.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -59.51 131.73 51.85 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 122.446 1.117 . . . . 25.0 111.639 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 160.38 170.44 24.97 Favored Glycine 0 C--O 1.24 0.476 0 N-CA-C 107.573 -2.211 . . . . 25.0 107.573 -179.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -148.22 167.73 24.35 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 118.299 1.05 . . . . 25.0 109.4 -177.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 62.98 38.6 10.94 Favored 'General case' 0 C--O 1.248 1.011 0 C-N-CA 124.518 1.127 . . . . 25.0 111.801 -174.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 65.82 44.18 92.56 Favored Glycine 0 C--O 1.242 0.629 0 N-CA-C 109.938 -1.265 . . . . 25.0 109.938 177.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.7 t -151.58 179.76 8.1 Favored 'General case' 0 C--O 1.212 -0.873 0 O-C-N 122.391 -0.476 . . . . 25.0 111.18 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 85.1 mt -106.8 167.02 10.16 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 103.855 -2.646 . . . . 25.0 103.855 173.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.54 131.17 42.88 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 119.597 1.09 . . . . 25.0 110.21 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 18.6 m -95.44 163.47 2.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.426 -0.806 . . . . 25.0 109.838 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 80.0 p -149.03 160.09 43.63 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.538 -0.726 . . . . 25.0 110.6 -177.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 28.0 m -122.44 165.16 18.71 Favored 'Isoleucine or valine' 0 C--O 1.252 1.221 0 N-CA-C 109.727 -0.471 . . . . 25.0 109.727 -177.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.3 t -76.28 -50.75 13.55 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 122.22 1.01 . . . . 25.0 109.682 176.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -162.18 -152.77 0.25 Allowed 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 103.753 -2.684 . . . . 25.0 103.753 -176.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -73.31 -6.19 44.47 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 119.211 0.914 . . . . 25.0 110.63 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -148.21 -146.68 4.38 Favored Glycine 0 C--O 1.247 0.958 0 N-CA-C 109.922 -1.271 . . . . 25.0 109.922 174.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.25 -152.55 0.39 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.051 0.541 . . . . 25.0 112.416 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -75.71 162.37 28.28 Favored 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 113.919 1.081 . . . . 25.0 113.919 -171.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.61 158.0 21.38 Favored 'General case' 0 C--O 1.213 -0.851 0 N-CA-C 105.978 -1.86 . . . . 25.0 105.978 175.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -129.66 144.57 51.34 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 124.12 0.887 . . . . 25.0 111.419 175.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 49.4 tp -115.41 122.77 46.83 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 102.778 -3.045 . . . . 25.0 102.778 173.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -121.59 155.29 35.38 Favored 'General case' 0 C--O 1.211 -0.957 0 CA-C-O 121.39 0.614 . . . . 25.0 110.411 -173.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 41.0 t -92.04 152.57 19.91 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.49 -1.3 . . . . 25.0 107.49 171.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -123.01 19.17 10.05 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 108.539 -0.912 . . . . 25.0 108.539 175.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -118.96 139.84 51.0 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 105.223 -2.14 . . . . 25.0 105.223 170.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -139.25 165.08 28.13 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.528 0.68 . . . . 25.0 110.231 -177.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -85.68 163.96 17.95 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.021 -1.474 . . . . 25.0 107.021 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.31 -24.41 67.27 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 108.116 -1.068 . . . . 25.0 108.116 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -74.86 -5.55 44.21 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.432 -0.804 . . . . 25.0 112.472 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.75 1.23 83.06 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 120.33 -0.938 . . . . 25.0 111.811 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.8 mt -75.74 133.99 40.59 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.417 -0.586 . . . . 25.0 109.417 175.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 88.1 p -144.44 -172.71 3.85 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 106.199 -1.778 . . . . 25.0 106.199 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -131.4 141.35 49.84 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 121.293 -0.163 . . . . 25.0 110.614 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -154.45 158.81 40.52 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 106.99 -1.485 . . . . 25.0 106.99 166.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.2 p -145.23 144.37 21.53 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 N-CA-C 108.247 -1.02 . . . . 25.0 108.247 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -105.36 136.67 44.48 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 108.453 -0.943 . . . . 25.0 108.453 -177.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.1 mp -134.03 129.8 36.62 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 106.957 -1.497 . . . . 25.0 106.957 -177.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -90.96 -1.75 57.79 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 119.224 -0.99 . . . . 25.0 112.482 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -66.35 -21.24 70.23 Favored Glycine 0 C--O 1.242 0.607 0 N-CA-C 115.139 0.816 . . . . 25.0 115.139 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 29.4 t0 53.14 59.11 4.65 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 123.626 1.679 . . . . 25.0 111.324 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -120.98 41.0 3.42 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 112.217 -2.265 . . . . 25.0 107.711 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.36 -35.39 75.57 Favored 'General case' 0 C--O 1.214 -0.796 0 CA-C-N 114.961 -1.018 . . . . 25.0 113.511 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.17 -29.42 62.83 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 118.232 0.469 . . . . 25.0 110.794 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -85.21 -13.22 50.61 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 112.8 0.667 . . . . 25.0 112.8 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 14.5 mt -69.87 128.2 35.55 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.94 0.719 . . . . 25.0 112.94 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 34.4 m -138.59 161.65 36.57 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.34 -0.985 . . . . 25.0 108.34 171.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.92 4.93 5.69 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 109.5 -0.556 . . . . 25.0 109.5 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -66.75 -30.74 71.04 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.684 0.615 . . . . 25.0 110.451 177.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -91.63 -4.0 55.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.129 0.49 . . . . 25.0 111.338 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 48.2 mm -94.02 126.26 46.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 106.542 -1.651 . . . . 25.0 106.542 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.2 p -103.43 114.57 43.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 122.113 0.958 . . . . 25.0 110.827 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -156.18 -9.17 0.11 Allowed 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.729 1.751 . . . . 25.0 115.729 -177.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -88.18 71.93 9.16 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 118.855 0.752 . . . . 25.0 111.264 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 56.49 21.15 5.36 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.27 1.028 . . . . 25.0 113.347 -178.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 53.84 38.33 28.41 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.756 -0.656 . . . . 25.0 111.415 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -123.26 124.8 43.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.36 0.6 . . . . 25.0 111.332 -178.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.09 -4.28 28.02 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.726 -0.67 . . . . 25.0 112.303 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.34 -13.01 61.03 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.644 -0.502 . . . . 25.0 109.644 174.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.24 -176.31 6.26 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 122.727 0.411 . . . . 25.0 110.497 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 58.85 -162.45 0.24 Allowed 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.201 -1.363 . . . . 25.0 113.045 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.15 22.04 77.05 Favored Glycine 0 C--N 1.336 0.578 0 N-CA-C 110.945 -0.862 . . . . 25.0 110.945 -175.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -112.99 93.85 4.62 Favored 'General case' 0 C--O 1.246 0.875 0 C-N-CA 123.673 0.789 . . . . 25.0 110.535 -176.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -128.84 145.57 51.17 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 109.148 -0.686 . . . . 25.0 109.148 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -119.35 24.08 8.28 Favored Glycine 0 N--CA 1.462 0.424 0 N-CA-C 111.368 -0.693 . . . . 25.0 111.368 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 44.6 t -71.59 -30.15 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 122.083 0.944 . . . . 25.0 109.44 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.49 134.58 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 122.196 0.998 . . . . 25.0 109.211 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 154.81 152.14 6.05 Favored Glycine 0 C--O 1.242 0.611 0 CA-C-N 115.393 -0.821 . . . . 25.0 112.992 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -148.38 123.62 10.21 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.355 -0.609 . . . . 25.0 109.355 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 56.2 p -151.97 160.14 43.57 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.316 -0.994 . . . . 25.0 108.316 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 166.06 -172.8 41.52 Favored Glycine 0 C--N 1.319 -0.374 0 C-N-CA 121.252 -0.499 . . . . 25.0 112.161 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -138.99 109.3 7.67 Favored Pre-proline 0 C--O 1.244 0.766 0 N-CA-C 107.943 -1.132 . . . . 25.0 107.943 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.92 164.48 31.54 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 117.655 -1.097 . . . . 25.0 113.266 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -128.52 156.03 43.93 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.531 -0.759 . . . . 25.0 109.124 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -132.01 87.74 43.37 Favored Pre-proline 0 C--O 1.243 0.733 0 N-CA-C 108.912 -0.773 . . . . 25.0 108.912 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -71.29 156.18 59.35 Favored 'Trans proline' 0 C--N 1.353 0.8 0 N-CA-C 113.893 0.689 . . . . 25.0 113.893 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 11.8 t -123.3 -11.49 7.93 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.286 0.565 . . . . 25.0 110.927 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 10.1 p . . . . . 0 C--O 1.235 0.342 0 N-CA-C 107.654 -1.239 . . . . 25.0 107.654 177.341 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.456 0.17 . . . . 25.0 110.67 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -140.21 114.2 7.57 Favored Pre-proline 0 C--O 1.248 0.998 0 N-CA-C 108.184 -1.043 . . . . 25.0 108.184 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.02 167.04 28.41 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 118.119 -0.787 . . . . 25.0 113.503 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.41 56.82 0.01 OUTLIER Glycine 0 C--O 1.225 -0.416 0 O-C-N 121.921 -0.487 . . . . 25.0 112.023 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.514 HG22 ' H ' ' A' ' 7' ' ' GLY . 7.2 p -64.42 137.71 24.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 122.027 0.917 . . . . 25.0 111.287 -176.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -105.66 -4.53 20.94 Favored 'General case' 0 C--O 1.242 0.661 0 O-C-N 121.742 -0.599 . . . . 25.0 110.849 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.514 ' H ' HG22 ' A' ' 5' ' ' VAL . . . -84.99 -141.54 5.51 Favored Glycine 0 C--O 1.221 -0.692 0 C-N-CA 121.492 -0.385 . . . . 25.0 113.384 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.0 p 69.78 157.8 0.15 Allowed Pre-proline 0 N--CA 1.485 1.31 0 C-N-CA 125.413 1.485 . . . . 25.0 111.61 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -72.84 3.07 4.7 Favored 'Trans proline' 0 C--N 1.353 0.774 0 N-CA-C 116.46 1.677 . . . . 25.0 116.46 -177.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.4 p -67.17 -18.15 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 116.196 1.925 . . . . 25.0 116.196 -170.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.4 p -148.27 144.28 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 CA-C-N 119.222 0.919 . . . . 25.0 113.39 -176.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.29 15.59 80.77 Favored Glycine 0 C--N 1.333 0.379 0 N-CA-C 117.18 1.632 . . . . 25.0 117.18 174.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.3 t -52.64 -48.68 66.25 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.887 1.069 . . . . 25.0 113.887 -171.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -77.72 3.82 13.11 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 115.198 1.555 . . . . 25.0 115.198 -173.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.93 168.82 18.99 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.903 1.075 . . . . 25.0 113.903 -177.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.62 129.39 41.69 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.573 0.583 . . . . 25.0 112.573 -175.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -128.52 159.88 34.07 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 115.451 1.649 . . . . 50.0 115.451 -174.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -112.86 118.1 33.97 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 104.529 -2.397 . . . . 25.0 104.529 162.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.2 mt -121.14 85.82 2.47 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.956 0.884 . . . . 25.0 111.627 -173.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -90.01 110.64 21.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.296 -0.865 . . . . 25.0 109.984 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.02 170.45 43.42 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 116.181 1.232 . . . . 25.0 116.181 -176.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.2 p -71.81 174.89 6.27 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.753 0.787 . . . . 25.0 112.989 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 73.6 mt -86.13 18.6 3.01 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.099 -0.955 . . . . 25.0 111.193 176.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.66 176.35 16.06 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.402 -1.079 . . . . 25.0 110.402 176.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.4 t -70.73 136.63 49.06 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 117.649 0.725 . . . . 25.0 110.517 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -143.51 159.32 42.64 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 120.903 0.382 . . . . 50.0 110.044 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -95.96 131.12 42.66 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 102.959 -2.978 . . . . 25.0 102.959 161.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.8 mm -121.36 121.9 65.92 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 N-CA-C 105.497 -2.038 . . . . 25.0 105.497 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.5 tt -123.45 124.0 41.92 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.066 -1.087 . . . . 25.0 108.066 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.3 -38.27 11.24 Favored Glycine 0 CA--C 1.502 -0.722 0 C-N-CA 119.947 -1.12 . . . . 25.0 113.102 -177.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 72.19 -147.25 40.73 Favored Glycine 0 C--O 1.254 1.364 0 CA-C-N 118.983 1.391 . . . . 25.0 112.018 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.95 164.78 54.63 Favored Glycine 0 C--O 1.243 0.691 0 N-CA-C 111.751 -0.54 . . . . 25.0 111.751 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.22 163.67 34.82 Favored Glycine 0 C--O 1.244 0.719 0 CA-C-O 119.462 -0.632 . . . . 25.0 113.741 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.5 103.34 11.97 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.165 -1.42 . . . . 25.0 107.165 176.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -103.32 157.63 16.89 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.471 -0.491 . . . . 50.0 110.258 -172.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -120.56 90.66 3.37 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 108.82 -0.807 . . . . 25.0 108.82 177.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.0 mp -86.06 136.5 33.21 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.035 -0.529 . . . . 25.0 110.694 -175.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -138.55 106.62 5.72 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.331 -0.618 . . . . 25.0 109.331 174.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.98 -28.17 54.85 Favored Glycine 0 N--CA 1.467 0.766 0 CA-C-O 118.011 -1.438 . . . . 25.0 116.184 -175.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 54.8 -147.99 0.49 Allowed 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 118.187 0.994 . . . . 25.0 111.428 -177.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.94 163.47 19.64 Favored 'General case' 0 C--O 1.256 1.409 0 CA-C-O 122.153 0.978 . . . . 25.0 112.495 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.05 157.63 33.66 Favored Glycine 0 CA--C 1.521 0.452 0 CA-C-N 114.358 -1.292 . . . . 25.0 110.173 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -81.77 110.96 17.57 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 105.635 -1.987 . . . . 25.0 105.635 177.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -110.6 150.81 28.44 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.934 -0.706 . . . . 50.0 110.02 -171.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 mp -112.9 95.07 5.21 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.957 0.786 . . . . 25.0 109.457 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.8 mp -100.74 116.34 32.4 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 114.963 1.468 . . . . 25.0 114.963 -170.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -118.03 111.92 19.56 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 115.3 -0.864 . . . . 25.0 109.207 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.37 -32.61 79.86 Favored Glycine 0 C--O 1.254 1.389 0 N-CA-C 117.262 1.665 . . . . 25.0 117.262 -174.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.47 -163.78 42.97 Favored Glycine 0 N--CA 1.458 0.143 0 C-N-CA 120.91 -0.662 . . . . 25.0 111.909 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.2 159.46 17.63 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.307 0.575 . . . . 25.0 112.317 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.38 173.1 47.55 Favored Glycine 0 C--O 1.227 -0.291 0 CA-C-N 115.447 -0.797 . . . . 25.0 114.113 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.54 125.26 33.65 Favored 'General case' 0 C--O 1.208 -1.112 0 N-CA-C 104.069 -2.567 . . . . 25.0 104.069 176.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -117.96 157.56 26.51 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.907 0.384 . . . . 50.0 110.967 -174.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -113.26 131.04 56.07 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 102.869 -3.011 . . . . 25.0 102.869 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -148.98 149.05 30.52 Favored 'General case' 0 C--O 1.248 0.997 0 C-N-CA 119.374 -0.93 . . . . 25.0 111.691 -175.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.19 146.76 35.61 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 109.6 -0.519 . . . . 25.0 109.6 -176.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -98.85 -42.75 2.79 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-O 118.649 -1.084 . . . . 25.0 113.445 -174.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.34 -169.6 52.79 Favored Glycine 0 C--O 1.248 0.991 0 CA-C-N 118.843 1.322 . . . . 25.0 111.534 -177.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -60.58 155.08 19.51 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.846 -0.797 . . . . 25.0 110.21 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.0 163.23 32.24 Favored Glycine 0 C--O 1.249 1.063 0 CA-C-N 115.312 -0.858 . . . . 25.0 111.036 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.75 96.09 9.15 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 123.395 0.678 . . . . 25.0 110.028 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -88.94 158.25 18.12 Favored 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 123.258 0.623 . . . . 50.0 111.622 -170.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.1 m -123.15 134.04 54.22 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.965 -0.754 . . . . 25.0 108.965 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -126.45 100.81 6.42 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.467 -1.309 . . . . 25.0 107.467 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 54.2 mtt85 -100.13 -27.67 13.42 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.552 0.945 . . . . 25.0 113.552 -178.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 67.77 162.22 0.19 Allowed 'General case' 0 CA--C 1.534 0.356 0 O-C-N 125.276 1.61 . . . . 25.0 110.386 -174.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.8 -49.56 17.73 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 116.166 1.913 . . . . 25.0 116.166 -170.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 81.8 mt -153.98 -179.65 8.06 Favored 'General case' 0 C--O 1.205 -1.251 0 O-C-N 121.45 -0.781 . . . . 25.0 109.535 -171.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -55.86 -27.1 50.07 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.635 -0.876 . . . . 25.0 108.635 167.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -71.29 -10.28 59.49 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 112.965 0.728 . . . . 25.0 112.965 -178.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -99.34 155.32 17.58 Favored 'General case' 0 C--O 1.215 -0.719 0 O-C-N 121.76 -0.588 . . . . 25.0 110.463 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.4 m 42.83 56.49 3.95 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.093 -0.958 . . . . 25.0 113.464 169.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 42.8 p-80 -134.38 168.79 18.27 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 122.02 0.914 . . . . 25.0 111.482 -174.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -125.75 138.93 53.88 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 102.992 -2.966 . . . . 25.0 102.992 173.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.5 p -134.99 172.51 7.13 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 108.316 -0.994 . . . . 25.0 108.316 -173.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -60.13 -15.73 35.74 Favored 'Trans proline' 0 CA--C 1.555 1.559 0 N-CA-C 114.782 1.032 . . . . 25.0 114.782 175.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.6 mt -85.23 -24.67 27.73 Favored 'General case' 0 C--O 1.215 -0.723 0 N-CA-C 111.8 0.296 . . . . 25.0 111.8 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.06 -165.21 30.68 Favored Glycine 0 C--O 1.21 -1.393 0 C-N-CA 120.39 -0.909 . . . . 25.0 111.618 -175.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.9 t -106.55 141.41 37.88 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 122.762 1.268 . . . . 25.0 112.089 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -132.96 32.95 3.72 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-N 114.989 -1.005 . . . . 25.0 109.73 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -73.16 160.99 54.21 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 110.481 -1.047 . . . . 25.0 110.481 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -104.46 169.79 8.27 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 117.994 0.897 . . . . 50.0 110.539 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -121.07 104.58 9.89 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.432 1.093 . . . . 25.0 110.545 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.4 mt -94.02 135.13 29.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 106.747 -1.575 . . . . 25.0 106.747 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 21.6 mt -84.48 -45.63 12.45 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.729 1.751 . . . . 25.0 115.729 -174.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -135.27 38.1 2.95 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 115.134 -0.939 . . . . 25.0 113.429 -169.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -59.26 125.07 22.13 Favored 'General case' 0 C--O 1.218 -0.605 0 N-CA-C 108.791 -0.818 . . . . 25.0 108.791 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -92.1 103.82 9.2 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.897 -0.592 . . . . 25.0 109.697 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -69.04 -4.25 13.17 Favored 'Trans proline' 0 CA--C 1.548 1.209 0 N-CA-C 115.841 1.439 . . . . 25.0 115.841 -175.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.6 t -95.78 -43.3 7.93 Favored 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 122.193 -0.317 . . . . 25.0 110.829 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -97.43 -38.08 9.75 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 113.812 1.041 . . . . 25.0 113.812 -174.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -86.81 170.57 11.58 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.729 -0.388 . . . . 75.0 110.687 -172.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -145.62 149.34 34.35 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 116.208 -0.451 . . . . 25.0 111.006 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 67.7 mt -124.92 125.83 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 107.6 -1.259 . . . . 25.0 107.6 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -89.34 136.23 33.14 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-O 122.02 0.914 . . . . 25.0 108.913 173.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 p -134.46 2.97 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 114.452 -1.249 . . . . 25.0 108.539 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.475 ' HB2' ' HA ' ' A' ' 156' ' ' PHE . 23.7 t -67.32 -47.84 69.34 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 120.722 -0.391 . . . . 25.0 111.146 -175.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.19 -36.0 82.18 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.894 0.702 . . . . 25.0 112.894 -175.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.3 -49.64 4.19 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.585 0.958 . . . . 25.0 113.585 -175.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.31 -78.8 1.32 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 116.375 1.31 . . . . 25.0 116.375 -169.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -157.06 171.37 20.58 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 117.518 0.659 . . . . 25.0 110.114 -168.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 30.6 t -105.51 -36.25 7.19 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.587 0.755 . . . . 25.0 111.451 -177.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -105.91 145.68 15.97 Favored Glycine 0 N--CA 1.468 0.819 0 CA-C-O 118.355 -1.247 . . . . 25.0 111.354 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -61.61 148.31 42.84 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-N 118.814 1.307 . . . . 25.0 110.245 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.0 -167.1 41.15 Favored Glycine 0 C--O 1.243 0.708 0 CA-C-N 114.764 -1.107 . . . . 25.0 113.309 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -65.23 142.11 58.41 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.385 -0.968 . . . . 25.0 108.385 177.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 169.9 178.2 40.77 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 108.723 -1.751 . . . . 25.0 108.723 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -138.18 168.93 18.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 118.102 0.951 . . . . 25.0 109.485 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 61.05 35.28 18.88 Favored 'General case' 0 C--O 1.253 1.241 0 O-C-N 123.958 0.786 . . . . 25.0 112.489 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 65.03 39.32 96.32 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 120.785 -0.722 . . . . 25.0 111.74 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.7 t -146.24 177.43 9.0 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.752 -0.462 . . . . 25.0 109.752 -176.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 92.5 mt -90.08 170.27 10.47 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 105.507 -2.034 . . . . 25.0 105.507 175.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.21 111.72 1.84 Allowed 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 118.575 0.625 . . . . 25.0 110.679 -177.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 17.0 m -102.57 155.19 5.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 107.078 -1.453 . . . . 25.0 107.078 174.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 83.5 p -156.46 173.52 16.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 118.316 0.507 . . . . 25.0 110.715 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.1 m -118.97 160.39 18.87 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 N-CA-C 109.245 -0.65 . . . . 25.0 109.245 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.6 t -69.71 -52.48 25.14 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.837 -1.542 . . . . 25.0 106.837 173.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -164.28 -160.74 0.55 Allowed 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 102.947 -2.983 . . . . 25.0 102.947 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -55.16 -38.87 68.85 Favored 'General case' 0 C--O 1.252 1.225 0 CA-C-N 118.078 0.399 . . . . 25.0 111.104 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.72 -156.42 13.57 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 112.073 -0.411 . . . . 25.0 112.073 176.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.87 -168.67 0.18 Allowed 'General case' 0 C--O 1.251 1.132 0 C-N-CA 124.128 0.971 . . . . 25.0 111.475 177.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 64.9 mtt85 -72.83 160.35 32.3 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.46 0.911 . . . . 25.0 113.46 -171.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -102.6 168.16 9.45 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 105.575 -2.009 . . . . 25.0 105.575 175.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -131.57 156.03 46.46 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.778 0.799 . . . . 25.0 111.961 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 52.5 tp -127.32 116.21 20.17 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 102.976 -2.972 . . . . 25.0 102.976 174.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -122.69 162.99 20.92 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 108.601 -0.889 . . . . 25.0 108.601 -173.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.0 t -140.09 144.41 36.77 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 103.123 -2.918 . . . . 25.0 103.123 172.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -102.4 12.45 36.53 Favored 'General case' 0 C--O 1.245 0.859 0 N-CA-C 109.163 -0.68 . . . . 25.0 109.163 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -81.25 135.11 35.7 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 105.192 -2.151 . . . . 25.0 105.192 172.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -141.91 147.35 36.93 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 122.367 1.08 . . . . 25.0 110.96 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.26 159.51 31.13 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.232 -1.396 . . . . 25.0 107.232 174.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.07 -20.32 66.13 Favored 'General case' 0 CA--C 1.548 0.886 0 O-C-N 121.688 -0.632 . . . . 25.0 109.665 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -77.29 -4.45 45.03 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.49 -0.777 . . . . 25.0 113.072 175.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.18 6.14 63.29 Favored Glycine 0 CA--C 1.51 -0.247 0 N-CA-C 116.571 1.388 . . . . 25.0 116.571 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 69.2 mt -86.52 120.02 27.4 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 110.313 -0.255 . . . . 25.0 110.313 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 25.6 p -119.51 176.57 5.3 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.442 0.697 . . . . 25.0 109.248 -178.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -118.1 132.06 56.38 Favored 'General case' 0 C--O 1.257 1.456 0 N-CA-C 114.126 1.158 . . . . 25.0 114.126 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -152.57 151.69 30.96 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.169 -1.048 . . . . 25.0 108.169 167.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.5 p -149.09 147.83 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 106.113 -1.81 . . . . 25.0 106.113 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -109.73 145.22 36.95 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 111.685 0.254 . . . . 25.0 111.685 -177.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mp -134.0 128.34 34.16 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.451 -1.314 . . . . 25.0 107.451 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -86.9 -12.77 46.75 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 114.905 1.446 . . . . 25.0 114.905 -173.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -75.75 -6.22 81.11 Favored Glycine 0 C--O 1.212 -1.267 0 N-CA-C 116.347 1.299 . . . . 25.0 116.347 -171.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 47.7 t0 50.87 54.11 11.82 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 122.216 1.008 . . . . 25.0 113.068 -175.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 14.5 p80 -114.35 41.44 2.3 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 107.227 -1.397 . . . . 25.0 107.227 174.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.53 -36.61 84.33 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.004 -0.998 . . . . 25.0 111.624 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -77.49 -24.04 50.18 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.105 -0.997 . . . . 25.0 111.219 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.13 -24.71 37.46 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.541 -0.754 . . . . 25.0 110.699 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 8.1 mt -63.22 139.12 58.74 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 119.8 -0.76 . . . . 25.0 111.756 177.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 92.8 p -138.27 165.74 25.95 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.543 -0.91 . . . . 25.0 108.543 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.68 -3.18 29.82 Favored 'General case' 0 C--N 1.312 -1.03 0 O-C-N 120.997 -1.064 . . . . 25.0 109.879 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -77.43 -37.0 52.59 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 120.944 -1.098 . . . . 25.0 111.398 -177.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -89.72 -5.44 57.01 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 121.138 -0.225 . . . . 25.0 111.421 -177.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 44.4 mm -99.63 122.01 50.96 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.793 0 N-CA-C 103.833 -2.654 . . . . 25.0 103.833 173.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.7 p -112.82 125.08 70.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 122.779 1.276 . . . . 25.0 111.377 -174.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.475 ' HA ' ' HB2' ' A' ' 97' ' ' SER . 1.3 p90 -141.68 -32.22 0.54 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 112.774 -2.012 . . . . 25.0 109.717 -176.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -75.47 55.41 0.81 Allowed 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.674 1.361 . . . . 25.0 114.674 -176.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 60.1 15.88 5.51 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 115.616 1.71 . . . . 25.0 115.616 175.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.4 m 65.29 -23.99 0.09 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.965 1.706 . . . . 25.0 115.599 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -58.86 125.35 23.18 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.248 0.619 . . . . 25.0 111.24 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -96.89 15.04 23.32 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.174 0.805 . . . . 25.0 113.174 -175.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.9 2.26 12.94 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.92 1.081 . . . . 25.0 113.92 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -145.87 -174.96 4.56 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.323 -1.362 . . . . 25.0 107.323 177.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 67.74 -178.24 0.21 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.442 1.097 . . . . 25.0 111.58 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 86.59 21.44 51.09 Favored Glycine 0 C--O 1.24 0.498 0 N-CA-C 109.159 -1.576 . . . . 25.0 109.159 -172.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -77.56 89.44 3.89 Favored 'General case' 0 C--O 1.247 0.96 0 C-N-CA 123.198 0.599 . . . . 25.0 111.659 -177.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -123.28 143.36 50.11 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.598 -0.889 . . . . 25.0 108.598 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -140.79 32.92 2.09 Favored Glycine 0 N--CA 1.461 0.358 0 N-CA-C 109.781 -1.328 . . . . 25.0 109.781 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 47.9 t -71.48 -35.08 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 112.03 0.382 . . . . 25.0 112.03 -175.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.27 130.19 25.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-O 121.195 0.521 . . . . 25.0 111.374 -177.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 152.58 158.67 8.6 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 109.298 -1.521 . . . . 25.0 109.298 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -151.95 144.49 24.18 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 118.625 1.213 . . . . 25.0 110.593 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 68.9 p -142.7 162.77 34.61 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 105.637 -1.986 . . . . 25.0 105.637 175.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -174.02 161.83 32.21 Favored Glycine 0 C--N 1.318 -0.427 0 C-N-CA 120.249 -0.977 . . . . 25.0 113.283 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -136.7 83.29 30.27 Favored Pre-proline 0 C--O 1.241 0.645 0 N-CA-C 108.364 -0.976 . . . . 25.0 108.364 177.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.24 161.54 45.62 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 118.15 -0.767 . . . . 25.0 112.376 -174.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -113.24 150.49 32.31 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 123.51 0.724 . . . . 25.0 110.212 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -138.17 70.73 48.03 Favored Pre-proline 0 N--CA 1.479 0.998 0 CA-C-O 120.903 0.382 . . . . 25.0 110.967 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -73.06 153.85 52.28 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 116.918 -1.588 . . . . 25.0 112.875 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.6 t -84.63 7.05 21.58 Favored 'General case' 0 C--O 1.25 1.085 0 CA-C-O 120.902 0.382 . . . . 25.0 111.658 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 C--O 1.254 1.33 0 CA-C-O 116.833 -1.556 . . . . 25.0 110.335 -177.664 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.452 0 N-CA-C 110.158 -0.312 . . . . 25.0 110.158 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -129.35 112.51 18.12 Favored Pre-proline 0 C--O 1.254 1.311 0 N-CA-C 108.062 -1.088 . . . . 25.0 108.062 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.71 149.67 67.51 Favored 'Trans proline' 0 N--CA 1.476 0.468 0 C-N-CA 116.882 -1.612 . . . . 25.0 114.409 -177.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.09 65.95 0.05 OUTLIER Glycine 0 C--O 1.222 -0.655 0 C-N-CA 121.106 -0.569 . . . . 25.0 112.489 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.7 p -61.49 132.0 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 122.742 1.258 . . . . 25.0 111.417 -176.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -91.94 -19.88 21.98 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 114.986 -1.007 . . . . 25.0 111.203 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.76 -146.13 7.78 Favored Glycine 0 C--O 1.223 -0.568 0 N-CA-C 116.899 1.52 . . . . 25.0 116.899 -175.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.7 p 73.36 155.59 0.16 Allowed Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 126.928 2.091 . . . . 25.0 110.427 -175.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -67.4 13.12 0.17 Allowed 'Trans proline' 0 CA--C 1.545 1.07 0 N-CA-C 117.386 2.033 . . . . 25.0 117.386 -175.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.55 -20.78 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 115.38 1.622 . . . . 25.0 115.38 -174.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.7 p -146.47 141.5 20.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.999 0.74 . . . . 25.0 112.999 -175.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.56 17.15 69.14 Favored Glycine 0 C--O 1.241 0.585 0 N-CA-C 118.324 2.09 . . . . 25.0 118.324 173.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.2 t -51.51 -54.6 25.56 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.517 0.932 . . . . 25.0 113.517 -174.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -82.48 12.6 4.36 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 117.535 2.42 . . . . 25.0 117.535 -174.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -147.95 170.48 17.62 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 122.038 -0.414 . . . . 25.0 111.837 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -58.3 136.24 57.32 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 112.795 0.665 . . . . 25.0 112.795 -175.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -123.0 160.79 25.54 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 116.221 1.934 . . . . 50.0 116.221 -173.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -137.23 105.36 5.69 Favored 'General case' 0 C--O 1.249 1.042 0 N-CA-C 103.795 -2.668 . . . . 25.0 103.795 160.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.6 mt -125.29 131.21 53.11 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.312 0.486 . . . . 25.0 112.312 -175.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -118.59 111.86 19.12 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 122.489 0.316 . . . . 25.0 111.839 -176.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.32 -177.9 51.38 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 117.916 1.926 . . . . 25.0 117.916 -174.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.1 p -81.55 173.32 12.5 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.051 0.94 . . . . 25.0 112.054 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.4 mt -84.56 5.89 25.95 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.748 -0.595 . . . . 25.0 111.494 174.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -100.23 -179.24 30.06 Favored Glycine 0 N--CA 1.464 0.544 0 N-CA-C 111.83 -0.508 . . . . 25.0 111.83 177.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.3 t -78.54 124.92 28.67 Favored 'General case' 0 C--O 1.24 0.585 0 O-C-N 122.121 -0.635 . . . . 25.0 110.053 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -131.36 156.24 45.86 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.899 0.38 . . . . 50.0 111.018 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -98.42 129.14 45.05 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 102.825 -3.028 . . . . 25.0 102.825 163.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.8 mm -126.59 124.48 65.3 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.56 0 N-CA-C 105.969 -1.863 . . . . 25.0 105.969 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.8 mp -125.85 121.72 34.04 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.35 -1.352 . . . . 25.0 107.35 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.23 -34.31 37.35 Favored Glycine 0 C--N 1.318 -0.424 0 C-N-CA 120.68 -0.771 . . . . 25.0 114.933 -178.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 72.31 -145.59 37.82 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 110.415 -1.074 . . . . 25.0 110.415 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -78.63 169.79 54.46 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-O 121.897 0.721 . . . . 25.0 111.352 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.77 159.92 27.52 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.574 -0.822 . . . . 25.0 113.553 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.72 104.49 13.01 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 105.629 -1.989 . . . . 25.0 105.629 176.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -103.31 148.9 25.27 Favored 'General case' 0 C--N 1.314 -0.941 0 O-C-N 121.365 -0.834 . . . . 50.0 111.073 -169.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -112.34 98.57 7.38 Favored 'General case' 0 C--O 1.246 0.92 0 N-CA-C 105.135 -2.172 . . . . 25.0 105.135 176.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 62.8 mt -106.86 133.55 51.35 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.118 -0.492 . . . . 25.0 111.532 -172.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -130.3 106.87 8.86 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 122.659 0.384 . . . . 25.0 110.166 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.12 -19.69 49.38 Favored Glycine 0 CA--C 1.534 1.279 0 N-CA-C 117.682 1.833 . . . . 25.0 117.682 -178.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 53.35 -148.18 0.46 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 118.711 1.255 . . . . 25.0 113.188 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.63 165.87 20.27 Favored 'General case' 0 C--O 1.254 1.292 0 CA-C-O 121.247 0.546 . . . . 25.0 112.087 -176.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.37 153.53 30.16 Favored Glycine 0 N--CA 1.452 -0.269 0 N-CA-C 109.629 -1.388 . . . . 25.0 109.629 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -80.07 101.03 8.48 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.644 -1.613 . . . . 25.0 106.644 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -101.8 151.65 21.81 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.801 -0.636 . . . . 50.0 111.568 -170.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.7 mp -114.0 95.8 5.49 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.591 -0.522 . . . . 25.0 109.591 177.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.7 mp -101.46 128.03 47.86 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.336 0.589 . . . . 25.0 112.103 -173.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -125.73 135.94 52.62 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 106.485 -1.672 . . . . 25.0 106.485 174.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -89.54 -41.07 5.83 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 119.778 -1.201 . . . . 25.0 114.826 -174.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.46 -166.21 50.83 Favored Glycine 0 C--O 1.238 0.353 0 CA-C-N 117.662 0.731 . . . . 25.0 112.829 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.68 149.65 21.34 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.099 0.407 . . . . 25.0 112.099 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.4 153.64 29.03 Favored Glycine 0 C--O 1.238 0.365 0 CA-C-N 115.38 -0.827 . . . . 25.0 112.837 -177.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.34 120.26 21.36 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 105.193 -2.151 . . . . 25.0 105.193 176.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -109.05 156.2 20.05 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.983 -0.377 . . . . 50.0 109.983 -172.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -123.9 117.99 26.07 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 103.928 -2.619 . . . . 25.0 103.928 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -144.23 132.28 21.63 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 116.753 2.131 . . . . 25.0 116.753 -168.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 64.3 m -100.63 135.49 41.99 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.454 -0.573 . . . . 25.0 109.454 176.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.49 -32.91 7.85 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.038 -1.225 . . . . 25.0 110.038 173.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.07 -163.01 54.5 Favored Glycine 0 C--O 1.247 0.954 0 CA-C-O 122.836 1.242 . . . . 25.0 111.805 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -67.23 161.01 25.81 Favored 'General case' 0 C--N 1.322 -0.629 0 O-C-N 121.922 -0.752 . . . . 25.0 110.108 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.44 164.42 37.15 Favored Glycine 0 CA--C 1.521 0.418 0 CA-C-N 115.757 -0.656 . . . . 25.0 111.807 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.66 92.08 8.08 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-O 122.352 1.072 . . . . 25.0 109.957 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -86.01 152.35 22.98 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.105 -0.952 . . . . 50.0 112.338 -172.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.5 m -121.93 127.99 51.02 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.899 -1.046 . . . . 25.0 109.735 -178.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -122.8 84.56 2.28 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.605 -1.257 . . . . 25.0 107.605 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 54.8 mtt85 -85.64 -21.72 28.28 Favored 'General case' 0 CA--C 1.497 -1.068 0 O-C-N 121.54 -0.725 . . . . 25.0 111.358 -178.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 68.22 159.07 0.16 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.017 1.327 . . . . 25.0 112.173 -175.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -93.62 -28.13 16.19 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 115.795 1.776 . . . . 25.0 115.795 -167.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 70.7 mt -145.91 166.02 27.22 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.39 0.515 . . . . 25.0 112.39 -171.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.33 -28.15 69.01 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.642 -0.873 . . . . 25.0 108.642 170.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -82.87 -0.19 47.09 Favored 'General case' 0 C--O 1.252 1.187 0 CA-C-N 114.363 -1.289 . . . . 25.0 113.814 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -91.0 134.65 34.32 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 121.719 -0.613 . . . . 25.0 110.145 -173.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.3 t 47.32 42.75 14.31 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 115.291 1.589 . . . . 25.0 115.291 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 15.5 p-80 -110.79 165.44 11.84 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.419 -0.81 . . . . 25.0 112.375 -174.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -116.06 142.24 47.06 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 106.805 -1.554 . . . . 25.0 106.805 176.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 82.5 p -136.27 166.56 27.03 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 108.278 -1.008 . . . . 25.0 108.278 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -61.14 -22.49 74.84 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 117.885 -0.944 . . . . 25.0 113.528 174.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 86.9 mt -76.79 -21.82 54.59 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.733 0.778 . . . . 25.0 111.174 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 150.52 175.18 22.31 Favored Glycine 0 CA--C 1.506 -0.479 0 CA-C-N 116.17 -0.468 . . . . 25.0 112.11 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.0 t -95.09 148.4 22.4 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 122.01 0.909 . . . . 25.0 111.137 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -131.55 30.82 4.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.833 -1.076 . . . . 25.0 108.448 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.0 142.03 44.34 Favored Glycine 0 C--O 1.243 0.675 0 N-CA-C 111.157 -0.777 . . . . 25.0 111.157 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -85.52 169.22 13.8 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 120.575 0.226 . . . . 50.0 110.393 -177.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -124.08 98.38 5.76 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.001 0.52 . . . . 25.0 111.468 -173.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.9 mt -85.34 132.73 31.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 107.56 -1.274 . . . . 25.0 107.56 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 98.0 mt -84.66 -44.55 13.33 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 114.894 1.442 . . . . 25.0 114.894 -169.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 57.5 p30 -134.45 38.62 3.09 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 114.799 1.407 . . . . 25.0 114.799 -174.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -57.35 129.64 42.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.703 0.763 . . . . 25.0 112.384 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -99.66 105.07 31.8 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 108.212 -1.033 . . . . 25.0 108.212 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -67.61 -16.83 47.68 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 116.228 -2.048 . . . . 25.0 115.802 -176.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.7 t -82.86 -26.66 31.41 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 120.607 0.241 . . . . 25.0 110.988 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -115.78 -33.1 5.26 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 115.432 1.641 . . . . 25.0 115.432 -173.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -91.8 167.63 12.02 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 123.432 0.457 . . . . 50.0 110.367 -170.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -144.65 145.91 31.99 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.212 0.449 . . . . 25.0 112.212 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 88.3 mt -127.41 127.83 69.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.281 -1.007 . . . . 25.0 108.281 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -91.25 148.0 22.65 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.509 -0.923 . . . . 25.0 108.509 173.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.4 p -147.79 -6.72 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 113.175 0.806 . . . . 25.0 113.175 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 26.4 t -61.44 -43.77 98.28 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.532 0.568 . . . . 25.0 112.532 -175.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.05 -28.86 54.91 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.9 1.074 . . . . 25.0 113.9 -178.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.62 -0.33 13.04 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 116.655 2.094 . . . . 25.0 116.655 -169.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -145.0 -72.45 0.02 OUTLIER Glycine 0 C--O 1.241 0.576 0 N-CA-C 116.555 1.382 . . . . 25.0 116.555 -178.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -157.98 169.25 25.01 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.597 -0.89 . . . . 25.0 108.597 -175.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 38.5 t -124.11 -39.8 2.33 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.111 0.482 . . . . 25.0 110.344 177.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -88.48 121.72 6.08 Favored Glycine 0 N--CA 1.465 0.585 0 N-CA-C 111.053 -0.819 . . . . 25.0 111.053 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -73.53 154.16 39.98 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 117.633 0.716 . . . . 25.0 111.87 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.15 -171.84 45.75 Favored Glycine 0 N--CA 1.463 0.467 0 CA-C-N 116.281 -0.418 . . . . 25.0 112.108 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -75.6 81.71 2.6 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.611 0.967 . . . . 25.0 113.611 -177.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -105.86 176.62 22.21 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 108.973 -1.651 . . . . 25.0 108.973 173.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -125.96 166.19 17.38 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 118.106 0.953 . . . . 25.0 110.683 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 54.09 36.43 24.67 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 114.083 1.142 . . . . 25.0 114.083 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 77.35 31.26 52.13 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 120.214 -0.993 . . . . 25.0 112.11 177.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.3 t -138.78 -174.37 3.82 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 117.382 0.591 . . . . 25.0 110.468 -177.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.56 161.01 15.23 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 102.294 -3.225 . . . . 25.0 102.294 173.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.78 115.01 10.48 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 118.744 0.702 . . . . 25.0 110.325 -173.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.1 m -85.3 165.1 2.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 108.112 -1.07 . . . . 25.0 108.112 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 92.0 p -150.39 162.59 40.26 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.673 -0.492 . . . . 25.0 109.673 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.5 m -115.95 164.2 12.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.698 -0.853 . . . . 25.0 108.698 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.5 t -76.55 -56.4 4.65 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.186 -1.413 . . . . 25.0 107.186 170.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -161.31 -159.94 0.68 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 103.436 -2.801 . . . . 25.0 103.436 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -66.52 -24.22 66.35 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 121.062 0.458 . . . . 25.0 110.311 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -118.86 -159.02 10.94 Favored Glycine 0 C--O 1.244 0.758 0 N-CA-C 109.661 -1.376 . . . . 25.0 109.661 176.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 59.44 -161.85 0.26 Allowed 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 112.913 0.708 . . . . 25.0 112.913 176.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 39.4 mtt85 -76.33 163.81 26.64 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.292 1.219 . . . . 25.0 114.292 -169.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.14 159.91 18.76 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 106.233 -1.766 . . . . 25.0 106.233 171.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -132.01 159.21 39.44 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.245 0.545 . . . . 25.0 110.452 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 55.7 tp -133.05 119.37 19.94 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 104.356 -2.461 . . . . 25.0 104.356 170.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -116.51 155.62 28.31 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.435 -0.58 . . . . 25.0 109.435 -175.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.4 t -100.02 149.92 22.98 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 104.272 -2.492 . . . . 25.0 104.272 166.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -116.13 9.56 14.74 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 122.089 0.947 . . . . 25.0 109.783 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -102.18 143.17 32.31 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 104.185 -2.524 . . . . 25.0 104.185 171.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -138.7 155.12 48.52 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.604 0.716 . . . . 25.0 109.802 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -75.29 160.01 30.84 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 105.543 -2.021 . . . . 25.0 105.543 175.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.7 -16.65 63.96 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.496 0.589 . . . . 25.0 111.485 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -76.13 -9.44 58.63 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.157 0.503 . . . . 25.0 112.141 174.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.69 3.29 68.81 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.483 -0.647 . . . . 25.0 111.483 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.3 mt -73.76 138.47 44.59 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.372 -0.973 . . . . 25.0 108.372 177.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.87 -178.43 6.35 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 106.848 -1.538 . . . . 25.0 106.848 -175.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -132.35 140.99 48.74 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-N 118.91 0.777 . . . . 25.0 112.995 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -153.58 156.02 37.22 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 108.06 -1.089 . . . . 25.0 108.06 170.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.5 p -146.06 143.93 21.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 N-CA-C 105.818 -1.919 . . . . 25.0 105.818 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -107.36 142.64 36.86 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.032 -1.47 . . . . 25.0 107.032 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.413 HD22 ' HE1' ' A' ' 145' ' ' HIS . 2.9 mp -131.49 127.92 38.31 Favored 'General case' 0 C--O 1.207 -1.141 0 N-CA-C 103.552 -2.759 . . . . 25.0 103.552 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -100.19 3.53 43.78 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 119.278 0.945 . . . . 25.0 113.304 -174.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -79.07 -2.28 86.8 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 120.668 -0.777 . . . . 25.0 113.775 177.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 44.8 t0 49.16 48.93 20.39 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 122.075 0.94 . . . . 25.0 112.14 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.413 ' HE1' HD22 ' A' ' 141' ' ' LEU . 5.0 p80 -108.18 32.67 4.61 Favored 'General case' 0 C--O 1.249 1.03 0 CA-C-O 122.53 1.157 . . . . 25.0 108.615 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -55.1 -34.3 63.56 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.044 -0.98 . . . . 25.0 112.492 176.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.97 -12.78 61.98 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 113.275 0.842 . . . . 25.0 113.275 -178.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -116.86 -5.0 11.53 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.635 0.605 . . . . 25.0 112.635 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 16.1 mt -70.7 127.37 32.41 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.495 -0.928 . . . . 25.0 108.495 178.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 71.2 m -127.64 164.37 22.19 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.616 -1.624 . . . . 25.0 106.616 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -73.64 -1.87 20.68 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.197 -0.668 . . . . 25.0 109.197 176.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -71.33 -29.77 65.4 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 115.673 -0.694 . . . . 25.0 112.385 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -98.15 1.14 47.17 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 122.065 -0.397 . . . . 25.0 111.324 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 38.9 mm -105.5 111.36 34.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 105.535 -2.024 . . . . 25.0 105.535 175.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.8 p -98.15 115.95 39.62 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-O 123.064 1.412 . . . . 25.0 112.558 -173.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -137.36 0.51 2.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 112.98 -1.918 . . . . 25.0 110.362 174.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -81.61 43.95 0.78 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 122.752 0.421 . . . . 25.0 111.441 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 55.94 24.39 7.57 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.202 1.186 . . . . 25.0 114.202 -177.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.56 9.09 0.73 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.657 1.725 . . . . 25.0 115.657 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -79.01 134.94 36.77 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 121.353 -0.842 . . . . 25.0 110.787 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.34 -19.69 63.04 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.354 -0.61 . . . . 25.0 109.354 178.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.3 47.39 0.68 Allowed 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 121.264 0.554 . . . . 25.0 111.513 176.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -150.3 173.18 14.27 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.164 -1.421 . . . . 25.0 107.164 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 62.77 -172.1 0.16 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.64 1.176 . . . . 25.0 111.905 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 81.55 23.41 58.35 Favored Glycine 0 C--N 1.32 -0.311 0 N-CA-C 110.081 -1.207 . . . . 25.0 110.081 -176.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -121.34 101.74 7.83 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 109.38 -0.6 . . . . 25.0 109.38 -176.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -127.8 157.49 40.28 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.179 -0.674 . . . . 25.0 109.179 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -136.74 26.01 3.05 Favored Glycine 0 N--CA 1.464 0.532 0 CA-C-N 116.426 -0.352 . . . . 25.0 113.636 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 47.1 t -80.96 -31.99 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 116.915 0.357 . . . . 25.0 110.8 -177.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.15 133.67 27.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 CA-C-O 121.571 0.7 . . . . 25.0 111.135 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.38 168.0 26.85 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 108.614 -1.794 . . . . 25.0 108.614 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -146.29 143.58 29.25 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.436 1.618 . . . . 25.0 110.601 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 80.5 p -155.51 167.82 29.12 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.556 -0.905 . . . . 25.0 108.556 178.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 179.3 -179.74 48.84 Favored Glycine 0 CA--C 1.507 -0.418 0 C-N-CA 120.628 -0.796 . . . . 25.0 114.299 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -145.82 106.19 4.26 Favored Pre-proline 0 N--CA 1.468 0.456 0 N-CA-C 107.895 -1.15 . . . . 25.0 107.895 177.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -72.94 152.23 51.6 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 116.194 -2.07 . . . . 25.0 113.67 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -113.24 144.5 42.6 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.835 -1.913 . . . . 25.0 105.835 175.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -136.2 67.2 61.44 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 112.644 0.609 . . . . 25.0 112.644 -174.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -73.45 150.83 46.94 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 117.874 -0.951 . . . . 25.0 112.575 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.7 t -139.95 20.96 2.47 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 122.02 0.914 . . . . 25.0 109.803 -177.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.4 p . . . . . 0 C--O 1.248 0.975 0 CA-C-O 117.618 -1.182 . . . . 25.0 110.759 -178.19 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.784 0 N-CA-C 110.025 -0.361 . . . . 25.0 110.025 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -123.54 118.23 27.51 Favored Pre-proline 0 C--O 1.241 0.65 0 O-C-N 123.296 0.372 . . . . 25.0 110.652 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.37 142.75 46.01 Favored 'Trans proline' 0 C--O 1.247 0.967 0 C-N-CA 116.726 -1.716 . . . . 25.0 114.293 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.9 51.52 0.06 OUTLIER Glycine 0 C--O 1.237 0.3 0 N-CA-C 109.625 -1.39 . . . . 25.0 109.625 -177.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.9 p -57.86 133.58 22.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.758 0.79 . . . . 25.0 111.03 -174.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -102.37 -8.81 20.86 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.197 -0.91 . . . . 25.0 110.204 -173.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -82.52 -141.79 4.04 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.882 -0.599 . . . . 25.0 112.413 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.5 p 69.12 159.4 0.15 Allowed Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 126.064 1.746 . . . . 25.0 110.835 -175.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -65.97 -5.06 11.28 Favored 'Trans proline' 0 N--CA 1.483 0.9 0 N-CA-C 116.64 1.746 . . . . 25.0 116.64 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.97 -4.2 4.22 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 N-CA-C 114.192 1.182 . . . . 25.0 114.192 -170.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.3 p -141.34 141.35 30.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 121.56 0.695 . . . . 25.0 111.713 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.48 18.5 73.67 Favored Glycine 0 C--N 1.336 0.577 0 N-CA-C 119.681 2.633 . . . . 25.0 119.681 171.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.2 t -51.4 -51.63 53.06 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 120.641 -1.505 . . . . 25.0 113.826 -172.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -85.85 13.94 6.67 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 115.187 1.551 . . . . 25.0 115.187 -171.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.24 168.58 19.44 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.32 0.489 . . . . 25.0 112.32 -176.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -63.93 130.86 45.79 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 118.208 0.458 . . . . 25.0 110.809 -177.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -127.0 170.09 12.66 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 116.6 2.074 . . . . 50.0 116.6 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -136.01 92.56 2.81 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 104.449 -2.426 . . . . 25.0 104.449 168.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 52.4 mt -106.95 123.28 47.95 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.385 0.884 . . . . 25.0 113.385 -173.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -111.43 114.77 28.12 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.815 -0.629 . . . . 25.0 109.401 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.07 174.71 51.21 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 116.948 1.539 . . . . 25.0 116.948 -175.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.3 p -69.47 169.69 12.01 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.504 0.669 . . . . 25.0 111.574 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 89.3 mt -87.33 16.09 5.71 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.521 -0.763 . . . . 25.0 110.905 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -120.6 -178.96 16.19 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.368 -0.693 . . . . 25.0 111.368 175.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.7 t -68.17 135.07 51.51 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 117.365 0.582 . . . . 25.0 110.924 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -144.92 166.44 25.29 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.083 0.553 . . . . 50.0 109.791 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -109.78 129.8 55.59 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 103.284 -2.858 . . . . 25.0 103.284 162.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.4 mm -119.23 121.71 67.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 108.138 -1.06 . . . . 25.0 108.138 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 9.0 mp -124.36 125.96 45.19 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 105.801 -1.926 . . . . 25.0 105.801 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.21 -26.62 27.9 Favored Glycine 0 C--O 1.246 0.904 0 N-CA-C 115.355 0.902 . . . . 25.0 115.355 -176.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.24 -147.33 47.33 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.122 -1.037 . . . . 25.0 112.003 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.31 174.3 52.21 Favored Glycine 0 C--O 1.248 0.983 0 O-C-N 122.73 -0.277 . . . . 25.0 112.889 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.49 160.92 20.99 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.597 -0.811 . . . . 25.0 113.82 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.57 92.0 8.75 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 122.526 1.155 . . . . 25.0 108.008 175.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -89.31 157.29 18.25 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.762 -1.108 . . . . 50.0 112.635 -169.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -117.35 94.99 4.77 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 107.469 -1.308 . . . . 25.0 107.469 172.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 49.6 mt -101.83 134.73 44.55 Favored 'General case' 0 C--O 1.213 -0.847 0 N-CA-C 112.614 0.598 . . . . 25.0 112.614 -172.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -131.51 106.79 8.44 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.174 0.512 . . . . 25.0 111.015 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.96 -25.61 57.51 Favored Glycine 0 C--O 1.246 0.845 0 N-CA-C 116.066 1.186 . . . . 25.0 116.066 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 49.99 -152.19 0.17 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.928 1.084 . . . . 25.0 113.928 -178.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.97 160.39 20.85 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 113.164 0.801 . . . . 25.0 113.164 -173.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.06 156.5 31.35 Favored Glycine 0 C--O 1.247 0.955 0 N-CA-C 109.591 -1.404 . . . . 25.0 109.591 -177.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 22.0 m-20 -81.42 106.08 13.1 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 107.149 -1.426 . . . . 25.0 107.149 177.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -106.84 161.8 14.37 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 120.946 0.403 . . . . 50.0 111.098 -170.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 mp -119.87 136.88 54.32 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 104.832 -2.284 . . . . 25.0 104.832 174.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 mp -136.1 125.42 24.83 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 114.49 1.293 . . . . 25.0 114.49 -172.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -125.19 137.84 54.13 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 113.968 -1.469 . . . . 25.0 107.542 174.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.48 -31.79 8.64 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.32 -0.943 . . . . 25.0 114.704 -178.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.98 -171.0 55.12 Favored Glycine 0 C--O 1.253 1.285 0 N-CA-C 110.784 -0.926 . . . . 25.0 110.784 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.6 157.11 9.61 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.956 0.884 . . . . 25.0 112.422 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.38 164.73 40.48 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-N 115.212 -0.903 . . . . 25.0 111.888 -176.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.97 123.72 33.57 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 104.7 -2.333 . . . . 25.0 104.7 176.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -113.44 157.08 22.4 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.663 0.986 . . . . 50.0 113.663 -169.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -113.2 127.08 56.07 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 103.493 -2.78 . . . . 25.0 103.493 174.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -147.83 137.3 22.43 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.901 1.074 . . . . 25.0 113.901 -176.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 62.1 m -116.04 142.59 46.6 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.02 -1.104 . . . . 25.0 108.02 176.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -93.49 -34.21 6.76 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 111.079 -0.808 . . . . 25.0 111.079 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.81 -173.25 55.33 Favored Glycine 0 C--O 1.244 0.732 0 CA-C-N 117.987 0.893 . . . . 25.0 113.462 -178.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -66.1 159.21 26.62 Favored 'General case' 0 C--O 1.241 0.612 0 O-C-N 121.455 -1.027 . . . . 25.0 109.65 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.1 156.45 32.21 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.57 -1.012 . . . . 25.0 110.57 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.97 124.09 26.33 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 109.184 -0.672 . . . . 25.0 109.184 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -116.3 151.6 35.53 Favored 'General case' 0 C--N 1.313 -0.987 0 O-C-N 121.614 -0.679 . . . . 50.0 112.08 -173.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 98.5 m -114.27 122.57 47.15 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 109.046 -0.724 . . . . 25.0 109.046 177.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -108.96 124.37 50.58 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 106.424 -1.695 . . . . 25.0 106.424 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 49.2 mtt85 -122.49 -36.68 2.89 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.121 0.785 . . . . 25.0 113.121 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 71.69 155.1 0.15 Allowed 'General case' 0 N--CA 1.475 0.817 0 O-C-N 125.07 1.481 . . . . 25.0 108.101 -169.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.52 -43.19 19.12 Favored 'General case' 0 C--N 1.318 -0.765 0 O-C-N 121.852 -0.53 . . . . 25.0 112.158 -165.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 58.6 mt -130.9 163.46 27.42 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 122.054 0.93 . . . . 25.0 111.423 -173.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -56.14 -27.56 54.56 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 114.497 -1.228 . . . . 25.0 108.868 169.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -72.71 -4.68 32.74 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 115.01 1.485 . . . . 25.0 115.01 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -99.09 153.55 18.8 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.41 -0.806 . . . . 25.0 112.894 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.9 t 43.35 48.7 5.93 Favored 'General case' 0 C--O 1.217 -0.649 0 N-CA-C 114.806 1.41 . . . . 25.0 114.806 170.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 28.0 p-80 -131.91 170.23 15.18 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.143 -0.935 . . . . 25.0 110.195 -175.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.5 ttt180 -122.55 142.65 50.39 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 105.707 -1.96 . . . . 25.0 105.707 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 77.9 p -137.55 168.95 14.4 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.207 -0.664 . . . . 25.0 109.207 -176.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -61.45 -24.23 78.02 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 CA-C-N 118.841 0.622 . . . . 25.0 113.266 175.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.2 mt -75.59 -26.49 57.92 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.542 0.687 . . . . 25.0 111.303 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.17 -174.13 32.65 Favored Glycine 0 N--CA 1.463 0.455 0 N-CA-C 110.595 -1.002 . . . . 25.0 110.595 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.8 t -103.18 149.21 24.88 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-O 122.742 1.258 . . . . 25.0 112.956 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -129.03 21.61 5.79 Favored 'General case' 0 C--O 1.252 1.2 0 CA-C-N 114.247 -1.342 . . . . 25.0 109.004 175.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.04 140.5 46.32 Favored Glycine 0 N--CA 1.473 1.105 0 O-C-N 124.549 1.156 . . . . 25.0 111.414 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -96.99 167.37 11.12 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 108.35 -0.981 . . . . 50.0 108.35 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.45 ' HG3' ' HB3' ' A' ' 140' ' ' ALA . 0.3 OUTLIER -123.89 109.32 13.45 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.135 0.791 . . . . 25.0 113.135 -175.074 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 41.5 mt -87.98 139.46 17.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 105.865 -1.902 . . . . 25.0 105.865 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.2 mt -90.9 -44.44 9.37 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 114.868 1.432 . . . . 25.0 114.868 -176.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.6 p-10 -130.13 39.51 3.66 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 116.165 1.913 . . . . 25.0 116.165 -173.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -55.99 126.84 27.64 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 122.3 -0.25 . . . . 25.0 111.114 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -97.57 104.14 19.46 Favored Pre-proline 0 N--CA 1.474 0.771 0 N-CA-C 108.878 -0.786 . . . . 25.0 108.878 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -70.67 -4.97 15.71 Favored 'Trans proline' 0 C--O 1.213 -0.757 0 N-CA-C 114.973 1.105 . . . . 25.0 114.973 -176.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.8 t -89.42 -28.71 19.56 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.087 0.47 . . . . 25.0 111.08 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -118.72 -38.28 3.13 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 115.217 1.562 . . . . 25.0 115.217 -172.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -85.76 175.01 8.94 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.714 0.635 . . . . 75.0 112.714 -172.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.72 152.26 36.31 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.182 0.808 . . . . 25.0 113.182 170.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 55.9 mt -119.03 132.03 70.1 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 N-CA-C 108.854 -0.795 . . . . 25.0 108.854 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -85.6 145.05 27.53 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 122.32 1.057 . . . . 25.0 111.458 173.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.0 p -143.19 -0.85 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 CA-C-N 114.724 -1.125 . . . . 25.0 110.085 178.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.8 t -64.76 -42.51 95.07 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.283 0.563 . . . . 25.0 111.11 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.92 -27.85 63.1 Favored 'General case' 0 C--O 1.249 1.066 0 CA-C-N 115.656 -0.702 . . . . 25.0 111.693 -177.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.0 mt -99.12 -58.07 2.02 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 114.255 1.206 . . . . 25.0 114.255 -169.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -104.33 -65.26 0.69 Allowed Glycine 0 C--O 1.242 0.643 0 N-CA-C 116.609 1.404 . . . . 25.0 116.609 -168.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -156.47 164.8 37.82 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.012 0.478 . . . . 25.0 110.451 -168.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.9 p -117.57 -19.74 9.28 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.99 0.516 . . . . 25.0 110.47 173.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -108.32 117.12 4.97 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 109.199 -1.56 . . . . 25.0 109.199 175.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -60.08 151.44 26.66 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 116.216 1.932 . . . . 25.0 116.216 -175.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.89 -169.25 36.63 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 114.856 -1.066 . . . . 25.0 114.798 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -55.8 135.46 51.76 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 113.435 0.902 . . . . 25.0 113.435 -177.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 168.4 177.68 39.62 Favored Glycine 0 C--O 1.236 0.257 0 N-CA-C 107.961 -2.056 . . . . 25.0 107.961 178.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -142.99 168.96 18.48 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.119 1.46 . . . . 25.0 109.21 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 57.8 35.74 25.77 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.737 0.815 . . . . 25.0 111.527 -177.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 69.37 36.66 78.63 Favored Glycine 0 C--N 1.32 -0.333 0 N-CA-C 111.114 -0.795 . . . . 25.0 111.114 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.3 t -140.09 177.85 7.69 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.193 -0.669 . . . . 25.0 109.193 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 84.3 mt -104.5 155.29 18.94 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 102.347 -3.205 . . . . 25.0 102.347 172.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.39 136.37 55.66 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 119.367 -0.933 . . . . 25.0 109.257 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.0 m -110.74 161.62 9.01 Favored 'Isoleucine or valine' 0 C--O 1.248 1.008 0 N-CA-C 108.89 -0.781 . . . . 25.0 108.89 -177.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 80.4 p -142.56 163.32 33.13 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 116.569 -0.287 . . . . 25.0 111.557 -177.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.2 m -116.41 160.99 15.49 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 N-CA-C 107.555 -1.276 . . . . 25.0 107.555 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.5 t -74.07 -48.78 27.49 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.739 -1.208 . . . . 25.0 107.739 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -168.09 -162.47 0.42 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 102.175 -3.268 . . . . 25.0 102.175 -178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -77.55 12.55 1.56 Allowed 'General case' 0 CA--C 1.546 0.803 0 CA-C-O 121.754 0.788 . . . . 25.0 111.746 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -150.91 -164.13 11.8 Favored Glycine 0 C--O 1.243 0.716 0 N-CA-C 107.438 -2.265 . . . . 25.0 107.438 176.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.42 -154.85 0.36 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.028 0.381 . . . . 25.0 112.028 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.8 mtt180 -84.08 166.52 17.62 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.925 0.713 . . . . 25.0 112.925 -173.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.68 165.98 12.22 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 105.584 -2.006 . . . . 25.0 105.584 174.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -134.55 158.4 44.08 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.762 0.791 . . . . 25.0 111.8 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 41.8 tp -127.08 129.27 47.66 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 103.834 -2.654 . . . . 25.0 103.834 174.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -123.6 154.21 39.62 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.327 0.584 . . . . 25.0 111.346 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.1 t -99.44 151.21 21.37 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 104.533 -2.395 . . . . 25.0 104.533 167.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -118.67 14.66 13.55 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 107.943 -1.132 . . . . 25.0 107.943 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -105.23 140.41 38.42 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 104.578 -2.378 . . . . 25.0 104.578 172.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -138.43 155.44 48.48 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 123.937 0.773 . . . . 25.0 109.64 -177.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -85.73 163.87 17.96 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.57 -0.741 . . . . 25.0 109.633 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.75 -24.0 67.48 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-O 121.444 0.64 . . . . 25.0 111.819 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -74.33 -4.13 34.44 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.754 0.65 . . . . 25.0 112.754 175.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.18 17.73 64.25 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.568 -0.825 . . . . 25.0 112.247 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.2 mt -93.69 141.95 27.91 Favored 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 107.311 -1.366 . . . . 25.0 107.311 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 63.9 p -141.49 178.41 7.46 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 106.854 -1.535 . . . . 25.0 106.854 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -123.31 133.17 54.18 Favored 'General case' 0 C--O 1.252 1.198 0 CA-C-N 118.544 0.611 . . . . 25.0 111.818 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -148.89 151.43 34.66 Favored 'General case' 0 C--O 1.25 1.103 0 N-CA-C 108.56 -0.904 . . . . 25.0 108.56 171.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.1 p -149.19 146.7 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 107.313 -1.366 . . . . 25.0 107.313 -178.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.45 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . . . -104.98 145.57 30.24 Favored 'General case' 0 C--O 1.247 0.972 0 N-CA-C 109.025 -0.732 . . . . 25.0 109.025 -177.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.9 mp -135.45 120.31 18.52 Favored 'General case' 0 C--O 1.211 -0.921 0 N-CA-C 105.1 -2.185 . . . . 25.0 105.1 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -88.06 -13.1 42.36 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 118.302 2.704 . . . . 25.0 118.302 -169.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -78.36 9.0 36.6 Favored Glycine 0 CA--C 1.535 1.332 0 N-CA-C 117.009 1.563 . . . . 25.0 117.009 -175.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 39.9 t0 48.46 51.14 15.78 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 122.716 1.246 . . . . 25.0 112.957 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -110.97 31.97 5.63 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.753 -1.203 . . . . 25.0 107.753 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.29 -38.43 83.59 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 115.232 -0.895 . . . . 25.0 110.968 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.42 -22.41 66.95 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.101 0.56 . . . . 25.0 112.111 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -98.23 -10.71 23.6 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.037 0.754 . . . . 25.0 113.037 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 13.9 mt -66.1 145.85 55.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.776 0.798 . . . . 25.0 112.214 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 72.1 m -142.97 157.34 44.65 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.853 -1.165 . . . . 25.0 107.853 177.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -81.4 9.04 7.88 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.451 0.3 . . . . 25.0 110.424 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -92.72 -22.87 19.14 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.857 0.36 . . . . 25.0 110.071 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -99.17 20.63 13.14 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 122.79 1.281 . . . . 25.0 109.048 173.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 39.8 mm -122.04 130.01 74.92 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 N-CA-C 101.753 -3.425 . . . . 25.0 101.753 170.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.2 p -108.64 128.34 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 119.35 0.977 . . . . 25.0 110.948 -172.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -167.17 -24.64 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.885 -1.052 . . . . 25.0 113.376 -176.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -82.16 80.63 8.33 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.719 -0.613 . . . . 25.0 110.802 -172.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 59.22 8.61 1.13 Allowed 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 115.326 1.602 . . . . 25.0 115.326 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 m 66.37 -37.87 0.29 Allowed 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 116.59 2.07 . . . . 25.0 116.59 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -65.3 138.07 57.95 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 122.009 -0.432 . . . . 25.0 111.414 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.0 -6.22 31.88 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 121.009 0.433 . . . . 25.0 110.83 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.85 -13.7 61.75 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 116.175 -0.466 . . . . 25.0 111.083 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -102.88 160.33 14.7 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 109.764 -0.458 . . . . 25.0 109.764 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 56.56 -163.52 0.16 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.945 1.461 . . . . 25.0 114.945 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 90.43 15.97 56.11 Favored Glycine 0 N--CA 1.459 0.207 0 N-CA-C 114.662 0.625 . . . . 25.0 114.662 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -83.41 115.9 22.25 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 117.271 0.535 . . . . 25.0 111.696 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -110.68 134.12 52.73 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.133 -0.691 . . . . 25.0 109.133 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.8 45.78 0.7 Allowed Glycine 0 C--O 1.224 -0.505 0 N-CA-C 111.513 -0.635 . . . . 25.0 111.513 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 43.1 t -84.46 -32.01 7.8 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 CA-C-O 121.678 0.752 . . . . 25.0 109.619 -177.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.68 135.4 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 CA-C-O 121.713 0.768 . . . . 25.0 112.082 -176.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 161.84 133.88 1.55 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.622 -1.391 . . . . 25.0 109.622 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -148.49 152.12 36.35 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 117.393 0.597 . . . . 25.0 110.941 -177.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 51.2 p -155.41 166.54 33.22 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.365 -0.976 . . . . 25.0 108.365 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 161.67 146.99 4.83 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 121.179 -0.534 . . . . 25.0 113.707 176.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -98.56 110.15 55.73 Favored Pre-proline 0 C--O 1.247 0.957 0 C-N-CA 123.599 0.76 . . . . 25.0 109.512 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.59 150.13 79.76 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 116.936 -1.576 . . . . 25.0 111.853 176.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -110.3 141.46 43.27 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 109.662 -0.496 . . . . 25.0 109.662 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -130.41 79.29 72.7 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-O 120.955 0.407 . . . . 25.0 111.81 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.3 157.81 52.82 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 N-CA-C 114.066 0.756 . . . . 25.0 114.066 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.8 t -99.04 -17.4 18.28 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.248 -0.649 . . . . 25.0 109.248 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 12.0 p . . . . . 0 C--O 1.246 0.894 0 CA-C-O 117.338 -1.315 . . . . 25.0 108.473 173.411 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 119.791 -0.147 . . . . 25.0 110.67 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -104.9 91.45 4.34 Favored Pre-proline 0 C--O 1.244 0.791 0 C-N-CA 123.679 0.792 . . . . 25.0 110.24 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -68.75 135.28 32.49 Favored 'Trans proline' 0 C--N 1.349 0.586 0 N-CA-C 115.691 1.381 . . . . 25.0 115.691 -174.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.27 51.76 0.29 Allowed Glycine 0 C--O 1.211 -1.3 0 N-CA-C 106.807 -2.517 . . . . 25.0 106.807 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.6 p -55.35 125.83 11.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 N-CA-C 114.564 1.32 . . . . 25.0 114.564 -172.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -105.64 11.2 32.52 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-O 122.189 0.995 . . . . 25.0 109.555 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -94.31 -155.73 31.85 Favored Glycine 0 N--CA 1.447 -0.625 0 O-C-N 121.38 -0.825 . . . . 25.0 113.704 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.0 p 70.18 158.2 0.16 Allowed Pre-proline 0 N--CA 1.486 1.343 0 C-N-CA 126.08 1.752 . . . . 25.0 112.518 -176.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.444 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 35.2 Cg_exo -66.2 -0.78 4.5 Favored 'Trans proline' 0 C--N 1.358 1.073 0 N-CA-C 116.957 1.868 . . . . 25.0 116.957 -174.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.1 p -65.56 -11.28 11.9 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 N-CA-C 115.91 1.818 . . . . 25.0 115.91 -171.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.8 p -146.42 127.2 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 N-CA-C 114.713 1.375 . . . . 25.0 114.713 -176.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.26 18.66 71.53 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 118.148 2.019 . . . . 25.0 118.148 173.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.7 t -50.86 -37.33 42.67 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 115.331 1.604 . . . . 25.0 115.331 -174.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -75.12 2.43 10.77 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 114.88 1.437 . . . . 25.0 114.88 -175.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.25 173.22 11.72 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 118.971 0.805 . . . . 25.0 110.598 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -51.11 128.41 21.7 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 112.886 0.698 . . . . 25.0 112.886 -177.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -129.91 159.4 36.75 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.39 0.885 . . . . 50.0 113.39 -173.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -125.9 95.98 4.6 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 105.353 -2.092 . . . . 25.0 105.353 165.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 80.9 mt -103.57 108.49 19.78 Favored 'General case' 0 C--O 1.212 -0.895 0 N-CA-C 112.976 0.732 . . . . 25.0 112.976 -176.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -98.82 109.75 22.46 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.962 -0.563 . . . . 25.0 109.596 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.0 172.53 51.63 Favored Glycine 0 C--O 1.219 -0.813 0 N-CA-C 115.893 1.117 . . . . 25.0 115.893 -175.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.8 p -72.31 175.76 5.86 Favored 'General case' 0 C--O 1.246 0.889 0 C-N-CA 123.656 0.782 . . . . 25.0 111.404 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 66.6 mt -87.91 16.73 5.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.52 0.676 . . . . 25.0 110.712 174.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.91 179.5 17.94 Favored Glycine 0 N--CA 1.461 0.331 0 N-CA-C 110.029 -1.228 . . . . 25.0 110.029 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.8 t -74.39 133.24 42.47 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.818 0.447 . . . . 25.0 110.454 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -144.54 166.56 24.81 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.453 0.701 . . . . 50.0 109.495 -177.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -110.37 121.89 46.39 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 104.839 -2.282 . . . . 25.0 104.839 164.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.0 mm -111.03 122.41 65.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 107.1 -1.445 . . . . 25.0 107.1 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.444 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 10.9 mp -119.58 122.72 42.22 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.467 -0.938 . . . . 25.0 108.467 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.17 -37.48 32.18 Favored Glycine 0 CA--C 1.496 -1.115 0 CA-C-O 117.888 -1.506 . . . . 25.0 116.074 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.64 -150.21 51.79 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 119.498 1.649 . . . . 25.0 112.357 -177.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.04 168.79 47.02 Favored Glycine 0 CA--C 1.526 0.776 0 O-C-N 121.855 -0.791 . . . . 25.0 114.12 -178.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.05 167.03 29.65 Favored Glycine 0 C--O 1.246 0.871 0 C-N-CA 121.378 -0.439 . . . . 25.0 113.391 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.44 101.25 12.46 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 106.601 -1.629 . . . . 25.0 106.601 177.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -96.32 152.16 18.84 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 113.255 0.835 . . . . 50.0 113.255 -169.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -119.06 88.42 2.93 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 107.531 -1.285 . . . . 25.0 107.531 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 52.4 mt -97.41 143.77 27.81 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.581 -0.736 . . . . 25.0 110.437 -169.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -137.21 106.65 6.11 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 121.905 -0.497 . . . . 25.0 111.497 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.62 -30.1 53.78 Favored Glycine 0 N--CA 1.466 0.659 0 CA-C-O 118.721 -1.044 . . . . 25.0 113.667 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 50.46 -149.71 0.27 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 117.865 0.832 . . . . 25.0 111.51 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.49 163.09 27.54 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.933 0.873 . . . . 25.0 112.736 -174.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.72 156.65 31.64 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 110.514 -1.034 . . . . 25.0 110.514 -174.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -86.82 100.57 12.63 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.213 -1.403 . . . . 25.0 107.213 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -102.84 152.0 21.78 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.23 -0.896 . . . . 50.0 112.955 -169.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mp -110.72 122.79 48.69 Favored 'General case' 0 C--O 1.217 -0.605 0 N-CA-C 107.005 -1.479 . . . . 25.0 107.005 176.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.9 mp -123.21 130.85 53.32 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 114.598 1.332 . . . . 25.0 114.598 -172.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -121.65 143.44 49.33 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.563 1.545 . . . . 25.0 109.011 175.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.76 -37.6 3.16 Favored Glycine 0 C--O 1.242 0.621 0 N-CA-C 115.296 0.878 . . . . 25.0 115.296 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.03 -168.38 54.71 Favored Glycine 0 C--O 1.246 0.885 0 CA-C-N 117.868 0.834 . . . . 25.0 111.974 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.61 151.72 23.98 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.196 -1.179 . . . . 25.0 112.427 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.99 162.13 38.19 Favored Glycine 0 N--CA 1.466 0.698 0 CA-C-N 115.353 -0.84 . . . . 25.0 111.693 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.74 122.71 29.01 Favored 'General case' 0 C--O 1.212 -0.892 0 N-CA-C 105.255 -2.128 . . . . 25.0 105.255 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -114.42 156.71 24.0 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 122.017 0.913 . . . . 50.0 110.526 -172.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -114.88 122.29 45.86 Favored 'General case' 0 C--O 1.218 -0.595 0 N-CA-C 102.305 -3.22 . . . . 25.0 102.305 177.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -142.19 131.01 22.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 119.165 0.893 . . . . 25.0 113.194 -175.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.99 142.03 34.78 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 115.722 -0.672 . . . . 25.0 109.26 177.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.91 -40.57 5.53 Favored Glycine 0 C--O 1.246 0.868 0 N-CA-C 109.294 -1.522 . . . . 25.0 109.294 175.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.0 -172.97 55.05 Favored Glycine 0 C--O 1.244 0.77 0 C-N-CA 120.278 -0.963 . . . . 25.0 112.786 -176.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -64.07 159.02 21.18 Favored 'General case' 0 C--O 1.251 1.142 0 O-C-N 122.178 -0.601 . . . . 25.0 110.864 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.75 161.87 37.24 Favored Glycine 0 C--O 1.247 0.91 0 CA-C-N 115.141 -0.936 . . . . 25.0 111.413 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.95 105.74 14.19 Favored 'General case' 0 C--O 1.217 -0.649 0 N-CA-C 107.807 -1.183 . . . . 25.0 107.807 -178.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -99.54 156.74 16.89 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 122.666 0.387 . . . . 50.0 111.826 -172.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 47.8 m -123.71 111.52 16.27 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.82 0.819 . . . . 25.0 110.09 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -88.39 96.46 10.6 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 104.917 -2.253 . . . . 25.0 104.917 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.4 mmt85 -81.22 -37.69 28.21 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.595 0.591 . . . . 25.0 112.595 -174.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 64.36 149.3 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 O-C-N 125.882 1.989 . . . . 25.0 111.998 -172.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.32 -59.99 2.56 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 114.995 1.48 . . . . 25.0 114.995 -168.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 48.7 mt -135.52 175.65 9.39 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 108.286 -1.005 . . . . 25.0 108.286 -170.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.62 -27.81 42.23 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.019 0.928 . . . . 25.0 110.838 171.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -76.06 -7.38 54.56 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 115.114 1.524 . . . . 25.0 115.114 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -90.16 136.49 33.01 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.325 -0.859 . . . . 25.0 112.84 -174.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.0 t 43.97 44.16 5.83 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 116.312 1.967 . . . . 25.0 116.312 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -113.66 173.91 6.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.886 -1.052 . . . . 25.0 112.18 -177.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -125.69 139.93 53.13 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 104.076 -2.565 . . . . 25.0 104.076 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 57.7 p -134.27 169.47 13.8 Favored Pre-proline 0 C--O 1.214 -0.786 0 N-CA-C 108.501 -0.925 . . . . 25.0 108.501 -176.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -61.91 -15.82 45.51 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 120.399 0.733 . . . . 25.0 112.764 176.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 89.7 mt -84.76 -31.48 23.95 Favored 'General case' 0 C--O 1.245 0.819 0 O-C-N 121.622 -0.674 . . . . 25.0 111.077 177.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.34 177.47 32.46 Favored Glycine 0 CA--C 1.503 -0.716 0 C-N-CA 121.108 -0.567 . . . . 25.0 112.761 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.2 t -88.49 146.8 24.98 Favored 'General case' 0 C--O 1.253 1.255 0 CA-C-O 121.983 0.896 . . . . 25.0 112.127 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -135.1 32.58 3.16 Favored 'General case' 0 C--O 1.254 1.331 0 CA-C-N 113.8 -1.545 . . . . 25.0 108.371 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -64.91 137.38 38.68 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 109.541 -1.424 . . . . 25.0 109.541 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -87.49 168.59 12.96 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 117.699 0.75 . . . . 50.0 110.659 -177.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -118.25 107.46 13.93 Favored 'General case' 0 C--O 1.245 0.847 0 O-C-N 123.789 0.681 . . . . 25.0 111.44 -175.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 52.7 mt -86.93 131.39 35.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 107.05 -1.463 . . . . 25.0 107.05 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.0 mt -75.88 -49.57 17.51 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 116.175 1.917 . . . . 25.0 116.175 -173.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -137.78 41.59 2.33 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.537 0.684 . . . . 25.0 112.282 -169.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -56.51 138.61 51.5 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.902 0.858 . . . . 25.0 110.72 -176.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -105.84 99.19 20.91 Favored Pre-proline 0 C--O 1.215 -0.74 0 N-CA-C 109.224 -0.658 . . . . 25.0 109.224 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -67.53 1.6 3.01 Favored 'Trans proline' 0 C--N 1.358 1.034 0 N-CA-C 115.39 1.265 . . . . 25.0 115.39 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.5 t -103.89 -42.27 5.64 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 117.515 0.143 . . . . 25.0 110.795 175.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -99.39 -36.99 9.41 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 115.15 1.537 . . . . 25.0 115.15 -175.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -85.08 170.74 12.64 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.028 -0.73 . . . . 75.0 109.028 -171.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -146.42 158.04 43.84 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.953 0.901 . . . . 25.0 110.363 177.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 64.9 mt -130.34 134.84 61.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.91 -0.774 . . . . 25.0 108.91 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -90.12 148.48 22.98 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 122.197 0.999 . . . . 25.0 109.367 175.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.5 p -153.55 -9.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 114.803 -1.09 . . . . 25.0 110.841 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.8 t -60.82 -39.71 90.04 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.036 0.446 . . . . 25.0 111.358 -178.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -86.48 -7.87 58.05 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 115.084 1.513 . . . . 25.0 115.084 -176.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.78 0.28 1.78 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 116.074 1.879 . . . . 25.0 116.074 -172.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -143.26 -69.38 0.02 OUTLIER Glycine 0 N--CA 1.467 0.76 0 N-CA-C 116.094 1.198 . . . . 25.0 116.094 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -156.03 163.81 39.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 117.467 0.634 . . . . 25.0 110.174 -174.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 30.8 t -112.71 -34.15 5.89 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 122.034 0.921 . . . . 25.0 110.552 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -107.12 137.38 13.93 Favored Glycine 0 C--O 1.223 -0.587 0 N-CA-C 107.824 -2.111 . . . . 25.0 107.824 176.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.88 151.39 45.74 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 118.936 -1.106 . . . . 25.0 109.269 -177.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -92.37 -164.11 38.11 Favored Glycine 0 C--O 1.222 -0.645 0 CA-C-N 115.839 -0.619 . . . . 25.0 112.04 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -53.59 129.04 31.45 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.798 0.809 . . . . 25.0 111.801 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 174.99 -176.47 47.14 Favored Glycine 0 C--O 1.215 -1.051 0 N-CA-C 109.928 -1.269 . . . . 25.0 109.928 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -155.94 167.62 29.81 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 118.451 1.126 . . . . 25.0 111.09 -178.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 53.92 43.7 30.5 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 124.319 1.048 . . . . 25.0 112.65 -178.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 68.94 30.24 72.34 Favored Glycine 0 C--O 1.219 -0.796 0 CA-C-N 115.291 -0.868 . . . . 25.0 112.864 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.406 ' HA ' ' H ' ' A' ' 151' ' ' ALA . 6.2 t -142.51 171.69 13.72 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 118.316 1.058 . . . . 25.0 111.722 -177.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 83.6 mt -90.42 164.1 14.42 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 103.329 -2.841 . . . . 25.0 103.329 171.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.68 110.36 7.91 Favored 'General case' 0 C--O 1.252 1.226 0 N-CA-C 107.753 -1.203 . . . . 25.0 107.753 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 18.7 m -71.89 162.7 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-N 115.349 -0.841 . . . . 25.0 109.587 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 29.5 m -145.8 169.78 17.85 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 120.292 -0.563 . . . . 25.0 109.883 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 34.9 m -121.77 164.38 18.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 108.738 -0.838 . . . . 25.0 108.738 177.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.8 t -76.14 -48.64 19.84 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.319 -1.363 . . . . 25.0 107.319 170.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -165.73 -170.42 1.79 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 101.502 -3.518 . . . . 25.0 101.502 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -69.85 -2.84 13.38 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 119.164 0.893 . . . . 25.0 112.856 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -137.35 -160.94 8.75 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 106.204 -2.759 . . . . 25.0 106.204 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.16 -160.34 0.28 Allowed 'General case' 0 C--O 1.249 1.062 0 CA-C-N 117.865 0.832 . . . . 25.0 111.093 177.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 47.0 mtt85 -71.08 166.86 20.51 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 122.279 1.038 . . . . 25.0 112.975 -171.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.1 p -114.15 165.92 12.16 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 105.74 -1.948 . . . . 25.0 105.74 173.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -133.55 153.56 51.55 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 121.14 0.495 . . . . 25.0 111.772 -177.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 28.2 tp -128.01 118.92 24.4 Favored 'General case' 0 C--O 1.25 1.099 0 N-CA-C 103.684 -2.709 . . . . 25.0 103.684 171.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -115.23 145.17 42.69 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 115.829 -0.623 . . . . 25.0 112.298 -174.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.9 t -99.71 147.83 25.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 105.221 -2.14 . . . . 25.0 105.221 168.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -114.79 11.48 16.76 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.889 1.328 . . . . 25.0 108.456 -177.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -93.62 141.17 28.78 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 105.53 -2.026 . . . . 25.0 105.53 174.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -140.83 150.34 43.16 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 122.055 0.931 . . . . 25.0 109.81 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -76.6 167.01 22.59 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.331 -1.304 . . . . 25.0 108.791 177.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -62.96 -32.39 73.7 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.591 -0.892 . . . . 25.0 108.591 176.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -65.42 -9.28 23.95 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 114.423 1.268 . . . . 25.0 114.423 174.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.57 21.85 61.23 Favored Glycine 0 C--O 1.241 0.581 0 N-CA-C 109.453 -1.459 . . . . 25.0 109.453 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.5 mt -92.05 136.8 32.88 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 106.092 -1.818 . . . . 25.0 106.092 175.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.6 p -141.55 -179.7 6.31 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.867 -1.16 . . . . 25.0 107.867 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -127.94 131.77 49.3 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 119.085 -1.046 . . . . 25.0 113.222 -178.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -147.61 153.95 40.04 Favored 'General case' 0 C--O 1.26 1.619 0 N-CA-C 106.818 -1.549 . . . . 25.0 106.818 168.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.1 p -142.12 146.6 22.42 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 106.93 -1.508 . . . . 25.0 106.93 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -103.2 140.93 36.72 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 107.094 -1.447 . . . . 25.0 107.094 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.2 mp -129.42 131.2 46.72 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 105.177 -2.157 . . . . 25.0 105.177 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -108.9 15.83 23.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.142 0.973 . . . . 25.0 110.541 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -72.91 -8.42 73.2 Favored Glycine 0 C--O 1.238 0.386 0 CA-C-N 114.761 -1.109 . . . . 25.0 110.719 171.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 40.0 t0 51.08 55.92 8.79 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.585 0.707 . . . . 25.0 112.445 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -133.14 43.55 2.93 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-O 122.178 0.989 . . . . 25.0 109.913 -174.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.66 -31.03 64.0 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 121.633 -0.667 . . . . 25.0 111.061 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.74 -14.83 61.63 Favored 'General case' 0 C--O 1.256 1.399 0 N-CA-C 112.406 0.521 . . . . 25.0 112.406 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -109.48 -10.72 14.87 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.108 0.48 . . . . 25.0 111.743 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 29.7 mt -73.69 126.21 29.8 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 123.193 1.473 . . . . 25.0 112.562 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 68.0 m -127.96 158.72 37.08 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 105.553 -2.017 . . . . 25.0 105.553 175.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.406 ' H ' ' HA ' ' A' ' 111' ' ' SER . . . -80.13 -3.57 49.38 Favored 'General case' 0 C--O 1.211 -0.95 0 CA-C-N 115.854 -0.612 . . . . 25.0 110.418 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -67.1 -35.98 80.97 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 117.69 0.223 . . . . 25.0 111.297 -173.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -75.89 -11.44 59.97 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 120.307 -0.557 . . . . 25.0 110.597 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 22.5 mm -83.91 119.9 33.89 Favored 'Isoleucine or valine' 0 C--O 1.247 0.957 0 N-CA-C 106.449 -1.685 . . . . 25.0 106.449 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.6 p -95.94 109.37 22.59 Favored 'Isoleucine or valine' 0 C--O 1.253 1.247 0 CA-C-O 123.044 1.402 . . . . 25.0 113.797 -174.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -145.21 -12.92 0.53 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.649 -1.614 . . . . 25.0 112.185 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -76.75 54.19 0.96 Allowed 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 113.302 0.853 . . . . 25.0 113.302 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 57.87 27.65 14.92 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 113.784 1.031 . . . . 25.0 113.784 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 55.98 0.65 0.06 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 119.361 3.097 . . . . 25.0 119.361 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -88.12 134.23 33.81 Favored 'General case' 0 C--N 1.314 -0.962 0 O-C-N 121.255 -0.903 . . . . 25.0 110.758 -176.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -68.84 -14.28 62.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.918 -0.583 . . . . 25.0 109.578 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.11 -28.1 69.39 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.121 0.486 . . . . 25.0 111.626 177.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.1 162.06 28.86 Favored 'General case' 0 C--O 1.251 1.138 0 CA-C-O 121.264 0.555 . . . . 25.0 111.822 -177.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 61.38 -157.38 0.34 Allowed 'General case' 0 C--O 1.242 0.663 0 CA-C-N 114.629 -1.169 . . . . 25.0 112.619 177.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 90.95 -1.25 77.57 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.597 -0.335 . . . . 25.0 112.429 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -104.32 115.28 30.1 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.779 -0.823 . . . . 25.0 108.779 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -123.53 139.94 53.51 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.274 -0.639 . . . . 25.0 109.274 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -113.93 26.0 10.33 Favored Glycine 0 C--O 1.241 0.59 0 N-CA-C 112.314 -0.314 . . . . 25.0 112.314 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 52.3 t -79.18 -37.27 19.08 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 N-CA-C 109.463 -0.569 . . . . 25.0 109.463 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.43 135.64 24.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.629 0.728 . . . . 25.0 111.238 -175.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 133.58 141.78 4.62 Favored Glycine 0 C--O 1.247 0.969 0 N-CA-C 110.935 -0.866 . . . . 25.0 110.935 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -151.72 161.12 43.2 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.272 -0.64 . . . . 25.0 109.272 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 84.7 p -152.91 165.67 34.74 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 107.732 -1.21 . . . . 25.0 107.732 176.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -177.31 -171.13 40.52 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 119.887 -1.149 . . . . 25.0 112.114 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -138.78 92.54 11.22 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 117.587 0.693 . . . . 25.0 110.96 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.12 161.67 40.38 Favored 'Trans proline' 0 C--O 1.232 0.209 0 O-C-N 122.801 0.895 . . . . 25.0 112.115 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -134.64 151.43 51.04 Favored 'General case' 0 CA--C 1.508 -0.638 0 C-N-CA 123.535 0.734 . . . . 25.0 109.772 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -122.86 75.1 47.7 Favored Pre-proline 0 N--CA 1.481 1.084 0 CA-C-O 121.399 0.619 . . . . 25.0 110.842 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -77.44 160.33 32.16 Favored 'Trans proline' 0 CA--C 1.513 -0.526 0 C-N-CA 116.787 -1.675 . . . . 25.0 112.533 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 12.2 t -125.64 -4.9 7.06 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.211 -0.904 . . . . 25.0 110.741 174.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 6.3 p . . . . . 0 C--O 1.246 0.871 0 N-CA-C 109.61 -0.515 . . . . 25.0 109.61 176.72 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.866 0 CA-C-O 120.442 0.163 . . . . 25.0 110.573 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -150.28 101.72 3.15 Favored Pre-proline 0 C--N 1.33 -0.246 0 C-N-CA 122.236 0.214 . . . . 25.0 110.637 177.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.74 147.07 74.82 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 118.594 0.533 . . . . 25.0 113.097 -175.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -150.25 44.49 0.7 Allowed Glycine 0 CA--C 1.536 1.352 0 N-CA-C 114.533 0.573 . . . . 25.0 114.533 -177.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.498 HG22 ' H ' ' A' ' 7' ' ' GLY . 7.9 p -52.51 129.94 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 114.776 1.398 . . . . 25.0 114.776 -176.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -93.49 -7.71 43.58 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.838 -1.073 . . . . 25.0 111.536 -178.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.498 ' H ' HG22 ' A' ' 5' ' ' VAL . . . -81.93 -149.5 7.47 Favored Glycine 0 CA--C 1.507 -0.464 0 CA-C-N 115.597 -0.729 . . . . 25.0 114.344 179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.2 p 71.94 156.43 0.16 Allowed Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 126.266 1.826 . . . . 25.0 110.581 -173.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.61 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 24.6 Cg_exo -69.27 -0.21 6.19 Favored 'Trans proline' 0 C--N 1.354 0.849 0 N-CA-C 114.846 1.056 . . . . 25.0 114.846 -175.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.8 p -66.9 -14.43 18.03 Favored 'Isoleucine or valine' 0 C--O 1.248 0.983 0 N-CA-C 113.954 1.094 . . . . 25.0 113.954 -171.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.4 p -133.57 132.12 57.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 N-CA-C 113.758 1.022 . . . . 25.0 113.758 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.7 13.62 74.97 Favored Glycine 0 C--O 1.246 0.888 0 N-CA-C 118.642 2.217 . . . . 25.0 118.642 171.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.3 t -51.2 -41.78 60.46 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.153 1.168 . . . . 25.0 114.153 -171.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -78.61 4.96 12.09 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 116.243 1.942 . . . . 25.0 116.243 -174.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.93 176.94 9.11 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 118.832 -0.604 . . . . 25.0 111.438 -177.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -57.64 133.28 55.17 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.339 0.59 . . . . 25.0 111.585 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -130.18 157.27 42.93 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.539 0.941 . . . . 50.0 113.539 -173.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -132.25 73.08 1.51 Allowed 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 106.738 -1.578 . . . . 25.0 106.738 169.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.6 mt -91.48 125.8 36.35 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 114.366 1.247 . . . . 25.0 114.366 -174.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -110.1 109.93 20.64 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 116.327 -0.397 . . . . 25.0 110.901 176.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -80.62 176.61 54.62 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 115.855 1.102 . . . . 25.0 115.855 -175.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.7 p -69.08 170.76 9.36 Favored 'General case' 0 C--O 1.256 1.444 0 C-N-CA 123.885 0.874 . . . . 25.0 110.361 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 48.6 mt -87.06 20.82 2.53 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.657 -0.702 . . . . 25.0 110.769 170.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -128.62 -174.01 13.61 Favored Glycine 0 C--O 1.223 -0.56 0 CA-C-O 118.615 -1.103 . . . . 25.0 112.505 176.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.9 t -71.08 133.1 46.01 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 113.857 1.058 . . . . 25.0 113.857 -176.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -145.18 158.52 43.8 Favored 'General case' 0 C--O 1.219 -0.541 0 O-C-N 123.211 0.32 . . . . 50.0 111.682 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -99.61 134.15 42.91 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 103.352 -2.833 . . . . 25.0 103.352 162.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.9 mm -128.41 117.92 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 105.676 -1.972 . . . . 25.0 105.676 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.61 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 8.3 mp -115.55 116.19 27.74 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 106.888 -1.523 . . . . 25.0 106.888 178.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.76 -36.11 90.72 Favored Glycine 0 CA--C 1.502 -0.779 0 C-N-CA 120.567 -0.825 . . . . 25.0 115.062 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.34 -147.21 45.37 Favored Glycine 0 C--O 1.254 1.39 0 C-N-CA 120.813 -0.708 . . . . 25.0 112.027 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.99 165.66 54.74 Favored Glycine 0 C--O 1.249 1.039 0 N-CA-C 111.847 -0.501 . . . . 25.0 111.847 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.84 162.96 28.94 Favored Glycine 0 C--N 1.316 -0.546 0 N-CA-C 114.967 0.747 . . . . 25.0 114.967 174.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.78 106.65 16.47 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 106.524 -1.658 . . . . 25.0 106.524 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -103.58 155.3 18.65 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 112.892 0.701 . . . . 50.0 112.892 -169.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -122.77 93.7 4.05 Favored 'General case' 0 C--O 1.246 0.906 0 N-CA-C 106.277 -1.749 . . . . 25.0 106.277 176.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.8 mt -101.21 140.09 35.98 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 114.881 -1.054 . . . . 25.0 111.356 -170.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -135.64 102.73 5.19 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.563 -0.532 . . . . 25.0 109.563 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.56 -20.7 59.57 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 116.463 1.345 . . . . 25.0 116.463 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 50.29 -150.51 0.23 Allowed 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 119.548 1.674 . . . . 25.0 115.126 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.68 162.2 13.62 Favored 'General case' 0 CA--C 1.552 1.041 0 O-C-N 120.908 -1.12 . . . . 25.0 112.752 -177.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.86 156.12 28.25 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 114.828 -1.078 . . . . 25.0 111.574 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -77.91 106.6 9.86 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 106.943 -1.503 . . . . 25.0 106.943 173.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -111.93 151.83 28.74 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 121.577 -0.702 . . . . 50.0 110.649 -170.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mp -116.13 94.82 4.81 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.966 -1.124 . . . . 25.0 107.966 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 mp -99.25 127.01 45.19 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.701 0.8 . . . . 25.0 112.912 -175.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -124.4 148.81 47.32 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 104.35 -2.463 . . . . 25.0 104.35 175.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.47 -39.37 3.46 Favored Glycine 0 N--CA 1.462 0.432 0 N-CA-C 116.193 1.237 . . . . 25.0 116.193 -175.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.38 -175.55 48.77 Favored Glycine 0 C--O 1.243 0.718 0 N-CA-C 110.266 -1.134 . . . . 25.0 110.266 -177.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.01 149.14 12.31 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 112.752 0.649 . . . . 25.0 112.752 -178.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.41 153.47 29.6 Favored Glycine 0 N--CA 1.46 0.251 0 N-CA-C 111.017 -0.833 . . . . 25.0 111.017 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.5 125.38 29.28 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 104.222 -2.511 . . . . 25.0 104.222 177.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -109.65 153.12 24.68 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.328 -0.619 . . . . 50.0 109.328 -173.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -116.02 122.62 45.74 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 102.409 -3.182 . . . . 25.0 102.409 177.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -145.41 130.86 18.72 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 114.707 1.373 . . . . 25.0 114.707 -171.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.0 m -107.44 132.25 53.4 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 105.99 -1.855 . . . . 25.0 105.99 176.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -91.57 -27.53 17.15 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 111.581 -0.607 . . . . 25.0 111.581 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.21 -169.41 54.91 Favored Glycine 0 N--CA 1.466 0.648 0 CA-C-N 118.022 0.911 . . . . 25.0 113.704 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -66.2 163.41 17.84 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.903 -0.763 . . . . 25.0 110.956 177.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.44 160.29 36.39 Favored Glycine 0 C--O 1.25 1.124 0 CA-C-O 119.897 -0.391 . . . . 25.0 112.678 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.33 102.3 6.7 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.631 0.729 . . . . 25.0 109.853 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -94.85 154.1 17.4 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.773 -0.649 . . . . 50.0 111.545 -174.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.5 m -121.96 127.91 50.9 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.054 -1.461 . . . . 25.0 107.054 -177.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -116.8 82.09 1.74 Allowed 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 106.992 -1.484 . . . . 25.0 106.992 176.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.71 -27.27 40.66 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-N 115.634 -0.712 . . . . 25.0 110.946 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 66.98 153.84 0.09 Allowed 'General case' 0 N--CA 1.479 1.018 0 O-C-N 125.678 1.861 . . . . 25.0 112.112 -172.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.06 -50.8 8.67 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.917 1.08 . . . . 25.0 113.917 -166.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 46.6 mt -130.4 168.86 16.29 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-O 121.372 0.605 . . . . 25.0 109.564 -172.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.17 -28.47 53.09 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.977 0.911 . . . . 25.0 110.585 173.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -75.4 -12.88 60.34 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 115.576 1.695 . . . . 25.0 115.576 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -73.26 134.74 44.35 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.026 1.121 . . . . 25.0 114.026 -174.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.3 t 50.22 42.56 25.62 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 114.759 -1.109 . . . . 25.0 113.655 176.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -107.75 162.45 13.97 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.135 -0.484 . . . . 25.0 111.623 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -122.9 144.6 49.11 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 103.799 -2.667 . . . . 25.0 103.799 177.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 99.3 p -140.12 172.08 6.86 Favored Pre-proline 0 C--N 1.325 -0.478 0 C-N-CA 123.71 0.804 . . . . 25.0 108.963 -173.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -61.1 -19.26 62.56 Favored 'Trans proline' 0 C--N 1.354 0.829 0 O-C-N 122.653 0.817 . . . . 25.0 113.592 174.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.0 mt -79.36 -23.62 43.23 Favored 'General case' 0 C--O 1.245 0.857 0 N-CA-C 113.037 0.754 . . . . 25.0 113.037 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 148.51 -172.35 28.73 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 116.216 -0.447 . . . . 25.0 112.09 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.7 t -101.23 137.71 39.22 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.734 0.778 . . . . 25.0 111.859 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -122.63 29.93 6.68 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.22 -1.355 . . . . 25.0 107.694 173.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.91 146.56 50.43 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 109.765 -1.334 . . . . 25.0 109.765 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -95.84 163.66 13.07 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.41 -1.053 . . . . 50.0 110.316 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -126.04 104.06 8.07 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 111.992 0.367 . . . . 25.0 111.992 -170.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 21.6 mt -86.47 135.1 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 107.206 -1.405 . . . . 25.0 107.206 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.3 mt -89.02 -42.49 11.73 Favored 'General case' 0 C--O 1.21 -0.991 0 N-CA-C 114.77 1.396 . . . . 25.0 114.77 -175.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 46.8 p-10 -127.62 41.17 3.56 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.989 1.477 . . . . 25.0 114.989 -172.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -60.23 142.76 54.02 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 113.399 0.889 . . . . 25.0 113.399 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -117.1 100.13 53.11 Favored Pre-proline 0 N--CA 1.476 0.835 0 N-CA-C 108.948 -0.76 . . . . 25.0 108.948 177.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.9 1.66 4.32 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 N-CA-C 117.129 1.934 . . . . 25.0 117.129 -172.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.6 t -100.7 -35.84 9.33 Favored 'General case' 0 CA--C 1.554 1.099 0 O-C-N 121.763 -0.585 . . . . 25.0 110.753 175.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -98.86 -39.14 8.74 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 114.281 1.215 . . . . 25.0 114.281 -177.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -83.48 163.69 20.34 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.973 -0.558 . . . . 75.0 110.525 -172.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -142.26 146.14 34.82 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.003 0.814 . . . . 25.0 112.486 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 80.1 mt -125.96 131.92 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 107.753 -1.203 . . . . 25.0 107.753 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -88.29 144.5 26.38 Favored 'General case' 0 C--O 1.214 -0.814 0 O-C-N 120.958 -1.089 . . . . 25.0 110.185 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.4 p -146.69 4.42 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.359 0 CA-C-N 115.232 -0.894 . . . . 25.0 110.242 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.2 t -55.67 -57.72 10.8 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 112.9 0.704 . . . . 25.0 112.9 -173.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.44 -14.1 57.46 Favored 'General case' 0 C--O 1.256 1.404 0 N-CA-C 112.445 0.535 . . . . 25.0 112.445 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.9 mt -89.44 -52.91 4.79 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.285 0.564 . . . . 25.0 112.299 -175.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -109.03 -65.2 0.56 Allowed Glycine 0 CA--C 1.506 -0.523 0 N-CA-C 116.637 1.415 . . . . 25.0 116.637 -171.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -157.84 169.31 24.89 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 117.003 0.401 . . . . 25.0 111.353 -171.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.0 t -109.52 -23.6 11.41 Favored 'General case' 0 CA--C 1.557 1.233 0 O-C-N 123.869 0.731 . . . . 25.0 111.977 177.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -120.4 145.03 17.42 Favored Glycine 0 C--O 1.235 0.173 0 N-CA-C 105.593 -3.003 . . . . 25.0 105.593 172.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -58.28 154.0 14.23 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.095 1.146 . . . . 25.0 114.095 -173.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -90.17 -166.2 41.16 Favored Glycine 0 C--O 1.223 -0.59 0 CA-C-N 115.272 -0.876 . . . . 25.0 112.989 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -57.04 131.38 49.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.356 0.598 . . . . 25.0 112.202 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 160.41 178.1 34.1 Favored Glycine 0 N--CA 1.466 0.698 0 N-CA-C 107.054 -2.418 . . . . 25.0 107.054 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -141.76 166.72 23.95 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.932 1.366 . . . . 25.0 110.321 -175.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 55.04 34.23 22.04 Favored 'General case' 0 C--O 1.26 1.627 0 C-N-CA 123.392 0.677 . . . . 25.0 112.038 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.09 41.3 54.56 Favored Glycine 0 C--O 1.216 -1.018 0 N-CA-C 111.269 -0.732 . . . . 25.0 111.269 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.5 t -142.95 175.87 9.51 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.887 -0.782 . . . . 25.0 108.887 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 82.6 mt -106.48 164.65 11.88 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 105.655 -1.98 . . . . 25.0 105.655 173.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.418 ' HB3' ' CE1' ' A' ' 128' ' ' TYR . . . -72.89 120.5 18.6 Favored 'General case' 0 C--O 1.245 0.85 0 N-CA-C 108.302 -0.999 . . . . 25.0 108.302 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.9 m -89.71 158.36 2.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.874 -0.788 . . . . 25.0 108.874 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.4 m -132.98 154.09 50.82 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.038 -0.727 . . . . 25.0 109.038 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.3 m -120.33 160.38 20.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 108.633 -0.877 . . . . 25.0 108.633 177.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 17.2 t -75.84 -47.4 25.72 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 105.828 -1.915 . . . . 25.0 105.828 170.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -173.86 -162.52 0.15 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 101.229 -3.619 . . . . 25.0 101.229 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -61.02 -35.93 78.17 Favored 'General case' 0 C--O 1.246 0.88 0 CA-C-N 118.157 0.435 . . . . 25.0 111.088 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -103.01 -154.05 24.48 Favored Glycine 0 C--O 1.225 -0.463 0 CA-C-O 121.574 0.541 . . . . 25.0 112.293 176.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.91 -138.75 0.4 Allowed 'General case' 0 C--O 1.237 0.435 0 C-N-CA 122.75 0.42 . . . . 25.0 111.747 174.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 33.7 mtt85 -105.48 167.05 10.01 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 121.679 -0.638 . . . . 25.0 112.188 -174.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.28 165.58 13.28 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 105.402 -2.073 . . . . 25.0 105.402 177.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -138.45 152.65 48.52 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.767 -0.827 . . . . 25.0 108.767 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 27.0 tp -128.75 114.8 17.04 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 105.1 -2.185 . . . . 25.0 105.1 175.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -116.97 151.18 37.26 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 122.588 1.185 . . . . 25.0 112.101 -171.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.1 t -93.77 142.55 27.24 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 104.543 -2.392 . . . . 25.0 104.543 171.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.418 ' CE1' ' HB3' ' A' ' 113' ' ' ALA . 62.7 m-85 -115.6 11.08 15.74 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 122.539 1.161 . . . . 25.0 108.207 176.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -91.1 136.1 33.32 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 105.258 -2.127 . . . . 25.0 105.258 168.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -131.5 152.43 50.73 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-O 121.892 0.853 . . . . 25.0 110.433 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -86.54 166.72 15.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.392 -1.276 . . . . 25.0 109.382 -176.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -61.38 -32.14 72.05 Favored 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 122.676 0.39 . . . . 25.0 111.192 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -76.6 -4.54 43.46 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.325 0.861 . . . . 25.0 113.325 175.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.01 13.64 63.98 Favored Glycine 0 CA--C 1.501 -0.838 0 C-N-CA 120.919 -0.657 . . . . 25.0 112.176 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 65.7 mt -83.47 158.3 22.1 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 106.472 -1.677 . . . . 25.0 106.472 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.6 p -154.56 177.77 10.83 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 104.851 -2.278 . . . . 25.0 104.851 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -127.77 137.55 52.46 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-O 119.044 -0.503 . . . . 25.0 110.199 -176.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -152.56 153.49 33.52 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 118.996 0.816 . . . . 25.0 109.071 171.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.2 p -143.7 142.05 25.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 106.792 -1.559 . . . . 25.0 106.792 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -100.31 146.76 26.55 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.361 -0.977 . . . . 25.0 108.361 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.0 mp -137.48 132.76 33.78 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 104.669 -2.345 . . . . 25.0 104.669 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -101.82 12.16 37.49 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 121.26 1.845 . . . . 25.0 115.803 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -73.81 -14.91 79.7 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.398 -0.906 . . . . 25.0 113.081 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 42.2 t0 53.26 43.0 32.07 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 123.826 1.774 . . . . 25.0 110.902 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -109.55 41.1 1.73 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 113.547 -1.661 . . . . 25.0 107.606 -176.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.94 -29.95 63.59 Favored 'General case' 0 C--O 1.209 -1.047 0 CA-C-N 113.923 -1.49 . . . . 25.0 113.293 177.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.58 -31.66 57.66 Favored 'General case' 0 C--N 1.319 -0.756 0 O-C-N 120.285 -1.51 . . . . 25.0 112.135 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -77.27 -29.83 54.03 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.975 0.731 . . . . 25.0 112.975 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 15.9 mt -60.91 129.9 43.78 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 122.65 1.214 . . . . 25.0 110.413 -176.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.9 m -138.73 163.8 31.21 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 104.999 -2.222 . . . . 25.0 104.999 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.04 4.47 17.0 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 118.562 0.619 . . . . 25.0 109.734 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -75.01 -29.86 60.98 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.39 -0.823 . . . . 25.0 111.662 -177.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -87.32 -8.74 56.35 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 122.092 -0.38 . . . . 25.0 110.8 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 40.6 mm -91.95 132.78 35.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 104.609 -2.367 . . . . 25.0 104.609 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.4 p -115.11 132.76 63.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 122.053 0.93 . . . . 25.0 111.496 -175.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -155.33 -34.13 0.09 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 114.701 1.371 . . . . 25.0 114.701 -174.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.33 60.43 5.58 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 113.234 0.827 . . . . 25.0 113.234 -173.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 58.75 21.17 8.63 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.843 1.053 . . . . 25.0 113.843 176.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.65 11.52 2.44 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 114.675 1.361 . . . . 25.0 114.675 175.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -89.87 129.59 36.21 Favored 'General case' 0 C--O 1.238 0.448 0 O-C-N 121.999 -0.438 . . . . 25.0 110.304 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -66.69 -15.29 63.4 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.376 0.608 . . . . 25.0 111.07 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.7 -19.08 64.35 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 121.699 -0.626 . . . . 25.0 112.269 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.48 157.4 22.42 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 111.982 0.364 . . . . 25.0 111.982 -178.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 56.59 -163.79 0.16 Allowed 'General case' 0 CA--C 1.549 0.933 0 O-C-N 124.434 1.084 . . . . 25.0 113.417 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 97.67 0.98 58.96 Favored Glycine 0 N--CA 1.465 0.628 0 N-CA-C 114.94 0.736 . . . . 25.0 114.94 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -75.85 110.87 10.64 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 117.239 0.519 . . . . 25.0 111.193 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -129.85 155.44 46.0 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.553 0.341 . . . . 25.0 111.01 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -136.44 39.86 1.59 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.096 -1.202 . . . . 25.0 110.096 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 60.8 t -73.99 -36.21 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 109.76 -0.459 . . . . 25.0 109.76 -176.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.4 130.93 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-O 121.684 0.754 . . . . 25.0 111.639 -177.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 139.0 155.25 6.61 Favored Glycine 0 C--O 1.247 0.929 0 CA-C-N 115.336 -0.847 . . . . 25.0 111.741 -178.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -163.2 170.72 17.32 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 108.731 -0.84 . . . . 25.0 108.731 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 77.4 p -150.58 168.73 23.4 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 105.826 -1.916 . . . . 25.0 105.826 173.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -159.04 140.68 7.03 Favored Glycine 0 CA--C 1.501 -0.808 0 C-N-CA 119.728 -1.225 . . . . 25.0 115.062 177.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -131.64 80.16 67.08 Favored Pre-proline 0 C--O 1.24 0.561 0 N-CA-C 106.998 -1.482 . . . . 25.0 106.998 177.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -68.75 155.33 69.09 Favored 'Trans proline' 0 C--O 1.236 0.406 0 N-CA-C 113.582 0.57 . . . . 25.0 113.582 -174.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -120.66 151.96 38.81 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 106.871 -1.529 . . . . 25.0 106.871 -177.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -143.47 64.85 14.19 Favored Pre-proline 0 C--O 1.248 0.997 0 N-CA-C 115.559 1.689 . . . . 25.0 115.559 -178.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -71.53 151.28 58.71 Favored 'Trans proline' 0 C--O 1.244 0.814 0 C-N-CA 116.969 -1.554 . . . . 25.0 111.345 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 11.5 t -137.63 22.68 2.91 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.397 0.618 . . . . 25.0 110.919 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 C--O 1.247 0.944 0 CA-C-O 116.874 -1.536 . . . . 25.0 110.825 -179.665 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.971 0 N-CA-C 109.914 -0.402 . . . . 25.0 109.914 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -128.04 121.05 21.61 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 107.357 -1.349 . . . . 25.0 107.357 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.51 146.65 68.69 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 115.069 -2.82 . . . . 25.0 113.268 -175.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.88 46.39 0.04 OUTLIER Glycine 0 CA--C 1.522 0.511 0 CA-C-N 115.427 -0.806 . . . . 25.0 111.11 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.1 p -57.54 133.85 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 CA-C-O 121.497 0.665 . . . . 25.0 109.997 -175.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -99.76 -11.57 20.71 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.703 -0.68 . . . . 25.0 109.742 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.33 -147.55 8.43 Favored Glycine 0 CA--C 1.501 -0.836 0 CA-C-N 115.621 -0.718 . . . . 25.0 113.028 177.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.2 p 71.3 159.09 0.16 Allowed Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 125.632 1.573 . . . . 25.0 111.135 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.551 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 31.2 Cg_exo -66.19 1.76 2.25 Favored 'Trans proline' 0 C--N 1.351 0.67 0 N-CA-C 117.406 2.041 . . . . 25.0 117.406 -175.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.3 p -63.98 -24.06 34.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 115.735 1.754 . . . . 25.0 115.735 -168.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.6 p -145.93 140.43 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 114.233 1.197 . . . . 25.0 114.233 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.85 10.0 86.53 Favored Glycine 0 N--CA 1.466 0.678 0 CA-C-N 114.753 -1.112 . . . . 25.0 115.434 171.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.6 t -50.95 -39.3 54.71 Favored 'General case' 0 C--O 1.21 -1.025 0 N-CA-C 114.075 1.139 . . . . 25.0 114.075 -170.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -81.71 8.07 10.9 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 115.044 1.498 . . . . 25.0 115.044 -175.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -142.99 173.96 11.09 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 118.852 -0.594 . . . . 25.0 111.459 176.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -58.79 124.12 18.72 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 115.314 1.598 . . . . 25.0 115.314 -173.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -124.32 164.47 19.54 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.611 1.708 . . . . 50.0 115.611 -175.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -130.85 77.03 1.76 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 107.469 -1.308 . . . . 25.0 107.469 169.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.1 mt -90.74 120.24 31.62 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.861 1.06 . . . . 25.0 113.861 -175.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -110.9 124.54 52.29 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 122.799 0.44 . . . . 25.0 110.69 178.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.45 172.72 41.52 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-O 122.626 1.126 . . . . 25.0 114.973 -176.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.8 p -84.97 175.44 9.06 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.037 -1.081 . . . . 25.0 110.484 175.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 66.2 mt -79.42 4.22 16.11 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.507 0.723 . . . . 25.0 112.733 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.61 177.78 24.82 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 119.438 -0.646 . . . . 25.0 113.879 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.1 t -70.14 129.98 40.85 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 117.303 0.552 . . . . 25.0 111.995 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -145.51 159.36 43.22 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.129 -0.357 . . . . 50.0 110.774 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -94.33 138.97 31.68 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 106.119 -1.808 . . . . 25.0 106.119 164.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.3 mm -129.69 105.99 12.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 105.49 -2.041 . . . . 25.0 105.49 178.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.551 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 8.9 mp -105.57 117.45 34.06 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.735 -0.839 . . . . 25.0 108.735 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.64 -42.54 62.44 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.196 -1.002 . . . . 25.0 114.303 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.8 -149.55 48.12 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 120.277 -0.963 . . . . 25.0 112.53 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.46 168.16 52.91 Favored Glycine 0 C--O 1.247 0.929 0 CA-C-O 122.001 0.778 . . . . 25.0 114.25 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.85 167.22 26.47 Favored Glycine 0 C--O 1.24 0.47 0 N-CA-C 111.954 -0.458 . . . . 25.0 111.954 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.06 120.15 28.03 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 105.773 -1.936 . . . . 25.0 105.773 176.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -115.09 154.74 28.35 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 120.41 -0.516 . . . . 50.0 111.984 -172.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -118.86 90.63 3.37 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 107.068 -1.456 . . . . 25.0 107.068 177.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.4 mt -98.4 138.22 35.95 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 123.078 0.551 . . . . 25.0 111.876 -171.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -135.31 105.78 6.42 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 118.554 0.616 . . . . 25.0 111.537 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.27 -30.65 45.02 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 115.316 0.887 . . . . 25.0 115.316 -175.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 53.93 -150.1 0.4 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.058 0.943 . . . . 25.0 112.289 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.36 162.9 24.3 Favored 'General case' 0 C--O 1.254 1.305 0 O-C-N 121.072 -1.018 . . . . 25.0 112.353 -175.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.75 159.04 32.54 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 114.922 -1.036 . . . . 25.0 111.71 -177.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -81.02 102.78 10.41 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.058 -1.089 . . . . 25.0 108.058 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -106.04 150.07 26.09 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.521 0.677 . . . . 50.0 112.72 -170.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 mp -113.05 89.37 3.06 Favored 'General case' 0 C--O 1.217 -0.626 0 N-CA-C 108.436 -0.95 . . . . 25.0 108.436 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.9 mp -92.75 129.67 38.61 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.303 0.482 . . . . 25.0 112.303 -176.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -127.1 146.61 50.32 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 104.516 -2.402 . . . . 25.0 104.516 175.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -98.19 -33.74 5.61 Favored Glycine 0 N--CA 1.466 0.689 0 N-CA-C 117.253 1.661 . . . . 25.0 117.253 -176.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.94 -162.19 52.66 Favored Glycine 0 C--O 1.257 1.587 0 N-CA-C 110.608 -0.997 . . . . 25.0 110.608 -174.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.68 161.79 7.39 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.674 0.75 . . . . 25.0 112.758 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.4 170.95 37.94 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 115.07 -0.968 . . . . 25.0 113.683 174.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.72 124.03 30.46 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 106.28 -1.748 . . . . 25.0 106.28 177.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -115.56 152.36 33.19 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 120.979 0.418 . . . . 50.0 111.593 -175.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -115.09 129.53 56.71 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 103.879 -2.637 . . . . 25.0 103.879 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -148.41 127.45 12.8 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 115.884 1.809 . . . . 25.0 115.884 -174.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.9 m -99.37 134.2 42.57 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.481 -0.781 . . . . 25.0 108.899 172.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.03 -33.95 9.25 Favored Glycine 0 C--O 1.244 0.777 0 C-N-CA 120.07 -1.062 . . . . 25.0 112.681 175.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.6 -169.39 54.73 Favored Glycine 0 C--O 1.255 1.442 0 CA-C-O 122.54 1.078 . . . . 25.0 115.111 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -67.75 162.45 23.83 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.375 -1.073 . . . . 25.0 110.605 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.77 164.48 39.63 Favored Glycine 0 C--O 1.244 0.761 0 N-CA-C 111.218 -0.753 . . . . 25.0 111.218 -177.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.74 105.13 16.05 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 109.619 -0.511 . . . . 25.0 109.619 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -99.15 151.71 20.68 Favored 'General case' 0 C--O 1.215 -0.73 0 CA-C-N 115.691 -0.686 . . . . 50.0 110.531 -170.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 58.9 m -121.64 126.67 49.58 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.925 -0.769 . . . . 25.0 108.925 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -114.36 87.59 2.67 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.615 -1.254 . . . . 25.0 107.615 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 30.8 mtt85 -85.87 -23.22 27.17 Favored 'General case' 0 CA--C 1.505 -0.763 0 O-C-N 121.602 -0.686 . . . . 25.0 112.661 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 67.75 142.6 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 O-C-N 125.161 1.538 . . . . 25.0 112.876 -174.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.28 -52.91 10.89 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 114.791 1.404 . . . . 25.0 114.791 -163.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 98.0 mt -135.82 176.53 8.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.308 1.051 . . . . 25.0 110.04 -176.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.58 -28.41 32.03 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.104 -0.953 . . . . 25.0 112.362 173.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -77.91 -10.83 59.77 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 114.707 1.373 . . . . 25.0 114.707 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.15 138.4 41.99 Favored 'General case' 0 C--O 1.213 -0.844 0 O-C-N 120.845 -1.159 . . . . 25.0 111.709 -175.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.8 t 45.61 39.42 4.9 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-N 113.682 -1.599 . . . . 25.0 114.005 173.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -104.31 167.31 9.83 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.097 -0.956 . . . . 25.0 109.434 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -127.47 143.84 51.14 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 104.791 -2.3 . . . . 25.0 104.791 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.6 p -135.9 166.76 25.86 Favored Pre-proline 0 C--N 1.315 -0.904 0 N-CA-C 108.021 -1.103 . . . . 25.0 108.021 -176.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -63.04 -23.48 73.81 Favored 'Trans proline' 0 C--N 1.353 0.774 0 CA-C-N 118.917 0.649 . . . . 25.0 112.68 175.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 73.7 mt -72.85 -23.85 60.81 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.418 0.628 . . . . 25.0 111.036 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 149.23 177.49 23.41 Favored Glycine 0 CA--C 1.5 -0.847 0 N-CA-C 111.028 -0.829 . . . . 25.0 111.028 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.3 t -97.59 155.12 17.12 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 118.072 0.936 . . . . 25.0 112.765 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -136.36 24.78 3.21 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 106.622 -1.621 . . . . 25.0 106.622 175.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.53 146.33 48.49 Favored Glycine 0 C--O 1.218 -0.865 0 CA-C-O 118.885 -0.953 . . . . 25.0 111.733 178.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -98.37 166.27 11.46 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 118.11 0.955 . . . . 50.0 112.311 -177.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -124.11 99.82 6.42 Favored 'General case' 0 C--O 1.253 1.26 0 O-C-N 123.593 0.558 . . . . 25.0 111.844 -172.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.8 mt -84.19 135.49 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 106.082 -1.821 . . . . 25.0 106.082 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.424 ' HA ' ' HG2' ' A' ' 142' ' ' GLU . 12.9 mt -89.99 -45.13 9.39 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 115.607 1.706 . . . . 25.0 115.607 -171.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -131.23 32.11 4.3 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.816 1.043 . . . . 25.0 113.816 -170.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -51.25 138.97 19.74 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.795 1.035 . . . . 25.0 113.795 -175.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -107.93 106.93 59.62 Favored Pre-proline 0 C--O 1.235 0.329 0 N-CA-C 108.293 -1.003 . . . . 25.0 108.293 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -69.8 -8.17 22.93 Favored 'Trans proline' 0 CA--C 1.547 1.161 0 N-CA-C 117.743 2.17 . . . . 25.0 117.743 -174.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.8 t -96.84 -35.81 10.81 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-O 120.481 0.181 . . . . 25.0 111.41 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -98.83 -37.66 9.35 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 113.349 0.87 . . . . 25.0 113.349 -173.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -86.59 167.0 14.96 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.922 0.391 . . . . 75.0 110.551 -173.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -145.59 149.09 33.91 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 109.356 -0.609 . . . . 25.0 109.356 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 68.5 mt -125.51 133.21 69.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 108.05 -1.093 . . . . 25.0 108.05 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -95.59 144.33 26.13 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.754 -1.202 . . . . 25.0 107.754 174.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.1 p -143.41 -10.16 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.722 -0.672 . . . . 25.0 111.612 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 39.0 t -58.85 -42.6 89.74 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.416 0.895 . . . . 25.0 113.416 -175.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.54 -20.82 61.98 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 113.977 1.102 . . . . 25.0 113.977 -176.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.79 -45.38 1.9 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 116.436 2.013 . . . . 25.0 116.436 -170.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -94.74 -75.57 1.29 Allowed Glycine 0 N--CA 1.463 0.47 0 C-N-CA 119.999 -1.096 . . . . 25.0 113.099 -175.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -148.75 167.09 26.51 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.068 -0.716 . . . . 25.0 109.068 -175.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.8 t -124.38 -27.96 3.7 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.453 0.644 . . . . 25.0 110.362 176.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -101.0 120.14 6.78 Favored Glycine 0 N--CA 1.466 0.691 0 N-CA-C 108.294 -1.922 . . . . 25.0 108.294 172.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -66.24 150.4 48.87 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 119.776 1.788 . . . . 25.0 109.55 -176.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -102.57 -146.33 17.4 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-O 122.755 1.197 . . . . 25.0 115.723 -173.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -60.01 134.35 56.96 Favored 'General case' 0 C--O 1.251 1.16 0 CA-C-N 113.605 -1.298 . . . . 25.0 112.238 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 159.28 -176.98 36.01 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 123.28 0.363 . . . . 25.0 112.504 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -144.57 179.07 7.52 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 109.609 -0.515 . . . . 25.0 109.609 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 56.74 32.85 21.93 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 113.967 1.099 . . . . 25.0 113.967 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 69.06 29.7 72.24 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 109.964 -1.254 . . . . 25.0 109.964 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.8 t -143.32 174.3 10.85 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.373 0.606 . . . . 25.0 109.69 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 5.5 mp -92.7 161.82 14.39 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 103.337 -2.838 . . . . 25.0 103.337 173.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.84 118.01 10.49 Favored 'General case' 0 C--O 1.269 2.087 0 CA-C-N 118.953 0.797 . . . . 25.0 112.196 -172.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 26.4 m -79.75 162.05 3.9 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 CA-C-O 121.56 0.695 . . . . 25.0 109.363 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 56.1 m -145.88 171.3 15.01 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.714 -0.847 . . . . 25.0 108.714 -177.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 34.0 m -125.17 162.68 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 109.156 -0.683 . . . . 25.0 109.156 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 40.2 t -80.92 -40.17 25.01 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.464 -1.68 . . . . 25.0 106.464 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -174.27 -163.49 0.16 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 102.628 -3.101 . . . . 25.0 102.628 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -63.63 -23.76 67.51 Favored 'General case' 0 C--O 1.248 1.013 0 N-CA-C 112.39 0.515 . . . . 25.0 112.39 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -121.6 -153.61 9.0 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 109.499 -1.441 . . . . 25.0 109.499 175.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.83 -154.01 0.37 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 122.859 0.464 . . . . 25.0 110.295 175.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.0 mtt85 -81.46 160.29 24.03 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 114.43 1.27 . . . . 25.0 114.43 -173.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.1 p -105.21 162.62 13.25 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 105.642 -1.985 . . . . 25.0 105.642 172.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -130.27 150.68 51.4 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.394 0.616 . . . . 25.0 112.175 -177.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 64.8 tp -127.53 120.05 27.39 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 104.022 -2.584 . . . . 25.0 104.022 171.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -118.41 146.19 44.63 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.686 0.624 . . . . 25.0 112.686 -171.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.2 t -89.15 147.94 23.93 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 106.201 -1.778 . . . . 25.0 106.201 167.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -116.5 -0.04 12.59 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.624 -1.251 . . . . 25.0 107.624 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -86.0 137.43 32.72 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 104.085 -2.561 . . . . 25.0 104.085 169.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -146.2 158.42 43.88 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 124.697 1.248 . . . . 25.0 109.38 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -80.6 160.61 25.06 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.733 -1.122 . . . . 25.0 107.976 175.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.47 -22.37 66.94 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 122.002 -0.436 . . . . 25.0 110.625 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -69.41 -11.82 61.14 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 113.455 0.909 . . . . 25.0 113.455 174.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.63 16.14 57.18 Favored Glycine 0 C--O 1.22 -0.781 0 N-CA-C 111.64 -0.584 . . . . 25.0 111.64 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.3 mt -88.66 130.21 35.35 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.985 -1.117 . . . . 25.0 107.985 178.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 72.7 p -138.95 -179.69 5.98 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.477 -0.564 . . . . 25.0 109.477 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -122.13 133.11 54.76 Favored 'General case' 0 C--O 1.257 1.453 0 CA-C-O 119.177 -0.44 . . . . 25.0 110.452 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.4 pt-20 -145.91 152.17 39.02 Favored 'General case' 0 C--O 1.247 0.956 0 N-CA-C 108.293 -1.002 . . . . 25.0 108.293 171.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.8 p -145.85 139.82 21.31 Favored 'Isoleucine or valine' 0 C--O 1.248 0.985 0 N-CA-C 106.712 -1.588 . . . . 25.0 106.712 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -103.41 147.6 26.93 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 107.704 -1.221 . . . . 25.0 107.704 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.7 mp -136.61 129.96 31.55 Favored 'General case' 0 C--O 1.208 -1.132 0 N-CA-C 105.186 -2.153 . . . . 25.0 105.186 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.424 ' HG2' ' HA ' ' A' ' 85' ' ' LEU . 17.4 pt-20 -99.66 6.54 45.62 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 119.889 1.222 . . . . 25.0 112.158 -175.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -71.1 -12.35 71.71 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.718 -0.753 . . . . 25.0 112.275 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 38.7 t0 53.53 54.86 9.4 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.915 0.864 . . . . 25.0 111.371 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -126.94 39.63 3.88 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.56 -1.2 . . . . 25.0 109.129 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.74 -37.01 82.66 Favored 'General case' 0 C--O 1.214 -0.791 0 O-C-N 121.792 -0.567 . . . . 25.0 111.673 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.16 -10.29 59.46 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 121.53 -0.731 . . . . 25.0 112.085 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -98.12 -26.13 14.68 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 111.789 0.292 . . . . 25.0 111.789 175.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.0 mt -62.69 136.06 57.69 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 122.581 1.181 . . . . 25.0 111.357 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.5 m -135.81 164.26 28.32 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 105.558 -2.016 . . . . 25.0 105.558 171.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -77.05 8.38 3.94 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.71 0.29 . . . . 25.0 110.716 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -65.66 -39.34 91.26 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.301 0.482 . . . . 25.0 112.301 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -81.54 -10.41 59.46 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.075 -0.966 . . . . 25.0 111.079 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 13.4 mm -91.27 126.1 43.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 106.312 -1.736 . . . . 25.0 106.312 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.0 p -103.05 122.77 55.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 O-C-N 120.996 -1.065 . . . . 25.0 111.555 -177.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -157.22 -16.05 0.09 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 114.684 -1.144 . . . . 25.0 113.563 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.96 61.48 6.45 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 121.878 -0.514 . . . . 25.0 111.261 -172.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 55.44 15.39 1.42 Allowed 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 115.94 1.83 . . . . 25.0 115.94 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 64.76 -21.82 0.08 Allowed 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 116.557 2.058 . . . . 25.0 116.557 176.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -70.64 116.48 11.01 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.917 -1.114 . . . . 25.0 110.201 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.42 -5.7 44.0 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 113.238 0.829 . . . . 25.0 113.238 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.24 -20.11 65.62 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.316 0.579 . . . . 25.0 110.811 177.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -90.99 -162.26 0.89 Allowed 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.588 -0.733 . . . . 25.0 111.198 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 60.79 -160.45 0.3 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.138 0.975 . . . . 25.0 113.106 176.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 79.98 24.05 60.51 Favored Glycine 0 C--O 1.228 -0.263 0 C-N-CA 121.367 -0.444 . . . . 25.0 112.272 -178.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -97.37 93.49 6.52 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.791 -0.829 . . . . 25.0 109.788 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -121.86 152.67 39.33 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.249 0.547 . . . . 25.0 109.834 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -140.5 33.77 2.03 Favored Glycine 0 CA--C 1.51 -0.251 0 CA-C-O 122.281 0.934 . . . . 25.0 111.173 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 61.3 t -82.69 -35.79 12.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 O-C-N 122.221 -0.576 . . . . 25.0 110.675 -176.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -53.27 137.84 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 115.843 -0.617 . . . . 25.0 111.246 -178.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 140.35 155.3 6.5 Favored Glycine 0 C--O 1.245 0.784 0 CA-C-N 115.843 -0.617 . . . . 25.0 112.759 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -155.94 143.67 19.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.565 0.683 . . . . 25.0 110.077 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 87.1 p -154.13 163.67 39.74 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 122.477 0.311 . . . . 25.0 110.916 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 172.41 -179.25 44.09 Favored Glycine 0 N--CA 1.47 0.956 0 N-CA-C 110.982 -0.847 . . . . 25.0 110.982 176.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -138.99 113.06 8.25 Favored Pre-proline 0 C--O 1.248 0.98 0 CA-C-N 118.152 0.976 . . . . 25.0 110.917 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.82 169.06 23.01 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 N-CA-C 115.365 1.256 . . . . 25.0 115.365 -177.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -122.49 149.02 44.46 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.078 -0.712 . . . . 25.0 109.078 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -138.49 73.78 41.62 Favored Pre-proline 0 N--CA 1.472 0.641 0 C-N-CA 123.349 0.66 . . . . 25.0 110.372 175.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -76.4 155.2 36.51 Favored 'Trans proline' 0 N--CA 1.478 0.577 0 C-N-CA 118.448 -0.568 . . . . 25.0 113.29 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.7 t -96.08 -2.16 47.21 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 121.951 -0.468 . . . . 25.0 111.965 -177.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 C--O 1.257 1.496 0 CA-C-O 118.554 -0.736 . . . . 25.0 110.017 -177.827 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 109.557 -0.535 . . . . 25.0 109.557 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -102.95 115.22 64.51 Favored Pre-proline 0 C--O 1.25 1.081 0 N-CA-C 110.029 -0.36 . . . . 25.0 110.029 178.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -67.98 146.39 71.09 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 117.223 -1.385 . . . . 25.0 112.194 -177.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.64 60.67 0.03 OUTLIER Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.993 -0.623 . . . . 25.0 111.899 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.57 HG22 ' H ' ' A' ' 7' ' ' GLY . 7.1 p -55.84 134.68 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 122.504 1.145 . . . . 25.0 111.217 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -101.99 0.31 34.97 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 121.556 0.693 . . . . 25.0 111.045 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.57 ' H ' HG22 ' A' ' 5' ' ' VAL . . . -92.08 -147.96 21.6 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.499 -0.773 . . . . 25.0 113.694 176.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.8 p 69.98 155.59 0.15 Allowed Pre-proline 0 N--CA 1.489 1.521 0 C-N-CA 126.011 1.724 . . . . 25.0 111.226 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -73.89 4.68 3.96 Favored 'Trans proline' 0 C--O 1.24 0.625 0 C-N-CA 121.631 1.554 . . . . 25.0 115.318 -177.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.0 p -54.18 -31.5 21.98 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 N-CA-C 116.02 1.859 . . . . 25.0 116.02 -170.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.0 p -148.26 152.83 12.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 O-C-N 120.943 -1.098 . . . . 25.0 111.01 -177.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.91 7.32 88.44 Favored Glycine 0 N--CA 1.468 0.788 0 N-CA-C 115.425 0.93 . . . . 25.0 115.425 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.2 t -56.65 -40.4 75.39 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 113.914 1.079 . . . . 25.0 113.914 -172.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -78.87 10.17 3.6 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 116.41 2.004 . . . . 25.0 116.41 -175.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.59 169.74 18.97 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 119.205 -0.426 . . . . 25.0 110.545 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -51.0 139.01 18.34 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 118.664 0.666 . . . . 25.0 111.892 -177.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -131.0 161.93 30.88 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.436 1.273 . . . . 50.0 114.436 -175.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -133.87 96.15 3.6 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 104.682 -2.34 . . . . 25.0 104.682 163.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 97.5 mt -112.01 126.26 54.95 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 121.341 0.591 . . . . 25.0 111.213 -176.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -119.72 117.19 27.6 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.226 -0.897 . . . . 25.0 109.753 -176.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.58 177.29 51.38 Favored Glycine 0 CA--C 1.502 -0.763 0 N-CA-C 116.063 1.185 . . . . 25.0 116.063 -175.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.7 p -79.81 174.26 11.76 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 114.302 -0.949 . . . . 25.0 111.407 178.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 77.3 mt -87.3 18.3 3.85 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 121.551 -0.718 . . . . 25.0 111.336 175.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -123.92 179.4 16.15 Favored Glycine 0 CA--C 1.502 -0.76 0 N-CA-C 111.475 -0.65 . . . . 25.0 111.475 177.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.2 t -67.29 134.09 50.92 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.146 0.424 . . . . 25.0 112.146 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -147.02 171.96 14.47 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 123.402 0.681 . . . . 50.0 111.843 -176.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -119.34 126.77 52.21 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.802 -1.555 . . . . 25.0 106.802 166.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.9 mm -123.75 130.41 74.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 106.652 -1.61 . . . . 25.0 106.652 -178.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.6 tt -134.78 123.93 24.36 Favored 'General case' 0 C--O 1.21 -1.012 0 N-CA-C 106.761 -1.57 . . . . 25.0 106.761 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.2 -34.33 37.41 Favored Glycine 0 CA--C 1.497 -1.051 0 N-CA-C 116.22 1.248 . . . . 25.0 116.22 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.38 -143.91 38.13 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.465 -0.874 . . . . 25.0 110.99 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.44 165.9 54.72 Favored Glycine 0 CA--C 1.498 -1.014 0 CA-C-O 122.672 1.151 . . . . 25.0 113.201 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.14 167.28 30.38 Favored Glycine 0 N--CA 1.459 0.212 0 CA-C-N 114.837 -0.682 . . . . 25.0 113.495 178.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.11 111.61 19.48 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 106.498 -1.667 . . . . 25.0 106.498 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -109.36 152.55 25.16 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 113.67 0.989 . . . . 50.0 113.67 -171.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -114.7 105.14 12.7 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 106.816 -1.549 . . . . 25.0 106.816 171.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 58.1 mt -110.8 133.6 53.22 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.221 0.452 . . . . 25.0 112.221 -174.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -131.71 110.59 11.0 Favored 'General case' 0 C--N 1.316 -0.875 0 O-C-N 121.224 -0.922 . . . . 25.0 112.99 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.25 -29.72 29.93 Favored Glycine 0 C--O 1.242 0.601 0 N-CA-C 117.713 1.845 . . . . 25.0 117.713 -174.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 53.01 -154.42 0.22 Allowed 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.683 0.994 . . . . 25.0 113.683 -177.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.93 160.3 15.1 Favored 'General case' 0 C--O 1.258 1.515 0 N-CA-C 112.306 0.484 . . . . 25.0 112.306 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.63 152.11 27.94 Favored Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 110.316 -1.113 . . . . 25.0 110.316 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -78.95 119.04 21.54 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 106.385 -1.709 . . . . 25.0 106.385 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -119.18 151.77 37.76 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 111.797 0.295 . . . . 50.0 111.797 -172.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.82 127.77 48.48 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 107.089 -1.449 . . . . 25.0 107.089 170.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.7 mp -127.37 121.34 30.71 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 122.015 0.912 . . . . 25.0 112.747 -176.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -118.93 135.14 54.74 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 108.553 -0.906 . . . . 25.0 108.553 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.61 -38.5 5.54 Favored Glycine 0 CA--C 1.498 -0.987 0 O-C-N 120.137 -1.602 . . . . 25.0 113.519 -174.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.83 -166.67 50.68 Favored Glycine 0 C--O 1.246 0.884 0 CA-C-O 121.947 0.748 . . . . 25.0 111.396 -177.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.91 157.94 14.22 Favored 'General case' 0 C--O 1.248 1.003 0 C-N-CA 123.241 0.617 . . . . 25.0 111.631 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.41 165.38 32.47 Favored Glycine 0 N--CA 1.466 0.695 0 CA-C-N 116.063 -0.517 . . . . 25.0 114.009 178.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.58 122.86 28.64 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 105.286 -2.116 . . . . 25.0 105.286 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -114.24 156.99 23.32 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.625 -0.509 . . . . 50.0 109.625 -175.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -124.19 122.95 39.17 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 106.382 -1.71 . . . . 25.0 106.382 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -146.38 139.89 25.95 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 116.728 2.121 . . . . 25.0 116.728 -170.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 70.3 m -108.31 143.33 37.33 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 114.958 -1.019 . . . . 25.0 108.473 175.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.9 -32.24 6.93 Favored Glycine 0 C--N 1.323 -0.173 0 N-CA-C 109.005 -1.638 . . . . 25.0 109.005 175.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.45 -174.88 54.52 Favored Glycine 0 CA--C 1.502 -0.741 0 C-N-CA 119.599 -1.286 . . . . 25.0 112.834 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -62.62 159.04 16.81 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.794 -0.827 . . . . 25.0 110.84 177.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.34 156.52 32.72 Favored Glycine 0 C--O 1.224 -0.487 0 CA-C-N 114.875 -1.057 . . . . 25.0 111.089 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.62 108.36 14.19 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.934 -1.136 . . . . 25.0 107.934 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -101.08 159.93 14.81 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.31 -0.859 . . . . 50.0 110.969 -172.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 57.4 m -124.67 119.09 28.01 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 109.102 -0.703 . . . . 25.0 109.102 177.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -99.65 83.94 2.86 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 106.589 -1.634 . . . . 25.0 106.589 175.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -83.16 -20.86 33.92 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.277 -0.874 . . . . 25.0 111.229 -173.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 61.91 160.6 0.07 Allowed 'General case' 0 CA--C 1.547 0.845 0 O-C-N 124.858 1.349 . . . . 25.0 112.181 -176.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -93.45 -70.39 0.7 Allowed 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.81 1.041 . . . . 25.0 113.81 -168.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.1 mt -116.48 175.17 5.68 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.68 0.753 . . . . 25.0 111.482 -171.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.94 -32.34 32.7 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.484 0.714 . . . . 25.0 111.435 176.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -80.02 -6.94 58.5 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.52 0.933 . . . . 25.0 113.52 -174.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.68 127.89 34.51 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 122.087 0.946 . . . . 25.0 111.594 -177.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.1 t 49.94 39.56 18.91 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 115.63 1.715 . . . . 25.0 115.63 173.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -103.59 160.94 14.31 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.722 -1.126 . . . . 25.0 110.12 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -115.09 139.91 49.5 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 104.056 -2.572 . . . . 25.0 104.056 176.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 62.8 p -124.29 166.0 21.7 Favored Pre-proline 0 C--N 1.317 -0.824 0 N-CA-C 108.623 -0.881 . . . . 25.0 108.623 -175.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -65.07 -19.5 63.41 Favored 'Trans proline' 0 C--O 1.245 0.861 0 C-N-CA 117.769 -1.02 . . . . 25.0 112.702 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 81.2 mt -76.17 -29.65 57.79 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.283 0.563 . . . . 25.0 112.181 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 160.76 179.15 35.33 Favored Glycine 0 N--CA 1.472 1.044 0 CA-C-O 118.412 -1.216 . . . . 25.0 110.182 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.4 t -98.02 148.78 23.15 Favored 'General case' 0 C--O 1.251 1.146 0 CA-C-N 118.884 1.342 . . . . 25.0 113.034 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -130.29 28.95 4.93 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-N 114.643 -1.162 . . . . 25.0 108.156 174.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.51 146.92 50.27 Favored Glycine 0 N--CA 1.463 0.455 0 N-CA-C 109.073 -1.611 . . . . 25.0 109.073 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -93.69 166.29 12.29 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 117.343 0.571 . . . . 50.0 111.405 -176.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.92 104.6 9.95 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 122.656 0.383 . . . . 25.0 111.65 -173.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.0 mt -91.16 135.7 26.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 107.889 -1.152 . . . . 25.0 107.889 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.446 ' HA ' ' HG2' ' A' ' 142' ' ' GLU . 85.5 mt -88.32 -56.57 3.26 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.539 0.94 . . . . 25.0 113.539 -174.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -124.61 39.37 3.99 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.672 0.99 . . . . 25.0 113.672 -171.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -55.53 138.77 45.9 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.76 0.79 . . . . 25.0 111.665 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -105.85 102.75 40.62 Favored Pre-proline 0 N--CA 1.469 0.497 0 N-CA-C 108.804 -0.813 . . . . 25.0 108.804 177.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -67.74 -6.7 17.46 Favored 'Trans proline' 0 C--N 1.359 1.087 0 N-CA-C 116.31 1.619 . . . . 25.0 116.31 -174.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.9 t -97.48 -42.87 7.51 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.005 0.522 . . . . 25.0 109.97 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -96.31 -43.11 7.83 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 113.283 0.845 . . . . 25.0 113.283 -171.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -82.44 164.81 20.73 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 121.472 -0.767 . . . . 75.0 110.336 -173.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -142.05 152.07 43.01 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.9 -0.591 . . . . 25.0 111.347 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 77.5 mt -126.49 131.92 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 107.63 -1.248 . . . . 25.0 107.63 -177.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -93.2 151.03 20.07 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 108.526 -0.916 . . . . 25.0 108.526 174.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 p -150.41 -3.91 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 N-CA-C 112.834 0.679 . . . . 25.0 112.834 -175.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.6 t -60.68 -48.49 81.54 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.831 1.048 . . . . 25.0 113.831 -173.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.54 -31.63 60.14 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.158 0.799 . . . . 25.0 113.158 -177.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.55 -22.95 16.24 Favored 'General case' 0 C--O 1.246 0.881 0 N-CA-C 115.919 1.822 . . . . 25.0 115.919 -173.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -134.11 -72.76 0.08 OUTLIER Glycine 0 CA--C 1.53 1.024 0 N-CA-C 116.102 1.201 . . . . 25.0 116.102 -174.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -154.57 167.06 31.38 Favored 'General case' 0 C--O 1.211 -0.926 0 CA-C-N 117.471 0.636 . . . . 25.0 109.438 -173.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 30.9 t -120.45 -47.77 2.33 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.191 -1.04 . . . . 25.0 108.191 176.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.15 120.9 5.37 Favored Glycine 0 CA--C 1.501 -0.814 0 N-CA-C 108.588 -1.805 . . . . 25.0 108.588 175.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -68.41 158.13 34.3 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 117.302 0.551 . . . . 25.0 111.744 -175.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -100.51 -160.31 27.99 Favored Glycine 0 N--CA 1.457 0.073 0 N-CA-C 115.109 0.804 . . . . 25.0 115.109 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -48.35 134.7 14.64 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.681 -0.76 . . . . 25.0 112.794 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 158.98 -175.07 35.99 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 108.676 -1.769 . . . . 25.0 108.676 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -152.9 168.21 26.54 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 118.694 1.247 . . . . 25.0 108.343 -177.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 52.59 39.04 27.41 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.85 1.056 . . . . 25.0 113.85 -177.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 69.47 35.1 74.83 Favored Glycine 0 C--O 1.245 0.801 0 N-CA-C 110.751 -0.939 . . . . 25.0 110.751 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.603 ' HA ' ' H ' ' A' ' 151' ' ' ALA . 7.6 t -136.97 176.57 8.59 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 121.623 -0.928 . . . . 25.0 109.905 -178.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.1 mt -110.34 164.58 12.54 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 102.47 -3.159 . . . . 25.0 102.47 176.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.63 120.98 23.33 Favored 'General case' 0 C--O 1.258 1.509 0 N-CA-C 108.063 -1.088 . . . . 25.0 108.063 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.7 m -80.23 159.32 4.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 C-N-CA 122.86 0.464 . . . . 25.0 111.374 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 73.3 m -134.83 163.0 30.81 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.438 -0.949 . . . . 25.0 108.438 177.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.0 m -124.37 165.51 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.362 0 N-CA-C 107.544 -1.28 . . . . 25.0 107.544 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.6 t -80.13 -49.07 12.23 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 106.574 -1.639 . . . . 25.0 106.574 173.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -161.57 -161.99 0.84 Allowed 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 101.941 -3.355 . . . . 25.0 101.941 174.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -67.09 -0.22 3.11 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.498 0.666 . . . . 25.0 112.536 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -142.64 -155.72 6.53 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 108.786 -1.726 . . . . 25.0 108.786 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 53.32 -145.86 0.57 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.116 0.784 . . . . 25.0 113.116 176.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.4 mtt85 -75.89 174.04 10.42 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.934 0.873 . . . . 25.0 113.336 -173.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.26 163.19 29.86 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 105.342 -2.095 . . . . 25.0 105.342 176.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -136.92 155.1 50.17 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.703 -0.48 . . . . 25.0 109.703 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 29.7 tp -125.43 127.17 46.1 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.161 -1.792 . . . . 25.0 106.161 171.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -126.37 151.51 47.53 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.386 0.513 . . . . 25.0 112.386 -171.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 84.0 p -88.63 150.01 23.25 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 105.115 -2.18 . . . . 25.0 105.115 169.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -117.33 27.78 8.88 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 105.621 -1.992 . . . . 25.0 105.621 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -122.88 141.67 51.63 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 112.578 -2.101 . . . . 25.0 106.468 174.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -138.41 153.83 48.9 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 124.221 0.95 . . . . 25.0 111.465 -178.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -77.96 160.29 28.29 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.498 -1.297 . . . . 25.0 107.498 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.73 -20.07 65.45 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-O 122.505 1.145 . . . . 25.0 109.142 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -74.12 -12.3 60.56 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 114.682 -1.145 . . . . 25.0 113.549 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.25 9.02 67.8 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 115.888 -0.596 . . . . 25.0 113.776 -178.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 63.0 mt -83.33 147.53 27.88 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 108.128 -1.064 . . . . 25.0 108.128 174.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 69.6 p -149.76 179.57 7.91 Favored 'General case' 0 C--O 1.248 0.976 0 N-CA-C 107.642 -1.244 . . . . 25.0 107.642 177.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -123.8 135.61 53.9 Favored 'General case' 0 C--O 1.253 1.268 0 CA-C-N 118.871 0.76 . . . . 25.0 111.76 -176.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -151.41 154.97 37.67 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.756 -1.572 . . . . 25.0 106.756 171.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.69 139.39 19.66 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 105.771 -1.937 . . . . 25.0 105.771 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -101.53 143.92 30.93 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 107.685 -1.228 . . . . 25.0 107.685 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mp -136.5 139.13 42.06 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 106.29 -1.744 . . . . 25.0 106.29 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.446 ' HG2' ' HA ' ' A' ' 85' ' ' LEU . 12.9 pt-20 -110.15 11.65 23.66 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.992 1.269 . . . . 25.0 110.603 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -68.41 -19.82 72.95 Favored Glycine 0 CA--C 1.499 -0.944 0 CA-C-N 115.218 -0.901 . . . . 25.0 111.006 173.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.1 t0 54.74 51.69 13.39 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 122.999 1.381 . . . . 25.0 110.733 175.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -121.63 42.75 3.02 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 113.513 -1.676 . . . . 25.0 108.151 -175.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -55.84 -31.59 62.85 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 114.596 -1.184 . . . . 25.0 112.462 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -77.18 -29.43 54.42 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 118.678 0.672 . . . . 25.0 111.878 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.55 -20.33 26.6 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 120.574 -0.45 . . . . 25.0 111.799 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 22.2 mt -62.12 136.54 57.99 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 121.082 0.468 . . . . 25.0 111.088 177.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 70.3 m -144.7 161.5 39.05 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 107.541 -1.281 . . . . 25.0 107.541 175.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.603 ' H ' ' HA ' ' A' ' 111' ' ' SER . . . -79.74 -0.09 32.83 Favored 'General case' 0 C--O 1.206 -1.206 0 N-CA-C 107.367 -1.346 . . . . 25.0 107.367 177.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -74.09 -26.77 60.55 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.372 -0.831 . . . . 25.0 110.788 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -89.66 -6.72 55.89 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.591 -0.693 . . . . 25.0 109.524 176.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 49.1 mm -90.22 136.6 23.46 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.621 0 N-CA-C 103.708 -2.701 . . . . 25.0 103.708 173.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.9 p -116.39 128.93 73.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 122.656 1.217 . . . . 25.0 110.861 -176.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -158.05 -17.13 0.08 Allowed 'General case' 0 C--O 1.211 -0.937 0 CA-C-N 113.95 -1.477 . . . . 25.0 113.121 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.75 43.34 0.91 Allowed 'General case' 0 C--O 1.246 0.897 0 O-C-N 121.454 -0.779 . . . . 25.0 112.183 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 58.17 29.09 17.42 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.891 0.877 . . . . 25.0 112.964 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.4 m 51.53 37.26 19.09 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 122.334 1.064 . . . . 25.0 111.342 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -76.36 123.81 26.53 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.71 1.004 . . . . 25.0 113.71 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.82 -18.32 60.47 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.29 -0.868 . . . . 25.0 112.719 177.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -81.07 -21.5 39.97 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 122.305 -0.247 . . . . 25.0 110.596 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.45 177.56 8.89 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.835 0.454 . . . . 25.0 111.108 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 63.47 178.66 0.16 Allowed 'General case' 0 CA--C 1.547 0.861 0 O-C-N 124.682 1.239 . . . . 25.0 113.939 176.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 82.04 22.63 58.97 Favored Glycine 0 C--O 1.237 0.294 0 CA-C-N 115.296 -0.865 . . . . 25.0 111.141 -177.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -106.99 104.79 14.55 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 112.338 0.496 . . . . 25.0 112.338 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -130.29 151.59 50.63 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 107.62 -1.252 . . . . 25.0 107.62 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -135.57 33.72 2.38 Favored Glycine 0 CA--C 1.502 -0.761 0 N-CA-C 110.802 -0.919 . . . . 25.0 110.802 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 54.6 t -79.53 -27.27 12.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 CA-C-O 121.939 0.876 . . . . 25.0 108.774 -176.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -53.86 134.39 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 CA-C-N 114.485 -1.234 . . . . 25.0 113.025 -174.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 141.12 150.66 5.43 Favored Glycine 0 C--O 1.246 0.895 0 N-CA-C 109.5 -1.44 . . . . 25.0 109.5 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -142.86 145.36 33.07 Favored 'General case' 0 C--O 1.252 1.232 0 O-C-N 122.197 -0.59 . . . . 25.0 111.249 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 13.3 p -150.72 154.77 38.0 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.725 0.774 . . . . 25.0 111.306 175.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 176.71 166.74 34.27 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 115.138 -0.937 . . . . 25.0 113.85 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -133.55 111.07 12.53 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 107.312 -1.366 . . . . 25.0 107.312 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.88 160.91 39.92 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 116.879 -1.614 . . . . 25.0 113.137 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -119.15 147.02 44.65 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.032 -1.099 . . . . 25.0 108.032 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -143.74 73.11 17.08 Favored Pre-proline 0 C--O 1.251 1.171 0 O-C-N 123.536 0.523 . . . . 25.0 111.198 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -69.9 164.07 36.06 Favored 'Trans proline' 0 C--O 1.249 1.031 0 N-CA-C 113.857 0.676 . . . . 25.0 113.857 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 12.6 t -125.66 8.68 7.62 Favored 'General case' 0 C--O 1.256 1.414 0 N-CA-C 109.652 -0.499 . . . . 25.0 109.652 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 C--O 1.245 0.853 0 N-CA-C 108.565 -0.902 . . . . 25.0 108.565 178.043 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 120.776 0.322 . . . . 25.0 110.36 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -135.73 115.51 11.41 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 107.463 -1.31 . . . . 25.0 107.463 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -69.33 144.24 55.63 Favored 'Trans proline' 0 CA--C 1.531 0.356 0 C-N-CA 116.407 -1.929 . . . . 25.0 113.856 -176.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -163.66 31.64 0.27 Allowed Glycine 0 CA--C 1.521 0.417 0 CA-C-O 119.429 -0.651 . . . . 25.0 112.26 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.5 p -60.35 133.11 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 122.027 0.918 . . . . 25.0 111.194 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -99.07 -18.57 17.67 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.647 -0.706 . . . . 25.0 112.197 -177.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.79 -134.11 3.84 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-O 121.715 0.62 . . . . 25.0 114.56 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.9 p 69.08 156.64 0.15 Allowed Pre-proline 0 N--CA 1.483 1.208 0 C-N-CA 125.858 1.663 . . . . 25.0 110.392 -173.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.425 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 32.4 Cg_exo -65.9 0.11 3.43 Favored 'Trans proline' 0 N--CA 1.485 1.008 0 N-CA-C 117.707 2.156 . . . . 25.0 117.707 -173.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.6 p -68.01 -22.14 27.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 114.787 1.403 . . . . 25.0 114.787 -172.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.2 p -128.1 121.57 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 117.329 2.344 . . . . 25.0 117.329 -171.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.05 20.6 79.06 Favored Glycine 0 C--O 1.224 -0.47 0 N-CA-C 117.423 1.729 . . . . 25.0 117.423 173.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.2 t -50.07 -37.87 35.56 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 114.726 1.38 . . . . 25.0 114.726 -174.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -80.74 13.61 2.52 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 114.649 1.352 . . . . 25.0 114.649 -176.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -149.63 171.22 17.02 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.531 -0.73 . . . . 25.0 110.542 176.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.76 121.57 14.32 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.293 0.637 . . . . 25.0 111.538 -173.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -120.72 169.69 10.16 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 115.296 1.591 . . . . 50.0 115.296 -173.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -123.35 114.55 20.32 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 103.775 -2.676 . . . . 25.0 103.775 160.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 82.3 mt -120.04 102.57 8.63 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.536 0.684 . . . . 25.0 111.761 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -93.4 121.8 35.16 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.709 -0.678 . . . . 25.0 109.837 177.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.15 -174.29 47.67 Favored Glycine 0 N--CA 1.464 0.565 0 N-CA-C 115.245 0.858 . . . . 25.0 115.245 -178.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.7 p -91.67 173.71 7.73 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.778 0.831 . . . . 25.0 112.404 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 75.4 mt -83.67 12.41 5.88 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.356 0.873 . . . . 25.0 113.356 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.85 179.31 20.04 Favored Glycine 0 N--CA 1.462 0.378 0 CA-C-N 116.284 -0.416 . . . . 25.0 112.175 178.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.5 t -71.48 130.93 42.51 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 122.701 0.4 . . . . 25.0 110.635 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -143.41 165.89 26.29 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 123.265 0.353 . . . . 50.0 111.527 -174.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -111.11 125.49 53.83 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 106.108 -1.812 . . . . 25.0 106.108 166.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.0 mm -115.49 129.22 72.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 107.043 -1.465 . . . . 25.0 107.043 -177.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.425 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 1.0 OUTLIER -129.27 123.33 31.63 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 105.418 -2.067 . . . . 25.0 105.418 179.677 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.54 -36.32 23.53 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 114.969 0.747 . . . . 25.0 114.969 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.52 -149.03 50.42 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.268 -0.733 . . . . 25.0 111.268 -176.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -78.41 170.47 54.84 Favored Glycine 0 C--O 1.257 1.585 0 O-C-N 121.728 -0.866 . . . . 25.0 112.061 -176.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.34 165.06 33.83 Favored Glycine 0 C--N 1.316 -0.557 0 CA-C-O 119.639 -0.534 . . . . 25.0 112.91 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.14 101.07 13.14 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.053 -1.091 . . . . 25.0 108.053 178.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -98.48 153.57 18.51 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.915 0.709 . . . . 50.0 112.915 -168.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -115.15 99.85 7.73 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 105.745 -1.946 . . . . 25.0 105.745 175.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 33.2 mt -104.26 137.82 41.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.798 -1.092 . . . . 25.0 111.571 -171.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -133.77 99.42 4.46 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.925 0.713 . . . . 25.0 112.925 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.38 -35.2 63.47 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-O 118.342 -1.255 . . . . 25.0 115.8 -177.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 55.17 -154.47 0.29 Allowed 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 118.814 1.307 . . . . 25.0 113.672 -178.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.97 160.13 15.56 Favored 'General case' 0 C--O 1.249 1.034 0 N-CA-C 113.486 0.921 . . . . 25.0 113.486 -176.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.12 159.93 33.51 Favored Glycine 0 C--O 1.223 -0.546 0 CA-C-N 115.187 -0.915 . . . . 25.0 111.451 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -82.15 115.5 21.29 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 104.688 -2.338 . . . . 25.0 104.688 177.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -116.67 154.33 30.76 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.758 -0.377 . . . . 50.0 110.514 -171.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 mp -114.05 133.08 55.76 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 105.792 -1.929 . . . . 25.0 105.792 174.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.6 mp -133.28 128.92 36.84 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 113.967 1.099 . . . . 25.0 113.967 -173.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -129.92 135.13 47.99 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.181 -1.414 . . . . 25.0 107.181 177.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -93.36 -40.65 4.73 Favored Glycine 0 N--CA 1.475 1.26 0 N-CA-C 115.409 0.924 . . . . 25.0 115.409 -175.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.34 -174.92 55.22 Favored Glycine 0 C--O 1.24 0.491 0 N-CA-C 110.88 -0.888 . . . . 25.0 110.88 -176.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.83 154.06 9.88 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.328 0.585 . . . . 25.0 109.911 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.1 150.66 24.12 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.493 -0.776 . . . . 25.0 112.028 -176.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -74.92 127.87 34.23 Favored 'General case' 0 C--O 1.212 -0.92 0 N-CA-C 104.737 -2.32 . . . . 25.0 104.737 176.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -117.68 150.94 38.22 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 121.707 -0.62 . . . . 50.0 111.046 -174.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -112.76 121.56 45.09 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 103.764 -2.68 . . . . 25.0 103.764 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -144.7 131.5 20.16 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 117.743 2.497 . . . . 25.0 117.743 -171.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.3 m -99.45 141.19 32.55 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-N 115.8 -0.637 . . . . 25.0 109.534 174.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -94.72 -35.71 5.8 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 110.443 -1.063 . . . . 25.0 110.443 172.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.17 -176.33 51.74 Favored Glycine 0 N--CA 1.465 0.62 0 CA-C-N 118.198 0.999 . . . . 25.0 113.373 -178.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -59.51 156.1 13.92 Favored 'General case' 0 C--O 1.246 0.884 0 O-C-N 121.595 -0.944 . . . . 25.0 110.724 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.01 162.54 34.63 Favored Glycine 0 C--O 1.246 0.903 0 N-CA-C 108.943 -1.663 . . . . 25.0 108.943 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.95 121.32 26.36 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 106.842 -1.54 . . . . 25.0 106.842 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -112.0 152.19 28.41 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.184 0.516 . . . . 50.0 110.17 -175.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.5 m -117.47 110.31 17.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.851 0.834 . . . . 25.0 110.329 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -94.21 119.94 33.75 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 106.032 -1.84 . . . . 25.0 106.032 176.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.9 mmt85 -114.5 -32.25 5.96 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.967 -0.561 . . . . 25.0 112.339 -177.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 68.09 148.53 0.06 Allowed 'General case' 0 CA--C 1.55 0.948 0 O-C-N 124.741 1.275 . . . . 25.0 110.667 -174.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.16 -34.98 21.99 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 114.822 1.416 . . . . 25.0 114.822 -165.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 70.5 mt -132.25 161.66 32.9 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.1 0.476 . . . . 25.0 110.602 -172.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.83 -31.35 66.55 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 107.095 -1.446 . . . . 25.0 107.095 169.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -87.69 9.34 21.82 Favored 'General case' 0 C--O 1.254 1.31 0 N-CA-C 115.571 1.693 . . . . 25.0 115.571 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -94.7 141.54 28.5 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.034 -1.042 . . . . 25.0 110.101 -177.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.8 t 47.32 50.48 14.48 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 114.556 1.317 . . . . 25.0 114.556 -178.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 31.0 p-80 -114.35 169.54 8.96 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.47 -0.786 . . . . 25.0 111.403 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -121.45 148.79 43.97 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 104.621 -2.362 . . . . 25.0 104.621 173.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 92.4 p -139.59 170.96 8.74 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 107.299 -1.371 . . . . 25.0 107.299 -177.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -62.79 -20.45 71.21 Favored 'Trans proline' 0 C--N 1.361 1.185 0 CA-C-N 119.044 0.694 . . . . 25.0 113.087 174.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 80.9 mt -73.64 -27.5 61.3 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 121.748 -0.595 . . . . 25.0 110.91 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.91 -177.95 30.29 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.683 -0.967 . . . . 25.0 110.683 -174.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.3 t -101.7 141.73 34.12 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 122.811 1.291 . . . . 25.0 111.54 -178.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -127.71 27.36 5.77 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 114.678 -1.146 . . . . 25.0 109.167 176.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.2 145.17 45.77 Favored Glycine 0 N--CA 1.462 0.39 0 O-C-N 124.07 0.856 . . . . 25.0 112.124 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -85.33 170.1 13.09 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 122.694 -0.297 . . . . 50.0 111.321 -177.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -128.11 105.95 8.72 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.694 0.798 . . . . 25.0 111.394 -174.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.0 mt -87.82 133.91 29.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 121.853 0.835 . . . . 25.0 108.789 -178.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.448 ' HA ' ' HG2' ' A' ' 142' ' ' GLU . 85.0 mt -85.1 -43.93 13.45 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 116.401 2.001 . . . . 25.0 116.401 -172.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -137.67 40.16 2.39 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.09 1.144 . . . . 25.0 114.09 -173.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -55.97 132.21 49.29 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.579 -0.737 . . . . 25.0 112.287 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -102.37 105.43 43.36 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 106.011 -1.848 . . . . 25.0 106.011 174.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -70.48 -4.39 14.42 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 N-CA-C 116.622 1.739 . . . . 25.0 116.622 -172.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.3 t -97.29 -45.62 6.42 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.201 0.524 . . . . 25.0 111.079 174.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -82.53 -41.26 19.88 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.357 0.873 . . . . 25.0 113.357 -174.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -84.95 165.44 17.61 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.694 -0.484 . . . . 75.0 109.694 -169.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -140.73 146.24 37.5 Favored 'General case' 0 C--O 1.246 0.874 0 N-CA-C 108.523 -0.917 . . . . 25.0 108.523 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 76.5 mt -128.66 126.52 65.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 107.926 -1.138 . . . . 25.0 107.926 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -80.91 148.14 30.0 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.809 0.814 . . . . 25.0 110.361 172.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.0 p -143.32 -7.91 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.317 -0.856 . . . . 25.0 110.628 176.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.8 t -63.92 -41.16 97.73 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.282 0.563 . . . . 25.0 111.943 -173.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.62 -4.61 57.97 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.028 0.751 . . . . 25.0 113.028 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 11.9 mt -115.04 -38.25 3.93 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.989 1.477 . . . . 25.0 114.989 -169.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -136.42 -54.68 0.06 OUTLIER Glycine 0 C--O 1.24 0.477 0 N-CA-C 117.644 1.818 . . . . 25.0 117.644 -174.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -155.04 164.02 39.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 117.569 0.684 . . . . 25.0 109.826 -174.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 45.8 t -121.26 -25.53 5.23 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 124.12 0.887 . . . . 25.0 109.018 173.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -100.65 121.59 7.29 Favored Glycine 0 N--CA 1.464 0.565 0 N-CA-C 107.615 -2.194 . . . . 25.0 107.615 172.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.68 146.49 53.72 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 118.565 1.183 . . . . 25.0 113.246 -174.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -80.85 -175.19 49.45 Favored Glycine 0 C--N 1.32 -0.316 0 CA-C-N 115.349 -0.841 . . . . 25.0 114.415 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -60.84 142.62 56.01 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 121.196 0.522 . . . . 25.0 111.701 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 166.83 -171.94 41.84 Favored Glycine 0 C--O 1.245 0.787 0 N-CA-C 109.363 -1.495 . . . . 25.0 109.363 -177.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -141.52 165.25 28.0 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.833 1.317 . . . . 25.0 111.465 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 57.52 33.9 23.88 Favored 'General case' 0 C--O 1.246 0.878 0 O-C-N 124.454 1.096 . . . . 25.0 113.541 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 74.56 39.32 41.81 Favored Glycine 0 C--O 1.222 -0.653 0 N-CA-C 109.969 -1.252 . . . . 25.0 109.969 177.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 11.1 t -148.6 167.64 24.92 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 108.998 -0.741 . . . . 25.0 108.998 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.4 mt -84.78 159.91 20.36 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 103.069 -2.937 . . . . 25.0 103.069 169.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.66 128.9 38.03 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 119.291 -0.964 . . . . 25.0 109.158 178.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.9 m -91.48 159.23 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 109.65 -0.5 . . . . 25.0 109.65 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.19 164.71 26.77 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 110.169 -0.308 . . . . 25.0 110.169 -177.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.4 m -118.58 162.64 16.5 Favored 'Isoleucine or valine' 0 C--O 1.25 1.08 0 N-CA-C 106.726 -1.583 . . . . 25.0 106.726 175.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.8 t -83.06 -51.23 7.72 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 106.295 -1.743 . . . . 25.0 106.295 170.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -166.69 -164.58 0.66 Allowed 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 100.825 -3.768 . . . . 25.0 100.825 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -68.12 -25.07 65.11 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 119.173 0.897 . . . . 25.0 110.658 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -106.9 -164.64 22.3 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 108.17 -1.972 . . . . 25.0 108.17 174.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 56.18 -162.79 0.17 Allowed 'General case' 0 C--O 1.248 0.976 0 N-CA-C 113.538 0.94 . . . . 25.0 113.538 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 64.3 mtt85 -79.24 169.29 18.35 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.755 1.02 . . . . 25.0 113.755 -168.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.7 p -115.3 165.56 12.82 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 105.111 -2.181 . . . . 25.0 105.111 174.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -134.73 157.97 45.33 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 121.404 0.621 . . . . 25.0 111.357 -177.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 51.1 tp -130.13 113.97 15.15 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 103.781 -2.674 . . . . 25.0 103.781 171.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -116.13 148.67 40.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.979 0.419 . . . . 25.0 110.19 -174.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 43.0 t -97.27 147.18 24.4 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 106.061 -1.829 . . . . 25.0 106.061 171.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -116.9 17.28 15.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.562 0.696 . . . . 25.0 110.532 -177.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -107.8 140.06 41.45 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 104.674 -2.343 . . . . 25.0 104.674 172.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -140.04 154.65 47.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.698 0.761 . . . . 25.0 112.404 -176.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -75.03 166.22 24.01 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.924 -1.035 . . . . 25.0 109.318 177.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.83 -25.27 66.35 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 108.443 -0.947 . . . . 25.0 108.443 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -74.02 -5.37 41.0 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.372 -0.831 . . . . 25.0 112.995 175.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.32 10.48 77.47 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 121.299 -0.477 . . . . 25.0 112.619 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.5 mt -83.8 134.03 34.74 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 122.288 -0.536 . . . . 25.0 109.663 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 59.8 p -138.69 176.89 8.3 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 106.605 -1.628 . . . . 25.0 106.605 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -125.64 134.46 51.87 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 120.328 -0.549 . . . . 25.0 110.349 -175.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -152.76 152.93 32.22 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 108.979 -0.749 . . . . 25.0 108.979 171.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 13.0 p -145.23 143.78 21.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 106.244 -1.762 . . . . 25.0 106.244 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -102.45 146.14 28.53 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 107.081 -1.452 . . . . 25.0 107.081 -177.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.5 mp -132.19 134.98 46.0 Favored 'General case' 0 C--O 1.201 -1.479 0 N-CA-C 104.908 -2.256 . . . . 25.0 104.908 177.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.448 ' HG2' ' HA ' ' A' ' 85' ' ' LEU . 8.7 pt-20 -103.18 10.55 37.73 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 119.923 1.238 . . . . 25.0 111.059 -178.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.7 -10.2 66.92 Favored Glycine 0 N--CA 1.458 0.164 0 C-N-CA 120.952 -0.642 . . . . 25.0 113.57 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 37.9 t0 53.09 40.9 31.98 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 123.327 1.536 . . . . 25.0 110.557 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -115.92 38.29 3.38 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.053 -1.43 . . . . 25.0 109.811 -179.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.28 -32.57 68.54 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.067 0.766 . . . . 25.0 113.067 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.14 -28.49 62.27 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.017 0.377 . . . . 25.0 112.017 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -85.49 -29.56 24.17 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-N 116.744 -0.207 . . . . 25.0 111.041 -177.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 29.4 mt -59.35 139.5 56.97 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-O 122.431 1.11 . . . . 25.0 112.581 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.4 m -143.06 160.43 40.39 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.3 -1.741 . . . . 25.0 106.3 176.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.64 3.76 15.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.17 0.509 . . . . 25.0 109.987 176.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -68.38 -29.59 68.33 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.174 -0.466 . . . . 25.0 110.307 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -92.07 1.63 57.08 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.39 0.614 . . . . 25.0 110.867 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 31.4 mm -101.02 125.42 54.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.821 0 N-CA-C 104.821 -2.289 . . . . 25.0 104.821 178.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.74 119.4 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 122.934 1.35 . . . . 25.0 112.14 -174.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -156.0 -20.76 0.1 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 113.248 -1.797 . . . . 25.0 110.908 177.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -76.11 52.18 0.71 Allowed 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.211 1.189 . . . . 25.0 114.211 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 63.68 11.37 5.74 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 115.229 1.566 . . . . 25.0 115.229 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 6.5 m 64.96 -59.2 0.25 Allowed 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 116.686 2.106 . . . . 25.0 116.686 176.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -64.27 137.91 58.17 Favored 'General case' 0 C--O 1.244 0.772 0 O-C-N 121.946 -0.471 . . . . 25.0 111.381 -175.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -81.69 61.09 4.92 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 113.349 0.87 . . . . 25.0 113.349 -176.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.04 -37.02 78.35 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.77 -0.826 . . . . 25.0 108.77 177.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -135.87 -104.73 0.21 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.534 -0.757 . . . . 25.0 109.702 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 55.71 -159.7 0.2 Allowed 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.247 1.019 . . . . 25.0 111.17 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 63.44 25.83 68.99 Favored Glycine 0 C--O 1.218 -0.863 0 C-N-CA 121.227 -0.511 . . . . 25.0 112.648 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -82.54 94.94 7.59 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.596 0.712 . . . . 25.0 110.647 -174.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -125.32 150.73 46.87 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 108.493 -0.929 . . . . 25.0 108.493 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -146.0 32.0 1.57 Allowed Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 109.125 -1.59 . . . . 25.0 109.125 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 39.9 t -65.34 -37.66 80.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 109.99 -0.374 . . . . 25.0 109.99 -175.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.8 128.65 21.09 Favored 'Isoleucine or valine' 0 C--O 1.244 0.8 0 CA-C-O 122.197 0.999 . . . . 25.0 110.913 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 158.58 146.27 4.48 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 109.082 -1.607 . . . . 25.0 109.082 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -141.09 154.57 46.0 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-N 117.503 0.652 . . . . 25.0 111.159 -176.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 93.7 p -149.86 158.24 43.98 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.339 -1.356 . . . . 25.0 107.339 176.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 178.79 174.27 44.86 Favored Glycine 0 C--O 1.241 0.541 0 C-N-CA 120.06 -1.067 . . . . 25.0 113.578 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -152.9 85.49 4.33 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 107.728 -1.212 . . . . 25.0 107.728 178.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.42 150.28 75.58 Favored 'Trans proline' 0 C--N 1.354 0.818 0 O-C-N 122.015 0.481 . . . . 25.0 112.054 -177.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -114.81 154.51 28.46 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.201 -0.454 . . . . 25.0 110.575 -174.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -136.32 61.16 37.19 Favored Pre-proline 0 C--O 1.25 1.087 0 N-CA-C 113.225 0.824 . . . . 25.0 113.225 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -71.97 160.27 48.08 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 115.623 -2.451 . . . . 25.0 112.498 177.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.9 t -120.22 -15.75 8.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.017 -0.538 . . . . 25.0 111.181 -177.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.746 -0.645 . . . . 25.0 110.763 177.266 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 110.428 -0.212 . . . . 25.0 110.428 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -138.89 107.73 7.56 Favored Pre-proline 0 C--O 1.243 0.716 0 C-N-CA 122.533 0.333 . . . . 25.0 110.659 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.9 154.19 71.37 Favored 'Trans proline' 0 N--CA 1.48 0.7 0 N-CA-C 113.692 0.612 . . . . 25.0 113.692 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -178.02 54.04 0.1 OUTLIER Glycine 0 C--O 1.224 -0.528 0 N-CA-C 110.557 -1.017 . . . . 25.0 110.557 -178.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.4 p -60.52 132.41 25.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 122.261 1.029 . . . . 25.0 112.346 -174.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -103.11 -6.14 22.54 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.397 -1.274 . . . . 25.0 110.482 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.97 -148.12 4.91 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 116.36 -0.382 . . . . 25.0 112.717 178.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.4 p 68.39 159.85 0.15 Allowed Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 125.974 1.71 . . . . 25.0 112.204 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -66.52 1.3 2.7 Favored 'Trans proline' 0 C--N 1.359 1.122 0 N-CA-C 116.634 1.744 . . . . 25.0 116.634 -176.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.3 p -68.53 -18.98 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 N-CA-C 115.24 1.57 . . . . 25.0 115.24 -170.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.3 p -146.92 143.64 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 113.288 0.848 . . . . 25.0 113.288 -177.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.32 13.68 81.44 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 115.607 1.003 . . . . 25.0 115.607 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.2 t -54.21 -50.95 65.94 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 122.337 -0.508 . . . . 25.0 111.459 -173.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -86.8 19.26 3.03 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 114.758 1.392 . . . . 25.0 114.758 -172.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -152.39 170.83 19.13 Favored 'General case' 0 CA--C 1.561 1.397 0 O-C-N 121.653 -0.654 . . . . 25.0 111.391 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -59.38 134.18 56.77 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 112.47 0.544 . . . . 25.0 112.47 -175.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -121.54 163.22 19.22 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 115.575 1.694 . . . . 50.0 115.575 -173.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -138.08 87.04 2.21 Favored 'General case' 0 C--O 1.249 1.043 0 N-CA-C 102.857 -3.016 . . . . 25.0 102.857 164.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 89.2 mt -102.65 122.6 44.75 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 117.764 0.256 . . . . 25.0 111.551 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -110.75 122.88 48.91 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 123.61 0.568 . . . . 25.0 110.257 -179.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.99 176.65 40.95 Favored Glycine 0 CA--C 1.54 1.646 0 C-N-CA 120.59 -0.814 . . . . 25.0 114.349 -178.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.1 p -87.43 179.33 6.59 Favored 'General case' 0 C--O 1.256 1.429 0 C-N-CA 123.581 0.752 . . . . 25.0 110.981 177.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 51.7 mt -82.48 13.96 3.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.232 -0.895 . . . . 25.0 112.736 175.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.4 176.04 20.7 Favored Glycine 0 C--O 1.242 0.597 0 CA-C-N 115.479 -0.782 . . . . 25.0 111.834 177.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.3 t -78.07 131.35 37.27 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 121.85 -0.794 . . . . 25.0 108.884 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -142.65 153.58 43.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.308 0.575 . . . . 50.0 110.545 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -87.52 133.97 33.69 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 102.809 -3.034 . . . . 25.0 102.809 164.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 34.6 mm -127.04 116.69 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 105.292 -2.114 . . . . 25.0 105.292 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.1 tt -122.36 122.22 38.53 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.462 -1.31 . . . . 25.0 107.462 -177.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.21 -38.71 28.84 Favored Glycine 0 N--CA 1.445 -0.733 0 O-C-N 123.986 0.804 . . . . 25.0 114.71 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.66 -147.48 38.66 Favored Glycine 0 C--O 1.241 0.552 0 O-C-N 121.485 -1.009 . . . . 25.0 110.991 -176.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.37 165.02 54.77 Favored Glycine 0 CA--C 1.505 -0.588 0 CA-C-O 121.181 0.323 . . . . 25.0 112.762 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.57 167.27 36.46 Favored Glycine 0 C--O 1.236 0.274 0 C-N-CA 121.024 -0.608 . . . . 25.0 113.875 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.7 107.68 15.51 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.282 -1.007 . . . . 25.0 108.282 177.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -106.4 147.56 29.12 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.086 0.773 . . . . 50.0 113.086 -170.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -113.34 107.03 15.31 Favored 'General case' 0 C--O 1.249 1.073 0 N-CA-C 107.343 -1.354 . . . . 25.0 107.343 172.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 53.6 mt -111.39 133.51 53.64 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 116.161 -0.472 . . . . 25.0 110.613 -171.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -128.83 107.3 9.53 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.483 0.659 . . . . 25.0 111.715 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.71 -34.12 28.78 Favored Glycine 0 N--CA 1.463 0.489 0 N-CA-C 116.732 1.453 . . . . 25.0 116.732 -175.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 55.48 -153.5 0.33 Allowed 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 118.374 1.087 . . . . 25.0 111.959 -173.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.83 164.53 9.97 Favored 'General case' 0 C--O 1.252 1.193 0 N-CA-C 112.798 0.666 . . . . 25.0 112.798 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.67 155.19 31.66 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 115.279 -0.873 . . . . 25.0 111.351 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -78.59 98.54 6.19 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 106.99 -1.485 . . . . 25.0 106.99 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -100.24 151.42 21.47 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 122.032 -0.417 . . . . 50.0 110.183 -171.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.9 mp -113.16 90.6 3.39 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.767 -0.827 . . . . 25.0 108.767 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.4 mp -92.92 125.24 37.42 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 112.14 0.422 . . . . 25.0 112.14 -172.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -122.79 132.76 54.36 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 106.937 -1.505 . . . . 25.0 106.937 173.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.1 -38.76 8.32 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 119.715 -1.231 . . . . 25.0 115.028 -177.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.71 -171.83 51.44 Favored Glycine 0 C--O 1.223 -0.546 0 O-C-N 121.824 -0.81 . . . . 25.0 111.612 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.34 149.48 12.96 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.533 0.683 . . . . 25.0 110.935 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.35 166.93 42.35 Favored Glycine 0 C--N 1.332 0.327 0 CA-C-N 115.482 -0.781 . . . . 25.0 111.939 -178.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.71 129.23 34.86 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 105.16 -2.163 . . . . 25.0 105.16 176.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -120.85 154.16 36.18 Favored 'General case' 0 C--O 1.251 1.153 0 O-C-N 121.733 -0.605 . . . . 50.0 111.656 -175.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -116.57 128.3 55.29 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 103.607 -2.738 . . . . 25.0 103.607 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -147.76 141.58 25.74 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 115.831 1.789 . . . . 25.0 115.831 -174.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.6 m -109.3 138.02 46.29 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.194 -1.409 . . . . 25.0 107.194 176.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.03 -38.57 5.69 Favored Glycine 0 C--N 1.317 -0.512 0 N-CA-C 111.06 -0.816 . . . . 25.0 111.06 174.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.52 -170.37 54.54 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 118.749 1.274 . . . . 25.0 111.992 -177.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -64.15 161.63 15.95 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.088 0.471 . . . . 25.0 111.419 176.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.99 164.06 40.01 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-N 115.503 -0.771 . . . . 25.0 111.724 -176.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.13 106.5 16.63 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.129 -1.063 . . . . 25.0 108.129 -177.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -97.04 156.65 16.27 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 112.548 0.573 . . . . 50.0 112.548 -170.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 57.1 m -122.63 125.66 46.09 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.524 -0.917 . . . . 25.0 108.524 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -120.51 85.57 2.41 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.942 -0.762 . . . . 25.0 108.942 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -89.12 -23.95 22.36 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 112.313 0.486 . . . . 25.0 112.313 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 66.41 162.02 0.16 Allowed 'General case' 0 CA--C 1.548 0.898 0 O-C-N 125.212 1.57 . . . . 25.0 108.595 -171.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.13 -46.1 21.54 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 115.663 1.727 . . . . 25.0 115.663 -165.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.9 mt -144.12 169.28 18.15 Favored 'General case' 0 C--O 1.197 -1.691 0 C-N-CA 123.008 0.523 . . . . 25.0 111.246 -169.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.68 -32.69 30.8 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.574 -0.739 . . . . 25.0 110.571 169.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -80.99 1.44 31.2 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.732 1.382 . . . . 25.0 114.732 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -104.16 142.58 34.25 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.95 0.722 . . . . 25.0 112.95 -175.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.9 t 51.87 54.38 10.99 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 115.142 1.534 . . . . 25.0 115.142 177.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 36.9 p-80 -132.13 170.64 14.71 Favored 'General case' 0 C--O 1.208 -1.111 0 CA-C-N 116.441 -0.345 . . . . 25.0 111.884 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -118.07 144.92 45.21 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 106.696 -1.594 . . . . 25.0 106.696 178.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.9 p -133.31 164.83 41.17 Favored Pre-proline 0 C--O 1.244 0.797 0 N-CA-C 108.443 -0.947 . . . . 25.0 108.443 178.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -64.66 -15.84 52.16 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 117.504 -1.198 . . . . 25.0 113.436 174.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 87.9 mt -82.34 -21.51 35.96 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.075 -0.511 . . . . 25.0 111.817 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.77 171.77 24.13 Favored Glycine 0 C--O 1.219 -0.839 0 N-CA-C 109.875 -1.29 . . . . 25.0 109.875 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.1 t -101.13 147.88 25.72 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 122.659 1.218 . . . . 25.0 112.91 178.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -131.21 21.45 4.84 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.235 -0.893 . . . . 25.0 110.647 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.2 152.04 51.7 Favored Glycine 0 N--CA 1.473 1.164 0 N-CA-C 109.572 -1.411 . . . . 25.0 109.572 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -96.94 171.34 8.56 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 118.529 1.165 . . . . 50.0 110.536 -174.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.439 ' HG3' ' HB3' ' A' ' 140' ' ' ALA . 0.0 OUTLIER -126.85 108.5 11.06 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 121.931 -0.481 . . . . 25.0 112.231 -175.228 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.3 mt -89.39 138.68 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 109.212 -0.662 . . . . 25.0 109.212 -176.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.419 ' HA ' ' HG2' ' A' ' 142' ' ' GLU . 76.9 mt -86.33 -52.62 5.51 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 115.77 1.767 . . . . 25.0 115.77 -175.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -127.82 32.46 4.95 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 113.982 1.105 . . . . 25.0 113.982 -168.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -52.94 143.33 17.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.423 -1.262 . . . . 25.0 114.029 -175.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -118.17 103.35 49.78 Favored Pre-proline 0 C--O 1.237 0.398 0 C-N-CA 123.032 0.533 . . . . 25.0 111.333 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.23 -13.21 35.6 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 N-CA-C 114.549 0.942 . . . . 25.0 114.549 -175.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.0 t -81.26 -39.33 25.45 Favored 'General case' 0 C--O 1.245 0.836 0 N-CA-C 108.737 -0.838 . . . . 25.0 108.737 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -95.33 -43.53 7.99 Favored 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 117.196 2.295 . . . . 25.0 117.196 -175.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -90.19 172.75 8.58 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.572 -1.195 . . . . 75.0 112.03 -162.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -142.81 147.32 35.28 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 112.36 0.504 . . . . 25.0 112.36 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 90.7 mt -127.35 128.78 70.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 108.604 -0.887 . . . . 25.0 108.604 -178.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -86.62 148.6 25.41 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 122.124 0.964 . . . . 25.0 111.617 174.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.41 HG11 ' CZ ' ' A' ' 101' ' ' PHE . 8.4 p -146.75 -2.8 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 115.566 -0.743 . . . . 25.0 111.043 175.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 44.9 t -60.97 -44.57 97.15 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.662 0.744 . . . . 25.0 111.464 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.82 -28.53 58.33 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.372 -0.831 . . . . 25.0 112.074 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.6 mt -92.09 -41.61 10.4 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 116.288 1.958 . . . . 25.0 116.288 -171.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -138.54 -48.12 0.06 OUTLIER Glycine 0 N--CA 1.463 0.491 0 N-CA-C 118.156 2.022 . . . . 25.0 118.156 -172.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.41 ' CZ ' HG11 ' A' ' 96' ' ' VAL . 50.2 p90 -160.14 153.03 21.45 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 118.579 1.19 . . . . 25.0 112.714 -172.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 25.2 t -109.15 -16.94 13.98 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.511 -0.552 . . . . 25.0 109.511 178.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -121.46 132.61 9.12 Favored Glycine 0 N--CA 1.47 0.912 0 N-CA-C 108.363 -1.895 . . . . 25.0 108.363 176.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -68.15 156.0 38.43 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.963 1.468 . . . . 25.0 114.963 -172.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -101.77 -161.25 26.79 Favored Glycine 0 N--CA 1.464 0.53 0 O-C-N 121.583 -0.698 . . . . 25.0 112.828 -177.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -54.57 138.99 39.62 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 113.482 0.919 . . . . 25.0 113.482 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 168.72 -176.42 42.98 Favored Glycine 0 C--O 1.227 -0.292 0 CA-C-N 115.242 -0.89 . . . . 25.0 110.995 177.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -146.56 165.93 28.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.573 0.687 . . . . 25.0 109.283 -177.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 54.99 34.02 21.5 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 114.449 1.277 . . . . 25.0 114.449 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.62 25.39 65.35 Favored Glycine 0 N--CA 1.465 0.617 0 N-CA-C 111.159 -0.776 . . . . 25.0 111.159 177.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.428 ' HA ' ' H ' ' A' ' 151' ' ' ALA . 4.8 t -136.64 176.4 8.74 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 109.01 -0.737 . . . . 25.0 109.01 -178.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 69.7 mt -89.48 164.89 14.63 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 104.056 -2.572 . . . . 25.0 104.056 169.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.66 108.12 4.24 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 122.199 1.0 . . . . 25.0 109.894 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 18.0 m -73.16 160.34 5.36 Favored 'Isoleucine or valine' 0 C--O 1.247 0.968 0 N-CA-C 108.893 -0.78 . . . . 25.0 108.893 -177.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.47 168.87 20.8 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 110.382 -0.229 . . . . 25.0 110.382 -176.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.6 m -124.97 160.09 30.76 Favored 'Isoleucine or valine' 0 C--O 1.251 1.138 0 O-C-N 121.876 -0.515 . . . . 25.0 110.222 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.6 t -73.5 -49.12 28.3 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.692 -1.225 . . . . 25.0 107.692 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -168.94 -160.59 0.28 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 103.854 -2.647 . . . . 25.0 103.854 -177.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -72.82 -0.08 12.41 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 121.291 -0.88 . . . . 25.0 111.987 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -143.63 -157.79 7.31 Favored Glycine 0 C--O 1.241 0.575 0 N-CA-C 108.007 -2.037 . . . . 25.0 108.007 177.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.65 -153.59 0.37 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.184 0.809 . . . . 25.0 113.184 178.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.4 mtt85 -80.72 161.58 24.52 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 113.496 0.924 . . . . 25.0 113.496 -172.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.64 164.58 11.68 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 105.827 -1.916 . . . . 25.0 105.827 171.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -128.77 155.92 44.38 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 121.603 0.716 . . . . 25.0 110.357 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 29.8 tp -132.5 115.92 16.11 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 102.705 -3.072 . . . . 25.0 102.705 169.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -116.7 153.49 32.26 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 112.638 0.607 . . . . 25.0 112.638 -174.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 33.4 t -97.25 149.66 21.8 Favored 'General case' 0 C--O 1.215 -0.721 0 N-CA-C 103.889 -2.634 . . . . 25.0 103.889 168.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -119.35 10.17 11.85 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 124.828 1.33 . . . . 25.0 109.581 -178.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -97.95 152.78 18.89 Favored 'General case' 0 C--O 1.251 1.154 0 CA-C-N 114.291 -1.322 . . . . 25.0 107.504 171.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -142.88 160.4 40.41 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 122.234 1.016 . . . . 25.0 112.537 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -75.18 165.07 25.77 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 106.277 -1.749 . . . . 25.0 106.277 172.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.62 -22.83 67.11 Favored 'General case' 0 C--O 1.248 0.999 0 CA-C-O 122.287 1.042 . . . . 25.0 109.374 176.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -80.27 -6.78 58.47 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.859 -1.064 . . . . 25.0 112.788 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.59 2.53 72.72 Favored Glycine 0 C--O 1.223 -0.58 0 N-CA-C 114.419 0.528 . . . . 25.0 114.419 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.9 mt -72.68 137.17 45.83 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.83 -1.174 . . . . 25.0 107.83 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 88.7 p -140.25 -179.88 6.24 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 109.461 -0.57 . . . . 25.0 109.461 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -122.84 140.2 53.2 Favored 'General case' 0 C--O 1.247 0.951 0 O-C-N 121.926 -0.484 . . . . 25.0 111.717 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -156.97 155.49 31.38 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 107.476 -1.305 . . . . 25.0 107.476 170.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.8 p -148.78 147.07 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 N-CA-C 105.12 -2.178 . . . . 25.0 105.12 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.439 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . . . -115.38 149.64 37.63 Favored 'General case' 0 C--O 1.254 1.305 0 N-CA-C 109.306 -0.627 . . . . 25.0 109.306 -175.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mp -139.15 129.22 25.18 Favored 'General case' 0 C--O 1.205 -1.254 0 N-CA-C 107.522 -1.288 . . . . 25.0 107.522 -175.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.419 ' HG2' ' HA ' ' A' ' 85' ' ' LEU . 6.9 pt-20 -86.33 0.77 53.21 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.347 -0.941 . . . . 25.0 113.058 -177.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -65.17 -17.84 64.17 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 116.033 1.173 . . . . 25.0 116.033 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 38.5 t0 54.4 45.77 26.43 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 122.423 1.106 . . . . 25.0 112.199 -178.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -122.05 43.37 2.88 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 113.993 -1.458 . . . . 25.0 109.418 -174.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -52.63 -37.51 58.58 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 113.995 1.109 . . . . 25.0 113.995 178.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.59 -28.18 63.64 Favored 'General case' 0 C--O 1.248 0.996 0 CA-C-N 118.923 0.783 . . . . 25.0 111.473 -178.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.56 -27.47 34.33 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 121.413 0.625 . . . . 25.0 112.377 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 46.1 mt -66.6 128.58 36.79 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 119.87 -0.732 . . . . 25.0 110.337 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.9 m -131.15 160.93 33.31 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 107.176 -1.416 . . . . 25.0 107.176 177.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.428 ' H ' ' HA ' ' A' ' 111' ' ' SER . . . -79.51 1.37 26.02 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 107.619 -1.252 . . . . 25.0 107.619 177.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -68.47 -30.8 69.73 Favored 'General case' 0 N--CA 1.437 -1.106 0 O-C-N 123.465 0.478 . . . . 25.0 111.803 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -91.31 -10.41 41.43 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.733 -0.469 . . . . 25.0 109.733 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 26.9 mm -83.75 136.01 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 104.435 -2.432 . . . . 25.0 104.435 175.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.9 p -113.51 126.35 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 O-C-N 120.47 -1.394 . . . . 25.0 110.965 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -153.77 -30.43 0.12 Allowed 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 114.38 -1.282 . . . . 25.0 112.743 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -82.77 69.84 9.64 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 112.849 0.685 . . . . 25.0 112.849 -175.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 54.37 20.77 2.87 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.871 1.063 . . . . 25.0 113.871 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.12 17.95 4.89 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.705 0.802 . . . . 25.0 111.721 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -98.57 131.55 44.69 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.553 0.341 . . . . 25.0 110.976 -174.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.4 -10.33 58.78 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.957 0.725 . . . . 25.0 112.957 -176.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.07 -32.3 72.83 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.221 0.452 . . . . 25.0 112.221 -178.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.71 162.97 26.58 Favored 'General case' 0 C--O 1.247 0.961 0 N-CA-C 111.978 0.362 . . . . 25.0 111.978 -175.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 57.59 -169.81 0.11 Allowed 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 114.034 1.124 . . . . 25.0 114.034 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 90.83 2.18 72.41 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.787 -0.721 . . . . 25.0 113.789 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -102.48 115.29 30.28 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.841 -1.17 . . . . 25.0 107.841 176.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -134.47 161.78 34.09 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.287 -1.005 . . . . 25.0 108.287 -177.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -135.11 27.34 3.16 Favored Glycine 0 C--O 1.242 0.606 0 N-CA-C 110.419 -1.072 . . . . 25.0 110.419 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 47.7 t -70.2 -34.83 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.32 0.648 . . . . 25.0 110.355 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -58.36 133.69 23.32 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 CA-C-O 121.727 0.775 . . . . 25.0 111.735 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 156.81 160.18 9.93 Favored Glycine 0 C--N 1.336 0.564 0 N-CA-C 110.757 -0.937 . . . . 25.0 110.757 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -136.37 152.42 50.62 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 122.382 -0.481 . . . . 25.0 110.031 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 54.5 p -148.71 159.16 44.38 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.239 0.542 . . . . 25.0 110.0 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -179.93 168.77 39.25 Favored Glycine 0 N--CA 1.461 0.318 0 O-C-N 121.677 -0.639 . . . . 25.0 113.717 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -154.23 114.19 2.5 Favored Pre-proline 0 C--O 1.246 0.908 0 N-CA-C 107.767 -1.197 . . . . 25.0 107.767 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -68.84 157.05 63.4 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 117.304 -1.331 . . . . 25.0 112.559 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -117.75 146.67 43.62 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 108.208 -1.034 . . . . 25.0 108.208 177.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -140.15 64.27 25.9 Favored Pre-proline 0 N--CA 1.478 0.969 0 N-CA-C 112.405 0.52 . . . . 25.0 112.405 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.21 161.39 32.26 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 117.579 -1.147 . . . . 25.0 112.616 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 15.2 t -119.17 2.91 11.43 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 116.328 -0.396 . . . . 25.0 110.894 177.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 C--O 1.254 1.307 0 CA-C-O 117.494 -1.241 . . . . 25.0 111.283 178.829 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 121.429 0.633 . . . . 25.0 109.906 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -148.76 113.82 3.7 Favored Pre-proline 0 N--CA 1.477 0.893 0 O-C-N 121.626 -0.671 . . . . 25.0 109.901 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -70.18 147.22 59.7 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 117.65 -1.1 . . . . 25.0 112.653 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.79 36.34 0.22 Allowed Glycine 0 N--CA 1.473 1.107 0 C-N-CA 121.173 -0.537 . . . . 25.0 113.838 -177.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.429 HG12 ' H ' ' A' ' 5' ' ' VAL . 0.9 OUTLIER -50.03 119.6 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 114.119 1.155 . . . . 25.0 114.119 -175.523 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -93.43 8.5 40.29 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 122.176 0.989 . . . . 25.0 108.341 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.92 -152.67 17.71 Favored Glycine 0 C--O 1.22 -0.742 0 CA-C-N 115.865 -0.607 . . . . 25.0 113.993 176.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.6 p 69.13 158.19 0.15 Allowed Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 125.988 1.715 . . . . 25.0 112.048 -174.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -69.7 22.77 0.17 Allowed 'Trans proline' 0 C--N 1.359 1.098 0 N-CA-C 118.803 2.578 . . . . 25.0 118.803 -176.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.07 -25.76 17.07 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.504 0 N-CA-C 114.516 1.302 . . . . 25.0 114.516 -171.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.6 p -146.69 145.76 19.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 CA-C-N 119.644 1.111 . . . . 25.0 112.223 -175.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.2 24.15 41.69 Favored Glycine 0 N--CA 1.466 0.681 0 N-CA-C 118.719 2.247 . . . . 25.0 118.719 172.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.7 t -49.49 -66.11 0.45 Allowed 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 118.641 1.22 . . . . 25.0 112.719 -175.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -86.49 17.83 3.62 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 115.588 1.699 . . . . 25.0 115.588 -167.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.16 168.75 19.07 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 120.821 -1.175 . . . . 25.0 110.927 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -68.9 132.22 46.37 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.233 0.54 . . . . 25.0 110.848 -175.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -123.67 160.46 27.14 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.896 1.443 . . . . 50.0 114.896 -174.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -124.38 99.03 6.01 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 104.492 -2.41 . . . . 25.0 104.492 161.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 87.1 mt -108.44 109.72 21.07 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 111.664 0.246 . . . . 25.0 111.664 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -103.18 117.12 33.81 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.498 -0.556 . . . . 25.0 109.498 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.78 -171.59 46.04 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 117.644 1.818 . . . . 25.0 117.644 -168.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.439 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 81.8 p -87.1 169.02 12.76 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.561 0.744 . . . . 25.0 109.102 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 68.7 mt -86.54 11.28 13.03 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.23 -0.441 . . . . 25.0 111.464 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -112.26 175.78 17.35 Favored Glycine 0 N--CA 1.461 0.357 0 N-CA-C 109.115 -1.594 . . . . 25.0 109.115 177.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.3 t -66.33 140.74 58.12 Favored 'General case' 0 C--O 1.207 -1.143 0 CA-C-N 117.978 0.889 . . . . 25.0 110.745 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.439 ' CD ' ' H ' ' A' ' 22' ' ' THR . 26.2 mt-10 -149.11 156.99 43.03 Favored 'General case' 0 C--O 1.246 0.895 0 C-N-CA 122.917 0.487 . . . . 50.0 110.106 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -89.93 138.23 31.67 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 104.544 -2.391 . . . . 25.0 104.544 161.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.5 mm -126.62 92.98 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 106.042 -1.836 . . . . 25.0 106.042 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 11.0 mp -104.5 120.96 42.46 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 104.652 -2.351 . . . . 25.0 104.652 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.27 -26.39 36.69 Favored Glycine 0 CA--C 1.505 -0.586 0 CA-C-O 119.729 -0.484 . . . . 25.0 112.051 -174.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.6 -149.24 46.49 Favored Glycine 0 C--O 1.249 1.077 0 N-CA-C 110.165 -1.174 . . . . 25.0 110.165 -173.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.49 179.12 40.82 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-O 123.059 1.366 . . . . 25.0 112.475 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.97 164.19 19.97 Favored Glycine 0 C--O 1.248 0.976 0 CA-C-N 114.207 -0.996 . . . . 25.0 114.266 179.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.56 100.02 12.11 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 106.722 -1.584 . . . . 25.0 106.722 176.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -96.83 156.36 16.38 Favored 'General case' 0 C--O 1.214 -0.783 0 C-N-CA 120.207 -0.597 . . . . 50.0 112.148 -170.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -115.61 91.26 3.55 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 106.233 -1.766 . . . . 25.0 106.233 174.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 70.0 mt -97.77 136.19 38.46 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-N 114.024 -1.444 . . . . 25.0 112.613 -172.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -131.64 95.14 3.66 Favored 'General case' 0 C--O 1.252 1.189 0 CA-C-O 121.53 0.681 . . . . 25.0 111.743 -176.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.88 -27.13 69.49 Favored Glycine 0 CA--C 1.521 0.426 0 CA-C-O 119.118 -0.823 . . . . 25.0 113.926 -176.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 48.79 -148.25 0.24 Allowed 'General case' 0 C--O 1.243 0.721 0 C-N-CA 124.405 1.082 . . . . 25.0 111.852 -176.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.91 159.58 34.41 Favored 'General case' 0 C--O 1.25 1.11 0 CA-C-O 121.69 0.757 . . . . 25.0 111.633 -177.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.33 156.64 21.49 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.51 -1.036 . . . . 25.0 110.51 -175.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -86.45 90.15 8.12 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.516 -0.92 . . . . 25.0 108.516 176.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -90.57 160.28 16.02 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.028 -0.987 . . . . 50.0 112.43 -170.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 tp -124.27 99.69 6.34 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.378 -0.971 . . . . 25.0 108.378 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.3 mp -101.83 117.83 35.66 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 116.016 1.858 . . . . 25.0 116.016 -166.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -122.23 101.62 7.63 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.117 -0.947 . . . . 25.0 109.137 174.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.42 -29.17 70.88 Favored Glycine 0 CA--C 1.523 0.585 0 O-C-N 120.141 -1.599 . . . . 25.0 112.769 -177.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.57 -168.08 54.1 Favored Glycine 0 N--CA 1.471 1.029 0 N-CA-C 108.938 -1.665 . . . . 25.0 108.938 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.86 151.89 33.27 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.86 0.689 . . . . 25.0 112.86 -175.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.79 165.98 33.12 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 115.847 1.099 . . . . 25.0 115.847 -175.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.415 ' HD2' ' HA ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -91.03 105.84 18.1 Favored 'General case' 0 C--O 1.212 -0.893 0 N-CA-C 105.667 -1.975 . . . . 25.0 105.667 176.293 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -99.98 151.45 21.33 Favored 'General case' 0 CA--C 1.483 -1.63 0 O-C-N 123.879 0.737 . . . . 50.0 112.093 -168.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -112.03 125.36 53.99 Favored 'General case' 0 C--O 1.211 -0.955 0 N-CA-C 103.374 -2.825 . . . . 25.0 103.374 177.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -149.31 132.68 16.56 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 122.348 1.07 . . . . 25.0 113.27 -174.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 71.5 m -96.77 136.11 37.78 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 106.979 -1.489 . . . . 25.0 106.979 173.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -88.06 -40.94 6.42 Favored Glycine 0 CA--C 1.499 -0.909 0 N-CA-C 110.357 -1.097 . . . . 25.0 110.357 174.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.62 -171.64 54.09 Favored Glycine 0 C--O 1.252 1.228 0 CA-C-O 122.633 1.129 . . . . 25.0 113.402 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -63.01 163.09 10.33 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 121.661 -0.905 . . . . 25.0 110.225 176.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.91 164.52 40.3 Favored Glycine 0 C--O 1.243 0.684 0 CA-C-O 118.554 -1.137 . . . . 25.0 112.514 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.51 113.24 20.11 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.967 -0.753 . . . . 25.0 108.967 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -104.9 154.41 20.11 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 121.541 -0.724 . . . . 50.0 110.576 -177.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.3 m -120.58 129.08 53.61 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 106.271 -1.751 . . . . 25.0 106.271 177.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -115.38 128.7 56.24 Favored 'General case' 0 C--O 1.207 -1.153 0 N-CA-C 104.827 -2.286 . . . . 25.0 104.827 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 61.9 mtt85 -133.41 -29.88 1.35 Allowed 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 113.393 0.886 . . . . 25.0 113.393 174.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 68.23 163.03 0.21 Allowed 'General case' 0 CA--C 1.537 0.459 0 O-C-N 124.794 1.309 . . . . 25.0 110.201 -172.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.22 -41.34 49.58 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.473 1.657 . . . . 25.0 115.473 -165.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 66.5 mt -136.53 170.39 16.14 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 115.217 1.562 . . . . 25.0 115.217 -171.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.09 -28.33 64.5 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.13 -1.396 . . . . 25.0 109.198 168.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -81.29 6.98 12.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.161 -1.381 . . . . 25.0 114.423 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -111.32 152.96 26.64 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.119 -1.613 . . . . 25.0 113.237 -174.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.6 t 41.27 50.77 3.48 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 117.897 2.554 . . . . 25.0 117.897 -178.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 24.5 p-80 -125.43 161.28 27.43 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 114.411 -1.268 . . . . 25.0 112.237 -176.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -109.37 138.72 45.29 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 104.859 -2.275 . . . . 25.0 104.859 174.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.4 p -122.6 172.14 5.66 Favored Pre-proline 0 C--N 1.322 -0.629 0 O-C-N 124.129 0.893 . . . . 25.0 109.975 -178.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -61.94 -23.97 76.45 Favored 'Trans proline' 0 C--O 1.254 1.315 0 C-N-CA 117.707 -1.062 . . . . 25.0 112.639 174.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 75.1 mt -78.22 -29.03 48.07 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.339 0.496 . . . . 25.0 112.339 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.23 -179.6 32.88 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.08 -1.208 . . . . 25.0 110.08 -172.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.5 t -98.12 151.42 20.41 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.106 1.15 . . . . 25.0 114.106 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.415 ' HA ' ' HD2' ' A' ' 52' ' ' ARG . 72.7 m-85 -135.47 29.73 3.26 Favored 'General case' 0 C--O 1.251 1.166 0 CA-C-N 114.419 -1.264 . . . . 25.0 108.889 175.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.53 146.8 42.77 Favored Glycine 0 C--N 1.335 0.476 0 O-C-N 124.102 0.876 . . . . 25.0 112.138 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -84.2 169.46 14.76 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 122.543 -0.387 . . . . 50.0 111.647 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -128.78 108.22 10.28 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 110.166 -0.309 . . . . 25.0 110.166 -176.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.5 mt -98.13 135.67 31.91 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 N-CA-C 107.618 -1.253 . . . . 25.0 107.618 -177.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.6 mt -84.83 -41.19 16.3 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 115.723 1.749 . . . . 25.0 115.723 -171.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.9 p-10 -137.22 39.07 2.51 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.991 1.108 . . . . 25.0 113.991 -172.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -58.24 132.89 54.94 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.126 -0.943 . . . . 25.0 110.655 -177.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -113.7 106.25 54.03 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 108.375 -0.972 . . . . 25.0 108.375 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.1 -16.64 56.08 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 N-CA-C 116.338 1.63 . . . . 25.0 116.338 -173.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.7 t -88.33 -29.11 20.57 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.895 0.378 . . . . 25.0 111.374 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -93.44 -48.93 6.17 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.609 0.719 . . . . 25.0 111.575 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -96.56 165.5 12.13 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 114.169 -1.378 . . . . 50.0 110.92 -159.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -142.18 151.54 42.3 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 113.921 1.082 . . . . 25.0 113.921 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 75.3 mt -126.51 123.54 63.43 Favored 'Isoleucine or valine' 0 C--O 1.247 0.969 0 N-CA-C 107.55 -1.278 . . . . 25.0 107.55 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -81.58 147.35 29.65 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 122.257 1.027 . . . . 25.0 108.363 173.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -155.63 -12.02 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 115.232 -0.895 . . . . 25.0 112.45 -179.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.6 t -62.67 -38.34 89.95 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 120.738 -1.226 . . . . 25.0 110.237 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.65 -21.0 56.05 Favored 'General case' 0 CA--C 1.555 1.149 0 N-CA-C 114.812 1.412 . . . . 25.0 114.812 -176.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.39 0.63 2.81 Favored 'General case' 0 CA--C 1.556 1.176 0 N-CA-C 117.61 2.448 . . . . 25.0 117.61 -170.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -143.32 -67.05 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 119.021 0.828 . . . . 25.0 115.012 177.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -160.11 164.92 32.64 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.99 0.9 . . . . 25.0 110.992 -174.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.8 t -119.48 -26.76 5.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.773 -1.103 . . . . 25.0 110.521 174.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -93.95 120.68 6.39 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 118.718 -1.046 . . . . 25.0 112.699 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -65.93 157.17 31.37 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.442 1.621 . . . . 25.0 112.356 178.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -90.7 -172.03 43.88 Favored Glycine 0 C--N 1.32 -0.332 0 CA-C-O 118.88 -0.956 . . . . 25.0 112.263 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -79.54 83.1 5.57 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 118.646 1.223 . . . . 25.0 112.111 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.06 -175.43 17.96 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 108.348 -1.901 . . . . 25.0 108.348 168.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -127.05 160.7 30.34 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.971 1.385 . . . . 25.0 111.879 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 51.83 47.24 25.18 Favored 'General case' 0 C--O 1.266 1.951 0 N-CA-C 114.946 1.462 . . . . 25.0 114.946 -176.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.26 48.69 36.96 Favored Glycine 0 N--CA 1.48 1.591 0 N-CA-C 109.253 -1.539 . . . . 25.0 109.253 176.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.5 t -148.33 173.84 12.64 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 117.838 0.819 . . . . 25.0 111.905 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.7 mp -105.36 168.57 8.99 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 101.816 -3.402 . . . . 25.0 101.816 173.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.55 135.48 39.27 Favored 'General case' 0 C--O 1.254 1.31 0 C-N-CA 117.915 -1.514 . . . . 25.0 108.009 -176.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.7 m -102.35 163.58 3.42 Favored 'Isoleucine or valine' 0 C--O 1.248 0.997 0 CA-C-O 118.524 -0.75 . . . . 25.0 109.165 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.0 p -149.78 163.41 38.05 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-N 118.514 0.597 . . . . 25.0 112.247 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 28.0 m -115.89 160.82 15.05 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 N-CA-C 105.787 -1.931 . . . . 25.0 105.787 176.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.9 t -78.76 -42.67 27.42 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 107.055 -1.461 . . . . 25.0 107.055 176.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -168.31 -169.13 1.03 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 103.78 -2.674 . . . . 25.0 103.78 -175.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -59.76 -24.78 64.35 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.662 0.601 . . . . 25.0 112.534 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -126.9 -147.38 6.72 Favored Glycine 0 C--O 1.252 1.231 0 N-CA-C 111.114 -0.795 . . . . 25.0 111.114 174.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 53.72 -142.69 0.78 Allowed 'General case' 0 C--O 1.246 0.872 0 N-CA-C 113.891 1.071 . . . . 25.0 113.891 -179.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.7 mtt85 -91.39 162.83 14.42 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 114.716 1.376 . . . . 25.0 114.716 -170.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.5 p -113.08 162.48 15.88 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 104.73 -2.322 . . . . 25.0 104.73 176.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -132.7 156.14 47.55 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 109.245 -0.65 . . . . 25.0 109.245 -175.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 33.6 tp -135.16 127.66 30.6 Favored 'General case' 0 C--O 1.251 1.17 0 N-CA-C 102.695 -3.076 . . . . 25.0 102.695 171.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -128.65 159.6 35.07 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 115.787 -0.642 . . . . 25.0 112.673 -170.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.2 t -94.64 149.77 20.91 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.295 -1.372 . . . . 25.0 107.295 171.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -119.82 24.15 10.7 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 106.93 -1.507 . . . . 25.0 106.93 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -125.91 135.88 52.41 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 106.364 -1.717 . . . . 25.0 106.364 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -139.39 156.31 47.07 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 122.558 1.17 . . . . 25.0 109.672 -172.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -74.08 159.35 32.75 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-N 114.782 -1.099 . . . . 25.0 109.225 173.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.29 -20.64 66.5 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.733 -0.604 . . . . 25.0 109.789 173.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -69.89 -12.27 61.49 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 118.675 -0.678 . . . . 25.0 112.502 175.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.13 22.93 46.75 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 111.51 -0.636 . . . . 25.0 111.51 -177.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.7 mt -100.18 141.01 33.6 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 107.636 -1.246 . . . . 25.0 107.636 177.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 59.7 p -147.61 171.43 15.61 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 106.789 -1.56 . . . . 25.0 106.789 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -115.76 138.38 51.18 Favored 'General case' 0 C--O 1.257 1.453 0 CA-C-N 118.667 0.667 . . . . 25.0 112.624 -173.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -152.63 153.21 32.87 Favored 'General case' 0 C--O 1.248 1.02 0 CA-C-O 121.717 0.77 . . . . 25.0 110.088 172.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.9 p -145.03 143.79 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.784 0 N-CA-C 105.858 -1.904 . . . . 25.0 105.858 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -107.86 142.69 37.55 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.41 -1.329 . . . . 25.0 107.41 -176.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.6 mp -131.13 137.13 48.9 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.489 -1.3 . . . . 25.0 107.489 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -109.71 7.29 24.27 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 121.251 1.841 . . . . 25.0 115.858 -176.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -76.9 4.94 51.45 Favored Glycine 0 N--CA 1.469 0.894 0 N-CA-C 116.322 1.289 . . . . 25.0 116.322 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 46.6 t0 51.34 51.94 15.83 Favored 'General case' 0 C--O 1.256 1.43 0 C-N-CA 124.046 0.939 . . . . 25.0 111.875 176.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -129.84 29.83 4.94 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 124.849 1.26 . . . . 25.0 110.714 -174.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.85 -31.98 70.26 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 119.275 -0.97 . . . . 25.0 111.52 176.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.6 -20.95 66.12 Favored 'General case' 0 C--O 1.251 1.171 0 CA-C-N 118.777 0.717 . . . . 25.0 111.349 177.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -95.67 -27.77 15.13 Favored 'General case' 0 C--O 1.259 1.603 0 N-CA-C 114.048 1.129 . . . . 25.0 114.048 176.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 74.6 mt -58.39 137.36 57.31 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 114.126 1.158 . . . . 25.0 114.126 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 62.7 m -137.15 167.15 22.1 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 105.642 -1.985 . . . . 25.0 105.642 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -77.45 -2.88 37.52 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 120.458 -1.401 . . . . 25.0 111.324 174.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -68.42 -29.09 67.68 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.777 -0.577 . . . . 25.0 112.353 -176.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -87.02 -2.48 58.66 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.882 -0.599 . . . . 25.0 111.209 174.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 36.7 mm -96.64 127.32 48.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 104.679 -2.341 . . . . 25.0 104.679 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.1 p -105.42 104.4 16.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 124.063 1.887 . . . . 25.0 114.78 -174.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -141.81 -1.1 1.29 Allowed 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 112.625 -2.079 . . . . 25.0 111.091 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -80.91 53.5 1.97 Allowed 'General case' 0 CA--C 1.549 0.905 0 O-C-N 121.151 -0.968 . . . . 25.0 112.603 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 58.85 18.07 5.8 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 114.434 1.272 . . . . 25.0 114.434 -175.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.58 -39.88 0.39 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 118.264 2.69 . . . . 25.0 118.264 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -70.81 150.01 46.27 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-O 121.388 0.613 . . . . 25.0 110.622 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -80.3 19.93 0.72 Allowed 'General case' 0 C--O 1.218 -0.564 0 C-N-CA 124.09 0.956 . . . . 25.0 112.32 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.74 -21.78 66.84 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 115.487 1.662 . . . . 25.0 115.487 -177.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -140.28 -160.59 1.09 Allowed 'General case' 0 CA--C 1.547 0.862 0 CA-C-O 121.567 0.699 . . . . 25.0 111.37 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 64.21 -171.11 0.18 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 115.359 1.614 . . . . 25.0 115.359 177.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 81.38 24.38 56.87 Favored Glycine 0 C--O 1.225 -0.456 0 CA-C-O 122.985 1.325 . . . . 25.0 110.515 -175.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -98.7 114.59 27.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.444 -0.878 . . . . 25.0 109.165 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -123.68 143.22 50.39 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 108.532 -0.914 . . . . 25.0 108.532 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -111.07 16.83 27.45 Favored Glycine 0 C--O 1.225 -0.432 0 N-CA-C 112.155 -0.378 . . . . 25.0 112.155 -177.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 49.0 t -68.59 -37.33 77.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.697 -0.252 . . . . 25.0 111.297 -174.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.0 133.31 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-O 121.599 0.714 . . . . 25.0 111.57 -176.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 149.04 159.01 8.33 Favored Glycine 0 N--CA 1.463 0.435 0 N-CA-C 110.058 -1.217 . . . . 25.0 110.058 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -151.69 153.04 33.6 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-O 122.285 1.04 . . . . 25.0 111.338 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 92.6 p -165.34 163.11 19.95 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 105.074 -2.195 . . . . 25.0 105.074 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 174.7 159.84 21.7 Favored Glycine 0 C--O 1.245 0.803 0 C-N-CA 119.963 -1.113 . . . . 25.0 114.241 174.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -116.86 110.75 41.58 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 109.047 -0.724 . . . . 25.0 109.047 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.37 169.5 21.83 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 116.328 -1.981 . . . . 25.0 114.335 -175.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -124.57 140.95 52.47 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.368 -0.975 . . . . 25.0 108.368 175.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -143.66 73.47 17.1 Favored Pre-proline 0 N--CA 1.487 1.383 0 CA-C-O 121.11 0.481 . . . . 25.0 111.75 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -67.99 152.89 76.36 Favored 'Trans proline' 0 C--O 1.242 0.682 0 N-CA-C 114.062 0.755 . . . . 25.0 114.062 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.6 t -124.05 11.05 8.86 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.712 -0.676 . . . . 25.0 109.363 -176.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.257 1.457 0 N-CA-C 109.157 -0.683 . . . . 25.0 109.157 178.717 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.526 3.327 0 N-CA-C 110.156 -0.313 . . . . 25.0 110.156 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -140.86 100.12 6.63 Favored Pre-proline 0 N--CA 1.486 1.358 0 O-C-N 121.788 -0.57 . . . . 25.0 109.512 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -71.16 142.9 42.88 Favored 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 117.02 -1.52 . . . . 25.0 114.297 -177.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -163.83 49.76 0.3 Allowed Glycine 0 N--CA 1.467 0.759 0 N-CA-C 108.467 -1.853 . . . . 25.0 108.467 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.447 HG22 ' H ' ' A' ' 7' ' ' GLY . 9.2 p -54.58 128.87 15.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-O 122.918 1.342 . . . . 25.0 110.495 -175.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -101.19 -1.63 33.36 Favored 'General case' 0 C--O 1.252 1.226 0 O-C-N 121.289 -0.882 . . . . 25.0 110.389 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.447 ' H ' HG22 ' A' ' 5' ' ' VAL . . . -86.48 -142.55 6.99 Favored Glycine 0 C--O 1.241 0.539 0 CA-C-N 116.421 -0.354 . . . . 25.0 112.79 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.0 p 68.43 157.75 0.15 Allowed Pre-proline 0 N--CA 1.486 1.353 0 C-N-CA 125.811 1.644 . . . . 25.0 111.739 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.577 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 25.5 Cg_exo -71.1 -2.35 10.97 Favored 'Trans proline' 0 C--N 1.354 0.86 0 N-CA-C 116.046 1.518 . . . . 25.0 116.046 -172.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.6 p -65.04 -13.59 15.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 115.974 1.842 . . . . 25.0 115.974 -171.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.3 p -139.69 134.94 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 114.693 1.368 . . . . 25.0 114.693 -177.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.6 13.18 83.21 Favored Glycine 0 N--CA 1.466 0.665 0 N-CA-C 117.026 1.57 . . . . 25.0 117.026 174.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.7 t -47.12 -49.74 21.5 Favored 'General case' 0 C--O 1.209 -1.028 0 CA-C-N 118.98 1.39 . . . . 25.0 113.279 -168.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -78.61 6.91 7.68 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 116.85 2.167 . . . . 25.0 116.85 -174.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 pp -142.57 169.52 17.42 Favored 'General case' 0 C--O 1.203 -1.352 0 O-C-N 121.277 -0.889 . . . . 25.0 111.428 -177.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -61.5 128.47 36.44 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 113.139 0.792 . . . . 25.0 113.139 -174.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -130.08 167.15 18.78 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 114.081 1.141 . . . . 50.0 114.081 -175.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -125.34 107.73 10.98 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 104.008 -2.59 . . . . 25.0 104.008 169.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.3 mt -122.66 114.43 20.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 119.069 0.85 . . . . 25.0 110.143 -175.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -108.22 121.94 45.91 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.618 -0.882 . . . . 25.0 108.618 173.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.2 -177.89 47.33 Favored Glycine 0 N--CA 1.471 1.026 0 N-CA-C 115.063 0.785 . . . . 25.0 115.063 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.4 p -81.02 178.11 8.63 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.021 0.928 . . . . 25.0 111.229 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 79.7 mt -90.31 13.55 15.08 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.193 0.52 . . . . 25.0 110.103 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.77 -177.09 20.64 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.455 -0.658 . . . . 25.0 111.455 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.8 t -75.38 129.4 37.29 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.128 1.159 . . . . 25.0 114.128 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -145.01 159.82 42.34 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.045 -1.034 . . . . 50.0 112.998 -174.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -98.66 120.97 39.99 Favored 'General case' 0 C--O 1.26 1.608 0 N-CA-C 105.498 -2.038 . . . . 25.0 105.498 164.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.1 mm -115.98 107.88 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 N-CA-C 105.291 -2.115 . . . . 25.0 105.291 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.577 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 9.2 mp -115.89 132.11 56.74 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 105.084 -2.191 . . . . 25.0 105.084 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.89 -33.94 9.4 Favored Glycine 0 CA--C 1.483 -1.962 0 N-CA-C 114.72 0.648 . . . . 25.0 114.72 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 72.94 -145.59 36.81 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 111.793 -0.523 . . . . 25.0 111.793 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.39 163.13 52.76 Favored Glycine 0 N--CA 1.438 -1.185 0 CA-C-O 121.783 0.657 . . . . 25.0 113.569 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.24 166.76 41.44 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.216 -0.754 . . . . 25.0 111.216 177.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.38 112.08 20.02 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.045 -1.094 . . . . 25.0 108.045 176.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -107.09 157.7 17.63 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 113.662 0.986 . . . . 50.0 113.662 -172.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -117.93 87.17 2.66 Favored 'General case' 0 C--O 1.255 1.386 0 N-CA-C 106.668 -1.604 . . . . 25.0 106.668 178.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 53.6 mt -96.34 137.99 34.61 Favored 'General case' 0 C--O 1.207 -1.141 0 CA-C-N 115.572 -0.74 . . . . 25.0 112.07 -174.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -131.34 112.77 13.04 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 107.117 -1.438 . . . . 25.0 107.117 177.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -92.14 -22.68 29.3 Favored Glycine 0 CA--C 1.507 -0.453 0 CA-C-O 118.877 -0.957 . . . . 25.0 115.455 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 51.12 -147.47 0.41 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.127 0.971 . . . . 25.0 113.303 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.34 165.03 19.51 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 123.313 1.53 . . . . 25.0 112.326 -177.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.11 157.12 32.79 Favored Glycine 0 C--O 1.246 0.869 0 CA-C-N 113.876 -1.511 . . . . 25.0 111.253 -176.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.2 m-20 -78.29 114.81 17.53 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 103.853 -2.647 . . . . 25.0 103.853 177.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -119.78 160.13 23.2 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.986 -0.746 . . . . 50.0 108.986 -172.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.0 mp -111.12 124.56 52.42 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 104.31 -2.478 . . . . 25.0 104.31 171.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.59 100.89 7.26 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 121.875 -0.516 . . . . 25.0 111.991 -175.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -117.74 103.73 10.28 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.971 -1.122 . . . . 25.0 107.971 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.86 -24.53 68.42 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 116.88 1.512 . . . . 25.0 116.88 -177.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.39 -168.09 51.28 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 118.371 -1.238 . . . . 25.0 111.036 -178.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.41 153.86 3.78 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.55 1.315 . . . . 25.0 114.55 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.03 171.78 47.82 Favored Glycine 0 CA--C 1.502 -0.74 0 O-C-N 124.6 1.187 . . . . 25.0 110.406 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.08 156.18 27.18 Favored 'General case' 0 C--O 1.203 -1.35 1 N-CA-C 99.922 -4.103 . . . . 25.0 99.922 173.258 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -144.77 156.61 44.14 Favored 'General case' 0 C--O 1.247 0.948 0 C-N-CA 120.437 -0.505 . . . . 50.0 110.821 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -119.91 121.38 38.88 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 103.33 -2.841 . . . . 25.0 103.33 174.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.7 130.72 26.33 Favored 'General case' 0 C--O 1.211 -0.921 0 N-CA-C 113.916 1.08 . . . . 25.0 113.916 -171.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.29 126.84 52.55 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.157 -0.965 . . . . 25.0 108.816 -178.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -80.85 -48.43 6.14 Favored Glycine 0 C--O 1.247 0.916 0 C-N-CA 119.94 -1.124 . . . . 25.0 112.624 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.63 -167.8 53.22 Favored Glycine 0 CA--C 1.535 1.339 0 O-C-N 122.414 -0.462 . . . . 25.0 114.244 -177.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -67.12 159.77 28.17 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 121.274 -1.133 . . . . 25.0 111.086 177.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.21 156.99 33.12 Favored Glycine 0 C--O 1.242 0.599 0 N-CA-C 110.538 -1.025 . . . . 25.0 110.538 -177.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.81 98.64 5.64 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 122.121 0.962 . . . . 25.0 110.853 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -89.21 155.94 19.09 Favored 'General case' 0 C--O 1.252 1.21 0 CA-C-N 114.391 -1.277 . . . . 50.0 112.587 -174.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 46.8 m -128.12 125.23 38.76 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.156 0.503 . . . . 25.0 110.025 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -113.32 103.16 11.04 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.914 -0.772 . . . . 25.0 108.914 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 24.6 mmt85 -105.0 -30.32 9.86 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-N 115.916 -0.584 . . . . 25.0 110.052 -178.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 64.75 165.79 0.16 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.88 1.272 . . . . 25.0 110.437 -171.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -87.13 -38.77 16.15 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.862 0.69 . . . . 25.0 112.862 -168.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.1 mt -136.03 161.6 35.23 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 122.089 0.947 . . . . 25.0 111.538 -173.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.93 -25.68 63.67 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 114.894 -1.048 . . . . 25.0 109.051 172.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -78.06 3.09 15.81 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.389 -1.278 . . . . 25.0 114.171 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -95.57 148.52 22.42 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 115.386 1.625 . . . . 25.0 115.386 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.6 t 53.23 39.41 29.67 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.871 1.434 . . . . 25.0 114.871 173.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 27.2 p-80 -114.7 163.67 15.12 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.326 -0.852 . . . . 25.0 112.737 -175.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -110.49 142.89 41.63 Favored 'General case' 0 C--O 1.208 -1.097 0 N-CA-C 103.564 -2.754 . . . . 25.0 103.564 173.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 97.5 p -135.32 170.07 12.09 Favored Pre-proline 0 CA--C 1.512 -0.506 0 N-CA-C 107.039 -1.467 . . . . 25.0 107.039 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -62.48 -18.78 65.07 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 CA-C-N 119.385 0.816 . . . . 25.0 113.32 173.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.4 mt -77.82 -24.29 48.77 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.304 0.573 . . . . 25.0 111.822 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 144.68 -176.95 23.52 Favored Glycine 0 C--O 1.25 1.117 0 N-CA-C 110.155 -1.178 . . . . 25.0 110.155 -178.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.4 t -84.13 147.29 27.42 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 122.788 1.28 . . . . 25.0 112.193 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -133.94 27.32 3.91 Favored 'General case' 0 C--O 1.256 1.409 0 N-CA-C 105.731 -1.952 . . . . 25.0 105.731 169.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.16 143.95 42.08 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 114.323 -1.308 . . . . 25.0 110.545 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -87.65 166.69 14.5 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.493 -0.928 . . . . 50.0 108.493 -174.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -130.06 117.43 19.99 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 107.466 -1.309 . . . . 25.0 107.466 -175.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.0 mt -100.42 135.83 34.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 106.906 -1.516 . . . . 25.0 106.906 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.413 ' HA ' ' HG2' ' A' ' 142' ' ' GLU . 92.6 mt -79.49 -55.64 4.9 Favored 'General case' 0 C--O 1.217 -0.608 0 C-N-CA 124.037 0.935 . . . . 25.0 112.938 -173.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 -132.12 51.07 2.18 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-O 122.749 1.262 . . . . 25.0 113.309 -175.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -61.76 143.52 56.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.773 -1.103 . . . . 25.0 108.933 175.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -125.11 107.06 28.09 Favored Pre-proline 0 CA--C 1.505 -0.756 0 N-CA-C 107.392 -1.336 . . . . 25.0 107.392 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.37 -9.68 26.42 Favored 'Trans proline' 0 CA--C 1.555 1.552 0 N-CA-C 117.538 2.092 . . . . 25.0 117.538 -172.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.6 t -76.76 -37.24 56.25 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.603 -0.888 . . . . 25.0 108.603 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -111.37 -33.71 6.33 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 115.522 1.675 . . . . 25.0 115.522 -171.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -90.36 152.0 21.2 Favored 'General case' 0 C--O 1.212 -0.869 0 CA-C-N 117.908 0.322 . . . . 50.0 110.429 -170.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -129.34 141.97 50.94 Favored 'General case' 0 C--O 1.26 1.623 0 CA-C-O 119.141 -0.456 . . . . 25.0 110.126 -174.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 77.0 mt -125.52 133.12 69.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.277 -0.638 . . . . 25.0 109.277 178.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.55 141.59 28.42 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.884 -0.784 . . . . 25.0 108.884 172.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.6 p -139.65 -4.66 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.096 -0.956 . . . . 25.0 112.193 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.3 t -73.17 -31.46 64.25 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.962 -0.755 . . . . 25.0 108.962 -177.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.85 -36.73 80.84 Favored 'General case' 0 C--O 1.254 1.298 0 CA-C-N 115.641 -0.709 . . . . 25.0 112.713 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.79 -29.63 8.98 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 117.354 2.353 . . . . 25.0 117.354 -170.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -124.26 -72.44 0.23 Allowed Glycine 0 CA--C 1.5 -0.87 0 N-CA-C 117.931 1.932 . . . . 25.0 117.931 -168.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -154.61 172.76 17.33 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 109.705 -0.48 . . . . 25.0 109.705 -167.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.9 t -128.0 -20.26 3.85 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 112.065 0.394 . . . . 25.0 112.065 174.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -97.59 126.95 9.05 Favored Glycine 0 N--CA 1.488 2.136 0 O-C-N 121.421 -0.799 . . . . 25.0 112.703 176.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.63 151.14 47.94 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.618 0.599 . . . . 25.0 112.618 178.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -88.46 -173.26 47.1 Favored Glycine 0 C--O 1.223 -0.563 0 N-CA-C 114.771 0.668 . . . . 25.0 114.771 -175.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -76.11 82.36 2.94 Favored 'General case' 0 C--O 1.258 1.505 0 CA-C-N 118.919 1.36 . . . . 25.0 110.874 -178.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -115.62 -172.85 17.18 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 109.214 -1.554 . . . . 25.0 109.214 174.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -143.03 168.35 19.92 Favored 'General case' 0 C--O 1.241 0.632 0 O-C-N 121.815 -0.815 . . . . 25.0 110.301 175.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 58.38 32.11 21.71 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.776 1.23 . . . . 25.0 113.76 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 80.54 23.41 60.44 Favored Glycine 0 C--N 1.316 -0.581 0 CA-C-O 118.863 -0.965 . . . . 25.0 111.55 176.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.2 t -132.79 169.65 16.41 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 119.04 1.42 . . . . 25.0 109.671 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.4 mp -88.6 163.46 15.83 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 103.302 -2.851 . . . . 25.0 103.302 171.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.42 122.55 19.19 Favored 'General case' 0 C--O 1.257 1.468 0 C-N-CA 119.081 -1.047 . . . . 25.0 111.141 -176.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.9 m -90.75 160.73 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 107.032 -1.47 . . . . 25.0 107.032 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 60.0 p -147.81 166.28 28.04 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 123.918 0.761 . . . . 25.0 109.45 -177.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 22.0 m -117.64 166.81 11.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 107.629 -1.248 . . . . 25.0 107.629 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.8 t -74.66 -55.08 6.27 Favored 'General case' 0 C--O 1.216 -0.69 0 N-CA-C 106.828 -1.545 . . . . 25.0 106.828 169.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -159.6 -158.34 0.65 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 105.216 -2.142 . . . . 25.0 105.216 -176.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -61.15 -33.36 73.29 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 120.153 -0.619 . . . . 25.0 109.793 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -119.34 -148.51 8.3 Favored Glycine 0 C--O 1.244 0.77 0 N-CA-C 109.647 -1.381 . . . . 25.0 109.647 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.89 -144.18 0.53 Allowed 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 113.893 1.072 . . . . 25.0 113.893 177.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.9 mtt85 -82.33 167.29 18.71 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.994 0.902 . . . . 25.0 112.704 -171.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.86 161.43 18.25 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 105.524 -2.028 . . . . 25.0 105.524 171.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.431 ' CE2' ' HB2' ' A' ' 140' ' ' ALA . 31.8 m-85 -137.01 145.9 44.66 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 108.704 -0.85 . . . . 25.0 108.704 -177.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 43.0 tp -125.15 125.95 44.49 Favored 'General case' 0 C--O 1.257 1.499 0 N-CA-C 103.427 -2.805 . . . . 25.0 103.427 177.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -121.77 154.75 36.54 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.262 -0.881 . . . . 25.0 109.379 -173.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 37.6 t -99.47 155.42 17.57 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 106.023 -1.843 . . . . 25.0 106.023 169.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -122.38 13.71 10.29 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.834 0.35 . . . . 25.0 111.116 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -106.63 132.49 52.56 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 106.646 -1.612 . . . . 25.0 106.646 171.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -128.13 153.21 47.1 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-O 122.699 1.238 . . . . 25.0 109.08 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -79.51 165.5 22.94 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.692 -1.14 . . . . 25.0 111.198 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.94 -34.31 67.87 Favored 'General case' 0 C--O 1.21 -0.978 0 CA-C-O 122.218 1.009 . . . . 25.0 109.024 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -72.46 -2.34 19.17 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 115.25 1.574 . . . . 25.0 115.25 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.87 7.82 85.14 Favored Glycine 0 N--CA 1.471 1.012 0 CA-C-O 122.353 0.974 . . . . 25.0 113.15 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 41.3 mt -84.32 139.28 32.4 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.436 -1.038 . . . . 25.0 109.798 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 95.2 p -147.81 -179.55 6.98 Favored 'General case' 0 C--O 1.249 1.066 0 N-CA-C 107.351 -1.352 . . . . 25.0 107.351 -177.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -119.47 136.52 54.28 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.608 -0.837 . . . . 25.0 112.955 -178.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -147.74 148.7 31.26 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.876 -1.157 . . . . 25.0 107.876 167.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.3 p -145.33 148.28 17.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 105.381 -2.081 . . . . 25.0 105.381 175.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.431 ' HB2' ' CE2' ' A' ' 124' ' ' TYR . . . -108.44 148.13 30.62 Favored 'General case' 0 C--O 1.264 1.861 0 N-CA-C 108.593 -0.892 . . . . 25.0 108.593 -179.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.8 mp -139.0 124.07 18.95 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 105.067 -2.197 . . . . 25.0 105.067 -177.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.413 ' HG2' ' HA ' ' A' ' 85' ' ' LEU . 17.9 pt-20 -103.99 9.22 36.66 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 120.832 1.651 . . . . 25.0 113.625 -171.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -69.38 -16.34 71.31 Favored Glycine 0 N--CA 1.459 0.176 0 C-N-CA 120.515 -0.85 . . . . 25.0 112.805 175.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 31.2 t0 58.01 58.33 3.63 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 122.039 0.924 . . . . 25.0 111.982 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -124.26 42.02 3.35 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.394 -1.276 . . . . 25.0 109.229 -177.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.51 -34.48 72.66 Favored 'General case' 0 C--O 1.206 -1.234 0 N-CA-C 113.466 0.913 . . . . 25.0 113.466 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.49 -23.75 62.73 Favored 'General case' 0 C--O 1.254 1.293 0 CA-C-N 119.358 0.981 . . . . 25.0 112.067 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -89.84 -25.41 21.05 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 113.75 1.019 . . . . 25.0 113.75 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 11.8 mt -63.33 126.41 27.36 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.196 -0.911 . . . . 25.0 111.108 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 39.8 m -135.06 157.62 46.46 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 107.633 -1.247 . . . . 25.0 107.633 174.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.08 -2.56 24.92 Favored 'General case' 0 C--N 1.349 0.551 0 N-CA-C 112.656 0.613 . . . . 25.0 112.656 -176.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.27 -30.73 71.63 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.462 0.649 . . . . 25.0 110.115 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -90.22 0.67 57.09 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 112.619 0.6 . . . . 25.0 112.619 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 34.7 mm -105.33 122.87 59.17 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 N-CA-C 103.985 -2.598 . . . . 25.0 103.985 175.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 14.8 p -105.64 119.98 55.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 O-C-N 120.885 -1.134 . . . . 25.0 113.611 -176.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -148.84 18.51 1.0 Allowed 'General case' 0 C--O 1.243 0.759 0 CA-C-N 112.757 -2.02 . . . . 25.0 108.465 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -102.47 41.89 1.19 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.729 0.776 . . . . 25.0 111.187 -175.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 55.22 25.79 7.71 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 114.431 1.271 . . . . 25.0 114.431 -173.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.8 m 64.75 -10.63 0.15 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.581 1.696 . . . . 25.0 115.581 176.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -72.35 139.98 48.21 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.761 -1.212 . . . . 25.0 109.389 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -91.4 4.78 51.62 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.748 -0.66 . . . . 25.0 110.465 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.03 16.66 0.12 Allowed 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.639 0.776 . . . . 25.0 112.994 177.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -144.02 -158.32 0.87 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 107.913 -1.143 . . . . 25.0 107.913 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 60.58 178.69 0.1 Allowed 'General case' 0 CA--C 1.555 1.144 0 N-CA-C 114.333 1.234 . . . . 25.0 114.333 176.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.74 24.17 75.02 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 115.876 -0.602 . . . . 25.0 112.898 -176.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -91.26 114.72 27.32 Favored 'General case' 0 C--N 1.316 -0.858 0 O-C-N 122.399 -0.471 . . . . 25.0 112.168 -175.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.48 144.08 48.9 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.309 0.576 . . . . 25.0 109.624 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -145.92 33.55 1.5 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.894 -0.882 . . . . 25.0 110.894 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.3 t -93.85 -29.79 4.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 113.288 0.847 . . . . 25.0 113.288 -172.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.01 132.82 27.86 Favored 'Isoleucine or valine' 0 C--O 1.248 0.98 0 CA-C-N 115.337 -0.847 . . . . 25.0 112.229 -174.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 168.58 159.61 14.61 Favored Glycine 0 N--CA 1.48 1.597 0 N-CA-C 110.227 -1.149 . . . . 25.0 110.227 175.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -147.68 146.71 29.39 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 119.264 1.532 . . . . 25.0 112.161 -176.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 93.1 p -155.22 174.71 14.82 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 106.217 -1.771 . . . . 25.0 106.217 177.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -177.52 167.21 38.11 Favored Glycine 0 C--N 1.309 -0.936 0 C-N-CA 120.104 -1.046 . . . . 25.0 114.854 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 11.9 tp-100 -146.12 81.03 9.93 Favored Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 108.229 -1.026 . . . . 25.0 108.229 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -70.6 151.66 64.41 Favored 'Trans proline' 0 CA--C 1.509 -0.736 0 C-N-CA 121.054 1.17 . . . . 25.0 113.071 -173.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -107.38 147.32 30.51 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.413 -0.812 . . . . 25.0 111.004 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -144.76 75.57 14.45 Favored Pre-proline 0 C--N 1.312 -1.045 0 O-C-N 124.191 0.932 . . . . 25.0 110.414 177.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -72.97 169.62 21.74 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 121.587 1.525 . . . . 25.0 113.255 -175.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.5 t -120.02 2.46 10.97 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 116.417 -0.356 . . . . 25.0 110.358 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 C--O 1.249 1.059 0 CA-C-O 116.707 -1.616 . . . . 25.0 110.817 -178.605 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 110.038 -0.356 . . . . 25.0 110.038 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -139.99 118.94 8.72 Favored Pre-proline 0 C--N 1.317 -0.834 0 O-C-N 123.703 0.627 . . . . 25.0 111.061 -178.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.03 151.96 56.48 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 117.256 -1.363 . . . . 25.0 113.877 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.79 59.69 0.03 OUTLIER Glycine 0 CA--C 1.524 0.612 0 C-N-CA 121.052 -0.594 . . . . 25.0 111.816 -176.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.8 p -63.9 132.82 29.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 121.734 0.778 . . . . 25.0 110.05 -173.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -91.02 -15.4 29.68 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 119.622 -0.831 . . . . 25.0 110.789 -178.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.28 -147.13 3.87 Favored Glycine 0 C--O 1.207 -1.55 0 N-CA-C 115.952 1.141 . . . . 25.0 115.952 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.7 p 77.96 156.9 0.15 Allowed Pre-proline 0 CA--C 1.558 1.274 0 C-N-CA 126.832 2.053 . . . . 25.0 110.408 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.659 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 50.1 Cg_exo -62.55 -3.36 4.25 Favored 'Trans proline' 0 C--N 1.362 1.249 0 N-CA-C 117.761 2.177 . . . . 25.0 117.761 -175.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.6 p -63.65 -17.67 20.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 114.757 1.391 . . . . 25.0 114.757 -173.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.5 p -142.44 140.95 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-O 122.554 1.168 . . . . 25.0 113.373 -178.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.32 16.03 80.9 Favored Glycine 0 C--O 1.226 -0.344 0 N-CA-C 118.248 2.059 . . . . 25.0 118.248 175.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.2 t -46.21 -58.96 3.2 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 114.15 1.167 . . . . 25.0 114.15 -175.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -78.24 3.14 16.14 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 116.076 1.88 . . . . 25.0 116.076 -169.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.28 171.82 13.62 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.456 -0.778 . . . . 25.0 111.82 -172.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -58.9 135.32 57.52 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.149 0.58 . . . . 25.0 112.534 -177.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -128.52 163.35 25.15 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 113.537 0.94 . . . . 50.0 113.537 -174.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -136.53 108.66 7.22 Favored 'General case' 0 C--O 1.255 1.348 0 N-CA-C 101.683 -3.451 . . . . 25.0 101.683 161.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 89.7 mt -126.0 126.13 43.8 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.909 0.861 . . . . 25.0 110.46 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -114.69 134.6 54.95 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 107.507 -1.294 . . . . 25.0 107.507 178.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -106.14 178.39 22.75 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 115.294 0.878 . . . . 25.0 115.294 -173.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.5 p -79.86 175.41 10.65 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-O 121.856 0.836 . . . . 25.0 112.558 178.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 39.0 mt -83.6 10.54 8.91 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 113.25 0.833 . . . . 25.0 113.25 176.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.07 178.35 25.63 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 123.073 0.368 . . . . 25.0 112.208 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.2 t -74.68 128.66 36.11 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.888 0.475 . . . . 25.0 110.92 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -143.96 151.18 39.41 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.006 0.431 . . . . 50.0 110.542 -174.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -94.36 125.59 39.09 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 102.546 -3.131 . . . . 25.0 102.546 168.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.3 mm -119.02 103.86 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.018 0 N-CA-C 107.257 -1.386 . . . . 25.0 107.257 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.659 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 9.8 mp -100.69 131.55 46.53 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 104.06 -2.57 . . . . 25.0 104.06 177.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.86 -29.83 14.63 Favored Glycine 0 C--N 1.313 -0.745 0 CA-C-N 114.907 -1.042 . . . . 25.0 113.086 176.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.04 -148.7 50.63 Favored Glycine 0 N--CA 1.466 0.685 0 C-N-CA 120.293 -0.956 . . . . 25.0 112.278 -178.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.7 170.68 52.57 Favored Glycine 0 C--O 1.247 0.929 0 CA-C-N 118.219 1.01 . . . . 25.0 113.096 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.25 162.51 23.84 Favored Glycine 0 C--O 1.256 1.525 0 O-C-N 124.035 0.491 . . . . 25.0 114.225 176.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.08 108.58 11.47 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 106.678 -1.601 . . . . 25.0 106.678 177.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -107.57 149.33 28.15 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.992 -0.744 . . . . 50.0 108.992 -173.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -116.61 105.14 12.11 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 106.856 -1.535 . . . . 25.0 106.856 171.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 80.8 mt -111.37 129.11 56.11 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.58 -0.736 . . . . 25.0 112.568 -170.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -125.11 102.48 7.51 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-O 121.802 0.81 . . . . 25.0 110.449 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.45 -29.43 61.87 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-O 118.742 -1.032 . . . . 25.0 115.204 -176.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 53.54 -156.11 0.2 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.09 0.956 . . . . 25.0 112.461 -177.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.19 166.77 9.19 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.098 -1.001 . . . . 25.0 112.767 -175.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.29 160.0 34.26 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 108.239 -1.944 . . . . 25.0 108.239 -176.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -85.73 106.36 16.93 Favored 'General case' 0 C--O 1.251 1.151 0 O-C-N 122.125 -0.633 . . . . 25.0 109.387 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -109.43 144.4 37.71 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.84 -0.744 . . . . 50.0 111.677 -168.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 mp -105.65 92.89 4.37 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.274 -0.876 . . . . 25.0 108.873 177.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 mp -97.3 113.98 25.68 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-O 121.894 0.854 . . . . 25.0 111.783 -174.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -117.41 94.76 4.68 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 106.709 -1.589 . . . . 25.0 106.709 178.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -57.2 -20.53 36.03 Favored Glycine 0 N--CA 1.473 1.133 0 CA-C-O 118.478 -1.179 . . . . 25.0 115.198 -175.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.98 -168.86 49.73 Favored Glycine 0 C--O 1.249 1.06 0 CA-C-N 119.163 1.482 . . . . 25.0 110.531 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.74 153.07 11.22 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 114.805 -0.697 . . . . 25.0 112.49 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.82 177.1 45.31 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.588 -0.733 . . . . 25.0 111.876 178.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -97.34 132.24 43.26 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 105.779 -1.934 . . . . 25.0 105.779 176.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -125.62 159.78 31.29 Favored 'General case' 0 CA--C 1.485 -1.542 0 CA-C-O 118.851 -0.595 . . . . 50.0 110.743 -172.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -121.67 121.97 38.55 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 103.399 -2.815 . . . . 25.0 103.399 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -146.73 131.4 17.87 Favored 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 116.402 2.001 . . . . 25.0 116.402 -167.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 27.5 m -100.54 141.45 33.37 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.33 0.586 . . . . 25.0 112.26 176.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.96 -35.09 5.2 Favored Glycine 0 C--O 1.206 -1.597 0 O-C-N 121.499 -0.751 . . . . 25.0 111.887 177.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.92 -167.91 50.66 Favored Glycine 0 C--O 1.245 0.83 0 O-C-N 121.644 -0.915 . . . . 25.0 113.776 -177.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -59.83 161.51 6.33 Favored 'General case' 0 C--O 1.251 1.156 0 O-C-N 121.204 -1.174 . . . . 25.0 110.672 176.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.76 167.3 36.31 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 115.215 -0.902 . . . . 25.0 113.195 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.82 93.9 9.62 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 122.102 0.953 . . . . 25.0 110.931 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.14 153.44 22.06 Favored 'General case' 0 C--O 1.247 0.927 0 CA-C-N 115.302 -0.863 . . . . 50.0 111.651 -170.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.453 HG22 ' HG3' ' A' ' 65' ' ' ARG . 24.3 m -125.27 116.52 22.08 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 122.314 1.055 . . . . 25.0 109.685 178.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -104.38 102.55 12.21 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.714 -1.217 . . . . 25.0 107.714 177.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.453 ' HG3' HG22 ' A' ' 63' ' ' THR . 97.1 mtt180 -106.75 -23.14 12.5 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 113.541 0.941 . . . . 25.0 113.541 -177.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 67.79 160.46 0.17 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.508 1.523 . . . . 25.0 112.13 -176.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.72 -45.49 14.36 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 115.345 1.609 . . . . 25.0 115.345 -168.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 65.4 mt -139.23 169.56 17.54 Favored 'General case' 0 C--O 1.207 -1.137 0 CA-C-O 121.43 0.633 . . . . 25.0 111.925 -174.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.78 -23.95 32.84 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.273 0.629 . . . . 25.0 110.76 171.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -80.35 -6.63 58.3 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.307 1.043 . . . . 25.0 113.745 -177.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -90.13 152.77 20.97 Favored 'General case' 0 C--O 1.213 -0.831 0 N-CA-C 113.658 0.984 . . . . 25.0 113.658 176.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.8 t 45.14 48.77 9.86 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.702 1.601 . . . . 25.0 113.807 165.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -135.83 165.8 24.77 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 115.178 -0.919 . . . . 25.0 111.162 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 59.2 ttt180 -112.89 136.42 52.56 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 105.375 -2.083 . . . . 25.0 105.375 176.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 81.2 p -126.28 171.17 8.29 Favored Pre-proline 0 C--N 1.325 -0.467 0 C-N-CA 125.023 1.329 . . . . 25.0 108.167 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.22 -24.6 68.04 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 117.828 -0.981 . . . . 25.0 113.618 177.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 38.1 mt -71.89 -27.31 62.75 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 112.997 0.739 . . . . 25.0 112.997 177.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 145.56 -176.41 24.57 Favored Glycine 0 C--O 1.213 -1.195 0 N-CA-C 111.019 -0.832 . . . . 25.0 111.019 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 15.2 t -86.07 146.32 26.68 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 122.817 1.294 . . . . 25.0 112.6 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -127.28 28.7 5.68 Favored 'General case' 0 C--O 1.246 0.896 0 C-N-CA 125.432 1.493 . . . . 25.0 107.316 169.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -62.22 143.9 48.88 Favored Glycine 0 C--N 1.34 0.802 0 N-CA-C 110.57 -1.012 . . . . 25.0 110.57 178.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -92.05 163.11 14.09 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 120.277 -0.569 . . . . 50.0 110.944 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.75 110.06 15.01 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.178 0.299 . . . . 25.0 110.485 -175.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 30.3 mt -91.7 136.59 24.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.094 -1.076 . . . . 25.0 108.094 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.6 mt -83.64 -42.8 16.28 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 114.457 1.281 . . . . 25.0 114.457 -172.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 47.3 p-10 -137.86 38.82 2.38 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.46 1.282 . . . . 25.0 114.46 -169.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -56.24 139.06 49.16 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.041 0.386 . . . . 25.0 112.041 -177.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -116.16 101.52 53.87 Favored Pre-proline 0 C--O 1.248 0.98 0 N-CA-C 108.012 -1.107 . . . . 25.0 108.012 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.03 -9.16 25.59 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 N-CA-C 114.643 0.978 . . . . 25.0 114.643 -172.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.6 t -80.41 -45.02 18.35 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-O 121.228 0.537 . . . . 25.0 109.724 177.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -95.91 -39.23 9.9 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 115.006 1.484 . . . . 25.0 115.006 -173.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -89.3 173.06 8.6 Favored 'General case' 0 C--O 1.218 -0.585 0 CA-C-N 115.837 -0.619 . . . . 75.0 110.542 -167.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -151.77 152.85 33.23 Favored 'General case' 0 C--O 1.26 1.652 0 CA-C-N 116.214 -0.448 . . . . 25.0 110.509 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 45.6 mt -129.03 132.04 67.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 109.346 -0.613 . . . . 25.0 109.346 -178.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -84.85 150.61 24.88 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 123.039 1.399 . . . . 25.0 108.831 174.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.2 p -150.17 -9.5 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.333 0 O-C-N 121.18 -0.95 . . . . 25.0 112.155 176.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.437 ' HB2' ' HA ' ' A' ' 156' ' ' PHE . 31.5 t -61.15 -47.16 87.48 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.657 0.741 . . . . 25.0 109.731 -175.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.29 -43.15 67.7 Favored 'General case' 0 C--O 1.251 1.158 0 N-CA-C 114.451 1.278 . . . . 25.0 114.451 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.47 -3.87 20.45 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 116.094 1.887 . . . . 25.0 116.094 -169.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -139.77 -72.53 0.04 OUTLIER Glycine 0 CA--C 1.533 1.185 0 N-CA-C 118.312 2.085 . . . . 25.0 118.312 -176.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -158.05 170.61 21.91 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 119.058 1.429 . . . . 25.0 109.543 -175.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.9 t -121.45 -33.54 3.62 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 112.453 0.538 . . . . 25.0 112.453 172.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -91.89 129.1 9.67 Favored Glycine 0 N--CA 1.466 0.694 0 O-C-N 120.754 -1.217 . . . . 25.0 110.309 177.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -69.61 148.25 49.61 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 118.374 1.087 . . . . 25.0 111.645 -177.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -81.67 -167.9 39.83 Favored Glycine 0 C--O 1.223 -0.572 0 CA-C-N 115.894 -0.594 . . . . 25.0 112.375 -176.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -79.53 70.5 6.0 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.305 0.854 . . . . 25.0 113.305 -176.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -105.69 -168.29 23.51 Favored Glycine 0 C--O 1.211 -1.282 0 N-CA-C 107.873 -2.091 . . . . 25.0 107.873 172.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -138.26 164.54 28.97 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 120.023 1.912 . . . . 25.0 109.425 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 54.78 35.63 24.54 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 122.944 0.498 . . . . 25.0 111.563 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.09 39.57 73.04 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 120.64 -1.288 . . . . 25.0 112.312 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 8.4 t -135.6 -178.75 5.26 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 117.778 0.789 . . . . 25.0 109.82 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 85.2 mt -101.07 164.88 11.59 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 102.149 -3.278 . . . . 25.0 102.149 173.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.04 111.95 10.79 Favored 'General case' 0 C--O 1.267 1.996 0 CA-C-O 123.119 1.438 . . . . 25.0 107.32 -178.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.8 m -70.25 153.11 8.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 N-CA-C 108.348 -0.982 . . . . 25.0 108.348 -176.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.39 162.29 33.46 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.852 -1.155 . . . . 25.0 110.526 -175.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.7 m -127.65 161.92 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 108.631 -0.878 . . . . 25.0 108.631 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.6 t -82.03 -50.75 8.74 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 105.67 -1.974 . . . . 25.0 105.67 172.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -166.21 -162.84 0.56 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 100.666 -3.827 . . . . 25.0 100.666 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -67.28 -19.21 65.46 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 109.258 -0.645 . . . . 25.0 109.258 -178.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -119.81 -153.01 9.15 Favored Glycine 0 C--O 1.238 0.393 0 N-CA-C 111.115 -0.794 . . . . 25.0 111.115 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 56.91 -132.23 1.48 Allowed 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 112.806 0.669 . . . . 25.0 112.806 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.4 mtt85 -103.5 157.42 17.05 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.425 0.898 . . . . 25.0 113.425 -173.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.31 158.66 16.47 Favored 'General case' 0 C--O 1.253 1.249 0 N-CA-C 105.952 -1.87 . . . . 25.0 105.952 171.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -130.1 160.05 34.91 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.39 -0.967 . . . . 25.0 108.39 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 30.5 tp -132.87 102.81 5.78 Favored 'General case' 0 C--O 1.216 -0.684 0 N-CA-C 103.132 -2.914 . . . . 25.0 103.132 171.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -103.77 151.93 22.47 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.353 0.597 . . . . 25.0 109.947 -172.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 41.5 t -92.03 154.74 18.57 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 104.225 -2.509 . . . . 25.0 104.225 171.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -126.76 26.33 6.23 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 122.874 1.321 . . . . 25.0 108.415 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -117.14 147.07 42.76 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 103.592 -2.744 . . . . 25.0 103.592 171.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -149.16 151.52 34.49 Favored 'General case' 0 C--O 1.217 -0.654 0 O-C-N 124.158 0.911 . . . . 25.0 110.662 -175.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -77.09 164.58 25.57 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 124.091 0.957 . . . . 25.0 110.033 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.11 -19.72 64.86 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.742 -0.599 . . . . 25.0 112.181 -175.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -75.99 -9.02 58.27 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 122.526 0.331 . . . . 25.0 111.543 176.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 92.2 14.07 56.53 Favored Glycine 0 C--O 1.219 -0.805 0 CA-C-O 121.963 0.757 . . . . 25.0 112.573 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.0 mt -83.92 137.48 33.63 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 121.323 -1.104 . . . . 25.0 109.663 178.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 84.4 p -145.73 174.48 11.17 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.482 -0.562 . . . . 25.0 109.482 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -115.95 141.6 47.89 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 118.273 0.488 . . . . 25.0 111.649 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -150.93 156.42 41.15 Favored 'General case' 0 C--O 1.251 1.145 0 N-CA-C 106.343 -1.725 . . . . 25.0 106.343 169.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 13.4 p -146.96 147.69 17.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 104.933 -2.247 . . . . 25.0 104.933 173.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -107.59 141.95 38.27 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.018 -1.475 . . . . 25.0 107.018 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.2 mp -131.39 125.24 32.12 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 103.363 -2.828 . . . . 25.0 103.363 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -104.87 15.22 28.2 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 120.395 -1.441 . . . . 25.0 111.698 -173.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -83.95 4.41 82.93 Favored Glycine 0 C--O 1.241 0.57 0 CA-C-N 114.994 -1.003 . . . . 25.0 114.732 177.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 28.2 t0 49.34 47.04 22.78 Favored 'General case' 0 C--O 1.252 1.202 0 N-CA-C 114.586 1.328 . . . . 25.0 114.586 175.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -122.88 41.08 3.54 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.24 -0.891 . . . . 25.0 111.272 -175.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.67 -29.62 64.78 Favored 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 113.685 0.994 . . . . 25.0 113.685 173.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.99 -17.77 62.63 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 119.506 1.048 . . . . 25.0 110.371 -177.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -102.1 -8.48 21.37 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 113.341 0.867 . . . . 25.0 113.341 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.9 mt -79.37 133.66 36.58 Favored 'General case' 0 C--O 1.207 -1.161 0 C-N-CA 120.33 -0.548 . . . . 25.0 109.806 -176.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.0 m -141.32 165.81 26.5 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 106.932 -1.507 . . . . 25.0 106.932 172.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -81.79 4.02 23.68 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 121.733 0.778 . . . . 25.0 109.865 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -66.37 -31.31 72.0 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.119 -1.4 . . . . 25.0 110.656 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -94.16 0.35 55.73 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 112.14 0.422 . . . . 25.0 112.14 177.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 26.3 mm -99.33 123.45 52.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 N-CA-C 104.329 -2.471 . . . . 25.0 104.329 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.1 p -100.71 119.36 48.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 122.592 1.187 . . . . 25.0 113.281 -172.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.437 ' HA ' ' HB2' ' A' ' 97' ' ' SER . 9.3 p90 -149.63 -12.25 0.29 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 112.835 -1.984 . . . . 25.0 111.567 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.43 53.01 2.37 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 121.086 -1.009 . . . . 25.0 113.231 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 60.42 25.98 15.55 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 115.857 1.799 . . . . 25.0 115.857 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 m 65.63 -45.13 0.38 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 117.887 2.551 . . . . 25.0 117.887 177.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.19 120.13 13.25 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 121.439 -0.788 . . . . 25.0 110.44 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -79.14 31.09 0.21 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.439 0.903 . . . . 25.0 113.439 -174.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.62 -2.8 15.48 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 112.756 0.65 . . . . 25.0 112.756 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -151.52 -176.42 5.59 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 123.793 0.683 . . . . 25.0 110.596 -176.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 63.72 -166.65 0.22 Allowed 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 114.026 1.121 . . . . 25.0 114.026 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.36 25.89 67.2 Favored Glycine 0 CA--C 1.535 1.322 0 N-CA-C 111.372 -0.691 . . . . 25.0 111.372 -177.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -92.54 134.49 34.93 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.668 -0.864 . . . . 25.0 108.668 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -129.39 141.04 51.15 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 107.704 -1.221 . . . . 25.0 107.704 176.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -126.85 38.38 2.19 Favored Glycine 0 N--CA 1.464 0.501 0 CA-C-O 122.371 0.984 . . . . 25.0 111.26 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 26.3 t -84.25 -28.5 7.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 O-C-N 121.945 -0.738 . . . . 25.0 110.546 -174.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.39 133.18 24.78 Favored 'Isoleucine or valine' 0 C--O 1.26 1.607 0 CA-C-O 122.872 1.32 . . . . 25.0 111.071 -178.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 164.99 156.72 9.21 Favored Glycine 0 C--O 1.239 0.441 0 CA-C-N 115.076 -0.966 . . . . 25.0 112.277 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -151.02 142.81 23.78 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 121.621 -0.929 . . . . 25.0 110.482 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 59.0 p -149.96 163.53 37.85 Favored 'General case' 0 C--O 1.248 1.003 0 N-CA-C 106.484 -1.673 . . . . 25.0 106.484 176.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.53 -174.33 40.44 Favored Glycine 0 C--O 1.246 0.859 0 C-N-CA 120.415 -0.898 . . . . 25.0 114.322 176.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -154.4 86.39 3.65 Favored Pre-proline 0 C--O 1.252 1.198 0 C-N-CA 123.449 0.699 . . . . 25.0 109.533 -178.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -69.28 160.55 49.39 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 117.703 -1.065 . . . . 25.0 112.568 -176.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -131.16 155.27 47.3 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 124.446 1.091 . . . . 25.0 108.066 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -141.43 80.49 16.33 Favored Pre-proline 0 C--O 1.245 0.819 0 CA-C-N 118.387 0.539 . . . . 25.0 112.088 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.74 135.53 28.35 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 118.169 -0.754 . . . . 25.0 112.146 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.9 t -88.81 -4.41 58.5 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 112.822 0.675 . . . . 25.0 112.822 -177.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 3.7 p . . . . . 0 C--O 1.254 1.297 0 CA-C-O 118.213 -0.898 . . . . 25.0 109.671 179.959 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 110.425 -0.213 . . . . 25.0 110.425 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -147.63 129.6 7.51 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-O 121.238 0.542 . . . . 25.0 109.727 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.89 147.24 43.67 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 117.444 -1.238 . . . . 25.0 113.215 -174.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.14 49.32 0.08 OUTLIER Glycine 0 N--CA 1.473 1.157 0 N-CA-C 110.961 -0.855 . . . . 25.0 110.961 178.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.42 HG22 ' H ' ' A' ' 7' ' ' GLY . 2.9 p -55.41 132.06 18.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 123.657 0.783 . . . . 25.0 112.048 -176.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -98.06 -2.05 41.11 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.366 -0.834 . . . . 25.0 110.302 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.42 ' H ' HG22 ' A' ' 5' ' ' VAL . . . -85.03 -145.11 7.32 Favored Glycine 0 C--O 1.206 -1.624 0 CA-C-N 116.032 -0.531 . . . . 25.0 113.336 177.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.0 p 67.76 153.97 0.13 Allowed Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 126.006 1.723 . . . . 25.0 112.672 -173.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.618 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 47.0 Cg_exo -61.91 -3.91 4.25 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.74 2.293 . . . . 25.0 116.148 -178.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.3 p -63.66 -16.63 18.68 Favored 'Isoleucine or valine' 0 C--O 1.248 0.986 0 N-CA-C 116.85 2.167 . . . . 25.0 116.85 -167.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.8 p -143.82 131.76 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 113.341 0.867 . . . . 25.0 113.341 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.87 19.88 56.9 Favored Glycine 0 N--CA 1.469 0.855 0 N-CA-C 117.592 1.797 . . . . 25.0 117.592 176.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.9 t -47.68 -56.76 6.58 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 117.985 0.893 . . . . 25.0 112.346 -176.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -75.19 -1.99 25.84 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 115.496 1.665 . . . . 25.0 115.496 -170.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -137.57 174.64 10.38 Favored 'General case' 0 C--O 1.207 -1.158 0 CA-C-N 116.234 -0.439 . . . . 25.0 111.784 -171.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.27 144.1 47.28 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-O 122.276 1.036 . . . . 25.0 109.135 -175.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -131.06 150.25 52.23 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 114.632 -1.167 . . . . 50.0 113.018 -176.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -131.22 105.03 7.4 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 100.541 -3.874 . . . . 25.0 100.541 165.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 89.0 mt -127.95 132.72 49.22 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 109.734 -0.469 . . . . 25.0 109.734 -175.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -120.0 115.9 24.67 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.272 -1.381 . . . . 25.0 107.272 -178.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -80.5 176.38 54.67 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 116.554 1.382 . . . . 25.0 116.554 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.5 p -82.33 175.8 9.96 Favored 'General case' 0 C--O 1.251 1.132 0 C-N-CA 124.349 1.06 . . . . 25.0 110.582 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 82.3 mt -80.65 4.46 18.63 Favored 'General case' 0 N--CA 1.463 0.198 0 O-C-N 121.99 -0.443 . . . . 25.0 111.334 174.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -95.85 -176.0 36.66 Favored Glycine 0 C--O 1.226 -0.39 0 CA-C-O 121.374 0.43 . . . . 25.0 112.063 -178.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.6 t -82.12 131.1 35.24 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 109.18 -0.674 . . . . 25.0 109.18 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -145.57 159.89 42.45 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.756 0.788 . . . . 50.0 109.203 -177.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -100.82 131.94 46.46 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 104.773 -2.306 . . . . 25.0 104.773 165.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.4 mm -120.29 103.75 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 N-CA-C 106.736 -1.579 . . . . 25.0 106.736 178.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.618 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 5.3 mp -105.78 128.39 53.68 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 104.427 -2.435 . . . . 25.0 104.427 -178.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.95 -32.19 11.2 Favored Glycine 0 C--N 1.307 -1.049 0 N-CA-C 117.447 1.739 . . . . 25.0 117.447 -177.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.91 -147.14 49.18 Favored Glycine 0 C--O 1.243 0.659 0 CA-C-N 118.934 1.367 . . . . 25.0 111.944 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.95 175.61 50.25 Favored Glycine 0 C--O 1.244 0.768 0 O-C-N 121.734 -0.862 . . . . 25.0 112.837 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.26 160.73 12.51 Favored Glycine 0 C--O 1.256 1.529 0 C-N-CA 120.329 -0.939 . . . . 25.0 111.523 175.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.7 113.02 20.99 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 105.565 -2.013 . . . . 25.0 105.565 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -105.0 154.08 20.59 Favored 'General case' 0 C--O 1.251 1.156 0 N-CA-C 113.211 0.819 . . . . 50.0 113.211 -172.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -121.36 92.61 3.79 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 107.093 -1.447 . . . . 25.0 107.093 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 34.5 mt -108.3 137.3 46.49 Favored 'General case' 0 C--O 1.203 -1.364 0 N-CA-C 114.455 1.28 . . . . 25.0 114.455 -169.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -131.71 117.6 18.84 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.299 0.571 . . . . 25.0 111.719 -179.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -87.92 -24.7 34.27 Favored Glycine 0 C--O 1.245 0.831 0 CA-C-O 117.247 -1.863 . . . . 25.0 116.78 -178.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 53.14 -153.36 0.25 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.978 1.389 . . . . 25.0 112.068 -177.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.71 167.22 15.74 Favored 'General case' 0 C--O 1.249 1.055 0 O-C-N 120.615 -1.303 . . . . 25.0 111.376 -178.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.5 158.52 31.67 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 114.993 -1.003 . . . . 25.0 111.606 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -85.71 94.29 9.07 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 107.385 -1.339 . . . . 25.0 107.385 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -99.38 159.83 14.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.175 -0.921 . . . . 50.0 110.588 -170.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 mp -120.38 106.37 11.79 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 108.529 -0.915 . . . . 25.0 108.529 174.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 mp -111.7 106.15 14.86 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 113.05 0.759 . . . . 25.0 113.05 -172.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -118.99 92.41 3.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.736 -1.12 . . . . 25.0 108.986 -177.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.38 -12.42 32.17 Favored Glycine 0 N--CA 1.467 0.719 0 N-CA-C 118.366 2.106 . . . . 25.0 118.366 -177.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 61.48 -162.45 24.76 Favored Glycine 0 N--CA 1.462 0.399 0 CA-C-N 119.546 1.673 . . . . 25.0 113.853 177.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.69 158.86 1.21 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 114.227 1.195 . . . . 25.0 114.227 -177.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.93 179.46 51.78 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 115.138 -0.937 . . . . 25.0 112.809 -177.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.79 141.62 29.03 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 101.498 -3.519 . . . . 25.0 101.498 176.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -133.53 158.12 43.93 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.57 -0.9 . . . . 50.0 108.57 -175.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -124.01 120.09 31.42 Favored 'General case' 0 C--O 1.212 -0.906 0 N-CA-C 107.766 -1.198 . . . . 25.0 107.766 173.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -141.64 132.48 25.84 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 115.644 1.72 . . . . 25.0 115.644 -169.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 63.9 m -95.22 140.98 29.36 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 123.278 0.631 . . . . 25.0 109.752 175.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.39 -39.18 4.54 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 107.9 -2.08 . . . . 25.0 107.9 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.03 -164.38 52.87 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 117.997 0.898 . . . . 25.0 113.387 -177.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.0 158.73 15.72 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.03 0.532 . . . . 25.0 110.202 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.97 157.85 26.24 Favored Glycine 0 N--CA 1.476 1.324 0 N-CA-C 111.502 -0.639 . . . . 25.0 111.502 175.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.0 110.91 8.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.627 1.203 . . . . 25.0 111.915 -176.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -104.86 155.22 19.12 Favored 'General case' 0 C--O 1.25 1.123 0 CA-C-N 114.625 -1.17 . . . . 50.0 109.505 -173.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 88.0 m -125.33 131.01 53.1 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.418 0.687 . . . . 25.0 110.444 -177.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -124.31 104.05 8.57 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 108.015 -1.105 . . . . 25.0 108.015 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 54.5 mtt85 -115.09 -16.59 11.59 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 121.669 -0.645 . . . . 25.0 111.531 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 62.44 164.22 0.1 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.692 1.597 . . . . 25.0 111.571 -175.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.15 -39.49 48.99 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 114.317 1.228 . . . . 25.0 114.317 -172.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.7 mt -135.37 164.81 26.91 Favored 'General case' 0 C--O 1.207 -1.149 0 C-N-CA 123.114 0.566 . . . . 25.0 112.341 -170.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -17.97 64.2 Favored 'General case' 0 C--O 1.209 -1.067 0 N-CA-C 108.386 -0.968 . . . . 25.0 108.386 170.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -82.53 6.06 18.74 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.811 1.041 . . . . 25.0 113.811 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -111.22 151.81 27.83 Favored 'General case' 0 C--O 1.213 -0.849 0 N-CA-C 115.798 1.777 . . . . 25.0 115.798 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.0 t 54.91 36.32 26.45 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 113.712 -1.586 . . . . 25.0 112.975 175.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 24.0 p-80 -121.05 167.65 12.39 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.869 -1.06 . . . . 25.0 112.507 -173.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 -123.44 140.99 52.44 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 106.748 -1.575 . . . . 25.0 106.748 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.6 p -133.94 173.29 6.01 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 107.949 -1.13 . . . . 25.0 107.949 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -61.39 -25.68 80.36 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 115.831 -2.313 . . . . 25.0 112.999 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 68.6 mt -68.77 -27.09 65.59 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.533 0.682 . . . . 25.0 111.916 -178.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.53 -173.83 32.94 Favored Glycine 0 CA--C 1.498 -0.995 0 N-CA-C 110.414 -1.074 . . . . 25.0 110.414 -177.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.1 t -100.41 148.02 25.19 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.487 1.137 . . . . 25.0 111.345 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -134.09 31.0 3.59 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 114.622 -1.172 . . . . 25.0 108.496 172.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.56 148.94 50.28 Favored Glycine 0 C--O 1.249 1.057 0 CA-C-N 114.085 -1.416 . . . . 25.0 109.578 176.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -91.8 167.18 12.34 Favored 'General case' 0 C--N 1.314 -0.961 0 O-C-N 121.888 -0.772 . . . . 50.0 110.133 -176.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -120.75 111.34 17.47 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.575 0.75 . . . . 25.0 109.989 -177.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.8 mt -97.32 129.36 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-O 121.676 0.75 . . . . 25.0 109.021 -177.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 81.4 mt -83.78 -41.71 17.29 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 115.717 1.747 . . . . 25.0 115.717 -170.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.4 p-10 -140.45 45.63 1.83 Allowed 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.755 1.391 . . . . 25.0 114.755 -176.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -55.83 129.92 41.42 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 122.241 1.02 . . . . 25.0 112.943 -178.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -91.97 105.11 12.39 Favored Pre-proline 0 C--O 1.246 0.872 0 CA-C-N 114.231 -1.35 . . . . 25.0 108.081 174.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.38 3.93 3.79 Favored 'Trans proline' 0 C--O 1.205 -1.143 0 N-CA-C 115.779 1.415 . . . . 25.0 115.779 -173.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.2 t -110.83 -43.8 3.74 Favored 'General case' 0 C--O 1.253 1.281 0 O-C-N 121.809 -0.557 . . . . 25.0 111.259 176.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -87.26 -38.66 16.11 Favored 'General case' 0 C--O 1.241 0.624 0 O-C-N 123.51 0.506 . . . . 25.0 110.58 -172.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -88.43 158.44 18.36 Favored 'General case' 0 CA--C 1.552 1.048 0 N-CA-C 112.271 0.471 . . . . 50.0 112.271 -170.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -137.81 147.89 45.0 Favored 'General case' 0 C--O 1.252 1.201 0 N-CA-C 113.859 1.059 . . . . 25.0 113.859 -175.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 68.2 mt -131.81 130.39 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 108.773 -0.825 . . . . 25.0 108.773 -175.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -90.05 147.44 23.65 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.047 -1.033 . . . . 25.0 108.927 171.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.0 p -141.35 -5.02 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 115.484 -0.78 . . . . 25.0 109.417 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.0 t -65.65 -41.96 91.94 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 121.294 0.569 . . . . 25.0 111.313 -170.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.91 -34.3 57.72 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 119.937 -0.705 . . . . 25.0 112.855 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.97 -3.25 18.98 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 116.502 2.038 . . . . 25.0 116.502 -169.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -142.58 -74.08 0.03 OUTLIER Glycine 0 C--O 1.214 -1.124 0 CA-C-O 119.256 -0.747 . . . . 25.0 114.561 -178.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -160.23 165.16 32.0 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 117.814 0.807 . . . . 25.0 112.007 -173.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.9 t -121.27 -10.9 8.88 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 121.0 0.429 . . . . 25.0 112.1 176.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.43 133.41 11.07 Favored Glycine 0 N--CA 1.467 0.722 0 N-CA-C 108.613 -1.795 . . . . 25.0 108.613 170.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.15 150.11 42.45 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-N 117.314 0.557 . . . . 25.0 112.172 -175.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -86.06 -177.7 49.96 Favored Glycine 0 C--O 1.223 -0.545 0 O-C-N 122.125 -0.36 . . . . 25.0 113.1 -174.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -63.81 101.15 0.34 Allowed 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.624 0.602 . . . . 25.0 112.624 -175.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -150.85 -165.62 12.94 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.006 -1.237 . . . . 25.0 110.006 175.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -148.43 165.88 29.8 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 119.645 1.722 . . . . 25.0 113.164 -177.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 58.94 33.97 23.35 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.464 1.283 . . . . 25.0 114.464 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 77.36 30.54 53.89 Favored Glycine 0 N--CA 1.465 0.617 0 C-N-CA 119.857 -1.163 . . . . 25.0 110.27 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.6 t -143.61 168.63 19.42 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 121.32 -1.106 . . . . 25.0 108.965 -178.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.8 mt -93.02 172.24 8.44 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 106.144 -1.799 . . . . 25.0 106.144 175.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.58 118.95 19.75 Favored 'General case' 0 C--O 1.254 1.323 0 CA-C-N 119.446 1.021 . . . . 25.0 110.099 177.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.8 m -87.85 159.15 3.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 109.45 -0.574 . . . . 25.0 109.45 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 99.4 p -147.0 163.69 35.42 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 108.77 -0.826 . . . . 25.0 108.77 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.5 m -126.02 165.89 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 N-CA-C 107.532 -1.284 . . . . 25.0 107.532 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.1 t -74.49 -49.32 22.65 Favored 'General case' 0 C--O 1.255 1.346 0 N-CA-C 104.251 -2.5 . . . . 25.0 104.251 173.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -168.8 -170.89 1.25 Allowed 'General case' 0 C--O 1.207 -1.133 1 N-CA-C 99.201 -4.37 . . . . 25.0 99.201 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -60.23 -20.46 58.95 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 119.175 0.898 . . . . 25.0 111.912 -178.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.22 -151.45 9.68 Favored Glycine 0 C--O 1.216 -1.02 0 N-CA-C 110.602 -0.999 . . . . 25.0 110.602 176.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 54.66 -133.75 1.66 Allowed 'General case' 0 N--CA 1.465 0.325 0 O-C-N 124.066 0.51 . . . . 25.0 112.094 -179.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 22.8 mtt85 -105.37 155.53 19.03 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 112.473 0.546 . . . . 25.0 112.473 -174.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.3 p -103.3 163.01 12.52 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.173 -2.528 . . . . 25.0 104.173 175.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.493 ' CE2' ' HB2' ' A' ' 140' ' ' ALA . 57.8 m-85 -141.33 149.86 41.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 118.63 0.65 . . . . 25.0 111.328 -176.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 55.8 tp -124.57 128.21 48.56 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 105.298 -2.112 . . . . 25.0 105.298 177.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -126.15 155.75 41.21 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 122.597 1.189 . . . . 25.0 112.218 -172.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 32.3 t -90.96 158.28 16.81 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 103.481 -2.785 . . . . 25.0 103.481 168.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -129.69 17.08 5.82 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 106.773 -1.566 . . . . 25.0 106.773 176.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -115.44 144.78 43.31 Favored 'General case' 0 C--O 1.25 1.125 0 CA-C-N 112.525 -2.125 . . . . 25.0 106.667 173.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -144.52 168.18 20.74 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.334 0.587 . . . . 25.0 110.18 -178.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -97.13 161.35 13.86 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.946 -1.131 . . . . 25.0 107.946 176.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.22 -26.72 68.64 Favored 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 109.647 -0.501 . . . . 25.0 109.647 -176.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -67.26 -7.16 22.06 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 112.929 0.715 . . . . 25.0 112.929 174.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.89 22.18 53.63 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 121.84 0.689 . . . . 25.0 113.404 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 78.1 mt -90.99 133.48 35.25 Favored 'General case' 0 CA--C 1.506 -0.728 0 O-C-N 121.899 -0.766 . . . . 25.0 109.951 177.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 66.3 p -141.43 -179.46 6.15 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.414 -1.328 . . . . 25.0 107.414 178.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -124.77 136.26 53.7 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 119.614 -0.232 . . . . 25.0 111.221 -178.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -149.15 152.53 36.24 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 106.622 -1.622 . . . . 25.0 106.622 166.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.5 p -144.63 144.65 21.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 105.004 -2.221 . . . . 25.0 105.004 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.493 ' HB2' ' CE2' ' A' ' 124' ' ' TYR . . . -105.54 142.98 34.35 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.963 -1.495 . . . . 25.0 106.963 -176.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.8 mp -130.77 132.66 45.42 Favored 'General case' 0 C--O 1.195 -1.81 0 N-CA-C 105.404 -2.073 . . . . 25.0 105.404 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -105.35 6.19 32.46 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 119.646 -1.909 . . . . 25.0 114.195 -174.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -87.34 8.66 76.12 Favored Glycine 0 CA--C 1.542 1.765 0 C-N-CA 120.753 -0.737 . . . . 25.0 113.415 -179.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 35.7 t0 43.98 57.36 4.2 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 114.7 1.371 . . . . 25.0 114.7 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -123.82 36.16 4.69 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-N 114.95 -1.023 . . . . 25.0 109.284 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.97 -33.32 68.74 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.348 -0.387 . . . . 25.0 112.027 174.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.36 -22.91 62.73 Favored 'General case' 0 C--O 1.255 1.374 0 O-C-N 121.297 -0.877 . . . . 25.0 112.442 178.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.5 -15.92 20.35 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 112.333 0.494 . . . . 25.0 112.333 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 12.9 mt -64.59 139.02 58.72 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 123.009 1.385 . . . . 25.0 112.265 176.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 57.8 m -143.52 154.7 43.89 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 106.66 -1.607 . . . . 25.0 106.66 177.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.05 -2.93 29.61 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.657 0.614 . . . . 25.0 112.657 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -67.0 -31.55 72.19 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 108.366 -0.975 . . . . 25.0 108.366 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -85.6 -5.03 59.32 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 120.377 -0.529 . . . . 25.0 112.309 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 48.3 mm -97.27 122.79 49.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 104.481 -2.414 . . . . 25.0 104.481 176.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.1 p -103.2 112.93 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-O 123.12 1.438 . . . . 25.0 113.568 -174.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -142.0 -7.21 0.94 Allowed 'General case' 0 C--O 1.251 1.158 0 CA-C-N 112.656 -2.066 . . . . 25.0 111.782 176.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -85.86 50.61 2.01 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.56 0.948 . . . . 25.0 113.56 -176.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 60.09 20.06 9.28 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 116.456 2.021 . . . . 25.0 116.456 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.0 -21.28 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 119.886 3.291 . . . . 25.0 119.886 174.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -70.0 139.8 52.82 Favored 'General case' 0 N--CA 1.444 -0.746 0 O-C-N 121.606 -0.684 . . . . 25.0 110.196 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -75.25 -1.83 25.27 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.462 0.912 . . . . 25.0 113.462 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.29 34.97 0.21 Allowed 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.883 0.849 . . . . 25.0 111.164 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -145.66 -171.59 3.72 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.267 -0.879 . . . . 25.0 108.921 -175.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 59.65 -168.98 0.15 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.632 1.573 . . . . 25.0 113.083 175.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 80.18 6.2 89.31 Favored Glycine 0 C--O 1.25 1.145 0 CA-C-O 121.682 0.601 . . . . 25.0 114.418 -173.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -81.86 69.73 8.61 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.868 0.867 . . . . 25.0 111.364 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -125.01 141.15 52.31 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 122.853 0.461 . . . . 25.0 111.297 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -142.67 44.76 0.95 Allowed Glycine 0 CA--C 1.527 0.784 0 O-C-N 124.222 0.951 . . . . 25.0 112.097 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 45.6 t -70.87 -37.26 67.67 Favored 'Isoleucine or valine' 0 C--O 1.251 1.143 0 O-C-N 121.758 -0.848 . . . . 25.0 111.684 -178.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.11 136.47 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-O 122.245 1.022 . . . . 25.0 111.645 -177.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 166.84 170.38 31.66 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 109.22 -1.552 . . . . 25.0 109.22 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -146.55 148.8 32.54 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.855 0.836 . . . . 25.0 110.721 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 95.2 p -158.42 169.93 23.35 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-N 114.782 -1.099 . . . . 25.0 110.169 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 150.58 167.12 14.19 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 116.289 1.276 . . . . 25.0 116.289 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -136.66 95.0 12.82 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 124.948 1.299 . . . . 25.0 107.618 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.86 158.29 57.97 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 119.809 0.339 . . . . 25.0 112.094 -178.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -114.03 154.75 27.15 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 107.951 -1.129 . . . . 25.0 107.951 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -127.2 67.88 71.55 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 115.574 -0.739 . . . . 25.0 110.818 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -72.15 158.19 52.55 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 CA-C-O 122.945 1.144 . . . . 25.0 112.25 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.2 t -132.48 27.52 4.39 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 105.828 -1.915 . . . . 25.0 105.828 172.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 C--O 1.25 1.115 0 CA-C-N 113.876 -1.511 . . . . 25.0 111.821 179.056 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.34 0 N-CA-C 110.506 -0.183 . . . . 25.0 110.506 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -103.39 112.37 65.64 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 119.404 -0.331 . . . . 25.0 111.451 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -69.66 140.08 42.17 Favored 'Trans proline' 0 C--N 1.324 -0.724 0 N-CA-C 113.531 0.55 . . . . 25.0 113.531 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.64 46.1 0.04 OUTLIER Glycine 0 N--CA 1.472 1.087 0 CA-C-O 117.539 -1.701 . . . . 25.0 110.474 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -51.67 120.89 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 O-C-N 125.592 1.407 . . . . 25.0 113.0 -176.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -92.29 -8.59 44.75 Favored 'General case' 0 C--O 1.259 1.557 0 CA-C-N 113.516 -1.675 . . . . 25.0 110.899 -173.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.01 -137.17 3.34 Favored Glycine 0 C--N 1.298 -1.567 0 O-C-N 124.01 0.819 . . . . 25.0 113.403 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.7 p 65.69 156.34 0.13 Allowed Pre-proline 0 N--CA 1.498 1.966 0 C-N-CA 126.225 1.81 . . . . 25.0 111.665 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.582 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 47.3 Cg_exo -64.23 -3.31 5.98 Favored 'Trans proline' 0 C--N 1.364 1.344 0 N-CA-C 118.17 2.335 . . . . 25.0 118.17 -177.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 p -68.74 -9.92 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 116.822 2.156 . . . . 25.0 116.822 -173.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.7 p -138.87 133.02 40.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 113.547 0.943 . . . . 25.0 113.547 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.11 15.8 74.66 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 118.093 1.997 . . . . 25.0 118.093 172.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 89.4 p -54.75 -35.21 63.51 Favored 'General case' 0 CA--C 1.565 1.549 0 O-C-N 120.776 -1.426 . . . . 25.0 113.815 -170.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -78.22 3.81 14.33 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 117.576 2.435 . . . . 25.0 117.576 -175.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.4 pp -149.98 177.64 9.67 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 123.181 0.592 . . . . 25.0 110.478 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -59.32 128.7 38.39 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 112.548 0.573 . . . . 25.0 112.548 -174.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -125.9 160.61 29.48 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 114.298 1.222 . . . . 50.0 114.298 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -124.24 97.39 5.3 Favored 'General case' 0 C--O 1.279 2.639 0 N-CA-C 106.237 -1.764 . . . . 25.0 106.237 159.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.4 mt -104.44 128.68 52.39 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.932 0.872 . . . . 25.0 112.691 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -115.67 120.47 39.48 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 109.114 -0.699 . . . . 25.0 109.114 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.83 173.88 40.35 Favored Glycine 0 N--CA 1.472 1.083 0 N-CA-C 120.238 2.855 . . . . 25.0 120.238 -178.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.5 p -71.72 174.42 6.84 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.521 1.153 . . . . 25.0 113.06 175.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.5 mt -93.5 16.85 12.61 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.483 -0.78 . . . . 25.0 109.904 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -119.24 -177.62 16.48 Favored Glycine 0 C--O 1.24 0.494 0 N-CA-C 109.479 -1.448 . . . . 25.0 109.479 174.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.7 t -68.45 133.92 49.36 Favored 'General case' 0 C--O 1.253 1.278 0 C-N-CA 123.347 0.659 . . . . 25.0 111.483 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -144.98 160.5 41.25 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.974 -1.121 . . . . 50.0 107.974 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -104.27 124.55 49.35 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 104.916 -2.253 . . . . 25.0 104.916 163.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.0 mm -114.84 128.65 71.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 N-CA-C 106.378 -1.712 . . . . 25.0 106.378 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.582 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 4.4 mp -126.9 124.46 39.6 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 102.942 -2.985 . . . . 25.0 102.942 178.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.32 -30.87 56.24 Favored Glycine 0 N--CA 1.483 1.777 0 N-CA-C 114.625 0.61 . . . . 25.0 114.625 176.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.5 -149.56 48.59 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 118.781 1.29 . . . . 25.0 111.352 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -79.14 170.43 54.57 Favored Glycine 0 C--N 1.298 -1.561 0 N-CA-C 109.362 -1.495 . . . . 25.0 109.362 -177.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.82 167.98 41.92 Favored Glycine 0 C--N 1.307 -1.032 0 N-CA-C 110.861 -0.896 . . . . 25.0 110.861 177.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.91 102.97 15.58 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.53 1.132 . . . . 25.0 108.319 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -102.78 147.25 27.09 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 122.589 1.185 . . . . 50.0 111.381 -167.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -118.16 92.29 3.79 Favored 'General case' 0 C--O 1.285 2.934 0 N-CA-C 107.477 -1.305 . . . . 25.0 107.477 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 23.3 mt -102.69 140.37 37.05 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.558 0.947 . . . . 25.0 113.558 -169.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -134.31 106.18 6.98 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.633 -0.877 . . . . 25.0 108.633 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.38 -17.75 63.79 Favored Glycine 0 N--CA 1.476 1.354 0 N-CA-C 115.86 1.104 . . . . 25.0 115.86 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 47.93 -149.64 0.16 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 119.335 1.568 . . . . 25.0 113.939 -177.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.98 163.1 25.36 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-N 115.633 -0.712 . . . . 25.0 112.918 -173.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.5 160.62 35.97 Favored Glycine 0 C--O 1.252 1.258 0 O-C-N 124.979 1.424 . . . . 25.0 113.672 -175.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -81.59 102.53 10.7 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.901 -1.148 . . . . 25.0 107.901 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -109.69 152.95 24.96 Favored 'General case' 0 CA--C 1.505 -0.754 0 C-N-CA 119.48 -0.888 . . . . 50.0 110.92 -169.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.44 120.79 43.15 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 105.15 -2.167 . . . . 25.0 105.15 177.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.8 mp -124.14 121.3 34.75 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.275 1.213 . . . . 25.0 114.275 -176.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -116.08 148.02 40.68 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 113.801 -1.545 . . . . 25.0 106.888 174.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.15 -34.32 4.87 Favored Glycine 0 N--CA 1.476 1.333 0 N-CA-C 116.173 1.229 . . . . 25.0 116.173 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.72 -171.38 53.5 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-O 123.593 1.663 . . . . 25.0 110.335 -177.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.28 149.64 16.01 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 114.253 -0.973 . . . . 25.0 112.422 -176.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.56 168.32 44.47 Favored Glycine 0 CA--C 1.496 -1.155 0 CA-C-O 118.31 -1.272 . . . . 25.0 111.723 -176.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.49 134.32 33.62 Favored 'General case' 0 C--O 1.209 -1.07 0 N-CA-C 101.637 -3.468 . . . . 25.0 101.637 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -123.1 157.71 32.25 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 109.655 -0.498 . . . . 50.0 109.655 -174.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -120.73 127.59 52.15 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 101.994 -3.336 . . . . 25.0 101.994 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -149.48 135.04 18.51 Favored 'General case' 0 C--O 1.2 -1.507 0 N-CA-C 116.493 2.034 . . . . 25.0 116.493 -174.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.2 m -99.55 145.6 27.33 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.995 -1.002 . . . . 25.0 110.228 171.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.92 -34.54 5.4 Favored Glycine 0 C--O 1.215 -1.076 0 N-CA-C 108.779 -1.728 . . . . 25.0 108.779 173.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.69 -165.1 53.56 Favored Glycine 0 C--O 1.217 -0.946 0 CA-C-O 122.009 0.783 . . . . 25.0 111.659 -177.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -71.16 156.06 40.02 Favored 'General case' 0 C--O 1.258 1.53 0 CA-C-O 121.938 0.875 . . . . 25.0 109.344 178.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.54 161.45 33.61 Favored Glycine 0 C--O 1.258 1.605 0 CA-C-O 117.982 -1.454 . . . . 25.0 110.121 -175.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.75 112.29 17.99 Favored 'General case' 0 C--O 1.2 -1.532 0 O-C-N 124.697 0.881 . . . . 25.0 109.428 177.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -104.15 153.4 20.98 Favored 'General case' 0 CA--C 1.487 -1.462 0 CA-C-N 116.58 -0.282 . . . . 50.0 110.901 -174.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 79.5 m -116.36 122.54 45.17 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 107.843 -1.169 . . . . 25.0 107.843 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -108.13 89.26 2.94 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 104.137 -2.542 . . . . 25.0 104.137 177.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -92.12 -25.84 18.55 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 114.822 -1.081 . . . . 25.0 111.626 -174.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 66.86 150.03 0.06 Allowed 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.477 1.511 . . . . 25.0 112.198 -175.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.65 -43.36 31.61 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 117.061 2.245 . . . . 25.0 117.061 -165.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.4 mt -142.9 173.57 11.43 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.572 -0.899 . . . . 25.0 108.572 -165.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.55 -30.23 69.64 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-N 115.179 -0.919 . . . . 25.0 110.125 167.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -78.17 -6.59 55.27 Favored 'General case' 0 C--O 1.263 1.796 0 N-CA-C 114.539 1.311 . . . . 25.0 114.539 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -90.59 151.17 21.43 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 121.209 -0.932 . . . . 25.0 109.499 -172.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.8 t 29.1 47.05 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 117.569 2.433 . . . . 25.0 117.569 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 -119.15 178.63 4.44 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.56 -0.746 . . . . 25.0 109.532 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -126.84 140.17 52.55 Favored 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 107.963 -1.125 . . . . 25.0 107.963 176.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 84.1 p -129.81 166.1 28.52 Favored Pre-proline 0 C--O 1.189 -2.108 0 N-CA-C 108.216 -1.031 . . . . 25.0 108.216 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -64.68 -24.58 62.25 Favored 'Trans proline' 0 C--O 1.243 0.735 0 C-N-CA 115.667 -2.422 . . . . 25.0 112.677 178.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 31.7 mt -65.64 -38.99 90.94 Favored 'General case' 0 C--O 1.201 -1.498 0 CA-C-O 121.826 0.822 . . . . 25.0 112.459 178.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 171.46 167.29 31.48 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 115.001 -1.0 . . . . 25.0 111.383 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.8 t -86.42 149.64 24.86 Favored 'General case' 0 C--N 1.353 0.751 0 CA-C-O 124.425 2.059 . . . . 25.0 110.855 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -132.83 28.09 4.24 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 112.337 -2.21 . . . . 25.0 111.355 175.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.74 140.41 36.59 Favored Glycine 0 N--CA 1.474 1.231 0 CA-C-O 122.31 0.95 . . . . 25.0 111.917 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -91.18 169.39 10.88 Favored 'General case' 0 C--O 1.249 1.067 0 O-C-N 119.884 -1.95 . . . . 50.0 111.998 -176.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -122.18 97.4 5.46 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.662 0.785 . . . . 25.0 110.936 -170.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 22.1 mt -84.41 132.7 30.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 N-CA-C 106.92 -1.511 . . . . 25.0 106.92 -178.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.448 ' HA ' ' HG2' ' A' ' 142' ' ' GLU . 90.4 mt -87.47 -43.81 11.78 Favored 'General case' 0 C--O 1.253 1.289 0 N-CA-C 115.774 1.768 . . . . 25.0 115.774 -172.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 54.0 p-10 -137.78 44.55 2.2 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.539 0.57 . . . . 25.0 112.539 -174.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -57.28 138.55 54.64 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.823 1.249 . . . . 25.0 111.971 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -106.16 105.5 54.02 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 106.807 -1.553 . . . . 25.0 106.807 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -68.05 -5.4 14.59 Favored 'Trans proline' 0 C--O 1.199 -1.427 0 N-CA-C 117.703 2.155 . . . . 25.0 117.703 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 37.7 t -99.87 -38.78 8.5 Favored 'General case' 0 CA--C 1.557 1.213 0 CA-C-O 120.815 0.341 . . . . 25.0 110.921 177.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -93.45 -42.3 9.33 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-N 116.668 -0.242 . . . . 25.0 111.578 -174.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -87.56 167.66 13.74 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 115.134 -0.939 . . . . 50.0 109.516 -170.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -139.99 151.11 45.23 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 122.977 0.511 . . . . 25.0 110.733 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 86.0 mt -124.93 133.71 68.78 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.596 0 N-CA-C 107.945 -1.131 . . . . 25.0 107.945 177.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -100.15 154.53 18.37 Favored 'General case' 0 C--O 1.212 -0.914 0 N-CA-C 107.896 -1.15 . . . . 25.0 107.896 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.8 p -154.33 2.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 121.467 -0.771 . . . . 25.0 111.448 -176.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 11.0 t -62.74 -45.97 90.26 Favored 'General case' 0 C--O 1.258 1.546 0 N-CA-C 115.464 1.653 . . . . 25.0 115.464 -173.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.63 -42.01 22.88 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.9 -0.591 . . . . 25.0 111.07 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.37 -8.32 48.33 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 117.136 2.273 . . . . 25.0 117.136 -172.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -140.44 -72.07 0.04 OUTLIER Glycine 0 C--N 1.337 0.613 0 N-CA-C 116.72 1.448 . . . . 25.0 116.72 -176.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -160.63 168.61 24.57 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 108.283 -1.006 . . . . 25.0 108.283 -176.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.0 t -127.73 -30.99 2.48 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.8 0.81 . . . . 25.0 111.925 175.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -94.06 121.36 6.65 Favored Glycine 0 CA--C 1.483 -1.968 0 N-CA-C 107.467 -2.253 . . . . 25.0 107.467 175.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.82 146.07 47.61 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.038 -0.581 . . . . 25.0 111.813 -178.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -102.68 -160.3 25.81 Favored Glycine 0 C--O 1.244 0.727 0 CA-C-O 122.415 1.008 . . . . 25.0 114.539 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -56.48 139.36 49.51 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 122.262 1.03 . . . . 25.0 113.673 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 164.28 -175.67 40.32 Favored Glycine 0 C--O 1.25 1.141 0 N-CA-C 110.15 -1.18 . . . . 25.0 110.15 -177.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -146.61 165.26 30.07 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.834 1.317 . . . . 25.0 110.995 -177.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 56.4 37.38 28.78 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 113.243 0.831 . . . . 25.0 113.243 177.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 79.02 32.6 39.23 Favored Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.204 -1.474 . . . . 25.0 110.945 176.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.7 t -148.59 179.72 7.6 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 120.02 1.91 . . . . 25.0 110.682 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 65.4 mt -90.52 168.58 11.72 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 104.519 -2.401 . . . . 25.0 104.519 168.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.77 121.94 20.72 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 108.07 -1.085 . . . . 25.0 108.07 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 28.9 m -93.86 162.37 2.42 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 O-C-N 125.081 1.488 . . . . 25.0 108.945 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.4 p -148.93 163.84 36.28 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.414 0.894 . . . . 25.0 113.414 -177.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.8 m -120.91 167.69 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 106.729 -1.582 . . . . 25.0 106.729 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 37.4 t -75.51 -55.07 6.03 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 106.615 -1.624 . . . . 25.0 106.615 173.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -165.6 -150.95 0.13 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 103.854 -2.647 . . . . 25.0 103.854 -176.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -69.39 -15.08 63.23 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 122.44 1.114 . . . . 25.0 111.114 -176.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -140.09 -155.24 6.51 Favored Glycine 0 C--O 1.258 1.606 0 CA-C-O 117.391 -1.783 . . . . 25.0 110.895 178.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 68.01 -150.25 0.16 Allowed 'General case' 0 C--O 1.247 0.973 0 C-N-CA 125.113 1.365 . . . . 25.0 111.061 177.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 46.6 mtt85 -93.16 168.8 10.87 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-O 122.062 0.934 . . . . 25.0 111.419 -174.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 8.4 p -109.97 165.38 11.77 Favored 'General case' 0 C--O 1.251 1.146 0 N-CA-C 104.023 -2.584 . . . . 25.0 104.023 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -133.01 156.71 46.86 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-O 123.817 1.77 . . . . 25.0 110.056 175.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 59.9 tp -128.41 127.93 43.51 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 104.212 -2.514 . . . . 25.0 104.212 170.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -125.37 152.79 44.32 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.067 -0.716 . . . . 25.0 109.067 -172.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 41.1 t -96.07 149.88 21.11 Favored 'General case' 0 C--O 1.248 0.987 0 N-CA-C 106.039 -1.837 . . . . 25.0 106.039 171.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -115.31 19.74 15.34 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 122.551 1.167 . . . . 25.0 107.957 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -115.12 149.78 37.04 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 106.635 -1.617 . . . . 25.0 106.635 176.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -149.55 153.01 36.48 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 124.062 0.851 . . . . 25.0 111.516 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -83.18 162.35 21.27 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.509 -1.293 . . . . 25.0 107.509 177.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.99 -20.49 66.52 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 118.418 0.554 . . . . 25.0 111.381 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -82.39 -1.25 49.4 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 112.736 0.643 . . . . 25.0 112.736 176.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.26 14.4 68.95 Favored Glycine 0 CA--C 1.497 -1.035 0 O-C-N 124.112 0.882 . . . . 25.0 111.728 177.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 80.9 mt -83.87 139.16 32.81 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.634 -1.617 . . . . 25.0 106.634 177.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 61.4 p -149.85 -177.1 5.71 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 116.331 -1.795 . . . . 25.0 106.349 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -133.04 133.97 43.76 Favored 'General case' 0 C--O 1.274 2.39 0 N-CA-C 115.055 1.502 . . . . 25.0 115.055 -176.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -144.09 156.4 44.34 Favored 'General case' 0 C--O 1.269 2.114 0 N-CA-C 109.316 -0.624 . . . . 25.0 109.316 169.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.9 p -144.76 144.6 21.85 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 N-CA-C 107.252 -1.388 . . . . 25.0 107.252 -178.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -112.04 138.56 48.52 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 118.992 0.814 . . . . 25.0 110.445 -177.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.6 mp -130.4 135.37 47.95 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.741 -0.837 . . . . 25.0 108.741 -175.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.448 ' HG2' ' HA ' ' A' ' 85' ' ' LEU . 17.4 pt-20 -102.3 7.83 40.53 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 117.918 -1.513 . . . . 25.0 111.622 -176.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -73.44 -6.4 70.3 Favored Glycine 0 C--O 1.216 -1.021 0 O-C-N 124.3 1.0 . . . . 25.0 113.121 178.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 49.1 t0 49.98 47.22 23.6 Favored 'General case' 0 C--O 1.262 1.743 0 CA-C-O 122.051 0.929 . . . . 25.0 111.689 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -125.17 35.49 4.76 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 107.279 -1.378 . . . . 25.0 107.279 -178.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.4 -32.21 69.96 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 121.007 0.432 . . . . 25.0 110.093 172.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.27 -11.45 60.72 Favored 'General case' 0 C--O 1.26 1.647 0 C-N-CA 119.834 -0.746 . . . . 25.0 111.675 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -110.21 -1.08 17.55 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 113.852 1.056 . . . . 25.0 113.852 174.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 20.6 mt -79.25 120.94 24.44 Favored 'General case' 0 C--O 1.248 0.997 0 O-C-N 123.831 0.707 . . . . 25.0 111.636 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 71.8 m -135.56 160.45 38.46 Favored 'General case' 0 N--CA 1.4 -2.972 0 CA-C-N 114.405 -1.27 . . . . 25.0 108.292 176.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -68.1 -7.53 30.39 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 122.47 1.129 . . . . 25.0 110.474 -177.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -61.14 -27.22 68.24 Favored 'General case' 0 C--O 1.208 -1.106 0 CA-C-N 114.426 -1.261 . . . . 25.0 109.131 177.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -103.1 -1.89 28.36 Favored 'General case' 0 C--O 1.26 1.613 0 N-CA-C 114.509 1.3 . . . . 25.0 114.509 176.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 23.1 mm -101.08 114.88 41.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 104.931 -2.248 . . . . 25.0 104.931 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 13.7 p -97.78 110.72 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 119.735 -1.853 . . . . 25.0 113.86 -168.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -151.07 -4.04 0.31 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 113.083 -1.871 . . . . 25.0 113.824 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -84.96 58.65 5.14 Favored 'General case' 0 C--N 1.346 0.443 0 N-CA-C 113.574 0.953 . . . . 25.0 113.574 -175.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 52.35 26.62 4.21 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 116.854 2.168 . . . . 25.0 116.854 178.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.11 -6.23 0.11 Allowed 'General case' 0 CA--C 1.564 1.502 0 N-CA-C 117.244 2.313 . . . . 25.0 117.244 178.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -65.75 133.72 51.63 Favored 'General case' 0 CA--C 1.551 0.991 0 O-C-N 121.442 -0.786 . . . . 25.0 111.174 -176.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.3 -18.74 61.17 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.02 0.528 . . . . 25.0 109.674 175.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -77.87 -8.44 58.08 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.83 -0.433 . . . . 25.0 109.83 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.37 168.84 18.88 Favored 'General case' 0 C--O 1.252 1.227 0 CA-C-O 121.159 0.504 . . . . 25.0 110.73 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 51.58 -155.56 0.15 Allowed 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 115.175 1.546 . . . . 25.0 115.175 177.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.95 16.37 74.7 Favored Glycine 0 C--O 1.247 0.93 0 N-CA-C 114.936 0.734 . . . . 25.0 114.936 -178.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -101.55 97.66 8.07 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 124.388 0.699 . . . . 25.0 109.834 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.25 136.96 54.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 122.273 1.035 . . . . 25.0 111.768 -176.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -140.11 28.18 2.5 Favored Glycine 0 C--N 1.336 0.583 0 N-CA-C 109.251 -1.54 . . . . 25.0 109.251 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 60.4 t -74.85 -37.76 42.6 Favored 'Isoleucine or valine' 0 C--O 1.251 1.147 0 N-CA-C 108.451 -0.944 . . . . 25.0 108.451 -177.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.63 128.02 16.44 Favored 'Isoleucine or valine' 0 C--O 1.246 0.872 0 O-C-N 124.57 1.169 . . . . 25.0 111.009 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 166.16 167.29 26.58 Favored Glycine 0 N--CA 1.43 -1.731 0 CA-C-N 114.046 -1.434 . . . . 25.0 110.836 -177.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -149.91 139.64 21.74 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.196 -1.038 . . . . 25.0 108.196 -176.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 85.0 p -154.74 158.07 38.99 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.128 -1.064 . . . . 25.0 108.128 177.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 159.58 161.08 10.93 Favored Glycine 0 C--O 1.24 0.472 0 N-CA-C 116.097 1.199 . . . . 25.0 116.097 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 -105.16 107.37 58.77 Favored Pre-proline 0 C--O 1.251 1.162 0 CA-C-O 121.022 0.439 . . . . 25.0 109.871 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -71.04 163.17 40.16 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 116.636 -1.776 . . . . 25.0 111.892 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -129.85 154.82 46.89 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 106.82 -1.548 . . . . 25.0 106.82 -178.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -140.3 69.12 33.54 Favored Pre-proline 0 C--N 1.306 -1.297 0 O-C-N 121.694 -0.629 . . . . 25.0 109.579 -178.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.19 139.45 42.24 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 116.382 -1.946 . . . . 25.0 112.921 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 15.3 t -93.52 -14.95 26.01 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.217 -0.901 . . . . 25.0 111.501 -176.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 10.7 p . . . . . 0 C--O 1.258 1.55 0 N-CA-C 107.592 -1.262 . . . . 25.0 107.592 179.373 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.933 0 CA-C-O 121.978 0.894 . . . . 25.0 110.781 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -143.61 101.79 5.04 Favored Pre-proline 0 C--O 1.241 0.638 0 N-CA-C 106.869 -1.53 . . . . 25.0 106.869 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.85 139.84 28.08 Favored 'Trans proline' 0 CA--C 1.511 -0.643 0 C-N-CA 116.258 -2.028 . . . . 25.0 112.968 -171.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -155.2 61.64 0.36 Allowed Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 107.764 -2.134 . . . . 25.0 107.764 177.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.415 HG12 ' H ' ' A' ' 5' ' ' VAL . 1.4 p -54.76 126.49 11.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 124.158 0.983 . . . . 25.0 110.236 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -100.54 8.96 43.15 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.506 -0.77 . . . . 25.0 110.841 -178.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -90.25 -146.95 16.68 Favored Glycine 0 C--O 1.215 -1.088 0 CA-C-N 115.527 -0.76 . . . . 25.0 112.503 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.7 p 68.92 154.74 0.14 Allowed Pre-proline 0 CA--C 1.563 1.458 0 C-N-CA 126.084 1.753 . . . . 25.0 112.628 -175.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.673 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 50.1 Cg_exo -62.68 1.25 1.11 Allowed 'Trans proline' 0 N--CA 1.498 1.746 0 N-CA-C 117.254 1.982 . . . . 25.0 117.254 -177.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.8 p -63.98 -18.17 22.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 118.831 2.9 . . . . 25.0 118.831 -168.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.5 p -134.8 119.1 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 117.308 2.336 . . . . 25.0 117.308 -175.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.56 36.28 91.18 Favored Glycine 0 C--O 1.211 -1.283 0 CA-C-N 115.481 -0.781 . . . . 25.0 113.945 174.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.3 t -51.98 -38.55 57.03 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 119.219 -0.42 . . . . 25.0 111.678 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -80.73 5.61 15.26 Favored 'General case' 0 C--O 1.249 1.037 0 N-CA-C 115.266 1.58 . . . . 25.0 115.266 -173.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 pp -143.15 178.4 7.73 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-O 118.029 -0.986 . . . . 25.0 109.773 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -56.71 132.75 52.94 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 114.023 1.12 . . . . 25.0 114.023 -173.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -134.33 155.66 49.85 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 114.266 1.21 . . . . 50.0 114.266 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -122.93 113.35 18.99 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 104.128 -2.545 . . . . 25.0 104.128 164.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 88.7 mt -120.74 118.35 29.83 Favored 'General case' 0 C--O 1.207 -1.139 0 CA-C-O 121.394 0.616 . . . . 25.0 110.122 -177.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -110.06 106.99 16.69 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.593 -1.262 . . . . 25.0 107.593 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.51 -171.3 47.06 Favored Glycine 0 C--O 1.244 0.73 0 N-CA-C 118.753 2.261 . . . . 25.0 118.753 -172.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.1 p -82.49 175.72 9.98 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.761 -0.72 . . . . 25.0 111.315 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 69.2 mt -90.97 -2.86 57.65 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 123.546 0.529 . . . . 25.0 110.711 173.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -95.39 -174.27 37.17 Favored Glycine 0 C--O 1.244 0.74 0 N-CA-C 110.02 -1.232 . . . . 25.0 110.02 176.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.4 t -74.91 138.89 42.71 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.676 0.621 . . . . 25.0 112.676 -177.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -145.8 152.9 40.27 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 117.806 0.276 . . . . 50.0 111.538 -178.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -98.09 128.51 44.64 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 103.0 -2.963 . . . . 25.0 103.0 166.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 34.2 mm -124.59 108.65 20.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 107.513 -1.291 . . . . 25.0 107.513 -178.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.673 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 9.6 mp -108.85 118.0 35.65 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 104.408 -2.441 . . . . 25.0 104.408 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.43 -36.5 59.19 Favored Glycine 0 CA--C 1.497 -1.078 0 CA-C-O 119.517 -0.602 . . . . 25.0 113.353 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.87 -151.81 41.44 Favored Glycine 0 CA--C 1.497 -1.091 0 C-N-CA 119.834 -1.174 . . . . 25.0 112.303 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -78.35 169.21 54.31 Favored Glycine 0 C--O 1.247 0.948 0 N-CA-C 110.262 -1.135 . . . . 25.0 110.262 -177.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.3 164.95 23.14 Favored Glycine 0 N--CA 1.432 -1.608 0 C-N-CA 120.819 -0.705 . . . . 25.0 113.507 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.63 109.85 17.18 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.104 -1.073 . . . . 25.0 108.104 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -106.8 156.64 18.45 Favored 'General case' 0 C--N 1.316 -0.873 0 O-C-N 124.252 0.97 . . . . 50.0 112.403 -170.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -127.91 95.28 4.16 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 105.368 -2.086 . . . . 25.0 105.368 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.1 mt -102.21 138.0 39.72 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 113.739 -1.573 . . . . 25.0 112.034 -170.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -134.88 103.13 5.48 Favored 'General case' 0 C--O 1.267 1.986 0 CA-C-O 121.969 0.89 . . . . 25.0 111.502 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.74 -26.91 52.67 Favored Glycine 0 C--N 1.314 -0.68 0 CA-C-N 115.257 -0.883 . . . . 25.0 114.393 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 52.39 -145.75 0.54 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.384 1.074 . . . . 25.0 111.363 -176.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.56 169.19 13.12 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 121.503 -0.748 . . . . 25.0 112.724 -175.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.67 157.29 30.14 Favored Glycine 0 C--O 1.225 -0.417 0 CA-C-N 115.14 -0.936 . . . . 25.0 111.579 -173.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -79.36 112.49 16.64 Favored 'General case' 0 C--O 1.261 1.671 0 N-CA-C 105.812 -1.921 . . . . 25.0 105.812 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -113.68 149.16 35.1 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.023 -0.671 . . . . 50.0 109.598 -171.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mp -111.31 92.86 4.2 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.922 0.889 . . . . 25.0 109.34 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.1 mp -107.09 120.99 43.6 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.479 1.289 . . . . 25.0 114.479 -170.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -123.51 139.41 54.04 Favored 'General case' 0 C--O 1.246 0.876 0 N-CA-C 107.728 -1.212 . . . . 25.0 107.728 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -90.71 -36.59 6.78 Favored Glycine 0 C--O 1.257 1.539 0 CA-C-O 118.105 -1.386 . . . . 25.0 115.588 -173.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.91 -166.42 52.98 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 118.552 1.176 . . . . 25.0 112.388 -176.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.14 148.19 22.7 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.319 -0.94 . . . . 25.0 111.412 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.53 162.57 38.01 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-O 122.518 1.066 . . . . 25.0 114.534 -176.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -88.54 127.94 35.55 Favored 'General case' 0 CA--C 1.479 -1.776 0 N-CA-C 101.692 -3.447 . . . . 25.0 101.692 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -121.87 156.93 32.25 Favored 'General case' 0 C--O 1.255 1.357 0 C-N-CA 122.74 0.416 . . . . 50.0 111.211 -170.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -119.3 125.54 49.32 Favored 'General case' 0 C--O 1.212 -0.91 0 N-CA-C 101.821 -3.4 . . . . 25.0 101.821 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -145.41 132.77 20.64 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 115.689 1.737 . . . . 25.0 115.689 -174.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 63.9 m -102.0 140.45 36.27 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.526 -0.916 . . . . 25.0 108.526 175.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.92 -44.52 4.78 Favored Glycine 0 N--CA 1.467 0.721 0 N-CA-C 109.183 -1.567 . . . . 25.0 109.183 174.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.32 -175.09 54.89 Favored Glycine 0 N--CA 1.465 0.593 0 CA-C-N 116.988 0.394 . . . . 25.0 112.648 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -60.83 155.24 19.97 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 122.701 1.238 . . . . 25.0 110.371 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.37 159.62 32.12 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 115.18 -0.918 . . . . 25.0 111.717 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.58 107.55 13.48 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 122.206 1.003 . . . . 25.0 108.445 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -95.6 162.93 13.42 Favored 'General case' 0 C--O 1.27 2.132 0 CA-C-N 115.075 -0.966 . . . . 50.0 111.137 -172.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.8 m -128.35 132.02 48.59 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 122.536 1.16 . . . . 25.0 109.002 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -122.32 129.06 51.79 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 105.3 -2.111 . . . . 25.0 105.3 175.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.403 ' HD3' ' HB3' ' A' ' 95' ' ' ASP . 26.4 mmt85 -127.13 -15.42 5.27 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 121.277 0.561 . . . . 25.0 109.953 179.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 60.59 174.8 0.1 Allowed 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 115.216 -0.902 . . . . 25.0 112.426 -171.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -89.92 -51.87 5.26 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 115.108 1.522 . . . . 25.0 115.108 -172.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.1 mt -141.87 174.07 10.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.906 -1.043 . . . . 25.0 109.519 -173.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.12 -27.58 63.87 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 107.725 -1.213 . . . . 25.0 107.725 171.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -72.02 -9.2 58.06 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-O 122.758 1.266 . . . . 25.0 113.447 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -94.1 141.41 28.57 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.843 1.306 . . . . 25.0 111.732 -173.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.3 t 46.85 42.58 12.23 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 113.389 -1.732 . . . . 25.0 115.347 175.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -118.7 162.03 19.12 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.423 -1.262 . . . . 25.0 111.427 -178.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -104.68 146.49 28.87 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 105.403 -2.073 . . . . 25.0 105.403 175.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.7 p -138.71 167.44 19.46 Favored Pre-proline 0 C--O 1.211 -0.932 0 N-CA-C 108.165 -1.05 . . . . 25.0 108.165 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -61.03 -20.06 65.93 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 CA-C-O 122.377 0.907 . . . . 25.0 113.234 174.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 73.1 mt -79.26 -23.58 43.55 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 119.924 -1.735 . . . . 25.0 111.13 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 147.99 -175.73 27.16 Favored Glycine 0 C--O 1.212 -1.232 0 CA-C-N 115.384 -0.825 . . . . 25.0 111.916 177.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.0 t -89.15 137.99 31.82 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 123.375 1.559 . . . . 25.0 112.485 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -117.64 17.9 14.31 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-N 114.768 -1.105 . . . . 25.0 110.532 171.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.35 138.41 49.38 Favored Glycine 0 C--N 1.338 0.661 0 CA-C-N 115.184 -0.916 . . . . 25.0 111.519 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -85.22 173.53 10.33 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 117.353 0.576 . . . . 50.0 111.745 -176.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.74 103.89 7.77 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 123.217 0.607 . . . . 25.0 112.105 -179.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.8 mt -87.02 133.75 29.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 106.579 -1.638 . . . . 25.0 106.579 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.84 -38.9 22.38 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.608 0.966 . . . . 25.0 113.608 -172.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.6 p-10 -144.79 44.32 1.37 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.787 1.032 . . . . 25.0 113.787 -167.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -61.1 131.14 49.59 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.95 1.093 . . . . 25.0 113.95 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -96.39 106.32 28.45 Favored Pre-proline 0 N--CA 1.48 1.065 0 N-CA-C 106.749 -1.575 . . . . 25.0 106.749 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -77.56 -4.29 14.47 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 N-CA-C 114.17 0.796 . . . . 25.0 114.17 -171.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 45.6 t -93.28 -41.93 9.6 Favored 'General case' 0 C--N 1.315 -0.918 0 O-C-N 124.26 0.975 . . . . 25.0 111.091 177.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -98.19 -37.15 9.81 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.979 1.474 . . . . 25.0 114.979 -172.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -87.16 168.63 13.07 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.259 0.466 . . . . 50.0 112.259 -172.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -146.04 145.84 30.74 Favored 'General case' 0 C--O 1.263 1.785 0 O-C-N 121.805 -0.559 . . . . 25.0 112.288 -178.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 75.1 mt -130.74 129.1 63.79 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 N-CA-C 109.266 -0.642 . . . . 25.0 109.266 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.403 ' HB3' ' HD3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -91.69 141.24 28.9 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 119.771 -1.83 . . . . 25.0 107.393 174.928 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.7 p -134.09 -5.9 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 121.463 0.649 . . . . 25.0 111.423 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.87 -36.27 78.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.851 -0.613 . . . . 25.0 111.929 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.46 -24.69 53.9 Favored 'General case' 0 C--O 1.248 0.989 0 N-CA-C 113.91 1.078 . . . . 25.0 113.91 -178.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.88 9.4 5.37 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 115.946 1.832 . . . . 25.0 115.946 -168.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -151.08 -75.05 0.01 OUTLIER Glycine 0 C--O 1.219 -0.81 0 C-N-CA 119.868 -1.158 . . . . 25.0 115.067 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -155.39 167.74 29.4 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 109.592 -0.521 . . . . 25.0 109.592 -171.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.2 t -120.22 -39.81 2.76 Favored 'General case' 0 C--O 1.248 0.997 0 N-CA-C 108.963 -0.755 . . . . 25.0 108.963 176.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -92.04 123.15 7.11 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 109.31 -1.516 . . . . 25.0 109.31 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.16 148.81 46.99 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.254 0.55 . . . . 25.0 111.222 -177.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -83.16 -176.48 51.51 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 115.945 -0.571 . . . . 25.0 112.008 -177.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -61.94 100.2 0.15 Allowed 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 115.05 1.5 . . . . 25.0 115.05 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -141.03 -157.4 7.16 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-O 117.222 -1.876 . . . . 25.0 108.659 176.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -152.99 162.97 40.68 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 121.114 2.457 . . . . 25.0 112.566 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 51.16 44.33 28.76 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.214 1.006 . . . . 25.0 113.118 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.24 31.82 63.36 Favored Glycine 0 C--O 1.257 1.579 0 N-CA-C 111.031 -0.828 . . . . 25.0 111.031 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.6 t -139.76 174.23 10.72 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 117.719 0.759 . . . . 25.0 110.364 -177.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.7 mt -95.18 172.64 7.99 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 101.424 -3.547 . . . . 25.0 101.424 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.33 119.8 22.88 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.652 -1.24 . . . . 25.0 107.652 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.4 m -80.06 157.6 4.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.148 -0.686 . . . . 25.0 109.148 -176.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.46 160.25 40.92 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.754 -0.832 . . . . 25.0 108.754 -176.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.502 HG12 HG22 ' A' ' 123' ' ' THR . 16.3 m -123.31 163.9 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 116.33 -0.395 . . . . 25.0 110.268 177.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 35.1 t -70.84 -52.44 20.33 Favored 'General case' 0 C--O 1.204 -1.325 0 N-CA-C 107.52 -1.289 . . . . 25.0 107.52 174.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -159.61 -143.79 0.1 Allowed 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 104.997 -2.223 . . . . 25.0 104.997 -178.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -69.92 -21.14 63.32 Favored 'General case' 0 C--O 1.253 1.285 0 N-CA-C 109.564 -0.532 . . . . 25.0 109.564 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -141.54 -145.44 4.55 Favored Glycine 0 C--O 1.24 0.509 0 N-CA-C 110.532 -1.027 . . . . 25.0 110.532 178.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.55 -145.13 0.33 Allowed 'General case' 0 C--O 1.245 0.843 0 C-N-CA 124.082 0.953 . . . . 25.0 109.784 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.6 mtt85 -82.09 159.06 23.5 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 113.127 0.788 . . . . 25.0 113.127 -176.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.502 HG22 HG12 ' A' ' 116' ' ' VAL . 0.5 OUTLIER -111.3 166.28 11.23 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 104.822 -2.288 . . . . 25.0 104.822 177.404 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -135.65 151.4 50.18 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.997 -0.547 . . . . 25.0 111.378 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 34.4 tp -124.61 104.34 8.64 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 103.595 -2.743 . . . . 25.0 103.595 168.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -104.46 153.03 21.63 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.634 -0.712 . . . . 25.0 110.793 -172.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 43.5 t -99.5 150.87 21.77 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.397 -2.075 . . . . 25.0 105.397 170.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -119.81 25.02 10.24 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 106.534 -1.654 . . . . 25.0 106.534 -178.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -116.1 134.84 54.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.367 -1.288 . . . . 25.0 109.461 174.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -134.12 150.02 51.11 Favored 'General case' 0 C--O 1.216 -0.673 0 O-C-N 125.176 1.547 . . . . 25.0 110.549 -175.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -74.52 165.13 25.72 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 124.11 0.964 . . . . 25.0 109.127 174.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.97 -15.33 62.9 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.683 0.754 . . . . 25.0 111.463 178.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -79.03 -11.34 60.0 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.614 -0.721 . . . . 25.0 112.348 174.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.58 26.26 39.54 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 120.505 -0.855 . . . . 25.0 112.162 -176.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 69.5 mt -101.07 141.97 33.19 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.386 -1.338 . . . . 25.0 107.386 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 80.1 p -149.24 -175.44 4.98 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.338 -1.356 . . . . 25.0 107.338 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -123.2 139.21 54.29 Favored 'General case' 0 C--O 1.247 0.926 0 N-CA-C 113.223 0.823 . . . . 25.0 113.223 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -152.07 153.99 35.04 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.789 -1.189 . . . . 25.0 107.789 166.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 10.5 p -148.51 143.8 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 N-CA-C 104.603 -2.369 . . . . 25.0 104.603 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -105.86 148.93 27.01 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 107.186 -1.413 . . . . 25.0 107.186 -175.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.5 mp -137.98 131.03 30.17 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 104.301 -2.481 . . . . 25.0 104.301 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -104.37 4.91 33.98 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 121.198 1.817 . . . . 25.0 114.758 -174.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -77.16 1.58 63.83 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 120.283 -0.961 . . . . 25.0 114.817 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 47.7 t0 52.84 61.68 3.07 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-O 122.08 0.943 . . . . 25.0 110.728 175.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -130.98 41.92 3.3 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.707 -1.133 . . . . 25.0 111.762 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.95 -25.18 66.63 Favored 'General case' 0 C--O 1.209 -1.051 0 C-N-CA 119.345 -0.942 . . . . 25.0 110.809 176.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.12 -32.15 70.03 Favored 'General case' 0 C--O 1.275 2.418 0 C-N-CA 124.094 0.957 . . . . 25.0 112.282 177.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -93.62 -27.31 16.66 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.734 1.013 . . . . 25.0 113.734 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 11.4 mt -62.84 139.79 58.74 Favored 'General case' 0 C--O 1.247 0.923 0 CA-C-O 121.947 0.88 . . . . 25.0 109.492 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 72.5 m -141.77 159.78 41.52 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 102.012 -3.329 . . . . 25.0 102.012 169.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -86.24 10.36 14.93 Favored 'General case' 0 C--O 1.214 -0.813 0 N-CA-C 108.107 -1.072 . . . . 25.0 108.107 -176.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -72.11 -26.23 62.05 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.692 0.758 . . . . 25.0 110.386 178.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 24.3 p30 -86.06 -1.25 57.2 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 109.694 -0.484 . . . . 25.0 109.694 176.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 37.3 mm -98.39 128.88 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 102.415 -3.18 . . . . 25.0 102.415 173.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.3 p -105.82 113.77 43.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 122.936 1.35 . . . . 25.0 111.665 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -142.42 9.12 1.82 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 112.524 -2.125 . . . . 25.0 107.379 178.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.9 51.75 1.57 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.421 1.088 . . . . 25.0 111.301 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 56.43 33.7 22.92 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.384 1.073 . . . . 25.0 113.665 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 18.2 m 65.29 -43.99 0.35 Allowed 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 117.468 2.396 . . . . 25.0 117.468 176.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -76.65 154.11 34.59 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 114.27 1.211 . . . . 25.0 114.27 -173.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -80.77 20.14 0.78 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.26 -0.882 . . . . 25.0 111.752 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.85 -25.52 56.29 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.986 -0.552 . . . . 25.0 111.833 -177.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -112.0 -161.32 0.75 Allowed 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 108.839 -0.8 . . . . 25.0 108.839 -174.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 67.49 -174.2 0.19 Allowed 'General case' 0 C--O 1.25 1.13 0 N-CA-C 115.796 1.776 . . . . 25.0 115.796 175.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 81.46 17.44 71.15 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 114.195 0.438 . . . . 25.0 114.195 175.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -98.94 109.86 22.55 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 122.466 -0.432 . . . . 25.0 110.888 -174.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -127.35 157.71 39.22 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 107.425 -1.324 . . . . 25.0 107.425 178.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -140.78 30.45 2.28 Favored Glycine 0 C--O 1.209 -1.451 0 N-CA-C 110.761 -0.935 . . . . 25.0 110.761 178.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.11 -28.38 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 CA-C-O 122.157 0.98 . . . . 25.0 110.939 -175.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.12 136.38 26.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 CA-C-O 122.167 0.984 . . . . 25.0 109.823 -177.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 161.89 157.52 8.95 Favored Glycine 0 N--CA 1.466 0.654 0 CA-C-N 114.605 -1.18 . . . . 25.0 111.951 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -149.67 141.97 24.18 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 108.584 -0.895 . . . . 25.0 108.584 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 88.6 p -159.46 171.54 19.53 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.865 0.866 . . . . 25.0 110.097 177.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 171.17 174.9 39.28 Favored Glycine 0 C--O 1.25 1.102 0 CA-C-N 118.814 0.734 . . . . 25.0 111.773 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -136.75 101.9 9.54 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 108.702 -0.851 . . . . 25.0 108.702 177.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.35 152.64 49.89 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 N-CA-C 115.471 1.296 . . . . 25.0 115.471 -174.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -121.84 151.38 40.71 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 107.805 -1.183 . . . . 25.0 107.805 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -141.51 76.84 20.27 Favored Pre-proline 0 C--O 1.24 0.599 0 CA-C-N 118.366 0.53 . . . . 25.0 110.49 176.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.11 155.48 61.29 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 118.35 -0.634 . . . . 25.0 113.404 -176.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.9 t -122.68 -3.46 8.76 Favored 'General case' 0 C--O 1.245 0.827 0 O-C-N 121.49 -0.756 . . . . 25.0 111.977 -177.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--O 1.271 2.214 0 N-CA-C 107.943 -1.132 . . . . 25.0 107.943 176.918 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.92 -0.4 . . . . 25.0 109.92 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -137.38 111.16 9.07 Favored Pre-proline 0 C--N 1.318 -0.798 0 O-C-N 121.739 -0.601 . . . . 25.0 109.624 175.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -67.84 149.65 78.22 Favored 'Trans proline' 0 C--O 1.245 0.842 0 C-N-CA 116.601 -1.799 . . . . 25.0 112.3 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.83 57.43 0.03 OUTLIER Glycine 0 C--O 1.244 0.727 0 N-CA-C 109.836 -1.306 . . . . 25.0 109.836 -177.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.475 HG22 ' H ' ' A' ' 7' ' ' GLY . 7.7 p -63.87 131.82 29.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 122.08 0.943 . . . . 25.0 111.568 -172.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -96.61 -6.42 36.79 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 115.3 -0.864 . . . . 25.0 110.978 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.475 ' H ' HG22 ' A' ' 5' ' ' VAL . . . -83.58 -152.57 13.47 Favored Glycine 0 C--O 1.244 0.762 0 CA-C-N 115.758 -0.655 . . . . 25.0 112.704 177.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 p 73.38 159.69 0.16 Allowed Pre-proline 0 CA--C 1.563 1.459 0 C-N-CA 126.343 1.857 . . . . 25.0 109.474 -177.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.455 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 30.3 Cg_exo -68.52 6.89 0.8 Allowed 'Trans proline' 0 CA--C 1.553 1.427 0 N-CA-C 116.069 1.526 . . . . 25.0 116.069 -174.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.8 p -69.01 -16.74 21.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 115.926 1.824 . . . . 25.0 115.926 -169.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.85 139.04 22.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 O-C-N 121.218 -0.927 . . . . 25.0 113.199 -174.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.87 9.09 70.02 Favored Glycine 0 N--CA 1.469 0.852 0 N-CA-C 117.586 1.794 . . . . 25.0 117.586 171.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.5 t -50.72 -43.02 57.85 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 114.272 1.212 . . . . 25.0 114.272 -169.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -77.47 7.4 5.49 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 114.167 1.173 . . . . 25.0 114.167 -176.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.33 175.28 10.21 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 120.27 -1.519 . . . . 25.0 111.221 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -56.65 125.33 21.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 123.702 0.626 . . . . 25.0 111.308 -175.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -121.94 162.83 20.36 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.981 0.734 . . . . 50.0 112.981 -173.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -130.73 114.96 16.02 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 102.518 -3.142 . . . . 25.0 102.518 163.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.0 mt -128.05 128.87 45.74 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 122.077 0.942 . . . . 25.0 109.66 -177.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 66.9 m80 -117.45 121.3 40.65 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.218 -0.901 . . . . 25.0 110.35 177.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.15 175.26 46.24 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 122.644 1.136 . . . . 25.0 115.094 -174.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.2 p -82.24 172.42 13.16 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.109 -1.046 . . . . 25.0 109.81 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.6 mt -86.79 12.09 11.7 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.176 0.512 . . . . 25.0 111.938 177.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -111.69 -172.91 19.37 Favored Glycine 0 N--CA 1.471 0.975 0 CA-C-N 114.826 -1.079 . . . . 25.0 111.581 177.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.2 t -77.16 134.02 38.79 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.013 0.745 . . . . 25.0 113.013 -178.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -148.02 163.99 35.18 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.457 -0.777 . . . . 50.0 110.853 -173.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -112.32 125.3 54.03 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 101.078 -3.675 . . . . 25.0 101.078 169.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 40.6 mm -119.13 99.95 8.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 104.92 -2.252 . . . . 25.0 104.92 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.455 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 9.4 mp -107.9 120.23 41.7 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 103.646 -2.724 . . . . 25.0 103.646 -176.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.22 -27.54 36.46 Favored Glycine 0 CA--C 1.488 -1.628 0 N-CA-C 115.264 0.866 . . . . 25.0 115.264 -171.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.74 -149.86 50.2 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 109.982 -1.247 . . . . 25.0 109.982 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.4 172.41 47.91 Favored Glycine 0 C--O 1.247 0.952 0 CA-C-N 114.901 -0.65 . . . . 25.0 114.473 -175.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.42 172.57 24.53 Favored Glycine 0 N--CA 1.439 -1.101 0 CA-C-O 119.132 -0.815 . . . . 25.0 114.281 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.8 112.78 24.72 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 104.722 -2.325 . . . . 25.0 104.722 177.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -108.96 156.35 19.81 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.052 -0.522 . . . . 50.0 110.578 -169.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -119.55 90.89 3.42 Favored 'General case' 0 C--O 1.248 1.019 0 N-CA-C 107.099 -1.445 . . . . 25.0 107.099 175.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 31.9 mt -100.81 128.63 46.77 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 113.862 -1.517 . . . . 25.0 110.869 -171.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -125.43 105.2 8.89 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.137 0.494 . . . . 25.0 112.008 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.73 -26.09 47.36 Favored Glycine 0 C--O 1.246 0.853 0 CA-C-O 116.797 -2.113 . . . . 25.0 115.929 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 52.77 -150.38 0.35 Allowed 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 119.551 1.676 . . . . 25.0 111.952 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.38 165.76 9.24 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.588 0.958 . . . . 25.0 113.588 -178.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.11 157.55 33.58 Favored Glycine 0 N--CA 1.438 -1.193 0 N-CA-C 110.097 -1.201 . . . . 25.0 110.097 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -80.87 115.29 20.28 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.52 -1.659 . . . . 25.0 106.52 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -123.56 147.55 47.18 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 119.887 -0.725 . . . . 50.0 111.166 -169.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 mp -108.65 104.57 13.9 Favored 'General case' 0 C--O 1.204 -1.308 0 N-CA-C 108.121 -1.066 . . . . 25.0 108.121 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 mp -109.21 109.83 20.88 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.784 0.802 . . . . 25.0 112.848 -174.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -118.78 96.44 5.26 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-N 113.977 -1.465 . . . . 25.0 108.101 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -59.74 -22.26 56.74 Favored Glycine 0 C--O 1.216 -0.989 0 N-CA-C 118.474 2.15 . . . . 25.0 118.474 -177.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.84 -159.07 53.79 Favored Glycine 0 C--O 1.245 0.839 0 CA-C-N 118.427 1.113 . . . . 25.0 112.444 -178.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.14 159.36 14.82 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-O 122.046 0.927 . . . . 25.0 112.524 -176.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.67 -178.32 53.3 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 114.826 -1.079 . . . . 25.0 114.229 -177.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -96.91 145.39 25.93 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 101.779 -3.415 . . . . 25.0 101.779 172.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -135.36 155.14 51.08 Favored 'General case' 0 CA--C 1.5 -0.943 0 C-N-CA 120.745 -0.382 . . . . 50.0 111.682 -170.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -109.17 122.36 47.14 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 104.994 -2.224 . . . . 25.0 104.994 174.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -142.05 136.19 29.94 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 122.466 1.126 . . . . 25.0 113.244 -176.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.7 m -113.63 133.89 55.04 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 115.169 -0.923 . . . . 25.0 110.181 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.04 -44.0 4.25 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.2 -1.16 . . . . 25.0 110.2 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.86 -161.24 52.19 Favored Glycine 0 C--O 1.252 1.234 0 C-N-CA 123.13 0.395 . . . . 25.0 113.019 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -67.25 161.82 24.03 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 122.176 -0.602 . . . . 25.0 112.296 174.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.44 167.24 41.7 Favored Glycine 0 CA--C 1.533 1.215 0 N-CA-C 111.129 -0.788 . . . . 25.0 111.129 -177.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.9 107.09 18.53 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.755 0.788 . . . . 25.0 109.711 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -102.38 153.2 20.24 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.853 -0.612 . . . . 50.0 110.479 -172.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.9 m -128.54 123.41 33.4 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-N 115.172 -0.922 . . . . 25.0 110.302 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -115.34 117.9 31.74 Favored 'General case' 0 C--O 1.21 -1.003 0 N-CA-C 108.432 -0.951 . . . . 25.0 108.432 -177.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 51.2 mtt85 -114.94 -33.41 5.44 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 113.007 0.743 . . . . 25.0 113.007 177.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 71.78 151.46 0.11 Allowed 'General case' 0 CA--C 1.551 1.017 0 O-C-N 125.195 1.559 . . . . 25.0 109.723 -173.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.74 -51.03 45.78 Favored 'General case' 0 C--O 1.24 0.576 0 O-C-N 121.015 -1.053 . . . . 25.0 113.562 -167.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.7 mt -131.8 166.6 21.21 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 121.918 0.866 . . . . 25.0 109.224 -174.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.89 -21.06 56.72 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.695 0.798 . . . . 25.0 109.341 175.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -73.8 3.27 6.8 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 115.049 1.5 . . . . 25.0 115.049 176.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -114.53 149.88 35.77 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.998 0.904 . . . . 25.0 112.202 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.2 t 55.03 46.1 24.94 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 122.903 1.335 . . . . 25.0 113.697 169.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 47.6 p-80 -134.97 -178.98 5.34 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.198 -0.91 . . . . 25.0 109.225 -175.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -122.63 145.41 48.38 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 103.823 -2.658 . . . . 25.0 103.823 175.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.8 p -133.98 167.56 22.28 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 107.129 -1.434 . . . . 25.0 107.129 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.32 -22.79 67.06 Favored 'Trans proline' 0 C--N 1.367 1.538 0 C-N-CA 116.393 -1.938 . . . . 25.0 113.693 177.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.9 -27.05 67.91 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 122.051 0.929 . . . . 25.0 111.173 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 139.5 179.05 17.2 Favored Glycine 0 C--O 1.246 0.852 0 N-CA-C 109.687 -1.365 . . . . 25.0 109.687 -171.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.6 t -81.87 150.07 27.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 123.461 1.6 . . . . 25.0 113.258 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -131.42 29.93 4.51 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 113.521 -1.672 . . . . 25.0 107.503 170.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.93 140.3 32.68 Favored Glycine 0 CA--C 1.501 -0.808 0 N-CA-C 109.144 -1.582 . . . . 25.0 109.144 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -82.03 167.91 18.36 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 118.72 -0.657 . . . . 50.0 109.517 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -124.41 114.08 19.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 118.438 0.563 . . . . 25.0 109.897 -176.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mt -100.16 127.13 53.43 Favored 'Isoleucine or valine' 0 C--O 1.25 1.122 0 N-CA-C 108.207 -1.035 . . . . 25.0 108.207 -178.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.3 mt -81.05 -44.24 18.32 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 115.292 1.59 . . . . 25.0 115.292 -173.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 57.0 p30 -133.54 44.78 2.75 Favored 'General case' 0 C--O 1.252 1.188 0 N-CA-C 113.585 0.957 . . . . 25.0 113.585 -172.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -59.24 145.23 43.64 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.351 0.66 . . . . 25.0 111.962 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -121.6 103.17 41.21 Favored Pre-proline 0 N--CA 1.473 0.695 0 CA-C-N 115.763 -0.653 . . . . 25.0 109.784 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -65.08 -12.4 34.49 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 N-CA-C 117.985 2.264 . . . . 25.0 117.985 -174.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.3 t -91.69 -32.32 15.48 Favored 'General case' 0 C--O 1.209 -1.069 0 N-CA-C 109.521 -0.548 . . . . 25.0 109.521 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -89.73 -48.23 7.4 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 113.954 1.094 . . . . 25.0 113.954 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -93.08 172.26 8.42 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.281 -1.327 . . . . 50.0 113.373 -161.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -146.64 149.95 34.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 119.343 -0.361 . . . . 25.0 110.843 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 86.2 mt -129.34 126.64 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 123.265 0.626 . . . . 25.0 109.732 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -86.44 139.63 30.73 Favored 'General case' 0 CA--C 1.502 -0.903 0 O-C-N 121.579 -0.701 . . . . 25.0 109.624 178.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.0 p -141.5 -8.3 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.173 0 CA-C-O 120.844 0.354 . . . . 25.0 110.85 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.6 t -67.42 -40.14 85.53 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 122.54 1.162 . . . . 25.0 109.495 -175.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.28 -23.61 63.85 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.407 -0.815 . . . . 25.0 111.942 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.5 mt -96.62 -65.95 0.93 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.745 1.017 . . . . 25.0 113.745 -172.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -116.24 -49.12 0.46 Allowed Glycine 0 CA--C 1.502 -0.773 0 N-CA-C 118.532 2.173 . . . . 25.0 118.532 -167.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -155.27 165.85 35.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 118.396 1.098 . . . . 25.0 111.93 -173.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.69 -24.76 3.22 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.194 0.521 . . . . 25.0 111.201 178.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -95.02 126.75 8.86 Favored Glycine 0 C--O 1.245 0.792 0 N-CA-C 110.594 -1.002 . . . . 25.0 110.594 173.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.11 140.74 57.81 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.981 0.896 . . . . 25.0 111.096 -176.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.29 -158.38 34.61 Favored Glycine 0 C--N 1.335 0.479 0 N-CA-C 110.833 -0.907 . . . . 25.0 110.833 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -67.75 140.46 56.71 Favored 'General case' 0 C--O 1.254 1.307 0 CA-C-O 122.175 0.988 . . . . 25.0 113.057 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 165.58 -172.95 41.23 Favored Glycine 0 C--O 1.253 1.292 0 N-CA-C 108.955 -1.658 . . . . 25.0 108.955 175.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -149.17 168.84 22.15 Favored 'General case' 0 C--O 1.245 0.857 0 C-N-CA 122.496 0.318 . . . . 25.0 110.294 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 56.58 36.49 27.69 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.26 1.207 . . . . 25.0 114.26 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 69.92 28.34 71.97 Favored Glycine 0 CA--C 1.538 1.513 0 N-CA-C 111.393 -0.683 . . . . 25.0 111.393 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 8.6 t -138.14 -178.32 5.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 117.383 0.591 . . . . 25.0 110.343 -175.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 87.2 mt -113.85 167.51 10.57 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 103.432 -2.803 . . . . 25.0 103.432 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.66 119.7 17.26 Favored 'General case' 0 C--O 1.257 1.465 0 C-N-CA 118.091 -1.444 . . . . 25.0 112.474 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.7 m -98.31 161.74 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 124.107 0.963 . . . . 25.0 109.151 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 54.0 p -148.73 171.11 16.75 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 118.901 -0.571 . . . . 25.0 111.621 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.5 m -120.95 162.6 19.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.473 0 N-CA-C 108.289 -1.004 . . . . 25.0 108.289 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.6 t -74.45 -53.72 9.0 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 106.121 -1.807 . . . . 25.0 106.121 170.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -159.83 -160.9 0.85 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 104.26 -2.496 . . . . 25.0 104.26 -177.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -65.56 -16.3 63.56 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 122.121 0.962 . . . . 25.0 111.877 176.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -133.52 -156.6 8.07 Favored Glycine 0 N--CA 1.469 0.851 0 N-CA-C 107.428 -2.269 . . . . 25.0 107.428 175.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.67 -142.25 0.32 Allowed 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.056 0.542 . . . . 25.0 109.7 178.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -96.21 170.21 9.42 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.296 1.221 . . . . 25.0 114.296 -168.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.36 160.72 28.68 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 105.952 -1.87 . . . . 25.0 105.952 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -134.89 153.78 51.92 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 117.536 0.153 . . . . 25.0 110.663 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 31.9 tp -127.65 120.85 28.97 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 104.848 -2.279 . . . . 25.0 104.848 172.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -121.95 153.43 38.51 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 118.405 0.548 . . . . 25.0 111.914 -172.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.6 t -102.55 147.25 27.0 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 103.654 -2.721 . . . . 25.0 103.654 171.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -115.5 19.04 15.67 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.931 -0.766 . . . . 25.0 108.931 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -110.89 143.37 41.61 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 105.521 -2.029 . . . . 25.0 105.521 171.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -141.12 157.69 44.94 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.879 0.737 . . . . 25.0 111.097 -176.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -80.16 164.6 23.18 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.332 -0.988 . . . . 25.0 108.332 175.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.72 -30.18 71.19 Favored 'General case' 0 C--O 1.221 -0.44 0 O-C-N 121.515 -0.74 . . . . 25.0 110.78 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -70.58 -5.06 26.4 Favored 'General case' 0 CA--C 1.554 1.096 0 C-N-CA 123.401 0.68 . . . . 25.0 112.342 177.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.59 7.53 84.31 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 115.66 -0.7 . . . . 25.0 111.915 -178.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 88.8 mt -73.16 136.83 44.82 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 106.595 -1.632 . . . . 25.0 106.595 174.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 94.4 p -148.92 -177.43 5.8 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 107.654 -1.239 . . . . 25.0 107.654 -175.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -128.38 132.54 48.53 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 119.426 1.012 . . . . 25.0 113.381 -175.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -152.51 156.71 39.93 Favored 'General case' 0 C--O 1.256 1.421 0 N-CA-C 107.205 -1.405 . . . . 25.0 107.205 168.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.9 p -146.66 147.38 17.94 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.804 0 N-CA-C 105.919 -1.882 . . . . 25.0 105.919 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -112.31 143.01 44.12 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.747 -0.66 . . . . 25.0 109.967 -170.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.8 mp -132.17 154.28 49.7 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.932 -1.136 . . . . 25.0 107.932 -177.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.51 0.97 10.06 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 116.992 2.219 . . . . 25.0 116.992 -177.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.3 -3.65 88.58 Favored Glycine 0 C--O 1.224 -0.493 0 C-N-CA 120.04 -1.076 . . . . 25.0 112.997 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 50.5 t0 48.74 61.41 3.1 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 122.323 1.058 . . . . 25.0 111.488 -177.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -123.3 41.48 3.46 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.282 -1.326 . . . . 25.0 107.624 175.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.53 -25.95 68.48 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 115.192 -0.913 . . . . 25.0 112.949 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.56 -23.82 64.54 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.424 0.63 . . . . 25.0 111.01 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -101.8 -0.04 34.92 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.769 -0.65 . . . . 25.0 112.031 -175.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 11.4 mt -78.0 134.39 37.83 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.111 -0.635 . . . . 25.0 109.328 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.2 m -135.54 162.27 33.14 Favored 'General case' 0 CA--C 1.492 -1.252 0 CA-C-N 114.605 -1.18 . . . . 25.0 109.036 173.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.44 -1.6 57.22 Favored 'General case' 0 C--O 1.204 -1.296 0 CA-C-O 122.624 1.202 . . . . 25.0 109.473 -177.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.36 -31.69 72.99 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.178 -1.374 . . . . 25.0 109.383 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -89.21 -7.05 56.34 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.877 1.323 . . . . 25.0 112.849 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 47.0 mm -95.93 108.13 20.68 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.012 0 N-CA-C 104.944 -2.243 . . . . 25.0 104.944 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 14.5 p -94.83 121.48 45.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 122.545 1.164 . . . . 25.0 111.695 -169.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -152.98 -3.57 0.22 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 112.968 -1.924 . . . . 25.0 112.298 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -74.55 51.36 0.46 Allowed 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.73 1.011 . . . . 25.0 113.73 -177.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 54.32 22.65 3.85 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.207 0.817 . . . . 25.0 113.207 -175.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.07 3.1 0.9 Allowed 'General case' 0 C--O 1.246 0.916 0 N-CA-C 115.247 1.573 . . . . 25.0 115.247 175.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -82.09 137.39 35.03 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.394 -0.522 . . . . 25.0 110.572 178.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -76.88 -12.37 59.95 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 109.198 -0.667 . . . . 25.0 109.198 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -82.72 42.64 0.79 Allowed 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 112.292 0.479 . . . . 25.0 112.292 176.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -154.25 175.16 13.84 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.065 0.946 . . . . 25.0 109.012 -178.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 62.3 -156.98 0.34 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.831 1.252 . . . . 25.0 111.638 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 58.33 28.72 62.21 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 121.926 -0.178 . . . . 25.0 113.269 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -106.63 98.64 8.28 Favored 'General case' 0 C--O 1.249 1.056 0 C-N-CA 123.083 0.553 . . . . 25.0 109.582 -176.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.87 145.11 47.97 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 121.636 0.731 . . . . 25.0 112.712 -178.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -121.94 29.7 5.5 Favored Glycine 0 C--O 1.222 -0.595 0 CA-C-N 115.154 -0.93 . . . . 25.0 112.342 174.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 58.1 t -70.64 -38.93 75.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 O-C-N 121.757 -0.849 . . . . 25.0 112.425 -174.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.9 133.05 30.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.832 0.825 . . . . 25.0 110.581 -175.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 170.07 153.43 8.64 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-N 114.607 -1.178 . . . . 25.0 110.892 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -150.88 143.66 24.51 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 117.854 0.827 . . . . 25.0 109.878 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.6 p -150.77 169.23 22.15 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 106.193 -1.78 . . . . 25.0 106.193 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -175.39 163.99 34.17 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 115.625 1.01 . . . . 25.0 115.625 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -137.38 83.56 25.87 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 107.815 -1.18 . . . . 25.0 107.815 175.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.17 161.23 46.76 Favored 'Trans proline' 0 C--N 1.349 0.589 0 O-C-N 121.99 0.469 . . . . 25.0 112.67 -176.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -130.67 159.79 36.2 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.937 -0.764 . . . . 25.0 108.937 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -135.73 84.48 32.77 Favored Pre-proline 0 C--O 1.246 0.87 0 C-N-CA 122.74 0.416 . . . . 25.0 112.034 -177.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.23 161.14 43.71 Favored 'Trans proline' 0 C--O 1.246 0.897 0 C-N-CA 116.995 -1.537 . . . . 25.0 113.323 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.5 t -127.78 17.27 6.85 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 122.061 0.934 . . . . 25.0 110.44 176.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 C--O 1.258 1.537 0 CA-C-O 117.349 -1.31 . . . . 25.0 109.566 178.639 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.954 0 CA-C-O 119.818 -0.134 . . . . 25.0 110.697 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -135.86 115.74 11.34 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 109.174 -0.676 . . . . 25.0 109.174 -178.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.1 147.38 48.43 Favored 'Trans proline' 0 C--O 1.24 0.587 0 C-N-CA 115.772 -2.352 . . . . 25.0 111.929 -177.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.33 56.84 0.26 Allowed Glycine 0 C--O 1.244 0.76 0 CA-C-O 119.043 -0.865 . . . . 25.0 112.803 -176.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.408 HG22 ' H ' ' A' ' 7' ' ' GLY . 5.9 p -70.4 125.29 28.33 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.965 0 CA-C-O 122.08 0.943 . . . . 25.0 111.525 -176.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -100.27 4.22 44.03 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.156 -0.929 . . . . 25.0 110.732 -176.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.408 ' H ' HG22 ' A' ' 5' ' ' VAL . . . -97.96 -145.2 18.47 Favored Glycine 0 C--O 1.24 0.513 0 N-CA-C 111.211 -0.756 . . . . 25.0 111.211 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.4 p 73.86 156.67 0.16 Allowed Pre-proline 0 N--CA 1.483 1.177 0 C-N-CA 126.508 1.923 . . . . 25.0 109.024 -176.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.549 ' HG3' ' H ' ' A' ' 29' ' ' LEU . 32.8 Cg_exo -63.63 1.0 1.56 Allowed 'Trans proline' 0 N--CA 1.478 0.603 0 N-CA-C 116.25 1.596 . . . . 25.0 116.25 -176.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.5 p -63.8 -25.09 37.38 Favored 'Isoleucine or valine' 0 C--O 1.258 1.538 0 N-CA-C 114.786 1.402 . . . . 25.0 114.786 -171.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.8 p -130.7 135.84 59.47 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 CA-C-O 122.857 1.313 . . . . 25.0 114.477 -172.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.47 14.54 79.42 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 114.582 -1.19 . . . . 25.0 115.405 171.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.5 t -45.82 -48.67 15.67 Favored 'General case' 0 C--O 1.209 -1.043 0 N-CA-C 114.349 1.241 . . . . 25.0 114.349 -171.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -78.14 0.39 25.05 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 115.694 1.739 . . . . 25.0 115.694 -175.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.77 169.73 17.18 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.118 -0.989 . . . . 25.0 111.637 -175.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -60.07 125.87 25.32 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 124.431 1.082 . . . . 25.0 110.991 -171.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -120.46 165.7 14.59 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.725 1.38 . . . . 50.0 114.725 -176.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -128.47 101.13 6.05 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 101.967 -3.346 . . . . 25.0 101.967 163.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.3 mt -109.62 120.31 42.11 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 119.239 -0.41 . . . . 25.0 111.899 -177.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -112.9 113.45 25.52 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 123.537 0.523 . . . . 25.0 110.71 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.63 -177.72 49.42 Favored Glycine 0 N--CA 1.469 0.871 0 N-CA-C 116.534 1.374 . . . . 25.0 116.534 -172.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.9 p -76.66 172.82 12.42 Favored 'General case' 0 C--O 1.252 1.236 0 C-N-CA 123.326 0.65 . . . . 25.0 110.541 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 44.6 mt -86.15 9.89 16.11 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.314 0.578 . . . . 25.0 109.918 174.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.37 -179.4 26.01 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.926 -0.579 . . . . 25.0 111.679 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.6 t -72.09 130.4 40.82 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 122.672 0.389 . . . . 25.0 110.879 175.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -142.37 157.32 44.92 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.491 -0.559 . . . . 50.0 109.491 -177.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -94.85 123.52 38.36 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 102.942 -2.985 . . . . 25.0 102.942 160.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.1 mm -114.0 100.96 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 108.374 -0.973 . . . . 25.0 108.374 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.549 ' H ' ' HG3' ' A' ' 9' ' ' PRO . 10.4 mp -104.93 127.47 52.78 Favored 'General case' 0 C--O 1.212 -0.88 0 N-CA-C 103.766 -2.679 . . . . 25.0 103.766 -177.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.43 -32.1 14.55 Favored Glycine 0 CA--C 1.493 -1.309 0 C-N-CA 120.167 -1.016 . . . . 25.0 113.262 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.23 -143.34 39.12 Favored Glycine 0 C--O 1.242 0.608 0 N-CA-C 110.648 -0.981 . . . . 25.0 110.648 178.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.7 164.96 53.98 Favored Glycine 0 C--O 1.248 0.988 0 N-CA-C 114.443 0.537 . . . . 25.0 114.443 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.44 164.94 33.8 Favored Glycine 0 C--O 1.248 1.025 0 N-CA-C 114.743 0.657 . . . . 25.0 114.743 175.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.19 99.5 7.83 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.34 -1.356 . . . . 25.0 107.34 173.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -94.1 152.14 18.98 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 113.665 0.987 . . . . 50.0 113.665 -175.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -117.35 96.69 5.53 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.616 -1.253 . . . . 25.0 107.616 174.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 32.7 mt -104.53 137.56 42.2 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.573 -0.739 . . . . 25.0 110.329 -168.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -128.43 97.7 4.81 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.722 -0.611 . . . . 25.0 109.509 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.57 -33.47 60.85 Favored Glycine 0 C--N 1.318 -0.425 0 N-CA-C 116.352 1.301 . . . . 25.0 116.352 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 53.3 -149.6 0.4 Allowed 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.602 1.161 . . . . 25.0 113.948 -178.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.96 161.48 30.87 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-O 121.451 0.643 . . . . 25.0 110.368 -173.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.6 158.74 31.64 Favored Glycine 0 C--O 1.246 0.879 0 N-CA-C 109.549 -1.42 . . . . 25.0 109.549 -176.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -84.67 101.49 12.22 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.222 -1.029 . . . . 25.0 108.222 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -103.38 148.0 26.41 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 113.731 1.011 . . . . 50.0 113.731 -172.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mp -108.27 107.93 18.73 Favored 'General case' 0 C--O 1.217 -0.631 0 N-CA-C 107.052 -1.462 . . . . 25.0 107.052 177.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 mp -109.21 113.43 26.26 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 122.62 1.2 . . . . 25.0 112.976 -171.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -118.15 96.55 5.38 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 105.221 -2.14 . . . . 25.0 105.221 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.56 -28.57 71.56 Favored Glycine 0 C--O 1.253 1.282 0 O-C-N 121.734 -0.604 . . . . 25.0 114.373 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.1 -157.18 52.82 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 120.748 -0.739 . . . . 25.0 112.617 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.22 154.54 12.99 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 122.407 1.099 . . . . 25.0 113.504 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.97 178.59 52.52 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 114.32 -1.309 . . . . 25.0 109.964 -177.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -96.88 143.51 27.7 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 101.345 -3.576 . . . . 25.0 101.345 176.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -130.65 153.08 49.32 Favored 'General case' 0 CA--C 1.5 -0.948 0 C-N-CA 120.065 -0.654 . . . . 50.0 110.258 -171.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -110.71 126.75 54.88 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 101.445 -3.539 . . . . 25.0 101.445 174.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -149.6 129.86 13.71 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-O 123.136 1.446 . . . . 25.0 113.956 -175.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.3 m -96.55 140.33 31.34 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.335 -1.302 . . . . 25.0 109.489 177.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.1 -40.19 4.35 Favored Glycine 0 C--O 1.242 0.632 0 N-CA-C 111.608 -0.597 . . . . 25.0 111.608 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.91 -167.39 54.05 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-O 123.298 1.499 . . . . 25.0 113.771 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -63.95 162.96 12.91 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 113.646 -1.277 . . . . 25.0 108.789 175.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.05 163.0 38.56 Favored Glycine 0 C--N 1.344 1.005 0 N-CA-C 111.644 -0.583 . . . . 25.0 111.644 -177.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.89 109.46 20.24 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 122.038 0.923 . . . . 25.0 109.214 178.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -105.49 150.8 25.0 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.462 -0.79 . . . . 50.0 111.17 -169.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.4 m -121.27 128.23 52.15 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 124.195 0.935 . . . . 25.0 111.119 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -115.38 103.23 10.59 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.39 -0.823 . . . . 25.0 110.953 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 60.9 mtt85 -109.68 -28.98 8.56 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 118.516 0.598 . . . . 25.0 110.859 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 68.22 161.65 0.19 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.391 -0.966 . . . . 25.0 108.391 -175.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.91 -37.88 23.61 Favored 'General case' 0 C--O 1.246 0.875 0 O-C-N 120.939 -1.1 . . . . 25.0 113.964 -165.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.4 mt -137.5 166.34 24.11 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.925 0.869 . . . . 25.0 111.252 -176.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.13 -28.2 57.02 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.977 1.311 . . . . 25.0 108.474 169.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -75.17 -2.98 30.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.43 -0.805 . . . . 25.0 112.123 -177.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -105.96 154.16 20.98 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 115.721 1.749 . . . . 25.0 115.721 -177.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.7 t 50.58 48.39 22.67 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.542 1.682 . . . . 25.0 115.542 174.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 35.1 p-80 -133.44 175.58 9.29 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 114.356 -1.293 . . . . 25.0 108.966 -178.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -122.97 140.37 53.09 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 105.357 -2.09 . . . . 25.0 105.357 174.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 55.3 p -128.52 171.29 8.83 Favored Pre-proline 0 N--CA 1.471 0.624 0 O-C-N 125.165 1.54 . . . . 25.0 109.564 -178.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -58.16 -22.47 56.68 Favored 'Trans proline' 0 C--N 1.364 1.347 0 CA-C-N 119.616 0.899 . . . . 25.0 113.565 174.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.1 mt -82.9 -10.78 58.65 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.605 0.594 . . . . 25.0 112.605 -176.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 143.54 -171.3 25.3 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-O 117.681 -1.621 . . . . 25.0 113.376 -177.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.2 t -102.84 147.24 27.13 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.393 1.596 . . . . 25.0 113.153 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -126.08 20.57 7.56 Favored 'General case' 0 C--O 1.263 1.771 0 CA-C-N 113.719 -1.582 . . . . 25.0 109.48 174.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.86 143.48 41.83 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 111.249 -0.74 . . . . 25.0 111.249 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -92.62 167.98 11.55 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.945 -0.738 . . . . 50.0 111.006 -172.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.57 103.44 8.43 Favored 'General case' 0 C--O 1.259 1.56 0 O-C-N 121.915 -0.491 . . . . 25.0 111.882 -171.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 mt -92.07 130.43 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-O 122.085 0.945 . . . . 25.0 108.535 -174.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.3 mt -82.58 -41.67 19.26 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 116.248 1.944 . . . . 25.0 116.248 -173.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 44.5 p-10 -139.51 53.44 1.71 Allowed 'General case' 0 C--O 1.252 1.193 0 CA-C-O 122.137 0.97 . . . . 25.0 113.594 -176.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -64.66 131.57 47.29 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 114.887 -1.051 . . . . 25.0 110.218 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -111.66 104.66 56.3 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 106.919 -1.512 . . . . 25.0 106.919 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -69.23 -12.26 33.47 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 N-CA-C 116.287 1.61 . . . . 25.0 116.287 -175.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.2 p -85.02 -16.7 39.89 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.627 -0.879 . . . . 25.0 108.627 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -108.78 -48.04 3.37 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 115.028 1.492 . . . . 25.0 115.028 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -92.08 169.13 10.88 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.218 -0.901 . . . . 50.0 112.348 -160.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -146.11 146.08 30.76 Favored 'General case' 0 C--O 1.249 1.052 0 C-N-CA 123.275 0.63 . . . . 25.0 111.812 -176.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 67.2 mt -127.73 134.87 64.52 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.051 0 N-CA-C 107.524 -1.288 . . . . 25.0 107.524 -177.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.77 139.49 30.52 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 107.446 -1.316 . . . . 25.0 107.446 174.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.3 p -137.76 -12.38 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 115.714 1.746 . . . . 25.0 115.714 -178.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.7 t -72.17 -27.57 62.67 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.709 1.14 . . . . 25.0 109.816 -177.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.31 -24.82 61.38 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.626 -1.17 . . . . 25.0 112.141 174.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 16.5 mt -107.19 -45.08 4.2 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.781 1.4 . . . . 25.0 114.781 -172.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -123.03 -66.58 0.22 Allowed Glycine 0 N--CA 1.472 1.035 0 N-CA-C 117.974 1.95 . . . . 25.0 117.974 -171.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -150.63 166.85 29.06 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 109.675 -0.491 . . . . 25.0 109.675 -170.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.7 t -118.51 -31.12 5.0 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.708 -1.133 . . . . 25.0 110.841 176.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -100.98 122.32 7.56 Favored Glycine 0 N--CA 1.462 0.373 0 N-CA-C 106.967 -2.453 . . . . 25.0 106.967 175.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.25 145.4 55.81 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-O 121.383 0.611 . . . . 25.0 111.744 -177.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -81.0 -170.97 44.11 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 115.328 -0.851 . . . . 25.0 113.773 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -64.33 132.94 51.63 Favored 'General case' 0 C--O 1.253 1.278 0 CA-C-O 121.769 0.795 . . . . 25.0 111.532 -177.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -177.95 -172.36 42.32 Favored Glycine 0 CA--C 1.539 1.59 0 N-CA-C 109.045 -1.622 . . . . 25.0 109.045 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -143.43 167.14 22.89 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 118.847 1.323 . . . . 25.0 112.017 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 55.11 42.24 30.94 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.143 1.377 . . . . 25.0 112.901 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 69.36 32.98 72.24 Favored Glycine 0 C--O 1.245 0.83 0 N-CA-C 110.097 -1.201 . . . . 25.0 110.097 176.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.5 t -146.78 166.43 26.68 Favored 'General case' 0 C--O 1.214 -0.788 0 CA-C-N 118.349 1.074 . . . . 25.0 110.573 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.5 mt -88.37 166.57 14.17 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 104.421 -2.437 . . . . 25.0 104.421 176.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.49 119.27 15.4 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-N 119.245 0.929 . . . . 25.0 110.241 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 35.4 m -85.79 162.1 2.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.047 -0.979 . . . . 25.0 110.481 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.7 m -140.86 168.41 19.87 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 110.32 -0.252 . . . . 25.0 110.32 -177.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 30.4 m -128.54 161.75 36.69 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 N-CA-C 107.223 -1.399 . . . . 25.0 107.223 175.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.2 t -72.09 -47.37 51.88 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 106.518 -1.66 . . . . 25.0 106.518 173.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -167.03 -161.51 0.43 Allowed 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 102.13 -3.285 . . . . 25.0 102.13 -176.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -68.32 -17.73 64.34 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 120.259 1.391 . . . . 25.0 112.039 -177.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -129.33 -155.04 8.37 Favored Glycine 0 N--CA 1.44 -1.048 0 N-CA-C 108.497 -1.841 . . . . 25.0 108.497 176.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 56.06 -150.68 0.42 Allowed 'General case' 0 N--CA 1.473 0.708 0 O-C-N 122.82 -0.223 . . . . 25.0 111.137 -178.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 27.8 mtt85 -77.45 158.78 29.83 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 116.851 2.167 . . . . 25.0 116.851 -169.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.0 163.36 16.03 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 113.47 -1.695 . . . . 25.0 106.591 177.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -137.51 154.32 49.88 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 118.451 0.569 . . . . 25.0 111.519 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 33.8 tp -123.56 119.63 30.48 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 105.754 -1.943 . . . . 25.0 105.754 169.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -119.24 154.9 32.69 Favored 'General case' 0 C--O 1.246 0.91 0 CA-C-O 121.712 0.768 . . . . 25.0 112.811 -173.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.1 t -103.0 153.69 19.98 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 104.666 -2.346 . . . . 25.0 104.666 169.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -120.67 9.52 10.81 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 122.346 1.069 . . . . 25.0 109.054 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -93.92 136.58 34.05 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 105.423 -2.065 . . . . 25.0 105.423 171.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -139.11 147.56 42.12 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.895 0.855 . . . . 25.0 110.057 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -73.99 159.25 32.98 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.012 -1.107 . . . . 25.0 108.012 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -61.98 -23.8 66.62 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 120.867 0.365 . . . . 25.0 110.587 177.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -75.83 -2.45 30.05 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.702 0.801 . . . . 25.0 111.934 177.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.39 15.8 70.55 Favored Glycine 0 C--O 1.238 0.351 0 C-N-CA 121.365 -0.445 . . . . 25.0 112.895 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 75.4 mt -88.87 139.48 30.42 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.529 -1.286 . . . . 25.0 107.529 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 86.8 p -148.56 176.19 10.53 Favored 'General case' 0 C--O 1.249 1.05 0 N-CA-C 108.771 -0.826 . . . . 25.0 108.771 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -122.28 131.8 54.1 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 113.439 0.903 . . . . 25.0 113.439 -176.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -150.28 154.21 37.5 Favored 'General case' 0 C--O 1.266 1.924 0 N-CA-C 107.317 -1.364 . . . . 25.0 107.317 168.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.4 p -145.73 146.79 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 106.813 -1.551 . . . . 25.0 106.813 175.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -112.1 142.45 44.53 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.533 -0.914 . . . . 25.0 108.533 -171.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.2 mp -133.78 143.96 48.74 Favored 'General case' 0 C--O 1.197 -1.685 0 N-CA-C 103.617 -2.734 . . . . 25.0 103.617 -173.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -115.88 5.56 14.07 Favored 'General case' 0 C--O 1.206 -1.225 0 N-CA-C 117.885 2.55 . . . . 25.0 117.885 -175.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.94 0.59 86.78 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 116.244 1.258 . . . . 25.0 116.244 177.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 41.8 t0 55.45 53.07 10.28 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 122.832 1.301 . . . . 25.0 110.359 178.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -118.65 38.64 3.7 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 113.455 -1.702 . . . . 25.0 108.428 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.9 -39.49 78.04 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.773 -0.648 . . . . 25.0 112.084 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.78 -19.47 62.0 Favored 'General case' 0 CA--C 1.577 2.005 0 O-C-N 121.156 -0.965 . . . . 25.0 112.545 -177.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.22 -26.42 20.1 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 116.132 -0.486 . . . . 25.0 111.805 177.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 22.0 mt -60.25 132.39 53.76 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 121.203 0.525 . . . . 25.0 109.646 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.9 m -135.22 160.96 36.73 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 107.529 -1.286 . . . . 25.0 107.529 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.83 -1.29 57.1 Favored 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 108.232 -1.025 . . . . 25.0 108.232 178.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -69.2 -30.04 68.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.884 -0.598 . . . . 25.0 110.838 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -90.44 -5.93 55.5 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.268 0.556 . . . . 25.0 111.018 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 17.0 mm -89.91 123.99 42.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 105.785 -1.932 . . . . 25.0 105.785 176.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.7 p -98.45 117.1 42.88 Favored 'Isoleucine or valine' 0 C--O 1.251 1.145 0 CA-C-O 122.831 1.301 . . . . 25.0 113.318 -175.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -143.97 0.56 1.08 Allowed 'General case' 0 C--O 1.251 1.146 0 CA-C-N 112.358 -2.201 . . . . 25.0 108.547 178.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.15 45.0 0.98 Allowed 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.009 0.374 . . . . 25.0 112.009 -178.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . 53.49 37.57 26.02 Favored 'General case' 0 CA--C 1.561 1.4 0 CA-C-O 121.172 0.51 . . . . 25.0 112.363 -178.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.99 -4.32 0.2 Allowed 'General case' 0 CA--C 1.56 1.363 0 N-CA-C 115.636 1.717 . . . . 25.0 115.636 177.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -89.96 125.32 35.33 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 120.713 -1.242 . . . . 25.0 113.612 -177.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -77.22 -4.18 43.45 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 113.405 0.891 . . . . 25.0 113.405 -177.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -77.04 40.5 0.26 Allowed 'General case' 0 C--O 1.217 -0.649 0 N-CA-C 114.577 1.325 . . . . 25.0 114.577 178.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -152.93 -165.43 2.18 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.128 -0.694 . . . . 25.0 109.128 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . 60.97 -167.11 0.19 Allowed 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 113.6 0.963 . . . . 25.0 113.6 174.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 82.2 15.89 73.28 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.374 -0.69 . . . . 25.0 111.374 -177.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -99.66 108.61 21.02 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.95 0.722 . . . . 25.0 112.95 -176.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -128.57 155.68 44.53 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 106.71 -1.589 . . . . 25.0 106.71 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -125.95 31.19 4.17 Favored Glycine 0 C--O 1.217 -0.945 0 CA-C-O 121.746 0.636 . . . . 25.0 111.895 175.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 92.3 t -73.45 -38.11 52.21 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 O-C-N 122.286 -0.538 . . . . 25.0 110.33 -175.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.56 137.73 23.83 Favored 'Isoleucine or valine' 0 C--O 1.258 1.532 0 CA-C-O 121.459 0.647 . . . . 25.0 110.442 -175.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 153.9 165.95 14.29 Favored Glycine 0 C--O 1.245 0.836 0 CA-C-N 115.482 -0.781 . . . . 25.0 111.991 -178.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -143.85 139.53 29.32 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 112.957 0.725 . . . . 25.0 112.957 176.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 84.4 p -142.69 179.9 6.71 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.857 -1.164 . . . . 25.0 107.857 175.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 135.5 172.96 12.86 Favored Glycine 0 C--O 1.24 0.517 0 N-CA-C 115.034 0.774 . . . . 25.0 115.034 175.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -137.04 113.54 9.75 Favored Pre-proline 0 C--O 1.26 1.608 0 CA-C-N 114.929 -0.635 . . . . 25.0 110.382 178.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -68.06 153.95 73.77 Favored 'Trans proline' 0 C--N 1.356 0.964 0 O-C-N 122.509 0.741 . . . . 25.0 110.663 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -128.36 139.52 52.34 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.772 -1.196 . . . . 25.0 107.772 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -131.52 69.11 81.64 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 112.689 0.626 . . . . 25.0 112.689 -177.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -70.26 150.25 64.88 Favored 'Trans proline' 0 C--N 1.346 0.419 0 CA-C-O 122.107 0.795 . . . . 25.0 113.016 -178.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.4 t -97.71 1.33 48.42 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.357 -0.838 . . . . 25.0 111.734 -175.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 C--O 1.253 1.281 0 CA-C-O 118.089 -0.957 . . . . 25.0 110.86 -177.429 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_